PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Tuomisto, H; Ruokolainen, K				Tuomisto, Hanna; Ruokolainen, Kalle			Comment on "Disentangling the Drivers of beta Diversity Along Latitudinal and Elevational Gradients"	SCIENCE			English	Editorial Material							SPECIES RICHNESS; ALPHA; SIMILARITY		[Tuomisto, Hanna; Ruokolainen, Kalle] Univ Turku, Dept Biol, FI-20014 Turku, Finland	University of Turku	Tuomisto, H (corresponding author), Univ Turku, Dept Biol, FI-20014 Turku, Finland.	hanna.tuomisto@utu.fi	Tuomisto, Hanna/G-6483-2012; Ruokolainen, Kalle/G-3141-2013	Tuomisto, Hanna/0000-0003-1640-490X; Ruokolainen, Kalle/0000-0002-7494-9417				Beck J, 2007, J APPL ECOL, V44, P672, DOI 10.1111/j.1365-2664.2007.01291.x; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chao A, 2009, ECOLOGY, V90, P1125, DOI 10.1890/07-2147.1; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Condit R, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P79; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jost L, 2010, ECOLOGY, V91, P1969, DOI 10.1890/09-0368.1; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; NELSON BW, 1990, NATURE, V345, P714, DOI 10.1038/345714a0; Schulman L, 2007, J BIOGEOGR, V34, P1388, DOI 10.1111/j.1365-2699.2007.01716.x; Tuomisto H, 2010, ECOGRAPHY, V33, P23, DOI 10.1111/j.1600-0587.2009.06148.x; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; WOLDA H, 1981, OECOLOGIA, V50, P296, DOI 10.1007/BF00344966	13	26	26	3	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076								10.1126/science.1216393	http://dx.doi.org/10.1126/science.1216393			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461591				2022-12-28	WOS:000302062600022
J	Qian, H; Wang, XL; Zhang, YJ				Qian, Hong; Wang, Xianli; Zhang, Yangjian			Comment on "Disentangling the Drivers of beta Diversity Along Latitudinal and Elevational Gradients"	SCIENCE			English	Editorial Material									[Qian, Hong] Illinois State Museum, Res & Collect Ctr, Springfield, IL 62703 USA; [Qian, Hong] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Huitong Expt Stn Forest Ecol, Shenyang 110164, Peoples R China; [Wang, Xianli] Univ Alberta, Dept Renewable Resources, Edmonton, AB T6G 2H1, Canada; [Zhang, Yangjian] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modelling, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; University of Alberta; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Qian, H (corresponding author), Illinois State Museum, Res & Collect Ctr, 1011 E Ash St, Springfield, IL 62703 USA.	hqian@museum.state.il.us	Tuomisto, Hanna/G-6483-2012; Ruokolainen, Kalle/G-3141-2013	Tuomisto, Hanna/0000-0003-1640-490X; Ruokolainen, Kalle/0000-0002-7494-9417				Ahrens C.D., 2019, METEOROLOGY TODAY IN, V12th ed.; Barbour M.G., 1999, N AM TERRESTRIAL VEG; Blackburn TM, 2004, ECOGRAPHY, V27, P715, DOI 10.1111/j.0906-7590.2004.03999.x; Boyle B. L., 1996, THESIS WASHINGTON U; CRITCHFIELD WILLIAM B., 1966, US DEP AGR MIS PUBLICATION, V991, P1; Jump AS, 2009, TRENDS ECOL EVOL, V24, P694, DOI 10.1016/j.tree.2009.06.007; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; LITTLE EL, 1976, USDA MISCELLANEOUS P, V1314; Little EL, 1971, USDA MISCELLANEOUS P, V1; LITTLE EL, 1978, USDA MISCELLANEOUS P, V1361; Little Jr EL, 1977, USDA MISCELLANEOUS P, V1342; Phillips O, 2002, GLOBAL PATTERNS PLAN; Qian H, 2000, NATURE, V407, P180, DOI 10.1038/35025052; Qian H, 2005, ECOL LETT, V8, P15, DOI 10.1111/j.1461-0248.2004.00682.x; Stephenson NL, 2011, SCIENCE, V334, DOI 10.1126/science.1205740	15	26	26	3	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076								10.1126/science.1216450	http://dx.doi.org/10.1126/science.1216450			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461591				2022-12-28	WOS:000302062600021
J	Bazzocchi, A; Diano, D; Battista, G				Bazzocchi, Alberto; Diano, Danila; Battista, Giuseppe			How fat is fat?	LANCET			English	Editorial Material									[Bazzocchi, Alberto; Diano, Danila; Battista, Giuseppe] Univ Bologna, Imaging Div, Clin Dept Radiol & Histocytopathol Sci, StOrsola Malpighi Hosp, I-40138 Bologna, Italy; [Bazzocchi, Alberto] Rizzoli Orthopaed Inst, Bologna, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Istituto Ortopedico Rizzoli	Bazzocchi, A (corresponding author), Univ Bologna, Imaging Div, Clin Dept Radiol & Histocytopathol Sci, StOrsola Malpighi Hosp, Via Massarenti 9, I-40138 Bologna, Italy.	abazzo@inwind.it	Bazzocchi, Alberto/O-8048-2016; Battista, Giuseppe/AAC-3362-2021	Bazzocchi, Alberto/0000-0002-2659-4535; Battista, Giuseppe/0000-0003-3639-3494					0	8	8	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 14	2012	380	9837					E1	E1		10.1016/S0140-6736(11)61925-9	http://dx.doi.org/10.1016/S0140-6736(11)61925-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	973KN	22484135				2022-12-28	WOS:000306359100001
J	Arnold, FW				Arnold, Frank W.			Non-communicable diseases in prisons	LANCET			English	Editorial Material											Arnold, FW (corresponding author), 14 Coll Rd, Reading RG6 1QB, Berks, England.	arnold_frank@hotmail.com						Amnesty International, 2003, COMB TORT MAN ACT; [Anonymous], INQ QUAL HEALTHC YAR; Augustin YS, PREVENTING TORTURE R; COMFORT A, 1948, LANCET, V254, P460; Herbert K, 2012, LANCET, V379, P1975, DOI 10.1016/S0140-6736(12)60319-5; HM Prison Service, ELD PRIS COMP REL; HM Prison Service, DEATHS PRIS; Kariminia A, 2007, AUST NZ J PUBL HEAL, V31, P366, DOI 10.1111/j.1753-6405.2007.00089.x; MacFarlane IA, 1996, POSTGRAD MED J, V72, P214, DOI 10.1136/pgmj.72.846.214; Rosen DL, 2011, ANN EPIDEMIOL, V21, P719, DOI 10.1016/j.annepidem.2011.04.007; Sim Joe, 1990, MEDICAL POWER PRISON	11	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2012	379	9830					1931	1933		10.1016/S0140-6736(12)60471-1	http://dx.doi.org/10.1016/S0140-6736(12)60471-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	951YV	22521518				2022-12-28	WOS:000304757700010
J	Ethier, C; Oby, ER; Bauman, MJ; Miller, LE				Ethier, C.; Oby, E. R.; Bauman, M. J.; Miller, L. E.			Restoration of grasp following paralysis through brain-controlled stimulation of muscles	NATURE			English	Article							FUNCTIONAL ELECTRICAL-STIMULATION; IMPLANTED NEUROPROSTHESIS; MOTOR; PREDICTION; RECOVERY	Patients with spinal cord injury lack the connections between brain and spinal cord circuits that are essential for voluntary movement. Clinical systems that achieve muscle contraction through functional electrical stimulation (FES) have proven to be effective in allowing patients with tetraplegia to regain control of hand movements and to achieve a greater measure of independence in daily activities(1,2). In existing clinical systems, the patient uses residual proximal limb movements to trigger pre-programmed stimulation that causes the paralysed muscles to contract, allowing use of one or two basic grasps. Instead, we have developed an FES system in primates that is controlled by recordings made from microelectrodes permanently implanted in the brain. We simulated some of the effects of the paralysis caused by C5 or C6 spinal cord injury(3) by injecting rhesus monkeys with a local anaesthetic to block the median and ulnar nerves at the elbow. Then, using recordings from approximately 100 neurons in the motor cortex, we predicted the intended activity of several of the paralysed muscles, and used these predictions to control the intensity of stimulation of the same muscles. This process essentially bypassed the spinal cord, restoring to the monkeys voluntary control of their paralysed muscles. This achievement is a major advance towards similar restoration of hand function in human patients through brain-controlled FES. We anticipate that in human patients, this neuroprosthesis would allow much more flexible and dexterous use of the hand than is possible with existing FES systems.	[Ethier, C.; Oby, E. R.; Miller, L. E.] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Bauman, M. J.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Miller, L. E.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Miller, L. E.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University; Northwestern University; Feinberg School of Medicine	Miller, LE (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, 303 E Chicago Ave, Chicago, IL 60611 USA.	lm@northwestern.edu		Ethier, Christian/0000-0002-5048-6884	National Institute of Neurological Disorders and Stroke [NS053603]; Fonds de la Recherche en Sante du Quebec; Chicago Community Trust through Rehabilitation Institute of Chicago; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS071737, R01NS053603] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Chicago Community Trust through Rehabilitation Institute of Chicago; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grant NS053603 from the National Institute of Neurological Disorders and Stroke to L. E. M. and a post-doctoral fellowship from the Fonds de la Recherche en Sante du Quebec to C. E., with further support from the Chicago Community Trust through the Searle Program for Neurological Restoration at the Rehabilitation Institute of Chicago. We also acknowledge the technical assistance of D. Tyler and K. Kilgore as well as the surgical assistance of J. Ko and S. Paisley Agnew.	Adams MM, 2005, SPINAL CORD, V43, P577, DOI 10.1038/sj.sc.3101757; Agarwal S, 2003, J REHABIL RES DEV, V40, P241; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Bryden AM, 2005, TOP SPINAL CORD INJ, V10, P38, DOI DOI 10.1310/G9T5-CCK9-Y0WT-4714; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Cherian A, 2011, J NEUROPHYSIOL, V106, P564, DOI 10.1152/jn.00553.2010; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; Fagg AH, 2009, IEEE T NEUR SYS REH, V17, P487, DOI 10.1109/TNSRE.2009.2029313; Fitzwater R, 2002, ARTIF ORGANS, V26, P284, DOI 10.1046/j.1525-1594.2002.06936.x; Gupta R, 2009, IEEE T NEUR SYS REH, V17, P254, DOI 10.1109/TNSRE.2009.2023290; HUMPHREY DR, 1970, SCIENCE, V170, P758, DOI 10.1126/science.170.3959.758; KEITH MW, 1989, J HAND SURG-AM, V14A, P524, DOI 10.1016/S0363-5023(89)80017-6; Kern H, 2002, ARTIF ORGANS, V26, P216, DOI 10.1046/j.1525-1594.2002.06933.x; Kilgore KL, 1997, J BONE JOINT SURG AM, V79A, P533, DOI 10.2106/00004623-199704000-00008; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Nightingale EJ, 2007, SPINAL CORD, V45, P646, DOI 10.1038/sj.sc.3102101; Oby ER, 2010, STATISTICAL SIGNAL PROCESSING FOR NEUROSCIENCE AND NEUROTECHNOLOGY, P369, DOI 10.1016/B978-0-12-375027-3.00011-9; Peckham PH, 2001, ARCH PHYS MED REHAB, V82, P1380, DOI 10.1053/apmr.2001.25910; Pohlmeyer EA, 2007, INT C REHAB ROBOT, P454, DOI 10.1109/ICORR.2007.4428464; Pohlmeyer EA, 2007, J NEURAL ENG, V4, P369, DOI 10.1088/1741-2560/4/4/003; Pohlmeyer EA, 2009, J NEUROSCI METH, V182, P165, DOI 10.1016/j.jneumeth.2009.06.006; Pohlmeyer EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005924; Popovic MR, 2002, NEUROL RES, V24, P443, DOI 10.1179/016164102101200311; WATERS RL, 1993, ARCH PHYS MED REHAB, V74, P242	24	301	313	2	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2012	485	7398					368	371		10.1038/nature10987	http://dx.doi.org/10.1038/nature10987			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22522928	Green Accepted			2022-12-28	WOS:000304099100042
J	Nora, EP; Lajoie, BR; Schulz, EG; Giorgetti, L; Okamoto, I; Servant, N; Piolot, T; van Berkum, NL; Meisig, J; Sedat, J; Gribnau, J; Barillot, E; Bluthgen, N; Dekker, J; Heard, E				Nora, Elphege P.; Lajoie, Bryan R.; Schulz, Edda G.; Giorgetti, Luca; Okamoto, Ikuhiro; Servant, Nicolas; Piolot, Tristan; van Berkum, Nynke L.; Meisig, Johannes; Sedat, John; Gribnau, Joost; Barillot, Emmanuel; Bluethgen, Nils; Dekker, Job; Heard, Edith			Spatial partitioning of the regulatory landscape of the X-inactivation centre	NATURE			English	Article							CHROMOSOME INACTIVATION; GENE-EXPRESSION; NONCODING RNAS; GENOME; CONFORMATION; ARCHITECTURE; METHYLATION; PRINCIPLES; REVEALS; CELLS	In eukaryotes transcriptional regulation often involves multiple long-range elements and is influenced by the genomic environment(1). A prime example of this concerns the mouse X-inactivation centre (Xic), which orchestrates the initiation of X-chromosome inactivation (XCI) by controlling the expression of the non-protein-coding Xist transcript. The extent of Xic sequences required for the proper regulation of Xist remains unknown. Here we use chromosome conformation capture carbon-copy (5C)(2) and super-resolution microscopy to analyse the spatial organization of a 4.5-megabases (Mb) region including Xist. We discover a series of discrete 200-kilobase to 1Mb topologically associating domains (TADs), present both before and after cell differentiation and on the active and inactive X. TADs align with, but do not rely on, several domain-wide features of the epigenome, such as H3K27me3 or H3K9me2 blocks and lamina-associated domains. TADs also align with coordinately regulated gene clusters. Disruption of a TAD boundary causes ectopic chromosomal contacts and long-range transcriptional misregulation. The Xist/Tsix sense/antisense unit illustrates how TADs enable the spatial segregation of oppositely regulated chromosomal neighbourhoods, with the respective promoters of Xist and Tsix lying in adjacent TADs, each containing their known positive regulators. We identify a novel distal regulatory region of Tsix within its TAD, which produces a long intervening RNA, Linx. In addition to uncovering a new principle of cis-regulatory architecture of mammalian chromosomes, our study sets the stage for the full genetic dissection of the X-inactivation centre.	[Nora, Elphege P.; Schulz, Edda G.; Giorgetti, Luca; Okamoto, Ikuhiro; Servant, Nicolas; Piolot, Tristan; Barillot, Emmanuel; Heard, Edith] Inst Curie, F-75248 Paris, France; [Nora, Elphege P.; Schulz, Edda G.; Giorgetti, Luca; Okamoto, Ikuhiro; Piolot, Tristan; Heard, Edith] CNRS, UMR3215, F-75248 Paris, France; [Nora, Elphege P.; Schulz, Edda G.; Giorgetti, Luca; Okamoto, Ikuhiro; Piolot, Tristan; Heard, Edith] INSERM, U934, F-75248 Paris, France; [Lajoie, Bryan R.; van Berkum, Nynke L.; Dekker, Job] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Programs Syst Biol & Gene Funct & Express, Worcester, MA 01605 USA; [Servant, Nicolas; Barillot, Emmanuel] INSERM, U900, F-75248 Paris, France; [Servant, Nicolas; Barillot, Emmanuel] Mines ParisTech, F-77300 Fontainebleau, France; [Meisig, Johannes; Bluethgen, Nils] Charite, Inst Pathol, D-10117 Berlin, Germany; [Meisig, Johannes; Bluethgen, Nils] Humboldt Univ, Inst Theoret Biol, D-10115 Berlin, Germany; [Sedat, John] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Gribnau, Joost] Univ Med Ctr, Erasmus MC, Dept Reprod & Dev, NL-3000 CA Rotterdam, Netherlands	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Massachusetts System; University of Massachusetts Worcester; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; University of California System; University of California San Francisco; Erasmus University Rotterdam; Erasmus MC	Heard, E (corresponding author), Inst Curie, 26 Rue Ulm, F-75248 Paris, France.	job.dekker@umassmed.edu; edith.heard@curie.fr	Bluthgen, Nils/A-1711-2011; Nora, Elphège/AAW-9646-2021; Heard, Edith/D-7197-2017	Bluthgen, Nils/0000-0002-0171-7447; Nora, Elphège/0000-0002-8347-4396; Heard, Edith/0000-0001-8052-7117; BARILLOT, Emmanuel/0000-0003-2724-2002; Servant, Nicolas/0000-0003-1678-7410	Ministere de la Recherche et de l'Enseignement Superieur; ARC; HFSP [LT000597/2010-L]; EU EpiGeneSys FP7 Network of Excellence [257082]; Fondation pour la Recherche Medicale; ANR; ERC [250367]; EU [242129]; BMBF (FORSYS); EMBO [ASTF 307-2011]; NIH [R01 HG003143]; W. M. Keck Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER	Ministere de la Recherche et de l'Enseignement Superieur; ARC(Australian Research Council); HFSP(Human Frontier Science Program); EU EpiGeneSys FP7 Network of Excellence; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); ANR(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission); EU(European Commission); BMBF (FORSYS)(Federal Ministry of Education & Research (BMBF)); EMBO(European Molecular Biology Organization (EMBO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank T. Pollex and T. Forne for experimental help; the imaging facility PICTIBiSA@BDD for technical assistance, D. Gentien and C. Hego for microarray hybridizations. We thank K. Bernhard, F. Stewart and A. Smith for protocols and material for 2i culture and EpiSC differentiation. We are grateful to members of the E. H. laboratory for critical input. This work was funded by grants from the Ministere de la Recherche et de l'Enseignement Superieur and the ARC (to E.P.N.); a HFSP Long term fellowship (LT000597/2010-L) (to E. G. S.). EU EpiGeneSys FP7 Network of Excellence no. 257082, the Fondation pour la Recherche Medicale, ANR, ERC Advanced Investigator award no. 250367 and EU FP7 SYBOSS grant no. 242129 (to E. H.). N.B. was supported by BMBF (FORSYS) and EMBO (fellowship ASTF 307-2011). J.D., B. R. L. and N.L.v.B. were supported by NIH (R01 HG003143) and a W. M. Keck Foundation Distinguished Young Scholar Award.	Anguera MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002248; Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heard E, 1996, HUM MOL GENET, V5, P441, DOI 10.1093/hmg/5.4.441; Heard E, 1999, MOL CELL BIOL, V19, P3156; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Kleinjan DA, 2008, ADV GENET, V61, P339, DOI 10.1016/S0065-2660(07)00013-2; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lienert F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002090; Marks H, 2009, GENOME RES, V19, P1361, DOI 10.1101/gr.092643.109; Mercier R, 2008, CELL, V135, P475, DOI 10.1016/j.cell.2008.08.031; Monkhorst K, 2008, CELL, V132, P410, DOI 10.1016/j.cell.2007.12.036; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Pauler FM, 2009, GENOME RES, V19, P221, DOI 10.1101/gr.080861.108; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; RASTAN S, 1983, J EMBRYOL EXP MORPH, V78, P1; RASTAN S, 1985, J EMBRYOL EXP MORPH, V90, P379; Rougeulle C, 2004, MOL CELL BIOL, V24, P5475, DOI 10.1128/MCB.24.12.5475-5484.2004; Ruf S, 2011, NAT GENET, V43, P379, DOI 10.1038/ng.790; Seidl CIM, 2006, EMBO J, V25, P3565, DOI 10.1038/sj.emboj.7601245; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Spencer R. J., 2011, GENETICS; Splinter E, 2011, GENE DEV, V25, P1371, DOI 10.1101/gad.633311; Tsai CL, 2008, DEV BIOL, V319, P416, DOI 10.1016/j.ydbio.2008.04.010; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297	30	1726	1762	1	187	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					381	385		10.1038/nature11049	http://dx.doi.org/10.1038/nature11049			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22495304	Green Accepted, Green Published			2022-12-28	WOS:000304099100045
J	Hu, LY; Crawford, SE; Czako, R; Cortes-Penfield, NW; Smith, DF; Le Pendu, J; Estes, MK; Prasad, BVV				Hu, Liya; Crawford, Sue E.; Czako, Rita; Cortes-Penfield, Nicolas W.; Smith, David F.; Le Pendu, Jacques; Estes, Mary K.; Prasad, B. V. Venkataram			Cell attachment protein VP8*of a human rotavirus specifically interacts with A-type histo-blood group antigen	NATURE			English	Article							SIALIC-ACID BINDING; MOLECULAR CHARACTERIZATION; STRAINS; RECEPTOR; RECOGNITION; DIVERSITY; SEROTYPE; SYSTEM; DOMAIN; SUITE	As with many other viruses, the initial cell attachment of rotaviruses, which are the major causative agent of infantile gastroenteritis, is mediated by interactions with specific cellular glycans(1-4). The distally located VP8* domain of the rotavirus spike protein VP4 (ref. 5) mediates such interactions. The existing paradigm is that 'sialidase-sensitive' animal rotavirus strains bind to glycans with terminal sialic acid (Sia), whereas 'sialidase-insensitive' human rotavirus strains bind to glycans with internal Sia such as GM1 (ref. 3). Although the involvement of Sia in the animal strains is firmly supported by crystallographic studies(1,3,6,7), it is not yet known how VP8* of human rotaviruses interacts with Sia and whether their cell attachment necessarily involves sialoglycans. Here we show that VP8* of a human rotavirus strain specifically recognizes A-type histo-blood group antigen (HBGA) using a glycan array screen comprised of 511 glycans, and that virus infectivity in HT-29 cells is abrogated by anti-A-type antibodies as well as significantly enhanced in Chinese hamster ovary cells genetically modified to express the A-type HBGA, providing a novel paradigm for initial cell attachment of human rotavirus. HBGAs are genetically determined glycoconjugates present in mucosal secretions, epithelia and on red blood cells(8), and are recognized as susceptibility and cell attachment factors for gastric pathogens like Helicobacter pylori(9) and noroviruses(10). Our crystallographic studies show that the A-type HBGA binds to the human rotavirus VP8* at the same location as the Sia in the VP8* of animal rotavirus, and suggest how subtle changes within the same structural framework allow for such receptor switching. These results raise the possibility that host susceptibility to specific human rotavirus strains and pathogenesis are influenced by genetically controlled expression of different HBGAs among the world's population.	[Hu, Liya; Prasad, B. V. Venkataram] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Crawford, Sue E.; Czako, Rita; Cortes-Penfield, Nicolas W.; Estes, Mary K.; Prasad, B. V. Venkataram] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Smith, David F.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Le Pendu, Jacques] Univ Nantes, INSERM, UMR892, F-44007 Nantes, France; [Le Pendu, Jacques] Univ Nantes, CNRS, UMR 6299, F-44007 Nantes, France	Baylor College of Medicine; Baylor College of Medicine; Emory University; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite	Prasad, BVV (corresponding author), Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	vprasad@bcm.edu	Cortes-Penfield, Nicolas/ACS-1833-2022; Le Pendu, Jacques/F-4760-2013	Le Pendu, Jacques/0000-0002-4856-0387; Czako, Rita/0000-0001-8686-0260; Prasad, B.V.Venkataram/0000-0002-1172-2071	NIH [AI36040, AI 080656, P30 DK56338, GM62116]; Robert Welch foundation [Q1279]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI036040, R56AI080656, R01AI036040, R01AI080656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116, P41GM103694] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Welch foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the support from NIH grants AI36040 (to B.V.V.P.), AI 080656 and P30 DK56338 (to M.K.E.), GM62116 (to the Consortium for Functional Glycomics), and the Robert Welch foundation (Q1279) to B.V.V.P. We thank R. Atmar and S. Shanker for helpful discussions and BCM X-ray core facility for data collection.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Angel J, 2007, NAT REV MICROBIOL, V5, P529, DOI 10.1038/nrmicro1692; Blanchard H, 2007, J MOL BIOL, V367, P1215, DOI 10.1016/j.jmb.2007.01.028; Bohne A, 1999, BIOINFORMATICS, V15, P767, DOI 10.1093/bioinformatics/15.9.767; Byres E, 2008, NATURE, V456, P648, DOI 10.1038/nature07428; Chitambar SD, 2011, VET MICROBIOL, V148, P384, DOI 10.1016/j.vetmic.2010.08.027; Ciarlet M, 1999, J GEN VIROL, V80, P943, DOI 10.1099/0022-1317-80-4-943; Crawford SE, 2006, J VIROL, V80, P4820, DOI 10.1128/JVI.80.10.4820-4832.2006; Dormitzer PR, 2002, J VIROL, V76, P10512, DOI 10.1128/JVI.76.20.10512-10517.2002; Dormitzer PR, 2002, EMBO J, V21, P885, DOI 10.1093/emboj/21.5.885; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESTES MK, 2007, FIELDS VIROLOGY, V2, P1917; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fukai K, 2004, VIRUS RES, V105, P101, DOI 10.1016/j.virusres.2004.04.016; Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499; GERNA G, 1994, VIROLOGY, V200, P66, DOI 10.1006/viro.1994.1163; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Gray J, 2011, METHODS MOL BIOL, V665, P325, DOI 10.1007/978-1-60761-817-1_18; Guillon P, 2008, GLYCOBIOLOGY, V18, P1085, DOI 10.1093/glycob/cwn093; Haselhorst T, 2009, NAT CHEM BIOL, V5, P91, DOI 10.1038/nchembio.134; Hutson AM, 2003, J VIROL, V77, P405, DOI 10.1128/JVI.77.1.405-415.2003; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Kraschnefski MJ, 2009, GLYCOBIOLOGY, V19, P194, DOI 10.1093/glycob/cwn119; Lopez S, 2006, CURR TOP MICROBIOL, V309, P39; Lutteke T, 2005, NUCLEIC ACIDS RES, V33, pD242; Marionneau S, 2001, BIOCHIMIE, V83, P565, DOI 10.1016/S0300-9084(01)01321-9; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Matthijnssens J, 2009, J VIROL, V83, P2917, DOI 10.1128/JVI.02246-08; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Midgley SE, 2012, EPIDEMIOL INFECT, V140, P1013, DOI 10.1017/S0950268811001981; Monnier N, 2006, J VIROL, V80, P1513, DOI 10.1128/JVI.80.3.1513-1523.2006; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Neu U, 2010, CELL HOST MICROBE, V8, P309, DOI 10.1016/j.chom.2010.09.004; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Settembre EC, 2011, EMBO J, V30, P408, DOI 10.1038/emboj.2010.322; Smith DF, 2010, METHOD ENZYMOL, V480, P417, DOI 10.1016/S0076-6879(10)80033-3; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	41	230	249	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2012	485	7397					256	U147		10.1038/nature10996	http://dx.doi.org/10.1038/nature10996			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22504179	Green Accepted			2022-12-28	WOS:000303799800045
J	Song, ZR; Landon, BE				Song, Zirui; Landon, Bruce E.			Controlling Health Care Spending - The Massachusetts Experiment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Song, Zirui; Landon, Bruce E.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Landon, Bruce E.] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; [Song, Zirui] Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; National Bureau of Economic Research	Song, ZR (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.				NIA NIH HHS [F30 AG039175] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [F30AG039175] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 2011, ACT IMPR QUAL HLTH C; [Anonymous], 2011, EX HLTH CAR COST TRE; Centers for Medicare & Medicaid Services, NAT HLTH EXP ACC; Landon BE, 2012, NEW ENGL J MED, V366, P393, DOI 10.1056/NEJMp1112637; Massachusetts Health Care Quality and Cost Council, 2009, ROADM COST CONT	5	23	23	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 26	2012	366	17					1560	1561		10.1056/NEJMp1201261	http://dx.doi.org/10.1056/NEJMp1201261			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	931FC	22494111	Green Accepted			2022-12-28	WOS:000303200100002
J	Boyce, N				Boyce, Niall			The art of medicine Outsider Art	LANCET			English	Editorial Material												niall.boyce@lancet.com						GAIMAN N, PUBLICATION LIST	1	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 21	2012	379	9825					1480	1481		10.1016/S0140-6736(12)60621-7	http://dx.doi.org/10.1016/S0140-6736(12)60621-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	930BJ	22530245				2022-12-28	WOS:000303110200014
J	Foti, JJ; Devadoss, B; Winkler, JA; Collins, JJ; Walker, GC				Foti, James J.; Devadoss, Babho; Winkler, Jonathan A.; Collins, James J.; Walker, Graham C.			Oxidation of the Guanine Nucleotide Pool Underlies Cell Death by Bactericidal Antibiotics	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; MUTT-TYPE ENZYME; ESCHERICHIA-COLI; DNA-POLYMERASES; HYDROGEN-PEROXIDE; PROTEIN; REPLICATION; MECHANISMS; DAMAGE; MUTAGENESIS	A detailed understanding of the mechanisms that underlie antibiotic killing is important for the derivation of new classes of antibiotics and clinically useful adjuvants for current antimicrobial therapies. Our efforts to understand why DinB (DNA polymerase IV) overproduction is cytotoxic to Escherichia coli led to the unexpected insight that oxidation of guanine to 8-oxo-guanine in the nucleotide pool underlies much of the cell death caused by both DinB overproduction and bactericidal antibiotics. We propose a model in which the cytotoxicity of beta-lactams and quinolones predominantly results from lethal double-strand DNA breaks caused by incomplete repair of closely spaced 8-oxo-deoxyguanosine lesions, whereas the cytotoxicity of aminoglycosides might additionally result from mistranslation due to the incorporation of 8-oxo-guanine into newly synthesized RNAs.	[Foti, James J.; Devadoss, Babho; Walker, Graham C.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Winkler, Jonathan A.] Boston Univ, Program Mol Biol Cell Biol & Biochem, Boston, MA 02215 USA; [Collins, James J.] Boston Univ, Howard Hughes Med Inst, Dept Biomed Engn, Boston, MA 02215 USA; [Collins, James J.] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02118 USA	Massachusetts Institute of Technology (MIT); Boston University; Boston University; Howard Hughes Medical Institute; Boston University; Harvard University	Walker, GC (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	gwalker@mit.edu		/0000-0001-7243-8261	NIH [R01 CA021615, F32 GM079885, DP1 OD003644, P30 ES002019]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA021615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM079885] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank S. Bell and D. Kim for use of equipment and S. Lovett for strains. This work was supported by NIH grants R01 CA021615 (to G.C.W.), F32 GM079885 (to J.J.F.), DP1 OD003644 (to J.C.C.), and P30 ES002019 (to the Massachusetts Institute of Technology Center for Environmental Sciences) as well as the Howard Hughes Medical Institute. G.C.W. is an American Cancer Society Professor.	BONURA T, 1975, RADIAT RES, V63, P567, DOI 10.2307/3574108; BRENNER DJ, 1992, INT J RADIAT BIOL, V61, P737, DOI 10.1080/09553009214551591; Caldon CE, 2001, MOL MICROBIOL, V41, P289, DOI 10.1046/j.1365-2958.2001.02536.x; Cooper MA, 2011, NATURE, V472, P32, DOI 10.1038/472032a; Davies BW, 2009, MOL CELL, V36, P845, DOI 10.1016/j.molcel.2009.11.024; Dukan S, 2000, P NATL ACAD SCI USA, V97, P5746, DOI 10.1073/pnas.100422497; FIJALKOWSKA IJ, 1993, GENETICS, V134, P1023; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Fujikawa K, 1999, J BIOL CHEM, V274, P18201, DOI 10.1074/jbc.274.26.18201; Goodell B, 1997, J BIOTECHNOL, V53, P133, DOI 10.1016/S0168-1656(97)01681-7; Haghdoost S, 2006, FREE RADICAL BIO MED, V41, P620, DOI 10.1016/j.freeradbiomed.2006.05.003; Hori M, 2005, DNA REPAIR, V4, P33, DOI 10.1016/j.dnarep.2004.07.010; Hori M, 2006, BIOL PHARM BULL, V29, P1087, DOI 10.1248/bpb.29.1087; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Indiani C, 2009, P NATL ACAD SCI USA, V106, P6031, DOI 10.1073/pnas.0901403106; Ito R, 2005, BIOCHEMISTRY-US, V44, P6670, DOI 10.1021/bi047550k; Jarosz DF, 2006, NATURE, V439, P225, DOI 10.1038/nature04318; Katafuchi A, 2010, NUCLEIC ACIDS RES, V38, P859, DOI 10.1093/nar/gkp1095; Kobayashi M, 1998, J BIOL CHEM, V273, P26394, DOI 10.1074/jbc.273.41.26394; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Morel Chantal M, 2010, BMJ, V340, pc2115, DOI 10.1136/bmj.c2115; Neeley WL, 2006, CHEM RES TOXICOL, V19, P491, DOI 10.1021/tx0600043; NOVOGRODSKY A, 1982, P NATL ACAD SCI-BIOL, V79, P1171, DOI 10.1073/pnas.79.4.1171; Pankey GA, 2004, CLIN INFECT DIS, V38, P864, DOI 10.1086/381972; Pursell ZF, 2008, NUCLEIC ACIDS RES, V36, P2174, DOI 10.1093/nar/gkn062; REPINE JE, 1981, J BIOL CHEM, V256, P7094; Rotman E, 2007, J BACTERIOL, V189, P6976, DOI 10.1128/JB.00776-07; Taddei F, 1997, SCIENCE, V278, P128, DOI 10.1126/science.278.5335.128; Tassotto ML, 2002, J BIOL CHEM, V277, P15807, DOI 10.1074/jbc.M200965200; TOUATI D, 1995, J BACTERIOL, V177, P2305, DOI 10.1128/jb.177.9.2305-2314.1995; Uchida K, 2008, MOL MICROBIOL, V70, P608, DOI 10.1111/j.1365-2958.2008.06423.x; Wagner J, 2000, EMBO REP, V1, P484; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; WARD JF, 1987, BR J CANC S, V8, P105; Wu J, 2009, J CELL PHYSIOL, V220, P297, DOI 10.1002/jcp.21797	37	314	324	9	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2012	336	6079					315	319		10.1126/science.1219192	http://dx.doi.org/10.1126/science.1219192			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22517853	Green Accepted, Green Submitted			2022-12-28	WOS:000302995400037
J	Hertwig, R				Hertwig, Ralph			Tapping into the Wisdom of the Crowd-with Confidence	SCIENCE			English	Editorial Material									[Hertwig, Ralph] Univ Basel, Dept Psychol, CH-4055 Basel, Switzerland; [Hertwig, Ralph] Max Planck Inst Human Dev, D-14195 Berlin, Germany	University of Basel; Max Planck Society	Hertwig, R (corresponding author), Univ Basel, Dept Psychol, Missionsstr 60-64, CH-4055 Basel, Switzerland.	ralph.hertwig@unibas.ch	Hertwig, Ralph/B-3468-2015	Hertwig, Ralph/0000-0002-9908-9556				Dhami MK, 2004, PSYCHOL BULL, V130, P959, DOI 10.1037/0033-2909.130.6.959; Galton F, 1907, NATURE, V75, P450, DOI 10.1038/075450a0; Gigerenzer G., 2012, ECOLOGICAL RATIONALI, DOI DOI 10.1093/ACPROF; Grice P., 1989, STUDIES WAY WORDS; Griffin D., 2004, BLACKWELL HDB JUDGME, P177, DOI [10.1002/9780470752937.ch9, DOI 10.1002/9780470752937.CH9]; Hastie R, 2005, PSYCHOL REV, V112, P494, DOI 10.1037/0033-295X.112.2.494; Herzog SM, 2009, PSYCHOL SCI, V20, P231, DOI 10.1111/j.1467-9280.2009.02271.x; Hoffrage U., 2012, SIMPLE HEURISTICS SO; Hogarth R., 2001, ED INTUITION; Janis Irving L, 1972, GROUPTHINK PSYCHOL S; Kerr NL, 2004, ANNU REV PSYCHOL, V55, P623, DOI 10.1146/annurev.psych.55.090902.142009; Koriat A, 2012, SCIENCE, V336, P360, DOI 10.1126/science.1216549; Le Bon Gustave, 1895, CROWD; Osborn A. F., 1957, APPL IMAGINATION, V2nd; Soll JB, 2009, J EXP PSYCHOL LEARN, V35, P780, DOI 10.1037/a0015145; Surowiecki James, 2004, WISDOM CROWDS	16	49	50	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2012	336	6079					303	304		10.1126/science.1221403	http://dx.doi.org/10.1126/science.1221403			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	928PO	22517847	Green Submitted			2022-12-28	WOS:000302995400031
J	Pegues, DA				Pegues, David A.			Review: Fidaxomicin is better than vancomycin for Clostridium difficile recurrence	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Hosp Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Pegues, DA (corresponding author), Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA.							Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Zar FA, 2007, CLIN INFECT DIS, V45, P302, DOI 10.1086/519265	3	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2012	156	8							JC4-9	10.7326/0003-4819-156-8-201204170-02009	http://dx.doi.org/10.7326/0003-4819-156-8-201204170-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930PO	22508749				2022-12-28	WOS:000303151800008
J	Fleishman, SJ; Baker, D				Fleishman, Sarel J.; Baker, David			Role of the Biomolecular Energy Gap in Protein Design, Structure, and Evolution	CELL			English	Review							INTRINSICALLY UNSTRUCTURED PROTEINS; DE-NOVO DESIGN; COMPUTATIONAL DESIGN; STRUCTURE PREDICTION; CRYSTAL-STRUCTURE; HIGH-AFFINITY; SPECIFICITY; SEQUENCE; BINDING; DIVERSITY	The folding of natural biopolymers into unique three-dimensional structures that determine their function is remarkable considering the vast number of alternative states and requires a large gap in the energy of the functional state compared to the many alternatives. This Perspective explores the implications of this energy gap for computing the structures of naturally occurring biopolymers, designing proteins with new structures and functions, and optimally integrating experiment and computation in these endeavors. Possible parallels between the generation of functional molecules in computational design and natural evolution are highlighted.	[Fleishman, Sarel J.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98199 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98199 USA	Weizmann Institute of Science; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Fleishman, SJ (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	sarel@weizmann.ac.il; dabaker@uw.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Fleishman, Sarel/0000-0003-3177-7560	Geffen Trust; Yeda-Sela Center for Basic Research; National Institutes of Health; Defense Advanced Research Program Agency; Defense Threat Reduction Agency; Howard Hughes Medical Institute	Geffen Trust; Yeda-Sela Center for Basic Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Program Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The authors thank Yibing Shan, David E. Shaw, Vladimir Yarov-Yarovoy, Mike Tyka, Oliver Lange, Rhiju Das, and Ingemar Andre for providing the data used to produce Figure 2 and Ingemar Andre, Gira Bhabha, Rhiju Das, Sagar Khare, Olga Khersonsky, Tanja Kortemme, Eva-Maria Strauch, and Dan S Tawfik for critical reading. S.J.F. is supported by a grant from the Geffen Trust, the Yeda-Sela Center for Basic Research, a donation from Sam Switzer and Family, and the Human Frontier Science Program. Research in the Baker lab was supported by grants from the National Institutes of Health, the Defense Advanced Research Program Agency, the Defense Threat Reduction Agency, and the Howard Hughes Medical Institute.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Ambroggio XI, 2006, J AM CHEM SOC, V128, P1154, DOI 10.1021/ja054718w; Andre I, 2007, P NATL ACAD SCI USA, V104, P17656, DOI 10.1073/pnas.0702626104; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Ashworth J, 2010, NUCLEIC ACIDS RES, V38, P5601, DOI 10.1093/nar/gkq283; Baker ML, 2010, NAT PROTOC, V5, P1697, DOI 10.1038/nprot.2010.126; Barth P, 2009, P NATL ACAD SCI USA, V106, P1409, DOI 10.1073/pnas.0808323106; Borgia MB, 2011, NATURE, V474, P662, DOI 10.1038/nature10099; Bouvignies G, 2011, NATURE, V477, P111, DOI 10.1038/nature10349; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Brady GP, 1997, CURR OPIN STRUC BIOL, V7, P215, DOI 10.1016/S0959-440X(97)80028-0; Cochran FV, 2005, J AM CHEM SOC, V127, P1346, DOI 10.1021/ja044129a; Collins CH, 2006, NAT BIOTECHNOL, V24, P708, DOI 10.1038/nbt1209; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Correll CC, 2003, NUCLEIC ACIDS RES, V31, P6806, DOI 10.1093/nar/gkg908; Cozzetto D, 2008, MOL BIOTECHNOL, V39, P1, DOI 10.1007/s12033-007-9023-6; Das R, 2007, P NATL ACAD SCI USA, V104, P14664, DOI 10.1073/pnas.0703836104; Das R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020044; DeLano W.L, PYMOL MOL GRAPHICS S; DiMaio F, 2011, NATURE, V473, P540, DOI 10.1038/nature09964; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; EKINS S, 2006, COMPUTER APPL PHARM; EPSTEIN CJ, 1962, J BIOL CHEM, V237, P2175; Feher M, 2003, J CHEM INF COMP SCI, V43, P218, DOI 10.1021/ci0200467; Fleishman SJ, 2011, J MOL BIOL, V414, P289, DOI 10.1016/j.jmb.2011.09.031; Fleishman SJ, 2011, J MOL BIOL, V413, P1047, DOI 10.1016/j.jmb.2011.09.001; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fleishman SJ, 2011, PROTEIN SCI, V20, P753, DOI 10.1002/pro.604; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; Havranek JJ, 2004, J MOL BIOL, V344, P59, DOI 10.1016/j.jmb.2004.09.029; Huang PS, 2007, PROTEIN SCI, V16, P2770, DOI 10.1110/ps.073125207; INGRAM VM, 1956, NATURE, V178, P792, DOI 10.1038/178792a0; Jha RK, 2010, J MOL BIOL, V400, P257, DOI 10.1016/j.jmb.2010.05.006; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Jones AK, 2007, J AM CHEM SOC, V129, P14844, DOI 10.1021/ja075116a; Karanicolas J, 2011, MOL CELL, V42, P250, DOI 10.1016/j.molcel.2011.03.010; Khersonsky O, 2011, J MOL BIOL, V407, P391, DOI 10.1016/j.jmb.2011.01.041; Kinch L., 2011, PROTEINS S10, V79, P59; Koder RL, 2009, NATURE, V458, P305, DOI 10.1038/nature07841; Korendovych IV, 2011, P NATL ACAD SCI USA, V108, P6823, DOI 10.1073/pnas.1018191108; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Levin KB, 2009, NAT STRUCT MOL BIOL, V16, P1049, DOI 10.1038/nsmb.1670; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Meenan NAG, 2010, P NATL ACAD SCI USA, V107, P10080, DOI 10.1073/pnas.0910756107; Miller ME, 2001, J CELL SCI, V114, P1811; Mizianty MJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-245; Moran U, 2010, CELL, V141, P1262, DOI 10.1016/j.cell.2010.06.019; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Otzen DE, 1999, BIOCHEMISTRY-US, V38, P6499, DOI 10.1021/bi982819j; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; PAULING L, 1948, NATURE, V161, P707, DOI 10.1038/161707a0; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; ROSSMANN MG, 1989, J BIOL CHEM, V264, P14587; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Samish I, 2011, ANNU REV PHYS CHEM, V62, P129, DOI 10.1146/annurev-physchem-032210-103509; Scalley-Kim M, 2004, J MOL BIOL, V338, P573, DOI 10.1016/j.jmb.2004.02.055; Scalley-Kim M, 2003, PROTEIN SCI, V12, P197, DOI 10.1110/ps.0232003; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Shan YB, 2011, J AM CHEM SOC, V133, P9181, DOI 10.1021/ja202726y; Shapiro L, 2000, CELL, V100, P89, DOI 10.1016/S0092-8674(00)81686-4; SHARP KA, 1990, ANNU REV BIOPHYS BIO, V19, P301, DOI 10.1146/annurev.bb.19.060190.001505; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Stetefeld J, 2000, NAT STRUCT BIOL, V7, P772, DOI 10.1038/79006; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tyka MD, 2011, J MOL BIOL, V405, P607, DOI 10.1016/j.jmb.2010.11.008; vanMeerwijk JPM, 1997, J EXP MED, V185, P377, DOI 10.1084/jem.185.3.377; Wang L, 2012, J MOL BIOL, V415, P615, DOI 10.1016/j.jmb.2011.10.043; Watters AL, 2007, CELL, V128, P613, DOI 10.1016/j.cell.2006.12.042; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xu GF, 2001, P NATL ACAD SCI USA, V98, P3652, DOI 10.1073/pnas.071400098; Yin H, 2007, SCIENCE, V315, P1817, DOI 10.1126/science.1136782; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178	90	77	80	1	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 13	2012	149	2					262	273		10.1016/j.cell.2012.03.016	http://dx.doi.org/10.1016/j.cell.2012.03.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500796	Bronze			2022-12-28	WOS:000302805600008
J	Howell, AS; Jin, M; Wu, CF; Zyla, TR; Elston, TC; Lew, DJ				Howell, Audrey S.; Jin, Meng; Wu, Chi-Fang; Zyla, Trevin R.; Elston, Timothy C.; Lew, Daniel J.			Negative Feedback Enhances Robustness in the Yeast Polarity Establishment Circuit	CELL			English	Article							FUNGUS ASHBYA-GOSSYPII; CELL POLARITY; SACCHAROMYCES-CEREVISIAE; SYMMETRY-BREAKING; SEPTIN RING; BUDDING YEAST; CDC42P; POLARIZATION; GROWTH; ACTIN	Many cells undergo symmetry-breaking polarization toward a randomly oriented "front" in the absence of spatial cues. In budding yeast, such polarization involves a positive feedback loop that enables amplification of stochastically arising clusters of polarity factors. Previous mathematical modeling suggested that, if more than one cluster were amplified, the clusters would compete for limiting resources and the largest would "win," explaining why yeast cells always make one and only one bud. Here, using imaging with improved spatiotemporal resolution, we show the transient coexistence of multiple clusters during polarity establishment, as predicted by the model. Unexpectedly, we also find that initial polarity factor clustering is oscillatory, revealing the presence of a negative feedback loop that disperses the factors. Mathematical modeling predicts that negative feedback would confer robustness to the polarity circuit and make the kinetics of competition between polarity factor clusters relatively insensitive to polarity factor concentration. These predictions are confirmed experimentally.	[Howell, Audrey S.; Wu, Chi-Fang; Zyla, Trevin R.; Lew, Daniel J.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Jin, Meng] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Elston, Timothy C.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Lew, DJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	daniel.lew@duke.edu	Jin, Meng/W-3206-2017	Jin, Meng/0000-0002-2579-3823	NIH [GM79271, GM84071, GM62300]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062300, R01GM084071, R01GM079271] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Nick Buchler, Beverle Errede, Steve Haase, Joe Heitman, Sally Kornbluth, and members of the Lew lab for stimulating discussions and comments on the manuscript. Thanks to Sam Johnson and the Light Microscopy Core Facility at Duke University for making experiments possible and for providing assistance. We thank Rong Li and Erfei Bi for providing Cdc42p probes and Peter Pryciak for the estrogen-responsive Gal4p. This work was supported by NIH grants GM79271 and GM84071 (T. C. E.) and GM62300 (D.J.L.), as well as a supplement for collaborative science (D.J.L. and T.C.E.).	Altschuler SJ, 2008, NATURE, V454, P886, DOI 10.1038/nature07119; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; Bi EF, 2000, MOL BIOL CELL, V11, P773, DOI 10.1091/mbc.11.2.773; Bose I, 2001, J BIOL CHEM, V276, P7176, DOI 10.1074/jbc.M010546200; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Carlton PM, 2010, P NATL ACAD SCI USA, V107, P16016, DOI 10.1073/pnas.1004037107; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; Chen H, 2011, BIOL CHEM, V392, P689, DOI 10.1515/BC.2011.075; Cheong R, 2010, CURR OPIN GENET DEV, V20, P665, DOI 10.1016/j.gde.2010.08.007; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Feijo JA, 2001, BIOESSAYS, V23, P86, DOI 10.1002/1521-1878(200101)23:1&lt;86::AID-BIES1011&gt;3.0.CO;2-D; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; Harris SD, 2008, MYCOLOGIA, V100, P823, DOI 10.3852/08-177; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; Howell AS, 2009, CELL, V139, P731, DOI 10.1016/j.cell.2009.10.024; Irazoqui JE, 2005, MOL BIOL CELL, V16, P1296, DOI 10.1091/mbc.E04-05-0430; Irazoqui JE, 2003, NAT CELL BIOL, V5, P1062, DOI 10.1038/ncb1068; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001121; Johnson JM, 2011, CURR OPIN GENET DEV, V21, P740, DOI 10.1016/j.gde.2011.09.007; Kadota J, 2004, MOL BIOL CELL, V15, P5329, DOI 10.1091/mbc.E04-03-0254; Knaus M, 2007, EMBO J, V26, P4501, DOI 10.1038/sj.emboj.7601873; Knechtle P, 2003, MOL BIOL CELL, V14, P4140, DOI 10.1091/mbc.E03-03-0167; Kozubowski L, 2005, MOL BIOL CELL, V16, P3455, DOI 10.1091/mbc.E04-09-0764; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; Layton AT, 2011, CURR BIOL, V21, P184, DOI 10.1016/j.cub.2011.01.012; McMurray MA, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-18; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Oh Y, 2011, TRENDS CELL BIOL, V21, P141, DOI 10.1016/j.tcb.2010.11.006; Ozbudak EM, 2005, DEV CELL, V9, P565, DOI 10.1016/j.devcel.2005.08.014; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Riquelme M, 2004, FUNGAL GENET BIOL, V41, P842, DOI 10.1016/j.fgb.2004.04.006; Schmitz HP, 2006, MOL BIOL CELL, V17, P130, DOI 10.1091/mbc.e05-06-0479; Takahashi S, 2008, CURR BIOL, V18, P1184, DOI 10.1016/j.cub.2008.07.050; Tong ZT, 2007, J CELL BIOL, V179, P1375, DOI 10.1083/jcb.200705160; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; Yamamoto T, 2010, MOL BIOL CELL, V21, P1237, DOI 10.1091/mbc.E09-05-0412; Yan A, 2009, P NATL ACAD SCI USA, V106, P22002, DOI 10.1073/pnas.0910811106; ZIMAN M, 1994, YEAST, V10, P463, DOI 10.1002/yea.320100405	40	136	136	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 13	2012	149	2					322	333		10.1016/j.cell.2012.03.012	http://dx.doi.org/10.1016/j.cell.2012.03.012			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500799	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000302805600012
J	Melo, JA; Ruvkun, G				Melo, Justine A.; Ruvkun, Gary			Inactivation of Conserved C. elegans Genes Engages Pathogen- and Xenobiotic-Associated Defenses	CELL			English	Article							CAENORHABDITIS-ELEGANS; SIGNALING PATHWAY; PROTEIN; INFECTION; KINASE; MAPK; RNAI; SURVIVAL; IMMUNITY; DAMAGE	The nematode C. elegans is attracted to nutritious bacteria and is repelled by pathogens and toxins. Here we show that RNAi and toxin-mediated disruption of core cellular activities, including translation, respiration, and protein turnover, stimulate behavioral avoidance of normally attractive bacteria. RNAi of these and other essential processes induces expression of detoxification and innate immune effectors, even in the absence of toxins or pathogens. Disruption of core processes in non-neuronal tissues was sufficient to stimulate aversion behavior, revealing a neuroendocrine axis of control that additionally required serotonergic and Jnk kinase signaling pathways. We propose that surveillance pathways overseeing core cellular activities allow animals to detect invading pathogens that deploy toxins and virulence factors to undermine vital host functions. Variation in cellular surveillance and endocrine pathways controlling behavior, detoxification, and immunity selected by past toxin or microbial interactions could underlie aberrant responses to foods, medicines, and microbes.	[Melo, Justine A.; Ruvkun, Gary] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Melo, Justine A.; Ruvkun, Gary] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu	Melo, Justine/AAH-4339-2021	Melo, Justine/0000-0002-7476-0470	Jane Coffin Childs Memorial Fund; Bank of America Charles King Trust; MGH; NIH [DK070147]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043184] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund; Bank of America Charles King Trust; MGH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank F. Ausubel, D. McEwan, R. Pukkila-Worley, E. Troemel, S. Curran, A. Frand, J. Kim, D. Kim, Y. Tabach, B. Cezairliyan, A. Jose, J. Gray, B. Shtonda, L. Avery, C. Bargmann, and D. Hopwood for helpful discussions, D. Shore for participation in stress reporter assays, E. O'Rourke and B. Samuel for assistance with pharyngeal pumping assays, and Rusty Howson for figure support. We thank the CGC, OMRF knockout consortium, National Bioresource Project of Japan, F. Ausubel, D. Kim, E. Troemel, J. Irazoqui, J. Kaplan, J. Kim, A. Soukas, L. Avery, and R. Losick for strains, and the C. elegans resource Wormbase. For sharing unpublished results, we thank F. Ausubel, D. Kim, E. Troemel, Y. Tabach, L. Avery, and S. Politz. Salary support for J. A. M. was provided by the Jane Coffin Childs Memorial Fund, the Bank of America Charles King Trust, and the MGH Fund for Medical Discovery. This work was funded by NIH grant DK070147.	Bargmann C.I., 2006, CHEMOSENSATION C ELG, DOI [10.1895/wormbook.1.7.1, DOI 10.1895/WORMBOOK.1.7.1]; Bolz DD, 2010, J BIOL CHEM, V285, P10832, DOI 10.1074/jbc.M109.091629; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; Dunbar TL, 2012, CELL HOST MICROBE, V11, P375, DOI 10.1016/j.chom.2012.02.008; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Estes KA, 2010, P NATL ACAD SCI USA, V107, P2153, DOI 10.1073/pnas.0914643107; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; Hao LM, 2006, DEV DYNAM, V235, P1469, DOI 10.1002/dvdy.20721; Hart A. C., 2006, WORMBOOK; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iordanov MS, 1997, MOL CELL BIOL, V17, P3373, DOI 10.1128/MCB.17.6.3373; Iser WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017369; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jose AM, 2009, P NATL ACAD SCI USA, V106, P2283, DOI 10.1073/pnas.0809760106; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kao CY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001314; Kim DH, 2004, P NATL ACAD SCI USA, V101, P10990, DOI 10.1073/pnas.0403546101; Lamitina T, 2006, P NATL ACAD SCI USA, V103, P12173, DOI 10.1073/pnas.0602987103; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; McEwan DL, 2012, CELL HOST MICROBE, V11, P364, DOI 10.1016/j.chom.2012.02.007; Mizuno T, 2004, EMBO J, V23, P2226, DOI 10.1038/sj.emboj.7600226; Mizuno T, 2008, MOL CELL BIOL, V28, P7041, DOI 10.1128/MCB.00938-08; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Powell JR, 2009, P NATL ACAD SCI USA, V106, P2782, DOI 10.1073/pnas.0813048106; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Prahlad V, 2011, P NATL ACAD SCI USA, V108, P14204, DOI 10.1073/pnas.1106557108; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Pujol N, 2008, CURR BIOL, V18, P481, DOI 10.1016/j.cub.2008.02.079; Qadota H, 2007, GENE, V400, P166, DOI 10.1016/j.gene.2007.06.020; Schulenburg H, 2004, PARASITOLOGY, V128, P433, DOI 10.1017/S003118200300461X; Schulenburg H, 2007, MOL MICROBIOL, V66, P563, DOI 10.1111/j.1365-2958.2007.05946.x; Sicard M, 2007, ENVIRON MICROBIOL, V9, P12, DOI 10.1111/j.1462-2920.2006.01099.x; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Yook K, 2007, GENETICS, V175, P681, DOI 10.1534/genetics.106.060087; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	42	239	244	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 13	2012	149	2					452	466		10.1016/j.cell.2012.02.050	http://dx.doi.org/10.1016/j.cell.2012.02.050			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500807	Green Accepted, Bronze			2022-12-28	WOS:000302805600022
J	Papke, RT; Gogarten, JP				Papke, R. Thane; Gogarten, J. Peter			How Bacterial Lineages Emerge	SCIENCE			English	Editorial Material							COMPETENCE; ORIGIN		[Papke, R. Thane; Gogarten, J. Peter] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	University of Connecticut	Papke, RT (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	thane@uconn.edu; gogarten@uconn.edu		Gogarten, Johann Peter/0000-0001-6459-6518; Papke, Robertson/0000-0003-1371-2341	Division Of Environmental Biology [0830024] Funding Source: National Science Foundation	Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Coyne J.A., 2004, SPECIATION; CROW JAMES F., 1965, AMER NATUR, V99, P439, DOI 10.1086/282389; Doolittle WF, 2009, GENOME RES, V19, P744, DOI 10.1101/gr.086645.108; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Hanage WP, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-6; Havarstein LS, 1999, CELL-CELL SIGNALING IN BACTERIA, P9; Li YH, 2002, J BACTERIOL, V184, P2699, DOI 10.1128/JB.184.10.2699-2708.2002; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Papke RT, 2007, P NATL ACAD SCI USA, V104, P14092, DOI 10.1073/pnas.0706358104; Retchless AC, 2007, SCIENCE, V317, P1093, DOI 10.1126/science.1144876; Shapiro BJ, 2012, SCIENCE, V336, P48, DOI 10.1126/science.1218198; Zhaxybayeva O, 2009, GENOME BIOL EVOL, V1, P325, DOI 10.1093/gbe/evp032; Zhaxybayeva O, 2009, P NATL ACAD SCI USA, V106, P5865, DOI 10.1073/pnas.0901260106	14	27	28	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2012	336	6077					45	46		10.1126/science.1219241	http://dx.doi.org/10.1126/science.1219241			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920LG	22491845				2022-12-28	WOS:000302405400044
J	O'Grady, M; O'Hare, G				O'Grady, Michael; O'Hare, Gregory			How Smart Is Your City?	SCIENCE			English	Editorial Material									[O'Grady, Michael; O'Hare, Gregory] Univ Coll Dublin, Dublin 4, Ireland	University College Dublin	O'Grady, M (corresponding author), Univ Coll Dublin, Dublin 4, Ireland.	michael.j.ogrady@ucd.ie	O'Hare, Gregory M.P./AAA-7756-2022	O'Hare, Gregory M.P./0000-0002-5124-1686; O'Grady, Michael/0000-0002-3024-3666				Broring A, 2011, SENSORS-BASEL, V11, P7568, DOI 10.3390/s110807568; Cook DJ, 2012, SCIENCE, V335, P1579, DOI 10.1126/science.1217640; De Jong K. A., 2008, COMPUT INTELL MAG IE, V3, P12; Gershenfeld N, 2010, SCIENCE, V327, P1086, DOI 10.1126/science.1174082; Hildebrandt Mireille, 2008, REGULATING TECHNOLOG, p[175, 187]; Kabassi Katerina, 2010, Telematics and Informatics, V27, P51, DOI 10.1016/j.tele.2009.05.003; KASPER JD, 1994, J APPL GERONTOL, V13, P371, DOI 10.1177/073346489401300403; Landau R, 2010, QUAL HEALTH RES, V20, P409, DOI 10.1177/1049732309359171; Reggente M, 2010, CHEM ENGINEER TRANS, V23, P273, DOI 10.3303/CET1023046; Sheth A, 2008, IEEE INTERNET COMPUT, V12, P78, DOI 10.1109/MIC.2008.87; Streitz N., 2011, LECT NOTES COMPUT 3, P425; Vullers R. J. M., 2010, IEEE SOLID STATE CIR, V2, P29, DOI [10.1109/MSSC.2010.936667, DOI 10.1109/MSSC.2010.936667]	12	66	66	5	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1581	1582		10.1126/science.1217637	http://dx.doi.org/10.1126/science.1217637			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	915YD	22461597	Green Submitted			2022-12-28	WOS:000302062600029
J	Rogulja, D; Young, MW				Rogulja, Dragana; Young, Michael W.			Control of Sleep by Cyclin A and Its Regulator	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; CIRCADIAN CLOCK; BEHAVIOR; CIRCUIT; REST	How and why the brain reversibly switches from a waking to a sleep state remain among the most intriguing questions in biology. We show that cyclin A (CycA) and regulator of cyclin A1, essential cell cycle factors, function in postmitotic neurons to promote sleep in Drosophila melanogaster. Reducing the abundance of CycA in neurons delayed the wake-sleep transition, caused multiple arousals from sleep, and reduced the homeostatic response to sleep deprivation. CycA is expressed in similar to 40 to 50 neurons in the adult brain, most of which are intermingled with circadian clock neurons, suggesting functional interactions among neurons controlling sleep and circadian behavior.	[Rogulja, Dragana; Young, Michael W.] Rockefeller Univ, Genet Lab, New York, NY 10065 USA	Rockefeller University	Young, MW (corresponding author), Rockefeller Univ, Genet Lab, 1230 York Ave, New York, NY 10065 USA.	young@mail.rockefeller.edu	, 机智的马小跳和机智的羊不愁/ABC-5169-2020		NIH [NS053087, GM054339]; Jane Coffin Childs Memorial Fund for Medical Research; Merck fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054339, R37GM054339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053087] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund for Medical Research; Merck fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Allada, B. Dickson, J. Hall, C. Lehner, A. Sehgal, F. Sprenger, and NIG-Fly Stock Center for reagents; N. Stavropoulos for custom MatLab software; and C. Bargmann, M. Crickmore, C. Desplan, A. Keene, S. Shaham, L. Vosshall, and members of the Young lab for helpful discussions and comments on the manuscript. This work was supported by NIH grants NS053087 and GM054339 (to M.W.Y.). D.R. was supported by a postdoctoral fellowship from the Jane Coffin Childs Memorial Fund for Medical Research and by a Merck fellowship.	Boothroyd CE, 2008, ANN NY ACAD SCI, V1129, P350, DOI 10.1196/annals.1417.006; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dong XZ, 1997, GENE DEV, V11, P94, DOI 10.1101/gad.11.1.94; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Grosskortenhaus R, 2002, DEV CELL, V2, P29, DOI 10.1016/S1534-5807(01)00104-6; Helfrich-Forster C, 2005, GENES BRAIN BEHAV, V4, P65, DOI 10.1111/j.1601-183X.2004.00092.X; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Lear BC, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000154; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Odajima J, 2011, DEV CELL, V21, P655, DOI 10.1016/j.devcel.2011.08.009; Ou CY, 2010, CELL, V141, P846, DOI 10.1016/j.cell.2010.04.011; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Rothenfluh A, 2000, GENETICS, V156, P665; Sehgal A, 2011, CELL, V146, P194, DOI 10.1016/j.cell.2011.07.004; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Zielke N, 2006, EMBO REP, V7, P1266, DOI 10.1038/sj.embor.7400851	20	55	55	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1617	1621		10.1126/science.1212476	http://dx.doi.org/10.1126/science.1212476			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461610	Green Accepted			2022-12-28	WOS:000302062600043
J	Haile-Selassie, Y; Saylor, BZ; Deino, A; Levin, NE; Alene, M; Latimer, BM				Haile-Selassie, Yohannes; Saylor, Beverly Z.; Deino, Alan; Levin, Naomi E.; Alene, Mulugeta; Latimer, Bruce M.			A new hominin foot from Ethiopia shows multiple Pliocene bipedal adaptations	NATURE			English	Article							WORANSO-MILLE; CENTRAL AFAR; EARLY AUSTRALOPITHECUS; HADAR FORMATION; EVOLUTION; JOINT; METATARSAL; BONES; ANKLE; FEET	A newly discovered partial hominin foot skeleton from eastern Africa indicates the presence of more than one hominin locomotor adaptation at the beginning of the Late Pliocene epoch. Here we show that new pedal elements, dated to about 3.4 million years ago, belong to a species that does not match the contemporaneous Australopithecus afarensis in its morphology and inferred locomotor adaptations, but instead are more similar to the earlier Ardipithecus ramidus in possessing an opposable great toe. This not only indicates the presence of more than one hominin species at the beginning of the Late Pliocene of eastern Africa, but also indicates the persistence of a species with Ar. ramidus-like locomotor adaptation into the Late Pliocene.	[Haile-Selassie, Yohannes] Cleveland Museum Nat Hist, Cleveland, OH 44106 USA; [Haile-Selassie, Yohannes; Saylor, Beverly Z.; Latimer, Bruce M.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Deino, Alan] Berkeley Geochronol Ctr, Berkeley, CA 94720 USA; [Levin, Naomi E.] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Alene, Mulugeta] Univ Addis Ababa, Addis Ababa, Ethiopia	Cleveland Museum of Natural History; Case Western Reserve University; Berkeley Geochronolgy Center; Johns Hopkins University; Addis Ababa University	Haile-Selassie, Y (corresponding author), Cleveland Museum Nat Hist, Cleveland, OH 44106 USA.	yhailese@cmnh.org	Levin, Naomi E/B-4124-2010	Levin, Naomi E/0000-0001-5703-3717; Haile-Selassie, Yohannes/0000-0001-6423-9705; Saylor, Beverly/0000-0002-1825-8953	LSB Leakey Foundation; National Geographic Society; Cleveland Museum of Natural History; NSF [BCS-0234320, BCS-0321893, BCS-0542037, BCS-1124705]; Direct For Social, Behav & Economic Scie [1125345] Funding Source: National Science Foundation; Division Of Behavioral and Cognitive Sci [1124705] Funding Source: National Science Foundation	LSB Leakey Foundation; National Geographic Society(National Geographic Society); Cleveland Museum of Natural History; NSF(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	We thank the Authority for Research and Conservation of Cultural Heritage and the Afar Regional State of Ethiopia for permission to conduct field and laboratory research, and the Afar people of the Woranso-Mille area for support in the field. We also thank M. Asnake, R. Bernor, S. Frost, D. Geraads, I. Giaourtsakis, M. Lewis, W. Sanders and L. Werdelin for faunal identifications. We thank B. Passey for aid with isotope analyses; E. Guthrie for unpublished primary data; L. Russell for photography; S. Melillo and H. Gebreyesus for fieldwork; O. Lovejoy, S. Simpson, G. Suwa and T. White for comments and discussions; D. Su for discussions and assistance in statistical analysis; and L. Jellema for assistance in photography. This research was supported by funding from the LSB Leakey Foundation, the National Geographic Society, the Cleveland Museum of Natural History, and NSF grants BCS-0234320, BCS-0321893, BCS-0542037 and BCS-1124705.	CLARKE RJ, 1995, SCIENCE, V269, P521, DOI 10.1126/science.7624772; D'Aout K, 2002, AM J PHYS ANTHROPOL, V119, P37, DOI 10.1002/ajpa.10112; DAY MH, 1964, NATURE, V201, P969, DOI 10.1038/201969a0; Deino AL, 2010, J HUM EVOL, V58, P111, DOI 10.1016/j.jhevol.2009.11.001; deMenocal Peter B., 1999, P23; DeSilva JM, 2009, P NATL ACAD SCI USA, V106, P6567, DOI 10.1073/pnas.0900270106; Elftman H, 1935, J ANAT, V70, P56; Elftman H, 1935, AM J PHYS ANTHROPOL, V20, P69, DOI 10.1002/ajpa.1330200109; Feibel CS, 1995, BIOM HUM ANTHR, V4, P149; Griffin NL, 2010, AM J PHYS ANTHROPOL, V141, P116, DOI 10.1002/ajpa.21121; Haile-Selassie Y, 2007, ANTHROPOL SCI, V115, P215, DOI 10.1537/ase.070426; Haile-Selassie Y, 2010, PHILOS T R SOC B, V365, P3323, DOI 10.1098/rstb.2010.0064; Haile-Selassie Y, 2010, P NATL ACAD SCI USA, V107, P12121, DOI 10.1073/pnas.1004527107; Haile-Selassie Y, 2010, AM J PHYS ANTHROPOL, V141, P406, DOI 10.1002/ajpa.21159; Harcourt-Smith WEH, 2004, J ANAT, V204, P403, DOI 10.1111/j.0021-8782.2004.00296.x; Kuiper KF, 2008, SCIENCE, V320, P500, DOI 10.1126/science.1154339; LATIMER B, 1990, AM J PHYS ANTHROPOL, V83, P13, DOI 10.1002/ajpa.1330830103; LATIMER B, 1990, AM J PHYS ANTHROPOL, V82, P125, DOI 10.1002/ajpa.1330820202; LATIMER BM, 1982, AM J PHYS ANTHROPOL, V57, P701, DOI 10.1002/ajpa.1330570412; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175832; McDougall I, 2008, J GEOL SOC LONDON, V165, P549, DOI 10.1144/0016-76492006-170; Passey BH, 2010, P NATL ACAD SCI USA, V107, P11245, DOI 10.1073/pnas.1001824107; Vereecke E, 2003, AM J PHYS ANTHROPOL, V120, P373, DOI 10.1002/ajpa.10163; Walker A.C., 1983, P325; WALTER RC, 1993, J HUM EVOL, V25, P229, DOI 10.1006/jhev.1993.1046; Ward CV, 2011, SCIENCE, V331, P750, DOI 10.1126/science.1201463; WHITE TD, 1987, AM J PHYS ANTHROPOL, V72, P485, DOI 10.1002/ajpa.1330720409; Zipfel B, 2011, SCIENCE, V333, P1417, DOI 10.1126/science.1202703	28	120	123	0	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2012	483	7391					565	U79		10.1038/nature10922	http://dx.doi.org/10.1038/nature10922			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	915EF	22460901				2022-12-28	WOS:000302006100032
J	Jonker, JW; Suh, JM; Atkins, AR; Ahmadian, M; Li, PP; Whyte, J; He, MX; Juguilon, H; Yin, YQ; Phillips, CT; Yu, RT; Olefsky, JM; Henry, RR; Downes, M; Evans, RM				Jonker, Johan W.; Suh, Jae Myoung; Atkins, Annette R.; Ahmadian, Maryam; Li, Pingping; Whyte, Jamie; He, Mingxiao; Juguilon, Henry; Yin, Yun-Qiang; Phillips, Colin T.; Yu, Ruth T.; Olefsky, Jerrold M.; Henry, Robert R.; Downes, Michael; Evans, Ronald M.			A PPAR gamma-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis	NATURE			English	Article							CAUSES INSULIN-RESISTANCE; PPAR-GAMMA; FAT NECROSIS; OBESITY; TISSUE; FIBROBLAST-GROWTH-FACTOR-1; ADIPOCYTES; BIOLOGY; FAMILY; MUSCLE	Although feast and famine cycles illustrate that remodelling of adipose tissue in response to fluctuations in nutrient availability is essential for maintaining metabolic homeostasis, the underlying mechanisms remain poorly understood(1,2). Here we identify fibroblast growth factor 1 (FGF1) as a critical transducer in this process in mice, and link its regulation to the nuclear receptor PPAR gamma (peroxisome proliferator activated receptor gamma), which is the adipocyte master regulator and the target of the thiazolidinedione class of insulin sensitizing drugs(3-5). FGF1 is the prototype of the 22-member FGF family of proteins and has been implicated in a range of physiological processes, including development, wound healing and cardiovascular changes(6). Surprisingly, FGF1 knockout mice display no significant phenotype under standard laboratory conditions(7-9). We show that FGF1 is highly induced in adipose tissue in response to a high-fat diet and that mice lacking FGF1 develop an aggressive diabetic phenotype coupled to aberrant adipose expansion when challenged with a high-fat diet. Further analysis of adipose depots in FGF1-deficient mice revealed multiple histopathologies in the vasculature network, an accentuated inflammatory response, aberrant adipocyte size distribution and ectopic expression of pancreatic lipases. On withdrawal of the high-fat diet, this inflamed adipose tissue fails to properly resolve, resulting in extensive fat necrosis. In terms of mechanisms, we show that adipose induction of FGF1 in the fed state is regulated by PPAR gamma acting through an evolutionarily conserved promoter proximal PPAR response element within the FGF1 gene. The discovery of a phenotype for the FGF1 knockout mouse establishes the PPAR gamma-FGF1 axis as critical for maintaining metabolic homeostasis and insulin sensitization.	[Jonker, Johan W.; Suh, Jae Myoung; Atkins, Annette R.; Ahmadian, Maryam; Whyte, Jamie; He, Mingxiao; Juguilon, Henry; Yin, Yun-Qiang; Phillips, Colin T.; Yu, Ruth T.; Downes, Michael; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Li, Pingping; Olefsky, Jerrold M.; Henry, Robert R.] Univ Calif San Diego, Div Endocrinol & Metab, Dept Med, La Jolla, CA 92093 USA; [Henry, Robert R.] Vet Affairs San Diego Healthcare Syst, Sect Diabetes Metab, San Diego, CA 92161 USA; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Howard Hughes Medical Institute; Salk Institute	Evans, RM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	downes@salk.edu; evans@salk.edu	Evans, Ronald/AAF-4001-2019; Suh, Jae Myoung/B-3268-2015; Li, Pingping/F-1109-2019; Jonker, Johan W./ABE-6853-2020	Evans, Ronald/0000-0002-9986-5965; Suh, Jae Myoung/0000-0001-8097-4662; Li, Pingping/0000-0003-0679-270X; Jonker, Johan W./0000-0002-3919-5437; Yu, Ruth/0000-0002-9527-9627; Phillips, Colin/0000-0002-6543-0234; Atkins, Annette/0000-0003-2558-7058	National Institutes of Health [DK062434, DK057978, DK090962, DK063491, HL105278]; Helmsley Charitable Trust; Howard Hughes Medical Institute; Human Frontier Science Program (HFSP); Netherlands Organization for Scientific Research (NWO); EU [IRG-277169]; NIDDK; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD012303] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, U19DK062434, R01DK033651, R37DK033651, R37DK057978, R24DK090962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmsley Charitable Trust; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); EU(European Commission); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Alvarez, S. Kaufman, N. H. Uhlenhaut, M. Hassan and E. Williams for technical assistance, and L. Ong and S. Ganley for administrative assistance. R. M. E. is an Investigator of the Howard Hughes Medical Institute at the Salk Institute and March of Dimes Chair in Molecular and Developmental Biology. This work was supported by National Institutes of Health grants (DK062434, DK057978, DK090962, DK063491 and HL105278), the Helmsley Charitable Trust, and the Howard Hughes Medical Institute. J. W. J. is supported by the Human Frontier Science Program (HFSP), the Netherlands Organization for Scientific Research (NWO) and an EU Marie Curie Reintegration grant (IRG-277169). M. A. is supported by an F32 Ruth L. Kirschstein National Research Service Award (NIDDK).	Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Chua Felix, 2006, Proc Am Thorac Soc, V3, P424, DOI 10.1513/pats.200603-078AW; Fang S, 2011, P NATL ACAD SCI USA, V108, P3412, DOI 10.1073/pnas.1017707108; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Hutley L, 2004, DIABETES, V53, P3097, DOI 10.2337/diabetes.53.12.3097; Hutley LJ, 2011, MOL CELL ENDOCRINOL, V339, P165, DOI 10.1016/j.mce.2011.04.012; Itoh N, 2008, DEV DYNAM, V237, P18, DOI 10.1002/dvdy.21388; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kharitonenkov A, 2009, CURR OPIN PHARMACOL, V9, P805, DOI 10.1016/j.coph.2009.07.001; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Lee J, 2010, CURR OPIN CLIN NUTR, V13, P371, DOI 10.1097/MCO.0b013e32833aabef; LEE PC, 1979, SURG GYNECOL OBSTET, V148, P39; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Miller DL, 2000, MOL CELL BIOL, V20, P2260, DOI 10.1128/MCB.20.6.2260-2268.2000; Moore DD, 2007, SCIENCE, V316, P1436, DOI 10.1126/science.1144837; MYERS RL, 1993, ONCOGENE, V8, P341; Nofsinger RR, 2008, P NATL ACAD SCI USA, V105, P20021, DOI 10.1073/pnas.0811012105; SCHMITZMOORMANN P, 1978, PATHOL RES PRACT, V163, P93, DOI 10.1016/S0344-0338(78)80078-8; Springer ML, 2000, MOL THER, V1, P82, DOI 10.1006/mthe.1999.0006; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829	31	192	228	3	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2012	485	7398					391	U143		10.1038/nature10998	http://dx.doi.org/10.1038/nature10998			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22522926	Green Accepted			2022-12-28	WOS:000304099100047
J	Goodarzi, H; Najafabadi, HS; Oikonomou, P; Greco, TM; Fish, L; Salavati, R; Cristea, IM; Tavazoie, S				Goodarzi, Hani; Najafabadi, Hamed S.; Oikonomou, Panos; Greco, Todd M.; Fish, Lisa; Salavati, Reza; Cristea, Ileana M.; Tavazoie, Saeed			Systematic discovery of structural elements governing stability of mammalian messenger RNAs	NATURE			English	Article							GENE-EXPRESSION; SECONDARY STRUCTURE; PREDICTION; MOTIFS; CHIP	Decoding post-transcriptional regulatory programs in RNA is a critical step towards the larger goal of developing predictive dynamical models of cellular behaviour. Despite recent efforts(1-3), the vast landscape of RNA regulatory elements remains largely uncharacterized. A long-standing obstacle is the contribution of local RNA secondary structure to the definition of interaction partners in a variety of regulatory contexts, including-but not limited to-transcript stability(3), alternative splicing(4) and localization(3). There are many documented instances where the presence of a structural regulatory element dictates alternative splicing patterns (for example, human cardiac troponin T) or affects other aspects of RNA biology(5). Thus, a full characterization of post-transcriptional regulatory programs requires capturing information provided by both local secondary structures and the underlying sequence(3,6). Here we present a computational framework based on context-free grammars(3,7) and mutual information(2) that systematically explores the immense space of small structural elements and reveals motifs that are significantly informative of genome-wide measurements of RNA behaviour. By applying this framework to genome-wide human mRNA stability data, we reveal eight highly significant elements with substantial structural information, for the strongest of which we show a major role in global mRNA regulation. Through biochemistry, mass spectrometry and in vivo binding studies, we identified human HNRPA2B1 (heterogeneous nuclear ribonucleoprotein A2/B1, also known as HNRNPA2B1) as the key regulator that binds this element and stabilizes a large number of its target genes. We created a global post-transcriptional regulatory map based on the identity of the discovered linear and structural cis-regulatory elements, their regulatory interactions and their target pathways. This approach could also be used to reveal the structural elements that modulate other aspects of RNA behaviour.	[Goodarzi, Hani; Oikonomou, Panos; Tavazoie, Saeed] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08540 USA; [Goodarzi, Hani; Oikonomou, Panos; Greco, Todd M.; Cristea, Ileana M.; Tavazoie, Saeed] Princeton Univ, Dept Mol Biol, Princeton, NJ 08540 USA; [Najafabadi, Hamed S.; Salavati, Reza] McGill Univ, Inst Parasitol, Montreal, PQ H3G 1Y6, Canada; [Najafabadi, Hamed S.; Salavati, Reza] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ H3G 1Y6, Canada; [Fish, Lisa] Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA; [Salavati, Reza] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	Princeton University; Princeton University; McGill University; McGill University; Rockefeller University; McGill University	Tavazoie, S (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	st2744@columbia.edu	Greco, Todd/E-8279-2010; Oikonomou, Panos/J-5106-2014	Greco, Todd/0000-0002-5845-713X; Oikonomou, Panos/0000-0001-7387-0312; Najafabadi, Hamed/0000-0003-2735-4231; Goodarzi, Hani/0000-0002-9648-8949; Fish, Lisa/0000-0001-9184-0512	Ruth L. Kirschstein National Research Service Award [T32-GM066699]; NHGRI [2R01HG003219]; NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026192] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003787] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the members of the Tavazoie laboratory for comments on the project and manuscript. We are also grateful to N. Pencheva, B. Tsui, S. Tavazoie and L. Dolken for their intellectual and technical contributions. L.F. was supported by a Ruth L. Kirschstein National Research Service Award (T32-GM066699). S.T. was supported by grants from NHGRI (2R01HG003219) and the NIH Director's Pioneer Award.	Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; BIAMONTI G, 1994, NUCLEIC ACIDS RES, V22, P1996, DOI 10.1093/nar/22.11.1996; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cutroneo KR, 2006, CRIT REV EUKAR GENE, V16, P23; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Giannopoulou EG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-277; Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016; Greco TM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004317; Hofacker IL, 2002, J MOL BIOL, V319, P1059, DOI 10.1016/S0022-2836(02)00308-X; Jensen Kirk B., 2008, V488, P85, DOI 10.1007/978-1-60327-475-3_6; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, P3258, DOI 10.1093/nar/gkh650; Rabani M, 2008, P NATL ACAD SCI USA, V105, P14885, DOI 10.1073/pnas.0803169105; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Searls DB, 2002, NATURE, V420, P211, DOI 10.1038/nature01255; Wan Y, 2011, NAT REV GENET, V12, P641, DOI 10.1038/nrg3049; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Windbichler N, 2006, NAT PROTOC, V1, P638, DOI 10.1038/nprot.2006.95; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Yang Y, 2011, NAT STRUCT MOL BIOL, V18, P159, DOI 10.1038/nsmb.1959	26	112	117	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2012	485	7397					264	U160		10.1038/nature11013	http://dx.doi.org/10.1038/nature11013			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22495308	Green Submitted, Green Accepted			2022-12-28	WOS:000303799800047
J	Chen, T; Heller, E; Beronja, S; Oshimori, N; Stokes, N; Fuchs, E				Chen, Ting; Heller, Evan; Beronja, Slobodan; Oshimori, Naoki; Stokes, Nicole; Fuchs, Elaine			An RNA interference screen uncovers a new molecule in stem cell self-renewal and long-term regeneration	NATURE			English	Article							DIFFERENTIATION; NICHE; TBX1; PROLIFERATION; INDUCTION; QUIESCENT; DISTINCT; MICE	Adult stem cells sustain tissue maintenance and regeneration throughout the lifetime of an animal(1,2). These cells often reside in specific signalling niches that orchestrate the stem cell's balancing act between quiescence and cell-cycle re-entry based on the demand for tissue regeneration(2-4). How stem cells maintain their capacity to replenish themselves after tissue regeneration is poorly understood. Here we use RNA-interference-based loss-of-function screening as a powerful approach to uncover transcriptional regulators that govern the self-renewal capacity and regenerative potential of stem cells. Hair follicle stem cells provide an ideal model. These cells have been purified and characterized from their native niche in vivo and, in contrast to their rapidly dividing progeny, they can be maintained and passaged long-term in vitro(5-7). Focusing on the nuclear proteins and/or transcription factors that are enriched in stem cells compared with their progeny(5,6), we screened similar to 2,000 short hairpin RNAs for their effect on long-term, but not short-term, stem cell self-renewal in vitro. To address the physiological relevance of our findings, we selected one candidate that was uncovered in the screen: TBX1. This transcription factor is expressed in many tissues but has not been studied in the context of stem cell biology. By conditionally ablating Tbx1 in vivo, we showed that during homeostasis, tissue regeneration occurs normally but is markedly delayed. We then devised an in vivo assay for stem cell replenishment and found that when challenged with repetitive rounds of regeneration, the Tbx1-deficient stem cell niche becomes progressively depleted. Addressing the mechanism of TBX1 action, we discovered that TBX1 acts as an intrinsic rheostat of BMP signalling: it is a gatekeeper that governs the transition between stem cell quiescence and proliferation in hair follicles. Our results validate the RNA interference screen and underscore its power in unearthing new molecules that govern stem cell self-renewal and tissue-regenerative potential.	[Chen, Ting; Heller, Evan; Beronja, Slobodan; Oshimori, Naoki; Stokes, Nicole; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	fuchs@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Beronja, Slobodan/0000-0002-6769-9261	NYSTEM [C026722]; NYSDOH [C023046]; National Institutes of Health [R01-AR050452]; Empire State Stem Cell [NYSTEM N09G074]; New York Stem Cell Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452] Funding Source: NIH RePORTER	NYSTEM; NYSDOH; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Empire State Stem Cell; New York Stem Cell Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to A. Baldini for the Tbx1<SUP>fl/fl</SUP> mice, the Comparative Biology Centre (AAALAC-accredited) for expert handling and care of the mice, The Rockefeller University FCRC for FACS sorting (supported by NYSTEM funds through NYSDOH, contract C023046), S. Dewell and The Rockefeller University Genomic Resource Centre for high-throughput sequencing, The Memorial Sloan Kettering Genomics Core Facility for RNA and microarray processing, Fuchs' lab members Y. Hsu, B. Keyes, X. Wu, D. Devenport and L. Zhang for comments and suggestions, W. H. Lien for providing epigenetic ChIP-seq data for the Tbx1 gene in vivo and P. Janki for assisting in the production of the pooled virus for screening. This work was supported by grants from the National Institutes of Health (R01-AR050452; E. F.), the Empire State Stem Cell (NYSTEM N09G074; E. F.), a New York Stem Cell Foundation-Druckenmiller Fellowship (T. C.) and a NYSTEM Scholar Award (C026722; T. C.). E. F. is an Investigator of the Howard Hughes Medical Institute.	Aggarwal VS, 2010, DEV BIOL, V344, P669, DOI 10.1016/j.ydbio.2010.05.496; Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; BLESSING M, 1993, GENE DEV, V7, P204, DOI 10.1101/gad.7.2.204; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; Chen L, 2009, CIRC RES, V105, P842, DOI 10.1161/CIRCRESAHA.109.200295; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Fulcoli FG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006049; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kulessa H, 2000, EMBO J, V19, P6664, DOI 10.1093/emboj/19.24.6664; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Oshimori N, 2012, CELL STEM CELL, V10, P63, DOI 10.1016/j.stem.2011.11.005; Osorio KM, 2008, DEVELOPMENT, V135, P1059, DOI 10.1242/dev.012799; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Watt FM, 2009, EMBO MOL MED, V1, P260, DOI 10.1002/emmm.200900033; Xu HS, 2004, DEVELOPMENT, V131, P3217, DOI 10.1242/dev.01174; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	31	76	80	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					104	U134		10.1038/nature10940	http://dx.doi.org/10.1038/nature10940			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22495305	Green Accepted			2022-12-28	WOS:000303451900043
J	Pearson, RA; Barber, AC; Rizzi, M; Hippert, C; Xue, T; West, EL; Duran, Y; Smith, AJ; Chuang, JZ; Azam, SA; Luhmann, UFO; Benucci, A; Sung, CH; Bainbridge, JW; Carandini, M; Yau, KW; Sowden, JC; Ali, RR				Pearson, R. A.; Barber, A. C.; Rizzi, M.; Hippert, C.; Xue, T.; West, E. L.; Duran, Y.; Smith, A. J.; Chuang, J. Z.; Azam, S. A.; Luhmann, U. F. O.; Benucci, A.; Sung, C. H.; Bainbridge, J. W.; Carandini, M.; Yau, K. -W.; Sowden, J. C.; Ali, R. R.			Restoration of vision after transplantation of photoreceptors	NATURE			English	Article							RETINITIS-PIGMENTOSA; VISUAL-ACUITY; CONE VISION; WILD-TYPE; MOUSE; MICE; PRECURSORS; ADULT; CELLS; INTEGRATION	Cell transplantation is a potential strategy for treating blindness caused by the loss of photoreceptors. Although transplanted rod-precursor cells are able to migrate into the adult retina and differentiate to acquire the specialized morphological features of mature photoreceptor cells(1), the fundamental question remains whether transplantation of photoreceptor cells can actually improve vision. Here we provide evidence of functional rod-mediated vision after photoreceptor transplantation in adult Gnat1(-/-) mice, which lack rod function and are a model of congenital stationary night blindness(2). We show that transplanted rod precursors form classic triad synaptic connections with second-order bipolar and horizontal cells in the recipient retina. The newly integrated photoreceptor cells are light-responsive with dim-flash kinetics similar to adult wild-type photoreceptors. By using intrinsic imaging under scotopic conditions we demonstrate that visual signals generated by transplanted rods are projected to higher visual areas, including V1. Moreover, these cells are capable of driving optokinetic head tracking and visually guided behaviour in the Gnat1(-/-) mouse under scotopic conditions. Together, these results demonstrate the feasibility of photoreceptor transplantation as a therapeutic strategy for restoring vision after retinal degeneration.	[Pearson, R. A.; Barber, A. C.; Rizzi, M.; Hippert, C.; West, E. L.; Duran, Y.; Smith, A. J.; Azam, S. A.; Luhmann, U. F. O.; Bainbridge, J. W.; Ali, R. R.] UCL, Dept Genet, UCL Inst Ophthalmol, London EC1V 9EL, England; [Benucci, A.; Carandini, M.] UCL, UCL Inst Ophthalmol, Dept Visual Neurosci, London EC1V 9EL, England; [Xue, T.; Yau, K. -W.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Chuang, J. Z.; Sung, C. H.] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, Dyson Vision Res Inst,Dept Ophthalmol, New York, NY 10021 USA; [Sowden, J. C.] UCL, UCL Inst Child Hlth, Dev Biol Unit, London WC1N 1EH, England; [Ali, R. R.] UCL, UCL Inst Child Hlth, Mol Immunol Unit, London WC1N 1EH, England	University of London; University College London; University of London; University College London; Johns Hopkins University; Cornell University; University of London; University College London; University of London; University College London	Pearson, RA (corresponding author), UCL, Dept Genet, UCL Inst Ophthalmol, 11-43 Bath St, London EC1V 9EL, England.	rachael.pearson@ucl.ac.uk; r.ali@ucl.ac.uk	Pearson, Rachael/Y-3339-2018; Smith, Alexander/A-5142-2009; Xue, Tian/G-9009-2018; Luhmann, Ulrich/D-8905-2012; Benucci, Andrea/N-6361-2015; West, Emma L/C-5252-2013; Carandini, Matteo/ABD-8296-2021	Pearson, Rachael/0000-0002-1107-1969; Benucci, Andrea/0000-0002-7698-6289; Carandini, Matteo/0000-0003-4880-7682; Sowden, Jane/0000-0003-0937-2479; Rizzi, Matteo/0000-0003-4922-397X; Ali, Robin/0000-0003-3126-6517; West, Emma/0000-0002-7006-3686; Bainbridge, James/0000-0003-1318-8201	Medical Research Council UK [G03000341]; Wellcome Trust [082217]; Royal Society [RG080398]; British Retinitis Pigmentosa Society [GR566]; Miller's Trust; Department of Health's National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital; Alcon Research Institute; Great Ormond Street Hospital Children's Charity; US National Institutes of Health [EY06837]; Antonio Champalimaud Vision Award (Portugal); Research to Prevent Blindness [EY11307, EY016805]; European Research Council; Medical Research Council [G0800791, MR/J004553/1, G0901550, G0700438] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10130, NIHR-RP-011-003] Funding Source: researchfish; Fight for Sight [1779/80, 1351/52] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1221, V1257] Funding Source: researchfish; MRC [G0700438, MR/J004553/1, G0800791, G0901550] Funding Source: UKRI; NATIONAL EYE INSTITUTE [F32EY006837, R01EY011307, R01EY016805, R01EY006837, R37EY006837] Funding Source: NIH RePORTER	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); British Retinitis Pigmentosa Society; Miller's Trust; Department of Health's National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital(National Institute for Health Research (NIHR)); Alcon Research Institute(Novartis); Great Ormond Street Hospital Children's Charity; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Antonio Champalimaud Vision Award (Portugal); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight; Great Ormond Street Hospital Childrens Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Medical Research Council UK (G03000341), the Wellcome Trust (082217), the Royal Society (RG080398), the British Retinitis Pigmentosa Society (GR566) and The Miller's Trust. R. A. P. is a Royal Society University Research Fellow. R. R. A is partly funded by the Department of Health's National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and Alcon Research Institute. J.C.S. is supported by Great Ormond Street Hospital Children's Charity. T. X. and K.-W.Y. were supported by a US National Institutes of Health grant (EY06837) and the Antonio Champalimaud Vision Award (Portugal). C. H. S. was supported by grants EY11307, EY016805, Research to Prevent Blindness. M. C. holds the GlaxoSmithKline/Fight for Sight Chair in Visual Neuroscience and is supported by the European Research Council. We thank Y. Umino and the late R. Barlow for advice and training with optomotor recordings, A. Eddaoudi for FACS assistance, G. Holder for advice on ERG recordings, C. Hogg for light calibrations, L. Cao for technical suggestions on suction-pipette recordings, and the Department of Genetics, UCL Institute of Ophthalmology, for discussions on the data.	Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Alexander JJ, 2007, NAT MED, V13, P685, DOI 10.1038/nm1596; Bartsch U, 2008, EXP EYE RES, V86, P691, DOI 10.1016/j.exer.2008.01.018; Berson EL, 2007, EXP EYE RES, V85, P7, DOI 10.1016/j.exer.2007.03.001; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Elias R, 2004, MOL VIS, V10, P672; Fu YB, 2008, NAT NEUROSCI, V11, P565, DOI 10.1038/nn.2110; Garner CC, 2000, CURR OPIN NEUROBIOL, V10, P321, DOI 10.1016/S0959-4388(00)00093-3; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Maeda T, 2005, INVEST OPHTH VIS SCI, V46, P4320, DOI 10.1167/iovs.05-0478; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Pearson RA, 2010, CELL TRANSPLANT, V19, P487, DOI 10.3727/096368909X486057; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Schuett S, 2002, J NEUROSCI, V22, P6549; Tan MH, 2009, HUM MOL GENET, V18, P2099, DOI 10.1093/hmg/ddp133; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; West EL, 2008, EXP EYE RES, V86, P601, DOI 10.1016/j.exer.2008.01.004; West EL, 2010, STEM CELLS, V28, P1997, DOI 10.1002/stem.520; Wong AA, 2007, NEUROBIOL AGING, V28, P1577, DOI 10.1016/j.neurobiolaging.2006.07.023	22	337	349	0	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					99	103		10.1038/nature10997	http://dx.doi.org/10.1038/nature10997			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22522934	Green Accepted			2022-12-28	WOS:000303451900042
J	Pauli, H; Gottfried, M; Dullinger, S; Abdaladze, O; Akhalkatsi, M; Alonso, JLB; Coldea, G; Dick, J; Erschbamer, B; Calzado, RF; Ghosn, D; Holten, JI; Kanka, R; Kazakis, G; Kollar, J; Larsson, P; Moiseev, P; Moiseev, D; Molau, U; Mesa, JM; Nagy, L; Pelino, G; Puscas, M; Rossi, G; Stanisci, A; Syverhuset, AO; Theurillat, JP; Tomaselli, M; Unterluggauer, P; Villar, L; Vittoz, P; Grabherr, G				Pauli, Harald; Gottfried, Michael; Dullinger, Stefan; Abdaladze, Otari; Akhalkatsi, Maia; Benito Alonso, Jose Luis; Coldea, Gheorghe; Dick, Jan; Erschbamer, Brigitta; Fernandez Calzado, Rosa; Ghosn, Dany; Holten, Jarle I.; Kanka, Robert; Kazakis, George; Kollar, Jozef; Larsson, Per; Moiseev, Pavel; Moiseev, Dmitry; Molau, Ulf; Molero Mesa, Joaquin; Nagy, Laszlo; Pelino, Giovanni; Puscas, Mihai; Rossi, Graziano; Stanisci, Angela; Syverhuset, Anne O.; Theurillat, Jean-Paul; Tomaselli, Marcello; Unterluggauer, Peter; Villar, Luis; Vittoz, Pascal; Grabherr, Georg			Recent Plant Diversity Changes on Europe's Mountain Summits	SCIENCE			English	Article							CLIMATE-CHANGE; RANGE SHIFTS; VEGETATION; ALPS	In mountainous regions, climate warming is expected to shift species' ranges to higher altitudes. Evidence for such shifts is still mostly from revisitations of historical sites. We present recent (2001 to 2008) changes in vascular plant species richness observed in a standardized monitoring network across Europe's major mountain ranges. Species have moved upslope on average. However, these shifts had opposite effects on the summit floras' species richness in boreal-temperate mountain regions (+3.9 species on average) and Mediterranean mountain regions (-1.4 species), probably because recent climatic trends have decreased the availability of water in the European south. Because Mediterranean mountains are particularly rich in endemic species, a continuation of these trends might shrink the European mountain flora, despite an average increase in summit species richness across the region.	[Gottfried, Michael; Dullinger, Stefan] Univ Vienna, Fac Ctr Biodivers, A-1030 Vienna, Austria; [Pauli, Harald; Grabherr, Georg] Univ Vienna, Austrian Acad Sci, Inst Mt Res, A-1030 Vienna, Austria; [Dullinger, Stefan] Vienna Inst Nat Conservat & Analyses, A-1090 Vienna, Austria; [Abdaladze, Otari; Akhalkatsi, Maia] Ilia State Univ, Inst Ecol, GE-0162 Tbilisi, Georgia; [Benito Alonso, Jose Luis; Villar, Luis] CSIC, Inst Pirenaico Ecol, Jaca 22700, Spain; [Coldea, Gheorghe] Inst Biol Res, Dept Taxon & Plant Ecol, Cluj Napoca 400015, Romania; [Dick, Jan] Ctr Ecol & Hydrol, Penicuik EH26 0QB, Midlothian, Scotland; [Erschbamer, Brigitta] Univ Innsbruck, A-6020 Innsbruck, Austria; [Fernandez Calzado, Rosa; Molero Mesa, Joaquin; Unterluggauer, Peter] Univ Granada, Fac Pharm, Dept Bot, E-18071 Granada, Spain; [Ghosn, Dany; Kazakis, George] Mediterranean Agron Inst Chania, Deptment Environm Management, Khania 73100, Greece; [Holten, Jarle I.; Syverhuset, Anne O.] Norwegian Univ Sci & Technol, Dept Biol, N-7491 Trondheim, Norway; [Kanka, Robert; Kollar, Jozef] Slovak Acad Sci, Inst Landscape Ecol, Bratislava 81499, Slovakia; [Larsson, Per; Molau, Ulf] Univ Goteborg, Dept Plant & Environm Sci, S-40530 Gothenburg, Sweden; [Moiseev, Pavel; Moiseev, Dmitry] Russian Acad Sci, Inst Plant & Anim Ecol, Ekaterinburg 620144, Russia; [Nagy, Laszlo] EcoSci Scotland, Glasgow G41 4QP, Lanark, Scotland; [Nagy, Laszlo] Inst Nacl de Pesquisas da Amazonia, BR-2936 Manaus, Amazonas, Brazil; [Pelino, Giovanni; Stanisci, Angela] Univ Molise, Lab Environmetr, I-86090 Pesche, Italy; [Puscas, Mihai] Univ Babes Bolyai, Alexandru Borza Bot Garden, Cluj Napoca 400015, Romania; [Rossi, Graziano] Univ Pavia, Dept Earth & Environm Sci, I-27100 Pavia, Italy; [Theurillat, Jean-Paul] Fdn JM Aubert, Ctr Alpien Phytogeog, CH-1938 Champex Lac, Switzerland; [Theurillat, Jean-Paul] Univ Geneva, Sect Biol, CH-1292 Chambesy, Switzerland; [Tomaselli, Marcello] Univ Parma, Dept Evolutionary & Funct Biol, I-43100 Parma, Italy; [Vittoz, Pascal] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland	University of Vienna; Austrian Academy of Sciences; University of Vienna; Ilia State University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); National Research Institute for Biological Sciences; UK Centre for Ecology & Hydrology (UKCEH); University of Innsbruck; University of Granada; CIHEAM; CIHEAM IAM Chania; Norwegian University of Science & Technology (NTNU); Slovak Academy of Sciences; University of Gothenburg; Russian Academy of Sciences; Institute of Plant & Animal Ecology of the Russian Academy of Sciences; Institute Nacional de Pesquisas da Amazonia; University of Molise; Babes Bolyai University from Cluj; University of Pavia; University of Geneva; University of Parma; University of Lausanne	Gottfried, M (corresponding author), Univ Vienna, Fac Ctr Biodivers, A-1030 Vienna, Austria.	michael.gottfried@univie.ac.at	Gottfried, Michael/C-2923-2011; Akhalkatsi, Maia/B-2187-2008; Theurillat, Jean-Paul/AAS-4676-2021; Puscas, Mihai/C-4689-2012; Stanisci, Angela/F-4725-2012; Garden, Alexandru Borza Botanic/J-8087-2012; Coldea, Gheorghe/C-3929-2012; Ghosn, Dany/AAL-9131-2020; Moiseev, Pavel A/M-9132-2013; Dick, Jan/I-6839-2012; Mesa, Joaquín Molero/L-2790-2014; Nagy, Laszlo/A-7689-2014; Rossi, Graziano/P-3353-2015	Akhalkatsi, Maia/0000-0002-9770-7840; Theurillat, Jean-Paul/0000-0002-1843-5809; Puscas, Mihai/0000-0002-2632-640X; Ghosn, Dany/0000-0003-1898-9681; Moiseev, Pavel A/0000-0003-4808-295X; Rossi, Graziano/0000-0002-5102-5019; Stanisci, Angela/0000-0002-5302-0932; tomaselli, marcello/0000-0003-4208-3433; Molero Mesa, Joaquin/0000-0003-3106-8414; Vittoz, Pascal/0000-0003-4218-4517; Pauli, Harald/0000-0002-9842-9934; Benito Alonso, Jose Luis/0000-0003-1086-8834; Dullinger, Stefan/0000-0003-3919-0887	Switzerland (OFES) [00.0184-1]; Swiss MAVA Foundation for Nature Conservation; Austrian Federal Ministry of Science and Research; Austrian Academy of Sciences (Institute of Mountain Research); University of Vienna; Natural Environment Research Council [CEH010021] Funding Source: researchfish	Switzerland (OFES); Swiss MAVA Foundation for Nature Conservation; Austrian Federal Ministry of Science and Research; Austrian Academy of Sciences (Institute of Mountain Research); University of Vienna; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Baseline data were collected within the European Union FP-5 project GLORIA-Europe (EVK2-CT-2000-0006) and with the support of Switzerland (OFES 00.0184-1). Resurvey was supported by the Swiss MAVA Foundation for Nature Conservation and by a number of national funding agencies, and analysis was supported by the Austrian Federal Ministry of Science and Research; the Austrian Academy of Sciences (Institute of Mountain Research); and the University of Vienna, where data are archived in the central GLORIA database and are available from the authors upon request. We thank the European Topic Centre on Biological Diversity for ambituos discussions in the early stage, C. Klettner for data compilation, S. Laimer for administration assistance, 17 GLORIA-Europe field teams with more than 80 fieldworkers for species recording, and protected-area authorities for logistic support. We also thank three anonymous referees for their valuable comments and suggestions.	Benito B, 2011, CLIMATIC CHANGE, V108, P471, DOI 10.1007/s10584-010-0015-3; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; del Rio S, 2011, INT J CLIMATOL, V31, P656, DOI 10.1002/joc.2111; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; Feeley KJ, 2011, J BIOGEOGR, V38, P783, DOI 10.1111/j.1365-2699.2010.02444.x; Gottfried M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/1/014013; Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/nclimate1329, 10.1038/NCLIMATE1329]; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Klanderud K, 2003, HOLOCENE, V13, P1, DOI 10.1191/0959683603hl589ft; Mariotti A, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/4/044001; McCain CM, 2011, ECOL LETT, V14, P1236, DOI 10.1111/j.1461-0248.2011.01695.x; Bravo DN, 2008, AMBIO, V37, P280, DOI 10.1579/0044-7447(2008)37[280:CCIMMD]2.0.CO;2; Pauli H, 2004, GLORIA FIELD MANUAL; Pauli H, 2007, GLOBAL CHANGE BIOL, V13, P147, DOI 10.1111/j.1365-2486.2006.01282.x; Theurillat JP, 2001, CLIMATIC CHANGE, V50, P77, DOI 10.1023/A:1010632015572; Thompson, 2003, ALPINE BIODIVERSITY, V167; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Toreti A, 2009, INT J CLIMATOL, V29, P1976, DOI 10.1002/joc.1840; Van de Ven CM, 2007, EARTH INTERACT, V11, DOI 10.1175/EI205.1; Vittoz P, 2008, J VEG SCI, V19, P671, DOI 10.3170/2008-8-18434; Walter H., 1991, SPEZIELLE OKOLOGIE G; Walther GR, 2005, J VEG SCI, V16, P541, DOI 10.1111/j.1654-1103.2005.tb02394.x	26	582	615	19	446	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2012	336	6079					353	355		10.1126/science.1219033	http://dx.doi.org/10.1126/science.1219033			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22517860	Green Submitted			2022-12-28	WOS:000302995400048
J	Appleby, J				Appleby, John			Drinking nation: have we had enough?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London W1G 0AN, England		Appleby, J (corresponding author), Kings Fund, London W1G 0AN, England.	j.appleby@kingsfund.org.uk						Collis J., 2010, 10 HMRC; Hawkes N, 2012, ALCOHOL GUIDE PERPLE; HM Revenue and Customs, 2012, PERS INC STAT 2009 1; Purshouse R, 2009, MODELLING A IN PRESS; Secretary of State for the Home Department, 2012, CMND8336; The NHS and Social Care Information Centre, 2011, GP EARN EXP 2009 10	6	5	5	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 17	2012	344								e2634	10.1136/bmj.e2634	http://dx.doi.org/10.1136/bmj.e2634			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	931CN	22511304				2022-12-28	WOS:000303192100020
J	Cicerone, RJ; Molina, MJ; Blake, DR				Cicerone, Ralph J.; Molina, Mario J.; Blake, Donald R.			F. Sherwood Rowland (1927-2012)	SCIENCE			English	Biographical-Item									[Cicerone, Ralph J.] Natl Acad Sci, Washington, DC 20001 USA; [Molina, Mario J.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Blake, Donald R.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	National Academies of Sciences, Engineering & Medicine; University of California System; University of California San Diego; University of California System; University of California Irvine	Cicerone, RJ (corresponding author), Natl Acad Sci, 500 5th St NW, Washington, DC 20001 USA.	rcicerone@nas.edu; mjmolina@ucsd.edu; drblake@uci.edu		Blake, Donald/0000-0002-8283-5014				ROWLAND FS, PUBLICATION LIST	1	0	0	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2012	336	6078					170	170		10.1126/science.1222108	http://dx.doi.org/10.1126/science.1222108			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924PN	22499934				2022-12-28	WOS:000302703900035
J	Hodges, A				Hodges, Andrew			Beyond Turing's Machines	SCIENCE			English	Editorial Material									Univ Oxford Wadham Coll, Oxford OX1 3PN, England	University of Oxford	Hodges, A (corresponding author), Univ Oxford Wadham Coll, Oxford OX1 3PN, England.	andrew.hodges@wadh.ox.ac.uk						Davis M., 2012, UNIVERSAL COMPUTER R; French RM, 2012, SCIENCE, V336, P164, DOI 10.1126/science.1218350; Hodges A., 2012, 1983 ALAN TURING ENI, VThe Centenary Edition, DOI [10.1515/9781400844975, DOI 10.1515/9781400844975]; Penrose R., 1989, EMPERORS NEW MIND; Turing A.M., 1950, MIND, P433, DOI DOI 10.1093/MIND/LIX.236.433; Turing AM, 1939, P LOND MATH SOC, V45, P161; Turing AM, 1937, P LOND MATH SOC, V42, P230, DOI 10.1112/plms/s2-42.1.230	7	9	9	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2012	336	6078					163	164		10.1126/science.1218417	http://dx.doi.org/10.1126/science.1218417			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924PN	22499929				2022-12-28	WOS:000302703900030
J	Maurer, SP; Fourniol, FJ; Bohner, G; Moores, CA; Surrey, T				Maurer, Sebastian P.; Fourniol, Franck J.; Bohner, Gergo; Moores, Carolyn A.; Surrey, Thomas			EBs Recognize a Nucleotide-Dependent Structural Cap at Growing Microtubule Ends	CELL			English	Article							ALPHA-BETA-TUBULIN; TRACKING PROTEINS; GTP HYDROLYSIS; DYNAMICS; LATTICE; CLIP-170; HOMOLOG; STABILIZES; ACTIVATION; MECHANISM	Growing microtubule ends serve as transient binding platforms for essential proteins that regulate microtubule dynamics and their interactions with cellular substructures. End-binding proteins (EBs) autonomously recognize an extended region at growing microtubule ends with unknown structural characteristics and then recruit other factors to the dynamic end structure. Using cryo-electron microscopy, subnanometer single-particle reconstruction, and fluorescence imaging, we present a pseudoatomic model of how the calponin homology (CH) domain of the fission yeast EB Mal3 binds to the end regions of growing microtubules. The Mal3 CH domain bridges protofilaments except at the microtubule seam. By binding close to the exchangeable GTP-binding site, the CH domain is ideally positioned to sense the microtubule's nucleotide state. The same microtubule-end region is also a stabilizing structural cap protecting the microtubule from depolymerization. This insight supports a common structural link between two important biological phenomena, microtubule dynamic instability and end tracking.	[Moores, Carolyn A.] Univ London Birkbeck Coll, Inst Struct & Mol Biol, London WC1E 7HX, England; [Maurer, Sebastian P.; Fourniol, Franck J.; Bohner, Gergo; Surrey, Thomas] Canc Res UK London Res Inst, Lincolns Inn Fields Labs, London WC2A 3LY, England; [Maurer, Sebastian P.; Surrey, Thomas] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany	University of London; Birkbeck University London; Cancer Research UK; European Molecular Biology Laboratory (EMBL)	Moores, CA (corresponding author), Univ London Birkbeck Coll, Inst Struct & Mol Biol, London WC1E 7HX, England.	c.moores@mail.cryst.bbk.ac.uk; thomas.surrey@cancer.org.uk	Moores, Carolyn A/R-2497-2019; Maurer, Sebastian P/D-4727-2009; Surrey, Thomas/AAC-4608-2021	Moores, Carolyn A/0000-0001-5686-6290; Maurer, Sebastian P/0000-0003-4532-1994; Surrey, Thomas/0000-0001-9082-1870	Cancer Research UK; Marie Curie fellowship [PIEF-GA-2009-253043]; EMBO [ALTF 1032-2009, ALTF 219-2011]; Wellcome Trust [WT085945, WT079605]; MRC [MR/J000973/1] Funding Source: UKRI; Cancer Research UK [14256] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Marie Curie fellowship(European Commission); EMBO(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK)	We thank Charles Sindelar for his microtubule-processing scripts; Maya Topf for assistance with Flex-EM; Kevin Slep for sharing unpublished data; Claude Antony, Rachel Santarella, and James Riches for EM support and discussions; Nicholas Cade for support with TIRF microscopy; and Peter Bieling, Jan Ellenberg, Takashi Toda, Frank Uhlmann, and Gabriel Waksman for critical comments on the manuscript. This work was supported by Cancer Research UK. S. P. M. is supported by Marie Curie (PIEF-GA-2009-253043) and EMBO (ALTF 1032-2009) fellowships. F.J.F. is supported by an EMBO fellowship (ALTF 219-2011). C. A. M. is supported by a Wellcome Trust University Award (WT085945) and a Wellcome Trust Equipment Grant (WT079605).	Akhmanova A, 2010, J CELL SCI, V123, P3415, DOI 10.1242/jcs.062414; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Browning H, 2003, NAT CELL BIOL, V5, P812, DOI 10.1038/ncb1034; Busch KE, 2004, CURR BIOL, V14, P548, DOI 10.1016/j.cub.2004.03.029; Caplow M, 1996, MOL BIOL CELL, V7, P663, DOI 10.1091/mbc.7.4.663; CARLIER MF, 1984, P NATL ACAD SCI-BIOL, V81, P771, DOI 10.1073/pnas.81.3.771; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; des Georges A, 2008, NAT STRUCT MOL BIOL, V15, P1102, DOI 10.1038/nsmb.1482; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; DRECHSEL DN, 1994, CURR BIOL, V4, P1053, DOI 10.1016/S0960-9822(00)00243-8; Fourniol FJ, 2010, J CELL BIOL, V191, P463, DOI 10.1083/jcb.201007081; Galjart N, 2010, CURR BIOL, V20, pR528, DOI 10.1016/j.cub.2010.05.022; Gardner MK, 2011, CELL, V146, P582, DOI 10.1016/j.cell.2011.06.053; Gouveia SM, 2010, CURR BIOL, V20, P1717, DOI 10.1016/j.cub.2010.08.020; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Honnappa S, 2006, MOL CELL, V23, P663, DOI 10.1016/j.molcel.2006.07.013; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; Iimori M, 2012, EXP CELL RES, V318, P262, DOI 10.1016/j.yexcr.2011.11.006; Katsuki M, 2009, J BIOL CHEM, V284, P29246, DOI 10.1074/jbc.C109.052159; Komarova YA, 2002, J CELL BIOL, V159, P589, DOI 10.1083/jcb.200208058; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Kueh HY, 2009, SCIENCE, V325, P960, DOI 10.1126/science.1168823; Kukulski W, 2011, J CELL BIOL, V192, P111, DOI 10.1083/jcb.201009037; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Maurer SP, 2011, P NATL ACAD SCI USA, V108, P3988, DOI 10.1073/pnas.1014758108; McIntosh JR, 2009, J MOL BIOL, V394, P177, DOI 10.1016/j.jmb.2009.09.033; Meurer-Grob P, 2001, BIOCHEMISTRY-US, V40, P8000, DOI 10.1021/bi010343p; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mizuno N, 2004, EMBO J, V23, P2459, DOI 10.1038/sj.emboj.7600240; Nawrotek A, 2011, J MOL BIOL, V412, P35, DOI 10.1016/j.jmb.2011.07.029; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; REIJO RA, 1994, MOL BIOL CELL, V5, P29, DOI 10.1091/mbc.5.1.29; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Richards KL, 2000, MOL BIOL CELL, V11, P1887, DOI 10.1091/mbc.11.5.1887; Ruhnow F, 2011, BIOPHYS J, V100, P2820, DOI 10.1016/j.bpj.2011.04.023; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sandblad L, 2006, CELL, V127, P1415, DOI 10.1016/j.cell.2006.11.025; Schek HT, 2007, CURR BIOL, V17, P1445, DOI 10.1016/j.cub.2007.07.011; Sindelar CV, 2010, P NATL ACAD SCI USA, V107, P4111, DOI 10.1073/pnas.0911208107; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Sui HX, 2010, STRUCTURE, V18, P1022, DOI 10.1016/j.str.2010.05.010; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Topf M, 2008, STRUCTURE, V16, P295, DOI 10.1016/j.str.2007.11.016; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; Zanic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007585; Zimniak T, 2009, J CELL BIOL, V186, P379, DOI 10.1083/jcb.200901036	58	246	249	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 13	2012	149	2					371	382		10.1016/j.cell.2012.02.049	http://dx.doi.org/10.1016/j.cell.2012.02.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500803	Green Published, hybrid			2022-12-28	WOS:000302805600016
J	Redmond, SA; Chan, JR				Redmond, Stephanie A.; Chan, Jonah R.			Revitalizing Remyelination-the Answer Is Circulating	SCIENCE			English	Editorial Material							DIFFERENTIATION		[Redmond, Stephanie A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Redmond, SA (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA.	jonah.chan@ucsf.edu		Redmond, Stephanie/0000-0002-5580-6269	NINDS NIH HHS [R01 NS062796] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062796] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chong SYC, 2012, P NATL ACAD SCI USA, V109, P1299, DOI 10.1073/pnas.1113540109; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Durafourt BA, 2012, GLIA, V60, P717, DOI 10.1002/glia.22298; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357	9	5	5	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2012	336	6078					161	162		10.1126/science.1221689	http://dx.doi.org/10.1126/science.1221689			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924PN	22499927				2022-12-28	WOS:000302703900028
J	Shulman, MD; Dial, OE; Harvey, SP; Bluhm, H; Umansky, V; Yacoby, A				Shulman, M. D.; Dial, O. E.; Harvey, S. P.; Bluhm, H.; Umansky, V.; Yacoby, A.			Demonstration of Entanglement of Electrostatically Coupled Singlet-Triplet Qubits	SCIENCE			English	Article							ELECTRON SPIN; QUANTUM COMPUTATION; DOTS; BITS	Quantum computers have the potential to solve certain problems faster than classical computers. To exploit their power, it is necessary to perform interqubit operations and generate entangled states. Spin qubits are a promising candidate for implementing a quantum processor because of their potential for scalability and miniaturization. However, their weak interactions with the environment, which lead to their long coherence times, make interqubit operations challenging. We performed a controlled two-qubit operation between singlet-triplet qubits using a dynamically decoupled sequence that maintains the two-qubit coupling while decoupling each qubit from its fluctuating environment. Using state tomography, we measured the full density matrix of the system and determined the concurrence and the fidelity of the generated state, providing proof of entanglement.	[Shulman, M. D.; Dial, O. E.; Harvey, S. P.; Bluhm, H.; Yacoby, A.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Umansky, V.] Weizmann Inst Sci, Dept Condensed Matter Phys, Braun Ctr Submicron Res, IL-76100 Rehovot, Israel	Harvard University; Weizmann Institute of Science	Yacoby, A (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	yacoby@physics.harvard.edu	Umansky, Vladimir/P-1334-2019; Bluhm, Hendrik/D-3422-2014	Umansky, Vladimir/0000-0001-5727-2064; Bluhm, Hendrik/0000-0002-5224-7254; Harvey, Shannon/0000-0002-7272-3609	U.S. Army Research Office (ARO); ARO [W911NF-11-1-0068]; National Science Foundation [ECS-0335765]	U.S. Army Research Office (ARO); ARO; National Science Foundation(National Science Foundation (NSF))	This work is supported through the U.S. Army Research Office (ARO) Precision Quantum Control and Error-Suppressing Quantum Firmware for Robust Quantum Computing and the Intelligence Advanced Research Projects Activity (IARPA) Multi-Qubit Coherent Operations (MQCO) Program. This work was partially supported by the ARO under contract W911NF-11-1-0068. This work was performed in part at the Center for Nanoscale Systems (CNS), a member of the National Nanotechnology Infrastructure Network (NNIN), which is supported by the National Science Foundation under NSF award ECS-0335765. CNS is part of Harvard University. V.U. prepared the crystal; M.D.S. fabricated the sample; and M.D.S., O.E.D., H.B., S.P.H., and A.Y. carried out the experiment, analyzed the data, and wrote the paper. The authors declare no competing financial interests.	Ansmann M, 2009, NATURE, V461, P504, DOI 10.1038/nature08363; Barthel C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.160503; Bennett CH, 1996, PHYS REV LETT, V76, P722, DOI 10.1103/PhysRevLett.76.722; Bluhm H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.216803; Churchill HOH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.166802; Cywinski L, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.174509; Daniel F. V., 2001, PHYS REV A; Foletti S, 2009, NAT PHYS, V5, P903, DOI 10.1038/NPHYS1424; HAHN EL, 1950, PHYS REV, V80, P580, DOI 10.1103/PhysRev.80.580; Hill S, 1997, PHYS REV LETT, V78, P5022, DOI 10.1103/PhysRevLett.78.5022; Koppens FHL, 2006, NATURE, V442, P766, DOI 10.1038/nature05065; Leibfried D, 2003, NATURE, V422, P412, DOI 10.1038/nature01492; Levy J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.147902; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Nadj-Perge S, 2010, NATURE, V468, P1084, DOI 10.1038/nature09682; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Nowack KC, 2007, SCIENCE, V318, P1430, DOI 10.1126/science.1148092; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Pioro-Ladriere M, 2008, NAT PHYS, V4, P776, DOI 10.1038/nphys1053; Pioro-Ladriere M, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2430906; Reilly DJ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2794995; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; Taylor JM, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.035315; Taylor JM, 2005, NAT PHYS, V1, P177, DOI 10.1038/nphys174; Trifunovic L, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.011006; Viola L, 1999, PHYS REV LETT, V82, P2417, DOI 10.1103/PhysRevLett.82.2417; Yu T, 2006, OPT COMMUN, V264, P393, DOI 10.1016/j.optcom.2006.01.061	28	439	450	7	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2012	336	6078					202	205		10.1126/science.1217692	http://dx.doi.org/10.1126/science.1217692			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924PN	22499942	Green Submitted			2022-12-28	WOS:000302703900043
J	Hickman, AJ; Sanford, MS				Hickman, Amanda J.; Sanford, Melanie S.			High-valent organometallic copper and palladium in catalysis	NATURE			English	Review							C-H ACTIVATION; CROSS-COUPLING REACTIONS; X-RAY-STRUCTURE; REDUCTIVE-ELIMINATION; BOND-FORMATION; CONJUGATE ADDITION; OXIDATIVE-ADDITION; SUBSTITUTION-REACTIONS; TERMINAL ALKYNES; ARYL	Copper and palladium catalysts are critically important in numerous commercial chemical processes. Improvements in the activity, selectivity and scope of these catalysts could drastically reduce the environmental impact, and increase the sustainability, of chemical reactions. One rapidly developing strategy for achieving these goals is to use 'high-valent' organometallic copper and palladium intermediates in catalysis. Here we describe recent advances involving both the fundamental chemistry and the applications of these high-valent metal complexes in numerous synthetically useful catalytic transformations.	[Hickman, Amanda J.; Sanford, Melanie S.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Sanford, MS (corresponding author), Univ Michigan, Dept Chem, 930 N Univ Ave, Ann Arbor, MI 48109 USA.	mssanfor@umich.edu	Sanford, Melanie/G-8619-2016	Sanford, Melanie/0000-0001-9342-9436	NIH-NIGMS [GM073836]; US NSF [CHE-0545909, CHE-1111563]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073836] Funding Source: NIH RePORTER	NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work of the group of M. S. S. described herein was supported by the NIH-NIGMS (GM073836) and by the US NSF (CHE-0545909 and CHE-1111563).	Alexakis A, 1997, TETRAHEDRON LETT, V38, P7745, DOI 10.1016/S0040-4039(97)10068-5; ALSTERS PL, 1993, ORGANOMETALLICS, V12, P1831, DOI 10.1021/om00029a045; Arnold PL, 2009, J AM CHEM SOC, V131, P13912, DOI 10.1021/ja905713t; Ball ND, 2011, J AM CHEM SOC, V133, P7577, DOI 10.1021/ja201726q; Ball ND, 2009, J AM CHEM SOC, V131, P3796, DOI 10.1021/ja8054595; Bartholomew ER, 2008, J AM CHEM SOC, V130, P11244, DOI 10.1021/ja801186c; Bartholomew ER, 2008, CHEM COMMUN, P1176, DOI 10.1039/b717290g; Beletskaya IP, 2004, COORDIN CHEM REV, V248, P2337, DOI 10.1016/j.ccr.2004.09.014; Bertz SH, 1996, CHEM COMMUN, P815, DOI 10.1039/cc9960000815; Bertz SH, 2007, ANGEW CHEM INT EDIT, V46, P7082, DOI 10.1002/anie.200703035; Bertz SH, 2007, J AM CHEM SOC, V129, P7208, DOI 10.1021/ja067533d; Brasche G, 2008, ANGEW CHEM INT EDIT, V47, P1932, DOI 10.1002/anie.200705420; BYERS PK, 1986, J CHEM SOC CHEM COMM, P1722, DOI 10.1039/c39860001722; Canty AJ, 2009, DALTON T, P10409, DOI 10.1039/b914080h; Casitas A, 2011, J AM CHEM SOC, V133, P19386, DOI 10.1021/ja2058567; Casitas A, 2010, CHEM SCI, V1, P326, DOI 10.1039/c0sc00245c; Ceder RM, 1996, ORGANOMETALLICS, V15, P4618, DOI 10.1021/om960309k; Chan DMT, 2005, BORONIC ACIDS: PREPARATION AND APPLICATIONS IN ORGANIC SYNTHESIS AND MEDICINE, P205, DOI 10.1002/3527606548.ch5; Chen B, 2011, J AM CHEM SOC, V133, P7668, DOI 10.1021/ja201425e; Chen X, 2006, J AM CHEM SOC, V128, P6790, DOI 10.1021/ja061715q; Cho EJ, 2010, SCIENCE, V328, P1679, DOI 10.1126/science.1190524; COHEN T, 1974, TETRAHEDRON LETT, P3555; Collman J. P., 1982, PRINCIPLES APPL ORGA, P322; Corbet JP, 2006, CHEM REV, V106, P2651, DOI 10.1021/cr0505268; Cotton FA, 2006, J AM CHEM SOC, V128, P13674, DOI 10.1021/ja0656595; Das P, 2010, CURR ORG CHEM, V14, P754, DOI 10.2174/138527210791111830; Deprez NR, 2009, J AM CHEM SOC, V131, P11234, DOI 10.1021/ja904116k; Deprez NR, 2006, J AM CHEM SOC, V128, P4972, DOI 10.1021/ja060809x; Dick AR, 2004, J AM CHEM SOC, V126, P2300, DOI 10.1021/ja031543m; DORIGO AE, 1995, ANGEW CHEM INT EDIT, V34, P476, DOI 10.1002/anie.199504761; Evano G, 2008, CHEM REV, V108, P3054, DOI 10.1021/cr8002505; FAHEY DR, 1971, J ORGANOMET CHEM, V27, P283; Fleischmann F., 2006, ULLMANNS ENCY IND CH, P191; Furuta H, 2000, J AM CHEM SOC, V122, P803, DOI 10.1021/ja992679g; Furuya T, 2010, J AM CHEM SOC, V132, P3793, DOI 10.1021/ja909371t; Gartner T, 2007, J AM CHEM SOC, V129, P11362, DOI 10.1021/ja074788y; Gao YX, 2009, J AM CHEM SOC, V131, P7956, DOI 10.1021/ja9023397; GROVE DM, 1983, J AM CHEM SOC, V105, P1379, DOI 10.1021/ja00343a056; Grushin VV, 2010, ACCOUNTS CHEM RES, V43, P160, DOI 10.1021/ar9001763; Hamada T, 2008, J AM CHEM SOC, V130, P833, DOI 10.1021/ja077406x; Hartwig JF, 2007, INORG CHEM, V46, P1936, DOI 10.1021/ic061926w; HECK RF, 1968, J AM CHEM SOC, V90, P5538, DOI 10.1021/ja01022a038; Hickman AJ, 2011, ACS CATAL, V1, P170, DOI 10.1021/cs1001543; Higgs AT, 2009, ORGANOMETALLICS, V28, P6142, DOI 10.1021/om900849m; Hu HP, 2007, J AM CHEM SOC, V129, P7210, DOI 10.1021/ja0675346; Huffman LM, 2008, J AM CHEM SOC, V130, P9196, DOI 10.1021/ja802123p; Hull KL, 2006, J AM CHEM SOC, V128, P14047, DOI 10.1021/ja065718e; Jones GO, 2010, J AM CHEM SOC, V132, P6205, DOI 10.1021/ja100739h; Kalyani D, 2010, J AM CHEM SOC, V132, P8419, DOI 10.1021/ja101851v; Karlstrom ASE, 2001, CHEM-EUR J, V7, P1981, DOI 10.1002/1521-3765(20010504)7:9<1981::AID-CHEM1981>3.0.CO;2-C; King AE, 2010, J AM CHEM SOC, V132, P12068, DOI 10.1021/ja1045378; Krause N, 2002, MODERN ORGANOCOPPER CHEMISTRY, P145, DOI 10.1002/3527600086.ch4; Kunz K, 2003, SYNLETT, P2428, DOI 10.1055/s-2003-42473; Lin BL, 2002, J AM CHEM SOC, V124, P2890, DOI 10.1021/ja017652n; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; Magano J, 2011, CHEM REV, V111, P2177, DOI 10.1021/cr100346g; Michael FE, 2008, ORG LETT, V10, P793, DOI 10.1021/ol702922c; Mizuhara T, 2009, CHEM COMMUN, P3413, DOI 10.1039/b905586j; Monnier F, 2009, ANGEW CHEM INT EDIT, V48, P6954, DOI 10.1002/anie.200804497; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Muniz K, 2007, ANGEW CHEM INT EDIT, V46, P7125, DOI 10.1002/anie.200702160; Muniz K, 2009, ANGEW CHEM INT EDIT, V48, P9412, DOI 10.1002/anie.200903671; Nakamura E, 2000, ANGEW CHEM INT EDIT, V39, P3750, DOI 10.1002/1521-3773(20001103)39:21<3750::AID-ANIE3750>3.0.CO;2-L; Oestreich M., 2009, MIZOROKI HECK REACTI; Phipps RJ, 2008, J AM CHEM SOC, V130, P8172, DOI 10.1021/ja801767s; Phipps RJ, 2009, SCIENCE, V323, P1593, DOI 10.1126/science.1169975; Powers DC, 2010, J AM CHEM SOC, V132, P14530, DOI 10.1021/ja1054274; Powers DC, 2009, J AM CHEM SOC, V131, P17050, DOI 10.1021/ja906935c; Racowski JM, 2011, J AM CHEM SOC, V133, P18022, DOI 10.1021/ja2051099; Ribas X, 2002, ANGEW CHEM INT EDIT, V41, P2991, DOI 10.1002/1521-3773(20020816)41:16<2991::AID-ANIE2991>3.0.CO;2-6; Ribas X., 2010, IDEAS CHEM MOL SCI C, P31; Rosewall CF, 2009, J AM CHEM SOC, V131, P9488, DOI 10.1021/ja9031659; Roy AH, 2003, J AM CHEM SOC, V125, P13944, DOI 10.1021/ja037959h; Santo R, 2006, ANGEW CHEM INT EDIT, V45, P7611, DOI 10.1002/anie.200603127; Sehnal P, 2010, CHEM REV, V110, P824, DOI 10.1021/cr9003242; Siemsen P, 2000, ANGEW CHEM INT EDIT, V39, P2633; SNYDER JP, 1995, J AM CHEM SOC, V117, P11025, DOI 10.1021/ja00149a033; Sperotto E, 2010, DALTON T, V39, P10338, DOI 10.1039/c0dt00674b; Tang PP, 2010, J AM CHEM SOC, V132, P12150, DOI 10.1021/ja105834t; Torborg C, 2009, ADV SYNTH CATAL, V351, P3027, DOI 10.1002/adsc.200900587; TREMONT SJ, 1984, J AM CHEM SOC, V106, P5759, DOI 10.1021/ja00331a073; Tye JW, 2008, J AM CHEM SOC, V130, P9971, DOI 10.1021/ja076668w; Ueda S, 2008, ANGEW CHEM INT EDIT, V47, P6411, DOI 10.1002/anie.200801240; Ueda S, 2009, J ORG CHEM, V74, P4272, DOI 10.1021/jo900513z; Uemura T, 2006, CHEM LETT, V35, P842, DOI 10.1246/cl.2006.842; Ullmann F, 1904, BER DTSCH CHEM GES, V37, P853, DOI 10.1002/cber.190403701141; Ullmann F., 1903, BER DTSCH CHEM GES 2, V36, P2382, DOI DOI 10.1002/CBER.190303602174; Vicente J, 2011, INORG CHEM, V50, P5339, DOI 10.1021/ic2006869; Wang WH, 2010, J ORG CHEM, V75, P2415, DOI 10.1021/jo1000719; Wang XS, 2010, J AM CHEM SOC, V132, P3648, DOI 10.1021/ja909522s; Wendlandt AE, 2011, ANGEW CHEM INT EDIT, V50, P11062, DOI 10.1002/anie.201103945; Whitfield SR, 2007, J AM CHEM SOC, V129, P15142, DOI 10.1021/ja077866q; WILLERTPORADA MA, 1989, J CHEM SOC CHEM COMM, P1633, DOI 10.1039/c39890001633; Wu T, 2009, J AM CHEM SOC, V131, P16354, DOI 10.1021/ja9076588; Xu J, 2011, CHEM COMMUN, V47, P4300, DOI 10.1039/c1cc10359h; Xu LM, 2010, CHEM SOC REV, V39, P712, DOI 10.1039/b809912j; Ye YD, 2010, J AM CHEM SOC, V132, P14682, DOI 10.1021/ja107780w; Yu HZ, 2010, J AM CHEM SOC, V132, P18078, DOI 10.1021/ja104264v; Zhang J, 2008, CHEM COMMUN, P3625, DOI 10.1039/b803156h; Zhang YH, 2009, J AM CHEM SOC, V131, P14654, DOI 10.1021/ja907198n	100	643	642	35	577	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					177	185		10.1038/nature11008	http://dx.doi.org/10.1038/nature11008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22498623	Green Accepted			2022-12-28	WOS:000303149900024
J	Norris, BRM; Tuthill, PG; Ireland, MJ; Lacour, S; Zijlstra, AA; Lykou, F; Evans, TM; Stewart, P; Bedding, TR				Norris, Barnaby R. M.; Tuthill, Peter G.; Ireland, Michael J.; Lacour, Sylvestre; Zijlstra, Albert A.; Lykou, Foteini; Evans, Thomas M.; Stewart, Paul; Bedding, Timothy R.			A close halo of large transparent grains around extreme red giant stars	NATURE			English	Article							MASS-LOSS RATES; CIRCUMSTELLAR ENVELOPES; MIRA VARIABLES; DUST FORMATION; WINDS; ATMOSPHERES; MINERALOGY	An intermediate-mass star ends its life by ejecting the bulk of its envelope in a slow, dense wind(1-3). Stellar pulsations are thought to elevate gas to an altitude cool enough for the condensation of dust(1), which is then accelerated by radiation pressure, entraining the gas and driving the wind(2,4,5). Explaining the amount of mass loss, however, has been a problem because of the difficulty of observing tenuous gas and dust only tens of milliarcseconds from the star. For this reason, there is no consensus on the way sufficient momentum is transferred from the light from the star to the outflow. Here we report spatially resolved, multiwavelength observations of circumstellar dust shells of three stars on the asymptotic giant branch of the Hertzsprung-Russell diagram. When imaged in scattered light, dust shells were found at remarkably small radii (less than about two stellar radii) and with unexpectedly large grains (about 300 nanometres in radius). This proximity to the photosphere argues for dust species that are transparent to the light from the star and, therefore, resistant to sublimation by the intense radiation field. Although transparency usually implies insufficient radiative pressure to drive a wind(6,7), the radiation field can accelerate these large grains through photon scattering rather than absorption(8)-a plausible mass loss mechanism for lower-amplitude pulsating stars.	[Norris, Barnaby R. M.; Tuthill, Peter G.; Ireland, Michael J.; Evans, Thomas M.; Stewart, Paul; Bedding, Timothy R.] Univ Sydney, Sch Phys, Sydney Inst Astron, Sydney, NSW 2006, Australia; [Ireland, Michael J.] Macquarie Univ, Dept Phys & Astron, N Ryde, NSW 2109, Australia; [Ireland, Michael J.] Australian Astron Observ, Epping, NSW 1710, Australia; [Lacour, Sylvestre] Univ Paris Diderot, Univ Paris 06, CNRS, LESIA Observ Paris, F-92190 Meudon, France; [Zijlstra, Albert A.; Lykou, Foteini] Univ Manchester, Sch Phys & Astron, Jodrell Bank Ctr Astrophys, Manchester M13 9PL, Lancs, England; [Evans, Thomas M.] Univ Oxford, Dept Phys, Oxford OX1 3RH, England	University of Sydney; Macquarie University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; University of Manchester; Jodrell Bank Centre for Astrophysics; University of Oxford	Norris, BRM (corresponding author), Univ Sydney, Sch Phys, Sydney Inst Astron, Sydney, NSW 2006, Australia.	bnorris@physics.usyd.edu.au	Bedding, Timothy/AAU-9400-2021	Bedding, Timothy/0000-0001-5222-4661; Ireland, Michael/0000-0002-6194-043X; Norris, Barnaby Richard/0000-0002-8352-7515; Bedding, Timothy/0000-0001-5943-1460; Lacour, Sylvestre/0000-0002-6948-0263; Evans, Thomas/0000-0001-5442-1300; Tuthill, Peter/0000-0001-7026-6291; Lykou, Foteini/0000-0002-6394-8013; Stewart, Paul/0000-0002-4242-3971; Zijlstra, Albert/0000-0002-3171-5469	STFC [ST/I001425/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/I001425/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Draine BT, 2003, ANNU REV ASTRON ASTR, V41, P241, DOI 10.1146/annurev.astro.41.011802.094840; Frisch PC, 1999, ASTROPHYS J, V525, P492, DOI 10.1086/307869; Gail HP, 2003, LECT NOTES PHYS, V609, P55; Gustafsson B, 2004, ASTR AST LI, P149; Habing HJ, 1996, ASTRON ASTROPHYS REV, V7, P97, DOI 10.1007/PL00013287; Hofner S, 2008, ASTRON ASTROPHYS, V491, pL1, DOI 10.1051/0004-6361:200810641; Hofner S, 2009, ASTR SOC P, V414, P3; Ireland MJ, 2011, MON NOT R ASTRON SOC, V418, P114, DOI 10.1111/j.1365-2966.2011.19469.x; Ireland MJ, 2006, MON NOT R ASTRON SOC, V367, P1585, DOI 10.1111/j.1365-2966.2006.10064.x; Ireland MJ, 2005, MON NOT R ASTRON SOC, V361, P337, DOI 10.1111/j.1365-2966.2005.09181.x; Jager C, 2003, ASTRON ASTROPHYS, V408, P193, DOI 10.1051/0004-6361:20030916; Lacour S, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201116712; Lagadec E, 2008, MON NOT R ASTRON SOC, V390, pL59, DOI 10.1111/j.1745-3933.2008.00535.x; Lenzen R, 2003, P SOC PHOTO-OPT INS, V4841, P944, DOI 10.1117/12.460044; LOUP C, 1993, ASTRON ASTROPHYS SUP, V99, P291; Marengo M, 2009, PUBL ASTRON SOC AUST, V26, P365, DOI 10.1071/AS09004; Olofsson H, 2002, ASTRON ASTROPHYS, V391, P1053, DOI 10.1051/0004-6361:20020841; Tuthill P, 2010, PROC SPIE, V7735, DOI 10.1117/12.856806; Tuthill PG, 2000, PUBL ASTRON SOC PAC, V112, P555, DOI 10.1086/316550; van Leeuwen F, 2007, ASTRON ASTROPHYS, V474, P653, DOI 10.1051/0004-6361:20078357; Waters LBFM, 1996, ASTRON ASTROPHYS, V315, pL361; Weingartner JC, 2001, ASTROPHYS J, V548, P296, DOI 10.1086/318651; Wittkowski M, 2011, ASTR SOC P, V445, P107; Woitke P, 2006, ASTRON ASTROPHYS, V460, pL9, DOI 10.1051/0004-6361:20066322; WOOD PR, 1979, ASTROPHYS J, V227, P220, DOI 10.1086/156721	25	142	144	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					220	222		10.1038/nature10935	http://dx.doi.org/10.1038/nature10935			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22498626	Green Submitted			2022-12-28	WOS:000303149900030
J	Njau, J				Njau, Jackson			Reading Pliocene Bones	SCIENCE			English	Editorial Material							CARNIVORE TOOTH-MARKS; OLDUVAI GORGE; PERCUSSION MARKS; STONE TOOLS; FLK ZINJANTHROPUS; TANZANIA; HOMINID; ETHIOPIA; PLEISTOCENE; SURFACES		Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Njau, J (corresponding author), Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA.	jknjau@indiana.edu						BEHRENSMEYER AK, 1986, NATURE, V319, P768, DOI 10.1038/319768a0; Binford L.R., 1981, BONES ANCIENT MEN MO; BLUMENSCHINE RJ, 1988, NATURE, V333, P763, DOI 10.1038/333763a0; BLUMENSCHINE RJ, 1995, J HUM EVOL, V29, P21, DOI 10.1006/jhev.1995.1046; Blumenschine RJ, 1996, J ARCHAEOL SCI, V23, P493, DOI 10.1006/jasc.1996.0047; Blumenschine RJ, 2007, J HUM EVOL, V53, P420, DOI 10.1016/j.jhevol.2007.01.011; BUNN HT, 1981, NATURE, V291, P574, DOI 10.1038/291574a0; Capaldo SD, 1997, J HUM EVOL, V33, P555, DOI 10.1006/jhev.1997.0150; Dominguez-Rodrigo M, 2006, J HUM EVOL, V50, P170, DOI 10.1016/j.jhevol.2005.09.005; Dominguez-Rodrigo M, 2005, J HUM EVOL, V48, P109, DOI 10.1016/j.jhevol.2004.09.004; Dominguez-Rodrigo M, 2010, P NATL ACAD SCI USA, V107, P20929, DOI 10.1073/pnas.1013711107; Fernandez-Jalvo Y, 2011, J HUM EVOL, V60, P117, DOI 10.1016/j.jhevol.2010.08.003; ISAAC GL, 1978, J ANTHROPOL RES, V34, P311; Lartet M.E., 1860, Q J GEOL SOC LOND, V16, P471, DOI DOI 10.1144/GSL.JGS.1860.016.01-02.63; McPherron SP, 2010, NATURE, V466, P857, DOI 10.1038/nature09248; Njau JK, 2006, J HUM EVOL, V50, P142, DOI 10.1016/j.jhevol.2005.08.008; OLIVER JS, 1994, J HUM EVOL, V27, P267, DOI 10.1006/jhev.1994.1046; OLSEN SL, 1988, J ARCHAEOL SCI, V15, P535, DOI 10.1016/0305-4403(88)90081-7; POTTS R, 1981, NATURE, V291, P577, DOI 10.1038/291577a0; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; Turner C. G., 1983, CARNIVORES HUMAN SCA, P219	21	21	21	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2012	336	6077					46	47		10.1126/science.1216221	http://dx.doi.org/10.1126/science.1216221			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	920LG	22491846				2022-12-28	WOS:000302405400045
J	Begley, CG; Ellis, LM				Begley, C. Glenn; Ellis, Lee M.			Raise standards for preclinical cancer research	NATURE			English	Editorial Material									[Begley, C. Glenn] Amgen Inc, Thousand Oaks, CA 91359 USA; [Ellis, Lee M.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Amgen; University of Texas System; UTMD Anderson Cancer Center	Begley, CG (corresponding author), Amgen Inc, Thousand Oaks, CA 91359 USA.	lellis@mdanderson.org	Coles, Simon/A-1795-2009	Coles, Simon/0000-0001-8414-9272				Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010271; Francia G, 2010, NAT BIOTECHNOL, V28, P561, DOI 10.1038/nbt0610-561; Hutchinson L, 2011, NAT REV CLIN ONCOL, V8, P189, DOI [10.1038/nrclinonc.2010.204, 10.1038/nrclinonc.2011.34]; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Rubin E. H., 2012, NATURE REV CLIN ONCO	5	1742	1780	2	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2012	483	7391					531	533		10.1038/483531a	http://dx.doi.org/10.1038/483531a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	915EF	22460880				2022-12-28	WOS:000302006100013
J	Deschamps, P; Durand, N; Bard, E; Hamelin, B; Camoin, G; Thomas, AL; Henderson, GM; Okuno, J; Yokoyama, Y				Deschamps, Pierre; Durand, Nicolas; Bard, Edouard; Hamelin, Bruno; Camoin, Gilbert; Thomas, Alexander L.; Henderson, Gideon M.; Okuno, Jun'ichi; Yokoyama, Yusuke			Ice-sheet collapse and sea-level rise at the Bolling warming 14,600 years ago	NATURE			English	Article							LAST GLACIAL MAXIMUM; MELTWATER PULSE 1A; YOUNGER DRYAS; SOUTHERN-OCEAN; REEF; DEGLACIATION; CONSTRAINTS; CIRCULATION; RESUMPTION; TRIGGER	Past sea-level records provide invaluable information about the response of ice sheets to climate forcing. Some such records suggest that the last deglaciation was punctuated by a dramatic period of sea-level rise, of about 20 metres, in less than 500 years. Controversy about the amplitude and timing of this meltwater pulse (MWP-1A) has, however, led to uncertainty about the source of the melt water and its temporal and causal relationships with the abrupt climate changes of the deglaciation. Here we show that MWP-1A started no earlier than 14,650 years ago and ended before 14,310 years ago, making it coeval with the Bolling warming. Our results, based on corals drilled offshore from Tahiti during Integrated Ocean Drilling Project Expedition 310, reveal that the increase in sea level at Tahiti was between 12 and 22 metres, with a most probable value between 14 and 18 metres, establishing a significant meltwater contribution from the Southern Hemisphere. This implies that the rate of eustatic sea-level rise exceeded 40 millimetres per year during MWP-1A.	[Deschamps, Pierre; Durand, Nicolas; Bard, Edouard; Hamelin, Bruno; Camoin, Gilbert] UMR Aix Marseille Univ, CNRS, IRD, Coll France,CEREGE, F-13545 Aix En Provence 4, France; [Thomas, Alexander L.; Henderson, Gideon M.] Dept Earth Sci, Oxford OX1 3AN, England; [Okuno, Jun'ichi; Yokoyama, Yusuke] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan; [Okuno, Jun'ichi; Yokoyama, Yusuke] Univ Tokyo, Dept Earth & Planetary Sci, Kashiwa, Chiba 2778564, Japan; [Okuno, Jun'ichi] Natl Inst Polar Res, Tachikawa, Tokyo 1908518, Japan; [Yokoyama, Yusuke] JAMSTEC, Inst Biogeosci, Yokosuka, Kanagawa 2370061, Japan	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; PSL Research University Paris; College de France; University of Tokyo; University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Deschamps, P (corresponding author), UMR Aix Marseille Univ, CNRS, IRD, Coll France,CEREGE, Technopole Arbois,BP 80, F-13545 Aix En Provence 4, France.	deschamps@cerege.fr	Bard, Edouard/G-7717-2014; Thomas, Alex/D-1028-2012; Deschamps, Pierre/M-9632-2013; Yokoyama, Yusuke/N-9623-2013	Thomas, Alex/0000-0002-0734-9593; Deschamps, Pierre/0000-0003-1687-3765; Henderson, Gideon/0000-0002-6279-7137; CAMOIN, Gilbert/0000-0002-7466-4155	Comer Science and Education Foundation; European Science Foundation (EuroMARC); European Community; College de France; IRD (Institut de Recherche pour le Developpement); UK Natural Environment Research Council [NE/D001250/1]; JSPS [GR031]	Comer Science and Education Foundation; European Science Foundation (EuroMARC)(European Science Foundation (ESF)); European Community(European Commission); College de France; IRD (Institut de Recherche pour le Developpement); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank the IODP and ECORD (European Consortium for Ocean Research Drilling) for drilling offshore from Tahiti, and the Bremen Core Repository members for organizing the onshore sampling party. We dedicate this article to the memory of G. Cabioch, who died at the end of 2011: a reef geology expert, he was a member of the IODP expedition to Tahiti. The CEREGE group thanks W. Barthelemy for maintaining mass spectrometers; D. Borschneck for help with X-ray diffraction analyses; and P. Dussouillez for help with maps. Palaeoclimate work at CEREGE is supported by the Comer Science and Education Foundation, the European Science Foundation (EuroMARC), the European Community (Project Past4Future), the College de France and the IRD (Institut de Recherche pour le Developpement). The Oxford University team is supported by UK Natural Environment Research Council grant NE/D001250/1 and the Comer Science and Education Foundation. The University of Tokyo group is partly supported by JSPS (NEXT program GR031).	Aharon P, 2006, EARTH PLANET SC LETT, V241, P260, DOI 10.1016/j.epsl.2005.10.034; Alley RB, 2005, SCIENCE, V310, P456, DOI 10.1126/science.1114613; Andersen MB, 2007, EARTH PLANET SC LETT, V259, P171, DOI 10.1016/j.epsl.2007.04.051; Bamber JL, 2009, SCIENCE, V324, P901, DOI 10.1126/science.1169335; Bard E, 1996, NATURE, V382, P241, DOI 10.1038/382241a0; BARD E, 1990, NATURE, V346, P456, DOI 10.1038/346456a0; Bard E, 2010, SCIENCE, V327, P1235, DOI 10.1126/science.1180557; Bassett SE, 2007, QUATERNARY SCI REV, V26, P2113, DOI 10.1016/j.quascirev.2007.06.011; Bassett SE, 2005, SCIENCE, V309, P925, DOI 10.1126/science.1111575; Bentley MJ, 2010, J QUATERNARY SCI, V25, P5, DOI 10.1002/jqs.1287; Blanchon P, 2003, SEDIMENTOLOGY, V50, P1271, DOI 10.1111/j.1365-3091.2003.00603.x; BLANCHON P, 1995, GEOLOGY, V23, P4, DOI 10.1130/0091-7613(1995)023<0004:RDDTLD>2.3.CO;2; Cabioch G, 1999, QUATERNARY SCI REV, V18, P1681, DOI 10.1016/S0277-3791(99)00014-1; Camoin G., 2007, P IODP; Carlson AE, 2009, QUATERNARY SCI REV, V28, P1625, DOI 10.1016/j.quascirev.2009.02.011; Clark PU, 2004, SCIENCE, V304, P1141, DOI 10.1126/science.1094449; Clark PU, 2002, QUATERNARY SCI REV, V21, P1, DOI 10.1016/S0277-3791(01)00118-4; Clark PU, 2002, SCIENCE, V295, P2438; Clark PU, 1996, PALEOCEANOGRAPHY, V11, P563, DOI 10.1029/96PA01419; Cutler KB, 2003, EARTH PLANET SC LETT, V206, P253, DOI 10.1016/S0012-821X(02)01107-X; Denton GH, 2002, QUATERNARY SCI REV, V21, P193, DOI 10.1016/S0277-3791(01)00090-7; EDWARDS RL, 1993, SCIENCE, V260, P962, DOI 10.1126/science.260.5110.962; Fairbanks RG, 2005, QUATERNARY SCI REV, V24, P1781, DOI 10.1016/j.quascirev.2005.04.007; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Hanebuth T, 2000, SCIENCE, V288, P1033, DOI 10.1126/science.288.5468.1033; Kienast M, 2003, GEOLOGY, V31, P67, DOI 10.1130/0091-7613(2003)031<0067:SOMPAT>2.0.CO;2; Knorr G, 2003, NATURE, V424, P532, DOI 10.1038/nature01855; Knorr G, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001604; Liu J. Paul, 2004, Journal of Ocean University of China, V3, P183, DOI 10.1007/s11802-004-0033-8; MANABE S, 1995, NATURE, V378, P165, DOI 10.1038/378165a0; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Milne GA, 2009, NAT GEOSCI, V2, P471, DOI 10.1038/ngeo544; Milne GA, 2008, QUATERNARY SCI REV, V27, P2292, DOI 10.1016/j.quascirev.2008.08.018; Peltier WR, 2006, QUATERNARY SCI REV, V25, P3322, DOI 10.1016/j.quascirev.2006.04.010; Peltier WR, 2002, QUATERNARY SCI REV, V21, P377, DOI 10.1016/S0277-3791(01)00084-1; Peltier WR, 2005, QUATERNARY SCI REV, V24, P1655, DOI 10.1016/j.quascirev.2004.06.023; PELTIER WR, 1994, SCIENCE, V265, P195, DOI 10.1126/science.265.5169.195; Pfeffer WT, 2008, SCIENCE, V321, P1340, DOI 10.1126/science.1159099; Rasmussen T. L., 2006, J GEOPHYS RES, V111; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Roche DM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL032064; Stanford JD, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2006PA001340; Swingedouw D, 2009, CLIM DYNAM, V33, P365, DOI 10.1007/s00382-008-0496-1; Tarasov L, 2006, QUATERNARY SCI REV, V25, P659, DOI 10.1016/j.quascirev.2005.12.006; Tarasov L, 2005, NATURE, V435, P662, DOI 10.1038/nature03617; Thomas AL, 2009, SCIENCE, V324, P1186, DOI 10.1126/science.1168754; Weaver AJ, 2003, SCIENCE, V299, P1709, DOI 10.1126/science.1081002; Webster JM, 2004, GEOLOGY, V32, P249, DOI 10.1130/G20170.1; Yokoyama Y, 2000, NATURE, V406, P713, DOI 10.1038/35021035	50	370	376	5	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2012	483	7391					559	564		10.1038/nature10902	http://dx.doi.org/10.1038/nature10902			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915EF	22460900	Green Accepted			2022-12-28	WOS:000302006100031
J	Guan, Y; Webby, R; Capua, I; Waldenstrom, J				Guan, Yi; Webby, Richard; Capua, Ilaria; Waldenstrom, Jonas			How to track a flu virus	NATURE			English	Editorial Material									[Guan, Yi] Shantou Univ, Coll Med, Joint Influenza Res Ctr, Shantou, Peoples R China; [Guan, Yi] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Webby, Richard] St Jude Childrens Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Capua, Ilaria] Vet Publ Hlth Inst, Int Reference Lab Avian Influenza & Newcastle Dis, Legnaro, Italy; [Waldenstrom, Jonas] Linnaeus Univ, Sch Nat Sci, Kalmar, Sweden	Shantou University; University of Hong Kong; St Jude Children's Research Hospital; Linnaeus University	Guan, Y (corresponding author), Shantou Univ, Coll Med, Joint Influenza Res Ctr, Shantou, Peoples R China.		Webby, Richard J/N-5657-2018; Waldenström, Jonas/E-4460-2013	Waldenström, Jonas/0000-0002-1152-4235; Guan, Yi/0000-0001-6057-9243					0	8	8	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2012	483	7391					535	536						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	915EF	22460882	Bronze			2022-12-28	WOS:000302006100015
J	Curtis, C; Shah, SP; Chin, SF; Turashvili, G; Rueda, OM; Dunning, MJ; Speed, D; Lynch, AG; Samarajiwa, S; Yuan, YY; Graf, S; Ha, G; Haffari, G; Bashashati, A; Russell, R; McKinney, S; Langerod, A; Green, A; Provenzano, E; Wishart, G; Pinder, S; Watson, P; Markowetz, F; Murphy, L; Ellis, I; Purushotham, A; Borresen-Dale, AL; Brenton, JD; Tavare, S; Caldas, C; Aparicio, S				Curtis, Christina; Shah, Sohrab P.; Chin, Suet-Feung; Turashvili, Gulisa; Rueda, Oscar M.; Dunning, Mark J.; Speed, Doug; Lynch, Andy G.; Samarajiwa, Shamith; Yuan, Yinyin; Graef, Stefan; Ha, Gavin; Haffari, Gholamreza; Bashashati, Ali; Russell, Roslin; McKinney, Steven; Langerod, Anita; Green, Andrew; Provenzano, Elena; Wishart, Gordon; Pinder, Sarah; Watson, Peter; Markowetz, Florian; Murphy, Leigh; Ellis, Ian; Purushotham, Arnie; Borresen-Dale, Anne-Lise; Brenton, James D.; Tavare, Simon; Caldas, Carlos; Aparicio, Samuel		METABRIC Grp	The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups	NATURE			English	Article							GENE-EXPRESSION; CANCER; PROTEIN; SUPPRESSOR; CARCINOMA; SUBTYPE	The elucidation of breast cancer subgroups and their molecular drivers requires integrated views of the genome and transcriptome from representative numbers of patients. We present an integrated analysis of copy number and gene expression in a discovery and validation set of 997 and 995 primary breast tumours, respectively, with long-term clinical follow-up. Inherited variants (copy number variants and single nucleotide polymorphisms) and acquired somatic copy number aberrations (CNAs) were associated with expression in similar to 40% of genes, with the landscape dominated by cis-and trans-acting CNAs. By delineating expression outlier genes driven in cis by CNAs, we identified putative cancer genes, including deletions in PPP2R2A, MTAP and MAP2K4. Unsupervised analysis of paired DNA-RNA profiles revealed novel subgroups with distinct clinical outcomes, which reproduced in the validation cohort. These include a high-risk, oestrogen-receptor-positive 11q13/14 cis-acting subgroup and a favourable prognosis subgroup devoid of CNAs. Trans-acting aberration hotspots were found to modulate subgroup-specific gene networks, including a TCR deletion-mediated adaptive immune response in the 'CNA-devoid' subgroup and a basal-specific chromosome 5 deletion-associated mitotic network. Our results provide a novel molecular stratification of the breast cancer population, derived from the impact of somatic CNAs on the transcriptome.	[Curtis, Christina; Chin, Suet-Feung; Rueda, Oscar M.; Lynch, Andy G.; Samarajiwa, Shamith; Yuan, Yinyin; Graef, Stefan; Markowetz, Florian; Tavare, Simon; Caldas, Carlos] Univ Cambridge, Dept Oncol, Cambridge CB2 2XZ, England; [Curtis, Christina; Chin, Suet-Feung; Rueda, Oscar M.; Dunning, Mark J.; Speed, Doug; Lynch, Andy G.; Samarajiwa, Shamith; Yuan, Yinyin; Graef, Stefan; Russell, Roslin; Markowetz, Florian; Brenton, James D.; Tavare, Simon; Caldas, Carlos] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Shah, Sohrab P.; Turashvili, Gulisa; Ha, Gavin; Haffari, Gholamreza; Bashashati, Ali; McKinney, Steven; Watson, Peter; Aparicio, Samuel] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; [Shah, Sohrab P.; Turashvili, Gulisa; McKinney, Steven; Watson, Peter; Aparicio, Samuel] British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada; [Speed, Doug; Tavare, Simon] Univ Cambridge, Dept Appl Math & Theoret Phys, Ctr Math Sci, Cambridge CB3 0WA, England; [Langerod, Anita; Borresen-Dale, Anne-Lise] Radiumhosp, Dept Genet, Inst Canc Res, Oslo Univ Hosp, N-0310 Oslo, Norway; [Green, Andrew; Ellis, Ian] Univ Nottingham, Dept Histopathol, Sch Mol Med Sci, Nottingham NG5 1PB, England; [Provenzano, Elena; Wishart, Gordon; Caldas, Carlos] Cambridge Univ Hosp NHS Fdn Trust, Cambridge Breast Unit, Addenbrookes Hosp, Cambridge CB2 2QQ, England; [Pinder, Sarah; Purushotham, Arnie] Kings Coll London, Breakthrough Breast Canc Res Unit, London WC2R 2LS, England; [Pinder, Sarah; Borresen-Dale, Anne-Lise] NIHR Cambridge Biomed Res Ctr, London WC2R 2LS, England; [Watson, Peter; Murphy, Leigh] Univ Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada; [Purushotham, Arnie] Guys & St Thomas NHS Fdn Trust, NIHR Comprehens Biomed Res Ctr, London WC2R 2LS, England; [Borresen-Dale, Anne-Lise] Univ Oslo, Inst Clin Med, Fac Med, N-0316 Oslo, Norway; [Brenton, James D.; Caldas, Carlos] Cambridge Expt Canc Med Ctr, Cambridge CB2 0RE, England; [Tavare, Simon] Univ So Calif, Mol & Computat Biol Program, Los Angeles, CA 90089 USA	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of British Columbia; British Columbia Cancer Agency; University of Cambridge; University of Oslo; University of Nottingham; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; King's College London; University of Manitoba; Guy's & St Thomas' NHS Foundation Trust; University of Oslo; University of Southern California	Caldas, C (corresponding author), Univ Cambridge, Dept Oncol, Hills Rd, Cambridge CB2 2XZ, England.	carlos.caldas@cancer.org.uk; saparicio@bccrc.ca	Caldas, Carlos/U-7250-2019; Rueda, Oscar/ABF-5479-2020; Caldas, Carlos/A-7543-2008; Speed, Doug/AAM-1032-2021; Hadfield, James/A-1874-2013; Green, Andrew/AAF-1991-2020; Samarajiwa, Shamith/B-1601-2013; Maia, Ana-Teresa/F-4404-2012; Ha, Gavin/N-1984-2019; Brenton, James D/B-3174-2008	Caldas, Carlos/0000-0003-3547-1489; Rueda, Oscar/0000-0003-0008-4884; Hadfield, James/0000-0001-9868-4989; Samarajiwa, Shamith/0000-0003-1046-0601; Maia, Ana-Teresa/0000-0002-0454-9207; Ha, Gavin/0000-0001-7578-7272; Brenton, James D/0000-0002-5738-6683; Chan, Derek Steven/0000-0002-6350-9993; Murphy, Leigh C/0000-0002-7676-6032; Speed, Doug/0000-0002-0096-9765; Rakha, Emad/0000-0002-5009-5525; Watson, Peter/0000-0002-1642-0638; Yuan, Yinyin/0000-0002-8556-4707; Aparicio, Samuel/0000-0002-0487-9599; chin, suet-feung/0000-0001-5697-1082; Purushotham, Arnie/0000-0001-8577-9655; Green, Andrew/0000-0002-0488-5913; Curtis, Christina/0000-0003-0166-3802; Papatheodorou, Irene/0000-0001-7270-5470; Ding, Zhihao/0000-0003-0961-2284; Lynch, Andy/0000-0002-7876-7338; /0000-0003-4167-8910; Dunning, Mark/0000-0002-8853-9435; Turashvili, Gulisa/0000-0001-6125-5865; Sammut, Stephen John/0000-0003-4472-904X; Ellis, Ian/0000-0001-5292-8474; Grigoriadis, Anita/0000-0003-3434-201X	Cancer Research UK; British Columbia Cancer Foundation; Canadian Breast Cancer Foundation BC/Yukon; University of Cambridge; Hutchinson Whampoa; NIHR Cambridge Biomedical Research Centre; Cambridge Experimental Cancer Medicine Centre; Centre for Translational Genomics (CTAG) Vancouver; BCCA Breast Cancer Outcomes Unit; Canada Research Chair; National Institutes of Health Centers of Excellence in Genomics Science [P50 HG02790]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; Cancer Research UK [19556, 15601] Funding Source: researchfish; National Institute for Health Research [ACF-2012-14-006, NF-SI-0611-10154] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); British Columbia Cancer Foundation; Canadian Breast Cancer Foundation BC/Yukon; University of Cambridge(University of Cambridge); Hutchinson Whampoa; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridge Experimental Cancer Medicine Centre; Centre for Translational Genomics (CTAG) Vancouver; BCCA Breast Cancer Outcomes Unit; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); National Institutes of Health Centers of Excellence in Genomics Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	The METABRIC project was funded by Cancer Research UK, the British Columbia Cancer Foundation and Canadian Breast Cancer Foundation BC/Yukon. The authors also acknowledge the support of the University of Cambridge, Hutchinson Whampoa, the NIHR Cambridge Biomedical Research Centre, the Cambridge Experimental Cancer Medicine Centre, the Centre for Translational Genomics (CTAG) Vancouver and the BCCA Breast Cancer Outcomes Unit. S. P. S. is a Michael Smith Foundation for Health Research fellow. S. A. is supported by a Canada Research Chair. This work was supported by the National Institutes of Health Centers of Excellence in Genomics Science grant P50 HG02790 (S. T.). The authors thank C. Perou and J. Parker for discussions on the use of the PAM50 centroids. They also acknowledge the patients who donated tissue and the associated pseudo-anonymized clinical data for this project.	Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Brown LA, 2008, GENE CHROMOSOME CANC, V47, P481, DOI 10.1002/gcc.20549; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Christopher SA, 2002, CANCER RES, V62, P6639; Daniel J, 2011, P NATL ACAD SCI USA, V108, P5384, DOI 10.1073/pnas.1007645108; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Holland DG, 2011, EMBO MOL MED, V3, P167, DOI 10.1002/emmm.201100122; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Hughes-Davies L, 2003, CELL, V115, P523, DOI 10.1016/S0092-8674(03)00930-9; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kapp AV, 2007, BIOSTATISTICS, V8, P9, DOI 10.1093/biostatistics/kxj029; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; McConechy MK, 2011, J PATHOL, V223, P567, DOI 10.1002/path.2848; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Russnes HG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000611; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tan J, 2010, CANCER CELL, V18, P459, DOI 10.1016/j.ccr.2010.10.021; Teng DHF, 1997, CANCER RES, V57, P4177; Teschendorff AE, 2006, BIOINFORMATICS, V22, P2269, DOI 10.1093/bioinformatics/btl174; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299	29	3494	3571	18	445	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2012	486	7403					346	352		10.1038/nature10983	http://dx.doi.org/10.1038/nature10983			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22522925	Green Accepted, Green Published			2022-12-28	WOS:000305466800033
J	Shah, SP; Roth, A; Goya, R; Oloumi, A; Ha, G; Zhao, YJ; Turashvili, G; Ding, JR; Tse, K; Haffari, G; Bashashati, A; Prentice, LM; Khattra, J; Burleigh, A; Yap, D; Bernard, V; McPherson, A; Shumansky, K; Crisan, A; Giuliany, R; Heravi-Moussavi, A; Rosner, J; Lai, D; Birol, I; Varhol, R; Tam, A; Dhalla, N; Zeng, T; Ma, K; Chan, SK; Griffith, M; Moradian, A; Cheng, SWG; Morin, GB; Watson, P; Gelmon, K; Chia, S; Chin, SF; Curtis, C; Rueda, OM; Pharoah, PD; Damaraju, S; Mackey, J; Hoon, K; Harkins, T; Tadigotla, V; Sigaroudinia, M; Gascard, P; Tlsty, T; Costello, JF; Meyer, IM; Eaves, CJ; Wasserman, WW; Jones, S; Huntsman, D; Hirst, M; Caldas, C; Marra, MA; Aparicio, S				Shah, Sohrab P.; Roth, Andrew; Goya, Rodrigo; Oloumi, Arusha; Ha, Gavin; Zhao, Yongjun; Turashvili, Gulisa; Ding, Jiarui; Tse, Kane; Haffari, Gholamreza; Bashashati, Ali; Prentice, Leah M.; Khattra, Jaswinder; Burleigh, Angela; Yap, Damian; Bernard, Virginie; McPherson, Andrew; Shumansky, Karey; Crisan, Anamaria; Giuliany, Ryan; Heravi-Moussavi, Alireza; Rosner, Jamie; Lai, Daniel; Birol, Inanc; Varhol, Richard; Tam, Angela; Dhalla, Noreen; Zeng, Thomas; Ma, Kevin; Chan, Simon K.; Griffith, Malachi; Moradian, Annie; Cheng, S. -W. Grace; Morin, Gregg B.; Watson, Peter; Gelmon, Karen; Chia, Stephen; Chin, Suet-Feung; Curtis, Christina; Rueda, Oscar M.; Pharoah, Paul D.; Damaraju, Sambasivarao; Mackey, John; Hoon, Kelly; Harkins, Timothy; Tadigotla, Vasisht; Sigaroudinia, Mahvash; Gascard, Philippe; Tlsty, Thea; Costello, Joseph F.; Meyer, Irmtraud M.; Eaves, Connie J.; Wasserman, Wyeth W.; Jones, Steven; Huntsman, David; Hirst, Martin; Caldas, Carlos; Marra, Marco A.; Aparicio, Samuel			The clonal and mutational evolution spectrum of primary triple-negative breast cancers	NATURE			English	Article							RETINOBLASTOMA TUMOR-SUPPRESSOR; SQUAMOUS-CELL CARCINOMA; BASAL-LIKE; GENOME; GENES; TP53; HEAD	Primary triple-negative breast cancers (TNBCs), a tumour type defined by lack of oestrogen receptor, progesterone receptor and ERBB2 gene amplification, represent approximately 16% of all breast cancers(1). Here we show in 104 TNBC cases that at the time of diagnosis these cancers exhibit a wide and continuous spectrum of genomic evolution, with some having only a handful of coding somatic aberrations in a few pathways, whereas others contain hundreds of coding somatic mutations. High-throughput RNA sequencing (RNA-seq) revealed that only approximately 36% of mutations are expressed. Using deep re-sequencing measurements of allelic abundance for 2,414 somatic mutations, we determine for the first time-to our knowledge-in an epithelial tumour subtype, the relative abundance of clonal frequencies among cases representative of the population. We show that TNBCs vary widely in their clonal frequencies at the time of diagnosis, with the basal subtype of TNBC2,3 showing more variation than non-basal TNBC. Although p53 (also known as TP53), PIK3CA and PTEN somatic mutations seem to be clonally dominant compared to other genes, in some tumours their clonal frequencies are incompatible with founder status. Mutations in cytoskeletal, cell shape and motility proteins occurred at lower clonal frequencies, suggesting that they occurred later during tumour progression. Taken together, our results show that understanding the biology and therapeutic responses of patients with TNBC will require the determination of individual tumour clonal genotypes.	[Shah, Sohrab P.; Roth, Andrew; Oloumi, Arusha; Ha, Gavin; Turashvili, Gulisa; Ding, Jiarui; Haffari, Gholamreza; Bashashati, Ali; Prentice, Leah M.; Khattra, Jaswinder; Burleigh, Angela; Yap, Damian; McPherson, Andrew; Shumansky, Karey; Crisan, Anamaria; Giuliany, Ryan; Heravi-Moussavi, Alireza; Rosner, Jamie; Lai, Daniel; Watson, Peter; Huntsman, David; Aparicio, Samuel] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; [Shah, Sohrab P.; Roth, Andrew; Oloumi, Arusha; Ha, Gavin; Turashvili, Gulisa; Ding, Jiarui; Haffari, Gholamreza; Bashashati, Ali; Prentice, Leah M.; Khattra, Jaswinder; Burleigh, Angela; Yap, Damian; McPherson, Andrew; Shumansky, Karey; Crisan, Anamaria; Giuliany, Ryan; Heravi-Moussavi, Alireza; Rosner, Jamie; Lai, Daniel; Huntsman, David; Aparicio, Samuel] British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada; [Goya, Rodrigo; Zhao, Yongjun; Tse, Kane; Birol, Inanc; Varhol, Richard; Tam, Angela; Dhalla, Noreen; Zeng, Thomas; Ma, Kevin; Chan, Simon K.; Griffith, Malachi; Moradian, Annie; Cheng, S. -W. Grace; Morin, Gregg B.; Jones, Steven; Hirst, Martin; Marra, Marco A.] Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Bernard, Virginie; Wasserman, Wyeth W.] Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada; [Morin, Gregg B.; Meyer, Irmtraud M.; Wasserman, Wyeth W.; Jones, Steven; Marra, Marco A.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada; [Chin, Suet-Feung; Curtis, Christina; Rueda, Oscar M.; Pharoah, Paul D.; Caldas, Carlos] Cancer Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Chin, Suet-Feung; Curtis, Christina; Rueda, Oscar M.; Caldas, Carlos] Univ Cambridge, Dept Oncol, Cambridge CB2 2XZ, England; [Curtis, Christina] Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90033 USA; [Damaraju, Sambasivarao; Mackey, John] Univ Alberta, Dept Oncol, Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Damaraju, Sambasivarao; Mackey, John] Univ Alberta, Dept Lab Med & Pathol, Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Hoon, Kelly; Harkins, Timothy; Tadigotla, Vasisht] Life Technol, Foster City, CA 94404 USA; [Sigaroudinia, Mahvash; Gascard, Philippe; Tlsty, Thea] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Costello, Joseph F.] Univ Calif San Francisco, Brain Tumor Res Ctr, Dept Neurosurg, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Meyer, Irmtraud M.] Univ British Columbia, Dept Comp Sci, Vancouver, BC V6T 1Z4, Canada; [Meyer, Irmtraud M.; Hirst, Martin] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V6T 1Z4, Canada; [Eaves, Connie J.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Jones, Steven] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Huntsman, David] British Columbia Canc Agcy, Ctr Translat & Appl Gen, Vancouver, BC V5Z 4E6, Canada; [Hirst, Martin] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Caldas, Carlos] Cambridge Univ Hosp NHS Fdn Trust, Cambridge Breast Unit, Addenbrookes Hosp, Cambridge CB2 2QQ, England; [Caldas, Carlos] NIHR Cambridge Biomed Res Ctr, Cambridge CB2 2QQ, England; [Caldas, Carlos] Cambridge Expt Canc Med Ctr ECMC, Cambridge CB2 0RE, England	University of British Columbia; British Columbia Cancer Agency; University of British Columbia; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; University of Southern California; University of Alberta; University of Alberta; Thermo Fisher Scientific; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; Simon Fraser University; British Columbia Cancer Agency; University of British Columbia; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Aparicio, S (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada.	carlos.caldas@cancer.org.uk; mmarra@bcgsc.ca; saparicio@bccrc.ca	Marra, Marco A/B-5987-2008; Caldas, Carlos/A-7543-2008; Griffith, Malachi/P-1285-2014; Ha, Gavin/N-1984-2019; Rueda, Oscar/ABF-5479-2020; Huntsman, David/ABE-6082-2020; Morin, Gregg B/E-9123-2012; Birol, Inanc/G-5440-2011; Caldas, Carlos/U-7250-2019; Wasserman, Wyeth/I-4866-2015; Jones, Steven J/C-3621-2009; Hirst, Martin/B-7684-2016; Pharoah, Paul/V-6658-2019	Marra, Marco A/0000-0001-7146-7175; Griffith, Malachi/0000-0002-6388-446X; Ha, Gavin/0000-0001-7578-7272; Rueda, Oscar/0000-0003-0008-4884; Morin, Gregg B/0000-0001-8949-4374; Birol, Inanc/0000-0003-0950-7839; Caldas, Carlos/0000-0003-3547-1489; Jones, Steven J/0000-0003-3394-2208; Pharoah, Paul/0000-0001-8494-732X; Aparicio, Samuel/0000-0002-0487-9599; Watson, Peter/0000-0002-1642-0638; Wasserman, Wyeth/0000-0001-6098-6412; Yap, Damian/0000-0002-5370-4592; Turashvili, Gulisa/0000-0001-6125-5865; chin, suet-feung/0000-0001-5697-1082; Lai, Daniel/0000-0001-9203-6323; Eaves, Connie/0000-0002-3452-1926; Curtis, Christina/0000-0003-0166-3802; Gascard, Philippe/0000-0001-5912-5228; Rosner, Jamie/0000-0001-8901-7228	BC Cancer Agency Tumour Bank; CBCF Breast Tumour Bank Alberta; Addenbrookes Tumour bank supported by NIHR; Addenbrookes Tumour bank supported by ECMC; BC Cancer Foundation; US Department of Defense CDMRP program; Canadian Breast Cancer Foundation; Michael Smith Foundation for Health Research; US National Institutes of Health (NIH) Roadmap Epigenomics Program; NIH [5U01ES017154-02]; Cancer Research UK; National Institute of General Medical Sciences [R01GM084875]; Canadian Breast Cancer Research Alliance; Canadian Cancer Society; National Institute for Health Research [NF-SI-0611-10154] Funding Source: researchfish; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084875] Funding Source: NIH RePORTER	BC Cancer Agency Tumour Bank; CBCF Breast Tumour Bank Alberta; Addenbrookes Tumour bank supported by NIHR; Addenbrookes Tumour bank supported by ECMC; BC Cancer Foundation; US Department of Defense CDMRP program; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); US National Institutes of Health (NIH) Roadmap Epigenomics Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Canadian Breast Cancer Research Alliance; Canadian Cancer Society(Canadian Cancer Society (CCS)); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The support of the BC Cancer Agency Tumour Bank, CBCF Breast Tumour Bank Alberta and the Addenbrookes Tumour bank (supported by NIHR and ECMC) is acknowledged. Technical support is acknowledged from the Centre for Translational Genomics, the Michael Smith Genome Sciences Centre technical group, the BCCA Flow Cytometry Core Facility in the Terry Fox Laboratory and the Cancer Research UK Cambridge Research Institute. Supported by the BC Cancer Foundation, US Department of Defense CDMRP program, Canadian Breast Cancer Foundation (BC Yukon) (to S. A. and S. S.), Michael Smith Foundation for Health Research (to S. S.), US National Institutes of Health (NIH) Roadmap Epigenomics Program, NIH grant 5U01ES017154-02 (to M. H., M. A. M., J.C. and T. T.), Cancer Research UK (to C. Caldas and P. D. P.) and the National Institute of General Medical Sciences (R01GM084875 to W. W. W.), the Canadian Breast Cancer Research Alliance and the Canadian Cancer Society (to S. A. and C. E.). We thank B. Reva, Y. Antipin and C. Sander (Memorial Sloan Kettering Cancer Center) for assistance with MutationAssessor, and G. Wu (Ontario Institute for Cancer Research) for assistance with Reactome.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Borresen-Dale AL, 2003, HUM MUTAT, V21, P292, DOI 10.1002/humu.10174; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Ding JR, 2012, BIOINFORMATICS, V28, P167, DOI 10.1093/bioinformatics/btr629; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Herschkowitz JI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2142; Langerod A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1675; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Poulogiannis G, 2010, P NATL ACAD SCI USA, V107, P15145, DOI 10.1073/pnas.1009941107; Roth A., 2012, BIOINFORMATICS  0127; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Youn A, 2011, BIOINFORMATICS, V27, P175, DOI 10.1093/bioinformatics/btq630	22	1374	1413	11	272	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2012	486	7403					395	399		10.1038/nature10933	http://dx.doi.org/10.1038/nature10933			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22495314	Green Accepted, Green Published			2022-12-28	WOS:000305466800042
J	Engert, A; Haverkamp, H; Kobe, C; Markova, J; Renner, C; Ho, A; Zijlstra, J; Kral, Z; Fuchs, M; Hallek, M; Kanz, L; Dohner, H; Dorken, B; Engel, N; Topp, M; Klutmann, S; Amthauer, H; Bockisch, A; Kluge, R; Kratochwil, C; Schober, O; Greil, R; Andreesen, R; Kneba, M; Pfreundschuh, M; Stein, H; Eich, HT; Muller, RP; Dietlein, M; Borchmann, P; Diehl, V				Engert, Andreas; Haverkamp, Heinz; Kobe, Carsten; Markova, Jana; Renner, Christoph; Ho, Antony; Zijlstra, Josee; Kral, Zdenek; Fuchs, Michael; Hallek, Michael; Kanz, Lothar; Doehner, Hartmut; Doerken, Bernd; Engel, Nicole; Topp, Max; Klutmann, Susanne; Amthauer, Holger; Bockisch, Andreas; Kluge, Regine; Kratochwil, Clemens; Schober, Otmar; Greil, Richard; Andreesen, Reinhard; Kneba, Michael; Pfreundschuh, Michael; Stein, Harald; Eich, Hans Theodor; Mueller, Rolf-Peter; Dietlein, Markus; Borchmann, Peter; Diehl, Volker		German Hodgkin Study Grp; Swiss Grp Clinical Canc Res; Arbeitsgemeinschaft Medikamentose	Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial	LANCET			English	Article							POSITRON-EMISSION-TOMOGRAPHY; MOPP/ABV HYBRID; PROGNOSTIC SCORE; STANFORD-V; DISEASE; ABVD; RISK; COMBINATIONS; PROGRESSION; SURVIVAL	Background The intensity of chemotherapy and need for additional radiotherapy in patients with advanced stage Hodgkin's lymphoma has been unclear. We did a prospective randomised clinical trial comparing two reduced-intensity chemotherapy variants with our previous standard regimen. Chemotherapy was followed by PET-guided radiotherapy. Methods In this parallel group, open-label, multicentre, non-inferiority trial (HD15), 2182 patients with newly diagnosed advanced stage Hodgkin's lymphoma aged 18-60 years were randomly assigned to receive either eight cycles of BEACOPP(escalated) (8xB(esc) group), six cycles of BEACOPP(escalated) (6xB(esc) group), or eight cycles of BEACOPP(14) (8xB(14) group). Randomisation (1:1:1) was done centrally by stratified minimisation. Non-inferiority of the primary endpoint, freedom from treatment failure, was assessed using repeated CIs for the hazard ratio (HR) according to the intention-to-treat principle. Patients with a persistent mass after chemotherapy measuring 2.5 cm or larger and positive on PET scan received additional radiotherapy with 30 Gy; the negative predictive value for tumour recurrence of PET at 12 months was an independent endpoint. This trial is registered with Current Controlled Trials, number ISRCTN32443041. Findings Of the 2182 patients enrolled in the study, 2126 patients were included in the intention-to-treat analysis set, 705 in the 8xB(esc) group, 711 in the 6xB(esc) group, and 710 in the 8xB(14) group. Freedom from treatment failure was sequentially non-inferior for the 6xB(esc) and 8xB(14) groups as compared with 8xB(esc). 5-year freedom from treatment failure rates were 84.4% (97.5% CI 81.0-87.7) for the 8xB(esc) group, 89.3% (86.5-92.1) for 6xB(esc) group, and 85.4% (82.1-88.7) for the 8xB(14) group (97.5% CI for difference between 6xB(esc) and 8xB(esc) was 0.5-9.3). Overall survival in the three groups was 91.9%, 95.3%, and 94.5% respectively, and was significantly better with 6xB(esc) than with 8xB(esc) (97.5% CI 0.2-6.5). The 8xB(esc) group showed a higher mortality (7.5%) than the 6xB(esc) (4.6%) and 8xB(14) (5.2%) groups, mainly due to differences in treatment-related events (2.1%, 0.8%, and 0.8%, respectively) and secondary malignancies (1.8%, 0.7%, and 1.1%, respectively). The negative predictive value for PET at 12 months was 94.1% (95% CI 92.1-96.1); and 225 (11%) of 2126 patients received additional radiotherapy. Interpretation Treatment with six cycles of BEACOPP(escalated) followed by PET-guided radiotherapy was more effective in terms of freedom from treatment failure and less toxic than eight cycles of the same chemotherapy regimen. Thus, six cycles of BEACOPP(escalated) should be the treatment of choice for advanced stage Hodgkin's lymphoma. PET done after chemotherapy can guide the need for additional radiotherapy in this setting.	[Engert, Andreas; Hallek, Michael] Univ Hosp Cologne, Dept Internal Med 1, D-50924 Cologne, Germany; [Engert, Andreas; Haverkamp, Heinz; Fuchs, Michael; Borchmann, Peter; Diehl, Volker] Univ Hosp Cologne, German Hodgkin Study Grp GHSG, D-50924 Cologne, Germany; [Kobe, Carsten; Dietlein, Markus] Univ Hosp Cologne, Dept Nucl Med, D-50924 Cologne, Germany; [Markova, Jana] Charles Univ Prague, Univ Hosp Kralovske Vinohrady, Dept Clin Haematol, Prague, Czech Republic; [Markova, Jana] Charles Univ Prague, Fac Med 3, Prague, Czech Republic; [Renner, Christoph] Swiss Grp Clin Canc Res SAKK, Bern, Switzerland; [Ho, Antony] Heidelberg Univ, Dept Internal Med 5, Heidelberg, Germany; [Zijlstra, Josee] Univ Med Ctr, Dept Haematol, Amsterdam, Netherlands; [Kral, Zdenek] Masaryk Univ, Dept Internal Med Haematooncol, Univ Hosp, Brno, Czech Republic; [Kral, Zdenek] Masaryk Univ, Fac Med, Brno, Czech Republic; [Kanz, Lothar] Univ Tubingen, Dept Internal Med 2, Tubingen, Germany; [Doehner, Hartmut] Univ Ulm, Dept Internal Med 3, D-7900 Ulm, Germany; [Doerken, Bernd] Charite Campus Virchow, Dept Haematol & Oncol, Berlin, Germany; [Engel, Nicole] Univ Munich, Dept Internal Med 3, Univ Hosp Grosshadern, Munich, Germany; [Topp, Max] Univ Wurzburg, Inst Pathol, D-8700 Wurzburg, Germany; [Klutmann, Susanne] Univ Med Ctr Hamburg Eppendorf, Dept Nucl Med, Hamburg, Germany; [Amthauer, Holger] Charite, Campus Virchow Klinikum, Klin Strahlenheilkunde, D-13353 Berlin, Germany; [Bockisch, Andreas] Univ Duisburg Essen, Dept Nucl Med, Essen, Germany; [Kluge, Regine] Univ Leipzig, Dept Nucl Med, Leipzig, Germany; [Kratochwil, Clemens] Univ Heidelberg Hosp, Dept Nucl Med Diagnost & Intervent Radiol, Heidelberg, Germany; [Schober, Otmar] Univ Munster, Dept Nucl Med, Munster, Germany; [Greil, Richard] Paracelsus Univ Salzburg, Dept Med 3, Salzburg, Austria; [Andreesen, Reinhard] Univ Hosp Regensburg, Dept Haematol & Oncol, Regensburg, Germany; [Kneba, Michael] Univ Med Ctr Schleswig Holstein Kiel, Med Clin 2, Kiel, Germany; [Pfreundschuh, Michael] Saarland Univ Hosp, Dept Med 1, Homburg, Germany; [Stein, Harald] Berlin Reference Ctr Lymphoma & Haematopathol, Berlin, Germany; [Eich, Hans Theodor; Mueller, Rolf-Peter] Univ Hosp Cologne, Dept Radiat Oncol, D-50924 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; Charles University Prague; University Hospital Vinohrady; Charles University Prague; Swiss Group for Clinical Cancer Research (SAKK); Ruprecht Karls University Heidelberg; Vrije Universiteit Amsterdam; Masaryk University Brno; University Hospital Brno; Masaryk University Brno; Eberhard Karls University of Tubingen; Ulm University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich; University of Wurzburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Duisburg Essen; Leipzig University; Ruprecht Karls University Heidelberg; University of Munster; Paracelsus Private Medical University; University of Regensburg; University of Kiel; Universitatsklinikum des Saarlandes; University of Cologne	Engert, A (corresponding author), Univ Hosp Cologne, Dept Internal Med 1, D-50924 Cologne, Germany.	a.engert@uni-koeln.de	Hallek, Michael/Y-3191-2019; shaoping, liang/I-3447-2012; Topp, Max/F-2868-2012; Greil, Richard F/C-7673-2017; Döhner, Hartmut/C-8933-2016	Hallek, Michael/0000-0002-7425-4455; Greil, Richard F/0000-0002-4462-3694; Döhner, Hartmut/0000-0003-2116-5536; Amthauer, Holger/0000-0003-4414-0657; Haverkamp, Heinz/0000-0001-6895-4132	Deutsche Krebshilfe; Swiss Federal Government; Federal Ministry for Education and Research (Bundesministerium fur Bildung und Forschung)	Deutsche Krebshilfe(Deutsche Krebshilfe); Swiss Federal Government; Federal Ministry for Education and Research (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF))	The Deutsche Krebhilfe and the Swiss Federal Government provided financial support for the clinical trial. The GHSG is a founder member of the Competence Network Malignant Lymphoma and has been granted partial support by the Federal Ministry for Education and Research (Bundesministerium fur Bildung und Forschung) from 1999-2009. Preliminary results of the PET objective of the trial were partly presented at the 52nd American Society of Hematology (ASH) Annual Meeting and Exposition, Orlando, FL, USA, on Dec 4-7, 2010, and at the 2011 American Society of Clinical Oncology Annual Meeting, Chicago, IL, USA, on June 3-7, 2011. Results of the chemotherapy objective were presented at the 53rd ASH Annual Meeting and Exposition, San Diego, CA, USA, on Dec 10-13, 2011.	Aleman BMP, 2003, NEW ENGL J MED, V348, P2396, DOI 10.1056/NEJMoa022628; Aleman BMP, 2003, J CLIN ONCOL, V21, P3431, DOI 10.1200/JCO.2003.07.131; Bauer K, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007941, 10.1002/14651858.CD007941.pub2]; Borchmann P, 2011, J CLIN ONCOL, V29, P4234, DOI 10.1200/JCO.2010.33.9549; CANELLOS GP, 1992, NEW ENGL J MED, V327, P1478, DOI 10.1056/NEJM199211193272102; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Connors JM, 1997, J CLIN ONCOL, V15, P1638, DOI 10.1200/JCO.1997.15.4.1638; Connors JM, 2005, J CLIN ONCOL, V23, P6400, DOI 10.1200/JCO.2005.05.016; CURTIS RE, 1992, NEW ENGL J MED, V326, P1745, DOI 10.1056/NEJM199206253262605; Diehl V, 2003, NEW ENGL J MED, V348, P2386, DOI 10.1056/NEJMoa022473; Duggan DB, 2003, J CLIN ONCOL, V21, P607, DOI 10.1200/JCO.2003.12.086; Engert A, 2011, HEMATOL MALIG, P1, DOI 10.1007/978-3-642-12780-9; Engert A, 2010, NEW ENGL J MED, V363, P640, DOI 10.1056/NEJMoa1000067; Engert A, 2010, J CLIN ONCOL, V28, P2239, DOI 10.1200/JCO.2009.25.1835; Engert A, 2009, J CLIN ONCOL, V27, P4548, DOI 10.1200/JCO.2008.19.8820; Federico M, 2009, J CLIN ONCOL, V27, P805, DOI 10.1200/JCO.2008.17.0910; Franklin J, 2006, ANN ONCOL, V17, P1749, DOI 10.1093/annonc/mdl302; Gallamini A, 2007, J CLIN ONCOL, V25, P3746, DOI 10.1200/JCO.2007.11.6525; Glick JH, 1998, J CLIN ONCOL, V16, P19, DOI 10.1200/JCO.1998.16.1.19; Gobbi PG, 2005, J CLIN ONCOL, V23, P9198, DOI 10.1200/JCO.2005.02.907; Gordon LI, 2010, BLOOD, V116, P415; Hasenclever D, 1998, NEW ENGL J MED, V339, P1506, DOI 10.1056/NEJM199811193392104; Horning SJ, 2002, J CLIN ONCOL, V20, P630, DOI 10.1200/JCO.20.3.630; Hoskin PJ, 2009, J CLIN ONCOL, V27, P5390, DOI 10.1200/JCO.2009.23.3239; Hutchings M, 2006, BLOOD, V107, P52, DOI 10.1182/blood-2005-06-2252; JENNISON C, 1989, J R STAT SOC B, V51, P305; Juweid ME, 2007, J CLIN ONCOL, V25, P571, DOI 10.1200/JCO.2006.08.2305; Kobe C, 2008, BLOOD, V112, P3989, DOI 10.1182/blood-2008-06-155820; Mocikova H, 2010, ANN ONCOL, V21, P1222, DOI 10.1093/annonc/mdp522; Sieber M, 2003, J CLIN ONCOL, V21, P1734, DOI 10.1200/JCO.2003.06.028; Spaepen K, 2001, BRIT J HAEMATOL, V115, P272, DOI 10.1046/j.1365-2141.2001.03169.x; VANLEEUWEN FE, 1994, J CLIN ONCOL, V12, P1063, DOI 10.1200/JCO.1994.12.5.1063; Viviani S, 1996, J CLIN ONCOL, V14, P1421, DOI 10.1200/JCO.1996.14.5.1421; Viviani S, 2011, NEW ENGL J MED, V365, P203, DOI 10.1056/NEJMoa1100340; Zinzani PL, 2006, ANN ONCOL, V17, P1296, DOI 10.1093/annonc/mdl122	35	428	444	0	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2012	379	9828					1791	1799		10.1016/S0140-6736(11)61940-5	http://dx.doi.org/10.1016/S0140-6736(11)61940-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	941BR	22480758				2022-12-28	WOS:000303937700033
J	Spence, D				Spence, Des			All applicants to medical school should be interviewed	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 23	2012	344								e2889	10.1136/bmj.e2889	http://dx.doi.org/10.1136/bmj.e2889			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934HA	22529303				2022-12-28	WOS:000303433600003
J	Gordon, JRS; Brieva, JC				Gordon, Jennifer R. S.; Brieva, Joaquin C.			Unilateral Dermatoheliosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gordon, Jennifer R. S.; Brieva, Joaquin C.] Northwestern Univ, Chicago, IL 60611 USA	Northwestern University	Gordon, JRS (corresponding author), Northwestern Univ, Chicago, IL 60611 USA.	jrsgordon@gmail.com							0	34	34	5	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 19	2012	366	16					E25	E25		10.1056/NEJMicm1104059	http://dx.doi.org/10.1056/NEJMicm1104059			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	927UE	22512500				2022-12-28	WOS:000302934800011
J	Podolsky, SH; Greene, JA; Jones, DS				Podolsky, Scott H.; Greene, Jeremy A.; Jones, David S.			200th Anniversary Article The Evolving Roles of the Medical Journal	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Podolsky, Scott H.; Greene, Jeremy A.; Jones, David S.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Podolsky, Scott H.] Ctr Hist Med, Countway Lib Med, Boston, MA USA; [Greene, Jeremy A.] Brigham & Womens Hosp, Div Pharmacoepidemiol, Boston, MA 02115 USA; [Greene, Jeremy A.; Jones, David S.] Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University	Podolsky, SH (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA.							ABELSON PH, 1966, SCIENCE, V154, P727, DOI 10.1126/science.154.3750.727; Connor L., 1884, JAMA-J AM MED ASSOC, V11, P650; FOX T, 1965, CRISIS COMMUNICATION; Hutchison R, 1939, LANCET, V2, P1059; Knoll E, 1992, MEDICAL J MEDICAL KN, P146; Salisbury JH, 1906, J AMER MED ASSOC, V46, P1337	6	15	16	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 19	2012	366	16					1457	1461		10.1056/NEJMp1113567	http://dx.doi.org/10.1056/NEJMp1113567			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	927UE	22512480	Green Published			2022-12-28	WOS:000302934800001
J	Floyd, JS; Heckbert, SR; Weiss, NS; Carrell, DS; Psaty, BM				Floyd, James S.; Heckbert, Susan R.; Weiss, Noel S.; Carrell, David S.; Psaty, Bruce M.			Use of Administrative Data to Estimate the Incidence of Statin-Related Rhabdomyolysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							SIMVASTATIN; MYOPATHY		[Floyd, James S.; Heckbert, Susan R.; Weiss, Noel S.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Carrell, David S.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative	Floyd, JS (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	jfloyd@uw.edu	Floyd, James/G-7563-2015		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085251, R01HL078888, T32HL007902] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006375] Funding Source: NIH RePORTER; NHGRI NIH HHS [U01 HG006375] Funding Source: Medline; NHLBI NIH HHS [HL078888, HL085251, T32 HL007902, R01 HL085251, R01 HL078888] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andrade SE, 2005, J CLIN EPIDEMIOL, V58, P171, DOI 10.1016/j.jclinepi.2004.10.004; Armitage J, 2010, LANCET, V376, P1658, DOI 10.1016/S0140-6736(10)60310-8; Egan A, 2011, NEW ENGL J MED, V365, P285, DOI 10.1056/NEJMp1106689; Graham DJ, 2004, JAMA-J AM MED ASSOC, V292, P2585, DOI 10.1001/jama.292.21.2585; Staffa JA, 2002, NEW ENGL J MED, V346, P539, DOI 10.1056/NEJM200202143460721	5	41	42	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2012	307	15					1580	1582		10.1001/jama.2012.489	http://dx.doi.org/10.1001/jama.2012.489			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927GU	22511681	Green Accepted			2022-12-28	WOS:000302896100015
J	Doran, T; Kontopantelis, E; Fullwood, C; Lester, H; Valderas, JM; Campbell, S				Doran, Tim; Kontopantelis, Evangelos; Fullwood, Catherine; Lester, Helen; Valderas, Jose M.; Campbell, Stephen			Exempting dissenting patients from pay for performance schemes: retrospective analysis of exception reporting in the UK Quality and Outcomes Framework	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; FOR-PERFORMANCE; CONTRACT; ENGLAND; ASSOCIATION; DEPRIVATION; INDICATORS; DELIVERY; DATABASE; EQUITY	Objective To examine the reasons why practices exempt patients from the UK Quality and Outcomes Framework pay for performance scheme (exception reporting) and to identify the characteristics of general practices associated with informed dissent. Design Retrospective analysis. Setting Data for 2008-9 extracted from the clinical computing systems of general practices in England. Participants 8229 English family practices. Main outcome measures Rates of exception reporting for 37 clinical quality indicators, associations of patient and general practice factors with exception rates, and financial gain for practices relating to their use of exception reporting. Results The median rate of exception reporting was 2.7% (interquartile range 1.9-3.9%) overall and 0.44% (0.14-1.1%) for informed dissent, but variation in rates was wide between practices and across indicators. Common reasons for exception reporting were logistical (40.6% of exceptions), clinical contraindication (18.7%), and patient informed dissent (30.1%). Higher rates of informed dissent were associated with: higher numbers of registered patients, higher levels of local area deprivation, and failure of the practice to secure maximum remuneration in the previous year. Exception reporting increased the cost of the scheme by 30 pound 844 500 ((sic)36 877 700; $49 053 200) (0.58 pound per patient), with two indicators accounting for a quarter of this additional cost. Conclusions The provision to exception report enables practices to exempt dissenting patients without being financially penalised. Relatively few patients were excluded for informed dissent, however, suggesting that the incentivised activities were broadly acceptable to patients.	[Doran, Tim; Kontopantelis, Evangelos; Campbell, Stephen] Univ Manchester, Hlth Sci Res Grp Primary Care, Manchester M13 9PL, Lancs, England; [Fullwood, Catherine] Univ Manchester, Manchester Acad, Hlth Sci Ctr, Cent Manchester Univ Hosp NHS Fdn Trust, Manchester M13 9PL, Lancs, England; [Lester, Helen] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England; [Valderas, Jose M.] Univ Oxford, NIHR Sch Primary Care Res, Hlth Serv & Policy Res Grp, Dept Primary Care Hlth Sci, Oxford, England	University of Manchester; University of Manchester; University of Birmingham; University of Oxford	Doran, T (corresponding author), Univ Manchester, Hlth Sci Res Grp Primary Care, Manchester M13 9PL, Lancs, England.	tim.doran@manchester.ac.uk	Valderas, Jose M/G-7967-2014; Valderas, Jose M/Y-9814-2019; Kontopantelis, Evangelos/H-2966-2019	Valderas, Jose M/0000-0002-9299-1555; Kontopantelis, Evangelos/0000-0001-6450-5815; Fullwood, Catherine/0000-0003-4136-2027; Campbell, Stephen/0000-0002-2328-4136	Medical Research Council [MC_PC_13042, MR/K006665/1] Funding Source: Medline; Department of Health [NIHR/CS/010/024, CDF-2011-04-016] Funding Source: Medline; National Institute for Health Research [SPCR-006, NIHR/CS/010/024, CDF-2011-04-016] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Ashworth M, 2007, BRIT J GEN PRACT, V57, P441; Audit Commission, 2011, PAY GPS IMPR QUAL AU; Bottle A, 2008, J GEN INTERN MED, V23, P135, DOI 10.1007/s11606-007-0390-2; Campbell S, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X567117; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; Doran T, 2008, LANCET, V372, P728, DOI 10.1016/S0140-6736(08)61123-X; Doran T, 2008, NEW ENGL J MED, V359, P274, DOI 10.1056/NEJMsa0800310; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; EDINA, 2010, UKBORDERS; Fischbacher CM, 2009, J PUBLIC HEALTH-UK, V31, P239, DOI 10.1093/pubmed/fdp003; Fleetcroft R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-131; Flodgren G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009255; General Medical Council, 2008, CONS PAT DOCT MAK DE; Gravelle H, 2010, ECON J, V120, pF129, DOI 10.1111/j.1468-0297.2009.02340.x; Heath I, 2007, BRIT MED J, V335, P1075, DOI 10.1136/bmj.39377.387373.AD; Kiran T, 2010, J EPIDEMIOL COMMUN H, V64, P927, DOI 10.1136/jech.2009.098806; McDonald R, 2009, ANN FAM MED, V7, P121, DOI 10.1370/afm.946; National Institute for Health and Clinical Excellence, 2011, HIGH LEV SUMM REC RE; NHS Employers, 2005, EST ACC QOF DAT; Purdy S, 2011, J HEALTH SERV RES PO, V16, P133, DOI 10.1258/jhsrp.2010.010013; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Scott A, 2011, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD008451.PUB2; Serumaga B, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d108; Sigfrid LA, 2006, J PUBLIC HEALTH-UK, V28, P221, DOI 10.1093/pubmed/fdl028; Simpson CR, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-56; Sirovich BE, 2011, ARCH INTERN MED, V171, P1582, DOI 10.1001/archinternmed.2011.437; Sutton M, 2006, BRIT MED J, V332, P389, DOI 10.1136/bmj.38742.554468.55	28	22	22	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2012	344								e2405	10.1136/bmj.e2405	http://dx.doi.org/10.1136/bmj.e2405			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	931CN	22511209	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000303192100001
J	Juusola, JL; Brandeau, ML; Owens, DK; Bendavid, E				Juusola, Jessie L.; Brandeau, Margaret L.; Owens, Douglas K.; Bendavid, Eran			The Cost-Effectiveness of Preexposure Prophylaxis for HIV Prevention in the United States in Men Who Have Sex With Men	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NEW-YORK-CITY; ANTIRETROVIRAL THERAPY; VIRAL LOAD; CASUAL PARTNERSHIPS; CLINICAL-OUTCOMES; LIMITED KNOWLEDGE; RISK BEHAVIORS; HEALTHY-ADULTS; YOUNG MEN	Background: A recent randomized, controlled trial showed that daily oral preexposure chemoprophylaxis (PrEP) was effective for HIV prevention in men who have sex with men (MSM). The Centers for Disease Control and Prevention recently provided interim guidance for PrEP in MSM at high risk for HIV. Previous studies did not reach a consistent estimate of its cost-effectiveness. Objective: To estimate the effectiveness and cost-effectiveness of PrEP in MSM in the United States. Design: Dynamic model of HIV transmission and progression combined with a detailed economic analysis. Data Sources: Published literature. Target Population: MSM aged 13 to 64 years in the United States. Time Horizon: Lifetime. Perspective: Societal. Intervention: PrEP was evaluated in both the general MSM population and in high-risk MSM and was assumed to reduce infection risk by 44% on the basis of clinical trial results. Outcome Measures: New HIV infections, discounted quality-adjusted life-years (QALYs) and costs, and incremental cost-effectiveness ratios. Results of Base-Case Analysis: Initiating PrEP in 20% of MSM in the United States would reduce new HIV infections by an estimated 13% and result in a gain of 550 166 QALYs over 20 years at a cost of $172 091 per QALY gained. Initiating PrEP in a larger proportion of MSM would prevent more infections but at an increasing cost per QALY gained (up to $216 480 if all MSM receive PrEP). Pre-exposure chemoprophylaxis in only high-risk MSM can improve cost-effectiveness. For MSM with an average of 5 partners per year, PrEP costs approximately $50 000 per QALY gained. Providing PrEP to all high-risk MSM for 20 years would cost $75 billion more in health care-related costs than the status quo and $600 000 per HIV infection prevented, compared with incremental costs of $95 billion and $2 million per infection prevented for 20% coverage of all MSM. Results of Sensitivity Analysis: PrEP in the general MSM population would cost less than $100 000 per QALY gained if the daily cost of antiretroviral drugs for PrEP was less than $15 or if PrEP efficacy was greater than 75%. Limitation: When examining PrEP in high-risk MSM, the investigators did not model a mix of low-and high-risk MSM because of lack of data on mixing patterns. Conclusion: PrEP in the general MSM population could prevent a substantial number of HIV infections, but it is expensive. Use in high-risk MSM compares favorably with other interventions that are considered cost-effective but could result in annual PrEP expenditures of more than $4 billion.	[Juusola, Jessie L.] Stanford Univ, Dept Management Sci & Engn, Huang Engn Ctr, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Juusola, JL (corresponding author), Stanford Univ, Dept Management Sci & Engn, Huang Engn Ctr, Suite 263,475 Via Ortega, Stanford, CA 94305 USA.	jjuusola@stanford.edu		Juusola, Jessie/0000-0002-2885-2008	National Institute on Drug Abuse [R01-DA15612]; Department of Veterans Affairs; National Institute of Allergy and Infectious Diseases [K01-AI084582]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI084582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015612, R01DA015612] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Department of Veterans Affairs(US Department of Veterans Affairs); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	By grant R01-DA15612 from the National Institute on Drug Abuse and the Department of Veterans Affairs (Dr. Owens), and grant K01-AI084582 from the National Institute of Allergy and Infectious Diseases (Dr. Bendavid).	Abbas UL, 2006, JAIDS-J ACQ IMM DEF, V41, P632, DOI 10.1097/01.qai.0000194234.31078.bf; Alistar SS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000423; [Anonymous], 2011, GUID US ANT AG HIV 1, P1; Arias Elizabeth, 2007, Natl Vital Stat Rep, V56, P1; Barash EA, 2010, AIDS PATIENT CARE ST, V24, P689, DOI 10.1089/apc.2010.0173; Barnett PG, 2011, MED CARE, V49, P848, DOI 10.1097/MLR.0b013e31821b34c0; Bollinger RC, 1997, JAMA-J AM MED ASSOC, V278, P2085, DOI 10.1001/jama.278.23.2085; Bozzette SA, 2001, NEW ENGL J MED, V344, P817, DOI 10.1056/NEJM200103153441107; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Campsmith M. L., 2008, Morbidity and Mortality Weekly Report, V57, P1073; Celentano DD, 1998, SCIENCE, V280, P1889, DOI 10.1126/science.280.5371.1889; CensusScope, 2000, US AG DISTR; Centers for Disease Control and Prevention, 2010, HIV AIDS GAY BIS MEN; Centers for Disease Control and Prevention, 2008, EST NEW HIV INF US; Centers for Disease Control and Prevention, 2006, 5 CDCP; Centers for Disease Control and Prevention, 2011, CDC TRIAL AN MAJ STU; Centers for Medicare & Medicaid Services, 2010, MED INF PROV PARTN H; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Colfax GN, 2002, AIDS, V16, P1529, DOI 10.1097/00002030-200207260-00010; Daar ES, 2001, ANN INTERN MED, V134, P25, DOI 10.7326/0003-4819-134-1-200101020-00010; Desai K, 2008, AIDS, V22, P1829, DOI 10.1097/QAD.0b013e32830e00f5; Dunn D, 2008, J INFECT DIS, V197, P398, DOI 10.1086/524686; Farnham PG, 2008, PUBLIC HEALTH REP, V123, P51, DOI 10.1177/00333549081230S307; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gebo KA, 1999, AIDS, V13, P963, DOI 10.1097/00002030-199905280-00013; Gold MR, 1996, COST EFFECTIVENESS H; Golub Sarit A, 2010, Curr HIV/AIDS Rep, V7, P201, DOI 10.1007/s11904-010-0057-1; Golub SA, 2010, JAIDS-J ACQ IMM DEF, V54, P548, DOI 10.1097/QAI.0b013e3181e19a54; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Greenwald Jeffrey L, 2006, Curr Infect Dis Rep, V8, P125, DOI 10.1007/s11908-006-0008-6; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Harawa NT, 2004, JAIDS-J ACQ IMM DEF, V35, P526, DOI 10.1097/00126334-200404150-00011; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Holtgrave DR, 1997, J ACQ IMMUN DEF SYND, V16, P54, DOI 10.1097/00042560-199709010-00009; Honiden S, 2006, QUAL LIFE RES, V15, P69, DOI 10.1007/s11136-005-8485-x; Hutchinson AB, 2006, JAIDS-J ACQ IMM DEF, V43, P451, DOI 10.1097/01.qai.0000243090.32866.4e; Juusola JL, 2011, AIDS, V25, P1779, DOI 10.1097/QAD.0b013e328349f067; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; KAPLAN EH, 1995, AIDS, V9, P1113, DOI 10.1097/00002030-199510000-00001; Khazeni N, 2009, ANN INTERN MED, V151, P829, DOI [10.7326/0000605-200912150-00157, 10.7326/0003-4819-151-12-200912150-00157]; Koblin BA, 2003, AM J PUBLIC HEALTH, V93, P926, DOI 10.2105/AJPH.93.6.926; Liu AY, 2008, JAIDS-J ACQ IMM DEF, V47, P241, DOI 10.1097/QAI.0b013e31815e4041; Long EF, 2006, AIDS, V20, P2207, DOI 10.1097/QAD.0b013e328010c7d0; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; Long EF, 2009, VACCINE, V27, P5402, DOI 10.1016/j.vaccine.2009.06.063; MacKellar DA, 2006, AIDS, V20, P1637, DOI 10.1097/01.aids.0000238410.67700.d1; Manning SE, 2007, J URBAN HEALTH, V84, P212, DOI 10.1007/s11524-006-9135-5; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; McCormick AW, 2007, CLIN INFECT DIS, V44, P1115, DOI 10.1086/512816; Meara E, 2004, HEALTH AFFAIR, V23, P176, DOI 10.1377/hlthaff.23.4.176; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; Myers GM, 2011, AIDS PATIENT CARE ST, V25, P63, DOI 10.1089/apc.2010.0222; Mylonakis E, 2000, AM J MED, V109, P568, DOI 10.1016/S0002-9343(00)00583-0; Neuner JM, 2003, ANN INTERN MED, V139, P113, DOI 10.7326/0003-4819-139-2-200307150-00011; Nyman JA, 2007, MED CARE, V45, P618, DOI 10.1097/MLR.0b013e31803dce05; O'Brien BJ, 2003, VALUE HEALTH, V6, P116, DOI 10.1046/j.1524-4733.2003.00213.x; Owens DK, 1996, ARCH INTERN MED, V156, P394, DOI 10.1001/archinte.156.4.394; Owens DK, 2011, ANN INTERN MED, V154, P174, DOI 10.7326/0003-4819-154-3-201102010-00007; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Pathela P, 2006, ANN INTERN MED, V145, P416, DOI 10.7326/0003-4819-145-6-200609190-00005; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pinkerton SD, 2007, AIDS, V21, P1625, DOI 10.1097/QAD.0b013e32826fb6a6; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rietmeijer CA, 1998, SEX TRANSM DIS, V25, P353, DOI 10.1097/00007435-199808000-00006; Rose CD, 2010, JAIDS-J ACQ IMM DEF, V55, P572, DOI 10.1097/QAI.0b013e3181ee4c62; Sanchez Travis, 2006, Morbidity and Mortality Weekly Report, V55, P1; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Smith D. K., 2011, Morbidity and Mortality Weekly Report, V60, P65; Steward WT, 2009, AIDS BEHAV, V13, P1054, DOI 10.1007/s10461-009-9582-6; Sullivan PW, 2006, MED DECIS MAKING, V26, P401, DOI 10.1177/0272989X06290496; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; Teshale E., 2005, 12 C RETR OPP INF BO; Thomson PDR, 2010, RED BOOK PHARM FUNDA; Turner DA, 2006, VACCINE, V24, P1035, DOI 10.1016/j.vaccine.2004.12.033; U. S. Census Bureau, 2008, NAT POP PROJ REL 200; Vergis EN, 2000, INFECT DIS CLIN N AM, V14, P809, DOI 10.1016/S0891-5520(05)70135-5; Vernazza P, 2008, LANCET, V372, P1806, DOI 10.1016/S0140-6736(08)61753-5; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; Xiridou M, 2004, AIDS, V18, P1311, DOI 10.1097/00002030-200406180-00010; Xiridou M, 2003, AIDS, V17, P1029, DOI 10.1097/00002030-200305020-00012; Xu FJ, 2010, SEX TRANSM DIS, V37, P399, DOI 10.1097/OLQ.0b013e3181ce122b	91	108	108	1	53	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2012	156	8					541	U144		10.7326/0003-4819-156-8-201204170-00004	http://dx.doi.org/10.7326/0003-4819-156-8-201204170-00004			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	930PO	22508731				2022-12-28	WOS:000303151800013
J	Marinkovic, SP; Rovner, ES; Moldwin, RM; Stanton, SL; Gillen, LM; Marinkovic, CM				Marinkovic, Serge P.; Rovner, Eric S.; Moldwin, Robert M.; Stanton, Stuart L.; Gillen, Lisa M.; Marinkovic, Christina M.			The management of overactive bladder syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DRUG-THERAPY; GUIDELINES; SYMPTOMS		[Marinkovic, Serge P.] St Joseph Hosp, Ft Wayne, IN USA; [Rovner, Eric S.] Med Univ S Carolina, Dept Urol, Charleston, SC 29425 USA; [Moldwin, Robert M.] Albert Einstein Coll Med, Arthur Smith Inst Urol, New Hyde Pk, NY USA; [Stanton, Stuart L.] St Georges Sch Med, London, England; [Gillen, Lisa M.] So Illinois Sch Med, Dept Urol, Springfield, IL USA; [Marinkovic, Christina M.] So Illinois Sch Med, Dept Family Med, Decatur, IL USA	Medical University of South Carolina; Northwell Health; Yeshiva University; St Georges University London; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Marinkovic, SP (corresponding author), St Joseph Hosp, Ft Wayne, IN USA.	urourogyn@yahoo.com						Abrams P, 2007, BJU INT, V100, P987, DOI 10.1111/j.1464-410X.2007.07205.x; Brading AF, 1997, UROLOGY, V50, P57, DOI 10.1016/S0090-4295(97)00591-8; Burgio KL, 2000, J AM GERIATR SOC, V48, P370, DOI 10.1111/j.1532-5415.2000.tb04692.x; Chapple CR, 2008, EUR UROL, V54, P543, DOI 10.1016/j.eururo.2008.06.047; Cho SY, 2012, NEUROUROL URODYNAM, V31, P64, DOI 10.1002/nau.21186; Coyne K, 2002, QUAL LIFE RES, V11, P563, DOI 10.1023/A:1016370925601; de Groat WC, 1997, UROLOGY, V50, P36, DOI 10.1016/S0090-4295(97)00587-6; Ellsworth Pamela, 2010, Urol Nurs, V30, P29; Gillespie JI, 2004, BJU INT, V93, P393, DOI 10.1111/j.1464-410X.2003.04624.x; Hashim H, 2008, BJU INT, V102, P62, DOI 10.1111/j.1464-410X.2008.07463.x; Haylen BT, 2010, NEUROUROL URODYNAM, V29, P4, DOI 10.1002/nau.20798; Laksmi Purwita W, 2008, Acta Med Indones, V40, P233; Lee S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-55; Lohsiriwat S, 2011, UROL ANNALS, V3, P14, DOI 10.4103/0974-7796.75862; Milsom I, 2001, BJU INT, V87, P760, DOI 10.1046/j.1464-410x.2001.02228.x; Nabi G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003781.pub2; NHS Scotland, 2021, SCOTT REF GUID SUSP; Onukwugha Ebere, 2009, Am J Manag Care, V15, pS90; Ouslander JG, 2004, NEW ENGL J MED, V350, P786, DOI 10.1056/NEJMra032662; Roe B, 2007, J ADV NURS, V57, P15, DOI 10.1111/j.1365-2648.2006.04097.x; Soda T, 2010, J UROLOGY, V184, P1000, DOI 10.1016/j.juro.2010.05.038; Stewart WF, 2002, WORLD J UROL, V20, P327, DOI 10.1007/s00345-002-0301-4; Tahtinen RM, 2011, OBSTET GYNECOL, V118, P643, DOI 10.1097/AOG.0b013e318227b7ac; Thuroff JW, 2011, ACTAS UROL ESP, V35, P373, DOI 10.1016/j.acuro.2011.03.012; Vella Vijaya L, 2009, J Reprod Med, V54, P597; Wagg AS, 2007, BJU INT, V99, P502, DOI 10.1111/j.1464-410X.2006.06677.x; Welsh A, 2006, UR INC MAN UR INC WO, P12; Yamaguchi O, 2009, INT J UROL, V16, P126, DOI 10.1111/j.1442-2042.2008.02177.x	28	29	30	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2012	344								e2365	10.1136/bmj.e2365	http://dx.doi.org/10.1136/bmj.e2365			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	931CN	22511208				2022-12-28	WOS:000303192100014
J	Platt, ML; Adams, GK				Platt, Michael L.; Adams, Geoffrey K.			Monkey See, Monkey Read	SCIENCE			English	Editorial Material							ORGANIZATION; HISTORY		[Platt, Michael L.; Adams, Geoffrey K.] Duke Univ, Duke Inst Brain Sci, Durham, NC 27710 USA	Duke University	Platt, ML (corresponding author), Duke Univ, Duke Inst Brain Sci, Durham, NC 27710 USA.	platt@neuro.duke.edu						BLOUGH DS, 1982, SCIENCE, V218, P397, DOI 10.1126/science.7123242; Changizi MA, 2005, P ROY SOC B-BIOL SCI, V272, P267, DOI 10.1098/rspb.2004.2942; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; Grainger J, 2012, SCIENCE, V336, P245, DOI 10.1126/science.1218152; Shaywitz SE, 1998, P NATL ACAD SCI USA, V95, P2636, DOI 10.1073/pnas.95.5.2636; Vinckier F, 2007, NEURON, V55, P143, DOI 10.1016/j.neuron.2007.05.031; WALKER W, 1993, ETHNOHISTORY, V40, P70, DOI 10.2307/482159	7	5	5	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2012	336	6078					168	169		10.1126/science.1221402	http://dx.doi.org/10.1126/science.1221402			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924PN	22499933				2022-12-28	WOS:000302703900034
J	Redberg, RF; Katz, MH				Redberg, Rita F.; Katz, Mitchell H.			Healthy Men Should Not Take Statins	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK; WOMEN		[Redberg, Rita F.] Univ Calif San Francisco, Div Cardiol, Dept Med, San Francisco, CA 94143 USA; [Katz, Mitchell H.] Dept Hlth Serv, Los Angeles, CA USA	University of California System; University of California San Francisco	Redberg, RF (corresponding author), Univ Calif San Francisco, Div Cardiol, Dept Med, 505 Parnassus Ave,M1180, San Francisco, CA 94143 USA.	redberg@medicine.ucsf.edu						Culver AL, 2012, ARCH INTERN MED, V172, P144, DOI 10.1001/archinternmed.2011.625; Fernandez Genaro, 2011, Cleve Clin J Med, V78, P393, DOI 10.3949/ccjm.78a.10073; Gupta BP, 2011, ARCH INTERN MED, V171, P1797, DOI 10.1001/archinternmed.2011.440; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2197; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Muldoon MF, 2000, AM J MED, V108, P538, DOI 10.1016/S0002-9343(00)00353-3; Muldoon MF, 2004, AM J MED, V117, P823, DOI 10.1016/j.amjmed.2004.07.041; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4	10	62	64	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2012	307	14					1491	1492		10.1001/jama.2012.423	http://dx.doi.org/10.1001/jama.2012.423			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922HN	22496261				2022-12-28	WOS:000302538100020
J	Gregg, JM				Gregg, J. Marty			Stressing Ferroelectrics	SCIENCE			English	Editorial Material							ELECTRIC POLARIZATION; TITANATE		Queens Univ Belfast, Sch Math & Phys, Belfast BT7 1NN, Antrim, North Ireland	Queens University Belfast	Gregg, JM (corresponding author), Queens Univ Belfast, Sch Math & Phys, Univ Rd, Belfast BT7 1NN, Antrim, North Ireland.	m.gregg@qub.ac.uk		Gregg, Marty/0000-0002-6451-7768				BURSIAN EV, 1968, FIZ TVERD TELA+, V10, P1121; KOGAN SM, 1964, SOV PHYS-SOL STATE, V5, P2069; Lu H, 2012, SCIENCE, V336, P59, DOI 10.1126/science.1218693; Ma WH, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2211309; Ma WH, 2003, APPL PHYS LETT, V82, P3293, DOI 10.1063/1.1570517; Ma WH, 2002, APPL PHYS LETT, V81, P3440, DOI 10.1063/1.1518559; TAGANTSEV AK, 1991, PHASE TRANSIT, V35, P119, DOI 10.1080/01411599108213201; TAGANTSEV AK, 1986, PHYS REV B, V34, P5883, DOI 10.1103/PhysRevB.34.5883; Zubko P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.167601	9	16	17	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2012	336	6077					41	42		10.1126/science.1220827	http://dx.doi.org/10.1126/science.1220827			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920LG	22491842				2022-12-28	WOS:000302405400041
J	Pietrzynski, G; Thompson, IB; Gieren, W; Graczyk, D; Stepien, K; Bono, G; Moroni, PGP; Pilecki, B; Udalski, A; Soszynski, I; Preston, GW; Nardetto, N; McWilliam, A; Roederer, IU; Gorski, M; Konorski, P; Storm, J				Pietrzynski, G.; Thompson, I. B.; Gieren, W.; Graczyk, D.; Stepien, K.; Bono, G.; Moroni, P. G. Prada; Pilecki, B.; Udalski, A.; Soszynski, I.; Preston, G. W.; Nardetto, N.; McWilliam, A.; Roederer, I. U.; Gorski, M.; Konorski, P.; Storm, J.			RR-Lyrae-type pulsations from a 0.26-solar-mass star in a binary system	NATURE			English	Article							VARIABLES; CONTACT; CURVES; LIGHT; MASS	RR Lyrae pulsating stars have been extensively used as tracers of old stellar populations for the purpose of determining the ages of galaxies, and as tools to measure distances to nearby galaxies(1-3). There was accordingly considerable interest when the RR Lyrae star OGLE-BLG-RRLYR-02792 (referred to here as RRLYR-02792) was found to be a member of an eclipsing binary system(4), because the mass of the pulsator (hitherto constrained only by models) could be unambiguously determined. Here we report that RRLYR-02792 has a mass of 0.26 solar masses (M-circle dot) and therefore cannot be a classical RR Lyrae star. Using models, we find that its properties are best explained by the evolution of a close binary system that started with 1.4M(circle dot) and 0.8M(circle dot) stars orbiting each other with an initial period of 2.9 days. Mass exchange over 5.4 billion years produced the observed system, which is now in a very short-lived phase where the physical properties of the pulsator happen to place it in the same instability strip of the Hertzsprung-Russell diagram as that occupied by RR Lyrae stars. We estimate that only 0.2 per cent of RR Lyrae stars may be contaminated by systems similar to this one, which implies that distances measured with RR Lyrae stars should not be significantly affected by these binary interlopers.	[Pietrzynski, G.; Gieren, W.; Graczyk, D.; Pilecki, B.; Gorski, M.; Konorski, P.] Univ Concepcion, Dept Astron, Concepcion, Chile; [Pietrzynski, G.; Stepien, K.; Pilecki, B.; Udalski, A.; Soszynski, I.; Gorski, M.; Konorski, P.] Univ Warsaw Observ, PL-00478 Warsaw, Poland; [Thompson, I. B.; Preston, G. W.; McWilliam, A.; Roederer, I. U.] Carnegie Observ, Pasadena, CA 91101 USA; [Bono, G.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Bono, G.] Osserv Astron Roma, INAF, I-00040 Monte Porzio Catone, Italy; [Moroni, P. G. Prada] Univ Pisa, Dipartimento Fis E Fermi, I-56127 Pisa, Italy; [Moroni, P. G. Prada] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Nardetto, N.] UNS CNRS OCA, UMR7293, Lab Lagrange, F-06300 Nice, France; [Storm, J.] Leibniz Inst Astrophys, D-14482 Potsdam, Germany	Universidad de Concepcion; University of Warsaw; Warsaw University Observatory; Carnegie Institution for Science; University of Rome Tor Vergata; Istituto Nazionale Astrofisica (INAF); University of Pisa; Istituto Nazionale di Fisica Nucleare (INFN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; Leibniz Institut fur Astrophysik Potsdam (AIP)	Pietrzynski, G (corresponding author), Univ Concepcion, Dept Astron, Casilla 160-C, Concepcion, Chile.	pietrzyn@astrouw.edu.pl	Nardetto, Nicolas/GSE-2085-2022; Storm, Jesper/AAM-7106-2021; Moroni, Pier Giorgio Prada/G-5565-2011	Storm, Jesper/0000-0002-8627-6096; Pietrzynski, Grzegorz/0000-0002-9443-4138; Pilecki, Bogumil/0000-0003-3861-8124; Soszynski, Igor/0000-0002-7777-0842; Gorski, Marek/0000-0002-3125-9088; Udalski, Andrzej/0000-0001-5207-5619; Prada Moroni, Pier Giorgio/0000-0001-9712-9916	Chilean Center for Astrophysics FONDAP; BASAL Centro de Astrofisica y Tecnologias Afines (CATA); NSF; Polish Ministry of Science (Ideas Plus); Foundation for Polish Science (FOCUS, TEAM); GEMINI-CONICYT; European Research Council; Las Campanas and ESO Paranal [287.D-5022(A)]	Chilean Center for Astrophysics FONDAP(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); BASAL Centro de Astrofisica y Tecnologias Afines (CATA)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); NSF(National Science Foundation (NSF)); Polish Ministry of Science (Ideas Plus); Foundation for Polish Science (FOCUS, TEAM)(Foundation for Polish Science); GEMINI-CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); European Research Council(European Research Council (ERC)European Commission); Las Campanas and ESO Paranal	We acknowledge financial support from the Chilean Center for Astrophysics FONDAP, the BASAL Centro de Astrofisica y Tecnologias Afines (CATA), NSF, the Polish Ministry of Science (Ideas Plus), the Foundation for Polish Science (FOCUS, TEAM), and the GEMINI-CONICYT found. The OGLE project received funding from the European Research Council 'Advanced Grant' Program. We thank the staff astronomers at Las Campanas and ESO Paranal (program 287.D-5022(A)) who provided support in data acquisition.	Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Bono G, 1997, ASTROPHYS J, V483, P811, DOI 10.1086/304284; Bono G, 2003, MON NOT R ASTRON SOC, V344, P1097, DOI 10.1046/j.1365-8711.2003.06878.x; Bono G, 2005, ESA SPEC PUBL, V576, P659; CHRISTY RF, 1964, ASTRON J, V69, P536, DOI 10.1086/109442; Kunder A, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/1/15; Mateo M, 1998, ANNU REV ASTRON ASTR, V36, P435, DOI 10.1146/annurev.astro.36.1.435; Moroni PGP, 2009, ASTRON ASTROPHYS, V507, P1575, DOI 10.1051/0004-6361/200912847; Smith H.A., 2004, RR LYRAE STARS; Soszynski I, 2011, ACTA ASTRONOM, V61, P1; Stepien K, 2006, ACTA ASTRONOM, V56, P199; Stepien K, 2011, ACTA ASTRONOM, V61, P139; Szewczyk O, 2008, ASTRON J, V136, P272, DOI 10.1088/0004-6256/136/1/272; Tognelli E, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/200913913; Van Hamme W, 2007, ASTROPHYS J, V661, P1129, DOI 10.1086/517870; WILSON RE, 1971, ASTROPHYS J, V166, P605, DOI 10.1086/150986	16	86	86	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2012	484	7392					75	77		10.1038/nature10966	http://dx.doi.org/10.1038/nature10966			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	919QN	22481359	Green Submitted			2022-12-28	WOS:000302343400036
J	Vash, P				Vash, Peter			Filling the Void	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Vash, P (corresponding author), Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA.	petervashmd@sbcglobal.net						FELITTI VJ, 1991, SOUTHERN MED J, V84, P328, DOI 10.1097/00007611-199103000-00008	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2012	307	13					1381	1382		10.1001/jama.2012.403	http://dx.doi.org/10.1001/jama.2012.403			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919AY	22474201				2022-12-28	WOS:000302294200024
J	Globus, ST; Keeney, S				Globus, Samuel T.; Keeney, Scott			The Joy of Six: How to Control Your Crossovers	CELL			English	Editorial Material							MEIOTIC RECOMBINATION; INTERFERENCE	Meiotic cells tightly regulate the number and distribution of crossovers to promote accurate chromosome segregation. Yokoo and colleagues uncover a metazoan-specific, cyclin-like protein that is crucial for crossover formation. They utilize this protein's unique properties to explore a remarkable example of biological numerology, whereby nearly every meiotic cell in C. elegans makes precisely six crossovers, one for each of its six chromosome pairs.	[Globus, Samuel T.; Keeney, Scott] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Keeney, Scott] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10065 USA; [Keeney, Scott] Howard Hughes Med Inst, Chevy Chase, MD USA	Memorial Sloan Kettering Cancer Center; Cornell University; Howard Hughes Medical Institute	Keeney, S (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA.	s-keeney@ski.mskcc.org	Keeney, Scott/GVR-8515-2022	Keeney, Scott/0000-0002-1283-6417	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058673] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM058673] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; Cole F, 2012, NAT CELL BIOL, V14, P424, DOI 10.1038/ncb2451; de Boer E, 2006, P NATL ACAD SCI USA, V103, P9607, DOI 10.1073/pnas.0600418103; Garcia-Muse T, 2007, CHROMOSOME RES, V15, P607, DOI 10.1007/s10577-007-1146-x; HUNTER N, 2007, MOL GENETICS RECOMBI, P381; Jones GH, 2006, CELL, V126, P246, DOI 10.1016/j.cell.2006.07.010; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Rosu S, 2011, SCIENCE, V334, P1286, DOI 10.1126/science.1212424; Yokoo R, 2012, CELL, V149, P75, DOI 10.1016/j.cell.2012.01.052; Zhang LR, 2011, P NATL ACAD SCI USA, V108, P20036, DOI 10.1073/pnas.1117937108	10	7	7	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 30	2012	149	1					11	12		10.1016/j.cell.2012.03.011	http://dx.doi.org/10.1016/j.cell.2012.03.011			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464316	Bronze			2022-12-28	WOS:000302235400002
J	Barretina, J; Caponigro, G; Stransky, N; Venkatesan, K; Margolin, AA; Kim, S; Wilson, CJ; Lehar, J; Kryukov, GV; Sonkin, D; Reddy, A; Liu, MW; Murray, L; Berger, MF; Monahan, JE; Morais, P; Meltzer, J; Korejwa, A; Jane-Valbuena, J; Mapa, FA; Thibault, J; Bric-Furlong, E; Raman, P; Shipway, A; Engels, IH; Cheng, J; Yu, GYK; Yu, JJ; Aspesi, P; de Silva, M; Jagtap, K; Jones, MD; Wang, L; Hatton, C; Palescandolo, E; Gupta, S; Mahan, S; Sougnez, C; Onofrio, RC; Liefeld, T; MacConaill, L; Winckler, W; Reich, M; Li, NX; Mesirov, JP; Gabriel, SB; Getz, G; Ardlie, K; Chan, V; Myer, VE; Weber, BL; Porter, J; Warmuth, M; Finan, P; Harris, JL; Meyerson, M; Golub, TR; Morrissey, MP; Sellers, WR; Schlegel, R; Garraway, LA				Barretina, Jordi; Caponigro, Giordano; Stransky, Nicolas; Venkatesan, Kavitha; Margolin, Adam A.; Kim, Sungjoon; Wilson, Christopher J.; Lehar, Joseph; Kryukov, Gregory V.; Sonkin, Dmitriy; Reddy, Anupama; Liu, Manway; Murray, Lauren; Berger, Michael F.; Monahan, John E.; Morais, Paula; Meltzer, Jodi; Korejwa, Adam; Jane-Valbuena, Judit; Mapa, Felipa A.; Thibault, Joseph; Bric-Furlong, Eva; Raman, Pichai; Shipway, Aaron; Engels, Ingo H.; Cheng, Jill; Yu, Guoying K.; Yu, Jianjun; Aspesi, Peter, Jr.; de Silva, Melanie; Jagtap, Kalpana; Jones, Michael D.; Wang, Li; Hatton, Charles; Palescandolo, Emanuele; Gupta, Supriya; Mahan, Scott; Sougnez, Carrie; Onofrio, Robert C.; Liefeld, Ted; MacConaill, Laura; Winckler, Wendy; Reich, Michael; Li, Nanxin; Mesirov, Jill P.; Gabriel, Stacey B.; Getz, Gad; Ardlie, Kristin; Chan, Vivien; Myer, Vic E.; Weber, Barbara L.; Porter, Jeff; Warmuth, Markus; Finan, Peter; Harris, Jennifer L.; Meyerson, Matthew; Golub, Todd R.; Morrissey, Michael P.; Sellers, William R.; Schlegel, Robert; Garraway, Levi A.			The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity	NATURE			English	Article							MALIGNANT-MELANOMA; INHIBITOR; KINASE; RECEPTOR; ANTAGONIST; EXPRESSION	The systematic translation of cancer genomic data into knowledge of tumour biology and therapeutic possibilities remains challenging. Such efforts should be greatly aided by robust preclinical model systems that reflect the genomic diversity of human cancers and for which detailed genetic and pharmacological annotation is available(1). Here we describe the Cancer Cell Line Encyclopedia (CCLE): a compilation of gene expression, chromosomal copy number and massively parallel sequencing data from947 human cancer cell lines. When coupled with pharmacological profiles for 24 anticancer drugs across 479 of the cell lines, this collection allowed identification of genetic, lineage, and gene-expression-based predictors of drug sensitivity. In addition to known predictors, we found that plasma cell lineage correlated with sensitivity to IGF1 receptor inhibitors; AHR expression was associated with MEK inhibitor efficacy in NRAS-mutant lines; and SLFN11 expression predicted sensitivity to topoisomerase inhibitors. Together, our results indicate that large, annotated cell-line collections may help to enable preclinical stratification schemata for anticancer agents. The generation of genetic predictions of drug response in the preclinical setting and their incorporation into cancer clinical trial design could speed the emergence of 'personalized' therapeutic regimens(2).	[Barretina, Jordi; Stransky, Nicolas; Margolin, Adam A.; Kryukov, Gregory V.; Murray, Lauren; Berger, Michael F.; Morais, Paula; Korejwa, Adam; Jane-Valbuena, Judit; Gupta, Supriya; Mahan, Scott; Sougnez, Carrie; Onofrio, Robert C.; Liefeld, Ted; Winckler, Wendy; Reich, Michael; Mesirov, Jill P.; Gabriel, Stacey B.; Getz, Gad; Ardlie, Kristin; Meyerson, Matthew; Golub, Todd R.; Garraway, Levi A.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Barretina, Jordi; Jane-Valbuena, Judit; Meyerson, Matthew; Garraway, Levi A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Barretina, Jordi; Hatton, Charles; Palescandolo, Emanuele; MacConaill, Laura; Meyerson, Matthew; Golub, Todd R.; Garraway, Levi A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Caponigro, Giordano; Venkatesan, Kavitha; Wilson, Christopher J.; Lehar, Joseph; Sonkin, Dmitriy; Reddy, Anupama; Liu, Manway; Monahan, John E.; Meltzer, Jodi; Mapa, Felipa A.; Bric-Furlong, Eva; Raman, Pichai; Aspesi, Peter, Jr.; de Silva, Melanie; Jagtap, Kalpana; Jones, Michael D.; Wang, Li; Myer, Vic E.; Weber, Barbara L.; Porter, Jeff; Warmuth, Markus; Finan, Peter; Morrissey, Michael P.; Sellers, William R.; Schlegel, Robert] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Kim, Sungjoon; Thibault, Joseph; Shipway, Aaron; Engels, Ingo H.; Li, Nanxin; Harris, Jennifer L.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Cheng, Jill; Yu, Guoying K.; Yu, Jianjun; Chan, Vivien] Novartis Inst Biomed Res, Emeryville, CA 94608 USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Novartis; Novartis; Novartis; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute	Garraway, LA (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	robert.schlegel@novartis.com; Levi_Garraway@dfci.harvard.edu	Meyerson, Matthew L/E-7123-2012; Chan, Vivien W/N-7980-2019; Morrissey, Michael/C-6792-2013; Mesirov, Jill/AGF-7626-2022; Kryukov, Gregory V/A-9592-2008; Barretina, Jordi/A-7192-2013	Chan, Vivien W/0000-0001-7663-1130; Wilson, Christopher/0000-0002-9146-522X; Sonkin, Dmitriy/0000-0002-1649-0652; Barretina, Jordi/0000-0002-3478-4080; Keskula, Paula/0000-0002-0458-9153; Reich, Michael/0000-0003-4735-5514; Jones, Michael/0000-0001-7541-7634; Meyerson, Matthew/0000-0002-9133-8108; Kryukov, Gregory/0000-0002-6131-9483; Hatton, Charlie/0000-0001-9903-4291; Monahan, John/0000-0002-3125-8704	Novartis Institutes for Biomedical Research; National Cancer Institute; Starr Cancer Consortium; NIH; NATIONAL CANCER INSTITUTE [R33CA126674, R33CA155554] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002750] Funding Source: NIH RePORTER	Novartis Institutes for Biomedical Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Starr Cancer Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the staff of the Biological Samples Platform, the Genetic Analysis Platform and the Sequencing Platform at the Broad Institute. We thank S. Banerji, J. Che, C. M. Johannessen, A. Su and N. Wagle for advice and discussion. We are grateful for the technical assistance and support of G. Bonamy, R. Brusch III, E. Gelfand, K. Gravelin, T. Huynh, S. Kehoe, K. Matthews, J. Nedzel, L. Niu, R. Pinchback, D. Roby, J. Slind, T. R. Smith, L. Tan, V. Trinh, C. Vickers, G. Yang, Y. Yao and X. Zhang. The Cancer Cell Line Encyclopedia project was enabled by a grant from the Novartis Institutes for Biomedical Research. Additional funding support was provided by the National Cancer Institute (M. M., L. A. G.), the Starr Cancer Consortium (M. F. B., L. A. G.), and the NIH Director's New Innovator Award (L.A.G.).	Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Caponigro G, 2011, NAT REV DRUG DISCOV, V10, P179, DOI 10.1038/nrd3385; Dry JR, 2010, CANCER RES, V70, P2264, DOI 10.1158/0008-5472.CAN-09-1577; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Greshock J, 2010, CANCER RES, V70, P3677, DOI 10.1158/0008-5472.CAN-09-3788; Guo WC, 2005, CANCER RES, V65, P10006, DOI 10.1158/0008-5472.CAN-05-2029; Kelland LR, 1999, J NATL CANCER I, V91, P1940, DOI 10.1093/jnci/91.22.1940; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; MacConaill LE, 2010, J CLIN ONCOL, V28, P5219, DOI 10.1200/JCO.2009.27.4944; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Moreau P, 2011, LEUKEMIA, V25, P872, DOI 10.1038/leu.2011.4; Muller CR, 2007, INT J CANCER, V121, P199, DOI 10.1002/ijc.22643; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nishio M, 2011, J THORAC ONCOL, V6, P1889, DOI 10.1097/JTO.0b013e3182286d41; Reiners JJ, 1998, MOL PHARMACOL, V53, P438, DOI 10.1124/mol.53.3.438; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Wagner LM, 2007, PEDIATR BLOOD CANCER, V48, P132, DOI 10.1002/pbc.20697; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443	26	4615	4731	18	537	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2012	483	7391					603	607		10.1038/nature11003	http://dx.doi.org/10.1038/nature11003			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915EF	22460905	Green Accepted			2022-12-28	WOS:000302006100040
J	Uhlemann, AC; Fidock, DA				Uhlemann, Anne-Catrin; Fidock, David A.			Loss of malarial susceptibility to artemisinin in Thailand	LANCET			English	Editorial Material							PLASMODIUM-FALCIPARUM; RESISTANCE		[Uhlemann, Anne-Catrin; Fidock, David A.] Columbia Univ Coll Phys & Surg, Dept Med, Div Infect Dis, New York, NY 10032 USA; [Fidock, David A.] Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA	Columbia University; Columbia University	Fidock, DA (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, Div Infect Dis, New York, NY 10032 USA.	df2260@columbia.edu		Fidock, David/0000-0001-6753-8938				Barnes KI, 2008, J INFECT DIS, V197, P1605, DOI 10.1086/587645; Carrara VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004551; Chavchich M, 2010, ANTIMICROB AGENTS CH, V54, P2455, DOI 10.1128/AAC.00947-09; Cui LW, 2012, ACTA TROP, V121, P227, DOI 10.1016/j.actatropica.2011.02.016; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Flegg JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-339; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; O'Brien C, 2011, CURR OPIN INFECT DIS, V24, P570, DOI 10.1097/QCO.0b013e32834cd3ed; Pyae Pho A, 2012, LANCET, P60484, DOI [10.1016/S0140-6736, DOI 10.1016/S0140-6736(12)60484-X]; Saralamba S, 2011, P NATL ACAD SCI USA, V108, P397, DOI 10.1073/pnas.1006113108; Stepniewska K, 2010, J INFECT DIS, V201, P570, DOI 10.1086/650301; Witkowski B, 2010, ANTIMICROB AGENTS CH, V54, P1872, DOI 10.1128/AAC.01636-09	12	16	16	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 26	2012	379	9830					1928	1930		10.1016/S0140-6736(12)60488-7	http://dx.doi.org/10.1016/S0140-6736(12)60488-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951YV	22484133				2022-12-28	WOS:000304757700008
J	Hawley, SA; Fullerton, MD; Ross, FA; Schertzer, JD; Chevtzoff, C; Walker, KJ; Peggie, MW; Zibrova, D; Green, KA; Mustard, KJ; Kemp, BE; Sakamoto, K; Steinberg, GR; Hardie, DG				Hawley, Simon A.; Fullerton, Morgan D.; Ross, Fiona A.; Schertzer, Jonathan D.; Chevtzoff, Cyrille; Walker, Katherine J.; Peggie, Mark W.; Zibrova, Darya; Green, Kevin A.; Mustard, Kirsty J.; Kemp, Bruce E.; Sakamoto, Kei; Steinberg, Gregory R.; Hardie, D. Grahame			The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase	SCIENCE			English	Article							MECHANISM; ASPIRIN; PHOSPHORYLATION; INHIBITION; METABOLISM; SALSALATE; A-769662; CELLS; BETA	Salicylate, a plant product, has been in medicinal use since ancient times. More recently, it has been replaced by synthetic derivatives such as aspirin and salsalate, both of which are rapidly broken down to salicylate in vivo. At concentrations reached in plasma after administration of salsalate or of aspirin at high doses, salicylate activates adenosine monophosphate-activated protein kinase (AMPK), a central regulator of cell growth and metabolism. Salicylate binds at the same site as the synthetic activator A-769662 to cause allosteric activation and inhibition of dephosphorylation of the activating phosphorylation site, threonine-172. In AMPK knockout mice, effects of salicylate to increase fat utilization and to lower plasma fatty acids in vivo were lost. Our results suggest that AMPK activation could explain some beneficial effects of salsalate and aspirin in humans.	[Hawley, Simon A.; Ross, Fiona A.; Chevtzoff, Cyrille; Walker, Katherine J.; Green, Kevin A.; Mustard, Kirsty J.; Hardie, D. Grahame] Univ Dundee, Coll Life Sci, Div Cell Signalling & Immunol, Dundee DD1 5EH, Scotland; [Fullerton, Morgan D.; Schertzer, Jonathan D.; Steinberg, Gregory R.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Fullerton, Morgan D.; Schertzer, Jonathan D.; Steinberg, Gregory R.] McMaster Univ, Dept Med, Div Endocrinol, Hamilton, ON L8N 3Z5, Canada; [Fullerton, Morgan D.; Schertzer, Jonathan D.; Steinberg, Gregory R.] McMaster Univ, Dept Med, Div Metab, Hamilton, ON L8N 3Z5, Canada; [Peggie, Mark W.; Zibrova, Darya; Sakamoto, Kei] Univ Dundee, Coll Life Sci, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; [Kemp, Bruce E.; Steinberg, Gregory R.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Kemp, Bruce E.; Steinberg, Gregory R.] Univ Melbourne, Dept Med, Fitzroy, Vic 3065, Australia	University of Dundee; McMaster University; McMaster University; McMaster University; University of Dundee; St. Vincent's Institute of Medical Research; University of Melbourne	Hardie, DG (corresponding author), Univ Dundee, Coll Life Sci, Div Cell Signalling & Immunol, Dundee DD1 5EH, Scotland.	d.g.hardie@dundee.ac.uk	Kemp, Bruce E/L-2633-2014; sakamoto, kei/C-8806-2019; Kemp, Bruce/G-9602-2019; Hardie, David/Z-1979-2019; Schertzer, Jonathan/P-3395-2017	Kemp, Bruce E/0000-0001-6735-5082; sakamoto, kei/0000-0001-8839-5980; Kemp, Bruce/0000-0001-6735-5082; Schertzer, Jonathan/0000-0002-1547-5856; Steinberg, Gregory/0000-0001-5425-8275; Hardie, Grahame/0000-0002-8373-7379	Wellcome Trust [080982]; Medical Research Council; AstraZeneca; Boehringer-Ingelheim; GlaxoSmithKline; Merck Serono; Pfizer; Canadian Institutes of Health Research (CIHR); Canadian Diabetes Association; National Health and Medical Research Council of Australia; Australian Research Council; Victorian Government; Medical Research Council [MC_U127088492] Funding Source: researchfish; MRC [MC_U127088492] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AstraZeneca(AstraZeneca); Boehringer-Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Merck Serono(Merck & Company); Pfizer(Pfizer); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Victorian Government; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	D.G.H. was supported by a Programme Grant (080982) from the Wellcome Trust and K.S. by the Medical Research Council. D.G.H. and K.S. were also funded by the companies (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck Serono, and Pfizer) supporting the Division of Signal Transduction Therapy, Univ. of Dundee. The studies were also supported by grants and fellowship from the Canadian Institutes of Health Research (CIHR) (M.D.F. and G.R.S.), the Canadian Diabetes Association (J.D.S. and G.R.S.), the National Health and Medical Research Council of Australia (G.R.S. and B.E.K.), and the Australian Research Council and the Victorian Government's Operational Infrastructure Support Program (B.E.K.). J.D.S. is a DeGroote Academic Fellow (McMaster Univ.), and M.D.F. a Banting Postdoctoral Fellow (CIHR). G.R.S. is a Canada Research Chair in Metabolism and Obesity.	Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; BRODY TM, 1956, J PHARMACOL EXP THER, V117, P39; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Cronstein BN, 1999, P NATL ACAD SCI USA, V96, P6377, DOI 10.1073/pnas.96.11.6377; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; DAY RO, 1989, BRIT J CLIN PHARMACO, V28, P695, DOI 10.1111/j.1365-2125.1989.tb03562.x; Dzamko N, 2010, J BIOL CHEM, V285, P115, DOI 10.1074/jbc.M109.056762; Fleischman A, 2008, DIABETES CARE, V31, P289, DOI 10.2337/dc07-1338; Gao ZG, 2003, J BIOL CHEM, V278, P24944, DOI 10.1074/jbc.M300423200; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; HIGGS GA, 1984, ANN CLIN RES, V16, P287; HIGGS GA, 1987, P NATL ACAD SCI USA, V84, P1417, DOI 10.1073/pnas.84.5.1417; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Ogunleye AA, 2009, BRIT J CANCER, V101, P1199, DOI 10.1038/sj.bjc.6605240; Reymond P, 1998, CURR OPIN PLANT BIOL, V1, P404, DOI 10.1016/S1369-5266(98)80264-1; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; WILLIAMS FM, 1985, CLIN PHARMACOKINET, V10, P392, DOI 10.2165/00003088-198510050-00002; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	30	522	544	3	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					918	922		10.1126/science.1215327	http://dx.doi.org/10.1126/science.1215327			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22517326	Green Accepted			2022-12-28	WOS:000304145600066
J	Akhtar-Zaidi, B; Lari, RCS; Corradin, O; Saiakhova, A; Bartels, CF; Balasubramanian, D; Myeroff, L; Lutterbaugh, J; Jarrar, A; Kalady, MF; Willis, J; Moore, JH; Tesar, PJ; Laframboise, T; Markowitz, S; Lupien, M; Scacheri, PC				Akhtar-Zaidi, Batool; Lari, Richard Cowper-Sal; Corradin, Olivia; Saiakhova, Alina; Bartels, Cynthia F.; Balasubramanian, Dheepa; Myeroff, Lois; Lutterbaugh, James; Jarrar, Awad; Kalady, Matthew F.; Willis, Joseph; Moore, Jason H.; Tesar, Paul J.; Laframboise, Thomas; Markowitz, Sanford; Lupien, Mathieu; Scacheri, Peter C.			Epigenomic Enhancer Profiling Defines a Signature of Colon Cancer	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; COLORECTAL-CANCER; SUSCEPTIBILITY LOCI; HUMAN BREAST; RISK; 8Q24; METAANALYSIS; CHROMATIN	Cancer is characterized by gene expression aberrations. Studies have largely focused on coding sequences and promoters, even though distal regulatory elements play a central role in controlling transcription patterns. We used the histone mark H3K4me1 to analyze gain and loss of enhancer activity genome-wide in primary colon cancer lines relative to normal colon crypts. We identified thousands of variant enhancer loci (VELs) that comprise a signature that is robustly predictive of the in vivo colon cancer transcriptome. Furthermore, VELs are enriched in haplotype blocks containing colon cancer genetic risk variants, implicating these genomic regions in colon cancer pathogenesis. We propose that reproducible changes in the epigenome at enhancer elements drive a specific transcriptional program to promote colon carcinogenesis.	[Akhtar-Zaidi, Batool; Corradin, Olivia; Saiakhova, Alina; Bartels, Cynthia F.; Balasubramanian, Dheepa; Tesar, Paul J.; Laframboise, Thomas; Markowitz, Sanford; Scacheri, Peter C.] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Akhtar-Zaidi, Batool; Scacheri, Peter C.] Case Western Reserve Univ, Dept Mol Med, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Lari, Richard Cowper-Sal; Moore, Jason H.; Lupien, Mathieu] Dartmouth Med Sch, Dept Genet, Norris Cotton Canc Ctr, Inst Quantitat Biomed Sci, Lebanon, NH 03756 USA; [Myeroff, Lois; Lutterbaugh, James; Kalady, Matthew F.; Willis, Joseph; Tesar, Paul J.; Laframboise, Thomas; Markowitz, Sanford; Scacheri, Peter C.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Jarrar, Awad; Kalady, Matthew F.] Cleveland Clin Fdn, Dept Colorectal Surg, Cleveland, OH 44195 USA; [Kalady, Matthew F.] Cleveland Clin Fdn, Lerner Res Inst, Canc Biol Dept, Cleveland, OH 44195 USA; [Willis, Joseph] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Markowitz, Sanford] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Lupien, Mathieu] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Lupien, Mathieu] Univ Toronto, Ontario Canc Inst, Univ Hlth Network, Toronto, ON M5G 1L7, Canada	Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation; Dartmouth College; Norris Cotton Cancer Center; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Scacheri, PC (corresponding author), Case Western Reserve Univ, Dept Genet, Sch Med, 10900 Euclid Ave,BRB 627, Cleveland, OH 44106 USA.	pxs183@case.edu	Tesar, Paul/GPK-5942-2022; Tesar, Paul J/C-9848-2014; Moore, Jason H./AAV-9645-2021	Tesar, Paul/0000-0003-1532-3155; Tesar, Paul J/0000-0003-1532-3155; Moore, Jason H./0000-0002-5015-1099; Lupien, Mathieu/0000-0003-0929-9478; Corradin, Olivia/0000-0002-9484-0873	NIH [R01HD056369, R01CA160356, R01CA1555004, R01-LM009012, R01-LM010098, 1P50CA150964, UO1 CA152756, 5T32GM008056-29]; Med into Grad initiative of the Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD056369] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA152756, P50CA150964, R01CA155004, R01CA160356] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103534, T32GM008056] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009012, R01LM010098] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Med into Grad initiative of the Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank A. Ting and K. Guda for helpful comments and discussion; Z. Zhang for providing Perl scripts for data analysis; P. Manaenkov for assistance with data visualization; and S. Edelheit, N. Beckloff, and N. Molyneaux from the Case Western Reserve University Genomics Core for sequencing and informatics assistance. This work was supported in part by NIH grants R01HD056369 and R01CA160356 (to P.C.S.), R01CA1555004 (to M.L.), R01-LM009012 and R01-LM010098 (to J.H.M. and R.C.-S.), 1P50CA150964 and NIH UO1 CA152756 (to S.M.), and 5T32GM008056-29 (to O.C.). B.A.-Z. is a predoctoral student in the Molecular Medicine Ph. D. Program of Cleveland Clinic and Case Western Reserve University, funded in part by the Med into Grad initiative of the Howard Hughes Medical Institute. All data are available in Gene Expression Omnibus through the accession numbers GSE36401, GSE36204, and GSE36400.	Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Cui R, 2011, GUT, V60, P799, DOI 10.1136/gut.2010.215947; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Figueiredo JC, 2011, CANCER EPIDEM BIOMAR, V20, P758, DOI 10.1158/1055-9965.EPI-10-0675; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Lascorz J, 2010, CARCINOGENESIS, V31, P1612, DOI 10.1093/carcin/bgq146; Lubbe SJ, 2012, ONCOGENE, V31, P3777, DOI 10.1038/onc.2011.564; Myung SJ, 2006, P NATL ACAD SCI USA, V103, P12098, DOI 10.1073/pnas.0603235103; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Poynter JN, 2007, CANCER RES, V67, P11128, DOI 10.1158/0008-5472.CAN-07-3239; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111	21	242	249	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2012	336	6082					736	739		10.1126/science.1217277	http://dx.doi.org/10.1126/science.1217277			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22499810	Green Accepted			2022-12-28	WOS:000303872300054
J	Beitelshees, AL				Beitelshees, Amber L.			Personalised antiplatelet treatment: a RAPIDly moving target	LANCET			English	Editorial Material							CYP2C19 GENOTYPE; METAANALYSIS; OUTCOMES		Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Beitelshees, AL (corresponding author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.	abeitels@medicine.umaryland.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL091120] Funding Source: NIH RePORTER; NHLBI NIH HHS [K23 HL091120] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Holmes MV, 2011, JAMA-J AM MED ASSOC, V306, P2704, DOI 10.1001/jama.2011.1880; Mega JL, 2010, JAMA-J AM MED ASSOC, V304, P1821, DOI 10.1001/jama.2010.1543; Price MJ, 2011, CIRCULATION, V124, P1132, DOI 10.1161/CIRCULATIONAHA.111.029165; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Roberts JD, 2012, LANCET, V379, P1705, DOI 10.1016/S0140-6736(12)60161-5; Scott SA, 2011, CLIN PHARMACOL THER, V90, P328, DOI 10.1038/clpt.2011.132; Sofi F, 2011, PHARMACOGENOMICS J, V11, P199, DOI 10.1038/tpj.2010.21	7	8	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 5	2012	379	9827					1680	1682		10.1016/S0140-6736(12)60431-0	http://dx.doi.org/10.1016/S0140-6736(12)60431-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937KX	22464341				2022-12-28	WOS:000303658500006
J	Hayashi, M; Nakashima, T; Taniguchi, M; Kodama, T; Kumanogoh, A; Takayanagi, H				Hayashi, Mikihito; Nakashima, Tomoki; Taniguchi, Masahiko; Kodama, Tatsuhiko; Kumanogoh, Atsushi; Takayanagi, Hiroshi			Osteoprotection by semaphorin 3A	NATURE			English	Article							TERMINAL DIFFERENTIATION; BONE-FORMATION; OSTEOCLAST; EXPRESSION; GROWTH; RANKL; WNT; OSTEOPOROSIS; NEUROPILIN-1; ACTIVATION	The bony skeleton is maintained by local factors that regulate bone-forming osteoblasts and bone-resorbing osteoclasts, in addition to hormonal activity. Osteoprotegerin protects bone by inhibiting osteoclastic bone resorption, but no factor has yet been identified as a local determinant of bone mass that regulates both osteoclasts and osteoblasts. Here we show that semaphorin 3A (Sema3A) exerts an osteoprotective effect by both suppressing osteoclastic bone resorption and increasing osteoblastic bone formation. The binding of Sema3A to neuropilin-1 (Nrp1) inhibited receptor activator of nuclear factor-kappa B ligand (RANKL)-induced osteoclast differentiation by inhibiting the immunoreceptor tyrosine-based activation motif (ITAM) and RhoA signalling pathways. In addition, Sema3A and Nrp1 binding stimulated osteoblast and inhibited adipocyte differentiation through the canonical Wnt/beta-catenin signalling pathway. The osteopenic phenotype in Sema3a(-/-) mice was recapitulated by mice in which the Sema3A-binding site of Nrp1 had been genetically disrupted. Intravenous Sema3A administration in mice increased bone volume and expedited bone regeneration. Thus, Sema3A is a promising new therapeutic agent in bone and joint diseases.	[Hayashi, Mikihito; Nakashima, Tomoki; Takayanagi, Hiroshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cell Signaling, Bunkyo Ku, Tokyo 1138549, Japan; [Hayashi, Mikihito; Nakashima, Tomoki; Takayanagi, Hiroshi] Japan Sci & Technol Agcy, Exploratory Res Adv Technol Program, Takayanagi Osteonetwork Project, Bunkyo Ku, Tokyo 1138549, Japan; [Hayashi, Mikihito; Nakashima, Tomoki; Takayanagi, Hiroshi] Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence Program, Bunkyo Ku, Tokyo 1138549, Japan; [Taniguchi, Masahiko] Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Mol Med Sci,Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Kodama, Tatsuhiko] Univ Tokyo, Dept Mol Biol & Med, Res Ctr Adv Sci & Technol, Lab Syst Biol & Med,Meguro Ku, Tokyo 1538904, Japan; [Kumanogoh, Atsushi] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka 5650871, Japan; [Kumanogoh, Atsushi] Osaka Univ, Immunol Frontier Res Ctr, Dept Immunopathol, Suita, Osaka 5650871, Japan; [Takayanagi, Hiroshi] Univ Western Australia, Sch Surg, Ctr Orthopaed Res, Nedlands, WA 6009, Australia	Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); Sapporo Medical University; University of Tokyo; Osaka University; Osaka University; University of Western Australia	Takayanagi, H (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cell Signaling, Bunkyo Ku, Yushima 1-5-45, Tokyo 1138549, Japan.	taka.csi@tmd.ac.jp			Japan Science and Technology Agency; Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology of Japan; Tokyo Biochemical Research Foundation; Life Science Foundation of Japan; Takeda Science Foundation; Uehara Memorial Foundation; Naito Foundation; BMKK RA; Astellas Foundation for Research on Metabolic Disorders	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokyo Biochemical Research Foundation; Life Science Foundation of Japan(Life Science Foundation of Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); BMKK RA; Astellas Foundation for Research on Metabolic Disorders	We are grateful to D. D. Ginty and A. L. Kolodkin for providing the Nrp1<SUP>Serna-</SUP> knockin mice. We thank Y. Goshima for providing vectors and technical help. We thank A. Yamaguchi, H. Asahara and F. Suto for providing reagents and technical help. We also thank K. Okamoto, T. Negishi-Koga, K. Nishikawa, H. Inoue, T. Suda, T. Ando, Y. Kunisawa, Y. Ogihara and S. Fukuse for discussion and assistance. This work was supported in part by a grant for the Exploratory Research for Advanced Technology Program, the Takayanagi Osteonetwork Project from the Japan Science and Technology Agency; Grant-in-Aid for Young Scientist A from the Japan Society for the Promotion of Science (JSPS); a Grant-in-Aid for Challenging Exploratory Research from the JSPS; grants for the Global Center of Excellence Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and grants from the Tokyo Biochemical Research Foundation, the Life Science Foundation of Japan, Takeda Science Foundation, Uehara Memorial Foundation, Naito Foundation, BMKK RA Research Fund and Astellas Foundation for Research on Metabolic Disorders.	Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Elefteriou F, 2008, ARCH BIOCHEM BIOPHYS, V473, P231, DOI 10.1016/j.abb.2008.03.016; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Gomez C, 2005, DEV DYNAM, V234, P393, DOI 10.1002/dvdy.20512; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Hayashi M, 2010, BIOCHEM BIOPH RES CO, V393, P432, DOI 10.1016/j.bbrc.2010.02.013; HAYDEN JM, 1995, BONE, V17, pS93, DOI 10.1016/8756-3282(95)00186-H; Jacquin C, 2006, J BONE MINER RES, V21, P67, DOI 10.1359/JBMR.051007; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Kawai M, 2011, NAT REV DRUG DISCOV, V10, P141, DOI 10.1038/nrd3299; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lewiecki EM, 2011, NAT REV RHEUMATOL, V7, P631, DOI 10.1038/nrrheum.2011.130; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Mizuno A, 1998, BIOCHEM BIOPH RES CO, V247, P610, DOI 10.1006/bbrc.1998.8697; Nagashima M, 2005, BONE, V36, P502, DOI 10.1016/j.bone.2004.11.013; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Narazaki M, 2006, BLOOD, V107, P3892, DOI 10.1182/blood-2005-10-4113; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Nishikawa K, 2010, J CLIN INVEST, V120, P3455, DOI 10.1172/JCI42528; Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Reid IR, 2010, J BONE MINER RES, V25, P2256, DOI 10.1002/jbmr.149; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takada I, 2009, NAT REV RHEUMATOL, V5, P442, DOI 10.1038/nrrheum.2009.137; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Takegahara N, 2010, FASEB J, V24, P4782, DOI 10.1096/fj.10-158212; Takegahara N, 2006, NAT CELL BIOL, V8, P615, DOI 10.1038/ncb1416; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Toyofuku T, 2005, NAT NEUROSCI, V8, P1712, DOI 10.1038/nn1596; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448	46	387	417	10	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					69	U96		10.1038/nature11000	http://dx.doi.org/10.1038/nature11000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22522930				2022-12-28	WOS:000303451900035
J	Lutz, RA; Falkowski, PG				Lutz, Richard A.; Falkowski, Paul G.			A Dive to Challenger Deep	SCIENCE			English	Editorial Material							MARIANA TRENCH; SEA; BACTERIA		[Lutz, Richard A.; Falkowski, Paul G.] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Lutz, RA (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA.	rlutz@marine.rut-gers.edu; falko@marine.rutgers.edu						Fujikura K, 1999, MAR ECOL PROG SER, V190, P17, DOI 10.3354/meps190017; Huang HB, 2012, J NAT PROD, V75, P202, DOI 10.1021/np2008335; JONES ML, 1985, BIOL SOC WASH B, V6, P1; Kato C, 1998, APPL ENVIRON MICROB, V64, P1510; Li SM, 2011, MAR DRUGS, V9, P1428, DOI 10.3390/md9081428; LUTZ RA, 1994, NATURE, V371, P663, DOI 10.1038/371663a0; Lutz Richard A., 1994, National Geographic Magazine, V186, P114; Lutz RA, 2012, LIFE AT EXTREMES: ENVIRONMENTS, ORGANISMS AND STRATEGIES FOR SURVIVAL, P242, DOI 10.1079/9781845938147.0242; MCNEILL MM, 1994, CLIN MICROBIOL REV, V7, P357, DOI 10.1128/CMR.7.3.357-417.1994; Pathom-aree W, 2006, EXTREMOPHILES, V10, P181, DOI 10.1007/s00792-005-0482-z; YAYANOS AA, 1982, APPL ENVIRON MICROB, V44, P1356, DOI 10.1128/AEM.44.6.1356-1361.1982	11	14	14	4	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2012	336	6079					301	302		10.1126/science.1222641	http://dx.doi.org/10.1126/science.1222641			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22499808				2022-12-28	WOS:000302995400029
J	Suzuki, G; Shimazu, N; Tanaka, M				Suzuki, Genjiro; Shimazu, Naoyuki; Tanaka, Motomasa			A Yeast Prion, Mod5, Promotes Acquired Drug Resistance and Cell Survival Under Environmental Stress	SCIENCE			English	Article							RNA-MODIFYING ENZYMES; SACCHAROMYCES-CEREVISIAE; GENETIC-VARIATION; PROTEIN; AGGREGATION; INHERITANCE; GENERATION; MECHANISM; TRAITS; VITRO	Prion conversion from a soluble protein to an aggregated state may be involved in the cellular adaptation of yeast to the environment. However, it remains unclear whether and how cells actively use prion conversion to acquire a fitness advantage in response to environmental stress. We identified Mod5, a yeast transfer RNA isopentenyltransferase lacking glutamine/asparagine-rich domains, as a yeast prion protein and found that its prion conversion in yeast regulated the sterol biosynthetic pathway for acquired cellular resistance against antifungal agents. Furthermore, selective pressure by antifungal drugs on yeast facilitated the de novo appearance of Mod5 prion states for cell survival. Thus, phenotypic changes caused by active prion conversion under environmental selection may contribute to cellular adaptation in living organisms.	[Suzuki, Genjiro; Shimazu, Naoyuki; Tanaka, Motomasa] RIKEN Brain Sci Inst, Lab Prot Conformat Dis, Wako, Saitama 3510198, Japan	RIKEN	Tanaka, M (corresponding author), RIKEN Brain Sci Inst, Lab Prot Conformat Dis, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	motomasa@brain.riken.jp	Tanaka, Motomasa/N-5064-2015	Tanaka, Motomasa/0000-0002-2994-7703	Japan Science and Technology Agency PRESTO; Ministry of Education, Culture, Sports, Science and Technology of Japan (Priority Area on Protein Society); Next Program; Sumitomo Foundation (Japan); Novartis Foundation (Japan) for the Promotion of Science	Japan Science and Technology Agency PRESTO(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan (Priority Area on Protein Society); Next Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sumitomo Foundation (Japan); Novartis Foundation (Japan) for the Promotion of Science(Novartis)	We thank J. Weissman (Univ. of California, San Francisco) for providing plasmids and yeast stains, C. Yokoyama for critical reading of the manuscript, Y. Komi and M. Yoshizawa for help with the construction of plasmids and yeast strains and drug-sensitivity assays, Y. Ohhashi for advice on structural analyses of amyloids, Y. Nekooki for providing huntingtin-exon1 Q62 protein, N. Takahashi for help with the screen for QIN, and Y. Sakamaki for transmission electron microscopy analysis. DNA sequencing and mass spectrometry were performed at the RIKEN Brain Science Institute Research Resources Center facility. Funding was provided by Japan Science and Technology Agency PRESTO; grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Priority Area on Protein Society); the Next Program; and the Sumitomo Foundation and the Novartis Foundation (Japan) for the Promotion of Science (M.T.).	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Benko AL, 2000, P NATL ACAD SCI USA, V97, P61, DOI 10.1073/pnas.97.1.61; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; BREIVIK ON, 1957, J AGR FOOD CHEM, V5, P360, DOI 10.1021/jf60075a005; Chernoff Y, 2004, CURR OPIN CHEM BIOL, V8, P665, DOI 10.1016/j.cbpa.2004.09.002; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; DIHANICH ME, 1987, MOL CELL BIOL, V7, P177, DOI 10.1128/MCB.7.1.177; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Gustavsson M, 2008, RNA, V14, P666, DOI 10.1261/rna.966208; Halfmann R, 2010, SCIENCE, V330, P629, DOI 10.1126/science.1191081; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Nelson R, 2006, CURR OPIN STRUC BIOL, V16, P260, DOI 10.1016/j.sbi.2006.03.007; Ness F, 2002, MOL CELL BIOL, V22, P5593, DOI 10.1128/MCB.22.15.5593-5605.2002; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Patel BK, 2007, J MOL BIOL, V365, P773, DOI 10.1016/j.jmb.2006.10.069; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Robbins N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002257; Suzuki T, 2007, METHOD ENZYMOL, V425, P211, DOI 10.1016/S0076-6876(07)25009-8; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; TUITE MF, 1981, GENETICS, V98, P691; Tuite MF, 2010, NAT REV MOL CELL BIO, V11, P823, DOI 10.1038/nrm3007; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708	31	172	177	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2012	336	6079					355	359		10.1126/science.1219491	http://dx.doi.org/10.1126/science.1219491			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22517861				2022-12-28	WOS:000302995400049
J	Behrouzi, R; Roh, JH; Kilburn, D; Briber, RM; Woodson, SA				Behrouzi, Reza; Roh, Joon Ho; Kilburn, Duncan; Briber, R. M.; Woodson, Sarah A.			Cooperative Tertiary Interaction Network Guides RNA Folding	CELL			English	Article							GROUP-I RIBOZYME; TETRAHYMENA-THERMOPHILA RIBOZYME; COMPARATIVE SEQUENCE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CORE HELICES; ACTIVE-SITE; INTRON; STABILITY; COLLAPSE	Noncoding RNAs form unique 3D structures, which perform many regulatory functions. To understand how RNAs fold uniquely despite a small number of tertiary interaction motifs, we mutated the major tertiary interactions in a group I ribozyme by single-base substitutions. The resulting perturbations to the folding energy landscape were measured using SAXS, ribozyme activity, hydroxyl radical footprinting, and native PAGE. Double-and triple-mutant cycles show that most tertiary interactions have a small effect on the stability of the native state. Instead, the formation of core and peripheral structural motifs is cooperatively linked in near-native folding intermediates, and this cooperativity depends on the native helix orientation. The emergence of a cooperative interaction network at an early stage of folding suppresses nonnative structures and guides the search for the native state. We suggest that cooperativity in noncoding RNAs arose from natural selection of architectures conducive to forming a unique, stable fold.	[Behrouzi, Reza; Kilburn, Duncan; Woodson, Sarah A.] Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA; [Roh, Joon Ho; Briber, R. M.] Univ Maryland, Dept Mat Sci & Engn, College Pk, MD 20742 USA; [Roh, Joon Ho] Natl Inst Stand & Technol, Ctr Neutron Res, Gaithersburg, MD 20899 USA	Johns Hopkins University; University System of Maryland; University of Maryland College Park; National Institute of Standards & Technology (NIST) - USA	Woodson, SA (corresponding author), Johns Hopkins Univ, TC Jenkins Dept Biophys, 3400 N Charles St, Baltimore, MD 21218 USA.	swoodson@jhu.edu	Behrouzi, Reza/M-6604-2013; Briber, Robert M/A-3588-2012	Behrouzi, Reza/0000-0003-3064-9743; Briber, Robert M/0000-0002-8358-5942; Woodson, Sarah/0000-0003-0170-1987	National Institutes of Health (NIH) [GM60819, RR-08630]; National Institute of Standards and Technology; US Department of Energy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060819] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank L. Guo and T. Irving for assistance with SAXS experiments, and D. Barrick, D. Draper, E. Westhof, J. Lecomte, D. Zappulla, and members of the laboratory of S. A. W. for discussion and comments. This work was supported by grants from the National Institutes of Health (NIH) (GM60819) and National Institute of Standards and Technology. BioCAT is an NIH-supported Research Center (RR-08630). Access to the APS was made possible by support from the US Department of Energy. R. B. designed and performed experiments, analyzed the data, and wrote the paper, J. H. R. and D. K. performed SAXS experiments, R. M. B. designed SAXS experiments and edited the paper, and S. A. W. designed the experiments and wrote the paper.	Adams PL, 2004, RNA, V10, P1867, DOI 10.1261/rna.7140504; Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; Bailor MH, 2010, SCIENCE, V327, P202, DOI 10.1126/science.1181085; Baird NJ, 2010, J MOL BIOL, V397, P1298, DOI 10.1016/j.jmb.2010.02.025; Baird NJ, 2006, RNA, V12, P598, DOI 10.1261/rna.2186506; Baird NJ, 2005, J MOL BIOL, V352, P712, DOI 10.1016/j.jmb.2005.07.010; Battle DJ, 2002, P NATL ACAD SCI USA, V99, P11676, DOI 10.1073/pnas.182221799; Bevilacqua PC, 1996, BIOCHEMISTRY-US, V35, P648, DOI 10.1021/bi951962z; Bokinsky G, 2003, P NATL ACAD SCI USA, V100, P9302, DOI 10.1073/pnas.1133280100; Brion P, 1999, RNA, V5, P947, DOI 10.1017/S1355838299990477; Buchmueller KL, 2003, BIOCHEMISTRY-US, V42, P13869, DOI 10.1021/bi035476k; Butcher SE, 2011, ACCOUNTS CHEM RES, V44, P1302, DOI 10.1021/ar200098t; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Chauhan S, 2005, J MOL BIOL, V353, P1199, DOI 10.1016/j.jmb.2005.09.015; Chauhan S, 2008, J AM CHEM SOC, V130, P1296, DOI 10.1021/ja076166i; Chauhan S, 2009, J MOL BIOL, V386, P1167, DOI 10.1016/j.jmb.2008.12.075; CREIGHTON TE, 1990, BIOCHEM J, V270, P1; Das R, 2003, J MOL BIOL, V332, P311, DOI 10.1016/S0022-2836(03)00854-4; Di Cera E, 1998, ADV PROTEIN CHEM, V51, P59; DOUDNA JA, 1995, RNA, V1, P36; Fang XW, 1999, NAT STRUCT BIOL, V6, P1091; Fang XW, 1999, BIOCHEMISTRY-US, V38, P16840, DOI 10.1021/bi991700n; Fang XW, 2001, P NATL ACAD SCI USA, V98, P4355, DOI 10.1073/pnas.071050698; Fiore JL, 2009, BIOCHEMISTRY-US, V48, P2550, DOI 10.1021/bi8019788; Fujita Y, 2009, RNA, V15, P877, DOI 10.1261/rna.1461309; Gilbert SD, 2008, NAT STRUCT MOL BIOL, V15, P177, DOI 10.1038/nsmb.1371; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P10159, DOI 10.1021/bi00496a003; Hogg R.V., 2006, PROBABILITY STAT INF, Vseventh; Holbrook SR, 2008, ANNU REV BIOPHYS, V37, P445, DOI 10.1146/annurev.biophys.36.040306.132755; Ikawa Y, 2000, NUCLEIC ACIDS RES, V28, P3269, DOI 10.1093/nar/28.17.3269; JAEGER L, 1994, J MOL BIOL, V236, P1271, DOI 10.1016/0022-2836(94)90055-8; Kilburn D, 2010, J AM CHEM SOC, V132, P8690, DOI 10.1021/ja101500g; Kuo LY, 1999, BBA-GENE STRUCT EXPR, V1489, P281, DOI 10.1016/S0167-4781(99)00200-6; Laing C, 2011, CURR OPIN STRUC BIOL, V21, P306, DOI 10.1016/j.sbi.2011.03.015; Lambert D, 2010, J MOL BIOL, V404, P138, DOI 10.1016/j.jmb.2010.09.043; Lehnert V, 1996, CHEM BIOL, V3, P993, DOI 10.1016/S1074-5521(96)90166-0; Leipply D, 2010, BIOCHEMISTRY-US, V49, P1843, DOI 10.1021/bi902036j; Leontis NB, 2006, CURR OPIN STRUC BIOL, V16, P279, DOI 10.1016/j.sbi.2006.05.009; Lescoute A, 2006, NUCLEIC ACIDS RES, V34, P6587, DOI 10.1093/nar/gkl963; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Moghaddam S, 2009, J MOL BIOL, V393, P753, DOI 10.1016/j.jmb.2009.08.044; Montange RK, 2008, ANNU REV BIOPHYS, V37, P117, DOI 10.1146/annurev.biophys.37.032807.130000; Pan J, 1999, P NATL ACAD SCI USA, V96, P6149, DOI 10.1073/pnas.96.11.6149; Perez-Salas UA, 2004, BIOCHEMISTRY-US, V43, P1746, DOI 10.1021/bi035642o; PYLE AM, 1991, NATURE, V350, P628, DOI 10.1038/350628a0; Rangan P, 2003, J MOL BIOL, V329, P229, DOI 10.1016/S0022-2836(03)00430-3; Rangan P, 2003, P NATL ACAD SCI USA, V100, P1574, DOI 10.1073/pnas.0337743100; Sattint BD, 2008, J AM CHEM SOC, V130, P6085, DOI 10.1021/ja800919q; Schultes EA, 2005, NAT STRUCT MOL BIOL, V12, P1130, DOI 10.1038/nsmb1014; Shank EA, 2010, NATURE, V465, P637, DOI 10.1038/nature09021; Siegfried NA, 2009, METHOD ENZYMOL, V455, P365, DOI 10.1016/S0076-6879(08)04213-4; Silverman SK, 1999, BIOCHEMISTRY-US, V38, P8691, DOI 10.1021/bi9906118; Strauss-Soukup JK, 2000, J MOL BIOL, V302, P339, DOI 10.1006/jmbi.2000.4056; Su LHJ, 2003, J MOL BIOL, V334, P639, DOI 10.1016/j.jmb.2003.09.071; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Szewczak AA, 1997, RNA, V3, P838; Tanner MA, 1996, RNA, V2, P74; Tanner MA, 1997, SCIENCE, V275, P847, DOI 10.1126/science.275.5301.847; Theimer CA, 2005, MOL CELL, V17, P671, DOI 10.1016/j.molcel.2005.01.017; Thirumalai D, 2005, BIOCHEMISTRY-US, V44, P4957, DOI 10.1021/bi047314+; Toor N, 2008, NAT STRUCT MOL BIOL, V15, P1221, DOI 10.1038/nsmb.1509; Treiber DK, 1998, SCIENCE, V279, P1943, DOI 10.1126/science.279.5358.1943; Walter NG, 1999, NAT STRUCT BIOL, V6, P544; Wan YQ, 2011, BIOCHEMISTRY-US, V50, P864, DOI 10.1021/bi101467q; Watters AL, 2007, CELL, V128, P613, DOI 10.1016/j.cell.2006.12.042; Weber G, 1975, Adv Protein Chem, V29, P1, DOI 10.1016/S0065-3233(08)60410-6; Weinberg Z, 2009, NATURE, V462, P656, DOI 10.1038/nature08586; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; Westhof E, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-108; Zarrinkar PP, 1996, NAT STRUCT BIOL, V3, P432, DOI 10.1038/nsb0596-432	70	74	75	2	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 13	2012	149	2					348	357		10.1016/j.cell.2012.01.057	http://dx.doi.org/10.1016/j.cell.2012.01.057			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500801	Green Accepted, Bronze			2022-12-28	WOS:000302805600014
J	Zakharyevich, K; Tang, SM; Ma, YM; Hunter, N				Zakharyevich, Kseniya; Tang, Shangming; Ma, Yunmei; Hunter, Neil			Delineation of Joint Molecule Resolution Pathways in Meiosis Identifies a Crossover-Specific Resolvase	CELL			English	Article							DOUBLE-STRAND BREAK; HOLLIDAY JUNCTION RESOLUTION; STRUCTURE-SPECIFIC NUCLEASES; CROSSING-OVER; MEIOTIC RECOMBINATION; MISMATCH REPAIR; BLM HELICASE; KINASE CDC5; D-LOOPS; MUS81/MMS4 ENDONUCLEASE	At the final step of homologous recombination, Holliday junction-containing joint molecules (JMs) are resolved to form crossover or noncrossover products. The enzymes responsible for JM resolution in vivo remain uncertain, but three distinct endonucleases capable of resolving JMs in vitro have been identified: Mus81-Mms4(EME1), Slx1-Slx4(BTBD12), and Yen1(GEN1). Using physical monitoring of recombination during budding yeast meiosis, we show that all three endonucleases are capable of promoting JM resolution in vivo. However, in mms4 slx4 yen1 triple mutants, JM resolution and crossing over occur efficiently. Paradoxically, crossing over in this background is strongly dependent on the Blooms helicase ortholog Sgs1, a component of a well-characterized anticrossover activity. Sgs1-dependent crossing over, but not JM resolution per se, also requires XPG family nuclease Exo1 and the MutLg complex Mlh1-Mlh3. Thus, Sgs1, Exo1, and MutLg together define a previously undescribed meiotic JM resolution pathway that produces the majority of crossovers in budding yeast and, by inference, in mammals.	[Zakharyevich, Kseniya; Tang, Shangming; Ma, Yunmei; Hunter, Neil] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Zakharyevich, Kseniya; Hunter, Neil] Univ Calif Davis, Microbiol Grad Grp, Davis, CA 95616 USA; [Tang, Shangming; Hunter, Neil] Univ Calif Davis, Biochem Mol Cellular & Dev Biol Grad Grp, Davis, CA 95616 USA; [Ma, Yunmei; Hunter, Neil] Univ Calif Davis, Howard Hughes Med Inst, Davis, CA 95616 USA; [Hunter, Neil] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Hunter, Neil] Univ Calif Davis, Dept Cell Biol & Human Anat, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Howard Hughes Medical Institute; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Hunter, N (corresponding author), Univ Calif Davis, Dept Microbiol, 1 Shields Ave, Davis, CA 95616 USA.	nhunter@ucdavis.edu			 [GM074223]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074223] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Thanks to Eric Alani for the mlh3-D523N::KanMX cassette, Chu-Chun Huang for help with tetrad analysis, Wolf Heyer for valuable input, and Arnaud Muyt and Michael Lichten for communication of unpublished data and stimulating discussions. This work was supported by grant GM074223. N.H. is an Early Career Scientist of the Howard Hughes Medical Institute.	Agmon N, 2011, NUCLEIC ACIDS RES, V39, P7009, DOI 10.1093/nar/gkr277; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Andersen SL, 2009, MOL CELL, V35, P128, DOI 10.1016/j.molcel.2009.06.019; Bachrati CZ, 2006, NUCLEIC ACIDS RES, V34, P2269, DOI 10.1093/nar/gkl258; BELL LR, 1982, COLD SPRING HARB SYM, V47, P829, DOI 10.1101/SQB.1983.047.01.095; Berchowitz LE, 2007, PLOS GENET, V3, P1355, DOI 10.1371/journal.pgen.0030132; Berchowitz LE, 2010, CURR GENOMICS, V11, P91, DOI 10.2174/138920210790886835; Blanco MG, 2010, DNA REPAIR, V9, P394, DOI 10.1016/j.dnarep.2009.12.017; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Bzymek M, 2010, NATURE, V464, P937, DOI 10.1038/nature08868; Cejka P, 2010, NAT STRUCT MOL BIOL, V17, P1377, DOI 10.1038/nsmb.1919; Cejka Petr, 2010, J Biol Chem, V285, P8290, DOI 10.1074/jbc.M109.083196; Cha RS, 2000, GENE DEV, V14, P493; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; Cromie GA, 2008, GENETICS, V179, P1157, DOI 10.1534/genetics.108.088955; Cromie GA, 2006, CELL, V127, P1167, DOI 10.1016/j.cell.2006.09.050; de los Santos T, 2003, GENETICS, V164, P81; De Muyt A, 2012, MOL CELL, V46, P43, DOI 10.1016/j.molcel.2012.02.020; Dunin-Horkawicz S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-98; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Fricke WM, 2003, GENE DEV, V17, P1768, DOI 10.1101/gad.1105203; Furukawa T, 2003, PLANT MOL BIOL, V51, P59, DOI 10.1023/A:1020789314722; Gilbertson LA, 1996, GENETICS, V144, P27; Hickson ID, 2011, CELL CYCLE, V10, DOI 10.4161/cc.10.18.16919; Higgins JD, 2008, PLANT J, V55, P28, DOI 10.1111/j.1365-313X.2008.03470.x; Higgins JD, 2008, PLANT J, V54, P152, DOI 10.1111/j.1365-313X.2008.03403.x; Ho CK, 2010, MOL CELL, V40, P988, DOI 10.1016/j.molcel.2010.11.016; Holloway JK, 2010, J CELL BIOL, V188, P779, DOI 10.1083/jcb.200909048; Holloway JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000186; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Hunter N., 2006, MOL GENETICS RECOMBI, P381, DOI 10.1007/978-3-540-71021-9_14; Hunter N, 2011, CELL CYCLE, V10, P2607, DOI 10.4161/cc.10.16.16452; Ip SCY, 2008, NATURE, V456, P357, DOI 10.1038/nature07470; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Ishikawa G, 2004, NUCLEIC ACIDS RES, V32, P6251, DOI 10.1093/nar/gkh962; Jessop L, 2008, MOL CELL, V31, P313, DOI 10.1016/j.molcel.2008.05.021; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Keelagher RE, 2011, DNA REPAIR, V10, P126, DOI 10.1016/j.dnarep.2010.09.024; Kneitz B, 2000, GENE DEV, V14, P1085; Kolas NK, 2004, CYTOGENET GENOME RES, V107, P216, DOI 10.1159/000080600; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Lyndaker AM, 2009, BIOESSAYS, V31, P315, DOI 10.1002/bies.200800195; Lynn A, 2007, CHROMOSOME RES, V15, P591, DOI 10.1007/s10577-007-1150-1; Martini E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002305; Matos J, 2011, CELL, V147, P158, DOI 10.1016/j.cell.2011.08.032; Mcvey M, 2007, GENETICS, V176, P1979, DOI 10.1534/genetics.106.070052; Mimitou EP, 2009, TRENDS BIOCHEM SCI, V34, P264, DOI 10.1016/j.tibs.2009.01.010; Moens PB, 2002, J CELL SCI, V115, P1611; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Nishant KT, 2008, GENETICS, V179, P747, DOI 10.1534/genetics.108.086645; Oh SD, 2008, MOL CELL, V31, P324, DOI 10.1016/j.molcel.2008.07.006; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Oh SD, 2009, METHODS MOL BIOL, V557, P209, DOI 10.1007/978-1-59745-527-5_14; Pluciennik A, 2010, P NATL ACAD SCI USA, V107, P16066, DOI 10.1073/pnas.1010662107; Prakash R, 2009, GENE DEV, V23, P67, DOI 10.1101/gad.1737809; Rass U, 2010, GENE DEV, V24, P1559, DOI 10.1101/gad.585310; Saito TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000735; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Schwartz EK, 2011, CHROMOSOMA, V120, P109, DOI 10.1007/s00412-010-0304-7; Singh TR, 2008, GENE DEV, V22, P2856, DOI 10.1101/gad.1725108; Smith GR, 2003, GENETICS, V165, P2289; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Sourirajan A, 2008, GENE DEV, V22, P2627, DOI 10.1101/gad.1711408; Stahl FW, 2004, GENETICS, V168, P35, DOI 10.1534/genetics.104.027789; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Tay YD, 2010, J BIOL CHEM, V285, P11427, DOI 10.1074/jbc.M110.108399; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; XU LZ, 1995, MOL CELL BIOL, V15, P6572; Yildiz O, 2002, MOL CELL, V10, P1503, DOI 10.1016/S1097-2765(02)00782-7; Youds JL, 2010, SCIENCE, V327, P1254, DOI 10.1126/science.1183112; Zakharyevich K, 2010, MOL CELL, V40, P1001, DOI 10.1016/j.molcel.2010.11.032; Zalevsky J, 1999, GENETICS, V153, P1271; ZETKA MC, 1995, GENETICS, V141, P1339	82	192	196	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 13	2012	149	2					334	347		10.1016/j.cell.2012.03.023	http://dx.doi.org/10.1016/j.cell.2012.03.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500800	Green Accepted, Bronze			2022-12-28	WOS:000302805600013
J	Kelly, DP				Kelly, Daniel P.			Irisin, Light My Fire	SCIENCE			English	Editorial Material							BROWN ADIPOSE-TISSUE; SKELETAL-MUSCLE; ADULT HUMANS; EXERCISE; PGC-1; FAT; DRIVES		Sanford Burnham Med Res Inst, Diabet & Obes Res Ctr, Orlando, FL 32827 USA	Sanford Burnham Prebys Medical Discovery Institute	Kelly, DP (corresponding author), Sanford Burnham Med Res Inst, Diabet & Obes Res Ctr, Orlando, FL 32827 USA.	dkelly@sanfordburnham.org	Kelly, Daniel/ABG-2056-2021		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045416] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK045416] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Speakman JR, 2003, P NUTR SOC, V62, P621, DOI 10.1079/PNS2003282; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Xu XH, 2011, AM J PHYSIOL-REG I, V300, pR1115, DOI 10.1152/ajpregu.00806.2010; Yan Z, 2011, J APPL PHYSIOL, V110, P264, DOI 10.1152/japplphysiol.00993.2010; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008	14	103	121	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2012	336	6077					42	43		10.1126/science.1221688	http://dx.doi.org/10.1126/science.1221688			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920LG	22491843				2022-12-28	WOS:000302405400042
J	Marty, T				Marty, Thomas			Clean up the waste	NATURE			English	Editorial Material									Berinfor, Management Acad Inst, Zurich, Switzerland		Marty, T (corresponding author), Berinfor, Management Acad Inst, Zurich, Switzerland.	thomas.marty@berinfor.ch						[Anonymous], 2011, EFFICIENCY EFFECTIVE; Balocco M., 2011, WISSENSCHAFTSMANAGEM, V4, P11; Diehl R. L., 2011, MAINTAINING EXCELLEN; Lewin T., 2009, NY TIMES        1114	4	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2012	484	7392					27	28		10.1038/484027a	http://dx.doi.org/10.1038/484027a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	919QN	22481338	Bronze			2022-12-28	WOS:000302343400014
J	Morrison, AP; French, P; Stewart, SLK; Birchwood, M; Fowler, D; Gumley, AI; Jones, PB; Bentall, RP; Lewis, SW; Murray, GK; Patterson, P; Brunet, K; Conroy, J; Parker, S; Reilly, T; Byrne, R; Davies, LM; Dunn, G				Morrison, Anthony P.; French, Paul; Stewart, Suzanne L. K.; Birchwood, Max; Fowler, David; Gumley, Andrew I.; Jones, Peter B.; Bentall, Richard P.; Lewis, Shon W.; Murray, Graham K.; Patterson, Paul; Brunet, Kat; Conroy, Jennie; Parker, Sophie; Reilly, Tony; Byrne, Rory; Davies, Linda M.; Dunn, Graham			Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ULTRA-HIGH RISK; COGNITIVE-BEHAVIOR THERAPY; YOUNG-PEOPLE; MAJOR DEPRESSION; SOCIAL PHOBIA; FOLLOW-UP; DISORDERS; PREVENTION; SCHIZOPHRENIA; METAANALYSIS	Objective To determine whether cognitive therapy is effective in preventing the worsening of emerging psychotic symptoms experienced by help seeking young people deemed to be at risk for serious conditions such as schizophrenia. Design Multisite single blind randomised controlled trial. Setting Diverse services at five UK sites. Participants 288 participants aged 14-35 years (mean 20.74, SD 4.34 years) at high risk of psychosis: 144 were assigned to cognitive therapy plus monitoring of mental state and 144 to monitoring of mental state only. Participants were followed-up for a minimum of 12 months and a maximum of 24 months. Intervention Cognitive therapy (up to 26 (mean 9.1) sessions over six months) plus monitoring of mental state compared with monitoring of mental state only. Main outcome measures Primary outcome was scores on the comprehensive assessment of at risk mental states (CAARMS), which provides a dichotomous transition to psychosis score and ordinal scores for severity of psychotic symptoms and distress. Secondary outcomes included emotional dysfunction and quality of life. Results Transition to psychosis based on intention to treat was analysed using discrete time survival models. Overall, the prevalence of transition was lower than expected (23/288; 8%), with no significant difference between the two groups (proportional odds ratio 0.73, 95% confidence interval 0.32 to 1.68). Changes in severity of symptoms and distress, as well as secondary outcomes, were analysed using random effects regression (analysis of covariance) adjusted for site and baseline symptoms. Distress from psychotic symptoms did not differ (estimated difference at 12 months -3.00, 95% confidence interval -6.95 to 0.94) but their severity was significantly reduced in the group assigned to cognitive therapy (estimated between group effect size at 12 months -3.67, -6.71 to -0.64, P=0.018). Conclusions Cognitive therapy plus monitoring did not significantly reduce transition to psychosis or symptom related distress but reduced the severity of psychotic symptoms in young people at high risk. Most participants in both groups improved over time. The results have important implications for the at risk mental state concept.	[Morrison, Anthony P.; Stewart, Suzanne L. K.] Univ Manchester, Sch Psychol Sci, Manchester M13 9PL, Lancs, England; [Morrison, Anthony P.; French, Paul; Parker, Sophie; Byrne, Rory] Greater Manchester W Mental Hlth NHS Fdn Trust, Manchester, Lancs, England; [Birchwood, Max; Brunet, Kat] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Fowler, David] Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; [Gumley, Andrew I.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Jones, Peter B.; Murray, Graham K.] Univ Cambridge, Dept Psychiat, Cambridge, England; [Bentall, Richard P.] Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England; [Lewis, Shon W.] Univ Manchester, Sch Med, Mental Hlth & Neurodegenerat Res Grp, Manchester M13 9PL, Lancs, England; [Patterson, Paul] Birmingham & Solihull Mental Hlth NHS Trust, Early Detect & Intervent Team, Birmingham, W Midlands, England; [Conroy, Jennie] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England; [Reilly, Tony] Norfolk & Waveney Mental Hlth NHS Trust, Early Intervent Team, Norwich, Norfolk, England; [Davies, Linda M.; Dunn, Graham] Univ Manchester, Sch Med, Hlth Sci Res Grp, Manchester M13 9PL, Lancs, England	University of Manchester; University of Birmingham; University of East Anglia; University of Glasgow; University of Cambridge; University of Liverpool; University of Manchester; University of Manchester	Morrison, AP (corresponding author), Univ Manchester, Sch Psychol Sci, Manchester M13 9PL, Lancs, England.	tony.morrison@manchester.ac.uk	Birchwood, Max/E-3474-2017	Birchwood, Max/0000-0002-7476-0171; Jones, Peter Brian/0000-0002-0387-880X; Patterson, Paul/0000-0003-3310-8635; Fowler, David/0000-0001-5806-2659; Lewis, Shon/0000-0003-1861-4652; Gumley, Andrew/0000-0002-8888-938X; Morrison, Anthony/0000-0002-4389-2091; Murray, Graham/0000-0001-8296-1742; Stewart, Suzanne/0000-0003-2152-0091; Davies, Linda/0000-0001-8801-3559	National Institute for Health Research through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC); Medical Research Council [G0500264]; Department of Health; Medical Research Council [G0701911] Funding Source: researchfish; MRC [G0701911, G0500264] Funding Source: UKRI	National Institute for Health Research through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Hannah Taylor, Carolyn Crane, Melissa Wardle, and the other EDIE-2 (early detection and intervention evaluation for people at risk of psychosis) research assistants for their data collection work; our trial therapists (Jamie Kirk, Vicky Brooks, Rosalyn Hartwell, Aoiffe Kilcommons, Katie Mackie, Elizabeth Newton, and Gary Willington); the members of the trial steering committee (David Kingdon, Julia Renton, Paul Salkovskis, and Jo Smith) and the data monitoring and ethics committee (Douglas Turkington, Daniel Freeman, and Sabine Landau). Graham Dunn had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. We thank the Mental Health Research Network, the Scottish Mental Health Research Network, and the OpenCDMS team for their support and assistance. MB and PP were funded by the National Institute for Health Research through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme. The views expressed in this publication are not necessarily those of the Medical Research Council, National Institute for Health Research, or Department of Health.; This research was supported by the Medical Research Council (G0500264) and the Department of Health.	Addington J, 2011, AM J PSYCHIAT, V168, P800, DOI 10.1176/appi.ajp.2011.10081191; Addington J, 2011, SCHIZOPHR RES, V125, P54, DOI 10.1016/j.schres.2010.10.015; Ainsworth J, 2007, INT J HEALTHC INF SY, V2, P1, DOI 10.4018/jhisi.2007040101; Alvarez-Jimenez M, 2008, BRIT J PSYCHIAT, V193, P101, DOI 10.1192/bjp.bp.107.042853; Amminger GP, 2010, ARCH GEN PSYCHIAT, V67, P146, DOI 10.1001/archgenpsychiatry.2009.192; [Anonymous], 1994, BRIT PSYCH SOC ANN C; [Anonymous], 2005, BR J PSYCHIAT S, P120; Beck AT, 1997, BEHAV RES THER, V35, P785, DOI 10.1016/S0005-7967(97)00025-9; Bell K, 2008, EARLY INTERV PSYCHIA, V2, pA16; Birchwood M, 1996, COGNITIVE BEHAV INTE, P171; Blackburn IM, 2001, BEHAV COGN PSYCHOTH, V29, P431, DOI 10.1017/S1352465801004040; Cannon TD, 2008, ARCH GEN PSYCHIAT, V65, P28, DOI 10.1001/archgenpsychiatry.2007.3; CLARK DM, 1994, BRIT J PSYCHIAT, V164, P759, DOI 10.1192/bjp.164.6.759; Cuijpers P, 2010, PSYCHOL MED, V40, P211, DOI 10.1017/S0033291709006114; Dominguez MDG, 2011, SCHIZOPHRENIA BULL, V37, P84, DOI 10.1093/schbul/sbp022; Everitt B.S., 1991, APPL MULTIVARIATE DA; Foley DL, 2011, ARCH GEN PSYCHIAT, V68, P609, DOI 10.1001/archgenpsychiatry.2011.2; Foster C, 2010, J BEHAV THER EXP PSY, V41, P45, DOI 10.1016/j.jbtep.2009.09.001; French P., 2004, EARLY DETECTION COGN; HAUSMAN JA, 1978, ECONOMETRICA, V46, P1251, DOI 10.2307/1913827; Ho BC, 2011, ARCH GEN PSYCHIAT, V68, P128, DOI 10.1001/archgenpsychiatry.2010.199; Little R.J.A., 2002, STAT ANAL MISSING DA; Loewy RL, 2007, SCHIZOPHR RES, V93, P144, DOI 10.1016/j.schres.2007.02.010; Maracy M, 2011, STAT METHODS MED RES, V20, P191, DOI 10.1177/0962280208097243; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; McGlashan TH, 2006, AM J PSYCHIAT, V163, P790, DOI 10.1176/appi.ajp.163.5.790; McGorry PD, 2006, AUST NZ J PSYCHIAT, V40, P616, DOI 10.1111/j.1440-1614.2006.01860.x; McGorry PD, 2002, ARCH GEN PSYCHIAT, V59, P921, DOI 10.1001/archpsyc.59.10.921; Moncrieff J, 2010, PSYCHOL MED, V40, P1409, DOI 10.1017/S0033291709992297; Morrison AP, 2007, SCHIZOPHRENIA BULL, V33, P682, DOI 10.1093/schbul/sbl042; Morrison AP, 2010, PSYCHOSIS, V2, P96, DOI 10.1080/17522431003759982; Morrison AP, 2011, EARLY INTERV PSYCHIA, V5, P24, DOI 10.1111/j.1751-7893.2010.00254.x; Morrison AP, 2001, BEHAV COGN PSYCHOTH, V29, P257, DOI 10.1017/S1352465801003010; Morrison AP, 2004, BRIT J PSYCHIAT, V185, P291, DOI 10.1192/bjp.185.4.291; Morrison AP, 2002, BRIT J PSYCHIAT, V181, pS78, DOI 10.1192/bjp.181.43.s78; Nagelkerke N, 2000, STAT MED, V19, P1849, DOI 10.1002/1097-0258(20000730)19:14<1849::AID-SIM506>3.0.CO;2-1; Peters L, 2000, BEHAV RES THER, V38, P943, DOI 10.1016/S0005-7967(99)00131-X; Phillips LJ, 2007, SCHIZOPHR RES, V96, P25, DOI 10.1016/j.schres.2007.05.018; Priebe S, 1999, INT J SOC PSYCHIATR, V45, P7, DOI 10.1177/002076409904500102; Ruhrmann S, 2010, ARCH GEN PSYCHIAT, V67, P241, DOI 10.1001/archgenpsychiatry.2009.206; Sensky T, 2000, ARCH GEN PSYCHIAT, V57, P165, DOI 10.1001/archpsyc.57.2.165; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Tarrier N, 1998, BRIT MED J, V317, P303, DOI 10.1136/bmj.317.7154.303; Tost H, 2010, NAT NEUROSCI, V13, P920, DOI 10.1038/nn.2572; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; van Os Jim, 2003, Epidemiol Psichiatr Soc, V12, P242; van Rossum I, 2011, SCHIZOPHRENIA BULL, V37, P561, DOI 10.1093/schbul/sbp101; Varghese D, 2011, SCHIZOPHRENIA BULL, V37, P389, DOI 10.1093/schbul/sbp083; Velthorst E, 2009, SCHIZOPHR RES, V109, P60, DOI 10.1016/j.schres.2009.02.002; Wykes T, 2008, SCHIZOPHRENIA BULL, V34, P523, DOI 10.1093/schbul/sbm114; Yung AR, 2007, SCHIZOPHRENIA BULL, V33, P673, DOI 10.1093/schbul/sbm015; Yung AR, 2011, J CLIN PSYCHIAT, V72, P430, DOI 10.4088/JCP.08m04979ora; Yung AR, 2005, AUST NZ J PSYCHIAT, V39, P964, DOI 10.1080/j.1440-1614.2005.01714.x; Yung AR, 1996, SCHIZOPHRENIA BULL, V22, P283, DOI 10.1093/schbul/22.2.283	54	221	225	0	46	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 5	2012	344								e2233	10.1136/bmj.e2233	http://dx.doi.org/10.1136/bmj.e2233			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	923HF	22491790	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000302609700002
J	Calderon, L; Boehm, T				Calderon, Lesly; Boehm, Thomas			Synergistic, Context-Dependent, and Hierarchical Functions of Epithelial Components in Thymic Microenvironments	CELL			English	Article							STEM-CELL-NICHE; DELTA-LIKE 4; T-CELL; BONE-MARROW; IMMATURE THYMOCYTES; LINEAGE COMMITMENT; BETA-SELECTION; SELF-RENEWAL; FETAL BLOOD; MAST-CELLS	Specialized niche environments specify and maintain stem and progenitor cells, but little is known about the identities and functional interactions of niche components in vivo. Here, we describe a modular system for the generation of artificial thymopoietic environments in the mouse embryo. Thymic epithelium that lacks hematopoietic function but is physiologically accessible for hematopoietic progenitor cells is functionalized by individual and combinatorial expression of four factors, the chemokines Ccl25 and Cxcl12, the cytokine Scf, and the Notch ligand DLL4. The distinct phenotypes and variable numbers of hematopoietic cells in the resulting epithelial environments reveal synergistic, context-dependent, and hierarchical interactions among effector molecules. The surprisingly simple rules determining hematopoietic properties enable the in vivo engineering of artificial environments conducive to the presence of distinct myeloid or T or B lymphoid lineage precursors; moreover, synthetic environments facilitate the procurement of physiological progenitor cell types for analytical purposes and future therapeutic applications.	[Calderon, Lesly; Boehm, Thomas] Max Planck Inst Immunbiol & Epigenet, Dept Dev Immunol, D-79108 Freiburg, Germany	Max Planck Society	Boehm, T (corresponding author), Max Planck Inst Immunbiol & Epigenet, Dept Dev Immunol, Stuebeweg 51, D-79108 Freiburg, Germany.	boehm@immunbio.mpg.de		Calderon, Lesly/0000-0001-5253-7369	Max-Planck Society; Deutsche Forschungsgemeinschaft	Max-Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank A. Haas-Assenbaum and B. Kanzler for help with the generation of transgenic mice, C. Happe, B. Hammerschmidt, and S. Birmelin for technical support, A. Wuerch and S. Hobitz for help with cell sorting, J.B. Swann, V. Taylor, and H.R. Rodewald for advice and helpful discussions, and R. Kemler and D. Vestweber for reagents. We also acknowledge the contributions of C. Hetzer-Egger during early stages of this project. Financial support for these studies was provided by the Max-Planck Society and the Deutsche Forschungsgemeinschaft. L.C. was a member of the International Max-Planck Research School for Molecular and Cellular Biology (IMPRS-MCB), a joint international PhD programme of the Max Planck Institute of Immunobiology and Epigenetics (MPI-IB) and the University of Freiburg, Germany.	Anderson G, 2006, IMMUNOL REV, V209, P10, DOI 10.1111/j.0105-2896.2006.00347.x; Ara T, 2003, J IMMUNOL, V170, P4649, DOI 10.4049/jimmunol.170.9.4649; Bajoghli B, 2011, NATURE, V470, P90, DOI 10.1038/nature09655; Bajoghli B, 2009, CELL, V138, P186, DOI 10.1016/j.cell.2009.04.017; Benz C, 2005, J EXP MED, V202, P21, DOI 10.1084/jem.20050146; Benz C, 2004, EUR J IMMUNOL, V34, P3652, DOI 10.1002/eji.200425248; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; Bleul CC, 2000, EUR J IMMUNOL, V30, P3371, DOI 10.1002/1521-4141(2000012)30:12<3371::AID-IMMU3371>3.0.CO;2-L; Boehm T, 2008, CURR OPIN IMMUNOL, V20, P178, DOI 10.1016/j.coi.2008.03.001; Boehm T, 2011, NAT REV IMMUNOL, V11, P307, DOI 10.1038/nri2944; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Calderon L, 2011, P NATL ACAD SCI USA, V108, P7517, DOI 10.1073/pnas.1016428108; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Charbord P, 2002, EXP HEMATOL, V30, P1202, DOI 10.1016/S0301-472X(02)00895-0; Chen CC, 2005, P NATL ACAD SCI USA, V102, P11408, DOI 10.1073/pnas.0504197102; Corbeaux T, 2010, P NATL ACAD SCI USA, V107, P16613, DOI 10.1073/pnas.1004623107; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; Feyerabend TB, 2009, IMMUNITY, V30, P67, DOI 10.1016/j.immuni.2008.10.016; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; Janas ML, 2010, J EXP MED, V207, P247, DOI 10.1084/jem.20091430; JENKINSON EJ, 1981, J EXP MED, V153, P280, DOI 10.1084/jem.153.2.280; Kawamoto H, 2000, IMMUNITY, V12, P441, DOI 10.1016/S1074-7613(00)80196-X; Kawamoto H, 2009, TRENDS IMMUNOL, V30, P193, DOI 10.1016/j.it.2009.03.001; King AG, 2002, P NATL ACAD SCI USA, V99, P4508, DOI 10.1073/pnas.072087899; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Liu CL, 2006, BLOOD, V108, P2531, DOI 10.1182/blood-2006-05-024190; Martinic MM, 2006, P NATL ACAD SCI USA, V103, P14435, DOI 10.1073/pnas.0606707103; Moritz DR, 1998, J IMMUNOL, V161, P4866; Nagasawa T, 2000, INT J HEMATOL, V72, P408; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97; Peerani R, 2010, J CLIN INVEST, V120, P60, DOI 10.1172/JCI41158; RODEWALD HR, 1995, IMMUNITY, V3, P313, DOI 10.1016/1074-7613(95)90116-7; RODEWALD HR, 1994, EMBO J, V13, P4229, DOI 10.1002/j.1460-2075.1994.tb06743.x; RODEWALD HR, 1995, CURR OPIN IMMUNOL, V7, P176, DOI 10.1016/0952-7915(95)80002-6; Rodewald HR, 1996, SCIENCE, V271, P818, DOI 10.1126/science.271.5250.818; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Schlenner SM, 2010, TRENDS IMMUNOL, V31, P303, DOI 10.1016/j.it.2010.06.002; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Soza-Ried C, 2008, J IMMUNOL, V181, P5272, DOI 10.4049/jimmunol.181.8.5272; Terszowski G, 2006, SCIENCE, V312, P284, DOI 10.1126/science.1123497; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Trampont PC, 2010, NAT IMMUNOL, V11, P162, DOI 10.1038/ni.1830; Tsukamoto N, 2005, CELL IMMUNOL, V234, P77, DOI 10.1016/j.cellimm.2005.06.009; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011; WORTIS HH, 1971, J EXP MED, V134, P681, DOI 10.1084/jem.134.3.681; Wurbel MA, 2001, BLOOD, V98, P2626, DOI 10.1182/blood.V98.9.2626; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Zamisch M, 2005, J IMMUNOL, V174, P60, DOI 10.4049/jimmunol.174.1.60	55	86	89	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 30	2012	149	1					159	172		10.1016/j.cell.2012.01.049	http://dx.doi.org/10.1016/j.cell.2012.01.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464328	Bronze			2022-12-28	WOS:000302235400018
J	Goldhaber, SZ; Bounameaux, H				Goldhaber, Samuel Z.; Bounameaux, Henri			Pulmonary embolism and deep vein thrombosis	LANCET			English	Article							PREVENT VENOUS THROMBOEMBOLISM; HOSPITALIZED MEDICAL PATIENTS; MOLECULAR-WEIGHT HEPARIN; D-DIMER; COMPUTED-TOMOGRAPHY; UNFRACTIONATED HEPARIN; EMERGENCY-DEPARTMENT; PRETEST PROBABILITY; ELECTRONIC ALERTS; INITIAL TREATMENT	Pulmonary embolism is the third most common cause of death from cardiovascular disease after heart attack and stroke. Sequelae occurring after venous thrombo embolism include chronic thromboembolic pulmonary hypertension and post-thrombotic syndrome. Venous thromboembolism and atherothrombosis share common risk factors and the common pathophysiological characteristics of inflammation, hypercoagulability, and endothelial injury. Clinical probability assessment helps to identify patients with low clinical probability for whom the diagnosis of venous thromboembolism can be excluded solely with a negative result from a plasma D-dimer test. The diagnosis is usually confirmed with compression ultrasound showing deep vein thrombosis or with chest CT showing pulmonary embolism. Most patients with venous thromboembolism will respond to anticoagulation, which is the foundation of treatment. Patients with pulmonary embolism should undergo risk stratification to establish whether they will benefit from the addition of advanced treatment, such as thrombolysis or embolectomy. Several novel oral anticoagulant drugs are in development. These drugs, which could replace vitamin K antagonists and heparins in many patients, are prescribed in fixed doses and do not need any coagulation monitoring in the laboratory. Although rigorous clinical trials have reported the effectiveness and safety of pharmacological prevention with low, fixed doses of anticoagulant drugs, prophylaxis remains underused in patients admitted to hospital at moderate risk and high risk for venous thromboembolism. In this Seminar, we discuss pulmonary embolism and deep vein thrombosis of the legs.	[Goldhaber, Samuel Z.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Cardiovasc Div, Boston, MA 02115 USA; [Bounameaux, Henri] Univ Hosp Geneva, Fac Med Geneva, Div Angiol & Hemostasis, Dept Med Specialties, Geneva, Switzerland	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Geneva	Goldhaber, SZ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Cardiovasc Div, Boston, MA 02115 USA.	sgoldhaber@partners.org	Franzeck, Fabian C/B-5055-2011		Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; EKOS; Johnson Johnson; Sanofi-Aventis; Baxter; Daiichi Sankyo; Medscape; Merck; Pfizer; Portola; Bayer Schering Pharmaceutical AG	Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Eisai(Eisai Co Ltd); EKOS; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Sanofi-Aventis(Sanofi-Aventis); Baxter; Daiichi Sankyo(Daiichi Sankyo Company Limited); Medscape; Merck(Merck & Company); Pfizer(Pfizer); Portola; Bayer Schering Pharmaceutical AG	SZG has received research grants from Boehringer Ingelheim, Bristol-Myers Squibb, Eisai, EKOS, Johnson & Johnson, and Sanofi-Aventis; fees for consultancy from Baxter, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Eisai, EKOS, Medscape, Merck, Pfizer, Portola, and Sanofi-Aventis. HB has received research grants from Bayer Schering Pharmaceutical AG, honoraria from Bayer Schering Pharmaceutical, Daiichi Sankyo, GlaxoSmithKline, Pfizer, Sanofi-Aventis, and Servier, and fees for serving on advisory boards for Bayer Schering Pharmaceutical, Boehringer Ingelheim, Canyon Pharmaceuticals, Daiichi Sankyo, GlaxoSmithKline, Pfizer, and Sanofi-Aventis.	Ageno W, 2009, J THROMB HAEMOST, V7, P736, DOI 10.1111/j.1538-7836.2009.03327.x; Agnelli G, 2010, NEW ENGL J MED, V363, P266, DOI 10.1056/NEJMra0907731; Amin A, 2007, J THROMB HAEMOST, V5, P1610, DOI 10.1111/j.1538-7836.2007.02650.x; Anderson DR, 2005, J EMERG MED, V29, P399, DOI 10.1016/j.jemermed.2005.05.010; Anderson FA, 2010, AM J MED, V123, P1099, DOI 10.1016/j.amjmed.2010.07.011; [Anonymous], 2011, RIV COMP FAV EN PREV; Aujesky D, 2005, AM J RESP CRIT CARE, V172, P1041, DOI 10.1164/rccm.200506-862OC; Aujesky D, 2011, LANCET, V378, P41, DOI 10.1016/S0140-6736(11)60824-6; Baccarelli A, 2009, CIRCULATION, V119, P3118, DOI 10.1161/CIRCULATIONAHA.108.836163; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Blanco-Molina A, 2009, THROMB HAEMOSTASIS, V101, P478, DOI 10.1160/TH08-10-0684; Bloomfield HE, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00005; Bounameaux H, 2004, J THROMB HAEMOST, V2, P551, DOI 10.1111/j.1538-7933.2004.00648.x; Bounameaux H, 2010, J THROMB HAEMOST, V8, P627, DOI 10.1111/j.1538-7836.2010.03759.x; Bounameaux H, 2009, NAT REV CARDIOL, V6, P499, DOI 10.1038/nrcardio.2009.116; Buller HR, 2004, ANN INTERN MED, V140, P867, DOI 10.7326/0003-4819-140-11-200406010-00007; Buller HR, 2003, NEW ENGL J MED, V349, P1695; Carrier M, 2009, THROMB HAEMOSTASIS, V101, P886, DOI 10.1160/TH-08-10-0689; Ceriani E, 2010, J THROMB HAEMOST, V8, P957, DOI 10.1111/j.1538-7836.2010.03801.x; Chandra D, 2009, ANN INTERN MED, V151, P180, DOI 10.7326/0003-4819-151-3-200908040-00129; Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Corral J, 2010, HAEMATOL-HEMATOL J, V95, P863, DOI 10.3324/haematol.2010.023432; Dalen JE, 2008, AM J MED, V121, P458, DOI 10.1016/j.amjmed.2007.10.042; de Monye W, 1999, THROMB RES, V96, P293, DOI 10.1016/S0049-3848(99)00118-8; Douma RA, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1475; Fanikos J, 2010, AM J MED, V123, P536, DOI 10.1016/j.amjmed.2009.11.017; Fiumara K, 2010, THROMB HAEMOSTASIS, V103, P312, DOI 10.1160/TH09-09-0634; Folsom AR, 2009, THROMB HAEMOSTASIS, V102, P615, DOI 10.1160/TH09-04-0274; Gage BF, 2006, AM HEART J, V151, P713, DOI 10.1016/j.ahj.2005.04.017; Garcia-Alamino Josep M, 2010, Cochrane Database Syst Rev, pCD003839, DOI 10.1002/14651858.CD003839.pub2; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Ghaye B, 2001, RADIOLOGY, V219, P629, DOI 10.1148/radiology.219.3.r01jn32629; Goldhaber SZ, 2010, THROMB HAEMOSTASIS, V104, P1089, DOI 10.1160/TH10-05-0267; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Goldhaber SZ, 2004, AM J CARDIOL, V93, P259, DOI 10.1016/j.amjcard.2003.09.057; Gould MK, 1999, ANN INTERN MED, V130, P800, DOI 10.7326/0003-4819-130-10-199905180-00003; Halkin H, 1999, LANCET, V353, P1972, DOI 10.1016/S0140-6736(05)77184-1; Heit JA, 2008, ARTERIOSCL THROM VAS, V28, P370, DOI 10.1161/ATVBAHA.108.162545; Hull RD, 2010, ANN INTERN MED, V153, P8, DOI 10.7326/0003-4819-153-1-201007060-00004; Jimenez D, 2010, ARCH INTERN MED, V170, P1383, DOI 10.1001/archinternmed.2010.199; Johnson SA, 2010, JAMA-J AM MED ASSOC, V303, P438, DOI 10.1001/jama.2010.43; Kahn SR, 2008, ANN INTERN MED, V149, P698, DOI 10.7326/0003-4819-149-10-200811180-00004; Kahn SR, 2010, HEMATOL-AM SOC HEMAT, P216, DOI 10.1182/asheducation-2010.1.216; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Kent DM, 2010, ANN INTERN MED, V153, P51, DOI 10.7326/0003-4819-153-1-201007060-00012; Klok FA, 2010, AM J RESP CRIT CARE, V181, P501, DOI 10.1164/rccm.200907-1141OC; Kucher N, 2005, NEW ENGL J MED, V352, P969, DOI 10.1056/NEJMoa041533; Kucher N, 2006, CIRCULATION, V113, P577, DOI 10.1161/CIRCULATIONAHA.105.592592; Kucher N, 2010, ANN ONCOL, V21, P931, DOI 10.1093/annonc/mdp406; Kucher N, 2011, NEW ENGL J MED, V364, P861, DOI 10.1056/NEJMcp1008740; Kyrle PA, 2010, LANCET, V376, P2032, DOI 10.1016/S0140-6736(10)60962-2; Laporte S, 2008, CIRCULATION, V117, P1711, DOI 10.1161/CIRCULATIONAHA.107.726232; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; Le Gal G, 2009, J THROMB HAEMOST, V7, P752, DOI 10.1111/j.1538-7836.2009.03324.x; Lecumberri R, 2008, THROMB HAEMOSTASIS, V100, P699, DOI 10.1160/TH08-05-0337; Lee AYY, 2010, HEMATOL-AM SOC HEMAT, P144, DOI 10.1182/asheducation-2010.1.144; Lobo JL, 2007, BRIT J HAEMATOL, V138, P400, DOI 10.1111/j.1365-2141.2007.06679.x; Matchar DB, 2010, NEW ENGL J MED, V363, P1608, DOI 10.1056/NEJMoa1002617; Mavrakanas T, 2011, PHARMACOL THERAPEUT, V130, P46, DOI 10.1016/j.pharmthera.2010.12.007; Moores LK, 2004, ANN INTERN MED, V141, P866, DOI 10.7326/0003-4819-141-11-200412070-00011; Musset D, 2002, LANCET, V360, P1914, DOI 10.1016/S0140-6736(02)11914-3; Naess IA, 2007, J THROMB HAEMOST, V5, P692, DOI 10.1111/j.1538-7836.2007.02450.x; Ng ACC, 2011, CIRC-CARDIOVASC QUAL, V4, P122, DOI 10.1161/CIRCOUTCOMES.110.958397; NORDSTROM M, 1992, J INTERN MED, V232, P155, DOI 10.1111/j.1365-2796.1992.tb00565.x; Palareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444; Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905; Perrier A, 2001, ANN INTERN MED, V135, P88, DOI 10.7326/0003-4819-135-2-200107170-00008; Piazza G, 2008, CIRCULATION, V118, P1598, DOI 10.1161/CIRCULATIONAHA.108.803965; Piazza G, 2007, CHEST, V132, P554, DOI 10.1378/chest.07-0430; Piazza G, 2011, NEW ENGL J MED, V364, P351, DOI 10.1056/NEJMra0910203; Piazza G, 2010, CIRCULATION, V121, P2146, DOI 10.1161/CIRCULATIONAHA.110.951236; Piazza G, 2009, CIRCULATION, V120, P1133, DOI 10.1161/CIRCULATIONAHA.109.884031; Piazza G, 2009, CIRCULATION, V119, P2196, DOI 10.1161/CIRCULATIONAHA.108.841197; Pollack CV, 2011, J AM COLL CARDIOL, V57, P700, DOI 10.1016/j.jacc.2010.05.071; Prandoni P, 2002, ANN INTERN MED, V137, P955, DOI 10.7326/0003-4819-137-12-200212170-00008; Righini M, 2008, J THROMB HAEMOST, V6, P1059, DOI 10.1111/j.1538-7836.2008.02981.x; Righini M, 2006, THROMB HAEMOSTASIS, V95, P56, DOI 10.1160/TH05-08-0588; Righini M, 2005, J AM GERIATR SOC, V53, P1039, DOI 10.1111/j.1532-5415.2005.53309.x; Righini M, 2008, LANCET, V371, P1343, DOI 10.1016/S0140-6736(08)60594-2; Roy PM, 2006, ANN INTERN MED, V144, P157, DOI 10.7326/0003-4819-144-3-200602070-00003; Roy PM, 2005, BMJ-BRIT MED J, V331, P259, DOI 10.1136/bmj.331.7511.259; Ruiz-Gimenez N, 2008, THROMB HAEMOSTASIS, V100, P26, DOI 10.1160/TH08-03-0193; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Schwarz UI, 2008, NEW ENGL J MED, V358, P999, DOI 10.1056/NEJMoa0708078; Severinsen MT, 2009, J THROMB HAEMOST, V7, P1297, DOI 10.1111/j.1538-7836.2009.03490.x; Sim DS, 2010, J CARDIOL, V56, P1, DOI 10.1016/j.jjcc.2010.04.002; Simonneau G, 1997, NEW ENGL J MED, V337, P663, DOI 10.1056/NEJM199709043371002; Spencer FA, 2007, ARCH INTERN MED, V167, P1471, DOI 10.1001/archinte.167.14.1471; Spencer FA, 2010, CIRC-CARDIOVASC QUAL, V3, P390, DOI 10.1161/CIRCOUTCOMES.110.937441; Spyropoulos AC, 2011, CHEST, V140, P706, DOI 10.1378/chest.10-1944; Stein PD, 2008, AM J MED, V121, P565, DOI 10.1016/j.amjmed.2008.02.033; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; Stein PD, 2011, AM J MED, V124, P655, DOI 10.1016/j.amjmed.2011.02.021; Stein PD, 2010, ANN INTERN MED, V152, P434, DOI 10.7326/0003-4819-152-7-201004060-00008; Sweetland S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4583; Ten Wolde M, 2004, J THROMB HAEMOST, V2, P1110, DOI 10.1111/j.1538-7836.2004.00769.x; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; van Beek EJR, 2001, CLIN RADIOL, V56, P838, DOI 10.1053/crad.2001.0778; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; Warkentin TE, 2008, CHEST, V133, p340S, DOI 10.1378/chest.08-0677; Wells PS, 1997, LANCET, V350, P1795, DOI 10.1016/S0140-6736(97)08140-3; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416	102	578	613	16	159	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2012	379	9828					1835	1846		10.1016/S0140-6736(11)61904-1	http://dx.doi.org/10.1016/S0140-6736(11)61904-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	941BR	22494827	Green Published			2022-12-28	WOS:000303937700038
J	Sanders, SJ; Murtha, MT; Gupta, AR; Murdoch, JD; Raubeson, MJ; Willsey, AJ; Ercan-Sencicek, AG; DiLullo, NM; Parikshak, NN; Stein, JL; Walker, MF; Ober, GT; Teran, NA; Song, Y; El-Fishawy, P; Murtha, RC; Choi, M; Overton, JD; Bjornson, RD; Carriero, NJ; Meyer, KA; Bilguvar, K; Mane, SM; Sestan, N; Lifton, RP; Gunel, M; Roeder, K; Geschwind, DH; Devlin, B; State, MW				Sanders, Stephan J.; Murtha, Michael T.; Gupta, Abha R.; Murdoch, John D.; Raubeson, Melanie J.; Willsey, A. Jeremy; Ercan-Sencicek, A. Gulhan; DiLullo, Nicholas M.; Parikshak, Neelroop N.; Stein, Jason L.; Walker, Michael F.; Ober, Gordon T.; Teran, Nicole A.; Song, Youeun; El-Fishawy, Paul; Murtha, Ryan C.; Choi, Murim; Overton, John D.; Bjornson, Robert D.; Carriero, Nicholas J.; Meyer, Kyle A.; Bilguvar, Kaya; Mane, Shrikant M.; Sestan, Nenad; Lifton, Richard P.; Guenel, Murat; Roeder, Kathryn; Geschwind, Daniel H.; Devlin, Bernie; State, Matthew W.			De novo mutations revealed by whole-exome sequencing are strongly associated with autism	NATURE			English	Article							SPECTRUM DISORDERS; GENE SCN2A; SCHIZOPHRENIA; COMPONENTS; CONSTRAINT; EVOLUTION; PROTEOME; EPILEPSY	Multiple studies have confirmed the contribution of rare de novo copy number variations to the risk for autism spectrum disorders(1-3). But whereas de novo single nucleotide variants have been identified in affected individuals(4), their contribution to risk has yet to be clarified. Specifically, the frequency and distribution of these mutations have not been well characterized in matched unaffected controls, and such data are vital to the interpretation of de novo coding mutations observed in probands. Here we show, using whole-exome sequencing of 928 individuals, including 200 phenotypically discordant sibling pairs, that highly disruptive (nonsense and splice-site) de novo mutations in brain-expressed genes are associated with autism spectrum disorders and carry large effects. On the basis of mutation rates in unaffected individuals, we demonstrate that multiple independent de novo single nucleotide variants in the same gene among unrelated probands reliably identifies risk alleles, providing a clear path forward for gene discovery. Among a total of 279 identified de novo coding mutations, there is a single instance in probands, and none in siblings, in which two independent nonsense variants disrupt the same gene, SCN2A (sodium channel, voltage-gated, type II, alpha subunit), a result that is highly unlikely by chance.	[Sanders, Stephan J.; Murtha, Michael T.; Murdoch, John D.; Raubeson, Melanie J.; Willsey, A. Jeremy; Ercan-Sencicek, A. Gulhan; DiLullo, Nicholas M.; Walker, Michael F.; Ober, Gordon T.; Teran, Nicole A.; Song, Youeun; El-Fishawy, Paul; Murtha, Ryan C.; State, Matthew W.] Yale Univ, Sch Med, Dept Genet, Ctr Child Study,Dept Psychiat,Program Neurogenet, New Haven, CT 06520 USA; [Gupta, Abha R.] Yale Univ, Sch Med, Dept Pediat, Ctr Child Study, New Haven, CT 06520 USA; [Parikshak, Neelroop N.; Stein, Jason L.; Geschwind, Daniel H.] Univ Calif Los Angeles, Neurogenet Program, Los Angeles, CA 90095 USA; [Choi, Murim; Overton, John D.; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA; [Bjornson, Robert D.; Carriero, Nicholas J.] Yale Univ, Dept Comp Sci, Yale Ctr Genome Anal, New Haven, CT 06511 USA; [Meyer, Kyle A.; Sestan, Nenad] Yale Univ, Sch Med, Kavli Inst Neurosci, Dept Neurobiol, New Haven, CT 06520 USA; [Bilguvar, Kaya; Guenel, Murat] Yale Univ, Sch Med, Program Neurogenet, Ctr Human Genet & Genom,Dept Neurosurg, New Haven, CT 06520 USA; [Mane, Shrikant M.] Yale Ctr Genome Anal, West Haven, CT 06516 USA; [Roeder, Kathryn] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Devlin, Bernie] Univ Pittsburgh, Sch Med, Dept Psychiat & Human Genet, Pittsburgh, PA 15213 USA	Yale University; Yale University; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	State, MW (corresponding author), Yale Univ, Sch Med, Dept Genet, Ctr Child Study,Dept Psychiat,Program Neurogenet, 230 S Frontage Rd, New Haven, CT 06520 USA.	dhg@mednet.ucla.edu; devlinbj@upmc.edu; matthew.state@yale.edu	Choi, Murim/AAP-9120-2021; Sanders, Stephan/S-8645-2019; State, Matthew/W-2256-2019; Willsey, A Jeremy/H-3001-2019	Willsey, A Jeremy/0000-0002-9922-3612; Roeder, Kathryn/0000-0002-8869-6254; Sanders, Stephan/0000-0001-9112-5148; Parikshak, Neel/0000-0003-2027-1871; Stein, Jason/0000-0003-4829-0513; State, Matthew/0000-0003-1624-8302	Simons Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH087639, R25MH077823, U01MH081896] Funding Source: NIH RePORTER	Simons Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to all of the families participating in the Simons Foundation Autism Research Initiative (SFARI) Simplex Collection (SSC). This work was supported by a grant from the Simons Foundation. R. P. L. is an Investigator of the Howard Hughes Medical Institute. We thank the SSC principal investigators A. L. Beaudet, R. Bernier, J. Constantino, E. H. Cook Jr, E. Fombonne, D. Geschwind, D. E. Grice, A. Klin, D. H. Ledbetter, C. Lord, C. L. Martin, D. M. Martin, R. Maxim, J. Miles, O. Ousley, B. Peterson, J. Piggot, C. Saulnier, M. W. State, W. Stone, J. S. Sutcliffe, C. A. Walsh and E. Wijsman and the coordinators and staff at the SSC sites for the recruitment and comprehensive assessment of simplex families; the SFARI staff, in particular M. Benedetti, for facilitating access to the SSC; Prometheus Research for phenotypic data management and Prometheus Research and the Rutgers University Cell and DNA repository for accessing biomaterials; the Yale Center of Genomic Analysis, in particular M. Mahajan, S. Umlauf, I. Tikhonova and A. Lopez, for generating sequencing data; T. Brooks-Boone, N. Wright-Davis and M. Wojciechowski for their help in administering the project at Yale; I. Hart for support; G. D. Fischbach, A. Packer, J. Spiro, M. Benedetti and M. Carlson for their suggestions throughout; and B. Neale and M. Daly for discussions regarding de novo variation. We also acknowledge T. Lehner and the Autism Sequencing Consortium for providing an opportunity for pre-publication data exchange among the participating groups.	Abul-Husn NS, 2009, PROTEOMICS, V9, P3303, DOI 10.1002/pmic.200800767; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Kamiya K, 2004, J NEUROSCI, V24, P2690, DOI 10.1523/JNEUROSCI.3089-03.2004; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Meisler MH, 2010, J PHYSIOL-LONDON, V588, P1841, DOI 10.1113/jphysiol.2010.188482; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Ogiwara I, 2009, NEUROLOGY, V73, P1046, DOI 10.1212/WNL.0b013e3181b9cebc; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Weiss LA, 2003, MOL PSYCHIATR, V8, P186, DOI 10.1038/sj.mp.4001241; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902	23	1371	1411	3	244	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2012	485	7397					237	U124		10.1038/nature10945	http://dx.doi.org/10.1038/nature10945			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22495306	Green Accepted			2022-12-28	WOS:000303799800041
J	Roberts, JD; Wells, GA; Le May, MR; Labinaz, M; Glover, C; Froeschl, M; Dick, A; Marquis, JF; O'Brien, E; Goncalves, S; Druce, I; Stewart, A; Gollob, MH; So, DYF				Roberts, Jason D.; Wells, George A.; Le May, Michel R.; Labinaz, Marino; Glover, Chris; Froeschl, Michael; Dick, Alexander; Marquis, Jean-Francois; O'Brien, Edward; Goncalves, Sandro; Druce, Irena; Stewart, Alexandre; Gollob, Michael H.; So, Derek Y. F.			Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial	LANCET			English	Article							PERCUTANEOUS CORONARY INTERVENTION; RESIDUAL PLATELET REACTIVITY; CLOPIDOGREL-TREATED PATIENTS; CYP2C19 GENOTYPE; CARDIOVASCULAR OUTCOMES; STENT THROMBOSIS; PRASUGREL; POLYMORPHISMS; EVENTS; ASSAY	Background Prospective assessment of pharmacogenetic strategies has been limited by an inability to undertake bedside genetic testing. The CYP2C19*2 allele is a common genetic variant associated with increased rates of major adverse events in individuals given clopidogrel after percutaneous coronary intervention (PCI). We used a novel point-of-care genetic test to identify carriers of the CYP2C19*2 allele and aimed to assess a pharmacogenetic approach to dual antiplatelet treatment after PCI. Methods Between Aug 26, 2010, and July 7, 2011, 200 patients were enrolled into our prospective, randomised, proof-of-concept study. Patients undergoing PCI for acute coronary syndrome or stable angina were randomly assigned to rapid point-of-care genotyping or to standard treatment. Individuals in the rapid genotyping group were screened for the CYP2C19*2 allele. Carriers were given 10 mg prasugrel daily, and non-carriers and patients in the standard treatment group were given 75 mg clopidogrel daily. The primary endpoint was the proportion of CYP2C19*2 carriers with high on-treatment platelet reactivity (P2Y12 reactivity unit [PRU] value of more than 234) after 1 week of dual antiplatelet treatment, which is a marker associated with increased adverse cardiovascular events. Interventional cardiologists and data analysts were masked to genetic status and treatment. Patients were not masked to treatment allocation. All analyses were by intention to treat. This study is registered with ClinicalTrials.gov, NCT01184300. Findings After randomisation, 187 patients completed follow-up (91 rapid genotyping group, 96 standard treatment). 23 individuals in each group carried at least one CYP2C19*2 allele. None of the 23 carriers in the rapid genotyping group had a PRU value of more than 234 at day 7, compared with seven (30%) given standard treatment (p=0.0092). The point-of-care genetic test had a sensitivity of 100% (95% CI 92.3-100) and a specificity of 99.3% (96.3-100). Interpretation Point-of-care genetic testing after PCI can be done effectively at the bedside and treatment of identified CYP2C19*2 carriers with prasugrel can reduce high on-treatment platelet reactivity.	[Roberts, Jason D.; Le May, Michel R.; Labinaz, Marino; Glover, Chris; Froeschl, Michael; Dick, Alexander; Marquis, Jean-Francois; O'Brien, Edward; Goncalves, Sandro; Druce, Irena; Gollob, Michael H.; So, Derek Y. F.] Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON K1Y 4W7, Canada; [Wells, George A.] Univ Ottawa, Inst Heart, Cardiovasc Methods Ctr, Ottawa, ON K1Y 4W7, Canada; [Stewart, Alexandre] Univ Ottawa, Inst Heart, Canadian Cardiovasc Genet Ctr, Ottawa, ON K1Y 4W7, Canada	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa Heart Institute	So, DYF (corresponding author), Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON K1Y 4W7, Canada.	dso@ottawaheart.ca	O'Brien, Edward R/J-6621-2013; Gonçalves, Sandro Cadaval/AAN-1218-2021; Wells, George A/M-4549-2017; Gonçalves, Sandro Cadaval/W-5228-2019	O'Brien, Edward R/0000-0003-1039-9425; Wells, George A/0000-0002-2289-9139; Stewart, Alexandre/0000-0003-2673-9164; Cadaval Goncalves, Sandro/0000-0001-8401-479X; Gollob, Michael/0000-0003-0242-5208	Sanofi-Aventis Canada; Abbott Vascular Canada; Spartan Biosciences; Heart and Stroke Foundation of Ontario; Canadian Institutes of Health Research	Sanofi-Aventis Canada(Sanofi-Aventis); Abbott Vascular Canada; Spartan Biosciences; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	DYFS has received unrestricted research grants for physician-initiated studies from Sanofi-Aventis Canada, Abbott Vascular Canada, and Spartan Biosciences; and honoraria from Eli Lilly Canada. The other authors declare that they have no conflicts of interest.; The RAPID GENE study was funded by Spartan Biosciences. DYFS is supported by grants from the Heart and Stroke Foundation of Ontario and the Canadian Institutes of Health Research. We thank Lyne Stuewe, Cheryl Charlebois, Colleen Chilton, Jordan Bernick, and Luan Tran for their invaluable assistance.	Alexopoulos D, 2011, JACC-CARDIOVASC INTE, V4, P403, DOI 10.1016/j.jcin.2010.12.011; Angiolillo DJ, 2007, J AM COLL CARDIOL, V49, P1505, DOI 10.1016/j.jacc.2006.11.044; Bonello L, 2010, J AM COLL CARDIOL, V56, P919, DOI 10.1016/j.jacc.2010.04.047; Bouman HJ, 2011, NAT MED, V17, P110, DOI 10.1038/nm.2281; Brandt JT, 2007, J THROMB HAEMOST, V5, P2429, DOI 10.1111/j.1538-7836.2007.02775.x; Breet NJ, 2010, JAMA-J AM MED ASSOC, V303, P754, DOI 10.1001/jama.2010.181; Cayla G, 2011, JAMA-J AM MED ASSOC, V306, P1765, DOI 10.1001/jama.2011.1529; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hochholzer W, 2010, J AM COLL CARDIOL, V55, P2427, DOI 10.1016/j.jacc.2010.02.031; Holmes MV, 2011, JAMA-J AM MED ASSOC, V306, P2704, DOI 10.1001/jama.2011.1880; Hulot JS, 2010, J AM COLL CARDIOL, V56, P134, DOI 10.1016/j.jacc.2009.12.071; Jakubowski JA, 2008, THROMB HAEMOSTASIS, V99, P409, DOI 10.1160/TH07-09-0575; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Marcucci R, 2009, CIRCULATION, V119, P237, DOI 10.1161/CIRCULATIONAHA.108.812636; Mega JL, 2011, JAMA-J AM MED ASSOC, V306, P2221, DOI 10.1001/jama.2011.1703; Mega JL, 2010, LANCET, V376, P1312, DOI 10.1016/S0140-6736(10)61273-1; Mega JL, 2010, JAMA-J AM MED ASSOC, V304, P1821, DOI 10.1001/jama.2010.1543; Mega JL, 2009, CIRCULATION, V119, P2553, DOI 10.1161/CIRCULATIONAHA.109.851949; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Pare G, 2010, NEW ENGL J MED, V363, P1704, DOI 10.1056/NEJMoa1008410; Parodi G, 2011, JAMA-J AM MED ASSOC, V306, P1215, DOI 10.1001/jama.2011.1332; Pena A, 2009, CIRCULATION, V119, P2854, DOI 10.1161/CIRCULATIONAHA.108.857722; Price MJ, 2008, EUR HEART J, V29, P992, DOI 10.1093/eurheartj/ehn046; Price MJ, 2011, CIRCULATION, V124, P1132, DOI 10.1161/CIRCULATIONAHA.111.029165; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Scott SA, 2011, CLIN PHARMACOL THER, V90, P328, DOI 10.1038/clpt.2011.132; Sibbing D, 2011, EUR HEART J, V32, P1605, DOI 10.1093/eurheartj/ehr155; Sibbing D, 2010, CIRCULATION, V121, P512, DOI 10.1161/CIRCULATIONAHA.109.885194; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; US Food and Drug Administration, 2010, FDA DRUG SAF COMM RE; Varenhorst C, 2009, EUR HEART J, V30, P1744, DOI 10.1093/eurheartj/ehp157; Wallentin L, 2010, LANCET, V376, P1320, DOI 10.1016/S0140-6736(10)61274-3; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wang LW, 2011, NEW ENGL J MED, V364, P1144, DOI 10.1056/NEJMra1010600; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Xie HG, 2000, LIFE SCI, V66, pPL175, DOI 10.1016/S0024-3205(00)00446-X	41	289	310	1	37	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2012	379	9827					1705	1711		10.1016/S0140-6736(12)60161-5	http://dx.doi.org/10.1016/S0140-6736(12)60161-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937KX	22464343				2022-12-28	WOS:000303658500030
J	Tahrani, AA; Bailey, CJ; Barnett, AH				Tahrani, Abd A.; Bailey, Clifford J.; Barnett, Anthony H.			Insulin degludec: a new ultra-longacting insulin	LANCET			English	Editorial Material							BASAL-BOLUS TREATMENT; OPEN-LABEL; TYPE-2; THERAPY; ASPART; GLARGINE; PHASE-3		[Barnett, Anthony H.] Birmingham Heartlands Hosp, Ctr Diabet, Birmingham B9 5SS, W Midlands, England; [Tahrani, Abd A.] Univ Birmingham, Inst Biomed Res, Ctr Endocrinol Diabet & Metab, Birmingham, W Midlands, England; [Bailey, Clifford J.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	Heart of England NHS Foundation Trust; University of Birmingham; University of Birmingham; Aston University	Barnett, AH (corresponding author), Birmingham Heartlands Hosp, Ctr Diabet, Birmingham B9 5SS, W Midlands, England.	anthony.barnett@heartofengland.nhs.uk	Tahrani, Abd/C-6939-2014	Tahrani, Abd/0000-0001-9037-1937; Bailey, Clifford J/0000-0002-6998-6811	Department of Health [RTF/01/094] Funding Source: Medline; National Institute for Health Research [RTF/01/094] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Chen JW, 2003, DIABETES OBES METAB, V5, P223, DOI 10.1046/j.1463-1326.2003.00266.x; Farcasiu E, 2011, CLIN THER, V33, P1682, DOI 10.1016/j.clinthera.2011.10.001; Garber AJ, 2012, LANCET, V379, P1498, DOI 10.1016/S0140-6736(12)60205-0; Heller S, 2012, LANCET, V379, P1489, DOI 10.1016/S0140-6736(12)60204-9; Holman RR, 2007, NEW ENGL J MED, V357, P1716, DOI 10.1056/NEJMoa075392; Horvath K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005613.pub3; Jonassen I, 2010, DIABETES, V59, pA11; Nathan DM, 2006, DIABETES CARE, V29, P1963, DOI 10.2337/dc06-9912; Nishimura E, 2010, DIABETOLOGIA, V53; Russell-Jones D, 2007, DIABETES OBES METAB, V9, P799, DOI 10.1111/j.1463-1326.2006.00686.x; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X	11	9	9	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2012	379	9825					1465	1467		10.1016/S0140-6736(12)60527-3	http://dx.doi.org/10.1016/S0140-6736(12)60527-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930BJ	22521058				2022-12-28	WOS:000303110200006
J	Heath, I				Heath, Iona			LIFE AND DEATH In memoriam	BRITISH MEDICAL JOURNAL			English	Editorial Material												iona.heath22@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 18	2012	344								e2725	10.1136/bmj.e2725	http://dx.doi.org/10.1136/bmj.e2725			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	931CQ	22514222				2022-12-28	WOS:000303192400004
J	Smith, DA				Smith, Donald A.			Adding niacin to simvastatin did not improve clinical outcomes in patients with CV disease and dyslipidemia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Mt Sinai Sch Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Smith, DA (corresponding author), Mt Sinai Sch Med, New York, NY 10029 USA.							CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245, DOI 10.1016/S0735-1097(86)80293-5; Taylor AJ, 2009, NEW ENGL J MED, V361, P2113, DOI 10.1056/NEJMoa0907569	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2012	156	8							JC4-8	10.7326/0003-4819-156-8-201204170-02008	http://dx.doi.org/10.7326/0003-4819-156-8-201204170-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930PO	22508748				2022-12-28	WOS:000303151800007
J	Eisenstein, M				Eisenstein, Michael			Stem cells: Don't believe the hype	NATURE			English	Editorial Material																			0	2	2	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					S5	S5		10.1038/nature11107	http://dx.doi.org/10.1038/nature11107			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22509506	Bronze			2022-12-28	WOS:000303149900047
J	Watts, G				Watts, Geoff			Christine Petit: interdisciplinary geneticist	LANCET			English	Biographical-Item																		PETIT C, PUBLICATION LIST	1	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 7	2012	379	9823					1291	1291		10.1016/S0140-6736(12)60545-5	http://dx.doi.org/10.1016/S0140-6736(12)60545-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922FB	22483022				2022-12-28	WOS:000302531100012
J	Askar, M; Chueh, SCJ; Huang, TE; Sankari, BR				Askar, Medhat; Chueh, Shih-Chieh Jeff; Huang, T. Edgar; Sankari, Bashir R.			Does one plus one always equal two?	LANCET			English	Editorial Material									[Chueh, Shih-Chieh Jeff; Huang, T. Edgar; Sankari, Bashir R.] Charleston Area Med Ctr, Charleston, WV 25301 USA; [Askar, Medhat; Chueh, Shih-Chieh Jeff; Sankari, Bashir R.] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Chueh, Shih-Chieh Jeff; Sankari, Bashir R.] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA; [Askar, Medhat] Cleveland Clin, Transplant Ctr, Allogen Labs, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Chueh, SCJ (corresponding author), Charleston Area Med Ctr, 1201 Washington St E,Suite 100, Charleston, WV 25301 USA.	jeffchueh@gmail.com	CHUEH, JEFF S/F-5245-2011	CHUEH, JEFF S/0000-0002-0713-4904; Askar, Medhat/0000-0003-2633-9363				American Cancer Society, KIDN CANC AD REN CEL; Chambade D, 2008, J UROLOGY, V180, P2106, DOI 10.1016/j.juro.2008.07.055; Kable T, 2005, EUR UROL, V47, P156; Melchior S, 2011, J UROLOGY, V185, P428, DOI 10.1016/j.juro.2010.09.091; Nobushita T, 2008, INT J UROL, V15, P175, DOI 10.1111/j.1442-2042.2007.01941.x	5	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 31	2012	379	9822					1272	1272		10.1016/S0140-6736(12)60076-2	http://dx.doi.org/10.1016/S0140-6736(12)60076-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	918DV	22464387				2022-12-28	WOS:000302230400040
J	Chen, CH; Gutierrez, ED; Thompson, W; Panizzon, MS; Jernigan, TL; Eyler, LT; Fennema-Notestine, C; Jak, AJ; Neale, MC; Franz, CE; Lyons, MJ; Grant, MD; Fischl, B; Seidman, LJ; Tsuang, MT; Kremen, WS; Dale, AM				Chen, Chi-Hua; Gutierrez, E. D.; Thompson, Wes; Panizzon, Matthew S.; Jernigan, Terry L.; Eyler, Lisa T.; Fennema-Notestine, Christine; Jak, Amy J.; Neale, Michael C.; Franz, Carol E.; Lyons, Michael J.; Grant, Michael D.; Fischl, Bruce; Seidman, Larry J.; Tsuang, Ming T.; Kremen, William S.; Dale, Anders M.			Hierarchical Genetic Organization of Human Cortical Surface Area	SCIENCE			English	Article							HUMAN BRAIN; NEOCORTEX; RECONSTRUCTION; TRANSCRIPTOME; SEGMENTATION; EXPRESSION; HINDBRAIN; EVOLUTION; BEHAVIOR; CORTEX	Surface area of the cerebral cortex is a highly heritable trait, yet little is known about genetic influences on regional cortical differentiation in humans. Using a data-driven, fuzzy clustering technique with magnetic resonance imaging data from 406 twins, we parceled cortical surface area into genetic subdivisions, creating a human brain atlas based solely on genetically informative data. Boundaries of the genetic divisions corresponded largely to meaningful structural and functional regions; however, the divisions represented previously undescribed phenotypes different from conventional (non-genetically based) parcellation systems. The genetic organization of cortical area was hierarchical, modular, and predominantly bilaterally symmetric across hemispheres. We also found that the results were consistent with human-specific regions being subdivisions of previously described, genetically based lobar regionalization patterns.	[Chen, Chi-Hua; Thompson, Wes; Panizzon, Matthew S.; Jernigan, Terry L.; Eyler, Lisa T.; Fennema-Notestine, Christine; Jak, Amy J.; Franz, Carol E.; Tsuang, Ming T.; Kremen, William S.; Dale, Anders M.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Gutierrez, E. D.; Jernigan, Terry L.] Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; [Eyler, Lisa T.] Vet Adm VA San Diego Healthcare Syst, San Diego, CA 92161 USA; [Fennema-Notestine, Christine; Dale, Anders M.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Jak, Amy J.; Tsuang, Ming T.; Kremen, William S.] VA Ctr Excellence Stress & Mental Hlth, San Diego, CA 92093 USA; [Neale, Michael C.; Tsuang, Ming T.; Kremen, William S.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA 23219 USA; [Neale, Michael C.; Tsuang, Ming T.; Kremen, William S.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23219 USA; [Franz, Carol E.] Univ Calif San Diego, Ctr Behav Genom, La Jolla, CA 92093 USA; [Lyons, Michael J.; Grant, Michael D.] Boston Univ, Dept Psychol, Boston, MA 02215 USA; [Fischl, Bruce] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Fischl, Bruce] Massachusetts Gen Hosp, Boston, MA 02115 USA; [Seidman, Larry J.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02215 USA; [Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Virginia Commonwealth University; Virginia Commonwealth University; University of California System; University of California San Diego; Boston University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Diego	Kremen, WS (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	wkremen@ucsd.edu	Neale, Michael/AAD-5056-2020; Eyler, Lisa/AAQ-4337-2021	Franz, Carol/0000-0002-8987-1755; Kremen, William/0000-0002-8629-5609; Lyons, Michael/0000-0001-6516-9219; Fennema-Notestine, Christine/0000-0002-6527-6361	National Institute on Aging [AG022381, AG018386, AG018384, AG022982, AG031224]; National Institute of Drug Abuse [DA029475]; National Institute of Neurological Disorders and Stroke [NS056883]; National Center for Research Resources [P41-RR14075, BIRN002, U24 RR021382]; National Institute for Biomedical Imaging and Bioengineering [EB006758]; National Center for Alternative Medicine [RC1 AT005728-01]; National Institute for Neurological Disorders and Stroke [NS052585-01, 1R21NS072652-01, 1R01NS070963]; National Institutes of Health [T32DC000041]; Ellison Medical Foundation; VA San Diego Center of Excellence for Stress and Mental Health; Office of Research and Development, U.S. Department of Veterans Affairs; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [RC1AT005728] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075, U24RR021382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052585, R21NS072652, R01NS070963, U54NS056883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018386, R01AG018384, R01AG022982, R01AG031224, R01AG022381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC2DA029475] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute for Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Center for Alternative Medicine; National Institute for Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); VA San Diego Center of Excellence for Stress and Mental Health; Office of Research and Development, U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by the National Institute on Aging (AG022381, AG018386, AG018384, AG022982, and AG031224), National Institute of Drug Abuse (DA029475), National Institute of Neurological Disorders and Stroke (NS056883), National Center for Research Resources (P41-RR14075, BIRN002, and U24 RR021382), National Institute for Biomedical Imaging and Bioengineering (EB006758), National Center for Alternative Medicine (RC1 AT005728-01), National Institute for Neurological Disorders and Stroke (NS052585-01, 1R21NS072652-01, and 1R01NS070963), National Institutes of Health (T32DC000041), and the Ellison Medical Foundation. This material is also partly the result of work supported with resources of the VA San Diego Center of Excellence for Stress and Mental Health. The Cooperative Studies Program, Office of Research and Development, U.S. Department of Veterans Affairs has provided financial support for the development and maintenance of the Vietnam Era Twin (VET) Registry. A.M.D. is a founder and holds equity in CorTechs Laboratories and also serves on its Scientific Advisory Board. The terms of this arrangement have been reviewed and approved by the University of California, San Diego, in accordance with its conflict of interest policies.	Abrahams BS, 2007, P NATL ACAD SCI USA, V104, P17849, DOI 10.1073/pnas.0706128104; BERGQUIST H, 1953, ACTA ANAT, V18, P65; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Chen CH, 2011, NEURON, V72, P537, DOI 10.1016/j.neuron.2011.08.021; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; EAVES LJ, 1978, HEREDITY, V41, P249, DOI 10.1038/hdy.1978.101; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Joyner AH, 2009, P NATL ACAD SCI USA, V106, P15483, DOI 10.1073/pnas.0901866106; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Konopka G, 2010, NEURON, V68, P231, DOI 10.1016/j.neuron.2010.10.012; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Puelles L, 2003, TRENDS NEUROSCI, V26, P469, DOI 10.1016/S0166-2236(03)00234-0; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rimol LM, 2010, P NATL ACAD SCI USA, V107, P384, DOI 10.1073/pnas.0908454107; Sun T, 2005, SCIENCE, V308, P1794, DOI 10.1126/science.1110324; Tan P., 2006, INTRO DATA MINING; Werner H., 1948, COMP PSYCHOL MENTAL; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0	24	196	198	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1634	1636		10.1126/science.1215330	http://dx.doi.org/10.1126/science.1215330			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461613	Green Accepted, Green Submitted			2022-12-28	WOS:000302062600047
J	Solt, LA; Wang, YJ; Banerjee, S; Hughes, T; Kojetin, DJ; Lundasen, T; Shin, Y; Liu, J; Cameron, MD; Noel, R; Yoo, SH; Takahashi, JS; Butler, AA; Kamenecka, TM; Burris, TP				Solt, Laura A.; Wang, Yongjun; Banerjee, Subhashis; Hughes, Travis; Kojetin, Douglas J.; Lundasen, Thomas; Shin, Youseung; Liu, Jin; Cameron, Michael D.; Noel, Romain; Yoo, Seung-Hee; Takahashi, Joseph S.; Butler, Andrew A.; Kamenecka, Theodore M.; Burris, Thomas P.			Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists	NATURE			English	Article							ORPHAN NUCLEAR RECEPTORS; ALPHA; CLOCK; HEME; COMPONENTS; LIGAND; BETA; IDENTIFICATION; TRANSCRIPTION; EXPRESSION	Synchronizing rhythms of behaviour and metabolic processes is important for cardiovascular health and preventing metabolic diseases. The nuclear receptors REV-ERB-alpha and REV-ERB-beta have an integral role in regulating the expression of core clock proteins driving rhythms in activity and metabolism. Here we describe the identification of potent synthetic REV-ERB agonists with in vivo activity. Administration of synthetic REV-ERB ligands alters circadian behaviour and the circadian pattern of core clock gene expression in the hypothalami of mice. The circadian pattern of expression of an array of metabolic genes in the liver, skeletal muscle and adipose tissue was also altered, resulting in increased energy expenditure. Treatment of diet-induced obese mice with a REV-ERB agonist decreased obesity by reducing fat mass and markedly improving dyslipidaemia and hyperglycaemia. These results indicate that synthetic REV-ERB ligands that pharmacologically target the circadian rhythm may be beneficial in the treatment of sleep disorders as well as metabolic diseases.	[Solt, Laura A.; Wang, Yongjun; Banerjee, Subhashis; Hughes, Travis; Kojetin, Douglas J.; Lundasen, Thomas; Liu, Jin; Burris, Thomas P.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Shin, Youseung; Cameron, Michael D.; Noel, Romain; Kamenecka, Theodore M.] Scripps Res Inst, Translat Res Inst, Jupiter, FL 33458 USA; [Yoo, Seung-Hee; Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Yoo, Seung-Hee; Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Butler, Andrew A.] Scripps Res Inst, Dept Metab & Aging, Jupiter, FL 33458 USA; [Burris, Thomas P.] Scripps Res Inst, Ctr Diabet & Metab Dis, Jupiter, FL 33458 USA	Scripps Research Institute; Scripps Research Institute; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Scripps Research Institute; Scripps Research Institute	Burris, TP (corresponding author), Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA.	tburris@scripps.edu	NOEL, Romain/AAR-2564-2021; Burris, Thomas P/B-3886-2016; Takahashi, Joseph S./Y-2781-2019; Takahashi, Joseph S/E-8482-2012	Burris, Thomas P/0000-0003-2922-4449; Takahashi, Joseph S./0000-0003-0384-8878; Takahashi, Joseph S/0000-0003-0384-8878; Hughes, Travis/0000-0002-5764-5884; Butler, Andrew/0000-0001-7196-0170; Cameron, Michael/0000-0003-3154-4775	National Institutes of Health [DK080201, MH092769, DK089984]; Howard Hughes Medical Institute; individual National Research Service Award [DK088499]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080201, R24DK089984, R01DK073189, F32DK088499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093429, R01MH092769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); individual National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grants (DK080201, MH092769 and DK089984) and the Howard Hughes Medical Institute. L. A. S. is the recipient of an individual National Research Service Award (DK088499).	Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bray MS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.R110.214643; Burris TP, 2008, MOL ENDOCRINOL, V22, P1509, DOI 10.1210/me.2007-0519; Busby SA, 2011, ACS CHEM BIOL, V6, P618, DOI 10.1021/cb100396s; Crumbley C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017290; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Duez H, 2009, J APPL PHYSIOL, V107, P1972, DOI 10.1152/japplphysiol.00570.2009; Gimble JM, 2011, NAT REV ENDOCRINOL, V7, P98, DOI 10.1038/nrendo.2010.214; Grant D, 2010, ACS CHEM BIOL, V5, P925, DOI 10.1021/cb100141y; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kojetin D, 2011, ACS CHEM BIOL, V6, P131, DOI 10.1021/cb1002575; Kumar N, 2010, ENDOCRINOLOGY, V151, P3015, DOI 10.1210/en.2009-0800; Kumar N, 2010, MOL PHARMACOL, V77, P228, DOI 10.1124/mol.109.060905; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Meng QJ, 2008, J CELL SCI, V121, P3629, DOI 10.1242/jcs.035048; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Ramakrishnan SN, 2005, J BIOL CHEM, V280, P8651, DOI 10.1074/jbc.M413949200; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Raspe E, 2002, J LIPID RES, V43, P2172, DOI 10.1194/jlr.M200386-JLR200; Wang J, 2006, J BIOL CHEM, V281, P33842, DOI 10.1074/jbc.M607873200; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yin Lei, 2010, Nucl Recept Signal, V8, pe001, DOI 10.1621/nrs.08001; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	28	484	508	10	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					62	68		10.1038/nature11030	http://dx.doi.org/10.1038/nature11030			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22460951	Green Accepted			2022-12-28	WOS:000303451900034
J	Brooks, RC; Hasley, PB; Jasti, H; Macpherson, D				Brooks, Robert C.; Hasley, Peggy B.; Jasti, Harish; Macpherson, David			Update in General Internal Medicine: Evidence Published in 2011	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							AMBULATORY BLOOD-PRESSURE; VENOUS THROMBOEMBOLISM; PRIMARY-CARE; RISK; THERAPY; HOME		Univ Pittsburgh, Sch Med, Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Vet Integrated Serv Network 4, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Macpherson, D (corresponding author), 323 N Shore Dr,Suite 400, Pittsburgh, PA 15212 USA.	David.Macpherson@va.gov						[Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Decousus H, 2011, CHEST, V139, P69, DOI 10.1378/chest.09-3081; Dentali F, 2007, ANN INTERN MED, V146, P278, DOI 10.7326/0003-4819-146-4-200702200-00007; Gaborieau V, 2008, J HYPERTENS, V26, P1919, DOI 10.1097/HJH.0b013e32830c4368; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Joint Commission, 2009, JT COMM PERSPECT, V29, P4; Lovibond K, 2011, LANCET, V378, P1219, DOI 10.1016/S0140-6736(11)61184-7; Oken MM, 2011, JAMA-J AM MED ASSOC, V306, P1865, DOI 10.1001/jama.2011.1591; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Sharma M, 2009, ANN INTERN MED, V151, P622, DOI 10.7326/0003-4819-151-9-200911030-00144; Sirovich BE, 2011, ARCH INTERN MED, V171, P1582, DOI 10.1001/archinternmed.2011.437; Spyropoulos AC, 2011, CHEST, V140, P706, DOI 10.1378/chest.10-1944; Spyropoulos AC, 2010, CURR OPIN PULM MED, V16, P419, DOI 10.1097/MCP.0b013e32833b4669; Staessen JA, 1999, JAMA-J AM MED ASSOC, V282, P539, DOI 10.1001/jama.282.6.539; Verberk WJ, 2005, J AM COLL CARDIOL, V46, P743, DOI 10.1016/j.jacc.2005.05.058	16	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2012	156	9					649	U85		10.7326/0003-4819-156-9-201205010-00410	http://dx.doi.org/10.7326/0003-4819-156-9-201205010-00410			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933YR	22517813				2022-12-28	WOS:000303403700005
J	Daniels, JP; Middleton, LJ; Champaneria, R; Khan, KS; Cooper, K; Mol, BWJ; Bhattacharya, S				Daniels, J. P.; Middleton, L. J.; Champaneria, R.; Khan, K. S.; Cooper, K.; Mol, B. W. J.; Bhattacharya, S.		Int Heavy Menstrual Bleeding IPD M	Second generation endometrial ablation techniques for heavy menstrual bleeding: network meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; 5-YEAR FOLLOW-UP; THERMAL BALLOON; ROLLERBALL ABLATION; TRANSCERVICAL RESECTION; EPISODE STATISTICS; TREAT MENORRHAGIA; MULTICENTER; SYSTEM; HYSTERECTOMY	Objective To determine the relative effectiveness of second generation ablation techniques in the treatment of heavy menstrual bleeding. Design Network meta-analysis on the primary outcome measures of amenorrhoea, heavy bleeding, and patients' dissatisfaction with treatment. Data sources Nineteen randomised controlled trials (involving 3287 women) were identified through electronic searches of the Cochrane Library, Medline, Embase and PsycINFO databases from inception to April 2011. The reference lists of known relevant articles were searched for further articles. Two reviewers independently selected articles without language restrictions. Eligibility criteria for selecting studies Randomised controlled trials involving second generation endometrial destruction techniques for women with heavy menstrual bleeding unresponsive to medical treatment. Results Of the three most commonly used techniques, network meta-analysis showed that bipolar radiofrequency and microwave ablation resulted in higher rates of amenorrhoea than thermal balloon ablation at around 12 months (odds ratio 2.51, 95% confidence interval 1.53 to 4.12, P<0.001; and 1.66, 1.01 to 2.71, P=0.05, respectively), but there was no evidence of a convincing difference between the three techniques in the number of women dissatisfied with treatment or still experiencing heavy bleeding. Compared with bipolar radio frequency and microwave devices, an increased number of women still experienced heavy bleeding after free fluid ablation (2.19, 1.07 to 4.50, P=0.03; and 2.91, 1.23 to 6.88, P=0.02, respectively). Compared with radio frequency ablation, free fluid ablation was associated with reduced rates of amenorrhoea (0.36, 0.19 to 0.67, P=0.004) and increased rates of dissatisfaction (4.79, 1.07 to 21.5, P=0.04). Of the less commonly used devices, endometrial laser intrauterine thermotherapy was associated with increased rates of amenorrhoea compared with all the other devices, while cryoablation led to a reduced rate compared with bipolar radio frequency and microwave. Conclusions Bipolar radio frequency and microwave ablative devices are more effective than thermal balloon and free fluid ablation in the treatment of heavy menstrual bleeding with second generation endometrial ablation devices.	[Daniels, J. P.; Middleton, L. J.; Champaneria, R.] Univ Birmingham, Clin Trials Unit, Birmingham B15 2TT, W Midlands, England; [Khan, K. S.] Barts & London Queen Marys Sch Med & Dent, London E1 2DD, England; [Cooper, K.; Bhattacharya, S.] Univ Aberdeen, Sch Med & Dent, Aberdeen AB25 2ZD, Scotland; [Mol, B. W. J.] Acad Med Ctr, NL-1105 DE Amsterdam, Netherlands	University of Birmingham; University of London; Queen Mary University London; University of Aberdeen; University of Amsterdam; Academic Medical Center Amsterdam	Daniels, JP (corresponding author), Univ Birmingham, Clin Trials Unit, Birmingham B15 2TT, W Midlands, England.	j.p.daniels@bham.ac.uk	Mol, Ben/I-4526-2012; Khan, Khalid S/AAT-8824-2020	Khan, Khalid S/0000-0001-5084-7312; Bhattacharya, Siladitya/0000-0002-4588-356X; cooper, kevin/0000-0003-1486-0071; Middleton, Lee/0000-0003-4621-1922	National Institute for Health Research (NIHR) [05/45/02]; University of Birmingham Clinical Trials Unit; National Institute for Health Research [05/45/02] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); University of Birmingham Clinical Trials Unit; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was partly funded by the National Institute for Health Research (NIHR) Health Technology Assessment project (reference 05/45/02). 50 Further support came from the University of Birmingham Clinical Trials Unit, which is funded by an infrastructure grant from the NIHR. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, NHS, or the Department of Health.	Abbott J, 2003, FERTIL STERIL, V80, P203, DOI 10.1016/S0015-0282(03)00549-1; Bhattacharya S, 2011, Health Technol Assess, V15, piii, DOI 10.3310/hta15190; Bongers MY, 2004, BJOG-INT J OBSTET GY, V111, P1095, DOI 10.1111/j.1471-0528.2004.00253.x; Boujida VH, 2002, OBSTET GYNECOL, V99, P988, DOI 10.1016/S0029-7844(02)01954-3; Brun JL, 2006, J MINIM INVAS GYN, V13, P424, DOI 10.1016/j.jmig.2006.05.006; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Chapple A, 1999, J ADV NURS, V29, P1500, DOI 10.1046/j.1365-2648.1999.01038.x; Clark TJ, 2011, OBSTET GYNECOL, V117, P109, DOI 10.1097/AOG.0b013e3182020401; Cooper J, 2002, J AM ASSOC GYN LAP, V9, P418, DOI 10.1016/S1074-3804(05)60513-0; Cooper JM, 2004, J AM ASSOC GYN LAP, V11, P394, DOI 10.1016/S1074-3804(05)60057-6; Cooper KG, 2005, BJOG-INT J OBSTET GY, V112, P470, DOI 10.1111/j.1471-0528.2004.00511.x; Cooper KG, 1999, LANCET, V354, P1859, DOI 10.1016/S0140-6736(99)04101-X; Corson SL, 2001, J AM ASSOC GYN LAP, V8, P359, DOI 10.1016/S1074-3804(05)60331-3; Corson SL, 2000, J AM ASSOC GYN LAP, V7, P489, DOI 10.1016/S1074-3804(05)60361-1; Duleba AJ, 2003, J AM ASSOC GYN LAP, V10, P17, DOI 10.1016/S1074-3804(05)60229-0; Early Breast Cancer Trialists' Collaborative Group, 1990, TREATM EARL BREAST C; Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Hawe J, 2003, BJOG-INT J OBSTET GY, V110, P350, DOI 10.1016/S1470-0328(03)02924-0; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HIGHAM JM, 1990, BRIT J OBSTET GYNAEC, V97, P734, DOI 10.1111/j.1471-0528.1990.tb16249.x; Kilonzo MM, 2010, VALUE HEALTH, V13, P528, DOI 10.1111/j.1524-4733.2010.00704.x; Lethaby A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001501.pub2; Lethaby A, 2003, BMJ-BRIT MED J, V327, P1243, DOI 10.1136/bmj.327.7426.1243; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Loffer FD, 2002, J AM ASSOC GYN LAP, V9, P429, DOI 10.1016/S1074-3804(05)60514-2; Loffer FD, 2001, J AM ASSOC GYN LAP, V8, P48, DOI 10.1016/S1074-3804(05)60548-8; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Madhu CK, 2009, ARCH GYNECOL OBSTET, V280, P599, DOI 10.1007/s00404-009-0982-7; Meyer WR, 1998, OBSTET GYNECOL, V92, P98, DOI 10.1016/S0029-7844(98)00141-0; Middleton LJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3929; NHS Information Centre, 2011, HOSP EP STAT 2011; Overton C, 1997, BRIT J OBSTET GYNAEC, V104, P1351, DOI 10.1111/j.1471-0528.1997.tb11003.x; Pellicano M, 2002, AM J OBSTET GYNECOL, V187, P545, DOI 10.1067/mob.2002.124958; Penninx JPM, 2010, OBSTET GYNECOL, V116, P819, DOI 10.1097/AOG.0b013e3181f2e3e3; Perino A, 2004, FERTIL STERIL, V82, P731, DOI 10.1016/j.fertnstert.2004.01.045; Prentice A, 1999, BEST PRACT RES CL OB, V13, P181, DOI 10.1053/beog.1999.0016; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Reid PC, 2005, BRIT MED J, V330, P938, DOI 10.1136/bmj.38376.505382.AE; Reid PC, 2007, EUR J OBSTET GYN R B, V135, P191, DOI 10.1016/j.ejogrb.2006.08.008; Romer T, 1998, Zentralbl Gynakol, V120, P511; Sambrook AM, 2009, BJOG-INT J OBSTET GY, V116, P1038, DOI 10.1111/j.1471-0528.2009.02181.x; Shapley M, 2004, BRIT J GEN PRACT, V54, P359; Soysal ME, 2001, GYNECOL OBSTET INVES, V51, P128, DOI 10.1159/000052908; Stewart LA, 2002, EVAL HEALTH PROF, V25, P76, DOI 10.1177/0163278702025001006; Thijs V, 2008, EUR HEART J, V29, P1086, DOI 10.1093/eurheartj/ehn106; van der Valk R, 2009, J CLIN EPIDEMIOL, V62, P1279, DOI 10.1016/j.jclinepi.2008.04.012; Van Zon-Rabelink IAA, 2004, EUR J OBSTET GYN R B, V114, P97, DOI 10.1016/j.ejogrb.2003.10.010; Whitehead A., 2002, METAANALYSIS CONTROL; Yin CS, 2010, TAIWAN J OBSTET GYNE, V49, P311, DOI 10.1016/S1028-4559(10)60067-8	50	57	57	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2012	344								e2564	10.1136/bmj.e2564	http://dx.doi.org/10.1136/bmj.e2564			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	934HA	22529302	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000303433600001
J	Whitehorn, PR; O'Connor, S; Wackers, FL; Goulson, D				Whitehorn, Penelope R.; O'Connor, Stephanie; Wackers, Felix L.; Goulson, Dave			Neonicotinoid Pesticide Reduces Bumble Bee Colony Growth and Queen Production	SCIENCE			English	Article							BOMBUS-TERRESTRIS HYMENOPTERA; APIS-MELLIFERA; LANDSCAPE-SCALE; NEST DENSITY; APIDAE; INSECTICIDES; POLLINATION; SUNFLOWER; HAZARDS; CROPS	Growing evidence for declines in bee populations has caused great concern because of the valuable ecosystem services they provide. Neonicotinoid insecticides have been implicated in these declines because they occur at trace levels in the nectar and pollen of crop plants. We exposed colonies of the bumble bee Bombus terrestris in the laboratory to field-realistic levels of the neonicotinoid imidacloprid, then allowed them to develop naturally under field conditions. Treated colonies had a significantly reduced growth rate and suffered an 85% reduction in production of new queens compared with control colonies. Given the scale of use of neonicotinoids, we suggest that they may be having a considerable negative impact on wild bumble bee populations across the developed world.	[Whitehorn, Penelope R.; O'Connor, Stephanie; Goulson, Dave] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland; [Wackers, Felix L.] Univ Lancaster, Lancaster Environm Ctr LEC, Lancaster LA1 4YQ, England	University of Stirling; Lancaster University	Goulson, D (corresponding author), Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland.	dave.goulson@stir.ac.uk	Serrano, Jose/A-2854-2009; Goulson, David/A-2462-2010	Serrano, Jose/0000-0002-1565-5216; Goulson, David/0000-0003-4421-2876; Whitehorn, Penelope/0000-0001-9852-1012				Bonmatin JM, 2005, J AGR FOOD CHEM, V53, P5336, DOI 10.1021/jf0479362; Bonmatin JM, 2003, ANAL CHEM, V75, P2027, DOI 10.1021/ac020600b; Brittain C, 2011, BASIC APPL ECOL, V12, P321, DOI 10.1016/j.baae.2010.12.004; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Diekotter T, 2010, J APPL ECOL, V47, P209, DOI 10.1111/j.1365-2664.2009.01759.x; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; FELL RD, 1986, J KANSAS ENTOMOL SOC, V59, P72; Gels JA, 2002, J ECON ENTOMOL, V95, P722, DOI 10.1603/0022-0493-95.4.722; Goulson D, 2010, J APPL ECOL, V47, P1207, DOI 10.1111/j.1365-2664.2010.01872.x; Hayter KE, 2006, J APPL ECOL, V43, P1196, DOI 10.1111/j.1365-2664.2006.01219.x; Knight ME, 2005, MOL ECOL, V14, P1811, DOI 10.1111/j.1365-294X.2005.02540.x; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Morandin LA, 2003, ENVIRON ENTOMOL, V32, P555, DOI 10.1603/0046-225X-32.3.555; MULLER CB, 1992, ECOL ENTOMOL, V17, P343, DOI 10.1111/j.1365-2311.1992.tb01068.x; Osborne JL, 2008, J ANIM ECOL, V77, P406, DOI 10.1111/j.1365-2656.2007.01333.x; Ramirez-Romero R, 2005, APIDOLOGIE, V36, P601, DOI 10.1051/apido:2005039; Schmuck R, 2001, PEST MANAG SCI, V57, P225, DOI 10.1002/ps.270; Tasei JN, 2000, PEST MANAG SCI, V56, P784, DOI 10.1002/1526-4998(200009)56:9<784::AID-PS208>3.0.CO;2-T; Tasei JN, 2001, J ECON ENTOMOL, V94, P623, DOI 10.1603/0022-0493-94.3.623	20	785	830	28	1138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2012	336	6079					351	352		10.1126/science.1215025	http://dx.doi.org/10.1126/science.1215025			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22461500				2022-12-28	WOS:000302995400047
J	Has, C; Sparta, G; Kiritsi, D; Weibel, L; Moeller, A; Vega-Warner, V; Waters, A; He, YH; Anikster, Y; Esser, P; Straub, BK; Hausser, I; Bockenhauer, D; Dekel, B; Hildebrandt, F; Bruckner-Tuderman, L; Laube, GF				Has, Cristina; Sparta, Giuseppina; Kiritsi, Dimitra; Weibel, Lisa; Moeller, Alexander; Vega-Warner, Virginia; Waters, Aoife; He, Yinghong; Anikster, Yair; Esser, Philipp; Straub, Beate K.; Hausser, Ingrid; Bockenhauer, Detlef; Dekel, Benjamin; Hildebrandt, Friedhelm; Bruckner-Tuderman, Leena; Laube, Guido F.			Integrin alpha(3) Mutations with Kidney, Lung, and Skin Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALPHA-3-BETA-1 INTEGRIN; 3 BETA-1-INTEGRIN; CEREBRAL-CORTEX; MIGRATION; EPIDERMIS; ORGANIZATION; EXPRESSION	Integrin alpha(3) is a transmembrane integrin receptor subunit that mediates signals between the cells and their microenvironment. We identified three patients with homozygous mutations in the integrin alpha(3) gene that were associated with disrupted basement-membrane structures and compromised barrier functions in kidney, lung, and skin. The patients had a multiorgan disorder that included congenital nephrotic syndrome, interstitial lung disease, and epidermolysis bullosa. The renal and respiratory features predominated, and the lung involvement accounted for the lethal course of the disease. Although skin fragility was mild, it provided clues to the diagnosis.	[Has, Cristina; Kiritsi, Dimitra; Anikster, Yair; Esser, Philipp; Bruckner-Tuderman, Leena] Univ Freiburg, Med Ctr, Dept Dermatol, Freiburg, Germany; [Straub, Beate K.] Univ Heidelberg, Dept Pathol, D-6900 Heidelberg, Germany; [Hausser, Ingrid] Univ Heidelberg, Dept Dermatol, D-6900 Heidelberg, Germany; [Sparta, Giuseppina; Laube, Guido F.] Childrens Hosp Zurich, Dept Pediat Nephrol, Zurich, Switzerland; [Weibel, Lisa] Childrens Hosp Zurich, Dept Dermatol, Zurich, Switzerland; [Moeller, Alexander] Childrens Hosp Zurich, Dept Pulmonol, Zurich, Switzerland; [Weibel, Lisa] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; [Vega-Warner, Virginia; Hildebrandt, Friedhelm] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Waters, Aoife; Bockenhauer, Detlef] UCL, Inst Child Hlth, London, England; [Waters, Aoife; Bockenhauer, Detlef] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Anikster, Yair] Tel Aviv Univ, Sackler Sch Med, Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr,Metabol Dis Unit, IL-69978 Tel Aviv, Israel; [Dekel, Benjamin] Tel Aviv Univ, Sackler Sch Med, Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr,Pediat Stem Cell Res Inst, IL-69978 Tel Aviv, Israel; [Dekel, Benjamin] Tel Aviv Univ, Sackler Sch Med, Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr,Div Pediat Nephrol, IL-69978 Tel Aviv, Israel	University of Freiburg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University Children's Hospital Zurich; University Children's Hospital Zurich; University Children's Hospital Zurich; University of Zurich; University Zurich Hospital; University of Michigan System; University of Michigan; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Sparta, G (corresponding author), Univ Childrens Hosp, Steinwiesstr 75, CH-8032 Zurich, Switzerland.	giuseppina.sparta@kispi.uzh.ch	Esser, Philipp/F-6849-2011; Has, Cristina/B-3310-2017; Bockenhauer, Detlef/AAF-6495-2020; Has, Cristina/AGF-7185-2022; Has, Cristina/V-2132-2019; Kiritsi, Dimitra/AAL-4762-2020	Esser, Philipp/0000-0002-7379-9699; Has, Cristina/0000-0001-6066-507X; Bockenhauer, Detlef/0000-0001-5878-941X; Has, Cristina/0000-0001-6066-507X; Has, Cristina/0000-0001-6066-507X; Kiritsi, Dimitra/0000-0002-2331-8981; Weibel, Lisa/0000-0002-8696-8164; Moeller, Alexander/0000-0001-7284-4251; Straub, Beate/0000-0002-4857-1561	Federal Ministry for Education and Research; Excellence Initiative of the German Federal Government; Institute for Advanced Studies School of Life Sciences-LifeNet; National Institutes of Health [DK076683, DK086542]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076683, RC1DK086542] Funding Source: NIH RePORTER; Medical Research Council [G0802138] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V0901] Funding Source: researchfish; MRC [G0802138] Funding Source: UKRI	Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Excellence Initiative of the German Federal Government; Institute for Advanced Studies School of Life Sciences-LifeNet; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Great Ormond Street Hospital Childrens Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by a grant from the Federal Ministry for Education and Research (to Dr. Bruckner-Tuderman), a grant from the Excellence Initiative of the German Federal Government and the Freiburg Institute for Advanced Studies School of Life Sciences-LifeNet (to Dr. Bruckner-Tuderman), and grants from the National Institutes of Health (DK076683 and DK086542, to Dr. Hildebrandt).	Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Clement A, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-22; Conti FJA, 2003, J CELL SCI, V116, P2737, DOI 10.1242/jcs.00475; Danen EHJ, 2003, J PATHOL, V201, P632, DOI 10.1002/path.1472; DiPersio CM, 1997, J CELL BIOL, V137, P729, DOI 10.1083/jcb.137.3.729; Has C, 2006, J DERMATOL SCI, V44, P129, DOI 10.1016/j.jdermsci.2006.08.003; Hildebrandt F, 2010, LANCET, V375, P1287, DOI 10.1016/S0140-6736(10)60236-X; Hodivala-Dilke KM, 1998, J CELL BIOL, V142, P1357, DOI 10.1083/jcb.142.5.1357; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Ivaska J, 2010, CELL TISSUE RES, V339, P111, DOI 10.1007/s00441-009-0857-z; Kambham N, 2000, AM J KIDNEY DIS, V36, P190, DOI 10.1053/ajkd.2000.8293; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Kreidberg JA, 1996, DEVELOPMENT, V122, P3537; Lubman RL, 2000, AM J PHYSIOL-LUNG C, V279, pL183, DOI 10.1152/ajplung.2000.279.1.L183; Margadant C, 2010, FASEB J, V24, P4133, DOI 10.1096/fj.09-151449; Margadant C, 2009, J CELL SCI, V122, P278, DOI 10.1242/jcs.029108; Mitchell K, 2009, J CELL SCI, V122, P1778, DOI 10.1242/jcs.040956; Reiser J, 2004, J BIOL CHEM, V279, P34827, DOI 10.1074/jbc.M401973200; Sachs N, 2006, J CELL BIOL, V175, P33, DOI 10.1083/jcb.200603073; Schmid RS, 2003, CEREB CORTEX, V13, P219, DOI 10.1093/cercor/13.3.219; Wang ZM, 1999, J CELL SCI, V112, P2925; Wen TT, 2010, WOUND REPAIR REGEN, V18, P325, DOI 10.1111/j.1524-475X.2010.00590.x	22	150	154	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 19	2012	366	16					1508	1514		10.1056/NEJMoa1110813	http://dx.doi.org/10.1056/NEJMoa1110813			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927UE	22512483	Green Accepted			2022-12-28	WOS:000302934800008
J	Wang, KL; Hu, Y; He, JH				Wang, Kelin; Hu, Yan; He, Jiangheng			Deformation cycles of subduction earthquakes in a viscoelastic Earth	NATURE			English	Review							INTERSEISMIC DEFORMATION; DISLOCATION MODEL; POSTSEISMIC DEFORMATION; CRUSTAL DEFORMATION; CHILE EARTHQUAKE; MANTLE RHEOLOGY; ZONE; SLIP; MEGATHRUST; MECHANICS	Subduction zones produce the largest earthquakes. Over the past two decades, space geodesy has revolutionized our view of crustal deformation between consecutive earthquakes. The short time span of modern measurements necessitates comparative studies of subduction zones that are at different stages of the deformation cycle. Piecing together geodetic 'snapshots' from different subduction zones leads to a unifying picture in which the deformation is controlled by both the short-term (years) and long-term (decades and centuries) viscous behaviour of the mantle. Traditional views based on elastic models, such as coseismic deformation being a mirror image of interseismic deformation, are being thoroughly revised.	[Wang, Kelin; He, Jiangheng] Geol Survey Canada, Pacific Geosci Ctr, Nat Resources Canada, Sidney, BC V8L 4B2, Canada; [Wang, Kelin; Hu, Yan] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8W 3V6, Canada	Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; University of Victoria	Wang, KL (corresponding author), Geol Survey Canada, Pacific Geosci Ctr, Nat Resources Canada, Sidney, BC V8L 4B2, Canada.	kwang@nrcan.gc.ca	Hu, Yan/N-9570-2014	Hu, Yan/0000-0002-5704-4827				Ali ST, 2010, GEOPHYS J INT, V183, P557, DOI 10.1111/j.1365-246X.2010.04784.x; Azua BM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014702; Bachmann R, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005927; Billen MI, 2001, EARTH PLANET SC LETT, V193, P227, DOI 10.1016/S0012-821X(01)00482-4; BOTT MHP, 1973, NATURE, V243, P339, DOI 10.1038/243339a0; Brooks B. A, 2011, AGU FALL M; Burgmann R, 2008, ANNU REV EARTH PL SC, V36, P531, DOI 10.1146/annurev.earth.36.031207.124326; Chlieh M, 2007, B SEISMOL SOC AM, V97, pS152, DOI 10.1785/0120050631; Cohen SC, 1999, ADV GEOPHYS, V41, P133, DOI 10.1016/S0065-2687(08)60027-8; Currie CA, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004024; Elsasser W.V., 1967, APPL MODERN PHYS EAR, P223; Freed AM, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008562; Freymueller J. T., 2008, GEOPHYS MONOGR SER, V179, P1, DOI DOI 10.1029/179GM02; Grijalva K. A., 2009, EOS S, V90; Han SC, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2008JB005705; HANKS TC, 1979, J GEOPHYS RES, V84, P2348, DOI 10.1029/JB084iB05p02348; Hetland EA, 2010, GEOPHYS J INT, V181, P99, DOI 10.1111/j.1365-246X.2009.04482.x; Hirth G., 2003, INSIDE SUBDUCTION FA, V138, P83, DOI [10.1029/138GM06, DOI 10.1029/138GM06]; Hu Y, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003163; Hu Y, 2004, J GEOPHYS R IN PRESS; James TS, 2000, QUATERNARY SCI REV, V19, P1527, DOI 10.1016/S0277-3791(00)00076-7; Khazaradze G, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015986; Khazaradze G, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001879; Kogan MG, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046855; MATSUURA M, 1989, GEOPHYS J INT, V96, P23, DOI 10.1111/j.1365-246X.1989.tb05247.x; McCaffrey R, 2007, GEOPHYS J INT, V169, P1315, DOI 10.1111/j.1365-246X.2007.03371.x; Mitrovica JX, 1996, J GEOPHYS RES-SOL EA, V101, P555, DOI 10.1029/95JB03208; Moreno M, 2011, EARTH PLANET SC LETT, V305, P413, DOI 10.1016/j.epsl.2011.03.025; Moucha R, 2007, GEOPHYS J INT, V169, P113, DOI 10.1111/j.1365-246X.2006.03225.x; NUR A, 1974, SCIENCE, V183, P204, DOI 10.1126/science.183.4121.204; Panet I, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002905; Peltier W. R., 1981, Anelasticity in the Earth, P59, DOI 10.1029/GD004p0059; Peng ZG, 2010, NAT GEOSCI, V3, P599, DOI 10.1038/NGEO940; Perfettini H, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003522; Pollitz FF, 2003, EARTH PLANET SC LETT, V215, P89, DOI 10.1016/S0012-821X(03)00432-1; Pollitz F, 2008, GEOPHYS J INT, V173, P189, DOI [10.1111/j.1365-246X.2007.03666.x, 10.1111/J.1365-246X.2007.03666.X]; Pritchard ME, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2006JB004258; SAVAGE JC, 1992, J GEOPHYS RES-SOL EA, V97, P11117, DOI 10.1029/92JB00810; SAVAGE JC, 1983, J GEOPHYS RES, V88, P4984, DOI 10.1029/JB088iB06p04984; Sawai Y, 2004, SCIENCE, V306, P1918, DOI 10.1126/science.1104895; Scholl D. W., 2011, AGU FALL M; Scholz CH, 1998, NATURE, V391, P37, DOI 10.1038/34097; Schubert G, 2001, MANTLE CONVECTION EA; Segall P, 2010, EARTHQUAKE AND VOLCANO DEFORMATION, P1; Shearer P, 2010, ANNU REV EARTH PL SC, V38, P103, DOI 10.1146/annurev-earth-040809-152537; Simons M, 2011, SCIENCE, V332, P1421, DOI 10.1126/science.1206731; Suito H, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005954; THATCHER W, 1984, J GEOPHYS RES, V89, P7631, DOI 10.1029/JB089iB09p07631; Wada I, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002570; Wallace LM, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007717; Wang K, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001227; Wang K., 2007, SEISMOGENIC ZONE SUB, P540, DOI [10.7312/dixo13866-017, DOI 10.7312/DIXO13866-017]; Wang K, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001721; Wang KL, 2011, GEOLOGY, V39, P819, DOI 10.1130/G31856.1; Wang KL, 2001, EARTH PLANETS SPACE, V53, P295, DOI 10.1186/BF03352386; Wang KL, 1995, PURE APPL GEOPHYS, V145, P537, DOI 10.1007/BF00879588; WEERTMAN J, 1975, ANNU REV EARTH PL SC, V3, P293, DOI 10.1146/annurev.ea.03.050175.001453	57	293	306	5	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2012	484	7394					327	332		10.1038/nature11032	http://dx.doi.org/10.1038/nature11032			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927YM	22517160				2022-12-28	WOS:000302946500023
J	Jackson, RS; Chang, DC; Freischlag, JA				Jackson, Rubie Sue; Chang, David C.; Freischlag, Julie A.			Comparison of Long-term Survival After Open vs Endovascular Repair of Intact Abdominal Aortic Aneurysm Among Medicare Beneficiaries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; EUROSTAR EXPERIENCE; OUTCOMES	Context Endovascular repair of abdominal aortic aneurysm (AAA) compared with open repair increases perioperative survival, but it is not known if it increases long-term survival. Objective To compare long-term outcomes after open vs endovascular repair of AAA. Design, Setting, and Patients Retrospective analysis of patients 65 years or older in the Medicare Standard Analytic File, 2003-2007, who underwent isolated repair of intact AAA. Cause of death was determined from the National Death Index. Main Outcome Measures The primary outcome was all-cause mortality. Secondary outcomes were AAA-related mortality, hospital length of stay, 1-year readmission, repeat AAA repair, incisional hernia repair, and lower extremity amputation. Results Of 4529 included patients, 703 were classified as having undergone open repair and 3826 as having undergone endovascular repair. Mean and median follow-up times were 2.6 (SD, 1.5) and 2.5 (interquartile range, 2.4) years, respectively. In unadjusted analysis, both all-cause mortality (173 vs 752; 89 vs 76/1000 person-years, P=.04) and AAA-specific mortality (22 vs 28; 11.3 vs 2.8/1000 person-years, P<.001) were higher after open vs endovascular repair. After adjusting for emergency admission, age, calendar year, sex, race, and comorbidities, there was a higher risk of both all-cause mortality (hazard ratio [HR], 1.24 [95% CI, 1.05-1.47]; P=.01) and AAA-related mortality (HR, 4.37 [95% CI, 2.51-7.66]; P<.001) after open vs endovascular repair. The adjusted hospital length of stay was, on average, 6.5 days (95% CI, 6.0-7.0 days, P<.001) longer after open repair (mean, 10.4 days), compared with endovascular repair (mean, 3.6 days). Incidence of incisional hernia repair was higher after open AAA repair (19 vs 23; 12 vs 3 per 1000 person-years; adjusted HR, 4.45 [95% CI, 2.37-8.34, P<.001]), whereas the incidence of 1-year readmission (188 vs 1070; 274 vs 376/1000 person-years; adjusted HR, 0.96 [95% CI, 0.85-1.09, P=.52]), repeat AAA repair (15 vs 93; 9.7 vs 12.3/1000 person-years; adjusted HR, 0.80 [95% CI, 0.46-1.38, P=.42]), and lower extremity amputation (3 vs 25; 1.9 vs 3.3/1000 person-years; adjusted HR, 0.55 [95% CI, 0.16-1.86, P=.34]) did not differ by repair type. Conclusion Among older patients with isolated intact AAA, use of open repair compared with endovascular repair was associated with increased risk of all-cause mortality and AAA-related mortality. JAMA. 2012;307(15):1621-1628	[Jackson, Rubie Sue] Georgetown Univ Hosp, Dept Surg, Washington, DC 20007 USA; [Chang, David C.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Freischlag, Julie A.] Johns Hopkins Med Inst, Dept Surg, Baltimore, MD 21205 USA	Georgetown University; University of California System; University of California San Diego; Johns Hopkins University; Johns Hopkins Medicine	Jackson, RS (corresponding author), Georgetown Univ Hosp, Dept Surg, 3800 Reservoir Rd, Washington, DC 20007 USA.	rmaybury@jhsph.edu			SCANNER, Agency for Healthcare Research and Quality [R01 HS19913-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS019913] Funding Source: NIH RePORTER	SCANNER, Agency for Healthcare Research and Quality; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Dr Chang is supported in part by SCANNER grant R01 HS19913-01 awarded by the Agency for Healthcare Research and Quality.	Blankensteijn JD, 2005, NEW ENGL J MED, V352, P2398, DOI 10.1056/NEJMoa051255; Centers for Disease Control and Prevention, NAT DEATH IND; *CTR MED MED SERV, STAND AN FIL LDS; Elixhauser A, 2010, CLIN CLASSIFICATIONS; Giles KA, 2009, J VASC SURG, V50, P256, DOI 10.1016/j.jvs.2009.01.044; Greenhalgh RM, 2005, LANCET, V365, P2179, DOI 10.1016/S0140-6736(05)66627-5; Greenhalgh RM, 2005, LANCET, V365, P2187, DOI 10.1016/S0140-6736(05)66628-7; Harris PL, 2000, J VASC SURG, V32, P739, DOI 10.1067/mva.2000.109990; HERTZER NR, 1980, ANN SURG, V192, P667; HOLLIER LH, 1984, J VASC SURG, V1, P290, DOI 10.1067/mva.1984.avs0010290; Holt PJE, 2009, CIRC-CARDIOVASC QUAL, V2, P624, DOI 10.1161/CIRCOUTCOMES.109.848465; Hopkins R, 2008, VASC HEALTH RISK MAN, V4, P1011, DOI 10.2147/VHRM.S3810; KELLY TF, 1981, ANN SURG, V193, P686, DOI 10.1097/00000658-198106000-00003; Koskas F, 1997, ANN VASC SURG, V11, P473, DOI 10.1007/s100169900078; Landon BE, 2010, CIRCULATION, V122, P1290, DOI 10.1161/CIRCULATIONAHA.110.949172; Lederle FA, 1997, ANN INTERN MED, V126, P441, DOI 10.7326/0003-4819-126-6-199703150-00004; Lederle FA, 2009, JAMA-J AM MED ASSOC, V302, P1535, DOI 10.1001/jama.2009.1426; Leurs LJ, 2007, EUR J VASC ENDOVASC, V33, P172, DOI 10.1016/j.ejvs.2006.09.011; Levin David C, 2009, J Am Coll Radiol, V6, P506, DOI 10.1016/j.jacr.2009.02.003; Parodi J C, 1991, Ann Vasc Surg, V5, P491, DOI 10.1007/BF02015271; Schermerhorn ML, 2008, NEW ENGL J MED, V358, P464, DOI 10.1056/NEJMoa0707348; Schermerhorn ML, 2011, J AM COLL SURGEONS, V212, P349, DOI 10.1016/j.jamcollsurg.2010.12.003; Schlosser FJV, 2010, ANN SURG, V251, P158, DOI 10.1097/SLA.0b013e3181bc9c4d; StataCorp, 2007, STAT STAT SOFTW REL; Sternbergh WC, 2000, J VASC SURG, V31, P237, DOI 10.1016/S0741-5214(00)90154-X; Townsend CM, 2004, TXB SURG, V17th; van Marrewijk C, 2002, J VASC SURG, V35, P461, DOI 10.1067/mva.2002.118823	27	89	90	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2012	307	15					1621	1628		10.1001/jama.2012.453	http://dx.doi.org/10.1001/jama.2012.453			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927GU	22511690	Bronze			2022-12-28	WOS:000302896100024
J	Palty, R; Raveh, A; Kaminsky, I; Meller, R; Reuveny, E				Palty, Raz; Raveh, Adi; Kaminsky, Ido; Meller, Ruth; Reuveny, Eitan			SARAF Inactivates the Store Operated Calcium Entry Machinery to Prevent Excess Calcium Refilling	CELL			English	Article							FAST CA2+-DEPENDENT INACTIVATION; STROMAL INTERACTION MOLECULE-1; ACTIVATES CRAC CHANNELS; PLASMA-MEMBRANE; CA2+ ENTRY; ENDOPLASMIC-RETICULUM; ORAI CHANNELS; FRET MICROSCOPY; SENSOR STIM1; T-CELLS	Store operated calcium entry (SOCE) is a principal cellular process by which cells regulate basal calcium, refill intracellular Ca2+ stores, and execute a wide range of specialized activities. STIM and Orai proteins have been identified as the essential components enabling the reconstitution of Ca2+ release-activated Ca2+ (CRAC) channels that mediate SOCE. Here, we report the molecular identification of SARAF as a negative regulator of SOCE. Using heterologous expression, RNAi-mediated silencing and site directed mutagenesis combined with electrophysiological, biochemical and imaging techniques we show that SARAF is an endoplasmic reticulum membrane resident protein that associates with STIM to facilitate slow Ca2+-dependent inactivation of SOCE. SARAF plays a key role in shaping cytosolic Ca2+ signals and determining the content of the major intracellular Ca2+ stores, a role that is likely to be important in protecting cells from Ca2+ overfilling.	[Palty, Raz; Raveh, Adi; Kaminsky, Ido; Meller, Ruth; Reuveny, Eitan] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Reuveny, E (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	e.reuveny@weizmann.ac.il	Palty, Raz/HCH-3978-2022		Clore postdoctoral fellowship; Josef Cohn Center for Biomembrane Research; Israeli Science Foundation (ISF) [207/09]; Minerva Foundation (Munich)	Clore postdoctoral fellowship; Josef Cohn Center for Biomembrane Research; Israeli Science Foundation (ISF)(Israel Science Foundation); Minerva Foundation (Munich)	The authors would like to thank Elisha Shalgi for technical help and Dr. Dan Minor for his helpful comments and critical reading of the manuscript. The work was supported in part by the Clore postdoctoral fellowship (RP), the Josef Cohn Center for Biomembrane Research, The Israeli Science Foundation (ISF grant 207/09) and the Minerva Foundation (Munich) all to ER.	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Barr VA, 2008, MOL BIOL CELL, V19, P2802, DOI 10.1091/mbc.E08-02-0146; Berry PA, 2011, PROSTATE, V71, P1646, DOI 10.1002/pros.21384; Bird GS, 2009, CURR BIOL, V19, P1724, DOI 10.1016/j.cub.2009.08.022; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Camargo A, 2008, GENOMICS, V92, P404, DOI 10.1016/j.ygeno.2008.05.007; Derler I, 2009, J BIOL CHEM, V284, P24933, DOI 10.1074/jbc.C109.024083; Enyedi B, 2010, ANTIOXID REDOX SIGN, V13, P721, DOI 10.1089/ars.2009.2880; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Frischauf I, 2009, J BIOL CHEM, V284, P21696, DOI 10.1074/jbc.M109.018408; HARDIE RC, 1993, TRENDS NEUROSCI, V16, P371, DOI 10.1016/0166-2236(93)90095-4; Hawkins BJ, 2010, J CELL BIOL, V190, P391, DOI 10.1083/jcb.201004152; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Korzeniowski MK, 2009, J BIOL CHEM, V284, P21027, DOI 10.1074/jbc.M109.012252; Lee KP, 2009, P NATL ACAD SCI USA, V106, P14687, DOI 10.1073/pnas.0904664106; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Litjens T, 2004, J PHYSIOL-LONDON, V558, P85, DOI 10.1113/jphysiol.2004.065870; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Louzao MC, 1996, J BIOL CHEM, V271, P14807, DOI 10.1074/jbc.271.25.14807; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Pani B, 2009, P NATL ACAD SCI USA, V106, P20087, DOI 10.1073/pnas.0905002106; Parekh AB, 1998, J BIOL CHEM, V273, P14925, DOI 10.1074/jbc.273.24.14925; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Raveh A, 2010, CELL, V143, P750, DOI 10.1016/j.cell.2010.10.018; Rios E, 2010, J PHYSIOL SCI, V60, P81, DOI 10.1007/s12576-009-0069-z; Riven I, 2003, NEURON, V38, P225, DOI 10.1016/S0896-6273(03)00193-4; Romanuik TL, 2009, AM J PATHOL, V175, P2264, DOI 10.2353/ajpath.2009.080868; Romanuik TL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-476; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Shen WW, 2011, J BIOL CHEM, V286, P36448, DOI 10.1074/jbc.M111.269415; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Srikanth S, 2010, NAT CELL BIOL, V12, P436, DOI 10.1038/ncb2045; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2009, J BIOL CHEM, V284, P728, DOI 10.1074/jbc.C800178200; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; Twine NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016266; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhang ZM, 2004, PROTEIN SCI, V13, P2819, DOI 10.1110/ps.04682504; Zhou YB, 2010, NAT STRUCT MOL BIOL, V17, P112, DOI 10.1038/nsmb.1724; ZWEIFACH A, 1995, J BIOL CHEM, V270, P14445, DOI 10.1074/jbc.270.24.14445	61	200	206	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 13	2012	149	2					425	438		10.1016/j.cell.2012.01.055	http://dx.doi.org/10.1016/j.cell.2012.01.055			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22464749	Bronze			2022-12-28	WOS:000302805600020
J	Xue, YX; Luo, YX; Wu, P; Shi, HS; Xue, LF; Chen, C; Zhu, WL; Ding, ZB; Bao, YP; Shi, J; Epstein, DH; Shaham, Y; Lu, L				Xue, Yan-Xue; Luo, Yi-Xiao; Wu, Ping; Shi, Hai-Shui; Xue, Li-Fen; Chen, Chen; Zhu, Wei-Li; Ding, Zeng-Bo; Bao, Yan-ping; Shi, Jie; Epstein, David H.; Shaham, Yavin; Lu, Lin			A Memory Retrieval-Extinction Procedure to Prevent Drug Craving and Relapse	SCIENCE			English	Article							LONG-TERM-MEMORY; COCAINE-SEEKING; DISRUPTING RECONSOLIDATION; BASOLATERAL AMYGDALA; PROTEIN-SYNTHESIS; FEAR MEMORIES; CUE-EXPOSURE; PKM-ZETA; MECHANISMS; ADDICTION	Drug use and relapse involve learned associations between drug-associated environmental cues and drug effects. Extinction procedures in the clinic can suppress conditioned responses to drug cues, but the extinguished responses typically reemerge after exposure to the drug itself (reinstatement), the drug-associated environment (renewal), or the passage of time (spontaneous recovery). We describe a memory retrieval-extinction procedure that decreases conditioned drug effects and drug seeking in rat models of relapse, and drug craving in abstinent heroin addicts. In rats, daily retrieval of drug-associated memories 10 minutes or 1 hour but not 6 hours before extinction sessions attenuated drug-induced reinstatement, spontaneous recovery, and renewal of conditioned drug effects and drug seeking. In heroin addicts, retrieval of drug-associated memories 10 minutes before extinction sessions attenuated cue-induced heroin craving 1, 30, and 180 days later. The memory retrieval-extinction procedure is a promising nonpharmacological method for decreasing drug craving and relapse during abstinence.	[Xue, Yan-Xue; Luo, Yi-Xiao; Wu, Ping; Shi, Hai-Shui; Xue, Li-Fen; Chen, Chen; Zhu, Wei-Li; Ding, Zeng-Bo; Bao, Yan-ping; Shi, Jie; Lu, Lin] Peking Univ, Natl Inst Drug Dependence, Beijing 100191, Peoples R China; [Shi, Hai-Shui] Hebei Med Univ, Basic Med Coll, Dept Biochem & Mol Biol, Shijiazhuang 050017, Peoples R China; [Epstein, David H.; Shaham, Yavin] NIDA, Intramural Res Program, NIH, Baltimore, MD 21224 USA	Peking University; Hebei Medical University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Lu, L (corresponding author), Peking Univ, Natl Inst Drug Dependence, Beijing 100191, Peoples R China.	linlu@bjmu.edu.cn	shaham, yavin/G-1306-2014; SHI, JIE/GXG-3394-2022		National Basic Research Program of China [2009CB522000, 2011CB707800]; Natural Science Foundation of China [91132716, 31070958]; National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000434, ZIADA000536] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the National Basic Research Program of China (No 2009CB522000 and 2011CB707800) and the Natural Science Foundation of China (No 91132716 and 31070958). The preparation of the manuscript was also supported in part by the Intramural Research Program of the National Institute on Drug Abuse. The authors declare that they do not have any conflicts of interest related to the data presented in this manuscript.	Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; BOUTON ME, 1991, CLIN PSYCHOL REV, V11, P123, DOI 10.1016/0272-7358(91)90091-8; Bouton ME, 2002, BIOL PSYCHIAT, V52, P976, DOI 10.1016/S0006-3223(02)01546-9; Chan Wan Yee Macy, 2010, Learn Mem, V17, P512, DOI 10.1101/lm.1912510; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Conklin CA, 2002, ADDICTION, V97, P155, DOI 10.1046/j.1360-0443.2002.00014.x; Crombag HS, 2008, PHILOS T R SOC B, V363, P3233, DOI 10.1098/rstb.2008.0090; Crombag HS, 2002, BEHAV NEUROSCI, V116, P169, DOI 10.1037//0735-7044.116.1.169; Davis M, 2006, BIOL PSYCHIAT, V60, P369, DOI 10.1016/j.biopsych.2006.03.084; DEWIT H, 1981, PSYCHOPHARMACOLOGY, V75, P134, DOI 10.1007/BF00432175; Diergaarde L, 2008, EUR J PHARMACOL, V585, P453, DOI 10.1016/j.ejphar.2008.03.010; Dudai Y, 2006, CURR OPIN NEUROBIOL, V16, P174, DOI 10.1016/j.conb.2006.03.010; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Graham BM, 2010, BEHAV NEUROSCI, V124, P337, DOI 10.1037/a0019582; He YY, 2011, NEUROPSYCHOPHARMACOL, V36, P1972, DOI 10.1038/npp.2011.63; Hernandez PJ, 2004, LEARN MEMORY, V11, P748, DOI 10.1101/lm.84904; Lee JLC, 2006, J NEUROSCI, V26, P5881, DOI 10.1523/JNEUROSCI.0323-06.2006; Lee JLC, 2005, NEURON, V47, P795, DOI 10.1016/j.neuron.2005.08.007; Li FQ, 2010, J NEUROSCI, V30, P10351, DOI 10.1523/JNEUROSCI.2112-10.2010; Li YQ, 2011, J NEUROSCI, V31, P5436, DOI 10.1523/JNEUROSCI.5884-10.2011; MARLATT GA, 1990, ADDICT BEHAV, V15, P395, DOI 10.1016/0306-4603(90)90048-3; Milekic MH, 2006, J NEUROSCI, V26, P3010, DOI 10.1523/JNEUROSCI.4818-05.2006; Miller CA, 2005, EUR J NEUROSCI, V21, P1385, DOI 10.1111/j.1460-9568.2005.03974.x; Milton AL, 2008, LEARN MEMORY, V15, P88, DOI 10.1101/lm.825008; Milton AL, 2010, EUR J NEUROSCI, V31, P2308, DOI 10.1111/j.1460-9568.2010.07249.x; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; OBrien Cp E.R., 1986, BEHAV ANAL DRUG DEPE, P329; Peters J, 2009, LEARN MEMORY, V16, P279, DOI 10.1101/lm.1041309; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; Sanchez H, 2010, J NEUROSCI, V30, P4401, DOI 10.1523/JNEUROSCI.3149-09.2010; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; See RE, 2005, EUR J PHARMACOL, V526, P140, DOI 10.1016/j.ejphar.2005.09.034; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Shaham Y, 1997, PSYCHOPHARMACOLOGY, V130, P396, DOI 10.1007/s002130050256; Shalev U, 2002, PHARMACOL REV, V54, P1, DOI 10.1124/pr.54.1.1; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Sinha R, 2000, PSYCHOPHARMACOLOGY, V152, P140, DOI 10.1007/s002130000499; Soeter M, 2011, LEARN MEMORY, V18, P357, DOI 10.1101/lm.2148511; STEWART J, 1984, PSYCHOL REV, V91, P251, DOI 10.1037/0033-295X.91.2.251; Taylor JR, 2009, NEUROPHARMACOLOGY, V56, P186, DOI 10.1016/j.neuropharm.2008.07.027; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090; Wouda JA, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00179	46	340	385	4	269	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2012	336	6078					241	245		10.1126/science.1215070	http://dx.doi.org/10.1126/science.1215070			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924PN	22499948	Green Accepted			2022-12-28	WOS:000302703900053
J	Hafler, DA				Hafler, David A.			Perspective: Deconstructing a disease	NATURE			English	Editorial Material																			0	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					S6	S6		10.1038/nature11100	http://dx.doi.org/10.1038/nature11100			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22509507	Bronze			2022-12-28	WOS:000303149900048
J	Zhang, Q; He, KB; Huo, H				Zhang, Qiang; He, Kebin; Huo, Hong			Cleaning China's air	NATURE			English	Editorial Material							QUALITY; CLIMATE		[Zhang, Qiang; He, Kebin; Huo, Hong] Tsinghua Univ, Beijing 100084, Peoples R China	Tsinghua University	Zhang, Q (corresponding author), Tsinghua Univ, Beijing 100084, Peoples R China.	hekb@tsinghua.edu.cn	He, Kebin/ABF-5224-2020; Zhang, Qiang/D-9034-2012	, Hong/0000-0001-7263-9127				National Bureau of Statistics of China, 2021, CHIN STAT YB 2020; National Bureau of Statistics of China, 2011, CHIN STAT YB; Shindell D, 2008, ATMOS CHEM PHYS, V8, P7101, DOI 10.5194/acp-8-7101-2008; Shindell D, 2011, NAT CLIM CHANGE, V1, P59, DOI [10.1038/NCLIMATE1066, 10.1038/nclimate1066]; Yang F, 2011, ATMOS CHEM PHYS, V11, P5207, DOI 10.5194/acp-11-5207-2011; Zhang L, 2008, ATMOS CHEM PHYS, V8, P6117, DOI 10.5194/acp-8-6117-2008	6	450	487	14	345	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					161	162		10.1038/484161a	http://dx.doi.org/10.1038/484161a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22498609				2022-12-28	WOS:000303149900012
J	Lindenauer, PK; Lagu, T; Shieh, MS; Pekow, PS; Rothberg, MB				Lindenauer, Peter K.; Lagu, Tara; Shieh, Meng-Shiou; Pekow, Penelope S.; Rothberg, Michael B.			Association of Diagnostic Coding With Trends in Hospitalizations and Mortality of Patients With Pneumonia, 2003-2009	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEVERE SEPSIS; PERFORMANCE-MEASURES; UNITED-STATES; OUTCOMES; CARE; GUIDELINES; MANAGEMENT; OLDER	Context Recent reports suggest that the mortality rate of patients hospitalized with pneumonia has steadily declined. While this may be the result of advances in clinical care or improvements in quality, it may also represent an artifact of changes in diagnostic coding. Objective To compare estimates of trends in hospitalizations and inpatient mortality among patients with pneumonia using 2 approaches to case definition: one limited to patients with a principal diagnosis of pneumonia, and another that includes patients with a secondary diagnosis of pneumonia if the principal diagnosis is sepsis or respiratory failure. Design, Setting, and Participants Trends study using data from the 2003-2009 releases of the Nationwide Inpatient Sample. Main Outcome Measures Change in the annual hospitalization rate and change in inpatient mortality over time. Results From 2003 to 2009, the annual hospitalization rate for patients with a principal diagnosis of pneumonia declined 27.4%, from 5.5 to 4.0 per 1000, while the age-and sex-adjusted mortality decreased from 5.8% to 4.2% (absolute risk reduction [ARR], 1.6%; 95% CI, 1.4%-1.9%; relative risk reduction [RRR], 28.2%; 95% CI, 25.2%-31.2%). Over the same period, hospitalization rates of patients with a principal diagnosis of sepsis and a secondary diagnosis of pneumonia increased 177.6% from 0.4 to 1.1 per 1000, while inpatient mortality decreased from 25.1% to 22.2% (ARR, 3.0%; 95% CI, 1.6%-4.4%; RRR, 12%; 95% CI, 7.5%-16.1%); hospitalization rates for patients with a principal diagnosis of respiratory failure and a secondary diagnosis of pneumonia increased 9.3% from 0.44 to 0.48 per 1000 and mortality declined from 25.1% to 19.2% (ARR, 6.0%; 95% CI, 4.6%-7.3%; RRR, 23.7%; 95% CI, 19.7%-27.8%). However, when the 3 groups were combined, the hospitalization rate declined only 12.5%, from 6.3 to 5.6 per 1000, while the age-and sex-adjusted inpatient mortality rate increased from 8.3% to 8.8% (AR increase, 0.5%; 95% CI, 0.1%-0.9%; RR increase, 6.0%; 95% CI, 3.3%-8.8%). Over this same time frame, the age-, sex-, and comorbidity-adjusted mortality rate declined from 8.3% to 7.8% (ARR, 0.5%; 95% CI, 0.2%-0.9%; RRR, 6.3%; 95% CI, 3.8%-8.8%). Conclusions From 2003 to 2009, hospitalization and inpatient mortality rates for patients with a principal diagnosis of pneumonia decreased substantially, whereas hospitalizations with a principal diagnosis of sepsis or respiratory failure accompanied by a secondary diagnosis of pneumonia increased and mortality declined. However, when the 3 pneumonia diagnoses were combined, the decline in the hospitalization rate was attenuated and inpatient mortality was little changed, suggesting an association of these results with temporal trends in diagnostic coding. JAMA. 2012;307(13):1405-1413	[Lindenauer, Peter K.; Lagu, Tara; Shieh, Meng-Shiou; Pekow, Penelope S.; Rothberg, Michael B.] Baystate Med Ctr, Ctr Qual Care Res, Springfield, MA 01199 USA; [Lindenauer, Peter K.; Lagu, Tara; Rothberg, Michael B.] Baystate Med Ctr, Div Gen Med & Geriatr, Springfield, MA 01199 USA; [Lindenauer, Peter K.; Lagu, Tara; Rothberg, Michael B.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Pekow, Penelope S.] Univ Massachusetts, Dept Publ Hlth, Div Biostat & Epidemiol, Amherst, MA 01003 USA	Baystate Medical Center; Baystate Medical Center; Tufts University; Massachusetts Department of Public Health; University of Massachusetts System; University of Massachusetts Amherst	Lindenauer, PK (corresponding author), Baystate Med Ctr, Ctr Qual Care Res, 280 Chestnut St,3rd Floor, Springfield, MA 01199 USA.	peter.lindenauer@bhs.org	Lagu, Tara/GPT-5173-2022	Lagu, Tara/0000-0001-6155-5796				[Anonymous], 2007, ICD 9 CM COD GUID PU; [Anonymous], 2007, ICD 9 CM COD GUID SE; [Anonymous], 2007, ICD 9 CM COD GUID PN; Baker DW, 2002, MED CARE, V40, P879, DOI 10.1097/00005650-200210000-00006; Bratzler DW, 2008, CLIN INFECT DIS, V47, pS193, DOI 10.1086/591404; Bratzler DW, 2007, CURR OPIN INFECT DIS, V20, P182, DOI 10.1097/QCO.0b013e3280495468; Bratzler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017401; Centers for Medicare and Medicaid Services, PREM HOSP QUAL INC D; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dellinger RP, 2004, CRIT CARE MED, V32, P1448; Drye EE, 2012, ANN INTERN MED, V156, P19, DOI 10.7326/0003-4819-156-1-201201030-00004; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; FastStats, FASTSTATS PNEUM; FEINSTEIN AR, 1985, NEW ENGL J MED, V312, P1604, DOI 10.1056/NEJM198506203122504; Fry AM, 2005, JAMA-J AM MED ASSOC, V294, P2712, DOI 10.1001/jama.294.21.2712; Healthcare Cost and Utilization Project, OV NAT IMP SAMPL; Kumar G, 2011, CHEST, V140, P1223, DOI 10.1378/chest.11-0352; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Lindenauer Peter K, 2010, J Hosp Med, V5, pE12, DOI 10.1002/jhm.822; Meehan TP, 2001, AM J MED, V111, P203, DOI 10.1016/S0002-9343(01)00803-8; Metersky ML, 2000, ARCH INTERN MED, V160, P3385, DOI 10.1001/archinte.160.22.3385; NIEDERMAN MS, 1993, AM REV RESPIR DIS, V148, P1418, DOI 10.1164/ajrccm/148.5.1418; Rothberg MB, 2010, HEALTH AFFAIR, V29, P1523, DOI 10.1377/hlthaff.2009.0287; Ruhnke GW, 2011, AM J MED, V124, P171, DOI 10.1016/j.amjmed.2010.08.019; The Joint Commission, IMPR AM HOSP JOINT C; The Joint Commission, FACTS ORYX HOSP NAT; Venditti M, 2009, ANN INTERN MED, V150, P19, DOI 10.7326/0003-4819-150-1-200901060-00005; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Whittle J, 1997, Am J Med Qual, V12, P187, DOI 10.1177/0885713X9701200404; Williams SC, 2005, NEW ENGL J MED, V353, P255, DOI 10.1056/NEJMsa043778; Yealy DM, 2005, ANN INTERN MED, V143, P881, DOI 10.7326/0003-4819-143-12-200512200-00006; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Zhan CL, 2003, JAMA-J AM MED ASSOC, V290, P1868, DOI 10.1001/jama.290.14.1868	35	228	230	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2012	307	13					1405	1413		10.1001/jama.2012.384	http://dx.doi.org/10.1001/jama.2012.384			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919AY	22474204	Bronze			2022-12-28	WOS:000302294200027
J	Zgierska, A; Miller, M; Rabago, D				Zgierska, Aleksandra; Miller, Michael; Rabago, David			Patient Satisfaction, Prescription Drug Abuse, and Potential Unintended Consequences	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHRONIC NONCANCER PAIN		[Zgierska, Aleksandra; Rabago, David] Univ Wisconsin, Dept Family Med, Sch Med & Publ Hlth, Madison, WI 53715 USA; [Miller, Michael] Univ Wisconsin, Dept Psychiat, Sch Med & Publ Hlth, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zgierska, A (corresponding author), Univ Wisconsin, Dept Family Med, Sch Med & Publ Hlth, 1100 Delaplaine Ct, Madison, WI 53715 USA.	aleksandra.zgierska@fammed.wisc.edu			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K23AA017508] Funding Source: NIH RePORTER; NIAAA NIH HHS [K23 AA017508] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Brett AS, 2012, JAMA-J AM MED ASSOC, V307, P149, DOI 10.1001/jama.2011.1999; Chou R, 2009, J PAIN, V10, P147, DOI 10.1016/j.jpain.2008.10.007; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Frantsve LME, 2007, PAIN MED, V8, P25, DOI 10.1111/j.1526-4637.2007.00250.x; Gugelmann HM, 2011, JAMA-J AM MED ASSOC, V306, P2258, DOI 10.1001/jama.2011.1712; Institute of Medicine, 2001, CROSSING QUALITY CHA; Matthias MS, 2010, PAIN MED, V11, P1688, DOI 10.1111/j.1526-4637.2010.00980.x; Office of National Drug Control Policy US Executive Office of the President, 2011, EP RESP AM PRESCR DR; Substance Abuse and Mental Health Services Administration, 2010, RES 2009 NAT SURV DR, VI	10	136	137	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2012	307	13					1377	1378		10.1001/jama.2012.419	http://dx.doi.org/10.1001/jama.2012.419			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	919AY	22474199	Green Accepted			2022-12-28	WOS:000302294200022
J	Krause, DS; Scadden, DT				Krause, Daniela S.; Scadden, David T.			Deconstructing the Complexity of a Microenvironmental Niche	CELL			English	Editorial Material							PROTEIN; THYMUS	Cells acquire their fate in vivo in the context of a complex microenvironmental "niche" comprised of heterologous cell types, signaling molecules, extracellular matrix, biophysical forces, and metabolic substrates. Now Calderon and Boehm report the "refunctionalization" of a defective thymic epithelial niche, offering insights into how signaling molecules may be hierarchically organized to direct differentiation outcomes.	[Krause, Daniela S.; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med & Canc Ctr, Boston, MA 02114 USA; [Krause, Daniela S.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Krause, Daniela S.; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Krause, Daniela S.; Scadden, David T.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Scadden, DT (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med & Canc Ctr, Boston, MA 02114 USA.	dscadden@mgh.harvard.edu			NATIONAL CANCER INSTITUTE [K08CA138916] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100402, R01HL044851] Funding Source: NIH RePORTER; NCI NIH HHS [K08 CA138916] Funding Source: Medline; NHLBI NIH HHS [R01 HL044851, U01 HL100402] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Calderon L, 2012, CELL, V149, P159, DOI 10.1016/j.cell.2012.01.049; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7	6	12	12	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 30	2012	149	1					16	17		10.1016/j.cell.2012.03.005	http://dx.doi.org/10.1016/j.cell.2012.03.005			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464318	Bronze, Green Accepted			2022-12-28	WOS:000302235400004
J	Markowitsch, HJ; Staniloiu, A				Markowitsch, Hans J.; Staniloiu, Angelica			Amnesic disorders	LANCET			English	Review							MEDIAL TEMPORAL-LOBE; TRANSIENT GLOBAL AMNESIA; TRAUMATIC BRAIN-INJURY; ELECTROCONVULSIVE-THERAPY; AUTOBIOGRAPHICAL MEMORIES; MAMMILLARY BODIES; HIPPOCAMPAL; IMPAIRMENT; RETRIEVAL; AMYGDALA	Memory disturbances frequently occur after brain damage, but can be associated with psychiatric illnesses as well. Amnesia-the most severe form of memory impairment-has several variants, including anterograde and retrograde amnesia, material-specific and modality-specific amnesia, and transient global amnesia. We searched databases to obtain an overview of amnesia research from the past 5 years. Research into amnesia has increased exponentially, probably because of the availability of modern brain-imaging techniques. In line with the view that memory is not a unity but is organised into several systems, amnesia is described as a multifaceted disease with a frequently poor prognosis.	[Markowitsch, Hans J.; Staniloiu, Angelica] Univ Bielefeld, D-33501 Bielefeld, Germany; [Markowitsch, Hans J.] Alfried Krupp Inst Adv Study, Greifswald, Germany; [Staniloiu, Angelica] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Staniloiu, Angelica] Univ Toronto, Toronto, ON M5S 1A1, Canada	University of Bielefeld; University of Toronto; Centre for Addiction & Mental Health - Canada; University of Toronto	Markowitsch, HJ (corresponding author), Univ Bielefeld, Postfach 10 01 31, D-33501 Bielefeld, Germany.	hjmarkowitsch@uni-bielefeld.de			University of Bielefeld; Cluster of Excellence "Cognitive Interaction Technology (CITEC)"; EU (NEST programme) [FP6-043460]; German Research Council [Br 2894/1, Br 2894/3]; Alfried-Krupp Stiftung, Greifswald	University of Bielefeld; Cluster of Excellence "Cognitive Interaction Technology (CITEC)"; EU (NEST programme); German Research Council(German Research Foundation (DFG)); Alfried-Krupp Stiftung, Greifswald	Our research was funded by the University of Bielefeld and grants from the Cluster of Excellence "Cognitive Interaction Technology (CITEC)", EU (NEST programme; "Eyewitness Memory"; FP6-043460), German Research Council (Br 2894/1, 3), and Alfried-Krupp Stiftung, Greifswald.	Abe N, 2008, CEREB CORTEX, V18, P2811, DOI 10.1093/cercor/bhn037; Adlam ALR, 2009, NEUROPSYCHOLOGIA, V47, P2207, DOI 10.1016/j.neuropsychologia.2009.01.038; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bartsch T, 2010, LANCET NEUROL, V9, P205, DOI 10.1016/S1474-4422(09)70344-8; Benke T, 2005, EUR J NEUROL, V12, P791, DOI 10.1111/j.1468-1331.2005.01063.x; Bird CM, 2007, NEUROPSYCHOLOGIA, V45, P1160, DOI 10.1016/j.neuropsychologia.2006.10.011; Borsutzky S, 2008, NEUROPSYCHOLOGIA, V46, P3133, DOI 10.1016/j.neuropsychologia.2008.07.005; Borsutzky S, 2010, NEUROPSYCHOLOGIA, V48, P2811, DOI 10.1016/j.neuropsychologia.2010.05.023; Brand M, 2003, PRINCIPLES OF LEARNING AND MEMORY, P171; Brand M, 2009, PSYCHIAT RES-NEUROIM, V174, P32, DOI 10.1016/j.pscychresns.2009.03.008; Brandt KR, 2009, NEUROCASE, V15, P60, DOI 10.1080/13554790802613025; Brunet A, 2008, J PSYCHIATR RES, V42, P503, DOI 10.1016/j.jpsychires.2007.05.006; Buchanan TW, 2005, J NEUROSCI, V25, P3151, DOI 10.1523/JNEUROSCI.4735-04.2005; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Butler CR, 2007, ANN NEUROL, V61, P587, DOI 10.1002/ana.21111; Carlesimo GA, 2011, NEUROPSYCHOLOGIA, V49, P777, DOI 10.1016/j.neuropsychologia.2011.01.026; Cejas C, 2010, STROKE, V41, P67, DOI 10.1161/STROKEAHA.109.566315; Cheng HD, 2010, BEHAV NEUROSCI, V124, P152, DOI 10.1037/a0018306; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cipolotti L, 2008, NEUROPSYCHOLOGIA, V46, P2745, DOI 10.1016/j.neuropsychologia.2008.05.009; Crosbie JH, 2007, DISABIL REHABIL, V29, P1139, DOI 10.1080/09638280600960909; Crosbie J.H., 2007, DISABIL REHABIL, V29, P47; Dewar BK, 2009, NEUROPSYCHOL REHABIL, V19, P383, DOI 10.1080/09602010802278152; Eustache F, 2008, NEUROPSYCHOL REV, V18, P53, DOI 10.1007/s11065-008-9052-3; Floel A, 2007, BRAIN RES REV, V53, P250, DOI 10.1016/j.brainresrev.2006.08.006; Fraser LM, 2008, J ECT, V24, P10, DOI 10.1097/YCT.0b013e3181616c26; Gaggioli A, 2006, NEUROREHAB NEURAL RE, V20, P503, DOI 10.1177/1545968306290224; Gerber DJ, 2004, BRAIN INJURY, V18, P1083, DOI 10.1080/02699050410001672341; Gilboa A, 2006, HIPPOCAMPUS, V16, P966, DOI 10.1002/hipo.20226; Gold PE, 2008, NEUROBIOL LEARN MEM, V89, P201, DOI 10.1016/j.nlm.2007.10.006; Greenberg DL, 2009, J NEUROSCI, V29, P10900, DOI 10.1523/JNEUROSCI.1202-09.2009; Greiffenstein MF, 2008, ARCH CLIN NEUROPSYCH, V23, P801, DOI 10.1016/j.acn.2008.07.005; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Hurlemann R, 2008, PSYCHOPHARMACOLOGY, V197, P13, DOI 10.1007/s00213-007-1002-x; Hurlemann R, 2007, NEUROPSYCHOLOGIA, V45, P877, DOI 10.1016/j.neuropsychologia.2006.08.027; Jeneson A, 2010, LEARN MEMORY, V17, P852, DOI 10.1101/lm.1546110; JETTER W, 1986, CORTEX, V22, P229, DOI 10.1016/S0010-9452(86)80047-8; Johnson JG, 2006, J PSYCHIAT RES, V40, P131, DOI 10.1016/j.jpsychires.2005.03.003; Kandel ER, 2009, J NEUROSCI, V29, P12748, DOI 10.1523/JNEUROSCI.3958-09.2009; Kanwisher N, 2010, P NATL ACAD SCI USA, V107, P11163, DOI 10.1073/pnas.1005062107; Kier EL, 2004, AM J NEURORADIOL, V25, P677; Knoops AJG, 2009, HIPPOCAMPUS, V19, P1115, DOI 10.1002/hipo.20575; Kopelman Michael D, 2008, Handb Clin Neurol, V88, P185, DOI 10.1016/S0072-9752(07)88008-0; Kwan D, 2010, NEUROPSYCHOLOGIA, V48, P3179, DOI 10.1016/j.neuropsychologia.2010.06.011; Laffan AJ, 2010, NEUROPSYCHOL REHABIL, V20, P197, DOI 10.1080/09602010903202432; Lakhan SE, 2006, J MED BIOL SCI, V1, P1; Laxton AW, 2010, ANN NEUROL, V68, P521, DOI 10.1002/ana.22089; Lemogne C, 2009, CONSCIOUS COGN, V18, P823, DOI 10.1016/j.concog.2009.04.002; Lim C, 2009, NEUROPSYCHOLOGIA, V47, P3045, DOI 10.1016/j.neuropsychologia.2009.08.002; Maguire EA, 2010, NEUROPSYCHOLOGIA, V48, P3187, DOI 10.1016/j.neuropsychologia.2010.06.037; Markowitsch HJ, 2011, NEUROPSYCHOLOGIA, V49, P718, DOI 10.1016/j.neuropsychologia.2010.10.007; Markowitsch Hans J, 2008, Handb Clin Neurol, V88, P155, DOI 10.1016/S0072-9752(07)88007-9; Markowitsch HJ, 2000, NEUROPSY NEUROPSY BE, V13, P60; Markowitsch HJ, 2003, NEUROIMAGE, V20, pS132, DOI 10.1016/j.neuroimage.2003.09.010; Markowitsch HJ, 2002, CORTEX, V38, P651, DOI 10.1016/S0010-9452(08)70030-3; Markowitsch HJ., 1992, INTELLECTUAL FUNCTIO; MARKOWITSCH HJ, 1990, TRANSIENT GLOBAL AMN; Martin M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006220.pub2; McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560; Mesulam M. M., 2000, PRINCIPLES BEHAV COG; Mohamed FB, 2006, RADIOLOGY, V238, P679, DOI 10.1148/radiol.2382050237; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Moses SN, 2008, HIPPOCAMPUS, V18, P121, DOI 10.1002/hipo.20378; Noel A, 2011, CORTEX, V47, P981, DOI 10.1016/j.cortex.2010.10.003; Papanicolaou AC, 2007, NEUROCASE, V13, P226, DOI 10.1080/13554790701594854; Papassotiropoulos A, 2013, MOL PSYCHIATR, V18, P255, DOI 10.1038/mp.2011.148; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Perren F, 2005, ARCH NEUROL-CHICAGO, V62, P1212, DOI 10.1001/archneur.62.8.1212; Pitel AL, 2008, ALCOHOL CLIN EXP RES, V32, P1229, DOI 10.1111/j.1530-0277.2008.00677.x; Preuschhof C, 2010, NEUROPSYCHOLOGIA, V48, P402, DOI 10.1016/j.neuropsychologia.2009.09.031; Rasch B, 2010, NEUROIMAGE, V53, P870, DOI 10.1016/j.neuroimage.2010.01.001; Ribot T. A., 1882, DIS MEMORY; Rutishauser U, 2008, P NATL ACAD SCI USA, V105, P329, DOI 10.1073/pnas.0706015105; Sackeim HA, 2008, BRAIN STIMUL, V1, P71, DOI 10.1016/j.brs.2008.03.001; Sackeim HA, 2007, NEUROPSYCHOPHARMACOL, V32, P244, DOI 10.1038/sj.npp.1301180; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Schon K, 2009, CEREB CORTEX, V19, P2561, DOI 10.1093/cercor/bhp006; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Segers-van Rijn J, 2010, EUR NEUROL, V63, P186, DOI 10.1159/000290249; Sepulcre J, 2008, NEUROIMAGE, V42, P1237, DOI 10.1016/j.neuroimage.2008.05.038; Shimamura AP, 2010, HIPPOCAMPUS, V20, P1206, DOI 10.1002/hipo.20856; Silver JM, 2009, BRAIN INJURY, V23, P123, DOI 10.1080/02699050802649696; Solheim O, 2005, MED HYPOTHESES, V65, P1142, DOI 10.1016/j.mehy.2005.05.042; Somerville LH, 2006, J COGNITIVE NEUROSCI, V18, P1253, DOI 10.1162/jocn.2006.18.8.1253; Squire LR, 2007, CURR OPIN NEUROBIOL, V17, P185, DOI 10.1016/j.conb.2007.02.006; Squire LR, 2010, P NATL ACAD SCI USA, V107, P19044, DOI 10.1073/pnas.1014391107; Staniloiu A, 2010, Z PSYCHOL, V218, P96, DOI 10.1027/0044-3409/a000017; Steinvorth S, 2005, NEUROPSYCHOLOGIA, V43, P479, DOI 10.1016/j.neuropsychologia.2005.01.001; Taylor LA, 2003, BRAIN INJURY, V17, P295, DOI 10.1080/0269905021000038401; Tramoni E, 2009, NEUROPSYCHOLOGIA, V47, P611, DOI 10.1016/j.neuropsychologia.2008.11.012; Tsivilis D, 2008, NAT NEUROSCI, V11, P834, DOI 10.1038/nn.2149; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Tulving E., 2005, MISSING LINK COGNITI, P3, DOI [10.1093/acprof:oso/9780195161564.003.0001, DOI 10.1093/ACPROF:OSO/9780195161564.003.0001]; Vann SD, 2010, NEUROPSYCHOLOGIA, V48, P2316, DOI 10.1016/j.neuropsychologia.2009.10.019; Vargha-Khadem F, 2003, P NATL ACAD SCI USA, V100, P10055, DOI 10.1073/pnas.1233756100; Winocur G, 2010, NEUROPSYCHOLOGIA, V48, P2339, DOI 10.1016/j.neuropsychologia.2010.04.016; Wisdom NM, 2011, NEUROBIOL AGING, V32, P63, DOI 10.1016/j.neurobiolaging.2009.02.003; World Health Organisation, 1993, ICD 10 CLASSIFICATIO; Writer BW, 2009, J NEUROPSYCH CLIN N, V21, P362, DOI 10.1176/appi.neuropsych.21.4.362; Yaffe K, 2010, ARCH GEN PSYCHIAT, V67, P608, DOI 10.1001/archgenpsychiatry.2010.61; Yochim BP, 2010, NEUROCASE, V16, P451, DOI 10.1080/13554791003623334; Zahr NM, 2011, NAT REV NEUROL, V7, P284, DOI 10.1038/nrneurol.2011.42; Zhang TY, 2010, ANNU REV PSYCHOL, V61, P439, DOI 10.1146/annurev.psych.60.110707.163625	103	72	73	0	71	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2012	380	9851					1429	1440		10.1016/S0140-6736(11)61304-4	http://dx.doi.org/10.1016/S0140-6736(11)61304-4			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025NM	22503117				2022-12-28	WOS:000310196500033
J	Phyo, AP; Nkhoma, S; Stepniewska, K; Ashley, EA; Nair, S; McGready, R; Moo, CL; Al-Saai, S; Dondorp, AM; Lwin, KM; Singhasivanon, P; Day, NPJ; White, NJ; Anderson, TJC; Nosten, F				Phyo, Aung Pyae; Nkhoma, Standwell; Stepniewska, Kasia; Ashley, Elizabeth A.; Nair, Shalini; McGready, Rose; Moo, Carit Ler; Al-Saai, Salma; Dondorp, Arjen M.; Lwin, Khin Maung; Singhasivanon, Pratap; Day, Nicholas P. J.; White, Nicholas J.; Anderson, Tim J. C.; Nosten, Francois			Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study	LANCET			English	Article							ANTIMALARIAL-DRUG RESISTANCE; FALCIPARUM-MALARIA; PARASITE CLEARANCE; SPREAD; HERITABILITY; ARTESUNATE; EPIDEMIOLOGY; MEFLOQUINE; CAMBODIA; AREA	Background Artemisinin-resistant falciparum malaria has arisen in western Cambodia. A concerted international effort is underway to contain artemisinin-resistant Plasmodium falciparum, but containment strategies are dependent on whether resistance has emerged elsewhere. We aimed to establish whether artemisinin resistance has spread or emerged on the Thailand-Myanmar (Burma) border. Methods In malaria clinics located along the northwestern border of Thailand, we measured six hourly parasite counts in patients with uncomplicated hyperparasitaemic falciparum malaria (>= 4% infected red blood cells) who had been given various oral artesunate-containing regimens since 2001. Parasite clearance half-lives were estimated and parasites were genotyped for 93 single nucleotide polymorphisms. Findings 3202 patients were studied between 2001 and 2010. Parasite clearance half-lives lengthened from a geometric mean of 2.6 h (95% CI 2.5-2.7) in 2001, to 3.7 h (3.6-3.8) in 2010, compared with a mean of 5.5 h (5.2-5.9) in 119 patients in western Cambodia measured between 2007 and 2010. The proportion of slow-clearing infections (half-life >= 6.2 h) increased from 0.6% in 2001, to 20% in 2010, compared with 42% in western Cambodia between 2007 and 2010. Of 1583 infections genotyped, 148 multilocus parasite genotypes were identified, each of which infected between two and 13 patients. The proportion of variation in parasite clearance attributable to parasite genetics increased from 30% between 2001 and 2004, to 66% between 2007 and 2010. Interpretation Genetically determined artemisinin resistance in P falciparum emerged along the Thailand-Myanmar border at least 8 years ago and has since increased substantially. At this rate of increase, resistance will reach rates reported in western Cambodia in 2-6 years.	[Phyo, Aung Pyae; Ashley, Elizabeth A.; McGready, Rose; Moo, Carit Ler; Lwin, Khin Maung; Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot 63110, Tak, Thailand; [Phyo, Aung Pyae; Stepniewska, Kasia; Ashley, Elizabeth A.; McGready, Rose; Dondorp, Arjen M.; Singhasivanon, Pratap; Day, Nicholas P. J.; White, Nicholas J.; Nosten, Francois] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Nkhoma, Standwell; Nair, Shalini; Al-Saai, Salma; Anderson, Tim J. C.] Texas Biomed Res Inst, San Antonio, TX USA; [Stepniewska, Kasia; Ashley, Elizabeth A.; McGready, Rose; Dondorp, Arjen M.; Day, Nicholas P. J.; White, Nicholas J.; Nosten, Francois] Churchill Hosp, Ctr Trop Med, Oxford OX3 7LJ, England; [Stepniewska, Kasia] Worldwide Antimalarial Resistance Network, Oxford, England	Mahidol University; Mahidol University; Texas Biomedical Research Institute; University of Oxford; Worldwide Antimalarial Resistance Network (WWARN)	Nosten, F (corresponding author), Shoklo Malaria Res Unit, POB 46, Mae Sot 63110, Tak, Thailand.	francois@tropmedres.ac	Nosten, Francois/AAC-5509-2019; Phyo, Aung Pyae/K-2413-2019; McGready, Rose/A-3290-2014; White, Nick/AAC-6527-2019; White, Nicholas J/I-4629-2012; Phyo, Aung Pyae/GYU-6181-2022	Nosten, Francois/0000-0002-7951-0745; Phyo, Aung Pyae/0000-0002-0383-9624; McGready, Rose/0000-0003-1621-3257; White, Nick/0000-0002-1897-1978; Phyo, Aung Pyae/0000-0002-0383-9624; Stepniewska, Kasia/0000-0002-1713-6209; Ashley, Elizabeth/0000-0002-7620-4822; Singhasivanon, Pratap/0000-0002-9759-1702	Wellcome Trust; National Institutes of Health [R01 AI048071]; National Center for Research Resources, National Institutes of Health [C06 RR013556]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR013556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048071, R37AI048071] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Wellcome Trust and National Institutes of Health.; The clinical study was done as part of the Wellcome Trust-Mahidol University-Oxford Tropical Medicine Research Programme supported by the Wellcome Trust. Molecular work was funded by National Institutes of Health grant R01 AI048071 awarded to TJCA and done in facilities constructed with support from Research Facilities Improvement Programme (grant number C06 RR013556) from the National Center for Research Resources, National Institutes of Health. We are grateful to all the patients and staff who contributed to data collection, to Verena Carrara for providing additional data and the maps, to Ian Cheeseman, to Christine Luxemburger, and to Ric Price. The genetic analysis was stimulated by discussions with Carol Sibley and Philippe Guerin (Worldwide Antimalarial Resistance Network).	Alifrangis M, 2009, AM J TROP MED HYG, V80, P523, DOI 10.4269/ajtmh.2009.80.523; Anderson TJC, 2010, P ROY SOC B-BIOL SCI, V277, P2531, DOI 10.1098/rspb.2010.0196; Anderson TJC, 2010, J INFECT DIS, V201, P1326, DOI 10.1086/651562; Anderson TJC, 2005, ACTA TROP, V94, P269, DOI 10.1016/j.actatropica.2005.04.010; [Anonymous], 2011, GLOB PLAN ART RES CO; [Anonymous], 2009, GLOB MAL CONTR EL RE; Antao T, 2011, P ROY SOC B-BIOL SCI, V278, P1705, DOI 10.1098/rspb.2010.1907; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bethell D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019283; Borrmann S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026005; Carrara VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004551; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Flegg JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-339; Luxemburger C, 1997, T ROY SOC TROP MED H, V91, P256, DOI 10.1016/S0035-9203(97)90066-3; LUXEMBURGER C, 1995, AM J TROP MED HYG, V53, P522, DOI 10.4269/ajtmh.1995.53.522; Maude RJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-31; Na-Bangchang K, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-273; Nair S, 2007, MOL BIOL EVOL, V24, P562, DOI 10.1093/molbev/msl185; Noedl H, 2010, CLIN INFECT DIS, V51, pE82, DOI 10.1086/657120; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; PAYNE D, 1987, PARASITOL TODAY, V3, P241, DOI 10.1016/0169-4758(87)90147-5; Roper C, 2003, LANCET, V361, P1174, DOI 10.1016/S0140-6736(03)12951-0; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Saralamba S, 2011, P NATL ACAD SCI USA, V108, P397, DOI 10.1073/pnas.1006113108; Song JP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-231; Stepniewska K, 2010, J INFECT DIS, V201, P570, DOI 10.1086/650301; VERDRAGER J, 1986, J TROP MED HYG, V89, P277; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; White NJ, 2010, LANCET, V376, P2051, DOI 10.1016/S0140-6736(10)61963-0	32	660	686	1	244	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2012	379	9830					1960	1966		10.1016/S0140-6736(12)60484-X	http://dx.doi.org/10.1016/S0140-6736(12)60484-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951YV	22484134	Green Published, Green Submitted			2022-12-28	WOS:000304757700030
J	Behrens, M; Studt, F; Kasatkin, I; Kuhl, S; Havecker, M; Abild-Pedersen, F; Zander, S; Girgsdies, F; Kurr, P; Kniep, BL; Tovar, M; Fischer, RW; Norskov, JK; Schlogl, R				Behrens, Malte; Studt, Felix; Kasatkin, Igor; Kuehl, Stefanie; Haevecker, Michael; Abild-Pedersen, Frank; Zander, Stefan; Girgsdies, Frank; Kurr, Patrick; Kniep, Benjamin-Louis; Tovar, Michael; Fischer, Richard W.; Norskov, Jens K.; Schloegl, Robert			The Active Site of Methanol Synthesis over Cu/ZnO/Al2O3 Industrial Catalysts	SCIENCE			English	Article							STRUCTURAL-CHANGES; ZINC-OXIDE; ZNO; CU(100); SURFACE; COPPER; CO2; CU; HYDROGENATION; KINETICS	One of the main stumbling blocks in developing rational design strategies for heterogeneous catalysis is that the complexity of the catalysts impairs efforts to characterize their active sites. We show how to identify the crucial atomic structure motif for the industrial Cu/ZnO/Al2O3 methanol synthesis catalyst by using a combination of experimental evidence from bulk, surface-sensitive, and imaging methods collected on real high-performance catalytic systems in combination with density functional theory calculations. The active site consists of Cu steps decorated with Zn atoms, all stabilized by a series of well-defined bulk defects and surface species that need to be present jointly for the system to work.	[Behrens, Malte; Kasatkin, Igor; Kuehl, Stefanie; Zander, Stefan; Girgsdies, Frank; Schloegl, Robert] Max Planck Gesell, Fritz Haber Inst, Dept Inorgan Chem, D-14195 Berlin, Germany; [Studt, Felix; Abild-Pedersen, Frank; Norskov, Jens K.] SLAC Natl Accelerator Lab, SUNCAT Ctr Interface Sci & Catalysis, Menlo Pk, CA 94025 USA; [Haevecker, Michael] Helmholtz Zentrum Berlin Mat & Energie, Div Solar Energy Res, Elektronenspeicherring BESSY 2, D-12489 Berlin, Germany; [Kurr, Patrick; Kniep, Benjamin-Louis; Fischer, Richard W.] Sud Chem AG, Res & Dev Catalysts, D-83052 Bruckmuhl, Germany; [Tovar, Michael] Helmholtz Zentrum Berlin Mat & Energie, Inst Complex Magnet Mat, D-14109 Berlin, Germany; [Norskov, Jens K.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA	Max Planck Society; Fritz Haber Institute of the Max Planck Society; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Clariant; Sud Chemie AG; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Stanford University	Behrens, M (corresponding author), Max Planck Gesell, Fritz Haber Inst, Dept Inorgan Chem, Faradayweg 4-6, D-14195 Berlin, Germany.	behrens@fhi-berlin.mpg.de; studt@slac.stanford.edu	Girgsdies, Frank/A-6240-2009; Norskov, Jens K/D-2539-2017; Abild-Pedersen, Frank/C-3248-2014; Studt, Felix/C-7874-2017; Kasatkin, Igor/N-7988-2019; Kasatkin, Igor A/E-6061-2010; Behrens, Malte/A-3035-2017	Girgsdies, Frank/0000-0002-0994-0686; Norskov, Jens K/0000-0002-4427-7728; Abild-Pedersen, Frank/0000-0002-1911-074X; Studt, Felix/0000-0001-6841-4232; Kasatkin, Igor/0000-0001-9586-5397; Kasatkin, Igor A/0000-0001-9586-5397; Behrens, Malte/0000-0003-3407-5011	Bundesministerium fur Bildung und Forschung [FKZ 01RI0529]; Sud-Chemie AG; Bayerisches Wissenschaftsministerium [NW-0810-0002]; (U.S.) Department of Energy, Office of Basic Energy Sciences	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Sud-Chemie AG; Bayerisches Wissenschaftsministerium; (U.S.) Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE))	We thank M. Muhler and O. Hinrichsen for fruitful discussions. M.B., I.K., S.K., S.Z.F.G., and R.S. acknowledge the Bundesministerium fur Bildung und Forschung (FKZ 01RI0529) and Sud-Chemie AG for financial support. P.K., B.-L.K., and R.W.F. thank the Bayerisches Wissenschaftsministerium (NW-0810-0002) for financial support of this work. F.S., F.A.-P., and J.K.N. wish to acknowledge support from the (U.S.) Department of Energy, Office of Basic Energy Sciences. The data presented in this work can be obtained from the corresponding authors upon request.	Behrens M, 2009, J CATAL, V267, P24, DOI 10.1016/j.jcat.2009.07.009; BURCH R, 1990, J CHEM SOC FARADAY T, V86, P2683, DOI 10.1039/ft9908602683; CHINCHEN GC, 1988, APPL CATAL, V36, P1, DOI 10.1016/S0166-9834(00)80103-7; d'Alnoncourt RN, 2006, PHYS CHEM CHEM PHYS, V8, P1525, DOI 10.1039/b515487a; Fisher IA, 1997, CATAL LETT, V44, P11, DOI 10.1023/A:1018916806816; FROST JC, 1988, NATURE, V334, P577, DOI 10.1038/334577a0; Grabow LC, 2011, ACS CATAL, V1, P365, DOI 10.1021/cs200055d; Grunwaldt JD, 2000, J CATAL, V194, P452, DOI 10.1006/jcat.2000.2930; Gunter MM, 2001, CATAL LETT, V71, P37, DOI 10.1023/A:1016696022840; Hansen J.B., 2008, HDB HETEROGENEOUS CA; Hansen PL, 2002, SCIENCE, V295, P2053, DOI 10.1126/science.1069325; Hu ZM, 1999, SURF SCI, V442, P90, DOI 10.1016/S0039-6028(99)00900-0; Jansen WPA, 2002, J CATAL, V210, P229, DOI 10.1006/jcat.2002.3679; Kasatkin I., 2007, ANGEW CHEM, V119, P7465, DOI DOI 10.1002/ANGE.200702600; KLIER K, 1982, ADV CATAL, V31, P243, DOI 10.1016/S0360-0564(08)60455-1; Kurtz M, 2004, CATAL LETT, V92, P49, DOI 10.1023/B:CATL.0000011085.88267.a6; Kurtz M, 2003, CATAL LETT, V86, P77, DOI 10.1023/A:1022663125977; Morikawa Y, 2001, APPL SURF SCI, V169, P11, DOI 10.1016/S0169-4332(00)00631-0; Nakamura J, 2003, TOP CATAL, V22, P277, DOI 10.1023/A:1023588322846; Nakamura J, 1996, CATAL TODAY, V28, P223, DOI 10.1016/0920-5861(95)00240-5; Olah G.A., 2006, OIL GAS METHANOL EC; PONEC V, 1992, SURF SCI, V272, P111, DOI 10.1016/0039-6028(92)91427-D; RASMUSSEN PB, 1994, CATAL LETT, V26, P373, DOI 10.1007/BF00810611; Sloczynski J, 2006, APPL CATAL A-GEN, V310, P127, DOI 10.1016/j.apcata.2006.05.035; Spencer MS, 1999, TOP CATAL, V8, P259, DOI 10.1023/A:1019181715731; SZANYI J, 1991, CATAL LETT, V10, P383, DOI 10.1007/BF00769173; Topsoe NY, 1999, TOP CATAL, V8, P267, DOI 10.1023/A:1019133832569; Warren B, 1990, XRAY DIFFRACTION, P253; WAUGH KC, 1992, CATAL TODAY, V15, P51, DOI 10.1016/0920-5861(92)80122-4; Yang YX, 2010, PHYS CHEM CHEM PHYS, V12, P9909, DOI 10.1039/c001484b; Yoshihara J, 1996, J CATAL, V161, P776, DOI 10.1006/jcat.1996.0240	31	1649	1685	144	2713	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					893	897		10.1126/science.1219831	http://dx.doi.org/10.1126/science.1219831			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22517324	Green Submitted			2022-12-28	WOS:000304145600059
J	Melzer, A; Cochran, S; Prentice, P; MacDonald, MP; Wang, ZG; Cuschieri, A				Melzer, Andreas; Cochran, Sandy; Prentice, Paul; MacDonald, Michael P.; Wang, Zhigang; Cuschieri, Alfred			Physics and Medicine 3 The importance of physics to progress in medical treatment	LANCET			English	Article							INTENSITY FOCUSED ULTRASOUND; SURGERY; CANCER; IMPLEMENTATION; LITHOTRIPSY; EXPERIENCE; THERAPY; BRAIN	Physics in therapy is as diverse as it is substantial. In this review, we highlight the role of physics-occasionally transitioning into engineering-through discussion of several established and emerging treatments. We specifically address minimal access surgery, ultrasound, photonics, and interventional MRI, identifying areas in which complementarity is being exploited. We also discuss some of the fundamental physical principles involved in the application of each treatment to medical practice.	[Melzer, Andreas; Cochran, Sandy; Prentice, Paul; MacDonald, Michael P.; Wang, Zhigang; Cuschieri, Alfred] Univ Dundee, Inst Med Sci & Technol, Dundee DD2 1FD, Scotland	University of Dundee	Cuschieri, A (corresponding author), Univ Dundee, Inst Med Sci & Technol, Dundee DD2 1FD, Scotland.	a.cuschieri@dundee.ac.uk	MacDonald, Michael P/F-5880-2011; Cochran, Sandy/M-4087-2017; Wang, Zhigang/A-5197-2013; Cuschieri, Alfred/O-4092-2019; Cuschieri, Alfred/A-7634-2013; Melzer, Andreas/D-7832-2012	MacDonald, Michael P/0000-0003-4415-5437; Cochran, Sandy/0000-0001-7324-7790; Wang, Zhigang/0000-0001-8309-7888; Cuschieri, Alfred/0000-0003-0764-5947; Prentice, Paul/0000-0003-2228-3622	Biotechnology and Biological Sciences Research Council; Medical Research Council; Engineering and Physical Sciences Research Council; European Research Council; Northern Research Partnership; European Regional Development Fund; European Union	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council(European Research Council (ERC)European Commission); Northern Research Partnership; European Regional Development Fund(European Commission); European Union(European Commission)	We thank Janice Aitken (College of Art and Design University of Dundee) for the production of the figures in this report. Institute for Medical Science and Technology (University of Dundee) academic staff have received financial support from the following funding councils: Biotechnology and Biological Sciences Research Council, Medical Research Council, Engineering and Physical Sciences Research Council, European Research Council, Northern Research Partnership, European Regional Development Fund, European Union Seventh Framework Program.	Baker KG, 2001, PHYS THER, V81, P1351, DOI 10.1093/ptj/81.7.1351; Black PM, 1997, NEUROSURGERY, V41, P831, DOI 10.1097/00006123-199710000-00013; BOYLE WS, 1970, BELL SYST TECH J, V49, P587, DOI 10.1002/j.1538-7305.1970.tb01790.x; Burl M, 1996, MAGNET RESON MED, V36, P491, DOI 10.1002/mrm.1910360326; Christensen C. M., 1997, INNOVATORS DILEMMA N; Cleary K, 2006, MINIM INVASIV THER, V15, P101, DOI 10.1080/13645700600674179; Curiel L, 2005, ULTRASOUND MED BIOL, V31, P1461, DOI 10.1016/j.ultrasmedbio.2005.06.013; Cuschieri A, 2005, SURG-J R COLL SURG E, V3, P125, DOI 10.1016/S1479-666X(05)80032-0; Dickinson A, 1998, US patent number, Patent No. 5631704; DOBSON SJ, 1989, J PHYS E SCI INSTRUM, V22, P450, DOI 10.1088/0022-3735/22/7/008; Dubinsky TJ, 2008, AM J ROENTGENOL, V190, P191, DOI 10.2214/AJR.07.2671; Ferrara KW, 2009, ACCOUNTS CHEM RES, V42, P881, DOI 10.1021/ar8002442; FISHER B, 1983, CANCER RES, V43, P1488; Furusawa H, 2006, J AM COLL SURGEONS, V203, P54, DOI 10.1016/j.jamcollsurg.2006.04.002; Gianfelice D, 2008, RADIOLOGY, V249, P355, DOI 10.1148/radiol.2491071523; Hand JW, 1998, ULTRASOUND MED; Hanna GB, 1998, ANN SURG, V227, P481, DOI 10.1097/00000658-199804000-00005; Hoffmann BA, 2010, EUR HEART J, V31, P450, DOI 10.1093/eurheartj/ehp460; Hopkins HH, 1964, UK patent number, Patent No. 954629; Hynynen KH, 2008, MRI GUIDED FOCUSED U; Iddan G, 2000, NATURE, V405, P417, DOI 10.1038/35013140; Immel E, 2006, MINIM INVASIV THER, V15, P85, DOI 10.1080/13645700600641004; Jolesz FA, 2002, CANCER J, V8, pS100; Kawamoto H, 2002, P IEEE, V90, P460, DOI 10.1109/JPROC.2002.1002521; Kennedy A, 1996, EUR J COGN PSYCHOL, V8, P831; Konig K, 2001, OPT LETT, V26, P819, DOI 10.1364/OL.26.000819; Konig K, 2003, J BIOMED OPT, V8, P432, DOI 10.1117/1.1577349; KREMKAU FW, 1979, J CLIN ULTRASOUND, V7, P287, DOI 10.1002/jcu.1870070410; LAUTERBUR PC, 1973, NATURE, V242, P190, DOI 10.1038/242190a0; Lewin JS, 2000, J MAGN RESON IMAGING, V12, P512, DOI 10.1002/1522-2586(200010)12:4<512::AID-JMRI2>3.0.CO;2-3; MAIMAN TH, 1960, NATURE, V187, P493, DOI 10.1038/187493a0; Manke C, 2001, RADIOLOGY, V219, P527, DOI 10.1148/radiology.219.2.r01ma03527; Melzer A, 2006, ISMRM P, V270, P61; Mitragotri S, 2005, NAT REV DRUG DISCOV, V4, P255, DOI 10.1038/nrd1662; Nimsky C, 2004, RADIOLOGY, V233, P67, DOI 10.1148/radiol.2331031352; Oar MA, 2005, CHEM MATER, V17, P2267, DOI 10.1021/cm047825i; Parsons JE, 2006, ULTRASOUND MED BIOL, V32, P115, DOI 10.1016/j.ultrasmedbio.2005.09.005; Pott Peter P, 2005, Comput Aided Surg, V10, P101, DOI 10.1080/10929080500228753; Rieke V, 2008, J MAGN RESON IMAGING, V27, P376, DOI 10.1002/jmri.21265; Robertson VJ, 2001, PHYS THER, V81, P1339, DOI 10.1093/ptj/81.7.1339; Sakimoto T, 2006, LANCET, V367, P1432, DOI 10.1016/S0140-6736(06)68275-5; Schaefers G, 2006, MINIM INVASIV THER, V15, P71, DOI 10.1080/13645700600640865; SHIRAKAWA H, 1977, J CHEM SOC CHEM COMM, P578, DOI 10.1039/c39770000578; Sofer M, 2002, J UROLOGY, V167, P31, DOI 10.1016/S0022-5347(05)65376-1; Szabo TL, 2004, DIAGNOSTIC ULTRASOUN; Tang MX, 2010, P I MECH ENG H, V224, P291, DOI 10.1243/09544119JEIM598; THOMAS DGT, 1986, AM J NEURORADIOL, V7, P161; TOMPSETT MF, 1971, IEEE T ELECTRON DEV, VED18, P992, DOI 10.1109/T-ED.1971.17321; TOMPSETT MF, 1970, APPL PHYS LETT, V17, P111, DOI 10.1063/1.1653327; Truwit CL, 2006, NEUROSURGERY, V58, P338, DOI 10.1227/01.NEU.0000205284.04252.87; Vassar GJ, 1999, J ENDOUROL, V13, P181, DOI 10.1089/end.1999.13.181; Vogl TJ, 1997, MINIM INVASIV THER, V6, P53; Vykhodtseva N, 2008, ULTRASONICS, V48, P279, DOI 10.1016/j.ultras.2008.04.004; Wu J, 2008, ADV DRUG DELIVER REV, V60, P1103, DOI 10.1016/j.addr.2008.03.009; Xiong LL, 2009, J PANCREAS, V10, P123; YAMAGISHI M, 1991, IEEE T ELECTRON DEV, V38, P976, DOI 10.1109/16.78368; Zangos S, 2011, RADIOLOGY, V259, P903, DOI 10.1148/radiol.11101559	57	9	9	0	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2012	379	9825					1534	1543		10.1016/S0140-6736(12)60428-0	http://dx.doi.org/10.1016/S0140-6736(12)60428-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930BJ	22516559				2022-12-28	WOS:000303110200032
J	Schroeder, E; Petrou, S; Patel, N; Hollowell, J; Puddicombe, D; Redshaw, M; Brocklehurst, P				Schroeder, Elizabeth; Petrou, Stavros; Patel, Nishma; Hollowell, Jennifer; Puddicombe, David; Redshaw, Maggie; Brocklehurst, Peter		Birthpl England Collaborative Grp	Cost effectiveness of alternative planned places of birth in woman at low risk of complications: evidence from the Birthplace in England national prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PERINATAL-MORTALITY RATES; BOOKED HOME BIRTHS	Objectives To estimate the cost effectiveness of alternative planned places of birth. Design Economic evaluation with individual level data from the Birthplace national prospective cohort study. Setting 142 of 147 trusts providing home birth services, 53 of 56 freestanding midwifery units, 43 of 51 alongside midwifery units, and a random sample of 36 of 180 obstetric units, stratified by unit size and geographical region, in England, over varying periods of time within the study period 1 April 2008 to 30 April 2010. Participants 64 538 women at low risk of complications before the onset of labour. Interventions Planned birth in four alternative settings: at home, in freestanding midwifery units, in alongside midwifery units, and in obstetric units. Main outcome measures Incremental cost per adverse perinatal outcome avoided, adverse maternal morbidity avoided, and additional normal birth. The non-parametric bootstrap method was used to generate net monetary benefits and construct cost effectiveness acceptability curves at alternative thresholds for cost effectiveness. Results The total unadjusted mean costs were 1066 pound, 1435 pound, 1461 pound, and 1631 pound for births planned at home, in freestanding midwifery units, in alongside midwifery units, and in obstetric units, respectively (equivalent to about (sic)1274, $1701; (sic)1715, $2290; (sic)1747, $2332; and (sic)1950, $2603). Overall, and for multiparous women, planned birth at home generated the greatest mean net benefit with a 100% probability of being the optimal setting across all thresholds of cost effectiveness when perinatal outcomes were considered. There was, however, an increased incidence of adverse perinatal outcome associated with planned birth at home in nulliparous low risk women, resulting in the probability of it being the most cost effective option at a cost effectiveness threshold of 20 pound 000 declining to 0.63. With regards to maternal outcomes in nulliparous and multiparous women, planned birth at home generated the greatest mean net benefit with a 100% probability of being the optimal setting across all thresholds of cost effectiveness. Conclusions For multiparous women at low risk of complications, planned birth at home was the most cost effective option. For nulliparous low risk women, planned birth at home is still likely to be the most cost effective option but is associated with an increase in adverse perinatal outcomes.	[Schroeder, Elizabeth; Petrou, Stavros; Patel, Nishma; Hollowell, Jennifer; Puddicombe, David; Redshaw, Maggie; Brocklehurst, Peter] Univ Oxford, Dept Publ Hlth, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England; [Petrou, Stavros] Univ Warwick, Warwick Med Sch, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England; [Brocklehurst, Peter] UCL, Inst Womens Hlth, London WC1E 6BT, England	University of Oxford; University of Warwick; University of London; University College London	Schroeder, E (corresponding author), Univ Oxford, Dept Publ Hlth, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England.	liz.schroeder@npeu.ox.ac.uk	Puddicombe, David M/F-1354-2011; Hollowell, Jennifer/B-5052-2009; Petrou, Stavros/ABD-8323-2021; Sandall, Jane/D-4146-2009	Puddicombe, David M/0000-0003-4343-4522; Hollowell, Jennifer/0000-0002-4041-5732; Petrou, Stavros/0000-0003-3121-6050; Sandall, Jane/0000-0003-2000-743X; Patel, Nishma/0000-0002-2652-5185; Schroeder, Elizabeth-Ann/0000-0003-0236-2833	Department of Health; National Institute for Health Research Service Delivery and Organisation; National Institute for Health [PB-PG-0107-12209]; National Institute for Health Research [08/1604/140, 10/1008/35] Funding Source: researchfish	Department of Health; National Institute for Health Research Service Delivery and Organisation(National Institute for Health Research (NIHR)); National Institute for Health; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was part of a larger study jointly funded by the Department of Health's Policy Research Programme and the National Institute for Health Research Service Delivery and Organisation programme. The related study formed part of a project funded by the National Institute for Health Research Research for Patient Benefit Programme through grant PB-PG-0107-12209. The views expressed are not necessarily those of the funders.	[Anonymous], 2008, GUID METH TECHN APPR; British Medical Association and Royal Pharmaceutical Society of Great Britain, 2011, BRIT NAT FORM 61; Brocklehurst P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7400; Campbell R, 1994, BE BORN DEBATE EVIDE; Curtis L., 2010, UNIT COSTS HLTH SOCI; de Jonge A, 2009, BJOG-INT J OBSTET GY, V116, P1177, DOI 10.1111/j.1471-0528.2009.02175.x; Department of Health, 2010, 13456 DEP HLTH; Department of Health, 2004, 11 DEP HLTH; Department of Health, 2002, IMPR EXP REF NEXT 3; Dixon Philip M., 1993, P290; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Gyte G, 2009, BJOG-INT J OBSTET GY, V116, P933, DOI 10.1111/j.1471-0528.2009.02147.x; Hodnett ED, 2010, ALTERNATIVE VERSUS C; Hollowell J, 2011, BIRTHPLACE NATL PROS; Janssen PA, 2009, CAN MED ASSOC J, V181, P377, DOI 10.1503/cmaj.081869; Lindgren HE, 2008, ACTA OBSTET GYN SCAN, V87, P751, DOI 10.1080/00016340802199903; Macfarlane A, 2011, ASSESSING IMPACT NEW; Maternity Care Working Party, 2007, MAK NORM BIRTH REAL; Mori R, 2008, BJOG-INT J OBSTET GY, V115, P554, DOI 10.1111/j.1471-0528.2008.01669.x; National Health Service Litigation Authority, 2010, NHSLA FACTSH 5; National Health Service Supply Chain, 2009, NHS SUPPL CHAIN CAT; NICE, 2007, INTR CAR HLTH WOM TH; Petrou S, 2003, BIRTH-ISS PERINAT C, V30, P217, DOI 10.1046/j.1523-536X.2003.0251a.x; Schroeder L, 2011, BIRTHPLACE COST EFFE; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197; Ungar W, 2009, EC EVALUATION CHILD; Wax J.R., 2010, AM J OBSTET GYNECOL, V243, pe1	28	79	79	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2012	344								e2292	10.1136/bmj.e2292	http://dx.doi.org/10.1136/bmj.e2292			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	931CU	22517916	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000303192900002
J	Jensen, MO; Jogini, V; Borhani, DW; Leffler, AE; Dror, RO; Shaw, DE				Jensen, Morten O.; Jogini, Vishwanath; Borhani, David W.; Leffler, Abba E.; Dror, Ron O.; Shaw, David E.			Mechanism of Voltage Gating in Potassium Channels	SCIENCE			English	Article							SHAKER K+-CHANNEL; MOLECULAR-DYNAMICS; SENSOR MUTATIONS; SODIUM-CHANNELS; ION-PERMEATION; S4 SEGMENT; WILD-TYPE; CHARGE; PORE; DOMAIN	The mechanism of ion channel voltage gating-how channels open and close in response to voltage changes-has been debated since Hodgkin and Huxley's seminal discovery that the crux of nerve conduction is ion flow across cellular membranes. Using all-atom molecular dynamics simulations, we show how a voltage-gated potassium channel (KV) switches between activated and deactivated states. On deactivation, pore hydrophobic collapse rapidly halts ion flow. Subsequent voltage-sensing domain (VSD) relaxation, including inward, 15-angstrom S4-helix motion, completes the transition. On activation, outward S4 motion tightens the VSD-pore linker, perturbing linker-S6-helix packing. Fluctuations allow water, then potassium ions, to reenter the pore; linker-S6 repacking stabilizes the open pore. We propose a mechanistic model for the sodium/potassium/calcium voltage-gated ion channel superfamily that reconciles apparently conflicting experimental data.	[Jensen, Morten O.; Jogini, Vishwanath; Borhani, David W.; Leffler, Abba E.; Dror, Ron O.; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Shaw, David E.] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA	D. E. Shaw Research; Columbia University	Jensen, MO (corresponding author), DE Shaw Res, New York, NY 10036 USA.	morten.jensen@DEShawResearch.com; david.shaw@DEShawResearch.com	Borhani, David/O-2692-2019	Borhani, David/0000-0002-8486-8792; Dror, Ron/0000-0002-6418-2793				Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; Ando H, 2005, J GEN PHYSIOL, V126, P529, DOI 10.1085/jgp.200509377; Banerjee A, 2008, J MOL BIOL, V381, P569, DOI 10.1016/j.jmb.2008.06.010; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; Cannon SC, 2010, J PHYSIOL-LONDON, V588, P1887, DOI 10.1113/jphysiol.2010.186874; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Delemotte L, 2010, BIOPHYS J, V99, pL72, DOI 10.1016/j.bpj.2010.08.069; Dror RO, 2009, P C HIGH PERF COMP N; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Jensen MO, 2010, P NATL ACAD SCI USA, V107, P5833, DOI 10.1073/pnas.0911691107; Khalili-Araghi F, 2012, BIOPHYS J, V102, P258, DOI 10.1016/j.bpj.2011.10.057; Kobertz WR, 1999, NAT STRUCT BIOL, V6, P1122; Labro AJ, 2008, J GEN PHYSIOL, V132, P667, DOI 10.1085/jgp.200810048; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Loboda A, 2001, BIOPHYS J, V81, P905, DOI 10.1016/S0006-3495(01)75750-5; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; MCCORMACK K, 1991, P NATL ACAD SCI USA, V88, P2931, DOI 10.1073/pnas.88.7.2931; Nelson R D, 1999, J Mol Microbiol Biotechnol, V1, P281; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Rodriguez BM, 1996, NEUROPHARMACOLOGY, V35, P775, DOI 10.1016/0028-3908(96)00111-6; Rodriguez BM, 1998, J GEN PHYSIOL, V112, P223, DOI 10.1085/jgp.112.2.223; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Sigworth FJ, 2003, NATURE, V423, P21, DOI 10.1038/423021a; Sokolov S, 2005, NEURON, V47, P183, DOI 10.1016/j.neuron.2005.06.012; Sokolov S, 2007, NATURE, V446, P76, DOI 10.1038/nature05598; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; Tao X, 2008, J MOL BIOL, V382, P24, DOI 10.1016/j.jmb.2008.06.085; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; VANDONGEN AMJ, 1990, NEURON, V5, P433, DOI 10.1016/0896-6273(90)90082-Q; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; ZIMMERBERG J, 1990, BIOPHYS J, V57, P1049, DOI 10.1016/S0006-3495(90)82623-0	48	426	430	18	256	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2012	336	6078					229	233		10.1126/science.1216533	http://dx.doi.org/10.1126/science.1216533			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924PN	22499946				2022-12-28	WOS:000302703900050
J	Petronczki, M; Uhlmann, F				Petronczki, Mark; Uhlmann, Frank			ESCRTing DNA at the Cleavage Site During Cytokinesis	SCIENCE			English	Editorial Material							CHROMOSOME; ABSCISSION; CHECKPOINT; KINASE; CELLS		[Petronczki, Mark] Canc Res UK London Res Inst, Clare Hall Labs, Cell Div, S Mimms EN6 3LD, Herts, England; [Petronczki, Mark] Canc Res UK London Res Inst, Clare Hall Labs, Aneuploidy Lab, S Mimms EN6 3LD, Herts, England; [Uhlmann, Frank] Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Chromosome Segregat Lab, London WC2A 3LY, England	Cancer Research UK; Cancer Research UK; Cancer Research UK	Petronczki, M (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, Cell Div, Blanche Lane, S Mimms EN6 3LD, Herts, England.	mark.petronczki@cancer.org.uk; frank.uhlmann@cancer.org.uk		Petronczki, Mark/0000-0003-0139-5692; Uhlmann, Frank/0000-0002-3527-6619				Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Carlton JG, 2012, SCIENCE, V336, P220, DOI 10.1126/science.1217180; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Mendoza M, 2009, NAT CELL BIOL, V11, P477, DOI 10.1038/ncb1855; Mora-Bermudez F, 2007, NAT CELL BIOL, V9, P822, DOI 10.1038/ncb1606; Nakazawa N, 2011, J CELL SCI, V124, P1795, DOI 10.1242/jcs.078733; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Tada K, 2011, NATURE, V474, P477, DOI 10.1038/nature10179	13	1	1	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2012	336	6078					166	167		10.1126/science.1221832	http://dx.doi.org/10.1126/science.1221832			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924PN	22499931				2022-12-28	WOS:000302703900032
J	van der Zand, A; Gent, J; Braakman, I; Tabak, HF				van der Zand, Adabella; Gent, Jurgen; Braakman, Ineke; Tabak, Henk F.			Biochemically Distinct Vesicles from the Endoplasmic Reticulum Fuse to Form Peroxisomes	CELL			English	Article							MATRIX PROTEIN IMPORT; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEINS; FLUORESCENCE COMPLEMENTATION; ANCHORED PROTEINS; LIVING CELLS; BIOGENESIS; PATHWAY; PEX3P; YEAST	As a rule, organelles in eukaryotic cells can derive only from pre-existing organelles. Peroxisomes are unique because they acquire their lipids and membrane proteins from the endoplasmic reticulum (ER), whereas they import their matrix proteins directly from the cytosol. We have discovered that peroxisomes are formed via heterotypic fusion of at least two biochemically distinct preperoxisomal vesicle pools that arise from the ER. These vesicles each carry half a peroxisomal translocon complex. Their fusion initiates assembly of the full peroxisomal translocon and subsequent uptake of enzymes from the cytosol. Our findings demonstrate a remarkable mechanism to maintain biochemical identity of organelles by transporting crucial components via different routes to their final destination.	[van der Zand, Adabella; Gent, Jurgen; Braakman, Ineke; Tabak, Henk F.] Univ Utrecht, Fac Sci, NL-3584 CH Utrecht, Netherlands	Utrecht University	van der Zand, A (corresponding author), Univ Utrecht, Fac Sci, NL-3584 CH Utrecht, Netherlands.	a.vanderzand@uu.nl	van der Zand, Adabella/F-8431-2013	van der Zand, Adabella/0000-0001-8980-7270; Braakman, Ineke/0000-0003-1592-4364	Netherlands Organisation of Scientific Research (NWO), Earth and Life Sciences (ALW) and Chemical Sciences (CW)	Netherlands Organisation of Scientific Research (NWO), Earth and Life Sciences (ALW) and Chemical Sciences (CW)	We thank D. Schildknegt for preparation of the GFP, Pex1p, and Pex6p antibodies and for excellent technical assistance. Drs. F. Chang, R. Erdman, D. Hoepfner, W. Huh, R. Rachubinski, and C. Stirling are gratefully acknowledged for providing reagents. We thank Drs. P. van der Sluijs and F. Reggiori for critically reading the manuscript. This work was supported by grants from the Netherlands Organisation of Scientific Research (NWO), Earth and Life Sciences (ALW) and Chemical Sciences (CW).	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Agrawal G, 2011, P NATL ACAD SCI USA, V108, P9113, DOI 10.1073/pnas.1018749108; Birschmann I, 2003, MOL BIOL CELL, V14, P2226, DOI 10.1091/mbc.E02-11-0752; Castillon GA, 2009, TRAFFIC, V10, P186, DOI 10.1111/j.1600-0854.2008.00857.x; Chang JL, 2009, J CELL BIOL, V187, P233, DOI 10.1083/jcb.200902117; Collins CS, 2000, MOL CELL BIOL, V20, P7516, DOI 10.1128/MCB.20.20.7516-7526.2000; de Duve C, 2007, NAT REV GENET, V8, P395, DOI 10.1038/nrg2071; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Faber KN, 1998, MOL CELL BIOL, V18, P936, DOI 10.1128/MCB.18.2.936; Gabaldon T, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-8; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Hazra PP, 2002, TRAFFIC, V3, P560, DOI 10.1034/j.1600-0854.2002.30806.x; Hettema EH, 2009, J CELL SCI, V122, P2331, DOI 10.1242/jcs.034363; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Hoepfner D, 2001, J CELL BIOL, V155, P979, DOI 10.1083/jcb.200107028; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Kim PK, 2006, J CELL BIOL, V173, P521, DOI 10.1083/jcb.200601036; Knoblach B, 2010, J BIOL CHEM, V285, P6670, DOI 10.1074/jbc.M109.094805; Kragt A, 2005, J BIOL CHEM, V280, P34350, DOI 10.1074/jbc.M505432200; Lam SK, 2010, P NATL ACAD SCI USA, V107, P21523, DOI 10.1073/pnas.1013397107; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Ma CL, 2011, J CELL BIOL, V193, P7, DOI 10.1083/jcb.201010022; Motley AM, 2007, J CELL BIOL, V178, P399, DOI 10.1083/jcb.200702167; Munck JM, 2009, J CELL BIOL, V187, P463, DOI 10.1083/jcb.200906161; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Nunnari J, 1996, CELL, V84, P389, DOI 10.1016/S0092-8674(00)81283-0; Nuttall JM, 2011, CURR OPIN CELL BIOL, V23, P421, DOI 10.1016/j.ceb.2011.05.005; Nyfeler B, 2007, BIOCHEM SOC T, V35, P970, DOI 10.1042/BST0350970; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; REXACH MF, 1994, J CELL BIOL, V126, P1133, DOI 10.1083/jcb.126.5.1133; Rosenkranz K, 2006, FEBS J, V273, P3804, DOI 10.1111/j.1742-4658.2006.05388.x; Rucktaschel R, 2011, BBA-BIOMEMBRANES, V1808, P892, DOI 10.1016/j.bbamem.2010.07.020; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Tam YYC, 2005, J BIOL CHEM, V280, P34933, DOI 10.1074/jbc.M506208200; Titorenko VI, 2000, J CELL BIOL, V148, P29, DOI 10.1083/jcb.148.1.29; Titorenko VI, 2000, J CELL BIOL, V150, P881, DOI 10.1083/jcb.150.4.881; van der Zand A, 2010, MOL BIOL CELL, V21, P2057, DOI 10.1091/mbc.E10-02-0082; Warren G, 1996, CELL, V84, P395, DOI 10.1016/S0092-8674(00)81284-2	41	132	132	2	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 13	2012	149	2					397	409		10.1016/j.cell.2012.01.054	http://dx.doi.org/10.1016/j.cell.2012.01.054			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500805	Bronze			2022-12-28	WOS:000302805600018
J	Kuehn, BM				Kuehn, Bridget M.			Collaborative Effort Seeks to Curb Hospital Infections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2012	307	14					1475	1475		10.1001/jama.2012.430	http://dx.doi.org/10.1001/jama.2012.430			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922HN	22496254				2022-12-28	WOS:000302538100004
J	Bhandoola, A; Artis, D				Bhandoola, Avinash; Artis, David			Rebuilding the Thymus	SCIENCE			English	Editorial Material							T-CELL; ROR-GAMMA; INTERLEUKIN-22; MODEL		[Bhandoola, Avinash] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Artis, David] Univ Penn, Dept Microbiol, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Bhandoola, A (corresponding author), Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	bhandooa@mail.med.upenn.edu		Artis, David/0000-0002-1753-4100	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059621] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL110741] Funding Source: Medline; NIAID NIH HHS [R01 AI059621] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Awong G, 2010, CURR OPIN HEMATOL, V17, P327, DOI 10.1097/MOH.0b013e3283395133; Boehm T, 2007, NAT IMMUNOL, V8, P131, DOI 10.1038/ni1435; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Griffith AV, 2012, AGING CELL, V11, P169, DOI 10.1111/j.1474-9726.2011.00773.x; Love PE, 2011, NAT REV IMMUNOL, V11, P469, DOI 10.1038/nri2989; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Shanley DP, 2009, TRENDS IMMUNOL, V30, P374, DOI 10.1016/j.it.2009.05.001; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023	16	5	5	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2012	336	6077					40	41		10.1126/science.1221677	http://dx.doi.org/10.1126/science.1221677			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920LG	22491841				2022-12-28	WOS:000302405400040
J	Lu, H; Bark, CW; de los Ojos, DE; Alcala, J; Eom, CB; Catalan, G; Gruverman, A				Lu, H.; Bark, C. -W.; Esque de los Ojos, D.; Alcala, J.; Eom, C. B.; Catalan, G.; Gruverman, A.			Mechanical Writing of Ferroelectric Polarization	SCIENCE			English	Article							SCANNING FORCE MICROSCOPY; THIN-FILMS; STRESS; NANOSCALE; BEHAVIOR	Ferroelectric materials are characterized by a permanent electric dipole that can be reversed through the application of an external voltage, but a strong intrinsic coupling between polarization and deformation also causes all ferroelectrics to be piezoelectric, leading to applications in sensors and high-displacement actuators. A less explored property is flexoelectricity, the coupling between polarization and a strain gradient. We demonstrate that the stress gradient generated by the tip of an atomic force microscope can mechanically switch the polarization in the nanoscale volume of a ferroelectric film. Pure mechanical force can therefore be used as a dynamic tool for polarization control and may enable applications in which memory bits are written mechanically and read electrically.	[Lu, H.; Gruverman, A.] Univ Nebraska, Dept Phys & Astron, Lincoln, NE 68588 USA; [Bark, C. -W.; Eom, C. B.] Univ Wisconsin, Dept Mat Sci & Engn, Madison, WI 53706 USA; [Esque de los Ojos, D.] Univ Politecn Cataluna, Dept Fluid Mech, Grp Interdept Colaborac Cient Aplicada GRICCA, Barcelona, Spain; [Alcala, J.] Univ Politecn Cataluna, Dept Mat Sci & Met Engn, Grp Interdept Colaborac Cient Aplicada GRICCA, Barcelona, Spain; [Catalan, G.] ICREA, Catalunya, Spain; [Catalan, G.] CSIC, Ctr Invest Nanosci & Nanotechnol CIN2, Barcelona, Spain; [Catalan, G.] ICN, Barcelona, Spain	University of Nebraska System; University of Nebraska Lincoln; University of Wisconsin System; University of Wisconsin Madison; Universitat Politecnica de Catalunya; Universitat Politecnica de Catalunya; ICREA; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-ICN - Centro de Investigacion en Nanociencia y Nanotecnologia (CIN2)	Catalan, G (corresponding author), ICREA, Catalunya, Spain.	gustau.catalan@cin2.es; agruverman2@unl.edu	Catalan, Gustau/AAC-6242-2020; Gruverman, Alexei/P-3537-2014; Catalan, Gustau/D-3233-2015; Alcala, Jorge/B-8905-2011; Esqué-de los Ojos, Daniel/C-7118-2012; Eom, Chang-Beom/I-5567-2014; Bark, Chung Wung/B-9534-2014	Catalan, Gustau/0000-0003-0214-4828; Gruverman, Alexei/0000-0003-0492-2750; Catalan, Gustau/0000-0003-0214-4828; Alcala, Jorge/0000-0002-6950-5766; Esqué-de los Ojos, Daniel/0000-0002-6279-2037; Bark, Chung Wung/0000-0002-9394-4240	Leverhulme Trust [F/00 203/V]; Ministerio de Educacion, Ciencia e Innovacion [MAT2011-23375]; Materials Research Science and Engineering Center (NSF) [DMR-0820521]; U.S. Department of Energy (DOE), Office of Basic Energy Sciences, Division of Materials Sciences and Engineering (DOE) [DE-SC0004876]; NSF [ECCS-0708759];  [MAT2010-10067-E];  [MAT2010-17771]; Direct For Mathematical & Physical Scien [0820521] Funding Source: National Science Foundation	Leverhulme Trust(Leverhulme Trust); Ministerio de Educacion, Ciencia e Innovacion; Materials Research Science and Engineering Center (NSF)(National Science Foundation (NSF)); U.S. Department of Energy (DOE), Office of Basic Energy Sciences, Division of Materials Sciences and Engineering (DOE)(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); ; ; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	A.G and G.C. conceived the idea, designed the experiment, and wrote the paper; H.L. implemented experimental measurements; C.-W.B. fabricated the samples; C.-B.E. supervised sample preparation and reviewed the paper; and D.E.O., J.A., and G.C. performed finite-element and free-energy calculations. G.C. and A.G. thank the Leverhulme Trust for international network funding (F/00 203/V) for the funds that have enabled this collaboration. G.C. acknowledges financial support from grants MAT2010-10067-E and MAT2010-17771, and J.A. acknowledges support from grant MAT2011-23375 (Ministerio de Educacion, Ciencia e Innovacion). The work at Univ. of Nebraska-Lincoln was supported by the Materials Research Science and Engineering Center (NSF grant DMR-0820521) and by the U.S. Department of Energy (DOE), Office of Basic Energy Sciences, Division of Materials Sciences and Engineering (DOE grant DE-SC0004876). The work at Univ. of Wisconsin-Madison was supported by the NSF under grant ECCS-0708759.	Belenky LJ, 2005, J APPL PHYS, V97, DOI 10.1063/1.1850384; Bonnell DA, 2009, MRS BULL, V34, P648, DOI 10.1557/mrs2009.176; Catalan G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.127602; Catalan G, 2004, J PHYS-CONDENS MAT, V16, P2253, DOI 10.1088/0953-8984/16/13/006; Catalan G, 2012, REV MOD PHYS, V84, P119, DOI 10.1103/RevModPhys.84.119; Catalan G, 2011, NAT MATER, V10, P963, DOI [10.1038/NMAT3141, 10.1038/nmat3141]; Choi KJ, 2004, SCIENCE, V306, P1005, DOI 10.1126/science.1103218; Emelyanov AY, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.214108; EOM CB, 1992, SCIENCE, V258, P1766, DOI 10.1126/science.258.5089.1766; Fong DD, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.127601; Gaillard Y, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/8/085502; Garcia V, 2009, NATURE, V460, P81, DOI 10.1038/nature08128; Gruverman A, 2003, APPL PHYS LETT, V83, P728, DOI 10.1063/1.1593830; Gruverman A, 2001, APPL PHYS LETT, V78, P2751, DOI 10.1063/1.1366644; Hong JW, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/11/112201; Kholkin AL, 2003, APPL PHYS LETT, V82, P2127, DOI 10.1063/1.1565177; KOGAN SM, 1964, SOV PHYS-SOL STATE, V5, P2069; Lee D, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.057602; Ma WH, 2008, PHYS STATUS SOLIDI B, V245, P761, DOI 10.1002/pssb.200743514; Ma WH, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2211309; Majdoub MS, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.121407; Maranganti R, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.054109; Nagarajan V, 2006, J APPL PHYS, V100, DOI 10.1063/1.2337363; SCOTT JF, 1968, J CHEM PHYS, V48, P874, DOI 10.1063/1.1668727; Vettiger P, 2002, IEEE T NANOTECHNOL, V1, P39, DOI 10.1109/TNANO.2002.1005425; Zavala G, 1997, J APPL PHYS, V81, P7480, DOI 10.1063/1.365350	26	544	552	35	679	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2012	336	6077					59	61		10.1126/science.1218693	http://dx.doi.org/10.1126/science.1218693			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920LG	22491848	Green Published			2022-12-28	WOS:000302405400049
J	DeConto, RM; Galeotti, S; Pagani, M; Tracy, D; Schaefer, K; Zhang, TJ; Pollard, D; Beerling, DJ				DeConto, Robert M.; Galeotti, Simone; Pagani, Mark; Tracy, David; Schaefer, Kevin; Zhang, Tingjun; Pollard, David; Beerling, David J.			Past extreme warming events linked to massive carbon release from thawing permafrost	NATURE			English	Article							EOCENE THERMAL MAXIMUM; ATMOSPHERIC CO2; LATE PALEOCENE; CLIMATE-CHANGE; GLOBAL CARBON; METHANE; MODEL; OCEAN; HYPERTHERMALS; SENSITIVITY	Between about 55.5 and 52 million years ago, Earth experienced a series of sudden and extreme global warming events (hyperthermals) superimposed on a long-term warming trend(1). The first and largest of these events, the Palaeocene-Eocene Thermal Maximum (PETM), is characterized by a massive input of carbon, ocean acidification(2) and an increase in global temperature of about 5 degrees C within a few thousand years(3). Although various explanations for the PETM have been proposed(4-6), a satisfactory model that accounts for the source, magnitude and timing of carbon release at the PETM and successive hyperthermals remains elusive. Here we use a new astronomically calibrated cyclostratigraphic record from central Italy(7) to show that the Early Eocene hyperthermals occurred during orbits with a combination of high eccentricity and high obliquity. Corresponding climate-ecosystem-soil simulations accounting for rising concentrations of background greenhouse gases(8) and orbital forcing show that the magnitude and timing of the PETM and subsequent hyperthermals can be explained by the orbitally triggered decomposition of soil organic carbon in circum-Arctic and Antarctic terrestrial permafrost. This massive carbon reservoir had the potential to repeatedly release thousands of petagrams (10(15) grams) of carbon to the atmosphere-ocean system, once a long-term warming threshold had been reached just before the PETM. Replenishment of permafrost soil carbon stocks following peak warming probably contributed to the rapid recovery from each event(9), while providing a sensitive carbon reservoir for the next hyperthermal(10). As background temperatures continued to rise following the PETM, the areal extent of permafrost steadily declined, resulting in an incrementally smaller available carbon pool and smaller hyperthermals at each successive orbital forcing maximum. A mechanism linking Earth's orbital properties with release of soil carbon from permafrost provides a unifying model accounting for the salient features of the hyperthermals.	[DeConto, Robert M.; Tracy, David] Univ Massachusetts, Dept Geosci, Amherst, MA 01002 USA; [Galeotti, Simone] Univ Urbino, Earth Life & Environm Sci Dept, I-61029 Urbino, Italy; [Pagani, Mark] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Schaefer, Kevin; Zhang, Tingjun] Univ Colorado, Cooperat Inst Res Environm Sci, Natl Snow & Ice Data Ctr, Boulder, CO 80309 USA; [Pollard, David] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [Beerling, David J.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Zhang, Tingjun] Lanzhou Univ, Minist Educ, Key Lab W Chinas Environm Syst, Lanzhou 730000, Gansu, Peoples R China	University of Massachusetts System; University of Massachusetts Amherst; University of Urbino; Yale University; University of Colorado System; University of Colorado Boulder; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Sheffield; Lanzhou University	DeConto, RM (corresponding author), Univ Massachusetts, Dept Geosci, Amherst, MA 01002 USA.	deconto@geo.umass.edu	Beerling, David J/C-2840-2009; Pagani, Mark/B-3233-2008; ZHANG, TINGJUN/AAX-3662-2020	Beerling, David J/0000-0003-1869-4314; Galeotti, Simone/0000-0001-9636-9344; ZHANG, Tingjun/0000-0001-6974-9501	US National Science Foundation [ATM-0513402/0513421, EAR-0628358]; Royal Society; Division Of Polar Programs [0901962] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Royal Society(Royal Society of London); Division Of Polar Programs(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded by the US National Science Foundation under award ATM-0513402/0513421 to R.M.D. and D.P., and EAR-0628358 to M.P. D.J.B. acknowledges support from a Royal Society-Wolfson Research Merit Award.	Beerling D, 2009, AM J SCI, V309, P97, DOI 10.2475/02.2009.01; Beerling DJ, 2011, P NATL ACAD SCI USA, V108, P9770, DOI 10.1073/pnas.1102409108; Bowen GJ, 2010, NAT GEOSCI, V3, P866, DOI 10.1038/NGEO1014; Buffett B, 2004, EARTH PLANET SC LETT, V227, P185, DOI 10.1016/j.epsl.2004.09.005; CLYMO RS, 1984, PHILOS T R SOC B, V303, P605, DOI 10.1098/rstb.1984.0002; Cramer BS, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000909; Dickens GR, 2003, EARTH PLANET SC LETT, V213, P169, DOI 10.1016/S0012-821X(03)00325-X; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Dutta K, 2006, GLOBAL CHANGE BIOL, V12, P2336, DOI 10.1111/j.1365-2486.2006.01259.x; Elberling B, 2010, NAT GEOSCI, V3, P332, DOI 10.1038/NGEO803; Galeotti S, 2010, EARTH PLANET SC LETT, V290, P192, DOI 10.1016/j.epsl.2009.12.021; Higgins JA, 2006, EARTH PLANET SC LETT, V245, P523, DOI 10.1016/j.epsl.2006.03.009; Kalkreuth WD, 1996, INT J COAL GEOL, V30, P151, DOI 10.1016/0166-5162(96)00005-5; Kaplan JO, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002559; Kent DV, 2003, EARTH PLANET SC LETT, V211, P13, DOI 10.1016/S0012-821X(03)00188-2; Khvorostyanov DV, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033639; Kiehl JT, 1998, J CLIMATE, V11, P1131, DOI 10.1175/1520-0442(1998)011<1131:TNCFAR>2.0.CO;2; Kurtz AC, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000908; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lourens LJ, 2005, NATURE, V435, P1083, DOI 10.1038/nature03814; Nicolo MJ, 2007, GEOLOGY, V35, P699, DOI 10.1130/G23648A.1; Pagani M, 2006, SCIENCE, V314, P1556, DOI 10.1126/science.1136110; Pagani M, 2009, NATURE, V460, P85, DOI 10.1038/nature08133; Panchuk K, 2008, GEOLOGY, V36, P315, DOI 10.1130/G24474A.1; Price JS, 2005, HYDROL PROCESS, V19, P3469, DOI 10.1002/hyp.6068; Ramaswamy V., 2001, CLIMATE CHANGE 2001, P351; Rohl U, 2004, GEOPH MONOG SERIES, V151, P113; RONOV AB, 1989, ATLAS LITHOLOGICAL P; Schaefer K, 2011, TELLUS B, V63, P165, DOI 10.1111/j.1600-0889.2011.00527.x; Schuur EAG, 2008, BIOSCIENCE, V58, P701, DOI 10.1641/B580807; Schuur EAG, 2009, NATURE, V459, P556, DOI 10.1038/nature08031; Sewall JO, 2000, GLOBAL PLANET CHANGE, V26, P445, DOI 10.1016/S0921-8181(00)00056-4; SHI GY, 1992, SCI CHINA SER B, V35, P217; SLOAN LC, 1992, NATURE, V357, P320, DOI 10.1038/357320a0; Sluijs A, 2006, NATURE, V441, P610, DOI 10.1038/nature04668; Storey M, 2007, SCIENCE, V316, P587, DOI 10.1126/science.1135274; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; THOMPSON SL, 1995, J CLIMATE, V8, P732, DOI 10.1175/1520-0442(1995)008<0732:AGCMWA>2.0.CO;2; Thompson SL, 1997, J CLIMATE, V10, P871, DOI 10.1175/1520-0442(1997)010<0871:GAAMBF>2.0.CO;2; Westerhold T, 2009, EARTH PLANET SC LETT, V287, P412, DOI 10.1016/j.epsl.2009.08.027; Wilson DS, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039297; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004; Zech M, 2008, GEODERMA, V143, P281, DOI 10.1016/j.geoderma.2007.11.012; Zeebe RE, 2009, NAT GEOSCI, V2, P576, DOI 10.1038/NGEO578; Zhang T.J., 2000, POLAR GEOGR, V24, P126, DOI [10.1080/10889370009377692, DOI 10.1080/10889370009377692]	46	219	227	11	422	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2012	484	7392					87	+		10.1038/nature10929	http://dx.doi.org/10.1038/nature10929			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	919QN	22481362				2022-12-28	WOS:000302343400039
J	Salerni, G; Alonso, C				Salerni, Gabriel; Alonso, Carlos			Digital Mucous Cyst	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Salerni, Gabriel; Alonso, Carlos] Hosp Prov Centenario Rosario, Santa Fe, Argentina		Salerni, G (corresponding author), Hosp Prov Centenario Rosario, Santa Fe, Argentina.	gabrielsalerni@hotmail.com		salerni, gabriel/0000-0001-6386-4402					0	8	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 5	2012	366	14					1335	1335		10.1056/NEJMicm1111833	http://dx.doi.org/10.1056/NEJMicm1111833			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	919QJ	22475597				2022-12-28	WOS:000302343000011
J	Katz, SJ; Morrow, M				Katz, Steven J.; Morrow, Monica			The Challenge of Individualizing Treatments for Patients With Breast Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							WOMEN		[Katz, Steven J.] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Katz, Steven J.] Univ Michigan, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; [Morrow, Monica] Mem Sloan Kettering Canc Ctr, Dept Clin Oncol, New York, NY 10021 USA; [Morrow, Monica] Cornell Univ, Weill Med Coll, New York, NY 10021 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Memorial Sloan Kettering Cancer Center; Cornell University	Katz, SJ (corresponding author), Univ Michigan, Dept Med, 300 N Ingalls,Room 7E10, Ann Arbor, MI 48109 USA.	skatz@umich.edu	KATZ, STEVEN/ABH-8886-2020					Anderson WF, 2007, J CLIN ONCOL, V25, P3923, DOI 10.1200/JCO.2007.11.6079; Gilovich T., 2002, HEURISTICS BIASES PS, DOI [DOI 10.1017/CBO9780511808098.004, DOI 10.1017/CBO9780511808098]; Haidt J., 2006, HAPPINESS HYPOTHESIS; HEWITT M, 1999, ENSURING QUALITY CAN, P97; Lantz PM, 2005, HEALTH SERV RES, V40, P745, DOI 10.1111/j.1475-6773.2005.00383.x; Morrow M, 2011, LANCET, V378, P1804, DOI 10.1016/S0140-6736(11)61350-0; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Patlak M., 2010, POLICY ISSUES DEV PE; Schwartz B., 2004, PARADOX CHOICE	9	27	27	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2012	307	13					1379	1380		10.1001/jama.2012.409	http://dx.doi.org/10.1001/jama.2012.409			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919AY	22474200				2022-12-28	WOS:000302294200023
J	Dang, CV				Dang, Chi V.			MYC on the Path to Cancer	CELL			English	Review							ONCOGENE-INDUCED SENESCENCE; ENDOTHELIAL GROWTH-FACTOR; LONG-RANGE INTERACTION; C-MYC; N-MYC; IN-VIVO; TRANSCRIPTIONAL ACTIVATION; BURKITT-LYMPHOMA; GENE-EXPRESSION; DROSOPHILA-MYC	The MYC oncogene contributes to the genesis of many human cancers. Recent insights into its expression and function have led to therapeutic opportunities. MYC's activation by bromodomain proteins could be inhibited by drug-like molecules, resulting in tumor inhibition in vivo. Tumor growth can also be curbed by pharmacologically uncoupling bioenergetic pathways involving glucose or glutamine metabolism from Myc-induced cellular biomass accumulation. Other approaches to halt Myc on the path to cancer involve targeting Myc-Max dimerization or Myc-induced microRNA expression. Here the richness of our understanding of MYC is reviewed, highlighting new biological insights and opportunities for cancer therapies.	Univ Penn, Perelman Sch Med, Abramson Canc Ctr,Div Hematol Oncol, Abramson Family Canc Res Inst,Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Dang, CV (corresponding author), Univ Penn, Perelman Sch Med, Abramson Canc Ctr,Div Hematol Oncol, Abramson Family Canc Res Inst,Dept Med, Philadelphia, PA 19104 USA.	dangvchi@upenn.edu	Dang, Chi/Y-3375-2019	Dang, Chi/0000-0002-4031-2522	Leukemia and Lymphoma Foundation; National Institutes of Health; National Cancer Institute; AACR; Abramson Family Cancer Research Institute; NATIONAL CANCER INSTITUTE [P30CA016520, R01CA057341, R01CA051497] Funding Source: NIH RePORTER	Leukemia and Lymphoma Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AACR; Abramson Family Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	I thank the reviewers for comments. Our primary work is supported in part by the Leukemia and Lymphoma Foundation, National Institutes of Health, National Cancer Institute, an AACR Stand-Up-to-Cancer translational grant, and the Abramson Family Cancer Research Institute. I apologize for omissions, which necessarily happen because of space limitation. C.V.D. is The John H. Glick, MD, Professor.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; AMATI B, 1993, CELL, V72, P233, DOI 10.1016/0092-8674(93)90663-B; AMATI B, 1992, NATURE, V359, P423, DOI 10.1038/359423a0; ARMELIN HA, 1984, NATURE, V310, P655, DOI 10.1038/310655a0; Arvanitis C, 2006, SEMIN CANCER BIOL, V16, P313, DOI 10.1016/j.semcancer.2006.07.012; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Baena E, 2005, P NATL ACAD SCI USA, V102, P7286, DOI 10.1073/pnas.0409260102; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Beer S, 2004, PLOS BIOL, V2, P1785, DOI 10.1371/journal.pbio.0020332; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; BLACKWOOD EM, 1994, MOL BIOL CELL, V5, P597, DOI 10.1091/mbc.5.5.597; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Boxer RB, 2004, CANCER CELL, V6, P577, DOI 10.1016/j.ccr.2004.10.013; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Brooks Tracy A, 2010, Genes Cancer, V1, P641; Brown RV, 2011, J BIOL CHEM, V286, P41018, DOI 10.1074/jbc.M111.274720; Cannell IG, 2010, P NATL ACAD SCI USA, V107, P5375, DOI 10.1073/pnas.0910015107; Cappellen D, 2007, EMBO REP, V8, P70, DOI 10.1038/sj.embor.7400849; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Challagundla KB, 2011, MOL CELL BIOL, V31, P4007, DOI 10.1128/MCB.05810-11; Chan JC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001754; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chesi M, 2008, CANCER CELL, V13, P167, DOI 10.1016/j.ccr.2008.01.007; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Clausen DM, 2010, J PHARMACOL EXP THER, V335, P715, DOI 10.1124/jpet.110.170555; Cole MD, 2008, NAT REV MOL CELL BIO, V9, P810, DOI 10.1038/nrm2467; Conacci-Sorrell M, 2010, CELL, V142, P480, DOI 10.1016/j.cell.2010.06.037; Cowling VH, 2006, MOL CELL BIOL, V26, P4226, DOI 10.1128/MCB.01959-05; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Dai JX, 2011, J AM CHEM SOC, V133, P17673, DOI 10.1021/ja205646q; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; Dang CV, 2008, ERNST SCHERING FOUND, V4, P35, DOI 10.1007/2789_2008_088; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; DANG CV, 1988, MOL CELL BIOL, V8, P4048, DOI 10.1128/MCB.8.10.4048; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; den Hollander J, 2010, BLOOD, V116, P1498, DOI 10.1182/blood-2009-11-251074; Dews M, 2010, CANCER RES, V70, P8233, DOI 10.1158/0008-5472.CAN-10-2412; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; DUESBERG PH, 1979, P NATL ACAD SCI USA, V76, P1633, DOI 10.1073/pnas.76.4.1633; Egler RA, 2005, ONCOGENE, V24, P8038, DOI 10.1038/sj.onc.1208821; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Felsher Dean W, 2010, Genes Cancer, V1, P597, DOI 10.1177/1947601910377798; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; Felton-Edkins ZA, 2003, CELL CYCLE, V2, P181, DOI 10.4161/cc.2.3.375; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Fladvad M, 2005, J MOL BIOL, V346, P175, DOI 10.1016/j.jmb.2004.11.029; Follis AV, 2009, BIOORG MED CHEM LETT, V19, P807, DOI 10.1016/j.bmcl.2008.12.025; Follis AV, 2008, CHEM BIOL, V15, P1149, DOI 10.1016/j.chembiol.2008.09.011; Frenzel Anna, 2010, Genes Cancer, V1, P660, DOI 10.1177/1947601910377488; Frye M, 2003, DEVELOPMENT, V130, P2793, DOI 10.1242/dev.00462; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Giuriato S, 2006, P NATL ACAD SCI USA, V103, P16266, DOI 10.1073/pnas.0608017103; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Graves JA, 2009, J BIOL CHEM, V284, P6520, DOI 10.1074/jbc.M807564200; Greasley PJ, 2000, NUCLEIC ACIDS RES, V28, P446, DOI 10.1093/nar/28.2.446; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Grinberg AV, 2004, MOL CELL BIOL, V24, P4294, DOI 10.1128/MCB.24.10.4294-4308.2004; Guney I, 2006, P NATL ACAD SCI USA, V103, P3645, DOI 10.1073/pnas.0600069103; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Habib T, 2007, J CELL BIOL, V179, P717, DOI 10.1083/jcb.200704173; Hammoudeh DI, 2009, J AM CHEM SOC, V131, P7390, DOI 10.1021/ja900616b; HANN SR, 1992, GENE DEV, V6, P1229, DOI 10.1101/gad.6.7.1229; He LS, 2000, EMBO J, V19, P1034, DOI 10.1093/emboj/19.5.1034; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; HOLLEY RW, 1974, P NATL ACAD SCI USA, V71, P2942, DOI 10.1073/pnas.71.8.2942; HOPEWELL R, 1995, MOL CELL BIOL, V15, P3470; Hu JZ, 2005, BIOCHEMISTRY-US, V44, P11855, DOI 10.1021/bi050206i; HU SSF, 1979, P NATL ACAD SCI USA, V76, P1265, DOI 10.1073/pnas.76.3.1265; Huang MJ, 2006, EXP HEMATOL, V34, P1480, DOI 10.1016/j.exphem.2006.06.019; Hurley LH, 2006, SEMIN ONCOL, V33, P498, DOI 10.1053/j.seminoncol.2006.04.012; Ilic N, 2011, P NATL ACAD SCI USA, V108, pE699, DOI 10.1073/pnas.1108237108; Iritani BM, 2002, EMBO J, V21, P4820, DOI 10.1093/emboj/cdf492; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Ji HK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026057; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Jonkers J, 2004, CANCER CELL, V6, P535, DOI 10.1016/j.ccr.2004.12.002; Karlsson A, 2003, P NATL ACAD SCI USA, V100, P9974, DOI 10.1073/pnas.1732638100; KATO GJ, 1992, GENE DEV, V6, P81, DOI 10.1101/gad.6.1.81; KATO GJ, 1990, MOL CELL BIOL, V10, P5914, DOI 10.1128/MCB.10.11.5914; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; Kenneth NS, 2007, P NATL ACAD SCI USA, V104, P14917, DOI 10.1073/pnas.0702909104; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Kim S, 2000, P NATL ACAD SCI USA, V97, P11198, DOI 10.1073/pnas.200372597; Knies-Bamforth UE, 2004, CANCER RES, V64, P6563, DOI 10.1158/0008-5472.CAN-03-3176; Koh CM, 2011, ONCOTARGET, V2, P669, DOI 10.18632/oncotarget.327; Koh CM, 2011, AM J PATHOL, V178, P1824, DOI 10.1016/j.ajpath.2010.12.040; KOHL NE, 1984, SCIENCE, V226, P1335, DOI 10.1126/science.6505694; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kress TR, 2011, MOL CELL, V41, P445, DOI 10.1016/j.molcel.2011.01.023; KRETZNER L, 1992, NATURE, V359, P426, DOI 10.1038/359426a0; Krycer JR, 2010, TRENDS ENDOCRIN MET, V21, P268, DOI 10.1016/j.tem.2010.01.001; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Laurenti E, 2009, CURR OPIN CELL BIOL, V21, P844, DOI 10.1016/j.ceb.2009.09.006; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; LEDER A, 1986, CELL, V45, P485, DOI 10.1016/0092-8674(86)90280-1; Levens David, 2010, Genes Cancer, V1, P547; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Li F, 2006, CANCER RES, V66, P5608, DOI 10.1158/0008-5472.CAN-05-4242; Li Q, 1999, MOL CELL BIOL, V19, P5339; Li ZL, 2008, P NATL ACAD SCI USA, V105, P18794, DOI 10.1073/pnas.0806879105; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Liu XH, 2003, J BIOL CHEM, V278, P20405, DOI 10.1074/jbc.M211795200; Louis SF, 2005, P NATL ACAD SCI USA, V102, P9613, DOI 10.1073/pnas.0407512102; Loven J, 2010, P NATL ACAD SCI USA, V107, P1553, DOI 10.1073/pnas.0913517107; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Malynn BA, 2000, GENE DEV, V14, P1390; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; McEwan IJ, 1996, BIOCHEMISTRY-US, V35, P9584, DOI 10.1021/bi960793v; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Menssen A, 2007, CELL CYCLE, V6, P339, DOI 10.4161/cc.6.3.3808; Menssen A, 2012, P NATL ACAD SCI USA, V109, pE187, DOI 10.1073/pnas.1105304109; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Muellner MK, 2011, NAT CHEM BIOL, V7, P787, DOI 10.1038/nchembio.695; Murga M, 2011, NAT STRUCT MOL BIOL, V18, P1331, DOI 10.1038/nsmb.2189; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Mustata G, 2009, J MED CHEM, V52, P1247, DOI 10.1021/jm801278g; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; Neiman PE, 2006, ONCOGENE, V25, P6325, DOI 10.1038/sj.onc.1209646; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5054, DOI 10.1128/MCB.22.14.5054-5063.2002; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Okuyama H, 2010, CANCER RES, V70, P10213, DOI 10.1158/0008-5472.CAN-10-2720; Orian A, 2005, COLD SH Q B, V70, P299, DOI 10.1101/sqb.2005.70.019; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Palaskas N, 2011, CANCER RES, V71, P5164, DOI 10.1158/0008-5472.CAN-10-4633; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Park S, 2004, BBA-GEN SUBJECTS, V1670, P217, DOI 10.1016/j.bbagen.2003.12.007; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Perna D, 2012, ONCOGENE, V31, P1695, DOI 10.1038/onc.2011.359; Pickering MT, 2009, ONCOGENE, V28, P140, DOI 10.1038/onc.2008.372; Pineda-Lucena A, 2001, J BIOMOL NMR, V19, P191, DOI 10.1023/A:1008387817677; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Popov N, 2010, NAT CELL BIOL, V12, P973, DOI 10.1038/ncb2104; Prochownik EV, 2008, CURR MOL MED, V8, P446, DOI 10.2174/156652408785747988; Prochownik Edward V, 2010, Genes Cancer, V1, P650; Qing GL, 2010, CANCER RES, V70, P10351, DOI 10.1158/0008-5472.CAN-10-0740; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rakhra K, 2010, CANCER CELL, V18, P485, DOI 10.1016/j.ccr.2010.10.002; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Ray S, 2006, CANCER RES, V66, P6598, DOI 10.1158/0008-5472.CAN-05-3115; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Sauve S, 2007, J MOL BIOL, V365, P1163, DOI 10.1016/j.jmb.2006.10.044; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schlosser I, 2005, ONCOGENE, V24, P520, DOI 10.1038/sj.onc.1208198; Schlosser I, 2003, NUCLEIC ACIDS RES, V31, P6148, DOI 10.1093/nar/gkg794; Schneider A, 1997, CURR TOP MICROBIOL, V224, P137; Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666; Semenza G.L., 2007, SCI STKE, V2007, pcm8; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Seth P, 2011, NEOPLASIA, V13, P60, DOI 10.1593/neo.101020; Shachaf CM, 2008, CANCER RES, V68, P5132, DOI 10.1158/0008-5472.CAN-07-6192; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Sharma VM, 2006, MOL CELL BIOL, V26, P8022, DOI 10.1128/MCB.01091-06; Shchors K, 2006, GENE DEV, V20, P2527, DOI 10.1101/gad.1455706; SHEINESS D, 1979, J VIROL, V31, P514, DOI 10.1128/JVI.31.2.514-521.1979; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shim H, 1998, P NATL ACAD SCI USA, V95, P1511, DOI 10.1073/pnas.95.4.1511; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Shou YP, 2000, P NATL ACAD SCI USA, V97, P228, DOI 10.1073/pnas.97.1.228; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Sodir NM, 2011, GENE DEV, V25, P907, DOI 10.1101/gad.2038411; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Spotts GD, 1997, MOL CELL BIOL, V17, P1459, DOI 10.1128/MCB.17.3.1459; Steiger D, 2008, NAT GENET, V40, P1084, DOI 10.1038/ng.178; Stumpf CR, 2011, CURR OPIN GENET DEV, V21, P474, DOI 10.1016/j.gde.2011.03.007; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; Thomas LR, 2011, ADV CANCER RES, V110, P77, DOI 10.1016/B978-0-12-386469-7.00004-9; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; van Riggelen J, 2010, GENE DEV, V24, P1281, DOI 10.1101/gad.585710; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; VENNSTROM B, 1982, J VIROL, V42, P773, DOI 10.1128/JVI.42.3.773-779.1982; Wang H, 2008, ONCOGENE, V27, P1905, DOI 10.1038/sj.onc.1210823; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wang XY, 2011, CANCER RES, V71, P925, DOI 10.1158/0008-5472.CAN-10-1032; Wanzel M, 2008, NAT CELL BIOL, V10, P1051, DOI 10.1038/ncb1764; Wasserman NF, 2010, GENOME RES, V20, P1191, DOI 10.1101/gr.105361.110; Watt FM, 2008, NAT REV CANCER, V8, P234, DOI 10.1038/nrc2328; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Wilkins JA, 2008, CANCER RES, V68, P4963, DOI 10.1158/0008-5472.CAN-07-5558; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wonsey DR, 2002, P NATL ACAD SCI USA, V99, P6649, DOI 10.1073/pnas.102523299; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Xiao QR, 1998, GENE DEV, V12, P3803, DOI 10.1101/gad.12.24.3803; Xie H, 2009, MOL CANCER THER, V8, P626, DOI 10.1158/1535-7163.MCT-08-1049; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang D, 2010, P NATL ACAD SCI USA, V107, P13836, DOI 10.1073/pnas.1008366107; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Yustein JT, 2010, P NATL ACAD SCI USA, V107, P3534, DOI 10.1073/pnas.0901230107; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhuang D, 2008, ONCOGENE, V27, P6623, DOI 10.1038/onc.2008.258; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	228	2008	2071	14	420	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 30	2012	149	1					22	35		10.1016/j.cell.2012.03.003	http://dx.doi.org/10.1016/j.cell.2012.03.003			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464321	Bronze, Green Accepted			2022-12-28	WOS:000302235400007
J	Jensen, M; Hoerndli, FJ; Brockie, PJ; Wang, R; Johnson, E; Maxfield, D; Francis, MM; Madsen, DM; Maricq, AV				Jensen, Michael; Hoerndli, Frederic J.; Brockie, Penelope J.; Wang, Rui; Johnson, Erica; Maxfield, Dane; Francis, Michael M.; Madsen, David M.; Maricq, Andres V.			Wnt Signaling Regulates Acetylcholine Receptor Translocation and Synaptic Plasticity in the Adult Nervous System	CELL			English	Article							TYROSINE KINASE; NICOTINIC RECEPTOR; PROTEIN; TRANSMISSION; MECHANISMS; CAM-1	The adult nervous system is plastic, allowing us to learn, remember, and forget. Experience-dependent plasticity occurs at synapses-the specialized points of contact between neurons where signaling occurs. However, the mechanisms that regulate the strength of synaptic signaling are not well understood. Here, we define a Wnt-signaling pathway that modifies synaptic strength in the adult nervous system by regulating the translocation of one class of acetylcholine receptors (AChRs) to synapses. In Caenorhabditis elegans, we show that mutations in CWN-2 (Wnt ligand), LIN-17 (Frizzled), CAM-1 (Ror receptor tyrosine kinase), or the downstream effector DSH-1 (disheveled) result in similar sub-synaptic accumulations of ACR-16/alpha 7 AChRs, a consequent reduction in synaptic current, and predictable behavioral defects. Photoconversion experiments revealed defective translocation of ACR-16/alpha 7 to synapses in Wnt-signaling mutants. Using optogenetic nerve stimulation, we demonstrate activity-dependent synaptic plasticity and its dependence on ACR-16/alpha 7 translocation mediated by Wnt signaling via LIN-17/CAM-1 heteromeric receptors.	[Jensen, Michael; Hoerndli, Frederic J.; Brockie, Penelope J.; Wang, Rui; Johnson, Erica; Maxfield, Dane; Francis, Michael M.; Madsen, David M.; Maricq, Andres V.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Maricq, AV (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	maricq@biology.utah.edu	Wang, Rui/C-8424-2011	jensen, michael/0000-0002-4517-822X; Hoerndli, Frederic/0000-0001-6838-0386; francis, michael/0000-0002-8076-6668	National Institutes of Health [NIH] [R01 NS070280]; American Heart Association [09PRE2060730]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070280, R01NS064263] Funding Source: NIH RePORTER	National Institutes of Health [NIH](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Maricq laboratory for comments on the manuscript, Kang Shen and Erik Jorgensen for plasmids and transgenic strains, and the Caenorhabditis Genetics Center (funded by the National Institutes of Health [NIH]) for providing worm strains. This research was made possible by support from NIH Grant R01 NS070280 and American Heart Association Predoctoral Grant 09PRE2060730 (M.J.).	Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Boulin T, 2008, P NATL ACAD SCI USA, V105, P18590, DOI 10.1073/pnas.0806933105; Brown D, 2009, TRAFFIC, V10, P275, DOI 10.1111/j.1600-0854.2008.00867.x; Budnik V, 2011, CURR OPIN NEUROBIOL, V21, P151, DOI 10.1016/j.conb.2010.12.002; Ciani L, 2011, P NATL ACAD SCI USA, V108, P10732, DOI 10.1073/pnas.1018132108; Cuitino L, 2010, J NEUROSCI, V30, P8411, DOI 10.1523/JNEUROSCI.5736-09.2010; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; Fang-Yen C, 2009, WORM BREED GAZ, V18, P32; Farias GG, 2007, J NEUROSCI, V27, P5313, DOI 10.1523/JNEUROSCI.3934-06.2007; Farias GG, 2010, DEV DYNAM, V239, P94, DOI 10.1002/dvdy.22065; Francis MM, 2005, NEURON, V46, P581, DOI 10.1016/j.neuron.2005.04.010; Gleason JE, 2006, DEV BIOL, V298, P442, DOI 10.1016/j.ydbio.2006.06.050; Gottschalk A, 2005, EMBO J, V24, P2566, DOI 10.1038/sj.emboj.7600741; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; Green JL, 2007, DEVELOPMENT, V134, P4053, DOI 10.1242/dev.005363; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Henriquez JP, 2008, P NATL ACAD SCI USA, V105, P18812, DOI 10.1073/pnas.0806300105; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Jin Y, 2008, ANNU REV CELL DEV BI, V24, P237, DOI 10.1146/annurev.cellbio.23.090506.123417; Kennedy MJ, 2011, NEURON, V69, P856, DOI 10.1016/j.neuron.2011.02.032; Kennerdell JR, 2009, DEVELOPMENT, V136, P3801, DOI 10.1242/dev.038109; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kim C, 2003, DEV BIOL, V264, P376, DOI 10.1016/j.ydbio.2003.09.007; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Korkut C, 2009, NAT REV NEUROSCI, V10, P627, DOI 10.1038/nrn2681; Kourtis N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004547; Liewald JF, 2008, NAT METHODS, V5, P895, DOI 10.1038/NMETH.1252; Liu Q, 2009, P NATL ACAD SCI USA, V106, P10823, DOI 10.1073/pnas.0903570106; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Port F, 2010, TRAFFIC, V11, P1265, DOI 10.1111/j.1600-0854.2010.01076.x; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Sahores M, 2010, DEVELOPMENT, V137, P2215, DOI 10.1242/dev.046722; Shyu YJ, 2008, NAT PROTOC, V3, P588, DOI 10.1038/nprot.2008.16; Touroutine D, 2005, J BIOL CHEM, V280, P27013, DOI 10.1074/jbc.M502818200; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Watson RT, 2007, CELL SIGNAL, V19, P2209, DOI 10.1016/j.cellsig.2007.06.003; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Zheng Y, 2004, NATURE, V427, P451, DOI 10.1038/nature02244; Zinovyeva AY, 2008, GENETICS, V179, P1357, DOI 10.1534/genetics.108.090290	44	71	85	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 30	2012	149	1					173	187		10.1016/j.cell.2011.12.038	http://dx.doi.org/10.1016/j.cell.2011.12.038			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464329	Bronze, Green Accepted			2022-12-28	WOS:000302235400019
J	Martincorena, I; Seshasayee, ASN; Luscombe, NM				Martincorena, Inigo; Seshasayee, Aswin S. N.; Luscombe, Nicholas M.			Evidence of non-random mutation rates suggests an evolutionary risk management strategy	NATURE			English	Article							ESCHERICHIA-COLI; ENTEROBACTERIAL GENES; DNA-REPAIR; TRANSCRIPTION; SELECTION; GENOME; SEQUENCES; SPECTRUM; INCREASE; SITE	A central tenet in evolutionary theory is that mutations occur randomly with respect to their value to an organism; selection then governs whether they are fixed in a population. This principle has been challenged by long-standing theoretical models predicting that selection could modulate the rate of mutation itself(1,2). However, our understanding of how the mutation rate varies between different sites within a genome has been hindered by technical difficulties in measuring it. Here we present a study that overcomes previous limitations by combining phylogenetic and population genetic techniques. Upon comparing 34 Escherichia coli genomes, we observe that the neutral mutation rate varies by more than an order of magnitude across 2,659 genes, with mutational hot and cold spots spanning several kilobases. Importantly, the variation is not random: we detect a lower rate in highly expressed genes and in those undergoing stronger purifying selection. Our observations suggest that the mutation rate has been evolutionarily optimized to reduce the risk of deleterious mutations. Current knowledge of factors influencing the mutation rate-including transcription-coupled repair and context-dependent mutagenesis-do not explain these observations, indicating that additional mechanisms must be involved. The findings have important implications for our understanding of evolution and the control of mutations.	[Martincorena, Inigo; Seshasayee, Aswin S. N.; Luscombe, Nicholas M.] EMBL European Bioinformat Inst, Cambridge CB10 1SD, England; [Luscombe, Nicholas M.] Okinawa Inst Sci & Technol, Onna Son, Okinawa 9040495, Japan; [Luscombe, Nicholas M.] UCL, Dept Genet Environm & Evolut, UCL Genet Inst, London WC1E 6BT, England; [Luscombe, Nicholas M.] Canc Res UK London Res Inst, London WC2A 3LY, England	European Molecular Biology Laboratory (EMBL); Okinawa Institute of Science & Technology Graduate University; University of London; University College London; Cancer Research UK	Martincorena, I (corresponding author), EMBL European Bioinformat Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.	martinco@ebi.ac.uk; luscombe@ebi.ac.uk		Martincorena, Inigo/0000-0003-1122-4416	EMBL; Spanish Ministry of Science and Innovation; Caja Madrid Foundation; BBSRC [BB/E01075X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E01075X/1] Funding Source: researchfish; Cancer Research UK [16358] Funding Source: researchfish	EMBL; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Caja Madrid Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	We thank M. Ackermann, S. Brenner, G. Dougan, A. Eyre-Walker, N. Goldman, B. Lenhard, J. Marioni, J. Parkhill, O. Tenaillon, C. Tyler-Smith and F. Ulhmann for their suggestions during the preparation of this manuscript. The work was funded by EMBL, the Spanish Ministry of Science and Innovation and the Caja Madrid Foundation.	Andolfatto P, 2001, CURR OPIN GENET DEV, V11, P635, DOI 10.1016/S0959-437X(00)00246-X; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Beletskii A, 1996, P NATL ACAD SCI USA, V93, P13919, DOI 10.1073/pnas.93.24.13919; BRAVERMAN JM, 1995, GENETICS, V140, P783, DOI 10.1093/genetics/140.2.783; Bustamante CD, 2003, THEOR POPUL BIOL, V63, P91, DOI 10.1016/S0040-5809(02)00050-3; Chuang JH, 2004, PLOS BIOL, V2, P253, DOI 10.1371/journal.pbio.0020029; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; EYREWALKER A, 1995, GENETICS, V140, P1407; EYREWALKER A, 1993, NUCLEIC ACIDS RES, V21, P4599, DOI 10.1093/nar/21.19.4599; Francino MP, 1996, SCIENCE, V272, P107, DOI 10.1126/science.272.5258.107; HARTL DL, 1994, GENETICS, V138, P227; Hodgkinson A, 2009, PLOS BIOL, V7, P226, DOI 10.1371/journal.pbio.1000027; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; KIMURA M, 1967, GENET RES, V9, P23, DOI 10.1017/S0016672300010284; Klapacz J, 2002, J BACTERIOL, V184, P6866, DOI 10.1128/JB.184.24.6866-6872.2002; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; LEVINS R, 1967, GENETICS, V56, P163; McVean GAT, 1999, GENET RES, V74, P145, DOI 10.1017/S0016672399003912; McVean GT, 1997, NATURE, V386, P388, DOI 10.1038/386388a0; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; O'Fallon BD, 2010, MOL BIOL EVOL, V27, P2406, DOI 10.1093/molbev/msq132; Ochman H, 2003, MOL BIOL EVOL, V20, P2091, DOI 10.1093/molbev/msg229; Pal C, 2007, NATURE, V450, P1079, DOI 10.1038/nature06350; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12&lt;1057::AID-BIES3&gt;3.0.CO;2-W; Tenaillon O, 2001, RES MICROBIOL, V152, P11, DOI 10.1016/S0923-2508(00)01163-3; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Tu YQ, 1996, EMBO J, V15, P675, DOI 10.1002/j.1460-2075.1996.tb00400.x; Wagner A, 2003, J THEOR BIOL, V225, P45, DOI 10.1016/S0022-5193(03)00219-4	30	115	116	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					95	98		10.1038/nature10995	http://dx.doi.org/10.1038/nature10995			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22522932				2022-12-28	WOS:000303451900041
J	Castaigne, S; Pautas, C; Terre, C; Raffoux, E; Bordessoule, D; Bastie, JN; Legrand, O; Thomas, X; Turlure, P; Reman, O; de Revel, T; Gastaud, L; de Gunzburg, N; Contentin, N; Henry, E; Marolleau, JP; Aljijakli, A; Rousselot, P; Fenaux, P; Preudhomme, C; Chevret, S; Dombret, H				Castaigne, Sylvie; Pautas, Cecile; Terre, Christine; Raffoux, Emmanuel; Bordessoule, Dominique; Bastie, Jean-Noel; Legrand, Ollivier; Thomas, Xavier; Turlure, Pascal; Reman, Oumedaly; de Revel, Thierry; Gastaud, Lauris; de Gunzburg, Noemie; Contentin, Nathalie; Henry, Estelle; Marolleau, Jean-Pierre; Aljijakli, Ahmad; Rousselot, Philippe; Fenaux, Pierre; Preudhomme, Claude; Chevret, Sylvie; Dombret, Herve		Acute Leukemia French Association	Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study	LANCET			English	Article							INDUCTION; IMMUNOCONJUGATE; RECOMMENDATIONS; CHEMOTHERAPY; DAUNORUBICIN; DIAGNOSIS; MYLOTARG; EFFICACY; THERAPY; SAFETY	Background The results of the addition of gemtuzumab ozogamicin, an anti-CD33 antibody conjugate, to the standard treatment for patients with acute myeloid leukaemia in phase 3 trials were contradictory. We investigated whether the addition of low fractionated-dose gemtuzumab ozogamicin to standard front-line chemotherapy would improve the outcome of patients with this leukaemia without causing excessive toxicity. Methods In a phase 3, open-label study, undertaken in 26 haematology centres in France, patients aged 50-70 years with previously untreated de novo acute myeloid leukaemia were randomly assigned with a computer-generated sequence in a 1:1 ratio with block sizes of four to standard treatment (control group) with or without five doses of intravenous gemtuzumab ozogamicin (3 mg/m(2) on days 1, 4, and 7 during induction and day 1 of each of the two consolidation chemotherapy courses). The primary endpoint was event-free survival (EFS). Secondary endpoints were relapse-free (RFS), overall survival (OS), and safety. Analysis was by intention to treat. This study is registered with EudraCT, number 2007-002933-36. Findings 280 patients were randomly assigned to the control (n=140) and gemtuzumab ozogamicin groups (n=140), and 139 patients were analysed in each group. Complete response with or without incomplete platelet recovery to induction was 104 (75%) in the control group and 113 (81%) in the gemtuzumab ozogamicin group (odds ratio 1.46, 95% CI 0.20-2.59; p=0.25). At 2 years, EFS was estimated as 17.1% (10.8-27.1) in the control group versus 40.8% (32.8-50.8) in the gemtuzumab ozogamicin group (hazard ratio 0.58, 0.43-0.78; p=0.0003), OS 41.9% (33.1-53.1) versus 53.2% (44.6-63.5), respectively (0.69, 0.49-0.98; p=0.0368), and RFS 22.7% (14.5-35.7) versus 50.3% (41.0-61.6), respectively (0.52, 0.36-0.75; p=0.0003). Haematological toxicity, particularly persistent thrombocytopenia, was more common in the gemtuzumab ozogamicin group than in the control group (22 [16%] vs 4 [3%]; p<0.0001), without an increase in the risk of death from toxicity. Interpretation The use of fractionated lower doses of gemtuzumab ozogamicin allows the safe delivery of higher cumulative doses and substantially improves outcomes in patients with acute myeloid leukaemia. The findings warrant reassessment of gemtuzumab ozogamicin as front-line therapy for acute myeloid leukaemia.	[Castaigne, Sylvie; de Gunzburg, Noemie; Rousselot, Philippe] Univ Versailles St Quentin, Hop Mignot, Le Chesnay, France; [Pautas, Cecile] Univ Paris Est, Hop Henri Mondor, Assistance Publ Hop Paris, Creteil, France; [Terre, Christine] Univ Paris Est, Hop Mignot, Lab Cytogenet, Creteil, France; [Raffoux, Emmanuel] Univ Paris Diderot, Hop St Louis, Paris, France; [Bordessoule, Dominique; Turlure, Pascal] Ctr Hosp Univ, Limoges, France; [Bastie, Jean-Noel] CHU, Dijon, France; [Legrand, Ollivier] Univ Paris Pierre & Marie Curie, Hop St Antoine, Paris, France; [Thomas, Xavier] Univ Lyon 1, Ctr Hosp Lyon Sud, Hosp Civils Lyon, Pierre Benite, France; [Reman, Oumedaly] CHU Caen, F-14000 Caen, France; [de Revel, Thierry] Hop Percy, Clamart, France; [Gastaud, Lauris] Ctr Antoine Lacassagne, F-06054 Nice, France; [Contentin, Nathalie] Ctr Henri Becquerel, F-76038 Rouen, France; [Marolleau, Jean-Pierre] CHU, Amiens, France; [Aljijakli, Ahmad] Ctr Hosp, Argenteuil, France; [Fenaux, Pierre] Univ Paris 13, Hop Avicenne, Bobigny, France; [Preudhomme, Claude] CHU Lille, Ctr Biol Pathol, F-59037 Lille, France; [Chevret, Sylvie] Univ Paris Diderot, Hop St Louis, Dept Biostat, AP HP,INSERM S 717, Paris, France	Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre Hospitalier de Versailles; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Limoges; CHU Dijon Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU de Caen NORMANDIE; Universite de Caen Normandie; UNICANCER; Centre Antoine Lacassagne; UNICANCER; Centre Henri Becquerel; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Castaigne, S (corresponding author), Ctr Hosp Versailles, 177 Rue Versailles, F-78150 Le Chesnay, France.	scastaigne@ch-versailles.fr	Preudhomme, Claude/T-8553-2018; Boissel, Nicolas/P-2190-2018; maury, sebastien/Q-6573-2018	Preudhomme, Claude/0000-0002-1267-9546; maury, sebastien/0000-0002-1170-8683; chevret, sylvie/0000-0001-6449-4730; Casasnovas, Rene-Olivier/0000-0002-1156-8983; Hermine, Olivier/0000-0003-2574-3874	Wyeth (Pfizer); Wyeth	Wyeth (Pfizer)(WyethPfizer); Wyeth(Wyeth)	Wyeth (Pfizer).; SCa received consultancy fees from Wyeth from 2006 to 2008. The other authors declare that they have no conflicts of interest.	Brunnberg U, 2012, ANN ONCOL, V23, P990, DOI 10.1093/annonc/mdr346; Burnett AK, 2011, J CLIN ONCOL, V29, P369, DOI 10.1200/JCO.2010.31.4310; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; COX DR, 1972, J R STAT SOC B, V34, P187; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Farhat H, 2012, AM J HEMATOL, V87, P62, DOI 10.1002/ajh.22201; Fernandez HF, 2011, BLOOD, V117, P5306, DOI 10.1182/blood-2010-09-309229; Fernandez HF, 2009, NEW ENGL J MED, V361, P1249, DOI 10.1056/NEJMoa0904544; GAIL M, 1985, BIOMETRICS, V41, P361, DOI 10.2307/2530862; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; HINMAN LM, 1993, CANCER RES, V53, P3336; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kell WJ, 2003, BLOOD, V102, P4277, DOI 10.1182/blood-2003-05-1620; Linenberger ML, 2005, LEUKEMIA, V19, P176, DOI 10.1038/sj.leu.2403598; Lowenberg B, 2010, BLOOD, V115, P2586, DOI 10.1182/blood-2009-10-246470; Lowenberg B, 2009, NEW ENGL J MED, V361, P1235, DOI 10.1056/NEJMoa0901409; Mckoy JM, 2007, LEUKEMIA RES, V31, P599, DOI 10.1016/j.leukres.2006.07.005; Mitelman F, 1991, INT SYST HUM CYT N S, P1; Pautas C, 2010, J CLIN ONCOL, V28, P808, DOI 10.1200/JCO.2009.23.2652; Petersdorf S., 2009, BLOOD, V114, P790; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; Rowe Jacob M, 2009, Hematology Am Soc Hematol Educ Program, P396, DOI 10.1182/asheducation-2009.1.396; Sievers EL, 1999, BLOOD, V93, P3678, DOI 10.1182/blood.V93.11.3678; Sievers EL, 2001, J CLIN ONCOL, V19, P3244, DOI 10.1200/JCO.2001.19.13.3244; Stasi R, 2008, CANCER TREAT REV, V34, P49, DOI 10.1016/j.ctrv.2007.09.001; Taksin AL, 2007, LEUKEMIA, V21, P66, DOI 10.1038/sj.leu.2404434; van der Velden VHJ, 2001, BLOOD, V97, P3197, DOI 10.1182/blood.V97.10.3197	27	651	664	0	37	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2012	379	9825					1508	1516		10.1016/S0140-6736(12)60485-1	http://dx.doi.org/10.1016/S0140-6736(12)60485-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930BJ	22482940				2022-12-28	WOS:000303110200029
J	Braun, DC				Braun, Douglas C.			Comment on "Detection of Emerging Sunspot Regions in the Solar Interior"	SCIENCE			English	Editorial Material							FAR-SIDE; HELIOSEISMOLOGY; HOLOGRAPHY; PROSPECTS; SUN		NW Res Associates, Boulder, CO 80301 USA	NorthWest Research Associates	Braun, DC (corresponding author), NW Res Associates, 3380 Mitchell Lane, Boulder, CO 80301 USA.	dbraun@cora.nwra.com	Braun, Douglas C/T-3856-2017	Braun, Douglas C/0000-0001-6840-2717				Birch AC, 2010, ASTROPHYS J LETT, V723, pL190, DOI 10.1088/2041-8205/723/2/L190; Braun DC, 2007, ASTROPHYS J, V669, P1395, DOI 10.1086/521782; Braun DC, 2008, ASTROPHYS J LETT, V689, pL161, DOI 10.1086/595884; Braun DC, 2001, ASTROPHYS J, V560, pL189, DOI 10.1086/324323; Gizon L, 2004, ASTROPHYS J, V614, P472, DOI 10.1086/423367; Gizon L, 2010, ANNU REV ASTRON ASTR, V48, P289, DOI 10.1146/annurev-astro-082708-101722; ILONIDIS, 2011, REPORTS 0819, P993, DOI DOI 10.1126/SCIENCE.1206253; Ilonidis S, 2011, SCIENCE, V333, P993, DOI 10.1126/science.1206253; Lindsey C, 2004, ASTROPHYS J SUPPL S, V155, P209, DOI 10.1086/424736; Lindsey C, 2000, SCIENCE, V287, P1799, DOI 10.1126/science.287.5459.1799; Scherrer PH, 1995, SOL PHYS, V162, P129, DOI 10.1007/BF00733429; Zhao JW, 2007, ASTROPHYS J, V664, pL139, DOI 10.1086/520837	12	19	19	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2012	336	6079								10.1126/science.1215425	http://dx.doi.org/10.1126/science.1215425			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22517843				2022-12-28	WOS:000302995400024
J	Ferner, R				Ferner, Robin			DRUG TALES AND OTHER STORIES Consequences	BRITISH MEDICAL JOURNAL			English	Editorial Material									Birmingham City Hosp, W Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England		Ferner, R (corresponding author), Birmingham City Hosp, W Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England.	R.E.Ferner@bham.ac.uk		Ferner, Robin/0000-0003-3769-1346				2009, BRIT MED J, V338, pB1624, DOI DOI 10.1136/BMJ.B1624	1	0	0	1	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 20	2012	344								e2859	10.1136/bmj.e2859	http://dx.doi.org/10.1136/bmj.e2859			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	931CX	22522707				2022-12-28	WOS:000303193200007
J	Joyce, GF				Joyce, Gerald F.			Toward an Alternative Biology	SCIENCE			English	Editorial Material							NUCLEIC-ACID; SYSTEM		[Joyce, Gerald F.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Joyce, Gerald F.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Joyce, GF (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gjoyce@scripps.edu						Clarke A. C., 2010, 2010 ODYSSEY 2; JOYCE GF, 1987, P NATL ACAD SCI USA, V84, P4398, DOI 10.1073/pnas.84.13.4398; Pinheiro VB, 2012, SCIENCE, V336, P341, DOI 10.1126/science.1217622; Schoning KU, 2000, SCIENCE, V290, P1347, DOI 10.1126/science.290.5495.1347; Yu HY, 2012, NAT CHEM, V4, P183, DOI [10.1038/NCHEM.1241, 10.1038/nchem.1241]; Zhang LL, 2005, J AM CHEM SOC, V127, P4174, DOI 10.1021/ja042564z	6	30	30	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2012	336	6079					307	308		10.1126/science.1221724	http://dx.doi.org/10.1126/science.1221724			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22517850				2022-12-28	WOS:000302995400034
J	Keene, D; Gopinath, A; Watson, W; Maart, C; Bokhari, A				Keene, Daniel; Gopinath, Anjali; Watson, William; Maart, Clint; Bokhari, Awais			PICTURE QUIZ Signs of shock and raised jugular venous pressure	BRITISH MEDICAL JOURNAL			English	Editorial Material							MALIGNANT PERICARDIAL-EFFUSION; CARDIAC-TAMPONADE; MANAGEMENT		[Keene, Daniel; Gopinath, Anjali; Maart, Clint; Bokhari, Awais] Bedford Hosp, Dept Cardiol, Bedford MK42 9DJ, England; [Watson, William] Cambridge Univ Hosp, Cambridge, England	University of Cambridge	Keene, D (corresponding author), Bedford Hosp, Dept Cardiol, Bedford MK42 9DJ, England.	drkeene@doctors.org.uk		Keene, Daniel/0000-0001-7472-7358				Atar S, 1999, CHEST, V116, P1564, DOI 10.1378/chest.116.6.1564; Beck CS, 1935, J AMER MED ASSOC, V104, P714, DOI 10.1001/jama.1935.02760090018005; COLOMBO A, 1988, CLIN CARDIOL, V11, P389, DOI 10.1002/clc.4960110606; Eisenberg MJ, 1996, CHEST, V110, P318, DOI 10.1378/chest.110.2.318; Garcia-Riego A, 2001, ACTA CYTOL, V45, P561, DOI 10.1159/000327865; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; Johnson SK, 2009, CLIN MED RES, V7, P107, DOI 10.3121/cmr.2009.850; Kabukcu M, 2004, TEX HEART I J, V31, P398; Maziar Zafari A, 2004, HOSP PHYS, V10, P1; Olearczyk BM, 2009, CAN J CARDIOL, V25, P240, DOI 10.1016/S0828-282X(09)70080-7; Patel MR, 2006, AM HEART J, V151, P316, DOI 10.1016/j.ahj.2005.04.014; Roy CL, 2007, JAMA-J AM MED ASSOC, V297, P1810, DOI 10.1001/jama.297.16.1810; Sagrista-Sauleda J, 2000, AM J MED, V109, P95, DOI 10.1016/S0002-9343(00)00459-9; Schairer JR, 2011, CARDIOL REV, V19, P233, DOI 10.1097/CRD.0b013e31821e202c; Soler-Soler J, 2001, HEART, V86, P235, DOI 10.1136/heart.86.2.235; Spodick DH, 2003, NEW ENGL J MED, V349, P684, DOI 10.1056/NEJMra022643; Swanson N, 2008, CATHETER CARDIO INTE, V71, P504, DOI 10.1002/ccd.21431; VAITKUS PT, 1994, JAMA-J AM MED ASSOC, V272, P59, DOI 10.1001/jama.272.1.59; Wang JL, 2010, AM J MED SCI, V340, P276, DOI 10.1097/MAJ.0b013e3181e664c6	19	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 20	2012	344								e2643	10.1136/bmj.e2643	http://dx.doi.org/10.1136/bmj.e2643			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	931CX	22522817				2022-12-28	WOS:000303193200008
J	Gardner, K				Gardner, Katy			Tendering out general practice is bad for doctors-and patients	BRITISH MEDICAL JOURNAL			English	Editorial Material									Liverpool Community Hlth NHS Trust, Marybone Hlth Ctr, Liverpool L3 2BG, Merseyside, England		Gardner, K (corresponding author), Liverpool Community Hlth NHS Trust, Marybone Hlth Ctr, Liverpool L3 2BG, Merseyside, England.	katyagardner@btinternet.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 18	2012	344								e2461	10.1136/bmj.e2461	http://dx.doi.org/10.1136/bmj.e2461			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	931CQ	22514215				2022-12-28	WOS:000303192400006
J	Krishnamoorthy, HNS; Jacob, Z; Narimanov, E; Kretzschmar, I; Menon, VM				Krishnamoorthy, Harish N. S.; Jacob, Zubin; Narimanov, Evgenii; Kretzschmar, Ilona; Menon, Vinod M.			Topological Transitions in Metamaterials	SCIENCE			English	Article							NEGATIVE REFRACTION; OPTICAL HYPERLENS; EMISSION; METAL	Light-matter interactions can be controlled by manipulating the photonic environment. We uncovered an optical topological transition in strongly anisotropic metamaterials that results in a dramatic increase in the photon density of states-an effect that can be used to engineer this interaction. We describe a transition in the topology of the iso-frequency surface from a closed ellipsoid to an open hyperboloid by use of artificially nanostructured metamaterials. We show that this topological transition manifests itself in increased rates of spontaneous emission of emitters positioned near the metamaterial. Altering the topology of the iso-frequency surface by using metamaterials provides a fundamentally new route to manipulating light-matter interactions.	[Krishnamoorthy, Harish N. S.; Menon, Vinod M.] CUNY, Queens Coll, Dept Phys, Flushing, NY 11367 USA; [Krishnamoorthy, Harish N. S.; Menon, Vinod M.] Ctr Photon & Multiscale Nanomat, Flushing, NY 11367 USA; [Krishnamoorthy, Harish N. S.; Menon, Vinod M.] CUNY, Grad Ctr, Dept Phys, New York, NY 10016 USA; [Jacob, Zubin] Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB T6G 2V4, Canada; [Narimanov, Evgenii] Purdue Univ, Sch Elect & Comp Engn, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA; [Kretzschmar, Ilona] CUNY City Coll, Dept Chem Engn, New York, NY 10031 USA	City University of New York (CUNY) System; Queens College NY (CUNY); City University of New York (CUNY) System; University of Alberta; Purdue University System; Purdue University; Purdue University West Lafayette Campus; City University of New York (CUNY) System; City College of New York (CUNY)	Menon, VM (corresponding author), CUNY, Queens Coll, Dept Phys, Flushing, NY 11367 USA.	vmenon@qc.cuny.edu	jacob, zubin/ABF-2665-2020; Kretzschmar, Ilona/G-4237-2019; Menon, Vinod/ABB-1343-2021; Krishnamoorthy, Harish Natarajan Swaha/R-1483-2019	Kretzschmar, Ilona/0000-0001-7636-1679; Krishnamoorthy, Harish Natarajan Swaha/0000-0001-6107-3383; Menon, Vinod/0000-0002-9725-6445	Materials Research Science and Engineering Center of the National Science Foundation [DMR 1120923]; Army Research Office (ARO) [W911NF0710397]; Round 14 of the CUNY; ARO-Multidisciplinary University Research Initiative [50342-PH-MUR, W911NF-09-1-0539]; Natural Sciences and Engineering Research Council of Canada [402792]; Canadian School of Energy and Environment; U.S. Department of Energy, Office of Basic Energy Sciences [DE-AC02-98CH10886]; Direct For Mathematical & Physical Scien [1120923] Funding Source: National Science Foundation	Materials Research Science and Engineering Center of the National Science Foundation(National Science Foundation (NSF)); Army Research Office (ARO); Round 14 of the CUNY; ARO-Multidisciplinary University Research Initiative; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian School of Energy and Environment; U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	V.M.M. and H.N.S.K. acknowledge partial support through the Materials Research Science and Engineering Center program of the National Science Foundation through grant DMR 1120923 and the Army Research Office (ARO) grant W911NF0710397. V.M.M. and I.K. acknowledge support through Round 14 of the CUNY Collaborative Incentive Research Grant Program. E.N. was partially supported by ARO-Multidisciplinary University Research Initiative grants 50342-PH-MUR and W911NF-09-1-0539. Z.J. was partially supported by Natural Sciences and Engineering Research Council of Canada Discovery grant 402792 and Canadian School of Energy and Environment Proof of Principle Grant. The ellipsometric measurements were carried out at the Center for Functional Nanomaterials at Brookhaven National Laboratory, which is supported by the U.S. Department of Energy, Office of Basic Energy Sciences, under contract DE-AC02-98CH10886.	Andersen ML, 2011, NAT PHYS, V7, P215, DOI 10.1038/NPHYS1870; Born M., 2002, PRINCIPLES OPTICS; Felsen L. B., 1994, RAD SCATTERING WAVES; FORD GW, 1984, PHYS REP, V113, P195, DOI 10.1016/0370-1573(84)90098-X; Genov DA, 2009, NAT PHYS, V5, P687, DOI 10.1038/NPHYS1338; Gontijo I, 1999, PHYS REV B, V60, P11564, DOI 10.1103/PhysRevB.60.11564; Hoffman AJ, 2007, NAT MATER, V6, P946, DOI 10.1038/nmat2033; Jacob Z, 2010, APPL PHYS B-LASERS O, V100, P215, DOI 10.1007/s00340-010-4096-5; Jacob Z., 2009, ARXIV09103981V2PHYSO; Jacob Z, 2006, OPT EXPRESS, V14, P8247, DOI 10.1364/OE.14.008247; Kidwai O, 2011, OPT LETT, V36, P2530, DOI 10.1364/OL.36.002530; Kosevich AM, 2004, LOW TEMP PHYS+, V30, P97, DOI 10.1063/1.1645161; Leistikow MD, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.045301; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; LIFSHITZ IM, 1960, SOV PHYS JETP-USSR, V11, P1130; Liu ZW, 2007, SCIENCE, V315, P1686, DOI 10.1126/science.1137368; Monastryskiy M., 1999, RIEMANN TOPOLOGY PHY; Nakahara M., 2003, GEOMETRY TOPOLOGY PH; Narimanov EE, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3184594; Noginov MA, 2010, OPT LETT, V35, P1863, DOI 10.1364/OL.35.001863; Okamoto K, 2006, J OPT SOC AM B, V23, P1674, DOI 10.1364/JOSAB.23.001674; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Poddubny AN, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.023807; Shalaev VM, 2007, NAT PHOTONICS, V1, P41, DOI 10.1038/nphoton.2006.49; Smolyaninov II, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.067402; Yao PJ, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.195106	27	640	646	22	369	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2012	336	6078					205	209		10.1126/science.1219171	http://dx.doi.org/10.1126/science.1219171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924PN	22499943	Green Submitted			2022-12-28	WOS:000302703900044
J	Laplante, M; Sabatini, DM				Laplante, Mathieu; Sabatini, David M.			mTOR Signaling in Growth Control and Disease	CELL			English	Review							EXTENDS LIFE-SPAN; P70 S6 KINASE; TUBEROUS SCLEROSIS COMPLEX-2; CELL-CYCLE PROGRESSION; DIET-INDUCED OBESITY; MAMMALIAN TARGET; INSULIN-RESISTANCE; AMINO-ACIDS; SKELETAL-MUSCLE; OXIDATIVE-PHOSPHORYLATION	The mechanistic target of rapamycin (mTOR) signaling pathway senses and integrates a variety of environmental cues to regulate organismal growth and homeostasis. The pathway regulates many major cellular processes and is implicated in an increasing number of pathological conditions, including cancer, obesity, type 2 diabetes, and neurodegeneration. Here, we review recent advances in our understanding of the mTOR pathway and its role in health, disease, and aging. We further discuss pharmacological approaches to treat human pathologies linked to mTOR deregulation.	[Laplante, Mathieu; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Laplante, Mathieu; Sabatini, David M.] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Laplante, Mathieu; Sabatini, David M.] MIT, Koch Ctr Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		/0000-0002-1446-7256	National Institutes of Health; Howard Hughes Medical Institute; Department of Defense; Keck Foundation; Whitehead Institute; Canadian Institutes of Health Research; Les Fonds de la Recherche en Sante du Quebec; NATIONAL CANCER INSTITUTE [R01CA129105, R01CA103866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Department of Defense(United States Department of Defense); Keck Foundation(W.M. Keck Foundation); Whitehead Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Les Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Sabatini Lab for helpful discussions, particularly Alejo Efeyan and Dudley Lamming for a careful review of the manuscript. mTOR-related work in the Sabatini lab has been supported by the National Institutes of Health, Howard Hughes Medical Institute, Department of Defense, the Keck Foundation, and the Whitehead Institute. Fellowships from the Canadian Institutes of Health Research and from Les Fonds de la Recherche en Sante du Quebec supported M.L.	Aggarwal D, 2006, METABOLISM, V55, P794, DOI 10.1016/j.metabol.2006.01.017; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Blouet C, 2008, CELL METAB, V8, P459, DOI 10.1016/j.cmet.2008.10.004; Brachmann SM, 2009, P NATL ACAD SCI USA, V106, P22299, DOI 10.1073/pnas.0905152106; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Bryk B, 2010, DEV BIOL, V344, P150, DOI 10.1016/j.ydbio.2010.04.027; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; CAFFERKEY R, 1993, MOL CELL BIOL, V13, P6012, DOI 10.1128/MCB.13.10.6012; Carnevalli LS, 2010, DEV CELL, V18, P763, DOI 10.1016/j.devcel.2010.02.018; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Cota D, 2008, J NEUROSCI, V28, P7202, DOI 10.1523/JNEUROSCI.1389-08.2008; Cota D, 2009, PHYSIOL BEHAV, V97, P520, DOI 10.1016/j.physbeh.2009.03.006; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Cusi K, 2010, CURR DIABETES REP, V10, P306, DOI 10.1007/s11892-010-0122-6; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Elghazi L, 2010, DIABETES, V59, P2390, DOI 10.2337/db09-0851; Falcon BL, 2011, CANCER RES, V71, P1573, DOI 10.1158/0008-5472.CAN-10-3126; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881; Foster DA, 2009, BBA-MOL CELL BIOL L, V1791, P949, DOI 10.1016/j.bbalip.2009.02.009; Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gagnon A, 2001, J CELL PHYSIOL, V189, P14, DOI 10.1002/jcp.1132; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Gu YY, 2011, DIABETES, V60, P827, DOI 10.2337/db10-1194; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hietakangas V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-282; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaizuka T, 2010, J BIOL CHEM, V285, P20109, DOI 10.1074/jbc.M110.121699; Kantidakis T, 2010, P NATL ACAD SCI USA, V107, P11823, DOI 10.1073/pnas.1005188107; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748; Kim S, 2011, CELL METAB, V13, P215, DOI 10.1016/j.cmet.2011.01.007; King MA, 2008, MOL PHARMACOL, V73, P1052, DOI 10.1124/mol.107.043398; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Koren I, 2010, CURR BIOL, V20, P1093, DOI 10.1016/j.cub.2010.04.041; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Kumar A, 2010, DIABETES, V59, P1397, DOI 10.2337/db09-1061; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Li SY, 2011, BIOCHEM BIOPH RES CO, V412, P197, DOI 10.1016/j.bbrc.2011.07.038; Liu LH, 2010, DEV CELL, V19, P845, DOI 10.1016/j.devcel.2010.11.004; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Pearce LR, 2011, BIOCHEM J, V436, P169, DOI 10.1042/BJ20102103; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Philp A, 2011, J APPL PHYSIOL, V110, P561, DOI 10.1152/japplphysiol.00941.2010; Phung TL, 2006, CANCER CELL, V10, P159, DOI 10.1016/j.ccr.2006.07.003; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Rachdi L, 2008, P NATL ACAD SCI USA, V105, P9250, DOI 10.1073/pnas.0803047105; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sarkar S, 2008, MOL BIOSYST, V4, P895, DOI 10.1039/b804606a; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Shigeyama Y, 2008, MOL CELL BIOL, V28, P2971, DOI 10.1128/MCB.01695-07; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Shor B, 2010, J BIOL CHEM, V285, P15380, DOI 10.1074/jbc.M109.071639; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Stallone G, 2009, TRANSPLANTATION, V87, pS23, DOI 10.1097/TP.0b013e3181a05b7a; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217; Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Toth ML, 2008, AUTOPHAGY, V4, P330, DOI 10.4161/auto.5618; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Vilar E, 2011, MOL CANCER THER, V10, P395, DOI 10.1158/1535-7163.MCT-10-0905; Wander SA, 2011, J CLIN INVEST, V121, P1231, DOI 10.1172/JCI44145; Wang BT, 2011, P NATL ACAD SCI USA, V108, P15201, DOI 10.1073/pnas.1103746108; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Wang XN, 2006, ENDOCRINOLOGY, V147, P4160, DOI 10.1210/en.2006-0251; Yan LJ, 2010, MOL CELL, V37, P633, DOI 10.1016/j.molcel.2010.01.031; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yu K, 2010, CANCER RES, V70, P621, DOI 10.1158/0008-5472.CAN-09-2340; Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zhang HH, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006189, 10.1371/journal.pone.0007826]; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	178	5812	6094	40	1237	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 13	2012	149	2					274	293		10.1016/j.cell.2012.03.017	http://dx.doi.org/10.1016/j.cell.2012.03.017			20	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500797	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000302805600009
J	Channick, RN; Lorenzo, ME; Wu, CC; Hoang, MP				Channick, Richard N.; Lorenzo, Mayra E.; Wu, Carol C.; Hoang, Mai P.			Case 11-2012: A 60-Year-Old Man with Weakness, Rash, and Renal Failure Rocky Mountain spotted fever	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RICKETTSIA-RICKETTSII; RHABDOMYOLYSIS; IMMUNOPEROXIDASE; EHRLICHIOSIS; INFECTION; FEATURES; VIRUS		[Channick, Richard N.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Lorenzo, Mayra E.] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Wu, Carol C.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Hoang, Mai P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Channick, Richard N.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Lorenzo, Mayra E.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Wu, Carol C.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Hoang, Mai P.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Channick, RN (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.							Aruna AS, 2005, ANN PHARMACOTHER, V39, P1131, DOI 10.1345/aph.1E492; Authier FJ, 2005, MUSCLE NERVE, V32, P247, DOI 10.1002/mus.20338; Bakken JS, 1996, JAMA-J AM MED ASSOC, V275, P199, DOI 10.1001/jama.275.3.199; Blanco JR, 2002, SOUTHERN MED J, V95, P542, DOI 10.1097/00007611-200205000-00016; Bonawitz C, 1997, AM J NEURORADIOL, V18, P459; Cervellin G, 2010, CLIN CHEM LAB MED, V48, P749, DOI 10.1515/CCLM.2010.151; Chen LF, 2008, INFECT DIS CLIN N AM, V22, P415, DOI 10.1016/j.idc.2008.03.008; DUMLER JS, 1990, AM J CLIN PATHOL, V93, P410, DOI 10.1093/ajcp/93.3.410; FENG WC, 1980, AM J TROP MED HYG, V29, P691, DOI 10.4269/ajtmh.1980.29.691; FISHBEIN DB, 1994, ANN INTERN MED, V120, P736, DOI 10.7326/0003-4819-120-9-199405010-00003; Gentile D.A., 1989, P563; Jayed MZ, 2001, MAYO CLIN PROC, V76, P563, DOI 10.4065/76.5.563; Kao GF, 1997, J CUTAN PATHOL, V24, P604, DOI 10.1111/j.1600-0560.1997.tb01091.x; KIRK JL, 1990, MEDICINE, V69, P35, DOI 10.1097/00005792-199001000-00003; Levy C., 2004, Morbidity and Mortality Weekly Report, V53, P407; Mammen AL, 2010, CURR OPIN RHEUMATOL, V22, P644, DOI 10.1097/BOR.0b013e32833f0fc7; Melli G, 2005, MEDICINE, V84, P377, DOI 10.1097/01.md.0000188565.48918.41; Minami K, 2003, PEDIATR INFECT DIS J, V22, P291, DOI 10.1097/00006454-200303000-00023; Paddock CD, 1999, J INFECT DIS, V179, P1469, DOI 10.1086/314776; Parikh M, 2010, CLIN MICROBIOL INFEC, V16, P330, DOI 10.1111/j.1469-0691.2010.03185.x; Procop GW, 1997, ARCH PATHOL LAB MED, V121, P894; Scheuerman O, 2009, PEDIATR NEUROL, V40, P465, DOI 10.1016/j.pediatrneurol.2008.12.017; SEXTON DJ, 1992, CLIN INFECT DIS, V15, P439, DOI 10.1093/clind/15.3.439; SHEA KW, 1995, CLIN INFECT DIS, V21, P1056, DOI 10.1093/clinids/21.4.1056; Shimura C, 2008, J CLIN PATHOL, V61, P1062, DOI 10.1136/jcp.2008.057000; Stalkup JR, 2002, DERMATOL CLIN, V20, P209, DOI 10.1016/S0733-8635(01)00002-X; Talsness Stephen R, 2011, WMJ, V110, P82; WHITE, 1994, AM J CLIN PATHOL, V102, P559; WHITE WL, 1994, AM J CLIN PATHOL, V101, P747, DOI 10.1093/ajcp/101.6.747	29	0	0	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 12	2012	366	15					1434	1443		10.1056/NEJMcpc1111571	http://dx.doi.org/10.1056/NEJMcpc1111571			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923GV	22494124				2022-12-28	WOS:000302608600009
J	Desiraju, GR				Desiraju, Gautam R.			Bold strategies for Indian science	NATURE			English	Editorial Material							CHINA		[Desiraju, Gautam R.] Indian Inst Sci, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Desiraju, GR (corresponding author), Indian Inst Sci, Bangalore 560012, Karnataka, India.	desiraju@sscu.iisc.ernet.in	Desiraju, Gautam R./AAQ-6388-2021					Desiraju G. R., 2011, ANGEW CHEM, V123, P5704; Desiraju G. R., 2008, EC POLITICAL WKLY, V43, P37; Jayaraman K.S., 2012, NATURE; Kostoff RN, 2007, TECHNOL FORECAST SOC, V74, P1519, DOI 10.1016/j.techfore.2007.02.004; Shi YG, 2010, SCIENCE, V329, P1128, DOI 10.1126/science.1196916	5	8	8	2	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					159	160		10.1038/484159a	http://dx.doi.org/10.1038/484159a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22498608	Bronze, Green Accepted			2022-12-28	WOS:000303149900011
J	Salgado, CG; Barreto, JG				Salgado, Claudio Guedes; Barreto, Josafa Goncalves			Leonine Facies: Lepromatous Leprosy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Salgado, Claudio Guedes; Barreto, Josafa Goncalves] Fed Univ Para, Marituba, Brazil	Universidade Federal do Para	Salgado, CG (corresponding author), Fed Univ Para, Marituba, Brazil.		Barreto, Josafá G/F-9038-2015; Salgado, Claudio G/K-8931-2012; Salgado, Claudio G/C-5206-2014	Barreto, Josafá G/0000-0003-0817-3486; Salgado, Claudio G/0000-0003-3961-7764; Salgado, Claudio G/0000-0003-3961-7764					0	5	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 12	2012	366	15					1433	1433		10.1056/NEJMicm1106238	http://dx.doi.org/10.1056/NEJMicm1106238			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923GV	22494123				2022-12-28	WOS:000302608600007
J	Kumar, N; Lewis, DJ				Kumar, Neelam; Lewis, David J.			Fever and rash in a returning traveller	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DENGUE HEMORRHAGIC-FEVER; INFECTION; DIAGNOSIS; THAILAND		[Kumar, Neelam] St George Hosp, Clin Infect Unit, London SW17 0QT, England; [Lewis, David J.] St Georges Univ London, St Georges Vaccine Inst, London, England	St Georges University London; St Georges University London	Kumar, N (corresponding author), St George Hosp, Clin Infect Unit, London SW17 0QT, England.	neelamkumar@doctors.org.uk		Lewis, David JM/0000-0003-3105-9075; Kumar, Neelam/0000-0002-4346-2112				Allwinn R, 2008, INTERVIROLOGY, V51, P96, DOI 10.1159/000131667; COHEN SN, 1966, J PEDIATR-US, V68, P448, DOI 10.1016/S0022-3476(66)80249-4; Dussart P, 2006, CLIN VACCINE IMMUNOL, V13, P1185, DOI 10.1128/CVI.00229-06; Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; Kong YY, 2006, J VIROL METHODS, V138, P123, DOI 10.1016/j.jviromet.2006.08.003; Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813; Mayxay M, 2011, TROP MED INT HEALTH, V16, P127, DOI 10.1111/j.1365-3156.2010.02641.x; Phuong CXT, 2004, AM J TROP MED HYG, V70, P172, DOI 10.4269/ajtmh.2004.70.172; Srikiatkhachorn A, 2010, CLIN INFECT DIS, V50, P1135, DOI 10.1086/651268; Stephenson Iain, 2003, Travel Med Infect Dis, V1, P89, DOI 10.1016/S1477-8939(03)00061-9; de Souza VAUF, 2007, J CLIN VIROL, V39, P230, DOI 10.1016/j.jcv.2007.04.005; WHO, 1997, DENG HAEM FEV DIAGN; World Health Organization, 2009, DENGUE GUIDELINES DI	14	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 11	2012	344								e2400	10.1136/bmj.e2400	http://dx.doi.org/10.1136/bmj.e2400			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927UH	22496299				2022-12-28	WOS:000302935200002
J	Harrington, A				Harrington, Anne			The art of medicine The fall of the schizophrenogenic mother	LANCET			English	Editorial Material									Harvard Univ, Dept Hist Sci, Sci Ctr 371, Cambridge, MA 02138 USA	Harvard University	Harrington, A (corresponding author), Harvard Univ, Dept Hist Sci, Sci Ctr 371, Cambridge, MA 02138 USA.	aharring@fas.harvard.edu						Hogarty Gerard E, 2003, WORLD PSYCHIAT, V21, P29; Hopper Kim, 2007, RECOVERY SCHIZOPHREN; Mehta S, 1997, J SOC CLIN PSYCHOL, V16, P405, DOI 10.1521/jscp.1997.16.4.405; NEILL J, 1990, AM J PSYCHOTHER, V44, P499, DOI 10.1176/appi.psychotherapy.1990.44.4.499; Saks ER, 2007, CTR CANNOT HOLD MY J	5	21	21	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 7	2012	379	9823					1292	1293		10.1016/S0140-6736(12)60546-7	http://dx.doi.org/10.1016/S0140-6736(12)60546-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	922FB	22489328				2022-12-28	WOS:000302531100013
J	Dale, CW; Burton, KW; Greenwood, RC; Gannoun, A; Wade, J; Wood, BJ; Pearson, DG				Dale, Christopher W.; Burton, Kevin W.; Greenwood, Richard C.; Gannoun, Abdelmouhcine; Wade, Jonathan; Wood, Bernard J.; Pearson, D. Graham			Late Accretion on the Earliest Planetesimals Revealed by the Highly Siderophile Elements	SCIENCE			English	Article							CORE FORMATION; OXIDATION-STATE; SILICATE MELTS; EARLY DIFFERENTIATION; MANTLE; EARTH; CONSTRAINTS; SOLUBILITY; PALLADIUM; MOON	Late accretion of primitive chondritic material to Earth, the Moon, and Mars, after core formation had ceased, can account for the absolute and relative abundances of highly siderophile elements (HSEs) in their silicate mantles. Here we show that smaller planetesimals also possess elevated HSE abundances in chondritic proportions. This demonstrates that late addition of chondritic material was a common feature of all differentiated planets and planetesimals, irrespective of when they accreted; occurring <= 5 to >= 150 million years after the formation of the solar system. Parent-body size played a role in producing variations in absolute HSE abundances among these bodies; however, the oxidation state of the body exerted the major control by influencing the extent to which late-accreted material was mixed into the silicate mantle rather than removed to the core.	[Dale, Christopher W.; Burton, Kevin W.; Pearson, D. Graham] Univ Durham, Dept Earth Sci, Durham DH1 3LE, England; [Greenwood, Richard C.] Open Univ, Planetary & Space Sci Res Inst, Milton Keynes MK7 6AA, Bucks, England; [Gannoun, Abdelmouhcine] UBP, Lab Magmas & Volcans, OPGC, UMR 6524, F-63038 Clermont Ferrand, France; [Wade, Jonathan; Wood, Bernard J.] Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; [Pearson, D. Graham] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada	Durham University; Open University - UK; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); Universite Clermont Auvergne (UCA); Universite Jean Monnet; University of Oxford; University of Alberta	Dale, CW (corresponding author), Univ Durham, Dept Earth Sci, Durham DH1 3LE, England.	christopher.dale@durham.ac.uk	Wood, Bernard J/E-8173-2010; Dale, Christopher W/A-3416-2013; Pearson, Graham/AAN-5507-2020; Wade, Jon/H-7012-2012	Wood, Bernard J/0000-0003-1038-7301; Dale, Christopher W/0000-0002-7337-0948; Wade, Jon/0000-0002-6998-236X; Burton, Kevin/0000-0002-3381-7004; Greenwood, Richard/0000-0002-5544-8027	Natural Environment Research Council, UK [NER/C51902X/1]; Natural Environment Research Council [NE/F018266/1, NE/F005717/1] Funding Source: researchfish; Science and Technology Facilities Council [ST/I001964/1] Funding Source: researchfish; NERC [NE/F005717/1, NE/F018266/1] Funding Source: UKRI; STFC [ST/I001964/1] Funding Source: UKRI	Natural Environment Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We are grateful to the Natural History Museum, London, for the provision of numerous samples. C. W. D. acknowledges funding from grant NER/C51902X/1 from the Natural Environment Research Council, UK. We thank three anonymous referees for their constructive comments and H. Williams for useful discussions. Full HSE and Os isotope data are available in the supplementary materials.	Albarede F, 2009, NATURE, V461, P1227, DOI 10.1038/nature08477; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Becker H, 2006, GEOCHIM COSMOCHIM AC, V70, P4528, DOI 10.1016/j.gca.2006.06.004; BIRCK JL, 1994, EARTH PLANET SC LETT, V124, P139, DOI 10.1016/0012-821X(94)00086-7; BORISOV A, 1995, GEOCHIM COSMOCHIM AC, V59, P481, DOI 10.1016/0016-7037(94)00358-S; BORISOV A, 1994, GEOCHIM COSMOCHIM AC, V58, P705, DOI 10.1016/0016-7037(94)90500-2; Bottke WF, 2010, SCIENCE, V330, P1527, DOI 10.1126/science.1196874; Brandon AD, 2000, GEOCHIM COSMOCHIM AC, V64, P4083, DOI 10.1016/S0016-7037(00)00482-8; Brenan JM, 2009, NAT GEOSCI, V2, P798, DOI 10.1038/NGEO658; Canil D, 1997, NATURE, V389, P842, DOI 10.1038/39860; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; Chou CL., 1978, P 9 LUN SCI C, V1, P219; Day JMD, 2010, EARTH PLANET SC LETT, V289, P595, DOI 10.1016/j.epsl.2009.12.001; DUKE MB, 1965, J GEOPHYS RES, V70, P1523, DOI 10.1029/JZ070i006p01523; Ertel W, 2006, GEOCHIM COSMOCHIM AC, V70, P2591, DOI 10.1016/j.gca.2006.02.015; Ertel W, 1999, GEOCHIM COSMOCHIM AC, V63, P2439, DOI 10.1016/S0016-7037(99)00136-2; FLORAN RJ, 1981, GEOCHIM COSMOCHIM AC, V45, P2385, DOI 10.1016/0016-7037(81)90092-2; Frost DJ, 2008, PHILOS T R SOC A, V366, P4315, DOI 10.1098/rsta.2008.0147; Frost DJ, 2004, NATURE, V428, P409, DOI 10.1038/nature02413; Greenwood RC, 2005, NATURE, V435, P916, DOI 10.1038/nature03612; Holzheid A, 2000, NATURE, V406, P396, DOI 10.1038/35019050; Humayun M., 2007, LUNAR PLANET SCI C, VXXXVIII, P1221; Jones JH, 2003, CHEM GEOL, V196, P21, DOI 10.1016/S0009-2541(02)00404-7; Kleine T, 2009, GEOCHIM COSMOCHIM AC, V73, P5150, DOI 10.1016/j.gca.2008.11.047; Maier WD, 2009, NATURE, V460, P620, DOI 10.1038/nature08205; MURTHY VR, 1991, SCIENCE, V253, P303, DOI 10.1126/science.253.5017.303; Riches A. J. V., 2011, LUNAR PLANET SCI C, VXLII, P2288; Righter K, 2008, NAT GEOSCI, V1, P321, DOI 10.1038/ngeo180; Scott ERD, 2009, GEOCHIM COSMOCHIM AC, V73, P5835, DOI 10.1016/j.gca.2009.06.024; Trail D, 2011, NATURE, V480, P79, DOI 10.1038/nature10655; Wade J, 2005, EARTH PLANET SC LETT, V236, P78, DOI 10.1016/j.epsl.2005.05.017; Wadhwa M, 2008, REV MINERAL GEOCHEM, V68, P493, DOI 10.2138/rmg.2008.68.17; Walker R. J., 2011, LUNAR PLANET SCI C, VXLII, P1386; Walker RJ, 2009, CHEM ERDE-GEOCHEM, V69, P101, DOI 10.1016/j.chemer.2008.10.001	37	75	75	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2012	336	6077					72	75		10.1126/science.1214967	http://dx.doi.org/10.1126/science.1214967			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920LG	22491852	Green Accepted			2022-12-28	WOS:000302405400053
J	Etminan, M; Forooghian, F; Brophy, JM; Bird, ST; Maberley, D				Etminan, Mahyar; Forooghian, Farzin; Brophy, James M.; Bird, Steven T.; Maberley, David			Oral Fluoroquinolones and the Risk of Retinal Detachment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TENDON-RUPTURE; OLDER-ADULTS; CIPROFLOXACIN; TENDINOPATHY; GATIFLOXACIN; COLLAGEN; THERAPY	Context Fluoroquinolones are commonly prescribed classes of antibiotics. Despite numerous case reports of ocular toxicity, a pharmacoepidemiological study of their ocular safety, particularly retinal detachment, has not been performed. Objective To examine the association between use of oral fluoroquinolones and the risk of developing a retinal detachment. Design, Setting, and Patients Nested case-control study of a cohort of patients in British Columbia, Canada, who had visited an ophthalmologist between January 2000 and December 2007. Retinal detachment cases were defined as a procedure code for retinal repair surgery within 14 days of a physician service code. Ten controls were selected for each case using risk-set sampling, matching on age and the month and year of cohort entry. Main Outcome Measure The association between retinal detachment and current, recent, or past use of an oral fluoroquinolone. Results From a cohort of 989 591 patients, 4384 cases of retinal detachment and 43 840 controls were identified. Current use of fluoroquinolones was associated with a higher risk of developing a retinal detachment (3.3% of cases vs 0.6% of controls; adjusted rate ratio [ARR], 4.50 [95% CI, 3.56-5.70]). Neither recent use (0.3% of cases vs 0.2% of controls; ARR, 0.92 [95% CI, 0.45-1.87]) nor past use (6.6% of cases vs 6.1% of controls; ARR, 1.03 [95% CI, 0.89-1.19]) was associated with a retinal detachment. The absolute increase in the risk of a retinal detachment was 4 per 10 000 person-years (number needed to harm=2500 computed for any use of fluoroquinolones). There was no evidence of an association between development of a retinal detachment and beta-lactam antibiotics (ARR, 0.74 [95% CI, 0.35-1.57]) or short-acting beta-agonists (ARR, 0.95 [95% CI, 0.68-1.33]). Conclusion Patients taking oral fluoroquinolones were at a higher risk of developing a retinal detachment compared with nonusers, although the absolute risk for this condition was small. JAMA. 2012;307(13):1414-1419	[Etminan, Mahyar] Child & Family Res Inst British Columbia, Therapeut Evaluat Unit, Vancouver, BC, Canada; [Etminan, Mahyar] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Forooghian, Farzin; Maberley, David] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 1M9, Canada; [Brophy, James M.] McGill Univ, Dept Epidemiol, Montreal, PQ, Canada; [Brophy, James M.] McGill Univ, Dept Biostat, Montreal, PQ, Canada; [Brophy, James M.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Bird, Steven T.] US FDA, Ctr Drug Evaluat & Res Off Management, Silver Spring, MD USA; [Bird, Steven T.] Acad Collaborat Program, Silver Spring, MD USA	Child & Family Research Institute; University of British Columbia; University of British Columbia; McGill University; McGill University; McGill University; US Food & Drug Administration (FDA)	Etminan, M (corresponding author), 950 W 28th Ave,Room A4-195, Vancouver, BC V5Z 1L8, Canada.	metminan@popi.ubc.ca	brophy, james/H-6673-2019	brophy, james/0000-0001-8049-6875	Canadian National Institute for the Blind	Canadian National Institute for the Blind	The study was funded by the Canadian National Institute for the Blind.	Al-Amri AM, 2008, CORNEA, V27, P370, DOI 10.1097/ICO.0b013e31815dcfc4; British Columbia Ministry of Health, PHARMANET; Falagas ME, 2007, INT J ANTIMICROB AG, V29, P374, DOI 10.1016/j.ijantimicag.2006.11.011; Harrell RM, 1999, SOUTHERN MED J, V92, P622, DOI 10.1097/00007611-199906000-00014; Health Canada, 1999, 126410 HLTH CAN; Huybrechts KF, 2011, CAN MED ASSOC J, V183, pE411, DOI 10.1503/cmaj.101406; KEREN G, 1991, INVEST OPHTH VIS SCI, V32, P2388; Khaliq Y, 2003, CLIN INFECT DIS, V36, P1404, DOI 10.1086/375078; Leone R, 2003, DRUG SAFETY, V26, P109, DOI 10.2165/00002018-200326020-00004; Ministry of Health, MED SERV PLAN BRIT C; Park-Wyllie LY, 2006, NEW ENGL J MED, V354, P1352, DOI 10.1056/NEJMoa055191; Ponsioen TL, 2008, INVEST OPHTH VIS SCI, V49, P4089, DOI 10.1167/iovs.07-1456; Population Data British Columbia, DISCH ABSTR DAT; Rampal S, 2008, HUM EXP TOXICOL, V27, P409, DOI 10.1177/0960327108092295; Reviglio Victor E, 2003, BMC Ophthalmol, V3, P10, DOI 10.1186/1471-2415-3-10; RODRIGUES L, 1990, INT J EPIDEMIOL, V19, P205, DOI 10.1093/ije/19.1.205; Samarakoon N, 2007, CLIN EXP OPHTHALMOL, V35, P102, DOI 10.1111/j.1442-9071.2007.01427.x; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Sharma T, 2002, RETINA-J RET VIT DIS, V22, P423, DOI 10.1097/00006982-200208000-00005; SIRBAT D, 1983, J FR OPHTALMOL, V6, P829; Sodhi A, 2008, SURV OPHTHALMOL, V53, P50, DOI 10.1016/j.survophthal.2007.10.007; Solomon DH, 2011, JAMA-J AM MED ASSOC, V305, P2525, DOI 10.1001/jama.2011.878; SZARFMAN A, 1995, NEW ENGL J MED, V332, P193; Tsai WC, 2011, J ORTHOP RES, V29, P67, DOI 10.1002/jor.21196; US Department of Health and Human Services; US Food and Drug Administration, 21158S018 NDA US DEP; van der Linden PD, 2003, ARCH INTERN MED, V163, P1801, DOI 10.1001/archinte.163.15.1801; van der Linden PD, 2002, BRIT MED J, V324, P1306, DOI 10.1136/bmj.324.7349.1306; Williams JI, 1996, INVENTORY STUDIES AC; Williams RJ, 2000, AM J SPORT MED, V28, P364, DOI 10.1177/03635465000280031401	30	123	125	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2012	307	13					1414	1419		10.1001/jama.2012.383	http://dx.doi.org/10.1001/jama.2012.383			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919AY	22474205	Bronze			2022-12-28	WOS:000302294200028
J	Baltimore, D				Baltimore, David			Renato Dulbecco (1914-2012)	SCIENCE			English	Biographical-Item									CALTECH, Dept Biol, Pasadena, CA 91125 USA	California Institute of Technology	Baltimore, D (corresponding author), CALTECH, Dept Biol, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	baltimo@caltech.edu						DULBECCO R, PUBLICATION LIST	1	2	2	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1587	1587		10.1126/science.1221692	http://dx.doi.org/10.1126/science.1221692			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461601				2022-12-28	WOS:000302062600033
J	McCloskey, A; Taniguchi, I; Shinmyozu, K; Ohno, M				McCloskey, Asako; Taniguchi, Ichiro; Shinmyozu, Kaori; Ohno, Mutsuhito			hnRNP C Tetramer Measures RNA Length to Classify RNA Polymerase II Transcripts for Export	SCIENCE			English	Article							NUCLEAR RIBONUCLEOPROTEIN-PARTICLES; CAP-BINDING COMPLEX; PRE-MESSENGER-RNA; PROTEINS	Specific RNA recognition is usually achieved by specific RNA sequences and/or structures. However, we show here a mechanism by which RNA polymerase II (Pol II) transcripts are classified according to their length. The heterotetramer of the heterogeneous nuclear ribonucleoprotein (hnRNP) C1/C2 measures the length of the transcripts like a molecular ruler, by selectively binding to the unstructured RNA regions longer than 200 to 300 nucleotides. Thus, the tetramer sorts the transcripts into two RNA categories, to be exported as either messenger RNA or uridine-rich small nuclear RNA (U snRNA), depending on whether or not they are longer than the threshold, respectively. Our findings reveal a new function of the C tetramer and highlight the biological importance of RNA recognition by the length.	[McCloskey, Asako; Taniguchi, Ichiro; Ohno, Mutsuhito] Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan; [Shinmyozu, Kaori] RIKEN Ctr Dev Biol, Kobe, Hyogo 6500047, Japan	Kyoto University; RIKEN	Ohno, M (corresponding author), Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan.	hitoohno@virus.kyoto-u.ac.jp		taniguchi, ichiro/0000-0002-9364-2680	Ministry of Education, Culture, Sports, Science and Technology of Japan [20112007]; Grants-in-Aid for Scientific Research [20112001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the members of our laboratory, especially M. Kitabatake and H. Kiriu, for useful suggestions and unpublished materials. We also thank M. Yoshida, H. Miyoshi, and T. Tani for providing us with spliceostatin A (SSA) and the p27 plasmid, the lentiviral transduction system, and pCDNA3.1GST-NES-NLS-GFP, respectively. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "RNA regulation" (20112007) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. A.M. and I.T. performed the experiments, except the mass spectrometric analyses, which were performed by K.S. I.T. initiated the in vitro system. M.O. obtained the funding, designed some experiments, and wrote the manuscript.	BARNETT SF, 1989, MOL CELL BIOL, V9, P492, DOI 10.1128/MCB.9.2.492; BEYER AL, 1977, CELL, V11, P127, DOI 10.1016/0092-8674(77)90323-3; Carmody SR, 2009, J CELL SCI, V122, P1933, DOI 10.1242/jcs.041236; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Fuke H, 2008, NUCLEIC ACIDS RES, V36, P1037, DOI 10.1093/nar/gkm1120; HUANG M, 1994, MOL CELL BIOL, V14, P518, DOI 10.1128/MCB.14.1.518; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Masuyama K, 2004, GENE DEV, V18, P2074, DOI 10.1101/gad.1216204; McAfee JG, 1996, BIOCHEMISTRY-US, V35, P1212, DOI 10.1021/bi951974k; Nakielny S, 1996, J CELL BIOL, V134, P1365, DOI 10.1083/jcb.134.6.1365; Nojima T, 2007, J BIOL CHEM, V282, P15645, DOI 10.1074/jbc.M700629200; Ohno M, 2000, CELL, V101, P187, DOI 10.1016/S0092-8674(00)80829-6; Ohno M, 2002, MOL CELL, V9, P659, DOI 10.1016/S1097-2765(02)00454-9; Pawlicki JM, 2010, TRENDS CELL BIOL, V20, P52, DOI 10.1016/j.tcb.2009.10.004; Visa N, 1996, J CELL BIOL, V133, P5, DOI 10.1083/jcb.133.1.5	16	111	115	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1643	1646		10.1126/science.1218469	http://dx.doi.org/10.1126/science.1218469			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461616				2022-12-28	WOS:000302062600050
J	Nakamura, K; Greenwood, A; Binder, L; Bigio, EH; Denial, S; Nicholson, L; Zhou, XZ; Lu, KP				Nakamura, Kazuhiro; Greenwood, Alex; Binder, Lester; Bigio, Eileen H.; Denial, Sarah; Nicholson, Linda; Zhou, Xiao Zhen; Lu, Kun Ping			Proline Isomer-Specific Antibodies Reveal the Early Pathogenic Tau Conformation in Alzheimer's Disease	CELL			English	Article							CIS-TRANS ISOMERIZATION; PHOSPHORYLATED-TAU; PROLYL ISOMERIZATION; REGULATORY MECHANISM; MOUSE MODEL; PIN1; PROTEIN; CANCER; MICE; NEURODEGENERATION	cis-trans isomerization of proteins phosphorylated by proline-directed kinases is proposed to control numerous signaling molecules and is implicated in the pathogenesis of Alzheimer's and other diseases. However, there is no direct evidence for the existence of cis-trans protein isomers in vivo or for their conformation-specific function or regulation. Here we develop peptide chemistries that allow the generation of cis- and trans-specific antibodies and use them to raise antibodies specific for isomers of phosphorylated tau. cis, but not trans, p-tau appears early in the brains of humans with mild cognitive impairment, accumulates exclusively in degenerated neurons, and localizes to dystrophic neurites during Alzheimer's progression. Unlike trans p-tau, the cis isomer cannot promote microtubule assembly, is more resistant to dephosphorylation and degradation, and is more prone to aggregation. Pin1 converts cis to trans p-tau to prevent Alzheimer's tau pathology. Isomer-specific antibodies and vaccines may therefore have value for the early diagnosis and treatment of Alzheimer's disease.	[Nakamura, Kazuhiro; Zhou, Xiao Zhen; Lu, Kun Ping] Harvard Univ, Sch Med, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Greenwood, Alex; Denial, Sarah; Nicholson, Linda] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Binder, Lester] Northwestern Univ Feinberg, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Bigio, Eileen H.] Northwestern Univ Feinberg, Sch Med, Dept Pathol, Chicago, IL 60611 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Cornell University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Zhou, XZ (corresponding author), Harvard Univ, Sch Med, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	xzhou@bidmc.harvard.edu; klu@bidmc.harvard.edu	Greenwood, Alex/GWU-8292-2022		NIH [P30 AG13854, R01CA122434, R01AG029385, R01AG039405, R01AG17870, R01CA167677]; NATIONAL CANCER INSTITUTE [R01CA167677, R01CA122434] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG039405, R01AG029385, R01AG017870, P30AG013854] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Lew Cantley and Tony Hunter for insightful advice, Peter Davies for some tau antibodies, Virginia Lee for tau transgenic mice, and the members of the Lu/Zhou laboratories for stimulating discussions. This study was supported by NIH grants P30 AG13854 to the Northwestern Alzheimer Disease Center, R01CA122434 to X.Z.Z., R01AG029385 to L.N. and K.P.L. and R01AG039405, R01AG17870, and R01CA167677 to K.P.L.	An SSA, 1999, J AM CHEM SOC, V121, P11558, DOI 10.1021/ja9930317; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boimel M, 2010, EXP NEUROL, V224, P472, DOI 10.1016/j.expneurol.2010.05.010; Boutajangout A, 2011, J NEUROCHEM, V118, P658, DOI 10.1111/j.1471-4159.2011.07337.x; Boutajangout A, 2010, J NEUROSCI, V30, P16559, DOI 10.1523/JNEUROSCI.4363-10.2010; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Butterfield DA, 2006, J NEUROCHEM, V98, P1697, DOI 10.1111/j.1471-4159.2006.03995.x; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8; Davies P, 2000, METH MOLEC MED, V32, P361, DOI 10.1385/1-59259-195-7:361; Dawson HN, 2001, J CELL SCI, V114, P1179; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Dolan PJ, 2010, CURR OPIN DRUG DISC, V13, P595; Ewers M, 2007, NEUROLOGY, V69, P2205, DOI 10.1212/01.wnl.0000286944.22262.ff; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Hamdane M, 2006, MOL CELL NEUROSCI, V32, P155, DOI 10.1016/j.mcn.2006.03.006; Hampel H, 2001, ANN NEUROL, V49, P545, DOI 10.1002/ana.111; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Jicha GA, 1997, J NEUROCHEM, V69, P2087; Lee TH, 2011, MOL CELL, V42, P147, DOI 10.1016/j.molcel.2011.03.005; Lee TH, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001906; Li YH, 2006, HUM MOL GENET, V15, P2560, DOI 10.1093/hmg/ddl178; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lu PJ, 1999, NATURE, V399, P784; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Luna-Munoz J, 2007, J ALZHEIMERS DIS, V12, P365; Ma SL, 2012, J BIOL CHEM, V287, P6969, DOI 10.1074/jbc.C111.298596; Ma SL, 2012, NEUROBIOL AGING, V33, P804, DOI 10.1016/j.neurobiolaging.2010.05.018; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Nakamura M, 2001, CURR BIOL, V11, P1512, DOI 10.1016/S0960-9822(01)00456-0; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; SCHEFF SW, 1990, NEUROBIOL AGING, V11, P29, DOI 10.1016/0197-4580(90)90059-9; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Spires-Jones TL, 2009, TRENDS NEUROSCI, V32, P150, DOI 10.1016/j.tins.2008.11.007; Theuerkorn M, 2011, CURR OPIN PHARMACOL, V11, P281, DOI 10.1016/j.coph.2011.03.007; Tun-Kyi A, 2011, NAT IMMUNOL, V12, P733, DOI 10.1038/ni.2069; Wintjens R, 2001, J BIOL CHEM, V276, P25150, DOI 10.1074/jbc.M010327200; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yuan WC, 2011, CANCER CELL, V20, P214, DOI 10.1016/j.ccr.2011.07.008; Yukawa K, 2006, INT J MOL MED, V17, P869; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X; Zhou XZ, 1999, CELL MOL LIFE SCI, V56, P788, DOI 10.1007/s000180050026	53	183	199	0	50	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 30	2012	149	1					232	244		10.1016/j.cell.2012.02.016	http://dx.doi.org/10.1016/j.cell.2012.02.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464332	Green Accepted, Bronze			2022-12-28	WOS:000302235400023
J	Wedeen, VJ; Rosene, DL; Wang, RP; Dai, GP; Mortazavi, F; Hagmann, P; Kaas, JH; Tseng, WYI				Wedeen, Van J.; Rosene, Douglas L.; Wang, Ruopeng; Dai, Guangping; Mortazavi, Farzad; Hagmann, Patric; Kaas, Jon H.; Tseng, Wen-Yih I.			The Geometric Structure of the Brain Fiber Pathways	SCIENCE			English	Article							NERVOUS-SYSTEM; TRACTOGRAPHY; ARCHITECTURE; CORTEX; MRI	The structure of the brain as a product of morphogenesis is difficult to reconcile with the observed complexity of cerebral connectivity. We therefore analyzed relationships of adjacency and crossing between cerebral fiber pathways in four nonhuman primate species and in humans by using diffusion magnetic resonance imaging. The cerebral fiber pathways formed a rectilinear three-dimensional grid continuous with the three principal axes of development. Cortico-cortical pathways formed parallel sheets of interwoven paths in the longitudinal and medio-lateral axes, in which major pathways were local condensations. Cross-species homology was strong and showed emergence of complex gyral connectivity by continuous elaboration of this grid structure. This architecture naturally supports functional spatio-temporal coherence, developmental path-finding, and incremental rewiring with correlated adaptation of structure and function in cerebral plasticity and evolution.	[Wedeen, Van J.; Wang, Ruopeng; Dai, Guangping] Harvard Univ, Sch Med, Massachusetts Gen Hosp MGH, Dept Radiol, Charlestown, MA 02129 USA; [Wedeen, Van J.; Wang, Ruopeng; Dai, Guangping] MGH Massachussetts Inst Technol, Athinoula Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Rosene, Douglas L.; Mortazavi, Farzad] Boston Univ, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Hagmann, Patric] Univ Lausanne, Univ Hosp Ctr, Dept Radiol, CH-1011 Lausanne, Switzerland; [Kaas, Jon H.] Vanderbilt Univ, Coll Arts & Sci, Dept Psychol, Nashville, TN 37240 USA; [Tseng, Wen-Yih I.] Natl Taiwan Univ, Coll Med, Dept Radiol, Ctr Optoelect Biomed, Taipei 100, Taiwan	Harvard University; Massachusetts General Hospital; Boston University; University of Lausanne; Vanderbilt University; National Taiwan University	Wedeen, VJ (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp MGH, Dept Radiol, Bldg 129,13th St,2nd Floor, Charlestown, MA 02129 USA.	van@nmr.mgh.harvard.edu	Mortazavi, Farzad/AFT-4660-2022; Rosene, Douglas L/G-1973-2015; Mortazavi, Farzad/AAI-8136-2021	Mortazavi, Farzad/0000-0002-1911-5428; Mortazavi, Farzad/0000-0002-1911-5428; Rosene, Douglas/0000-0001-8719-1441; Tseng, Wen-Yih Isaac/0000-0002-2314-6868	Human Connectome Project [U01 MH093765];  [NSF PHY-0855161];  [NIH R01-MH652456];  [P41 RR-023953];  [P41 RR-14075]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR023953, P41RR014075] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY002686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH093765, R01MH064044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016446] Funding Source: NIH RePORTER	Human Connectome Project; ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank L. C. Abbate, J. W. Belliveau, D. A. Feinberg, B. R. Rosen, S. A. Wedeen, and M. W. Weiner for reviewing this manuscript; J. D. Schmahmann, B. I. Shraiman, R. Turner, H. E. Stanley, and T. J. Brady for their comments; K. Mansfield of the New England Primate Center and L. Worthylake of the Oregon National Primate Research Center for primate specimens; C. Devitt for myelin stains; and M. P. Frosch for human specimens. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Science Foundation, the National Institute Of Mental Health, or the National Institutes of Health. This work is directly supported by grants NSF PHY-0855161, NIH R01-MH652456, P41 RR-023953, P41 RR-14075, and The Human Connectome Project U01 MH093765. V.J.W. designed the methods of MRI acquisition, reconstruction, and analysis; acquired and analyzed the data; discovered the grid structure; and wrote the paper. W.-Y.I.T. collaborated in the development of theoretical, imaging, and anatomic ideas and methods. G.D. implemented MRI acquisition techniques, including hardware and pulse sequences; optimized protocols; and acquired ex vivo MRI. R.W. implemented analysis algorithms and created their user interface. J.H.K. and D.L.R. obtained and prepared specimens, participated in analyses, and contributed to this manuscript. F.M. optimized and obtained immunofluorescent microscopy. P.H. provided in vivo human studies. All authors discussed the results and commented on the manuscript. No author has a major competing interest to declare. All human studies were obtained after signed informed consent, with review and approval by the Institutional Review Board. Tissue specimens were studied as discarded materials, with review and approval by the Institutional Subcommittee on Animal Care. Human tissue specimens were studied as deidentified discarded materials, with review and approval by the Institutional Review Board.	Abeles M., 1991, CORTICONICS; Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BERGQUIST H, 1954, J COMP NEUROL, V100, P627, DOI 10.1002/cne.901000308; Bernside M. N., 1968, DEV BIOL, V18, P537; Chedotal A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001917; Clouchoux C, 2010, NEUROIMAGE, V50, P552, DOI 10.1016/j.neuroimage.2009.12.048; DEYOE EA, 1994, NATURE, V371, P151, DOI 10.1038/371151a0; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; His W., 1889, ABHANDL D MATH PHY K, V15, P675; Kaas JH, 2004, ANAT REC PART A, V281A, P1148, DOI 10.1002/ar.a.20120; KATZ MJ, 1980, NEUROSCIENCE, V5, P821, DOI 10.1016/0306-4522(80)90151-7; Kingsbury BF, 1920, J COMP NEUROL, V32, P113, DOI 10.1002/cne.900320106; Klingler J, 1935, SCHWEIZ ARCH NEUROL, V36, P247; Krieg W., 1963, CONNECTIONS CEREBRAL; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Meisner C. W., 1973, GRAVITATION; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; Nicholson C., 1998, CENTRAL NERVOUS SYST, V1; Nieuwenhuys R, 2002, BRAIN RES BULL, V57, P257, DOI 10.1016/S0361-9230(01)00668-2; Nieuwenhuys R, 2009, BRAIN STRUCT FUNCT, V214, P79, DOI 10.1007/s00429-009-0223-7; PUELLES L, 1995, BRAIN BEHAV EVOLUT, V46, P319, DOI 10.1159/000113282; Ramon y Cajal S., 1909, HISTOLOGIE SYSTEME N, DOI [DOI 10.5962/BHL.TITLE.48637, 10.5962/bhl.title.48637]; Sansom SN, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002519; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN, DOI DOI 10.1093/ACPROF:OSO/9780195104233.003.0014; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Stephan KE, 2001, PHILOS T ROY SOC B, V356, P1159, DOI 10.1098/rstb.2001.0908; Swanson LW, 2007, BRAIN RES REV, V55, P356, DOI 10.1016/j.brainresrev.2006.12.006; Thurston W. P., 1997, 3 DIMENSIONAL TAND G; Tseng WYI, 2003, J MAGN RESON IMAGING, V17, P31, DOI 10.1002/jmri.10223; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Vasung L, 2010, J ANAT, V217, P400, DOI 10.1111/j.1469-7580.2010.01260.x; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Wedeen V.J., 2006, P INT SOC MAG RESON, V14, P851; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642	36	315	333	5	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1628	1634		10.1126/science.1215280	http://dx.doi.org/10.1126/science.1215280			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461612	Green Accepted, Green Submitted			2022-12-28	WOS:000302062600046
J	Herbert, K; Plugge, E; Foster, C; Doll, H				Herbert, Katharine; Plugge, Emma; Foster, Charles; Doll, Helen			Prevalence of risk factors for non-communicable diseases in prison populations worldwide: a systematic review	LANCET			English	Article							BODY-MASS INDEX; WOMEN PRISONERS; OBESITY; WEIGHT; HEIGHT; OUTBREAK; BERIBERI; ADULTS	Background The burden of non-communicable diseases (NCDs) is disproportionately carried by low-income and middle-income countries and disadvantaged sectors of society such as prisoners. No systematic analysis has been done to assess the prevalence of poor diet, inadequate physical activity, and overweight and obesity in prisoners. We aim to synthesise current evidence and to highlight areas for action and further research. Methods We systematically searched online databases for reports published between 1948 and May, 2011. Studies were screened against eligibility criteria; two authors then independently extracted data with previously agreed proformas. The risk of bias was assessed for each study with a domain-based assessment. Data on body-mass index and physical activity were presented in forest plots; no overall estimates were calculated on account of data heterogeneity. Available data from the population subgroup most similar in terms of age and sex were used to calculate age-adjusted and sex-adjusted prevalence ratios, which estimate the likelihood of insufficient activity and obesity prevalence in prisoners compared with the national population. Findings 31 eligible studies were reported in 29 publications, including more than 60 000 prisoners in 884 institutions in 15 countries. Male prisoners were less likely to be obese than males in the general population (prevalence ratios ranged from 0.33 to 0.87) in all but one study (1.02, 0.92-1.07), whereas female prisoners were more likely to be obese than non-imprisoned women in the USA (1.18, 1.08-1.30) and Australia (prevalence ratios ranged from 1.15 to 1.20). Australian prisoners were more likely to achieve sufficient activity levels than the general population compared with prisoners in the UK (prevalence ratio 1.19, 95% CI 1.04-1.37, for women in Australia in 2009 vs 0.32, 0.21-0.47, for women in the UK; prevalence ratios ranged from 1.37 to 1.59 for men in Australia vs 0.71, 0.34-0.78, for men in the UK). Female mean energy intake exceeded recommended levels and sodium intake was about two to three times the recommended intake for all prisoners. Interpretation Contact with the criminal justice system is a public-health opportunity to promote health in this vulnerable population; the costs to the individual and to society of failing to do so are likely to be substantial. Improved monitoring and further research is essential to inform appropriate targeting of public health interventions.	[Herbert, Katharine; Foster, Charles] Univ Oxford, Dept Publ Hlth, British Heart Fdn Hlth Promot Res Grp, Oxford OX3 7LF, England; [Doll, Helen] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	University of Oxford; University of East Anglia	Herbert, K (corresponding author), Univ Oxford, Dept Publ Hlth, British Heart Fdn Hlth Promot Res Grp, Old Rd Campus, Oxford OX3 7LF, England.	katharine.herbert@medsci.ox.ac.uk			Oxford University Department of Public Health, Oxford University Hospitals NHS Trust; British Heart Foundation [BHF/PG/03/045]; Department of Public Health, University of Oxford; Norwich Medical School, University of East Anglia	Oxford University Department of Public Health, Oxford University Hospitals NHS Trust; British Heart Foundation(British Heart Foundation); Department of Public Health, University of Oxford; Norwich Medical School, University of East Anglia	Oxford University Department of Public Health, Oxford University Hospitals NHS Trust.; We thank Alexandra Tenovici, Olena Seminog, and Mira Schneiders for assistance with translation of non-English language articles; Jeff Walker, Jurgen Noeske, and Emma Plugge for additional data from their studies; and Nia Roberts for advice on the literature search. CF is funded by a British Heart Foundation Programme Grant BHF/PG/03/045. EP is paid by the Department of Public Health, University of Oxford. KH is employed by the NHS, Oxford University Hospitals. HD is paid by Norwich Medical School, University of East Anglia.	Ahoua L, 2007, FOOD NUTR BULL, V28, P283, DOI 10.1177/156482650702800304; AIHW, 2010, AUSTR HLTH 2010 AUST; [Anonymous], 1985, World Health Organ Tech Rep Ser, V724, P1; Australian Bureau of Statistics, 2010, NAT HLTH SURV SUMM R; Australian Bureau of Statistics, 2002, NAT HLTH SURV 2001 S; Banu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010759; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bennett M, 2005, TROP DOCT, V35, P81, DOI 10.1258/0049475054036896; Binswanger IA, 2009, J EPIDEMIOL COMMUN H, V63, P912, DOI 10.1136/jech.2009.090662; Butler T, 1997, PRELIMINARY FINDINGS; Butler T., 2003, 2001 NEW S WALES INM; Committee PAGA, 2008, PHYS ACT GUID ADV CO; Corston J, 2007, CORSTON REPORT REV W; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Craig R., 2010, HLTH SURVEY ENGLAND, V1; Craig R, 2009, HLTH SURVEY ENGLAND; Craig R, 2009, HLTH SURVEY ENGLAND, V2; Craig R, 2010, HLTH SURVEY ENGLAND, V2; Danubio ME, 2008, ECON HUM BIOL, V6, P181, DOI 10.1016/j.ehb.2007.04.002; de Montmollin D, 2002, TROP DOCT, V32, P234, DOI 10.1177/004947550203200419; Dekkers JC, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-69; Edwards J. S. A., 2001, Food Service Technology, V1, P25, DOI 10.1046/j.1471-5740.2001.00003.x; Edwards JSA, 2007, BRIT FOOD J, V109, P216, DOI 10.1108/00070700710732547; Faeh D, 2009, J EPIDEMIOL COMMUN H, V63, P863, DOI 10.1136/jech.2009.089060; Fazel S, 2006, ADDICTION, V101, P181, DOI 10.1111/j.1360-0443.2006.01316.x; Fazel S, 2002, LANCET, V359, P545, DOI 10.1016/S0140-6736(02)07740-1; Fisher J, 1988, FOOD HABITS AUSTR, P313; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Gesch CB, 2002, BRIT J PSYCHIAT, V181, P22, DOI 10.1192/bjp.181.1.22; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hockings BA, 2002, QUEENSLAND WOMEN PRI; Indig D., 2010, 2009 NSW INMATE HLTH; Ingram-Fogel C, 1991, J PRISON JAIL HLTH, V10, P43; Joint Health Surveys Unit, 2005, HLTH SURV ENGL 2004; Khattak I. A., 2008, Sarhad Journal of Agriculture, V24, P123; Khavjou OA, 2007, WOMEN HEALTH ISS, V17, P193, DOI 10.1016/j.whi.2007.02.008; Krawinkel M, 2006, ERNAHRUNGS UMSCHAU, V53, P309; Lai SW, 2008, AM J MED SCI, V335, P465, DOI 10.1097/MAJ.0b013e31815b9d40; Lee DH, 2011, J EPIDEMIOL, V21, P30, DOI 10.2188/jea.JE20100058; Lester C., 2003, Health Education Journal, V62, P341, DOI 10.1177/001789690306200406; Maddana S, 2008, SOC SCI J, V45, P330, DOI 10.1016/j.soscij.2008.03.009; Mataev S. V., 2004, Voprosy Pitaniya, V73, P25; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moller L, 2007, HLTH PRISONS WHO GUI; Nara K, 1998, IND HEALTH, V36, P1, DOI 10.2486/indhealth.36.1; Noeske J, 2006, East Afr Med J, V83, P25; Noeske J, 2011, INT J TUBERC LUNG D, V15, P223; Office of Population Censuses and Surveys Social Survey Division, 1998, PHYS HLTH PRIS 1994; Ogden CL, 2010, PREVALENCE OVERWEIGH; Olubodun JOB, 1996, EUR J CLIN NUTR, V50, P58; Park JY, 2011, EUR J CLIN NUTR, V65, P357, DOI 10.1038/ejcn.2010.259; Plugge EH, 2009, HEALTH PROMOT INT, V24, P334, DOI 10.1093/heapro/dap034; Ritter C, 2011, J PUBLIC HEALTH POL, V32, P32, DOI 10.1057/jphp.2010.47; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Simonati C. N., 2010, Journal of EcoAgriTourism, V6, P90; Subcommittee on the tenth edition of the recommended dietary allowances food and nutrition board commission on life sciences National Research Council, 1989, REC DIET ALL; Tatnell J, 1988, FOOD HABITS AUSTR, P319; UN, 2011, DRAFT POL DECL HIGH; van Poppel MNM, 2010, SPORTS MED, V40, P565, DOI 10.2165/11531930-000000000-00000; Walmsley R., 2006, WORLD FEMALE IMPRISO; Walmsley R, 2015, WORLD PRISON POPULAT; WHO, 2011, GLOB STAT REP NONC D; WHO, 2010, WHO GLOB INF DAT SAV; WHO Europe, 2003, DECL PRIS HLTH PUBL; WHO Europe, 2009, WOM HLTH PRIS CORR G; Willett W, 2009, BRIT J NUTR, V102, pS1, DOI 10.1017/S0007114509993102; Williams P., 2009, Journal of Foodservice, V20, P167, DOI 10.1111/j.1748-0159.2009.00144.x	69	112	114	1	39	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2012	379	9830					1975	1982		10.1016/S0140-6736(12)60319-5	http://dx.doi.org/10.1016/S0140-6736(12)60319-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	951YV	22521520				2022-12-28	WOS:000304757700032
J	Ricard, D; Idbaih, A; Ducray, F; Lahutte, M; Hoang-Xuan, K; Delattre, JY				Ricard, Damien; Idbaih, Ahmed; Ducray, Francois; Lahutte, Marion; Hoang-Xuan, Khe; Delattre, Jean-Yves			Primary brain tumours in adults	LANCET			English	Article							CENTRAL-NERVOUS-SYSTEM; PRIMARY CNS LYMPHOMA; HIGH-DOSE METHOTREXATE; LOW-GRADE GLIOMA; PHASE-II TRIAL; TERM-FOLLOW-UP; RECURSIVE PARTITIONING ANALYSIS; BEVACIZUMAB PLUS IRINOTECAN; INTEGRATED GENOMIC ANALYSIS; PROGRESSION-FREE SURVIVAL	Important advances have been made in the understanding and management of adult gliomas and primary CNS lymphomas-the two most common primary brain tumours. Progress in imaging has led to a better analysis of the nature and grade of these tumours. Findings from large phase 3 studies have yielded some standard treatments for gliomas, and have confirmed the prognostic value of specific molecular alterations. High-throughput methods that enable genome-wide analysis of tumours have improved the knowledge of tumour biology, which should lead to a better classification of gliomas and pave the way for so-called targeted therapy trials. Primary CNS lymphomas are a group of rare non-Hodgkin lymphomas. High-dose methotrexate-based regimens increase survival, but the standards of care and the place of whole-brain radiotherapy remain unclear, and are likely to depend on the age of the patient. The focus now is on the development of new polychemotherapy regimens to reduce or defer whole-brain radiotherapy and its delayed complications.	[Idbaih, Ahmed; Hoang-Xuan, Khe; Delattre, Jean-Yves] Grp Hosp Pitie Salpetriere, AP HP, Serv Neurol Mazarin 2, F-75634 Paris, France; [Ricard, Damien] Hop Instruct Armees Val de Grace, Serv Neurol, Serv Sante Armees, Paris, France; [Ricard, Damien] Ecole Val de Grace, Paris, France; [Lahutte, Marion] Hop St Antoine, Serv Radiol, F-75571 Paris, France; [Ricard, Damien; Idbaih, Ahmed; Hoang-Xuan, Khe; Delattre, Jean-Yves] Univ Paris 06, UMRS 975, Ctr Rech, Inst Cerveau & Moelle Epiniere CRICM, Paris, France; INSERM, U975, F-75013 Paris, France; [Ricard, Damien; Idbaih, Ahmed; Hoang-Xuan, Khe; Delattre, Jean-Yves] CNRS, UMR 7225, Paris, France; [Ducray, Francois] Univ Lyon 1, INSERM, CNRS,Neurooncol & Neuroinflammat Team, UMR5292,U1028,Lyon Neurosci Res Ctr, F-69365 Lyon, France; [Ducray, Francois] Hosp Civils Lyon, Hop Neurol, Serv Neurooncol, Lyon, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Val-de-Grace Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Ricard, D (corresponding author), Serv Neurol HIA Val de Grace, 74 Blvd Port Royal, F-75005 Paris, France.	damien.ricard@m4x.org	Hoang-Xuan, Khe/O-7527-2017; Idbaih, Ahmed/N-8746-2017	Idbaih, Ahmed/0000-0001-5290-1204; Ducray, Francois/0000-0002-8150-5785	Roche; Shering-Plough	Roche(Roche Holding); Shering-Plough	DR, AI, FD, KH-X, and J-YD have received expense facilities or payment for educational presentations from Roche and Shering-Plough. KH-X and J-YD have received grants for their institutions from Roche and Shering-Plough. Neither author received funding to write this Seminar.	Abrey LE, 1998, J CLIN ONCOL, V16, P859, DOI 10.1200/JCO.1998.16.3.859; Angelov L, 2009, J CLIN ONCOL, V27, P3503, DOI 10.1200/JCO.2008.19.3789; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Batchelor T, 2010, ANN ONCOL, V21, P4; Batchelor T, 2003, J CLIN ONCOL, V21, P1044, DOI 10.1200/JCO.2003.03.036; Behin A, 2003, LANCET, V361, P323, DOI 10.1016/S0140-6736(03)12328-8; Bettegowda C, 2011, SCIENCE, V333, P1453, DOI 10.1126/science.1210557; Brada M, 2010, J CLIN ONCOL, V28, P4601, DOI 10.1200/JCO.2009.27.1932; Brandes AA, 2008, CLIN CANCER RES, V14, P957, DOI 10.1158/1078-0432.CCR-07-1810; Brandsma D, 2008, LANCET ONCOL, V9, P453, DOI 10.1016/S1470-2045(08)70125-6; Buckner JC, 2003, J CLIN ONCOL, V21, P251, DOI 10.1200/JCO.2003.06.023; Buonerba C, 2011, CRIT REV ONCOL HEMAT, V80, P54, DOI 10.1016/j.critrevonc.2010.09.001; Cady FM, 2008, J CLIN ONCOL, V26, P4814, DOI 10.1200/JCO.2008.16.1455; CAIRNCROSS G, 1994, J CLIN ONCOL, V12, P2013, DOI 10.1200/JCO.1994.12.10.2013; Cairncross G, 2006, J CLIN ONCOL, V24, P2707, DOI 10.1200/JCO.2005.04.3414; Cairncross JG, 1998, J NATL CANCER I, V90, P1473, DOI 10.1093/jnci/90.19.1473; Camilleri-Broet S, 2006, BLOOD, V107, P190, DOI 10.1182/blood-2005-03-1024; Cardis E, 2010, INT J EPIDEMIOL, V39, P675, DOI 10.1093/ije/dyq079; Catt S, 2008, LANCET ONCOL, V9, P884, DOI 10.1016/S1470-2045(08)70230-4; Chamberlain MC, 2010, NEURO-ONCOLOGY, V12, P736, DOI 10.1093/neuonc/noq011; Chang EF, 2008, J NEUROSURG, V108, P227, DOI 10.3171/JNS/2008/108/2/0227; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Claus EB, 2005, CANCER-AM CANCER SOC, V103, P1227, DOI 10.1002/cncr.20867; Colombat P, 2006, BONE MARROW TRANSPL, V38, P417, DOI 10.1038/sj.bmt.1705452; CURRAN WJ, 1993, J NATL CANCER I, V85, P704, DOI 10.1093/jnci/85.9.704; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; DEANGELIS LM, 1992, J CLIN ONCOL, V10, P635, DOI 10.1200/JCO.1992.10.4.635; del Rio MS, 2009, ONCOLOGIST, V14, P526, DOI 10.1634/theoncologist.2008-0236; Dhermain FG, 2010, LANCET NEUROL, V9, P906, DOI 10.1016/S1474-4422(10)70181-2; Douw L, 2009, LANCET NEUROL, V8, P810, DOI 10.1016/S1474-4422(09)70204-2; Duffau H, 2004, CANCER-AM CANCER SOC, V100, P2622, DOI 10.1002/cncr.20297; Duffau H, 2005, LANCET NEUROL, V4, P476, DOI 10.1016/S1474-4422(05)70140-X; Ekenel M, 2008, CANCER-AM CANCER SOC, V113, P1025, DOI 10.1002/cncr.23670; Everhard S, 2006, ANN NEUROL, V60, P740, DOI 10.1002/ana.21044; Ferreri AJM, 2009, LANCET, V374, P1512, DOI 10.1016/S0140-6736(09)61416-1; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Fritsch K, 2011, ANN ONCOL, V22, P2080, DOI 10.1093/annonc/mdq712; Gavrilovic IT, 2006, J CLIN ONCOL, V24, P4570, DOI 10.1200/JCO.2006.06.6910; Gehring K, 2009, J CLIN ONCOL, V27, P3712, DOI 10.1200/JCO.2008.20.5765; Ghesquieres H, 2010, ANN ONCOL, V21, P842, DOI 10.1093/annonc/mdp529; Gilbert MR, 2011, ASCO M, V29; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Gu J, 2009, NEUROTHERAPEUTICS, V6, P427, DOI 10.1016/j.nurt.2009.05.001; Hadjipanayis CG, 2009, TRENDS MOL MED, V15, P519, DOI 10.1016/j.molmed.2009.09.003; Harting I, 2003, NEUROSCI LETT, V342, P163, DOI 10.1016/S0304-3940(03)00272-6; Hartmann M, 2003, NEUROSCI LETT, V338, P119, DOI 10.1016/S0304-3940(02)01367-8; Hatiboglu MA, 2009, NEUROSURGERY, V64, P1073, DOI 10.1227/01.NEU.0000345647.58219.07; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Herrlinger U, 2005, ANN NEUROL, V57, P843, DOI 10.1002/ana.20495; Hoang-Xuan K, 2004, J CLIN ONCOL, V22, P3133, DOI 10.1200/JCO.2004.10.169; Hoang-Xuan K, 2003, J CLIN ONCOL, V21, P2726, DOI 10.1200/JCO.2003.11.036; Houillier C, 2010, NEUROLOGY, V75, P1560, DOI 10.1212/WNL.0b013e3181f96282; Idbaih A, 2005, ANN NEUROL, V58, P483, DOI 10.1002/ana.20607; Idbaih A, 2008, INT J CANCER, V122, P1778, DOI 10.1002/ijc.23270; Illerhaus G, 2009, ANN ONCOL, V20, P319, DOI 10.1093/annonc/mdn628; Illerhaus G, 2006, J CLIN ONCOL, V24, P3865, DOI 10.1200/JCO.2006.06.2117; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jenkins RB, 2006, CANCER RES, V66, P9852, DOI 10.1158/0008-5472.CAN-06-1796; Juergens A, 2010, ANN NEUROL, V67, P182, DOI 10.1002/ana.21824; Kadan-Lottick NS, 2002, CANCER, V95, P193, DOI 10.1002/cncr.10643; Kaloshi G, 2007, NEUROLOGY, V68, P1831, DOI 10.1212/01.wnl.0000262034.26310.a2; Karim ABMF, 1996, INT J RADIAT ONCOL, V36, P549, DOI 10.1016/S0360-3016(96)00352-5; Keime-Guibert F, 2007, NEW ENGL J MED, V356, P1527, DOI 10.1056/NEJMoa065901; Kirson ED, 2007, P NATL ACAD SCI USA, V104, P10152, DOI 10.1073/pnas.0702916104; Kreisl TN, 2009, J CLIN ONCOL, V27, P740, DOI 10.1200/JCO.2008.16.3055; Kummar S, 2007, NAT REV CANCER, V7, P131, DOI 10.1038/nrc2066; Lee IH, 2010, EUR J RADIOL, V76, P48, DOI 10.1016/j.ejrad.2009.05.013; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Maher EA, 2006, CANCER RES, V66, P11502, DOI 10.1158/0008-5472.CAN-06-2072; Mandonnet E, 2003, ANN NEUROL, V53, P524, DOI 10.1002/ana.10528; McGirt MJ, 2008, NEUROSURGERY, V63, P700, DOI 10.1227/01.NEU.0000325729.41085.73; Mirimanoff RO, 2006, J CLIN ONCOL, V24, P2563, DOI 10.1200/JCO.2005.04.5963; Mohile NA, 2008, NEURO-ONCOLOGY, V10, P223, DOI 10.1215/15228517-2007-061; Montesinos-Rongen M, 2009, BLOOD, V113, P7, DOI 10.1182/blood-2008-04-149005; Nobusawa S, 2009, CLIN CANCER RES, V15, P6002, DOI 10.1158/1078-0432.CCR-09-0715; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Olson JE, 2002, CANCER, V95, P1504, DOI 10.1002/cncr.10851; Omuro A, 2011, J NEURO-ONCOL, V104, P323, DOI 10.1007/s11060-010-0497-x; Omuro AMP, 2005, ARCH NEUROL-CHICAGO, V62, P1595, DOI 10.1001/archneur.62.10.1595; Omuro AMP, 2007, J NEURO-ONCOL, V85, P207, DOI 10.1007/s11060-007-9397-0; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pels H, 2010, NEURO-ONCOLOGY, V12, P720, DOI 10.1093/neuonc/noq010; Persson AI, 2010, CANCER CELL, V18, P669, DOI 10.1016/j.ccr.2010.10.033; Peyre M, 2010, NEURO-ONCOLOGY, V12, P1078, DOI 10.1093/neuonc/noq055; Pignatti F, 2002, J CLIN ONCOL, V20, P2076, DOI 10.1200/JCO.2002.08.121; Raymond E, 2008, J CLIN ONCOL, V26, P4659, DOI 10.1200/JCO.2008.16.9235; Ricard D, 2007, ANN NEUROL, V61, P484, DOI 10.1002/ana.21125; Roa W, 2004, J CLIN ONCOL, V22, P1583, DOI 10.1200/JCO.2004.06.082; Sampson JH, 2010, J CLIN ONCOL, V28, P4722, DOI 10.1200/JCO.2010.28.6963; Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; Senft C, 2009, NEUROSURGERY, V65, P908, DOI 10.1227/01.NEU.0000356982.82378.BA; Shah GD, 2007, J CLIN ONCOL, V25, P4730, DOI 10.1200/JCO.2007.12.5062; Shaw E, 2002, J CLIN ONCOL, V20, P2267, DOI 10.1200/JCO.2002.09.126; Shaw EG, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.2006; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337; Soffietti R, 2010, EUR J NEUROL, V17, P1124, DOI 10.1111/j.1468-1331.2010.03151.x; Soussain C, 2008, J CLIN ONCOL, V26, P2512, DOI 10.1200/JCO.2007.13.5533; Stiles CD, 2008, NEURON, V58, P832, DOI 10.1016/j.neuron.2008.05.031; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stummer W, 2011, ACTA NEUROCHIR, V153, P1211, DOI 10.1007/s00701-011-1001-x; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2010, J CLIN ONCOL, V28, P2712, DOI 10.1200/JCO.2009.26.6650; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Thiel E, 2010, LANCET ONCOL, V11, P1036, DOI 10.1016/S1470-2045(10)70229-1; van den Bent MJ, 2006, J CLIN ONCOL, V24, P2715, DOI 10.1200/JCO.2005.04.6078; van den Bent MJ, 2010, ACTA NEUROPATHOL, V120, P297, DOI 10.1007/s00401-010-0725-7; van den Bent MJ, 2010, CLIN CANCER RES, V16, P1597, DOI 10.1158/1078-0432.CCR-09-2902; van den Bent MJ, 2009, J CLIN ONCOL, V27, P5881, DOI 10.1200/JCO.2009.24.1034; van den Bent MJ, 2009, J CLIN ONCOL, V27, P1268, DOI 10.1200/JCO.2008.17.5984; van den Bent MJ, 2005, LANCET, V366, P985, DOI 10.1016/S0140-6736(05)67070-5; van den Bent MJ, 2003, J CLIN ONCOL, V21, P2525, DOI 10.1200/JCO.2003.12.015; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vredenburgh JJ, 2007, J CLIN ONCOL, V25, P4722, DOI 10.1200/JCO.2007.12.2440; Waldman AD, 2009, NAT REV CLIN ONCOL, V6, P445, DOI 10.1038/nrclinonc.2009.92; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Westphal M, 2006, ACTA NEUROCHIR, V148, P269, DOI 10.1007/s00701-005-0707-z; Westphal M, 2003, NEURO-ONCOLOGY, V5, P79, DOI 10.1215/15228517-5-2-79; Wick W, 2010, J CLIN ONCOL, V28, P1168, DOI 10.1200/JCO.2009.23.2595; Wick W, 2009, J CLIN ONCOL, V27, P5874, DOI 10.1200/JCO.2009.23.6497; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yip S, 2012, J PATHOL, V226, P7, DOI 10.1002/path.2995; Young GS, 2007, NEUROL CLIN, V25, P947, DOI 10.1016/j.ncl.2007.07.010; Zhu JJ, 2009, NEURO-ONCOLOGY, V11, P211, DOI 10.1215/15228517-2008-067	128	451	465	4	121	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2012	379	9830					1984	1996		10.1016/S0140-6736(11)61346-9	http://dx.doi.org/10.1016/S0140-6736(11)61346-9			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951YV	22510398				2022-12-28	WOS:000304757700034
J	Knight, P				Knight, Peter			Physics and medicine-two tips for a long and happy marriage	LANCET			English	Editorial Material									Inst Phys, London W1B 1NT, England		Knight, P (corresponding author), Inst Phys, London W1B 1NT, England.	joseph.winters@iop.org						Institute of Physics, 2009, PHYS ADV WORLD LOOK; Keevil SF, 2012, LANCET, V379, P1517, DOI 10.1016/S0140-6736(11)60282-1; Melzer A, 2012, LANCET, V379, P1534, DOI 10.1016/S0140-6736(12)60428-0; Morris P, 2012, LANCET, V379, P1525, DOI 10.1016/S0140-6736(12)60429-2; O'Shea P, 2012, LANCET, V379, P1544, DOI 10.1016/S0140-6736(12)60476-0; West GB, 2012, LANCET, V379, P1551, DOI 10.1016/S0140-6736(12)60281-5	6	2	2	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 21	2012	379	9825					1463	1464		10.1016/S0140-6736(12)60603-5	http://dx.doi.org/10.1016/S0140-6736(12)60603-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	930BJ	22516555				2022-12-28	WOS:000303110200004
J	Meghzifene, A				Meghzifene, Ahmed			A call for recognition of the medical physics profession	LANCET			English	Editorial Material									IAEA, Div Human Hlth, Dosimetry & Med Radiat Phys Sect, A-1400 Vienna, Austria	International Atomic Energy Agency	Meghzifene, A (corresponding author), IAEA, Div Human Hlth, Dosimetry & Med Radiat Phys Sect, A-1400 Vienna, Austria.	a.meghzifene@iaea.org	Meghzifene, Ahmed/S-6990-2019					Eudaldo T, 2010, PHYS MEDICA, V26, P1, DOI 10.1016/j.ejmp.2009.02.005; IAEA, 2010, MED PHYS ASS CRIT RE; International Atomic Energy Agency, 2009, INT 6 054 MTG STRENG; International Labour Organization, 2008, ISCO 08 STRUCT PREL; Keevil SF, 2012, LANCET, V379, P1517, DOI 10.1016/S0140-6736(11)60282-1; Melzer A, 2012, LANCET, V379, P1534, DOI 10.1016/S0140-6736(12)60428-0; Morris P, 2012, LANCET, V379, P1525, DOI 10.1016/S0140-6736(12)60429-2; O'Shea P, 2012, LANCET, V379, P1544, DOI 10.1016/S0140-6736(12)60476-0; The American Association of Physicists in Medicine, WHAT DO MED PHYS DO; West GB, 2012, LANCET, V379, P1551, DOI 10.1016/S0140-6736(12)60281-5	10	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 21	2012	379	9825					1464	1465		10.1016/S0140-6736(11)60311-5	http://dx.doi.org/10.1016/S0140-6736(11)60311-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	930BJ	22516556				2022-12-28	WOS:000303110200005
J	Hailer, F; Kutschera, VE; Hallstrom, BM; Klassert, D; Fain, SR; Leonard, JA; Arnason, U; Janke, A				Hailer, Frank; Kutschera, Verena E.; Hallstroem, Bjoern M.; Klassert, Denise; Fain, Steven R.; Leonard, Jennifer A.; Arnason, Ulfur; Janke, Axel			Nuclear Genomic Sequences Reveal that Polar Bears Are an Old and Distinct Bear Lineage	SCIENCE			English	Article							MITOCHONDRIAL-DNA; ANCIENT HYBRIDIZATION; GENETIC-STRUCTURE; INFERENCE; URSIDAE; SPECIATION; PHYLOGENY; HISTORY; ORIGIN; WOLVES	Recent studies have shown that the polar bear matriline (mitochondrial DNA) evolved from a brown bear lineage since the late Pleistocene, potentially indicating rapid speciation and adaption to arctic conditions. Here, we present a high-resolution data set from multiple independent loci across the nuclear genomes of a broad sample of polar, brown, and black bears. Bayesian coalescent analyses place polar bears outside the brown bear clade and date the divergence much earlier, in the middle Pleistocene, about 600 (338 to 934) thousand years ago. This provides more time for polar bear evolution and confirms previous suggestions that polar bears carry introgressed brown bear mitochondrial DNA due to past hybridization. Our results highlight that multilocus genomic analyses are crucial for an accurate understanding of evolutionary history.	[Hailer, Frank; Kutschera, Verena E.; Hallstroem, Bjoern M.; Klassert, Denise; Janke, Axel] Senckenberg Gesell Naturforsch, Biodivers & Climate Res Ctr BiK F, D-60325 Frankfurt, Germany; [Fain, Steven R.] Natl Fish & Wildlife Forens Lab, Ashland, OR USA; [Leonard, Jennifer A.] Estn Biol Donana EBD CSIC, Conservat & Evolutionary Genet Grp, Seville 41092, Spain; [Arnason, Ulfur] Univ Lund Hosp, S-22100 Lund, Sweden; [Janke, Axel] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, D-60438 Frankfurt, Germany	Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Lund University; Skane University Hospital; Goethe University Frankfurt	Hailer, F (corresponding author), Senckenberg Gesell Naturforsch, Biodivers & Climate Res Ctr BiK F, Senckenberganlage 25, D-60325 Frankfurt, Germany.	frashai@gmx.net; ajanke@senckenberg.de	Kutschera, Verena E./H-8706-2013; Hailer, Frank/Y-3595-2019; Janke, Axel/M-2135-2013; Hailer, Frank/C-9114-2012; Leonard, Jennifer/A-7894-2010	Kutschera, Verena E./0000-0002-8930-534X; Hailer, Frank/0000-0002-2340-1726; Janke, Axel/0000-0002-9394-1904; Hailer, Frank/0000-0002-2340-1726; Leonard, Jennifer/0000-0003-0291-7819	Hesse's LOEWE, Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz	Hesse's LOEWE, Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz	The study was supported by Hesse's LOEWE, Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz. We thank E. W. Born, H.-G. Eiken, C. Frosch, S. Hagen, A. Kopatz, C. Nowak, M. Onucsan, M. Pfenninger, K. Skirnisson, F. Zachos, and P. Beerli for providing samples and for discussions. Obtained sequences have been deposited in the EMBL database (accession nos. HE657192 to HE657234 and HE657776 to HE658979). The authors declare no competing financial interests.	Amstrup SC., 2003, WILD MAMMALS N AM BI, P587; Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Blois JL, 2009, ANNU REV EARTH PL SC, V37, P181, DOI 10.1146/annurev.earth.031208.100055; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Davison J, 2011, QUATERNARY SCI REV, V30, P418, DOI 10.1016/j.quascirev.2010.11.023; Edwards CJ, 2011, CURR BIOL, V21, P1251, DOI 10.1016/j.cub.2011.05.058; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Good JM, 2008, MOL ECOL, V17, P1313, DOI 10.1111/j.1365-294X.2007.03640.x; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Kelly B, 2010, NATURE, V468, P891, DOI 10.1038/468891a; Kurten B., 1964, Acta Zoologica Fennica, V108, P1; Larsen PA, 2010, P NATL ACAD SCI USA, V107, P11447, DOI 10.1073/pnas.1000133107; Leonard JA, 2000, P NATL ACAD SCI USA, V97, P1651, DOI 10.1073/pnas.040453097; Lindqvist C, 2010, P NATL ACAD SCI USA, V107, P5053, DOI 10.1073/pnas.0914266107; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Nakagome S, 2008, MOL BIOL EVOL, V25, P1344, DOI 10.1093/molbev/msn086; Paetkau D, 1999, MOL ECOL, V8, P1571, DOI 10.1046/j.1365-294x.1999.00733.x; Pages M, 2008, MOL PHYLOGENET EVOL, V47, P73, DOI 10.1016/j.ympev.2007.10.019; Perini FA, 2010, J EVOLUTION BIOL, V23, P311, DOI 10.1111/j.1420-9101.2009.01901.x; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Pritchard JK, 2000, GENETICS, V155, P945; Roca AL, 2005, NAT GENET, V37, P96, DOI 10.1038/ng1485; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; SHIELDS GF, 1991, EVOLUTION, V45, P218, DOI 10.1111/j.1558-5646.1991.tb05279.x; Slater GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013870; Uyeda JC, 2011, P NATL ACAD SCI USA, V108, P15908, DOI 10.1073/pnas.1014503108; Welch AJ, 2011, MOL ECOL, V20, P1364, DOI 10.1111/j.1365-294X.2011.05008.x; Yu L, 2004, MOL PHYLOGENET EVOL, V32, P480, DOI 10.1016/j.ympev.2004.02.015; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	31	166	170	9	345	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2012	336	6079					344	347		10.1126/science.1216424	http://dx.doi.org/10.1126/science.1216424			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22517859	Green Submitted			2022-12-28	WOS:000302995400045
J	Dunn, AS				Dunn, Andrew S.			The simplified Pulmonary Embolism Severity Index and high-sensitivity troponin T predicted prognosis in PE	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Mt Sinai Sch Med, New York, NY USA	Icahn School of Medicine at Mount Sinai	Dunn, AS (corresponding author), Mt Sinai Sch Med, New York, NY USA.		Kostrubiec, Maciej/O-4136-2018	Kostrubiec, Maciej/0000-0002-1207-749X				Aujesky D, 2011, LANCET, V378, P41, DOI 10.1016/S0140-6736(11)60824-6; Jimenez D, 2010, ARCH INTERN MED, V170, P1383, DOI 10.1001/archinternmed.2010.199; Lankeit M, 2010, EUR HEART J, V31, P1836, DOI 10.1093/eurheartj/ehq234	3	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2012	156	8							JC4-12	10.7326/0003-4819-156-8-201204170-02012	http://dx.doi.org/10.7326/0003-4819-156-8-201204170-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930PO	22508752				2022-12-28	WOS:000303151800011
J	Wild, D				Wild, Dorothea			CHADS(2) score predicted bleeding and death in atrial fibrillation treated with anticoagulants	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DABIGATRAN; WARFARIN; STROKE		Griffin Hosp, Derby, CT USA		Wild, D (corresponding author), Griffin Hosp, Derby, CT USA.							Beyth RJ, 2011, ANN INTERN MED, V155, P714, DOI 10.7326/0003-4819-155-10-201111150-00012; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Gage BF, 2006, AM HEART J, V151, P713, DOI 10.1016/j.ahj.2005.04.017; Lip GYH, 2011, J AM COLL CARDIOL, V57, P173, DOI 10.1016/j.jacc.2010.09.024	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2012	156	8							JC4-13	10.7326/0003-4819-156-8-201204170-02013	http://dx.doi.org/10.7326/0003-4819-156-8-201204170-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930PO	22508753				2022-12-28	WOS:000303151800012
J	Schrappe, M; Hunger, SP; Pui, CH; Saha, V; Gaynon, PS; Baruchel, A; Conter, V; Otten, J; Ohara, A; Versluys, AB; Escherich, G; Heyman, M; Silverman, LB; Horibe, K; Mann, G; Camitta, BM; Harbott, J; Riehm, H; Richards, S; Devidas, M; Zimmermann, M				Schrappe, Martin; Hunger, Stephen P.; Pui, Ching-Hon; Saha, Vaskar; Gaynon, Paul S.; Baruchel, Andre; Conter, Valentino; Otten, Jacques; Ohara, Akira; Versluys, Anne Birgitta; Escherich, Gabriele; Heyman, Mats; Silverman, Lewis B.; Horibe, Keizo; Mann, Georg; Camitta, Bruce M.; Harbott, Jochen; Riehm, Hansjoerg; Richards, Sue; Devidas, Meenakshi; Zimmermann, Martin			Outcomes after Induction Failure in Childhood Acute Lymphoblastic Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MINIMAL RESIDUAL DISEASE; STEM-CELL TRANSPLANTATION; PROGNOSTIC VALUE; COMPLETE REMISSION; SALVAGE THERAPY; AIEOP-BFM; T-CELL; CHILDREN; RISK; CHEMOTHERAPY	BACKGROUND Failure of remission-induction therapy is a rare but highly adverse event in children and adolescents with acute lymphoblastic leukemia (ALL). METHODS We identified induction failure, defined by the persistence of leukemic blasts in blood, bone marrow, or any extramedullary site after 4 to 6 weeks of remission-induction therapy, in 1041 of 44,017 patients (2.4%) 0 to 18 years of age with newly diagnosed ALL who were treated by a total of 14 cooperative study groups between 1985 and 2000. We analyzed the relationships among disease characteristics, treatments administered, and outcomes in these patients. RESULTS Patients with induction failure frequently presented with high-risk features, including older age, high leukocyte count, leukemia with a T-cell phenotype, the Philadelphia chromosome, and 11q23 rearrangement. With a median follow-up period of 8.3 years (range, 1.5 to 22.1), the 10-year survival rate (+/- SE) was estimated at only 32 +/- 1%. An age of 10 years or older, T-cell leukemia, the presence of an 11q23 rearrangement, and 25% or more blasts in the bone marrow at the end of induction therapy were associated with a particularly poor outcome. High hyperdiploidy (a modal chromosome number >50) and an age of 1 to 5 years were associated with a favorable outcome in patients with precursor B-cell leukemia. Allogeneic stem-cell transplantation from matched, related donors was associated with improved outcomes in T-cell leukemia. Children younger than 6 years of age with precursor B-cell leukemia and no adverse genetic features had a 10-year survival rate of 72 +/- 5% when treated with chemotherapy only. CONCLUSIONS Pediatric ALL with induction failure is highly heterogeneous. Patients who have T-cell leukemia appear to have a better outcome with allogeneic stem-cell transplantation than with chemotherapy, whereas patients who have precursor B-cell leukemia without other adverse features appear to have a better outcome with chemotherapy. (Funded by Deutsche Krebshilfe and others.)	[Pui, Ching-Hon] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Pui, Ching-Hon] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA; [Schrappe, Martin] Univ Kiel, Dept Pediat, Univ Med Ctr Schleswig Holstein, D-2300 Kiel, Germany; [Escherich, Gabriele] Univ Med Ctr Eppendorf, Dept Pediat Hematol & Oncol, Hamburg, Germany; [Harbott, Jochen] Univ Giessen, Dept Pediat Hematol & Oncol, Oncogenet Lab, Giessen, Germany; [Riehm, Hansjoerg; Zimmermann, Martin] Hannover Med Sch, Dept Pediat Hematol & Oncol, D-3000 Hannover, Germany; [Hunger, Stephen P.] Univ Colorado, Sch Med, Aurora, CO USA; [Hunger, Stephen P.] Univ Colorado, Ctr Canc, Aurora, CO USA; [Hunger, Stephen P.] Childrens Hosp Colorado, Aurora, CO USA; [Saha, Vaskar] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Canc, Childrens Canc Grp, Manchester, Lancs, England; [Richards, Sue] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Gaynon, Paul S.] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Baruchel, Andre] Hop Robert Debre, Dept Pediat Hematoimmunol, F-75019 Paris, France; [Baruchel, Andre] Univ Paris Diderot, Paris, France; [Conter, Valentino] Univ Milano Bicocca, Pediat Clin, Osped San Gerardo, Monza, Italy; [Conter, Valentino] Osped Riuniti Bergamo, Dept Pediat, I-24100 Bergamo, Italy; [Otten, Jacques] Univ Ziekenhuis Brussel, Dept Pediat, Hematooncol Unit, Brussels, Belgium; [Ohara, Akira] Toho Univ, Dept Pediat 1, Tokyo, Japan; [Versluys, Anne Birgitta] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Versluys, Anne Birgitta] Dutch Childhood Oncol Grp, The Hague, Netherlands; [Heyman, Mats] Karolinska Inst, Astrid Lindgren Childrens Hosp, Childhood Canc Res Unit, Stockholm, Sweden; [Silverman, Lewis B.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Silverman, Lewis B.] Dana Farber Canc Inst, Div Hematol Oncol, Boston, MA 02115 USA; [Silverman, Lewis B.] Childrens Hosp Boston, Boston, MA USA; [Horibe, Keizo] Clin Res Ctr, Nagoya Med Ctr, Nagoya, Aichi, Japan; [Mann, Georg] Univ Med Sch, St Anna Childrens Hosp, Dept Pediat, Vienna, Austria; [Camitta, Bruce M.] Med Coll Wisconsin, Midwest Ctr Canc & Blood Disorders, Milwaukee, WI 53226 USA; [Camitta, Bruce M.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Camitta, Bruce M.] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA; [Devidas, Meenakshi] Stat & Data Ctr, Childrens Oncol Grp, Gainesville, FL USA; [Devidas, Meenakshi] Univ Florida, Dept Biostat, Gainesville, FL USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Kiel; Schleswig Holstein University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Justus Liebig University Giessen; Hannover Medical School; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Manchester; University of Oxford; Children's Hospital Los Angeles; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; San Gerardo Hospital; University of Milano-Bicocca; Ospedali Riuniti di Bergamo; University Hospital Brussels; Vrije Universiteit Brussel; Toho University; Utrecht University; Utrecht University Medical Center; Dutch Childhood Oncology Group; Karolinska Institutet; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Nagoya Medical Center; Saint Anna Children's Hospital; Medical College of Wisconsin; Medical College of Wisconsin; Children's Hospital of Wisconsin; Children's Oncology Group (COG); State University System of Florida; University of Florida	Pui, CH (corresponding author), St Jude Childrens Res Hosp, Dept Oncol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	ching-hon.pui@stjude.org	Schrappe, Martin/ABA-6144-2020; Pui, Ching-Hon/N-8076-2018; Devidas, Meenakshi/H-1170-2019	Pui, Ching-Hon/0000-0003-0303-5658; Devidas, Meenakshi/0000-0002-1099-3478; Saha, Vaskar/0000-0002-2916-9649	Deutsche Krebshilfe; St. Anna Children's Cancer Research Institute, Austria; Deutsche Krebshilfe, Germany; Madeleine-Schickedanz-Kinderkrebsstiftung, Germany; Fordergemeinschaft Kinderkrebszentrum Hamburg, Germany; National Cancer Institute (NCI) [5PO1CA068484]; Assistance Publique-Hopitaux de Paris, INSERM, Institut Universitaire d'Hematologie and Centre de Recherche en Hematologie, Oncologie, et Pediatrie, France; American Lebanese Syrian Associated Charities; Medical Research Council, United Kingdom; Swedish Childhood Cancer Foundation; Danish Childhood Cancer Foundation; Norwegian Cancer Society; Fonds Cancer, Belgium; Ministry of Health, Labour, and Welfare, Japan; Children's Cancer Association of Japan;  [CA13539];  [CA98543];  [CA98413];  [CA30969];  [CA29139];  [CA21765]; MRC [MC_U137686856] Funding Source: UKRI; Cancer Research UK [14840] Funding Source: researchfish; Medical Research Council [MC_U137686856] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U10CA098413, P01CA068484, U10CA013539, U10CA030969, P30CA021765, U10CA029139, U10CA098543] Funding Source: NIH RePORTER	Deutsche Krebshilfe(Deutsche Krebshilfe); St. Anna Children's Cancer Research Institute, Austria; Deutsche Krebshilfe, Germany(Deutsche Krebshilfe); Madeleine-Schickedanz-Kinderkrebsstiftung, Germany; Fordergemeinschaft Kinderkrebszentrum Hamburg, Germany; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Assistance Publique-Hopitaux de Paris, INSERM, Institut Universitaire d'Hematologie and Centre de Recherche en Hematologie, Oncologie, et Pediatrie, France; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Childhood Cancer Foundation(European Commission); Danish Childhood Cancer Foundation; Norwegian Cancer Society(Norwegian Cancer Society); Fonds Cancer, Belgium; Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Children's Cancer Association of Japan; ; ; ; ; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Deutsche Krebshilfe and others.; Supported by St. Anna Children's Cancer Research Institute, Austria; Deutsche Krebshilfe, Germany; Madeleine-Schickedanz-Kinderkrebsstiftung, Germany; grants (CA13539, CA98543, and CA98413) to the Children's Cancer Group; Fordergemeinschaft Kinderkrebszentrum Hamburg, Germany; a grant (NCI 5PO1CA068484) from the National Cancer Institute to the Dana-Farber Cancer Institute; Assistance Publique-Hopitaux de Paris, INSERM, Institut Universitaire d'Hematologie and Centre de Recherche en Hematologie, Oncologie, et Pediatrie, France; grants (CA30969, CA29139, CA98543, and CA98413) to the Pediatric Oncology Group; a grant (CA21765) and funding from American Lebanese Syrian Associated Charities to St. Jude Children's Research Hospital; the Medical Research Council, United Kingdom; the Swedish Childhood Cancer Foundation; the Danish Childhood Cancer Foundation; the Norwegian Cancer Society; Fonds Cancer, Belgium; a Clinical Cancer Research grant from the Ministry of Health, Labour, and Welfare, Japan; and the Children's Cancer Association of Japan.	Arico M, 2000, NEW ENGL J MED, V342, P998, DOI 10.1056/NEJM200004063421402; Arico M, 2002, BLOOD, V100, P420, DOI 10.1182/blood.V100.2.420; Arico M, 2008, J CLIN ONCOL, V26, P283, DOI 10.1200/JCO.2007.12.3927; Bader P, 2009, J CLIN ONCOL, V27, P377, DOI 10.1200/JCO.2008.17.6065; Balduzzi A, 2005, LANCET, V366, P635, DOI 10.1016/S0140-6736(05)66998-X; Biondi A, 2000, BLOOD, V96, P24, DOI 10.1182/blood.V96.1.24; Cave H, 1998, NEW ENGL J MED, V339, P591, DOI 10.1056/NEJM199808273390904; CHESSELLS JM, 1995, LANCET, V345, P143, DOI 10.1016/S0140-6736(95)90164-7; Conter V, 2010, LEUKEMIA, V24, P255, DOI 10.1038/leu.2009.250; Conter V, 2010, BLOOD, V115, P3206, DOI 10.1182/blood-2009-10-248146; COX DR, 1972, J R STAT SOC B, V34, P187; Duval M, 2002, BLOOD, V99, P2734, DOI 10.1182/blood.V99.8.2734; Eckert C, 2001, LANCET, V358, P1239, DOI 10.1016/S0140-6736(01)06355-3; Einsiedel HG, 2005, J CLIN ONCOL, V23, P7942, DOI 10.1200/JCO.2005.01.1031; Einsiedel HG, 2008, J CLIN ONCOL, V26, P2238; Gaynon PS, 2010, LEUKEMIA, V24, P285, DOI 10.1038/leu.2009.262; Gaynon PS, 2005, BRIT J HAEMATOL, V131, P579, DOI 10.1111/j.1365-2141.2005.05773.x; Heerema NA, 2000, J CLIN ONCOL, V18, P1876, DOI 10.1200/JCO.2000.18.9.1876; JANKASCHAUB GE, 1992, HAEMATOL BLOOD TRANS, V34, P233; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KASPERS GJL, 1995, BLOOD, V85, P751, DOI 10.1182/blood.V85.3.751.bloodjournal853751; Ko RH, 2010, J CLIN ONCOL, V28, P648, DOI 10.1200/JCO.2009.22.2950; Mann G, 2010, BLOOD, V116, P2644, DOI 10.1182/blood-2010-03-273532; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Mitchell C, 2010, LEUKEMIA, V24, P406, DOI 10.1038/leu.2009.256; Moricke A, 2010, LEUKEMIA, V24, P265, DOI 10.1038/leu.2009.257; Moghrabi A, 2007, BLOOD, V109, P896, DOI 10.1182/blood-2006-06-027714; Moorman AV, 2010, LANCET ONCOL, V11, P429, DOI 10.1016/S1470-2045(10)70066-8; Moricke A, 2009, BLOOD, V113, P4478; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Nachman JB, 2007, BLOOD, V110, P1112, DOI 10.1182/blood-2006-07-038299; Nachman JB, 1998, NEW ENGL J MED, V338, P1663, DOI 10.1056/NEJM199806043382304; Nguyen K, 2008, LEUKEMIA, V22, P2142, DOI 10.1038/leu.2008.251; Ottmann OG, 2007, CANCER-AM CANCER SOC, V109, P2068, DOI 10.1002/cncr.22631; Oudot C, 2008, J CLIN ONCOL, V26, P1496, DOI 10.1200/JCO.2007.12.2820; PIETERS R, 1991, LANCET, V338, P399, DOI 10.1016/0140-6736(91)91029-T; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Pui CH, 2002, LANCET, V359, P1909, DOI 10.1016/S0140-6736(02)08782-2; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; REITER A, 1994, BLOOD, V84, P3122, DOI 10.1182/blood.V84.9.3122.3122; RIEHM H, 1980, AM J PEDIAT HEMATOL, V2, P299; Salzer WL, 2010, LEUKEMIA, V24, P355, DOI 10.1038/leu.2009.261; Schmiegelow K, 2010, LEUKEMIA, V24, P345, DOI 10.1038/leu.2009.251; Schrappe M, 1998, BLOOD, V92, P2730; Schrappe M, 2000, BLOOD, V95, P3310; Schrappe M, 2011, BLOOD, V118, P2077, DOI 10.1182/blood-2011-03-338707; Schrauder A, 2006, J CLIN ONCOL, V24, P5742, DOI 10.1200/JCO.2006.06.2679; Schultz KR, 2007, BLOOD, V109, P926, DOI 10.1182/blood-2006-01-024729; Schultz KR, 2009, J CLIN ONCOL, V27, P5175, DOI 10.1200/JCO.2008.21.2514; Silverman LB, 2010, LEUKEMIA, V24, P320, DOI 10.1038/leu.2009.253; Silverman LB, 1999, CANCER-AM CANCER SOC, V85, P1395, DOI 10.1002/(SICI)1097-0142(19990315)85:6<1395::AID-CNCR25>3.0.CO;2-2; Smith M, 1996, J CLIN ONCOL, V14, P680, DOI 10.1200/JCO.1996.14.2.680; SYNOLD TW, 1994, J CLIN INVEST, V94, P1996, DOI 10.1172/JCI117552; Tallen G, 2010, J CLIN ONCOL, V28, P2339, DOI 10.1200/JCO.2009.25.1983; Tsuchida M, 2010, LEUKEMIA, V24, P383, DOI 10.1038/leu.2009.260; van Dongen JJM, 1998, LANCET, V352, P1731, DOI 10.1016/S0140-6736(98)04058-6; Vignetti M, 2007, BLOOD, V109, P3676, DOI 10.1182/blood-2006-10-052746; Yanada M, 2006, J CLIN ONCOL, V24, P460, DOI 10.1200/JCO.2005.03.2177	58	197	209	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 12	2012	366	15					1371	1381		10.1056/NEJMoa1110169	http://dx.doi.org/10.1056/NEJMoa1110169			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923GV	22494120	Green Accepted, Green Published			2022-12-28	WOS:000302608600001
J	Yuan, JH; Branch, RW; Hosu, BG; Berg, HC				Yuan, Junhua; Branch, Richard W.; Hosu, Basarab G.; Berg, Howard C.			Adaptation at the output of the chemotaxis signalling pathway	NATURE			English	Article							ESCHERICHIA-COLI CHEMOTAXIS; BACTERIAL FLAGELLAR MOTOR; RESONANCE ENERGY-TRANSFER; ROTARY MOTOR; ZERO LOAD; IN-VIVO; SENSITIVITY; PROTEIN; EXPRESSION; RECEPTORS	In the bacterial chemotaxis network, receptor clusters process input(1-3), and flagellar motors generate output(4). Receptor and motor complexes are coupled by the diffusible protein CheY-P. Receptor output (the steady-state concentration of CheY-P) varies from cell to cell(5). However, the motor is ultrasensitive, with a narrow operating range of CheY-P concentrations(6). How the match between receptor output and motor input might be optimized is unclear. Here we show that the motor can shift its operating range by changing its composition. The number of FliM subunits in the C-ring increases in response to a decrement in the concentration of CheY-P, increasing motor sensitivity. This shift in sensitivity explains the slow partial adaptation observed in mutants that lack the receptor methyltransferase and methylesterase(7,8) and why motors show signal-dependent FliM turnover(9). Adaptive remodelling is likely to be a common feature in the operation of many molecular machines.	[Yuan, Junhua; Branch, Richard W.; Hosu, Basarab G.; Berg, Howard C.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Berg, HC (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	hberg@mcb.harvard.edu			National Institutes of Health [AI016478]; EMBO; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI016478, R01AI016478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI016478. R.W.B. is a recipient of an EMBO Long-Term Fellowship.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Alon U, 1998, EMBO J, V17, P4238, DOI 10.1093/emboj/17.15.4238; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; BERG HC, 1984, J GEN MICROBIOL, V130, P2915; BLAIR DF, 1988, SCIENCE, V242, P1678, DOI 10.1126/science.2849208; Blat Y, 1996, J BIOL CHEM, V271, P1226, DOI 10.1074/jbc.271.2.1226; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Delalez NJ, 2010, P NATL ACAD SCI USA, V107, P11347, DOI 10.1073/pnas.1000284107; Duke TAJ, 1999, P NATL ACAD SCI USA, V96, P10104, DOI 10.1073/pnas.96.18.10104; Fukuoka H, 2010, BIOCHEM BIOPH RES CO, V394, P130, DOI 10.1016/j.bbrc.2010.02.129; Greenfield D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000137; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hansen CH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040001; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Levin MD, 1998, BIOPHYS J, V74, P175, DOI 10.1016/S0006-3495(98)77777-X; Lipkow K, 2006, PLOS COMPUT BIOL, V2, P301, DOI 10.1371/journal.pcbi.0020039; Mello BA, 2007, BIOPHYS J, V92, P2329, DOI 10.1529/biophysj.106.097808; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; PARKINSON JS, 1978, J BACTERIOL, V135, P45, DOI 10.1128/JB.135.1.45-53.1978; Reid SW, 2006, P NATL ACAD SCI USA, V103, P8066, DOI 10.1073/pnas.0509932103; SEGALL JE, 1986, P NATL ACAD SCI USA, V83, P8987, DOI 10.1073/pnas.83.23.8987; Shimizu TS, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.37; Shimizu TS, 2006, P NATL ACAD SCI USA, V103, P2093, DOI 10.1073/pnas.0510958103; Sourjik V, 2004, TRENDS MICROBIOL, V12, P569, DOI 10.1016/j.tim.2004.10.003; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P12669, DOI 10.1073/pnas.192463199; Sourjik V, 2007, METHOD ENZYMOL, V423, P365, DOI 10.1016/S0076-6879(07)23017-4; STOCK J, 1985, CELL, V42, P683, DOI 10.1016/0092-8674(85)90125-4; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Tumer L, 1996, BIOPHYS J, V71, P2227, DOI 10.1016/S0006-3495(96)79425-0; Yuan JH, 2008, P NATL ACAD SCI USA, V105, P1182, DOI 10.1073/pnas.0711539105; Yuan JH, 2010, P NATL ACAD SCI USA, V107, P12846, DOI 10.1073/pnas.1007333107; Yuan JH, 2009, J MOL BIOL, V390, P394, DOI 10.1016/j.jmb.2009.05.039	36	110	113	1	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					233	U115		10.1038/nature10964	http://dx.doi.org/10.1038/nature10964			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22498629	Green Submitted, Green Accepted			2022-12-28	WOS:000303149900033
J	Browne, OT; Bhandari, S				Browne, Oliver T.; Bhandari, Sunil			RATIONAL TESTING Interpreting and investigating proteinuria	BRITISH MEDICAL JOURNAL			English	Editorial Material							GENERAL-POPULATION; ALBUMIN EXCRETION; KIDNEY-FUNCTION; ASSOCIATION; PREDICTION; MORTALITY; OUTCOMES; DISEASE; EVENTS; RISK		[Bhandari, Sunil] Hull & E Yorkshire Hosp NHS Trust, Dept Renal Med, Kingston Upon Hull HU3 2JZ, Yorks, England; Hull York Med Sch, Kingston Upon Hull HU3 2JZ, Yorks, England	University of Hull; University of York - UK	Bhandari, S (corresponding author), Hull & E Yorkshire Hosp NHS Trust, Dept Renal Med, Kingston Upon Hull HU3 2JZ, Yorks, England.	sunil.bhandari@hey.nhs.uk		bhandari, sunil/0000-0002-0996-9622				Atkins RC, 2003, NEPHROL DIAL TRANSPL, V18, P2170, DOI 10.1093/ndt/gfg314; Brantsma AH, 2008, J AM SOC NEPHROL, V19, P1785, DOI 10.1681/ASN.2007101065; Car J, 2006, BMJ-BRIT MED J, V332, P94, DOI 10.1136/bmj.332.7533.94; Di Angelantonio E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4986; Garg AX, 2002, KIDNEY INT, V61, P2165, DOI 10.1046/j.1523-1755.2002.00356.x; Guy M, 2009, ANN CLIN BIOCHEM, V46, P468, DOI 10.1258/acb.2009.009001; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; HUTCHISON AS, 1988, CLIN CHEM, V34, P2019; JENKINS RD, 1986, JAMA-J AM MED ASSOC, V255, P3397, DOI 10.1001/jama.255.24.3397; Lambers Heerspink HJ, 2010, J AM SOC NEPHROL, V21, P1355, DOI 10.1681/ASN.2010010063; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; National Institute for Health and Clinical Excellence, 2008, CLIN GUID CG73; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; Price CP, 2005, CLIN CHEM, V51, P1577, DOI 10.1373/clinchem.2005.049742; *SCOTT INT GUID NE, 2008, DIAGN MAN CHRON KIDN; van der Velde M, 2009, J AM SOC NEPHROL, V20, P852, DOI 10.1681/ASN.2008060655	16	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 5	2012	344								e2339	10.1136/bmj.e2339	http://dx.doi.org/10.1136/bmj.e2339			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923HF	22491954				2022-12-28	WOS:000302609700012
J	Fang, F; Fall, K; Mittleman, MA; Sparen, P; Ye, WM; Adami, HO; Valdimarsdottir, U				Fang, Fang; Fall, Katja; Mittleman, Murray A.; Sparen, Par; Ye, Weimin; Adami, Hans-Olov; Valdimarsdottir, Unnur			Suicide and Cardiovascular Death after a Cancer Diagnosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BREAST-CANCER; PSYCHOLOGICAL DISTRESS; PROSTATE-CANCER; CASE-CROSSOVER; RISK; PREVALENCE; DISORDERS; THERAPY; ILLNESS; DISEASE	BACKGROUND Receiving a diagnosis of cancer is a traumatic experience that may trigger immediate adverse health consequences beyond the effects of the disease or treatment. METHODS Using Poisson and negative binomial regression models, we conducted a historical cohort study involving 6,073,240 Swedes to examine the associations between a cancer diagnosis and the immediate risk of suicide or death from cardiovascular causes from 1991 through 2006. To adjust for unmeasured confounders, we also performed a nested, self-matched case-crossover analysis among all patients with cancer who died from suicide or cardiovascular diseases in the cohort. RESULTS As compared with cancer-free persons, the relative risk of suicide among patients receiving a cancer diagnosis was 12.6 (95% confidence interval [CI], 8.6 to 17.8) during the first week (29 patients; incidence rate, 2.50 per 1000 person-years) and 3.1 (95% CI, 2.7 to 3.5) during the first year (260 patients; incidence rate, 0.60 per 1000 personyears). The relative risk of cardiovascular death after diagnosis was 5.6 (95% CI, 5.2 to 5.9) during the first week (1318 patients; incidence rate, 116.80 per 1000 person-years) and 3.3 (95% CI, 3.1 to 3.4) during the first 4 weeks (2641 patients; incidence rate, 65.81 per 1000 person-years). The risk elevations decreased rapidly during the first year after diagnosis. Increased risk was particularly prominent for cancers with a poor prognosis. The case-crossover analysis largely confirmed results from the main analysis. CONCLUSIONS In this large cohort study, patients who had recently received a cancer diagnosis had increased risks of both suicide and death from cardiovascular causes, as compared with cancer-free persons. (Funded by the Swedish Council for Working Life and Social Research and others.)	[Fang, Fang; Sparen, Par; Ye, Weimin; Adami, Hans-Olov] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Fall, Katja] Univ Orebro, Clin Epidemiol & Biostat Unit, Orebro, Sweden; [Fall, Katja] Orebro Univ Hosp, Orebro, Sweden; [Mittleman, Murray A.] Beth Israel Deaconess Med Ctr, Dept Med, Cardiovasc Epidemiol Res Unit, Boston, MA 02215 USA; [Mittleman, Murray A.] Harvard Univ, Sch Med, Boston, MA USA; [Fall, Katja; Mittleman, Murray A.; Adami, Hans-Olov; Valdimarsdottir, Unnur] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Fall, Katja; Valdimarsdottir, Unnur] Univ Iceland, Ctr Publ Hlth Sci, Reykjavik, Iceland	Karolinska Institutet; Orebro University; Orebro University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Iceland	Fang, F (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Box 281, S-17177 Stockholm, Sweden.	fang.fang@ki.se	Fall, Katja/AAE-1876-2021; Papadopoulos, Fotios/H-1319-2019	Fall, Katja/0000-0002-3649-2639; Papadopoulos, Fotios/0000-0002-8692-3652; Valdimarsdottir, Unnur/0000-0001-5382-946X; Fang, Fang/0000-0002-3310-6456; Sparen, Par/0000-0002-5184-8971; Mittleman, Murray/0000-0001-9788-7274	Swedish Council for Working Life and Social Research [2008-1310, 2011-0473]; Swedish Research Council [SIMSAM 80748301]; Hjarnfonden and Svenska Sallskapet for Medicinsk Forskning	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Hjarnfonden and Svenska Sallskapet for Medicinsk Forskning	Supported by grants from the Swedish Council for Working Life and Social Research (2008-1310 and 2011-0473) and the Swedish Research Council (SIMSAM 80748301) and by postdoctoral fellowships (to Dr. Fang) from Hjarnfonden and Svenska Sallskapet for Medicinsk Forskning.	ALLEBECK P, 1989, J CLIN EPIDEMIOL, V42, P611, DOI 10.1016/0895-4356(89)90003-6; Annunziata MA, 2011, SUPPORT CARE CANCER, V19, P291, DOI 10.1007/s00520-010-0818-9; Carlson LE, 2010, J CLIN ONCOL, V28, P4884, DOI 10.1200/JCO.2009.27.3698; Collier A, 2011, AM J CLIN ONCOL 0203; Fall K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000197; Fang F, 2010, JNCI-J NATL CANCER I, V102, P307, DOI 10.1093/jnci/djp537; Hem E, 2004, J CLIN ONCOL, V22, P4209, DOI 10.1200/jco.2004.02.052; Ikeda RM, 2001, SUICIDE LIFE-THREAT, V32, P60, DOI 10.1521/suli.32.1.5.60.24207; Johnson TV, 2011, PSYCHOONCOLOGY  0124; Kangas M, 2005, J CONSULT CLIN PSYCH, V73, P763, DOI 10.1037/0022-006X.73.4.763; Keating NL, 2010, J NATL CANCER I, V102, P39, DOI 10.1093/jnci/djp404; Llorente MD, 2005, AM J GERIAT PSYCHIAT, V13, P195, DOI 10.1176/appi.ajgp.13.3.195; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Mehnert A, 2007, PSYCHO-ONCOLOGY, V16, P181, DOI 10.1002/pon.1057; Millar K, 2005, J PSYCHOSOM RES, V58, P335, DOI 10.1016/j.jpsychores.2004.10.005; Miller M, 2008, J CLIN ONCOL, V26, P4720, DOI 10.1200/JCO.2007.14.3990; Misono S, 2008, J CLIN ONCOL, V26, P4731, DOI 10.1200/JCO.2007.13.8941; MITTLEMAN MA, 1995, AM J EPIDEMIOL, V142, P91, DOI 10.1093/oxfordjournals.aje.a117550; Mouridsen H, 2007, J CLIN ONCOL, V25, P5715, DOI 10.1200/JCO.2007.12.1665; Norton TR, 2004, J CLIN ONCOL, V22, P919, DOI 10.1200/JCO.2004.07.028; Quan H, 2002, SOC PSYCH PSYCH EPID, V37, P190, DOI 10.1007/s001270200014; Schairer C, 2006, JNCI-J NATL CANCER I, V98, P1416, DOI 10.1093/jnci/djj377; Sellick SM, 2007, PSYCHO-ONCOL, V16, P534, DOI 10.1002/pon.1085; Senf B, 2010, SUPPORT CARE CANCER, V18, P957, DOI 10.1007/s00520-010-0850-9; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747; Turner J, 2005, PSYCHO-ONCOLOGY, V14, P396, DOI 10.1002/pon.856; Van Hemelrijck M, 2010, J CLIN ONCOL, V28, P3448, DOI 10.1200/JCO.2010.29.1567	27	278	284	4	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 5	2012	366	14					1310	1318		10.1056/NEJMoa1110307	http://dx.doi.org/10.1056/NEJMoa1110307			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	919QJ	22475594				2022-12-28	WOS:000302343000008
J	Varadhan, KK; Neal, KR; Lobo, DN				Varadhan, Krishna K.; Neal, Keith R.; Lobo, Dileep N.			Safety and efficacy of antibiotics compared with appendicectomy for treatment of uncomplicated acute appendicitis: meta-analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SUSPECTED APPENDICITIS; DIAGNOSTIC-ACCURACY; HELICAL CT; THERAPY; MANAGEMENT; RISK; AGE	Objective To compare the safety and efficacy of antibiotic treatment versus appendicectomy for the primary treatment of uncomplicated acute appendicitis. Design Meta-analysis of randomised controlled trials. Population Randomised controlled trials of adult patients presenting with uncomplicated acute appendicitis, diagnosed by haematological and radiological investigations. Interventions Antibiotic treatment versus appendicectomy. Outcome measures The primary outcome measure was complications. The secondary outcome measures were efficacy of treatment, length of stay, and incidence of complicated appendicitis and readmissions. Results Four randomised controlled trials with a total of 900 patients (470 antibiotic treatment, 430 appendicectomy) met the inclusion criteria. Antibiotic treatment was associated with a 63% (277/438) success rate at one year. Meta-analysis of complications showed a relative risk reduction of 31% for antibiotic treatment compared with appendicectomy (risk ratio (Mantel-Haenszel, fixed) 0.69 (95% confidence interval 0.54 to 0.89); I-2=0%; P=0.004). A secondary analysis, excluding the study with crossover of patients between the two interventions after randomisation, showed a significant relative risk reduction of 39% for antibiotic therapy (risk ratio 0.61 (0.40 to 0.92); I-2=0%; P=0.02). Of the 65 (20%) patients who had appendicectomy after readmission, nine had perforated appendicitis and four had gangrenous appendicitis. No significant differences were seen for treatment efficacy, length of stay, or risk of developing complicated appendicitis. Conclusion Antibiotics are both effective and safe as primary treatment for patients with uncomplicated acute appendicitis. Initial antibiotic treatment merits consideration as a primary treatment option for early uncomplicated appendicitis.	[Varadhan, Krishna K.; Neal, Keith R.; Lobo, Dileep N.] Univ Nottingham Hosp, Queens Med Ctr, Div Gastrointestinal Surg, Nottingham Digest Dis Ctr NIHR Biomed Res Unit, Nottingham NG7 2UH, England; [Neal, Keith R.] Univ Nottingham Hosp, Dept Epidemiol & Publ Hlth, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham	Lobo, DN (corresponding author), Univ Nottingham Hosp, Queens Med Ctr, Div Gastrointestinal Surg, Nottingham Digest Dis Ctr NIHR Biomed Res Unit, Nottingham NG7 2UH, England.	Dileep.Lobo@nottingham.ac.uk	Lobo, Dileep/AAC-6207-2020	Lobo, Dileep/0000-0003-1187-5796	Nottingham Digestive Diseases Centre NIHR Biomedical Research Unit	Nottingham Digestive Diseases Centre NIHR Biomedical Research Unit	KKV was funded by a research fellowship from the Nottingham Digestive Diseases Centre NIHR Biomedical Research Unit. The funders had no role in the design, execution, and writing up of the study.	AIVAZYAN V P, 1975, Zhurnal Eksperimental'noi i Klinicheskoi Meditsiny, V15, P70; ANDERSSON RE, 1992, EUR J SURG, V158, P37; Ansaloni L, 2011, DIGEST SURG, V28, P210, DOI 10.1159/000324595; Blomqvist PG, 2001, ANN SURG, V233, P455, DOI 10.1097/00000658-200104000-00001; BOWERS W F, 1958, U S Armed Forces Med J, V9, P1545; Campbell MR, 2004, J AM COLL SURGEONS, V198, P822, DOI 10.1016/j.jamcollsurg.2004.01.009; Coldrey E., 1959, J INT COLL SURG, V32, P255; Coursey CA, 2010, RADIOLOGY, V254, P460, DOI 10.1148/radiol.09082298; Di Sebastiano P, 1999, LANCET, V354, P461, DOI 10.1016/S0140-6736(98)10463-4; ERIKSSON S, 1995, BRIT J SURG, V82, P166, DOI 10.1002/bjs.1800820207; Fitz RH, 1886, AM J MED SCI, V92, P246; Fitzmaurice GJ, 2011, CAN J SURG, V54, P307, DOI 10.1503/cjs.006610; Guller U, BR J SURG, V98, P589; Gurin N N, 1992, Vestn Khir Im I I Grek, V148, P144; Hansson J, 2009, BRIT J SURG, V96, P473, DOI 10.1002/bjs.6482; Jan Brozek AO, 2008, GRADEPRO COMPUTER PR; Konstantinidis KM, 2008, J LAPAROENDOSC ADV S, V18, P248, DOI 10.1089/lap.2006.0209; Liu K, 2007, AM SURGEON, V73, P1161; Liu K, 2011, SURGERY, V150, P673, DOI 10.1016/j.surg.2011.08.018; Livingston EH, 2007, ANN SURG, V245, P886, DOI 10.1097/01.sla.0000256391.05233.aa; Lopez PP, 2007, AM SURGEON, V73, P1232; LUCKMANN R, 1989, AM J EPIDEMIOL, V129, P905, DOI 10.1093/oxfordjournals.aje.a115224; Malik AA, 2009, J GASTROINTEST SURG, V13, P966, DOI 10.1007/s11605-009-0835-5; McBurney C., 1889, NY MED J, V50, P1676; McGreevy JM, 2002, SURG ENDOSC, V16, P1046, DOI 10.1007/s00464-001-8332-2; Ming PC, 2009, SURG LAPARO ENDO PER, V19, P244, DOI 10.1097/SLE.0b013e3181a4cda2; MUELLER BA, 1986, NEW ENGL J MED, V315, P1506, DOI 10.1056/NEJM198612113152402; Park HC, 2011, AM SURGEON, V77, P752; PUYLAERT JBCM, 1987, NEW ENGL J MED, V317, P666, DOI 10.1056/NEJM198709103171103; Rao PM, 1997, RADIOLOGY, V202, P139, DOI 10.1148/radiology.202.1.8988203; Rhea JT, 1999, RADIOL CLIN N AM, V37, P489, DOI 10.1016/S0033-8389(05)70108-1; Rivera-Chavez FA, 2004, ANN SURG, V240, P269, DOI 10.1097/01.sla.0000133184.10676.26; Rivera-Chavez FA, 2003, ANN SURG, V237, P408, DOI 10.1097/00000658-200303000-00016; Sauerland S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001546.pub3; Simillis C, 2010, SURGERY, V147, P818, DOI 10.1016/j.surg.2009.11.013; STEAD RH, 1990, J PATHOL, V161, P209, DOI 10.1002/path.1711610307; Styrud J, 2006, WORLD J SURG, V30, P1033, DOI 10.1007/s00268-005-0304-6; Styrud J, 1999, DIGEST SURG, V16, P39, DOI 10.1159/000018692; Turhan AN, 2009, ULUS TRAVMA ACIL CER, V15, P459; Varadhan KK, 2010, WORLD J SURG, V34, P199, DOI 10.1007/s00268-009-0343-5; Vons C, 2011, LANCET, V377, P1573, DOI 10.1016/S0140-6736(11)60410-8; Wang Y, 1996, LANCET, V347, P1076, DOI 10.1016/S0140-6736(96)90279-2; Wilms IM, 2011, COCHRANE DB SYST REV, V11, DOI DOI 10.1002/14651858.CD008359.PUB2REVIEW	43	231	236	0	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 5	2012	344								e2156	10.1136/bmj.e2156	http://dx.doi.org/10.1136/bmj.e2156			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923HF	22491789	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000302609700001
J	Zilles, K; Amunts, K				Zilles, Karl; Amunts, Katrin			Segregation and Wiring in the Brain	SCIENCE			English	Editorial Material							CEREBRAL-CORTEX; ARCHITECTURE; CYTO		[Zilles, Karl] Univ Dusseldorf, D-50001 Dusseldorf, Germany; [Zilles, Karl; Amunts, Katrin] Res Ctr Julich, Inst Neurosci & Med, D-52425 Julich, Germany; [Amunts, Katrin] Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, D-52056 Aachen, Germany	Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; RWTH Aachen University	Zilles, K (corresponding author), Univ Dusseldorf, D-50001 Dusseldorf, Germany.	k.zilles@fz-juelich.de	Zilles, Karl/Y-3784-2019; Zilles, Karl/J-9704-2013; Amunts, Katrin/I-3470-2013	Zilles, Karl/0000-0002-4705-4175; Zilles, Karl/0000-0001-9296-9959; Amunts, Katrin/0000-0001-5828-0867				Amunts K, 2007, NEUROIMAGE, V37, P1061, DOI 10.1016/j.neuroimage.2007.02.037; Blinkov S.M., 1986, HUMAN BRAIN FIGURES; Brockhaus H, 1940, J PSYCHOL NEUROL, V49, P249; Brodmann K, 1909, VERGLEICHENDE LOKALI; Chen CH, 2012, SCIENCE, V335, P1634, DOI 10.1126/science.1215330; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Kuhlenbeck H., 1973, CENTRAL NERVOUS SYST; SANIDES F, 1964, J Hirnforsch, V7, P269; Vogt O, 1910, J PSYCHOL NEUROL, V15, P221; Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280; Zilles K., 2012, HUMAN NERVOUS SYSTEM, P826; Zilles K, 2010, NAT REV NEUROSCI, V11, P139, DOI 10.1038/nrn2776; Zilles K, 2009, CURR OPIN NEUROL, V22, P331, DOI 10.1097/WCO.0b013e32832d95db	13	33	33	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1582	1584		10.1126/science.1221366	http://dx.doi.org/10.1126/science.1221366			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461598				2022-12-28	WOS:000302062600030
J	Zhao, TT; Graham, OS; Raposo, A; St Johnston, D				Zhao, Tongtong; Graham, Owen S.; Raposo, Alexandre; St Johnston, Daniel			Growing Microtubules Push the Oocyte Nucleus to Polarize the Drosophila Dorsal-Ventral Axis	SCIENCE			English	Article							LIVING CELLS; CYTOPLASMIC DYNEIN; OOGENESIS; MIGRATION; ORGANIZATION; CYTOSKELETON; CENTRIOLES; POSTERIOR; MOTORS; PAR-1	The Drosophila dorsal-ventral (DV) axis is polarized when the oocyte nucleus migrates from the posterior to the anterior margin of the oocyte. Prior work suggested that dynein pulls the nucleus to the anterior side along a polarized microtubule cytoskeleton, but this mechanism has not been tested. By imaging live oocytes, we find that the nucleus migrates with a posterior indentation that correlates with its direction of movement. Furthermore, both nuclear movement and the indentation depend on microtubule polymerization from centrosomes behind the nucleus. Thus, the nucleus is not pulled to the anterior but is pushed by the force exerted by growing microtubules. Nuclear migration and DV axis formation therefore depend on centrosome positioning early in oogenesis and are independent of anterior-posterior axis formation.	[Zhao, Tongtong; Raposo, Alexandre; St Johnston, Daniel] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Zhao, Tongtong; Raposo, Alexandre; St Johnston, Daniel] Univ Cambridge, Dept Genet, Cambridge CB2 1QN, England; [Graham, Owen S.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England	University of Cambridge; University of Cambridge; University of Cambridge	St Johnston, D (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	d.stjohnston@gurdon.cam.ac.uk	St Johnston, Daniel/C-9568-2009	St Johnston, Daniel/0000-0001-5582-3301; Raposo, Alexandre/0000-0002-2794-0508	Wellcome Trust; FAZIT Stiftung; Boehringer Ingelheim Fonds; Cambridge European Trust; Fundacao para a Ciencia e Tecnologia	Wellcome Trust(Wellcome TrustEuropean Commission); FAZIT Stiftung; Boehringer Ingelheim Fonds(Boehringer Ingelheim); Cambridge European Trust; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	We would like to thank J. Raff for providing the Dlic-GFP fly stock and centrosomal markers; H. Nash for providing the Mud antibody; S. Young for help with image analysis; and J. Guck, Y.-C. Oei, and P. K. Trong for help with the force calculations. This work was supported by a Wellcome Trust Principal Research Fellowship to D.StJ., Ph.D. scholarships from the FAZIT Stiftung, the Boehringer Ingelheim Fonds and the Cambridge European Trust to T.Z., the Gulbenkian Ph.D. scholarship of the Fundacao para a Ciencia e Tecnologia to A. R., and core support from the Wellcome Trust and Cancer Research UK.	Bastock R, 2008, CURR BIOL, V18, pR1082, DOI 10.1016/j.cub.2008.09.011; Bausch AR, 1999, BIOPHYS J, V76, P573, DOI 10.1016/S0006-3495(99)77225-5; Bolivar J, 2001, DEVELOPMENT, V128, P1889; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Dahlgaard K, 2007, DEV CELL, V13, P539, DOI 10.1016/j.devcel.2007.09.003; Dogterom M, 2005, CURR OPIN CELL BIOL, V17, P67, DOI 10.1016/j.ceb.2004.12.011; Duncan JE, 2002, CURR BIOL, V12, P1982, DOI 10.1016/S0960-9822(02)01303-9; Dupin I, 2011, INT J BIOCHEM CELL B, V43, P1698, DOI 10.1016/j.biocel.2011.09.004; Fichelson P, 2010, DEVELOPMENT, V137, P815, DOI 10.1242/dev.045013; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; Grieder NC, 2000, DEVELOPMENT, V127, P4253; Hochmuth RM, 2000, J BIOMECH, V33, P15, DOI 10.1016/S0021-9290(99)00175-X; Huynh JR, 2001, DEVELOPMENT, V128, P1201; Januschke J, 2002, CURR BIOL, V12, P1971, DOI 10.1016/S0960-9822(02)01302-7; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; KOCH EA, 1983, CELL TISSUE RES, V228, P21; LEE YC, 1982, J BIOL CHEM, V257, P6306; Lei YD, 2000, DEV BIOL, V226, P57, DOI 10.1006/dbio.2000.9848; MAHOWALD AP, 1970, J CELL BIOL, V45, P306, DOI 10.1083/jcb.45.2.306; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Mogilner A, 2003, CURR BIOL, V13, pR721, DOI 10.1016/j.cub.2003.08.050; Radulescu AE, 2010, TRENDS CELL BIOL, V20, P214, DOI 10.1016/j.tcb.2010.01.003; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; Rusan NM, 2009, TRAFFIC, V10, P472, DOI 10.1111/j.1600-0854.2009.00880.x; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; Stevens NR, 2007, CURR BIOL, V17, P1498, DOI 10.1016/j.cub.2007.07.060; Swan A, 1999, NAT CELL BIOL, V1, P444, DOI 10.1038/15680; Swan A, 1996, DEVELOPMENT, V122, P3577; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Watanabe N, 2010, P JPN ACAD B-PHYS, V86, P62, DOI 10.2183/pjab.86.62	30	101	101	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2012	336	6084					999	1003		10.1126/science.1219147	http://dx.doi.org/10.1126/science.1219147			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22499806	Green Accepted			2022-12-28	WOS:000304406800036
J	Dudin, YO; Kuzmich, A				Dudin, Y. O.; Kuzmich, A.			Strongly Interacting Rydberg Excitations of a Cold Atomic Gas	SCIENCE			English	Article							QUANTUM MEMORY; BLOCKADE	Highly excited Rydberg atoms have many exaggerated properties. In particular, the interaction strength between such atoms can be varied over an enormous range. In a mesoscopic ensemble, such strong, long-range interactions can be used for fast preparation of desired many-particle states. We generated Rydberg excitations in an ultra-cold atomic gas and subsequently converted them into light. As the principal quantum number n was increased beyond similar to 70, no more than a single excitation was retrieved from the entire mesoscopic ensemble of atoms. These results hold promise for studies of dynamics and disorder in many-body systems with tunable interactions and for scalable quantum information networks.	[Dudin, Y. O.; Kuzmich, A.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Kuzmich, A (corresponding author), Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA.	alex.kuzmich@physics.gatech.edu	Dudin, Yaroslav/E-3447-2010		Air Force Office of Scientific Research; Quantum Memories Multidisciplinary University Research Initiative; NSF	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Quantum Memories Multidisciplinary University Research Initiative; NSF(National Science Foundation (NSF))	We thank F. Bariani, B. Kennedy, A. Radnaev, A. Zangwill, and C. Campbell for discussions. This work was supported by the Air Force Office of Scientific Research Atomic Physics Program, Quantum Memories Multidisciplinary University Research Initiative, and NSF.	Bariani F, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.033811; Bariani F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.030501; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Brekke E, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.063830; Brion E, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.260501; CUMMINGS FW, 1983, PHYS REV A, V28, P2282, DOI 10.1103/PhysRevA.28.2282; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Gaetan A, 2009, NAT PHYS, V5, P115, DOI 10.1038/NPHYS1183; Gorshkov AV, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.133602; Heidemann R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.163601; Kubler H, 2010, NAT PHOTONICS, V4, P112, DOI 10.1038/NPHOTON.2009.260; Liebisch TC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.253002; Lukin MD, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.037901; Matsukevich DN, 2004, SCIENCE, V306, P663, DOI 10.1126/science.1103346; Muller M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.170502; Olmos B, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.185302; Pritchard JD, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.193603; Pupillo G, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.223002; Radnaev AG, 2010, NAT PHYS, V6, P894, DOI [10.1038/NPHYS1773, 10.1038/nphys1773]; Saffman M, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.042302; Saffman M, 2010, REV MOD PHYS, V82, P2313, DOI 10.1103/RevModPhys.82.2313; Singer K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.163001; Tong D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.063001; Urban E, 2009, NAT PHYS, V5, P110, DOI 10.1038/NPHYS1178; Vogt T, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.083003; Weimer H, 2010, NAT PHYS, V6, P382, DOI 10.1038/NPHYS1614; Zhao B, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.052329; Zhao R, 2009, NAT PHYS, V5, P100, DOI 10.1038/NPHYS1152; Zwierlein MW, 2005, NATURE, V435, P1047, DOI 10.1038/nature03858	30	387	393	9	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					887	889		10.1126/science.1217901	http://dx.doi.org/10.1126/science.1217901			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22517325				2022-12-28	WOS:000304145600057
J	Mohd-Sarip, A; Lagarou, A; Doyen, CM; van der Knaap, JA; Aslan, U; Bezstarosti, K; Yassin, Y; Brock, HW; Demmers, JAA; Verrijzer, CP				Mohd-Sarip, Adone; Lagarou, Anna; Doyen, Cecile M.; van der Knaap, Jan A.; Aslan, Ulku; Bezstarosti, Karel; Yassin, Yasmin; Brock, Hugh W.; Demmers, Jeroen A. A.; Verrijzer, C. Peter			Transcription-Independent Function of Polycomb Group Protein PSC in Cell Cycle Control	SCIENCE			English	Article							ANAPHASE-PROMOTING COMPLEX; H2A UBIQUITYLATION; DROSOPHILA EMBRYOS; DYNAMIC REGULATION; DESTRUCTION; MITOSIS; APC11; UBIQUITINATION; MECHANISMS; MUTANTS	Polycomb group (PcG) proteins control development and cell proliferation through chromatin-mediated transcriptional repression. We describe a transcription-independent function for PcG protein Posterior sex combs (PSC) in regulating the destruction of cyclin B (CYC-B). A substantial portion of PSC was found outside canonical PcG complexes, instead associated with CYC-B and the anaphase-promoting complex (APC). Cell-based experiments and reconstituted reactions established that PSC and Lemming (LMG, also called APC11) associate and ubiquitylate CYC-B cooperatively, marking it for proteosomal degradation. Thus, PSC appears to mediate both developmental gene silencing and posttranslational control of mitosis. Direct regulation of cell cycle progression might be a crucial part of the PcG system's function in development and cancer.	[Mohd-Sarip, Adone; Lagarou, Anna; Doyen, Cecile M.; van der Knaap, Jan A.; Aslan, Ulku; Verrijzer, C. Peter] Erasmus Univ, Med Ctr, Dept Biochem, NL-3000 DR Rotterdam, Netherlands; [Mohd-Sarip, Adone; Lagarou, Anna; Doyen, Cecile M.; van der Knaap, Jan A.; Aslan, Ulku; Verrijzer, C. Peter] Erasmus Univ, Med Ctr, Ctr Biomed Genet, NL-3000 DR Rotterdam, Netherlands; [Bezstarosti, Karel; Demmers, Jeroen A. A.] Erasmus Univ, Med Ctr, Prote Ctr, NL-3000 DR Rotterdam, Netherlands; [Yassin, Yasmin; Brock, Hugh W.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of British Columbia	Verrijzer, CP (corresponding author), Erasmus Univ, Med Ctr, Dept Biochem, POB 1738, NL-3000 DR Rotterdam, Netherlands.	c.verrijzer@erasmusmc.nl	Mohd-Sarip, Adone/AAI-7912-2020; Demmers, Jeroen AA/F-4046-2016	Mohd-Sarip, Adone/0000-0003-2932-954X; Demmers, Jeroen AA/0000-0002-8757-9611	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [700.57.406]	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission)	We thank S. Bray, J. Svejstrup, and Y. Moshkin for valuable discussions. This work was supported in part by Nederlandse Organisatie voor Wetenschappelijk Onderzoek Chemical Sciences Veni grant 700.57.406 (to A.M.-S.).	Beck SA, 2010, DEV BIOL, V339, P320, DOI 10.1016/j.ydbio.2009.12.031; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buchenau P, 1998, J CELL BIOL, V141, P469, DOI 10.1083/jcb.141.2.469; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Gmachl M, 2000, P NATL ACAD SCI USA, V97, P8973, DOI 10.1073/pnas.97.16.8973; Kwong C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000178; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Leverson JD, 2000, MOL BIOL CELL, V11, P2315, DOI 10.1091/mbc.11.7.2315; Martinez AM, 2006, GENE DEV, V20, P501, DOI 10.1101/gad.357106; Mills AA, 2010, NAT REV CANCER, V10, P669, DOI 10.1038/nrc2931; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; O'Dor E, 2006, DEV BIOL, V290, P312, DOI 10.1016/j.ydbio.2005.11.015; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Parry DH, 2003, CURR BIOL, V13, P647, DOI 10.1016/S0960-9822(03)00242-2; Parry DH, 2001, CURR BIOL, V11, P671, DOI 10.1016/S0960-9822(01)00204-4; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Tang ZY, 2001, MOL BIOL CELL, V12, P3839, DOI 10.1091/mbc.12.12.3839; Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066; Thornton BR, 2006, GENE DEV, V20, P3069, DOI 10.1101/gad.1478306; Voncken JW, 1999, J CELL SCI, V112, P4627; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985	29	26	26	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2012	336	6082					744	747		10.1126/science.1215927	http://dx.doi.org/10.1126/science.1215927			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22491092				2022-12-28	WOS:000303872300056
J	Gonzalez-Perez, V; Zeng, XH; Henzler-Wildman, K; Lingle, CJ				Gonzalez-Perez, Vivian; Zeng, Xu-Hui; Henzler-Wildman, Katie; Lingle, Christopher J.			Stereospecific binding of a disordered peptide segment mediates BK channel inactivation	NATURE			English	Article							ACTIVATED POTASSIUM CHANNELS; BETA-SUBUNIT; K+ CHANNEL; QUATERNARY AMMONIUM; RAPID INACTIVATION; MOLECULAR-BASIS; NMR STRUCTURE; VOLTAGE; MECHANISM; BLOCK	A number of functionally important actions of proteins are mediated by short, intrinsically disordered peptide segments(1), but the molecular interactions that allow disordered domains to mediate their effects remain a topic of active investigation(2-5). Many K+ channel proteins, after initial channel opening, show a time-dependent reduction in current flux, termed 'inactivation', which involves movement of mobile cytosolic peptide segments (approximately 20-30 residues) into a position that physically occludes ion permeation(6-8). Peptide segments that produce inactivation show little amino-acid identity(6,9-13) and tolerate appreciable mutational substitutions(13) without disrupting the inactivation process. Solution nuclear magnetic resonance of several isolated inactivation domains reveals substantial conformational heterogeneity with only minimal tendency to ordered structures(14-17). Channel inactivation mechanisms may therefore help us to decipher how intrinsically disordered regions mediate functional effects. Whereas many aspects of inactivation of voltage-dependent K+ channels (Kv) can be described by a simple one-step occlusion mechanism(6,7,18,19), inactivation of the voltage-dependent large-conductance Ca2+-gated K+ (BK) channel mediated by peptide segments of auxiliary beta-subunits involves two distinguishable kinetic steps(20,21). Here we show that two-step inactivation mediated by an intrinsically disordered BK beta-subunit peptide involves a stereospecific binding interaction that precedes blockade. In contrast, blocking mediated by a Shaker Kv inactivation peptide is consistent with direct, simple occlusion by a hydrophobic segment without substantial steric requirement. The results indicate that two distinct types of molecular interaction between disordered peptide segments and their binding sites produce qualitatively similar functions.	[Gonzalez-Perez, Vivian; Zeng, Xu-Hui; Lingle, Christopher J.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Henzler-Wildman, Katie] Washington Univ, Sch Med, Dept Biochem, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Lingle, CJ (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.	clingle@morpheus.wustl.edu		Lingle, Christopher/0000-0002-9916-3795; Henzler-Wildman, Katherine/0000-0002-5295-2121	Searle Scholars Program;  [GM-081748]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081748] Funding Source: NIH RePORTER	Searle Scholars Program; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by GM-081748 to C.J.L. and the Searle Scholars Program to K.H.-W. We thank E. Morrison and P. Schlesinger for assistance with dynamic light scattering measurements, and C. Frieden and K. Garai for assistance with circular dichroism spectroscopy. We thank H. Jiang, A. Scott and J. Jones for care of oocytes, and J. H. Steinbach and R. Pappu for comments on the manuscript.	Bentrop D, 2001, J BIOL CHEM, V276, P42116, DOI 10.1074/jbc.M107118200; Brelidze TI, 2005, J GEN PHYSIOL, V126, P105, DOI 10.1085/jgp.200509286; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; De Sancho D, 2012, MOL BIOSYST, V8, P256, DOI 10.1039/c1mb05252g; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; Dyson HJ, 2011, Q REV BIOPHYS, V44, P467, DOI 10.1017/S0033583511000060; Galea CA, 2008, J MOL BIOL, V376, P827, DOI 10.1016/j.jmb.2007.12.016; Gonzalez C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1446; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Kondoh S, 1997, J BIOL CHEM, V272, P19333, DOI 10.1074/jbc.272.31.19333; Li WY, 2004, J GEN PHYSIOL, V124, P43, DOI 10.1085/jgp.200409067; Lingle CJ, 2001, J GEN PHYSIOL, V117, P583, DOI 10.1085/jgp.117.6.583; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P949, DOI 10.1085/jgp.102.6.949; Prince-Carter A, 2009, J GEN PHYSIOL, V134, P15, DOI 10.1085/jgp.200910219; Rasmusson RL, 1997, ADV EXP MED BIOL, V430, P29; RUPPERSBERG JP, 1991, NATURE, V353, P657, DOI 10.1038/353657a0; Schott MK, 1998, EUR BIOPHYS J BIOPHY, V27, P99, DOI 10.1007/s002490050115; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tang QY, 2009, J GEN PHYSIOL, V134, P409, DOI 10.1085/jgp.200910251; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; TSENGCRANK J, 1993, J GEN PHYSIOL, V102, P1057, DOI 10.1085/jgp.102.6.1057; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; Wilkens CM, 2006, J GEN PHYSIOL, V128, P347, DOI 10.1085/jgp.200609579; Wissmann R, 2003, J BIOL CHEM, V278, P16142, DOI 10.1074/jbc.M210191200; Wissmann R, 1999, J BIOL CHEM, V274, P35521, DOI 10.1074/jbc.274.50.35521; Xia XM, 1999, J NEUROSCI, V19, P5255, DOI 10.1523/jneurosci.19-13-05255.1999; Xia XM, 2000, J NEUROSCI, V20, P4890; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; Zeng XH, 2003, NAT STRUCT BIOL, V10, P448, DOI 10.1038/nsb932; Zeng XH, 2007, J NEUROSCI, V27, P4707, DOI 10.1523/JNEUROSCI.0758-07.2007; Zeng XH, 2008, J GEN PHYSIOL, V132, P115, DOI 10.1085/jgp.200809969; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou Y, 2011, P NATL ACAD SCI USA, V108, P12161, DOI 10.1073/pnas.1104150108	35	16	16	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					133	U171		10.1038/nature10994	http://dx.doi.org/10.1038/nature10994			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22522931	Green Accepted			2022-12-28	WOS:000303451900049
J	Gassmann, R; Rechtsteiner, A; Yuen, KW; Muroyama, A; Egelhofer, T; Gaydos, L; Barron, F; Maddox, P; Essex, A; Monen, J; Ercan, S; Lieb, JD; Oegema, K; Strome, S; Desai, A				Gassmann, Reto; Rechtsteiner, Andreas; Yuen, Karen W.; Muroyama, Andrew; Egelhofer, Thea; Gaydos, Laura; Barron, Francie; Maddox, Paul; Essex, Anthony; Monen, Joost; Ercan, Sevinc; Lieb, Jason D.; Oegema, Karen; Strome, Susan; Desai, Arshad			An inverse relationship to germline transcription defines centromeric chromatin in C. elegans	NATURE			English	Article							CAENORHABDITIS-ELEGANS; CHROMOSOME SEGREGATION; CENP-A; KINETOCHORE; DYNAMICS; REQUIRES; EMBRYOS; MITOSIS	Centromeres are chromosomal loci that direct segregation of the genome during cell division. The histone H3 variant CENP-A (also known as CenH3) defines centromeres in monocentric organisms, which confine centromere activity to a discrete chromosomal region, and holocentric organisms, which distribute centromere activity along the chromosome length(1-3). Because the highly repetitive DNA found at most centromeres is neither necessary nor sufficient for centromere function, stable inheritance of CENP-A nucleosomal chromatin is postulated to propagate centromere identity epigenetically(4). Here, we show that in the holocentric nematode Caenorhabditis elegans pre-existing CENP-A nucleosomes are not necessary to guide recruitment of new CENP-A nucleosomes. This is indicated by lack of CENP-A transmission by sperm during fertilization and by removal and subsequent reloading of CENP-A during oogenic meiotic prophase. Genome-wide mapping of CENP-A location in embryos and quantification of CENP-A molecules in nuclei revealed that CENP-A is incorporated at low density in domains that cumulatively encompass half the genome. Embryonic CENP-A domains are established in a pattern inverse to regions that are transcribed in the germline and early embryo, and ectopic transcription of genes in a mutant germline altered the pattern of CENP-A incorporation in embryos. Furthermore, regions transcribed in the germline but not embryos fail to incorporate CENP-A throughout embryogenesis. We propose that germline transcription defines genomic regions that exclude CENP-A incorporation in progeny, and that zygotic transcription during early embryogenesis remodels and reinforces this basal pattern. These findings link centromere identity to transcription and shed light on the evolutionary plasticity of centromeres.	[Gassmann, Reto; Yuen, Karen W.; Muroyama, Andrew; Barron, Francie; Maddox, Paul; Essex, Anthony; Monen, Joost; Oegema, Karen; Desai, Arshad] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92037 USA; [Gassmann, Reto; Yuen, Karen W.; Muroyama, Andrew; Barron, Francie; Maddox, Paul; Essex, Anthony; Monen, Joost; Oegema, Karen; Desai, Arshad] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92037 USA; [Rechtsteiner, Andreas; Egelhofer, Thea; Gaydos, Laura; Strome, Susan] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Ercan, Sevinc; Lieb, Jason D.] Univ N Carolina, Dept Biol, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Ercan, Sevinc; Lieb, Jason D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Santa Cruz; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Desai, A (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92037 USA.	sstrome@ucsc.edu; abdesai@ucsd.edu	Gassmann, Reto/M-6488-2013	Gassmann, Reto/0000-0002-0360-2977; Muroyama, Andrew/0000-0003-0701-212X; Rechtsteiner, Andreas/0000-0001-6031-1087; Barron, Francie/0000-0001-6568-7358; Lieb, Jason/0000-0001-7601-8061	modENCODE [U01 HG004270]; NIH [GM074215, GM34059, T32 GM008646]; National Science Foundation of Switzerland; Ludwig Institute for Cancer Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034059, T32GM008646, R01GM074215] Funding Source: NIH RePORTER	modENCODE; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of Switzerland(Swiss National Science Foundation (SNSF)); Ludwig Institute for Cancer Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Ward for the purified sperm sample, M. Gupta for help with analysis, J. Ahringer for advice on fixation and ChIP procedures, and A. Dernburg and other members of the Lieb modENCODE group for helpful discussions. This work was supported by a modENCODE grant (U01 HG004270), and by grants from NIH to A. D. (GM074215 and ARRA supplement) and S. S. (GM34059). R. G. was supported by a fellowship from the National Science Foundation of Switzerland. L. G. was supported by NIH T32 GM008646. A. D. and K.O. receive salary and other support from the Ludwig Institute for Cancer Research.	Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Andersen EC, 2007, DEVELOPMENT, V134, P2991, DOI 10.1242/dev.009373; Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Choo KHA., 1997, CENTROMERE; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; EDGAR LG, 1994, DEVELOPMENT, V120, P443; Edgar LG, 1995, METHOD CELL BIOL, V48, P303; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Lomiento M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r173; Maddox PS, 2007, J CELL BIOL, V176, P757, DOI 10.1083/jcb.200701065; Malik HS, 2009, CELL, V138, P1067, DOI 10.1016/j.cell.2009.08.036; Meissner B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000537; Monen J, 2005, NAT CELL BIOL, V7, P1248, DOI 10.1038/ncb1331; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Piras FM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000845; Ravi M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002121; Rechtsteiner A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001091; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Seydoux G, 1997, DEVELOPMENT, V124, P2191; Shelby RD, 2000, J CELL BIOL, V151, P1113, DOI 10.1083/jcb.151.5.1113; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sullivan KF, 2001, CURR OPIN GENET DEV, V11, P182, DOI 10.1016/S0959-437X(00)00177-5; van Wolfswinkel JC, 2009, CELL, V139, P135, DOI 10.1016/j.cell.2009.09.012; Wang X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-213; Warburton PE, 2004, CHROMOSOME RES, V12, P617, DOI 10.1023/B:CHRO.0000036585.44138.4b	34	116	117	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					534	U166		10.1038/nature10973	http://dx.doi.org/10.1038/nature10973			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22495302	Green Submitted, Green Accepted			2022-12-28	WOS:000303200400055
J	Le Gal, G; Kercret, G; Ben Yahmed, K; Bressollette, L; Robert-Ebadi, H; Riberdy, L; Louis, P; Delluc, A; Labalette, ML; Baba-Ahmed, M; Bounameaux, H; Mottier, D; Righini, M				Le Gal, Gregoire; Kercret, Genevieve; Ben Yahmed, Khalil; Bressollette, Luc; Robert-Ebadi, Helia; Riberdy, Louise; Louis, Patrick; Delluc, Aurelien; Labalette, Marie-Luce; Baba-Ahmed, Mohamed; Bounameaux, Henri; Mottier, Dominique; Righini, Marc		EDVIGE Study Grp	Diagnostic value of single complete compression ultrasonography in pregnant and postpartum women with suspected deep vein thrombosis: prospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VENOUS THROMBOSIS; PULMONARY-EMBOLISM; D-DIMER; IMPEDANCE PLETHYSMOGRAPHY; CLINICAL VALIDITY; ULTRASOUND; LEG; STRATEGIES; EXCLUDE; RISK	Objective To assess the safety of using single complete compression ultrasonography in pregnant and postpartum women to rule out deep vein thrombosis. Design Prospective outcome study. Setting Two tertiary care centres and 18 private practices specialising in vascular medicine in France and Switzerland. Participants 226 pregnant and postpartum women referred for suspected deep vein thrombosis. Methods A single proximal and distal compression ultrasonography was performed. All women with a negative complete compression ultrasonography result did not receive anticoagulant therapy and were followed up for a three month period. Main outcome measures Symptoms of venous thromboembolism, second compression ultrasonography or chest imaging, a thromboembolic event, and anticoagulant treatment. Results 16 women were excluded, mainly because of associated suspected pulmonary embolism. Deep vein thrombosis was diagnosed in 22 out of the 210 included women (10.5%). 10 patients received full dose anticoagulation despite a negative test result during follow-up. Of the 177 patients without deep vein thrombosis and who did not receive full dose anticoagulant therapy, two (1.1%, 95% confidence interval 0.3% to 4.0%) had an objectively confirmed deep vein thrombosis during follow-up. Conclusions The rate of venous thromboembolic events after single complete compression ultrasonography in pregnant and postpartum women seems to be within the range of that observed in studies in the non-pregnant population. These data suggest that a negative single complete compression ultrasonography result may safely exclude the diagnosis of deep vein thrombosis in this setting.	[Le Gal, Gregoire; Mottier, Dominique] Ctr Hosp Univ Cavale Blanche, INSERM, CIC 05 02, Brest, France; [Le Gal, Gregoire; Ben Yahmed, Khalil; Bressollette, Luc; Delluc, Aurelien; Baba-Ahmed, Mohamed; Mottier, Dominique] Ctr Hosp Univ Cavale Blanche, Dept Med Interne & Pneumol, F-29609 Brest, France; [Robert-Ebadi, Helia; Riberdy, Louise; Bounameaux, Henri; Righini, Marc] Univ Hosp Geneva, Div Angiol & Hemostasis, Geneva, Switzerland	CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; CHU Brest; University of Geneva	Le Gal, G (corresponding author), Ctr Hosp Univ Cavale Blanche, INSERM, CIC 05 02, Brest, France.	gregoire.legal@chu-brest.fr	Righini, Marc/AAX-8731-2020; LE GAL, Gregoire/K-1077-2012; Robert-Ebadi, Helia/AAD-5021-2019; Fontana, Pierre/M-3702-2014	Fontana, Pierre/0000-0003-1546-0774; Luc, Bressollette/0000-0002-8354-469X; LE GAL, Gregoire/0000-0002-9253-248X	Projet Hospitalier de Recherche Clinique in France [2005 R 08.01]; Swiss National Foundation in Switzerland [3200B0-120760]	Projet Hospitalier de Recherche Clinique in France; Swiss National Foundation in Switzerland	The study was supported by grants from the Projet Hospitalier de Recherche Clinique (grant No 2005 R 08.01) in France, and from the Swiss National Foundation (grant No 3200B0-120760) in Switzerland. The sponsors had no role in the study design and the collection, analysis, and interpretation of data, the writing of the article, and the decision to submit it for publication.	Bernardi E, 2008, JAMA-J AM MED ASSOC, V300, P1653, DOI 10.1001/jama.300.14.1653; Chan WS, 2010, J THROMB HAEMOST, V8, P1004, DOI 10.1111/j.1538-7836.2010.03783.x; Chan WS, 2007, ANN INTERN MED, V147, P165, DOI 10.7326/0003-4819-147-3-200708070-00005; Chan Wee-Shian, 2009, Expert Rev Cardiovasc Ther, V7, P1479, DOI 10.1586/erc.09.136; Chan WS, 2009, ANN INTERN MED, V151, P85, DOI 10.7326/0003-4819-151-2-200907210-00004; Chan WS, 2002, ARCH INTERN MED, V162, P1170, DOI 10.1001/archinte.162.10.1170; Gibson NS, 2009, J THROMB HAEMOST, V7, P2035, DOI 10.1111/j.1538-7836.2009.03635.x; Greer IA, 1999, LANCET, V353, P1258, DOI 10.1016/S0140-6736(98)10265-9; HEIJBOER H, 1993, NEW ENGL J MED, V329, P1365, DOI 10.1056/NEJM199311043291901; HULL R, 1981, CIRCULATION, V64, P622, DOI 10.1161/01.CIR.64.3.622; HULL RD, 1990, ANN INTERN MED, V112, P663, DOI 10.7326/0003-4819-112-9-663; Jacobsen AF, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.041; Johnson SA, 2010, JAMA-J AM MED ASSOC, V303, P438, DOI 10.1001/jama.2010.43; Kearon C, 1998, ANN INTERN MED, V129, P1044, DOI 10.7326/0003-4819-129-12-199812150-00009; Kruip MJHA, 2003, ANN INTERN MED, V138, P941, DOI 10.7326/0003-4819-138-12-200306170-00005; Le Gal G, 2004, J THROMB HAEMOST, V2, P1244, DOI 10.1111/j.1538-7836.2004.00795.x; Le Gal G, 2006, THROMB RES, V118, P691, DOI 10.1016/j.thromres.2005.12.004; Melis F, 2004, AM J OBSTET GYNECOL, V191, P825, DOI 10.1016/j.ajog.2004.02.004; Righini M, 2008, J THROMB HAEMOST, V6, P1059, DOI 10.1111/j.1538-7836.2008.02981.x; Righini M, 2007, J THROMB HAEMOST, V5, P55, DOI 10.1111/j.1538-7836.2007.02468.x; Righini M, 2009, J THROMB HAEMOST, V7, P406, DOI 10.1111/j.1538-7836.2008.03264.x; Righini M, 2008, LANCET, V371, P1343, DOI 10.1016/S0140-6736(08)60594-2; Schellong SM, 2007, J THROMB HAEMOST, V5, P1431, DOI 10.1111/j.1538-7836.2007.02570.x; Stevens SM, 2004, ANN INTERN MED, V140, P985, DOI 10.7326/0003-4819-140-12-200406150-00007; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172	25	42	44	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2012	344								e2635	10.1136/bmj.e2635	http://dx.doi.org/10.1136/bmj.e2635			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	934HB	22531869	Green Published, hybrid			2022-12-28	WOS:000303433700003
J	Neudecker, P; Robustelli, P; Cavalli, A; Walsh, P; Lundstrom, P; Zarrine-Afsar, A; Sharpe, S; Vendruscolo, M; Kay, LE				Neudecker, Philipp; Robustelli, Paul; Cavalli, Andrea; Walsh, Patrick; Lundstroem, Patrik; Zarrine-Afsar, Arash; Sharpe, Simon; Vendruscolo, Michele; Kay, Lewis E.			Structure of an Intermediate State in Protein Folding and Aggregation	SCIENCE			English	Article							AMYLOID FORMATION; COMMON MECHANISM; OLIGOMERS; DYNAMICS; FIBRILS; PATHWAY; IMPLIES; DOMAIN	Protein-folding intermediates have been implicated in amyloid fibril formation involved in neurodegenerative disorders. However, the structural mechanisms by which intermediates initiate fibrillar aggregation have remained largely elusive. To gain insight, we used relaxation dispersion nuclear magnetic resonance spectroscopy to determine the structure of a low-populated, on-pathway folding intermediate of the A39V/N53P/V55L (A, Ala; V, Val; N, Asn; P, Pro; L, Leu) Fyn SH3 domain. The carboxyl terminus remains disordered in this intermediate, thereby exposing the aggregation-prone amino-terminal beta strand. Accordingly, mutants lacking the carboxyl terminus and thus mimicking the intermediate fail to safeguard the folding route and spontaneously form fibrillar aggregates. The structure provides a detailed characterization of the non-native interactions stabilizing an aggregation-prone intermediate under native conditions and insight into how such an intermediate can derail folding and initiate fibrillation.	[Neudecker, Philipp; Walsh, Patrick; Lundstroem, Patrik; Zarrine-Afsar, Arash; Sharpe, Simon; Kay, Lewis E.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Neudecker, Philipp; Lundstroem, Patrik; Zarrine-Afsar, Arash; Kay, Lewis E.] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Neudecker, Philipp; Lundstroem, Patrik; Kay, Lewis E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Neudecker, Philipp] Univ Dusseldorf, Inst Phys, D-40225 Dusseldorf, Germany; [Neudecker, Philipp] Forschungszentrum Julich, D-52425 Julich, Germany; [Robustelli, Paul; Cavalli, Andrea; Vendruscolo, Michele] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Walsh, Patrick; Sharpe, Simon; Kay, Lewis E.] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University of Toronto; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; University of Cambridge; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Kay, LE (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada.	kay@pound.med.utoronto.ca	Neudecker, Philipp/AAP-9005-2020; Walsh, Patrick/ABG-2479-2020; Neudecker, Philipp/G-5265-2013; Cavalli, Andrea/L-9147-2013; Vendruscolo, Michele/F-5901-2012	Neudecker, Philipp/0000-0002-0557-966X; Neudecker, Philipp/0000-0002-0557-966X; Vendruscolo, Michele/0000-0002-3616-1610; Robustelli, Paul/0000-0002-9282-8993; Cavalli, Andrea/0000-0003-4063-4502	Gates Cambridge Scholarship; NSF; Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC; Canadian Institutes of Health Research	Gates Cambridge Scholarship; NSF(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank J. Forman-Kay and A. Davidson for providing laboratory space. S.S. and L.E.K. hold Canada Research Chairs in Biochemistry. P.R. was funded by a Gates Cambridge Scholarship and an NSF Graduate Research Fellowship, and P.W. is funded by a Natural Sciences and Engineering Research Council of Canada (NSERC) Canada Graduate Scholarship. This work was supported by grants from the NSERC and the Canadian Institutes of Health Research (L.E.K). The ensembles of 10 structures each representing the A39V/N53P/V55L Fyn SH3 domain native state from Ser<SUP>1</SUP> to Asp<SUP>59</SUP> and the folding intermediate from Ser<SUP>1</SUP> to Ala<SUP>56</SUP> have been deposited with the Protein Data Bank (accession codes 2LP5 and 2L2P, respectively).	Bai YW, 2006, CHEM REV, V106, P1757, DOI 10.1021/cr040432i; Bayro MJ, 2010, BIOCHEMISTRY-US, V49, P7474, DOI 10.1021/bi100864t; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Capaldi AP, 1998, CURR OPIN STRUC BIOL, V8, P86, DOI 10.1016/S0959-440X(98)80014-6; Carullaa N, 2009, P NATL ACAD SCI USA, V106, P7828, DOI 10.1073/pnas.0812227106; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Eakin CM, 2006, NAT STRUCT MOL BIOL, V13, P202, DOI 10.1038/nsmb1068; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; Martin-Garcia JM, 2007, FEBS LETT, V581, P1701, DOI 10.1016/j.febslet.2007.03.059; Morel B, 2010, BIOPHYS J, V99, P3801, DOI 10.1016/j.bpj.2010.10.039; Neudecker P, 2007, P NATL ACAD SCI USA, V104, P15717, DOI 10.1073/pnas.0705097104; Neudecker P, 2006, J MOL BIOL, V363, P958, DOI 10.1016/j.jmb.2006.08.047; Neudecker P, 2009, BIOPHYS J, V96, P2045, DOI 10.1016/j.bpj.2008.12.3907; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Pechmann S, 2009, P NATL ACAD SCI USA, V106, P10159, DOI 10.1073/pnas.0812414106; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Riddle DS, 1999, NAT STRUCT BIOL, V6, P1016; Robustelli P, 2010, STRUCTURE, V18, P923, DOI 10.1016/j.str.2010.04.016; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Vallurupalli P, 2008, P NATL ACAD SCI USA, V105, P11766, DOI 10.1073/pnas.0804221105; Varela L, 2009, FEBS LETT, V583, P801, DOI 10.1016/j.febslet.2009.01.033; Zarrine-Afsar A, 2008, P NATL ACAD SCI USA, V105, P9999, DOI 10.1073/pnas.0801874105	32	283	284	5	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2012	336	6079					362	366		10.1126/science.1214203	http://dx.doi.org/10.1126/science.1214203			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22517863				2022-12-28	WOS:000302995400051
J	Gilhar, A; Etzioni, A; Paus, R				Gilhar, Amos; Etzioni, Amos; Paus, Ralf			Medical Progress Alopecia Areata	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HUMAN HAIR FOLLICLE; HUMAN SCALP EXPLANTS; IMMUNE PRIVILEGE; T-CELLS; C3H/HEJ MOUSE; TOPICAL MINOXIDIL; SUBSTANCE-P; DISEASE; MODEL; GENE	THE IMPACT OF CERTAIN SKIN DISEASES ON THE LIVES OF THOSE AFFECTED tends to be underestimated or even dismissed as simply a "cosmetic problem." Alopecia areata exemplifies such a condition, owing to its substantial disease burden and its often devastating effects on the patient's quality of life and self-esteem.(1,2) Although alopecia areata is one of the most common autoimmune diseases, the pathobiology of this chronic, relapsing hair-loss disorder is not fully understood, and the available therapies are disappointing.(3-6) This review summarizes the pathogenesis, clinical presentation, and management of alopecia areata and synthesizes relevant background information concerning the biologic and pathobiologic features of the hair follicle. Currently available evidence suggests that alopecia areata can be considered a T-cell-mediated autoimmune disease in which the gradual loss of protection provided by immune privilege of the normal hair follicle plays an important role.(7-9)	[Gilhar, Amos] Technion Israel Inst Technol, B Rappaport Fac Med, Skin Res Lab, Haifa, Israel; [Gilhar, Amos] Flieman Hosp, Haifa, Israel; [Etzioni, Amos] Meyers Childrens Hosp, Haifa, Israel; [Paus, Ralf] Univ Lubeck, Dept Dermatol, Lubeck, Germany; [Paus, Ralf] Univ Manchester, Sch Translat Med, Manchester, Lancs, England	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Lubeck; University of Manchester	Gilhar, A (corresponding author), Technion Israel Inst Technol, B Rappaport Fac Med, Skin Res Lab, Haifa, Israel.	doritg_2000@yahoo.com	Paus, Ralf/B-5279-2015	Paus, Ralf/0000-0002-3492-9358	National Alopecia Areata Foundation; Deutsche Forschungsgemeinschaft (DFG) [GRK 1727]; Shiseido; Henkel; Wolff Pharma; Giuliani; Bayer Germany; Curadis; Pfleger Germany; Unilever UK; Procter Gamble UK	National Alopecia Areata Foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Shiseido; Henkel; Wolff Pharma; Giuliani; Bayer Germany(Bayer AG); Curadis; Pfleger Germany; Unilever UK(Unilever); Procter Gamble UK(Procter & Gamble)	Supported in part by grants from the National Alopecia Areata Foundation (to Dr. Gilhar) and from Deutsche Forschungsgemeinschaft (DFG, GRK 1727 Autoimmunity) (to Dr. Paus). Dr. Paus reports receiving consulting fees from Henkel, Procter & Gamble UK, and Wolff Pharma and royalties from Thieme Publications and, on behalf of his institution, consulting fees from Wolff Pharma, Giuliani, and Bayer Germany and grant support from Shiseido, Henkel, Wolff Pharma, Giuliani, Bayer Germany, Curadis, Pfleger Germany, and Unilever UK. No other potential conflict of interest relevant to this article was reported.	Agesta N, 2002, DERMATOLOGY, V205, P300, DOI 10.1159/000065841; Alkhalifah A, 2010, J AM ACAD DERMATOL, V62, P191, DOI 10.1016/j.jaad.2009.10.031; Alkhalifah A, 2010, J AM ACAD DERMATOL, V62, P177, DOI 10.1016/j.jaad.2009.10.032; Alli R, 2012, J IMMUNOL, V188, P477, DOI 10.4049/jimmunol.1100657; [Anonymous], 2009, WEEDONS SKIN PATHOLO, VI, P422; Barahmani N, 2009, J AM ACAD DERMATOL, V61, P581, DOI 10.1016/j.jaad.2009.04.031; Betz RC, 2008, BRIT J DERMATOL, V158, P389, DOI 10.1111/j.1365-2133.2007.08312.x; Bodemer C, 2000, J INVEST DERMATOL, V114, P112, DOI 10.1046/j.1523-1747.2000.00828.x; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; Cetin ED, 2009, AM J DERMATOPATH, V31, P53, DOI 10.1097/DAD.0b013e318185a66e; Chang KH, 2009, J DRUGS DERMATOL, V8, P909; Christoph T, 2000, BRIT J DERMATOL, V142, P862, DOI 10.1046/j.1365-2133.2000.03464.x; Chu SY, 2011, J AM ACAD DERMATOL, V65, P949, DOI 10.1016/j.jaad.2010.08.032; COLOMBE BW, 1995, J AM ACAD DERMATOL, V33, P757; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Delamere FM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004413.pub2; Dressel D, 1997, J CUTAN PATHOL, V24, P164, DOI 10.1111/j.1600-0560.1997.tb01571.x; DUVIC M, 1991, ARCH DERMATOL, V127, P64, DOI 10.1001/archderm.127.1.64; Dy LC, 2011, DERMATOL THER, V24, P369, DOI 10.1111/j.1529-8019.2011.01414.x; Farshi S, 2010, INT J DERMATOL, V49, P1188, DOI 10.1111/j.1365-4632.2010.04576.x; FENTON DA, 1983, BRIT MED J, V287, P1015, DOI 10.1136/bmj.287.6398.1015; Ferran M, 2011, J EUR ACAD DERMATOL, V25, P479, DOI 10.1111/j.1468-3083.2010.03770.x; Finner AM, 2011, DERMATOL THER, V24, P348, DOI 10.1111/j.1529-8019.2011.01413.x; Garg S, 2009, SEMIN CUTAN MED SURG, V28, P15, DOI 10.1016/j.sder.2008.12.002; Gilhar A, 1998, J CLIN INVEST, V101, P62, DOI 10.1172/JCI551; Gilhar A, 2001, J INVEST DERMATOL, V117, P1357, DOI 10.1046/j.0022-202x.2001.01583.x; Gilhar A, 2002, ARCH DERMATOL, V138, P916, DOI 10.1001/archderm.138.7.916; GILHAR A, 1992, BRIT J DERMATOL, V126, P166, DOI 10.1111/j.1365-2133.1992.tb07815.x; Gilhar A, 2007, J CLIN INVEST, V117, P2019, DOI 10.1172/JCI31942; GODDARD CJR, 1989, POSTGRAD MED J, V65, P188, DOI 10.1136/pgmj.65.761.188; Goh C, 2006, J EUR ACAD DERMATOL, V20, P1055, DOI 10.1111/j.1468-3083.2006.01676.x; Gregersen PK, 2009, ANNU REV IMMUNOL, V27, P363, DOI 10.1146/annurev.immunol.021908.132653; Harries MJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3671; Harries MJ, 2010, AM J PATHOL, V177, P2152, DOI 10.2353/ajpath.2010.100454; Hedstrand H, 1999, J INVEST DERMATOL, V113, P1054, DOI 10.1046/j.1523-1747.1999.00778.x; Hoglund P, 2010, NAT REV IMMUNOL, V10, P724, DOI 10.1038/nri2835; Ito T, 2004, AM J PATHOL, V164, P623, DOI 10.1016/S0002-9440(10)63151-3; Ito T, 2008, J INVEST DERMATOL, V128, P1196, DOI 10.1038/sj.jid.5701183; John KKG, 2011, J INVEST DERMATOL, V131, P1169, DOI 10.1038/jid.2010.427; KALISH RS, 1992, ARCH DERMATOL, V128, P1072, DOI 10.1001/archderm.128.8.1072; Kang H, 2010, J INVEST DERMATOL, V130, P2677, DOI 10.1038/jid.2010.180; Kar BR, 2005, J AM ACAD DERMATOL, V52, P287, DOI 10.1016/j.jaad.2004.10.873; Kemp EH, 2006, HUM IMMUNOL, V67, P535, DOI 10.1016/j.humimm.2006.04.006; KHOURY EL, 1988, J INVEST DERMATOL, V90, P193, DOI 10.1111/1523-1747.ep12462213; Kinori M, 2011, INVEST OPHTH VIS SCI, V52, P4447, DOI 10.1167/iovs.10-7154; Kuchabal SD, 2010, CASE REP DERMATOL, V2, P27, DOI 10.1159/000296271; Kumar V, 2011, AM J PATHOL, V178, P983, DOI 10.1016/j.ajpath.2010.12.007; Kurtev A, 2005, INT J DERMATOL, V44, P457, DOI 10.1111/j.1365-4632.2005.01971.x; Kyriakis KP, 2009, J EUR ACAD DERMATOL, V23, P572, DOI 10.1111/j.1468-3083.2008.02956.x; Luggen P, 2008, J DTSCH DERMATOL GES, V6, P375, DOI 10.1111/j.1610-0387.2007.06608.x; Martinez-Mir A, 2007, AM J HUM GENET, V80, P316, DOI 10.1086/511442; McElwee KJ, 1996, BRIT J DERMATOL, V135, P211, DOI 10.1111/j.1365-2133.1996.tb01149.x; McElwee KJ, 2005, J INVEST DERMATOL, V124, P947, DOI 10.1111/j.0022-202X.2005.23692.x; McMichael AJ, 2007, J AM ACAD DERMATOL, V57, pS49, DOI 10.1016/j.jaad.2006.02.045; MESSENGER AG, 1986, BRIT J DERMATOL, V114, P337, DOI 10.1111/j.1365-2133.1986.tb02825.x; Meyer KC, 2008, BRIT J DERMATOL, V159, P1077, DOI 10.1111/j.1365-2133.2008.08818.x; Muto M, 2011, J DERMATOL SCI, V62, P70, DOI 10.1016/j.jdermsci.2010.10.012; Natarajan K, 2002, ANNU REV IMMUNOL, V20, P853, DOI 10.1146/annurev.immunol.20.100301.064812; Niederkorn JY, 2006, NAT IMMUNOL, V7, P354, DOI 10.1038/ni1328; Ohlmeier MC, 2011, J EUR ACAD DERM 0514; PASCHER F, 1970, DERMATOLOGICA, V141, P193, DOI 10.1159/000252466; PAUS R, 1993, YALE J BIOL MED, V66, P541; Paus R, 2005, TRENDS IMMUNOL, V26, P32, DOI 10.1016/j.it.2004.09.014; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Paus R, 2009, J INVEST DERMATOL, V129, P1324, DOI 10.1038/jid.2009.111; Peters EMJ, 2007, AM J PATHOL, V171, P1872, DOI 10.2353/ajpath.2007.061206; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Picardi A, 2003, PSYCHOSOMATICS, V44, P374, DOI 10.1176/appi.psy.44.5.374; PRICE VH, 1987, J AM ACAD DERMATOL, V16, P730, DOI 10.1016/S0190-9622(87)70095-4; Rodriguez TA, 2010, J AM ACAD DERMATOL, V62, P525, DOI 10.1016/j.jaad.2009.02.006; SAFAVI K, 1992, ARCH DERMATOL, V128, P702, DOI 10.1001/archderm.1992.01680150136027; SCHMOECKEL C, 1979, ARCH DERMATOL, V115, P1254, DOI 10.1001/archderm.115.10.1254; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Siebenhaar F, 2007, J INVEST DERMATOL, V127, P1489, DOI 10.1038/sj.jid.5700704; Singh TP, 2010, J IMMUNOL, V184, P7257, DOI 10.4049/jimmunol.0903719; Stelekati E, 2009, IMMUNITY, V31, P665, DOI 10.1016/j.immuni.2009.08.022; Sun J, 2008, EXP DERMATOL, V17, P793, DOI 10.1111/j.1600-0625.2008.00773.x; Sundberg JP, 2004, J INVEST DERMATOL, V123, P294, DOI 10.1111/j.0022-202X.2004.23222.x; Tazi-Ahnini R, 2003, HUM GENET, V112, P400, DOI 10.1007/s00439-002-0898-9; Tazi-Ahnini R, 2002, EUR J IMMUNOGENET, V29, P25, DOI 10.1046/j.1365-2370.2002.00271.x; Tobin DJ, 2011, PIGM CELL MELANOMA R, V24, P75, DOI 10.1111/j.1755-148X.2010.00803.x; Tobin DJ, 2003, J INVEST DERM SYMP P, V8, P176, DOI 10.1046/j.1087-0024.2003.00805.x; TOSTI A, 1986, J INVEST DERMATOL, V86, P553, DOI 10.1111/1523-1747.ep12355013; Tosti A, 2003, J AM ACAD DERMATOL, V49, P96, DOI 10.1067/mjd.2003.423; TOSTI A, 1985, DERMATOLOGICA, V170, P69, DOI 10.1159/000249501; Tosti A, 2008, J AM ACAD DERMATOL, V59, P64, DOI 10.1016/j.jaad.2008.03.031; Tosti A, 2009, EXPERT OPIN PHARMACO, V10, P1017, DOI [10.1517/14656560902876368, 10.1517/14656560902876368 ]; Wade MS, 2002, J AM ACAD DERMATOL, V46, P619, DOI 10.1067/mjd.2002.120604; Westerhof W, 2006, PIGMENTARY SYSTEM, P764; Whiting DA, 2003, ARCH DERMATOL, V139, P1555, DOI 10.1001/archderm.139.12.1555; Wiseman MC, 2001, ARCH DERMATOL, V137, P1063; Xiao FL, 2006, PEDIATR DERMATOL, V23, P13, DOI 10.1111/j.1525-1470.2006.00161.x	92	317	327	9	103	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 19	2012	366	16					1515	1525		10.1056/NEJMra1103442	http://dx.doi.org/10.1056/NEJMra1103442			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927UE	22512484				2022-12-28	WOS:000302934800009
J	Davies, BW; Bogard, RW; Young, TS; Mekalanos, JJ				Davies, Bryan W.; Bogard, Ryan W.; Young, Travis S.; Mekalanos, John J.			Coordinated Regulation of Accessory Genetic Elements Produces Cyclic Di-Nucleotides for V. cholerae Virulence	CELL			English	Article							COMPARATIVE GENOMIC ANALYSIS; VIBRIO-CHOLERAE; DNA-SEQUENCE; PROTEIN; GMP; BACTERIA; TOXT; AMP; ACTIVATION; EVOLUTION	The function of the Vibrio 7th pandemic island-1 (VSP-1) in cholera pathogenesis has remained obscure. Utilizing chromatin immunoprecipitation sequencing and RNA sequencing to map the regulon of the master virulence regulator ToxT, we identify a TCP island-encoded small RNA that reduces the expression of a previously unrecognized VSP-1-encoded transcription factor termed VspR. VspR modulates the expression of several VSP-1 genes including one that encodes a novel class of dinucleotide cyclase (DncV), which preferentially synthesizes a previously undescribed hybrid cyclic AMP-GMP molecule. We show that DncV is required for efficient intestinal colonization and downregulates V. cholerae chemotaxis, a phenotype previously associated with hyperinfectivity. This pathway couples the actions of previously disparate genomic islands, defines VSP-1 as a pathogenicity island in V. cholerae, and implicates its occurrence in 7th pandemic strains as a benefit for host adaptation through the production of a regulatory cyclic di-nucleotide.	[Davies, Bryan W.; Bogard, Ryan W.; Mekalanos, John J.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Young, Travis S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Mekalanos, JJ (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	jmekalanos@hms.harvard.edu		Davies, Bryan/0000-0002-2046-0341	Jane Coffin Childs Memorial Fund for Medical Research; National Research Council of Canada; National Institutes of Health [AI-018045]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026289, R01AI018045, R22AI018045, R37AI018045] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund for Medical Research; National Research Council of Canada; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. D. Ewen Cameron for support in use of the V. cholerae transposon library. B. W. D. was supported by the Jane Coffin Childs Memorial Fund for Medical Research and by the National Research Council of Canada H. L. Holmes Award. This work was supported by the National Institutes of Health Grant AI-018045 to J.J.M.	Beyhan S, 2006, J BACTERIOL, V188, P3600, DOI 10.1128/JB.188.10.3600-3613.2006; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Bradley ES, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002126; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Butler SM, 2006, MOL MICROBIOL, V60, P417, DOI 10.1111/j.1365-2958.2006.05096.x; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Davies BW, 2011, P NATL ACAD SCI USA, V108, P12467, DOI 10.1073/pnas.1107894108; DHO S, 1992, AM J PHYSIOL, V262, pC67, DOI 10.1152/ajpcell.1992.262.1.C67; DIRITA VJ, 1991, P NATL ACAD SCI USA, V88, P5403, DOI 10.1073/pnas.88.12.5403; Dziejman M, 2002, P NATL ACAD SCI USA, V99, P1556, DOI 10.1073/pnas.042667999; Faruque SM, 2003, TRENDS MICROBIOL, V11, P505, DOI 10.1016/j.tim.2003.09.003; Gomelsky M, 2011, MOL MICROBIOL, V79, P562, DOI 10.1111/j.1365-2958.2010.07514.x; Grim CJ, 2010, OMICS, V14, P1, DOI 10.1089/omi.2009.0087; Handstad T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018430; Hartmann R, 2003, MOL CELL, V12, P1173, DOI 10.1016/S1097-2765(03)00433-7; Hassan F, 2010, NATURE, V467, P982, DOI 10.1038/nature09469; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kaunitz JD, 2011, ACTA PHYSIOL, V201, P109, DOI 10.1111/j.1748-1716.2010.02156.x; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Lim B, 2007, J BACTERIOL, V189, P717, DOI 10.1128/JB.00834-06; Lowden MJ, 2010, P NATL ACAD SCI USA, V107, P2860, DOI 10.1073/pnas.0915021107; Mandlik A, 2011, CELL HOST MICROBE, V10, P165, DOI 10.1016/j.chom.2011.07.007; Merrell DS, 2002, NATURE, V417, P642, DOI 10.1038/nature00778; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Paauw A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008662; POLLITZER R, 1959, CHOLERA; Rahman MH, 2008, DNA CELL BIOL, V27, P347, DOI 10.1089/dna.2008.0737; Richard AL, 2010, MOL MICROBIOL, V78, P1171, DOI 10.1111/j.1365-2958.2010.07397.x; Ritchie JM, 2009, CURR TOP MICROBIOL, V337, P37, DOI 10.1007/978-3-642-01846-6_2; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Schubert S, 2004, MOL MICROBIOL, V51, P837, DOI 10.1046/j.1365-2958.2003.03870.x; Srivastava D, 2011, J BACTERIOL, V193, P6331, DOI 10.1128/JB.05167-11; STOCK A, 1987, J BIOL CHEM, V262, P535; Taviani E, 2010, FEMS MICROBIOL LETT, V308, P130, DOI 10.1111/j.1574-6968.2010.02008.x; Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x; Weber GG, 2011, INDIAN J MED RES, V133, P201; Withey JH, 2006, MOL MICROBIOL, V59, P1779, DOI 10.1111/j.1365-2958.2006.05053.x; Withey JH, 2005, J BACTERIOL, V187, P7890, DOI 10.1128/JB.187.23.7890-7900.2005; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Xu Q, 2003, P NATL ACAD SCI USA, V100, P1286, DOI 10.1073/pnas.0337479100	45	273	302	2	50	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 13	2012	149	2					358	370		10.1016/j.cell.2012.01.053	http://dx.doi.org/10.1016/j.cell.2012.01.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500802	Bronze, Green Accepted			2022-12-28	WOS:000302805600015
J	Miyajima, D; Araoka, F; Takezoe, H; Kim, J; Kato, K; Takata, M; Aida, T				Miyajima, Daigo; Araoka, Fumito; Takezoe, Hideo; Kim, Jungeun; Kato, Kenichi; Takata, Masaki; Aida, Takuzo			Ferroelectric Columnar Liquid Crystal Featuring Confined Polar Groups Within Core-Shell Architecture	SCIENCE			English	Article							ELECTRIC-FIELD; MOLECULES; PHASES; POLARIZATION; COMPLEX; FILMS; ORDER	Ferroelectric liquid crystals are materials that have a remnant and electrically invertible polar order. Columnar liquid crystals with a ferroelectric nature have potential use in ultrahigh-density memory devices, if electrical polarization occurs along the columnar axis. However, columnar liquid crystals having an axial nonzero polarization at zero electric field and its electrical invertibility have not been demonstrated. Here, we report a ferroelectric response for a columnar liquid crystal adopting a core-shell architecture that accommodates an array of polar cyano groups confined by a hydrogen-bonded amide network with an optimal strength. Under an applied electric field, both columns and core cyano groups align unidirectionally, thereby developing an extremely large macroscopic remnant polarization.	[Araoka, Fumito; Takezoe, Hideo] Tokyo Inst Technol, Dept Organ & Polymer Mat, Meguro Ku, Tokyo 1528552, Japan; [Miyajima, Daigo; Aida, Takuzo] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; [Kim, Jungeun; Takata, Masaki] Japan Synchrotron Radiat Res Inst JASRI, Sayo, Hyogo 6795148, Japan; [Kato, Kenichi; Takata, Masaki] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan	Tokyo Institute of Technology; University of Tokyo; Japan Synchrotron Radiation Research Institute; RIKEN	Takezoe, H (corresponding author), Tokyo Inst Technol, Dept Organ & Polymer Mat, Meguro Ku, 2-12-1 O Okayama, Tokyo 1528552, Japan.	takezoe.h.aa@m.titech.ac.jp; aida@macro.t.u-tokyo.ac.jp	Kato, Kenichi/AHE-1591-2022; Aida, Takuzo/I-9117-2012; Araoka, Fumito/A-8919-2014; Miyajima, Daigo/B-5623-2013; Takata, Masaki/M-1525-2014; Kim, Jungeun/J-9948-2012	Kato, Kenichi/0000-0002-1954-5508; Araoka, Fumito/0000-0002-9387-6081; Miyajima, Daigo/0000-0002-9578-7349; 	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	D.M. thanks the Japan Society for the Promotion of Science for award of a Young Scientist Fellowship. The synchrotron radiation experiments were performed at BL02B2 and BL44B2 in Spring-8 under the Budding Researchers Support Programs and the Priority Nanotechnology Support Program administered by the Japan Synchrotron Radiation Research Institute (Proposal nos. 2008B1777, 2009A1651, and 2009A1699) and with the approval of RIKEN (Proposal no. 20090021).	Araoka F, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051704; BOCK H, 1995, LIQ CRYST, V18, P707, DOI 10.1080/02678299508036680; CLARK NA, 1980, APPL PHYS LETT, V36, P899, DOI 10.1063/1.91359; Dalcanale E, 2000, LIQ CRYST, V27, P1161, DOI 10.1080/02678290050122006; Fitie CFC, 2010, J AM CHEM SOC, V132, P6892, DOI 10.1021/ja101734g; Gorecka E, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031704; Gorecka E, 2004, J AM CHEM SOC, V126, P15946, DOI 10.1021/ja044597k; Guo LF, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.031706; Haase W, 2002, LIQ CRYST, V29, P133, DOI 10.1080/02678290110093741; Horiuchi S, 2008, NAT MATER, V7, P357, DOI 10.1038/nmat2137; Horiuchi S, 2010, NATURE, V463, P789, DOI 10.1038/nature08731; Jakli A, 1997, LIQ CRYST, V22, P309, DOI 10.1080/026782997209379; Kilian D, 2000, LIQ CRYST, V27, P509, DOI 10.1080/026782900202705; Kishikawa K, 2005, J AM CHEM SOC, V127, P2565, DOI 10.1021/ja046100c; Largerwall S. T., 1999, FERROELECTRIC ANTIFE; Meyer R. B., 1975, J PHYS LETT-PARIS, V36, P69; Miyajima D, 2011, ANGEW CHEM INT EDIT, V50, P7865, DOI 10.1002/anie.201102472; Miyajima D, 2010, J AM CHEM SOC, V132, P8530, DOI 10.1021/ja101866e; Miyajima D, 2009, J AM CHEM SOC, V131, P44, DOI 10.1021/ja808396b; Okada Y, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.020701; Okada Y, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041701; Reddy RA, 2011, SCIENCE, V332, P72, DOI 10.1126/science.1197248; Reddy RA, 2006, J MATER CHEM, V16, P907, DOI 10.1039/b504400f; Rosen BM, 2009, J AM CHEM SOC, V131, P17500, DOI 10.1021/ja907882n; Rosen BM, 2009, CHEM REV, V109, P6275, DOI 10.1021/cr900157q; Takezoe H, 2006, J MATER CHEM, V16, P2412, DOI 10.1039/b603232j; Takezoe H, 2006, JPN J APPL PHYS 1, V45, P597, DOI 10.1143/JJAP.45.597; Tschierske C, 2007, CHEM SOC REV, V36, P1930, DOI 10.1039/b615517k; Watanabe T, 1996, JPN J APPL PHYS 2, V35, pL505, DOI 10.1143/JJAP.35.L505	29	173	173	7	210	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2012	336	6078					209	213		10.1126/science.1217954	http://dx.doi.org/10.1126/science.1217954			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924PN	22499944				2022-12-28	WOS:000302703900045
J	Liechty, J				Liechty, John			Scientists and bankers - a new model army	NATURE			English	Editorial Material									[Liechty, John] Penn State Univ, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park		jcl12@psu.edu							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					143	143		10.1038/484143a	http://dx.doi.org/10.1038/484143a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	930OV	22498589	Bronze			2022-12-28	WOS:000303149900003
J	Lee, CTA; Luffi, P; Chin, EJ; Bouchet, R; Dasgupta, R; Morton, DM; Le Roux, V; Yin, QZ; Jin, D				Lee, Cin-Ty A.; Luffi, Peter; Chin, Emily J.; Bouchet, Romain; Dasgupta, Rajdeep; Morton, Douglas M.; Le Roux, Veronique; Yin, Qing-zhu; Jin, Daphne			Copper Systematics in Arc Magmas and Implications for Crust-Mantle Differentiation	SCIENCE			English	Article							SUBDUCTION ZONE MAGMAS; SULFIDE SATURATION; CONTINENTAL ARCS; OXIDATION-STATE; SULFUR-CONTENT; SOURCE REGIONS; SIERRA-NEVADA; ISLAND ARCS; DEPOSITS; CU	Arc magmas are important building blocks of the continental crust. Because many arc lavas are oxidized, continent formation is thought to be associated with oxidizing conditions. On the basis of copper's (Cu's) affinity for reduced sulfur phases, we tracked the redox state of arc magmas from mantle source to emplacement in the crust. Primary arc and mid-ocean ridge basalts have identical Cu contents, indicating that the redox states of primitive arc magmas are indistinguishable from that of mid-ocean ridge basalts. During magmatic differentiation, the Cu content of most arc magmas decreases markedly because of sulfide segregation. Because a similar depletion in Cu characterizes global continental crust, the formation of sulfide-bearing cumulates under reducing conditions may be a critical step in continent formation.	[Lee, Cin-Ty A.; Luffi, Peter; Chin, Emily J.; Bouchet, Romain; Dasgupta, Rajdeep; Le Roux, Veronique; Jin, Daphne] Rice Univ, Dept Earth Sci, Houston, TX 77005 USA; [Bouchet, Romain] Ecole Normale Super Lyon, Lab Geol Lyon, F-69007 Lyon, France; [Bouchet, Romain] Univ Lyon 1, CNRS, UMR 5276, F-69007 Lyon, France; [Morton, Douglas M.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Le Roux, Veronique] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Yin, Qing-zhu] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; [Jin, Daphne] William P Clements High Sch, Sugar Land, TX 77479 USA	Rice University; Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of California System; University of California Riverside; Woods Hole Oceanographic Institution; University of California System; University of California Davis	Lee, CTA (corresponding author), Rice Univ, Dept Earth Sci, MS 126,6100 Main St, Houston, TX 77005 USA.	ctlee@rice.edu	Lee, Cin-Ty/A-5469-2008; Yin, Qing-Zhu/B-8198-2009; Luffi, Peter I/C-1229-2013; Dasgupta, Rajdeep/C-7252-2009; Le Roux, Veronique/C-4633-2011; Lee, Cin-Ty/AAV-8155-2021	Yin, Qing-Zhu/0000-0002-4445-5096; Luffi, Peter I/0000-0001-9536-5405; Dasgupta, Rajdeep/0000-0001-5392-415X; Lee, Cin-Ty/0000-0002-3586-0110; Le Roux, Veronique/0000-0002-5855-4888; Chin, Emily/0000-0002-9090-1077	NSF	NSF(National Science Foundation (NSF))	This work was funded by an NSF grant to C.-T.A.L. Discussions with F. Albarede, J. Blichert-Toft, S. Huang, D. Anderson, R, Rudnick, W. McDonough, and R. Arevalo are appreciated. D.J.'s participation in this project was made possible by F. Steinkamp's Scientific Research and Design course at William P. Clements High School in Sugar Land, TX. All data are available in the supplementary materials. C.-T.A.L. planned the research and wrote the manuscript. E. J. C. collected the whole-rock data for Sierran garnet pyroxenites. R. B. collected the olivine phenocryst-groundmass trace-element data. C.-T.A.L. and P. L. collected the mineral/mineral trace-element partition coefficients in peridotites, pyroxenites, and sulfides. D. J. developed the ideas behind Fig. 1C. All authors participated in interpretation of the data and modeling.	Alonso-Perez R, 2009, CONTRIB MINERAL PETR, V157, P541, DOI 10.1007/s00410-008-0351-8; ARCULUS RJ, 1985, ANNU REV EARTH PL SC, V13, P75, DOI 10.1146/annurev.ea.13.050185.000451; Arevalo R, 2010, CHEM GEOL, V271, P70, DOI 10.1016/j.chemgeo.2009.12.013; Canil D, 1997, NATURE, V389, P842, DOI 10.1038/39860; CARMICHAEL ISE, 1991, CONTRIB MINERAL PETR, V106, P129, DOI 10.1007/BF00306429; Cooke DR, 2005, ECON GEOL, V100, P801, DOI 10.2113/100.5.801; Dauphas N, 2009, EARTH PLANET SC LETT, V288, P255, DOI 10.1016/j.epsl.2009.09.029; Ducea MN, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000643; Ducea MN, 1998, CONTRIB MINERAL PETR, V133, P169, DOI 10.1007/s004100050445; Gaetani GA, 1997, GEOCHIM COSMOCHIM AC, V61, P1829, DOI 10.1016/S0016-7037(97)00033-1; Gill J., 1981, OROGENIC ANDESITES P; Handler MR, 1999, GEOLOGY, V27, P75, DOI 10.1130/0091-7613(1999)027<0075:EFCIOA>2.3.CO;2; Haschke M, 2010, ECON GEOL, V105, P855, DOI 10.2113/gsecongeo.105.4.855; HEDENQUIST JW, 1994, NATURE, V370, P519, DOI 10.1038/370519a0; Jenner FE, 2010, J PETROL, V51, P2445, DOI 10.1093/petrology/egq063; Jugo PJ, 2010, GEOCHIM COSMOCHIM AC, V74, P5926, DOI 10.1016/j.gca.2010.07.022; Jugo PJ, 2009, GEOLOGY, V37, P415, DOI 10.1130/G25527A.1; Jull M, 2001, J GEOPHYS RES-SOL EA, V106, P6423, DOI 10.1029/2000JB900357; Kelley KA, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003732; Kelley KA, 2009, SCIENCE, V325, P605, DOI 10.1126/science.1174156; Lee CTA, 2010, NATURE, V468, P681, DOI 10.1038/nature09617; Lee CTA, 2007, EARTH PLANET SC LETT, V263, P370, DOI 10.1016/j.epsl.2007.09.025; Lee CTA, 2006, CONTRIB MINERAL PETR, V151, P222, DOI 10.1007/s00410-005-0056-1; Lee CTA, 2005, J PETROL, V46, P2313, DOI 10.1093/petrology/egi056; LORAND JP, 1990, GEOCHIM COSMOCHIM AC, V54, P1487, DOI 10.1016/0016-7037(90)90173-I; LORAND JP, 1989, EARTH PLANET SC LETT, V93, P50, DOI 10.1016/0012-821X(89)90183-0; LYNTON SJ, 1993, ECON GEOL BULL SOC, V88, P901, DOI 10.2113/gsecongeo.88.4.901; Mavrogenes JA, 1999, GEOCHIM COSMOCHIM AC, V63, P1173, DOI 10.1016/S0016-7037(98)00289-0; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Mungall JE, 2002, GEOLOGY, V30, P915, DOI 10.1130/0091-7613(2002)030<0915:RTMSMA>2.0.CO;2; O'Neill HSC, 2002, J PETROL, V43, P1049, DOI 10.1093/petrology/43.6.1049; Oyarzun R, 2001, MINER DEPOSITA, V36, P794, DOI 10.1007/s001260100205; Richards JP, 2009, GEOLOGY, V37, P247, DOI 10.1130/G25451A.1; Richards JR, 2007, ECON GEOL, V102, P537, DOI 10.2113/gsecongeo.102.4.537; Ripley EM, 2002, GEOCHIM COSMOCHIM AC, V66, P2791, DOI 10.1016/S0016-7037(02)00872-4; Rudnick R.L., 2004, TREATISE GEOCHEMISTR, P1, DOI DOI 10.1016/B0-08-043751-6/03016-4; RUDNICK RL, 1995, NATURE, V378, P571, DOI 10.1038/378571a0; Sillitoe RH, 2010, ECON GEOL, V105, P3, DOI 10.2113/gsecongeo.105.1.3; Wallace PJ, 2005, J VOLCANOL GEOTH RES, V140, P217, DOI 10.1016/j.jvolgeores.2004.07.023	39	394	418	9	209	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2012	336	6077					64	68		10.1126/science.1217313	http://dx.doi.org/10.1126/science.1217313			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920LG	22491850				2022-12-28	WOS:000302405400051
J	Jones, FC; Grabherr, MG; Chan, YF; Russell, P; Mauceli, E; Johnson, J; Swofford, R; Pirun, M; Zody, MC; White, S; Birney, E; Searle, S; Schmutz, J; Grimwood, J; Dickson, MC; Myers, RM; Miller, CT; Summers, BR; Knecht, AK; Brady, SD; Zhang, HL; Pollen, AA; Howes, T; Amemiya, C; Lander, ES; Di Palma, F; Lindblad-Toh, K; Kingsley, DM				Jones, Felicity C.; Grabherr, Manfred G.; Chan, Yingguang Frank; Russell, Pamela; Mauceli, Evan; Johnson, Jeremy; Swofford, Ross; Pirun, Mono; Zody, Michael C.; White, Simon; Birney, Ewan; Searle, Stephen; Schmutz, Jeremy; Grimwood, Jane; Dickson, Mark C.; Myers, Richard M.; Miller, Craig T.; Summers, Brian R.; Knecht, Anne K.; Brady, Shannon D.; Zhang, Haili; Pollen, Alex A.; Howes, Timothy; Amemiya, Chris; Lander, Eric S.; Di Palma, Federica; Lindblad-Toh, Kerstin; Kingsley, David M.		Broad Inst Genome Sequencing Platf; Whole Genome Assembly Team	The genomic basis of adaptive evolution in threespine sticklebacks	NATURE			English	Article							GENETIC ARCHITECTURE; PARALLEL EVOLUTION; REGULATORY CHANGES; SIGNALING PATHWAY; PELVIC REDUCTION; EVO-DEVO; VERTEBRATE; DUPLICATION; ADAPTATION; INVERSIONS	Marine stickleback fish have colonized and adapted to thousands of streams and lakes formed since the last ice age, providing an exceptional opportunity to characterize genomic mechanisms underlying repeated ecological adaptation in nature. Here we develop a high-quality reference genome assembly for threespine sticklebacks. By sequencing the genomes of twenty additional individuals from a global set of marine and freshwater populations, we identify a genome-wide set of loci that are consistently associated with marine-freshwater divergence. Our results indicate that reuse of globally shared standing genetic variation, including chromosomal inversions, has an important role in repeated evolution of distinct marine and freshwater sticklebacks, and in the maintenance of divergent ecotypes during early stages of reproductive isolation. Both coding and regulatory changes occur in the set of loci underlying marine-freshwater evolution, but regulatory changes appear to predominate in this well known example of repeated adaptive evolution in nature.	[Grabherr, Manfred G.; Russell, Pamela; Mauceli, Evan; Johnson, Jeremy; Swofford, Ross; Pirun, Mono; Zody, Michael C.; Lander, Eric S.; Di Palma, Federica; Lindblad-Toh, Kerstin] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Jones, Felicity C.; Chan, Yingguang Frank; Miller, Craig T.; Summers, Brian R.; Knecht, Anne K.; Brady, Shannon D.; Zhang, Haili; Pollen, Alex A.; Howes, Timothy; Kingsley, David M.] Stanford Univ, Sch Med, Dept Dev Biol, Beckman Ctr B300, Stanford, CA 94305 USA; [Grabherr, Manfred G.; Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab Uppsala, S-75123 Uppsala, Sweden; [White, Simon; Searle, Stephen] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Birney, Ewan] European Bioinformat Inst, Cambridge CB10 1SA, England; [Schmutz, Jeremy; Grimwood, Jane; Dickson, Mark C.; Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Amemiya, Chris] Benaroya Res Inst Virginia Mason, Dept Mol Genet, Seattle, WA 98101 USA; [Kingsley, David M.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Stanford University; Uppsala University; Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); HudsonAlpha Institute for Biotechnology; Benaroya Research Institute; Virginia Mason Medical Center; Howard Hughes Medical Institute; Stanford University	Lindblad-Toh, K (corresponding author), Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA.	kersli@broad.mit.edu; kingsley@stanford.edu	Chan, Yingguang Frank/ABG-9852-2020; Jones, Felicity C/AAY-3523-2021; Schmutz, Jeremy/N-3173-2013; Miller, Craig/GWQ-5012-2022; Grimwood, Jane/ABD-5737-2021	Chan, Yingguang Frank/0000-0001-6292-9681; Jones, Felicity C/0000-0002-5027-1031; Schmutz, Jeremy/0000-0001-8062-9172; Di-Palma, Federica/0000-0002-4394-0102; Nicol, Robert/0000-0003-1932-1392; White, Simon/0000-0001-6375-2363; Russell, Pamela/0000-0003-2997-6392; Birney, Ewan/0000-0001-8314-8497; Howes, Timothy/0000-0002-0370-0200; Swofford, Ross/0000-0003-3676-8479; Grabherr, Manfred/0000-0001-8792-6508	National Human Genome Research Institute (NHGRI); NHGRI CEGS [P50-HG002568]; Stanford Affymetrix Bio-X; Jane Coffins Childs Fund; NSF; NDSEG; ESF; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003474, U54HG003067, P50HG002568] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI CEGS; Stanford Affymetrix Bio-X; Jane Coffins Childs Fund; NSF(National Science Foundation (NSF)); NDSEG; ESF(European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Stickleback sequencing at Broad Institute was supported by grants from the National Human Genome Research Institute (NHGRI). R.M.M., J.S., J.G. and D.M.K. were supported by NHGRI CEGS Grant P50-HG002568; Y.F.C. by a Stanford Affymetrix Bio-X Graduate Fellowship; C.T.M. by the Jane Coffins Childs Fund; and B.R.S., T.R.H. and A.A.P. by graduate fellowships from NSF and NDSEG. D.M.K. is an investigator of the Howard Hughes Medical Institute. K.L.-T. is a EURYI award recipient funded by ESF. We thank W. Cresko for the BEPA individual used for reference genome sequencing; M. Bell, J. McKinnon, B. Jonsson, S. Mori, C. Peichel, D. Schluter, M. Kalbe, T. Reimchen, D.-P. Hojgaard, M. McLaughlin, B. Geyti and B. Blackman for discussions and assistance with specimens used in population surveys; and G. Bejerano for useful discussions and assistance with computational analysis.	Albert AYK, 2008, EVOLUTION, V62, P76, DOI 10.1111/j.1558-5646.2007.00259.x; Allali-Hassani A, 2007, PLOS BIOL, V5, P1063, DOI 10.1371/journal.pbio.0050097; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Barrett RDH, 2008, SCIENCE, V322, P255, DOI 10.1126/science.1159978; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Barton NH, 1993, HYBRID ZONES EVOLUTI, P13, DOI DOI 10.1111/J.1558-5646.2009.00849.X; Bell M.A., 1994, EVOLUTIONARY BIOL TH; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Colosimo PF, 2004, PLOS BIOL, V2, P635, DOI 10.1371/journal.pbio.0020109; Cresko WA, 2004, P NATL ACAD SCI USA, V101, P6050, DOI 10.1073/pnas.0308479101; Deagle BE, 2011, P R SOC B, V279, P1277, DOI DOI 10.1098/RSPB.2011.1552); Endler J.A., 1986, Monographs in Population Biology, pviii; Feder JL, 2003, GENETICS, V163, P939; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; HAGEN DW, 1967, J FISH RES BOARD CAN, V24, P1637, DOI 10.1139/f67-138; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jones FC, 2006, J EVOLUTION BIOL, V19, P1531, DOI 10.1111/j.1420-9101.2006.01122.x; Joron M, 2011, NATURE, V477, P203, DOI 10.1038/nature10341; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kawahara R, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-209; Kimmel CB, 2005, P NATL ACAD SCI USA, V102, P5791, DOI 10.1073/pnas.0408533102; Kingsley David M., 2007, P41; Kingsley DM, 2004, BEHAVIOUR, V141, P1331, DOI 10.1163/1568539042948150; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; Kitano J, 2010, CURR BIOL, V20, P2124, DOI 10.1016/j.cub.2010.10.050; Knecht AK, 2007, EVOL DEV, V9, P141, DOI 10.1111/j.1525-142X.2007.00145.x; Kvitek DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002056; Lowry DB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000500; Marshall William S., 2006, P177; McKinnon JS, 2002, TRENDS ECOL EVOL, V17, P480, DOI 10.1016/S0169-5347(02)02579-X; McPhail J.D., 1994, P399; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Miyake A, 1999, J BIOL CHEM, V274, P25018, DOI 10.1074/jbc.274.35.25018; Miyake A, 2009, J NEUROSCI, V29, P14637, DOI 10.1523/JNEUROSCI.0901-09.2009; Peichel CL, 2001, NATURE, V414, P901, DOI 10.1038/414901a; REIMCHEN TE, 1985, CAN J ZOOL, V63, P2944, DOI 10.1139/z85-441; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Vinogradov AE, 1998, CYTOMETRY, V31, P100, DOI 10.1002/(SICI)1097-0320(19980201)31:2<100::AID-CYTO5>3.0.CO;2-Q; Wittkopp PJ, 2008, NAT GENET, V40, P346, DOI 10.1038/ng.77; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Yu J, 2009, DEVELOPMENT, V136, P161, DOI 10.1242/dev.022087	50	1161	1181	20	614	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2012	484	7392					55	61		10.1038/nature10944	http://dx.doi.org/10.1038/nature10944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	919QN	22481358	Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000302343400033
J	Hawkes, N				Hawkes, Nigel			BODY POLITIC Lansley has pulled off one of the profoundest reforms ever To sack the health secretary now would be an admission that all the blood and sweat was spilt in vain	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 4	2012	344								e2429	10.1136/bmj.e2429	http://dx.doi.org/10.1136/bmj.e2429			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	923HC	22491699				2022-12-28	WOS:000302609300004
J	Hellinger, WC; Bacalis, LP; Kay, RS; Thompson, ND; Xia, GL; Lin, YL; Khudyakov, YE; Perz, JF				Hellinger, Walter C.; Bacalis, Laura P.; Kay, Robyn S.; Thompson, Nicola D.; Xia, Guo-Liang; Lin, Yulin; Khudyakov, Yury E.; Perz, Joseph F.			Health Care-Associated Hepatitis C Virus Infections Attributed to Narcotic Diversion	ANNALS OF INTERNAL MEDICINE			English	Article							OPERATING-ROOM; UNITED-STATES; TRANSMISSION; ANESTHESIOLOGIST; PERSONNEL; PATIENT; WORKERS; SYSTEM; ORGAN; TIME	Background: Three cases of genetically related hepatitis C virus (HCV) infection that were unattributable to infection control breaches were identified at a health care facility. Objective: To investigate HCV transmission from an HCV-infected health care worker to patients through drug diversion. Design: Cluster and look-back investigations. Setting: Acute care hospital and affiliated multispecialty clinic. Patients: Inpatients and outpatients during the period of HCV transmission. Measurements: Employee work and narcotic dispensing records, blood testing for HCV antibody and RNA, and sequencing of the NS5B gene and the hypervariable region 1 of the E2 gene. Results: 21 employees were recorded as being at work or as retrieving a narcotic from an automated dispensing cabinet in an area where a narcotic was administered to each of the 3 case patients; all employees provided blood samples for HCV testing. One employee was infected with HCV that had more than 95% NS5B sequence homology with the HCV strains of the 3 case patients. Quasi-species analysis showed close genetic relatedness with variants from each of the case patients and more than 97.9% nucleotide identity. The employee acknowledged parenteral opiate diversion. An investigation identified 6132 patients at risk for exposure to HCV because of the drug diversion. Of the 3929 living patients, 3444 (87.7%) were screened for infection. Two additional cases of genetically related HCV infection attributable to the employee were identified. Limitation: Of the living patients at risk for HCV exposure, 12.3% were not tested. Conclusion: Five cases of HCV infection occurring over 3 to 4 years were attributed to drug diversion by an HCV-infected health care worker. Studies of drug diversion and assessments of strategies to prevent narcotics tampering in all health care settings are needed.	[Hellinger, Walter C.] Mayo Clin, Div Infect Dis, Jacksonville, FL 32224 USA; Florida Dept Hlth, Tallahassee, FL USA; Ctr Dis Control & Prevent, Atlanta, GA USA	Mayo Clinic; Florida Department of Health; Centers for Disease Control & Prevention - USA	Hellinger, WC (corresponding author), Mayo Clin, Div Infect Dis, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	helling@mayo.edu						Berge KH, 2008, ANESTHESIOLOGY, V109, P762, DOI 10.1097/ALN.0b013e31818a3814; Bosch X, 2000, LANCET, V355, P818, DOI 10.1016/S0140-6736(05)72446-6; Cody SH, 2002, ARCH INTERN MED, V162, P345, DOI 10.1001/archinte.162.3.345; Colorado Department of Public Health and Environment, 2009, FAQS COL HEP C INV; Domino KB, 2005, JAMA-J AM MED ASSOC, V293, P1453, DOI 10.1001/jama.293.12.1453; Dudzinski DM, 2010, NEW ENGL J MED, V363, P978, DOI 10.1056/NEJMhle1003134; Dunn D, 2005, AORN J, V82, P599; Dunn D, 2005, AORN J, V82, P592, DOI [DOI 10.1016/S0001-2092(06)60028-8, 10.1016/S0001-2092(06) 60028-8]; Dunn Debra, 2005, AORN J, V82, P573; Dunn S., 2005, AORN J, V82; Epstein RH, 2007, ANESTH ANALG, V105, P1053, DOI 10.1213/01.ane.0000281797.00935.08; Hadfield S, 2011, HEPATITIS C WOMAN LA; Henderson DK, 2010, INFECT CONT HOSP EP, V31, P203, DOI 10.1086/650298; Lee KC, 2005, 43 ANN M INF DIS SOC; MAKI DG, 1991, JAMA-J AM MED ASSOC, V265, P981, DOI 10.1001/jama.265.8.981; Nainan OV, 2006, GASTROENTEROLOGY, V131, P478, DOI 10.1053/j.gastro.2006.06.007; Ostrowsky BE, 2002, NEW ENGL J MED, V346, P1529, DOI 10.1056/NEJMoa012370; Perz Joseph F, 2010, Clin Liver Dis, V14, P137, DOI 10.1016/j.cld.2009.11.004; Ramachandran S, 2008, J VIROL METHODS, V151, P217, DOI 10.1016/j.jviromet.2008.05.005; Ross RS, 2000, NEW ENGL J MED, V343, P1851, DOI 10.1056/NEJM200012213432505; SCHMIDT KA, 1993, ANESTHESIOLOGY, V78, P184, DOI 10.1097/00000542-199301000-00025; SEHULSTER L, 1997, P INT C ANT AG CHEM, P293; Shemer-Avni Y, 2007, CLIN INFECT DIS, V45, pE32, DOI 10.1086/520014; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Substance Abuse and Mental Health Services Administration Office of Applied Studies, 1996, DHHS PUBL; Thompson ND, 2009, TRANSPL INFECT DIS, V11, P324, DOI 10.1111/j.1399-3062.2009.00406.x; Thompson ND, 2009, ANN INTERN MED, V150, P33, DOI 10.7326/0003-4819-150-1-200901060-00007; Tugwell BD, 2005, ANN INTERN MED, V143, P648, DOI 10.7326/0003-4819-143-9-200511010-00008; Williams IT, 2006, J CLIN VIROL, V36, pS43, DOI 10.1016/S1386-6532(06)80135-6; Williams IT, 2004, CLIN INFECT DIS, V38, P1592, DOI 10.1086/420935; Willock M, 1998, INT ANESTHESIOL CLIN, V36, P65, DOI 10.1097/00004311-199803610-00009	31	22	22	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2012	156	7					477	U34		10.7326/0003-4819-156-7-201204030-00002	http://dx.doi.org/10.7326/0003-4819-156-7-201204030-00002			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921GP	22473434				2022-12-28	WOS:000302466400001
J	Jacob, NP				Jacob, Nitya P.			Investigating Arabia Mountain: A Molecular Approach	SCIENCE			English	Editorial Material							COMMUNITIES		Emory Univ, Oxford Coll, Oxford, GA 30054 USA	Emory University	Jacob, NP (corresponding author), Emory Univ, Oxford Coll, Oxford, GA 30054 USA.	njacob@emory.edu						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ash C, 2008, SCIENCE, V320, P1027, DOI 10.1126/science.320.5879.1027; BURBANCK MP, 1964, ECOLOGY, V45, P292, DOI 10.2307/1933842; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; HOULE G, 1989, VEGETATIO, V80, P25, DOI 10.1007/BF00049138; Jacob N., 2008, J COLL SCI TEACH, V38, P54; Jacob N., 2008, COUNCIL UNDERGRAD RE, V29, P24; Morgan J. G., 2011, INVESTIGATING BIOL; Zul D, 2007, APPL ENVIRON MICROB, V73, P6916, DOI 10.1128/AEM.01533-07	9	5	5	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1588	1589		10.1126/science.1213692	http://dx.doi.org/10.1126/science.1213692			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461602				2022-12-28	WOS:000302062600034
J	Malhotra, V				Malhotra, Vivek			COPII Vesicles Get Supersized by Ubiquitin	CELL			English	Editorial Material							RETICULUM EXIT SITES; COLLAGEN SECRETION; TANGO1	Some proteins are too big to fit into conventional COPII-coated vesicles, which raises the question of how large cargo, such as procollagen fibrils, are exported from the endoplasmic reticulum. Jin et al. (2012) in Nature now report that the creation of oversized vesicles is facilitated by the ubiquitination of the COPII component Sec31p.	[Malhotra, Vivek] Ctr Genom Regulat CRG, Dept Cell & Dev Biol, Barcelona 08002, Spain; [Malhotra, Vivek] Univ Pompeu Fabra, Barcelona 08002, Spain; [Malhotra, Vivek] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA	Malhotra, V (corresponding author), Ctr Genom Regulat CRG, Dept Cell & Dev Biol, Barcelona 08002, Spain.	vivek.malhotra@crg.eu	Malhotra, Vivek/O-9811-2014	Malhotra, Vivek/0000-0001-6198-7943	ICREA Funding Source: Custom	ICREA(ICREA)		Jensen D, 2011, J CELL SCI, V124, P1, DOI 10.1242/jcs.069773; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Kim SD, 2012, J BIOL CHEM, V287, P10134, DOI 10.1074/jbc.M111.283382; Malhotra V, 2011, EMBO J, V30, P3475, DOI 10.1038/emboj.2011.255; Pastor-Pareja JC, 2011, DEV CELL, V21, P245, DOI 10.1016/j.devcel.2011.06.026; Saito K, 2011, MOL BIOL CELL, V22, P2301, DOI 10.1091/mbc.E11-02-0143; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; Wilson DG, 2011, J CELL BIOL, V193, P935, DOI 10.1083/jcb.201007162	10	3	3	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 30	2012	149	1					20	21		10.1016/j.cell.2012.03.006	http://dx.doi.org/10.1016/j.cell.2012.03.006			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464320	Bronze			2022-12-28	WOS:000302235400006
J	Schapira, AHV				Schapira, Anthony H. V.			Mitochondrial diseases	LANCET			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; ELECTRON-TRANSPORT CHAIN; PLACEBO-CONTROLLED TRIAL; COMPLEX-I; HUNTINGTONS-DISEASE; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; OXIDATIVE-PHOSPHORYLATION; QUALITY-CONTROL; COENZYME Q(10)	Mitochondria have a crucial role in cellular bioenergetics and apoptosis, and thus are important to support cell function and in determination of cell death pathways. Inherited mitochondrial diseases can be caused by mutations of mitochondrial DNA or of nuclear genes that encode mitochondrial proteins. Although many mitochondrial disorders are multisystemic, some are tissue specific-eg, optic neuropathy, sensorineural deafness, and type 2 diabetes mellitus. In the past few years, several disorders have been associated with mutations of nuclear genes responsible for mitochondrial DNA maintenance and function, and the potential contribution of mitochondrial abnormalities to progressive neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease has been recognised. The process of mitochondrial fission-fusion has become a focus of attention in human disease. Importantly, the mitochondrion is now a target for therapeutic interventions that encompass small molecules, transcriptional regulation, and genetic manipulation, offering opportunities to treat a diverse range of diseases.	UCL, Inst Neurol, Dept Clin Neurosci, London NW3 2PF, England	University of London; University College London	Schapira, AHV (corresponding author), UCL, Inst Neurol, Dept Clin Neurosci, London NW3 2PF, England.	a.schapira@medsch.ucl.ac.uk	Schapira, Anthony/A-1245-2010	Schapira, Anthony/0000-0002-3018-3966	Medical Research Council [MC_G1000735] Funding Source: Medline; Wellcome Trust [089698] Funding Source: Medline; MRC [MC_G1000735] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abramov AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025622; Alvarez-Erviti L, 2010, ARCH NEUROL-CHICAGO, V67, P1464, DOI 10.1001/archneurol.2010.198; Anekonda TS, 2006, J NEUROCHEM, V96, P305, DOI 10.1111/j.1471-4159.2005.03492.x; Area-Gomez E, 2009, AM J PATHOL, V175, P1810, DOI 10.2353/ajpath.2009.090219; Bandhyopadhyay U, 2007, EXP GERONTOL, V42, P120, DOI 10.1016/j.exger.2006.05.019; Batelli S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001884; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bender A, 2006, NEUROLOGY, V67, P1262, DOI 10.1212/01.wnl.0000238518.34389.12; Bitner-Glindzicz M, 2009, NEW ENGL J MED, V360, P640, DOI 10.1056/NEJMc0806396; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Cai W, 2008, J GENET GENOMICS, V35, P649, DOI 10.1016/S1673-8527(08)60086-7; Calvo J, 2009, ARCH NEUROL-CHICAGO, V66, P1511, DOI 10.1001/archneurol.2009.284; Carelli V, 2009, BBA-BIOENERGETICS, V1787, P518, DOI 10.1016/j.bbabio.2009.02.024; Chaturvedi RK, 2009, HUM MOL GENET, V18, P3048, DOI 10.1093/hmg/ddp243; Cheung KH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000818; Chinnery P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub2; Cho DH, 2010, CELL MOL LIFE SCI, V67, P3435, DOI 10.1007/s00018-010-0435-2; Cock HR, 1998, ANN NEUROL, V44, P187, DOI 10.1002/ana.410440208; Cooper JM, 2008, EUR J NEUROL, V15, P1371, DOI 10.1111/j.1468-1331.2008.02318.x; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Costa V, 2010, EMBO MOL MED, V2, P490, DOI 10.1002/emmm.201000102; Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Dagda RK, 2009, J BIOENERG BIOMEMBR, V41, P473, DOI 10.1007/s10863-009-9255-1; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; de Castro IP, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001456; Del Bo R, 2008, NEUROLOGY, V71, P1959, DOI 10.1212/01.wnl.0000327095.32005.a4; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; Di Prospero NA, 2007, LANCET NEUROL, V6, P878, DOI 10.1016/S1474-4422(07)70220-X; DiFrancesco JC, 2008, EXP NEUROL, V212, P152, DOI 10.1016/j.expneurol.2008.03.015; Duchen MR, 2010, ESSAYS BIOCHEM, V47, P115, DOI [10.1042/BSE0470115, 10.1042/bse0470115]; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Ferreirinha F, 2004, J CLIN INVEST, V113, P231, DOI 10.1172/JCI200420138; Finsterer J, 2009, EUR J NEUROL, V16, P1255, DOI 10.1111/j.1468-1331.2009.02811.x; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Gegg ME, 2011, AUTOPHAGY, V7, P243, DOI 10.4161/auto.7.2.14332; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Gegg ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004756; Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002; Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Grunewald A, 2009, EXP NEUROL, V219, P266, DOI 10.1016/j.expneurol.2009.05.027; Grunewald A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012962; Gu M, 1996, ANN NEUROL, V39, P385, DOI 10.1002/ana.410390317; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Halter J, 2011, BONE MARROW TRANSPL, V46, P330, DOI 10.1038/bmt.2010.100; Hart PE, 2005, ARCH NEUROL-CHICAGO, V62, P621, DOI 10.1001/archneur.62.4.621; Hersch SM, 2006, NEUROLOGY, V66, P250, DOI 10.1212/01.wnl.0000194318.74946.b6; Ho DJ, 2010, EXP NEUROL, V225, P74, DOI 10.1016/j.expneurol.2010.05.006; Hollerhage M, 2009, EXP NEUROL, V220, P133, DOI 10.1016/j.expneurol.2009.08.004; Hoepken HH, 2007, NEUROBIOL DIS, V25, P401, DOI 10.1016/j.nbd.2006.10.007; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jeppesen TD, 2009, EUR J NEUROL, V16, P1336, DOI 10.1111/j.1468-1331.2009.02660.x; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Kacerovsky-Bielesz G, 2009, DIABETES, V58, P1333, DOI 10.2337/db08-1240; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kerr DS, 2010, MOL GENET METAB, V99, P246, DOI 10.1016/j.ymgme.2009.11.005; Khan MM, 2010, BRAIN RES, V1328, P139, DOI 10.1016/j.brainres.2010.02.031; Kieburtz K, 2001, NEUROLOGY, V57, P397; Kim J, 2010, HUM MOL GENET, V19, P3919, DOI 10.1093/hmg/ddq306; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kong GYX, 2009, J GLAUCOMA, V18, P93, DOI 10.1097/IJG.0b013e318181284f; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Kyriakouli DS, 2008, GENE THER, V15, P1017, DOI 10.1038/gt.2008.91; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701; Lascaratos G, 2012, MITOCHONDRION, V12, P202, DOI 10.1016/j.mito.2011.11.004; Li WW, 2007, NEUROREPORT, V18, P1543, DOI 10.1097/WNR.0b013e3282f03db4; Lim D, 2008, J BIOL CHEM, V283, P5780, DOI 10.1074/jbc.M704704200; Lira VA, 2010, AM J PHYSIOL-ENDOC M, V299, pE145, DOI 10.1152/ajpendo.00755.2009; Liu GW, 2009, NEUROSCI LETT, V454, P187, DOI 10.1016/j.neulet.2009.02.056; Lodi R, 2000, ANN NEUROL, V48, P72; Luce K, 2010, ADV EXP MED BIOL, V694, P108; Lynch DR, 2010, ARCH NEUROL-CHICAGO, V67, P941, DOI 10.1001/archneurol.2010.168; Maher P, 2011, HUM MOL GENET, V20, P261, DOI 10.1093/hmg/ddq460; Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; MANN VM, 1992, FEBS LETT, V299, P218, DOI 10.1016/0014-5793(92)80118-Z; Martin LJ, 2010, J ALZHEIMERS DIS, V20, pS335, DOI 10.3233/JAD-2010-100348; McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2; Montini G, 2008, NEW ENGL J MED, V358, P2849, DOI 10.1056/NEJMc0800582; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; MORGANHUGHES JA, 1995, BBA-MOL BASIS DIS, V1271, P135, DOI 10.1016/0925-4439(95)00020-5; Moutaouakil F, 2009, REV NEUROL-FRANCE, V165, P482, DOI 10.1016/j.neurol.2008.08.006; Muftuoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695; Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Nakamura K, 2008, J NEUROSCI, V28, P12305, DOI 10.1523/JNEUROSCI.3088-08.2008; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nucci C, 2005, NEUROTOXICOLOGY, V26, P935, DOI 10.1016/j.neuro.2005.06.002; Orr AL, 2008, J NEUROSCI, V28, P2783, DOI 10.1523/JNEUROSCI.0106-08.2008; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Plun-Favreau H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001257; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Puglielli L, 2001, NAT CELL BIOL, V3, P905, DOI 10.1038/ncb1001-905; Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983; Ravina B, 2006, NEUROLOGY, V66, P664; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; Ritov VB, 2010, AM J PHYSIOL-ENDOC M, V298, pE49, DOI 10.1152/ajpendo.00317.2009; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ronn T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004793; Roses AD, 2010, PHARMACOGENOMICS J, V10, P375, DOI 10.1038/tpj.2009.69; Santos R, 2010, ANTIOXID REDOX SIGN, V13, P651, DOI 10.1089/ars.2009.3015; Schapira AH, 2009, EUR J NEUROL, V16, P1090, DOI 10.1111/j.1468-1331.2009.02793.x; Schapira AHV, 2010, EXP NEUROL, V224, P331, DOI 10.1016/j.expneurol.2010.03.028; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Schapira AHV, 2006, NEUROLOGY, V66, pS10, DOI 10.1212/WNL.66.10_suppl_4.S10; Scheele C, 2007, FASEB J, V21, P3653, DOI 10.1096/fj.07-8520com; Schiff M, 2009, J INHERIT METAB DIS, V32, P684, DOI 10.1007/s10545-009-1263-0; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Shults CW, 2002, ARCH NEUROL-CHICAGO, V59, P1541, DOI 10.1001/archneur.59.10.1541; Simon DK, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-53; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Storch A, 2007, ARCH NEUROL-CHICAGO, V64, P938, DOI 10.1001/archneur.64.7.nct60005; Supnet C, 2010, CELL CALCIUM, V47, P183, DOI 10.1016/j.ceca.2009.12.014; Taanman JW, 2009, NEUROMUSCULAR DISORD, V19, P151, DOI 10.1016/j.nmd.2008.11.002; Taanman JW, 2009, HUM MUTAT, V30, P248, DOI 10.1002/humu.20852; Tabrizi SJ, 1999, ANN NEUROL, V45, P25, DOI 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E; Tabrizi SJ, 2005, NEUROLOGY, V64, P1655, DOI 10.1212/01.WNL.0000160388.96242.77; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vandebona H, 2009, NEW ENGL J MED, V360, P642, DOI 10.1056/NEJMc0806397; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586; Wang HM, 2009, HUM MOL GENET, V18, P737, DOI 10.1093/hmg/ddn404; Warner TT, 2003, ANN NEUROL, V53, pS16, DOI 10.1002/ana.10487; Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006; Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012	140	310	332	8	132	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2012	379	9828					1825	1834		10.1016/S0140-6736(11)61305-6	http://dx.doi.org/10.1016/S0140-6736(11)61305-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	941BR	22482939				2022-12-28	WOS:000303937700037
J	Cho, H; Zhao, X; Hatori, M; Yu, RT; Barish, GD; Lam, MT; Chong, LW; DiTacchio, L; Atkins, AR; Glass, CK; Liddle, C; Auwerx, J; Downes, M; Panda, S; Evans, RM				Cho, Han; Zhao, Xuan; Hatori, Megumi; Yu, Ruth T.; Barish, Grant D.; Lam, Michael T.; Chong, Ling-Wa; DiTacchio, Luciano; Atkins, Annette R.; Glass, Christopher K.; Liddle, Christopher; Auwerx, Johan; Downes, Michael; Panda, Satchidananda; Evans, Ronald M.			Regulation of circadian behaviour and metabolism by REV-ERB-alpha and REV-ERB-beta	NATURE			English	Article							CLOCK; RECEPTOR; TRANSCRIPTION; RHYTHMS; GENES; ROLES; OSCILLATOR; MOUSE; LIVER; MICE	The circadian clock acts at the genomic level to coordinate internal behavioural and physiological rhythms via the CLOCK-BMAL1 transcriptional heterodimer. Although the nuclear receptors REV-ERB-alpha and REV-ERB-beta have been proposed to form an accessory feedback loop that contributes to clock function(1,2), their precise roles and importance remain unresolved. To establish their regulatory potential, we determined the genome-wide cis-acting targets (cistromes) of both REV-ERB isoforms in murine liver, which revealed shared recognition at over 50% of their total DNA binding sites and extensive overlap with the master circadian regulator BMAL1. Although REV-ERB-alpha has been shown to regulate Bmal1 expression directly(1,2), our cistromic analysis reveals a more profound connection between BMAL1 and the REV-ERB-alpha and REV-ERB-beta genomic regulatory circuits than was previously suspected. Genes within the intersection of the BMAL1, REV-ERB-alpha and REV-ERB-beta cistromes are highly enriched for both clock and metabolic functions. As predicted by the cistromic analysis, dual depletion of Rev-erb-alpha and Rev-erb-beta function by creating double-knockout mice profoundly disrupted circadian expression of core circadian clock and lipid homeostatic gene networks. As a result, double-knockout mice show markedly altered circadian wheel-running behaviour and deregulated lipid metabolism. These data now unite REV-ERB-alpha and REV-ERB-beta with PER, CRY and other components of the principal feedback loop that drives circadian expression and indicate a more integral mechanism for the coordination of circadian rhythm and metabolism.	[Cho, Han; Zhao, Xuan; Yu, Ruth T.; Barish, Grant D.; Chong, Ling-Wa; Atkins, Annette R.; Downes, Michael; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Hatori, Megumi; DiTacchio, Luciano; Panda, Satchidananda] Salk Inst Biol Studies, Regulatory Biol Lab, La Jolla, CA 92037 USA; [Lam, Michael T.; Glass, Christopher K.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Liddle, Christopher] Westmead Millennium Inst, Storr Liver Unit, Westmead, NSW 2145, Australia; [Liddle, Christopher] Univ Sydney, Westmead Hosp, Westmead, NSW 2145, Australia; [Auwerx, Johan] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; Salk Institute; University of California System; University of California San Diego; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Howard Hughes Medical Institute; Salk Institute	Evans, RM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	evans@salk.edu	DiTacchio, Luciano/D-6341-2011; Hatori, Megumi/GTY-3770-2022; Glass, Christopher/AAI-3933-2021; Evans, Ronald/AAF-4001-2019; Auwerx, Johan/ABE-9307-2021; Panda, Satchidananda/J-6891-2012	DiTacchio, Luciano/0000-0001-9570-7348; Glass, Christopher/0000-0003-4344-3592; Evans, Ronald/0000-0002-9986-5965; Yu, Ruth/0000-0002-9527-9627; Auwerx, Johan/0000-0002-5065-5393; Chong, Ling Wa/0000-0002-8571-5413; Hatori, Megumi/0000-0001-7888-158X	National Research Service Award [T32-HL007770]; National Institutes of Health [DK062434, DK057978, DK090962, DK091618, HL105278]; National Health and Medical Research Council of Australia [NHMRC 512354, 632886]; Helmsley Charitable Trust; Glenn Foundation; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007770, R01HL105278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK090962, U19DK062434, R01DK091618, R37DK057978] Funding Source: NIH RePORTER	National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Helmsley Charitable Trust; Glenn Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Kaufman, J. Alvarez, E. Banayo, H. Juguilon, S. Jacinto and H. Le for technical assistance; and L. Ong and S. Ganley for administrative assistance. We also thank L. Pei for discussion. R. M. E is an Investigator of the Howard Hughes Medical Institute at The Salk Institute for Biological Studies and March of Dimes Chair in Molecular and Developmental Biology. H. C. is a recipient of National Research Service Award (T32-HL007770). This work was supported by National Institutes of Health Grants (DK062434, DK057978, DK090962, DK091618 and HL105278), National Health and Medical Research Council of Australia Project Grants (NHMRC 512354 and 632886), the Helmsley Charitable Trust, the Glenn Foundation and the Howard Hughes Medical Institute.	Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chomez P, 2000, DEVELOPMENT, V127, P1489; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Hatanaka F, 2010, MOL CELL BIOL, V30, P5636, DOI 10.1128/MCB.00781-10; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Kojetin D, 2011, ACS CHEM BIOL, V6, P131, DOI 10.1021/cb1002575; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kumar N, 2010, ENDOCRINOLOGY, V151, P3015, DOI 10.1210/en.2009-0800; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Oster H, 2006, J BIOL RHYTHM, V21, P350, DOI 10.1177/0748730406293053; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raspe E, 2002, J LIPID RES, V43, P2172, DOI 10.1194/jlr.M200386-JLR200; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ukai-Tadenuma M, 2011, CELL, V144, P268, DOI 10.1016/j.cell.2010.12.019; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	29	667	697	11	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					123	127		10.1038/nature11048	http://dx.doi.org/10.1038/nature11048			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22460952	Green Accepted			2022-12-28	WOS:000303451900047
J	Nuth, JA; Johnson, NM				Nuth, Joseph A., III; Johnson, Natasha M.			Complex Protostellar Chemistry	SCIENCE			English	Editorial Material							SOLAR NEBULA; METEORITES; TRANSPORT; SYSTEM; ORIGIN; DUST		[Nuth, Joseph A., III; Johnson, Natasha M.] NASAs Goddard Space Flight Ctr, Solar Syst Explorat Div, Greenbelt, MD 20771 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Nuth, JA (corresponding author), NASAs Goddard Space Flight Ctr, Solar Syst Explorat Div, Greenbelt, MD 20771 USA.	joseph.a.nuth@nasa.gov	Johnson, Natasha/E-3093-2012; Nuth, Joseph/E-7085-2012					Ciesla FJ, 2009, ICARUS, V200, P655, DOI 10.1016/j.icarus.2008.12.009; Ciesla FJ, 2008, METEORIT PLANET SCI, V43, P639, DOI 10.1111/j.1945-5100.2008.tb00675.x; Clayton RN, 2002, NATURE, V415, P860, DOI 10.1038/415860b; CLAYTON RN, 1973, SCIENCE, V182, P485, DOI 10.1126/science.182.4111.485; HAYATSU R, 1981, TOP CURR CHEM, V99, P1; LEWIS JS, 1974, SCI AM, V230, P51, DOI 10.1038/scientificamerican0374-50; Llorca J, 1998, METEORIT PLANET SCI, V33, P243, DOI 10.1111/j.1945-5100.1998.tb01629.x; Lyons JR, 2005, NATURE, V435, P317, DOI 10.1038/nature03557; Nuth JA, 2001, AM SCI, V89, P228, DOI 10.1511/2001.22.871; Nuth JA, 2000, NATURE, V406, P275, DOI 10.1038/35018516; Nuth JA, 2008, ASTROPHYS J LETT, V673, pL225, DOI 10.1086/528741; Yurimoto H, 2004, SCIENCE, V305, P1763, DOI 10.1126/science.1100989; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842	15	4	4	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					424	425		10.1126/science.1219709	http://dx.doi.org/10.1126/science.1219709			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22461497	Green Submitted			2022-12-28	WOS:000303233400032
J	Hutchison, G				Hutchison, Grant			Guidelines can harm patients too	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland	University of Dundee	Hutchison, G (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland.	grant.hutchison@nhs.net						Lee DH, 2011, ARCH INTERN MED, V171, P18, DOI 10.1001/archinternmed.2010.482; McMurdo MET, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6165; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205	3	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 18	2012	344								e2685	10.1136/bmj.e2685	http://dx.doi.org/10.1136/bmj.e2685			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	931CQ	22514217				2022-12-28	WOS:000303192400007
J	Barnett, R				Barnett, Richard			The art of medicine Bitter medicine: gout and the birth of the cocktail	LANCET			English	Editorial Material									UCL, Dept Sci & Technol Studies, London WC1E 6BT, England	University of London; University College London	Barnett, R (corresponding author), UCL, Dept Sci & Technol Studies, Mortimer St, London WC1E 6BT, England.	ucgarba@googlemail.com							0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 14	2012	379	9824					1384	1385		10.1016/S0140-6736(12)60586-8	http://dx.doi.org/10.1016/S0140-6736(12)60586-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	926BR	22509528				2022-12-28	WOS:000302806800015
J	French, RM				French, Robert M.			Dusting Off the Turing Test	SCIENCE			English	Editorial Material									Univ Bourgogne, LEAD CNRS, Dijon, France	Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	French, RM (corresponding author), Univ Bourgogne, LEAD CNRS, Dijon, France.	robert.french@u-bourgogne.fr						Bell G, 2009, TOTAL RECALL E MEMOR; Dreyfus HL, 1992, WHAT COMPUTERS STILL; FRENCH RM, 1990, MIND, V99, P53; French RM, 2000, TRENDS COGN SCI, V4, P115, DOI 10.1016/S1364-6613(00)01453-4; Harnad S., 1991, Minds and Machines, V1, P43; Haugeland J., 1985, ARTIF INTELL; Hodges A, 2012, SCIENCE, V336, P163, DOI 10.1126/science.1218417; HOFSTADTER DR, 1985, METAMAGICAL THEMAS, P631; Kurzweil R., 2011, PC MAG; Marshall JB, 2006, J EXP THEOR ARTIF IN, V18, P267, DOI 10.1080/09528130600758626; ROY D, 2006, P 28 ANN COGN SCI C, P2059; Talbot D., 2011, TECHNOL REV      NOV; Turing A., 1950, MIND, V59, P433, DOI DOI 10.1093/MIND/LIX.236.433; Whitby B., 1996, MACHINES THOUGHT LEG	15	8	8	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2012	336	6078					164	165		10.1126/science.1218350	http://dx.doi.org/10.1126/science.1218350			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924PN	22499930				2022-12-28	WOS:000302703900031
J	Lee, IH; Kawai, Y; Fergusson, MM; Rovira, II; Bishop, AJR; Motoyama, N; Cao, L; Finkel, T				Lee, In Hye; Kawai, Yoshichika; Fergusson, Maria M.; Rovira, Ilsa I.; Bishop, Alexander J. R.; Motoyama, Noboru; Cao, Liu; Finkel, Toren			Atg7 Modulates p53 Activity to Regulate Cell Cycle and Survival During Metabolic Stress	SCIENCE			English	Article							DNA-DAMAGE RESPONSE; AUTOPHAGY; QUIESCENCE; APOPTOSIS	Withdrawal of nutrients triggers an exit from the cell division cycle, the induction of autophagy, and eventually the activation of cell death pathways. The relation, if any, among these events is not well characterized. We found that starved mouse embryonic fibroblasts lacking the essential autophagy gene product Atg7 failed to undergo cell cycle arrest. Independent of its E1-like enzymatic activity, Atg7 could bind to the tumor suppressor p53 to regulate the transcription of the gene encoding the cell cycle inhibitor p21(CDKN1A). With prolonged metabolic stress, the absence of Atg7 resulted in augmented DNA damage with increased p53-dependent apoptosis. Inhibition of the DNA damage response by deletion of the protein kinase Chk2 partially rescued postnatal lethality in Atg7(-/-) mice. Thus, when nutrients are limited, Atg7 regulates p53-dependent cell cycle and cell death pathways.	[Cao, Liu] China Med Univ, Key Lab Med Cell Biol, Shenyang 110001, Peoples R China; [Lee, In Hye; Kawai, Yoshichika; Fergusson, Maria M.; Rovira, Ilsa I.; Finkel, Toren] NHLBI, Ctr Mol Med, Bethesda, MD 20892 USA; [Bishop, Alexander J. R.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Motoyama, Noboru] Natl Ctr Geriatr & Gerontol, Res Inst, Dept Cognit Brain Sci, Aichi 4748511, Japan	China Medical University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Health San Antonio; National Center for Geriatrics & Gerontology	Cao, L (corresponding author), China Med Univ, Key Lab Med Cell Biol, Shenyang 110001, Peoples R China.	caoliu@mail.cmu.edu; finkelt@nih.gov	LEE, IN HYE/T-2714-2019; Kawai, Yoshichika/G-3231-2011	LEE, IN HYE/0000-0003-2334-3594; Bishop, Alexander/0000-0002-5742-4387	National Natural Science Foundation of China [81130042, 31171323]; NIH; Ellison Medical Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005012, ZICHL006019] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank M. Komatsu for providing the Atg7<SUP>+/-</SUP> mice. Supported by National Natural Science Foundation of China grants 81130042 and 31171323 (L.C.), NIH intramural funds, and a grant from the Ellison Medical Foundation (T.F.).	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Delavaine L, 1999, ONCOGENE, V18, P5381, DOI 10.1038/sj.onc.1202923; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; HARPER JW, 1993, CELL, V75, P805; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2001, J BIOL CHEM, V276, P9846, DOI 10.1074/jbc.M007737200; Kwon YH, 2002, J BIOL CHEM, V277, P41417, DOI 10.1074/jbc.M203388200; Ladha MH, 1998, MOL CELL BIOL, V18, P6605, DOI 10.1128/MCB.18.11.6605; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Pattison JS, 2011, CIRC RES, V109, P151, DOI 10.1161/CIRCRESAHA.110.237339; Perucca P, 2009, CELL CYCLE, V8, P105, DOI 10.4161/cc.8.1.7507; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rivard N, 1996, J BIOL CHEM, V271, P18337, DOI 10.1074/jbc.271.31.18337; Schiaffino S, 2008, AUTOPHAGY, V4, P727, DOI 10.4161/auto.6143; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tasdemir E, 2008, CELL CYCLE, V7, P3006, DOI 10.4161/cc.7.19.6702; Valentin M, 2008, CELL CYCLE, V7, P2762, DOI 10.4161/cc.7.17.6595; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005	25	229	243	2	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2012	336	6078					225	228		10.1126/science.1218395	http://dx.doi.org/10.1126/science.1218395			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924PN	22499945	Green Accepted			2022-12-28	WOS:000302703900049
J	Munsky, B; Neuert, G; van Oudenaarden, A				Munsky, Brian; Neuert, Gregor; van Oudenaarden, Alexander			Using Gene Expression Noise to Understand Gene Regulation	SCIENCE			English	Review							SINGLE-CELL LEVEL; ESCHERICHIA-COLI; HETEROGENEITY; TRANSCRIPTION; REVEALS; STOCHASTICITY; CONSEQUENCES; NETWORKS; ORIGINS	Phenotypic variation is ubiquitous in biology and is often traceable to underlying genetic and environmental variation. However, even genetically identical cells in identical environments display variable phenotypes. Stochastic gene expression, or gene expression "noise," has been suggested as a major source of this variability, and its physiological consequences have been topics of intense research for the last decade. Several recent studies have measured variability in protein and messenger RNA levels, and they have discovered strong connections between noise and gene regulation mechanisms. When integrated with discrete stochastic models, measurements of cell-to-cell variability provide a sensitive "fingerprint" with which to explore fundamental questions of gene regulation. In this review, we highlight several studies that used gene expression variability to develop a quantitative understanding of the mechanisms and dynamics of gene regulation.	[Munsky, Brian] Los Alamos Natl Lab, Informat Sci Grp, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA; [Munsky, Brian] Los Alamos Natl Lab, Natl Flow Cytometry Resource, Los Alamos, NM 87545 USA; [Neuert, Gregor; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [Neuert, Gregor; van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA; [van Oudenaarden, Alexander] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [van Oudenaarden, Alexander] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Munsky, B (corresponding author), Los Alamos Natl Lab, Informat Sci Grp, Ctr Nonlinear Studies, POB 1663, Los Alamos, NM 87545 USA.	munsky@lanl.gov; gneuert@mit.edu	Munsky, Brian/A-1947-2016; van Oudenaarden, Alexander/AAA-1705-2019; Schaefer, Franz/G-4365-2010	Munsky, Brian/0000-0001-6147-7329; 	National Science Foundation [ECCS-0835623]; NIH [1DP1OD003936]; NATIONAL CANCER INSTITUTE [DP1CA174420] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003936] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Science Foundation (ECCS-0835623) and a NIH Pioneer award (1DP1OD003936).	Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Bonetta L, 2005, NAT METHODS, V2, P785, DOI 10.1038/nmeth1005-785; Bumgarner SL, 2012, MOL CELL, V45, P470, DOI 10.1016/j.molcel.2011.11.029; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Dunlop MJ, 2008, NAT GENET, V40, P1493, DOI 10.1038/ng.281; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Gandhi SJ, 2011, NAT STRUCT MOL BIOL, V18, P27, DOI 10.1038/nsmb.1934; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Iyer-Biswas S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031911; Kalisky T, 2011, ANNU REV GENET, V45, P431, DOI 10.1146/annurev-genet-102209-163607; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Lidstrom ME, 2010, NAT CHEM BIOL, V6, P705, DOI [10.1038/nchembio.436, 10.1038/NCHEMBIO.436]; Munsky B, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2145882; Octavio LM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000673; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Snijder B, 2011, NAT REV MOL CELL BIO, V12, P119, DOI 10.1038/nrm3044; So LH, 2011, NAT GENET, V43, P554, DOI 10.1038/ng.821; Stewart-Ornstein J, 2012, MOL CELL, V45, P483, DOI 10.1016/j.molcel.2011.11.035; Tan RZ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.14; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	35	468	469	2	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2012	336	6078					183	187		10.1126/science.1216379	http://dx.doi.org/10.1126/science.1216379			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924PN	22499939	Green Accepted			2022-12-28	WOS:000302703900039
J	Berglund, J				Berglund, Jennifer			Alternative therapies: Desperate measures	NATURE			English	Editorial Material																			0	3	3	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					S11	S11		10.1038/nature11099	http://dx.doi.org/10.1038/nature11099			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22509512	Bronze			2022-12-28	WOS:000303149900053
J	Cook, DJ				Cook, Diane J.			How Smart Is Your Home?	SCIENCE			English	Editorial Material									Washington State Univ, Pullman, WA 99164 USA	Washington State University	Cook, DJ (corresponding author), Washington State Univ, Pullman, WA 99164 USA.	cook@eecs.wsu.edu			NIBIB NIH HHS [R01 EB009675, R01 EB015853] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009675, R01EB015853] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Alon J, 2009, IEEE T PATTERN ANAL, V31, P1685, DOI 10.1109/TPAMI.2008.203; Buracchio T, 2010, ARCH NEUROL-CHICAGO, V67, P980, DOI 10.1001/archneurol.2010.159; Das B, 2011, LECT NOTES COMPUT SC, V6719, P9, DOI 10.1007/978-3-642-21535-3_2; Dey AK, 2011, IEEE PERVAS COMPUT, V10, P4, DOI 10.1109/MPRV.2011.29; Kim E, 2010, IEEE PERVAS COMPUT, V9, P48, DOI 10.1109/MPRV.2010.7; O'Grady M, 2012, SCIENCE, V335, P1581, DOI 10.1126/science.1217637; Paradiso J, 2011, IEEE PERVAS COMPUT, V10, P11, DOI 10.1109/MPRV.2011.4; Pentland A, 2010, AM SCI, V98, P204, DOI 10.1511/2010.84.203; Song EY, 2008, IEEE INSTRU MEAS MAG, V11, P11, DOI 10.1109/MIM.2008.4483728; WEISER M, 1991, SCI AM, V265, P94, DOI 10.1038/scientificamerican0991-94; Youngblood GM, 2007, IEEE T SYST MAN CY C, V37, P561, DOI 10.1109/TSMCC.2007.897341	11	85	90	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1579	1581		10.1126/science.1217640	http://dx.doi.org/10.1126/science.1217640			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	915YD	22461596	Green Accepted			2022-12-28	WOS:000302062600028
J	Peterson, RL; Pennington, BF				Peterson, Robin L.; Pennington, Bruce F.			Developmental dyslexia	LANCET			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; EVENT-RELATED POTENTIALS; READING-DISABILITY; WHITE-MATTER; FAMILIAL RISK; PHONOLOGICAL REPRESENTATIONS; INDIVIDUAL-DIFFERENCES; LANGUAGE-DEVELOPMENT; BRAIN CONNECTIVITY; LITERACY SKILLS	Dyslexia is a neurodevelopmental disorder that is characterised by slow and inaccurate word recognition. Dyslexia has been reported in every culture studied, and mounting evidence draws attention to cross-linguistic similarity in its neurobiological and neurocognitive bases. Much progress has been made across research specialties spanning the behavioural, neuropsychological, neurobiological, and causal levels of analysis in the past 5 years. From a neuropsychological perspective, the phonological theory remains the most compelling, although phonological problems also interact with other cognitive risk factors. Work confirms that, neurobiologically, dyslexia is characterised by dysfunction of the normal left hemisphere language network and also implicates abnormal white matter development. Studies accounting for reading experience demonstrate that many recorded neural differences show causes rather than effects of dyslexia. Six predisposing candidate genes have been identified, and evidence shows gene by environment interaction.	[Peterson, Robin L.; Pennington, Bruce F.] Univ Denver, Dept Psychol, Denver, CO 80208 USA	University of Denver	Peterson, RL (corresponding author), Univ Denver, Dept Psychol, Denver, CO 80208 USA.	robin.peterson@du.edu		Krafnick, Anthony/0000-0002-1692-0413	Colorado Learning Disabilities Research Center from National Institute of Child Health and Development [P50 HD27802]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD027802] Funding Source: NIH RePORTER	Colorado Learning Disabilities Research Center from National Institute of Child Health and Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Colorado Learning Disabilities Research Center grant from National Institute of Child Health and Development (P50 HD27802).	Bach S, 2010, NEUROIMAGE, V53, P682, DOI 10.1016/j.neuroimage.2010.06.039; Beaulieu C, 2005, NEUROIMAGE, V25, P1266, DOI 10.1016/j.neuroimage.2004.12.053; Been PH, 2008, LIT STUD, V1, P93, DOI 10.1007/978-0-387-74980-8_3; Bishop DVM, 2009, CHILD DEV, V80, P593, DOI 10.1111/j.1467-8624.2009.01281.x; Boada R, 2006, J EXP CHILD PSYCHOL, V95, P153, DOI 10.1016/j.jecp.2006.04.003; Bosse ML, 2007, COGNITION, V104, P198, DOI 10.1016/j.cognition.2006.05.009; BRUCK M, 1990, DEV PSYCHOL, V26, P439, DOI 10.1037/0012-1649.26.3.439; Buchholz J, 2007, VISION RES, V47, P1292, DOI 10.1016/j.visres.2006.11.028; Caravolas M, 2005, J EXP CHILD PSYCHOL, V92, P107, DOI 10.1016/j.jecp.2005.04.003; Carter JC, 2009, PSYCHIAT RES-NEUROIM, V172, P215, DOI 10.1016/j.pscychresns.2008.09.005; Castles A, 2011, J EXP CHILD PSYCHOL, V108, P203, DOI 10.1016/j.jecp.2010.07.006; Catts HW, 2008, J SPEECH LANG HEAR R, V51, P1569, DOI 10.1044/1092-4388(2008/07-0259); Catts HW, 2002, J SPEECH LANG HEAR R, V45, P1142, DOI 10.1044/1092-4388(2002/093); Chang BS, 2007, NEUROLOGY, V69, P2146, DOI 10.1212/01.wnl.0000286365.41070.54; Chang BS, 2005, NEUROLOGY, V64, P799, DOI 10.1212/01.WNL.0000152874.57180.AF; Clarke T, 2007, EPILEPSIA, V48, P2258; Dehaene S, 2010, SCIENCE, V330, P1359, DOI 10.1126/science.1194140; Demonet JF, 2004, LANCET, V363, P1451, DOI 10.1016/S0140-6736(04)16106-0; Deutsch GK, 2005, CORTEX, V41, P354, DOI 10.1016/S0010-9452(08)70272-7; Dougherty RF, 2007, P NATL ACAD SCI USA, V104, P8556, DOI 10.1073/pnas.0608961104; Elbro C, 1998, SCAND J PSYCHOL, V39, P149, DOI 10.1111/1467-9450.393070; Facoetti A, 2008, CORTEX, V44, P1221, DOI 10.1016/j.cortex.2007.10.007; Fisher SE, 2002, NAT REV NEUROSCI, V3, P767, DOI 10.1038/nrn936; Friend A, 2008, PSYCHOL SCI, V19, P1124, DOI 10.1111/j.1467-9280.2008.02213.x; Gabrieli JDE, 2009, SCIENCE, V325, P280, DOI 10.1126/science.1171999; GALABURDA AM, 1985, ANN NEUROL, V18, P222, DOI 10.1002/ana.410180210; Giedd JN, 2007, PEDIATRICS, V119, pE232, DOI 10.1542/peds.2005-2969; Goldinger SD, 2003, J PHONETICS, V31, P305, DOI 10.1016/S0095-4470(03)00030-5; Goswami U, 2011, TRENDS COGN SCI, V15, P3, DOI 10.1016/j.tics.2010.10.001; Goswami U, 2011, J COGNITIVE NEUROSCI, V23, P325, DOI 10.1162/jocn.2010.21453; Greenberg S., 2006, LISTENING SPEECH AUD, P411; Guttorm TK, 2003, J NEURAL TRANSM, V110, P1059, DOI 10.1007/s00702-003-0014-x; Guttorm TK, 2005, CORTEX, V41, P291, DOI 10.1016/S0010-9452(08)70267-3; Hadzibeganovic T, 2010, CORTEX, V46, P1312, DOI 10.1016/j.cortex.2010.06.011; Hanley JR, 2005, BL HBK DEV PSYCHOL, P316, DOI 10.1002/9780470757642.ch17; Hawelka S, 2006, VISION RES, V46, P718, DOI 10.1016/j.visres.2005.09.017; Hoeft F, 2007, P NATL ACAD SCI USA, V104, P4234, DOI 10.1073/pnas.0609399104; Hoeft F, 2006, J NEUROSCI, V26, P10700, DOI 10.1523/JNEUROSCI.4931-05.2006; Hu W, 2010, BRAIN, V133, P1694, DOI 10.1093/brain/awq106; HUMPHREYS P, 1990, ANN NEUROL, V28, P727, DOI 10.1002/ana.410280602; Jimenez JE, 2009, EDUC PSYCHOL-UK, V29, P27, DOI 10.1080/01443410802459226; Johnson EP, 2011, J COMMUN DISORD, V44, P294, DOI 10.1016/j.jcomdis.2011.01.001; Kere J, 2011, WIRES COGN SCI, V2, P441, DOI 10.1002/wcs.138; Kevan A, 2009, NEUROPSYCHOLOGIA, V47, P3174, DOI 10.1016/j.neuropsychologia.2009.07.016; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Krasowicz-Kupis G, 2009, MED SCI MONITOR, V15, pCR460; Lallier M, 2009, BRAIN RES, V1302, P132, DOI 10.1016/j.brainres.2009.07.037; Landerl K, 1997, COGNITION, V63, P315, DOI 10.1016/S0010-0277(97)00005-X; Landerl K, 2008, J EDUC PSYCHOL, V100, P150, DOI 10.1037/0022-0663.100.1.150; Landerl K, 2010, J CHILD PSYCHOL PSYC, V51, P287, DOI 10.1111/j.1469-7610.2009.02164.x; Lassus-Sangosse D, 2008, VISION RES, V48, P979, DOI 10.1016/j.visres.2008.01.025; Ludwig KU, 2008, PSYCHIAT GENET, V18, P310, DOI 10.1097/YPG.0b013e3283063a78; Lyon GR, 2003, ANN DYSLEXIA, V53, P1, DOI 10.1007/s11881-003-0001-9; Manis FR, 1997, J EXP CHILD PSYCHOL, V66, P211, DOI 10.1006/jecp.1997.2383; Mathes PG, 2005, READ RES QUART, V40, P148, DOI 10.1598/RRQ.40.2.2; McGrath LM, 2006, TRENDS MOL MED, V12, P333, DOI 10.1016/j.molmed.2006.05.007; McGrath LM, 2011, J CHILD PSYCHOL PSYC, V52, P547, DOI 10.1111/j.1469-7610.2010.02346.x; Meaburn EL, 2008, MOL PSYCHIATR, V13, P729, DOI 10.1038/sj.mp.4002063; Meyler A, 2007, CEREB CORTEX, V17, P2780, DOI 10.1093/cercor/bhm006; Molfese DL, 2000, BRAIN LANG, V72, P238, DOI 10.1006/brln.2000.2287; MORAIS J, 1979, COGNITION, V7, P323, DOI 10.1016/0010-0277(79)90020-9; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; Nation K, 2010, J CHILD PSYCHOL PSYC, V51, P1031, DOI 10.1111/j.1469-7610.2010.02254.x; National Institute of Child Health and Human Development, 2000, REP NAT READ PAN TEA; Nicolson RI, 2007, TRENDS NEUROSCI, V30, P135, DOI 10.1016/j.tins.2007.02.003; Niogi SN, 2006, NEUROPSYCHOLOGIA, V44, P2178, DOI 10.1016/j.neuropsychologia.2006.01.011; Nittrouer S, APPL PSYCHO IN PRESS; Nittrouer S, 2010, CURR DIR PSYCHOL SCI, V19, P308, DOI 10.1177/0963721410383976; Odegard TN, 2009, NEUROPSYCHOLOGIA, V47, P1972, DOI 10.1016/j.neuropsychologia.2009.03.009; Orton ST, 1925, ARCH NEURO PSYCHIATR, V14, P581, DOI 10.1001/archneurpsyc.1925.02200170002001; Pammer K, 2004, BRAIN LANG, V89, P601, DOI 10.1016/j.bandl.2004.01.009; Papadopoulos TC, 2009, J LEARN DISABIL-US, V42, P528, DOI 10.1177/0022219409338745; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; Pennington BF, 2001, CHILD DEV, V72, P816, DOI 10.1111/1467-8624.00317; Pennington BF, 2011, CONTROVERSIAL THERAP, V37; Pennington BF, 2006, COGNITION, V101, P385, DOI 10.1016/j.cognition.2006.04.008; Pennington BF, 2005, BL HBK DEV PSYCHOL, P453, DOI 10.1002/9780470757642.ch24; Pennington BF, 2009, ANNU REV PSYCHOL, V60, P283, DOI 10.1146/annurev.psych.60.110707.163548; Perrachione TK, 2011, SCIENCE, V333, P595, DOI 10.1126/science.1207327; Peterson RL, 2009, J SPEECH LANG HEAR R, V52, P1175, DOI 10.1044/1092-4388(2009/08-0024); Port R, 2007, NEW IDEAS PSYCHOL, V25, P143, DOI 10.1016/j.newideapsych.2007.02.001; Puolakanaho A, 2008, J LEARN DISABIL-US, V41, P353, DOI 10.1177/0022219407311747; Qiu DQ, 2008, NEUROIMAGE, V41, P223, DOI 10.1016/j.neuroimage.2008.02.023; Ramus F, 2004, TRENDS NEUROSCI, V27, P720, DOI 10.1016/j.tins.2004.10.004; Ramus F, 2008, Q J EXP PSYCHOL, V61, P129, DOI 10.1080/17470210701508822; Raschle NM, 2011, NEUROIMAGE, V57, P742, DOI 10.1016/j.neuroimage.2010.09.055; Richards T, 2008, AM J NEURORADIOL, V29, P1134, DOI 10.3174/ajnr.A1007; Richlan F, 2009, HUM BRAIN MAPP, V30, P3299, DOI 10.1002/hbm.20752; Rimrodt SL, 2010, CORTEX, V46, P739, DOI 10.1016/j.cortex.2009.07.008; RODGERS B, 1983, BRIT J EDUC PSYCHOL, V53, P369, DOI 10.1111/j.2044-8279.1983.tb02570.x; Rutter M, 2004, JAMA-J AM MED ASSOC, V291, P2007, DOI 10.1001/jama.291.16.2007; Scammacca N., 2007, EXTENSIVE READING IN; SCARBOROUGH HS, 1990, CHILD DEV, V61, P1728, DOI 10.1111/j.1467-8624.1990.tb03562.x; Scerri TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013712; Scerri TS, 2011, BIOL PSYCHIAT, V70, P237, DOI 10.1016/j.biopsych.2011.02.005; Seymour PHK, 2003, BRIT J PSYCHOL, V94, P143, DOI 10.1348/000712603321661859; Shanahan MA, 2006, J ABNORM CHILD PSYCH, V34, P585, DOI 10.1007/s10802-006-9037-8; Share DL, 2008, PSYCHOL BULL, V134, P584, DOI 10.1037/0033-2909.134.4.584; Shaywitz SE, 2008, DEV PSYCHOPATHOL, V20, P1329, DOI 10.1017/S0954579408000631; Shaywitz SE, 2003, BIOL PSYCHIAT, V54, P25, DOI 10.1016/S0006-3223(02)01836-X; Shaywitz SE, 2005, BIOL PSYCHIAT, V57, P1301, DOI 10.1016/j.biopsych.2005.01.043; SHAYWITZ SE, 1992, NEW ENGL J MED, V326, P145, DOI 10.1056/NEJM199201163260301; SHAYWITZ SE, 1990, JAMA-J AM MED ASSOC, V264, P998, DOI 10.1001/jama.264.8.998; Silani G, 2005, BRAIN, V128, P2453, DOI 10.1093/brain/awh579; SILVA PA, 1985, J CHILD PSYCHOL PSYC, V26, P407, DOI 10.1111/j.1469-7610.1985.tb01942.x; Siok WT, 2004, NATURE, V431, P71, DOI 10.1038/nature02865; Smith SD, 2001, EMERY RIMOINS PRINCI, P2827; Snow C. E., 1998, PREVENTING READING D; Snowling MJ, 2003, CHILD DEV, V74, P358, DOI 10.1111/1467-8624.7402003; Specht K, 2009, SCAND J PSYCHOL, V50, P79, DOI 10.1111/j.1467-9450.2008.00688.x; Steinbrink C, 2008, NEUROPSYCHOLOGIA, V46, P3170, DOI 10.1016/j.neuropsychologia.2008.07.015; Stuebing KK, 2009, EXCEPT CHILDREN, V76, P31, DOI 10.1177/001440290907600102; Tan LH, 1998, READ WRIT, V10, P165, DOI 10.1023/A:1008086231343; Torgesen JK, 2003, SUMMARY OUTCOMES 1 G; Torgesen JK, 2005, BL HBK DEV PSYCHOL, P521, DOI 10.1002/9780470757642.ch27; Torppa M, 2010, J LEARN DISABIL-US, V43, P308, DOI 10.1177/0022219410369096; Vaessen A, 2009, J EXP CHILD PSYCHOL, V103, P202, DOI 10.1016/j.jecp.2008.12.004; Van der Mark S, 2009, NEUROIMAGE, V47, P1940, DOI 10.1016/j.neuroimage.2009.05.021; Vaughn S, 2003, REM SPEC EDUC, V24, P301, DOI 10.1177/07419325030240050501; Vaughn S, 2010, SCHOOL PSYCHOL REV, V39, P3; VELLUTINO FR, 1979, J LEARN DISABIL, V12, P160, DOI 10.1177/002221947901200307; Vidyasagar TR, 2010, TRENDS COGN SCI, V14, P57, DOI 10.1016/j.tics.2009.12.003; Wadsworth SJ, 2010, BEHAV GENET, V40, P751, DOI 10.1007/s10519-010-9349-x; Willcutt EG, 2000, J CHILD PSYCHOL PSYC, V41, P1039, DOI 10.1017/S0021963099006368; Willcutt EG, 2010, J DEV BEHAV PEDIATR, V31, P533, DOI 10.1097/DBP.0b013e3181ef42a1; Wolf M, 1999, J EDUC PSYCHOL, V91, P415, DOI 10.1037/0022-0663.91.3.415; Ziegler JC, 2010, DEVELOPMENTAL SCI, V13, pF8, DOI 10.1111/j.1467-7687.2010.00983.x; Ziegler JC, 2010, PSYCHOL SCI, V21, P551, DOI 10.1177/0956797610363406	128	374	390	15	225	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2012	379	9830					1997	2007		10.1016/S0140-6736(12)60198-6	http://dx.doi.org/10.1016/S0140-6736(12)60198-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	951YV	22513218	Green Accepted			2022-12-28	WOS:000304757700035
J	Smith, JT; Campbell, RM				Smith, John T.; Campbell, Robert M., Jr.			Magnetically controlled growing rods for spinal deformity	LANCET			English	Editorial Material							SCOLIOSIS; INSTRUMENTATION		[Smith, John T.] Univ Utah, Sch Med, Dept Orthopaed, Salt Lake City, UT 84113 USA; [Campbell, Robert M., Jr.] Univ Penn, Childrens Hosp Philadelphia, Div Orthopaed, Ctr Thorac Insufficiency Syndrome,Sch Med, Philadelphia, PA 19104 USA	Utah System of Higher Education; University of Utah; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Smith, JT (corresponding author), Univ Utah, Sch Med, Dept Orthopaed, Salt Lake City, UT 84113 USA.	john.smith@hsc.utah.edu	Smith, John/Y-2316-2019; Smith, John/GYJ-1302-2022	Smith, John/0000-0001-6885-1117; 				Akbarnia BA, 2005, SPINE, V30, pS46, DOI 10.1097/01.brs.0000175190.08134.73; Betz RR, 2005, CLIN ORTHOP RELAT R, P55, DOI 10.1097/01.blo.0000163472.46511.a8; Campbell RM, 2004, J BONE JOINT SURG AM, V86A, P1659, DOI 10.2106/00004623-200408000-00009; Cheung KMC, 2012, LANCET, V379, P1967, DOI 10.1016/S0140-6736(12)60112-3; Karol LA, 2008, J BONE JOINT SURG AM, V90A, P1272, DOI 10.2106/JBJS.G.00184; McCarthy R, 2005, TREATMENT EARLY ONSE; Ouellet J, 2011, CLIN ORTHOP RELAT R, V469, P1356, DOI 10.1007/s11999-011-1783-4; Sankar WN, 2011, SPINE, V36, P806, DOI 10.1097/BRS.0b013e318214d78f; Smith JT, 2007, ORTHOP CLIN N AM, V38, P547, DOI 10.1016/j.ocl.2007.03.009; Smith JT, 2004, SCOL RES SOC 39 ANN; TELLO CA, 1994, ORTHOP CLIN N AM, V25, P333; Thompson GH, 2005, SPINE, V30, P2039, DOI 10.1097/01.brs.0000179082.92712.89	12	6	6	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 26	2012	379	9830					1930	1931		10.1016/S0140-6736(12)60528-5	http://dx.doi.org/10.1016/S0140-6736(12)60528-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951YV	22520263				2022-12-28	WOS:000304757700009
J	James, ND; Hussain, SA; Hall, E; Jenkins, P; Tremlett, J; Rawlings, C; Crundwell, M; Sizer, B; Sreenivasan, T; Hendron, C; Lewis, R; Waters, R; Huddart, RA				James, Nicholas D.; Hussain, Syed A.; Hall, Emma; Jenkins, Peter; Tremlett, Jean; Rawlings, Christine; Crundwell, Malcolm; Sizer, Bruce; Sreenivasan, Thiagarajan; Hendron, Carey; Lewis, Rebecca; Waters, Rachel; Huddart, Robert A.		BC2001 Investigators	Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYNCHRONOUS CHEMORADIOTHERAPY; CONCURRENT CISPLATIN; CYSTECTOMY; RADIATION; CARCINOMA; MITOMYCIN; RISK; RTOG	Background Radiotherapy is an alternative to cystectomy in patients with muscle-invasive bladder cancer. In other disease sites, synchronous chemoradiotherapy has been associated with increased local control and improved survival, as compared with radiotherapy alone. Methods In this multicenter, phase 3 trial, we randomly assigned 360 patients with muscle-invasive bladder cancer to undergo radiotherapy with or without synchronous chemotherapy. The regimen consisted of fluorouracil (500 mg per square meter of body-surface area per day) during fractions 1 to 5 and 16 to 20 of radiotherapy and mitomycin C (12 mg per square meter) on day 1. Patients were also randomly assigned to undergo either whole-bladder radiotherapy or modified-volume radiotherapy (in which the volume of bladder receiving full-dose radiotherapy was reduced) in a partial 2-by-2 factorial design (results not reported here). The primary end point was survival free of locoregional disease. Secondary end points included overall survival and toxic effects. Results At 2 years, rates of locoregional disease-free survival were 67% (95% confidence interval [CI], 59 to 74) in the chemoradiotherapy group and 54% (95% CI, 46 to 62) in the radiotherapy group. With a median follow-up of 69.9 months, the hazard ratio in the chemoradiotherapy group was 0.68 (95% CI, 0.48 to 0.96; P = 0.03). Five-year rates of overall survival were 48% (95% CI, 40 to 55) in the chemoradiotherapy group and 35% (95% CI, 28 to 43) in the radiotherapy group (hazard ratio, 0.82; 95% CI, 0.63 to 1.09; P = 0.16). Grade 3 or 4 adverse events were slightly more common in the chemoradiotherapy group than in the radiotherapy group during treatment (36.0% vs. 27.5%, P = 0.07) but not during follow-up (8.3% vs. 15.7%, P = 0.07). Conclusions Synchronous chemotherapy with fluorouracil and mitomycin C combined with radiotherapy significantly improved locoregional control of bladder cancer, as compared with radiotherapy alone, with no significant increase in adverse events. (Funded by Cancer Research U.K.; BC2001 Current Controlled Trials number, ISRCTN68324339.)	[James, Nicholas D.] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England; [Hussain, Syed A.] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Hall, Emma; Lewis, Rebecca; Waters, Rachel; Huddart, Robert A.] Inst Canc Res, Sutton, Surrey, England; [Jenkins, Peter] Cheltenham Gen Hosp, Cheltenham, Glos, England; [Tremlett, Jean] Brighton & Sussex Univ Hosp Natl Hlth Serv NHS Tr, Brighton, E Sussex, England; [Rawlings, Christine] S Devon Healthcare NHS Fdn, Torquay, England; [Crundwell, Malcolm] Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England; [Sizer, Bruce] Essex Cty Hosp, Colchester, Essex, England; [Sreenivasan, Thiagarajan] United Lincolnshire Hosp NHS Trust, Lincoln, England	University of Birmingham; University of Liverpool; University of London; Institute of Cancer Research - UK; Gloucestershire Hospitals NHS Foundation Trust; Cheltenham General Hospital; University of Exeter	James, ND (corresponding author), Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England.	n.d.james@bham.ac.uk	James, Nick/AAL-6802-2020; Hussain, Syed/D-3255-2016	Hickish, Tamas/0000-0001-6770-7279; huddart, robert/0000-0003-3604-1990; Hussain, Syed/0000-0003-1552-511X; Hall, Emma/0000-0001-5999-5020; James, Nicholas/0000-0002-7314-8204; Landau, David/0000-0003-1770-9086	Cancer Research UK [C547/A2606, C547/A6845, C9764/A9904, C1491/A9895, CRUK/01/004]; National Institute for Health Research; Cancer Research U.K.; Cancer Research UK [10588] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); Cancer Research U.K.(Cancer Research UK); Cancer Research UK(Cancer Research UK)	Funded by Cancer Research U.K.; BC2001 Current Controlled Trials number, ISRCTN68324339.; Supported by grants (C547/A2606, C547/A6845, C9764/A9904, and C1491/A9895) from Cancer Research UK (trial reference number, CRUK/01/004) and by the National Institute for Health Research (to the National Cancer Research Network).	Ajani JA, 2008, JAMA-J AM MED ASSOC, V299, P1914, DOI 10.1001/jama.299.16.1914; [Anonymous], 1999, LANCET, V354, P1650; Arnott SJ, 1996, LANCET, V348, P1049; Cooke PW, 2000, EUR UROL, V38, P279, DOI 10.1159/000020294; Coppin CML, 1996, J CLIN ONCOL, V14, P2901, DOI 10.1200/JCO.1996.14.11.2901; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; Grossman HB, 2003, NEW ENGL J MED, V349, P1880; Grossman HB, 2003, NEW ENGL J MED, V349, P859, DOI 10.1056/NEJMoa022148; Hoskin PJ, 2010, J CLIN ONCOL, V28, P4912, DOI 10.1200/JCO.2010.28.4950; Hussain SA, 2001, ANN ONCOL, V12, P929, DOI 10.1023/A:1011133820532; Hussain SA, 2001, BRIT J CANCER, V85, P16; International Agency for Research on Cancer, GLOBOCAN 2008 CANC I; International Union Against Cancer, 2002, TNM CLASS MAL TUM; Keys HM, 1999, NEW ENGL J MED, V340, P1154, DOI 10.1056/NEJM199904153401503; Keys HM, 1999, NEW ENGL J MED, V341, P708; Med Res Council Adv Bladder Canc Working Party, 1999, LANCET, V354, P533; Morris M, 1999, NEW ENGL J MED, V340, P1137, DOI 10.1056/NEJM199904153401501; *NAT CANC I, COMM TOX CRIT VERS 2; Olivatto LO, 2011, INT J RADIAT ONCOL, V79, P490, DOI 10.1016/j.ijrobp.2009.11.057; PAVY JJ, 1995, RADIOTHER ONCOL, V35, P11, DOI 10.1016/0167-8140(95)97448-M; Rodel C, 2002, J CLIN ONCOL, V20, P3061, DOI 10.1200/JCO.2002.11.027; Rose PG, 1999, NEW ENGL J MED, V340, P1144, DOI 10.1056/NEJM199904153401502; Rose PG, 1999, NEW ENGL J MED, V341, P708; RUBIN P, 1995, INT J RADIAT ONCOL, V31, P1041, DOI 10.1016/0360-3016(95)00057-6; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Wolter P, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.4633	26	554	569	1	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 19	2012	366	16					1477	1488		10.1056/NEJMoa1106106	http://dx.doi.org/10.1056/NEJMoa1106106			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927UE	22512481				2022-12-28	WOS:000302934800005
J	Peters, SE; Gaines, RR				Peters, Shanan E.; Gaines, Robert R.			Formation of the 'Great Unconformity' as a trigger for the Cambrian explosion	NATURE			English	Article							SEAWATER CHEMISTRY; FLUID INCLUSIONS; ANIMALS; OCEAN; GEOCHEMISTRY; MINERALS; RISE	The transition between the Proterozoic and Phanerozoic eons, beginning 542 million years (Myr) ago, is distinguished by the diversification of multicellular animals and by their acquisition of mineralized skeletons during the Cambrian period(1). Considerable progress has been made in documenting and more precisely correlating biotic patterns in the Neoproterozoic-Cambrian fossil record with geochemical and physical environmental perturbations(2-5), but the mechanisms responsible for those perturbations remain uncertain(1,2). Here we use new stratigraphic and geochemical data to show that early Palaeozoic marine sediments deposited approximately 540-480 Myr ago record both an expansion in the area of shallow epicontinental seas and anomalous patterns of chemical sedimentation that are indicative of increased oceanic alkalinity and enhanced chemical weathering of continental crust. These geochemical conditions were caused by a protracted period of widespread continental denudation during the Neoproterozoic followed by extensive physical reworking of soil, regolith and basement rock during the first continental-scale marine transgression of the Phanerozoic. The resultant globally occurring stratigraphic surface, which in most regions separates continental crystalline basement rock from much younger Cambrian shallow marine sedimentary deposits, is known as the Great Unconformity(6). Although Darwin and others have interpreted this widespread hiatus in sedimentation on the continents as a failure of the geologic record, this palaeogeomorphic surface represents a unique physical environmental boundary condition that affected seawater chemistry during a time of profound expansion of shallow marine habitats. Thus, the formation of the Great Unconformity may have been an environmental trigger for the evolution of biomineralization and the 'Cambrian explosion' of ecologic and taxonomic diversity following the Neoproterozoic emergence of animals.	[Peters, Shanan E.] Univ Wisconsin, Dept Geosci, Madison, WI 53706 USA; [Gaines, Robert R.] Pomona Coll, Dept Geol, Claremont, CA 91711 USA	University of Wisconsin System; University of Wisconsin Madison; Claremont Colleges; Pomona College	Peters, SE (corresponding author), Univ Wisconsin, Dept Geosci, Madison, WI 53706 USA.	peters@geology.wisc.edu	Peters, Shanan E/A-5620-2013	Peters, Shanan E/0000-0002-3346-4317	NSF [EAR-0819931, EAR-1046233, DUE-0942447]; Directorate For Geosciences [1046233] Funding Source: National Science Foundation; Division Of Undergraduate Education [0942447] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Undergraduate Education(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU))	We thank D. Canfield, P. Cohen, W. Fischer, S. Finnegan, N. Heim, A. Carroll and R. Dott for discussion, and N. Butterfield, M. Foote, E. Hammarlund, P. Myrow, B. Wilkinson, R. Wood, S. Holland for feedback on ideas. Fieldwork and analysis was aided by P. Burke, J. B. Caron, L. Curtin, F. Dwan, Z. Feng, P. Fenton, L. Finley-Blasi, X. Hou, J. Lackey, C. Qi, J. Peng, J. Tian, J. Vorhies, Y. Yang, X. Zhang and Y. Zhao. Work was supported by NSF EAR-0819931 (to S. E. P.) and EAR-1046233 and DUE-0942447 (to R.R.G.).	Avigad D, 2005, EARTH PLANET SC LETT, V240, P818, DOI 10.1016/j.epsl.2005.09.021; BRASIER MD, 1980, J GEOL SOC LONDON, V137, P695, DOI 10.1144/gsjgs.137.6.0695; Brennan ST, 2004, GEOLOGY, V32, P473, DOI 10.1130/g20251.1; Canfield DE, 2007, SCIENCE, V315, P92, DOI 10.1126/science.1135013; Chafetz HS, 2000, SEDIMENT GEOL, V136, P29, DOI 10.1016/S0037-0738(00)00082-8; COLEMAN ML, 1985, PHILOS T R SOC A, V315, P39, DOI 10.1098/rsta.1985.0028; Cross T.A., 1997, INNOVATIVE APPL PETR, P183; Dahl TW, 2010, P NATL ACAD SCI USA, V107, P17911, DOI 10.1073/pnas.1011287107; Elrick M, 2002, SEDIMENTOLOGY, V49, P1021, DOI 10.1046/j.1365-3091.2002.00488.x; Erwin DH, 2011, SCIENCE, V334, P1091, DOI 10.1126/science.1206375; Gaines RR, 2012, P NATL ACAD SCI USA, V109, P5180, DOI 10.1073/pnas.1111784109; Gill BC, 2011, NATURE, V469, P80, DOI 10.1038/nature09700; Ginsburg R.N., 1982, 11 INT C SED, P114; KETO LS, 1988, EARTH PLANET SC LETT, V90, P395, DOI 10.1016/0012-821X(88)90138-0; Laird MG, 1991, GEOLOGICAL EVOLUTION, P177; Lowenstein TK, 2001, SCIENCE, V294, P1086, DOI 10.1126/science.1064280; Maloof AC, 2010, GEOL SOC AM BULL, V122, P1731, DOI 10.1130/B30346.1; Marshall CR, 2006, ANNU REV EARTH PL SC, V34, P355, DOI 10.1146/annurev.earth.33.031504.103001; Meyers SR, 2011, EARTH PLANET SC LETT, V303, P174, DOI 10.1016/j.epsl.2010.12.044; Millot R, 2002, EARTH PLANET SC LETT, V196, P83, DOI 10.1016/S0012-821X(01)00599-4; Mortatti J, 2003, CHEM GEOL, V197, P177, DOI 10.1016/S0009-2541(02)00349-2; ODIN GS, 1981, SEDIMENTOLOGY, V28, P611, DOI 10.1111/j.1365-3091.1981.tb01925.x; Petrychenko OY, 2005, CHEM GEOL, V219, P149, DOI 10.1016/j.chemgeo.2005.02.003; Ridgwell AJ, 2003, SCIENCE, V302, P859, DOI 10.1126/science.1088342; Robison R.A., 1960, GEOLOGY E CENTRAL NE, P43; RONOV AB, 1980, SEDIMENT GEOL, V25, P311, DOI 10.1016/0037-0738(80)90067-6; Sears JW, 2003, GEOL SOC AM BULL, V115, P943, DOI 10.1130/B25229.1; SLOSS LL, 1963, GEOL SOC AM BULL, V74, P93, DOI 10.1130/0016-7606(1963)74[93:SITCIO]2.0.CO;2; Walker LJ, 2002, J GEOL, V110, P75, DOI 10.1086/324318; Yochelson E., 2006, EARTH SCI HIST, V25, P251, DOI [10.17704/eshi.25.2.772747j430w13n61, DOI 10.17704/ESHI.25.2.772747J430W13N61]	30	202	226	6	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2012	484	7394					363	366		10.1038/nature10969	http://dx.doi.org/10.1038/nature10969			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927YM	22517163				2022-12-28	WOS:000302946500030
J	Swanson, SJ; Phares, CR; Mamo, B; Smith, KE; Cetron, MS; Stauffer, WM				Swanson, Stephen J.; Phares, Christina R.; Mamo, Blain; Smith, Kirk E.; Cetron, Martin S.; Stauffer, William M.			Albendazole Therapy and Enteric Parasites in United States-Bound Refugees	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSMITTED HELMINTH INFECTIONS; PRE-DEPARTURE TREATMENT; SUB-SAHARAN AFRICA; INTESTINAL PARASITES; MONTAGNARD REFUGEES; SUDANESE REFUGEES; HIGH-PREVALENCE; EFFICACY; SCHISTOSOMIASIS; POPULATION	Background Beginning on May 1, 1999, the Centers for Disease Control and Prevention (CDC) recommended presumptive treatment of refugees for intestinal parasites with a single dose of albendazole (600 mg), administered overseas before departure for the United States. Methods We conducted a retrospective cohort study involving 26,956 African and Southeast Asian refugees who were screened by means of microscopical examination of stool specimens for intestinal parasites on resettlement in Minnesota between 1993 and 2007. Adjusted prevalence ratios for intestinal nematodes, schistosoma species, giardia, and entamoeba were calculated among refugees who migrated before versus those who migrated after the CDC recommendation of presumptive predeparture albendazole treatment. Results Among 4370 untreated refugees, 20.8% had at least one stool nematode, most commonly hookworm (in 9.2%). Among 22,586 albendazole-treated refugees, only 4.7% had one or more nematodes, most commonly trichuris (in 3.9%). After adjustment for sex, age, and region, albendazole-treated refugees were less likely than untreated refugees to have any nematodes (prevalence ratio, 0.19), ascaris (prevalence ratio, 0.06), hookworm (prevalence ratio, 0.07), or trichuris (prevalence ratio, 0.27) but were not less likely to have giardia or entamoeba. Schistosoma ova were identified exclusively among African refugees and were less prevalent among those treated with albendazole (prevalence ratio, 0.60). After implementation of the albendazole protocol, the most common pathogens among 17,011 African refugees were giardia (in 5.7%), trichuris (in 5.0%), and schistosoma (in 1.8%); among 5575 Southeast Asian refugees, only giardia remained highly prevalent (present in 17.2%). No serious adverse events associated with albendazole use were reported. Conclusions Presumptive albendazole therapy administered overseas before departure for the United States was associated with a decrease in the prevalence of intestinal nematodes among newly arrived African and Southeast Asian refugees.	[Swanson, Stephen J.] Epidem Intelligence Serv, Atlanta, GA USA; [Phares, Christina R.; Cetron, Martin S.; Stauffer, William M.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Swanson, Stephen J.; Mamo, Blain; Smith, Kirk E.] Minnesota Dept Hlth, St Paul, MN USA; [Swanson, Stephen J.] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; [Swanson, Stephen J.; Stauffer, William M.] Univ Minnesota, Minneapolis, MN USA	Centers for Disease Control & Prevention - USA; Minnesota Department of Health (MHD); Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities	Swanson, SJ (corresponding author), Hennepin Cty Med Ctr, Dept Pediat, 701 Pk Ave,G7, Minneapolis, MN 55415 USA.	stephen.swanson@hcmed.org						Abramowicz ME, 2010, DRUGS PARASITIC INFE; [Anonymous], 2004, PRED ANT ANT PAR TRE; Bennett A, 2000, PARASITOL TODAY, V16, P71, DOI 10.1016/S0169-4758(99)01544-6; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Bethony J, 2002, CLIN INFECT DIS, V35, P1336, DOI 10.1086/344268; Boulware DR, 2007, AM J MED, V120, P545, DOI 10.1016/j.amjmed.2006.05.072; Brodine SK, 2009, AM J TROP MED HYG, V80, P425, DOI 10.4269/ajtmh.2009.80.425; BUCHWALD D, 1995, J CLIN PHARM THER, V20, P271, DOI 10.1111/j.1365-2710.1995.tb00662.x; Cartwright CP, 1999, J CLIN MICROBIOL, V37, P2408, DOI 10.1128/JCM.37.8.2408-2411.1999; Centers for Disease Control and Prevention, OV REF HLTH GUID INT; CHUNG WC, 1991, INT J PARASITOL, V21, P269, DOI 10.1016/0020-7519(91)90021-X; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Department of Health and Human Services Administration for Children and Families, REF ARR DAT; Department of Health and Human Services Administration for Children and Families, 1998, MMWR-MORBID MORTAL W; Dreyer G, 1996, J CLIN MICROBIOL, V34, P2569, DOI 10.1128/JCM.34.10.2569-2571.1996; Franco-Paredes C, 2007, AM J TROP MED HYG, V77, P633, DOI 10.4269/ajtmh.2007.77.633; Garg PK, 2005, AM J TROP MED HYG, V73, P386, DOI 10.4269/ajtmh.2005.73.386; Geltman PL, 2003, AM J TROP MED HYG, V69, P657, DOI 10.4269/ajtmh.2003.69.657; GODUE CB, 1990, CAN J PUBLIC HEALTH, V81, P191; Goswami ND, 2009, AM J TROP MED HYG, V81, P302, DOI 10.4269/ajtmh.2009.81.302; GYORKOS TW, 1992, J INFECT DIS, V166, P413, DOI 10.1093/infdis/166.2.413; HALL A, 1993, T ROY SOC TROP MED H, V87, P84, DOI 10.1016/0035-9203(93)90435-S; HALL A, 1994, T ROY SOC TROP MED H, V88, P110, DOI 10.1016/0035-9203(94)90525-8; Horton J, 2000, PARASITOLOGY, V121, pS113, DOI 10.1017/S0031182000007290; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Hotez PJ, 2004, NEW ENGL J MED, V351, P799, DOI 10.1056/NEJMra032492; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Lifson AR, 2002, PUBLIC HEALTH REP, V117, P69, DOI 10.1093/phr/117.1.69; Lurio J, 1991, J Am Board Fam Pract, V4, P71; Miller JM, 2000, AM J TROP MED HYG, V62, P115, DOI 10.4269/ajtmh.2000.62.115; Muennig P, 1999, NEW ENGL J MED, V340, P773, DOI 10.1056/NEJM199903113401006; Newberry AM, 2005, CHEST, V128, P3681, DOI 10.1378/chest.128.5.3681; Olds GR, 1999, J INFECT DIS, V179, P996, DOI 10.1086/314686; Pancera Christiane Finardi, 1997, Revista do Instituto de Medicina Tropical de Sao Paulo, V39, P159, DOI 10.1590/S0036-46651997000300007; Pengsaa Krisana, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P78; Peterson MH, 2001, DIAGN MICR INFEC DIS, V40, P75, DOI 10.1016/S0732-8893(01)00244-9; Posey DL, 2007, CLIN INFECT DIS, V45, P1310, DOI 10.1086/522529; RACCURT CP, 1990, TROP MED PARASITOL, V41, P46; Shah JJ, 2008, AM J TROP MED HYG, V78, P754, DOI 10.4269/ajtmh.2008.78.754; Stauffer WM, 2008, AM J TROP MED HYG, V79, P141, DOI 10.4269/ajtmh.2008.79.141	41	36	38	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 19	2012	366	16					1498	1507		10.1056/NEJMoa1103360	http://dx.doi.org/10.1056/NEJMoa1103360			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927UE	22512482				2022-12-28	WOS:000302934800007
J	Treiber, CD; Salzer, MC; Riegler, J; Edelman, N; Sugar, C; Breuss, M; Pichler, P; Cadiou, H; Saunders, M; Lythgoe, M; Shaw, J; Keays, DA				Treiber, Christoph Daniel; Salzer, Marion Claudia; Riegler, Johannes; Edelman, Nathaniel; Sugar, Cristina; Breuss, Martin; Pichler, Paul; Cadiou, Herve; Saunders, Martin; Lythgoe, Mark; Shaw, Jeremy; Keays, David Anthony			Clusters of iron-rich cells in the upper beak of pigeons are macrophages not magnetosensitive neurons	NATURE			English	Article							MAGNETITE-BASED MAGNETORECEPTION; HOMING PIGEONS; PUTATIVE MAGNETORECEPTOR; TRIGEMINAL MEDIATION; MIGRATORY BIRD; ORIENTATION; MECHANISM; FERRITIN; COMPASS; TISSUES	Understanding the molecular and cellular mechanisms that mediate magnetosensation in vertebrates is a formidable scientific problem(1,2). One hypothesis is that magnetic information is transduced into neuronal impulses by using a magnetite-based magnetoreceptor(3,4). Previous studies claim to have identified a magnetic sense system in the pigeon, common to avian species, which consists of magnetite-containing trigeminal afferents located at six specific loci in the rostral subepidermis of the beak(5-8). These studies have been widely accepted in the field and heavily relied upon by both behavioural biologists and physicists(9-11). Here we show that clusters of iron-rich cells in the rostro-medial upper beak of the pigeon Columbia livia are macrophages, not magnetosensitive neurons. Our systematic characterization of the pigeon upper beak identified iron-rich cells in the stratum laxum of the subepidermis, the basal region of the respiratory epithelium and the apex of feather follicles. Using a three-dimensional blueprint of the pigeon beak created by magnetic resonance imaging and computed tomography, we mapped the location of iron-rich cells, revealing unexpected variation in their distribution and number-an observation that is inconsistent with a role in magnetic sensation. Ultrastructure analysis of these cells, which are not unique to the beak, showed that their subcellular architecture includes ferritin-like granules, siderosomes, haemosiderin and filopodia, characteristics of iron-rich macrophages. Our conclusion that these cells are macrophages and not magnetosensitive neurons is supported by immunohistological studies showing co-localization with the antigen-presenting molecule major histocompatibility complex class II. Our work necessitates a renewed search for the true magnetite-dependent magnetoreceptor in birds.	[Treiber, Christoph Daniel; Salzer, Marion Claudia; Edelman, Nathaniel; Sugar, Cristina; Breuss, Martin; Pichler, Paul; Keays, David Anthony] Inst Mol Pathol, A-1030 Vienna, Austria; [Riegler, Johannes; Lythgoe, Mark] UCL, Ctr Adv Biomed Imaging, Dept Med, London WC1E 6DD, England; [Riegler, Johannes; Lythgoe, Mark] UCL, Inst Child Hlth, London WC1E 6DD, England; [Cadiou, Herve] Univ Strasbourg, INCI, CNRS, UPR 3212, F-67084 Strasbourg, France; [Breuss, Martin; Shaw, Jeremy] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Crawley 6009, Australia	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of London; University College London; University of London; University College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Western Australia	Keays, DA (corresponding author), Inst Mol Pathol, A-1030 Vienna, Austria.	keays@imp.ac.at	Saunders, Martin/B-3082-2011; Breuss, Martin/AAL-9509-2021; Shaw, Jeremy A/B-4156-2011; Edelman, Nathaniel/AAH-1804-2021; Salzer, Marion/AAB-1844-2020; Treiber, Christoph/D-6266-2018	Saunders, Martin/0000-0001-6873-7816; Shaw, Jeremy A/0000-0002-5140-457X; Edelman, Nathaniel/0000-0002-5142-6760; Treiber, Christoph/0000-0002-6994-091X; Breuss, Martin Werner/0000-0003-2200-8604; Lythgoe, Mark/0000-0002-4945-0171	Boehringer Ingelheim; Engineering and Physical Sciences Research Council [EP/I014667/1] Funding Source: researchfish; EPSRC [EP/I014667/1] Funding Source: UKRI	Boehringer Ingelheim(Boehringer Ingelheim); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We would like to thank M. Busslinger, M. Wild and J. Flint for their critical comments on earlier drafts of this manuscript. Thanks also to T. Iancu who commented on our electron micrographs and S. Soto who remarked on the inflammatory lesion in P199. Gratitude is owed to the bio-optics and electron microscopy facilities at the Institute of Molecular Pathology for their assistance in performing experiments. We wish to acknowledge the Centre for Microscopy, Characterisation and Analysis and the Australian Microscopy and Microanalysis Research Facility at the University of Western Australia, a facility funded by the University, State and Commonwealth Governments. Finally, we wish to thank Boehringer Ingelheim, which funds basic science at the Institute of Molecular Pathology.	BEASON RC, 1987, NEUROSCI LETT, V80, P229, DOI 10.1016/0304-3940(87)90659-8; Cadiou H, 2010, J R SOC INTERFACE, V7, pS193, DOI 10.1098/rsif.2009.0423.focus; Davila AF, 2005, BIOPHYS J, V89, P56, DOI 10.1529/biophysj.104.049346; Falkenberg G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009231; Fleissner G, 2003, J COMP NEUROL, V458, P350, DOI 10.1002/cne.10579; Fleissner G, 2007, NATURWISSENSCHAFTEN, V94, P631, DOI 10.1007/s00114-007-0236-0; Hanzlik M, 2000, BIOMETALS, V13, P325, DOI 10.1023/A:1009214526685; Heyers D, 2010, P NATL ACAD SCI USA, V107, P9394, DOI 10.1073/pnas.0907068107; Horng YM, 2006, THERIOGENOLOGY, V65, P1759, DOI 10.1016/j.theriogenology.2005.10.011; IANCU TC, 1992, ELECTRON MICROSC REV, V5, P209, DOI 10.1016/0892-0354(92)90011-E; Igyarto BZ, 2006, IMMUNOLOGY, V119, P278, DOI 10.1111/j.1365-2567.2006.02432.x; Johnsen S, 2005, NAT REV NEUROSCI, V6, P703, DOI 10.1038/nrn1745; Kirschvink JL, 2001, CURR OPIN NEUROBIOL, V11, P462, DOI 10.1016/S0959-4388(00)00235-X; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Meguro R, 2005, ARCH HISTOL CYTOL, V68, P171, DOI 10.1679/aohc.68.171; MOOS T, 1993, HISTOCHEMISTRY, V99, P471; Mora CV, 2004, NATURE, V432, P508, DOI 10.1038/nature03077; Mouritsen H, 2005, CURR OPIN NEUROBIOL, V15, P406, DOI 10.1016/j.conb.2005.06.003; RICHTER GW, 1978, AM J PATHOL, V91, P361; Ritz T, 2004, NATURE, V429, P177, DOI 10.1038/nature02534; SIMSON JV, 1972, J CELL BIOL, V52, P536, DOI 10.1083/jcb.52.3.536; Solov'yov IA, 2007, BIOPHYS J, V93, P1493, DOI 10.1529/biophysj.107.105098; Solov'yov IA, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041919; Stapput K, 2008, CURR BIOL, V18, P602, DOI 10.1016/j.cub.2008.03.046; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Williams MN, 2001, BRAIN RES, V889, P243, DOI 10.1016/S0006-8993(00)03114-0; Wiltschko R, 2010, CURR BIOL, V20, P1534, DOI 10.1016/j.cub.2010.06.073; Wiltschko W, 2009, P ROY SOC B-BIOL SCI, V276, P2227, DOI 10.1098/rspb.2009.0050; Winklhofer M., 2008, DOES AVIAN MAGNETORE; Zapka M, 2009, NATURE, V461, P1274, DOI 10.1038/nature08528	31	125	135	4	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2012	484	7394					367	U102		10.1038/nature11046	http://dx.doi.org/10.1038/nature11046			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927YM	22495303				2022-12-28	WOS:000302946500031
J	Farrell, L				Farrell, Liam			Good doctors being bad	BRITISH MEDICAL JOURNAL			English	Editorial Material												drfarrell@hotmail.co.uk							0	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 18	2012	344								e2705	10.1136/bmj.e2705	http://dx.doi.org/10.1136/bmj.e2705			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	931CQ	22514218				2022-12-28	WOS:000303192400008
J	Seki, S; Yu, XZ; Ishiwata, S; Tokura, Y				Seki, S.; Yu, X. Z.; Ishiwata, S.; Tokura, Y.			Observation of Skyrmions in a Multiferroic Material	SCIENCE			English	Article							REAL-SPACE OBSERVATION; MNSI	A magnetic skyrmion is a topologically stable particle-like object that appears as a vortex-like spin texture at the nanometer scale in a chiral-lattice magnet. Skyrmions have been observed in metallic materials, where they are controllable by electric currents. Here, we report the experimental discovery of magnetoelectric skyrmions in an insulating chiral-lattice magnet Cu2OSeO3 through Lorentz transmission electron microscopy and magnetic susceptibility measurements. We find that the skyrmion can magnetically induce electric polarization. The observed magnetoelectric coupling may potentially enable the manipulation of the skyrmion by an external electric field without losses due to joule heating.	[Seki, S.; Ishiwata, S.; Tokura, Y.] Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan; [Seki, S.; Ishiwata, S.; Tokura, Y.] Univ Tokyo, Quantum Phase Elect Ctr, Tokyo 1138656, Japan; [Yu, X. Z.; Tokura, Y.] RIKEN Adv Sci Inst, Cross Correlated Mat Res Grp, Wako, Saitama 3510198, Japan; [Yu, X. Z.; Tokura, Y.] RIKEN Adv Sci Inst, Correlated Elect Res Grp, Wako, Saitama 3510198, Japan; [Tokura, Y.] Japan Sci & Technol Agcy, Exploratory Res Adv Technol, Multiferro Project, Tokyo 1138656, Japan	University of Tokyo; University of Tokyo; RIKEN; RIKEN; Japan Science & Technology Agency (JST)	Seki, S (corresponding author), Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan.	seki@ap.t.u-tokyo.ac.jp	Yu, Xiuzhen/B-3634-2013; Tokura, Yoshinori/C-7352-2009; Seki, Shinichiro/A-1339-2010; Ishiwata, Shintaro/A-2637-2010; Ishida, Mari/AAU-3379-2020	Yu, Xiuzhen/0000-0003-3136-7289; Tokura, Yoshinori/0000-0002-2732-4983; Seki, Shinichiro/0000-0001-6094-8643; Ishiwata, Shintaro/0000-0003-1696-2514; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [20340086, 2010458]; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank N. Nagaosa, T. Arima, M. Mochizuki, S. Miyahara, N. Furukawa, B.-J. Yang, F. Kagawa, Y. Shiomi, N. Kanazawa, T. Kurumaji, M. Shibata, M. Rikiso, and A. Nakao for enlightening discussions and experimental contributions. This work was partly supported by Grants-In-Aid for Scientific Research (grants 20340086 and 2010458) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the FIRST Program by the Japan Society for the Promotion of Science.	Bauer A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.064404; Belesi M, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.094422; BOGDANOV AN, 1989, ZH EKSP TEOR FIZ+, V95, P178; Bos JWG, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.094416; Bruno P, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.096806; Cheong SW, 2007, NAT MATER, V6, P13, DOI 10.1038/nmat1804; EFFENBERGER H, 1986, MONATSH CHEM, V117, P887, DOI 10.1007/BF00811258; Fiebig M, 2005, J PHYS D APPL PHYS, V38, pR123, DOI 10.1088/0022-3727/38/8/R01; Grigoriev SV, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.224424; Huang CL, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.052402; ISHIKAWA Y, 1976, SOLID STATE COMMUN, V19, P525, DOI 10.1016/0038-1098(76)90057-0; ISHIKAWA Y, 1984, J PHYS SOC JPN, V53, P2726, DOI 10.1143/JPSJ.53.2726; Jonietz F, 2010, SCIENCE, V330, P1648, DOI 10.1126/science.1195709; Kimura T, 2003, NATURE, V426, P55, DOI 10.1038/nature02018; KOHN K, 1977, J PHYS SOC JPN, V42, P2065, DOI 10.1143/JPSJ.42.2065; MEUNIER G, 1976, J APPL CRYSTALLOGR, V9, P364, DOI 10.1107/S0021889876011540; Miller KH, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.144107; Muhlbauer S, 2009, SCIENCE, V323, P915, DOI 10.1126/science.1166767; Munzer W, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.041203; Murakawa H, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.147201; Neubauer A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.186602; Rossler UK, 2006, NATURE, V442, P797, DOI 10.1038/nature05056; Seki S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.127201; SKYRME THR, 1962, NUCL PHYS, V31, P556, DOI 10.1016/0029-5582(62)90775-7; Thessieu C, 1997, J PHYS-CONDENS MAT, V9, P6677, DOI 10.1088/0953-8984/9/31/019; Tokunaga Y, 2009, NAT MATER, V8, P558, DOI [10.1038/nmat2469, 10.1038/NMAT2469]; Tokura Y, 2010, ADV MATER, V22, P1554, DOI 10.1002/adma.200901961; Uchida M, 2006, SCIENCE, V311, P359, DOI 10.1126/science.1120639; Yamasaki Y, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.147204; Yu XZ, 2011, NAT MATER, V10, P106, DOI 10.1038/nmat2916; Yu XZ, 2010, NATURE, V465, P901, DOI 10.1038/nature09124	31	960	966	26	749	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2012	336	6078					198	201		10.1126/science.1214143	http://dx.doi.org/10.1126/science.1214143			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924PN	22499941				2022-12-28	WOS:000302703900042
J	Brody, H				Brody, Herb			MULTIPLE SCLEROSIS	NATURE			English	Editorial Material																			0	1	1	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					S1	S1		10.1038/nature11104	http://dx.doi.org/10.1038/nature11104			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22509502	Bronze			2022-12-28	WOS:000303149900043
J	D'Ath, P; Thomson, P				D'Ath, Penny; Thomson, Penny			Superficial spreading melanoma	BRITISH MEDICAL JOURNAL			English	Editorial Material									[D'Ath, Penny] City Univ London, Dept Optometry & Visual Sci, London EC1V 0HB, England; [Thomson, Penny] Barnet & Chase Farm Hosp NHS Trust, Barnet Hosp, Barnet EN5 3DJ, England	City University London	D'Ath, P (corresponding author), City Univ London, Dept Optometry & Visual Sci, London EC1V 0HB, England.	p.j.d'ath@city.ac.uk; penny.thomson@.nhs.net							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 11	2012	344								e2319	10.1136/bmj.e2319	http://dx.doi.org/10.1136/bmj.e2319			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	927UH	22496298	Green Accepted, Bronze			2022-12-28	WOS:000302935200001
J	Kolling, N; Behrens, TEJ; Mars, RB; Rushworth, MFS				Kolling, Nils; Behrens, Timothy E. J.; Mars, Rogier B.; Rushworth, Matthew F. S.			Neural Mechanisms of Foraging	SCIENCE			English	Article							ANTERIOR CINGULATE; VALUE COMPUTATIONS; DECISION-MAKING; REWARD SIGNALS; CORTEX; INFORMATION; VALUATION; STRIATUM	Behavioral economic studies involving limited numbers of choices have provided key insights into neural decision-making mechanisms. By contrast, animals' foraging choices arise in the context of sequences of encounters with prey or food. On each encounter, the animal chooses whether to engage or, if the environment is sufficiently rich, to search elsewhere. The cost of foraging is also critical. We demonstrate that humans can alternate between two modes of choice, comparative decision-making and foraging, depending on distinct neural mechanisms in ventromedial prefrontal cortex (vmPFC) and anterior cingulate cortex (ACC) using distinct reference frames; in ACC, choice variables are represented in invariant reference to foraging or searching for alternatives. Whereas vmPFC encodes values of specific well-defined options, ACC encodes the average value of the foraging environment and cost of foraging.	[Kolling, Nils; Behrens, Timothy E. J.; Mars, Rogier B.; Rushworth, Matthew F. S.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Behrens, Timothy E. J.; Mars, Rogier B.; Rushworth, Matthew F. S.] Univ Oxford, Oxford Ctr Funct Magnet Resonance Imaging Brain F, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Kolling, N (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	nils.kolling@psy.ox.ac.uk	Mars, Rogier/G-2312-2018; Mars, Rogier/GWZ-9665-2022	Mars, Rogier/0000-0001-6302-8631; Rushworth, Matthew/0000-0002-5578-9884; Kolling, Nils/0000-0002-0283-6966; Behrens, Timothy/0000-0003-0048-1177	U.K. Medical Research Council; Wellcome Trust; MRC [G0600994, G0700399, G0802146] Funding Source: UKRI; Medical Research Council [G0700399, G0802146, G0600994] Funding Source: researchfish	U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funded by U.K. Medical Research Council and the Wellcome Trust.	Basten U, 2010, P NATL ACAD SCI USA, V107, P21767, DOI 10.1073/pnas.0908104107; Boorman ED, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001093; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Croxson PL, 2009, J NEUROSCI, V29, P4531, DOI 10.1523/JNEUROSCI.4515-08.2009; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Fellows LK, 2006, BRAIN, V129, P944, DOI 10.1093/brain/awl017; Freidin E, 2011, SCIENCE, V334, P1000, DOI 10.1126/science.1209626; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Hare TA, 2011, P NATL ACAD SCI USA, V108, P18120, DOI 10.1073/pnas.1109322108; Hayden BY, 2011, NAT NEUROSCI, V14, P933, DOI 10.1038/nn.2856; Hayden BY, 2009, SCIENCE, V324, P948, DOI 10.1126/science.1168488; Kennerley SW, 2011, NAT NEUROSCI, V14, P1581, DOI 10.1038/nn.2961; Lim SL, 2011, J NEUROSCI, V31, P13214, DOI 10.1523/JNEUROSCI.1246-11.2011; Magno E, 2006, J NEUROSCI, V26, P4769, DOI 10.1523/JNEUROSCI.0369-06.2006; Mansouri FA, 2007, SCIENCE, V318, P987, DOI 10.1126/science.1146384; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Noonan MP, 2011, J NEUROSCI, V31, P14399, DOI 10.1523/JNEUROSCI.6456-10.2011; Noonan MP, 2010, P NATL ACAD SCI USA, V107, P20547, DOI 10.1073/pnas.1012246107; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Rudebeck PH, 2006, NAT NEUROSCI, V9, P1161, DOI 10.1038/nn1756; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Stephens D.W., 1986, pi; Vickery TJ, 2011, NEURON, V72, P166, DOI 10.1016/j.neuron.2011.08.011; Wise SP, 2008, TRENDS NEUROSCI, V31, P599, DOI 10.1016/j.tins.2008.08.008; Wunderlich K, 2012, NAT NEUROSCI, V15, P786, DOI 10.1038/nn.3068	30	363	364	2	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2012	336	6077					95	98		10.1126/science.1216930	http://dx.doi.org/10.1126/science.1216930			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920LG	22491854	Green Accepted			2022-12-28	WOS:000302405400059
J	Hughes, KJ; Kennedy, BK				Hughes, Katherine J.; Kennedy, Brian K.			Rapamycin Paradox Resolved	SCIENCE			English	Editorial Material							LIFE-SPAN; GENETICS; ELEGANS; KINASE; MTORC2; MICE		[Hughes, Katherine J.; Kennedy, Brian K.] Buck Inst Res Aging, Novato, CA 94945 USA	Buck Institute for Research on Aging	Hughes, KJ (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	bkennedy@buckinstitute.org		Kennedy, Brian/0000-0002-5754-1874				Anderson RM, 2010, TRENDS ENDOCRIN MET, V21, P134, DOI 10.1016/j.tem.2009.11.005; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kennedy BK, 2008, J INTERN MED, V263, P142, DOI 10.1111/j.1365-2796.2007.01903.x; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Liu QS, 2012, METHODS MOL BIOL, V821, P447, DOI 10.1007/978-1-61779-430-8_29; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a	14	21	21	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1578	1579		10.1126/science.1221365	http://dx.doi.org/10.1126/science.1221365			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461595				2022-12-28	WOS:000302062600027
J	Kinoshita, N; Paul, M; Kashiv, Y; Collon, P; Deibel, CM; DiGiovine, B; Greene, JP; Henderson, DJ; Jiang, CL; Marley, ST; Nakanishi, T; Pardo, RC; Rehm, KE; Robertson, D; Scott, R; Schmitt, C; Tang, XD; Vondrasek, R; Yokoyama, A				Kinoshita, N.; Paul, M.; Kashiv, Y.; Collon, P.; Deibel, C. M.; DiGiovine, B.; Greene, J. P.; Henderson, D. J.; Jiang, C. L.; Marley, S. T.; Nakanishi, T.; Pardo, R. C.; Rehm, K. E.; Robertson, D.; Scott, R.; Schmitt, C.; Tang, X. D.; Vondrasek, R.; Yokoyama, A.			A Shorter Sm-146 Half-Life Measured and Implications for Sm-146-Nd-142 Chronology in the Solar System	SCIENCE			English	Article							MAGMA OCEAN; EARLY DIFFERENTIATION; ND-142 EVIDENCE; SNC METEORITES; SILICATE EARTH; MARS; MANTLE; MOON; NEODYMIUM; CRUST	The extinct p-process nuclide Sm-146 serves as an astrophysical and geochemical chronometer through measurements of isotopic anomalies of its alpha-decay daughter Nd-142. Based on analyses of Sm-146/Sm-147 alpha-activity and atom ratios, we determined the half-life of Sm-146 to be 68 +/- 7 (1 sigma) million years, which is shorter than the currently used value of 103 +/- 5 million years. This half-life value implies a higher initial Sm-146 abundance in the early solar system, (Sm-146/Sm-144)(0) = 0.0094 +/- 0.0005 (2 sigma), than previously estimated. Terrestrial, lunar, and martian planetary silicate mantle differentiation events dated with Sm-146-Nd-142 converge to a shorter time span and in general to earlier times, due to the combined effect of the new Sm-146 half-life and (Sm-146/Sm-144)(0) values.	[Paul, M.] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Kinoshita, N.] Univ Tsukuba, Res Facil Ctr Sci & Technol, Tsukuba, Ibaraki 305, Japan; [Kashiv, Y.; Collon, P.; Robertson, D.; Schmitt, C.; Tang, X. D.] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; [Deibel, C. M.; DiGiovine, B.; Greene, J. P.; Henderson, D. J.; Jiang, C. L.; Marley, S. T.; Pardo, R. C.; Rehm, K. E.; Scott, R.; Vondrasek, R.] Argonne Natl Lab, Div Phys, Argonne, IL 60439 USA; [Deibel, C. M.] Michigan State Univ, Joint Inst Nucl Astrophys, E Lansing, MI 48824 USA; [Nakanishi, T.; Yokoyama, A.] Kanazawa Univ, Inst Sci & Engn, Fac Chem, Kanazawa, Ishikawa 9201192, Japan	Hebrew University of Jerusalem; University of Tsukuba; University of Notre Dame; United States Department of Energy (DOE); Argonne National Laboratory; Michigan State University; Kanazawa University	Paul, M (corresponding author), Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel.	paul@vms.huji.ac.il; ykashiv@nd.edu	Greene, John/AFJ-9796-2022; Robertson, Daniel/R-9912-2019; Tang, Xiaodong/F-4891-2016; Yokoyama, Akihiko/C-5975-2015	Greene, John/0000-0002-2095-1394; Robertson, Daniel/0000-0002-4961-1641; DiGiovine, Brad/0000-0002-5143-4576; Yokoyama, Akihiko/0000-0003-1950-8966; Marley, Scott/0000-0003-3705-7257	Japan Society for the Promotion of Science [20740161]; U.S. Department of Energy, Office of Nuclear Physics [DE-AC02-06CH11357]; NSF JINA [PHY0822648]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); U.S. Department of Energy, Office of Nuclear Physics(United States Department of Energy (DOE)); NSF JINA	We thank R. Carlson, W. Kutschera, K. Nollett, and J. Schiffer for helpful discussions, and three anonymous reviewers for comments that greatly benefited the paper. This work is supported in part by the Grant-in-Aid for Scientific Research Program of the Japan Society for the Promotion of Science (grant no. 20740161). This work is supported by the U.S. Department of Energy, Office of Nuclear Physics, under contract no. DE-AC02-06CH11357 and by NSF JINA grant no. PHY0822648. Data are available in the supporting online material.	AUDOUZE J, 1972, NATURE, V237, P447, DOI 10.1038/237447a0; Bennett VC, 2007, SCIENCE, V318, P1907, DOI 10.1126/science.1145928; Borg LE, 2011, NATURE, V477, P70, DOI 10.1038/nature10328; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Boyet M, 2007, EARTH PLANET SC LETT, V262, P505, DOI 10.1016/j.epsl.2007.08.009; Boyet M, 2010, EARTH PLANET SC LETT, V291, P172, DOI 10.1016/j.epsl.2010.01.010; Brandon AD, 2009, GEOCHIM COSMOCHIM AC, V73, P6421, DOI 10.1016/j.gca.2009.07.015; Caro G, 2008, NATURE, V452, P336, DOI 10.1038/nature06760; Caro G, 2011, ANNU REV EARTH PL SC, V39, P31, DOI 10.1146/annurev-earth-040610-133400; Dauphas N, 2011, NATURE, V473, P489, DOI 10.1038/nature10077; Dauphas N, 2003, NUCL PHYS A, V719, p287C, DOI 10.1016/S0375-9474(03)00934-5; Debaille V, 2007, NATURE, V450, P525, DOI 10.1038/nature06317; DUNLAVEY DC, 1953, PHYS REV, V92, P206, DOI 10.1103/PhysRev.92.206; Foley CN, 2005, GEOCHIM COSMOCHIM AC, V69, P4557, DOI 10.1016/j.gca.2005.05.009; FRIEDMAN AM, 1966, RADIOCHIM ACTA, V5, P192; HARPER CL, 1992, NATURE, V360, P728, DOI 10.1038/360728a0; HARPER CL, 1995, SCIENCE, V267, P213, DOI 10.1126/science.7809625; Kinoshita N, 2013, NUCL INSTRUM METH B, V294, P143, DOI 10.1016/j.nimb.2012.01.013; Kinoshita N, 2008, J PHYS G NUCL PARTIC, V35, DOI 10.1088/0954-3899/35/1/014033; Kossert K, 2009, APPL RADIAT ISOTOPES, V67, P1702, DOI 10.1016/j.apradiso.2009.03.013; LUGMAIR GW, 1977, EARTH PLANET SC LETT, V35, P273, DOI 10.1016/0012-821X(77)90131-5; MEISSNER F, 1987, Z PHYS A-HADRON NUCL, V327, P171, DOI 10.1007/BF01292406; Nurmia M., 1964, ANN ACAD SCI FENN A6, V148, P1; NYQUIST LE, 1995, GEOCHIM COSMOCHIM AC, V59, P2817, DOI 10.1016/0016-7037(95)00175-Y; NYQUIST LE, 1994, METEORITICS, V29, P872, DOI 10.1111/j.1945-5100.1994.tb01102.x; O'Neil J, 2008, SCIENCE, V321, P1828, DOI 10.1126/science.1161925; O'Neill HSC, 2008, PHILOS T R SOC A, V366, P4205, DOI 10.1098/rsta.2008.0111; PAUL M, 1989, NUCL INSTRUM METH A, V277, P418, DOI 10.1016/0168-9002(89)90771-7; PRINZHOFER A, 1992, GEOCHIM COSMOCHIM AC, V56, P797, DOI 10.1016/0016-7037(92)90099-5; STEWART BW, 1994, GEOCHIM COSMOCHIM AC, V58, P3487, DOI 10.1016/0016-7037(94)90100-7; Tazoe H, 2007, MAR CHEM, V103, P1, DOI 10.1016/j.marchem.2006.05.008; Wasserburg GJ, 2006, NUCL PHYS A, V777, P5, DOI 10.1016/j.nuclphysa.2005.07.015	32	123	125	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1614	1617		10.1126/science.1215510	http://dx.doi.org/10.1126/science.1215510			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461609	Green Submitted			2022-12-28	WOS:000302062600042
J	Powell, AE; Wang, Y; Li, YN; Poulin, EJ; Means, AL; Washington, MK; Higginbotham, JN; Juchheim, A; Prasad, N; Levy, SE; Guo, Y; Shyr, Y; Aronow, BJ; Haigis, KM; Franklin, JL; Coffey, RJ				Powell, Anne E.; Wang, Yang; Li, Yina; Poulin, Emily J.; Means, Anna L.; Washington, Mary K.; Higginbotham, James N.; Juchheim, Alwin; Prasad, Nripesh; Levy, Shawn E.; Guo, Yan; Shyr, Yu; Aronow, Bruce J.; Haigis, Kevin M.; Franklin, Jeffrey L.; Coffey, Robert J.			The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal Stem Cell Marker that Functions as a Tumor Suppressor	CELL			English	Article							IMMUNOHISTOCHEMICAL ANALYSIS; OXIDATIVE STRESS; EXPRESSION MARKS; CANCER; RECEPTOR; GENE; PROLIFERATION; GROWTH; CRYPTS; POPULATION	Lineage mapping has identified both proliferative and quiescent intestinal stem cells, but the molecular circuitry controlling stem cell quiescence is incompletely understood. By lineage mapping, we show Lrig1, a pan-ErbB inhibitor, marks predominately noncycling, long-lived stem cells that are located at the crypt base and that, upon injury, proliferate and divide to replenish damaged crypts. Transcriptome profiling of Lrig1(+) colonic stem cells differs markedly from the profiling of highly proliferative, Lgr5(+) colonic stem cells; genes upregulated in the Lrig1(+) population include those involved in cell cycle repression and response to oxidative damage. Loss of Apc in Lrig1(+) cells leads to intestinal adenomas, and genetic ablation of Lrig1 results in heightened ErbB1-3 expression and duodenal adenomas. These results shed light on the relationship between proliferative and quiescent intestinal stem cells and support a model in which intestinal stem cell quiescence is maintained by calibrated ErbB signaling with loss of a negative regulator predisposing to neoplasia.	[Powell, Anne E.; Wang, Yang; Li, Yina; Poulin, Emily J.; Higginbotham, James N.; Franklin, Jeffrey L.; Coffey, Robert J.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Powell, Anne E.; Wang, Yang; Li, Yina; Poulin, Emily J.; Higginbotham, James N.; Franklin, Jeffrey L.; Coffey, Robert J.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Means, Anna L.] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37232 USA; [Washington, Mary K.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Guo, Yan; Shyr, Yu] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN 37232 USA; [Coffey, Robert J.] Vanderbilt Univ, Med Ctr, Epithelial Biol Ctr, Nashville, TN 37232 USA; [Juchheim, Alwin; Haigis, Kevin M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mol Pathol Unit, Charlestown, MA 02129 USA; [Juchheim, Alwin; Haigis, Kevin M.] Harvard Univ, Sch Med, Dept Pathol, Charlestown, MA 02129 USA; [Prasad, Nripesh; Levy, Shawn E.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Aronow, Bruce J.] Cincinnati Childrens Hosp, Med Ctr, Dept Biomed Informat, Cincinnati, OH 45229 USA; [Aronow, Bruce J.] Cincinnati Childrens Hosp, Med Ctr, Dept Dev Biol, Cincinnati, OH 45229 USA; [Coffey, Robert J.] Dept Vet Affairs Med Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Harvard University; Massachusetts General Hospital; Harvard University; HudsonAlpha Institute for Biotechnology; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Coffey, RJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA.	robert.coffey@vanderbilt.edu	Wang, Yang/O-2300-2013; Aronow, Bruce J/F-8438-2012	Wang, Yang/0000-0003-2801-8416; Levy, Shawn/0000-0002-1369-5740; Prasad, Nripesh/0000-0003-4074-2538; Zemper, Anne/0000-0001-8238-1406	National Cancer Institute [CA151566, CA46413]; MMHCC [U01CA084239]; Gastrointestinal Specialized Program of Research Excellence [P50CA095103, T32GM008554, T32CA119925]; Vanderbilt's Clinical and Translational Science Award; Transgenic Mouse/ES Cell, Cell Imaging, and Flow Cytometry Shared Resources; Coffey Memorial Gastrointestinal Cancer Fund; NATIONAL CANCER INSTITUTE [P50CA095103, R01CA046413, U01CA084239, R01CA151566, T32CA119925] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008554] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MMHCC; Gastrointestinal Specialized Program of Research Excellence; Vanderbilt's Clinical and Translational Science Award; Transgenic Mouse/ES Cell, Cell Imaging, and Flow Cytometry Shared Resources; Coffey Memorial Gastrointestinal Cancer Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.E.P., Y.W., Y.L., K.M.H., J.L.F. and R.J.C. designed, executed and analyzed data. E.J.P., J.N.H., and A.J. provided technical assistance. S.E.L. conducted the RNA-Seq. A.L.M., M.K.W., N.P., Y.G., Y.S., and B.J.A. provided expert analysis. A.E.P. and R.J.C. assembled the manuscript. We thank Frank Revetta and Catherine Meador for technical assistance and Robert Whitehead for guidance. This work was supported by the National Cancer Institute CA151566 to R.J.C. and K.M.H., and CA46413, MMHCC U01CA084239, and Gastrointestinal Specialized Program of Research Excellence P50CA095103 to R.J.C., T32GM008554 to E.J.P. and T32CA119925 to A.E.P. The authors acknowledge the support of Vanderbilt's Clinical and Translational Science Award and Transgenic Mouse/ES Cell, Cell Imaging, and Flow Cytometry Shared Resources. We thank the Peter Powell and Mary Catherine Mundell Coffey Memorial Gastrointestinal Cancer Fund for its generous support.	AKASHI T, 1994, VIRCHOWS ARCH, V425, P399; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Cai WB, 1997, INT J RADIAT BIOL, V71, P573, DOI 10.1080/095530097143905; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Davies PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006530; Escobar M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1260; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Goldoni S, 2007, ONCOGENE, V26, P368, DOI 10.1038/sj.onc.1209803; Gracz AD, 2010, AM J PHYSIOL-GASTR L, V298, pG590, DOI 10.1152/ajpgi.00470.2009; Graham SM, 2007, STEM CELLS, V25, P3111, DOI 10.1634/stemcells.2007-0250; Hedman H, 2007, EUR J CANCER, V43, P676, DOI 10.1016/j.ejca.2006.10.021; HENDRY JH, 1992, RADIAT RES, V132, P115, DOI 10.2307/3578342; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Ledda F, 2008, J NEUROSCI, V28, P39, DOI 10.1523/JNEUROSCI.2196-07.2008; Li YN, 2004, DEV BIOL, V270, P214, DOI 10.1016/j.ydbio.2004.03.009; Ljuslinder I, 2007, ACTA ONCOL, V46, P1118, DOI 10.1080/02841860701426823; Miller JK, 2008, CANCER RES, V68, P8286, DOI 10.1158/0008-5472.CAN-07-6316; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; Potten CS, 1998, BRIT J CANCER, V78, P993, DOI 10.1038/bjc.1998.618; Powell AE, 2011, CANCER RES, V71, P1497, DOI 10.1158/0008-5472.CAN-10-3223; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shattuck DL, 2007, MOL CELL BIOL, V27, P1934, DOI 10.1128/MCB.00757-06; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Storz P, 2011, ANTIOXID REDOX SIGN, V14, P593, DOI 10.1089/ars.2010.3405; Suzuki Y, 2002, FEBS LETT, V521, P67, DOI 10.1016/S0014-5793(02)02824-7; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tanemura A, 2005, DERMATOL SURG, V31, P423, DOI 10.1097/00042728-200504000-00008; Thliveris AT, 2011, CANCER PREV RES, V4, P916, DOI 10.1158/1940-6207.CAPR-11-0022; Thomasson M, 2003, BRIT J CANCER, V89, P1285, DOI 10.1038/sj.bjc.6601208; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Wang Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-75; WHITEHEAD RH, 1987, IN VITRO CELL DEV B, V23, P436; Whitehead RH, 2009, AM J PHYSIOL-GASTR L, V296, pG455, DOI 10.1152/ajpgi.90381.2008; Wong MH, 1998, J CELL BIOL, V141, P765, DOI 10.1083/jcb.141.3.765; Ye F, 2009, J NEURO-ONCOL, V94, P183, DOI 10.1007/s11060-009-9836-1; Zhang X, 2011, NAT CELL BIOL, V13, P1092, DOI 10.1038/ncb2293	49	483	488	1	54	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 30	2012	149	1					146	158		10.1016/j.cell.2012.02.042	http://dx.doi.org/10.1016/j.cell.2012.02.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464327	Bronze, Green Accepted			2022-12-28	WOS:000302235400017
J	Caritis, SN; Simhan, H				Caritis, Steve N.; Simhan, Hyagriv			Cervical pessary use and preterm birth: how little we know	LANCET			English	Editorial Material									[Caritis, Steve N.; Simhan, Hyagriv] Magee Womens Hosp, Pittsburgh, PA 15213 USA		Caritis, SN (corresponding author), Magee Womens Hosp, Pittsburgh, PA 15213 USA.	scaritis@mail.magee.edu		caritis, steve/0000-0002-2169-0712				Abdel-Aleem H, 2010, COCHRANE DB SYST REV, V8; Berghella V, 2003, CLIN OBSTET GYNECOL, V46, P947, DOI 10.1097/00003081-200312000-00026; Berghella V, 2011, OBSTET GYNECOL, V117, P663, DOI 10.1097/AOG.0b013e31820ca847; Dharan VB, 2009, SEMIN PERINATOL, V33, P338, DOI 10.1053/j.semperi.2009.06.008; Goya M, 2012, LANCET, V379, P1800, DOI 10.1016/S0140-6736(12)60030-0; Harger JH, 2002, OBSTET GYNECOL, V100, P1313, DOI 10.1016/S0029-7844(02)02365-7; Hassan SS, 2011, ULTRASOUND OBST GYN, V38, P18, DOI 10.1002/uog.9017; Owen J, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.08.015	8	5	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2012	379	9828					1769	1770		10.1016/S0140-6736(12)60116-0	http://dx.doi.org/10.1016/S0140-6736(12)60116-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	941BR	22475492				2022-12-28	WOS:000303937700008
J	Zhang, TL; Lu, QM; Baumjohann, W; Russell, CT; Fedorov, A; Barabash, S; Coates, AJ; Du, AM; Cao, JB; Nakamura, R; Teh, WL; Wang, RS; Dou, XK; Wang, S; Glassmeier, KH; Auster, HU; Balikhin, M				Zhang, T. L.; Lu, Q. M.; Baumjohann, W.; Russell, C. T.; Fedorov, A.; Barabash, S.; Coates, A. J.; Du, A. M.; Cao, J. B.; Nakamura, R.; Teh, W. L.; Wang, R. S.; Dou, X. K.; Wang, S.; Glassmeier, K. H.; Auster, H. U.; Balikhin, M.			Magnetic Reconnection in the Near Venusian Magnetotail	SCIENCE			English	Article							TAIL RECONNECTION; FLUX ROPES; ATMOSPHERE; EXPRESS	Observations with the Venus Express magnetometer and low-energy particle detector revealed magnetic field and plasma behavior in the near-Venus wake that is symptomatic of magnetic reconnection, a process that occurs in Earth's magnetotail but is not expected in the magnetotail of a nonmagnetized planet such as Venus. On 15 May 2006, the plasma flow in this region was toward the planet, and the magnetic field component transverse to the flow was reversed. Magnetic reconnection is a plasma process that changes the topology of the magnetic field and results in energy exchange between the magnetic field and the plasma. Thus, the energetics of the Venus magnetotail resembles that of the terrestrial tail, where energy is stored and later released from the magnetic field to the plasma.	[Zhang, T. L.; Lu, Q. M.; Dou, X. K.; Wang, S.] Univ Sci & Technol China, Chinese Acad Sci, Key Lab Geospace Environm, Hefei 230026, Peoples R China; [Zhang, T. L.; Baumjohann, W.; Nakamura, R.; Teh, W. L.; Wang, R. S.] Austrian Acad Sci, Space Res Inst, A-8042 Graz, Austria; [Russell, C. T.] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; [Fedorov, A.] Ctr Etud Spatiale Rayonnements, F-31028 Toulouse, France; [Barabash, S.] Swedish Inst Space Phys, S-98128 Kiruna, Sweden; [Coates, A. J.] Univ Coll London, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; [Du, A. M.] Chinese Acad Sci, Inst Geol & Geophys, Beijing 100029, Peoples R China; [Cao, J. B.] Beihang Univ, Space Sci Inst, Beijing 100191, Peoples R China; [Glassmeier, K. H.; Auster, H. U.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Geophys & Extraterr Phys, D-38106 Braunschweig, Germany; [Balikhin, M.] Univ Sheffield, Dept Automat Control & Syst Engn, Sheffield S1 3JD, S Yorkshire, England	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Austrian Academy of Sciences; University of California System; University of California Los Angeles; University of London; University College London; Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Beihang University; Braunschweig University of Technology; University of Sheffield	Zhang, TL (corresponding author), Univ Sci & Technol China, Chinese Acad Sci, Key Lab Geospace Environm, Hefei 230026, Peoples R China.	tielong.zhang@oeaw.ac.at	Dou, xiankang/M-9106-2013; Baumjohann, Wolfgang/A-1012-2010; Russell, Christopher T/E-7745-2012; , Misha/U-9055-2019; Nakamura, Rumi/I-7712-2013; wang, Rongsheng/D-4306-2016; Coates, Andrew/C-2396-2008	Baumjohann, Wolfgang/0000-0001-6271-0110; Russell, Christopher T/0000-0003-1639-8298; Nakamura, Rumi/0000-0002-2620-9211; wang, Rongsheng/0000-0002-9511-7660; Coates, Andrew/0000-0002-6185-3125	National Natural Science Foundation of China [41121003, 41174156]; Austrian Science Fund [FWF: I429-N16]; NASA [NNX10AV29G]; STFC [ST/H00260X/1, ST/F002939/1] Funding Source: UKRI; Austrian Science Fund (FWF) [I 429] Funding Source: researchfish; Science and Technology Facilities Council [ST/F002939/1, ST/H00260X/1] Funding Source: researchfish; UK Space Agency [ST/G004188/1, PP/D000831/1] Funding Source: researchfish	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Austrian Science Fund(Austrian Science Fund (FWF)); NASA(National Aeronautics & Space Administration (NASA)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency	The work in China was supported by National Natural Science Foundation of China grants 41121003 and 41174156. The work at Graz was supported by Austrian Science Fund (FWF: I429-N16). The work at UCLA was supported by NASA under research grant NNX10AV29G.	Angelopoulos V, 2008, SCIENCE, V321, P931, DOI 10.1126/science.1160495; Barabash S, 2007, PLANET SPACE SCI, V55, P1772, DOI 10.1016/j.pss.2007.01.014; Barabash S, 2007, NATURE, V450, P650, DOI 10.1038/nature06434; Chen PF, 2011, LIVING REV SOL PHYS, V8, DOI 10.12942/lrsp-2011-1; Fedorov A, 2011, J GEOPHYS RES-SPACE, V116, DOI [10.1029/2010JA016427, 10.1029/2011JA016427]; Jackman CM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029764; Jia YD, 2009, ASTROPHYS J LETT, V696, pL56, DOI 10.1088/0004-637X/696/1/L56; Lammer H, 2006, PLANET SPACE SCI, V54, P1445, DOI 10.1016/j.pss.2006.04.022; MOLDWIN MB, 1991, J GEOPHYS RES-SPACE, V96, P14051, DOI 10.1029/91JA01167; PHILLIPS JL, 1991, SPACE SCI REV, V55, P1, DOI 10.1007/BF00177135; Russell C. T., 1983, Venus, P873; Russell C. T., 1974, CORRELATED INTERPLAN, P3; RUSSELL CT, 1986, J GEOPHYS RES, V91, P1417, DOI 10.1029/JA091iA02p01417; RUSSELL CT, 1979, NATURE, V279, P616, DOI 10.1038/279616a0; Russell CT, 1998, SCIENCE, V280, P1061, DOI 10.1126/science.280.5366.1061; Slavin JA, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037876; Slavin JA, 2009, SCIENCE, V324, P606, DOI 10.1126/science.1172011; Wei HY, 2010, ICARUS, V206, P174, DOI 10.1016/j.icarus.2009.03.014; Zhang TL, 2007, NATURE, V450, P654, DOI 10.1038/nature06026; Zhang TL, 2006, PLANET SPACE SCI, V54, P1336, DOI 10.1016/j.pss.2006.04.018; Zhang TL, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044020	21	94	98	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2012	336	6081					567	570		10.1126/science.1217013	http://dx.doi.org/10.1126/science.1217013			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22491094				2022-12-28	WOS:000303498800040
J	Wang, YG; Li, G; Goode, J; Paz, JC; Ouyang, KF; Screaton, R; Fischer, WH; Chen, J; Tabas, I; Montminy, M				Wang, Yiguo; Li, Gang; Goode, Jason; Paz, Jose C.; Ouyang, Kunfu; Screaton, Robert; Fischer, Wolfgang H.; Chen, Ju; Tabas, Ira; Montminy, Marc			Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes	NATURE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; DEPENDENT PROTEIN-KINASE; MODULATES GLUCONEOGENESIS; COACTIVATOR PGC-1; CREB; CALCIUM; PHOSPHORYLATION; TORC2; HEPATOCYTES; RELEASE	In the fasted state, increases in circulating glucagon promote hepatic glucose production through induction of the gluconeogenic program. Triggering of the cyclic AMP pathway increases gluconeogenic gene expression via the de-phosphorylation of the CREB co-activator CRTC2 (ref. 1). Glucagon promotes CRTC2 dephosphorylation in part through the protein kinase A (PKA)-mediated inhibition of the CRTC2 kinase SIK2. A number of Ser/Thr phosphatases seem to be capable of dephosphorylating CRTC2 (refs 2, 3), but the mechanisms by which hormonal cues regulate these enzymes remain unclear. Here we show in mice that glucagon stimulates CRTC2 dephosphorylation in hepatocytes by mobilizing intracellular calcium stores and activating the calcium/calmodulin-dependent Ser/Thr-phosphatase calcineurin (also known as PP3CA). Glucagon increased cytosolic calcium concentration through the PKA-mediated phosphorylation of inositol-1,4,5-trisphosphate receptors (InsP(3)Rs), which associate with CRTC2. After their activation, InsP(3)Rs enhanced gluconeogenic gene expression by promoting the calcineurin-mediated dephosphorylation of CRTC2. During feeding, increases in insulin signalling reduced CRTC2 activity via the AKT-mediated inactivation of InsP(3)Rs. InsP(3)R activity was increased in diabetes, leading to upregulation of the gluconeogenic program. As hepatic downregulation of InsP(3)Rs and calcineurin improved circulating glucose levels in insulin resistance, these results demonstrate how interactions between cAMP and calcium pathways at the level of the InsP(3)R modulate hepatic glucose production under fasting conditions and in diabetes.	[Wang, Yiguo; Goode, Jason; Paz, Jose C.; Fischer, Wolfgang H.; Montminy, Marc] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; [Li, Gang; Tabas, Ira] Columbia Univ, Dept Med, New York, NY 10032 USA; [Ouyang, Kunfu; Chen, Ju] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Screaton, Robert] Univ Ottawa, Eastern Ontario Res Inst, Childrens Hosp, Ottawa, ON K1H 8L1, Canada; [Screaton, Robert] Univ Ottawa, Dept Pediat, Ottawa, ON K1H 8L1, Canada; [Screaton, Robert] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8L1, Canada; [Tabas, Ira] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Tabas, Ira] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA	Salk Institute; Columbia University; University of California System; University of California San Diego; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa; Columbia University; Columbia University	Montminy, M (corresponding author), Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	montminy@salk.edu	ouyang, kunfu/B-3073-2011; Paz, Jose Carlos/I-5783-2015; Chen, Ju/E-5579-2011	ouyang, kunfu/0000-0003-0292-375X; Paz, Jose Carlos/0000-0001-9684-9735; Screaton, Robert/0000-0002-4917-9473	National Institutes of Health [R01-DK049777, R01-DK083834, R01-DK091618, HL087123]; Kieckhefer Foundation; Clayton Foundation for Medical Research; Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091618, R37DK083834, R01DK049777, R01DK083834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kieckhefer Foundation; Clayton Foundation for Medical Research; Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01-DK049777, R01-DK083834 and R01-DK091618 (M. M.), HL087123 (I. T.), the Kieckhefer Foundation, The Clayton Foundation for Medical Research, and the Leona M. and Harry B. Helmsley Charitable Trust.	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; BIRD GS, 1993, J BIOL CHEM, V268, P17917; Cruz LN, 2010, HEPATOLOGY, V52, P327, DOI 10.1002/hep.23625; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; FERRIS CD, 1991, P NATL ACAD SCI USA, V88, P2232, DOI 10.1073/pnas.88.6.2232; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Jansson D, 2008, P NATL ACAD SCI USA, V105, P10161, DOI 10.1073/pnas.0800796105; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Szado T, 2008, P NATL ACAD SCI USA, V105, P2427, DOI 10.1073/pnas.0711324105; Tovey SC, 2010, J BIOL CHEM, V285, P12979, DOI 10.1074/jbc.M109.096016; VOLPE P, 1990, AM J PHYSIOL, V258, pC1086, DOI 10.1152/ajpcell.1990.258.6.C1086; WAKELAM MJO, 1986, NATURE, V323, P68, DOI 10.1038/323068a0; Wang B, 2011, CELL, V145, P596, DOI 10.1016/j.cell.2011.04.013; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yoon YS, 2010, P NATL ACAD SCI USA, V107, P17704, DOI 10.1073/pnas.1012665107	21	134	141	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					128	U166		10.1038/nature10988	http://dx.doi.org/10.1038/nature10988			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22495310	Green Accepted			2022-12-28	WOS:000303451900048
J	Shibata, D				Shibata, Darryl			Heterogeneity and Tumor History	SCIENCE			English	Editorial Material							EVOLUTION; CANCER; GENOME; METASTASIS		Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA	University of Southern California	Shibata, D (corresponding author), Univ So Calif, Keck Sch Med, 1441 Eastlake Ave,NOR2424, Los Angeles, CA 90033 USA.	dshibata@usc.edu			NCI NIH HHS [R21 CA149990] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA149990] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; GOLDIE JH, 1979, CANCER TREAT REP, V63, P1727; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Longo DL, 2012, NEW ENGL J MED, V366, P956, DOI 10.1056/NEJMe1200656; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Siegmund KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021657; Wang TL, 2002, P NATL ACAD SCI USA, V99, P3076, DOI 10.1073/pnas.261714699; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	10	73	76	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2012	336	6079					304	305		10.1126/science.1222361	http://dx.doi.org/10.1126/science.1222361			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22517848				2022-12-28	WOS:000302995400032
J	Abbasi, R; Abdou, Y; Abu-Zayyad, T; Ackermann, M; Adams, J; Aguilar, JA; Ahlers, M; Altmann, D; Andeen, K; Auffenberg, J; Bai, X; Baker, M; Barwick, SW; Bay, R; Alba, JLB; Beattie, K; Beatty, JJ; Bechet, S; Becker, JK; Becker, KH; Bell, M; Benabderrahmane, ML; BenZvi, S; Berdermann, J; Berghaus, P; Berley, D; Bernardini, E; Bertrand, D; Besson, DZ; Bindig, D; Bissok, M; Blaufuss, E; Blumenthal, J; Boersma, DJ; Bohm, C; Bose, D; Boser, S; Botner, O; Brayeur, L; Brown, AM; Buitink, S; Caballero-Mora, KS; Carson, M; Casier, M; Chirkin, D; Christy, B; Clevermann, F; Cohen, S; Colnard, C; Cowen, DF; Silva, AHC; D'Agostino, MV; Danninger, M; Daughhetee, J; Davis, JC; DeClercq, C; Degner, T; Descamps, F; Desiati, P; de Vries-Uiterweerd, G; DeYoung, T; Diaz-Velez, JC; Dierckxsens, M; Dreyer, J; Dumm, JP; Dunkman, M; Eisch, J; Ellsworth, RW; Engdegard, O; Euler, S; Evenson, PA; Fadiran, O; Fazely, AR; Fedynitch, A; Feintzeig, J; Feusels, T; Filimonov, K; Finley, C; Fischer-Wasels, T; Flis, S; Franckowiak, A; Franke, R; Gaisser, TK; Gallagher, J; Gerhardt, L; Gladstone, L; Glusenkamp, T; Goldschmidt, A; Goodman, JA; Gora, D; Grant, D; Griesel, T; Gross, A; Grullon, S; Gurtner, M; Ha, C; Ismail, AH; Hallgren, A; Halzen, F; Han, K; Hanson, K; Heereman, D; Heinen, D; Helbing, K; Hellauer, R; Hickford, S; Hill, GC; Hoffman, KD; Hoffmann, B; Homeier, A; Hoshina, K; Huelsnitz, W; Hulss, JP; Hulth, PO; Hultqvist, K; Hussain, S; Ishihara, A; Jacobi, E; Jacobsen, J; Japaridze, S; Johansson, H; Kappes, A; Karg, T; Karle, A; Kiryluk, J; Kislat, F; Klein, SR; Kohne, JH; Kohnen, G; Kolanoski, H; Kopke, L; Kopper, S; Koskinen, DJ; Kowalski, M; Kowarik, T; Krasberg, M; Kroll, G; Kunnen, J; Kurahashi, N; Kuwabara, T; Labare, M; Laihem, K; Landsman, H; Larson, MJ; Lauer, R; Lunemann, J; Madsen, J; Marotta, A; Maruyama, R; Mase, K; Matis, HS; Meagher, K; Merck, M; Meszaros, P; Meures, T; Miarecki, S; Middell, E; Milke, N; Miller, J; Montaruli, T; Morse, R; Movit, SM; Nahnhauer, R; Nam, JW; Naumann, U; Nowicki, SC; Nygren, DR; Odrowski, S; Olivas, A; Olivo, M; O'Murchadha, A; Panknin, S; Paul, L; de los Heros, CP; Piegsa, A; Pieloth, D; Posselt, J; Price, PB; Przybylski, GT; Rawlins, K; Redl, P; Resconi, E; Rhode, W; Ribordy, M; Richman, M; Riedel, B; Rizzo, A; Rodrigues, JP; Rothmaier, F; Rott, C; Ruhe, T; Rutledge, D; Ruzybayev, B; Ryckbosch, D; Sander, HG; Santander, M; Sarkar, S; Schatto, K; Schmidt, T; Schoneberg, S; Schonwald, A; Schukraft, A; Schulte, L; Schultes, A; Schulz, O; Schunck, M; Seckel, D; Semburg, B; Seo, SH; Sestayo, Y; Seunarine, S; Silvestri, A; Smith, MWE; Spiczak, GM; Spiering, C; Stamatikos, M; Stanev, T; Stezelberger, T; Stokstad, RG; Stossl, A; Strahler, EA; Strom, R; Stuer, M; Sullivan, GW; Taavola, H; Taboada, I; Tamburro, A; Ter-Antonyan, S; Tilav, S; Toale, PA; Toscano, S; Tosi, D; van Eijndhoven, N; Van Overloop, A; van Santen, J; Vehring, M; Voge, M; Walck, C; Waldenmaier, T; Wallraff, M; Walter, M; Wasserman, R; Weaver, C; Wendt, C; Westerhoff, S; Whitehorn, N; Wiebe, K; Wiebusch, CH; Williams, DR; Wischnewski, R; Wissing, H; Wolf, M; Wood, TR; Woschnagg, K; Xu, C; Xu, DL; Xu, XW; Yanez, JP; Yodh, G; Yoshida, S; Zarzhitsky, P; Zoll, M				Abbasi, R.; Abdou, Y.; Abu-Zayyad, T.; Ackermann, M.; Adams, J.; Aguilar, J. A.; Ahlers, M.; Altmann, D.; Andeen, K.; Auffenberg, J.; Bai, X.; Baker, M.; Barwick, S. W.; Bay, R.; Alba, J. L. Bazo; Beattie, K.; Beatty, J. J.; Bechet, S.; Becker, J. K.; Becker, K. -H.; Bell, M.; Benabderrahmane, M. L.; BenZvi, S.; Berdermann, J.; Berghaus, P.; Berley, D.; Bernardini, E.; Bertrand, D.; Besson, D. Z.; Bindig, D.; Bissok, M.; Blaufuss, E.; Blumenthal, J.; Boersma, D. J.; Bohm, C.; Bose, D.; Boeser, S.; Botner, O.; Brayeur, L.; Brown, A. M.; Buitink, S.; Caballero-Mora, K. S.; Carson, M.; Casier, M.; Chirkin, D.; Christy, B.; Clevermann, F.; Cohen, S.; Colnard, C.; Cowen, D. F.; Silva, A. H. Cruz; D'Agostino, M. V.; Danninger, M.; Daughhetee, J.; Davis, J. C.; DeClercq, C.; Degner, T.; Descamps, F.; Desiati, P.; de Vries-Uiterweerd, G.; DeYoung, T.; Diaz-Velez, J. C.; Dierckxsens, M.; Dreyer, J.; Dumm, J. P.; Dunkman, M.; Eisch, J.; Ellsworth, R. W.; Engdegard, O.; Euler, S.; Evenson, P. A.; Fadiran, O.; Fazely, A. R.; Fedynitch, A.; Feintzeig, J.; Feusels, T.; Filimonov, K.; Finley, C.; Fischer-Wasels, T.; Flis, S.; Franckowiak, A.; Franke, R.; Gaisser, T. K.; Gallagher, J.; Gerhardt, L.; Gladstone, L.; Gluesenkamp, T.; Goldschmidt, A.; Goodman, J. A.; Gora, D.; Grant, D.; Griesel, T.; Gross, A.; Grullon, S.; Gurtner, M.; Ha, C.; Ismail, A. Haj; Hallgren, A.; Halzen, F.; Han, K.; Hanson, K.; Heereman, D.; Heinen, D.; Helbing, K.; Hellauer, R.; Hickford, S.; Hill, G. C.; Hoffman, K. D.; Hoffmann, B.; Homeier, A.; Hoshina, K.; Huelsnitz, W.; Huelss, J. -P.; Hulth, P. O.; Hultqvist, K.; Hussain, S.; Ishihara, A.; Jacobi, E.; Jacobsen, J.; Japaridze, S.; Johansson, H.; Kappes, A.; Karg, T.; Karle, A.; Kiryluk, J.; Kislat, F.; Klein, S. R.; Koehne, J. -H.; Kohnen, G.; Kolanoski, H.; Koepke, L.; Kopper, S.; Koskinen, D. J.; Kowalski, M.; Kowarik, T.; Krasberg, M.; Kroll, G.; Kunnen, J.; Kurahashi, N.; Kuwabara, T.; Labare, M.; Laihem, K.; Landsman, H.; Larson, M. J.; Lauer, R.; Luenemann, J.; Madsen, J.; Marotta, A.; Maruyama, R.; Mase, K.; Matis, H. S.; Meagher, K.; Merck, M.; Meszaros, P.; Meures, T.; Miarecki, S.; Middell, E.; Milke, N.; Miller, J.; Montaruli, T.; Morse, R.; Movit, S. M.; Nahnhauer, R.; Nam, J. W.; Naumann, U.; Nowicki, S. C.; Nygren, D. R.; Odrowski, S.; Olivas, A.; Olivo, M.; O'Murchadha, A.; Panknin, S.; Paul, L.; Perez de los Heros, C.; Piegsa, A.; Pieloth, D.; Posselt, J.; Price, P. B.; Przybylski, G. T.; Rawlins, K.; Redl, P.; Resconi, E.; Rhode, W.; Ribordy, M.; Richman, M.; Riedel, B.; Rizzo, A.; Rodrigues, J. P.; Rothmaier, F.; Rott, C.; Ruhe, T.; Rutledge, D.; Ruzybayev, B.; Ryckbosch, D.; Sander, H. -G.; Santander, M.; Sarkar, S.; Schatto, K.; Schmidt, T.; Schoeneberg, S.; Schoenwald, A.; Schukraft, A.; Schulte, L.; Schultes, A.; Schulz, O.; Schunck, M.; Seckel, D.; Semburg, B.; Seo, S. H.; Sestayo, Y.; Seunarine, S.; Silvestri, A.; Smith, M. W. E.; Spiczak, G. M.; Spiering, C.; Stamatikos, M.; Stanev, T.; Stezelberger, T.; Stokstad, R. G.; Stoessl, A.; Strahler, E. A.; Stroem, R.; Stueer, M.; Sullivan, G. W.; Taavola, H.; Taboada, I.; Tamburro, A.; Ter-Antonyan, S.; Tilav, S.; Toale, P. A.; Toscano, S.; Tosi, D.; van Eijndhoven, N.; Van Overloop, A.; van Santen, J.; Vehring, M.; Voge, M.; Walck, C.; Waldenmaier, T.; Wallraff, M.; Walter, M.; Wasserman, R.; Weaver, Ch.; Wendt, C.; Westerhoff, S.; Whitehorn, N.; Wiebe, K.; Wiebusch, C. H.; Williams, D. R.; Wischnewski, R.; Wissing, H.; Wolf, M.; Wood, T. R.; Woschnagg, K.; Xu, C.; Xu, D. L.; Xu, X. W.; Yanez, J. P.; Yodh, G.; Yoshida, S.; Zarzhitsky, P.; Zoll, M.		IceCube Collaboration	An absence of neutrinos associated with cosmic-ray acceleration in gamma-ray bursts	NATURE			English	Article							HIGH-ENERGY NEUTRINOS; ICECUBE; FLUX; TELESCOPE; SEARCH	Very energetic astrophysical events are required to accelerate cosmic rays to above 10(18) electronvolts. GRBs (c-ray bursts) have been proposed as possible candidate sources(1-3). In the GRB 'fireball' model, cosmic-ray acceleration should be accompanied by neutrinos produced in the decay of charged pions created in interactions between the high-energy cosmic-ray protons and gamma-rays(4). Previous searches for such neutrinos found none, but the constraints were weak because the sensitivity was at best approximately equal to the predicted flux(5-7). Here we report an upper limit on the flux of energetic neutrinos associated with GRBs that is at least a factor of 3.7 below the predictions(4,8-10). This implies either that GRBs are not the only sources of cosmic rays with energies exceeding 10(18) electronvolts or that the efficiency of neutrino production is much lower than has been predicted.	[Abbasi, R.; Ahlers, M.; Andeen, K.; Auffenberg, J.; Baker, M.; BenZvi, S.; Brown, A. M.; Chirkin, D.; Desiati, P.; Diaz-Velez, J. C.; Dumm, J. P.; Eisch, J.; Fadiran, O.; Feintzeig, J.; Gladstone, L.; Grullon, S.; Halzen, F.; Hoshina, K.; Jacobsen, J.; Karle, A.; Krasberg, M.; Kurahashi, N.; Landsman, H.; Maruyama, R.; Merck, M.; Morse, R.; O'Murchadha, A.; Riedel, B.; Rodrigues, J. P.; Santander, M.; Toscano, S.; van Santen, J.; Weaver, Ch.; Wendt, C.; Westerhoff, S.; Whitehorn, N.] Univ Wisconsin, Dept Phys, 1150 Univ Ave, Madison, WI 53706 USA; [Abdou, Y.; Carson, M.; Descamps, F.; de Vries-Uiterweerd, G.; Feusels, T.; Ismail, A. Haj; Ryckbosch, D.; Van Overloop, A.] Univ Ghent, Dept Phys & Astron, B-9000 Ghent, Belgium; [Abu-Zayyad, T.; Madsen, J.; Spiczak, G. M.] Univ Wisconsin, Dept Phys, River Falls, WI 54022 USA; [Ackermann, M.; Alba, J. L. Bazo; Benabderrahmane, M. L.; Berdermann, J.; Bernardini, E.; Silva, A. H. Cruz; Franke, R.; Gluesenkamp, T.; Gora, D.; Han, K.; Jacobi, E.; Kislat, F.; Lauer, R.; Middell, E.; Nahnhauer, R.; Schoenwald, A.; Spiering, C.; Stoessl, A.; Tosi, D.; Walter, M.; Wischnewski, R.; Yanez, J. P.] DESY, D-15735 Zeuthen, Germany; [Adams, J.; Hickford, S.] Univ Canterbury, Dept Phys & Astron, Christchurch 1, New Zealand; [Aguilar, J. A.; Montaruli, T.] Univ Geneva, Dept Phys Nucl & Corpusculaire, CH-1211 Geneva, Switzerland; [Altmann, D.; Bissok, M.; Blumenthal, J.; Boersma, D. J.; Euler, S.; Heinen, D.; Hoffmann, B.; Huelss, J. -P.; Laihem, K.; Paul, L.; Schukraft, A.; Schunck, M.; Vehring, M.; Wallraff, M.; Wiebusch, C. H.] Rhein Westfal TH Aachen, Phys Inst 3, D-52056 Aachen, Germany; [Bai, X.; Berghaus, P.; Evenson, P. A.; Gaisser, T. K.; Hussain, S.; Kuwabara, T.; Ruzybayev, B.; Seckel, D.; Stanev, T.; Tamburro, A.; Tilav, S.; Xu, C.] Univ Delaware, Bartol Res Inst, Newark, DE 19716 USA; [Bai, X.; Berghaus, P.; Evenson, P. A.; Gaisser, T. K.; Hussain, S.; Kuwabara, T.; Ruzybayev, B.; Seckel, D.; Stanev, T.; Tamburro, A.; Tilav, S.; Xu, C.] Univ Delaware, Dept Phys & Astron, Newark, DE 19716 USA; [Bai, X.] S Dakota Sch Mines & Technol, Dept Phys, Rapid City, SD 57701 USA; [Barwick, S. W.; Nam, J. W.; Silvestri, A.; Yodh, G.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; [Bay, R.; D'Agostino, M. V.; Filimonov, K.; Gerhardt, L.; Ha, C.; Klein, S. R.; Miarecki, S.; Price, P. B.; Woschnagg, K.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Beattie, K.; Gerhardt, L.; Goldschmidt, A.; Matis, H. S.; Nygren, D. R.; Przybylski, G. T.; Stezelberger, T.; Stokstad, R. G.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Beatty, J. J.; Davis, J. C.; Rott, C.; Stamatikos, M.] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Beatty, J. J.; Davis, J. C.; Rott, C.; Stamatikos, M.] Ohio State Univ, Ctr Cosmol & Astroparticle Phys, Columbus, OH 43210 USA; [Beatty, J. J.] Ohio State Univ, Dept Astron, Columbus, OH 43210 USA; [Bechet, S.; Bertrand, D.; Dierckxsens, M.; Hanson, K.; Heereman, D.; Marotta, A.; Meures, T.] Univ Libre Bruxelles, B-1050 Brussels, Belgium; [Becker, J. K.; DeYoung, T.; Dreyer, J.; Fedynitch, A.; Olivo, M.; Schoeneberg, S.] Ruhr Univ Bochum, Fak Phys & Astron, D-44780 Bochum, Germany; [Becker, K. -H.; Bindig, D.; Fischer-Wasels, T.; Gurtner, M.; Helbing, K.; Karg, T.; Kopper, S.; Naumann, U.; Posselt, J.; Schultes, A.; Semburg, B.] Univ Wuppertal, Dept Phys, D-42119 Wuppertal, Germany; [Bell, M.; Caballero-Mora, K. S.; Cowen, D. F.; Dunkman, M.; Koskinen, D. J.; Larson, M. J.; Meszaros, P.; Rutledge, D.; Smith, M. W. E.; Wasserman, R.] Penn State Univ, Dept Phys, University Pk, PA 16802 USA; [Berley, D.; Blaufuss, E.; Buitink, S.; Christy, B.; Ellsworth, R. W.; Goodman, J. A.; Hellauer, R.; Hoffman, K. D.; Huelsnitz, W.; Meagher, K.; Olivas, A.; Redl, P.; Richman, M.; Schmidt, T.; Sullivan, G. W.; Wissing, H.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Besson, D. Z.] Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA; [Bohm, C.; Danninger, M.; Finley, C.; Flis, S.; Hulth, P. O.; Hultqvist, K.; Johansson, H.; Seo, S. H.; Walck, C.; Wolf, M.; Zoll, M.] Stockholm Univ, Oskar Klein Ctr, SE-10691 Stockholm, Sweden; [Bohm, C.; Danninger, M.; Finley, C.; Flis, S.; Hulth, P. O.; Hultqvist, K.; Johansson, H.; Walck, C.; Wolf, M.; Zoll, M.] Stockholm Univ, Dept Phys, SE-10691 Stockholm, Sweden; [Bose, D.; Brayeur, L.; Casier, M.; DeClercq, C.; Kunnen, J.; Labare, M.; Rizzo, A.; Strahler, E. A.; van Eijndhoven, N.] Vrije Univ Brussel, Dienst ELEM, B-1050 Brussels, Belgium; [Boeser, S.; Degner, T.; Franckowiak, A.; Homeier, A.; Kowalski, M.; Panknin, S.; Schulte, L.; Stueer, M.; Voge, M.] Univ Bonn, Inst Phys, D-53115 Bonn, Germany; [Botner, O.; Engdegard, O.; Hallgren, A.; Miller, J.; Perez de los Heros, C.; Stroem, R.; Taavola, H.] Uppsala Univ, Dept Phys & Astron, S-75120 Uppsala, Sweden; [Clevermann, F.; Koehne, J. -H.; Milke, N.; Pieloth, D.; Rhode, W.; Ruhe, T.] TU Dortmund Univ, Dept Phys, D-44221 Dortmund, Germany; [Cohen, S.; Ribordy, M.] Ecole Polytech Fed Lausanne, Lab High Energy Phys, CH-1015 Lausanne, Switzerland; [Colnard, C.; Gross, A.; Odrowski, S.; Resconi, E.; Schulz, O.; Sestayo, Y.] Max Planck Inst Kernphys, D-69177 Heidelberg, Germany; [Meszaros, P.; Movit, S. M.] Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; [Daughhetee, J.; Taboada, I.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Daughhetee, J.; Taboada, I.] Georgia Inst Technol, Ctr Relativist Astrophys, Atlanta, GA 30332 USA; [Fazely, A. R.; Ter-Antonyan, S.; Xu, X. W.] So Univ, Dept Phys, Baton Rouge, LA 70813 USA; [Gallagher, J.] Univ Wisconsin, Dept Astron, Madison, WI 53706 USA; [Grant, D.; Nowicki, S. C.; Wood, T. R.] Univ Alberta, Dept Phys, Edmonton, AB T6G 2G7, Canada; [Griesel, T.; Koepke, L.; Kowarik, T.; Kroll, G.; Luenemann, J.; Piegsa, A.; Rothmaier, F.; Sander, H. -G.; Schatto, K.; Wiebe, K.] Johannes Gutenberg Univ Mainz, Inst Phys, D-55099 Mainz, Germany; [Hill, G. C.] Univ Adelaide, Sch Chem & Phys, Adelaide, SA 5005, Australia; [Hill, G. C.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Ishihara, A.; Kolanoski, H.; Mase, K.; Yoshida, S.] Chiba Univ, Dept Phys, Chiba 2638522, Japan; [Japaridze, S.] Clark Atlanta Univ, CTSPS, Atlanta, GA 30314 USA; [Kappes, A.; Waldenmaier, T.] Humboldt Univ, Inst Phys, D-12489 Berlin, Germany; [Kiryluk, J.] SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA; [Montaruli, T.] Sezione Ist Nazl Fis Nucl, Dipartimento Fis, I-70126 Bari, Italy; [Kohnen, G.] Univ Mons, B-7000 Mons, Belgium; [Rawlins, K.] Univ Alaska Anchorage, Dept Phys & Astron, Anchorage, AK 99508 USA; [Resconi, E.; Schulz, O.] Tech Univ Munich, D-85748 Garching, Germany; [Sarkar, S.] Univ Oxford, Dept Phys, Oxford OX1 3NP, England; [Seunarine, S.] Univ W Indies, Dept Phys, BB-11000 Bridgetown, Barbados; [Stamatikos, M.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Toale, P. A.; Williams, D. R.; Xu, D. L.; Zarzhitsky, P.] Univ Alabama, Dept Phys & Astron, Tuscaloosa, AL 35487 USA	University of Wisconsin System; University of Wisconsin Madison; Ghent University; University of Wisconsin System; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Canterbury; University of Geneva; RWTH Aachen University; University of Delaware; University of Delaware; South Dakota School Mines & Technology; University of California System; University of California Irvine; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Universite Libre de Bruxelles; Ruhr University Bochum; University of Wurzburg; University of Wuppertal; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Maryland; University of Maryland College Park; University of Kansas; Oskar Klein Centre; Stockholm University; Stockholm University; Vrije Universiteit Brussel; University of Bonn; Uppsala University; Dortmund University of Technology; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Max Planck Society; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Southern University System; Southern University & A&M College; University of Wisconsin System; University of Wisconsin Madison; University of Alberta; Johannes Gutenberg University of Mainz; University of Adelaide; United States Department of Energy (DOE); Los Alamos National Laboratory; Chiba University; Clark Atlanta University; Humboldt University of Berlin; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Istituto Nazionale di Fisica Nucleare (INFN); University of Mons; University of Alaska System; University of Alaska Anchorage; Technical University of Munich; University of Oxford; University West Indies Mona Jamaica; University of the West Indies Open Campus; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Alabama System; University of Alabama Tuscaloosa	Whitehorn, N (corresponding author), Univ Wisconsin, Dept Phys, 1150 Univ Ave, Madison, WI 53706 USA.	nwhitehorn@icecube.wisc.edu	Hallgren, Allan/A-8963-2013; Ismail, Abd Al Karim Haj/AAD-9991-2019; Kowalski, Marek/G-5546-2012; Rott, Carsten/ABB-1304-2021; Goodman, Jordan A/J-4188-2018; Ha, Chang Hyon/AAR-8120-2021; Koskinen, David J/G-3236-2014; Matis, Howard/AAO-2082-2021; Fedynitch, Anatoli/AAQ-9927-2021; Beatty, James/D-9310-2011; Tamburro, Alessio/A-5703-2013; Wiebusch, Christopher H.V./G-6490-2012; Ha, C/GZL-9046-2022; Whitehorn, Nathan/HDM-8864-2022; Auffenberg, Jan/D-3954-2014; Taavola, Henric/B-4497-2011; Seo, Seon Hee/K-9250-2014; Buitink, Stijn/F-2113-2016; Tjus, Julia/G-8145-2012; Sarkar, Subir/G-5978-2011; Heinen, Dirk/ABF-7280-2020; Seo, Seon-Hee/M-1189-2019; Resconi, Elisa/I-3874-2016; Ahlers, Markus/V-8757-2017; Gora, Dariusz/M-8695-2018; Botner, Olga/A-9110-2013; Venkateswararao, Gollakaram/B-5490-2015; Basu, Sumit/ABG-4301-2021; Przybylski, Grzegorz/F-7474-2015; Naidu, Rajagopal/K-3038-2016; Maruyama, Reina/A-1064-2013; sanchez, juan/GSD-8167-2022; Sánchez, Juan Antonio Aguilar/H-4467-2015; Sarkar, Subir/GPT-4902-2022; DeYoung, Tyce/O-6895-2019; Bernardini, Elisa/AAA-4810-2020; Diaz Velez, Juan Carlos/T-2788-2018; Miller, Jonathan/R-8518-2017	Ismail, Abd Al Karim Haj/0000-0003-4941-5154; Kowalski, Marek/0000-0001-8594-8666; Rott, Carsten/0000-0002-6958-6033; Goodman, Jordan A/0000-0002-9790-1299; Koskinen, David J/0000-0002-0514-5917; Fedynitch, Anatoli/0000-0003-2837-3477; Beatty, James/0000-0003-0481-4952; Wiebusch, Christopher H.V./0000-0002-6418-3008; Whitehorn, Nathan/0000-0002-3157-0407; Auffenberg, Jan/0000-0002-1185-9094; Taavola, Henric/0000-0002-2604-2810; Seo, Seon Hee/0000-0002-1496-624X; Buitink, Stijn/0000-0002-6177-497X; Tjus, Julia/0000-0002-1748-7367; Sarkar, Subir/0000-0002-3542-858X; Seo, Seon-Hee/0000-0002-1496-624X; Resconi, Elisa/0000-0003-0705-2770; Ahlers, Markus/0000-0003-0709-5631; Gora, Dariusz/0000-0002-4853-5974; Venkateswararao, Gollakaram/0000-0002-0327-7764; Basu, Sumit/0000-0003-0687-8124; Maruyama, Reina/0000-0003-2794-512X; Sánchez, Juan Antonio Aguilar/0000-0003-2252-9514; DeYoung, Tyce/0000-0003-4873-3783; Bernardini, Elisa/0000-0003-3108-1141; Heinen, Dirk/0000-0002-4502-7288; Santander, Juan Marcos/0000-0001-7297-8217; Carson, Michael/0000-0003-0400-7819; Yoshida, Shigeru/0000-0003-2480-5105; van Eijndhoven, Nick/0000-0001-5558-3328; De Clercq, Catherine/0000-0001-5266-7059; Helbing, Klaus/0000-0003-2072-4172; Ackermann, Markus/0000-0001-8952-588X; Schukraft, Anne/0000-0002-9112-5479; Montaruli, Teresa/0000-0001-5014-2152; Ha, Chang Hyon/0000-0002-9598-8589; Ter-Antonyan, Samvel/0000-0002-5788-1369; Diaz Velez, Juan Carlos/0000-0002-0087-0693; Desiati, Paolo/0000-0001-9768-1858; Karg, Timo/0000-0003-3251-2126; Strom, Rickard/0000-0002-4496-1626; Beattie, Keith/0000-0001-5026-2023; Caballero Mora, Karen Salome/0000-0002-4042-3855; Toscano, Simona/0000-0002-1860-2240; Danninger, Matthias/0000-0002-7807-7484; BenZvi, Segev/0000-0001-5537-4710; Klein, Spencer/0000-0003-2841-6553; Taboada, Ignacio/0000-0003-3509-3457; Bose, Debanjan/0000-0003-1071-5854; Benabderrahmane, Mohamed Lotfi/0000-0003-4410-5886; Perez de los Heros, Carlos/0000-0002-2084-5866; Kappes, Alexander/0000-0003-1315-3711; Spiczak, Glenn/0000-0002-0030-0519; Bazo Alba, Jose Luis/0000-0001-9148-9101; Daughhetee, Jacob/0000-0001-5220-7159; Meagher, Kevin/0000-0003-3967-1533; Miller, Jonathan/0000-0002-7992-8033; Lauer, Robert/0000-0003-1933-7861; Hill, Gary/0000-0001-8881-6802; Kolanoski, Hermann/0000-0003-0435-2524	US NSF; Office of Polar Programs; US NSF, Physics Division; University of Wisconsin Alumni Research Foundation; GLOW; OSG grids; US DOE, NERSCC; LONI grid; NSERC, Canada; Swedish Research Council; Swedish Polar Research Secretariat; SNIC; K. and A. Wallenberg Foundation, Sweden; German Ministry for Education and Research, Deutsche Forschungsgemeinschaft; Research Department of Plasmas; Complex Interactions (Bochum), Germany; FSR; FWO Odysseus; IWT; BELSPO, Belgium; University of Oxford, UK; Marsden Fund, New Zealand; Australian Research Council; JSPS, Japan; SNSF, Switzerland; Capes Foundation, Brazil; NSF GRFP; STFC [ST/J000507/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/J000507/1] Funding Source: researchfish	US NSF(National Science Foundation (NSF)); Office of Polar Programs(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); US NSF, Physics Division; University of Wisconsin Alumni Research Foundation; GLOW; OSG grids; US DOE, NERSCC(United States Department of Energy (DOE)); LONI grid; NSERC, Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Polar Research Secretariat; SNIC; K. and A. Wallenberg Foundation, Sweden(Knut & Alice Wallenberg Foundation); German Ministry for Education and Research, Deutsche Forschungsgemeinschaft; Research Department of Plasmas; Complex Interactions (Bochum), Germany; FSR; FWO Odysseus; IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); BELSPO, Belgium(Belgian Federal Science Policy Office); University of Oxford, UK; Marsden Fund, New Zealand(Royal Society of New ZealandMarsden Fund (NZ)); Australian Research Council(Australian Research Council); JSPS, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); SNSF, Switzerland(Swiss National Science Foundation (SNSF)); Capes Foundation, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We acknowledge support from the following agencies: US NSF, Office of Polar Programs, and US NSF, Physics Division; University of Wisconsin Alumni Research Foundation; the GLOW and OSG grids; US DOE, NERSCC; the LONI grid; NSERC, Canada; Swedish Research Council, Swedish Polar Research Secretariat, SNIC, K. and A. Wallenberg Foundation, Sweden; German Ministry for Education and Research, Deutsche Forschungsgemeinschaft; Research Department of Plasmas with Complex Interactions (Bochum), Germany; FSR, FWO Odysseus, IWT, BELSPO, Belgium; University of Oxford, UK; Marsden Fund, New Zealand; Australian Research Council; JSPS, Japan; SNSF, Switzerland. J.P.R was supported by the Capes Foundation, Brazil; N.W. by the NSF GRFP. We thank S. Hummer, E. Waxman and W. Winter for discussions.	Abbasi R, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.141101; Abbasi R, 2010, ASTROPHYS J, V710, P346, DOI 10.1088/0004-637X/710/1/346; Abbasi R, 2009, NUCL INSTRUM METH A, V601, P294, DOI 10.1016/j.nima.2009.01.001; Ahlers M, 2011, ASTROPART PHYS, V35, P87, DOI 10.1016/j.astropartphys.2011.05.008; Ahrens J, 2004, NUCL INSTRUM METH A, V524, P169, DOI 10.1016/j.nima.2004.01.065; Avrorin AV, 2011, ASTRON LETT+, V37, P692, DOI 10.1134/S106377371110001X; Baerwald P, 2012, ASTROPART PHYS, V35, P508, DOI 10.1016/j.astropartphys.2011.11.005; Becker JK, 2006, ASTROPART PHYS, V25, P118, DOI 10.1016/j.astropartphys.2005.12.006; Becker JK, 2008, PHYS REP, V458, P173, DOI 10.1016/j.physrep.2007.10.006; Feldman GJ, 1998, PHYS REV D, V57, P3873, DOI 10.1103/PhysRevD.57.3873; Guetta D, 2004, ASTROPART PHYS, V20, P429, DOI 10.1016/S0927-6505(03)00211-1; Guetta D, 2001, ASTROPHYS J, V559, P101, DOI 10.1086/322481; Hummer S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.231101; Meszaros P, 2006, REP PROG PHYS, V69, P2259, DOI 10.1088/0034-4885/69/8/R01; MILGROM M, 1995, ASTROPHYS J, V449, pL37, DOI 10.1086/309633; Rachen JP, 1998, AIP CONF PROC, P776; VIETRI M, 1995, ASTROPHYS J, V453, P883, DOI 10.1086/176448; Waxman E, 1997, PHYS REV LETT, V78, P2292, DOI 10.1103/PhysRevLett.78.2292; Waxman E, 2003, NUCL PHYS B-PROC SUP, V118, P353, DOI 10.1016/S0920-5632(03)01333-1; WAXMAN E, 1995, PHYS REV LETT, V75, P386, DOI 10.1103/PhysRevLett.75.386	20	229	233	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2012	484	7394					351	354		10.1038/nature11068	http://dx.doi.org/10.1038/nature11068			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927YM	22517161	Green Submitted, Green Published			2022-12-28	WOS:000302946500027
J	Hajdarbegovic, E; Balak, D				Hajdarbegovic, Enes; Balak, Deepak			Metastatic Inguinal Lymphadenopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hajdarbegovic, Enes; Balak, Deepak] Erasmus MC, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Hajdarbegovic, E (corresponding author), Erasmus MC, Rotterdam, Netherlands.			Balak, Deepak/0000-0002-0755-3770					0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 19	2012	366	16					1526	1526		10.1056/NEJMicm1111763	http://dx.doi.org/10.1056/NEJMicm1111763			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	927UE	22512485				2022-12-28	WOS:000302934800010
J	Feinbloom, D; Bauer, KA				Feinbloom, David; Bauer, Kenneth A.			Enoxaparin thrombophylaxis did not reduce mortality in acutely ill medical patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Feinbloom, David; Bauer, Kenneth A.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Feinbloom, D (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.							Lederle FA, 2011, ANN INTERN MED, V155, P602, DOI 10.7326/0003-4819-155-9-201111010-00008; Maynard G, 2008, AHRQ PUBLICATION	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2012	156	8							JC4-6	10.7326/0003-4819-156-8-201204170-02006	http://dx.doi.org/10.7326/0003-4819-156-8-201204170-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930PO	22508746				2022-12-28	WOS:000303151800005
J	Davies, J				Davies, Justine			Profile Stefan Willich: conductor and cardiologist	LANCET			English	Biographical-Item														Davies, Justine/0000-0001-6834-1838					0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 14	2012	379	9824					1383	1383		10.1016/S0140-6736(12)60585-6	http://dx.doi.org/10.1016/S0140-6736(12)60585-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	926BR	22500867				2022-12-28	WOS:000302806800014
J	Manaseki-Holland, S; Maroof, Z; Bruce, J; Mughal, MZ; Masher, MI; Bhutta, ZA; Walraven, G; Chandramohan, D				Manaseki-Holland, Semira; Maroof, Zabihullah; Bruce, Jane; Mughal, M. Zulf; Masher, Mohammad Isaq; Bhutta, Zulfiqar A.; Walraven, Gijs; Chandramohan, Daniel			Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: a randomised controlled superiority trial	LANCET			English	Article							D-DEFICIENCY; NUTRITIONAL RICKETS; DOUBLE-BLIND; CHILDREN; CALCIUM; PREVENTION; FRACTURES; RISK	Background Vitamin D has a role in regulating immune function, and its deficiency is a suggested risk factor for childhood pneumonia. Our aim was to assess whether oral supplementation of vitamin D-3 (cholecalciferol) will reduce the incidence and severity of pneumonia in a high-risk infant population. Methods We did a randomised placebo-controlled trial to compare oral 100 000 IU (2.5 mg) vitamin D-3 with placebo given to children aged 1-11 months in Kabul, Afghanistan. Randomisation was by use of a computer-generated list. Vitamin D or placebo was given by fieldworkers once every 3 months for 18 months. Children presenting at the study hospital with signs of pneumonia had their diagnosis confirmed radiographically. Our primary outcome was the first or only episode of radiologically confirmed pneumonia. Our analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00548379. Findings 1524 children were assigned to receive vitamin D-3 and 1522 placebo. There was no significant difference between the incidence of first or only pneumonia between the vitamin D (0.145 per child per year, 95% CI 0.129-0.164) and the placebo group (0.137, 0.121-0.155); the incidence rate ratio was 1.06 (95% CI 0.89-1.27). From 652 children during five separate periods of testing serum calcifediol, only one child in each of two testing periods had results greater than 375 nmol/L in the intervention group-a toxic level. Interpretations Quarterly bolus doses of oral vitamin D-3 supplementation to infants are not an effective intervention to reduce the incidence of pneumonia in infants in this setting.	[Manaseki-Holland, Semira] Univ Birmingham, Sch Hlth & Populat Sci, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Maroof, Zabihullah; Bruce, Jane; Chandramohan, Daniel] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [Mughal, M. Zulf] Royal Manchester Childrens Hosp, Dept Paediat Endocrinol, Manchester M27 1HA, Lancs, England; [Masher, Mohammad Isaq] Kabul Med Univ, Dept Paediat, Kabul, Afghanistan; [Bhutta, Zulfiqar A.] Aga Khan Univ, Div Women & Child Hlth, Karachi, Pakistan; [Walraven, Gijs] Delegat Aga Khan Dev Network Fdn, Gouvieux, France	University of Birmingham; University of London; London School of Hygiene & Tropical Medicine; Royal Manchester Children's Hospital; Aga Khan University	Manaseki-Holland, S (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Coll Med & Dent Sci, 90 Vincent Dr, Birmingham B15 2TT, W Midlands, England.	s.manasekiholland@bham.ac.uk	MUGHAL, Zulf/AAA-1230-2021; Manaseki-Holland, Semira/AFX-1728-2022; Manaseki-Holland, Semira/I-7303-2017	Manaseki-Holland, Semira/0000-0001-5827-8855; Manaseki-Holland, Semira/0000-0001-5827-8855	Wellcome Trust; British Council Delphi; USAID Afghanistan; Washington States University (WSU); British Council	Wellcome Trust(Wellcome TrustEuropean Commission); British Council Delphi; USAID Afghanistan(United States Agency for International Development (USAID)); Washington States University (WSU); British Council(The British Council in India)	Wellcome Trust and British Council.; We thank all the participating families in this study, the project field staff, especially the female Afghan fieldworkers (particularly supervisors Drs Ayob, Adel, and Khalid), the paediatricians (Drs Khesraw, Wali, Rashid, Mojahid, and Sadeq Faqiree), Mr Msjedi, and the radiology and outpatient departments. We thank Aga Khan Health Services Afghanistan staff, Dr Alawi and Dr Shams from the Ministry of Public Health, the Dean of the Medical School of Kabul, and Dr Kohdamani, the Director of the Maiwand Hospital. We acknowledge Latif Sheikh and Shamim Reza from the Pharmacy Department of the Aga Khan University Hospital, Karachi for providing the vitamin D and placebo, Arnold Rillera for training the radiographers and advising on radiographic techniques, Tabish Hazir and the ARC team at the Pakistan Institute of Medical Sciences, Islamabad, for reading the radiographs, Christian Diering from the German Medical Diagnostic Centre Ltd for processing and storing the blood samples, and J Jacqueline Berry from the Manchester Royal Infirmary for analysing the blood samples. We thank the Wellcome Trust and British Council Delphi programme for funding the study and USAID Afghanistan, and Washington States University (WSU) for providing a scholarship to ZM for the completion of his PhD based on this study.	Aloia JF, 2005, ARCH INTERN MED, V165, P1618, DOI 10.1001/archinte.165.14.1618; Avenell A, 2007, AGE AGEING, V36, P574, DOI 10.1093/ageing/afm091; Bischoff-Ferrari HA, 2009, ARCH INTERN MED, V169, P551, DOI 10.1001/archinternmed.2008.600; Enwere G, 2007, TROP MED INT HEALTH, V12, P1377, DOI 10.1111/j.1365-3156.2007.01922.x; Fraser DR, 2004, J STEROID BIOCHEM, V89-90, P491, DOI 10.1016/j.jsbmb.2004.03.057; Gallo S, 2010, APPL PHYSIOL NUTR ME, V35, P303, DOI 10.1139/H10-021; Kutluk G, 2002, J TROP PEDIATRICS, V48, P351, DOI 10.1093/tropej/48.6.351; Li-Ng M, 2009, EPIDEMIOL INFECT, V137, P1396, DOI 10.1017/S0950268809002404; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Manaseki-Holland S, 2008, INT J VITAM NUTR RES, V78, P16, DOI 10.1024/0300-9831.78.1.16; Manaseki-Holland S, 2010, TROP MED INT HEALTH, V15, P1148, DOI 10.1111/j.1365-3156.2010.02578.x; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Misra M, 2008, PEDIATRICS, V122, P398, DOI 10.1542/peds.2007-1894; Morcos M M, 1998, Boll Chim Farm, V137, P157; Muhe L, 1997, LANCET, V349, P1801, DOI 10.1016/S0140-6736(96)12098-5; Nursyam Elly Wijaya, 2006, Acta Med Indones, V38, P3; Pettifor JM, 2008, INDIAN J MED RES, V127, P245; REHMAN PKM, 1994, J TROP PEDIATRICS, V40, P58, DOI 10.1093/tropej/40.1.58; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Smith H, 2007, RHEUMATOLOGY, V46, P1852, DOI 10.1093/rheumatology/kem240; Tchibindat F, 2003, CARE PRACTICES FORMA; UNICEF, 2004, MULT IND CLUST SURV; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094; Vervel C, 1997, ARCH PEDIATRIE, V4, P126, DOI 10.1016/S0929-693X(97)86154-4; Vieth R, 2009, ANTICANCER RES, V29, P3675; Ward LM, 2007, CAN MED ASSOC J, V177, P161, DOI 10.1503/cmaj.061377; Wayse V, 2004, EUR J CLIN NUTR, V58, P563, DOI 10.1038/sj.ejcn.1601845; Wejse C, 2009, AM J RESP CRIT CARE, V179, P843, DOI 10.1164/rccm.200804-567OC; White JH, 2008, INFECT IMMUN, V76, P3837, DOI 10.1128/IAI.00353-08; WHO Pneumonia Vaccine Trial Investigators' Group, 2001, WHOVB0135 DEP VACC B; Yamshchikov AV, 2009, ENDOCR PRACT, V15, P438, DOI 10.4158/EP09101.ORR; ZEGHOUD F, 1994, AM J CLIN NUTR, V60, P393, DOI 10.1093/ajcn/60.3.393; Zeghoud F, 1997, AM J CLIN NUTR, V65, P771, DOI 10.1093/ajcn/65.3.771	36	146	153	0	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2012	379	9824					1419	1427		10.1016/S0140-6736(11)61650-4	http://dx.doi.org/10.1016/S0140-6736(11)61650-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	926BR	22494826	Green Accepted, Green Published			2022-12-28	WOS:000302806800030
J	Arie, S				Arie, Sophie			BMJ GROUP IMPROVING HEALTH AWARDS Clinical commissioning teams: pathfinders in shaping local health services	BRITISH MEDICAL JOURNAL			English	Editorial Material												mail@sophiearie.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 13	2012	344								e2678	10.1136/bmj.e2678	http://dx.doi.org/10.1136/bmj.e2678			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	927UL	22505036				2022-12-28	WOS:000302935600002
J	Kobayashi, Y; Kumakura, K; Akasaka, T; Makimoto, T				Kobayashi, Yasuyuki; Kumakura, Kazuhide; Akasaka, Tetsuya; Makimoto, Toshiki			Layered boron nitride as a release layer for mechanical transfer of GaN-based devices	NATURE			English	Article							LASER LIFT-OFF; BUFFER LAYER; THIN-FILMS; SAPPHIRE SUBSTRATE; EPITAXIAL-GROWTH; DIODES; BN	Nitride semiconductors are the materials of choice for a variety of device applications, notably optoelectronics(1,2) and high-frequency/high-power electronics(3). One important practical goal is to realize such devices on large, flexible and affordable substrates, on which direct growth of nitride semiconductors of sufficient quality is problematic. Several techniques-such as laser lift-off(4,5)-have been investigated to enable the transfer of nitride devices from one substrate to another, but existing methods still have some important disadvantages. Here we demonstrate that hexagonal boron nitride (h-BN) can form a release layer that enables the mechanical transfer of gallium nitride (GaN)-based device structures onto foreign substrates. The h-BN layer serves two purposes: it acts as a buffer layer for the growth of high-quality GaN-based semiconductors, and provides a shear plane that makes it straightforward to release the resulting devices. We illustrate the potential versatility of this approach by using h-BN-buffered sapphire substrates to grow an AlGaN/GaN heterostructure with electron mobility of 1,100 cm(2) V-1 s(-1), an InGaN/GaN multiple-quantum-well structure, and a multiple-quantum-well light-emitting diode. These device structures, ranging in area from five millimetres square to two centimetres square, are then mechanically released from the sapphire substrates and successfully transferred onto other substrates.	[Kobayashi, Yasuyuki; Kumakura, Kazuhide; Akasaka, Tetsuya; Makimoto, Toshiki] Nippon Telegraph & Tel Corp 3 1, NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan	Nippon Telegraph & Telephone Corporation	Kobayashi, Y (corresponding author), Nippon Telegraph & Tel Corp 3 1, NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan.	kobayashi.yasuyuki@lab.ntt.co.jp	Kumakura, Kazuhide/C-2432-2011; Kobayashi, Yasuyuki/G-4750-2014; Akasaka, Tetsuya/N-5822-2015	Kumakura, Kazuhide/0000-0002-3606-0596; 				Ahn JH, 2006, SCIENCE, V314, P1754, DOI 10.1126/science.1132394; AMANO H, 1989, JPN J APPL PHYS 2, V28, pL2112, DOI 10.1143/JJAP.28.L2112; AMANO H, 1986, APPL PHYS LETT, V48, P353, DOI 10.1063/1.96549; Boo JH, 1998, J CRYST GROWTH, V189, P439, DOI 10.1016/S0022-0248(98)00323-6; Bour DP, 2000, APPL PHYS LETT, V76, P2182, DOI 10.1063/1.126291; Cho CY, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.012104; Chu CF, 2004, J APPL PHYS, V95, P3916, DOI 10.1063/1.1651338; Chung K, 2010, SCIENCE, V330, P655, DOI 10.1126/science.1195403; Davydov VY, 1998, PHYS REV B, V58, P12899, DOI 10.1103/PhysRevB.58.12899; Kelly MK, 1999, JPN J APPL PHYS 2, V38, pL217, DOI 10.1143/JJAP.38.L217; KHAN MA, 1993, APPL PHYS LETT, V63, P1214, DOI 10.1063/1.109775; Kisielowski C, 1996, PHYS REV B, V54, P17745, DOI 10.1103/PhysRevB.54.17745; Kobayashi K, 1999, JPN J APPL PHYS 2, V38, pL611, DOI 10.1143/JJAP.38.L611; Kobayashi Y, 2008, J CRYST GROWTH, V310, P5044, DOI 10.1016/j.jcrysgro.2008.07.010; Kobayashi Y, 2010, PHYS STATUS SOLIDI C, V7, DOI 10.1002/pssc.200983598; Kumakura K, 2006, J CRYST GROWTH, V292, P155, DOI 10.1016/j.jcrysgro.2006.04.085; Lee KJ, 2006, J APPL PHYS, V100, DOI 10.1063/1.2349837; Lee SW, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3086890; Metzger T, 1998, PHILOS MAG A, V77, P1013, DOI 10.1080/01418619808221225; Nakamura S, 1996, JPN J APPL PHYS 2, V35, pL74, DOI 10.1143/JJAP.35.L74; NAKAMURA S, 1991, JPN J APPL PHYS 2, V30, pL1705, DOI 10.1143/JJAP.30.L1705; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Rogers DJ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2770655; Tamboli AC, 2007, NAT PHOTONICS, V1, P61, DOI 10.1038/nphoton.2006.52; Tripathy S, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2814062; Ueda T, 2003, APPL SURF SCI, V216, P512, DOI 10.1016/S0169-4332(03)00476-8; Wong WS, 1998, APPL PHYS LETT, V72, P599, DOI 10.1063/1.120816; Zang KY, 2010, NANOSCALE RES LETT, V5, P1051, DOI 10.1007/s11671-010-9601-6	28	309	320	29	512	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					223	227		10.1038/nature10970	http://dx.doi.org/10.1038/nature10970			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22498627				2022-12-28	WOS:000303149900031
J	Moore, W				Moore, Wendy			Lister and the reputation robbing historians	BRITISH MEDICAL JOURNAL			English	Editorial Material												wendymoore@ntlworld.com						LISTER, 1867, BRIT MED J, V2, P246	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 11	2012	344								e2603	10.1136/bmj.e2603	http://dx.doi.org/10.1136/bmj.e2603			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	927UH	22496304				2022-12-28	WOS:000302935200011
J	Redelmeier, DA; Yarnell, CJ				Redelmeier, Donald A.; Yarnell, Christopher J.			Road Crash Fatalities on US Income Tax Days	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Redelmeier, Donald A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Yarnell, Christopher J.] Sunnybrook Res Inst, Evaluat Clin Sci Program, Toronto, ON, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Redelmeier, DA (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	dar@ices.on.ca		Yarnell, Christopher/0000-0001-5657-9398	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Blincoe LJ., 2002, EC IMPACT MOTOR VEHI; Crabtree S, GALLUP HEALTHWAYS WE; Redelmeier DA, 2003, NEW ENGL J MED, V348, P368, DOI 10.1056/NEJM200301233480423; Redelmeier DA, 2010, CHANCE, V23, P20; Redelmeier DA, 2012, J CLIN EPIDEMIOL, V65, P467, DOI 10.1016/j.jclinepi.2011.09.007; Rowden P, 2011, ACCIDENT ANAL PREV, V43, P1332, DOI 10.1016/j.aap.2011.02.004	6	6	6	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2012	307	14					1486	1488		10.1001/jama.2012.450	http://dx.doi.org/10.1001/jama.2012.450			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922HN	22496259	Bronze			2022-12-28	WOS:000302538100018
J	Toope, SJ; Tan, CC; Fedoroff, NV				Toope, Stephen J.; Tan, Chorh Chuan; Fedoroff, Nina V.			Improving Asia-Pacific Science Collaboration	SCIENCE			English	Editorial Material									[Toope, Stephen J.] Univ British Columbia, Vancouver, BC V6T 1Z4, Canada; [Tan, Chorh Chuan] Natl Univ Singapore, Singapore 117548, Singapore; [Fedoroff, Nina V.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Fedoroff, Nina V.] King Abdullah Univ Sci & Technol, Thuwal 23955, Saudi Arabia	University of British Columbia; National University of Singapore; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; King Abdullah University of Science & Technology	Toope, SJ (corresponding author), Univ British Columbia, Vancouver, BC V6T 1Z4, Canada.	stephen.toope@ubc.ca						FUJITA K, 2005, 3507 WORLD BANK; Havemann Frank, 2006, J Biomed Discov Collab, V1, P6, DOI 10.1186/1747-5333-1-6; Jones BF, 2008, SCIENCE, V322, P1259, DOI 10.1126/science.1158357; Judge P., 1997, BUSINESSWEEK    0825; Porter ME, 2000, ECON DEV Q, V14, P15, DOI 10.1177/089124240001400105; Rowen H.S., 2000, SILICON VALLEY EDGE; The Royal Society, 2011, KNOWL NETW NAT GLOB; [No title captured]; 2010, ECONOMIST       0902	9	3	3	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2012	336	6077					38	39		10.1126/science.1208378	http://dx.doi.org/10.1126/science.1208378			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	920LG	22491840	Green Submitted			2022-12-28	WOS:000302405400039
J	Mills, EJ; Barnighausen, T; Negin, J				Mills, Edward J.; Baernighausen, Till; Negin, Joel			HIV and Aging - Preparing for the Challenges Ahead	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							AFRICA		[Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON K1N 6N5, Canada; [Baernighausen, Till] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Baernighausen, Till] Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa; [Negin, Joel] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia	University of Ottawa; Harvard University; Harvard T.H. Chan School of Public Health; University of Kwazulu Natal; University of Sydney	Mills, EJ (corresponding author), Univ Ottawa, Fac Hlth Sci, Ottawa, ON K1N 6N5, Canada.		Bärnighausen, Till/Y-2388-2019		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058482] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD058482] Funding Source: Medline; Wellcome Trust [097410] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission)		Bakanda C, 2011, AIDS, V25, P701, DOI 10.1097/QAD.0b013e3283437ed7; Hontelez JAC, 2011, AIDS, V25, P1665, DOI 10.1097/QAD.0b013e32834982ea; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Negin J, 2010, B WORLD HEALTH ORGAN, V88, P847, DOI 10.2471/BLT.10.076349; UNAIDS, 2010, REP GLOB AIDS EP	5	104	107	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 5	2012	366	14					1270	1273		10.1056/NEJMp1113643	http://dx.doi.org/10.1056/NEJMp1113643			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	919QJ	22475591				2022-12-28	WOS:000302343000004
J	Bloch, ED; Queen, WL; Krishna, R; Zadrozny, JM; Brown, CM; Long, JR				Bloch, Eric D.; Queen, Wendy L.; Krishna, Rajamani; Zadrozny, Joseph M.; Brown, Craig M.; Long, Jeffrey R.			Hydrocarbon Separations in a Metal-Organic Framework with Open Iron(II) Coordination Sites	SCIENCE			English	Article							CARBON-DIOXIDE; ADSORPTION; METHANE; PERMEATION; ACETYLENE; MEMBRANES; MIXTURES; ETHYLENE; STORAGE; ETHANE	The energy costs associated with large-scale industrial separation of light hydrocarbons by cryogenic distillation could potentially be lowered through development of selective solid adsorbents that operate at higher temperatures. Here, the metal-organic framework Fe-2(dobdc) (dobdc(4-): 2,5-dioxido-1,4-benzenedicarboxylate) is demonstrated to exhibit excellent performance characteristics for separation of ethylene/ethane and propylene/propane mixtures at 318 kelvin. Breakthrough data obtained for these mixtures provide experimental validation of simulations, which in turn predict high selectivities and capacities of this material for the fractionation of methane/ethane/ethylene/acetylene mixtures, removal of acetylene impurities from ethylene, and membrane-based olefin/paraffin separations. Neutron powder diffraction data confirm a side-on coordination of acetylene, ethylene, and propylene at the iron(II) centers, while also providing solid-state structural characterization of the much weaker interactions of ethane and propane with the metal.	[Bloch, Eric D.; Queen, Wendy L.; Zadrozny, Joseph M.; Long, Jeffrey R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Queen, Wendy L.; Brown, Craig M.] NIST, Ctr Neutron Res, Gaithersburg, MD 20899 USA; [Krishna, Rajamani] Univ Amsterdam, Vant Hoff Inst Mol Sci, NL-1098 XH Amsterdam, Netherlands; [Brown, Craig M.] Australian Nucl Sci & Technol Org, Bragg Inst, Menai, NSW 2234, Australia; [Long, Jeffrey R.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; National Institute of Standards & Technology (NIST) - USA; University of Amsterdam; Australian Nuclear Science & Technology Organisation; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Long, JR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	jrlong@berkeley.edu	Brown, Craig M/B-5430-2009; Krishna, Rajamani/A-1098-2012; Zadrozny, Joseph/D-8206-2015; Stangl, Kristin/D-1502-2015; EFRC, CGS/I-6680-2012; Zadrozny, Joseph/A-1429-2017	Brown, Craig M/0000-0002-9637-9355; Krishna, Rajamani/0000-0002-4784-8530; Zadrozny, Joseph/0000-0002-1309-6545; Zadrozny, Joseph/0000-0002-1309-6545; Queen, Wendy/0000-0002-8375-2341	Center for Gas Separations Relevant to Clean Energy Technologies, an Energy Frontier Research Center; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0001015]; National Institute of Standards and Technology National Research Council	Center for Gas Separations Relevant to Clean Energy Technologies, an Energy Frontier Research Center; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institute of Standards and Technology National Research Council(National Institute of Standards & Technology (NIST) - USA)	The data described in this paper are presented in the supporting online material. This research was supported through the Center for Gas Separations Relevant to Clean Energy Technologies, an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under award DE-SC0001015. In addition, we thank the National Institute of Standards and Technology National Research Council Postdoctoral Fellowship Research Associate program for support of W.L.Q.; V. K. Peterson and S. N. Maximoff for assistance and helpful discussions; C. J. Kepert for the use of his glovebox to prepare neutron powder diffraction samples; and J. M. van Baten for valuable assistance in the simulation work. Metrical data for the solid-state structures of the acetylene, ethylene, ethane, propylene, and propane adducts of Fe<INF>2</INF>(dobdc) are available free of charge from the Cambridge Crystallographic Data Centre under reference numbers CCDC 866357 to 866361. The authors and the University of California, Berkeley have filed a patent on the results presented herein.	Bae YS, 2008, CHEM COMMUN, P4135, DOI 10.1039/b805785k; Bae YS, 2012, ANGEW CHEM INT EDIT, V51, P1857, DOI 10.1002/anie.201107534; Bao ZB, 2011, LANGMUIR, V27, P13554, DOI 10.1021/la2030473; Bloch ED, 2011, J AM CHEM SOC, V133, P14814, DOI 10.1021/ja205976v; Bourrelly S, 2005, J AM CHEM SOC, V127, P13519, DOI 10.1021/ja054668v; Bux H, 2011, J MEMBRANE SCI, V369, P284, DOI 10.1016/j.memsci.2010.12.001; Das MC, 2011, CHEM-EUR J, V17, P7817, DOI 10.1002/chem.201100350; Eddaoudi M, 2002, SCIENCE, V295, P469, DOI 10.1126/science.1067208; ELDRIDGE RB, 1993, IND ENG CHEM RES, V32, P2208, DOI 10.1021/ie00022a002; Furstner A, 2008, J AM CHEM SOC, V130, P8773, DOI 10.1021/ja801466t; HYUN SH, 1982, J CHEM ENG DATA, V27, P196, DOI 10.1021/je00028a029; Gutierrez-Sevillano JJ, 2010, J PHYS CHEM C, V114, P14907, DOI 10.1021/jp101744k; Krishna R, 2011, J MEMBRANE SCI, V383, P289, DOI 10.1016/j.memsci.2011.08.067; Krishna R, 2011, J PHYS CHEM C, V115, P12941, DOI 10.1021/jp202203c; Krishna R, 2011, J MEMBRANE SCI, V377, P249, DOI 10.1016/j.memsci.2011.05.001; Krishna R, 2009, J PHYS CHEM C, V113, P19756, DOI 10.1021/jp906879d; Leclerc H, 2011, PHYS CHEM CHEM PHYS, V13, P11748, DOI 10.1039/c1cp20502a; Li JR, 2009, CHEM SOC REV, V38, P1477, DOI 10.1039/b802426j; Matsuda R, 2005, NATURE, V436, P238, DOI 10.1038/nature03852; Murray LJ, 2010, J AM CHEM SOC, V132, P7856, DOI 10.1021/ja1027925; Murray LJ, 2009, CHEM SOC REV, V38, P1294, DOI 10.1039/b802256a; MYERS AL, 1965, AICHE J, V11, P121, DOI 10.1002/aic.690110125; Noro S, 2000, ANGEW CHEM INT EDIT, V39, P2082; Plaza M. G., MICROPOR MESOPOR MAT; Reyes S. C., 2009, U.S. Patent, Patent No. [12,322,364, 12322364]; Rosi NL, 2003, SCIENCE, V300, P1127, DOI 10.1126/science.1083440; Safarik DJ, 1998, IND ENG CHEM RES, V37, P2571, DOI 10.1021/ie970897h; Tanaka K, 1996, J MEMBRANE SCI, V121, P197, DOI 10.1016/S0376-7388(96)00182-2; Wu H, 2009, J AM CHEM SOC, V131, P4995, DOI 10.1021/ja900258t; Xiang SC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1206; Yoon JW, 2010, ANGEW CHEM INT EDIT, V49, P5949, DOI 10.1002/anie.201001230; Zhang ZJ, 2011, CRYSTENGCOMM, V13, P5983, DOI 10.1039/c1ce05437f	32	1340	1400	55	1419	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1606	1610		10.1126/science.1217544	http://dx.doi.org/10.1126/science.1217544			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461607				2022-12-28	WOS:000302062600040
J	Mim, C; Cui, HS; Gawronski-Salerno, JA; Frost, A; Lyman, E; Voth, GA; Unger, VM				Mim, Carsten; Cui, Haosheng; Gawronski-Salerno, Joseph A.; Frost, Adam; Lyman, Edward; Voth, Gregory A.; Unger, Vinzenz M.			Structural Basis of Membrane Bending by the N-BAR Protein Endophilin	CELL			English	Article							CRYSTAL-STRUCTURE; DOMAIN PROTEINS; CURVATURE; DYNAMIN; INVAGINATION; SYNAPTOJANIN; AMPHIPHYSIN; HYDROLYSIS; GENERATION; MICROSCOPY	Functioning as key players in cellular regulation of membrane curvature, BAR domain proteins bend bilayers and recruit interaction partners through poorly understood mechanisms. Using electron cryo-microscopy, we present reconstructions of full-length endophilin and its N-terminal N-BAR domain in their membrane-bound state. Endophilin lattices expose large areas of membrane surface and are held together by promiscuous interactions between endophilin's amphipathic N-terminal helices. Coarse-grained molecular dynamics simulations reveal that endophilin lattices are highly dynamic and that the N-terminal helices are required for formation of a stable and regular scaffold. Furthermore, endophilin accommodates different curvatures through a quantized addition or removal of endophilin dimers, which in some cases causes dimerization of endophilin's SH3 domains, suggesting that the spatial presentation of SH3 domains, rather than affinity, governs the recruitment of downstream interaction partners.	[Mim, Carsten; Gawronski-Salerno, Joseph A.; Unger, Vinzenz M.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Mim, Carsten; Gawronski-Salerno, Joseph A.; Unger, Vinzenz M.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA; [Cui, Haosheng; Voth, Gregory A.] Univ Chicago, James Franck Inst, Dept Chem, Inst Biophys Dynam, Chicago, IL 60637 USA; [Cui, Haosheng; Voth, Gregory A.] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Lyman, Edward] Univ Delaware, Dept Phys & Astron, Newark, DE 19716 USA; [Lyman, Edward] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA; [Frost, Adam] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA	Northwestern University; Northwestern University; University of Chicago; University of Chicago; University of Delaware; University of Delaware; Utah System of Higher Education; University of Utah	Unger, VM (corresponding author), Northwestern Univ, Dept Mol Biosci, 2205 Campus Dr, Evanston, IL 60208 USA.	v-unger@northwestern.edu		Frost, Adam/0000-0003-2231-2577; Mim, Carsten/0000-0001-6402-8270	National Institutes of Health through the National Center for Research Resources' [RR017573]; Deutsche Forschungsgemeinschaft; Cancer Research Institute; PHS from the National Institutes of Health [DA24101, GM094479, GM063796]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063796, R01GM094479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA024101] Funding Source: NIH RePORTER	National Institutes of Health through the National Center for Research Resources'(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cancer Research Institute; PHS from the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Pietro De Camilli and members of his lab for critical discussions and feedback. The majority of data for this work were collected at the National Resource for Automated Molecular Microscopy, which is supported by the National Institutes of Health through the National Center for Research Resources' P41 program (RR017573). We are also indebted to David Morgan for letting us use the cryoEM facility at Indiana University. This work was funded by Deutsche Forschungsgemeinschaft (C.M.) and the Cancer Research Institute (C.M.), as well as PHS grants DA24101 (V.M.U.), GM094479 (V.M.U.), and GM063796 (G.A.V.) from the National Institutes of Health.	Chang-Ileto B, 2011, DEV CELL, V20, P206, DOI 10.1016/j.devcel.2010.12.008; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Demers JP, 2009, J AM CHEM SOC, V131, P4355, DOI 10.1021/ja808255d; Egelman EH, 2007, CURR OPIN STRUC BIOL, V17, P556, DOI 10.1016/j.sbi.2007.07.006; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gallop JL, 2005, BIOCHEM SOC SYMP, V72, P223, DOI 10.1042/bss0720223; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Hurley JH, 2010, CELL, V143, P875, DOI 10.1016/j.cell.2010.11.030; Jao CC, 2010, J BIOL CHEM, V285, P20164, DOI 10.1074/jbc.M110.127811; Johannes L, 2010, CELL, V142, P507, DOI 10.1016/j.cell.2010.08.007; Kaneko T, 2005, GENES CELLS, V10, P973, DOI 10.1111/j.1365-2443.2005.00895.x; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Llobet A, 2011, J NEUROSCI, V31, P8512, DOI 10.1523/JNEUROSCI.6223-09.2011; Lyman E, 2010, BIOPHYS J, V99, P1783, DOI 10.1016/j.bpj.2010.06.074; Mizuno N, 2010, J BIOL CHEM, V285, P23349, DOI 10.1074/jbc.M110.143776; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pykalainen A, 2011, NAT STRUCT MOL BIOL, V18, P902, DOI 10.1038/nsmb.2079; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Roux A, 2010, P NATL ACAD SCI USA, V107, P4141, DOI 10.1073/pnas.0913734107; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Solomaha E, 2005, J BIOL CHEM, V280, P23147, DOI 10.1074/jbc.M501745200; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Sousa D, 2007, J STRUCT BIOL, V157, P201, DOI 10.1016/j.jsb.2006.08.003; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Sundborger A, 2011, J CELL SCI, V124, P133, DOI 10.1242/jcs.072686; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Trempe JF, 2009, MOL CELL, V36, P1034, DOI 10.1016/j.molcel.2009.11.021; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013	36	176	176	1	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 30	2012	149	1					137	145		10.1016/j.cell.2012.01.048	http://dx.doi.org/10.1016/j.cell.2012.01.048			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464326	Green Accepted, Bronze			2022-12-28	WOS:000302235400016
J	Liu, LD; Ulbrich, J; Muller, J; Wustefeld, T; Aeberhard, L; Kress, TR; Muthalagu, N; Rycak, L; Rudalska, R; Moll, R; Kempa, S; Zender, L; Eilers, M; Murphy, DJ				Liu, Lidan; Ulbrich, Jannes; Mueller, Judith; Wuestefeld, Torsten; Aeberhard, Lukas; Kress, Theresia R.; Muthalagu, Nathiya; Rycak, Lukas; Rudalska, Ramona; Moll, Roland; Kempa, Stefan; Zender, Lars; Eilers, Martin; Murphy, Daniel J.			Deregulated MYC expression induces dependence upon AMPK-related kinase 5	NATURE			English	Article							SYNTHETIC LETHAL INTERACTION; C-MYC; MITOCHONDRIAL BIOGENESIS; CANCER-CELLS; B KINASE; METABOLISM; SUPPRESSION; GLUTAMINE; ADDICTION; GROWTH	Deregulated expression of the MYC oncoprotein contributes to the genesis of many human tumours, yet strategies to exploit this for a rational tumour therapy are scarce. MYC promotes cell growth and proliferation, andalters cellularmetabolismto enhance the provision of precursors for phospholipids and cellularmacromolecules(1,2). Here we showinhuman andmurine cell lines thatoncogenic levels ofMYC establish a dependence on AMPK-related kinase 5 (ARK5; also known as NUAK1) for maintaining metabolic homeostasis and for cell survival. ARK5 is an upstream regulator of AMPK and limits protein synthesis via inhibition of the mammalian target of rapamycin 1 (mTORC1) signalling pathway. ARK5 also maintains expression of mitochondrial respiratory chain complexes and respiratory capacity, which is required for efficient glutamine metabolism. Inhibition of ARK5 leads to a collapse of cellular ATP levels in cells expressing deregulated MYC, inducing multiple pro-apoptotic responses as a secondary consequence. Depletion of ARK5 prolongs survival in MYC-driven mouse models of hepatocellular carcinoma, demonstrating that targeting cellular energy homeostasis is a valid therapeutic strategy to eliminate tumour cells that express deregulated MYC.	[Liu, Lidan; Ulbrich, Jannes; Mueller, Judith; Kress, Theresia R.; Muthalagu, Nathiya; Eilers, Martin; Murphy, Daniel J.] Univ Wurzburg, Bioctr, Theodor Boveri Inst, D-97074 Wurzburg, Germany; [Wuestefeld, Torsten; Rudalska, Ramona; Zender, Lars] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [Wuestefeld, Torsten; Zender, Lars] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; [Aeberhard, Lukas; Kempa, Stefan] Berlin Inst Med Syst Biol, Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Rycak, Lukas] Inst Mol Biol & Tumor Res, D-35037 Marburg, Germany; [Moll, Roland] Univ Marburg, Inst Pathol, D-35033 Marburg, Germany	University of Wurzburg; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Philipps University Marburg	Eilers, M (corresponding author), Univ Wurzburg, Bioctr, Theodor Boveri Inst, Hubland, D-97074 Wurzburg, Germany.	martin.eilers@biozentrum.uni-wuerzburg.de; daniel.murphy@biozentrum.uni-wuerzburg.de	kempa, stefan/C-5213-2008; Murphy, Daniel/V-1079-2019	kempa, stefan/0000-0002-0696-9299; Murphy, Daniel/0000-0002-5538-5468; Eilers, Martin/0000-0002-0376-6533	GROWTHSTOP consortium of the European Union; Deutsche Forschungsgemeinschaft [Transregio 17, Transregio 77]; Emmy Noether Programme [ZE 545/2-1]; Bundesministerium fur Bildung und Forschung; Senate of Berlin; University of Wuerzburg Graduate School of Life Sciences and the "Rebirth" Cluster of Excellence	GROWTHSTOP consortium of the European Union; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Emmy Noether Programme(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Senate of Berlin; University of Wuerzburg Graduate School of Life Sciences and the "Rebirth" Cluster of Excellence	We thank R. Baumann for immunohistochemical staining, B. Samans, A. Filmer and M. Krause for help with the siRNA screen and expression array analysis, A. Rath for help with analysis of human tumour samples, W. Kolch for siRNA targeting LATS1, S. Lowe and J. Zuber for providing the tTGMP vector, S. Martin for His-tagged annexin V expression vector, P. Schirmacher for human HCC cell lines, V. Ellenrieder for human pancreatic cancer cell lines, H. Riedesel and the staff of the Helmholtz Centre for Infection Research animal facility for technical assistance. We thank P. Gallant and all members of the Eilers laboratory for critical reading of the manuscript. Funding for this work was provided by the GROWTHSTOP consortium of the European Union, the Deutsche Forschungsgemeinschaft via the Transregio 17 (M. E.), the Transregio 77 (L.Z.) and the Emmy Noether Programme ZE 545/2-1 (L.Z.), the Bundesministerium fur Bildung und Forschung, the Senate of Berlin, the University of Wuerzburg Graduate School of Life Sciences and the "Rebirth" Cluster of Excellence.	Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; BISSONNETTE RP, 1992, NATURE, V359, P552, DOI 10.1038/359552a0; Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004; Carayol N, 2010, P NATL ACAD SCI USA, V107, P12469, DOI 10.1073/pnas.1005114107; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Humbert N, 2010, EMBO J, V29, P376, DOI 10.1038/emboj.2009.342; Kempa S, 2007, PLANT J, V49, P1076, DOI 10.1111/j.1365-313X.2006.03025.x; Kempa S, 2009, J BASIC MICROB, V49, P82, DOI 10.1002/jobm.200800337; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Suzuki A, 2004, MOL CELL BIOL, V24, P3526, DOI 10.1128/MCB.24.8.3526-3535.2004; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yang D, 2010, P NATL ACAD SCI USA, V107, P13836, DOI 10.1073/pnas.1008366107; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	33	198	211	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2012	483	7391					608	U131		10.1038/nature10927	http://dx.doi.org/10.1038/nature10927			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915EF	22460906	Bronze			2022-12-28	WOS:000302006100041
J	Mesgarani, N; Chang, EF				Mesgarani, Nima; Chang, Edward F.			Selective cortical representation of attended speaker in multi-talker speech perception	NATURE			English	Article								Humans possess a remarkable ability to attend to a single speaker's voice in a multi-talker background(1-3). How the auditory system manages to extract intelligible speech under such acoustically complex and adverse listening conditions is not known, and, indeed, it is not clear how attended speech is internally represented(4,5). Here, using multi-electrode surface recordings from the cortex of subjects engaged in a listening task with two simultaneous speakers, we demonstrate that population responses in non-primary human auditory cortex encode critical features of attended speech: speech spectrograms reconstructed based on cortical responses to the mixture of speakers reveal the salient spectral and temporal features of the attended speaker, as if subjects were listening to that speaker alone. A simple classifier trained solely on examples of single speakers can decode both attended words and speaker identity. We find that task performance is well predicted by a rapid increase in attention-modulated neural selectivity across both single-electrode and population-level cortical responses. These findings demonstrate that the cortical representation of speech does not merely reflect the external acoustic environment, but instead gives rise to the perceptual aspects relevant for the listener's intended goal.	[Mesgarani, Nima; Chang, Edward F.] Univ Calif San Francisco, UCSF Ctr Integrat Neurosci, Dept Neurol Surg, San Francisco, CA 94143 USA; [Mesgarani, Nima; Chang, Edward F.] Univ Calif San Francisco, UCSF Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chang, EF (corresponding author), Univ Calif San Francisco, UCSF Ctr Integrat Neurosci, Dept Neurol Surg, San Francisco, CA 94143 USA.	changed@neurosurg.ucsf.edu			National Institutes of Health [R00-NS065120, DP2-OD00862, R01-DC012379]; Ester A. and Joseph Klingenstein Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS065120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012379] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ester A. and Joseph Klingenstein Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors would like to thank A. Ren for technical help, and C. Micheyl, S. Shamma and C. Schreiner for critical discussion and reading of the manuscript. E. F. C. was funded by National Institutes of Health grants R00-NS065120, DP2-OD00862, R01-DC012379, and the Ester A. and Joseph Klingenstein Foundation.	Bee MA, 2008, J COMP PSYCHOL, V122, P235, DOI 10.1037/0735-7036.122.3.235; Besle J, 2011, J NEUROSCI, V31, P3176, DOI 10.1523/JNEUROSCI.4518-10.2011; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Bolia RS, 2000, J ACOUST SOC AM, V107, P1065, DOI 10.1121/1.428288; Bregman A.S., 1994, AUDITORY SCENE ANAL; Brungart DS, 2001, J ACOUST SOC AM, V109, P1101, DOI 10.1121/1.1345696; Chang EF, 2010, NAT NEUROSCI, V13, P1428, DOI 10.1038/nn.2641; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Cooke M, 2010, COMPUT SPEECH LANG, V24, P1, DOI 10.1016/j.csl.2009.02.006; Crone NE, 2001, CLIN NEUROPHYSIOL, V112, P565, DOI 10.1016/S1388-2457(00)00545-9; Darwin CJ, 1997, TRENDS COGN SCI, V1, P327, DOI 10.1016/S1364-6613(97)01097-8; Elhilali M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000129; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Garofolo JS, 1993, TIMIT ACOUSTIC PHONE; Hackett TA, 2011, HEARING RES, V271, P133, DOI 10.1016/j.heares.2010.01.011; Kerlin JR, 2010, J NEUROSCI, V30, P620, DOI 10.1523/JNEUROSCI.3631-09.2010; Kidd G, 2005, J ACOUST SOC AM, V118, P3804, DOI 10.1121/1.2109187; Mesgarani N, 2009, J NEUROPHYSIOL, V102, P3329, DOI 10.1152/jn.91128.2008; Pasley BN, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001251; Rifkin R, 2003, NATO SCI SERIES 3, V190, P131, DOI DOI 10.1016/S0072-9752(06)80038-2; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; Scott SK, 2009, J ACOUST SOC AM, V125, P1737, DOI 10.1121/1.3050255; Shamma SA, 2011, TRENDS NEUROSCI, V34, P114, DOI 10.1016/j.tins.2010.11.002; Shen WD, 2008, INTERSPEECH 2008: 9TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2008, VOLS 1-5, P1630; Shinn-Cunningham BG, 2008, TRENDS COGN SCI, V12, P182, DOI 10.1016/j.tics.2008.02.003; Shinn-Cunningham Barbara G, 2008, Trends Amplif, V12, P283, DOI 10.1177/1084713808325306; Staeren N, 2009, CURR BIOL, V19, P498, DOI 10.1016/j.cub.2009.01.066; Steinschneider M, 2008, CEREB CORTEX, V18, P610, DOI 10.1093/cercor/bhm094; WARREN RM, 1970, SCIENCE, V167, P392, DOI 10.1126/science.167.3917.392	29	519	527	12	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2012	485	7397					233	U118		10.1038/nature11020	http://dx.doi.org/10.1038/nature11020			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22522927	Green Accepted			2022-12-28	WOS:000303799800040
J	Pegrum, J; Crisp, T; Padhiar, N				Pegrum, James; Crisp, Tom; Padhiar, Nat			Diagnosis and management of bone stress injuries of the lower limb in athletes	BMJ-BRITISH MEDICAL JOURNAL			English	Review							GROUND REACTION FORCES; RISK-FACTORS; FOLLOW-UP; FRACTURES; TRACK		[Pegrum, James] Queen Marys Univ, Ctr Sport & Exercise Med, London E1 4NS, England; [Crisp, Tom] BUPA Hlth & Wellbeing, London, England; [Pegrum, James; Padhiar, Nat] Milton Keynes Dist Gen Hosp, Milton Keynes MK6 5LD, Bucks, England	University of London; Queen Mary University London	Pegrum, J (corresponding author), Queen Marys Univ, Ctr Sport & Exercise Med, London E1 4NS, England.	jpegrum@doctors.net.uk						Arendt EA, 1997, CLIN SPORT MED, V16, P291, DOI 10.1016/S0278-5919(05)70023-5; BARROW GW, 1988, AM J SPORT MED, V16, P209, DOI 10.1177/036354658801600302; Bennell K, 2004, MED SCI SPORT EXER, V36, P397, DOI 10.1249/01.MSS.0000117116.90297.E1; Bennell KL, 1996, AM J SPORT MED, V24, P211, DOI 10.1177/036354659602400217; Bennell KL, 1996, AM J SPORT MED, V24, P810, DOI 10.1177/036354659602400617; Bennett MH, 2005, COCHRANE DB SYST REV, V1; Boden B P, 2000, J Am Acad Orthop Surg, V8, P344; Brukner P, 1998, PHYSICIAN SPORTSMED, V26, P39, DOI 10.3810/psm.1998.08.1104; Crossley K, 1999, MED SCI SPORT EXER, V31, P1088, DOI 10.1097/00005768-199908000-00002; Datir AP, 2007, CLIN RADIOL, V62, P828, DOI 10.1016/j.crad.2007.02.018; De Souza MJ, 2004, HUM REPROD UPDATE, V10, P433, DOI 10.1093/humupd/dmh033; Edwards WB, 2008, CLIN BIOMECH, V23, P1269, DOI 10.1016/j.clinbiomech.2008.06.011; Field AE, 2011, ARCH PEDIAT ADOL MED, V165, P723, DOI 10.1001/archpediatrics.2011.34; GILADI M, 1987, J BONE JOINT SURG BR, V69, P326, DOI 10.1302/0301-620X.69B2.3818769; Groves AM, 2005, CLIN RADIOL, V60, P1100, DOI 10.1016/j.crad.2005.05.014; Harrast MA, 2010, CLIN SPORT MED, V29, P399, DOI 10.1016/j.csm.2010.03.001; Ivkovic A, 2006, BRIT J SPORT MED, V40, P518, DOI 10.1136/bjsm.2005.023655; Kaeding CC, 2005, CLIN J SPORT MED, V15, P442, DOI 10.1097/01.jsm.0000188207.62608.35; Korpelainen R, 2001, AM J SPORT MED, V29, P304, DOI 10.1177/03635465010290030901; Krivickas LS, 1997, SPORTS MED, V24, P132, DOI 10.2165/00007256-199724020-00005; Lappe JM, 2001, OSTEOPOROSIS INT, V12, P35, DOI 10.1007/s001980170155; Mattila VM, 2007, MED SCI SPORT EXER, V39, P1061, DOI 10.1249/01.mss.0b013e318053721d; Milgrom C, 2004, BONE, V35, P418, DOI 10.1016/j.bone.2004.04.016; Milgrom C, 2003, BRIT J SPORT MED, V37, P160, DOI 10.1136/bjsm.37.2.160; MILGROM C, 1985, AM J SPORT MED, V13, P398, DOI 10.1177/036354658501300606; Pihlajamaki HK, 2006, J BONE JOINT SURG BR, V88B, P1574, DOI 10.1302/0301-620X.88B12.17996; Portland G, 2003, FOOT ANKLE INT, V24, P829, DOI 10.1177/107110070302401104; Rauh MJ, 2006, MED SCI SPORT EXER, V38, P1571, DOI 10.1249/01.mss.0000227543.51293.9d; Ross RA, 2002, MIL MED, V167, P560; Schnackenburg KE, 2011, MED SCI SPORT EXER, V43, P2110, DOI 10.1249/MSS.0b013e31821f8634; Shaffer RA, 2006, AM J SPORT MED, V34, P108, DOI 10.1177/0363546505278703; Stewart GW, 2005, CLIN J SPORT MED, V15, P92, DOI 10.1097/01.jsm.0000152716.06883.e0; Taunton JE, 2002, BRIT J SPORT MED, V36, P95, DOI 10.1136/bjsm.36.2.95; Tenforde AS, 2010, PM&R, V2, P945, DOI 10.1016/j.pmrj.2010.05.006; Tuan K, 2004, ORTHOPEDICS, V27, P583; Wegener C, 2008, AM J SPORT MED, V36, P2139, DOI 10.1177/0363546508318191	36	35	36	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2012	344								e2511	10.1136/bmj.e2511	http://dx.doi.org/10.1136/bmj.e2511			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	934HB	22532009				2022-12-28	WOS:000303433700001
J	Pinheiro, VB; Taylor, AI; Cozens, C; Abramov, M; Renders, M; Zhang, S; Chaput, JC; Wengel, J; Peak-Chew, SY; McLaughlin, SH; Herdewijn, P; Holliger, P				Pinheiro, Vitor B.; Taylor, Alexander I.; Cozens, Christopher; Abramov, Mikhail; Renders, Marleen; Zhang, Su; Chaput, John C.; Wengel, Jesper; Peak-Chew, Sew-Yeu; McLaughlin, Stephen H.; Herdewijn, Piet; Holliger, Philipp			Synthetic Genetic Polymers Capable of Heredity and Evolution	SCIENCE			English	Article							NUCLEIC-ACID STRUCTURE; IN-VITRO SELECTION; CHEMICAL ETIOLOGY; DNA-POLYMERASES; SYSTEM; RECOGNITION; ANALOGS; TNA	Genetic information storage and processing rely on just two polymers, DNA and RNA, yet whether their role reflects evolutionary history or fundamental functional constraints is currently unknown. With the use of polymerase evolution and design, we show that genetic information can be stored in and recovered from six alternative genetic polymers based on simple nucleic acid architectures not found in nature [xeno-nucleic acids (XNAs)]. We also select XNA aptamers, which bind their targets with high affinity and specificity, demonstrating that beyond heredity, specific XNAs have the capacity for Darwinian evolution and folding into defined structures. Thus, heredity and evolution, two hallmarks of life, are not limited to DNA and RNA but are likely to be emergent properties of polymers capable of information storage.	[Pinheiro, Vitor B.; Taylor, Alexander I.; Cozens, Christopher; Peak-Chew, Sew-Yeu; McLaughlin, Stephen H.; Holliger, Philipp] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Abramov, Mikhail; Renders, Marleen; Herdewijn, Piet] Katholieke Univ Leuven, Rega Inst, B-3000 Louvain, Belgium; [Zhang, Su; Chaput, John C.] Arizona State Univ, Biodesign Inst, Ctr Evolutionary Med & Informat, Tempe, AZ 85287 USA; [Wengel, Jesper] Univ So Denmark, Dept Phys & Chem, Nucle Acid Ctr, DK-5230 Odense M, Denmark	MRC Laboratory Molecular Biology; KU Leuven; Arizona State University; Arizona State University-Tempe; University of Southern Denmark	Holliger, P (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	ph1@mrc-lmb.cam.ac.uk	Renders, Marleen/L-2603-2015; Pinheiro, Vitor/O-5514-2017; wengel, jesper/K-1177-2013	Renders, Marleen/0000-0002-4099-9045; Pinheiro, Vitor/0000-0003-2491-0028; McLaughlin, Stephen/0000-0001-9135-6253; Cozens, Christopher/0000-0003-4067-6921; Herdewijn, Piet/0000-0003-3589-8503; Taylor, Alexander/0000-0001-7684-1437; Wengel, Jesper/0000-0001-9835-1009	MRC [U105178804]; European Union [FP6-STREP-029092 NEST]; European Science Foundation; Biotechnology and Biological Sciences Research Council (BBSRC) UK [09-EuroSYNBIO-OP-013]; European Research Council [ERC-2010-AdG_20100317]; Katholieke Universiteit Leuven (GOA/IDO); BBSRC [BB/I004793/1] Funding Source: UKRI; MRC [MC_U105178804] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I004793/1] Funding Source: researchfish; Medical Research Council [MC_U105178804] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); European Science Foundation(European Science Foundation (ESF)European Commission); Biotechnology and Biological Sciences Research Council (BBSRC) UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); Katholieke Universiteit Leuven (GOA/IDO); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the MRC (U105178804) (P. Holliger, V.B.P., C.C.) and by grants from the European Union Framework [FP6-STREP-029092 NEST (P. Holliger, V.B.P., M.A., M.R., P. Herdewijn)], the European Science Foundation and the Biotechnology and Biological Sciences Research Council (BBSRC) UK (09-EuroSYNBIO-OP-013) (A.I.T.), the European Research Council (ERC-2010-AdG_20100317) (J.W.), and Katholieke Universiteit Leuven (GOA/IDO programs) (P. Herdewijn). MRC has filed a patent continuation in part (U.S. 2010/018407 A1) and a patent application (WO 2011/135280 A2) on the CST selection system and the polymerases for XNA synthesis and reverse transcription. Polymerases are available for noncommercial purposes from P. Holliger on request subject to a material transfer agreement.	Benner SA, 2004, SCIENCE, V306, P625, DOI 10.1126/science.1101104; Boiziau C, 2001, ANTISENSE NUCLEIC A, V11, P379, DOI 10.1089/108729001753411344; Brudno Y, 2010, NAT CHEM BIOL, V6, P148, DOI [10.1038/NCHEMBIO.280, 10.1038/nchembio.280]; Burmeister PE, 2005, CHEM BIOL, V12, P25, DOI 10.1016/j.chembiol.2004.10.017; Campbell MA, 2011, CHEM SOC REV, V40, P5680, DOI 10.1039/c1cs15048k; Duconge F, 1999, RNA, V5, P1605, DOI 10.1017/S1355838299991318; Eschenmoser A, 1999, SCIENCE, V284, P2118, DOI 10.1126/science.284.5423.2118; Fogg MJ, 2002, NAT STRUCT BIOL, V9, P922, DOI 10.1038/nsb867; Gardner AF, 2002, NUCLEIC ACIDS RES, V30, P605, DOI 10.1093/nar/30.2.605; Hansen J. A., 2003, US Patent, Patent No. [2003/0228616 A1, 20030228616]; Herdewijn P, 2010, CHEM BIODIVERS, V7, P1, DOI 10.1002/cbdv.200900185; Ichida JK, 2005, NUCLEIC ACIDS RES, V33, P5219, DOI 10.1093/nar/gki840; Leconte AM, 2008, J AM CHEM SOC, V130, P2336, DOI 10.1021/ja078223d; Li ZY, 2002, J AM CHEM SOC, V124, P746, DOI 10.1021/ja017319j; Loakes D, 2001, NUCLEIC ACIDS RES, V29, P2437, DOI 10.1093/nar/29.12.2437; Loakes D, 2009, CHEM COMMUN, P4619, DOI 10.1039/b903307f; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; NIELSEN PE, 1995, ANNU REV BIOPH BIOM, V24, P167, DOI 10.1146/annurev.bb.24.060195.001123; Noronha AM, 2000, BIOCHEMISTRY-US, V39, P7050, DOI 10.1021/bi000280v; Potty ASR, 2011, INT J BIOL MACROMOL, V48, P392, DOI 10.1016/j.ijbiomac.2010.12.007; Rosenbaum DM, 2003, J AM CHEM SOC, V125, P13924, DOI 10.1021/ja038058b; Schoning KU, 2000, SCIENCE, V290, P1347, DOI 10.1126/science.290.5495.1347; Schrum JP, 2009, J AM CHEM SOC, V131, P14560, DOI 10.1021/ja906557v; Wilds CJ, 2000, NUCLEIC ACIDS RES, V28, P3625, DOI 10.1093/nar/28.18.3625; Yu HY, 2012, NAT CHEM, V4, P183, DOI [10.1038/NCHEM.1241, 10.1038/nchem.1241]	25	466	480	15	348	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2012	336	6079					341	344		10.1126/science.1217622	http://dx.doi.org/10.1126/science.1217622			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22517858	Green Accepted			2022-12-28	WOS:000302995400044
J	Milton, AL; Everitt, BJ				Milton, Amy L.; Everitt, Barry J.			Wiping Drug Memories	SCIENCE			English	Editorial Material							PKM-ZETA; RECONSOLIDATION; EXTINCTION; ADDICTION; RECEPTORS; MECHANISMS; FEAR		[Milton, Amy L.; Everitt, Barry J.] Univ Cambridge, Dept Expt Psychol, Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England	University of Cambridge	Milton, AL (corresponding author), Univ Cambridge, Dept Expt Psychol, Behav & Clin Neurosci Inst, Downing St, Cambridge CB2 3EB, England.	bje10@cam.ac.uk	Milton, Amy L/B-6839-2009	Milton, Amy L/0000-0003-0175-9417; Everitt, Barry/0000-0003-4431-6536	Medical Research Council [G1002231] Funding Source: Medline; MRC [G1002231] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bouton ME, 2002, BIOL PSYCHIAT, V52, P976, DOI 10.1016/S0006-3223(02)01546-9; Conklin CA, 2002, ADDICTION, V97, P155, DOI 10.1046/j.1360-0443.2002.00014.x; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lee JLC, 2009, TRENDS NEUROSCI, V32, P413, DOI 10.1016/j.tins.2009.05.002; Milton AL, 2008, J NEUROSCI, V28, P8230, DOI 10.1523/JNEUROSCI.1723-08.2008; Milton AL, 2012, NEUROSCI BIOBEHAV R, V36, P1119, DOI 10.1016/j.neubiorev.2012.01.002; Milton AL, 2010, EUR J NEUROSCI, V31, P2308, DOI 10.1111/j.1460-9568.2010.07249.x; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Myers KM, 2011, NEUROPSYCHOPHARMACOL, V36, P274, DOI 10.1038/npp.2010.88; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Torregrossa MM, 2011, NEUROBIOL LEARN MEM, V96, P609, DOI 10.1016/j.nlm.2011.02.014; Xue YX, 2012, SCIENCE, V336, P241, DOI 10.1126/science.1215070; Yao YD, 2008, J NEUROSCI, V28, P7820, DOI 10.1523/JNEUROSCI.0223-08.2008	15	17	19	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2012	336	6078					167	168		10.1126/science.1221691	http://dx.doi.org/10.1126/science.1221691			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924PN	22499932				2022-12-28	WOS:000302703900033
J	Scheffler, RM; Shortell, SM; Wilensky, GR				Scheffler, Richard M.; Shortell, Stephen M.; Wilensky, Gail R.			Accountable Care Organizations and Antitrust Restructuring the Health Care Market	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Shortell, Stephen M.] Univ Calif Berkeley, Sch Publ Hlth, Div Hlth Policy & Management, Berkeley, CA 94720 USA; [Scheffler, Richard M.] Univ Calif Berkeley, Goldman Sch Publ Policy, Berkeley, CA 94720 USA; [Wilensky, Gail R.] Project HOPE, Lane Millwood, VA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Shortell, SM (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Hlth Policy & Management, 417E Univ Hall, Berkeley, CA 94720 USA.	shortell@berkeley.edu						[Anonymous], 2011, EMPL EXPR ANT COST S; Bowers L, 2011, ACC CAR ORG ANT C NO; Center for Population Health at the Dartmouth Institute, ACOS FREQ ASK QUEST; Centers for Medicare & Medicaid Services (CMS) HHS, 2011, Fed Regist, V76, P67802; Federal Trade Commission; Department of Justice, 2011, FED REGISTER, V76, P67026; Gassman A, 2011, FINAL ACO RULES LOWE; Glied S, 2002, J HEALTH ECON, V21, P337, DOI 10.1016/S0167-6296(01)00131-X	7	22	23	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2012	307	14					1493	1494		10.1001/jama.2012.451	http://dx.doi.org/10.1001/jama.2012.451			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922HN	22496262				2022-12-28	WOS:000302538100021
J	Svanstrom, H; Pasternak, B; Hviid, A				Svanstrom, Henrik; Pasternak, Bjorn; Hviid, Anders			Association of Treatment With Losartan vs Candesartan and Mortality Among Patients With Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIAGNOSIS; REGISTERS	Context The benefit of angiotensin II-receptor blockers (ARBs) in heart failure is thought to be a class effect, but no head-to-head randomized trials have compared individual ARBs. Results from observational studies suggest that losartan may be associated with increased mortality in patients with heart failure compared with other ARBs. Objective To assess the hypothesis that losartan use is associated with increased all-cause mortality in heart failure patients as compared with candesartan. Design, Setting, and Participants We conducted a nationwide Danish registry-based cohort study, linking individual-level information on hospital contacts, filled prescriptions, and potential confounders. Patients aged 45 years and older with first-time hospitalization for heart failure in 1998-2008 were identified from the Danish National Patient Registry. New users of losartan and candesartan were selected for inclusion in the study cohort. Main Outcome Measures We used Cox proportional hazards regression to compare the risk of all-cause mortality in users of losartan and candesartan. Results Among 4397 users of losartan, 1212 deaths occurred during 11 347 person-years of follow-up (unadjusted incidence rate [IR]/100 person-years, 10.7; 95% CI, 10.1-11.3) compared with 330 deaths during 3675 person-years among 2082 users of candesartan (unadjusted IR/100 person-years, 9.0; 95% CI, 8.1-10.0). Compared with candesartan, losartan was not associated with increased all-cause mortality (adjusted hazard ratio [HR], 1.10; 95% CI, 0.96-1.25) or cardiovascular mortality (adjusted HR, 1.14; 95% CI, 0.96-1.36). Compared with high doses of candesartan (16-32 mg), low-dose (12.5 mg) and medium-dose losartan (50 mg) were associated with increased mortality (HR, 2.79; 95% CI, 2.19-3.55 and HR, 1.39; 95% CI, 1.11-1.73, respectively); use of high-dose losartan (100 mg) was similar in risk (HR, 0.71; 95% CI, 0.50-1.00). Conclusions Among patients with heart failure, overall use of losartan compared with candesartan was not associated with an increased mortality risk. Although low doses of losartan were associated with increased mortality, there was no increased mortality comparing high-dose losartan against the highest doses of candesartan. JAMA. 2012;307(14):1506-1512	[Svanstrom, Henrik; Pasternak, Bjorn; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark	Statens Serum Institut	Svanstrom, H (corresponding author), Statens Serum Inst, Orestads Blvd 5,206-305, DK-2300 Copenhagen S, Denmark.	htr@ssi.dk	Pasternak, Bjorn/H-5739-2012; Hviid, Anders/AAH-4319-2020	Pasternak, Bjorn/0000-0002-2097-8466; Hviid, Anders/0000-0002-7509-9127	Danish Medical Research Council	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Danish Medical Research Council.	Andersen TF, 1999, DAN MED BULL, V46, P263; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Desai RJ, 2012, PHARMACOEPIDEM DR S, V21, P233, DOI 10.1002/pds.2175; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Eklind-Cervenka M, 2011, JAMA-J AM MED ASSOC, V305, P175, DOI 10.1001/jama.2010.1949; Eshaghian S, 2006, AM J CARDIOL, V97, P1759, DOI 10.1016/j.amjcard.2005.12.072; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Hudson M, 2007, PHARMACOTHERAPY, V27, P526, DOI 10.1592/phco.27.4.526; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Juel K, 1999, DAN MED BULL, V46, P354; Kaplan N, 2011, JAMA-J AM MED ASSOC, V305, P1541, DOI 10.1001/jama.2011.463; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Konstam MA, 2005, AM HEART J, V150, P123, DOI 10.1016/j.ahj.2004.10.035; Konstam MA, 2009, LANCET, V374, P1840, DOI 10.1016/S0140-6736(09)61913-9; Kumler T, 2008, EUR J HEART FAIL, V10, P658, DOI 10.1016/j.ejheart.2008.05.006; Mard Shan, 2010, Clin Epidemiol, V2, P235, DOI 10.2147/CLEP.S12457; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Sturmer T, 2010, AM J EPIDEMIOL, V172, P843, DOI 10.1093/aje/kwq198; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83	22	32	32	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2012	307	14					1506	1512		10.1001/jama.2012.452	http://dx.doi.org/10.1001/jama.2012.452			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922HN	22496265	Bronze			2022-12-28	WOS:000302538100024
J	Spence, D				Spence, Des			FROM THE FRONTLINE Medical heresy: ditch the eponyms	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	4	4	1	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 4	2012	344								e2503	10.1136/bmj.e2503	http://dx.doi.org/10.1136/bmj.e2503			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	923HC	22491702				2022-12-28	WOS:000302609300008
J	Filippakopoulos, P; Picaud, S; Mangos, M; Keates, T; Lambert, JP; Barsyte-Lovejoy, D; Felletar, I; Volkmer, R; Muller, S; Pawson, T; Gingras, AC; Arrowsmith, CH; Knapp, S				Filippakopoulos, Panagis; Picaud, Sarah; Mangos, Maria; Keates, Tracy; Lambert, Jean-Philippe; Barsyte-Lovejoy, Dalia; Felletar, Ildiko; Volkmer, Rudolf; Mueller, Susanne; Pawson, Tony; Gingras, Anne-Claude; Arrowsmith, Cheryl H.; Knapp, Stefan			Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family	CELL			English	Article							CHROMATIN-REMODELING COMPLEX; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; PEPTIDE ARRAYS; TRANSCRIPTION ELONGATION; BET BROMODOMAINS; PHD FINGER; PROTEIN; ACETYLATION; IDENTIFICATION	Bromodomains (BRDs) are protein interaction modules that specifically recognize epsilon-N-lysine acetylation motifs, a key event in the reading process of epigenetic marks. The 61 BRDs in the human genome cluster into eight families based on structure/sequence similarity. Here, we present 29 high-resolution crystal structures, covering all BRD families. Comprehensive crossfamily structural analysis identifies conserved and family-specific structural features that are necessary for specific acetylation-dependent substrate recognition. Screening of more than 30 representative BRDs against systematic histone-peptide arrays identifies new BRD substrates and reveals a strong influence of flanking posttranslational modifications, such as acetylation and phosphorylation, suggesting that BRDs recognize combinations of marks rather than singly acetylated sequences. We further uncovered a structural mechanism for the simultaneous binding and recognition of diverse diacetyl-containing peptides by BRD4. These data provide a foundation for structure-based drug design of specific inhibitors for this emerging target family.	[Filippakopoulos, Panagis; Picaud, Sarah; Keates, Tracy; Felletar, Ildiko; Mueller, Susanne; Knapp, Stefan] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford OX3 7LD, England; [Knapp, Stefan] Univ Oxford, Dept Oncol, Oxford OX3 7LD, England; [Mangos, Maria; Barsyte-Lovejoy, Dalia; Arrowsmith, Cheryl H.] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M5G 1L7, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Lambert, Jean-Philippe; Pawson, Tony; Gingras, Anne-Claude] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Volkmer, Rudolf] Charite Univ Med Berlin, Inst Med Immunol, D-10115 Berlin, Germany; [Pawson, Tony; Gingras, Anne-Claude] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Knapp, Stefan] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Washington, DC 20037 USA	University of Oxford; University of Oxford; University of Toronto; Structural Genomics Consortium; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Toronto; George Washington University	Filippakopoulos, P (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Old Rd Campus Res Bldg,Roosevelt Dr, Oxford OX3 7LD, England.	panagis.filippakopoulos@sgc.ox.ac.uk; stefan.knapp@sgc.ox.ac.uk	Pawson, Tony J/E-4578-2013; Knapp, Stefan/AAG-2347-2019; Gingras, Anne-Claude/ABA-8341-2020; Gingras, Anne-Claude/E-9982-2010	Knapp, Stefan/0000-0001-5995-6494; Gingras, Anne-Claude/0000-0002-6090-4437; Gingras, Anne-Claude/0000-0002-6090-4437; Lambert, Jean-Philippe/0000-0002-0833-1221; Arrowsmith, Cheryl/0000-0002-4971-3250; Muller-Knapp, Susanne/0000-0003-2402-4157; Filippakopoulos, Panagis/0000-0002-1515-1317; Volkmer, Rudolf/0000-0003-4710-1143	Canadian Institutes for Health Research; Canada Foundation for Innovation; Genome Canada; GlaxoSmithKline; Pfizer; Eli Lilly; Novartis Research Foundation; Ontario Ministry of Research and Innovation; Wellcome Trust [095751/Z/11/Z]; Ontario Ministry of Health and Innovation; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); Eli Lilly(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Wellcome Trust(Wellcome TrustEuropean Commission); Ontario Ministry of Health and Innovation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The SGC is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada, GlaxoSmithKline, Pfizer, Eli Lilly, the Novartis Research Foundation, the Ontario Ministry of Research and Innovation, and the Wellcome Trust. P.F. is supported by a Wellcome Trust Career Development Fellowship (095751/Z/11/Z). T. P. and A.-C. G. are supported by a Global Leadership Round in Genomics and Life Sciences from the Ontario Ministry of Health and Innovation. J.-P.L. is supported by a fellowship from the Natural Sciences and Engineering Research Council of Canada. A.-C. G. and C. H. A. hold Canada Research Chairs in Functional Proteomics and Structural Proteomics, respectively.	Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Beyer M, 2009, METHODS MOL BIOL, V570, P309, DOI 10.1007/978-1-60327-394-7_16; Bloch DB, 2000, MOL CELL BIOL, V20, P6138, DOI 10.1128/MCB.20.16.6138-6146.2000; Cai Y, 2003, J BIOL CHEM, V278, P42733, DOI 10.1074/jbc.C300389200; Cavellan E, 2006, J BIOL CHEM, V281, P16264, DOI 10.1074/jbc.M600233200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chung CW, 2011, J MED CHEM, V54, P3827, DOI 10.1021/jm200108t; Ciro M, 2009, CANCER RES, V69, P8491, DOI 10.1158/0008-5472.CAN-09-2131; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Eswaran J, 2009, P NATL ACAD SCI USA, V106, P20198, DOI 10.1073/pnas.0901989106; Fairbridge NA, 2010, BIRTH DEFECTS RES A, V88, P619, DOI 10.1002/bdra.20695; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fossey SC, 2000, MAMM GENOME, V11, P919, DOI 10.1007/s003350010174; French CA, 2001, AM J PATHOL, V159, P1987, DOI 10.1016/S0002-9440(10)63049-0; French CA, 2010, J CLIN PATHOL, V63, P492, DOI 10.1136/jcp.2007.052902; French CA, 2010, CANCER GENET CYTOGEN, V203, P16, DOI 10.1016/j.cancergencyto.2010.06.007; Goodwin GH, 2001, GENE, V268, P1, DOI 10.1016/S0378-1119(01)00428-0; Gregory GD, 2007, MOL CELL BIOL, V27, P8466, DOI 10.1128/MCB.00993-07; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; HAYNES SR, 1992, NUCLEIC ACIDS RES, V20, P2603, DOI 10.1093/nar/20.10.2603; Hewings DS, 2011, J MED CHEM, V54, P6761, DOI 10.1021/jm200640v; Huang H, 2003, DEV DYNAM, V227, P608, DOI 10.1002/dvdy.10344; Huang HD, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-57; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jeanmougin F, 1997, TRENDS BIOCHEM SCI, V22, P151, DOI 10.1016/S0968-0004(97)01042-6; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jones MH, 2000, GENOMICS, V63, P40, DOI 10.1006/geno.1999.6071; Kaeser MD, 2008, J BIOL CHEM, V283, P32254, DOI 10.1074/jbc.M806061200; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Khetchoumian K, 2004, J BIOL CHEM, V279, P48329, DOI 10.1074/jbc.M404779200; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Laue K, 2008, DEVELOPMENT, V135, P1935, DOI 10.1242/dev.017160; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Li YY, 2011, J BIOL CHEM, V286, P13925, DOI 10.1074/jbc.M111.223198; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Lo WS, 2001, SCIENCE, V293, P1142, DOI 10.1126/science.1062322; Masselink H, 2000, ONCOGENE, V19, P1538, DOI 10.1038/sj.onc.1203421; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869; Muller S, 2011, EXPERT REV MOL MED, V13, P1, DOI 10.1017/S1462399411001992; Nady N, 2008, TRENDS BIOCHEM SCI, V33, P305, DOI 10.1016/j.tibs.2008.04.014; Nady N, 2011, J BIOL CHEM, V286, P24300, DOI 10.1074/jbc.M111.234104; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Org T, 2008, EMBO REP, V9, P370, DOI [10.1038/embor.2008.11, 10.1038/sj.embor.2008.11]; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Podcheko A, 2007, MOL CELL BIOL, V27, P6484, DOI 10.1128/MCB.02409-06; Racki LR, 2009, NATURE, V462, P1016, DOI 10.1038/nature08621; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Reineke U, 2001, CURR OPIN BIOTECH, V12, P59, DOI 10.1016/S0958-1669(00)00178-6; Reynoird N, 2010, EMBO J, V29, P2943, DOI 10.1038/emboj.2010.176; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shen WQ, 2007, BIOCHEMISTRY-US, V46, P2100, DOI 10.1021/bi0611208; Smith BC, 2011, ACS CHEM BIOL, V6, P146, DOI 10.1021/cb100218d; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Ullah M, 2008, MOL CELL BIOL, V28, P6828, DOI 10.1128/MCB.01297-08; Umehara T, 2010, J BIOL CHEM, V285, P7610, DOI 10.1074/jbc.M109.062422; Wang PJ, 2002, HUM MOL GENET, V11, P2341, DOI 10.1093/hmg/11.19.2341; Wang ZX, 2010, CELL, V141, P1183, DOI 10.1016/j.cell.2010.05.016; Wassarman DA, 2001, J CELL SCI, V114, P2895; Xue YT, 2000, P NATL ACAD SCI USA, V97, P13015, DOI 10.1073/pnas.240208597; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Yordy JS, 2005, ONCOGENE, V24, P916, DOI 10.1038/sj.onc.1208245; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010; Zhou YG, 2009, NAT CELL BIOL, V11, P1010, DOI 10.1038/ncb1914; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031; Zong RT, 2000, EMBO J, V19, P4123, DOI 10.1093/emboj/19.15.4123	84	1042	1123	12	196	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 30	2012	149	1					214	231		10.1016/j.cell.2012.02.013	http://dx.doi.org/10.1016/j.cell.2012.02.013			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464331	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000302235400022
J	Reddy, H; De Vittoris, A; Wahie, S				Reddy, H.; De Vittoris, A.; Wahie, S.			A scaly rash on the hands	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Reddy, H.] James Cook Univ Hosp, Dept Dermatol, Middlesbrough, Cleveland, England; [De Vittoris, A.; Wahie, S.] Univ Hosp N Durham, Dept Dermatol, Durham, England	James Cook University Hospital	Reddy, H (corresponding author), James Cook Univ Hosp, Dept Dermatol, Middlesbrough, Cleveland, England.	hari.reddy@nhs.net						Patient.co.uk, FING UN TOP STER	1	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAR 28	2012	344								e2252	10.1136/bmj.e2252	http://dx.doi.org/10.1136/bmj.e2252			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923FF	22457441				2022-12-28	WOS:000302604100008
J	Bosveld, F; Bonnet, I; Guirao, B; Tlili, S; Wang, ZM; Petitalot, A; Marchand, R; Bardet, PL; Marcq, P; Graner, F; Bellaiche, Y				Bosveld, Floris; Bonnet, Isabelle; Guirao, Boris; Tlili, Sham; Wang, Zhimin; Petitalot, Ambre; Marchand, Raphael; Bardet, Pierre-Luc; Marcq, Philippe; Graner, Francois; Bellaiche, Yohanns			Mechanical Control of Morphogenesis by Fat/Dachsous/Four-Jointed Planar Cell Polarity Pathway	SCIENCE			English	Article							FAT; DROSOPHILA; GROWTH; DACHS; EXPRESSION; DIVISIONS; AFFINITY; ENCODES; MYOSIN; MEMBER	During animal development, several planar cell polarity (PCP) pathways control tissue shape by coordinating collective cell behavior. Here, we characterize by means of multiscale imaging epithelium morphogenesis in the Drosophila dorsal thorax and show how the Fat/Dachsous/Four-jointed PCP pathway controls morphogenesis. We found that the proto-cadherin Dachsous is polarized within a domain of its tissue-wide expression gradient. Furthermore, Dachsous polarizes the myosin Dachs, which in turn promotes anisotropy of junction tension. By combining physical modeling with quantitative image analyses, we determined that this tension anisotropy defines the pattern of local tissue contraction that contributes to shaping the epithelium mainly via oriented cell rearrangements. Our results establish how tissue planar polarization coordinates the local changes of cell mechanical properties to control tissue morphogenesis.	[Bosveld, Floris; Bonnet, Isabelle; Guirao, Boris; Tlili, Sham; Wang, Zhimin; Petitalot, Ambre; Marchand, Raphael; Bardet, Pierre-Luc; Graner, Francois; Bellaiche, Yohanns] Inst Curie, CNRS, Polar Div & Morphogenesis Team, INSERM,UMR 3215,U934, F-75248 Paris 05, France; [Marcq, Philippe] Univ Paris 06, Inst Curie, Lab Phys Chim Curie, CNRS,UMR 168, F-75248 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS)	Bellaiche, Y (corresponding author), Inst Curie, CNRS, Polar Div & Morphogenesis Team, INSERM,UMR 3215,U934, 26 Rue Ulm, F-75248 Paris 05, France.	yohanns.bellaiche@curie.fr		Guirao, Boris/0000-0002-5583-0226; Bonnet, Isabelle/0000-0003-2343-3784; bellaiche, yohanns/0000-0003-1686-2943; Bardet, Pierre-Luc/0000-0003-1766-1318; bosveld, floris/0000-0002-4733-9074; Marcq, Philippe/0000-0002-3232-9156	L'Agence Nationale de la Recherche-MorphoDro [ARC-4830]; European Research Council-CePoDro; Fondation pour la Recherche Medicale; Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Rubicon	L'Agence Nationale de la Recherche-MorphoDro(French National Research Agency (ANR)); European Research Council-CePoDro; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Rubicon	We thank J. Axelrod, S. Blair, Y. Hong, K. Irvine, E. Martin-Blanco, M. Simon, D. Strutt, S. Tsukita, the Bloomington Drosophila Stock Center, Transgenic RNAi Project, and Vienna Drosophila RNAi Center for reagents; M. Coppey, A. Houdusse, F. Molino, S. Ritzenthaler, F. Serman, J. Shi, and the PICT-IBiSA@BDD for help; V. Hakim, E. Heard, J. Lopez-Gay, M. Labouesse, and A-M. Lennon for comments. This work was supported by ARC-4830, L'Agence Nationale de la Recherche-MorphoDro, and European Research Council-CePoDro grants; a Fondation pour la Recherche Medicale grant to I.B.; and a Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Rubicon grant to F.B.	Aigouy B, 2010, CELL, V142, P773, DOI 10.1016/j.cell.2010.07.042; Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; Brittle AL, 2010, CURR BIOL, V20, P803, DOI 10.1016/j.cub.2010.03.056; Brodsky MH, 1996, DEV BIOL, V173, P428, DOI 10.1006/dbio.1996.0038; Casal J, 2006, DEVELOPMENT, V133, P4561, DOI 10.1242/dev.02641; Cho E, 2004, DEVELOPMENT, V131, P4489, DOI 10.1242/dev.01315; CLARK HF, 1995, GENE DEV, V9, P1530, DOI 10.1101/gad.9.12.1530; Goodrich LV, 2011, DEVELOPMENT, V138, P1877, DOI 10.1242/dev.054080; Grusche FA, 2010, CURR BIOL, V20, pR574, DOI 10.1016/j.cub.2010.05.023; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Lecuit T, 2011, ANNU REV CELL DEV BI, V27, P157, DOI 10.1146/annurev-cellbio-100109-104027; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Mao YL, 2011, GENE DEV, V25, P131, DOI 10.1101/gad.610511; Mao YP, 2006, DEVELOPMENT, V133, P2539, DOI 10.1242/dev.02427; Matakatsu H, 2004, DEVELOPMENT, V131, P3785, DOI 10.1242/dev.01254; Matakatsu H, 2008, CURR BIOL, V18, P1390, DOI 10.1016/j.cub.2008.07.067; Matakatsu H, 2006, DEVELOPMENT, V133, P2315, DOI 10.1242/dev.02401; Rogulja D, 2008, DEV CELL, V15, P309, DOI 10.1016/j.devcel.2008.06.003; Schwank G, 2011, DEV CELL, V20, P123, DOI 10.1016/j.devcel.2010.11.007; Simon MA, 2010, CURR BIOL, V20, P811, DOI 10.1016/j.cub.2010.04.016; Strutt H, 2002, DEV CELL, V3, P851, DOI 10.1016/S1534-5807(02)00363-5; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X	23	242	244	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2012	336	6082					724	727		10.1126/science.1221071	http://dx.doi.org/10.1126/science.1221071			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22499807	Green Submitted			2022-12-28	WOS:000303872300051
J	Brook, E				Brook, Edward			The Ice Age Carbon Puzzle	SCIENCE			English	Editorial Material							ATMOSPHERIC CO2; LAST DEGLACIATION; SOUTHERN-OCEAN; VARIABILITY; VENTILATION; RESOLUTION; RECORD; RISE		Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	Oregon State University	Brook, E (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	brooke@oregonstate.edu	Brook, Edward/AAB-7807-2021					Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Broecker W, 2007, EARTH PLANET SC LETT, V256, P90, DOI 10.1016/j.epsl.2007.01.015; Burke A, 2012, SCIENCE, V335, P557, DOI 10.1126/science.1208163; Francey RJ, 1999, TELLUS B, V51, P170, DOI 10.1034/j.1600-0889.1999.t01-1-00005.x; Grootes PM, 1997, J GEOPHYS RES-OCEANS, V102, P26455, DOI 10.1029/97JC00880; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Lourantou A, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003545; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Lund DC, 2011, NAT GEOSCI, V4, P771, DOI [10.1038/NGEO1272, 10.1038/ngeo1272]; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Schmitt J, 2011, ATMOS MEAS TECH, V4, P1445, DOI 10.5194/amt-4-1445-2011; Schmitt J, 2012, SCIENCE, V336, P711, DOI 10.1126/science.1217161; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Skinner LC, 2010, SCIENCE, V328, P1147, DOI 10.1126/science.1183627; Smith HJ, 1999, NATURE, V400, P248, DOI 10.1038/22291	15	4	5	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2012	336	6082					682	683		10.1126/science.1219710	http://dx.doi.org/10.1126/science.1219710			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22461499				2022-12-28	WOS:000303872300038
J	Brassen, S; Gamer, M; Peters, J; Gluth, S; Buchel, C				Brassen, Stefanie; Gamer, Matthias; Peters, Jan; Gluth, Sebastian; Buechel, Christian			Don't Look Back in Anger! Responsiveness to Missed Chances in Successful and Nonsuccessful Aging	SCIENCE			English	Article							SEQUENTIAL INVESTMENT TASK; LIFE REGRETS; OLDER-ADULTS; CHOICE; EMOTION; CORTEX; SIGNAL; YOUNG; GOALS; SPAN	Life-span theories explain successful aging with an adaptive management of emotional experiences like regret. As opportunities to undo regrettable situations decline with age, a reduced engagement into these situations represents a potentially protective strategy to maintain well-being in older age. Yet, little is known about the underlying neurobiological mechanisms supporting this claim. We used a multimodal psychophysiological approach in combination with a sequential risk-taking task that induces the feeling of regret and investigated young as well as emotionally successfully and unsuccessfully (i.e., late-life depressed) aged participants. Responsiveness to regret was specifically reduced in successful aging paralleled by autonomic and frontostriatal characteristics indicating adaptive shifts in emotion regulation. Our results suggest that disengagement from regret reflects a critical resilience factor for emotional health in older age.	[Brassen, Stefanie; Gamer, Matthias; Peters, Jan; Gluth, Sebastian; Buechel, Christian] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Brassen, S (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany.	sbrassen@uke.de	Peters, Jan/GWC-6713-2022; Brassen, Stefanie/H-5386-2012; Peters, Jan/V-2910-2019; Gamer, Matthias/E-7967-2010	Peters, Jan/0000-0002-0195-5357; Peters, Jan/0000-0002-0195-5357; Gamer, Matthias/0000-0002-9676-9038; Brassen, Stefanie/0000-0002-8884-7593; Gluth, Sebastian/0000-0003-2241-5103	German Research Foundation (DFG) [BR 2877/2-1]; Bundesministerium fur Bildung und Forschung [Bernstein 01GQ0912]; DFG [GRK 1247]	German Research Foundation (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	S.B. is supported by the German Research Foundation (DFG, BR 2877/2-1). C. B. is supported by the Bundesministerium fur Bildung und Forschung (Bernstein 01GQ0912). S. G. is supported by the DFG (GRK 1247, CINACS).	Baltes P. B., 1990, SUCCESSFUL AGING PER, P1, DOI [10.1017/CBO9780511665684.003, DOI 10.1017/CBO9780511665684.003]; BELL DE, 1982, OPER RES, V30, P961, DOI 10.1287/opre.30.5.961; Blanchflower DG, 2008, SOC SCI MED, V66, P1733, DOI 10.1016/j.socscimed.2008.01.030; Brassen S, 2008, BIOL PSYCHIAT, V64, P349, DOI 10.1016/j.biopsych.2008.03.022; Brassen S, 2011, BIOL PSYCHIAT, V70, P131, DOI 10.1016/j.biopsych.2010.10.013; Buchel C, 2011, NEUROIMAGE, V57, P1124, DOI 10.1016/j.neuroimage.2011.05.031; Bylsma LM, 2008, CLIN PSYCHOL REV, V28, P676, DOI 10.1016/j.cpr.2007.10.001; Camille N, 2004, SCIENCE, V304, P1167, DOI 10.1126/science.1094550; Carstensen LL, 2006, SCIENCE, V312, P1913, DOI 10.1126/science.1127488; Chiu PH, 2008, NAT NEUROSCI, V11, P514, DOI 10.1038/nn2067; Coricelli G, 2005, NAT NEUROSCI, V8, P1255, DOI 10.1038/nn1514; Damasio A.R., 2005, DESCARTES ERROR EMOT; Gilovich T, 1998, PSYCHOL REV, V105, P602, DOI 10.1037/0033-295X.105.3.602; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Heckhausen J, 2010, PSYCHOL REV, V117, P32, DOI 10.1037/a0017668; Kahneman D., 1982, JUDGMENT UNCERTAINTY, DOI [10.1017/CBO9780511809477, DOI 10.1017/CBO9780511809477, 10.1017/cbo9780511809477]; Kop WJ, 2011, BIOL PSYCHOL, V86, P230, DOI 10.1016/j.biopsycho.2010.12.003; LECCI L, 1994, J PERS SOC PSYCHOL, V66, P731, DOI 10.1037/0022-3514.66.4.731; Lohrenz T, 2007, P NATL ACAD SCI USA, V104, P9493, DOI 10.1073/pnas.0608842104; Mellers B, 1999, J EXP PSYCHOL GEN, V128, P332, DOI 10.1037/0096-3445.128.3.332; Nicolle A, 2011, J NEUROSCI, V31, P3320, DOI 10.1523/JNEUROSCI.5615-10.2011; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Samanez-Larkin GR, 2007, NAT NEUROSCI, V10, P787, DOI 10.1038/nn1894; Scheibe S, 2009, PSYCHOL AGING, V24, P217, DOI 10.1037/a0013807; Stone AA, 2010, P NATL ACAD SCI USA, V107, P9985, DOI 10.1073/pnas.1003744107; Wrosch C, 2005, PSYCHOL AGING, V20, P657, DOI 10.1037/0882-7974.20.4.657; Wrosch C, 2002, PSYCHOL AGING, V17, P340, DOI 10.1037/0882-7974.17.2.340; Yacubian J, 2006, J NEUROSCI, V26, P9530, DOI 10.1523/JNEUROSCI.2915-06.2006	28	76	80	1	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2012	336	6081					612	614		10.1126/science.1217516	http://dx.doi.org/10.1126/science.1217516			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	935DJ	22517323				2022-12-28	WOS:000303498800052
J	Morris, P; Perkins, A				Morris, Peter; Perkins, Alan			Physics and Medicine 2 Diagnostic imaging	LANCET			English	Article							INTENSITY FOCUSED ULTRASOUND; LINE INTEGRALS; TOMOGRAPHY; FUTURE; MAGNETOENCEPHALOGRAPHY; REPRESENTATION; HISTORY; DESIGN; BRAIN; MRI	Physical techniques have always had a key role in medicine, and the second half of the 20th century in particular saw a revolution in medical diagnostic techniques with the development of key imaging instruments: x-ray imaging and emission tomography (nuclear imaging and PET), MRI, and ultrasound. These techniques use the full width of the electromagnetic spectrum, from gamma rays to radio waves, and sound. In most cases, the development of a medical imaging device was opportunistic; many scientists in physics laboratories were experimenting with simple x-ray images within the first year of the discovery of such rays, the development of the cyclotron and later nuclear reactors created the opportunity for nuclear medicine, and one of the co-inventors of MRI was initially attempting to develop an alternative to x-ray diffraction for the analysis of crystal structures. What all these techniques have in common is the brilliant insight of a few pioneering physical scientists and engineers who had the tenacity to develop their inventions, followed by a series of technical innovations that enabled the full diagnostic potential of these instruments to be realised. In this report, we focus on the key part played by these scientists and engineers and the new imaging instruments and diagnostic procedures that they developed. By bringing the key developments and applications together we hope to show the true legacy of physics and engineering in diagnostic medicine.	[Morris, Peter] Univ Nottingham, Sir Peter Mansfield Magnet Resonance Ctr, Sch Phys & Astron, Nottingham NG7 2RD, England; [Perkins, Alan] Univ Nottingham, Sch Clin Sci, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Morris, P (corresponding author), Univ Nottingham, Sir Peter Mansfield Magnet Resonance Ctr, Sch Phys & Astron, Univ Pk, Nottingham NG7 2RD, England.	peter.morris@nottingham.ac.uk		Perkins, Alan/0000-0002-1054-8200				Anger H., 1957, BIOL MED Q REPORT UC, V3653, P38; [Anonymous], 2000, NEW ENGL J MED, V342, P42; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Braver T.S., 2006, HDB FUNCTIONAL NEURO; Brookes MJ, 2010, NEUROIMAGE, V49, P525, DOI 10.1016/j.neuroimage.2009.07.043; Burns PN, 1996, CLIN RADIOL, V51, P50; Carlsson S, 1995, ACTA ONCOL, V34, P1095, DOI 10.3109/02841869509127236; CASSEN B, 1951, NUCLEONICS, V9, P46; Chiewitz O, 1935, NATURE, V136, P754, DOI 10.1038/136754a0; Christie DA, 2006, WELLCOME WITNESSES 2, V28; COHEN D, 1968, SCIENCE, V161, P784, DOI 10.1126/science.161.3843.784; Coolidge WD, 1913, PHYS REV, V2, P409, DOI 10.1103/PhysRev.2.409; CORMACK AM, 1964, J APPL PHYS, V35, P2908, DOI 10.1063/1.1713127; CORMACK AM, 1963, J APPL PHYS, V34, P2722, DOI 10.1063/1.1729798; Crouzet S, 2010, INT J HYPERTHER, V26, P796, DOI 10.3109/02656736.2010.498803; DAMADIAN R, 1971, SCIENCE, V171, P1151, DOI 10.1126/science.171.3976.1151; DAMADIAN R, 1977, PHYSIOL CHEM PHYS M, V9, P97; Deshpande N, 2010, CLIN RADIOL, V65, P567, DOI 10.1016/j.crad.2010.02.013; DONALD I, 1958, LANCET, V1, P1188; Edelman RR, 2006, CLIN MAGNET RESONANC; Eisenberg RL., 2010, CLIN IMAGING ATLAS D; Elahi SF, 2011, J BIOPHOTONICS, V4, P471, DOI 10.1002/jbio.201100048; Facey K, 2007, HEALTH TECHNOL ASSES, V11, P1; Fisher AE, 2008, INT J PSYCHOPHYSIOL, V68, P111, DOI 10.1016/j.ijpsycho.2007.12.005; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HARPER PV, 1962, J NUCL MED, V3, P209; Herman GT, 2009, ADV PATTERN RECOGNIT, P1, DOI 10.1007/978-1-84628-723-7; Hillner BE, 2009, CANCER, V115, P410, DOI 10.1002/cncr.24000; HOFFMAN EJ, 1976, J NUCL MED, V17, P493; HOUNDFIELD GN, 1973, BRIT J RADIOL, V46, P1016, DOI 10.1259/0007-1285-46-552-1016; Houston LE, 2009, PRENATAL DIAG, V29, P1204, DOI 10.1002/pd.2392; INGVAR DH, 1961, LANCET, V2, P806, DOI 10.1016/S0140-6736(61)91092-3; Johnson KA, 2007, ANN NEUROL, V62, P229, DOI 10.1002/ana.21164; Jones TA, 2003, POSITRON EMISSION TO, P4; Kalender WA, 2006, PHYS MED BIOL, V51, pR29, DOI 10.1088/0031-9155/51/13/R03; KUHL DE, 1963, RADIOLOGY, V80, P653, DOI 10.1148/80.4.653; Larsson S A, 1980, Acta Radiol Suppl, V363, P1; LAUTERBUR PC, 1973, NATURE, V242, P190, DOI 10.1038/242190a0; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; LOVE WD, 1954, CIRC RES, V2, P112, DOI 10.1161/01.RES.2.2.112; Low DA, 2011, MED PHYS, V38, P1313, DOI 10.1118/1.3514120; MANSFIELD P, 1977, BRIT J RADIOL, V50, P188, DOI 10.1259/0007-1285-50-591-188; MANSFIELD P, 1978, BRIT J RADIOL, V51, P921, DOI 10.1259/0007-1285-51-611-921; MANSFIELD P, 1977, J PHYS C SOLID STATE, V10, pL55, DOI 10.1088/0022-3719/10/3/004; MANSFIELD P, 1973, J PHYS C SOLID STATE, V6, pL422, DOI 10.1088/0022-3719/6/22/007; Moller HE, 2002, MAGN RESON MED, V47, P1029, DOI 10.1002/mrm.10173; MOULD RF, 1995, PHYS MED BIOL, V40, P1741, DOI 10.1088/0031-9155/40/11/001; Neumann-Haefelin T, 1999, STROKE, V30, P1591, DOI 10.1161/01.STR.30.8.1591; PAXTON R, 1974, BRIT J RADIOL, V47, P530, DOI 10.1259/0007-1285-47-561-530; Perkins AC, 2009, NUCL MED COMMUN, V30, P657, DOI 10.1097/MNM.0b013e32832da277; PHELPS ME, 1976, IEEE T NUCL SCI, V23, P516, DOI 10.1109/TNS.1976.4328298; Phillips RA, 2010, ULTRASOUND MED BIOL, V36, P1224, DOI 10.1016/j.ultrasmedbio.2010.03.020; Plathow C, 2008, J NUCL MED, V49, p43S, DOI 10.2967/jnumed.107.045930; Quaia E, 2007, EUR RADIOL, V17, P1995, DOI 10.1007/s00330-007-0623-0; RADON J, 1986, IEEE T MED IMAGING, V5, P170, DOI 10.1109/TMI.1986.4307775; Roentgen W.C., 1895, SITZUNGSBER PHYS MED, V9, P132; Rumack CM., 2011, DIAGNOSTIC ULTRASOUN, P2103; Schnall MD, 2006, RADIOLOGY, V238, P42, DOI 10.1148/radiol.2381042117; Simpson DR, 2010, CANCER-AM CANCER SOC, V116, P3953, DOI 10.1002/cncr.25129; SMITH FW, 1981, LANCET, V1, P78; Sterzing F, 2011, DTSCH ARZTEBL INT, V108, P274, DOI 10.3238/arztebl.2011.0274; STRAUSS HW, 1975, CIRCULATION, V51, P641, DOI 10.1161/01.CIR.51.4.641; SUBRAMANIAN G, 1971, RADIOLOGY, V99, P192, DOI 10.1148/99.1.192; Sutherland GR, 2008, NEUROSURGERY, V62, P286, DOI 10.1227/01.neu.0000315996.73269.18; SWEET WH, 1951, NEW ENGL J MED, V245, P875, DOI 10.1056/NEJM195112062452301; Tallantyre EC, 2009, INVEST RADIOL, V44, P491, DOI 10.1097/RLI.0b013e3181b4c144; TOBIAS CA, 1945, AM J PHYSIOL, V145, P253, DOI 10.1152/ajplegacy.1945.145.2.253; Toga A.W., 1996, BRAIN MAPPING METHOD; Tranquart F, 1999, ULTRASOUND MED BIOL, V25, P889, DOI 10.1016/S0301-5629(99)00060-5; UK RCoPot, 2003, POS EM TOM STRAT PRO; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Ward JF, 2011, SURG ONCOL CLIN N AM, V20, P389, DOI 10.1016/j.soc.2010.11.009; Wells PNT, 2001, MED ENG PHYS, V23, P147, DOI 10.1016/S1350-4533(01)00042-X; Wijesekera NT, 2010, BRIT MED BULL, V93, P49, DOI 10.1093/bmb/ldp043; Williams AK, 2010, EXPERT REV ANTICANC, V10, P33, DOI [10.1586/era.09.162, 10.1586/ERA.09.162]; WRENN FR, 1951, SCIENCE, V113, P525, DOI 10.1126/science.113.2940.525; Yacoub E, 2008, P NATL ACAD SCI USA, V105, P10607, DOI 10.1073/pnas.0804110105; YOUNG IR, 1981, LANCET, V2, P1063, DOI 10.1016/S0140-6736(81)91273-3	79	19	19	0	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2012	379	9825					1525	1533		10.1016/S0140-6736(12)60429-2	http://dx.doi.org/10.1016/S0140-6736(12)60429-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930BJ	22516558				2022-12-28	WOS:000303110200031
J	Coltice, N; Rolf, T; Tackley, PJ; Labrosse, S				Coltice, N.; Rolf, T.; Tackley, P. J.; Labrosse, S.			Dynamic Causes of the Relation Between Area and Age of the Ocean Floor	SCIENCE			English	Article							THERMAL EVOLUTION; HEAT-FLOW; FLUCTUATIONS; RATES; EARTH; MODEL	The distribution of seafloor ages determines fundamental characteristics of Earth such as sea level, ocean chemistry, tectonic forces, and heat loss from the mantle. The present-day distribution suggests that subduction affects lithosphere of all ages, but this is at odds with the theory of thermal convection that predicts that subduction should happen once a critical age has been reached. We used spherical models of mantle convection to show that plate-like behavior and continents cause the seafloor area-age distribution to be representative of present-day Earth. The distribution varies in time with the creation and destruction of new plate boundaries. Our simulations suggest that the ocean floor production rate previously reached peaks that were twice the present-day value.	[Coltice, N.; Labrosse, S.] Univ Lyon 1, Ecole Normale Super Lyon, CNRS, Lab Geol Lyon, F-69100 Villeurbanne, France; [Rolf, T.; Tackley, P. J.] ETH, Inst Geophys, CH-8092 Zurich, Switzerland	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Swiss Federal Institutes of Technology Domain; ETH Zurich	Coltice, N (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, CNRS, Lab Geol Lyon, F-69100 Villeurbanne, France.	nicolas.coltice@univ-lyon1.fr	Tackley, Paul J/D-8155-2016; Labrosse, Stéphane/M-5990-2019; Labrosse, Stéphane/C-8665-2012	Tackley, Paul J/0000-0003-4878-621X; Labrosse, Stéphane/0000-0002-7620-4363; Labrosse, Stéphane/0000-0002-7620-4363; Coltice, Nicolas/0000-0001-5444-414X	Institut Universitaire de France; ANR [ANR-08-JCJC-0084-01]; Crystal2Plate [PITN-GA-2008-215353]	Institut Universitaire de France; ANR(French National Research Agency (ANR)); Crystal2Plate	We thank R. D. Muller and T. W. Becker for fruitful reviews. Supported by Institut Universitaire de France and ANR grant DynBMO (Dynamique de l'ocean de magma basal) ANR-08-JCJC-0084-01 (N.C. and S.L.) and by Crystal2Plate, a FP-7 funded Marie Curie action under grant agreement PITN-GA-2008-215353 (T.R.). Supercomputing resources were provided by ETH and the Swiss Supercomputer Centre (CSCS).	Becker TW, 2009, EARTH PLANET SC LETT, V278, P233, DOI 10.1016/j.epsl.2008.12.007; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; Cogne JP, 2004, EARTH PLANET SC LETT, V227, P427, DOI 10.1016/j.epsl.2004.09.002; Conrad CP, 2007, GEOLOGY, V35, P29, DOI 10.1130/G22759A.1; Conrad CP, 1999, J GEOPHYS RES-SOL EA, V104, P17551, DOI 10.1029/1999JB900149; Demicco RV, 2004, GEOLOGY, V32, P485, DOI 10.1130/g20409.1; Flament N, 2008, EARTH PLANET SC LETT, V275, P326, DOI 10.1016/j.epsl.2008.08.029; GAFFIN S, 1987, AM J SCI, V287, P596, DOI 10.2475/ajs.287.6.596; Grigne C, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003376; Husson L, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026834; Labrosse S, 2007, EARTH PLANET SC LETT, V260, P465, DOI 10.1016/j.epsl.2007.05.046; Lee CTA, 2005, EARTH PLANET SC LETT, V230, P379, DOI 10.1016/j.epsl.2004.11.019; Muller RD, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001743; Muller RD, 2008, SCIENCE, V319, P1357, DOI 10.1126/science.1151540; PARSONS B, 1982, J GEOPHYS RES, V87, P289, DOI 10.1029/JB087iB01p00289; Rowley DB, 2002, GEOL SOC AM BULL, V114, P927, DOI 10.1130/0016-7606(2002)114<0927:ROPCAD>2.0.CO;2; SCLATER JG, 1980, REV GEOPHYS, V18, P269, DOI 10.1029/RG018i001p00269; Seton M, 2009, GEOLOGY, V37, P687, DOI 10.1130/G25624A.1; STEIN CA, 1992, NATURE, V359, P123, DOI 10.1038/359123a0; Yanagisawa T, 1999, GEOPHYS RES LETT, V26, P791, DOI 10.1029/1999GL900109	20	52	52	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2012	336	6079					335	338		10.1126/science.1219120	http://dx.doi.org/10.1126/science.1219120			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22517857				2022-12-28	WOS:000302995400042
J	Hock, RS; Or, F; Kolappa, K; Burkey, MD; Surkan, PJ; Eaton, WW				Hock, Rebecca S.; Or, Flora; Kolappa, Kavitha; Burkey, Matthew D.; Surkan, Pamela J.; Eaton, William W.			A new resolution for global mental health	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; PRIMARY-CARE; DEPRESSION		[Hock, Rebecca S.; Or, Flora; Eaton, William W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21205 USA; [Surkan, Pamela J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Kolappa, Kavitha] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Kolappa, Kavitha] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Harvard University; Harvard T.H. Chan School of Public Health	Hock, RS (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21205 USA.	rhock@jhsph.edu			NIMH NIH HHS [T32 MH014592] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH014592] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Araya R, 2003, LANCET, V361, P995, DOI 10.1016/S0140-6736(03)12825-5; Bass JK, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001159; Bloom DE, 2011, GLOBAL EC BURDEN NON; Keter SC, EMPOWERING PEOPLE AF; Patel V, 2010, LANCET, V376, P2086, DOI 10.1016/S0140-6736(10)61508-5; Sunkel C, 2012, LANCET, V379, P201, DOI 10.1016/S0140-6736(11)61270-1; Surkan PJ, 2011, B WORLD HEALTH ORGAN, V89, P607, DOI 10.2471/BLT.11.088187; WHO, 130 SESS WHO EX BOAR; WHO, 2008, WHO GLOB BURD DIS 20; World Health Organization, 2011, GLOB HLTH SECT STRAT	10	31	32	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 14	2012	379	9824					1367	1368		10.1016/S0140-6736(12)60243-8	http://dx.doi.org/10.1016/S0140-6736(12)60243-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	926BR	22500865	Green Accepted			2022-12-28	WOS:000302806800005
J	Gravitz, L				Gravitz, Lauren			Aetiology: The X factor	NATURE			English	Editorial Material																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					S2	S2		10.1038/nature11103	http://dx.doi.org/10.1038/nature11103			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22509503	Bronze			2022-12-28	WOS:000303149900044
J	Rice, J				Rice, Jocelyn			Animal models: Not close enough	NATURE			English	Editorial Material																			0	62	63	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					S9	S9		10.1038/nature11102	http://dx.doi.org/10.1038/nature11102			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22509510	Bronze			2022-12-28	WOS:000303149900051
J	Rodriguez-Arias, D; Deballon, IO				Rodriguez-Arias, David; Ortega Deballon, Ivan			Protocols for uncontrolled donation after circulatory death	LANCET			English	Editorial Material							CARDIOPULMONARY-RESUSCITATION; CARDIAC-ARREST; HYPOTHERMIA; GUIDELINES; SUPPORT		[Rodriguez-Arias, David] CSIC, Inst Philosophy, Ctr Human & Social Sci, Madrid 28037, Spain; [Ortega Deballon, Ivan] Helicopter Emergency Med Serv, Madrid, Spain; [Ortega Deballon, Ivan] Univ Alcala de Henares, Sch Nursing, Alcala De Henares, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Ciencias Humanas y Sociales (CCHS); CSIC - Instituto de Filosofia (IFS); Universidad de Alcala	Rodriguez-Arias, D (corresponding author), CSIC, Inst Philosophy, Ctr Human & Social Sci, Madrid 28037, Spain.	david.rodriguezarias@cchs.csic.es	Rodríguez-Arias, David/K-5894-2014; ORTEGA, IVAN/C-6307-2017	Rodríguez-Arias, David/0000-0002-4555-5259; ORTEGA, IVAN/0000-0002-0819-2399				Bernat JL, 2010, CRIT CARE MED, V38, P963, DOI 10.1097/CCM.0b013e3181c58916; Bottiger BW, 2001, LANCET, V357, P1583, DOI 10.1016/S0140-6736(00)04726-7; Childress JF, 2008, J LAW MED ETHICS, V36, P766, DOI 10.1111/j.1748-720X.2008.00336.x; Conseil francais de reanimation cardiopulmonaire, 2009, Ann Fr Anesth Reanim, V28, P182, DOI 10.1016/j.annfar.2008.12.011; Lederer W, 2004, RESUSCITATION, V61, P123, DOI 10.1016/j.resuscitation.2003.12.016; Massetti M, 2005, ANN THORAC SURG, V79, P178, DOI 10.1016/j.athoracsur.2004.06.095; Nagao K, 2010, CIRC J, V74, P77, DOI 10.1253/circj.CJ-09-0502; Nielsen N, 2005, RESUSCITATION, V65, P111, DOI 10.1016/j.resuscitation.2004.11.007; Nolan JP, 2010, RESUSCITATION, V81, P1219, DOI 10.1016/j.resuscitation.2010.08.021; Olivecrona G, 2011, INTERV CARDIOL, V6, P12; Thiagarajan RR, 2009, ANN THORAC SURG, V87, P778, DOI 10.1016/j.athoracsur.2008.12.079; Vanden Hoek TL, 2010, CIRCULATION, V122, pS829, DOI 10.1161/CIRCULATIONAHA.110.971069; Wall SP, 2011, AM J TRANSPLANT, V11, P1417, DOI 10.1111/j.1600-6143.2011.03582.x; Zeiler K, 2008, J MED ETHICS, V34, DOI 10.1136/jme.2007.021568	14	35	37	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2012	379	9823					1275	1276		10.1016/S0140-6736(11)61784-4	http://dx.doi.org/10.1016/S0140-6736(11)61784-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	922FB	22483020				2022-12-28	WOS:000302531100004
J	Hostetter, MK				Hostetter, Margaret Kendrick			What We Don't See	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MEASLES-VIRUS VACCINE; HOME-DWELLING CHILDREN; INSTITUTIONALIZED CHILDREN; POLIOMYELITIS; CHILDHOOD; INFANTS; CELL		[Hostetter, Margaret Kendrick] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University of Cincinnati	Hostetter, MK (corresponding author), Cincinnati Childrens Hosp, MLC 7017,3333 Burnet Ave, Cincinnati, OH 45229 USA.	margaret.hostetter@cchmc.org						Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; [Anonymous], 1814, NEW ENGL J MED, V3, P5; [Anonymous], 1975, BIC ED 1, V1; [Anonymous], 1914, BOSTON MED SURG J, V170, P181; [Anonymous], 1873, BOSTON MED SURG J, V88, P259; [Anonymous], 1853, BOSTON MED SURG J, V49, P145; [Anonymous], 1975, BIC ED 2, V2; [Anonymous], 1869, BOSTON MED SURG J, V80, P157; [Anonymous], 1884, BOSTON MED SURG J, V110, P46; Ausubel J.H., 2001, TECHNOL SOC, V23, P131; AVERY ME, 1986, NEW ENGL J MED, V315, P825, DOI 10.1056/NEJM198609253151308; Baker J., 2005, DEDICATED HLTH ALL C; Baker S., 1925, CHILD HYGIENE; BLACK FL, 1960, NEW ENGL J MED, V263, P165, DOI 10.1056/NEJM196007282630404; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; BREMAN JG, 1980, NEW ENGL J MED, V303, P1263, DOI 10.1056/NEJM198011273032204; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; EFRON ML, 1964, NEW ENGL J MED, V270, P1378, DOI 10.1056/NEJM196406252702602; ENDERS JF, 1960, NEW ENGL J MED, V263, P153, DOI 10.1056/NEJM196007282630401; ESKOLA J, 1987, NEW ENGL J MED, V317, P717, DOI 10.1056/NEJM198709173171201; GLENN WWL, 1958, NEW ENGL J MED, V259, P117, DOI 10.1056/NEJM195807172590304; HAGGERTY RJ, 1960, NEW ENGL J MED, V263, P178, DOI 10.1056/NEJM196007282630407; KATZ SL, 1960, NEW ENGL J MED, V263, P159, DOI 10.1056/NEJM196007282630402; KATZ SL, 1960, NEW ENGL J MED, V263, P180, DOI 10.1056/NEJM196007282630408; KEMPE CH, 1960, NEW ENGL J MED, V263, P162, DOI 10.1056/NEJM196007282630403; KRUGMAN S, 1960, NEW ENGL J MED, V263, P174, DOI 10.1056/NEJM196007282630406; LEMNA WK, 1990, NEW ENGL J MED, V322, P291, DOI 10.1056/NEJM199002013220503; LEPOW ML, 1961, NEW ENGL J MED, V264, P1071, DOI 10.1056/NEJM196105252642102; LEPOW ML, 1960, NEW ENGL J MED, V263, P170, DOI 10.1056/NEJM196007282630405; MCCOMB JA, 1950, NEW ENGL J MED, V243, P442, DOI 10.1056/NEJM195009212431204; Osgood H., 1881, BOSTON MED SURG J, V104, P289; Osler W., 1880, BOSTON MED SURG J, V103, P29; PAGANO JS, 1961, NEW ENGL J MED, V264, P155, DOI 10.1056/NEJM196101262640401; PAUL JR, 1961, NEW ENGL J MED, V264, P651, DOI 10.1056/NEJM196103302641307; PEARSON HA, 1969, NEW ENGL J MED, V281, P923, DOI 10.1056/NEJM196910232811703; PELTOLA H, 1984, NEW ENGL J MED, V310, P1561, DOI 10.1056/NEJM198406143102404; PONSONBY AL, 1993, NEW ENGL J MED, V329, P377, DOI 10.1056/NEJM199308053290601; POPE AS, 1956, NEW ENGL J MED, V254, P110, DOI 10.1056/NEJM195601192540305; PROVENZANO RW, 1959, NEW ENGL J MED, V261, P473, DOI 10.1056/NEJM195909032611001; Richardson V, 2010, NEW ENGL J MED, V362, P299, DOI 10.1056/NEJMoa0905211; Riis Jacob A, 1890, OTHER HALF LIVES; Rotoh TM, 1900, BOSTON MED SURG J, V143, P357; Schwartz TC., COMPUTATIONAL ALGORI; SHANNON JA, 1971, NEW ENGL J MED, V284, P75, DOI 10.1056/NEJM197101142840204; SMITH CA, 1973, NEW ENGL J MED, V289, P322, DOI 10.1056/NEJM197308092890613; TAWA A, 1985, NEW ENGL J MED, V313, P1033, DOI 10.1056/NEJM198510243131701; Ware J., 1850, BOSTON MED SURG J, V42, P233; Webster JO., 1873, BOSTON MED SURG J, V89, P173; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Wilfert CM, 1996, NEW ENGL J MED, V335, P1678, DOI 10.1056/NEJM199611283352210	50	20	20	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 5	2012	366	14					1328	1334		10.1056/NEJMra1111421	http://dx.doi.org/10.1056/NEJMra1111421			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919QJ	22475596				2022-12-28	WOS:000302343000010
J	Kaplan, RM; Satterfield, JM; Kington, RS				Kaplan, Robert M.; Satterfield, Jason M.; Kington, Raynard S.			Building a Better Physician - The Case for the New MCAT	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kaplan, Robert M.] NIH, Off Behav & Social Sci Res, Bethesda, MD 20892 USA; [Satterfield, Jason M.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Kington, Raynard S.] Grinnell Coll, Off President, Grinnell, IA 50112 USA	National Institutes of Health (NIH) - USA; University of California System; University of California San Francisco	Kaplan, RM (corresponding author), NIH, Off Behav & Social Sci Res, Bldg 10, Bethesda, MD 20892 USA.		KAPLAN, Robert/AAK-7342-2021		National Center for Complementary & Integrative Health [R25AT006573] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL060081] Funding Source: NIH RePORTER; NCCIH NIH HHS [R25 AT006573] Funding Source: Medline	National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CLINICAL CENTER; NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)		[Anonymous], 2011, MMWR SURVEILL SUMM, V60, P1; Dienstag JL, 2011, NEW ENGL J MED, V365, P1955, DOI 10.1056/NEJMp1110171; Hotchkiss JW, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000176; Los Angeles County Department of Public Health, 2010, LIF EXP LOS ANG LONG; Woolf SH, 2006, HARVARD HLTH POLICY, V7, P5	5	38	38	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 5	2012	366	14					1265	1268		10.1056/NEJMp1113274	http://dx.doi.org/10.1056/NEJMp1113274			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	919QJ	22475589	Green Accepted			2022-12-28	WOS:000302343000002
J	Safdar, N; Abad, CL; Kaul, DR; Saint, S				Safdar, Nasia; Abad, Cybele L.; Kaul, Daniel R.; Saint, Sanjay			Skin Deep	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYCOBACTERIUM-MARINUM; CUTANEOUS INFECTIONS; DIAGNOSIS		[Safdar, Nasia] Univ Wisconsin, Sch Med, Dept Med, Madison, WI 53705 USA; [Abad, Cybele L.] Milwaukee Hlth Serv, Early Intervent Program Clin, Milwaukee, WI USA; [Kaul, Daniel R.; Saint, Sanjay] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Saint, Sanjay] Dept Vet Affairs Hlth Serv Res & Dev Ctr Excellen, Ann Arbor, MI USA	University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan	Safdar, N (corresponding author), Univ Wisconsin, Sch Med, Dept Med, MFCB 5221,1685 Highland Ave, Madison, WI 53705 USA.	ns2@medicine.wisc.edu	Saint, Sanjay/AAF-5126-2019					Barton A, 1997, BRIT J RHEUMATOL, V36, P1207; Bhambri S, 2009, DERMATOL CLIN, V27, P63, DOI 10.1016/j.det.2008.07.009; COLLINS RJ, 1988, PATHOLOGY, V20, P340, DOI 10.3109/00313028809085215; FISHER AA, 1988, CUTIS, V41, P397; GLUCKMAN SJ, 1995, CLIN DERMATOL, V13, P273, DOI 10.1016/0738-081X(95)00023-9; HAUTMANN G, 1994, DERMATOL CLIN, V12, P657, DOI 10.1016/S0733-8635(18)30129-3; Huebner ES, 2006, GASTROENTEROL CLIN N, V35, P355, DOI 10.1016/j.gtc.2006.03.005; Kobashi Y, 2009, INT J TUBERC LUNG D, V13, P1422; KOSTMAN JR, 1993, ANN INTERN MED, V118, P883, DOI 10.7326/0003-4819-118-11-199306010-00009; KULLAVANIJAYA P, 1993, INT J DERMATOL, V32, P504, DOI 10.1111/j.1365-4362.1993.tb02834.x; Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; PHILPOTT JA, 1963, ARCH DERMATOL, V88, P158, DOI 10.1001/archderm.1963.01590200046008; PREVOST E, 1982, SOUTHERN MED J, V75, P1349, DOI 10.1097/00007611-198211000-00011; SILCOX VA, 1971, APPL MICROBIOL, V21, P327, DOI 10.1128/AEM.21.2.327-334.1971	15	5	5	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 5	2012	366	14					1336	1340		10.1056/NEJMcps0909226	http://dx.doi.org/10.1056/NEJMcps0909226			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	919QJ	22475598				2022-12-28	WOS:000302343000012
J	Wilkie, MD; Al-Mahfoudh, R				Wilkie, Mark D.; Al-Mahfoudh, Rafid			PICTURE QUIZ Acute headache and visual field defect	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PITUITARY APOPLEXY; CONSERVATIVE MANAGEMENT; SURGERY		[Wilkie, Mark D.; Al-Mahfoudh, Rafid] Walton Ctr Neurol & Neurosurg, Dept Neurosurg, Liverpool L9 7LJ, Merseyside, England	Walton Centre	Wilkie, MD (corresponding author), Walton Ctr Neurol & Neurosurg, Dept Neurosurg, Liverpool L9 7LJ, Merseyside, England.	mdwilkie@doctors.org.uk						Ayuk J, 2004, CLIN ENDOCRINOL, V61, P747, DOI 10.1111/j.1365-2265.2004.02162.x; Binning MJ, 2008, J NEUROSURG, V108, P3, DOI 10.3171/JNS/2008/108/01/0003; da Motta L A, 1999, J Neurosurg Sci, V43, P25; Davenport R, 2004, CLIN MED, V4, P108, DOI 10.7861/clinmedicine.4-2-108; Greenberg MS, 2006, HDB NEUROSURGERY, P438; Kearney T, 2007, POSTGRAD MED J, V83, P79, DOI 10.1136/pgmj.2006.049445; Kim SH, 2007, J CLIN NEUROSCI, V14, P1158, DOI 10.1016/j.jocn.2006.07.016; Levy A, 2003, CLIN ENDOCRINOL, V58, P543, DOI 10.1046/j.1365-2265.2003.01747.x; Leyer C, 2011, J ENDOCRINOL INVEST, V34, P502, DOI 10.3275/7241; MACCAGNAN P, 1995, J CLIN ENDOCR METAB, V80, P2190, DOI 10.1210/jc.80.7.2190; Mou CZ, 2009, J CLIN NEUROSCI, V16, P64, DOI 10.1016/j.jocn.2008.02.012; Murad-Kejbou S, 2009, CURR OPIN OPHTHALMOL, V20, P456, DOI 10.1097/ICU.0b013e3283319061; Nawar Rita N, 2008, J Intensive Care Med, V23, P75, DOI 10.1177/0885066607312992; ONESTI ST, 1990, NEUROSURGERY, V26, P980, DOI 10.1227/00006123-199006000-00010; Piotin M, 1999, EUR RADIOL, V9, P918, DOI 10.1007/s003300050767; Rajasekaran S, 2011, CLIN ENDOCRINOL, V74, P9, DOI 10.1111/j.1365-2265.2010.03913.x; Randeva HS, 1999, CLIN ENDOCRINOL, V51, P181, DOI 10.1046/j.1365-2265.1999.00754.x; Semple PL, 2008, J NEUROSURG, V108, P909, DOI 10.3171/JNS/2008/108/5/0909; Telesca M, 2009, INTENS CARE MED, V35, P185, DOI 10.1007/s00134-008-1285-3; Tosaka M, 2007, AM J NEURORADIOL, V28, P2023, DOI 10.3174/ajnr.A0692; Veldhuis J D, 1980, Endocr Rev, V1, P100; Verrees Meg, 2004, Neurosurg Focus, V16, pE6	22	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 4	2012	344								e2229	10.1136/bmj.e2229	http://dx.doi.org/10.1136/bmj.e2229			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923HC	22491696				2022-12-28	WOS:000302609300009
J	Thornton, JD; Alejandro-Rodriguez, M; Leon, JB; Albert, JM; Baldeon, EL; De Jesus, LM; Gallardo, A; Hossain, S; Perez, EA; Martin, JY; Lasalvia, S; Wong, KA; Allen, MD; Robinson, M; Heald, C; Bowen, G; Sehgal, AR				Thornton, J. Daryl; Alejandro-Rodriguez, Marilyn; Leon, Janeen B.; Albert, Jeffrey M.; Baldeon, Evelyn L.; De Jesus, Liza M.; Gallardo, Ana; Hossain, Sabina; Perez, Elba Adriana; Martin, Jovana Y.; Lasalvia, Susan; Wong, Kristine A.; Allen, Margaret D.; Robinson, Mark; Heald, Charles; Bowen, Gordon; Sehgal, Ashwini R.			Effect of an iPod Video Intervention on Consent to Donate Organs A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							HIGH-SCHOOL-STUDENTS; DONOR CARD; ATTITUDES; COMMUNICATION; WILLINGNESS; KNOWLEDGE; MODEL	Background: The gap between the supply of organs available for transplantation and demand is growing, especially among ethnic groups. Objective: To evaluate the effect of a video designed to address concerns of ethnic groups about organ donation. Design: Cluster randomized, controlled trial. Randomization was performed by using a random-number table with centralized allocation concealment. Participants and investigators assessing outcomes were not blinded to group assignment. (ClinicalTrials.gov registration number: NCT00870506) Setting: Twelve branches of the Ohio Bureau of Motor Vehicles in northeastern Ohio. Participants: 952 participants aged 15 to 66 years. Intervention: Video (intervention; n = 443) or usual Bureau of Motor Vehicles license practices (control; n = 509). Measurements: The primary outcome was the proportion of participants who provided consent for organ donation on a newly acquired driver's license, learner's permit, or state identification card. Secondary outcomes included willingness to make a living kidney donation to a family member in need and personal beliefs about donation. Results: More participants who viewed the video consented to donate organs than control participants (84% vs. 72%; difference, 12 percentage points [95% CI, 6 to 17 percentage points]). The video was effective among black participants (76% vs. 54%; difference, 22 percentage points [CI, 9 to 35 percentage points]) and white participants (88% vs. 77%; difference, 11 percentage points [CI, 5 to 15 percentage points]). At the end of the trial, fewer intervention than control participants reported having insufficient information about organ donation (34% vs. 44%; difference, -10 percentage points [CI, -16 to -4 percentage points]), wanting to be buried with all of their organs (14% vs. 25%; difference, -11 percentage points [CI, -16 to -6 percentage points]), and having conflicts with organ donation (7% vs. 11%; difference, -4 percentage points [CI, -8 to -2 percentage points]). Limitation: How the observed increases in consent to donate organs might translate into a greater organ supply in the region is unclear. Conclusion: Exposure to a brief video addressing concerns that ethnic groups have about organ donation just before obtaining a license, permit, or identification card increased consent to donate organs among white and black participants.	[Thornton, J. Daryl] Case Western Reserve Univ, Ctr Reducing Hlth Dispar, Cleveland Minor Organ Tissue Transplant Educ Prog, MetroHlth Med Ctr, Cleveland, OH 44109 USA; Univ Alabama Birmingham, Birmingham, AL USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; Benaroya Res Inst, Seattle, WA USA; Lifebanc, Cleveland, OH USA	Case Western Reserve University; MetroHealth System; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Berkeley; Benaroya Research Institute	Thornton, JD (corresponding author), Case Western Reserve Univ, Ctr Reducing Hlth Dispar, Cleveland Minor Organ Tissue Transplant Educ Prog, MetroHlth Med Ctr, MetroHlth Campus,2500 MetroHlth Dr,Rammelkamp R20, Cleveland, OH 44109 USA.	daryl.thornton@case.edu	Albert, Jeffrey/P-7273-2019	Albert, Jeffrey/0000-0003-2245-1745	National Institutes of Health; Robert Wood Johnson Foundation; National Institute on Minority Health and Health Disparities [1-P60MD002265-01]; National Center for Research Resources [UL1RR024989]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P60MD002265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	National Institutes of Health and the Robert Wood Johnson Foundation.; By the National Institute on Minority Health and Health Disparities (grant 1-P60MD002265-01), National Center for Research Resources (grant UL1RR024989), and Robert Wood Johnson Harold Amos Medical Faculty Development Program.	Alvaro EM, 2011, PSYCHOL HEALTH MED, V16, P686, DOI 10.1080/13548506.2011.564353; Arriola K, 2010, HEALTH EDUC BEHAV, V37, P264, DOI 10.1177/1090198109341725; Boulware LE, 2002, TRANSPLANTATION, V73, P1683; Callender C O, 1982, J Natl Med Assoc, V74, P807; Fahrenwald NL, 2010, AM J TRANSPLANT, V10, P1453, DOI 10.1111/j.1600-6143.2010.03120.x; Fahrenwald Nancy L, 2007, Prog Transplant, V17, P281; Gallup, 1992, AM PUBL ATT ORG DON; Harrison TR, 2008, PROG TRANSPLANT, V18, P301; Health Resources and Services Administration, 2011, ORG PROC TRANSPL NET; Horton R L, 1991, J Health Care Mark, V11, P36; HORTON RL, 1990, SOC SCI MED, V31, P791, DOI 10.1016/0277-9536(90)90174-Q; Little R.J.A., 2002, STAT ANAL MISSING DA; Merion RM, 2003, TRANSPLANTATION, V75, P1175, DOI 10.1097/01.TP.0000062845.51042.DD; Morgan SE, 2008, HEALTH COMMUN, V23, P23, DOI 10.1080/10410230701805158; Ohio Bureau of Motor Vehicles, 2010, 2009 BMV FACTS FIG; PROTTAS JM, 1983, MILBANK FUND Q, V61, P278, DOI 10.2307/3349908; Quinn Michael T, 2006, Prog Transplant, V16, P253; Rubin D. B., 2004, MULTIPLE IMPUTATION; Siminoff LA, 2004, SOC SCI MED, V59, P2325, DOI 10.1016/j.socscimed.2004.03.029; Siminoff LA, 2003, CRIT CARE MED, V31, P146, DOI 10.1097/00003246-200301000-00023; Skumanich SA, 1996, SOC SCI MED, V43, P401, DOI 10.1016/0277-9536(95)00404-1; Thornton JD, 2006, J ADOLESCENT HEALTH, V39, P266, DOI 10.1016/j.jadohealth.2005.12.028; U.S. Census Bureau, 2011, AM FACTFINDER; Vinokur AD, 2006, HEALTH EDUC BEHAV, V33, P773, DOI 10.1177/1090198106288596; Wagstaff David A, 2008, J Public Health Manag Pract, V14, pE7; WINKEL FW, 1984, SOC SCI MED, V19, P957, DOI 10.1016/0277-9536(84)90325-3; Young D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3911	27	39	39	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2012	156	7					483	U47		10.7326/0003-4819-156-7-201204030-00004	http://dx.doi.org/10.7326/0003-4819-156-7-201204030-00004			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	921GP	22473435				2022-12-28	WOS:000302466400002
J	Abraham, T				Abraham, Thomas			Polio eradication: a complex end game	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Hong Kong, Journalism & Media Studies Ctr, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Abraham, T (corresponding author), Univ Hong Kong, Journalism & Media Studies Ctr, Hong Kong, Hong Kong, Peoples R China.	thomas@hku.hk						[Anonymous], 2011, WHO WKLY EPIDEMIOL R, V46, P510; Berhane Y, 2009, LANCET INFECT DIS, V9, P655, DOI 10.1016/S1473-3099(09)70268-3; Global Polio Eradication Initiative, CIRC VACC DER POL CV	3	4	4	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 2	2012	344								e2398	10.1136/bmj.e2398	http://dx.doi.org/10.1136/bmj.e2398			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	923GB	22474304				2022-12-28	WOS:000302606500010
J	Collins, R				Collins, Rory			What makes UK Biobank special?	LANCET			English	Editorial Material							COHORT		UK Biobank, Stockport SK3 0SA, Lancs, England		Collins, R (corresponding author), UK Biobank, Stockport SK3 0SA, Lancs, England.	ukbiobank@ukbiobank.ac.uk			Wellcome Trust [093707] Funding Source: Medline; Medical Research Council [MC_qA137853] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Burton PR, 2009, INT J EPIDEMIOL, V38, P263, DOI 10.1093/ije/dyn147; Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120; Elliott P, 2008, INT J EPIDEMIOL, V37, P234, DOI 10.1093/ije/dym276; Grimes DA, 2002, LANCET, V359, P341, DOI 10.1016/S0140-6736(02)07500-1; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Manolio TA, 2010, JAMA-J AM MED ASSOC, V304, P2290, DOI 10.1001/jama.2010.1686; Palmer LJ, 2007, LANCET, V369, P1980, DOI 10.1016/S0140-6736(07)60924-6; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Tapia-Conyer R, 2006, INT J EPIDEMIOL, V35, P243, DOI 10.1093/ije/dyl042; UK Biobank, 2007, UKBBPROT0906; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4	12	427	436	3	44	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 31	2012	379	9822					1173	1174		10.1016/S0140-6736(12)60404-8	http://dx.doi.org/10.1016/S0140-6736(12)60404-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	918DV	22463865				2022-12-28	WOS:000302230400008
J	Duffy, MA; Ochs, JH; Penczykowski, RM; Civitello, DJ; Klausmeier, CA; Hall, SR				Duffy, Meghan A.; Ochs, Jessica Housley; Penczykowski, Rachel M.; Civitello, David J.; Klausmeier, Christopher A.; Hall, Spencer R.			Ecological Context Influences Epidemic Size and Parasite-Driven Evolution	SCIENCE			English	Article							RAPID EVOLUTION; SELECTIVE PREDATION; RESISTANCE; DAPHNIA; LIMITATION; PHOSPHORUS; FEEDBACKS; NITROGEN; LAKES	The occurrence and magnitude of disease outbreaks can strongly influence host evolution. In particular, when hosts face a resistance-fecundity trade-off, they might evolve increased resistance to infection during larger epidemics but increased susceptibility during smaller ones. We tested this theoretical prediction by using a zooplankton-yeast host-parasite system in which ecological factors determine epidemic size. Lakes with high productivity and low predation pressure had large yeast epidemics; during these outbreaks, hosts became more resistant to infection. However, with low productivity and high predation, epidemics remained small and hosts evolved increased susceptibility. Thus, by modulating disease outbreaks, ecological context (productivity and predation) shaped host evolution during epidemics. Consequently, anthropogenic alteration of productivity and predation might strongly influence both ecological and evolutionary outcomes of disease.	[Duffy, Meghan A.; Ochs, Jessica Housley; Penczykowski, Rachel M.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Civitello, David J.; Hall, Spencer R.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Klausmeier, Christopher A.] Michigan State Univ, WK Kellogg Biol Stn KBS, Hickory Corners, MI 49060 USA; [Klausmeier, Christopher A.] Michigan State Univ, Dept Zool, Hickory Corners, MI 49060 USA	University System of Georgia; Georgia Institute of Technology; Indiana University System; Indiana University Bloomington; Michigan State University; Michigan State University	Duffy, MA (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	duffy@gatech.edu	Penczykowski, Rachel/K-4007-2015; Duffy, Meghan/AFN-5376-2022; Duffy, Meghan A/E-6867-2016; Klausmeier, Christopher A/J-9339-2012; Duffy, Meghan A/A-9376-2008; Penczykowski, Rachel/AAH-4208-2019	Penczykowski, Rachel/0000-0003-4559-0609; Duffy, Meghan/0000-0002-8142-0802; Duffy, Meghan A/0000-0002-8142-0802; Penczykowski, Rachel/0000-0003-4559-0609; Klausmeier, Christopher/0000-0002-6987-5871	NSF [DEB-0841679, DEB-0841817, DEB-0845825, OCE-0928819]; James S. McDonnell Foundation	NSF(National Science Foundation (NSF)); James S. McDonnell Foundation	We thank S. Hernandez, K. Jansen, K. Kenline, A. Reynolds, B. Sarrell, K. van Rensburg, and C. Washington for assistance in the lab; K. Boatman, Z. Brown, A. Bowling, C. White, and P. Forys for their help with the field survey; and S. Auld and two anonymous reviewers for comments on the manuscript. This work was supported by NSF (grants DEB-0841679 to M.A.D., DEB-0841817 to S.R.H., and DEB-0845825 and OCE-0928819 to C.A.K.) and by a grant from the James S. McDonnell Foundation (to C.A.K.). We appreciate cooperation from S. Siscoe at the Indiana Department of Natural Resources's Division of Forestry and R. Ronk at the Division of Fish and Wildlife for the field survey. This is KBS contribution no. 1607. Data are available in the SOM and from the lead author (M.A.D.).	ANDERSON R M, 1991; ANTONOVICS J, 1994, P ROY SOC B-BIOL SCI, V257, P105, DOI 10.1098/rspb.1994.0101; Boots M, 1999, AM NAT, V153, P359, DOI 10.1086/303181; Boots M, 2009, PHILOS T R SOC B, V364, P27, DOI 10.1098/rstb.2008.0160; BOWERS RG, 1994, P ROY SOC B-BIOL SCI, V257, P247, DOI 10.1098/rspb.1994.0122; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Duffy MA, 2005, LIMNOL OCEANOGR, V50, P412, DOI 10.4319/lo.2005.50.2.0412; Duffy MA, 2008, AM NAT, V171, P499, DOI 10.1086/528998; Duffy MA, 2007, ECOL LETT, V10, P44, DOI 10.1111/j.1461-0248.2006.00995.x; Duffy MA, 2009, J ANIM ECOL, V78, P1106, DOI 10.1111/j.1365-2656.2009.01568.x; Duffy MA, 2009, ECOLOGY, V90, P1441, DOI 10.1890/08-1130.1; Duffy MA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-80; Dybdahl MF, 1998, EVOLUTION, V52, P1057, DOI [10.1111/j.1558-5646.1998.tb01833.x, 10.2307/2411236]; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Greenberg AE, 1995, STANDARD METHODS EXA; Guildford SJ, 2000, LIMNOL OCEANOGR, V45, P1213, DOI 10.4319/lo.2000.45.6.1213; Hall SR, 2011, OECOLOGIA, V166, P833, DOI 10.1007/s00442-011-1905-4; Hall SR, 2010, AM NAT, V176, P557, DOI 10.1086/656523; Hall SR, 2010, BIOSCIENCE, V60, P363, DOI 10.1525/bio.2010.60.5.6; Jokela J, 2009, AM NAT, V174, pS43, DOI 10.1086/599080; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; KITCHELL JA, 1980, LIMNOL OCEANOGR, V25, P389, DOI 10.4319/lo.1980.25.3.0389; Lafferty KD, 2003, ECOL LETT, V6, P654, DOI 10.1046/j.1461-0248.2003.00480.x; Overholt EP, 2012, ECOL LETT, V15, P47, DOI 10.1111/j.1461-0248.2011.01707.x; Packer C, 2003, ECOL LETT, V6, P797, DOI 10.1046/j.1461-0248.2003.00500.x; PARKER MA, 1991, EVOLUTION, V45, P1209, DOI 10.1111/j.1558-5646.1991.tb04387.x; Penczykowski RM, 2011, FRESHWATER BIOL, V56, P689, DOI 10.1111/j.1365-2427.2010.02499.x	27	76	76	2	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1636	1638		10.1126/science.1215429	http://dx.doi.org/10.1126/science.1215429			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461614				2022-12-28	WOS:000302062600048
J	Qian, L; Huang, Y; Spencer, CI; Foley, A; Vedantham, V; Liu, L; Conway, SJ; Fu, JD; Srivastava, D				Qian, Li; Huang, Yu; Spencer, C. Ian; Foley, Amy; Vedantham, Vasanth; Liu, Lei; Conway, Simon J.; Fu, Ji-dong; Srivastava, Deepak			In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes	NATURE			English	Article							DEFINED FACTORS; STEM-CELLS; DIRECT CONVERSION; GENE-TRANSFER; ADULT; HEART; INJURY; REPAIR; DIFFERENTIATION; EXPRESSION	The reprogramming of adult cells into pluripotent cells or directly into alternative adult cell types holds great promise for regenerative medicine. We reported previously that cardiac fibroblasts, which represent 50% of the cells in the mammalian heart, can be directly reprogrammed to adult cardiomyocyte-like cells in vitro by the addition of Gata4, Mef2c and Tbx5 (GMT). Here we use genetic lineage tracing to show that resident non-myocytes in the murine heart can be reprogrammed into cardiomyocyte-like cells in vivo by local delivery of GMT after coronary ligation. Induced cardiomyocytes became binucleate, assembled sarcomeres and had cardiomyocyte-like gene expression. Analysis of single cells revealed ventricular cardiomyocyte-like action potentials, beating upon electrical stimulation, and evidence of electrical coupling. In vivo delivery of GMT decreased infarct size and modestly attenuated cardiac dysfunction up to 3 months after coronary ligation. Delivery of the pro-angiogenic and fibroblast-activating peptide, thymosin beta 4, along with GMT, resulted in further improvements in scar area and cardiac function. These findings demonstrate that cardiac fibroblasts can be reprogrammed into cardiomyocyte-like cells in their native environment for potential regenerative purposes.	[Qian, Li; Huang, Yu; Spencer, C. Ian; Foley, Amy; Vedantham, Vasanth; Liu, Lei; Fu, Ji-dong; Srivastava, Deepak] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Qian, Li; Huang, Yu; Spencer, C. Ian; Foley, Amy; Liu, Lei; Fu, Ji-dong; Srivastava, Deepak] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Qian, Li; Huang, Yu; Spencer, C. Ian; Foley, Amy; Liu, Lei; Fu, Ji-dong; Srivastava, Deepak] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Vedantham, Vasanth] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Vedantham, Vasanth] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Conway, Simon J.] Indiana Univ Sch Med, Dev Biol & Neonatal Med Res Program, Indianapolis, IN 46202 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Indiana University System; Indiana University Bloomington	Srivastava, D (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA.	dsrivastava@gladstone.ucsf.edu	Fu, Jidong/E-8173-2012	Fu, Jidong/0000-0003-2797-5193; Vedantham, Vasanth/0000-0003-1032-700X	GlaxoSmithKline Research and Education Foundation; NIH/NHLBI [K08HL101989, R01 HL060714]; American Heart Association; CIRM; Younger Family Foundation; Roddenberry Foundation; L.K. Whittier Foundation; NIH/NCRR [C06 RR018928]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060714, K08HL101989] Funding Source: NIH RePORTER	GlaxoSmithKline Research and Education Foundation; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); CIRM(California Institute for Regenerative Medicine); Younger Family Foundation; Roddenberry Foundation; L.K. Whittier Foundation; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful for technical assistance from the Gladstone Histology Core (C. Miller), Gladstone Genomics Core (L. Ta, Y. Hao, B. Chadwick), UCSF MRI Core (M. Wendland, J. Hawkins) and Laboratory for Cell Analysis at UCSF (S. Elmes). We thank all the members of the Srivastava laboratory for helpful discussions; G. Howard and B. Taylor for editorial help; and B. Bruneau and B. Conklin for helpful discussions and critical reviews of the manuscript. We also thank J. Nerbonne, N. Foeger, and members of the Nerbonne laboratory for assistance with the adult myocyte isolation protocol. L. Q. is a postdoctoral scholar of the California Institute for Regenerative Medicine (CIRM). V. V. is supported by grants from the GlaxoSmithKline Research and Education Foundation and the NIH/NHLBI (K08HL101989). J.-d.F. is supported by a postdoctoral fellowship from American Heart Association. S. J. C. was supported by R01 HL060714 from NHLBI/NIH. D. S. was supported by grants from NHLBI/NIH, CIRM, the Younger Family Foundation, Roddenberry Foundation and the L.K. Whittier Foundation. This work was supported by NIH/NCRR grant (C06 RR018928) to the Gladstone Institutes.	Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Bock-Marquette I, 2009, J MOL CELL CARDIOL, V46, P728, DOI 10.1016/j.yjmcc.2009.01.017; Byun JH, 2000, J GENE MED, V2, P2; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Fenske S, 2011, CIRC RES, V109, P1015, DOI 10.1161/CIRCRESAHA.111.246173; Goldstein AL, 2005, TRENDS MOL MED, V11, P421, DOI 10.1016/j.molmed.2005.07.004; Hinkel R, 2008, CIRCULATION, V117, P2232, DOI 10.1161/CIRCULATIONAHA.107.758904; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kurrelmeyer KM, 2000, P NATL ACAD SCI USA, V97, P5456, DOI 10.1073/pnas.070036297; LARSEN TH, 1986, RES EXP MED, V186, P295, DOI 10.1007/BF01852306; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Li JF, 2005, CIRC RES, V97, P474, DOI 10.1161/01.RES.0000181132.11393.18; Ljubojevic S, 2011, BIOPHYS J, V100, P2356, DOI 10.1016/j.bpj.2011.03.060; Murry CE, 1996, J CLIN INVEST, V98, P2209, DOI 10.1172/JCI119030; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Qian L, 2011, J EXP MED, V208, P549, DOI 10.1084/jem.20101547; Saffitz JE, 2000, CIRC RES, V86, P723, DOI 10.1161/01.RES.86.7.723; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Snider P, 2008, CIRC RES, V102, P752, DOI 10.1161/CIRCRESAHA.107.159517; Snider P, 2009, CIRC RES, V105, P934, DOI 10.1161/CIRCRESAHA.109.201400; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srivastava D, 2006, NATURE, V441, P1097, DOI 10.1038/nature04961; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeda N, 2010, J CLIN INVEST, V120, P254, DOI 10.1172/JCI40295; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Xu HD, 1999, J GEN PHYSIOL, V113, P661, DOI 10.1085/jgp.113.5.661; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	40	922	980	9	262	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					593	+		10.1038/nature11044	http://dx.doi.org/10.1038/nature11044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949WP	22522929	Green Submitted, Green Accepted			2022-12-28	WOS:000304608000038
J	Sankaranarayanan, R				Sankaranarayanan, Rengaswamy			Verbal-autopsy-based projection of cancer deaths in India	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; CERVICAL-CANCER; BREAST; MORTALITY		[Sankaranarayanan, Rengaswamy] Int Agcy Res Canc, Screening Grp, F-69008 Lyon, France; Canc Inst WIA, Dept Biostat & Canc Registry, Madras, Tamil Nadu, India	World Health Organization; International Agency for Research on Cancer (IARC)	Sankaranarayanan, R (corresponding author), Int Agcy Res Canc, Screening Grp, F-69008 Lyon, France.	sankarr@iarc.fr						[Anonymous], 2010, HLTH NUTR POPUL SER; Dikshit R, 2012, LANCET, V379, P1807, DOI 10.1016/S0140-6736(12)60358-4; Ferlay J, 2010, IARC CANCERBASE, V10; Mittra I, 2010, INT J CANCER, V126, P976, DOI 10.1002/ijc.24840; NANDAKUMAR A, 1995, INT J CANCER, V60, P593, DOI 10.1002/ijc.2910600504; National Cancer Registry Programme. Indian Council of Medical Research, 2010, 3 YEAR REP POP BAS C; Office of the Registrar General India, 2011, SRS B, V45, P1; Sankaranarayanan R, 2005, LANCET, V365, P1927, DOI 10.1016/S0140-6736(05)66658-5; Sankaranarayanan R, 2011, IARC SCI PUBLICATION, V162; Sankaranarayanan R, 2007, LANCET, V370, P398, DOI 10.1016/S0140-6736(07)61195-7; Sankaranarayanan R, 2011, JNCI-J NATL CANCER I, V103, P1476, DOI 10.1093/jnci/djr304; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Swaminathan R, 2009, CANCER EPIDEMIOL, V33, P325, DOI 10.1016/j.canep.2009.09.008	13	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 12	2012	379	9828					1770	1772		10.1016/S0140-6736(12)60467-X	http://dx.doi.org/10.1016/S0140-6736(12)60467-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	941BR	22460345				2022-12-28	WOS:000303937700009
J	Shenoy, AR; Wellington, DA; Kumar, P; Kassa, H; Booth, CJ; Cresswell, P; MacMicking, JD				Shenoy, Avinash R.; Wellington, David A.; Kumar, Pradeep; Kassa, Hilina; Booth, Carmen J.; Cresswell, Peter; MacMicking, John D.			GBP5 Promotes NLRP3 Inflammasome Assembly and Immunity in Mammals	SCIENCE			English	Article							DIFFERENTIAL REQUIREMENT; CUTTING EDGE; HOST-DEFENSE; CELL-DEATH; ACTIVATION; CASPASE-1; INTERLEUKIN-1-BETA; CRYSTALS; ROLES; ASC	Inflammasomes are sensory complexes that alert the immune system to the presence of infection or tissue damage. These complexes assemble NLR (nucleotide binding and oligomerization, leucine-rich repeat) or ALR (absent in melanoma 2-like receptor) proteins to activate caspase-1 cleavage and interleukin (IL)-1 beta/IL-18 secretion. Here, we identified a non-NLR/ALR human protein that stimulates inflammasome assembly: guanylate binding protein 5 (GBP5). GBP5 promoted selective NLRP3 inflammasome responses to pathogenic bacteria and soluble but not crystalline inflammasome priming agents. Generation of Gbp5(-/-) mice revealed pronounced caspase-1 and IL-1 beta/IL-18 cleavage defects in vitro and impaired host defense and Nlrp3-dependent inflammatory responses in vivo. Thus, GBP5 serves as a unique rheostat for NLRP3 inflammasome activation and extends our understanding of the inflammasome complex beyond its core machinery.	[Shenoy, Avinash R.; Wellington, David A.; Kumar, Pradeep; Kassa, Hilina; MacMicking, John D.] Yale Univ, Sch Med, Sect Microbial Pathogenesis, Boyer Ctr Mol Med, New Haven, CT 06510 USA; [Wellington, David A.; Booth, Carmen J.] Yale Univ, Sch Med, Sect Comparat Med, New Haven, CT 06510 USA; [Cresswell, Peter] Yale Univ, Sch Med, Dept Immunobiol, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	MacMicking, JD (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, Boyer Ctr Mol Med, 333 Cedar St, New Haven, CT 06510 USA.	john.macmicking@yale.edu		Shenoy, Avinash/0000-0001-6228-9303	Yale Brown-Coxe fellowship; Anna Fuller postdoctoral fellowship; Howard Hughes Medical Institute; NIH National Institute of Allergy and Infectious Diseases [R01 AI068041-06]; Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award [1007845]; Searle Foundation [05-F-114]; Cancer Research Institute [CRI06-10]; Chrohn's and Colitis Foundation of America [R09928]; W. W. Winchester Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068041] Funding Source: NIH RePORTER	Yale Brown-Coxe fellowship; Anna Fuller postdoctoral fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award; Searle Foundation; Cancer Research Institute; Chrohn's and Colitis Foundation of America; W. W. Winchester Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Tschopp, M. Karin, W. Mothes, and C. Roy for plasmids. All data are tabulated in the main paper and the supplementary materials. A. R. S. was supported by Yale Brown-Coxe and Anna Fuller postdoctoral fellowships, P. C. by Howard Hughes Medical Institute, and J.D.M. by NIH National Institute of Allergy and Infectious Diseases (R01 AI068041-06), Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award (1007845), Searle Foundation Scholars Program (05-F-114), Cancer Research Institute Investigator Award Program (CRI06-10), Chrohn's and Colitis Foundation of America Senior Investigator Award (R09928), and W. W. Winchester Foundation.	Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Dombrowski Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002001; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; O'Connor W, 2003, J IMMUNOL, V171, P6329, DOI 10.4049/jimmunol.171.12.6329; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shiohara M, 2002, BIOCHEM BIOPH RES CO, V293, P1314, DOI 10.1016/S0006-291X(02)00384-4; Tsuji NM, 2004, INT IMMUNOL, V16, P335, DOI 10.1093/intimm/dxh041; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	26	302	313	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					481	485		10.1126/science.1217141	http://dx.doi.org/10.1126/science.1217141			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22461501				2022-12-28	WOS:000303233400049
J	Eisenhoffer, GT; Loftus, PD; Yoshigi, M; Otsuna, H; Chien, CB; Morcos, PA; Rosenblatt, J				Eisenhoffer, George T.; Loftus, Patrick D.; Yoshigi, Masaaki; Otsuna, Hideo; Chien, Chi-Bin; Morcos, Paul A.; Rosenblatt, Jody			Crowding induces live cell extrusion to maintain homeostatic cell numbers in epithelia	NATURE			English	Article							APOPTOTIC CELLS; PROLIFERATION; EXTRUDE; JNK	For an epithelium to provide a protective barrier, it must maintain homeostatic cell numbers by matching the number of dividing cells with the number of dying cells. Although compensatory cell division can be triggered by dying cells(1-3), it is unknown how cell death might relieve overcrowding due to proliferation. When we trigger apoptosis in epithelia, dying cells are extruded to preserve a functional barrier(4). Extrusion occurs by cells destined to die signalling to surrounding epithelial cells to contract an actomyosin ring that squeezes the dying cell out(4-6). However, it is not clear what drives cell death during normal homeostasis. Here we show in human, canine and zebrafish cells that overcrowding due to proliferation and migration induces extrusion of live cells to control epithelial cell numbers. Extrusion of live cells occurs at sites where the highest crowding occurs in vivo and can be induced by experimentally overcrowding monolayers in vitro. Like apoptotic cell extrusion, live cell extrusion resulting from overcrowding also requires sphingosine 1-phosphate signalling and Rho-kinase-dependent myosin contraction, but is distinguished by signalling through stretch-activated channels. Moreover, disruption of a stretch-activated channel, Piezo1, in zebrafish prevents extrusion and leads to the formation of epithelial cell masses. Our findings reveal that during homeostatic turnover, growth and division of epithelial cells on a confined substratum cause overcrowding that leads to their extrusion and consequent death owing to the loss of survival factors. These results suggest that live cell extrusion could be a tumour-suppressive mechanism that prevents the accumulation of excess epithelial cells.	[Eisenhoffer, George T.; Loftus, Patrick D.; Rosenblatt, Jody] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Yoshigi, Masaaki] Univ Utah, Dept Pediat, Salt Lake City, UT 84108 USA; [Otsuna, Hideo; Chien, Chi-Bin] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA; [Morcos, Paul A.] Gene Tools LLC, Philomath, OR 97370 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Rosenblatt, J (corresponding author), Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, 2000 Circle Hope Dr, Salt Lake City, UT 84112 USA.	jody.rosenblatt@hci.utah.edu	Rosenblatt, Jody/AAD-4260-2019	Rosenblatt, Jody/0000-0001-9460-5868	National Institute of Biomedical Imaging and Bioengineering [EB-4443]; NIH-NIGMS NIH [1 DP2OD002056-01]; Laura and Arthur Colwin Endowed Marine Biology Laboratories Summer Research Fellowship Fund; NIH [5T32 CA03247-8, MH092256]; American Cancer Society [120464-PF-11-095-01 CSM]; University of Utah;  [P30 CA042014]; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB004443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092256] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002056] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH-NIGMS NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Laura and Arthur Colwin Endowed Marine Biology Laboratories Summer Research Fellowship Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); University of Utah; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B. Welm, M. Redd and K. Ullman for valuable input on our manuscript and T. Marshall and D. Andrade for Lifeact- and BCL2-expressing MDCK lines. The custom-designed cell culture device was made with the support of National Institute of Biomedical Imaging and Bioengineering Grant EB-4443 to M.Y. (patent pending). This work was supported by a NIH-NIGMS NIH Director's New Innovator Award 1 DP2OD002056-01 and a Laura and Arthur Colwin Endowed Marine Biology Laboratories Summer Research Fellowship Fund to J.R., and a P30 CA042014 awarded to The Huntsman Cancer Institute for core facilities. An NIH Multidisciplinary Cancer Training Program Grant 5T32 CA03247-8 and American Cancer Society Salt Lake City Postdoctoral Fellowship (120464-PF-11-095-01 CSM) supported G. T. E., the University of Utah Undergraduate Research Opportunities Program Parent Fund Assistantship supported P. D. L., and an NIH R01 Grant MH092256 supported H.O. and C.B.C.	Andrade D, 2011, APOPTOSIS, V16, P491, DOI 10.1007/s10495-011-0587-z; Bhattacharya MRC, 2008, P NATL ACAD SCI USA, V105, P20015, DOI 10.1073/pnas.0810801105; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Davison JM, 2007, DEV BIOL, V304, P811, DOI 10.1016/j.ydbio.2007.01.033; Fan Y, 2008, TRENDS CELL BIOL, V18, P467, DOI 10.1016/j.tcb.2008.08.001; Fan Y, 2008, DEV CELL, V14, P399, DOI 10.1016/j.devcel.2008.01.003; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Gu YP, 2011, J CELL BIOL, V193, P667, DOI 10.1083/jcb.201010075; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Monks J, 2008, BIOL REPROD, V78, P586, DOI 10.1095/biolreprod.107.065045; Olsen SM, 2011, ANN BIOMED ENG, V39, P688, DOI 10.1007/s10439-010-0203-3; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102; Slattum G, 2009, J CELL BIOL, V186, P693, DOI 10.1083/jcb.200903079; Swindle EJ, 2009, J ALLERGY CLIN IMMUN, V124, P23, DOI 10.1016/j.jaci.2009.05.037; Tallafuss A, DEVELOPMENT IN PRESS; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; YANG XC, 1989, SCIENCE, V243, P1068, DOI 10.1126/science.2466333; Yoshigi M, 2005, J CELL BIOL, V171, P209, DOI 10.1083/jcb.200505018; Yoshigi M, 2003, CYTOM PART A, V55A, P109, DOI 10.1002/cyto.a.10076	27	497	508	5	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2012	484	7395					546	U183		10.1038/nature10999	http://dx.doi.org/10.1038/nature10999			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22504183	Green Accepted			2022-12-28	WOS:000303200400058
J	West, GB				West, Geoffrey B.			Physics and Medicine 5 The importance of quantitative systemic thinking in medicine	LANCET			English	Article							ALLOMETRIC SCALING LAWS; METABOLIC-RATE; GENERAL-MODEL; BIOLOGY; FRAMEWORK; ORIGIN	The study and practice of medicine could benefit from an enhanced engagement with the new perspectives provided by the emerging areas of complexity science and systems biology. A more integrated, systemic approach is needed to fully understand the processes of health, disease, and dysfunction, and the many challenges in medical research and education. Integral to this approach is the search for a quantitative, predictive, multilevel, theoretical conceptual framework that both complements the present approaches and stimulates a more integrated research agenda that will lead to novel questions and experimental programmes. As examples, the importance of network structures and scaling laws are discussed for the development of a broad, quantitative, mathematical understanding of issues that are important in health, including ageing and mortality, sleep, growth, circulatory systems, and drug doses. A common theme is the importance of understanding the quantifiable determinants of the baseline scale of life, and developing corresponding parameters that define the average, idealised, healthy individual.	Santa Fe Inst, Santa Fe, NM 87505 USA	The Santa Fe Institute	West, GB (corresponding author), Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87505 USA.	gbw@santafe.edu			National Science Foundation [PHY-0750037, PHY-0946635]; Engineering and Physical Sciences Research Council (through the Mathematics Department, Imperial College); Said Business School, Oxford University; John Templeton Foundation; Gene and Clare Thaw Charitable Trust; Bryan J and June B Zwan Foundation	National Science Foundation(National Science Foundation (NSF)); Engineering and Physical Sciences Research Council (through the Mathematics Department, Imperial College)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Said Business School, Oxford University; John Templeton Foundation; Gene and Clare Thaw Charitable Trust; Bryan J and June B Zwan Foundation	I have benefited enormously over the past several years from conversations and intense research collaboration with many colleagues on several of the topics discussed here. In helping to formulate these ideas I would especially like to thank James Brown, Brian Enquist, William Woodruff, Van Savage, and Chen Hou; additionally, David Wolfe played a seminal role in urging me to write this essay. I would also like to acknowledge the support of the National Science Foundation (awards PHY-0750037 and PHY-0946635), Engineering and Physical Sciences Research Council (through the Mathematics Department, Imperial College), Said Business School, Oxford University, John Templeton Foundation, Gene and Clare Thaw Charitable Trust, and Bryan J and June B Zwan Foundation.	[Anonymous], COMPUTATIONAL SYSTEM; Arrell DK, 2009, J PROTEOME RES, V8, P4823, DOI 10.1021/pr900561g; Bassingthwaighte J. B., 1994, FRACTAL PHYSL; Benedict FG, 1938, VITAL ENERGETICS STU; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; BLOOM ED, 1969, PHYS REV LETT, V23, P930, DOI 10.1103/PhysRevLett.23.930; Brown MF, 2007, AM J PHYSIOL-REG I, V292, pR2115, DOI 10.1152/ajpregu.00568.2006; Buchman TG, 2002, NATURE, V420, P246, DOI 10.1038/nature01260; Campo DS, COORDINATED EVOLUTIO; Caro C. G., 2012, MECH CIRCULATION, VSecond; Cooper NG, 1988, PARTICLE PHYS LOS AL; DELISI C, 1988, AM SCI, V76, P488; Galileo Galilei, 1954, DIALOGUES 2 NEW SCI; Gleick J., 1988, CHAOS MAKING NEW SCI; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; GROSS DJ, 1973, PHYS REV LETT, V30, P1343, DOI 10.1103/PhysRevLett.30.1343; Herman AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022973; Hood L, 2003, MECH AGEING DEV, V124, P9, DOI 10.1016/S0047-6374(02)00164-1; Kauffman S., 1995, HOME UNIVERSE SEARCH; Kirkwood TBL, 2008, NATURE, V451, P644, DOI 10.1038/451644a; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; KLEIBER MAX, 1932, HILGARDIA, V6, P315; Lewin R., 1992, COMPLEXITY LIFE EDGE; Mandelbrot B.B., 1982, FRACTAL GEOMETRY NAT, P480; Mitchell M., 2008, COMPLEXITY GUIDED TO; Moses ME, 2003, ECOL LETT, V6, P295, DOI 10.1046/j.1461-0248.2003.00446.x; Nelson TR, 1992, PRINCIPLES ORG ORGAN, P35; Parents, AC DOS CHART; Samaras TT, 2007, HUMAN BODY SIZE LAWS; Savage VM, 2007, P NATL ACAD SCI USA, V104, P1051, DOI 10.1073/pnas.0610080104; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Today in Science History, TODAY SCI HIST; Tylenol, CHILDR DOS GUID; Waldrop M. M., 1993, COMPLEXITY EMERGING; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 2005, J EXP BIOL, V208, P1575, DOI 10.1242/jeb.01589; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; West GB, 2002, P NATL ACAD SCI USA, V99, P2473, DOI 10.1073/pnas.012579799; West GB, 2009, J GERONTOL A-BIOL, V64, P205, DOI 10.1093/gerona/gln066; WEST LJ, 1962, SCIENCE, V138, P1100, DOI 10.1126/science.138.3545.1100; Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493	44	34	34	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2012	379	9825					1551	1559		10.1016/S0140-6736(12)60281-5	http://dx.doi.org/10.1016/S0140-6736(12)60281-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930BJ	22516561				2022-12-28	WOS:000303110200034
J	Roth, S; Panfilio, KA				Roth, Siegfried; Panfilio, Kristen A.			Making Waves for Segments	SCIENCE			English	Editorial Material									[Roth, Siegfried; Panfilio, Kristen A.] Univ Cologne, Inst Dev Biol, Bioctr, D-50674 Cologne, Germany	University of Cologne	Roth, S (corresponding author), Univ Cologne, Inst Dev Biol, Bioctr, Zulpicher Str 47B, D-50674 Cologne, Germany.	siegfried.roth@uni-koeln.de; kristen.panfilio@alum.swarthmore.edu	Panfilio, Kristen/S-3179-2019; Roth, Siegfried/E-8241-2010	Panfilio, Kristen/0000-0002-6417-251X; Roth, Siegfried/0000-0001-5772-3558				Brown S. J., 2009, COLD SPRING HARB PRO, V2009; Choe CP, 2006, P NATL ACAD SCI USA, V103, P6560, DOI 10.1073/pnas.0510440103; Oates AC, 2012, DEVELOPMENT, V139, P625, DOI 10.1242/dev.063735; Peel AD, 2005, NAT REV GENET, V6, P905, DOI 10.1038/nrg1724; Pueyo JI, 2008, P NATL ACAD SCI USA, V105, P16614, DOI 10.1073/pnas.0804093105; Roth S., 2004, P105; Sarrazin AF, 2012, SCIENCE, V336, P338, DOI 10.1126/science.1218256; Tautz D, 2004, DEV CELL, V7, P301, DOI 10.1016/j.devcel.2004.08.008	8	3	3	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2012	336	6079					306	307		10.1126/science.1222242	http://dx.doi.org/10.1126/science.1222242			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22517849				2022-12-28	WOS:000302995400033
J	Vanin, S; Bhutani, S; Montelli, S; Menegazzi, P; Green, EW; Pegoraro, M; Sandrelli, F; Costa, R; Kyriacou, CP				Vanin, Stefano; Bhutani, Supriya; Montelli, Stefano; Menegazzi, Pamela; Green, Edward W.; Pegoraro, Mirko; Sandrelli, Federica; Costa, Rodolfo; Kyriacou, Charalambos P.			Unexpected features of Drosophila circadian behavioural rhythms under natural conditions	NATURE			English	Article							ENDOGENOUS CLOCK; TEMPERATURE; LIGHT; MELANOGASTER; NEURONS; ENTRAINMENT; OSCILLATORS; MOONLIGHT; FAVORS; ALLELE	Circadian clocks have evolved to synchronize physiology, metabolism and behaviour to the 24-h geophysical cycles of the Earth(1). Drosophila melanogaster's rhythmic locomotor behaviour provides the main phenotype for the identification of higher eukaryotic clock genes(2,3). Under laboratory light-dark cycles, flies show enhanced activity before lights on and off signals(4,5), and these anticipatory responses have defined the neuronal sites of the corresponding morning (M) and evening (E) oscillators(6,7). However, the natural environment provides much richer cycling environmental stimuli than the laboratory, so we sought to examine fly locomotor rhythms in the wild. Here we show that several key laboratory-based assumptions about circadian behaviour are not supported by natural observations. These include the anticipation of light transitions, the midday 'siesta', the fly's crepuscular activity, its nocturnal behaviour under moonlight, and the dominance of light stimuli over temperature. We also observe a third major locomotor component in addition to M and E, which we term 'A' (afternoon). Furthermore, we show that these natural rhythm phenotypes can be observed in the laboratory by using realistic temperature and light cycle simulations. Our results suggest that a comprehensive re-examination of circadian behaviour and its molecular readouts under simulated natural conditions will provide a more authentic interpretation of the adaptive significance of this important rhythmic phenotype. Such studies should also help to clarify the underlying molecular and neuroanatomical substrates of the clock under natural protocols.	[Vanin, Stefano; Montelli, Stefano; Menegazzi, Pamela; Pegoraro, Mirko; Sandrelli, Federica; Costa, Rodolfo] Univ Padua, Dept Biol, I-35131 Padua, Italy; [Bhutani, Supriya; Green, Edward W.; Pegoraro, Mirko; Kyriacou, Charalambos P.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	University of Padua; University of Leicester	Costa, R (corresponding author), Univ Padua, Dept Biol, I-35131 Padua, Italy.	rodolfo.costa@unipd.it	Menegazzi, Pamela/AAE-3544-2020; Menegazzi, Pamela/M-7022-2017	Menegazzi, Pamela/0000-0001-5232-1920; Menegazzi, Pamela/0000-0001-5232-1920; Vanin, Stefano/0000-0003-1676-5916; Bhutani, Supriya/0000-0002-0855-2139; SANDRELLI, FEDERICA/0000-0002-5631-7467; Pegoraro, Mirko/0000-0001-9381-5249	European Community [018741]; Biotechnology and Biological Sciences Research Council; National Environmental Research Council; Royal Society; Medical Research Council; Italian Space Agency (DCMC); Ministero dell'Universita e delle Ricerca (MIUR); BBSRC [BB/J005169/1, BB/F008988/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J005169/1, BB/F008988/1] Funding Source: researchfish	European Community(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Italian Space Agency (DCMC)(Agenzia Spaziale Italiana (ASI)); Ministero dell'Universita e delle Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank S. Bastianello for building the natural light simulator, and C. Helfrich-Forster for comments on the manuscript. This work was funded by grants from the European Community (the 6th Framework Project EUCLOCK no. 018741; to R. C. and C. P. K.), the Biotechnology and Biological Sciences Research Council and National Environmental Research Council (to C. P. K.), the Royal Society Wolfson Research Merit Award (to C. P. K.) and a Medical Research Council studentship (to E. W. G.) R. C. also thanks the Italian Space Agency (DCMC grant) and the Ministero dell'Universita e delle Ricerca (MIUR).	Bachleitner W, 2007, P NATL ACAD SCI USA, V104, P3538, DOI 10.1073/pnas.0606870104; Busza A, 2007, J NEUROSCI, V27, P10722, DOI 10.1523/JNEUROSCI.2479-07.2007; Collins BH, 2005, P NATL ACAD SCI USA, V102, P19021, DOI 10.1073/pnas.0505392102; Collins BH, 2004, P NATL ACAD SCI USA, V101, P1945, DOI 10.1073/pnas.0308240100; Currie J, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-49; Daan S, 2011, J BIOL RHYTHM, V26, P118, DOI 10.1177/0748730410397645; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dowse H.B., 1987, Journal of Biological Rhythms, V2, P65, DOI 10.1177/074873048700200106; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gattermann R, 2008, BIOL LETTERS, V4, P253, DOI 10.1098/rsbl.2008.0066; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; HAMBLENCOYLE MJ, 1992, J INSECT BEHAV, V5, P417, DOI 10.1007/BF01058189; Hardin PE, 2011, ADV GENET, V74, P141, DOI 10.1016/B978-0-12-387690-4.00005-2; HELFRICH C, 1987, Z NATURFORSCH C, V42, P1335; Helfrich-Forster C, 2001, J INSECT PHYSIOL, V47, P877, DOI 10.1016/S0022-1910(01)00060-9; Kempinger L, 2009, CHRONOBIOL INT, V26, P151, DOI 10.1080/07420520902747124; Low KH, 2008, NEURON, V60, P1054, DOI 10.1016/j.neuron.2008.10.048; Majercak J, 1999, NEURON, V24, P219, DOI 10.1016/S0896-6273(00)80834-X; Miyasako Y, 2007, J BIOL RHYTHM, V22, P115, DOI 10.1177/0748730407299344; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Rieger D, 2007, J BIOL RHYTHM, V22, P387, DOI 10.1177/0748730407306198; Rosato E, 2006, NAT PROTOC, V1, P559, DOI 10.1038/nprot.2006.79; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Tanoue S, 2004, CURR BIOL, V14, P638, DOI 10.1016/j.cub.2004.04.009; Tauber E, 2007, SCIENCE, V316, P1895, DOI 10.1126/science.1138412; United. States Naval Observatory (USNO) Astronomy Application Department, 2011, RISC SET TWIL DEF; Yoshii T, 2007, J BIOL RHYTHM, V22, P103, DOI 10.1177/0748730406298176; Yoshii T, 2009, J BIOL RHYTHM, V24, P452, DOI 10.1177/0748730409348551; Zhang LY, 2010, CURR BIOL, V20, P591, DOI 10.1016/j.cub.2010.02.056; Zhang Y, 2010, CURR BIOL, V20, P600, DOI 10.1016/j.cub.2010.02.044	30	191	194	0	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2012	484	7394					371	U108		10.1038/nature10991	http://dx.doi.org/10.1038/nature10991			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927YM	22495312				2022-12-28	WOS:000302946500032
J	Canfield, SE; Dahm, P				Canfield, Steven E.; Dahm, Philipp			Review: Androgen deprivation therapy does not increase CV mortality in prostate cancer	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Canfield, Steven E.] Univ Texas Houston, Sch Med, Houston, TX 77030 USA; [Dahm, Philipp] Univ Florida, Coll Med, Gainesville, FL USA	University of Texas System; University of Texas Health Science Center Houston; State University System of Florida; University of Florida	Canfield, SE (corresponding author), Univ Texas Houston, Sch Med, Houston, TX 77030 USA.		Dahm, Philipp/I-1614-2019	Dahm, Philipp/0000-0003-2819-2553				Bannuru RR, 2011, ANN INTERN MED, V155, P171, DOI 10.7326/0003-4819-155-3-201108020-00347; US Food and Drug and Administration, FDA DRUG SAF COMM	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2012	156	8							JC4-4	10.7326/0003-4819-156-8-201204170-02004	http://dx.doi.org/10.7326/0003-4819-156-8-201204170-02004			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930PO	22508744				2022-12-28	WOS:000303151800003
J	Cheng, QJ				Cheng, Qijin			PERSONAL VIEW Are internet service providers responsible for online suicide pacts?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Hong Kong, Dept Social Work & Social Adm, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong	Cheng, QJ (corresponding author), Univ Hong Kong, Dept Social Work & Social Adm, Pokfulam, Hong Kong, Peoples R China.	chengqj@hku.hk		Cheng, Qijin/0000-0002-6223-5345				2010, BEIJING TIMES   1204, P14; 2011, J CLIN PSYCHIAT, V72, P313, DOI DOI 10.4088/JCP.09M05440BLU; 2010, PEOPLES DAILY   1210, P10	3	5	5	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 13	2012	344								d2113	10.1136/bmj.d2113	http://dx.doi.org/10.1136/bmj.d2113			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	927UL	22505035				2022-12-28	WOS:000302935600001
J	Mohan, M; Herz, HM; Shilatifard, A				Mohan, Man; Herz, Hans-Martin; Shilatifard, Ali			SnapShot: Histone Lysine Methylase Complexes	CELL			English	Editorial Material							MARK		[Mohan, Man; Herz, Hans-Martin; Shilatifard, Ali] Stowers Inst Med Res, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Mohan, M (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.		Herz, Hans-Martin/N-2594-2018	Herz, Hans-Martin/0000-0003-4780-9176; Mohan, Man/0000-0002-8811-8542	NATIONAL CANCER INSTITUTE [R01CA150265, R01CA089455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069905] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA150265, R01CA89455, R01 CA150265, R01 CA089455] Funding Source: Medline; NIGMS NIH HHS [R01GM069905, R01 GM069905] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Nguyen AT, 2011, GENE DEV, V25, P1345, DOI 10.1101/gad.2057811; Balakrishnan L, 2010, CRIT REV BIOCHEM MOL, V45, P440, DOI 10.3109/10409238.2010.504700; Buratowski S, 2010, COLD SH Q B, V75, P95, DOI 10.1101/sqb.2010.75.036; Fodor BD, 2010, ANNU REV CELL DEV BI, V26, P471, DOI 10.1146/annurev.cellbio.042308.113225; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mohan M, 2010, NAT REV CANCER, V10, P720, DOI 10.1038/nrc2915	6	31	31	1	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 13	2012	149	2					498	U259		10.1016/j.cell.2012.03.025	http://dx.doi.org/10.1016/j.cell.2012.03.025			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500810	Bronze, Green Accepted			2022-12-28	WOS:000302805600025
J	Zerbino, DR; Paten, B; Haussler, D				Zerbino, D. R.; Paten, B.; Haussler, D.			Integrating Genomes	SCIENCE			English	Review							RNA-SEQ; CHROMATIN; PROTEINS; SEQUENCE; CELLS	As genomic sequencing projects attempt ever more ambitious integration of genetic, molecular, and phenotypic information, a specialization of genomics has emerged, embodied in the subdiscipline of computational genomics. Models inherited from population genetics, phylogenetics, and human disease genetics merge with those from graph theory, statistics, signal processing, and computer science to provide a rich quantitative foundation for genomics that can only be realized with the aid of a computer. Unleashed on a rapidly increasing sample of the planet's 1030 organisms, these analyses will have an impact on diverse fields of science while providing an extraordinary new window into the story of life.	[Zerbino, D. R.; Paten, B.; Haussler, D.] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Haussler, D.] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz	Haussler, D (corresponding author), Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA.	haussler@soe.ucsc.edu		Zerbino, Daniel/0000-0001-5350-3056	Howard Hughes Medical Institute; National Human Genome Research Institute Data Analysis Center for the Encyclopedia of DNA Elements [U01]; American Association for Cancer Research	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Human Genome Research Institute Data Analysis Center for the Encyclopedia of DNA Elements; American Association for Cancer Research	We thank D. A. Earl for designing the figures, and E. Green, M. Ha ussler, J. Ma, D. Earl, H. Zerbino, R. Kuhn, G. Hickey, T. Pringle, K. Pollard, A. Krogh, R. Shamir, M. Waterman, and R. Durbin for their corrections and comments. Supported by the Howard Hughes Medical Institute (D.H.), National Human Genome Research Institute Data Analysis Center for the Encyclopedia of DNA Elements grant U01 (B.P.), and the American Association for Cancer Research (Stand Up To Cancer/An Integrated Approach to Targeting Breast Cancer Molecular Subtypes and Their Resistance Phenotypes) (D.R.Z.).	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; FIERS W, 1976, NATURE, V260, P500, DOI 10.1038/260500a0; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; GINGERAS TR, 1979, NUCLEIC ACIDS RES, V7, P529, DOI 10.1093/nar/7.2.529; HAMM GH, 1986, NUCLEIC ACIDS RES, V14, P5, DOI 10.1093/nar/14.1.5; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stein LD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-207; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2997, DOI 10.1093/nar/10.9.2997; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Underwood JG, 2010, NAT METHODS, V7, P995, DOI 10.1038/NMETH.1529	23	18	19	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2012	336	6078					179	182		10.1126/science.1216830	http://dx.doi.org/10.1126/science.1216830			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924PN	22499938				2022-12-28	WOS:000302703900038
J	Stephan, P				Stephan, Paula			Perverse incentives	NATURE			English	Editorial Material									[Stephan, Paula] Georgia State Univ, Atlanta, GA 30303 USA; [Stephan, Paula] Natl Bur Econ Res, Cambridge, MA 02138 USA	University System of Georgia; Georgia State University; National Bureau of Economic Research	Stephan, P (corresponding author), Georgia State Univ, Atlanta, GA 30303 USA.	pstephan@gsu.edu						[Anonymous], 2010, CURR POP SURV TABL P; Azoulay P., 2010, INCENTIVES CREATIVIT; Berg J., 2010, ANOTHER LOOK MEASURI; Franzoni C, 2011, SCIENCE, V333, P702, DOI 10.1126/science.1197286; Mallon WT, 2004, SCIENCE, V303, P476, DOI 10.1126/science.1094859; Sacks F., 2007, SCIENTIST       0911; Stephan P., 2012, EC SHAPES SCI	7	67	68	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2012	484	7392					29	31		10.1038/484029a	http://dx.doi.org/10.1038/484029a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	919QN	22481339				2022-12-28	WOS:000302343400015
J	Xu, X; Wang, KB; Zhang, K; Ma, QY; Xing, LD; Sullivan, C; Hu, DY; Cheng, SQ; Wang, S				Xu, Xing; Wang, Kebai; Zhang, Ke; Ma, Qingyu; Xing, Lida; Sullivan, Corwin; Hu, Dongyu; Cheng, Shuqing; Wang, Shuo			A gigantic feathered dinosaur from the Lower Cretaceous of China	NATURE			English	Article							TYRANNOSAUROID DINOSAUR; NORTH-AMERICA; THEROPODA; AGE	Numerous feathered dinosaur specimens have recently been recovered from the Middle-Upper Jurassic and Lower Cretaceous deposits of northeastern China, but most of them represent small animals(1). Here we report the discovery of a gigantic new basal tyrannosauroid, Yutyrannus huali gen. et sp. nov., based on three nearly complete skeletons representing two distinct ontogenetic stages from the Lower Cretaceous Yixian Formation of Liaoning Province, China. Y. huali shares some features, particularly of the cranium, with derived tyrannosauroids(2,3), but is similar to other basal tyrannosauroids(4-12) in possessing a three-fingered manus and a typical theropod pes. Morphometric analysis suggests that Y. huali differed from tyrannosaurids in its growth strategy(13,14). Most significantly, Y. huali bears long filamentous feathers, thus providing direct evidence for the presence of extensively feathered gigantic dinosaurs and offering new insights into early feather evolution.	[Xu, Xing; Ma, Qingyu; Sullivan, Corwin; Wang, Shuo] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing 100044, Peoples R China; [Xu, Xing; Hu, Dongyu] Shenyang Normal Univ, Liaoning Paleontol Museum, Shenyang 110034, Peoples R China; [Wang, Kebai; Cheng, Shuqing] Zhucheng Dinosaur Museum, Zhucheng 262200, Shandong, Peoples R China; [Zhang, Ke] China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China; [Xing, Lida] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Wang, Shuo] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Shenyang Normal University; China University of Geosciences; University of Alberta; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xu, X (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, 142 Xiwai St, Beijing 100044, Peoples R China.	xingxu@vip.sina.com	Wang, Shuo/AAX-8516-2020	Wang, Shuo/0000-0002-4076-0202; Xing, Lida/0000-0003-3923-9206; Sullivan, Corwin/0000-0002-5488-6797	Zhucheng Municipal Government; Erlianhaote Municipal Government; National Natural Science Foundation of China; Special Funds For Major State Basic Research Projects of China	Zhucheng Municipal Government; Erlianhaote Municipal Government; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Funds For Major State Basic Research Projects of China	We thank L. Zhang for discussions, R. Li, H. Zang and X. Ding for illustrations, and H. Wang, L. Xiang and R. Cao for preparing the specimens. We thank the Zhucheng Municipal Government and Erlianhaote Municipal Government for support. This study was supported by grants from the National Natural Science Foundation of China and Special Funds For Major State Basic Research Projects of China.	Amiot R, 2011, P NATL ACAD SCI USA, V108, P5179, DOI 10.1073/pnas.1011369108; Averianov A.O., 2010, Trudy Zoologicheskogo Instituta, V314, P42; Benson RBJ, 2008, J VERTEBR PALEONTOL, V28, P732, DOI 10.1671/0272-4634(2008)28[732:NIOSAT]2.0.CO;2; Brochu CA, 2003, J VERTEBR PALEONTOL, V22, P1, DOI [10.1080/02724634.2003.10010947, DOI 10.1080/02724634.2003.10010947, 10.2307/3889334, DOI 10.2307/3889334]; Brusatte SL, 2010, SCIENCE, V329, P1481, DOI 10.1126/science.1193304; Brusatte SL, 2009, P NATL ACAD SCI USA, V106, P17261, DOI 10.1073/pnas.0906911106; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Currie Philip J., 2003, Ichnos, V10, P1, DOI 10.1080/10420940390235071; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P191; Currie PJ, 2003, CAN J EARTH SCI, V40, P651, DOI 10.1139/E02-083; Deng T, 2011, SCIENCE, V333, P1285, DOI 10.1126/science.1206594; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Fiorillo AR, 2000, J VERTEBR PALEONTOL, V20, P675, DOI 10.1671/0272-4634(2000)020[0675:TTFTPC]2.0.CO;2; Fowler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021376; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P111; Hutt S, 2001, CRETACEOUS RES, V22, P227, DOI 10.1006/cres.2001.0252; Ji Qiang, 2009, Dizhi Tongbao, V28, P1369; Li DQ, 2010, P ROY SOC B-BIOL SCI, V277, P183, DOI 10.1098/rspb.2009.0249; Ortega F, 2010, NATURE, V467, P203, DOI 10.1038/nature09181; Paul G. S., 2008, TYRANNOSAURUS REX TY, P354; Rauhut OWM, 2010, ZOOL J LINN SOC-LOND, V158, P155, DOI 10.1111/j.1096-3642.2009.00591.x; Rauhut OWM, 2003, PALAEONTOLOGY, V46, P903, DOI 10.1111/1475-4983.00325; Sereno PC, 2009, SCIENCE, V326, P418, DOI 10.1126/science.1177428; Spicer RA, 2010, PALAEOGEOGR PALAEOCL, V295, P423, DOI 10.1016/j.palaeo.2010.02.025; Swisher CC, 2002, CHINESE SCI BULL, V47, P135; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670; Xu X, 2006, NATURE, V439, P715, DOI 10.1038/nature04511; Xu X, 2004, NATURE, V431, P680, DOI 10.1038/nature02855; Xu X, 2007, NATURE, V447, P844, DOI 10.1038/nature05849; Xu Xing, 2009, Vertebrata Palasiatica, V47, P311	30	89	101	3	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2012	484	7392					92	95		10.1038/nature10906	http://dx.doi.org/10.1038/nature10906			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	919QN	22481363				2022-12-28	WOS:000302343400040
J	Dacre, J				Dacre, Jane			PERSONAL VIEW We need female doctors at all levels and in all specialties	BRITISH MEDICAL JOURNAL			English	Editorial Material							CAREER CHOICES		UCL, UCL Med Sch, Fac Med Sci, London WC1E 6BT, England	University of London; University College London	Dacre, J (corresponding author), UCL, UCL Med Sch, Fac Med Sci, London WC1E 6BT, England.	j.dacre@ucl.ac.uk						BBC, 2004, BBC             0802; Bloor K, 2008, J ROY SOC MED, V101, P27, DOI 10.1258/jrsm.2007.070424; Dacre Jane, 2008, BMJ, V336, P749, DOI 10.1136/bmj.39505.566701.94; Deech R., 2009, WOMEN DOCTORS MAKING; Elston MA, 2009, WOMEN MED FUTURE; Goldacre MJ, 2005, BRIT J PSYCHIAT, V186, P158, DOI 10.1192/bjp.186.2.158; Lambert TW, 2003, BRIT MED J, V326, P194, DOI 10.1136/bmj.326.7382.194; McKinstry B, 2008, BRIT MED J, V336, P748, DOI 10.1136/bmj.39505.491065.94; NHS Future Forum, 2011, CLIN ADV LEAD	9	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 4	2012	344								e2325	10.1136/bmj.e2325	http://dx.doi.org/10.1136/bmj.e2325			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	923HC	22491698				2022-12-28	WOS:000302609300005
J	Palda, VA				Palda, Valerie A.			The Conductor	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									St Michaels Hosp, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Palda, VA (corresponding author), St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada.								0	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2012	156	7					538	538		10.7326/0003-4819-156-7-201204030-00013	http://dx.doi.org/10.7326/0003-4819-156-7-201204030-00013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921GP	22473440				2022-12-28	WOS:000302466400010
J	Barros, AJD; Ronsmans, C; Axelson, H; Loaiza, E; Bertoldi, AD; Franca, GVA; Bryce, J; Boerma, JT; Victora, CG				Barros, Aluisio J. D.; Ronsmans, Carine; Axelson, Henrik; Loaiza, Edilberto; Bertoldi, Andrea D.; Franca, Giovanny V. A.; Bryce, Jennifer; Boerma, J. Ties; Victora, Cesar G.			Equity in maternal, newborn, and child health interventions in Countdown to 2015: a retrospective review of survey data from 54 countries	LANCET			English	Article							SOCIOECONOMIC INEQUALITIES; INCOME COUNTRIES; SURVIVAL; WEALTH; EXPENDITURE; NUTRITION; COVERAGE; AFRICA; TRENDS; STATES	Background Countdown to 2015 tracks progress towards achievement of Millennium Development Goals (MDGs) 4 and 5, with particular emphasis on within-country inequalities. We assessed how inequalities in maternal, newborn, and child health interventions vary by intervention and country. Methods We reanalysed data for 12 maternal, newborn, and child health interventions from national surveys done in 54 Countdown countries between Jan 1, 2000, and Dec 31, 2008. We calculated coverage indicators for interventions according to standard definitions, and stratified them by wealth quintiles on the basis of asset indices. We assessed inequalities with two summary indices for absolute inequality and two for relative inequality. Findings Skilled birth attendant coverage was the least equitable intervention, according to all four summary indices, followed by four or more antenatal care visits. The most equitable intervention was early initation of breastfeeding. Chad, Nigeria, Somalia, Ethiopia, Laos, and Niger were the most inequitable countries for the interventions examined, followed by Madagascar, Pakistan, and India. The most equitable countries were Uzbekistan and Kyrgyzstan. Community-based interventions were more equally distributed than those delivered in health facilities. For all interventions, variability in coverage between countries was larger for the poorest than for the richest individuals. Interpretation We noted substantial variations in coverage levels between interventions and countries. The most inequitable interventions should receive attention to ensure that all social groups are reached. Interventions delivered in health facilities need specific strategies to enable the countries' poorest individuals to be reached. The most inequitable countries need additional efforts to reduce the gap between the poorest individuals and those who are more affluent.	[Barros, Aluisio J. D.; Bertoldi, Andrea D.; Franca, Giovanny V. A.; Victora, Cesar G.] Univ Fed Pelotas, Postgrad Program Epidemiol, BR-96020220 Pelotas, Brazil; [Ronsmans, Carine] London Sch Hyg & Trop Med, London WC1, England; [Axelson, Henrik] Lund Univ, Dept Econ, Lund, Sweden; [Boerma, J. Ties] WHO, Dept Measurement & Hlth Informat Syst, CH-1211 Geneva, Switzerland; [Loaiza, Edilberto] UNFPA, New York, NY USA; [Bryce, Jennifer] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Universidade Federal de Pelotas; University of London; London School of Hygiene & Tropical Medicine; Lund University; World Health Organization; United Nations Population Fund; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Barros, AJD (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, BR-96020220 Pelotas, Brazil.	abarros.epi@gmail.com	de França, Giovanny Vinícius Araújo/L-7385-2018; Bertoldi, Andrea Dâmaso/AAG-7396-2021; Victora, Cesar G/D-4476-2013; Barros, Aluisio JD/A-7417-2008; Victora, Cesar Gomes/Y-2455-2019	de França, Giovanny Vinícius Araújo/0000-0002-7530-2017; Victora, Cesar G/0000-0002-2465-2180; Barros, Aluisio JD/0000-0002-2022-8729; Victora, Cesar Gomes/0000-0002-2465-2180	Bill & Melinda Gates Foundation; Norad; World Bank	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Norad(CGIAR); World Bank(The World Bank India)	The study was funded by the Bill & Melinda Gates Foundation, Norad, and the World Bank.	Barros A. J. D., 2005, Reaching the poor with health, nutrition, and population services: what works, what doesn't and why, P281; Barros AJD, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-57; Barros FC, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P49; Barros FC, 2010, REV SAUDE PUBL, V44, P1, DOI 10.1590/S0034-89102010000100001; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Bryce J, 2005, LANCET, V365, P2153, DOI 10.1016/S0140-6736(05)66752-9; Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; Claeson M, 2003, LANCET, V362, P323, DOI 10.1016/S0140-6736(03)13977-3; Commission on Information and Accountability for Women's and Children's Health, 2011, KEEP PROM MEAS RES F; Countdown to 2015, TRACK PROGR MAT NEWB; Countdown to 2015, MAT NEWB CHILD SURV; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Filmer D, 2012, DEMOGRAPHY, V49, P359, DOI 10.1007/s13524-011-0077-5; GWATKIN DR, 2007, SOCIOECONOMIC DIFFER; Harper S, MILBANK Q, V88, P4; Hosseinpoor AR, 2011, B WORLD HEALTH ORGAN, V89, P881, DOI 10.2471/BLT.11.087536; Houweling TAJ, 2007, B WORLD HEALTH ORGAN, V85, P745, DOI 10.2471/BLT.06.038588; Houweling Tanja Aj, 2007, Int J Equity Health, V6, P15, DOI 10.1186/1475-9276-6-15; Houweling Tanja AJ, 2003, Int J Equity Health, V2, P8, DOI 10.1186/1475-9276-2-8; Howe LD, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-3; Kakwani N, 1997, J ECONOMETRICS, V77, P87, DOI 10.1016/S0304-4076(96)01807-6; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Li RW, 2002, BIRTH-ISS PERINAT C, V29, P251, DOI 10.1046/j.1523-536X.2002.00199.x; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Morris SS, 2000, J EPIDEMIOL COMMUN H, V54, P381, DOI 10.1136/jech.54.5.381; Moser K, 2007, INT J EPIDEMIOL, V36, P1285, DOI 10.1093/ije/dym176; Rutstein SO, 2004, DHS WEALTH INDEX, V6; TRUSSELL J, 1992, POP STUD-J DEMOG, V46, P285, DOI 10.1080/0032472031000146246; UNICEF, 2010, PROGR CHILDR 2010 AC; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; WHITEHEAD M, 1992, INT J HEALTH SERV, V22, P429, DOI 10.2190/986L-LHQ6-2VTE-YRRN	32	376	379	3	76	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 31	2012	379	9822					1225	1233		10.1016/S0140-6736(12)60113-5	http://dx.doi.org/10.1016/S0140-6736(12)60113-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	918DV	22464386				2022-12-28	WOS:000302230400035
J	Lever, C; Burgess, N				Lever, Colin; Burgess, Neil			The Virtues of Youth and Maturity (in Dentate Granule Cells)	CELL			English	Editorial Material							ADULT HIPPOCAMPAL NEUROGENESIS; MEMORY; REPRESENTATION	How does adult neurogenesis contribute to memory? Nakashiba and colleagues generated mutant mice in which synaptic output from older hippocampal granule cells was specifically blocked. Experiments with these mice reveal an unpredicted age-dependent specialization of function, demonstrating that recently born cells support pattern separation, whereas older cells support pattern completion.	[Lever, Colin] Univ Durham, Dept Psychol, Durham DH1 3LE, England; [Burgess, Neil] UCL Inst Cognit Neurosci, London WC1N 3AR, England; [Burgess, Neil] UCL Inst Neurol, London WC1N 3BG, England	Durham University; University of London; University College London; University of London; University College London	Lever, C (corresponding author), Univ Durham, Dept Psychol, Durham DH1 3LE, England.	colin.lever@durham.ac.uk; n.burgess@ucl.ac.uk	Lever, Colin/B-4860-2008; Burgess, Neil/B-2420-2009	Lever, Colin/0000-0002-8955-2885; Burgess, Neil/0000-0003-0646-6584	MRC [G1000854] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [G01342X/1] Funding Source: Medline; Medical Research Council [G1000854] Funding Source: Medline; Wellcome Trust [095811] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905	10	3	3	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 30	2012	149	1					18	20		10.1016/j.cell.2012.02.038	http://dx.doi.org/10.1016/j.cell.2012.02.038			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464319	hybrid, Green Submitted			2022-12-28	WOS:000302235400005
J	Farrar, J				Farrar, Jeremy			Shift expertise to where it matters	NATURE			English	Editorial Material									Oxford Univ Clin Res Unit, Hosp Trop Dis, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam		Farrar, J (corresponding author), Oxford Univ Clin Res Unit, Hosp Trop Dis, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam.	jfarrar@oucru.org	Farrar, Jeremy J./HGA-7610-2022	Farrar, Jeremy/0000-0002-2700-623X	Wellcome Trust [093724] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)			0	0	0	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2012	483	7391					534	535		10.1038/483534a	http://dx.doi.org/10.1038/483534a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	915EF	22460881	Green Published, Bronze			2022-12-28	WOS:000302006100014
J	Ardagh, MW; Richardson, SK; Robinson, V; Than, M; Gee, P; Henderson, S; Khodaverdi, L; Mckie, J; Robertson, G; Schroeder, PP; Deely, JM				Ardagh, Michael W.; Richardson, Sandra K.; Robinson, Viki; Than, Martin; Gee, Paul; Henderson, Seton; Khodaverdi, Laura; Mckie, John; Robertson, Gregory; Schroeder, Philip P.; Deely, Joanne M.			The initial health-system response to the earthquake in Christchurch, New Zealand, in February, 2011	LANCET			English	Review							RENAL DISASTER RELIEF; CHI-CHI EARTHQUAKE; MEDICAL RESPONSE; EPIDEMIOLOGY; MORBIDITY; EMERGENCY; INJURIES; TRIAGE; HAITI; IRAN	At 1251 h on Feb 22, 2011, an earthquake struck Christchurch, New Zealand, causing widespread destruction. The only regional acute hospital was compromised but was able to continue to provide care, supported by other hospitals and primary care facilities in the city. 6659 people were injured and 182 died in the initial 24 h. The massive peak ground accelerations, the time of the day, and the collapse of major buildings contributed to injuries, but the proximity of the hospital to the central business district, which was the most affected, and the provision of good medical care based on careful preparation helped reduce mortality and the burden of injury. Lessons learned from the health response to this earthquake include the need for emergency departments to prepare for: patients arriving by unusual means without prehospital care, manual registration and tracking of patients, patient reluctance to come into hospital buildings, complete loss of electrical power, management of the many willing helpers, alternative communication methods, control of the media, and teamwork with clear leadership. Additionally, atypical providers of acute injury care need to be integrated into response plans.	[Ardagh, Michael W.; Richardson, Sandra K.] Univ Otago, Christchurch, New Zealand; [Ardagh, Michael W.] Univ Otago, Emergency Dept, Christchurch Hosp, Christchurch, New Zealand; [Schroeder, Philip P.] Rolleston Med Ctr, Rolleston, New Zealand; [Deely, Joanne M.] Canterbury Dist Hlth Board, Christchurch, New Zealand	University of Otago; Christchurch Hospital New Zealand; University of Otago	Ardagh, MW (corresponding author), Univ Otago, Emergency Dept, Christchurch Hosp, Private Bag 4710, Christchurch, New Zealand.	michael.ardagh@cdhb.govt.nz	Richardson, Sandra Kathryn/H-6987-2019	Richardson, Sandra Kathryn/0000-0003-3008-9475	AKO Aotearoa New Zealand National Institute; Canterbury Community Trust (NZ); Health Research Council (NZ); National Heart Foundation (NZ); Emergency Care Foundation; Emergency Co-ordination Teams; Canterbury District Health Board	AKO Aotearoa New Zealand National Institute; Canterbury Community Trust (NZ); Health Research Council (NZ)(Health Research Council of New Zealand); National Heart Foundation (NZ); Emergency Care Foundation; Emergency Co-ordination Teams; Canterbury District Health Board	MWA is chair of the Rhise Group (Research re the Health Implications of Seismic Events), is National Clinical Director of Emergency Department Services with the Ministry of Health (New Zealand, NZ), and is a trustee of the Emergency Care Foundation. SKR has funding from AKO Aotearoa New Zealand National Institute for teaching and earthquake health care research. MT has funding from the Canterbury Community Trust (NZ), Health Research Council (NZ), and the National Heart Foundation (NZ) for unrelated research, and is a trustee of the Emergency Care Foundation. VR, PG, SH, LK, JM, GR, and PPS declare that they have no conflicts of interest. JMD received funding from the Emergency Co-ordination Teams and Emergency Care Foundation for medical writing.; We thank the many people, including members of the public, emergency services, health-care professionals, police, and urban search and rescue personnel who helped the injured people of Canterbury; Canterbury District Health Board for funding data collection and analysis; the Emergency Care Co-ordination Teams and Emergency Care Foundation for funding medical writing; the Accident Compensation Corporation of New Zealand, Southern Cross Hospital, St Georges Hospital, Pegasus Health 24 Hour Surgery, Rural Canterbury Primary Health Organisation, and Christchurch Primary Health Organisation for the provision of data; Shellaine le Roux for artwork; and Kaeli Rowland for cross-checking the injury data.	AGHABABIAN R, 1994, ANN EMERG MED, V23, P771, DOI 10.1016/S0196-0644(94)70313-2; Amundson D, 2010, ANN INTERN MED, V152, P733, DOI 10.7326/0003-4819-152-11-201006010-00215; [Anonymous], RESPONSE URBAN EARTH; Arciniegas G, ANAL SEISMOGENIC DAM; Auf der Heide E, 2006, ANN EMERG MED, V47, P34, DOI 10.1016/j.annemergmed.2005.05.009; Bulut M, 2005, EMERG MED J, V22, P494, DOI 10.1136/emj.2004.016295; Canterbury District Health Board, 2010, CANT DISTR HLTH BOAR; Chavez C W, 1996, J Emerg Med, V14, P445, DOI 10.1016/0736-4679(96)00083-2; Chen WK, 2001, ANN EMERG MED, V38, P556, DOI 10.1067/mem.2001.119054; DEBRUYCKER M, 1985, INT J EPIDEMIOL, V14, P113, DOI 10.1093/ije/14.1.113; Federal Emergency Management Agency, EARTHQ US FEMA REP U; Geonet, 2011, GEONET          0222; HAYNES BE, 1992, ANN EMERG MED, V21, P368, DOI 10.1016/S0196-0644(05)82652-6; Jaffer AK, 2010, ANN INTERN MED, V153, P262, DOI 10.7326/0003-4819-153-4-201008170-00266; Kennedy K, 1996, ANN EMERG MED, V28, P136, DOI 10.1016/S0196-0644(96)70053-7; Kreiss Y, 2010, ANN INTERN MED, V153, P45, DOI 10.7326/0003-4819-153-1-201007060-00253; Kunii O, 1995, MED GLOB SURVIV, V2, P214; LECHAT MF, 1990, EPIDEMIOL REV, V12, P192, DOI 10.1093/oxfordjournals.epirev.a036053; Lechat Michel F., 1993, Public Health Reviews, V21, P243; Lee S, 2010, W J EMERGENCY MED, V11, P5; Lerner EB, 2008, DISASTER MED PUBLIC, V2, pS25, DOI 10.1097/DMP.0b013e318182194e; Liang NJ, 2001, ANN EMERG MED, V38, P549, DOI 10.1067/mem.2001.118999; Matsuoka T, 2000, PUBLIC HEALTH, V114, P249, DOI 10.1016/S0033-3506(00)00339-5; Montazeri A, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-4; Motamedi MHK, 2009, PREHOSPITAL DISASTER, V24, P453, DOI 10.1017/S1049023X00007317; Mulvey JM, 2008, INJURY, V39, P554, DOI 10.1016/j.injury.2007.07.025; Oda J, 1997, J TRAUMA, V42, P470, DOI 10.1097/00005373-199703000-00015; Ramazi H, 2006, J ASIAN EARTH SCI, V27, P576, DOI 10.1016/j.jseaes.2005.05.009; Ramirez M, 2005, EPIDEMIOL REV, V27, P47, DOI 10.1093/epirev/mxi005; Reyners M, 2011, SEISMOL RES LETT, V82, P371, DOI 10.1785/gssrl.82.3.371; Salinas C, 1998, AM J EMERG MED, V16, P254, DOI 10.1016/S0735-6757(98)90095-X; Schultz CH, 2007, ANN EMERG MED, V50, P320, DOI 10.1016/j.annemergmed.2007.03.025; Sever MS, 2009, NEPHROL DIAL TRANSPL, V24, P1730, DOI 10.1093/ndt/gfp094; Silka PA, 1999, ANN EMERG MED, V34, pS62; Stevenson JR, 2011, BULL N Z SOC EARTHQ, V44, P65, DOI 10.5459/bnzsee.44.2.65-76; Tanaka H, 1999, AM J EMERG MED, V17, P186, DOI 10.1016/S0735-6757(99)90059-1; US Geological Survey, SHAK MAP US2010RJA6; Vanholder R, 2010, LANCET, V375, P1162, DOI 10.1016/S0140-6736(10)60513-2	38	101	101	2	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 2	2012	379	9831					2109	2115		10.1016/S0140-6736(12)60313-4	http://dx.doi.org/10.1016/S0140-6736(12)60313-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951ZI	22510397				2022-12-28	WOS:000304759100034
J	Keevil, SF				Keevil, Stephen F.			Physics and medicine: a historical perspective	LANCET			English	Article							RADIATION-THERAPY; CANCER; TOMOGRAPHY; ONCOLOGY; SURGERY; FUTURE; IODINE; NMR	Nowadays, the term medical physics usually refers to the work of physicists employed in hospitals, who are concerned mainly with medical applications of radiation, diagnostic imaging, and clinical measurement. This involvement in clinical work began barely 100 years ago, but the relation between physics and medicine has a much longer history. In this report, I have traced this history from the earliest recorded period, when physical agents such as heat and light began to be used to diagnose and treat disease. Later, great polymaths such as Leonardo da Vinci and Alhazen used physical principles to begin the quest to understand the function of the body. After the scientific revolution in the 17th century, early medical physicists developed a purely mechanistic approach to physiology, whereas others applied ideas derived from physics in an effort to comprehend the nature of life itself. These early investigations led directly to the development of specialties such as electrophysiology, biomechanics, and ophthalmology. Physics-based medical technology developed rapidly during the 19th century, but it was the revolutionary discoveries about radiation and radioactivity at the end of the century that ushered in a new era of radiation-based medical diagnosis and treatment, thereby giving rise to the modern medical physics profession. Subsequent developments in imaging in particular have revolutionised the practice of medicine. We now stand on the brink of a new revolution in post-genomic personalised medicine, with physics-based techniques again at the forefront. As before, these techniques are often the unpredictable fruits of earlier investment in basic physics research.	[Keevil, Stephen F.] Guys & St Thomas NHS Fdn Trust, Dept Med Phys, London, England; [Keevil, Stephen F.] Kings Coll London, Div Imaging Sci & Biomed Engn, London WC2R 2LS, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Keevil, SF (corresponding author), St Thomas Hosp, Rayne Inst, Dept Med Phys, London SE1 7EH, England.	stephen.keevil@kcl.ac.uk						Al-Kalili J, WORLDS 1 TRUE SCI; Anger H. O., 1958, REV SCI INSTRUM, V29, P1958; [Anonymous], 1967, JAMA, V202, P126; [Anonymous], 1998, MESMERIZED POWERS MI; Becquerel AH, 1901, CR HEBD ACAD SCI, V132, P1289; Beyer T, 2000, J NUCL MED, V41, P1369; Black AJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021922; Bloch P, 1901, ANN DERMATOL SYPHIL, V2, P986; Bramly Serge, 1992, LEONARDO ARTIST MAN; Butterfield Herbert, 1949, ORIGINS MODERN SCI 1; Caruana CJ, 2009, PHYS MEDICA, V25, P133, DOI 10.1016/j.ejmp.2008.11.001; Cerussi A, 2007, P NATL ACAD SCI USA, V104, P4014, DOI 10.1073/pnas.0611058104; Duck F, 1994, SCOPE, V3, P32; Haggith JW, 1983, HIST HOSP PHYS ASS; Hamilton JG, 1939, AM J PHYSIOL, V127, P557, DOI 10.1152/ajplegacy.1939.127.3.557; Hamilton Joseph G., 1942, JOUR CLIN INVEST, V21, P624; HARPER PV, 1964, NUCLEONICS, V22, P50; Herschel JFW, 1840, PHILOS T A, V90, P255; Hertz S, 1942, J CLIN INVEST, V21, P31, DOI 10.1172/JCI101276; Hockberger PE, 2002, PHOTOCHEM PHOTOBIOL, V76, P561, DOI 10.1562/0031-8655(2002)076<0561:AHOUPF>2.0.CO;2; HOUNDFIELD GN, 1973, BRIT J RADIOL, V46, P1016, DOI 10.1259/0007-1285-46-552-1016; Jennings WA, EARLY DAYS MED PHYS; JOHNS HE, 1952, BRIT J RADIOL, V25, P296, DOI 10.1259/0007-1285-25-294-296; Joliot F, 1934, COMPTES RENDUS LACAD, V198, P254; KARZMARK CJ, 1973, PHYS MED BIOL, V18, P321, DOI 10.1088/0031-9155/18/3/001; Kostylev V, 2000, BIOMED ENG, V34, P106, DOI 10.1007/BF02403684; KUHL DE, 1963, RADIOLOGY, V80, P653, DOI 10.1148/80.4.653; Laughlin J S, 1989, Radiographics, V9, P1245; LAUTERBUR PC, 1973, NATURE, V242, P190, DOI 10.1038/242190a0; LAWSON R, 1957, Can Serv Med J, V8, P517; Leszczynski K, 1997, RADIOTHER ONCOL, V42, P213, DOI 10.1016/S0167-8140(97)01940-3; Levin WP, 2005, BRIT J CANCER, V93, P849, DOI 10.1038/sj.bjc.6602754; Lundervold Arvid, 2010, Nonlinear Biomed Phys, V4 Suppl 1, pS9, DOI 10.1186/1753-4631-4-S1-S9; MANSFIELD P, 1973, J PHYS C SOLID STATE, V6, pL422, DOI 10.1088/0022-3719/6/22/007; MAQUET P, 1992, J BONE JOINT SURG BR, V74, P335, DOI 10.1302/0301-620X.74B3.1587872; Marsden PK, 2002, BRIT J RADIOL, V75, pS53, DOI 10.1259/bjr.75.suppl_9.750053; MAYNEORD WV, 1951, NATURE, V168, P762, DOI 10.1038/168762a0; MITCHELL JS, 1946, BRIT J RADIOL, V19, P481, DOI 10.1259/0007-1285-19-228-481; Mould RF, 1993, CENTURY XRAYS RADIOA, V1st; MOURINO MR, 1991, RADIOLOGY, V180, P593, DOI 10.1148/radiology.180.3.1871268; Muller GJ, 2006, MED LASER APPL, V21, P99; Natterer F, 2002, INT J IMAG SYST TECH, V12, P175, DOI 10.1002/ima.10021; Nguyen QT, 2010, P NATL ACAD SCI USA, V107, P4317, DOI 10.1073/pnas.0910261107; Otsuka K, 1997, PHYSIOL MEAS, V18, P227, DOI 10.1088/0967-3334/18/3/007; Pittler MH, 2007, CAN MED ASSOC J, V177, P736, DOI 10.1503/cmaj.061344; Porter R., 1997, GREATEST BENEFIT MAN; Purdy JA, 2007, FRONT RADIAT THER ON, V40, P18, DOI 10.1159/000106026; Roberts JE, 1999, MEANDERINGS MED PHYS; Robison RF, 1995, ACTA ONCOL, V34, P1055, DOI 10.3109/02841869509127233; Rontgen WC., 1896, NATURE, V53, P274, DOI DOI 10.1038/053274B0; ROWLAND S, 1995, BRIT J RADIOL, V68, pH2, DOI 10.1259/0007-1285-68-805-H2; Rowlands P, 2006, WAR PEACE LIFE WORK; Russell GA, 1996, ENCY HIST ARABIC SCI; Sakorafas GH, 2009, EUR J CANCER CARE, V18, P530, DOI 10.1111/j.1365-2354.2008.01059.x; SEIDLIN SM, 1946, JAMA-J AM MED ASSOC, V132, P838, DOI 10.1001/jama.1946.02870490016004; Shapin Steven, 1996, SCI REVOLUTION; STIEVE FE, 1991, PHYS MED BIOL, V36, P687, DOI 10.1088/0031-9155/36/6/013; SWEET WH, 1951, NEW ENGL J MED, V245, P875, DOI 10.1056/NEJM195112062452301; TERPOGOSSIAN MM, 1975, RADIOLOGY, V114, P89, DOI 10.1148/114.1.89; Tomes D., 1972, Physics Education, V7, P78, DOI 10.1088/0031-9120/7/2/004; Vertes PE, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-S1-O11; Webb S., 1990, WATCHING SHADOWS ORI; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Wells PNT, 2001, MED ENG PHYS, V23, P147, DOI 10.1016/S1350-4533(01)00042-X; Wilkop T, 2009, I EL EL ENG SENS C C; WILSON RR, 1946, RADIOLOGY, V47, P487, DOI 10.1148/47.5.487; Zhang XC, 2002, PHYS MED BIOL, V47, P3667, DOI 10.1088/0031-9155/47/21/301; Ziedses des Plantes BG, 1950, P 6 INT C RAD LOND, P172	68	32	32	0	29	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 21	2012	379	9825					1517	1524		10.1016/S0140-6736(11)60282-1	http://dx.doi.org/10.1016/S0140-6736(11)60282-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930BJ	22516557				2022-12-28	WOS:000303110200030
J	Hall, MA				Hall, Mark A.			Supreme Court Arguments on the ACA - A Clash of Two World Views	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hall, Mark A.] Wake Forest Univ, Sch Law, Winston Salem, NC 27109 USA; [Hall, Mark A.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA	Wake Forest University; Wake Forest University; Wake Forest Baptist Medical Center	Hall, MA (corresponding author), Wake Forest Univ, Sch Law, Winston Salem, NC 27109 USA.			Hall, Mark A./0000-0001-6277-144X					0	7	7	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 19	2012	366	16					1462	1463		10.1056/NEJMp1201848	http://dx.doi.org/10.1056/NEJMp1201848			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	927UE	22475540				2022-12-28	WOS:000302934800002
J	McNulty, W; Cox, G; Au-Yong, I				McNulty, William; Cox, Giles; Au-Yong, Iain			RATIONAL IMAGING Investigating the solitary pulmonary nodule	BRITISH MEDICAL JOURNAL			English	Editorial Material							NEEDLE ASPIRATION BIOPSY; CELL LUNG-CANCER; ENDOBRONCHIAL ULTRASOUND; FLEISCHNER-SOCIETY; LESIONS; CT; METAANALYSIS; DIAGNOSIS; BENIGN; DIFFERENTIATION		[Au-Yong, Iain] Kings Mill Hosp, Dept Radiol, Sutton In Ashfield NG17 4JL, Notts, England; [McNulty, William; Cox, Giles] Kings Mill Hosp, Dept Resp Med, Sutton In Ashfield NG17 4JL, Notts, England		Au-Yong, I (corresponding author), Kings Mill Hosp, Dept Radiol, Sutton In Ashfield NG17 4JL, Notts, England.	iauyong@doctors.org.uk		McNulty, William/0000-0002-1315-7942				Adams K, 2009, THORAX, V64, P757, DOI 10.1136/thx.2008.109868; [Anonymous], 2011, DIAGNOSIS TREATMENT; Baaklini WA, 2000, CHEST, V117, P1049, DOI 10.1378/chest.117.4.1049; Diederich S, 1999, AM J ROENTGENOL, V172, P353, DOI 10.2214/ajr.172.2.9930781; Eberhardt R, 2007, AM J RESP CRIT CARE, V176, P36, DOI 10.1164/rccm.200612-1866OC; Erasmus JJ, 2000, RADIOGRAPHICS, V20, P43, DOI 10.1148/radiographics.20.1.g00ja0343; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; Fischbach F, 2003, EUR RADIOL, V13, P2378, DOI 10.1007/s00330-003-1915-7; GOOD CA, 1958, JAMA-J AM MED ASSOC, V166, P210, DOI 10.1001/jama.1958.02990030008003; GURNEY JW, 1993, RADIOLOGY, V186, P405, DOI 10.1148/radiology.186.2.8421743; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Lacasse Y, 1999, THORAX, V54, P884, DOI 10.1136/thx.54.10.884; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Manhire A, 2003, THORAX, V58, P920, DOI 10.1136/thorax.58.11.920; Pieterman RM, 2000, NEW ENGL J MED, V343, P254, DOI 10.1056/NEJM200007273430404; Quekel LGBA, 1999, CHEST, V115, P720, DOI 10.1378/chest.115.3.720; Seemann MD, 2000, LUNG CANCER, V29, P105, DOI 10.1016/S0169-5002(00)00104-5; Shah PK, 2003, RADIOLOGY, V226, P235, DOI 10.1148/radiol.2261011924; Smith MA, 2006, ANN THORAC SURG, V81, P1824, DOI 10.1016/j.athoracsur.2005.11.010; Steinfort DP, 2011, EUR RESPIR J, V37, P902, DOI 10.1183/09031936.00075310; TOOMES H, 1983, CANCER-AM CANCER SOC, V51, P534, DOI 10.1002/1097-0142(19830201)51:3<534::AID-CNCR2820510328>3.0.CO;2-B; Wiener RS, 2011, ANN INTERN MED, V155, P137, DOI 10.7326/0003-4819-155-3-201108020-00003; Winer-Muram HT, 2006, RADIOLOGY, V239, P34, DOI 10.1148/radiol.2391050343; Yi CA, 2006, J NUCL MED, V47, P443	24	9	10	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 19	2012	344								e2759	10.1136/bmj.e2759	http://dx.doi.org/10.1136/bmj.e2759			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	931CU	22517934				2022-12-28	WOS:000303192900012
J	Selby, JV; Beal, AC; Frank, L				Selby, Joe V.; Beal, Anne C.; Frank, Lori			The Patient-Centered Outcomes Research Institute (PCORI) National Priorities for Research and Initial Research Agenda	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Selby, Joe V.; Beal, Anne C.; Frank, Lori] Patient Centered Outcomes Res Inst, Washington, DC 20006 USA		Selby, JV (corresponding author), Patient Centered Outcomes Res Inst, 1701 Penn Ave NW,Ste 300, Washington, DC 20006 USA.	jselby@pcori.org						[Anonymous], MISS STAT; COLWILL JM, 1964, NEW ENGL J MED, V271, P696, DOI 10.1056/NEJM196410012711402; JELLINEK EM, 1946, BIOMETRICS BULL, V2, P87, DOI 10.2307/3001983; Medicine Io, 2009, INITIAL NATL PRIORIT; National Priorities Partnership, 2008, NAT PRIOR GOALS ALIG; Patel K, 2010, HEALTH AFFAIR, V29, P1777, DOI 10.1377/hlthaff.2010.0874; Patient-Centered Outcomes Research Institute, NAT PRIOR R IN PRESS; *US DEP HHS, FED COORD COUNC COMP; Whitlock EP, 2009, METHODS GUIDE COMP E	9	404	406	0	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2012	307	15					1583	1584		10.1001/jama.2012.500	http://dx.doi.org/10.1001/jama.2012.500			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927GU	22511682				2022-12-28	WOS:000302896100016
J	Prochazka, AV; Caverly, TJ				Prochazka, Allan V.; Caverly, Tanner J.			Radical prostatectomy and watchful waiting for localized prostate cancer did not differ for quality of life	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Prochazka, Allan V.] Denver VAMC, Denver, CO USA; Univ Colorado, Denver Sch Med, Denver, CO 80202 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Prochazka, AV (corresponding author), Denver VAMC, Denver, CO USA.							Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375	2	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2012	156	8							JC4-3	10.7326/0003-4819-156-8-201204170-02003	http://dx.doi.org/10.7326/0003-4819-156-8-201204170-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930PO	22508743				2022-12-28	WOS:000303151800002
J	Klein, HL; Symington, LS				Klein, Hannah L.; Symington, Lorraine S.			Sgs1-The Maestro of Recombination	CELL			English	Editorial Material							MEIOTIC CROSSING-OVER; MISMATCH REPAIR; MEIOSIS; RESOLUTION	The Sgs1 DNA helicase and its mammalian homolog BLM control crossover formation in mitotic cells. Zakharyevich et al. and De Muyt et al. now uncover a key role for Sgs1 in meiotic crossover regulation, which in turn reveals a joint molecule resolution pathway that produces the majority of crossovers in budding yeast.	[Klein, Hannah L.] NYU, Sch Med, Dept Mol Pharmacol & Biochem, New York, NY 10016 USA; [Symington, Lorraine S.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA	New York University; Columbia University	Klein, HL (corresponding author), NYU, Sch Med, Dept Mol Pharmacol & Biochem, New York, NY 10016 USA.	hannah.klein@nyumc.org; lss5@columbia.edu		Klein, Hannah/0000-0003-4228-8535	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041784, R01GM094386] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM094386, R01 GM041784] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; De Muyt A, 2012, MOL CELL, V46, P43, DOI 10.1016/j.molcel.2012.02.020; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Matos J, 2011, CELL, V147, P158, DOI 10.1016/j.cell.2011.08.032; Nishant KT, 2008, GENETICS, V179, P747, DOI 10.1534/genetics.108.086645; Rockmill B, 2003, CURR BIOL, V13, P1954, DOI 10.1016/j.cub.2003.10.059; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Zakharyevich K, 2012, CELL, V149, P334, DOI 10.1016/j.cell.2012.03.023	10	10	10	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 13	2012	149	2					257	259		10.1016/j.cell.2012.03.020	http://dx.doi.org/10.1016/j.cell.2012.03.020			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500794	Bronze			2022-12-28	WOS:000302805600006
J	Prather, MJ; Blake, DR				Prather, Michael J.; Blake, Donald R.			F. Sherwood Rowland (1927-2012) Obituary	NATURE			English	Biographical-Item									[Prather, Michael J.; Blake, Donald R.] Univ Calif Irvine, Irvine, CA 92717 USA	University of California System; University of California Irvine	Prather, MJ (corresponding author), Univ Calif Irvine, Irvine, CA 92717 USA.	mprather@uci.edu						ROWLAND FS, PUBLICATION LIST	1	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					168	168		10.1038/484168a	http://dx.doi.org/10.1038/484168a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22498618	Bronze			2022-12-28	WOS:000303149900020
J	Needham, DM; Colantuoni, E; Mendez-Tellez, PA; Dinglas, VD; Sevransky, JE; Himmelfarb, CRD; Desai, SV; Shanholtz, C; Brower, RG; Pronovost, PJ				Needham, Dale M.; Colantuoni, Elizabeth; Mendez-Tellez, Pedro A.; Dinglas, Victor D.; Sevransky, Jonathan E.; Himmelfarb, Cheryl R. Dennison; Desai, Sanjay V.; Shanholtz, Carl; Brower, Roy G.; Pronovost, Peter J.			Lung protective mechanical ventilation and two year survival in patients with acute lung injury: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RESPIRATORY-DISTRESS-SYNDROME; INTENSIVE-CARE-UNIT; TIDAL VOLUME VENTILATION; LONG-TERM SURVIVAL; ORGAN FAILURE; OUTCOMES; MORTALITY; SYSTEM; RELIABILITY; VALIDATION	Objective To evaluate the association of volume limited and pressure limited (lung protective) mechanical ventilation with two year survival in patients with acute lung injury. Design Prospective cohort study. Setting 13 intensive care units at four hospitals in Baltimore, Maryland, USA. Participants 485 consecutive mechanically ventilated patients with acute lung injury. Main outcome measure Two year survival after onset of acute lung injury. Results 485 patients contributed data for 6240 eligible ventilator settings, as measured twice daily (median of eight eligible ventilator settings per patient; 41% of which adhered to lung protective ventilation). Of these patients, 311 (64%) died within two years. After adjusting for the total duration of ventilation and other relevant covariates, each additional ventilator setting adherent to lung protective ventilation was associated with a 3% decrease in the risk of mortality over two years (hazard ratio 0.97, 95% confidence interval 0.95 to 0.99, P=0.002). Compared with no adherence, the estimated absolute risk reduction in two year mortality for a prototypical patient with 50% adherence to lung protective ventilation was 4.0% (0.8% to 7.2%, P=0.012) and with 100% adherence was 7.8% (1.6% to 14.0%, P=0.011). Conclusions Lung protective mechanical ventilation was associated with a substantial long term survival benefit for patients with acute lung injury. Greater use of lung protective ventilation in routine clinical practice could reduce long term mortality in patients with acute lung injury.	[Needham, Dale M.; Dinglas, Victor D.; Sevransky, Jonathan E.; Desai, Sanjay V.; Brower, Roy G.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Outcomes Crit Illness & Surg Grp, Baltimore, MD 21205 USA; [Needham, Dale M.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21205 USA; [Colantuoni, Elizabeth] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Mendez-Tellez, Pedro A.; Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA; [Himmelfarb, Cheryl R. Dennison; Pronovost, Peter J.] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21205 USA; [Shanholtz, Carl] Univ Maryland, Div Pulm & Crit Care Med, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore	Needham, DM (corresponding author), Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Outcomes Crit Illness & Surg Grp, Baltimore, MD 21205 USA.	Dale.Needham@jhmi.edu	Shanholtz, Carl/P-1190-2019; Himmelfarb, Cheryl Dennison/V-5660-2019	Shanholtz, Carl/0000-0003-3938-178X; Himmelfarb, Cheryl Dennison/0000-0003-1918-4316	National Institutes of Health (Acute Lung Injury Specialized Centers of Clinically Oriented Research) [P050 HL 73994]; Canadian Institutes of Health Research; National Institutes of Health [NIGMS K-23 GMO7-1399]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL073994] Funding Source: NIH RePORTER	National Institutes of Health (Acute Lung Injury Specialized Centers of Clinically Oriented Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the National Institutes of Health (Acute Lung Injury Specialized Centers of Clinically Oriented Research grant No P050 HL 73994). DNM received support from a clinician-scientist award from the Canadian Institutes of Health Research. JES received support from the National Institutes of Health (NIGMS K-23 GMO7-1399). All researchers are independent of the funding bodies. The funding bodies had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the manuscript for publication.	Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Angus DC, 2004, CRIT CARE MED, V32, P2199, DOI 10.1097/01.CCM.0000145228.62451.F6; [Anonymous], 2006, GOODMAN GILMANS PHAR; [Anonymous], 2011, SOCIAL SECURITY DEAT; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cooke CR, 2008, CRIT CARE MED, V36, P1412, DOI 10.1097/CCM.0b013e318170a375; Cuthbertson BH, 2010, CRIT CARE, V14, DOI 10.1186/cc8848; Dennison CR, 2007, CRIT CARE MED, V35, P2747, DOI 10.1097/01.CCM.0000287591.09487.70; Desai SV, 2011, CRIT CARE MED, V39, P371, DOI 10.1097/CCM.0b013e3181fd66e5; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Fan E, 2005, JAMA-J AM MED ASSOC, V294, P2889, DOI 10.1001/jama.294.22.2889; Fan E, 2008, CRIT CARE MED, V36, P94, DOI 10.1097/01.CCM.0000295308.29870.4F; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kosuke A, 2004, J AM STAT ASSOC, V99, P865; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Needham DM, 2007, J CRIT CARE, V22, P275, DOI 10.1016/j.jcrc.2007.02.001; Needham DM, 2010, RESP CARE, V55, P922; Needham DM, 2005, CRIT CARE MED, V33, P574, DOI [10.1097/01.CCM.0000155992.21174.31, 10.1097/01.ccm.0000155992.21174.31]; Needham DM, 2004, CRIT CARE MED, V32, P1504, DOI 10.1097/01.CCM.0000129972.31533.37; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Petrucci N, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003844.pub3; Pronovost PJ, 2010, AM J RESP CRIT CARE, V182, P1463, DOI 10.1164/rccm.201008-1255ED; Putensen C, 2009, ANN INTERN MED, V151, P566, DOI 10.7326/0003-4819-151-8-200910200-00011; Rubenfeld G, 2001, AM J RESP CRIT CARE, V163, pA295; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rubenfeld GD, 2004, CRIT CARE MED, V32, P1289, DOI 10.1097/01.CCM.0000127266.39560.96; Rubenfeld GD, 2009, CRIT CARE MED, V37, pS112, DOI 10.1097/CCM.0b013e3181922bb7; Seeley E, 2008, THORAX, V63, P994, DOI 10.1136/thx.2007.093658; Seeley EJ, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-52; Slutsky AS, 1998, AM J RESP CRIT CARE, V157, P1721, DOI 10.1164/ajrccm.157.6.9709092; Umoh NJ, 2008, CRIT CARE MED, V36, P1463, DOI 10.1097/CCM.0b013e31816fc3d0; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Wang WW, 2011, J R STAT SOC C-APPL, V60, P475, DOI 10.1111/j.1467-9876.2010.00757.x; Weinert CR, 2003, AM J RESP CRIT CARE, V167, P1304, DOI 10.1164/rccm.200205-478OC; Williams TA, 2008, CRIT CARE MED, V36, P1523, DOI 10.1097/CCM.0b013e318170a405; Wunsch H, 2010, JAMA-J AM MED ASSOC, V303, P849, DOI 10.1001/jama.2010.216; Young MP, 2004, CRIT CARE MED, V32, P1260, DOI 10.1097/01.CCM.0000127784.54727.56	43	226	234	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 5	2012	344								e2124	10.1136/bmj.e2124	http://dx.doi.org/10.1136/bmj.e2124			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923HF	22491953	Green Published, hybrid			2022-12-28	WOS:000302609700003
J	Gale, C; Santhakumaran, S; Nagarajan, S; Statnikov, Y; Modi, N				Gale, C.; Santhakumaran, S.; Nagarajan, S.; Statnikov, Y.; Modi, N.		Neonatal Data Anal Unit; Med Neonates Investigator Grp	Impact of managed clinical networks on NHS specialist neonatal services in England: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-BIRTH-WEIGHT; PRETERM INFANTS; MORTALITY; CARE; LEVEL; TRANSPORT; RISK	Objective To assess the impact of reorganisation of neonatal specialist care services in England after a UK Department of Health report in 2003. Design A population-wide observational comparison of outcomes over two epochs, before and after the establishment of managed clinical neonatal networks. Setting Epoch one: 294 maternity and neonatal units in England, Wales, and Northern Ireland, 1 September 1998 to 31 August 2000, as reported by the Confidential Enquiry into Stillbirths and Sudden Deaths in Infancy Project 27/28. Epoch two: 146 neonatal units in England contributing data to the National Neonatal Research Database at the Neonatal Data Analysis Unit, 1 January 2009 to 31 December 2010. Participants Babies born at a gestational age of 27(+0)-28(+6) (weeks+days): 3522 live births in epoch one; 2919 babies admitted to a neonatal unit within 28 days of birth in epoch two. Intervention The national reorganisation of neonatal services into managed clinical networks. Main outcome measures The proportion of babies born at hospitals providing the highest volume of neonatal specialist care (>= 2000 neonatal intensive care days annually), having an acute transfer (within the first 24 hours after birth) and/or a late transfer (between 24 hours and 28 days after birth) to another hospital, assessed by change in distribution of transfer category ("none," "acute," "late"), and babies from multiple births separated by transfer. For acute transfers in epoch two, the level of specialist neonatal care provided at the destination hospital (British Association of Perinatal Medicine criteria). Results After reorganisation, there were increases in the proportions of babies born at 27-28 weeks' gestation in hospitals providing the highest volume of neonatal specialist care (18% (631/3495) v 49% (1325/2724); odds ratio 4.30, 95% confidence interval 3.83 to 4.82; P < 0.001) and in acute and late postnatal transfers (7% (235) v 12% (360) and 18% (579) v 22% (640), respectively; P < 0.001). There was no significant change in the proportion of babies from multiple births separated by transfer (33% (39) v 29% (38); 0.86, 0.50 to 1.46; P = 0.57). In epoch two, 32% of acute transfers were to a neonatal unit providing either an equivalent (n = 87) or lower (n = 26) level of specialist care. Conclusions There is evidence of some improvement in the delivery of neonatal specialist care after reorganisation. The increase in acute transfers in epoch two, in conjunction with the high proportion transferred to a neonatal unit providing an equivalent or lower level of specialist care, and the continued separation of babies from multiple births, are indicative of poor coordination between maternity and neonatal services to facilitate in utero transfer before delivery, and continuing inadequacies in capacity of intensive care cots. Historical data representing epoch one are available only in aggregate form, preventing examination of temporal trends or confounding factors. This limits the extent to which differences between epochs can be attributed to reorganisation and highlights the importance of routine, prospective data collection for evaluation of future health service reorganisations.	[Gale, C.; Santhakumaran, S.; Nagarajan, S.; Statnikov, Y.; Modi, N.; Neonatal Data Anal Unit; Med Neonates Investigator Grp] Univ London Imperial Coll Sci Technol & Med, Sect Neonatal Med, Dept Med, London SW10 9NH, England	Imperial College London	Modi, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sect Neonatal Med, Dept Med, Chelsea & Westminster Campus, London SW10 9NH, England.	n.modi@imperial.ac.uk	Gale, Chris/F-1833-2010	Gale, Chris/0000-0003-0707-876X; Greenough, Anne/0000-0002-8672-5349; Majeed, Azeem/0000-0002-2357-9858	National Institute of Health Research (NIHR) [RP-PG-0707-10010]; Department of Health; Danone; Abbott International; Royal College of Paediatrics and Child Health (RCPCH); Child Growth Foundation (CGF); Westminster Medical School Research Trust; Medical Research Council [G1000758, G1000758B] Funding Source: researchfish; National Institute for Health Research [RP-PG-0707-10010] Funding Source: researchfish	National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); Department of Health; Danone(Danone Nutricia); Abbott International(Abbott Laboratories); Royal College of Paediatrics and Child Health (RCPCH); Child Growth Foundation (CGF); Westminster Medical School Research Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The Neonatal Data Analysis Unit is supported by a Programme Grant for Applied Research (RP-PG-0707-10010) from the National Institute of Health Research (NIHR) and unrestricted funding from the Department of Health, Danone, and Abbott International. The study funders had no role in study design, collection, analysis, and interpretation of data, writing of the report, or in the decision to submit the article for publication; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare financial support for the submitted work from the National Institute for Health Research (NIHR) through a Programme Grant for Applied Research (RP-PG-0707-10010). SN receives part funding from the Royal College of Paediatrics and Child Health (RCPCH) National Neonatal Audit Programme. CG receives part funding though an unrelated award to NM from the Child Growth Foundation (CGF) and support from the Westminster Medical School Research Trust. SS and YS are funded by the National Institute for Health Research. The views expressed in this publication are those of the authors and not necessarily those of the RCPCH, CGF, Westminster Medical School Research Trust, NHS, NIHR, or Department of Health.	[Anonymous], 2007, PROVISION NEONATAL S; Binder S, 2011, PEDIATRICS, V127, P487, DOI 10.1542/peds.2010-1064; British Association of Perinatal Medicine (BAPM), 2001, STAND HOSP PROV NEON STAND HOSP PROV NEON, V2nd; Chien LY, 2001, OBSTET GYNECOL, V98, P247, DOI 10.1016/S0029-7844(01)01438-7; Chung JH, 2011, J PERINATOL, V31, P770, DOI 10.1038/jp.2011.29; COOKE RWI, 1992, ARCH DIS CHILD-FETAL, V67, P868; Crump C, 2011, JAMA-J AM MED ASSOC, V306, P1233, DOI 10.1001/jama.2011.1331; Goodwin N, 2004, MANAGING DIVERSE NET; Greene A, 2009, QUAL SAF HEALTH CARE, V18, P456, DOI 10.1136/qshc.2007.023119; Guthrie BG, 2010, DELIVERING HLTH CARE; Honest H, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13430; Kirrane H, 2010, CHANCE LIFETIME BLIS; KOLLEE LAA, 1992, OBSTET GYNECOL, V80, P635; Langhoff-Roos J, 2006, BMJ-BRIT MED J, V332, P937, DOI 10.1136/bmj.38751.524132.2F; Lasswell SM, 2010, JAMA-J AM MED ASSOC, V304, P992, DOI 10.1001/jama.2010.1226; Lui K, 2006, PEDIATRICS, V118, P2076, DOI 10.1542/peds.2006-1540; March of Dimes, 2012, PERISTATS; Marlow N, 2007, ARCH DIS CHILD-FETAL, V92, pF137, DOI 10.1136/adc.2005.086413; Mohamed MA, 2010, ARCH DIS CHILD-FETAL, V95, pF403, DOI 10.1136/adc.2010.183236; National Audit Office, 2007, CAR VULN BAB REORG N; National Institute for Health and Clinical Excellence, 2011, SPEC NEON CAR QUAL S; National Neonatal Audit Programme (NNAP), 2009, ANN REP NNAP; Norman JE, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000153; Phibbs CS, 2007, NEW ENGL J MED, V356, P2165, DOI 10.1056/NEJMsa065029; Provan KG, 2007, J MANAGE, V33, P479, DOI 10.1177/0149206307302554; Roberts C, 2005, CLIN TRIALS, V2, P152, DOI 10.1191/1740774505cn076oa; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Santhakumaran S, 2010, NEONATAL SPECIALIST; Scottish Executive, 1999, INTR MAN CLIN NETW N; Shlossman PA, 1997, AM J PERINAT, V14, P449, DOI 10.1055/s-2007-994178; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Thomas EL, 2011, PEDIATR RES, V70, P507, DOI 10.1203/PDR.0b013e31822d7860; Towers CV, 2000, OBSTET GYNECOL, V95, P291, DOI 10.1016/S0029-7844(99)00528-1; Zeitlin J, 2010, ARCH DIS CHILD-FETAL, V95, pF188, DOI 10.1136/adc.2008.156745	34	44	44	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2012	344								e2105	10.1136/bmj.e2105	http://dx.doi.org/10.1136/bmj.e2105			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923GM	22490978	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000302607700001
J	Kalager, M; Adami, HO; Bretthauer, M; Tamimi, RM				Kalager, Mette; Adami, Hans-Olov; Bretthauer, Michael; Tamimi, Rulla M.			Overdiagnosis of Invasive Breast Cancer Due to Mammography Screening: Results From the Norwegian Screening Program	ANNALS OF INTERNAL MEDICINE			English	Article							CARCINOMA IN-SITU; SOJOURN TIME; LEAD TIME; OVERDETECTION; OVERTREATMENT; COMPLETENESS; SENSITIVITY; PROGESTIN; ESTROGEN; REGISTRY	Background: Precise quantification of overdiagnosis of breast cancer (defined as the percentage of cases of cancer that would not have become clinically apparent in a woman's lifetime without screening) due to mammography screening has been hampered by lack of valid comparison groups that identify incidence trends attributable to screening versus those due to temporal trends in incidence. Objective: To estimate the percentage of overdiagnosis of breast cancer attributable to mammography screening. Design: Comparison of invasive breast cancer incidence with and without screening. Setting: A nationwide mammography screening program in Norway (inviting women aged 50 to 69 years), gradually implemented from 1996 to 2005. Participants: The Norwegian female population. Measurements: Concomitant incidence of invasive breast cancer from 1996 to 2005 in counties where the screening program was implemented compared with that in counties where the program was not yet implemented. To adjust for changes in temporal trends in breast cancer incidence, incidence rates during the preceding decade were also examined. The percentage of overdiagnosis was calculated by accounting for the expected decrease in incidence following cessation of screening after age 69 years (approach 1) and by comparing incidence in the current screening group with incidence among women 2 and 5 years older in the historical screening groups, accounting for average lead time (approach 2). Results: A total of 39 888 patients with invasive breast cancer were included, 7793 of whom were diagnosed after the screening program started. The estimated rate of overdiagnosis attributable to the program was 18% to 25% (P < 0.001) for approach 1 and 15% to 20% (P < 0.001) for approach 2. Thus, 15% to 25% of cases of cancer are overdiagnosed, translating to 6 to 10 women overdiagnosed for every 2500 women invited. Limitation: The study was registry-based. Conclusion: Mammography screening entails a substantial amount of overdiagnosis.	[Kalager, Mette] Brigham & Womens Hosp, Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Karolinska Inst, Stockholm, Sweden; Univ Oslo, Rikshosp, Oslo Univ Hosp, N-0027 Oslo, Norway; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health; Karolinska Institutet; University of Oslo; National Hospital Norway; Harvard University; Harvard Medical School	Kalager, M (corresponding author), Brigham & Womens Hosp, Harvard Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.	mkalager@hsph.harvard.edu			Norwegian Research Council and Frontier Science	Norwegian Research Council and Frontier Science	Norwegian Research Council and Frontier Science.	Autier P, 2011, ANN ONCOL, V22, P1726, DOI 10.1093/annonc/mdq633; Autier P, 2009, J CLIN ONCOL, V27, P5919, DOI 10.1200/JCO.2009.22.7041; Bakken L, 2004, INT J CANCER, V112, P130, DOI 10.1002/ijc.20389; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Biesheuvel C, 2007, LANCET ONCOL, V8, P1129, DOI 10.1016/S1470-2045(07)70380-7; BOER R, 1994, LANCET, V343, P979, DOI 10.1016/S0140-6736(94)90105-8; de Koning HJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1369; Duffy SW, 2008, BRIT J CANCER, V99, P1176, DOI 10.1038/sj.bjc.6604638; Duffy SW, 2005, BREAST CANCER RES, V7, P258, DOI 10.1186/bcr1354; Gotzsche PC, 2009, BRIT J CANCER, V100, P219, DOI 10.1038/sj.bjc.6604762; Gotzsche PC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub3; Gotzsche PC, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b86; Jatoi I, 2005, CURR PROB SURG, V42, P616, DOI 10.1067/j.cpsurg.2005.06.002; Jensen A, 2005, INT J CANCER, V113, P464, DOI 10.1002/ijc.20604; Jorgensen Karsten J, 2009, BMC Womens Health, V9, P36, DOI 10.1186/1472-6874-9-36; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Kalager M, 2010, NEW ENGL J MED, V363, P1203, DOI 10.1056/NEJMoa1000727; Kalager Mette, 2009, Tidsskr Nor Laegeforen, V129, P2595, DOI 10.4045/tidsskr.09.0024; Larsen IK, 2009, EUR J CANCER, V45, P1218, DOI 10.1016/j.ejca.2008.10.037; MacMahon B., 1996, EPIDEMIOLOGY PRINCIP, V2nd; Magnusson C, 1999, INT J CANCER, V81, P339, DOI 10.1002/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.3.CO;2-Y; Morrell S, 2010, CANCER CAUSE CONTROL, V21, P275, DOI 10.1007/s10552-009-9459-z; Paci E, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1625; PERRY NM, 1996, EUROPEAN GUIDELINES; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rostgaard K, 2010, ACTA ONCOL, V49, P313, DOI 10.3109/02841861003602074; Shen Y, 2005, BIOSTATISTICS, V6, P604, DOI 10.1093/biostatistics/kxi030; Sorum R, 2010, BREAST, V19, P499, DOI 10.1016/j.breast.2010.05.014; Statistics Norway, STAT NORW; Tingulstad S, 2002, INT J CANCER, V98, P907, DOI 10.1002/ijc.10254; Vainio H., 2001, IARC HDB CANC PREVEN; Waaseth M, 2009, MATURITAS, V63, P220, DOI 10.1016/j.maturitas.2009.03.017; Weedon-Fekjaer H, 2008, J MED SCREEN, V15, P83, DOI 10.1258/jms.2008.007071; Weedon-Fekjaer H, 2009, ARCH INTERN MED, V169, P996, DOI 10.1001/archinternmed.2009.90; Welch HG, 2008, JNCI-J NATL CANCER I, V100, P228, DOI 10.1093/jnci/djn013; Welch HG, 2006, BRIT MED J, V332, P727, DOI 10.1136/bmj.332.7543.727; Welch HG, 1997, ANN INTERN MED, V127, P1023, DOI 10.7326/0003-4819-127-11-199712010-00014; Widmark A, 1995, 19955 STAT SAL, V5; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C; Zahl PH, 2008, ARCH INTERN MED, V168, P2311, DOI 10.1001/archinte.168.21.2311; Zahl PH, 2008, LANCET ONCOL, V9, P199, DOI 10.1016/S1470-2045(08)70049-4; Zahl PH, 2004, BMJ-BRIT MED J, V328, P921, DOI 10.1136/bmj.38044.666157.63	42	168	171	1	28	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2012	156	7					491	U61		10.7326/0003-4819-156-7-201204030-00005	http://dx.doi.org/10.7326/0003-4819-156-7-201204030-00005			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921GP	22473436				2022-12-28	WOS:000302466400003
J	Brook, M; Smith, RWP; Gray, NK				Brook, Matthew; Smith, Richard W. P.; Gray, Nicola K.			A Molecular Doorstop Ensures a Trickle through Translational Repression	CELL			English	Editorial Material								Switching mRNA translation off and on is central to regulated gene expression, but what mechanisms moderate the extent of switch-off? Yao et al. describe how basal expression from interferon-gamma-induced transcripts is maintained during mRNA-specific translational repression. This antagonistic mechanism utilizes a truncated RNA-binding factor generated by a unique alternative polyadenylation event.	[Brook, Matthew; Smith, Richard W. P.; Gray, Nicola K.] Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Edinburgh	Gray, NK (corresponding author), Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland.	nicola.gray@ed.ac.uk	Brook, Matthew/I-5828-2019; Smith, Richard/J-8117-2019	Brook, Matthew/0000-0003-1245-7385; Smith, Richard/0000-0002-6475-6910; gray, nicola/0000-0002-0413-1767	Medical Research Council [G1002033, MR/J003069/1] Funding Source: Medline; Biotechnology and Biological Sciences Research Council [BB/I02137X/1] Funding Source: researchfish; BBSRC [BB/I02137X/1] Funding Source: UKRI; MRC [G1002033, MR/J003069/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Hentze MW, 2007, TRANSLATIONAL CONTRO, P269; Laitem C, 2009, ONCOGENE, V28, P2087, DOI 10.1038/onc.2009.72; Lyabin DN, 2011, RNA BIOL, V8, P883, DOI 10.4161/rna.8.5.16022; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Yao P, 2012, CELL, V149, P88, DOI 10.1016/j.cell.2012.02.018	9	0	0	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 30	2012	149	1					13	15		10.1016/j.cell.2012.03.010	http://dx.doi.org/10.1016/j.cell.2012.03.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464317	Bronze			2022-12-28	WOS:000302235400003
J	Farago, AF; Snyder, EL; Jacks, T				Farago, Anna F.; Snyder, Eric L.; Jacks, Tyler			SnapShot: Lung Cancer Models	CELL			English	Editorial Material							RAPAMYCIN COMBINATION THERAPY; SOMATIC MUTATIONS; MOUSE; ADENOCARCINOMA; CELL		[Farago, Anna F.; Snyder, Eric L.; Jacks, Tyler] MIT, Cambridge, MA 02139 USA; [Farago, Anna F.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Farago, Anna F.] Dana Farber Partners Canc Care, Boston, MA 02215 USA; [Snyder, Eric L.] Brigham & Womens Hosp, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Farago, AF (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.							Chen Z, 2010, CANCER RES, V70, P9827, DOI 10.1158/0008-5472.CAN-10-1671; de Seranno S, 2010, EUR RESPIR J, V35, P426, DOI 10.1183/09031936.00124709; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Lee CL, 2012, DIS MODEL MECH, V5, P397, DOI 10.1242/dmm.009084; Li DN, 2007, CANCER CELL, V12, P81, DOI 10.1016/j.ccr.2007.06.005; Perera SA, 2009, P NATL ACAD SCI USA, V106, P474, DOI 10.1073/pnas.0808930106; Schaffer BE, 2010, CANCER RES, V70, P3877, DOI 10.1158/0008-5472.CAN-09-4228; Sutherland KD, 2011, CANCER CELL, V19, P754, DOI 10.1016/j.ccr.2011.04.019; Zhou YH, 2010, NAT BIOTECHNOL, V28, P71, DOI 10.1038/nbt.1595	10	29	31	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 30	2012	149	1					246	+	246.e1	10.1016/j.cell.2012.03.015	http://dx.doi.org/10.1016/j.cell.2012.03.015			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464334	Bronze			2022-12-28	WOS:000302235400025
J	Eliezer, D				Eliezer, David			Visualizing Amyloid Assembly	SCIENCE			English	Editorial Material							PROTEINS		[Eliezer, David] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; [Eliezer, David] Weill Cornell Med Coll, Program Struct Biol, New York, NY 10065 USA	Cornell University; Cornell University	Eliezer, D (corresponding author), Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA.	dae2005@med.cornell.edu						Crowley CS, 2008, STRUCTURE, V16, P1324, DOI 10.1016/j.str.2008.05.013; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Kohlhoff KJ, 2009, J AM CHEM SOC, V131, P13894, DOI 10.1021/ja903772t; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Neudecker P, 2012, SCIENCE, V336, P362, DOI 10.1126/science.1214203; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Pechmann S, 2009, P NATL ACAD SCI USA, V106, P10159, DOI 10.1073/pnas.0812414106; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103	10	4	4	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2012	336	6079					308	309		10.1126/science.1220356	http://dx.doi.org/10.1126/science.1220356			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22517851				2022-12-28	WOS:000302995400035
J	Hadjiliadis, D				Hadjiliadis, Denis			Ivacaftor improved lung function in cystic fibrosis with G551D mutation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Hadjiliadis, D (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.							Flume PA, 2007, AM J RESP CRIT CARE, V176, P957, DOI 10.1164/rccm.200705-664OC; Sloane PA, 2010, CURR OPIN PULM MED, V16, P591, DOI 10.1097/MCP.0b013e32833f1d00	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2012	156	8							JC4-10	10.7326/0003-4819-156-8-201204170-02010	http://dx.doi.org/10.7326/0003-4819-156-8-201204170-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930PO	22508750				2022-12-28	WOS:000303151800009
J	Khademi, H; Malekzadeh, R; Pourshams, A; Jafari, E; Salahi, R; Semnani, S; Abaie, B; Islami, F; Nasseri-Moghaddam, S; Etemadi, A; Byrnes, G; Abnet, CC; Dawsey, SM; Day, NE; Pharoah, PD; Boffetta, P; Brennan, P; Kamangar, F				Khademi, Hooman; Malekzadeh, Reza; Pourshams, Akram; Jafari, Elham; Salahi, Rasool; Semnani, Shahryar; Abaie, Behrooz; Islami, Farhad; Nasseri-Moghaddam, Siavosh; Etemadi, Arash; Byrnes, Graham; Abnet, Christian C.; Dawsey, Sanford M.; Day, Nicholas E.; Pharoah, Paul D.; Boffetta, Paolo; Brennan, Paul; Kamangar, Farin			Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50 000 adults in Iran	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ESOPHAGEAL CANCER; HIGH-RISK; SOCIOECONOMIC-STATUS; BLADDER-CANCER; MORPHINE; ADDICTION; RELIABILITY; POPULATION; METABOLISM; CARCINOMA	Objectives To investigate the association between opium use and subsequent risk of death. Design Prospective cohort study. Setting The Golestan Cohort Study in north-eastern Iran collected detailed validated data on opium use and other exposures at baseline. Participants were enrolled between January 2004 and June 2008 and were followed to May 2011, with a follow-up success rate of over 99%. Participants 50 045 participants aged 40-75 at baseline. Main outcomes Mortality, all cause and major subcategories. Results 17% (n=8487) of the participants reported opium use, with a mean duration of 12.7 years. During the follow-up period 2145 deaths were reported. The adjusted hazard ratio for all cause mortality associated with ever use of opium was 1.86 (95% confidence interval 1.68 to 2.06). Opium consumption was significantly associated with increased risks of deaths from several causes including circulatory diseases (hazard ratio 1.81) and cancer (1.61). The strongest associations were seen with deaths from asthma, tuberculosis, and chronic obstructive pulmonary disease (11.0, 6.22, and 5.44, respectively). After exclusion of people who self prescribed opium after the onset of major chronic illnesses, the associations remained strong with a dose-response relation. Conclusion Opium users have an increased risk of death from multiple causes compared with non-users. Increased risks were also seen in people who used low amounts of opium for a long period and those who had no major illness before use.	[Khademi, Hooman; Malekzadeh, Reza; Pourshams, Akram; Jafari, Elham; Abaie, Behrooz; Islami, Farhad; Nasseri-Moghaddam, Siavosh; Etemadi, Arash; Kamangar, Farin] Univ Tehran Med Sci, Digest Dis Res Ctr, Shariati Hosp, Tehran, Iran; [Khademi, Hooman; Byrnes, Graham; Brennan, Paul] Int Agcy Res Canc, F-69372 Lyon, France; [Salahi, Rasool; Semnani, Shahryar] Golestan Univ Med Sci, Golestan Res Ctr Gastroenterol & Hepatol, Gorgan, Iran; [Islami, Farhad; Boffetta, Paolo] Mt Sinai Sch Med, Inst Translat Epidemiol, New York, NY USA; [Islami, Farhad; Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Etemadi, Arash; Abnet, Christian C.; Dawsey, Sanford M.; Kamangar, Farin] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Day, Nicholas E.; Pharoah, Paul D.] Univ Cambridge, Dept Oncol & Publ Hlth, Cambridge, England; [Day, Nicholas E.; Pharoah, Paul D.] Univ Cambridge, Dept Primary Care, Cambridge, England; [Boffetta, Paolo] Int Prevent Res Inst, Lyon, France; [Kamangar, Farin] Morgan State Univ, Dept Publ Hlth Anal, Sch Community Hlth & Policy, Baltimore, MD 21239 USA	Tehran University of Medical Sciences; World Health Organization; International Agency for Research on Cancer (IARC); Golestan University of Medical Sciences; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Cambridge; University of Cambridge; Morgan State University	Malekzadeh, R (corresponding author), Univ Tehran Med Sci, Digest Dis Res Ctr, Shariati Hosp, Tehran, Iran.	malek@ams.ac.ir; brennan@iarc.fr	Etemadi, Arash/C-1386-2016; Semnani, Shahryar/N-2270-2016; Malekzadeh, Reza/U-1382-2017; Abnet, Christian C/C-4111-2015; Etemadi, Arash/Y-7082-2018; Khademi, Hooman/AAZ-8798-2020; Boffetta, Paolo/AAI-7767-2021; Pharoah, Paul/V-6658-2019	Etemadi, Arash/0000-0002-3458-1072; Semnani, Shahryar/0000-0002-8768-6142; Malekzadeh, Reza/0000-0002-9820-6335; Abnet, Christian C/0000-0002-3008-7843; Etemadi, Arash/0000-0002-3458-1072; Boffetta, Paolo/0000-0002-3811-2791; Pharoah, Paul/0000-0001-8494-732X; Byrnes, Graham/0000-0003-3893-7539; Malekzadeh, Reza/0000-0003-1043-3814; Islami, Farhad/0000-0002-7357-5994; Pourshams, Akram/0000-0002-7950-3983	Tehran University of medical sciences [81/15]; Cancer Research UK [C20/A5860]; NCI, National Institutes of Health; IARC; Social Security Organization of Iran Golestan Branch; NATIONAL CANCER INSTITUTE [ZIACP000185] Funding Source: NIH RePORTER	Tehran University of medical sciences(Tehran University of Medical Sciences); Cancer Research UK(Cancer Research UK); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); IARC; Social Security Organization of Iran Golestan Branch; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Golestan Cohort Study was supported by Tehran University of medical sciences (grant No: 81/15), Cancer Research UK (grant No: C20/A5860), the Intramural Research Program of the NCI, National Institutes of Health, and through various collaborative research agreements with the IARC. The study has also received special support from the Social Security Organization of Iran Golestan Branch.	Abnet CC, 2004, CANCER EPIDEM BIOMAR, V13, P1068; Aliasgari M A, 2004, Urol J, V1, P253; Atici S, 2005, J BIOSCIENCES, V30, P245, DOI 10.1007/BF02703705; Bekheet SHM, 2010, TISSUE CELL, V42, P266, DOI 10.1016/j.tice.2010.06.001; BORZELLECA JF, 1994, J APPL TOXICOL, V14, P435, DOI 10.1002/jat.2550140609; Bosshart Herbert, 2011, J Opioid Manag, V7, P93; DACOSTA JL, 1971, THORAX, V26, P555, DOI 10.1136/thx.26.5.555; Elia Davide, 2010, Acta Biomed, V81, P63; Fewell Z, 2007, AM J EPIDEMIOL, V166, P646, DOI 10.1093/aje/kwm165; Fimiani C, 1999, CANCER LETT, V146, P45, DOI 10.1016/S0304-3835(99)00227-X; FRIESEN M, 1985, MUTAT RES, V150, P177, DOI 10.1016/0027-5107(85)90114-9; GHADIRIAN P, 1985, INT J CANCER, V35, P593, DOI 10.1002/ijc.2910350505; HEWER T, 1978, LANCET, V2, P494; Hosseini SY, 2010, UROL ONCOL-SEMIN ORI, V28, P610, DOI 10.1016/j.urolonc.2008.10.016; Islami F, 2009, INT J EPIDEMIOL, V38, P978, DOI 10.1093/ije/dyp195; Kalant H, 1997, ADDICTION, V92, P267; Khademi H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011183; Malekshah AF, 2006, EUR J CLIN NUTR, V60, P971, DOI 10.1038/sj.ejcn.1602407; Maslov LN, 2009, LIFE SCI, V84, P657, DOI 10.1016/j.lfs.2009.02.016; Masoomi M, 2010, INT J PREVENTIVE MED, V1, P182; Masoomi M, 2010, BLOOD COAGUL FIBRIN, V21, P109, DOI 10.1097/MBC.0b013e32832f2b1e; Masoumi M, 2010, J RES MED SCI, V15, P27; Mccandless LC, 2008, J CLIN EPIDEMIOL, V61, P247, DOI 10.1016/j.jclinepi.2007.05.006; McCrimmon DR, 2003, AM J PHYSIOL-REG I, V285, pR1274, DOI 10.1152/ajpregu.00428.2003; Meine TJ, 2005, AM HEART J, V149, P1043, DOI 10.1016/j.ahj.2005.02.010; Mousavi MRA, 2003, LARYNGOSCOPE, V113, P1939, DOI 10.1097/00005537-200311000-00016; NAGAMATSU K, 1986, BIOCHEM PHARMACOL, V35, P3543, DOI 10.1016/0006-2952(86)90624-6; Nasrollahzadeh D, 2008, BRIT J CANCER, V98, P1857, DOI 10.1038/sj.bjc.6604369; PACIFICI GM, 1986, XENOBIOTICA, V16, P123, DOI 10.3109/00498258609043514; Pinto LFR, 1997, CARCINOGENESIS, V18, P365; Pourshams A, 2005, BRIT J CANCER, V92, P176, DOI 10.1038/sj.bjc.6602249; Pourshams A, 2010, INT J EPIDEMIOL, V39, P52, DOI 10.1093/ije/dyp161; Sadeghian S, 2010, INT J CARDIOL, V141, P116, DOI 10.1016/j.ijcard.2008.11.063; Safaii N, 2010, GEN THORAC CARDIOVAS, V58, P62, DOI 10.1007/s11748-009-0529-7; Schiff PL, 2002, AM J PHARM EDUC, V66, P186; Shakhssalim N, 2010, ASIAN PAC J CANCER P, V11, P601; SIEMIATYCKI J, 1988, J OCCUP ENVIRON MED, V30, P617, DOI 10.1097/00043764-198808000-00004; Sumathi T, 2009, PHYTOMEDICINE, V16, P897, DOI 10.1016/j.phymed.2009.03.005; UNODC United Nations Office on Drugs and Crime Vienna, 2010, WORLD DRUG REP 2010; Vallejo Ricardo, 2004, Am J Ther, V11, P354, DOI 10.1097/01.mjt.0000132250.95650.85; VANDERLAAN JW, 1995, INT J IMMUNOPHARMACO, V17, P535, DOI 10.1016/0192-0561(95)00010-Y	41	107	107	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2012	344								e2502	10.1136/bmj.e2502	http://dx.doi.org/10.1136/bmj.e2502			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	931CN	22511302	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000303192100003
J	Auer, R; Bauer, DC; Marques-Vidal, P; Butler, J; Min, LJ; Cornuz, J; Satterfield, S; Newman, AB; Vittinghoff, E; Rodondi, N				Auer, Reto; Bauer, Douglas C.; Marques-Vidal, Pedro; Butler, Javed; Min, Lauren J.; Cornuz, Jacques; Satterfield, Suzanne; Newman, Anne B.; Vittinghoff, Eric; Rodondi, Nicolas		Hlth ABC Study	Association of Major and Minor ECG Abnormalities With Coronary Heart Disease Events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ST-T ABNORMALITIES; CARDIOVASCULAR EVENTS; PREDICTIVE ABILITY; ROC CURVE; RISK; MORTALITY; ELECTROCARDIOGRAMS; RECLASSIFICATION; ATHEROSCLEROSIS; MARKERS	Context In populations of older adults, prediction of coronary heart disease (CHD) events through traditional risk factors is less accurate than in middle-aged adults. Electrocardiographic (ECG) abnormalities are common in older adults and might be of value for CHD prediction. Objective To determine whether baseline ECG abnormalities or development of new and persistent ECG abnormalities are associated with increased CHD events. Design, Setting, and Participants A population-based study of 2192 white and black older adults aged 70 to 79 years from the Health, Aging, and Body Composition Study (Health ABC Study) without known cardiovascular disease. Adjudicated CHD events were collected over 8 years between 1997-1998 and 2006-2007. Baseline and 4-year ECG abnormalities were classified according to the Minnesota Code as major and minor. Using Cox proportional hazards regression models, the addition of ECG abnormalities to traditional risk factors were examined to predict CHD events. Main Outcome Measure Adjudicated CHD events (acute myocardial infarction [MI], CHD death, and hospitalization for angina or coronary revascularization). Results At baseline, 276 participants (13%) had minor and 506 (23%) had major ECG abnormalities. During follow-up, 351 participants had CHD events (96 CHD deaths, 101 acute MIs, and 154 hospitalizations for angina or coronary revascularizations). Both baseline minor and major ECG abnormalities were associated with an increased risk of CHD after adjustment for traditional risk factors (17.2 per 1000 person-years among those with no abnormalities; 29.3 per 1000 person-years; hazard ratio [HR], 1.35; 95% CI, 1.02-1.81; for minor abnormalities; and 31.6 per 1000 person-years; HR, 1.51; 95% CI, 1.20-1.90; for major abnormalities). When ECG abnormalities were added to a model containing traditional risk factors alone, 13.6% of intermediate-risk participants with both major and minor ECG abnormalities were correctly reclassified (overall net reclassification improvement [NRI], 7.4%; 95% CI, 3.1%-19.0%; integrated discrimination improvement, 0.99%; 95% CI, 0.32%-2.15%). After 4 years, 208 participants had new and 416 had persistent abnormalities. Both new and persistent ECG abnormalities were associated with an increased risk of subsequent CHD events (HR, 2.01; 95% CI, 1.33-3.02; and HR, 1.66; 95% CI, 1.18-2.34; respectively). When added to the Framingham Risk Score, the NRI was not significant (5.7%; 95% CI, -0.4% to 11.8%). Conclusions Major and minor ECG abnormalities among older adults were associated with an increased risk of CHD events. Depending on the model, adding ECG abnormalities was associated with improved risk prediction beyond traditional risk factors. JAMA. 2012;307(14):1497-1505	[Auer, Reto; Bauer, Douglas C.; Vittinghoff, Eric] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94107 USA; [Bauer, Douglas C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94107 USA; [Auer, Reto; Cornuz, Jacques] Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [Marques-Vidal, Pedro] Univ Lausanne, Inst Social & Prevent Med, Lausanne, Switzerland; [Marques-Vidal, Pedro] Univ Lausanne, Clin Res Ctr, Lausanne, Switzerland; [Butler, Javed] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Min, Lauren J.] US FDA, Silver Spring, MD USA; [Satterfield, Suzanne] Univ Tennessee, Hlth Sci Ctr, Dept Prevent Med, Memphis, TN USA; [Newman, Anne B.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Rodondi, Nicolas] Univ Bern, Dept Gen Internal Med, Bern, Switzerland	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Lausanne; University of Lausanne; University of Lausanne; Emory University; US Food & Drug Administration (FDA); University of Tennessee System; University of Tennessee Health Science Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Bern	Auer, R (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, 185 Berry St,Ste 5700, San Francisco, CA 94107 USA.	reto.auer@ucsf.edu	Newman, Anne B./C-6408-2013; Marques-Vidal, Pedro/C-9449-2009	Newman, Anne B./0000-0002-0106-1150; Auer, Reto/0000-0003-4222-4849; Marques-Vidal, Pedro/0000-0002-4548-8500; Rodondi, Nicolas/0000-0001-9083-6896; Kritchevsky, Stephen/0000-0003-3336-6781	Novartis; Amgen; National Institutes of Health; Medtronic; GE Healthcare; Boston Scientific; National Institute on Aging [R01-AG028050]; National Institute on Aging (NIA), National Institutes of Health (NIH) [N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106]; National Institute of Nursing Research [R01-R012459]; Swiss National Science Foundation [SPUM33CM30-124112, PBLAP3-136774]; Swiss Heart Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR051895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG062103, R01AG028050, N01AG062106, N01AG062101] Funding Source: NIH RePORTER	Novartis(Novartis); Amgen(Amgen); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medtronic(Medtronic); GE Healthcare(General ElectricGE Healthcare); Boston Scientific(Boston Scientific); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Aging (NIA), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Heart Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Bauer reported receiving grants from Novartis and Amgen. Dr Butler reported receiving research support from National Institutes of Health, Amgen, Medtronic, GE Healthcare, and Boston Scientific; and being a consultant to Bayer, Cardiomems, Trevena, Takeda, Ono Pharmaceutical, and Events Committee Corthera and World Heart. Dr Satterfield reported receiving a grant contract for Health ABC Study from the National Institute on Aging. Dr Vittinghoff reported receiving a grant for support as consulting statistician for training program from the National Institutes of Health. No other authors reported any disclosures.; This work was supported by grants N01-AG-6-2101, N01-AG-6-2103, and N01-AG-6-2106 from the National Institute on Aging (NIA), National Institutes of Health (NIH); grant R01-AG028050 from the NIA, grant R01-R012459 from the National Institute of Nursing Research, and in part by the Intramural Research Program of the NIH, NIA. The NIA funded the Health ABC Study, reviewed the manuscript, and approved its publication. Dr Auer's research on cardiovascular prevention is supported by grants SPUM33CM30-124112 and PBLAP3-136774 from the Swiss National Science Foundation and the Swiss Heart Foundation.	USA Pooling Project Research Group, 1978, Journal of Chronic Diseases, V31, P201; Ashley EA, 2001, PROG CARDIOVASC DIS, V44, P55, DOI 10.1053/pcad.2001.24683; Ashley EA, 2000, CURR PROB CARDIOLOGY, V25, P7, DOI 10.1016/S0146-2806(00)70020-X; Chou R, 2011, ANN INTERN MED, V155, P375, DOI 10.7326/0003-4819-155-6-201109200-00006; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cook NR, 2008, STAT MED, V27, P191, DOI 10.1002/sim.2987; Cook NR, 2011, BIOMETRICAL J, V53, P237, DOI 10.1002/bimj.201000078; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Daviglus ML, 1999, JAMA-J AM MED ASSOC, V281, P530, DOI 10.1001/jama.281.6.530; De Bacquer D, 1998, HEART, V80, P570, DOI 10.1136/hrt.80.6.570; De Ruijter W, 2008, SCAND J PRIM HEALTH, V26, P147, DOI 10.1080/02813430802095812; de Ruijter W, 2007, J AM GERIATR SOC, V55, P872, DOI 10.1111/j.1532-5415.2007.01180.x; Denes P, 2007, JAMA-J AM MED ASSOC, V297, P978, DOI 10.1001/jama.297.9.978; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Greenland P, 2003, AM J CARDIOL, V91, P1068, DOI 10.1016/S0002-9149(03)00150-4; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Ingelsson E, 2007, JAMA-J AM MED ASSOC, V298, P776, DOI 10.1001/jama.298.7.776; KANNEL WB, 1987, AM HEART J, V113, P370, DOI 10.1016/0002-8703(87)90280-8; Kim KP, 2009, ARCH INTERN MED, V169, P1188, DOI 10.1001/archinternmed.2009.162; Lauer MS, 2011, ANN INTERN MED, V155, P395, DOI 10.7326/0003-4819-155-6-201109200-00011; Lauer MS, 2009, NEW ENGL J MED, V361, P841, DOI 10.1056/NEJMp0904735; Lee CD, 2004, CIRCULATION, V109, P855, DOI 10.1161/01.CIR.0000116389.61864.DE; LIAO YL, 1987, CIRCULATION, V75, P347, DOI 10.1161/01.CIR.75.2.347; Newman AB, 2006, JAMA-J AM MED ASSOC, V295, P2018, DOI 10.1001/jama.295.17.2018; O'Malley PG, 2010, ARCH INTERN MED, V170, P1602, DOI 10.1001/archinternmed.2010.327; Parzen M, 1999, BIOMETRICS, V55, P580, DOI 10.1111/j.0006-341X.1999.00580.x; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Prineas R., 1982, MINNESOTA CODE MANUA; Psaty BM, 2004, J AM GERIATR SOC, V52, P1639, DOI 10.1111/j.1532-5415.2004.52455.x; RAJALA S, 1985, EUR HEART J, V6, P247, DOI 10.1093/oxfordjournals.eurheartj.a061848; Rodondi N, 2005, ARCH INTERN MED, V165, P2460, DOI 10.1001/archinte.165.21.2460; Rodondi N, 2010, AM J EPIDEMIOL, V171, P540, DOI 10.1093/aje/kwp428; Salerno SM, 2003, ANN INTERN MED, V138, P751, DOI 10.7326/0003-4819-138-9-200305060-00013; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373	38	124	130	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2012	307	14					1497	1505		10.1001/jama.2012.434	http://dx.doi.org/10.1001/jama.2012.434			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922HN	22496264	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000302538100023
J	Kamerow, D				Kamerow, Douglas			How will the US Supreme Court rule on health reform?	BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Durham, NC 27709 USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Durham, NC 27709 USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				Kamerow D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c500	1	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 11	2012	344								e2626	10.1136/bmj.e2626	http://dx.doi.org/10.1136/bmj.e2626			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	927UH	22496342				2022-12-28	WOS:000302935200016
J	Berg, WA; Zhang, Z; Lehrer, D; Jong, RA; Pisano, ED; Barr, RG; Bohm-Velez, M; Mahoney, MC; Evans, WP; Larsen, LH; Morton, MJ; Mendelson, EB; Farria, DM; Cormack, JB; Marques, HS; Adams, A; Yeh, NM; Gabrielli, G				Berg, Wendie A.; Zhang, Zheng; Lehrer, Daniel; Jong, Roberta A.; Pisano, Etta D.; Barr, Richard G.; Boehm-Velez, Marcela; Mahoney, Mary C.; Evans, W. Phil, III; Larsen, Linda H.; Morton, Marilyn J.; Mendelson, Ellen B.; Farria, Dione M.; Cormack, Jean B.; Marques, Helga S.; Adams, Amanda; Yeh, Nolin M.; Gabrielli, Glenna		ACRIN 6666 Investigators	Detection of Breast Cancer With Addition of Annual Screening Ultrasound or a Single Screening MRI to Mammography in Women With Elevated Breast Cancer Risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROSPECTIVE MULTICENTER COHORT; HIGH FAMILIAL RISK; DENSE BREASTS; US; SURVEILLANCE; SONOGRAPHY; ULTRASONOGRAPHY; TRIAL	Context Annual ultrasound screening may detect small, node-negative breast cancers that are not seen on mammography. Magnetic resonance imaging (MRI) may reveal additional breast cancers missed by both mammography and ultrasound screening. Objective To determine supplemental cancer detection yield of ultrasound and MRI in women at elevated risk for breast cancer. Design, Setting, and Participants From April 2004-February 2006, 2809 women at 21 sites with elevated cancer risk and dense breasts consented to 3 annual independent screens with mammography and ultrasound in randomized order. After 3 rounds of both screenings, 612 of 703 women who chose to undergo an MRI had complete data. The reference standard was defined as a combination of pathology (biopsy results that showed in situ or infiltrating ductal carcinoma or infiltrating lobular carcinoma in the breast or axillary lymph nodes) and 12-month follow-up. Main Outcome Measures Cancer detection rate (yield), sensitivity, specificity, positive predictive value (PPV3) of biopsies performed and interval cancer rate. Results A total of 2662 women underwent 7473 mammogram and ultrasound screenings, 110 of whom had 111 breast cancer events: 33 detected by mammography only, 32 by ultrasound only, 26 by both, and 9 by MRI after mammography plus ultrasound; 11 were not detected by any imaging screen. Among 4814 incidence screens in the second and third years combined, 75 women were diagnosed with cancer. Supplemental incidence-screening ultrasound identified 3.7 cancers per 1000 screens (95% CI, 2.1-5.8; P<.001). Sensitivity for mammography plus ultrasound was 0.76 (95% CI, 0.65-0.85); specificity, 0.84 (95% CI, 0.83-0.85); and PPV3, 0.16 (95% CI, 0.12-0.21). For mammography alone, sensitivity was 0.52 (95% CI, 0.40-0.64); specificity, 0.91 (95% CI, 0.90-0.92); and PPV3, 0.38 (95% CI, 0.28-0.49; P<.001 all comparisons). Of the MRI participants, 16 women (2.6%) had breast cancer diagnosed. The supplemental yield of MRI was 14.7 per 1000 (95% CI, 3.5-25.9; P=.004). Sensitivity for MRI and mammography plus ultrasound was 1.00 (95% CI, 0.79-1.00); specificity, 0.65 (95% CI, 0.61-0.69); and PPV3, 0.19 (95% CI, 0.11-0.29). For mammography and ultrasound, sensitivity was 0.44 (95% CI, 0.20-0.70, P=.004); specificity 0.84 (95% CI, 0.81-0.87; P<.001); and PPV3, 0.18 (95% CI, 0.08 to 0.34; P=.98). The number of screens needed to detect 1 cancer was 127(95% CI, 99-167) for mammography; 234(95% CI, 173-345) for supplemental ultrasound; and 68 (95% CI, 39-286) for MRI after negative mammography and ultrasound results. Conclusion The addition of screening ultrasound or MRI to mammography in women at increased risk of breast cancer resulted in not only a higher cancer detection yield but also an increase in false-positive findings.	[Berg, Wendie A.] Sch Med, Magee Womens Hosp, Dept Radiol, Univ Pittsburgh, Pittsburgh, PA 15213 USA; [Berg, Wendie A.; Gabrielli, Glenna] Amer Coll Radiol, Imaging Network, Philadelphia, PA USA; [Zhang, Zheng; Cormack, Jean B.; Marques, Helga S.; Adams, Amanda; Yeh, Nolin M.] Brown Univ, Ctr Stat Sci, Providence, RI 02912 USA; [Jong, Roberta A.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Radiol, Toronto, ON, Canada; [Lehrer, Daniel] CERIM, Buenos Aires, DF, Argentina; [Pisano, Etta D.] Univ N Carolina, Dept Radiol, Chapel Hill, NC USA; [Barr, Richard G.] Radiol Consultants Forum Hlth, Youngstown, OH USA; [Boehm-Velez, Marcela] Weinstein Imaging Associates, Pittsburgh, PA USA; [Mahoney, Mary C.] Univ Cincinnati, Med Ctr, Dept Radiol, Cincinnati, OH 45267 USA; [Evans, W. Phil, III] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Larsen, Linda H.] Univ So Calif, Keck Sch Med, Dept Radiol, Los Angeles, CA 90033 USA; [Morton, Marilyn J.] Mayo Clin, Dept Radiol, Rochester, MN USA; [Mendelson, Ellen B.] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA; [Farria, Dione M.] Washington Univ, Mallinckrodt Inst Radiol, Sch Med, St Louis, MO USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; American College of Radiology; Brown University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; University of Cincinnati; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Southern California; Mayo Clinic; Northwestern University; Feinberg School of Medicine; Washington University (WUSTL)	Berg, WA (corresponding author), Sch Med, Magee Womens Hosp, Dept Radiol, Univ Pittsburgh, 300 Halket St, Pittsburgh, PA 15213 USA.	wendieberg@gmail.com	Barr, Richard G./AEN-6134-2022; Zhang, Zheng/J-2388-2014; Soo, Mary S C/B-1580-2017	Barr, Richard G./0000-0001-8021-0072; Zhang, Zheng/0000-0003-2497-0362; Marques, Helga/0000-0003-2029-9241	Naviscan Inc; Hologic Inc; SuperSonic Imagine; Siemens; GE Healthcare; Konica Minolta; Sectra AB; Koning; Zumatek, Inc; R2; iCAD; Philips; SuperSonic Inc; Bracco; Avon Foundation; National Cancer Institute [CA 80098, CA 79778]; NATIONAL CANCER INSTITUTE [U10CA079778, U10CA080098, U01CA079778, U01CA080098] Funding Source: NIH RePORTER	Naviscan Inc; Hologic Inc; SuperSonic Imagine; Siemens(Siemens AG); GE Healthcare(General ElectricGE Healthcare); Konica Minolta(Konica Minolta Science and Technology Foundation); Sectra AB; Koning; Zumatek, Inc; R2; iCAD; Philips; SuperSonic Inc; Bracco; Avon Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Berg reports that she has served as a consultant to Naviscan Inc and SuperSonic Imagine, has received research support from Naviscan Inc, has prepared educational materials for Gamma Medica, has a research grant from Hologic Inc, and is on the medical advisory board of Philips. Dr Mendelson reports that she is a member of the scientific advisory boards of MediPattern, Hologic, and Siemens and has received equipment support from Philips and research support from SuperSonic Imagine and Siemens. Dr Bohm-Velez reports that she is a member of the scientific advisory board of Philips, does clinical validation studies for Philips Ultrasound, and is on the speakers bureau of Dilon. Dr Pisano reports that her laboratory received research support from GE Healthcare, Konica Minolta, Sectra AB, Naviscan Inc, Koning, Zumatek, Inc, equipment grants from R2 and iCAD, is a board member of ACR Imaging Metrix and NextRay Inc, and a stockholder in NextRay Inc. Dr Jong reports that she is a consultant to and receives research support from GE Healthcare. Dr Evans reports that he is a member of the scientific advisory board of Hologic. Dr Mahoney reports that she is a consultant to Ethicon EndoSurgery and SenoRx and on the scientific advisory board of Hologic and receives research support from Naviscan Inc. Dr Larsen reports that she receives equipment support from Naviscan Inc. Dr Barr reports that he is a member of the ultrasound advisory boards of and has received equipment support, research support, and speakers fees from Siemens and Philips, an equipment grant from SuperSonic Inc, and a research grant from Bracco. The remaining coauthors report no financial disclosures.; The study was funded by the Avon Foundation and grants CA 80098 and CA 79778 from the National Cancer Institute.	Berg WA, 2008, JAMA-J AM MED ASSOC, V299, P2151, DOI 10.1001/jama.299.18.2151; Berg WA, 2010, RADIOLOGY, V254, P79, DOI 10.1148/radiol.2541090953; Berg WA, 2009, AM J ROENTGENOL, V192, P390, DOI 10.2214/AJR.08.1706; Brennan ME, 2009, J CLIN ONCOL, V27, P5640, DOI 10.1200/JCO.2008.21.5756; Brennan S, 2010, AM J ROENTGENOL, V195, P510, DOI 10.2214/AJR.09.3573; Buchberger W, 2000, SEMIN ULTRASOUND CT, V21, P325, DOI 10.1016/S0887-2171(00)90027-1; Centers for Medicare & Medicaid Services, PHYS FEE SCHED SEARC; Corsetti V, 2006, RADIOL MED, V111, P440, DOI 10.1007/s11547-006-0040-5; Crystal P, 2003, AM J ROENTGENOL, V181, P177, DOI 10.2214/ajr.181.1.1810177; D'Orsi C, 2003, BREAST IMAGING REPOR; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Demartini WB, 2010, RAD SOC N AM NOV 28; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Fleiss JL., 2003, STAT METHODS RATES P; GORDON PB, 1995, CANCER, V76, P626, DOI 10.1002/1097-0142(19950815)76:4<626::AID-CNCR2820760413>3.0.CO;2-Z; Ikeda DM, 2003, BREAST IMAGING REPOR; Kaplan SS, 2001, RADIOLOGY, V221, P641, DOI 10.1148/radiol.2213010364; Kolb TM, 2002, RADIOLOGY, V225, P165, DOI 10.1148/radiol.2251011667; Kriege M, 2006, CANCER-AM CANCER SOC, V106, P2318, DOI 10.1002/cncr.21863; Kuhl C, 2010, J CLIN ONCOL, V28, P1450, DOI 10.1200/JCO.2009.23.0839; Kuhl CK, 2005, J CLIN ONCOL, V23, P8469, DOI 10.1200/JCO.2004.00.4960; Leach MO, 2005, LANCET, V365, P1769, DOI 10.1016/S0140-6736(05)66481-1; Leconte I, 2003, AM J ROENTGENOL, V180, P1675, DOI 10.2214/ajr.180.6.1801675; Lehman CD, 2007, RADIOLOGY, V244, P381, DOI 10.1148/radiol.2442060461; Mendelson EB, 2003, BREAST IMAGING REPOR; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Ohuchi N, 2011, JPN J CLIN ONCOL, V41, P275, DOI 10.1093/jjco/hyq214; Sardanelli F, 2007, RADIOLOGY, V242, P698, DOI 10.1148/radiol.2423051965; Sardanelli F, 2011, INVEST RADIOL, V46, P94, DOI 10.1097/RLI.0b013e3181f3fcdf; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Schell MJ, 2007, RADIOLOGY, V243, P681, DOI 10.1148/radiol.2433060372; Smith RA, 2004, RADIOL CLIN N AM, V42, P793, DOI 10.1016/j.rcl.2004.06.014; Tohno E, 2009, BREAST CANCER-TOKYO, V16, P18, DOI 10.1007/s12282-008-0082-8; Warner E, 2004, JAMA-J AM MED ASSOC, V292, P1317, DOI 10.1001/jama.292.11.1317	34	702	724	4	118	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2012	307	13					1394	1404		10.1001/jama.2012.388	http://dx.doi.org/10.1001/jama.2012.388			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919AY	22474203	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000302294200026
J	Vitale, J; Boni, L; Brumana, N				Vitale, Jose; Boni, Luigi; Brumana, Nazario			Biliary ileus	LANCET			English	Editorial Material									[Vitale, Jose; Brumana, Nazario] Osped Circolo, Dept Internal Med 1, I-21037 Lavena Ponte Tresa, Varese, Italy	Ospedale Circolo & Fondazione Macchi	Vitale, J (corresponding author), Osped Circolo, Dept Internal Med 1, I-21037 Lavena Ponte Tresa, Varese, Italy.	myownjo@gmail.com	Vitale, Josè/AAH-5984-2019; BONI, LUIGI/AAC-6005-2022	BONI, LUIGI/0000-0002-5906-3810					0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 28	2012	380	9839					366	366		10.1016/S0140-6736(12)60029-4	http://dx.doi.org/10.1016/S0140-6736(12)60029-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	979TN	22521521				2022-12-28	WOS:000306842800034
J	Coltart, CEM; Cheung, R; Ardolino, A; Bray, B; Rocos, B; Bailey, A; Bethune, R; Butler, J; Docherty, M; Drysdale, K; Fayaz, A; Greaves, F; Hafferty, J; Malik, ANJ; Moolla, A; Morganstein, L; Pathiraja, F; Shah, A; Sleat, G; Tang, V; Yardley, I; Donaldson, L				Coltart, Cordelia E. M.; Cheung, Ronny; Ardolino, Antonella; Bray, Ben; Rocos, Brett; Bailey, Alex; Bethune, Rob; Butler, John; Docherty, Mary; Drysdale, Kate; Fayaz, Alan; Greaves, Felix; Hafferty, Jonathan; Malik, Aeesha N. J.; Moolla, Ahmad; Morganstein, Louise; Pathiraja, Fiona; Shah, Aditi; Sleat, Graham; Tang, Vivian; Yardley, Iain; Donaldson, Liam			Leadership development for early career doctors	LANCET			English	Editorial Material									[Coltart, Cordelia E. M.; Cheung, Ronny; Ardolino, Antonella; Bray, Ben; Rocos, Brett; Bailey, Alex; Bethune, Rob; Butler, John; Docherty, Mary; Drysdale, Kate; Fayaz, Alan; Greaves, Felix; Hafferty, Jonathan; Malik, Aeesha N. J.; Moolla, Ahmad; Morganstein, Louise; Pathiraja, Fiona; Shah, Aditi; Sleat, Graham; Tang, Vivian; Yardley, Iain] CMO Clin Advisor Alumni, Fac Med Leadership & Management, London, England; [Donaldson, Liam] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Inst Global Hlth & Innovat, London, England	Imperial College London	Coltart, CEM (corresponding author), Hosp Trop Dis, Mortimer Market Ctr, Capper St, London NW1 0PE, England.	cordelia.coltart@uclh.nhs.uk	Fayaz, Alan/E-9967-2018; Greaves, Felix/A-1324-2012; Greaves, Felix/AAL-5891-2021; Rocos, Brett/D-6963-2018	Greaves, Felix/0000-0001-9393-3122; Greaves, Felix/0000-0001-9393-3122; Rocos, Brett/0000-0002-0808-5585; Malik, Aeesha Nusrat Jehan/0000-0002-9379-4350; Fayaz, Alan/0000-0002-4643-4846; Drysdale, Kathryn/0000-0002-3098-3672; Docherty, Mary/0000-0002-5745-7613; Bailey, Alex/0000-0002-2488-8791	National Institute for Health Research [ACF-2009-21-030] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Baker GR, ROLES LEADERS HIGH P; Crisp Nigel., 2010, TURNING WORLD UPSIDE; Crosson FJ, 2003, BRIT MED J, V326, P654, DOI 10.1136/bmj.326.7390.654; Darzi A., 2008, HIGH QUALITY CARE AL; Davies HTO, 2003, BMJ-BRIT MED J, V326, P646, DOI 10.1136/bmj.326.7390.646; Degeling P, 2003, BRIT MED J, V326, P649, DOI 10.1136/bmj.326.7390.649; Department of Health, 2008, EQ EXC LIB NHS; Dorgan S, MANAGEMENT HEALTHCAR; Ford J, TALENT MANAGEMENT DE; Francis R., 2010, INDEPENDENT INQUIRY; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Gandz J, TALENT DEV ARCHITECT; Griffiths Roy, 1983, NHS MANAGEMENT INQUI; Ham C, 2008, ENGAGING DOCTORS LEA; Ham C, MED CHIEF EXECUTIVES; Mountford J, CLIN LEAD; *ROYAL COLL PHYS, DOCT SOC MED PROF CH; SMALLWOOD KG, 1992, SOUTHERN MED J, V85, P840, DOI 10.1097/00007611-199208000-00011; Stoll L, 2010, MIND SHIFT EVALUATIO; The Kings Fund, 2011, FUT LEAD MAN NHS NO; WHO, STRENGTH MAN LOW INC	21	19	19	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 12	2012	379	9828					1847	1849		10.1016/S0140-6736(12)60271-2	http://dx.doi.org/10.1016/S0140-6736(12)60271-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	941BR	22531157				2022-12-28	WOS:000303937700039
J	Smith, CC; Wang, Q; Chin, CS; Salerno, S; Damon, LE; Levis, MJ; Perl, AE; Travers, KJ; Wang, S; Hunt, JP; Zarrinkar, PP; Schadt, EE; Kasarskis, A; Kuriyan, J; Shah, NP				Smith, Catherine C.; Wang, Qi; Chin, Chen-Shan; Salerno, Sara; Damon, Lauren E.; Levis, Mark J.; Perl, Alexander E.; Travers, Kevin J.; Wang, Susana; Hunt, Jeremy P.; Zarrinkar, Patrick P.; Schadt, Eric E.; Kasarskis, Andrew; Kuriyan, John; Shah, Neil P.			Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia	NATURE			English	Article							TYROSINE KINASE DOMAIN; MYELODYSPLASTIC SYNDROME; CRYSTAL-STRUCTURE; INSULIN-RECEPTOR; STRUCTURAL BASIS; BCR-ABL; RESISTANCE; INHIBITOR; AUTOINHIBITION; ACTIVATION	Effective targeted cancer therapeutic development depends upon distinguishing disease-associated 'driver' mutations, which have causative roles in malignancy pathogenesis, from 'passenger' mutations, which are dispensable for cancer initiation and maintenance. Translational studies of clinically active targeted therapeutics can definitively discriminate driver from passenger lesions and provide valuable insights into human cancer biology. Activating internal tandem duplication (ITD) mutations in FLT3 (FLT3-ITD) are detected in approximately 20% of acute myeloid leukaemia (AML) patients and are associated with a poor prognosis(1). Abundant scientific(2) and clinical evidence(1,3), including the lack of convincing clinical activity of early FLT3 inhibitors(4,5), suggests that FLT3-ITD probably represents a passenger lesion. Here we report point mutations at three residues within the kinase domain of FLT3-ITD that confer substantial in vitro resistance to AC220 (quizartinib), an active investigational inhibitor of FLT3, KIT, PDGFRA, PDGFRB and RET6,7; evolution of AC220-resistant substitutions at two of these amino acid positions was observed in eight of eight FLT3-ITD-positive AML patients with acquired resistance to AC220. Our findings demonstrate that FLT3-ITD can represent a driver lesion and valid therapeutic target in human AML. AC220-resistant FLT3 kinase domain mutants represent high-value targets for future FLT3 inhibitor development efforts.	[Smith, Catherine C.; Salerno, Sara; Damon, Lauren E.; Shah, Neil P.] Univ Calif San Francisco, Div Hematol Oncol, San Francisco, CA 94143 USA; [Wang, Qi; Kuriyan, John] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Chin, Chen-Shan; Travers, Kevin J.; Wang, Susana; Schadt, Eric E.; Kasarskis, Andrew] Pacific Biosci, Menlo Pk, CA 94025 USA; [Levis, Mark J.] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Dept Oncol, Baltimore, MD 21231 USA; [Perl, Alexander E.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Hunt, Jeremy P.; Zarrinkar, Patrick P.] Ambit Biosci, San Diego, CA 92121 USA; [Shah, Neil P.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94115 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; Johns Hopkins University; Johns Hopkins Medicine; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Shah, NP (corresponding author), Univ Calif San Francisco, Div Hematol Oncol, San Francisco, CA 94143 USA.	nshah@medicine.ucsf.edu	Wang, Qi/H-9399-2012	Wang, Qi/0000-0002-9703-1676	Leukemia and Lymphoma Society; Doris Duke Charitable Foundation; NCI Leukemia SPORE [P50 CA100632-06]; NCI [R01 CA12886]; NIH; Art and Alison Kern and the Edward S. Ageno family; NATIONAL CANCER INSTITUTE [P50CA100632, R01CA166616, R01CA128864] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NCI Leukemia SPORE; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Art and Alison Kern and the Edward S. Ageno family; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank K. Lin for technical assistance. This work was funded by grants from the Leukemia and Lymphoma Society (to C.C.S. and N.P.S.), the Doris Duke Charitable Foundation (to N.P.S.), NCI Leukemia SPORE P50 CA100632-06 (to M.J.L.), NCI R01 CA12886 (to M.J.L.) and the NIH T-32 Molecular Mechanisms of Cancer (to C.C.S.). C.C.S. would like to acknowledge the EHA/ASH Translational Research Training Institute. N.P.S. would like to thank Art and Alison Kern and the Edward S. Ageno family for their support.	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Barbie David A, 2006, Clin Adv Hematol Oncol, V4, P768; BARNARD GA, 1990, STAT MED, V9, P601, DOI 10.1002/sim.4780090606; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Choudhary C, 2007, BLOOD, V110, P370, DOI 10.1182/blood-2006-05-024018; Cortes J., 2011, 16 C EUR HEM ASS HAE; Fischer T, 2010, J CLIN ONCOL, V28, P4339, DOI 10.1200/JCO.2010.28.9678; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Heidel F, 2006, BLOOD, V107, P293, DOI 10.1182/blood-2005-06-2469; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Knapper S, 2006, BLOOD, V108, P3262, DOI 10.1182/blood-2006-04-015560; Kralovics R, 2006, BLOOD, V108, P1377, DOI 10.1182/blood-2005-11-009605; Lee BH, 2005, ONCOGENE, V24, P7882, DOI 10.1038/sj.onc.1208933; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Metzelder S, 2009, BLOOD, V113, P6567, DOI 10.1182/blood-2009-03-208298; Mol CD, 2003, J BIOL CHEM, V278, P31461, DOI 10.1074/jbc.C300186200; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Scholl S, 2011, ANN HEMATOL, V90, P473, DOI 10.1007/s00277-010-1027-9; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shih LY, 2004, LEUKEMIA, V18, P466, DOI 10.1038/sj.leu.2403274; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Travers KJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq543; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wodicka LM, 2010, CHEM BIOL, V17, P1241, DOI 10.1016/j.chembiol.2010.09.010; YATES F, 1984, J ROY STAT SOC A STA, V147, P426, DOI 10.2307/2981577; Zarrinkar PP, 2009, BLOOD, V114, P2984, DOI 10.1182/blood-2009-05-222034	33	528	558	4	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2012	485	7397					260	U153		10.1038/nature11016	http://dx.doi.org/10.1038/nature11016			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22504184	Green Accepted			2022-12-28	WOS:000303799800046
J	M'Gonigle, LK; Mazzucco, R; Otto, SP; Dieckmann, U				M'Gonigle, Leithen K.; Mazzucco, Rupert; Otto, Sarah P.; Dieckmann, Ulf			Sexual selection enables long-term coexistence despite ecological equivalence	NATURE			English	Article							SYMPATRIC SPECIATION; INCIPIENT SPECIATION; FEMALE CHOICE; HYBRID ZONES; EVOLUTION; PREFERENCE; DIVERSITY; MODELS; SPACE	Empirical data indicate that sexual preferences are critical for maintaining species boundaries(1-4), yet theoretical work has suggested that, on their own, they can have only a minimal role in maintaining biodiversity(5-9). This is because long-term coexistence within overlapping ranges is thought to be unlikely in the absence of ecological differentiation(9). Here we challenge this widely held view by generalizing a standard model of sexual selection to include two ubiquitous features of populations with sexual selection: spatial variation in local carrying capacity, and mate-search costs in females. We show that, when these two features are combined, sexual preferences can single-handedly maintain coexistence, even when spatial variation in local carrying capacity is so slight that it might go unnoticed empirically. This theoretical study demonstrates that sexual selection alone can promote the long-term coexistence of ecologically equivalent species with overlapping ranges, and it thus provides a novel explanation for the maintenance of species diversity.	[M'Gonigle, Leithen K.; Otto, Sarah P.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Mazzucco, Rupert; Dieckmann, Ulf] Int Inst Appl Syst Anal, Evolut & Ecol Program, A-2361 Laxenburg, Austria	University of British Columbia; International Institute for Applied Systems Analysis (IIASA)	M'Gonigle, LK (corresponding author), Univ Calif Berkeley, Dept Environm Sci, 130 Mulford Hall, Berkeley, CA 94720 USA.	mgonigle@zoology.ubc.ca	Otto, Sarah Perin/K-5625-2012; Dieckmann, Ulf/E-1424-2011	Otto, Sarah Perin/0000-0003-3042-0818; Mazzucco, Rupert/0000-0002-7608-0196; Dieckmann, Ulf/0000-0001-7089-0393	Natural Sciences and Engineering Research Council (Canada); European Science Foundation; WWTF; European Commission; Austrian Science Fund; Austrian Ministry of Science and Research; Austrian Science Fund (FWF) [I 106] Funding Source: researchfish	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); European Science Foundation(European Science Foundation (ESF)European Commission); WWTF; European Commission(European CommissionEuropean Commission Joint Research Centre); Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Ministry of Science and Research; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank J. S. Brown, R. G. Fitz John, D. E. Irwin, J. Ohlberger, J. L. Payne, A. Pomiankowski and G. S. van Doorn for discussions. Funding was provided by a Natural Sciences and Engineering Research Council (Canada) grant to L. K. M. (CGS-D) and S.P.O. (Discovery Grant). L. K. M. received additional support from the European Science Foundation Research Networking Programme 'Frontiers of Speciation Research'. R. M. and U. D. gratefully acknowledge support by the Vienna Science and Technology Fund (WWTF). U. D. received additional financial support from the European Commission, the European Science Foundation, the Austrian Science Fund and the Austrian Ministry of Science and Research.	BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; BARTON NH, 1989, NATURE, V341, P497, DOI 10.1038/341497a0; Dieckmann U., 2004, ADAPTIVE SPECIATION, P306; Eberhard W.G., 1985, SEXUAL SELECTION ANI; Feulner PGD, 2008, J PHYSIOLOGY-PARIS, V102, P340, DOI 10.1016/j.jphysparis.2008.10.002; Fisher R.A., 1930, GENETICAL THEORY NAT; Gray DA, 2000, P NATL ACAD SCI USA, V97, P14449, DOI 10.1073/pnas.97.26.14449; Hollocher H, 1997, EVOLUTION, V51, P1175, DOI 10.1111/j.1558-5646.1997.tb03965.x; Johansson J, 2006, AM NAT, V168, P572, DOI 10.1086/507996; KIRKPATRICK M, 1982, EVOLUTION, V36, P1, DOI [10.2307/2407961, 10.1111/j.1558-5646.1982.tb05003.x]; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; LANDE R, 1982, EVOLUTION, V36, P213, DOI 10.1111/j.1558-5646.1982.tb05034.x; Mallet J, 2009, J EVOLUTION BIOL, V22, P2332, DOI 10.1111/j.1420-9101.2009.01816.x; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; Panhuis TM, 2001, TRENDS ECOL EVOL, V16, P364, DOI 10.1016/S0169-5347(01)02160-7; Payne RJH, 1997, EVOLUTION, V51, P1, DOI 10.1111/j.1558-5646.1997.tb02382.x; RYAN MJ, 1988, SCIENCE, V240, P1786, DOI 10.1126/science.240.4860.1786; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 1999, ECOL LETT, V2, P262; SEGER J, 1985, EVOLUTION, V39, P1185, DOI [10.2307/2408776, 10.1111/j.1558-5646.1985.tb05685.x]; Tregenza T, 2000, EVOLUTION, V54, P1687, DOI 10.1111/j.0014-3820.2000.tb00713.x; TURNER GF, 1995, P ROY SOC B-BIOL SCI, V260, P287, DOI 10.1098/rspb.1995.0093; van Doorn GS, 2004, AM NAT, V163, P709, DOI 10.1086/383619; Weissing FJ, 2011, BEHAV ECOL SOCIOBIOL, V65, P461, DOI 10.1007/s00265-010-1125-7; Wilson AB, 2000, P ROY SOC B-BIOL SCI, V267, P2133, DOI 10.1098/rspb.2000.1260	26	61	61	0	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					506	509		10.1038/nature10971	http://dx.doi.org/10.1038/nature10971			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22466286	Green Submitted			2022-12-28	WOS:000303200400049
J	Koriat, A				Koriat, Asher			When Are Two Heads Better than One and Why?	SCIENCE			English	Article							SUBJECTIVE CONFIDENCE; ATTITUDE CERTAINTY; JUDGMENTS; INDIVIDUALS; CROWD	A recent study, using a perceptual task, indicated that two heads were better than one provided that the members could communicate freely, presumably sharing their confidence in their judgments. Capitalizing on recent work on subjective confidence, I replicated this effect in the absence of any dyadic interaction by selecting on each trial the decision of the more confident member of a virtual dyad. However, because subjective confidence monitors the consensuality rather than the accuracy of a decision, when most participants were in error, reliance on the more confident member yielded worse decisions than those of the better individual. Assuming that for each issue group decisions are dominated by the more confident member, these results help specify when groups will be more or less accurate than individuals.	[Koriat, Asher] Univ Haifa, Dept Psychol, IL-31905 Haifa, Israel; [Koriat, Asher] Univ Haifa, Inst Informat Proc & Decis Making, IL-31905 Haifa, Israel	University of Haifa; University of Haifa	Koriat, A (corresponding author), Univ Haifa, Dept Psychol, IL-31905 Haifa, Israel.	akoriat@research.haifa.ac.il			Max Wertheimer Minerva Center for Cognitive Processes and Human Performance, University of Haifa	Max Wertheimer Minerva Center for Cognitive Processes and Human Performance, University of Haifa	I am grateful to R. Gil and D. Klein for their help in the analyses of the results, and to S. Adiv for her assistance in the preparation of the article. Support for this project was received from the Max Wertheimer Minerva Center for Cognitive Processes and Human Performance, University of Haifa.	Ariely D, 2000, J EXP PSYCHOL-APPL, V6, P130, DOI 10.1037/1076-898X.6.2.130; Bahrami B, 2010, SCIENCE, V329, P1081, DOI 10.1126/science.1185718; Baron RS, 2005, ADV EXP SOC PSYCHOL, V37, P219, DOI 10.1016/S0065-2601(05)37004-3; Brewer WF, 2006, MEMORY, V14, P540, DOI 10.1080/09658210600590302; Burton R., 2008, BEING CERTAIN BELIEV; CLEMEN RT, 1989, INT J FORECASTING, V5, P559, DOI 10.1016/0169-2070(89)90012-5; CUTLER BL, 1988, LAW HUMAN BEHAV, V12, P41, DOI 10.1007/BF01064273; Dhami MK, 2004, PSYCHOL BULL, V130, P959, DOI 10.1037/0033-2909.130.6.959; Dunlosky J., 2009, METACOGNITION; Esser JK, 1998, ORGAN BEHAV HUM DEC, V73, P116, DOI 10.1006/obhd.1998.2758; Herzog SM, 2009, PSYCHOL SCI, V20, P231, DOI 10.1111/j.1467-9280.2009.02271.x; HILL GW, 1982, PSYCHOL BULL, V91, P517, DOI 10.1037/0033-2909.91.3.517; Hourihan KL, 2010, J EXP PSYCHOL LEARN, V36, P1068, DOI 10.1037/a0019694; Janis IL, 1982, GROUPTHINK PSYCHOL S; Kahneman D., 2011, THINKING FAST SLOW; KORIAT A, 1976, MEM COGNITION, V4, P244, DOI 10.3758/BF03213170; KORIAT A, 1995, J EXP PSYCHOL GEN, V124, P311, DOI 10.1037/0096-3445.124.3.311; Koriat A, 2008, J EXP PSYCHOL LEARN, V34, P945, DOI 10.1037/0278-7393.34.4.945; Koriat A, 2012, PSYCHOL REV, V119, P80, DOI 10.1037/a0025648; Koriat A, 2011, SOC COGNITION, V29, P577; Koriat A, 2011, J EXP PSYCHOL GEN, V140, P117, DOI 10.1037/a0022171; Laughlin PR, 2006, J PERS SOC PSYCHOL, V90, P644, DOI 10.1037/0022-3514.90.4.644; Surowiecki J., 2005, WISDOM CROWDS; Tormala ZL, 2007, SOC PERSONAL PSYCHOL, V1, P469, DOI 10.1111/j.1751-9004.2007.00025.x; Vul E, 2008, PSYCHOL SCI, V19, P645, DOI 10.1111/j.1467-9280.2008.02136.x; Wallsten TS, 2001, MATH SOC SCI, V41, P1, DOI 10.1016/S0165-4896(00)00053-6	27	119	121	4	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2012	336	6079					360	362		10.1126/science.1216549	http://dx.doi.org/10.1126/science.1216549			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	928PO	22517862				2022-12-28	WOS:000302995400050
J	Gehrig, SM; van der Poel, C; Sayer, TA; Schertzer, JD; Henstridge, DC; Church, JE; Lamon, S; Russell, AP; Davies, KE; Febbraio, MA; Lynch, GS				Gehrig, Stefan M.; van der Poel, Chris; Sayer, Timothy A.; Schertzer, Jonathan D.; Henstridge, Darren C.; Church, Jarrod E.; Lamon, Severine; Russell, Aaron P.; Davies, Kay E.; Febbraio, Mark A.; Lynch, Gordon S.			Hsp72 preserves muscle function and slows progression of severe muscular dystrophy	NATURE			English	Article							KAPPA-B; MDX; SKELETAL; PROTEIN; MICE; ACTIVATION; STRESS; OVEREXPRESSION; CONTRACTION; MYOPATHIES	Duchenne muscular dystrophy (DMD) is a severe and progressive muscle wasting disorder caused by mutations in the dystrophin gene that result in the absence of the membrane-stabilizing protein dystrophin(1-3). Dystrophin-deficient muscle fibres are fragile and susceptible to an influx of Ca2+, which activates inflammatory and muscle degenerative pathways(4-6). At present there is no cure for DMD, and existing therapies are ineffective. Here we show that increasing the expression of intramuscular heat shock protein 72 (Hsp72) preserves muscle strength and ameliorates the dystrophic pathology in two mouse models of muscular dystrophy. Treatment with BGP-15 (a pharmacological inducer of Hsp72 currently in clinical trials for diabetes) improved muscle architecture, strength and contractile function in severely affected diaphragm muscles in mdx dystrophic mice. In dko mice, a phenocopy of DMD that results in severe spinal curvature (kyphosis), muscle weakness and premature death(7,8), BGP-15 decreased kyphosis, improved the dystrophic pathophysiology in limb and diaphragm muscles and extended lifespan. We found that the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA, the main protein responsible for the removal of intracellular Ca2+) is dysfunctional in severely affected muscles of mdx and dko mice, and that Hsp72 interacts with SERCA to preserve its function under conditions of stress, ultimately contributing to the decreased muscle degeneration seen with Hsp72 upregulation. Treatment with BGP-15 similarly increased SERCA activity in dystrophic skeletal muscles. Our results provide evidence that increasing the expression of Hsp72 in muscle (through the administration of BGP-15) has significant therapeutic potential for DMD and related conditions, either as a self-contained therapy or as an adjuvant with other potential treatments, including gene, cell and pharmacological therapies.	[Gehrig, Stefan M.; van der Poel, Chris; Sayer, Timothy A.; Schertzer, Jonathan D.; Church, Jarrod E.; Lynch, Gordon S.] Univ Melbourne, Basic & Clin Myol Lab, Dept Physiol, Melbourne, Vic 3010, Australia; [Henstridge, Darren C.; Febbraio, Mark A.] Baker IDI Heart & Diabet Inst, Cellular & Mol Metab Lab, Melbourne, Vic 8008, Australia; [Lamon, Severine; Russell, Aaron P.] Deakin Univ, Ctr Phys Act & Nutr Res, Sch Exercise & Nutr Sci, Burwood, Vic 3125, Australia; [Davies, Kay E.] Univ Oxford, MRC Funct Genom Unit, Dept Physiol Anat & Genet, Oxford OX1 3QX, England	University of Melbourne; Baker Heart and Diabetes Institute; Deakin University; University of Oxford	Lynch, GS (corresponding author), Univ Melbourne, Basic & Clin Myol Lab, Dept Physiol, Melbourne, Vic 3010, Australia.	gsl@unimelb.edu.au	Lynch, Gordon/G-9553-2015; Febbraio, Mark/AAE-9632-2019; Schertzer, Jonathan/P-3395-2017	Lynch, Gordon/0000-0001-9220-9810; Febbraio, Mark/0000-0002-9296-4418; Schertzer, Jonathan/0000-0002-1547-5856; Church, Jarrod/0000-0001-8266-4043; Lamon, Severine/0000-0002-3271-6551; Russell, Aaron/0000-0002-7323-9501	National Health and Medical Research Council (NHMRC) [1009114, 472650, 1004441]; Association Francaise contre les Myopathies (France); Muscular Dystrophy Association (USA); Swiss National Science Foundation; National Heart Foundation (Australia); National Heart Foundation; Fondazione Telethon Funding Source: Custom; Medical Research Council [MC_U137761449] Funding Source: researchfish; MRC [MC_U137761449] Funding Source: UKRI	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Association Francaise contre les Myopathies (France)(Association Francaise contre les Myopathies); Muscular Dystrophy Association (USA)(Muscular Dystrophy Association); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Heart Foundation (Australia)(National Heart Foundation of Australia); National Heart Foundation(National Heart Foundation of Australia); Fondazione Telethon(Fondazione Telethon); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank R. Koopman, J. G. Ryall and G. I. Lancaster for comments; J. Trieu, B. G. Gleeson, T. Naim and A. Chee for technical support; and C. Angelini and the Neuromuscular bank of tissues and DNA samples - Telethon Network of Genetic Biobanks for the provision of human muscle specimens. We thank N-Gene R&D Inc. USA for providing the BGP-15 compound. This study was supported in part by research grants from the National Health and Medical Research Council (NHMRC; project numbers 1009114 to G. S. L. and 472650 and 1004441 to M.A.F.), Association Francaise contre les Myopathies (France, to G. S. L.) and the Muscular Dystrophy Association (USA, to G. S. L.). M. A. F. is a Senior Principal Research Fellow of the NHMRC. A. P. R. was supported by a NHMRC Biomedical career Development Award. S. L. was supported by a postdoctoral fellowship from the Swiss National Science Foundation. S. M. G. was supported by a National Heart Foundation Postgraduate Scholarship (Australia). D. C. H. was supported by a National Heart Foundation Post-Doctoral Fellowship.	Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; BORNMAN L, 1995, MUSCLE NERVE, V18, P23, DOI 10.1002/mus.880180105; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Chung J, 2008, P NATL ACAD SCI USA, V105, P1739, DOI 10.1073/pnas.0705799105; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Finsterer J, 2006, LUNG, V184, P205, DOI 10.1007/s00408-005-2584-x; FONG P, 1990, SCIENCE, V250, P673, DOI 10.1126/science.2173137; Gehrig SM, 2010, AM J PATHOL, V176, P29, DOI 10.2353/ajpath.2010.090760; Gervasio OL, 2008, J CELL SCI, V121, P2246, DOI 10.1242/jcs.032003; Goonasekera SA, 2011, J CLIN INVEST, V121, P1044, DOI 10.1172/JCI43844; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; GREEN MARGARET C., 1952, OHIO JOUR SCI, V52, P31; Gregorevic P, 2002, AM J PATHOL, V161, P2263, DOI 10.1016/S0002-9440(10)64502-6; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; Kolodziejczyk SM, 2001, CURR BIOL, V11, P1278, DOI 10.1016/S0960-9822(01)00397-9; Literati-Nagy B, 2010, BRAIN RES BULL, V83, P340, DOI 10.1016/j.brainresbull.2010.09.005; Literati-Nagy B, 2009, HORM METAB RES, V41, P374, DOI 10.1055/s-0028-1128142; Lou JS, 2010, AM J HOSP PALLIAT ME, V27, P145, DOI 10.1177/1049909109358420; MARBER MS, 1995, J CLIN INVEST, V95, P1446, DOI 10.1172/JCI117815; Monici MC, 2003, NEUROLOGY, V60, P993, DOI 10.1212/01.WNL.0000049913.27181.51; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Morine KJ, 2010, HUM GENE THER, V21, P1735, DOI 10.1089/hum.2010.077; Murphy KT, 2010, FASEB J, V24, P4433, DOI 10.1096/fj.10-159608; Nicolas-Metral V, 2001, J MUSCLE RES CELL M, V22, P69, DOI 10.1023/A:1010384625954; Park HS, 2001, EMBO J, V20, P446, DOI 10.1093/emboj/20.3.446; Plant DR, 2003, AM J PHYSIOL-CELL PH, V285, pC522, DOI 10.1152/ajpcell.00369.2002; Porter JD, 2002, HUM MOL GENET, V11, P263, DOI 10.1093/hmg/11.3.263; Saegusa T, 2003, J VET MED SCI, V65, P1365, DOI 10.1292/jvms.65.1365; Schertzer JD, 2005, AM J PHYSIOL-ENDOC M, V288, pE526, DOI 10.1152/ajpendo.00399.2004; Schertzer JD, 2007, AM J PATHOL, V171, P1180, DOI 10.2353/ajpath.2007.070292; Schertzer JD, 2006, AM J PHYSIOL-ENDOC M, V291, pE499, DOI 10.1152/ajpendo.00101.2006; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Taleb M, 2008, JARO-J ASSOC RES OTO, V9, P277, DOI 10.1007/s10162-008-0122-2; Tupling AR, 2004, J BIOL CHEM, V279, P52382, DOI 10.1074/jbc.M409336200; TURNER PR, 1988, NATURE, V335, P735, DOI 10.1038/335735a0; Tutdibi O, 1999, J PHYSIOL-LONDON, V515, P859, DOI 10.1111/j.1469-7793.1999.859ab.x	43	193	201	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2012	484	7394					394	398		10.1038/nature10980	http://dx.doi.org/10.1038/nature10980			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927YM	22495301				2022-12-28	WOS:000302946500037
J	Herman, MA; Peroni, OD; Villoria, J; Schon, MR; Abumrad, NA; Bluher, M; Klein, S; Kahn, BB				Herman, Mark A.; Peroni, Odile D.; Villoria, Jorge; Schoen, Michael R.; Abumrad, Nada A.; Blueher, Matthias; Klein, Samuel; Kahn, Barbara B.			A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism	NATURE			English	Article							CARBOHYDRATE-RESPONSE ELEMENT; FATTY-ACID SYNTHESIS; BINDING-PROTEIN CHREBP; UCSC GENOME BROWSER; INSULIN-RESISTANCE; DIABETES-MELLITUS; TRANSGENIC MICE; LIVER; GENE; LIPOGENESIS	The prevalence of obesity and type 2 diabetes is increasing worldwide and threatens to shorten lifespan. Impaired insulin action in peripheral tissues is a major pathogenic factor. Insulin stimulates glucose uptake in adipose tissue through the GLUT4 (also known as SLC2A4) glucose transporter, and alterations in adipose tissue GLUT4 expression or function regulate systemic insulin sensitivity. Downregulation of human and mouse adipose tissue GLUT4 occurs early in diabetes development. Here we report that adipose tissue GLUT4 regulates the expression of carbohydrate-responsive-element-binding protein (ChREBP; also known as MLXIPL), a transcriptional regulator of lipogenic and glycolytic genes. Furthermore, adipose ChREBP is a major determinant of adipose tissue fatty acid synthesis and systemic insulin sensitivity. We find a new mechanism for glucose regulation of ChREBP: glucose-mediated activation of the canonical ChREBP isoform (ChREBP-alpha) induces expression of a novel, potent isoform (ChREBP-beta) that is transcribed from an alternative promoter. ChREBP-beta expression in human adipose tissue predicts insulin sensitivity, indicating that it may be an effective target for treating diabetes.	[Herman, Mark A.; Peroni, Odile D.; Villoria, Jorge; Kahn, Barbara B.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Herman, Mark A.; Peroni, Odile D.; Villoria, Jorge; Kahn, Barbara B.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [Schoen, Michael R.] Stadt Klinikum Karlsruhe, Clin Visceral Surg, D-76133 Karlsruhe, Germany; [Abumrad, Nada A.; Klein, Samuel] Washington Univ, Sch Med, Ctr Human Nutr, St Louis, MO 63110 USA; [Blueher, Matthias] Univ Leipzig, Dept Med, D-04103 Leipzig, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Municipal Hospital Karlsruhe; Washington University (WUSTL); Leipzig University	Kahn, BB (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.	bkahn@bidmc.harvard.edu	Herman, Mark/H-3232-2012	Schon, Michael/0000-0002-0698-4130; Herman, Mark/0000-0001-6979-103X	NIH [R37 DK43051, K08 DK076726]; BADERC [DK057521]; BNORC [DK046200]; Picower and JPB Foundations; Radcliffe Institute for Advanced Study; Nutrition and Obesity Research Unit [DK056341, DK037948]; Deutsche Forschungsgemeinschft DFG [KFO152, BL833/1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, K08DK076726, P30DK056341, R01DK098002, P30DK046200, R37DK043051, R01DK037948] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BADERC; BNORC; Picower and JPB Foundations; Radcliffe Institute for Advanced Study; Nutrition and Obesity Research Unit; Deutsche Forschungsgemeinschft DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Towle for providing reagents and discussion. We thank P. Pissios, I. Astapova, E. Rosen and the Rosen laboratory for discussions, K. Uyeda for providing ChREBP KO mice, and E. Shu for technical assistance. This work was supported by NIH R37 DK43051 (B.B.K.), K08 DK076726 (M.A.H.), BADERC DK057521 (B.B.K., M.A.H.), BNORC DK046200 (M.A.H.), the Picower and JPB Foundations (B.B.K.), a Fellowship from the Radcliffe Institute for Advanced Study (B.B.K.), DK056341 (Nutrition and Obesity Research Unit) (S.K.), DK037948 (S.K.), and the Deutsche Forschungsgemeinschft DFG, KFO152, BL833/1 (M.B.).	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Attie AD, 2009, J LIPID RES, V50, pS395, DOI 10.1194/jlr.R800057-JLR200; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Caesar R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011525; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Carvalho E, 2005, AM J PHYSIOL-ENDOC M, V289, pE551, DOI 10.1152/ajpendo.00116.2005; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Denechaud PD, 2008, CURR OPIN LIPIDOL, V19, P301, DOI 10.1097/MOL.0b013e3282ffafaa; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Fukasawa M, 2010, BIOCHEM BIOPH RES CO, V391, P1166, DOI 10.1016/j.bbrc.2009.11.115; GNUDI L, 1995, ENDOCRINOLOGY, V136, P995, DOI 10.1210/en.136.3.995; HEMS DA, 1975, BIOCHEM J, V150, P167, DOI 10.1042/bj1500167; Hoffstedt J, 2007, J INTERN MED, V262, P131, DOI 10.1111/j.1365-2796.2007.01811.x; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Iizuka K, 2009, BIOCHEM BIOPH RES CO, V379, P499, DOI 10.1016/j.bbrc.2008.12.100; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Kotani K, 2004, J CLIN INVEST, V114, P1666, DOI 10.1172/JCI200421341; Kuriyama H, 2005, CELL METAB, V1, P41, DOI 10.1016/j.cmet.2004.11.004; Kursawe R, 2010, DIABETES, V59, P2288, DOI 10.2337/db10-0113; Li MV, 2006, DIABETES, V55, P1179, DOI 10.2337/db05-0822; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; Pashkov V, 2011, J BIOL CHEM, V286, P15116, DOI 10.1074/jbc.M110.216234; Ranganathan G, 2006, J LIPID RES, V47, P2444, DOI 10.1194/jlr.M600248-JLR200; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Roberts R, 2009, DIABETOLOGIA, V52, P882, DOI 10.1007/s00125-009-1300-4; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Sanchez J, 2009, ENDOCRINOLOGY, V150, P5341, DOI 10.1210/en.2009-0466; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; SHIH HM, 1995, J BIOL CHEM, V270, P21991, DOI 10.1074/jbc.270.37.21991; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Stoeckman AK, 2004, J BIOL CHEM, V279, P15662, DOI 10.1074/jbc.M311301200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsatsos NG, 2006, BIOCHEM BIOPH RES CO, V340, P449, DOI 10.1016/j.bbrc.2005.12.029	46	398	419	2	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2012	484	7394					333	U66		10.1038/nature10986	http://dx.doi.org/10.1038/nature10986			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927YM	22466288	Green Accepted, Green Submitted			2022-12-28	WOS:000302946500024
J	McCartney, M				McCartney, Margaret			Streptococcus B in pregnancy: to screen or not to screen?	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020; Mohan, Manoj/ABG-7231-2020	Mohan, Manoj/0000-0001-8818-7268; McCartney, Margaret/0000-0002-7238-6358				Carroll H, 2012, DAILY MAIL      0320; McKeegan A, 2012, MANCHESTER EVEN 0402; Royal College of Obstetricians and Gynaecologists, PREV EARL ONS NEON G; Russell ARB, 2006, BJOG-INT J OBSTET GY, V113, P758, DOI 10.1111/j.1471-0528.2006.00952.x; Stew M, 2012, ITV NEWS ANGLIA 0312; UK National Screening Committee, UK NSC POL GROUP B S	6	3	3	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 18	2012	344								e2803	10.1136/bmj.e2803	http://dx.doi.org/10.1136/bmj.e2803			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	931CQ	22514232				2022-12-28	WOS:000303192400005
J	Martineau, AR				Martineau, Adrian R.			Bolus-dose vitamin D and prevention of childhood pneumonia	LANCET			English	Editorial Material							LOWER RESPIRATORY-INFECTION; TUBERCULOSIS; ASSOCIATION		Queen Mary Univ London, Ctr Primary Care & Publ Hlth, Barts & London Sch Med & Dent, London E1 2AB, England	University of London; Queen Mary University London	Martineau, AR (corresponding author), Queen Mary Univ London, Ctr Primary Care & Publ Hlth, Barts & London Sch Med & Dent, London E1 2AB, England.	a.martineau@qmul.ac.uk	Martineau, Adrian R/A-3083-2010					Arabi A, 2010, NAT REV ENDOCRINOL, V6, P550, DOI 10.1038/nrendo.2010.146; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Lehouck A, 2012, ANN INTERN MED, V156, P105, DOI 10.7326/0003-4819-156-2-201201170-00004; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Manaseki-Holland S, 2012, LANCET, V379, P1419, DOI 10.1016/S0140-6736(11)61650-4; Martineau AR, 2010, EUR RESPIR J, V35, P1106, DOI 10.1183/09031936.00087009; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Nielsen NO, 2010, BRIT J NUTR, V104, P1487, DOI 10.1017/S0007114510002333; Roth DE, 2010, ACTA PAEDIATR, V99, P389, DOI 10.1111/j.1651-2227.2009.01594.x; Vieth R, 2009, ANTICANCER RES, V29, P3675; Wayse V, 2004, EUR J CLIN NUTR, V58, P563, DOI 10.1038/sj.ejcn.1601845	12	30	31	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 14	2012	379	9824					1373	1375		10.1016/S0140-6736(12)60405-X	http://dx.doi.org/10.1016/S0140-6736(12)60405-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	926BR	22494825				2022-12-28	WOS:000302806800009
J	Sparrow, DB; Chapman, G; Smith, AJ; Mattar, MZ; Major, JA; O'Reilly, VC; Saga, Y; Zackai, EH; Dormans, JP; Alman, BA; McGregor, L; Kageyama, R; Kusumi, K; Dunwoodie, SL				Sparrow, Duncan B.; Chapman, Gavin; Smith, Allanceson J.; Mattar, Muhammad Z.; Major, Joelene A.; O'Reilly, Victoria C.; Saga, Yumiko; Zackai, Elaine H.; Dormans, John P.; Alman, Benjamin A.; McGregor, Lesley; Kageyama, Ryoichiro; Kusumi, Kenro; Dunwoodie, Sally L.			A Mechanism for Gene-Environment Interaction in the Etiology of Congenital Scoliosis	CELL			English	Article							LUNATIC-FRINGE EXPRESSION; SOMITE SEGMENTATION CLOCK; PRESOMITIC MESODERM; SPONDYLOCOSTAL DYSOSTOSIS; VERTEBRAL SEGMENTATION; MOUSE SOMITOGENESIS; BOUNDARY FORMATION; DELTA-HOMOLOG; NOTCH; FGF8	Congenital scoliosis, a lateral curvature of the spine caused by vertebral defects, occurs in approximately 1 in 1,000 live births. Here we demonstrate that haploinsufficiency of Notch signaling pathway genes in humans can cause this congenital abnormality. We also show that in a mouse model, the combination of this genetic risk factor with an environmental condition (short-term gestational hypoxia) significantly increases the penetrance and severity of vertebral defects. We demonstrate that hypoxia disrupts FGF signaling, leading to a temporary failure of embryonic somitogenesis. Our results potentially provide a mechanism for the genesis of a host of common sporadic congenital abnormalities through gene-environment interaction.	[Sparrow, Duncan B.; Chapman, Gavin; Mattar, Muhammad Z.; Major, Joelene A.; O'Reilly, Victoria C.; Dunwoodie, Sally L.] Victor Chang Cardiac Res Inst, Dev & Stem Cell Biol Div, Sydney, NSW 2010, Australia; [Sparrow, Duncan B.; Chapman, Gavin; Dunwoodie, Sally L.] Univ New S Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW 2052, Australia; [Smith, Allanceson J.; Kusumi, Kenro] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Saga, Yumiko] Natl Inst Genet, Mammalian Dev Lab, Mishima, Shizuoka 4118540, Japan; [Zackai, Elaine H.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Dormans, John P.] Childrens Hosp Philadelphia, Div Orthopaed Surg, Philadelphia, PA 19104 USA; [Zackai, Elaine H.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Dormans, John P.] Univ Penn, Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA; [Alman, Benjamin A.] Univ Toronto, Inst Med Sci, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Alman, Benjamin A.] Univ Toronto, Div Orthopaed Surg, Toronto, ON M5G 1L5, Canada; [Alman, Benjamin A.] Univ Toronto, Dept Surg, Toronto, ON M5G 1L5, Canada; [Alman, Benjamin A.] Univ Toronto, Hosp Sick Children, Fac Med, Toronto, ON M5G 1X8, Canada; [McGregor, Lesley] Womens & Childrens Hosp, SA Pathol, S Australian Clin Genet Serv, Adelaide, SA 5006, Australia; [Kageyama, Ryoichiro] Kyoto Univ, Inst Virus Res, Kageyama Lab, Kyoto 6068507, Japan	Victor Chang Cardiac Research Institute; University of New South Wales Sydney; Arizona State University; Arizona State University-Tempe; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); SA Pathology; Kyoto University	Sparrow, DB (corresponding author), Victor Chang Cardiac Res Inst, Dev & Stem Cell Biol Div, Sydney, NSW 2010, Australia.	d.sparrow@victorchang.edu.au; s.dunwoodie@victorchang.edu.au	Sparrow, Duncan/B-3994-2008; Dunwoodie, Sally L/M-4019-2018; Kusumi, Kenro/J-2626-2012; Chapman, Gavin/A-9534-2012	Sparrow, Duncan/0000-0002-1141-6613; Dunwoodie, Sally L/0000-0002-2069-7349; Kusumi, Kenro/0000-0002-1458-4540; Chapman, Gavin/0000-0002-3513-723X	National Health and Medical Research Council [635500, 514900]; Westfield-Belconnen Fellowship; Hitchings-Elion Fellowship of the Burroughs Wellcome Fund; Cervical Spine Research Society; Ethel Brown Foerderer Fund for Excellence; Florence R.C. Murray Fund	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Westfield-Belconnen Fellowship; Hitchings-Elion Fellowship of the Burroughs Wellcome Fund; Cervical Spine Research Society; Ethel Brown Foerderer Fund for Excellence; Florence R.C. Murray Fund	We thank patients, their families, and clinicians for their contribution and cooperation; D. Chapman, S. Mansour, G. Martin, T. Vogt, and K. Willert for plasmids; K. Hozumi, R. Kopan, S. Piccolo, and P. Tam for mouse lines; E. Thompson and C. Barnett for assessment of family B; BioCORE staff, L. Tomlinson, S. Goettl, J.-S. Han, L. Lunny, and M. Maisenbacher for technical assistance; Herbert Smith for donating the confocal microscopes used in this study; and R. Harvey and K. Anderson for comments on the text. Work was supported by National Health and Medical Research Council Project grant 635500 (S. L. D. and D. B. S.); NHMRC Senior Research Fellowship 514900 (S. L. D.); a Westfield-Belconnen Fellowship (D. B. S.); and a Hitchings-Elion Fellowship of the Burroughs Wellcome Fund, Cervical Spine Research Society, Ethel Brown Foerderer Fund for Excellence and Florence R.C. Murray Fund (K. K.). D. B. S. dedicates this article to David Sparrow (December 11, 1927-March 22, 2012) an inspiring geneticist and loving father.	Alexander PG, 2010, BIRTH DEFECTS RES C, V90, P118, DOI 10.1002/bdrc.20179; [Anonymous], C SERIES DEV BIOL; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; BAGNALL KM, 1988, DEVELOPMENT, V103, P69; Bellen HJ, 2010, NAT REV NEUROSCI, V11, P514, DOI 10.1038/nrn2839; Bessho Y, 2003, GENE DEV, V17, P1451, DOI 10.1101/gad.1092303; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; Bulman MP, 2000, NAT GENET, V24, P438, DOI 10.1038/74307; BURKE AC, 1995, DEVELOPMENT, V121, P333; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; Chapman G, 2011, HUM MOL GENET, V20, P905, DOI 10.1093/hmg/ddq529; Christ B, 2007, DEV DYNAM, V236, P2382, DOI 10.1002/dvdy.21189; Cordes R, 2004, DEVELOPMENT, V131, P1221, DOI 10.1242/dev.01030; Daxinger L, 2010, GENOME RES, V20, P1623, DOI 10.1101/gr.106138.110; Dubrulle J, 2004, NATURE, V427, P419, DOI 10.1038/nature02216; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; Ferjentsik Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000662; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; Frank DU, 2002, DEVELOPMENT, V129, P4591; Garg V, 2006, CURR OPIN CARDIOL, V21, P180, DOI 10.1097/01.hco.0000221578.18254.70; Geffers I, 2007, J CELL BIOL, V178, P465, DOI 10.1083/jcb.200702009; Geoffroy Saint-Hilaire Etienne, 1820, J COMPLEMENTAIRE SCI, V7, P271; Giampietro PF, 2009, ANN NY ACAD SCI, V1151, P38, DOI 10.1111/j.1749-6632.2008.03452.x; Gibb S, 2010, TRENDS CELL BIOL, V20, P593, DOI 10.1016/j.tcb.2010.07.001; Hedequist D, 2007, J PEDIATR ORTHOPED, V27, P106, DOI 10.1097/BPO.0b013e31802b4993; Huang R, 1996, ACTA ANAT, V155, P231; Huppert SS, 2005, DEV CELL, V8, P677, DOI 10.1016/j.devcel.2005.02.019; Hutter D, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/401323; INGALLS TH, 1957, NEW ENGL J MED, V257, P1121, DOI 10.1056/NEJM195712052572306; INGALLS TH, 1952, NEW ENGL J MED, V247, P758, DOI 10.1056/NEJM195211132472004; JEGALIAN BG, 1992, CELL, V71, P901, DOI 10.1016/0092-8674(92)90387-R; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Maisenbacher MK, 2005, HUM GENET, V116, P416, DOI 10.1007/s00439-005-1253-8; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Moon AM, 2000, NAT GENET, V26, P455, DOI 10.1038/82601; Morales AV, 2002, DEV CELL, V3, P63, DOI 10.1016/S1534-5807(02)00211-3; Morimoto M, 2005, NATURE, V435, P354, DOI 10.1038/nature03591; Naiche LA, 2011, P NATL ACAD SCI USA, V108, P4018, DOI 10.1073/pnas.1007417108; Niwa Y, 2007, DEV CELL, V13, P298, DOI 10.1016/j.devcel.2007.07.013; Niwa Y, 2011, GENE DEV, V25, P1115, DOI [10.1101/gad.2035311, 10.1101/gad.2035311.]; Nomura-Kitabayashi A, 2002, DEVELOPMENT, V129, P2473; Oginuma M, 2008, DEVELOPMENT, V135, P2555, DOI 10.1242/dev.019877; Pourquie O, 2001, DEV CELL, V1, P619, DOI 10.1016/S1534-5807(01)00082-X; Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011; Riedel-Kruse IH, 2007, SCIENCE, V317, P1911, DOI 10.1126/science.1142538; Sawada A, 2001, DEVELOPMENT, V128, P4873; Shifley ET, 2008, DEVELOPMENT, V135, P899, DOI 10.1242/dev.006742; Solomon BD, 2010, HUM GENET, V127, P731, DOI 10.1007/s00439-010-0814-7; Sparrow DB, 2011, MAMM GENOME, V22, P362, DOI 10.1007/s00335-011-9335-5; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Takahashi Y, 2000, NAT GENET, V25, P390, DOI 10.1038/78062; TAM PPL, 1981, J EMBRYOL EXP MORPH, V65, P103; TAM PPL, 1982, DIFFERENTIATION, V21, P109, DOI 10.1111/j.1432-0436.1982.tb01203.x; Turnpenny PD, 2012, EUR J HUM GENET, V20, P251, DOI 10.1038/ejhg.2011.181; Verras M, 2008, MOL CELL BIOL, V28, P7212, DOI 10.1128/MCB.00947-08; Wahl MB, 2007, DEVELOPMENT, V134, P4033, DOI 10.1242/dev.009167; William DA, 2007, DEV BIOL, V305, P172, DOI 10.1016/j.ydbio.2007.02.007; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yasuhiko Y, 2006, P NATL ACAD SCI USA, V103, P3651, DOI 10.1073/pnas.0508238103	61	147	159	1	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 13	2012	149	2					295	306		10.1016/j.cell.2012.02.054	http://dx.doi.org/10.1016/j.cell.2012.02.054			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22484060	Bronze			2022-12-28	WOS:000302805600010
J	Zhang, JLA; Mortazavi, A; Williams, BA; Wold, BJ; Rothenberg, EV				Zhang, Jingli A.; Mortazavi, Ali; Williams, Brian A.; Wold, Barbara J.; Rothenberg, Ellen V.			Dynamic Transformations of Genome-wide Epigenetic Marking and Transcriptional Control Establish T Cell Identity	CELL			English	Article							CIS-REGULATORY ELEMENTS; GENE-EXPRESSION; LINEAGE COMMITMENT; INTERLEUKIN-7 RECEPTOR; FATE DETERMINATION; RNA-SEQ; PU.1; CHROMATIN; IDENTIFICATION; GATA-3	T cell development comprises a stepwise process of commitment from a multipotent precursor. To define molecular mechanisms controlling this progression, we probed five stages spanning the commitment process using RNA-seq and ChIP-seq to track genome-wide shifts in transcription, cohorts of active transcription factor genes, histone modifications at diverse classes of cis-regulatory elements, and binding repertoire of GATA-3 and PU.1, transcription factors with complementary roles in T cell development. The results highlight potential promoter-distal cis-regulatory elements in play and reveal both activation sites and diverse mechanisms of repression that silence genes used in alternative lineages. Histone marking is dynamic and reversible, and though permissive marks anticipate, repressive marks often lag behind changes in transcription. In vivo binding of PU.1 and GATA-3 relative to epigenetic marking reveals distinctive factor-specific rules for recruitment of these crucial transcription factors to different subsets of their potential sites, dependent on dose and developmental context.	[Zhang, Jingli A.; Mortazavi, Ali; Williams, Brian A.; Wold, Barbara J.; Rothenberg, Ellen V.] CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA; [Mortazavi, Ali; Williams, Brian A.; Wold, Barbara J.] CALTECH, Beckman Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Rothenberg, EV (corresponding author), CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA.	evroth@its.caltech.edu	Matsuo, Keitaro/H-6758-2019	Matsuo, Keitaro/0000-0003-1761-6314; Rothenberg, Ellen/0000-0002-3901-347X	NIH [R33HL089123, R01CA090233, R01CA090233-08S1, RC2CA148278]; Beckman Institute; Millard and Muriel Jacobs Genetics and Genomics Center; L.A. Garfinkle Memorial Laboratory; Al Sherman Foundation; Bren Professorship; A.B. Ruddock Professorship; NATIONAL CANCER INSTITUTE [RC2CA148278, R01CA090233] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL089123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095943] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Institute; Millard and Muriel Jacobs Genetics and Genomics Center; L.A. Garfinkle Memorial Laboratory; Al Sherman Foundation; Bren Professorship; A.B. Ruddock Professorship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Lorian Schaeffer and Vijaya Kumar for library preparation and sequencing, Henry Amrhein and Diane Trout for data curation, Igor Antoshechkin for sequencing facility management, Diana Perez, Josh Verceles, and Rochelle Diamond for cell sorting and advice, Tian Ling, Georgi Marinov, and Hao Yuan Kueh for statistical advice and programming, Rothenberg group members for sharing advice and unpublished data, and Robert Butler, Lorena Sandoval, and Scott Washburn for care of the mice. Support was from NIH grants R33HL089123, R01CA090233, R01CA090233-08S1, and RC2CA148278, the Beckman Institute, the Millard and Muriel Jacobs Genetics and Genomics Center, the L.A. Garfinkle Memorial Laboratory Fund, the Al Sherman Foundation, the Bren Professorship (B.J.W.), and the A.B. Ruddock Professorship (E.V.R.).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; David-Fung ES, 2009, DEV BIOL, V325, P444, DOI 10.1016/j.ydbio.2008.10.021; Decker T, 2009, IMMUNITY, V30, P508, DOI 10.1016/j.immuni.2009.01.012; DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8; Donaldson IJ, 2005, HUM MOL GENET, V14, P595, DOI 10.1093/hmg/ddi056; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Franco CB, 2006, P NATL ACAD SCI USA, V103, P11993, DOI 10.1073/pnas.0601188103; GEORGOPOULOS K, 1988, EMBO J, V7, P2401, DOI 10.1002/j.1460-2075.1988.tb03085.x; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Gomez-del Arco P, 2010, IMMUNITY, V33, P685, DOI 10.1016/j.immuni.2010.11.008; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hosoya T, 2010, IMMUNOL REV, V238, P110, DOI 10.1111/j.1600-065X.2010.00954.x; Hosoya T, 2009, J EXP MED, V206, P2987, DOI 10.1084/jem.20090934; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; McCormack MP, 2010, SCIENCE, V327, P879, DOI 10.1126/science.1182378; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Natoli G, 2010, IMMUNITY, V33, P12, DOI 10.1016/j.immuni.2010.07.006; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Orford K, 2008, DEV CELL, V14, P798, DOI 10.1016/j.devcel.2008.04.002; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Rothenberg EV, 2008, SEMIN IMMUNOL, V20, P236, DOI 10.1016/j.smim.2008.07.006; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Rothenberg EV, 2011, J IMMUNOL, V186, P6649, DOI 10.4049/jimmunol.1003703; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; Taghon T, 2007, NAT IMMUNOL, V8, P845, DOI 10.1038/ni1486; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Xue HH, 2004, NAT IMMUNOL, V5, P1036, DOI 10.1038/ni1117; Yang Q, 2010, IMMUNOL REV, V238, P12, DOI 10.1111/j.1600-065X.2010.00956.x; Yannoutsos N, 2004, NAT IMMUNOL, V5, P443, DOI 10.1038/ni1053; Yui MA, 2010, J IMMUNOL, V185, P284, DOI 10.4049/jimmunol.1000679; Zarnegar MA, 2010, MOL CELL BIOL, V30, P4922, DOI 10.1128/MCB.00354-10	40	251	254	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 13	2012	149	2					467	482		10.1016/j.cell.2012.01.056	http://dx.doi.org/10.1016/j.cell.2012.01.056			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500808	Green Accepted, Bronze			2022-12-28	WOS:000302805600023
J	Simmons, CP; Farrar, JJ; Nguyen, VVC; Wills, B				Simmons, Cameron P.; Farrar, Jeremy J.; Nguyen Van Vinh Chau; Wills, Bridget			CURRENT CONCEPTS Dengue	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SHOCK SYNDROME; HEMORRHAGIC-FEVER; PLATELET TRANSFUSION; VIETNAMESE CHILDREN; VIRUS-INFECTIONS; DISEASE SEVERITY; CASE DEFINITIONS; RISK-FACTORS; RAPID TEST; DIAGNOSIS		[Farrar, Jeremy J.] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Simmons, Cameron P.; Farrar, Jeremy J.; Wills, Bridget] Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam; [Simmons, Cameron P.; Farrar, Jeremy J.; Wills, Bridget] Univ Oxford, Churchill Hosp, Ctr Trop Med, Oxford, England	University of Oxford; University of Oxford	Farrar, JJ (corresponding author), Univ Oxford, Clin Res Unit, Hosp Trop Dis, 190 Ben Ham Tu,Quan 5, Ho Chi Minh City, Vietnam.	jfarrar@oucru.org	Farrar, Jeremy J./HGA-7610-2022; Simmons, Cameron P/ABA-3896-2021	Simmons, Cameron P/0000-0002-9039-7392; Wills, Bridget/0000-0001-9086-8804; Farrar, Jeremy/0000-0002-2700-623X	Unither Virology; Tibotec; Hoffmann-La Roche	Unither Virology; Tibotec; Hoffmann-La Roche(Hoffmann-La Roche)	Dr. Simmons reports that his institution receives consulting fees on his behalf from Unither Virology and Tibotec and grant support on his behalf from Hoffmann-La Roche. No other potential conflict of interest relevant to this article was reported.	Alexander N, 2011, TROP MED INT HE 0530; Anders KL, 2011, AM J TROP MED HYG, V84, P127, DOI 10.4269/ajtmh.2011.10-0476; Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183; Bridget W, 2009, AM J TROP MED HYG, V81, P638, DOI 10.4269/ajtmh.2009.08-0008; Brien JD, 2010, J VIROL, V84, P10630, DOI 10.1128/JVI.01190-10; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; Cardosa J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000423; Chaterji S, 2011, AM J TROP MED HYG, V84, P224, DOI 10.4269/ajtmh.2011.10-0316; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108; Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5; Durbin AP, 2010, CURR TOP MICROBIOL, V338, P129, DOI 10.1007/978-3-642-02215-9_10; Dussart P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000280; Fry SR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001199; Guy B., 2010, HUM VACCINES, V6, P9, DOI DOI 10.4161/HV.6.9; Guzman MG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000811; HALSTEAD SB, 1989, REV INFECT DIS, V11, pS830; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Hung NT, 2005, AM J TROP MED HYG, V72, P370; Hunsperger EA, 2009, EMERG INFECT DIS, V15, P436, DOI 10.3201/eid1503.080923; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960; KOURI GP, 1989, B WORLD HEALTH ORGAN, V67, P375; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Leong ASY, 2007, SEMIN DIAGN PATHOL, V24, P227, DOI 10.1053/j.semdp.2007.07.002; Levick JR, 2010, CARDIOVASC RES, V87, P198, DOI 10.1093/cvr/cvq062; Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365; Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813; Lye DC, 2009, CLIN INFECT DIS, V48, P1262, DOI 10.1086/597773; Mairuhu ATA, 2003, LANCET INFECT DIS, V3, P33, DOI 10.1016/S1473-3099(03)00487-0; Messer WB, 2003, EMERG INFECT DIS, V9, P800; Michel CC, 1999, PHYSIOL REV, V79, P703, DOI 10.1152/physrev.1999.79.3.703; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627; Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459; Phuong CXT, 2004, AM J TROP MED HYG, V70, P172, DOI 10.4269/ajtmh.2004.70.172; Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Rigau-Perez JG, 2006, LANCET INFECT DIS, V6, P297, DOI 10.1016/S1473-3099(06)70465-0; SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932; Schwartz E, 2008, EMERG INFECT DIS, V14, P1081, DOI 10.3201/eid1407.071412; Streit JA, 2011, EMERG INFECT DIS, V17, P914, DOI 10.3201/eid1705.101023; Thomas L, 2009, TRANSFUSION, V49, P1400, DOI 10.1111/j.1537-2995.2009.02132.x; Tricou V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001309; Tricou Vianney, 2010, PLoS Negl Trop Dis, V4, pe785, DOI 10.1371/journal.pntd.0000785; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Vu TTH, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000757; Wahala WMPB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000821; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Wichmann O, 2004, TROP MED INT HEALTH, V9, P1022, DOI 10.1111/j.1365-3156.2004.01295.x; Wills BA, 2005, NEW ENGL J MED, V353, P877, DOI 10.1056/NEJMoa044057; Wills BA, 2004, J INFECT DIS, V190, P810, DOI 10.1086/422754; Wills BA, 2002, CLIN INFECT DIS, V35, P277, DOI 10.1086/341410; World Health Organization, 2009, DENG GUID TREATM PRE	55	1093	1167	6	173	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 12	2012	366	15					1423	1432		10.1056/NEJMra1110265	http://dx.doi.org/10.1056/NEJMra1110265			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923GV	22494122	Green Published			2022-12-28	WOS:000302608600006
J	Dwyer, N; Kanani, R				Dwyer, Nathan; Kanani, Ronak			Left Main Coronary Artery Thrombosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dwyer, Nathan; Kanani, Ronak] Foothills Med Ctr, Calgary, AB, Canada	University of Calgary	Dwyer, N (corresponding author), Foothills Med Ctr, Calgary, AB, Canada.	ndwyer@utas.edu.au		Dwyer, Nathan/0000-0002-1583-8290					0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 5	2012	366	14					E21	E21		10.1056/NEJMicm1105065	http://dx.doi.org/10.1056/NEJMicm1105065			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	919QJ	22475617				2022-12-28	WOS:000302343000001
J	Groves, T				Groves, Trish			BMJ GROUP IMPROVING HEALTH AWARDS 2012 Research paper of the year: interventions to improve health	BRITISH MEDICAL JOURNAL			English	Editorial Material							MORTALITY					tgroves@bmj.com	Groves, Trish/A-9119-2009	Groves, Trish/0000-0001-7915-6419				Gill CJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d346; Kaczorowski J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d442; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Sundar S, 2011, LANCET, V377, P477, DOI 10.1016/S0140-6736(10)62050-8	4	0	0	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 4	2012	344								e2444	10.1136/bmj.e2444	http://dx.doi.org/10.1136/bmj.e2444			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	923HC	22491748				2022-12-28	WOS:000302609300013
J	Ship, AN; Trivedi, NS				Ship, Amy N.; Trivedi, Neha S.			Update: A 41-Year-Old Woman With Menorrhagia, Anemia, and Fibroids Review of Treatment of Uterine Fibroids	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material														Trivedi, Neha/0000-0003-1006-1408				Van Voorhis B, 2009, JAMA-J AM MED ASSOC, V301, P82, DOI 10.1001/jama.2008.791	1	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2012	307	13					1430	1430		10.1001/jama.2012.411	http://dx.doi.org/10.1001/jama.2012.411			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919AY	22474206				2022-12-28	WOS:000302294200030
J	Goldenberg, RL; McClure, EM				Goldenberg, Robert L.; McClure, Elizabeth M.			Disparities in interventions for child and maternal mortality	LANCET			English	Editorial Material							SYSTEMATIC ANALYSIS; NEWBORN; HEALTH; COUNTRIES; COUNTDOWN; SURVIVAL; TRENDS; RATES		[Goldenberg, Robert L.] Drexel Univ, Coll Med, Dept Obstet & Gynecol, Philadelphia, PA 19102 USA; [McClure, Elizabeth M.] Res Triangle Inst, Res Triangle Pk, NC 27709 USA	Drexel University; Research Triangle Institute	Goldenberg, RL (corresponding author), Drexel Univ, Coll Med, Dept Obstet & Gynecol, Philadelphia, PA 19102 USA.	rgoldenb@drexelmed.edu			NICHD NIH HHS [U01 HD040607, U01 HD040636, U24 HD092094] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD040636, U01HD040607] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alexander GR, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e61; [Anonymous], 2010, COUNTD 2015 COUNTD 2; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Barros FC, 2010, REV SAUDE PUBL, V44, P1, DOI 10.1590/S0034-89102010000100001; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Schiffman J, 2010, SEMIN PERINATOL, V34, P462, DOI 10.1053/j.semperi.2010.09.008	12	13	13	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 31	2012	379	9822					1178	1180		10.1016/S0140-6736(12)60474-7	http://dx.doi.org/10.1016/S0140-6736(12)60474-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	918DV	22464372	Green Accepted			2022-12-28	WOS:000302230400011
J	Ciesla, FJ; Sandford, SA				Ciesla, Fred J.; Sandford, Scott A.			Organic Synthesis via Irradiation and Warming of Ice Grains in the Solar Nebula	SCIENCE			English	Article							PROTOPLANETARY DISKS; CIRCUMSTELLAR DISKS; RESIDENCE TIMES; UV-IRRADIATION; INTERSTELLAR; EVOLUTION; MOLECULES; ANALOGS; PHOTOLYSIS; PARTICLES	Complex organic compounds, including many important to life on Earth, are commonly found in meteoritic and cometary samples, though their origins remain a mystery. We examined whether such molecules could be produced within the solar nebula by tracking the dynamical evolution of ice grains in the nebula and recording the environments to which they were exposed. We found that icy grains originating in the outer disk, where temperatures were less than 30 kelvin, experienced ultraviolet irradiation exposures and thermal warming similar to that which has been shown to produce complex organics in laboratory experiments. These results imply that organic compounds are natural by-products of protoplanetary disk evolution and should be important ingredients in the formation of all planetary systems, including our own.	[Ciesla, Fred J.] Univ Chicago, Dept Geophys Sci, Chicago, IL 60430 USA; [Sandford, Scott A.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	University of Chicago; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Ciesla, FJ (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60430 USA.	fciesla@uchicago.edu			NASA; Astrobiology Institute	NASA(National Aeronautics & Space Administration (NASA)); Astrobiology Institute	F.J.C. and S. A. S. acknowledge funding from NASA's Origins of Solar Systems program. S. A. S. also thanks the Astrobiology Institute for funds.	Adams FC, 2006, ASTROPHYS J, V641, P504, DOI 10.1086/500393; Bernstein MP, 1999, SCIENCE, V283, P1135, DOI 10.1126/science.283.5405.1135; Bernstein MP, 2002, NATURE, V416, P401, DOI 10.1038/416401a; BERNSTEIN MP, 1995, ASTROPHYS J, V454, P327, DOI 10.1086/176485; Bethell TJ, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/2/78; Caro GMM, 2002, NATURE, V416, P403, DOI 10.1038/416403a; Charnoz S, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/1/33; Chiang EI, 1997, ASTROPHYS J, V490, P368, DOI 10.1086/304869; Ciesla FJ, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/1/9; Ciesla FJ, 2010, ASTROPHYS J, V723, P514, DOI 10.1088/0004-637X/723/1/514; HABING HJ, 1968, B ASTRON I NETH, V19, P421; HAGEN W, 1979, ASTROPHYS SPACE SCI, V65, P215, DOI 10.1007/BF00643502; Hartmann L, 1998, ASTROPHYS J, V495, P385, DOI 10.1086/305277; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; Nakamura-Messenger K, 2006, SCIENCE, V314, P1439, DOI 10.1126/science.1132175; Nuevo M, 2011, ADV SPACE RES, V48, P1126, DOI 10.1016/j.asr.2011.05.020; Nuth JA, 2008, ASTROPHYS J LETT, V673, pL225, DOI 10.1086/528741; Oberg KI, 2009, ASTROPHYS J, V693, P1209, DOI 10.1088/0004-637X/693/2/1209; Peltzer E T, 1984, Adv Space Res, V4, P69, DOI 10.1016/0273-1177(84)90546-5; Sandford SA, 2001, METEORIT PLANET SCI, V36, P1117, DOI 10.1111/j.1945-5100.2001.tb01948.x; Sandford SA, 2006, SCIENCE, V314, P1720, DOI 10.1126/science.1135841; Sano T, 2000, ASTROPHYS J, V543, P486, DOI 10.1086/317075; SCHUTTE WA, 1992, ADV SPACE RES-SERIES, V12, P47, DOI 10.1016/0273-1177(92)90152-N; Throop HB, 2011, ICARUS, V212, P885, DOI 10.1016/j.icarus.2011.01.002; WEIDENSCHILLING SJ, 1984, ICARUS, V60, P553, DOI 10.1016/0019-1035(84)90164-7; Willacy K, 2007, ASTROPHYS J, V660, P441, DOI 10.1086/512796; Woitke P, 2009, ASTRON ASTROPHYS, V501, P383, DOI 10.1051/0004-6361/200911821; Zhu ZH, 2009, ASTROPHYS J, V694, P1045, DOI 10.1088/0004-637X/694/2/1045	30	136	136	2	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					452	454		10.1126/science.1217291	http://dx.doi.org/10.1126/science.1217291			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22461502	Green Submitted			2022-12-28	WOS:000303233400041
J	Ryan, A; Blustein, J				Ryan, Andrew; Blustein, Jan			Making the Best of Hospital Pay for Performance	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ryan, Andrew] Cornell Univ, Dept Publ Hlth, Div Outcomes & Effectiveness Res, Weill Med Coll, New York, NY 10021 USA; [Blustein, Jan] NYU, Wagner Grad Sch, New York, NY USA; [Blustein, Jan] NYU, Sch Med, Dept Med, New York, NY USA	Cornell University; New York University; New York University	Ryan, A (corresponding author), Cornell Univ, Dept Publ Hlth, Div Outcomes & Effectiveness Res, Weill Med Coll, New York, NY 10021 USA.							[Anonymous], FED REG; Epstein AM, 2007, NEW ENGL J MED, V356, P515, DOI 10.1056/NEJMe078002; Glickman SW, 2007, JAMA-J AM MED ASSOC, V297, P2373, DOI 10.1001/jama.297.21.2373; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Ryan AM, 2012, HEALTH AFFAIR, V31, P797, DOI 10.1377/hlthaff.2011.0626	5	31	32	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 26	2012	366	17					1557	1559		10.1056/NEJMp1202563	http://dx.doi.org/10.1056/NEJMp1202563			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	931FC	22512453				2022-12-28	WOS:000303200100001
J	Basch, E; Aronson, N; Berg, A; Flum, D; Gabriel, S; Goodman, SN; Helfand, M; Ioannidis, JPA; Lauer, M; Meltzer, D; Mittman, B; Newhouse, R; Normand, SL; Schneeweiss, S; Slutsky, J; Tinetti, M; Yancy, C				Basch, Ethan; Aronson, Naomi; Berg, Alfred; Flum, David; Gabriel, Sherine; Goodman, Steven N.; Helfand, Mark; Ioannidis, John P. A.; Lauer, Michael; Meltzer, David; Mittman, Brian; Newhouse, Robin; Normand, Sharon-Lise; Schneeweiss, Sebastian; Slutsky, Jean; Tinetti, Mary; Yancy, Clyde		Methodology Comm Patient-Centered	Methodological Standards and Patient-Centeredness in Comparative Effectiveness Research The PCORI Perspective	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPLEMENTATION-RESEARCH; RANDOMIZED-TRIALS; PROPENSITY SCORE; CLINICAL-TRIALS; QUALITY IMPROVEMENT; PUBLICATION BIAS; MEDICATIONS; EXPERIENCE; BENEFITS; LESSONS	Rigorous methodological standards help to ensure that medical research produces information that is valid and generalizable, and are essential in patient-centered outcomes research (PCOR). Patient-centeredness refers to the extent to which the preferences, decision-making needs, and characteristics of patients are addressed, and is the key characteristic differentiating PCOR from comparative effectiveness research. The Patient Protection and Affordable Care Act signed into law in 2010 created the Patient-Centered Outcomes Research Institute (PCORI), which includes an independent, federally appointed Methodology Committee. The Methodology Committee is charged to develop methodological standards for PCOR. The 4 general areas identified by the committee in which standards will be developed are (1) prioritizing research questions, (2) using appropriate study designs and analyses, (3) incorporating patient perspectives throughout the research continuum, and (4) fostering efficient dissemination and implementation of results. A Congressionally mandated PCORI methodology report (to be issued in its first iteration in May 2012) will begin to provide standards in each of these areas, and will inform future PCORI funding announcements and review criteria. The work of the Methodology Committee is intended to enable generation of information that is relevant and trustworthy for patients, and to enable decisions that improve patient-centered outcomes. JAMA. 2012;307(15):1636-1640 www.jama.com	[Basch, Ethan] Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, New York, NY 10463 USA; [Aronson, Naomi] Blue Cross Blue Shield Assoc, Chicago, IL USA; [Berg, Alfred; Flum, David] Univ Washington, Seattle, WA 98195 USA; [Gabriel, Sherine] Mayo Clin, Rochester, MN USA; [Goodman, Steven N.; Ioannidis, John P. A.] Stanford Univ, Stanford, CA 94305 USA; [Helfand, Mark] Portland VA Med Ctr, Portland, OR USA; [Lauer, Michael] NHLBI, Bethesda, MD 20892 USA; [Meltzer, David] Univ Chicago, Chicago, IL 60637 USA; [Mittman, Brian] Dept Vet Affairs, Sepulveda, CA USA; [Newhouse, Robin] Univ Maryland, Baltimore, MD 21201 USA; [Normand, Sharon-Lise; Schneeweiss, Sebastian] Harvard Univ, Sch Med, Boston, MA USA; [Normand, Sharon-Lise] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Slutsky, Jean] Agcy Healthcare Res & Qual, Rockville, MD USA; [Tinetti, Mary] Yale Univ, New Haven, CT USA; [Yancy, Clyde] Northwestern Univ, Chicago, IL 60611 USA	Memorial Sloan Kettering Cancer Center; University of Washington; University of Washington Seattle; Mayo Clinic; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Chicago; University System of Maryland; University of Maryland Baltimore; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Agency for Healthcare Research & Quality; Yale University; Northwestern University	Basch, E (corresponding author), Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, 307 63rd St, New York, NY 10463 USA.	ebasch@mskcc.org	Meltzer, David/C-2926-2009; Ioannidis, John P. A./G-9836-2011; Flum, David/GPX-7976-2022	Meltzer, David/0000-0003-2790-7393; Normand, Sharon-Lise/0000-0001-7027-4769; Goodman, Steven/0000-0002-3872-5723	PCORI of the Methodology Committee	PCORI of the Methodology Committee(Patient-Centered Outcomes Research Institute - PCORI)	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. All of the authors reported receiving funding from PCORI as members of the Methodology Committee, including compensation for travel and lodging for PCORI-related meetings as well as time spent providing service to the PCORI.	ALTMAN DG, 1994, BRIT MED J, V308, P283, DOI 10.1136/bmj.308.6924.283; [Anonymous], OUTC MEAS; Atkins D, 2010, AM J MED, V123, pE38, DOI 10.1016/j.amjmed.2010.10.007; Basch E, EFFECTIVENESS GUIDAN; Basch E, 2011, VALUE HEALTH, V14, P965, DOI 10.1016/j.jval.2011.10.002; Berwick DM, 2007, MED CARE, V45, P1123, DOI 10.1097/MLR.0b013e31815d18e6; Cai TX, 2011, BIOSTATISTICS, V12, P270, DOI 10.1093/biostatistics/kxq060; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Clarke M, 1998, JAMA-J AM MED ASSOC, V280, P280, DOI 10.1001/jama.280.3.280; Clarke M, 2010, LANCET, V376, P20, DOI 10.1016/S0140-6736(10)61045-8; Claxton KP, 2006, PHARMACOECONOMICS, V24, P1055, DOI 10.2165/00019053-200624110-00003; Craig P., 2008, DEV EVALUATING COMPL; Curran GM, 2012, MED CARE, V50, P217, DOI 10.1097/MLR.0b013e3182408812; Davidoff F, 2009, JAMA-J AM MED ASSOC, V302, P2580, DOI 10.1001/jama.2009.1845; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Gartlehner G, 2008, ANN INTERN MED, V149, P734, DOI 10.7326/0003-4819-149-10-200811180-00008; Glasziou P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3852; Gluud LL, 2006, AM J EPIDEMIOL, V163, P493, DOI 10.1093/aje/kwj069; Green LW, 2006, EVAL HEALTH PROF, V29, P126, DOI 10.1177/0163278705284445; Ioannidis John P A, 2008, Philos Ethics Humanit Med, V3, P14, DOI 10.1186/1747-5341-3-14; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; Kaplan HC, 2012, BMJ QUAL SAF, V21, P13, DOI 10.1136/bmjqs-2011-000010; Kuss O, 2011, J CLIN EPIDEMIOL, V64, P1076, DOI 10.1016/j.jclinepi.2011.01.005; Luce BR, 2009, ANN INTERN MED, V151, P206, DOI 10.7326/0003-4819-151-3-200908040-00126; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; Riegel B, 2009, CIRCULATION, V120, P1141, DOI 10.1161/CIRCULATIONAHA.109.192628; Rothwell PM, 2005, LANCET, V365, P176, DOI 10.1016/S0140-6736(05)17709-5; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Schneeweiss S, 2011, CLIN PHARMACOL THER, V90, P777, DOI 10.1038/clpt.2011.235; Selby JV, 2012, JAMA-J AM MED ASSOC, V307, P1583, DOI 10.1001/jama.2012.500; Shekelle PG, 2011, ANN INTERN MED, V154, P693, DOI 10.7326/0003-4819-154-10-201105170-00011; Stetler CB, 2006, J GEN INTERN MED, V21, pS1, DOI 10.1111/j.1525-1497.2006.00355.x; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Sutton AJ, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-29; Toh S, 2010, EPIDEMIOLOGY, V21, P528, DOI 10.1097/EDE.0b013e3181df1b69; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Walshe K, 2002, QUAL SAF HEALTH CARE, V11, P85, DOI 10.1136/qhc.11.1.85; Weiss NS, 2008, ARCH INTERN MED, V168, P133, DOI 10.1001/archinternmed.2007.30; Wisniewski SR, 2009, AM J PSYCHIAT, V166, P599, DOI 10.1176/appi.ajp.2008.08071027; Wu AW, 2010, HEALTH AFFAIR, V29, P1863, DOI 10.1377/hlthaff.2010.0660; Zwarenstein M, 2006, J CLIN EPIDEMIOL, V59, P1125, DOI 10.1016/j.jclinepi.2006.05.010	45	184	184	0	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2012	307	15					1636	1640		10.1001/jama.2012.466	http://dx.doi.org/10.1001/jama.2012.466			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927GU	22511692				2022-12-28	WOS:000302896100026
J	Fink, HA; Ishani, A; Taylor, BC; Greer, NL; MacDonald, R; Rossini, D; Sadiq, S; Lankireddy, S; Kane, RL; Wilt, TJ				Fink, Howard A.; Ishani, Areef; Taylor, Brent C.; Greer, Nancy L.; MacDonald, Roderick; Rossini, Dominic; Sadiq, Sameea; Lankireddy, Srilakshmi; Kane, Robert L.; Wilt, Timothy J.			Screening for, Monitoring, and Treatment of Chronic Kidney Disease Stages 1 to 3: A Systematic Review for the US Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline	ANNALS OF INTERNAL MEDICINE			English	Review							BLOOD-PRESSURE CONTROL; CONVERTING-ENZYME-INHIBITION; TYPE-2 DIABETES-MELLITUS; DIETARY-PROTEIN RESTRICTION; GLOMERULAR-FILTRATION-RATE; LOW-DOSE RAMIPRIL; CARDIOVASCULAR EVENTS; HEART-FAILURE; RENAL-FUNCTION; USUAL CARE	Background: Screening and monitoring for chronic kidney disease (CKD) could lead to earlier interventions that improve clinical outcomes. Purpose: To summarize evidence about the benefits and harms of screening for and monitoring and treatment of CKD stages 1 to 3 in adults. Data Sources: MEDLINE (1985 through November 2011), reference lists, and expert suggestions. Study Selection: English-language, randomized, controlled trials that evaluated screening for or monitoring or treatment of CKD and that reported clinical outcomes. Data Extraction: Two reviewers assessed study characteristics and rated quality and strength of evidence. Data Synthesis: No trials evaluated screening or monitoring, and 110 evaluated treatments. Angiotensin-converting enzyme inhibitors (relative risk, 0.65 [95% CI, 0.49 to 0.88]) and angiotensin II-receptor blockers (relative risk, 0.77 [CI, 0.66 to 0.90]) reduced end-stage renal disease versus placebo, primarily in patients with diabetes who have macroalbuminuria. Angiotensin-converting enzyme inhibitors reduced mortality versus placebo (relative risk, 0.79 [CI, 0.66 to 0.96]) in patients with microalbuminuria and cardiovascular disease or high-risk diabetes. Statins and beta-blockers reduced mortality and cardiovascular events versus placebo or control in patients with impaired estimated glomerular filtration rate and either hyperlipidemia or congestive heart failure, respectively. Risks for mortality, end-stage renal disease, or other clinical outcomes did not significantly differ between strict and usual blood pressure control. The strength of evidence was rated high for angiotensin II-receptor blockers and statins, moderate for angiotensin-converting enzyme inhibitors and beta-blockers, and low for strict blood pressure control. Limitations: Evidence about outcomes was sometimes scant and derived from post hoc analyses of subgroups of patients enrolled in trials. Few trials reported or systematically collected information about adverse events. Selective reporting and publication bias were possible. Conclusion: The role of CKD screening or monitoring in improving clinical outcomes is uncertain. Evidence for CKD treatment benefit is strongest for angiotensin-converting enzyme inhibitors and angiotensin II-receptor blockers, and in patients with albuminuria combined with diabetes or cardiovascular disease.	Univ Minnesota, Ctr Geriatr Res Educ & Clin, Minneapolis, MN USA; Univ Minnesota, Ctr Chron Dis Outcomes Res, Minneapolis, MN USA; Univ Minnesota, Minneapolis Vet Affairs Med Ctr, Minneapolis, MN USA; Univ Minnesota, Minnesota Evidence Based Practice Ctr, Minneapolis, MN USA; Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA	Geriatric Research Education & Clinical Center; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Fink, HA (corresponding author), Minneapolis Vet Affairs Med Ctr 11 G, 1 Vet Dr, Minneapolis, MN 55417 USA.	howard.fink@va.gov	Fink, Howard/F-3933-2012; Taylor, Brent C/A-8069-2009	Taylor, Brent C/0000-0002-2140-8377	AHRQ [HHSA 290-2007-10064-I]	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By a contract from the AHRQ to the Minnesota Evidence-based Practice Center (contract HHSA 290-2007-10064-I).	Anand IS, 2009, CIRCULATION, V120, P1577, DOI 10.1161/CIRCULATIONAHA.109.853648; Appel LJ, 2010, NEW ENGL J MED, V363, P918, DOI 10.1056/NEJMoa0910975; Asselbergs FW, 2004, CIRCULATION, V110, P2809, DOI 10.1161/01.CIR.0000146378.65439.7A; Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Barnett AH, 2004, NEW ENGL J MED, V351, P1952, DOI 10.1056/NEJMoa042274; Barrett BJ, 2011, CLIN J AM SOC NEPHRO, V6, P1241, DOI 10.2215/CJN.07160810; Bojestig M, 2001, DIABETES CARE, V24, P919, DOI 10.2337/diacare.24.5.919; Boulware LE, 2003, JAMA-J AM MED ASSOC, V290, P3101, DOI 10.1001/jama.290.23.3101; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Brugts JJ, 2007, J AM COLL CARDIOL, V50, P2148, DOI 10.1016/j.jacc.2007.08.029; Castagno D, 2010, EUR J HEART FAIL, V12, P607, DOI 10.1093/eurjhf/hfq038; Chan JC, 2009, DIABETES CARE, V32, P977, DOI 10.2337/dc08-1908; Chonchol M, 2007, AM J KIDNEY DIS, V49, P373, DOI 10.1053/j.ajkd.2006.11.043; CLOSE CF, 1995, BMJ-BRIT MED J, V311, P973; Cohen-Solal A, 2009, EUR J HEART FAIL, V11, P872, DOI 10.1093/eurjhf/hfp104; Colhoun HM, 2009, AM J KIDNEY DIS, V54, P810, DOI 10.1053/j.ajkd.2009.03.022; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Crepaldi G, 1998, DIABETES CARE, V21, P104, DOI 10.2337/diacare.21.1.104; DAMICO G, 1994, NEPHROL DIAL TRANSPL, V9, P1590; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Dussol B, 2005, J RENAL NUTR, V15, P398, DOI 10.1053/j.jrn.2005.07.003; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Eriksen BO, 2006, KIDNEY INT, V69, P375, DOI 10.1038/sj.ki.5000058; Fassett RG, 2010, ATHEROSCLEROSIS, V213, P218, DOI 10.1016/j.atherosclerosis.2010.07.053; Fink HA, 2012, CHRONIC KIDNEY DIS S; Gaede P, 1999, LANCET, V353, P617, DOI 10.1016/S0140-6736(98)07368-1; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Gerstein HC, 2000, LANCET, V355, P253; Ghali JK, 2009, J CARD FAIL, V15, P310, DOI 10.1016/j.cardfail.2008.11.003; Haller H, 2011, NEW ENGL J MED, V364, P907, DOI 10.1056/NEJMoa1007994; Harris LE, 1998, AM J MED, V105, P464, DOI 10.1016/S0002-9343(98)00329-5; Higgings JPT, 2008, COCHRANE HDB SYSTEMA; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoerger TJ, 2010, AM J KIDNEY DIS, V55, P463, DOI 10.1053/j.ajkd.2009.11.017; Hou FF, 2007, J AM SOC NEPHROL, V18, P1889, DOI 10.1681/ASN.2006121372; Hsu CY, 2003, J AM SOC NEPHROL, V14, P2902, DOI 10.1097/01.ASN.0000091586.46532.B4; Joss N, 2004, QJM-INT J MED, V97, P219, DOI 10.1093/qjmed/hch039; Kanno Y, 2006, CLIN J AM SOC NEPHRO, V1, P730, DOI 10.2215/CJN.01110905; Katayama S, 2002, DIABETES RES CLIN PR, V55, P113, DOI 10.1016/S0168-8227(01)00289-3; Kendrick J, 2010, AM J KIDNEY DIS, V55, P42, DOI 10.1053/j.ajkd.2009.09.020; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Koren MJ, 2009, AM J KIDNEY DIS, V53, P741, DOI 10.1053/j.ajkd.2008.11.025; Koya D, 2009, DIABETOLOGIA, V52, P2037, DOI 10.1007/s00125-009-1467-8; Lacourciere Y, 2000, KIDNEY INT, V58, P762, DOI 10.1046/j.1523-1755.2000.00224.x; LAFFEL LMB, 1995, AM J MED, V99, P497, DOI 10.1016/S0002-9343(99)80226-5; Lemos PA, 2005, AM J CARDIOL, V95, P445, DOI 10.1016/j.amjcard.2004.10.008; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Lewis JB, 1999, AM J KIDNEY DIS, V34, P809, DOI 10.1016/S0272-6386(99)70036-3; LOCATELLI F, 1991, LANCET, V337, P1299, DOI 10.1016/0140-6736(91)92977-A; Makino H, 2007, DIABETES CARE, V30, P1577, DOI 10.2337/dc06-1998; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Marre M, 2004, BRIT MED J, V328, P495, DOI 10.1136/bmj.37970.629537.0D; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mehdi UF, 2009, J AM SOC NEPHROL, V20, P2641, DOI 10.1681/ASN.2009070737; Menne J, 2008, J HYPERTENS, V26, P1860, DOI 10.1097/HJH.0b013e32830508aa; Miller WG, 2009, CLIN CHEM, V55, P24, DOI 10.1373/clinchem.2008.106567; Muirhead N, 1999, CURR THER RES CLIN E, V60, P650, DOI 10.1016/S0011-393X(99)90003-6; Nakamura H, 2009, ATHEROSCLEROSIS, V206, P512, DOI 10.1016/j.atherosclerosis.2009.03.031; O'Hare JP, 2000, DIABETES CARE, V23, P1823, DOI 10.2337/diacare.23.12.1823; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Pahor M, 1998, ARCH INTERN MED, V158, P1340, DOI 10.1001/archinte.158.12.1340; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Perkins BA, 2003, NEW ENGL J MED, V348, P2285, DOI 10.1056/NEJMoa021835; Perkovic V, 2007, J AM SOC NEPHROL, V18, P2766, DOI 10.1681/ASN.2007020256; Rahman M, 2008, AM J KIDNEY DIS, V52, P412, DOI 10.1053/j.ajkd.2008.05.027; RAVID M, 1993, ANN INTERN MED, V118, P577, DOI 10.7326/0003-4819-118-8-199304150-00001; Ridker PM, 2010, J AM COLL CARDIOL, V55, P1266, DOI 10.1016/j.jacc.2010.01.020; ROSMAN JB, 1989, KIDNEY INT, V36, pS96; Ruggenenti P, 1997, LANCET, V349, P1857; Ruggenenti P, 1999, LANCET, V354, P359, DOI 10.1016/S0140-6736(98)10363-X; Ruggenenti P, 2005, LANCET, V365, P939, DOI 10.1016/S0140-6736(05)71082-5; Ryan TP, 2007, AM J MED, V120, P981, DOI 10.1016/j.amjmed.2007.05.012; SANO T, 1994, DIABETES CARE, V17, P420, DOI 10.2337/diacare.17.5.420; Schmieder RE, 2011, J AM SOC NEPHROL, V22, P1353, DOI 10.1681/ASN.2010091001; Schrier RW, 2002, KIDNEY INT, V61, P1086, DOI 10.1046/j.1523-1755.2002.00213.x; Schulz KF, 2002, LANCET, V359, P614, DOI 10.1016/S0140-6736(02)07750-4; Sengul AM, 2006, DIABETES RES CLIN PR, V71, P210, DOI 10.1016/j.diabres.2005.06.010; SHULMAN N B, 1989, Hypertension (Dallas), V13, pI80; Solomon SD, 2006, CIRCULATION, V114, P26, DOI 10.1161/CIRCULATIONAHA.105.592733; Strippoli GFM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006254; Taal MW, 2006, KIDNEY INT, V70, P1694, DOI 10.1038/sj.ki.5001794; Tobe SW, 2011, CIRCULATION, V123, P1098, DOI 10.1161/CIRCULATIONAHA.110.964171; Tonelli M, 2004, CIRCULATION, V110, P1557, DOI 10.1161/01.CIR.0000143892.84582.60; Tonelli M, 2003, ANN INTERN MED, V138, P98, DOI 10.7326/0003-4819-138-2-200301210-00010; TOTO RD, 1995, KIDNEY INT, V48, P851, DOI 10.1038/ki.1995.361; TREVISAN R, 1995, AM J HYPERTENS, V8, P876, DOI 10.1016/0895-7061(95)00162-I; United States Renal Data System, 2006, US REN DAT SYST 2006; United States Renal Data System, 2009, US REN DAT SYST 2009; United States Renal Data System, 2006, US REN DAT SYST 2006; United States Renal Data System, 2010, US REN DAT SYST 2010; United States Renal Data System, 2009, US REN DAT SYST 2009; US Renal Data System, 2010, US REN DAT SYST 2010; Wali RK, 2011, CIRC-HEART FAIL, V4, P18, DOI 10.1161/CIRCHEARTFAILURE.109.932558; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421	100	140	148	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2012	156	8					570	U94		10.7326/0003-4819-156-8-201204170-00008	http://dx.doi.org/10.7326/0003-4819-156-8-201204170-00008			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930PO	22508734				2022-12-28	WOS:000303151800016
J	Munoz, D; Granger, CB				Munoz, Daniel; Granger, Christopher B.			Review: Statins reduce mortality and cardiovascular (CV) morbidity in patients with low CV risk	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Munoz, Daniel; Granger, Christopher B.] Duke Clin Res Inst, Durham, NC USA	Duke University	Munoz, D (corresponding author), Duke Clin Res Inst, Durham, NC USA.		Granger, Christopher B/D-3458-2014	Granger, Christopher B/0000-0002-0045-3291				Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182	1	1	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2012	156	8							JC4-7	10.7326/0003-4819-156-8-201204170-02007	http://dx.doi.org/10.7326/0003-4819-156-8-201204170-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930PO	22508747				2022-12-28	WOS:000303151800006
J	Gordon, R; Tyring, S				Gordon, Rachel; Tyring, Stephen			Vesicular Eruption	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ECZEMA HERPETICUM; ATOPIC-DERMATITIS; MANAGEMENT		[Gordon, Rachel] Ctr Clin Studies, Houston, TX 77030 USA; [Tyring, Stephen] Univ Texas Hlth Sci Ctr, Dept Dermatol, Houston, TX USA; [Tyring, Stephen] Ctr Clin Studies, Webster, TX USA	University of Texas System; University of Texas Health Science Center Houston	Gordon, R (corresponding author), Ctr Clin Studies, 6655 Travis St,Ste 120, Houston, TX 77030 USA.	rgordon@ccstexas.com						BORK K, 1988, J AM ACAD DERMATOL, V19, P1024, DOI 10.1016/S0190-9622(88)70267-4; Engler RJM, 2002, J ALLERGY CLIN IMMUN, V110, P357, DOI 10.1067/mai.2002.128052; Kaposi M, 1887, PATHOLOGIE THERAPIE, V3; Kress DW, 2011, CURR OPIN PEDIATR, V23, P403, DOI 10.1097/MOP.0b013e3283483efd; NIIMURA M, 1988, AM J MED, V85, P49; SANDERSON IR, 1987, BMJ-BRIT MED J, V294, P693, DOI 10.1136/bmj.294.6573.693; Wahn U, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.e2; WHEELER CE, 1966, ARCH DERMATOL, V93, P162, DOI 10.1001/archderm.93.2.162; Wollenberg A, 2003, J ALLERGY CLIN IMMUN, V112, P667, DOI 10.1016/j.jaci.2003.07.001; Wollenberg A, 2003, J AM ACAD DERMATOL, V49, P198, DOI 10.1067/S0190-9622(03)00896-X	10	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2012	307	14					1528	1529		10.1001/jama.2012.436	http://dx.doi.org/10.1001/jama.2012.436			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922HN	22496267				2022-12-28	WOS:000302538100027
J	Haynes, BF; Gilbert, PB; McElrath, MJ; Zolla-Pazner, S; Tomaras, GD; Alam, SM; Evans, DT; Montefiori, DC; Karnasuta, C; Sutthent, R; Liao, HX; DeVico, AL; Lewis, GK; Williams, C; Pinter, A; Fong, Y; Janes, H; DeCamp, A; Huang, YD; Rao, M; Billings, E; Karasavvas, N; Robb, ML; Ngauy, V; de Souza, MS; Paris, R; Ferrari, G; Bailer, RT; Soderberg, KA; Andrews, C; Berman, PW; Frahm, N; De Rosa, SC; Alpert, MD; Yates, NL; Shen, XY; Koup, RA; Pitisuttithum, P; Kaewkungwal, J; Nitayaphan, S; Rerks-Ngarm, S; Michael, NL; Kim, JH				Haynes, Barton F.; Gilbert, Peter B.; McElrath, M. Juliana; Zolla-Pazner, Susan; Tomaras, Georgia D.; Alam, S. Munir; Evans, David T.; Montefiori, David C.; Karnasuta, Chitraporn; Sutthent, Ruengpueng; Liao, Hua-Xin; DeVico, Anthony L.; Lewis, George K.; Williams, Constance; Pinter, Abraham; Fong, Youyi; Janes, Holly; DeCamp, Allan; Huang, Yunda; Rao, Mangala; Billings, Erik; Karasavvas, Nicos; Robb, Merlin L.; Ngauy, Viseth; de Souza, Mark S.; Paris, Robert; Ferrari, Guido; Bailer, Robert T.; Soderberg, Kelly A.; Andrews, Charla; Berman, Phillip W.; Frahm, Nicole; De Rosa, Stephen C.; Alpert, Michael D.; Yates, Nicole L.; Shen, Xiaoying; Koup, Richard A.; Pitisuttithum, Punnee; Kaewkungwal, Jaranit; Nitayaphan, Sorachai; Rerks-Ngarm, Supachai; Michael, Nelson L.; Kim, Jerome H.			Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEPENDENT CELLULAR CYTOTOXICITY; IMMUNODEFICIENCY-VIRUS; V1/V2 DOMAIN; ANTIBODY; PROTECTION; INFECTION; RESPONSES; SIV; NEUTRALIZATION; CHALLENGE	BACKGROUND In the RV144 trial, the estimated efficacy of a vaccine regimen against human immunodeficiency virus type 1 (HIV-1) was 31.2%. We performed a case-control analysis to identify antibody and cellular immune correlates of infection risk. METHODS In pilot studies conducted with RV144 blood samples, 17 antibody or cellular assays met prespecified criteria, of which 6 were chosen for primary analysis to determine the roles of T-cell, IgG antibody, and IgA antibody responses in the modulation of infection risk. Assays were performed on samples from 41 vaccinees who became infected and 205 uninfected vaccinees, obtained 2 weeks after final immunization, to evaluate whether immune-response variables predicted HIV-1 infection through 42 months of follow-up. RESULTS Of six primary variables, two correlated significantly with infection risk: the binding of IgG antibodies to variable regions 1 and 2 (V1V2) of HIV-1 envelope proteins (Env) correlated inversely with the rate of HIV-1 infection (estimated odds ratio, 0.57 per 1-SD increase; P = 0.02; q = 0.08), and the binding of plasma IgA antibodies to Env correlated directly with the rate of infection (estimated odds ratio, 1.54 per 1-SD increase; P = 0.03; q = 0.08). Neither low levels of V1V2 antibodies nor high levels of Env-specific IgA antibodies were associated with higher rates of infection than were found in the placebo group. Secondary analyses suggested that Env-specific IgA antibodies may mitigate the effects of potentially protective antibodies. CONCLUSIONS This immune-correlates study generated the hypotheses that V1V2 antibodies may have contributed to protection against HIV-1 infection, whereas high levels of Env-specific IgA antibodies may have mitigated the effects of protective antibodies. Vaccines that are designed to induce higher levels of V1V2 antibodies and lower levels of Env-specific IgA antibodies than are induced by the RV144 vaccine may have improved efficacy against HIV-1 infection.	[Haynes, Barton F.; Tomaras, Georgia D.; Alam, S. Munir; Montefiori, David C.; Liao, Hua-Xin; Ferrari, Guido; Soderberg, Kelly A.; Yates, Nicole L.; Shen, Xiaoying] Duke Univ, Human Vaccine Inst, Durham, NC 27710 USA; [Haynes, Barton F.; Tomaras, Georgia D.; Alam, S. Munir; Montefiori, David C.; Liao, Hua-Xin; Ferrari, Guido; Soderberg, Kelly A.; Yates, Nicole L.; Shen, Xiaoying] Duke Univ, Sch Med, Ctr HIV AIDS Vaccine Immunol, Durham, NC 27710 USA; [Gilbert, Peter B.; Fong, Youyi; Janes, Holly; DeCamp, Allan; Huang, Yunda] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA; [McElrath, M. Juliana; Frahm, Nicole; De Rosa, Stephen C.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Zolla-Pazner, Susan; Williams, Constance] Vet Affairs New York Harbor Healthcare Syst, New York, NY USA; [Zolla-Pazner, Susan; Williams, Constance] NYU, Sch Med, Dept Pathol, New York, NY USA; [Evans, David T.; Alpert, Michael D.] Harvard Univ, Sch Med, New England Reg Primate Ctr, Dept Microbiol & Immunobiol, Southborough, MA 01772 USA; [Rao, Mangala; Billings, Erik; Robb, Merlin L.; Paris, Robert; Andrews, Charla; Michael, Nelson L.; Kim, Jerome H.] Walter Reed Army Inst Res, US Mil Res Program, Silver Spring, MD USA; [Bailer, Robert T.; Koup, Richard A.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Karnasuta, Chitraporn; Karasavvas, Nicos; Ngauy, Viseth; de Souza, Mark S.] Armed Forces Res Inst Med Sci, US Army Component, Bangkok 10400, Thailand; [Nitayaphan, Sorachai] Armed Forces Res Inst Med Sci, Royal Thai Army, Bangkok 10400, Thailand; [Sutthent, Ruengpueng] Siriraj Hosp, Dept Microbiol, Natl HIV Repository & Bioinformat Ctr, Bangkok, Thailand; [Pitisuttithum, Punnee; Kaewkungwal, Jaranit] Mahidol Univ, Fac Trop Med, Bangkok 10700, Thailand; [Rerks-Ngarm, Supachai] Minist Publ Hlth, Dept Dis Control, Nonthaburi, Thailand; [Berman, Phillip W.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [DeVico, Anthony L.; Lewis, George K.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Pinter, Abraham] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA	Duke University; Duke University; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; New York University; Harvard University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Mahidol University; Mahidol University; Ministry of Public Health - Thailand; University of California System; University of California Santa Cruz; University System of Maryland; University of Maryland Baltimore; Rutgers State University New Brunswick; Rutgers State University Medical Center	Haynes, BF (corresponding author), Duke Univ, Med Ctr, Duke Human Vaccine Inst, 2 Genome Ct,Box 103020, Durham, NC 27710 USA.	hayne002@mc.duke.edu	Tomaras, Georgia/J-5041-2016; Ferrari, Guido/Z-2137-2019; Zolla-Pazner, Susan/S-1864-2019; Ferrari, Guido/A-6088-2015; Alam, S. Munir/AAC-6711-2019	Zolla-Pazner, Susan/0000-0002-0750-2666; Ferrari, Guido/0000-0001-7747-3349; Huang, Yunda/0000-0003-1546-6172; Kaewkungwal, Jaranit/0000-0001-7916-8460	Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery; U.S. Army Medical Research and Materiel Command; NIAID [Y1-AI-2642-12, U01-AI-067854]; Henry M. Jackson Foundation for the Advancement of Military Medicine; Department of Defense [W81XWH-07-2-0067]; HIV Vaccine Trials Network Laboratory [UM1-AI-068618]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087181, U01AI067854, R01AI084830, R37AI095098, U19AI067854, UM1AI068618, R01AI098485, ZIAAI005015, R01AI095098, ZIAAI005073, R01AI046283, UM1AI068614, R37AI054165, N01AI002642] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery; U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Henry M. Jackson Foundation for the Advancement of Military Medicine; Department of Defense(United States Department of Defense); HIV Vaccine Trials Network Laboratory; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in part by grants from the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (to Drs. Haynes, Koup, and Montefiori); an interagency agreement between the U.S. Army Medical Research and Materiel Command and the NIAID (Y1-AI-2642-12); a cooperative agreement between the Henry M. Jackson Foundation for the Advancement of Military Medicine and the Department of Defense (W81XWH-07-2-0067); and grants from the NIAID to the Center for HIV/AIDS Vaccine Immunology (U01-AI-067854) and the HIV Vaccine Trials Network Laboratory Program (UM1-AI-068618).	Barnett SW, 2010, J VIROL, V84, P5975, DOI 10.1128/JVI.02533-09; Barnetta SW, 2008, AIDS, V22, P339, DOI 10.1097/QAD.0b013e3282f3ca57; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Borgan O, 2000, LIFETIME DATA ANAL, V6, P39, DOI 10.1023/A:1009661900674; Breslow NE, 1997, J ROY STAT SOC B MET, V59, P447, DOI 10.1111/1467-9868.00078; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Changela A, 2011, J VIROL, V85, P2524, DOI 10.1128/JVI.02335-10; Cole KS, 1997, J VIROL, V71, P5069, DOI 10.1128/JVI.71.7.5069-5079.1997; Edlefsen P, 2011, AIDS VACC 2011 BANGK; Ferrari G, 2011, J VIROL, V85, P7029, DOI 10.1128/JVI.00171-11; Forthal DN, 2007, J IMMUNOL, V178, P6596, DOI 10.4049/jimmunol.178.10.6596; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Gilbert PB, 2011, INT J BIOSTAT, V7, DOI 10.2202/1557-4679.1341; Gorny MK, 2005, J VIROL, V79, P5232, DOI 10.1128/JVI.79.8.5232-5237.2005; GRIFFISS JM, 1983, J IMMUNOL, V130, P2882; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; JARVIS GA, 1991, J IMMUNOL, V147, P1962; Karnasuta C, 2005, VACCINE, V23, P2522, DOI 10.1016/j.vaccine.2004.10.028; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Letvin NL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002351; Mascola JR, 2003, CURR MOL MED, V3, P209, DOI 10.2174/1566524033479799; MATHEW GD, 1981, INT J CANCER, V27, P175, DOI 10.1002/ijc.2910270208; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mestecky J, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P153, DOI 10.1016/B978-012491543-5/50013-9; Nawaz F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001301; Nitayaphan S, 2004, J INFECT DIS, V190, P702, DOI 10.1086/422258; Onyango-Makumbi C, 2011, JAIDS-J ACQ IMM DEF, V58, P399, DOI 10.1097/QAI.0b013e31822f8914; Picker LJ, 2012, ANNU REV MED, V63, P95, DOI 10.1146/annurev-med-042010-085643; Pinter A, 1998, VACCINE, V16, P1803, DOI 10.1016/S0264-410X(98)00182-0; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Qin L, 2007, J INFECT DIS, V196, P1304, DOI 10.1086/522428; Quan CP, 1998, EUR J IMMUNOL, V28, P4001, DOI 10.1002/(SICI)1521-4141(199812)28:12<4001::AID-IMMU4001>3.3.CO;2-T; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2011, AIDS RES HUM RE 0927; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Walker BD, 2007, TOP HIV MED, V15, P134; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Zolla-Pazner S, 2011, AIDS RES HUM RETROV, V27, pA21	40	1400	1450	4	158	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 5	2012	366	14					1275	1286		10.1056/NEJMoa1113425	http://dx.doi.org/10.1056/NEJMoa1113425			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919QJ	22475592	Green Accepted			2022-12-28	WOS:000302343000005
J	Evans, R				Evans, Ronald			Wylie Walker Vale Jr (1941-2012)	NATURE			English	Biographical-Item									[Evans, Ronald] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Evans, Ronald] Salk Inst Biol Studies, March Dimes Chair Mol & Dev Biol, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute	Evans, R (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.	evans@salk.edu	Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965					0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2012	483	7391					542	542		10.1038/483542a	http://dx.doi.org/10.1038/483542a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915EF	22460892	Bronze			2022-12-28	WOS:000302006100024
J	Seeliger, JC				Seeliger, Jessica C.			Scientists must be taught to manage	NATURE			English	Editorial Material									SUNY Stony Brook, Sch Med, New York, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Seeliger, JC (corresponding author), SUNY Stony Brook, Sch Med, New York, NY 11794 USA.	jcs@pharm.stonybrook.edu	Seeliger, Jessica/J-3344-2014	Seeliger, Jessica/0000-0001-7148-1073					0	10	11	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2012	483	7391					511	511		10.1038/483511a	http://dx.doi.org/10.1038/483511a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	915EF	22460862	Bronze			2022-12-28	WOS:000302006100004
J	Zaks, B; Liu, RB; Sherwin, MS				Zaks, B.; Liu, R. B.; Sherwin, M. S.			Experimental observation of electron-hole recollisions	NATURE			English	Article							SIDE-BAND GENERATION; HIGH-HARMONIC-GENERATION; RADIATION; FIELD	An intense laser field can remove an electron from an atom or molecule and pull the electron into a large-amplitude oscillation in which it repeatedly collides with the charged core it left behind(1-4). Such recollisions result in the emission of very energetic photons by means of high-order-harmonic generation, which has been observed in atomic and molecular gases(5-7) as well as in a bulk crystal(8). An exciton is an atom-like excitation of a solid in which an electron that is excited from the valence band is bound by the Coulomb interaction to the hole it left behind(9,10). It has been predicted that recollisions between electrons and holes in excitons will result in a new phenomenon: high-order-sideband generation(11,12). In this process, excitons are created by a weak near-infrared laser of frequency f(NIR). An intense laser field at a much lower frequency, f(THz), then removes the electron from the exciton and causes it to recollide with the resulting hole. New emission is predicted to occur as sidebands of frequency f(NIR) + 12nf(THz), wheren is an integer that can be much greater than one. Here we report the observation of high-order-sideband generation in semiconductor quantum wells. Sidebands are observed up to eighteenth order (+18f(THz), or n 59). The intensity of the high-order sidebands decays only weakly with increasing sideband order, confirming the non-perturbative nature of the effect. Sidebands are strongest for linearly polarized terahertz radiation and vanish when the terahertz radiation is circularly polarized. Beyond their fundamental scientific significance, our results suggest a new mechanism for the ultrafast modulation of light, which has potential applications in terabit-rate optical communications.	[Zaks, B.; Sherwin, M. S.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Zaks, B.; Sherwin, M. S.] Univ Calif Santa Barbara, Inst Terahertz Sci & Technol, Santa Barbara, CA 93106 USA; [Liu, R. B.] Chinese Univ Hong Kong, Dept Phys, Shatin, Hong Kong, Peoples R China; [Liu, R. B.] Chinese Univ Hong Kong, Ctr Opt Sci, Shatin, Hong Kong, Peoples R China	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Chinese University of Hong Kong; Chinese University of Hong Kong	Sherwin, MS (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	sherwin@physics.ucsb.edu	Liu, Ren-Bao/B-3729-2011; Liu, Ren-Bao/AAZ-8261-2021; Sherwin, Mark S/Q-4762-2017	Liu, Ren-Bao/0000-0002-0620-2370; Sherwin, Mark S/0000-0002-3869-1893	NSF [DMR-1006603]; Hong Kong RGC/GRF [401011]	NSF(National Science Foundation (NSF)); Hong Kong RGC/GRF(Hong Kong Research Grants Council)	Samples are from the wafers grown at UCSB by C. Wang in the group of L. C. Coldren (15-nm quantum well) and by T. Truong in the group of P. M. Petroff (18- and 22-nm quantum wells; see Supplementary Information) for experiments described in refs 19 and 23, respectively. We would like to thank D. Enyeart for his help in running the UCSB FELs and N. H. Kwong for running simulations helpful to our understanding of these effects. This work was supported by NSF grant DMR-1006603 and Hong Kong RGC/GRF 401011.	Carter SG, 2005, SCIENCE, V310, P651, DOI 10.1126/science.1116195; Cerne J, 1997, APPL PHYS LETT, V70, P3543, DOI 10.1063/1.119227; Corkum PB, 2007, NAT PHYS, V3, P381, DOI 10.1038/nphys620; Corkum PB, 2011, PHYS TODAY, V64, P36, DOI 10.1063/1.3563818; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Danielson JR, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.237401; DINGLE R, 1974, PHYS REV LETT, V33, P827, DOI 10.1103/PhysRevLett.33.827; Eisele H, 2010, ELECTRON LETT, V46, pS8, DOI 10.1049/el.2010.3319; FERRAY M, 1988, J PHYS B-AT MOL OPT, V21, pL31, DOI 10.1088/0953-4075/21/3/001; Ghimire S, 2011, NAT PHYS, V7, P138, DOI 10.1038/NPHYS1847; Haessler S, 2010, NAT PHYS, V6, P200, DOI 10.1038/NPHYS1511; Itatani J, 2004, NATURE, V432, P867, DOI 10.1038/nature03183; KELDYSH LV, 1965, SOV PHYS JETP-USSR, V20, P1307; Kono J, 1997, PHYS REV LETT, V79, P1758, DOI 10.1103/PhysRevLett.79.1758; KRAUSE JL, 1992, PHYS REV LETT, V68, P3535, DOI 10.1103/PhysRevLett.68.3535; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; Leinss S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.246401; LEWENSTEIN M, 1994, PHYS REV A, V49, P2117, DOI 10.1103/PhysRevA.49.2117; LIANG Y, 1994, J PHYS B-AT MOL OPT, V27, P5119, DOI 10.1088/0953-4075/27/20/024; Liu RB, 2007, AIP CONF PROC, V893, P1455, DOI 10.1063/1.2730455; Nordstrom KB, 1998, PHYS REV LETT, V81, P457, DOI 10.1103/PhysRevLett.81.457; Nordstrom KB, 1997, PHYS STATUS SOLIDI B, V204, P52, DOI 10.1002/1521-3951(199711)204:1<52::AID-PSSB52>3.0.CO;2-N; Uiberacker M, 2007, NATURE, V446, P627, DOI 10.1038/nature05648; Vozzi C, 2011, NAT PHYS, V7, P822, DOI 10.1038/nphys2029; Wagner M, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3155189; Wagner M, 2011, PHYS STATUS SOLIDI B, V248, P859, DOI 10.1002/pssb.201000832; Wagner M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.167401; Wannier GH, 1937, PHYS REV, V52, P0191, DOI 10.1103/PhysRev.52.191; Yan JY, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.075204; Zaks B, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/8/083009	30	212	217	4	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2012	483	7391					580	583		10.1038/nature10864	http://dx.doi.org/10.1038/nature10864			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915EF	22460904				2022-12-28	WOS:000302006100035
J	McCartney, M				McCartney, Margaret			What companies don't tell you about screening	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Care Quality Commission, ION RAD REG GUID; Committee on Medical Aspects of Radiation, 2007, 12 COMM MED ASP RAD; iHealth, IND PACK; Secretary of State for Health, ION RAD MED EXP AM R	5	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAR 28	2012	344								e2311	10.1136/bmj.e2311	http://dx.doi.org/10.1136/bmj.e2311			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923FF	22457450				2022-12-28	WOS:000302604100013
J	Moynihan, R				Moynihan, Ray			Times like these you need some "One Four Five"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Newcastle, Callaghan, NSW 2308, Australia	University of Newcastle	Moynihan, R (corresponding author), Univ Newcastle, Callaghan, NSW 2308, Australia.	Ray.Moynihan@newcastle.edu.au	Moynihan, Ray/ABC-3010-2020					Bradt J, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006911.pub2, 10.1002/14651858.CD006911]; Gold C, 2009, CLIN PSYCHOL REV, V29, P193, DOI 10.1016/j.cpr.2009.01.001; Music In Hospitals, 2011, AB MUS HOSP; Procter S, 2011, NORD J MUSIC THER, V20, P242, DOI 10.1080/08098131.2010.489998	4	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2012	344								e2342	10.1136/bmj.e2342	http://dx.doi.org/10.1136/bmj.e2342			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	923FF	22457444				2022-12-28	WOS:000302604100006
J	O'Roak, BJ; Vives, L; Girirajan, S; Karakoc, E; Krumm, N; Coe, BP; Levy, R; Ko, A; Lee, C; Smith, JD; Turner, EH; Stanaway, IB; Vernot, B; Malig, M; Baker, C; Reilly, B; Akey, JM; Borenstein, E; Rieder, MJ; Nickerson, DA; Bernier, R; Shendure, J; Eichler, EE				O'Roak, Brian J.; Vives, Laura; Girirajan, Santhosh; Karakoc, Emre; Krumm, Niklas; Coe, Bradley P.; Levy, Roie; Ko, Arthur; Lee, Choli; Smith, Joshua D.; Turner, Emily H.; Stanaway, Ian B.; Vernot, Benjamin; Malig, Maika; Baker, Carl; Reilly, Beau; Akey, Joshua M.; Borenstein, Elhanan; Rieder, Mark J.; Nickerson, Deborah A.; Bernier, Raphael; Shendure, Jay; Eichler, Evan E.			Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations	NATURE			English	Article							GENOME-WIDE ASSOCIATION; COPY-NUMBER VARIATION; SPECTRUM; CHD8; INTEGRATION; STRATEGIES; REGION; GENES; NIMH; CNVS	It is well established that autism spectrum disorders (ASD) have a strong genetic component; however, for at least 70% of cases, the underlying genetic cause is unknown(1). Under the hypothesis that de novo mutations underlie a substantial fraction of the risk for developing ASD in families with no previous history of ASD or related phenotypes-so-called sporadic or simplex families(2,3)-we sequenced all coding regions of the genome (the exome) for parent-child trios exhibiting sporadic ASD, including 189 new trios and 20 that were previously reported(4). Additionally, we also sequenced the exomes of 50 unaffected siblings corresponding to these new (n = 531) and previously reported trios (n = 19)(4), for a total of 677 individual exomes from 209 families. Here we show that de novo point mutations are overwhelmingly paternal in origin (4:1 bias) and positively correlated with paternal age, consistent with the modest increased risk for children of older fathers to develop ASD(5). Moreover, 39% (49 of 126) of the most severe or disruptive de novo mutations map to a highly interconnected beta-catenin/chromatin remodelling protein network ranked significantly for autism candidate genes. In proband exomes, recurrent protein-altering mutations were observed in two genes: CHD8 and NTNG1. Mutation screening of six candidate genes in 1,703 ASD probands identified additional de novo, protein-altering mutations in GRIN2B, LAMC3 and SCN1A. Combined with copy number variant (CNV) data, these results indicate extreme locus heterogeneity but also provide a target for future discovery, diagnostics and therapeutics.	[O'Roak, Brian J.; Vives, Laura; Girirajan, Santhosh; Karakoc, Emre; Krumm, Niklas; Coe, Bradley P.; Levy, Roie; Ko, Arthur; Lee, Choli; Smith, Joshua D.; Turner, Emily H.; Stanaway, Ian B.; Vernot, Benjamin; Malig, Maika; Baker, Carl; Akey, Joshua M.; Borenstein, Elhanan; Rieder, Mark J.; Nickerson, Deborah A.; Shendure, Jay; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Reilly, Beau; Bernier, Raphael] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Borenstein, Elhanan] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Borenstein, Elhanan] Santa Fe Inst, Santa Fe, NM 87501 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; The Santa Fe Institute; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	shendure@uw.edu; eee@gs.washington.edu	Vernot, Benjamin/ABH-1495-2021; Shendure, Jay/AAU-3684-2021; Coe, Bradley/A-2878-2009	Vernot, Benjamin/0000-0002-6820-2181; Shendure, Jay/0000-0002-1516-1865; O'Roak, Brian/0000-0002-4141-0095; Coe, Bradley/0000-0001-8471-4016; Turner, Emily/0000-0001-9040-9229; Akey, Joshua/0000-0002-4411-1330	Simons Foundation Autism Research Initiative (SFARI) [137578, 191889]; NIH [HD065285]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD065285] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UC2HL102924, RC2HL102923, RC2HL102926, UC2HL102926, R01HL094976, RC2HL102924] Funding Source: NIH RePORTER	Simons Foundation Autism Research Initiative (SFARI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to thank and recognize the following ongoing studies that produced and provided exome variant calls for comparison: NHLBI Lung Cohort Sequencing Project (HL 1029230), NHLBI WHI Sequencing Project (HL 102924), NIEHS SNPs (HHSN273200800010C), NHLBI/NHGRI SeattleSeq (HL 094976), and the Northwest Genomics Center (HL102926). We are grateful to all of the families at the participating Simons Simplex Collection (SSC) sites, as well as the principal investigators (A. Beaudet, R. Bernier, J. Constantino, E. Cook, E. Fombonne, D. Geschwind, E. Hanson, D. Grice, A. Klin, R. Kochel, D. Ledbetter, C. Lord, C. Martin, D. Martin, R. Maxim, J. Miles, O. Ousley, K. Pelphrey, B. Peterson, J. Piggot, C. Saulnier, M. State, W. Stone, J. Sutcliffe, C. Walsh, Z. Warren and E. Wijsman). We also acknowledge M. State and the Simons Simplex Collection Genetics Consortium for providing Illumina genotyping data, T. Lehner and the Autism Sequencing Consortium for providing an opportunity for pre-publication data exchange among the participating groups. We appreciate obtaining access to phenotypic data on SFARI Base. This work was supported by the Simons Foundation Autism Research Initiative (SFARI 137578 and 191889; E.E.E., J.S. and R.B.) and NIH HD065285 (E.E.E. and J.S.). E.B. is an Alfred P. Sloan Research Fellow. E.E.E. is an Investigator of the Howard Hughes Medical Institute.	Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Batsukh T, 2010, HUM MOL GENET, V19, P2858, DOI 10.1093/hmg/ddq189; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Bedogni F, 2010, P NATL ACAD SCI USA, V107, P13129, DOI 10.1073/pnas.1002285107; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Borg I, 2005, EUR J HUM GENET, V13, P921, DOI 10.1038/sj.ejhg.5201429; BUNGE J, 1993, J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; Buysse K, 2008, AM J MED GENET A, V146A, P1330, DOI 10.1002/ajmg.a.32267; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; De Ferrari GV, 2006, ONCOGENE, V25, P7545, DOI 10.1038/sj.onc.1210064; DePristo MA, 2011, NAT GENET, V43; Erten S, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-19; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Hach F, 2010, NAT METHODS, V7, P576, DOI 10.1038/nmeth0810-576; Hehir-Kwa JY, 2011, J MED GENET, V48, P776, DOI 10.1136/jmedgenet-2011-100147; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Hultman CM, 2011, MOL PSYCHIATR, V16, P1203, DOI 10.1038/mp.2010.121; Ille F, 2005, CELL MOL LIFE SCI, V62, P1100, DOI 10.1007/s00018-005-4552-2; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Moldin SO, 2003, AM J PSYCHIAT, V160, P621, DOI 10.1176/appi.ajp.160.4.621; Moller RS, 2008, AM J HUM GENET, V82, P1165, DOI 10.1016/j.ajhg.2008.03.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nishimura-Akiyoshi S, 2007, P NATL ACAD SCI USA, V104, P14801, DOI 10.1073/pnas.0706919104; Nishiyama M, 2009, NAT CELL BIOL, V11, P172, DOI 10.1038/ncb1831; O'Roak BJ, 2008, AUTISM RES, V1, P4, DOI 10.1002/aur.3; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Sakai Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002166; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Schaaf CP, 2011, NEURON, V70, P806, DOI 10.1016/j.neuron.2011.05.025; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Talati A, 2008, MOL PSYCHIATR, V13, P122, DOI 10.1038/sj.mp.4002114; Tedeschi A, 2009, EMBO REP, V10, P576, DOI 10.1038/embor.2009.89; Thompson BA, 2008, MOL CELL BIOL, V28, P3894, DOI 10.1128/MCB.00322-08; Turner EH, 2009, NAT METHODS, V6, P315, DOI 10.1038/nmeth.f.248; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902	46	1470	1512	5	261	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2012	485	7397					246	U136		10.1038/nature10989	http://dx.doi.org/10.1038/nature10989			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22495309	Green Accepted, Green Published			2022-12-28	WOS:000303799800043
J	Marinari, E; Mehonic, A; Curran, S; Gale, J; Duke, T; Baum, B				Marinari, Eliana; Mehonic, Aida; Curran, Scott; Gale, Jonathan; Duke, Thomas; Baum, Buzz			Live-cell delamination counterbalances epithelial growth to limit tissue overcrowding	NATURE			English	Article							DROSOPHILA; MORPHOGENESIS; MECHANISM	The development and maintenance of an epithelium requires finely balanced rates of growth and cell death. However, the mechanical and biochemical mechanisms that ensure proper feedback control of tissue growth(1-4), which when deregulated contribute to tumorigenesis, are poorly understood. Here we use the fly notum as a model system(5) to identify a novel process of crowding-induced cell delamination that balances growth to ensure the development of well-ordered cell packing. In crowded regions of the tissue, a proportion of cells undergo a serial loss of cell-cell junctions and a progressive loss of apical area, before being squeezed out by their neighbours. This path of delamination is recapitulated by a simple computational model of epithelial mechanics, in which stochastic cell loss relieves overcrowding as the system tends towards equilibrium. We show that this process of delamination is mechanistically distinct from apoptosis-mediated cell extrusion(6-8) and precedes the first signs of cell death. Overall, this analysis reveals a simple mechanism that buffers epithelia against variations in growth. Because live-cell delamination constitutes a mechanistic link between epithelial hyperplasia and cell invasion, this is likely to have important implications for our understanding of the early stages of cancer development.	[Marinari, Eliana; Curran, Scott; Baum, Buzz] UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; [Mehonic, Aida; Duke, Thomas] UCL, London Ctr Nanotechnol, London WC1E 6BT, England; [Mehonic, Aida; Duke, Thomas] UCL, Dept Phys & Astron, London WC1E 6BT, England; [Gale, Jonathan] UCL, UCL Ear Inst, London WC1X 8EE, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Baum, B (corresponding author), UCL, MRC, Mol Cell Biol Lab, Gower St, London WC1E 6BT, England.	b.baum@ucl.ac.uk	Gale, Jonathan/AAG-6874-2019	Baum, Buzz/0000-0002-9201-6186; Gale, Jonathan/0000-0003-4678-4878; Curran, Scott/0000-0002-7996-8764	Cancer Research UK; University College London, Wellcome and the Royal Society; Medical Research Council [MC_CF12266] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); University College London, Wellcome and the Royal Society; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Rosenblatt for communicating results before publication; N. Tapon, F. Pichaud, G. Charras and J. Rohn for helpful comments on the text; and the members of the Baum laboratory, in particular K. Van Hegan, J. Bellis and J. Beira. B. B. and E. M. thank Cancer Research UK for funding. B. B. also thanks University College London, Wellcome and the Royal Society for financial support.	Aegerter-Wilmsen T, 2010, DEVELOPMENT, V137, P499, DOI 10.1242/dev.041731; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Cohen M, 2010, DEV CELL, V19, P78, DOI 10.1016/j.devcel.2010.06.006; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Emoto Y, 2008, J PHYSIOL SCI, V58, P371, DOI 10.2170/physiolsci.RP011108; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; FRISTROM D, 1988, TISSUE CELL, V20, P645, DOI 10.1016/0040-8166(88)90015-8; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Kafer J, 2007, P NATL ACAD SCI USA, V104, P18549, DOI 10.1073/pnas.0704235104; Koto A, 2011, CURR BIOL, V21, P278, DOI 10.1016/j.cub.2011.01.015; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Manjon C, 2007, NAT CELL BIOL, V9, P57, DOI 10.1038/ncb1518; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Oda H, 2001, J CELL SCI, V114, P493; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Toyama Y, 2008, SCIENCE, V321, P1683, DOI 10.1126/science.1157052; Zeitlinger J, 1999, DEVELOPMENT, V126, P3947	19	283	285	3	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					542	U177		10.1038/nature10984	http://dx.doi.org/10.1038/nature10984			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22504180				2022-12-28	WOS:000303200400057
J	Zielinski, CE; Mele, F; Aschenbrenner, D; Jarrossay, D; Ronchi, F; Gattorno, M; Monticelli, S; Lanzavecchia, A; Sallusto, F				Zielinski, Christina E.; Mele, Federico; Aschenbrenner, Dominik; Jarrossay, David; Ronchi, Francesca; Gattorno, Marco; Monticelli, Silvia; Lanzavecchia, Antonio; Sallusto, Federica			Pathogen-induced human T(H)17 cells produce IFN-gamma or IL-10 and are regulated by IL-1 beta	NATURE			English	Article							GROWTH-FACTOR-BETA; HYPER-IGE SYNDROME; CD4(+) T-CELLS; TH17 CELLS; TGF-BETA; HELPER-CELLS; DIFFERENTIATION; MEMORY; INTERLEUKIN-1-BETA; PROSTAGLANDIN-E2	IL-17-producing CD4(+) T helper cells (T(H)17) have been extensively investigated in mouse models of autoimmunity(1). However, the requirements for differentiation and the properties of pathogen-induced human T(H)17 cells remain poorly defined. Using an approach that combines the in vitro priming of naive T cells with the ex vivo analysis of memory T cells, we describe here two types of human T(H)17 cells with distinct effector function and differentiation requirements. Candida albicans-specific T(H)17 cells produced IL-17 and IFN-gamma, but no IL-10, whereas Staphylococcus aureus-specific T(H)17 cells produced IL-17 and could produce IL-10 upon restimulation. IL-6, IL-23 and IL-1 beta contributed to T(H)17 differentiation induced by both pathogens, but IL-1 beta was essential in C. albicans-induced T(H)17 differentiation to counteract the inhibitory activity of IL-12 and to prime IL-17/IFN-gamma double-producing cells. In addition, IL-1 beta inhibited IL-10 production in differentiating and in memory T(H)17 cells, whereas blockade of IL-1 beta in vivo led to increased IL-10 production by memory T(H)17 cells. We also show that, after restimulation, T(H)17 cells transiently downregulated IL-17 production through a mechanism that involved IL-2-induced activation of STAT5 and decreased expression of ROR-gamma t. Taken together these findings demonstrate that by eliciting different cytokines C. albicans and S. aureus prime T(H)17 cells that produce either IFN-gamma or IL-10, and identify IL-1 beta and IL-2 as pro-and anti-inflammatory regulators of T(H)17 cells both at priming and in the effector phase.	[Zielinski, Christina E.; Mele, Federico; Aschenbrenner, Dominik; Jarrossay, David; Ronchi, Francesca; Monticelli, Silvia; Lanzavecchia, Antonio; Sallusto, Federica] Inst Res Biomed, CH-6500 Bellinzona, Switzerland; [Gattorno, Marco] G Gaslini Sci Inst, I-16147 Genoa, Italy; [Lanzavecchia, Antonio] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland	Universita della Svizzera Italiana; University of Genoa; IRCCS Istituto Giannina Gaslini; Swiss Federal Institutes of Technology Domain; ETH Zurich	Sallusto, F (corresponding author), Inst Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.	christina.zielinski@charite.de; federica.sallusto@irb.usi.ch	Zielinski, Christina/Y-3362-2019; Gattorno, Marco/AAL-2974-2020; Monticelli, Silvia/ABE-7054-2020	Gattorno, Marco/0000-0003-0704-1916; Monticelli, Silvia/0000-0002-5909-8802; Aschenbrenner, Dominik/0000-0001-7580-2567; Zielinski, Christina/0000-0002-8184-0858; Ronchi, Francesca/0000-0002-2035-6528	German Research Foundation (DFG) [Zi 1262/1-1]; Swiss National Science Foundation [131092, 126027]; Institute of Arthritis Research (IAR); Helmut Horten Foundation	German Research Foundation (DFG)(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Institute of Arthritis Research (IAR); Helmut Horten Foundation	We thank O. Petrini and C. Fragoso for providing microorganisms, and M. Levings for providing the RORC lentiviral vector. We thank A. Rossetti for technical assistance, D. Baumjohann for artwork and S. Jacob and M. Uguccioni for critical reading of the manuscript. This work was supported by a fellowship of the German Research Foundation (DFG) to C.E.Z (Zi 1262/1-1) and by grants from the Swiss National Science Foundation (N. 131092 to F. S. and 126027 to A. L.) and the Institute of Arthritis Research (IAR). A. L. is supported by the Helmut Horten Foundation.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Crome SQ, 2009, EUR J IMMUNOL, V39, P1480, DOI 10.1002/eji.200838908; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; Geiger R, 2009, J EXP MED, V206, P1525, DOI 10.1084/jem.20090504; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Hoyer KK, 2008, IMMUNOL REV, V226, P19, DOI 10.1111/j.1600-065X.2008.00697.x; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mayoral RJ, 2010, METHODS MOL BIOL, V667, P205, DOI 10.1007/978-1-60761-811-9_14; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Napolitani G, 2009, EUR J IMMUNOL, V39, P1301, DOI 10.1002/eji.200838969; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Smeekens SP, 2010, INT IMMUNOL, V22, P889, DOI 10.1093/intimm/dxq442; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995	30	654	676	2	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					514	U139		10.1038/nature10957	http://dx.doi.org/10.1038/nature10957			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22466287				2022-12-28	WOS:000303200400051
J	Nagornova, NS; Rizzo, TR; Boyarkin, OV				Nagornova, Natalia S.; Rizzo, Thomas R.; Boyarkin, Oleg V.			Interplay of Intra- and Intermolecular H-Bonding in a Progressively Solvated Macrocyclic Peptide	SCIENCE			English	Article							DIP INFRARED-SPECTROSCOPY; AROMATIC-AMINO-ACIDS; PHASE GRAMICIDIN-S; GAS-PHASE; VIBRATIONAL SPECTROSCOPY; PROTONATED TRYPTOPHAN; WATER CLUSTERS; HYDRATION; TYROSINE; COLD	Studying solvation of a large molecule on an atomic level is challenging because of the transient character and inhomogeneity of hydrogen bonding in liquid water. We studied water clusters of a protonated macrocyclic decapeptide, gramicidin S, which were prepared in the gas phase and then cooled to cryogenic temperatures. The experiment spectroscopically tracked fine structural changes of the clusters upon increasing the number of attached water molecules from 1 to 50 and distinguished vibrational fingerprints of different conformers. The data indicate that only the first two water molecules induce a substantial change of the gramicidin S structure by breaking two intramolecular noncovalent bonds. The peptide structure remains largely intact upon further solvation, reflecting the interplay between the strong intramolecular and weaker intermolecular hydrogen bonds.	[Nagornova, Natalia S.; Rizzo, Thomas R.; Boyarkin, Oleg V.] Ecole Polytech Fed Lausanne EPFL, Lab Chim Phys Mol, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Boyarkin, OV (corresponding author), Ecole Polytech Fed Lausanne EPFL, Lab Chim Phys Mol, CH-1015 Lausanne, Switzerland.	oleg.boiarkin@epfl.ch	Boyarkin, Oleg V/K-3458-2017; Rizzo, Thomas R/D-1554-2011	Rizzo, Thomas R/0000-0003-2796-905X	EPFL; Swiss National Science Foundation (FNS) [200020-130579]; Science and Technology Swiss-Russian cooperation program	EPFL; Swiss National Science Foundation (FNS)(Swiss National Science Foundation (SNSF)); Science and Technology Swiss-Russian cooperation program	We thank EPFL, Swiss National Science Foundation (FNS) (grant no. 200020-130579), and Science and Technology Swiss-Russian cooperation program for their generous support of this work; O.V.B. thanks T. Zwier and A. Vilesov for useful discussions.	Biswal HS, 2011, J AM CHEM SOC, V133, P3931, DOI 10.1021/ja108643p; Boyarkin OV, 2006, J AM CHEM SOC, V128, P2816, DOI 10.1021/ja058383u; Carcabal P, 2004, PHYS CHEM CHEM PHYS, V6, P4546, DOI 10.1039/b411757c; Ebata T, 2006, PHYS CHEM CHEM PHYS, V8, P4783, DOI 10.1039/b609229b; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; Gao B, 2009, J AM CHEM SOC, V131, P4695, DOI 10.1021/ja8085017; Gruenloh CJ, 1998, J CHEM PHYS, V109, P6601, DOI 10.1063/1.477346; Gruenloh CJ, 1997, SCIENCE, V276, P1678, DOI 10.1126/science.276.5319.1678; Hamashima T, 2011, J PHYS CHEM A, V115, P620, DOI 10.1021/jp111586p; Headrick JM, 2005, SCIENCE, V308, P1765, DOI 10.1126/science.1113094; Kamariotis A, 2006, J AM CHEM SOC, V128, P905, DOI 10.1021/ja056079v; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Liu DF, 2003, J AM CHEM SOC, V125, P8458, DOI 10.1021/ja034638x; Llamas-Saiz AL, 2007, ACTA CRYSTALLOGR D, V63, P401, DOI 10.1107/S0907444906056435; Manas ES, 2000, J AM CHEM SOC, V122, P9883, DOI 10.1021/ja001782z; Mercier SR, 2006, J AM CHEM SOC, V128, P16938, DOI 10.1021/ja065980n; Miyazaki M, 2004, SCIENCE, V304, P1134, DOI 10.1126/science.1096037; Nagornova NS, 2011, ANGEW CHEM INT EDIT, V50, P5383, DOI 10.1002/anie.201100702; Nagornova NS, 2010, J AM CHEM SOC, V132, P4040, DOI 10.1021/ja910118j; PAGE RH, 1988, J CHEM PHYS, V88, P5362, DOI 10.1063/1.454574; Polfer NC, 2009, MASS SPECTROM REV, V28, P468, DOI 10.1002/mas.20215; Prell JS, 2010, J AM CHEM SOC, V132, P7811, DOI 10.1021/ja102765w; Prenner EJ, 1999, BBA-BIOMEMBRANES, V1462, P201, DOI 10.1016/S0005-2736(99)00207-2; Robertson EG, 2001, PHYS CHEM CHEM PHYS, V3, P1, DOI 10.1039/b008225m; RodriguezCruz SE, 1997, J AM SOC MASS SPECTR, V8, P565, DOI 10.1016/S1044-0305(97)00020-2; Schwing K, 2011, CHEMPHYSCHEM, V12, P1981, DOI 10.1002/cphc.201001055; Shin JW, 2004, SCIENCE, V304, P1137, DOI 10.1126/science.1096466; Snoek LC, 2002, PHYS CHEM CHEM PHYS, V4, P2130, DOI 10.1039/b200059h; Stearns JA, 2007, J AM CHEM SOC, V129, P11814, DOI 10.1021/ja0736010; XU Y, 1995, J BIOMOL NMR, V5, P37, DOI 10.1007/BF00227468; YEH LI, 1989, J CHEM PHYS, V91, P7319, DOI 10.1063/1.457305; Zwier TS, 2001, J PHYS CHEM A, V105, P8827, DOI 10.1021/jp011659+	32	132	132	2	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2012	336	6079					320	323		10.1126/science.1218709	http://dx.doi.org/10.1126/science.1218709			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22517854				2022-12-28	WOS:000302995400038
J	Mullins, CD; Abdulhalim, AM; Lavallee, DC				Mullins, C. Daniel; Abdulhalim, Abdulla M.; Lavallee, Danielle C.			Continuous Patient Engagement in Comparative Effectiveness Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SCIENCE; HEALTH		[Mullins, C. Daniel; Abdulhalim, Abdulla M.] Univ Maryland, Sch Pharm, Pharmaceut Hlth Serv Res Dept, Baltimore, MD 21201 USA; [Lavallee, Danielle C.] Ctr Med Technol Policy, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore	Mullins, CD (corresponding author), Univ Maryland, Sch Pharm, Pharmaceut Hlth Serv Res Dept, 220 Arch St,12th Floor, Baltimore, MD 21201 USA.	dmullins@rx.umaryland.edu		Lavallee, Danielle/0000-0002-5555-9675; Mullins, C. Daniel/0000-0003-4322-2490				Bonham AC, 2010, HEALTH AFFAIR, V29, P1901, DOI 10.1377/hlthaff.2010.0790; Eysenbach G, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.2.e13; Hoffman A, 2010, HEALTH AFFAIR, V29, P1834, DOI 10.1377/hlthaff.2010.0675; Lauer MS, 2010, JAMA-J AM MED ASSOC, V303, P2182, DOI 10.1001/jama.2010.726; Lo B, 2011, JAMA-J AM MED ASSOC, V306, P2260, DOI 10.1001/jama.2011.1727; Mullins CD, 2010, HEALTH AFFAIR, V29, P2098, DOI 10.1377/hlthaff.2010.0612; Palos GR, 2011, CANCER-AM CANCER SOC, V117, P3592, DOI 10.1002/cncr.26263; Sullivan P, 2011, JAMA-J AM MED ASSOC, V305, P400, DOI 10.1001/jama.2011.12; Wells K, 2009, JAMA-J AM MED ASSOC, V302, P320, DOI 10.1001/jama.2009.1033	9	131	132	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2012	307	15					1587	1588		10.1001/jama.2012.442	http://dx.doi.org/10.1001/jama.2012.442			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	927GU	22511684				2022-12-28	WOS:000302896100018
J	Fisher, MC; Henk, DA; Briggs, CJ; Brownstein, JS; Madoff, LC; McCraw, SL; Gurr, SJ				Fisher, Matthew C.; Henk, Daniel. A.; Briggs, Cheryl J.; Brownstein, John S.; Madoff, Lawrence C.; McCraw, Sarah L.; Gurr, Sarah J.			Emerging fungal threats to animal, plant and ecosystem health	NATURE			English	Review							PATHOGEN BATRACHOCHYTRIUM-DENDROBATIDIS; SUDDEN OAK DEATH; AMPHIBIAN CHYTRIDIOMYCOSIS; GEOMYCES-DESTRUCTANS; CLIMATE-CHANGE; PHYTOPHTHORA-RAMORUM; POPULATION-STRUCTURE; CRYPTOCOCCUS-GATTII; INFECTIOUS-DISEASES; SP-NOV	The past two decades have seen an increasing number of virulent infectious diseases in natural populations and managed landscapes. In both animals and plants, an unprecedented number of fungal and fungal-like diseases have recently caused some of the most severe die-offs and extinctions ever witnessed in wild species, and are jeopardizing food security. Human activity is intensifying fungal disease dispersal by modifying natural environments and thus creating new opportunities for evolution. We argue that nascent fungal infections will cause increasing attrition of biodiversity, with wider implications for human and ecosystem health, unless steps are taken to tighten biosecurity worldwide.	[Fisher, Matthew C.; Henk, Daniel. A.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England; [Briggs, Cheryl J.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Brownstein, John S.] Harvard Univ, Sch Med, Dept Pediat, Childrens Hosp Boston, Boston, MA 02115 USA; [Madoff, Lawrence C.] Univ Massachusetts, Sch Med, ProMED, Int Soc Infect Dis, Worcester, MA 01655 USA; [Madoff, Lawrence C.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01655 USA; [McCraw, Sarah L.] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England	Imperial College London; University of California System; University of California Santa Barbara; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Oxford	Fisher, MC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England.	matthew.fisher@imperial.ac.uk; sarah.gurr@plants.ox.ac.uk	Fisher, Matthew/B-9094-2011; Briggs, Cheryl/F-7456-2013	Fisher, Matthew/0000-0002-1862-6402; 	Wellcome Trust; Natural Environment Research Council (NERC); European Research Area (ERA)-net project BiodivERsA; Leverhulme Trust; US National Science Foundation (NSF) [EF-0723563]; UK Biotechnology and Biological Sciences Research Council (BBSRC); University of Oxford; Magdalen College, University of Oxford; Google.org; National Institutes of Health [5R01LM010812-02]; Biotechnology and Biological Sciences Research Council [BB/J008923/1, BB/E00282X/1, BB/G00207X/1] Funding Source: researchfish; Natural Environment Research Council [NE/G001944/1] Funding Source: researchfish; NATIONAL LIBRARY OF MEDICINE [R01LM010812] Funding Source: NIH RePORTER; BBSRC [BB/E00282X/1, BB/G00207X/1, BB/J008923/1] Funding Source: UKRI; NERC [NE/G001944/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Area (ERA)-net project BiodivERsA; Leverhulme Trust(Leverhulme Trust); US National Science Foundation (NSF)(National Science Foundation (NSF)); UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Oxford; Magdalen College, University of Oxford; Google.org(Google Incorporated); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	M. C. F. was supported by grants from the Wellcome Trust, Natural Environment Research Council (NERC), and the European Research Area (ERA)-net project BiodivERsA. D. A. H. was supported by a grant from the Leverhulme Trust, C.J.B. was supported by the US National Science Foundation (NSF) Ecology of Infectious Disease grant EF-0723563. S.J.G. was supported by grants from the UK Biotechnology and Biological Sciences Research Council (BBSRC) and the John Fell Fund of the University of Oxford, and S. L. M. was supported by a graduate scholarship from Magdalen College, University of Oxford. J.S.B. was supported by Google.org and the National Institutes of Health grant 5R01LM010812-02. N. Knowlton and J. Heitman provided impetus to develop this review.	Altizer S, 2007, J ANIM ECOL, V76, P304, DOI 10.1111/j.1365-2656.2007.01214.x; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Andrew TG, 2008, VET REC, V163, P629, DOI 10.1136/vr.163.21.629; [Anonymous], 2011, FUNG DIS EM THREAT H; Becker CG, 2011, P NATL ACAD SCI USA, V108, P9893, DOI 10.1073/pnas.1014497108; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Bosch J, 2007, P ROY SOC B-BIOL SCI, V274, P253, DOI 10.1098/rspb.2006.3713; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Brasier CM, 2008, PLANT PATHOL, V57, P792, DOI 10.1111/j.1365-3059.2008.01886.x; Brasier CM, 1995, PLANT PATHOL, V44, P999, DOI 10.1111/j.1365-3059.1995.tb02658.x; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Byrnes EJ, 2009, J VET DIAGN INVEST, V21, P133, DOI 10.1177/104063870902100122; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; CHAKRABORTY S, 2008, PERSPECTIVES AGR VET, V3, P1; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Coleman J, 2011, NATL PLAN ASSISTING; Colon-Gaud C, 2009, LIMNOL OCEANOGR, V54, P331, DOI 10.4319/lo.2009.54.1.0331; Coyne J.A., 2004, SPECIATION; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Cunningham AA, 2005, VET REC, V157, P386, DOI 10.1136/vr.157.13.386; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; Ellison CE, 2011, P NATL ACAD SCI USA, V108, P2831, DOI 10.1073/pnas.1014971108; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Fisher MC, 2001, P NATL ACAD SCI USA, V98, P4558, DOI 10.1073/pnas.071406098; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Frohlich-Nowoisky J, 2009, P NATL ACAD SCI USA, V106, P12814, DOI 10.1073/pnas.0811003106; Gange AC, 2007, SCIENCE, V316, P71, DOI 10.1126/science.1137489; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Garner TWJ, 2011, GLOBAL CHANGE BIOL, V17, P667, DOI 10.1111/j.1365-2486.2010.02272.x; Giraud T, 2010, TRENDS ECOL EVOL, V25, P387, DOI 10.1016/j.tree.2010.03.006; Goka K, 2009, MOL ECOL, V18, P4757, DOI 10.1111/j.1365-294X.2009.04384.x; Gonthier P, 2004, MYCOL RES, V108, P468, DOI 10.1017/S0953756204240369; Gregory PJ, 2009, J EXP BOT, V60, P2827, DOI 10.1093/jxb/erp080; Grunwald NJ, 2008, MOL PLANT PATHOL, V9, P729, DOI [10.1111/j.1364-3703.2008.00500.x, 10.1111/J.1364-3703.2008.00500.X]; Hansen EM, 2005, PLANT DIS, V89, P63, DOI 10.1094/PD-89-0063; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Henk DA, 2011, MOL ECOL, V20, P4288, DOI 10.1111/j.1365-294X.2011.05244.x; Holdich DM, 2009, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2009025; Holt RD, 2003, ECOL LETT, V6, P837, DOI 10.1046/j.1461-0248.2003.00501.x; Inderbitzin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018260; JAENIKE J, 1978, Evolutionary Theory, V3, P191; Jessup D., 2004, ECOHEALTH, V1, P239, DOI [10.1007/s10393-004-0093-7.4, DOI 10.1007/S10393-004-0093-7]; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kim K, 2004, AM NAT, V164, pS52, DOI 10.1086/424609; Klaassen CHW, 2012, MOL ECOL, V21, P57, DOI 10.1111/j.1365-294X.2011.05364.x; Kobayashi T, 2006, PHYTOPATHOLOGY, V96, P425, DOI 10.1094/PHYTO-96-0425; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Lake JA, 2009, J EXP BOT, V60, P3123, DOI 10.1093/jxb/erp147; Lindner DL, 2011, MYCOLOGIA, V103, P241, DOI 10.3852/10-262; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Loo J, 2009, BIOL INVASIONS, V11, P81, DOI 10.1007/s10530-008-9321-3; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Lubick N, 2010, NATURE, V465, P680, DOI 10.1038/465680a; Madgwick JW, 2011, EUR J PLANT PATHOL, V130, P117, DOI 10.1007/s10658-010-9739-1; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mazzoni R, 2003, EMERG INFECT DIS, V9, P995; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; Milgroom MG, 1996, MYCOLOGIA, V88, P179, DOI 10.2307/3760921; Miraglia M, 2009, FOOD CHEM TOXICOL, V47, P1009, DOI 10.1016/j.fct.2009.02.005; Mitchell KM, 2008, P ROY SOC B-BIOL SCI, V275, P329, DOI 10.1098/rspb.2007.1356; Newton AC, 2011, EUPHYTICA, V179, P3, DOI 10.1007/s10681-011-0359-4; NOWAK MA, 1994, P ROY SOC B-BIOL SCI, V255, P81, DOI 10.1098/rspb.1994.0012; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Paterson S, 2010, NATURE, V464, P275, DOI 10.1038/nature08798; Pennisi E, 2010, SCIENCE, V327, P804, DOI 10.1126/science.327.5967.804; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Pringle A, 2005, EVOLUTION, V59, P1886, DOI 10.1111/j.0014-3820.2005.tb01059.x; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; Richards TA, 2011, P NATL ACAD SCI USA, V108, P15258, DOI 10.1073/pnas.1105100108; Rizzo DM, 2003, FRONT ECOL ENVIRON, V1, P197, DOI 10.1890/1540-9295(2003)001[0197:SODECA]2.0.CO;2; Rohr JR, 2008, P NATL ACAD SCI USA, V105, P17436, DOI 10.1073/pnas.0806368105; Rypien KL, 2008, MOL ECOL, V17, P4068, DOI 10.1111/j.1365-294X.2008.03894.x; Sarmiento-Ramirez JM, 2010, FEMS MICROBIOL LETT, V312, P192, DOI 10.1111/j.1574-6968.2010.02116.x; Seimon TA, 2007, GLOBAL CHANGE BIOL, V13, P288, DOI 10.1111/j.1365-2486.2006.01278.x; Simwami SP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001343; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; Springer DJ, 2010, EMERG INFECT DIS, V16, P14, DOI 10.3201/eid1601.090369; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Stokstad E, 2009, SCIENCE, V324, P710, DOI 10.1126/science.324_710a; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114; Turner E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002204; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Verweij PE, 2007, NEW ENGL J MED, V356, P1481, DOI 10.1056/NEJMc061720; Walker SF, 2008, CURR BIOL, V18, pR853, DOI 10.1016/j.cub.2008.07.033; Wibbelt G, 2010, EMERG INFECT DIS, V16, P1237, DOI 10.3201/eid1608.100002; WILLS RT, 1993, AUST J ECOL, V18, P145, DOI 10.1111/j.1442-9993.1993.tb00439.x	97	1818	1901	55	1378	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					186	194		10.1038/nature10947	http://dx.doi.org/10.1038/nature10947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22498624	Green Accepted			2022-12-28	WOS:000303149900025
J	Hirschtick, RE				Hirschtick, Robert E.			Subjective Case	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Hirschtick, RE (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.	rober@northwestern.edu						[Anonymous], 2000, MEMOIRS SHERLOCK HOL; [Anonymous], 2000, ADVENTURES SHERLOCK; Seger Bob, WIND; WEED LL, 1968, NEW ENGL J MED, V278, P593, DOI 10.1056/NEJM196803142781105	4	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2012	307	14					1495	1496		10.1001/jama.2012.424	http://dx.doi.org/10.1001/jama.2012.424			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922HN	22496263				2022-12-28	WOS:000302538100022
J	Nesbitt, AD; Goadsby, PJ				Nesbitt, Alexander D.; Goadsby, Peter J.			Cluster headache	BMJ-BRITISH MEDICAL JOURNAL			English	Review							OCCIPITAL NERVE-STIMULATION; DOUBLE-BLIND; PLACEBO; ATTACKS; PROPHYLAXIS; MANAGEMENT; MECHANISMS; VERAPAMIL; FEATURES		[Nesbitt, Alexander D.; Goadsby, Peter J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94115 USA; [Nesbitt, Alexander D.] Univ Surrey, Surrey Sleep Res Ctr, Guildford GU2 7XP, Surrey, England	University of California System; University of California San Francisco; University of Surrey	Goadsby, PJ (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94115 USA.	pgoadsby@headache.ucsf.edu	Goadsby, Peter J/Z-1970-2019	Goadsby, Peter J/0000-0003-3260-5904	Patrick Berthoud Charitable Trust; Allergan; American Headache Society; Colucid; MAP Pharma; Merck; eNeura; Autonomic technologies; Boston Scientific; Eli-Lilly; Medtronic; Linde gases; Mennarini; BristolMyersSquibb; Pfizer; GlaxoSmithKline; Amgen	Patrick Berthoud Charitable Trust; Allergan(AbbVieAllergan); American Headache Society; Colucid; MAP Pharma; Merck(Merck & Company); eNeura; Autonomic technologies; Boston Scientific(Boston Scientific); Eli-Lilly(Eli Lilly); Medtronic(Medtronic); Linde gases; Mennarini; BristolMyersSquibb(Bristol-Myers Squibb); Pfizer(Pfizer); GlaxoSmithKline(GlaxoSmithKline); Amgen(Amgen)	Both authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: ADN had financial support from the Patrick Berthoud Charitable Trust for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work. PJG has consulted for or lectured in sessions supported by Allergan, American Headache Society, Colucid, MAP Pharma, Merck, eNeura, Autonomic technologies, Boston Scientific, Eli-Lilly, Medtronic, Linde gases, Mennarini, BristolMyersSquibb, and Pfizer, and had grant support from GlaxoSmithKline, MAP Pharma, Merck, eNeura, and Amgen.	Akerman S, 2011, NAT REV NEUROSCI, V12, P570, DOI 10.1038/nrn3057; Bahra A, 2002, NEUROLOGY, V58, P354, DOI 10.1212/WNL.58.3.354; Bahra A, 2004, ACTA NEUROL SCAND, V109, P175, DOI 10.1046/j.1600-0404.2003.00237.x; BALLA JI, 1964, BMJ-BRIT MED J, V1, P219, DOI 10.1136/bmj.1.5377.219; Burns B, 2007, LANCET, V369, P1099, DOI 10.1016/S0140-6736(07)60328-6; Burns B, 2009, NEUROLOGY, V72, P341, DOI 10.1212/01.wnl.0000341279.17344.c9; Chervin RD, 2000, NEUROLOGY, V54, P2302, DOI 10.1212/WNL.54.12.2302; Cittadini E, 2008, BRAIN, V131, P1142, DOI 10.1093/brain/awn010; Cittadini E, 2006, ARCH NEUROL-CHICAGO, V63, P1537, DOI 10.1001/archneur.63.11.nct60002; Cohen AS, 2007, NEUROLOGY, V69, P668, DOI 10.1212/01.wnl.0000267319.18123.d3; Cohen AS, 2006, BRAIN, V129, P2746, DOI 10.1093/brain/awl202; Cohen AS, 2009, JAMA-J AM MED ASSOC, V302, P2451, DOI 10.1001/jama.2009.1855; Donnet A, 2007, J NEUROL NEUROSUR PS, V78, P1354, DOI 10.1136/jnnp.2006.112037; Drummond PD, 2006, CEPHALALGIA, V26, P633, DOI 10.1111/j.1468-2982.2006.01106.x; EKBOM K, 1968, ARCH NEUROL-CHICAGO, V19, P487, DOI 10.1001/archneur.1968.00480050057005; EKBOM K, 1991, NEW ENGL J MED, V325, P322, DOI 10.1056/nejm199108013250505; Evans RW, 2006, HEADACHE, V46, P173, DOI 10.1111/j.1526-4610.2006.00316_4.x; Fischera M, 2008, CEPHALALGIA, V28, P614, DOI 10.1111/j.1468-2982.2008.01592.x; Goadsby PJ, 2002, LANCET NEUROL, V1, P251, DOI 10.1016/S1474-4422(02)00104-7; Irimia P, 2008, CEPHALALGIA, V28, P626, DOI 10.1111/j.1468-2982.2008.01565.x; JAMMES JL, 1975, DIS NERV SYST, V36, P375; Lai TH, 2009, J NEUROL NEUROSUR PS, V80, P1116, DOI 10.1136/jnnp.2008.157743; Leone M, 1996, CEPHALALGIA, V16, P494, DOI 10.1046/j.1468-2982.1996.1607494.x; Leone M, 2000, NEUROLOGY, V54, P1382, DOI 10.1212/WNL.54.6.1382; Leone M, 2006, LANCET NEUROL, V5, P873, DOI 10.1016/S1474-4422(06)70575-0; Leroux E, 2011, LANCET NEUROL, V10, P891, DOI 10.1016/S1474-4422(11)70186-7; Magis D, 2007, LANCET NEUROL, V6, P314, DOI 10.1016/S1474-4422(07)70058-3; Marmura MJ, 2010, CEPHALALGIA, V30, P1531, DOI 10.1177/0333102410372423; May A, 2006, EUR J NEUROL, V13, P1066, DOI 10.1111/j.1468-1331.2006.01566.x; May A, 1998, LANCET, V352, P275, DOI 10.1016/S0140-6736(98)02470-2; Nagy AJ, 2011, NEUROLOGY, V77, P1827, DOI 10.1212/WNL.0b013e3182377dbb; Russell MB, 2004, LANCET NEUROL, V3, P279, DOI 10.1016/S1474-4422(04)00735-5; Schoenen J, 2005, BRAIN, V128, P940, DOI 10.1093/brain/awh411; Schurks M, 2006, HEADACHE, V46, P1246, DOI 10.1111/j.1526-4610.2006.00534.x; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; van Vliet JA, 2003, NEUROLOGY, V60, P630, DOI 10.1212/01.WNL.0000046589.45855.30; Wilbrink LA, 2009, CURR OPIN NEUROL, V22, P247, DOI 10.1097/WCO.0b013e32832b4bb3	37	76	77	1	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 11	2012	344								e2407	10.1136/bmj.e2407	http://dx.doi.org/10.1136/bmj.e2407			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927UH	22496300				2022-12-28	WOS:000302935200003
J	Azoulay, P				Azoulay, Pierre			Turn the scientific method on ourselves	NATURE			English	Editorial Material									[Azoulay, Pierre] MIT, Alfred P Sloan Sch Management, Cambridge, MA 02139 USA; [Azoulay, Pierre] Natl Bur Econ Res, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); National Bureau of Economic Research	Azoulay, P (corresponding author), MIT, Alfred P Sloan Sch Management, Cambridge, MA 02139 USA.	pazoulay@mit.edu	Azoulay, Pierre/B-1405-2008	Azoulay, Pierre/0000-0001-6511-4824				Banerjee A., 2011, POOR EC RADICAL RETH; Cohen J, 2010, Q J ECON, V125, P1, DOI 10.1162/qjec.2010.125.1.1; Jones BF, 2009, REV ECON STUD, V76, P283, DOI 10.1111/j.1467-937X.2008.00531.x; Rockey S., 2012, AGE DISTRIBUTION NIH	4	18	18	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2012	484	7392					31	32		10.1038/484031a	http://dx.doi.org/10.1038/484031a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	919QN	22481340	Bronze			2022-12-28	WOS:000302343400016
J	Bohnet, JG; Chen, ZL; Weiner, JM; Meiser, D; Holland, MJ; Thompson, JK				Bohnet, Justin G.; Chen, Zilong; Weiner, Joshua M.; Meiser, Dominic; Holland, Murray J.; Thompson, James K.			A steady-state superradiant laser with less than one intracavity photon	NATURE			English	Article							ATOM LASER; QUANTUM; LINEWIDTH; DYNAMICS	The spectral purity of an oscillator is central to many applications, such as detecting gravity waves(1), defining the second(2,3), ground-state cooling and quantum manipulation of nanomechanical objects(4), and quantum computation(5). Recent proposals(6-9) suggest that laser oscillators which use very narrow optical transitions in atoms can be orders of magnitude more spectrally pure than present lasers. Lasers of this high spectral purity are predicted to operate deep in the 'bad-cavity', or superradiant, regime, where the bare atomic linewidth is much less than the cavity linewidth. Here we demonstrate a Raman superradiant laser source in which spontaneous synchronization of more than one million rubidium-87 atomic dipoles is continuously sustained by less than 0.2 photons on average inside the optical cavity. By operating at low intracavity photon number, we demonstrate isolation of the collective atomic dipole from the environment by a factor of more than ten thousand, as characterized by cavity frequency pulling measurements. The emitted light has a frequency linewidth, measured relative to the Raman dressing laser, that is less than that of single-particle decoherence linewidths and more than ten thousand times less than the quantum linewidth limit typically applied to 'good-cavity' optical lasers(10), for which the cavity linewidth is much less than the atomic linewidth. These results demonstrate several key predictions for future superradiant lasers, which could be used to improve the stability of passive atomic clocks(3) and which may lead to new searches for physics beyond the standard model(11,12).	[Bohnet, Justin G.; Chen, Zilong; Weiner, Joshua M.; Meiser, Dominic; Holland, Murray J.; Thompson, James K.] NIST, JILA, Boulder, CO 80309 USA; [Bohnet, Justin G.; Chen, Zilong; Weiner, Joshua M.; Meiser, Dominic; Holland, Murray J.; Thompson, James K.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder	Thompson, JK (corresponding author), NIST, JILA, 440 UCB, Boulder, CO 80309 USA.	jkt@jila.colorado.edu	Chen, Zilong/H-3405-2011	Chen, Zilong/0000-0003-4467-8537; Thompson, James/0000-0003-1160-5112; HOLLAND, MURRAY/0000-0002-3778-1352	NSF PFC; NIST; ARO; DARPA QuASaR through ARO; NSF; NSF GRF; A*STAR Singapore; Division Of Physics [1068560] Funding Source: National Science Foundation	NSF PFC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NIST(National Institute of Standards & Technology (NIST) - USA); ARO; DARPA QuASaR through ARO; NSF(National Science Foundation (NSF)); NSF GRF(National Science Foundation (NSF)); A*STAR Singapore(Agency for Science Technology & Research (A*STAR)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank J. Ye and A. M. Rey for discussions. J.G.B., Z.C., J.M.W. and J.K.T. acknowledge support from NSF PFC, NIST and ARO. M.J.H. and D.M. acknowledge support from the DARPA QuASaR programme through a grant from ARO and from NSF. J.G.B. acknowledges support from NSF GRF, and Z.C. acknowledges support from A*STAR Singapore.	Benmessai K, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.233901; BJORK G, 1993, PHYS REV A, V47, P4451, DOI 10.1103/PhysRevA.47.4451; Blatt S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.140801; Cagnoli G, 2000, PHYS REV LETT, V85, P2442, DOI 10.1103/PhysRevLett.85.2442; Chan HW, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.063003; Chen JB, 2009, CHINESE SCI BULL, V54, P348, DOI 10.1007/s11434-009-0073-y; Chen ZL, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.133601; DICKE RH, 1954, PHYS REV, V93, P99, DOI 10.1103/PhysRev.93.99; Fortier TM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.070801; Guerin W, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.093002; Hartnett JG, 2010, IEEE T MICROW THEORY, V58, P3580, DOI 10.1109/TMTT.2010.2086551; HILICO L, 1992, EUROPHYS LETT, V18, P685, DOI 10.1209/0295-5075/18/8/004; Jiang YY, 2011, NAT PHOTONICS, V5, P158, DOI [10.1038/nphoton.2010.313, 10.1038/NPHOTON.2010.313]; KLEPPNER D, 1962, PHYS REV, V126, P603, DOI 10.1103/PhysRev.126.603; KOLOBOV MI, 1993, PHYS REV A, V47, P1431, DOI 10.1103/PhysRevA.47.1431; Kuppens SJM, 1996, OPT COMMUN, V126, P79, DOI 10.1016/0030-4018(96)00034-X; KUPPENS SJM, 1994, PHYS REV LETT, V72, P3815, DOI 10.1103/PhysRevLett.72.3815; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; Leibrandt DR, 2011, OPT EXPRESS, V19, P10278, DOI 10.1364/OE.19.010278; Ludlow AD, 2008, SCIENCE, V319, P1805, DOI 10.1126/science.1153341; McKeever J, 2003, NATURE, V425, P268, DOI 10.1038/nature01974; Meiser D, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.063827; Meiser D, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.033847; Meiser D, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.163601; SCHAWLOW AL, 1958, PHYS REV, V112, P1940, DOI 10.1103/PhysRev.112.1940; Teufel JD, 2011, NATURE, V475, P359, DOI 10.1038/nature10261; Vrijsen G, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.063904; Wang H, 2000, OPT LETT, V25, P1732, DOI 10.1364/OL.25.001732; Young BC, 1999, PHYS REV LETT, V82, P3799, DOI 10.1103/PhysRevLett.82.3799	29	293	302	3	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2012	484	7392					78	81		10.1038/nature10920	http://dx.doi.org/10.1038/nature10920			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	919QN	22481360				2022-12-28	WOS:000302343400037
J	Yokoo, R; Zawadzki, KA; Nabeshima, K; Drake, M; Arur, S; Villeneuve, AM				Yokoo, Rayka; Zawadzki, Karl A.; Nabeshima, Kentaro; Drake, Melanie; Arur, Swathi; Villeneuve, Anne M.			COSA-1 Reveals Robust Homeostasis and Separable Licensing and Reinforcement Steps Governing Meiotic Crossovers	CELL			English	Article							CROSSING-OVER; CAENORHABDITIS-ELEGANS; C-ELEGANS; MUTS HOMOLOG; MAMMALIAN MEIOSIS; CHIASMA FORMATION; BUDDING YEAST; RECOMBINATION; SYNAPSIS; MECHANISM	Crossovers (COs) between homologous chromosomes ensure their faithful segregation during meiosis. We identify C. elegans COSA-1, a cyclin-related protein conserved in metazoa, as a key component required to convert meiotic double-strand breaks (DSBs) into COs. During late meiotic prophase, COSA-1 localizes to foci that correspond to the single CO site on each homolog pair and indicate sites of eventual concentration of other conserved CO proteins. Chromosomes gain and lose competence to load CO proteins during meiotic progression, with competence to load COSA-1 requiring prior licensing. Our data further suggest a self-reinforcing mechanism maintaining CO designation. Modeling of a nonlinear dose-response relationship between IR-induced DSBs and COSA-1 foci reveals efficient conversion of DSBs into COs when DSBs are limiting and a robust capacity to limit cytologically differentiated CO sites when DSBs are in excess. COSA-1 foci serve as a unique live cell readout for investigating CO formation and CO interference.	[Yokoo, Rayka; Villeneuve, Anne M.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Zawadzki, Karl A.; Nabeshima, Kentaro; Villeneuve, Anne M.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Drake, Melanie; Arur, Swathi] Univ Texas Houston, MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	Stanford University; Stanford University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Villeneuve, AM (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	annev@stanford.edu			NIH [HG00044, R01GM67268]; Leukemia and Lymphoma Society [5381-12]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044, K22HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067268] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Mitani (National Institute of Genetics, Japan) and S. Rosu (Villeneuve lab) for cosa-1(tm3298) and zhp-3(me95); N. Bhalla, A. Dernburg, A. la Volpe, B. Meyer, S. Boulton, M. Zetka, and the Caenorhabditis Genetics Center for strains and antibodies; and J. Bessler for technical support. We thank A.D. Kaiser, M. AlQuaraishi, C. Janda, C. Thomas, D. Riordan, S. Clarke, and members of the Villeneuve lab for discussions and D. Libuda and A. Fire for comments on the manuscript. This work was supported by Stanford Genome Training Program NIH HG00044 Training Grant for R.Y., Leukemia and Lymphoma Society Postdoctoral Fellowship 5381-12 to K.A.Z., and NIH grant R01GM67268 to A.M.V.	Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Anderson LK, 1999, GENETICS, V151, P1569; Ashley T, 2001, J CELL SCI, V114, P685; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Baudat F, 2007, CHROMOSOME RES, V15, P565, DOI 10.1007/s10577-007-1140-3; Bhalla N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000235; CARPENTER ATC, 1975, P NATL ACAD SCI USA, V72, P3186, DOI 10.1073/pnas.72.8.3186; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; de los Santos T, 2003, GENETICS, V164, P81; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Hammarlund M, 2005, GENETICS, V171, P1047, DOI 10.1534/genetics.105.044834; Hayashi M, 2007, PLOS GENET, V3, P2068, DOI 10.1371/journal.pgen.0030191; Henzel JV, 2011, GENETICS, V187, P685, DOI 10.1534/genetics.110.124958; Higgins JD, 2008, PLANT J, V55, P28, DOI 10.1111/j.1365-313X.2008.03470.x; Higgins JD, 2004, GENE DEV, V18, P2557, DOI 10.1101/gad.317504; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; HODGKIN J, 1979, GENETICS, V91, P67; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Jantsch V, 2004, MOL CELL BIOL, V24, P7998, DOI 10.1128/MCB.24.18.7998-8006.2004; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jones G.H., 1984, Symposia of the Society for Experimental Biology, P293; Kelly KO, 2000, GENETICS, V156, P617; Kneitz B, 2000, GENE DEV, V14, P1085; Lenzi ML, 2005, AM J HUM GENET, V76, P112, DOI 10.1086/427268; Lynn A, 2007, CHROMOSOME RES, V15, P591, DOI 10.1007/s10577-007-1150-1; Macqueen AJ, 2005, CELL, V123, P1037, DOI 10.1016/j.cell.2005.09.034; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; MacQueen AJ, 2009, CURR BIOL, V19, P1519, DOI 10.1016/j.cub.2009.08.048; Martinez-Perez E, 2005, GENE DEV, V19, P2727, DOI 10.1101/gad.1338505; Martinez-Perez E, 2008, GENE DEV, V22, P2886, DOI 10.1101/gad.1694108; Martinez-Perez E, 2009, CURR OPIN GENET DEV, V19, P105, DOI 10.1016/j.gde.2009.02.005; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Mets DG, 2009, CELL, V139, P73, DOI 10.1016/j.cell.2009.07.035; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; Muller HJ, 1916, AM NAT, V50, P350, DOI 10.1086/279547; Muller HJ, 1916, AM NAT, V50, P284, DOI 10.1086/279541; Muller HJ, 1916, AM NAT, V50, P421, DOI 10.1086/279553; Nabeshima K, 2004, GENETICS, V168, P1275, DOI 10.1534/genetics.104.030700; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Petri ET, 2007, CELL CYCLE, V6, P1342, DOI 10.4161/cc.6.11.4297; Phillips CM, 2005, CELL, V123, P1051, DOI 10.1016/j.cell.2005.09.035; Pochart P, 1997, J BIOL CHEM, V272, P30345, DOI 10.1074/jbc.272.48.30345; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Rosu S, 2011, SCIENCE, V334, P1286, DOI 10.1126/science.1212424; Santucci-Darmanin S, 2000, FASEB J, V14, P1539, DOI 10.1096/fj.14.11.1539; Schurko AM, 2010, INSECT MOL BIOL, V19, P165, DOI 10.1111/j.1365-2583.2009.00948.x; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Thompson L.H., 2000, ORIGIN RECOGNITION S; Tsai CJ, 2008, GENE DEV, V22, P194, DOI 10.1101/gad.1618508; Viera A, 2009, J CELL SCI, V122, P2149, DOI 10.1242/jcs.046706; Ward JO, 2007, PLOS GENET, V3, P1550, DOI 10.1371/journal.pgen.0030139; Youds JL, 2010, SCIENCE, V327, P1254, DOI 10.1126/science.1183112; Zalevsky J, 1999, GENETICS, V153, P1271; Zetka MC, 1999, GENE DEV, V13, P2258, DOI 10.1101/gad.13.17.2258; ZICKLER D, 1992, GENETICS, V132, P135	55	147	149	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 30	2012	149	1					75	87		10.1016/j.cell.2012.01.052	http://dx.doi.org/10.1016/j.cell.2012.01.052			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464324	Green Accepted, Bronze			2022-12-28	WOS:000302235400011
J	Godfrin, H; Meschke, M; Lauter, HJ; Sultan, A; Bohm, HM; Krotscheck, E; Panholzer, M				Godfrin, Henri; Meschke, Matthias; Lauter, Hans-Jochen; Sultan, Ahmad; Boehm, Helga M.; Krotscheck, Eckhard; Panholzer, Martin			Observation of a roton collective mode in a two-dimensional Fermi liquid	NATURE			English	Article							EFFECTIVE-MASS; ELEMENTARY EXCITATIONS; SPIN FLUCTUATIONS; ZERO SOUND; HE-3; PLASMONS; DYNAMICS	Understanding the dynamics of correlated many-body quantum systems is a challenge for modern physics. Owing to the simplicity of theirHamiltonians, He-4 (bosons) and He-3 (fermions) have served as model systems for strongly interacting quantum fluids, with substantial efforts devoted to their understanding. An important milestone was the direct observation of the collective phonon-roton mode in liquid He-4 by neutron scattering, verifying Landau's prediction(1) and his fruitful concept of elementary excitations. In a Fermi system, collective density fluctuations (known as 'zero-sound' in He-3, and 'plasmons' in charged systems) and incoherent particle-hole excitations are observed. At small wavevectors and energies, both types of excitation are described by Landau's theory of Fermi liquids(2,3). At higher wavevectors, the collectivemode enters the particle-hole band, where it is strongly damped. The dynamics of Fermi liquids at high wavevectors was thus believed to be essentially incoherent. Here we report inelastic neutron scattering measurements of a monolayer of liquid He-3, observing a roton-like excitation. We find that the collective density mode reappears as a well defined excitation atmomentum transfers larger than twice the Fermi momentum. We thus observe unexpected collective behaviour of a Fermi many-body system in the regime beyond the scope of Landau's theory. A satisfactory interpretation of the measured spectra is obtained using a dynamic many-body theory(4).	[Godfrin, Henri; Meschke, Matthias; Sultan, Ahmad] CNRS, Inst Neel, F-38042 Grenoble 9, France; [Godfrin, Henri; Meschke, Matthias; Sultan, Ahmad] Univ Grenoble 1, F-38042 Grenoble 9, France; [Meschke, Matthias] Aalto Univ, Low Temp Lab, Aalto 00076, Finland; [Lauter, Hans-Jochen] Inst Laue Langevin, F-38042 Grenoble 9, France; [Lauter, Hans-Jochen] Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; [Boehm, Helga M.; Krotscheck, Eckhard; Panholzer, Martin] Johannes Kepler Univ Linz, Inst Theoret Phys, A-4040 Linz, Austria; [Krotscheck, Eckhard] SUNY Buffalo, Dept Phys, Buffalo, NY 14260 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Aalto University; Institut Laue-Langevin (ILL); United States Department of Energy (DOE); Oak Ridge National Laboratory; Johannes Kepler University Linz; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Godfrin, H (corresponding author), CNRS, Inst Neel, BP 166, F-38042 Grenoble 9, France.	henri.godfrin@grenoble.cnrs.fr	Godfrin, Henri/AAC-4014-2020; Gramich, Matthias/AAE-5772-2020; Meschke, Matthias/G-5166-2012	Godfrin, Henri/0000-0001-8028-6923; 	Austrian Fonds zur Forderung der wissenschaftlichen Forschung (FWF) [P21264]; French Agence Nationale de la Recherche [ANR-2010-INTB-403-01]; EU [228464]	Austrian Fonds zur Forderung der wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); French Agence Nationale de la Recherche(French National Research Agency (ANR)); EU(European Commission)	We are grateful to the Austrian-French programme Amadeus for providing initial support; to the Austrian Fonds zur Forderung der wissenschaftlichen Forschung (FWF grant P21264), the French Agence Nationale de la Recherche (project ANR-2010-INTB-403-01) and the EU FRP7 low-temperature infrastructure grant Microkelvin (project number 228464) for funding this research; and to the Institut Laue-Langevin for use of the facility.	Bauerle C, 1998, J LOW TEMP PHYS, V110, P333, DOI 10.1023/A:1022540901706; Bohm HM, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.224505; Boronat J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.085302; Bostwick A, 2007, NAT PHYS, V3, P36, DOI 10.1038/nphys477; Campbell CE, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.174501; Casey A, 1998, J LOW TEMP PHYS, V113, P293, DOI 10.1023/A:1022598600411; Clements BE, 1996, PHYS REV B, V53, P12253, DOI 10.1103/PhysRevB.53.12253; FEYNMAN RP, 1956, PHYS REV, V102, P1189, DOI 10.1103/PhysRev.102.1189; FRIMAN BL, 1982, PHYS REV LETT, V49, P1705, DOI 10.1103/PhysRevLett.49.1705; Glyde H. R., 1994, EXCITATIONS LIQUID S; Glyde HR, 2000, PHYS REV B, V61, P1421, DOI 10.1103/PhysRevB.61.1421; Godfrin H., 1995, PROGR LOW TEMPERATUR, VXIV, P213, DOI DOI 10.1016/S0079-6417(06)80018-1; GREYWALL DS, 1990, PHYS REV B, V41, P1842, DOI 10.1103/PhysRevB.41.1842; JACKSON HW, 1973, PHYS REV A, V8, P1529, DOI 10.1103/PhysRevA.8.1529; Kohsaka Y, 2008, NATURE, V454, P1072, DOI 10.1038/nature07243; Krotscheck E, 2003, J LOW TEMP PHYS, V132, P281, DOI 10.1023/A:1024896432481; Landau L. D., 1947, J PHYS USSR, V11, P91; LANDAU LD, 1957, SOV PHYS JETP-USSR, V3, P920; LAUTER HJ, 1992, PHYS REV LETT, V68, P2484, DOI 10.1103/PhysRevLett.68.2484; Morhard KD, 1996, PHYS REV B, V53, P2658, DOI 10.1103/PhysRevB.53.2658; Neumann M, 2007, SCIENCE, V317, P1356, DOI 10.1126/science.1143607; Nozierez P, 2004, J LOW TEMP PHYS, V137, P45, DOI 10.1023/B:JOLT.0000044234.82957.2f; PINES D, 1981, PHYS TODAY, V34, P106, DOI 10.1063/1.2914350; Pines D., 1966, THEORY QUANTUM LIQUI; Reatto L., 2011, INT C LOW TEMP PHYS; RUVALDS J, 1987, NATURE, V328, P299, DOI 10.1038/328299a0; SCHERM R, 1987, PHYS REV LETT, V59, P217, DOI 10.1103/PhysRevLett.59.217; SKOLD K, 1976, PHYS REV LETT, V37, P842, DOI 10.1103/PhysRevLett.37.842; Thouless D J, 1972, QUANTUM MECH MANY BO; Uemura YJ, 2007, NAT PHYS, V3, P29, DOI 10.1038/nphys488	31	41	41	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2012	483	7391					576	579		10.1038/nature10919	http://dx.doi.org/10.1038/nature10919			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915EF	22460903	Green Submitted			2022-12-28	WOS:000302006100034
J	Schmitt, J; Schneider, R; Elsig, J; Leuenberger, D; Lourantou, A; Chappellaz, J; Kohler, P; Joos, F; Stocker, TF; Leuenberger, M; Fischer, H				Schmitt, Jochen; Schneider, Robert; Elsig, Joachim; Leuenberger, Daiana; Lourantou, Anna; Chappellaz, Jerome; Koehler, Peter; Joos, Fortunat; Stocker, Thomas F.; Leuenberger, Markus; Fischer, Hubertus			Carbon Isotope Constraints on the Deglacial CO2 Rise from Ice Cores	SCIENCE			English	Article							ATMOSPHERIC CO2; SOUTHERN-OCEAN; LAST; AGE; VENTILATION; EXCHANGE; CYCLES; RECORD	The stable carbon isotope ratio of atmospheric CO2 (delta C-13(atm)) is a key parameter in deciphering past carbon cycle changes. Here we present delta C-13(atm) data for the past 24,000 years derived from three independent records from two Antarctic ice cores. We conclude that a pronounced 0.3 per mil decrease in delta C-13(atm) during the early deglaciation can be best explained by upwelling of old, carbon-enriched waters in the Southern Ocean. Later in the deglaciation, regrowth of the terrestrial biosphere, changes in sea surface temperature, and ocean circulation governed the delta C-13(atm) evolution. During the Last Glacial Maximum, delta C-13(atm) and atmospheric CO2 concentration were essentially constant, which suggests that the carbon cycle was in dynamic equilibrium and that the net transfer of carbon to the deep ocean had occurred before then.	[Schmitt, Jochen; Schneider, Robert; Elsig, Joachim; Leuenberger, Daiana; Joos, Fortunat; Stocker, Thomas F.; Leuenberger, Markus; Fischer, Hubertus] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; [Schmitt, Jochen; Schneider, Robert; Elsig, Joachim; Leuenberger, Daiana; Joos, Fortunat; Stocker, Thomas F.; Leuenberger, Markus; Fischer, Hubertus] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland; [Schmitt, Jochen; Koehler, Peter; Fischer, Hubertus] Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; [Lourantou, Anna; Chappellaz, Jerome] Univ Grenoble 1, CNRS, LGGE, UMR 5183, F-38041 Grenoble, France	University of Bern; University of Bern; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Schmitt, J (corresponding author), Univ Bern, Inst Phys, CH-3012 Bern, Switzerland.	schmitt@climate.unibe.ch	Fischer, Hubertus/A-1211-2014; Köhler, Peter/F-7293-2010; Schmitt, Jochen/B-7893-2009; Stocker, Thomas/B-1273-2013; Chappellaz, Jérôme A./A-4872-2011; Joos, Fortunat/B-4118-2018; Leuenberger, Markus C/K-9655-2016	Fischer, Hubertus/0000-0002-2787-4221; Köhler, Peter/0000-0003-0904-8484; Schmitt, Jochen/0000-0003-4695-3029; Joos, Fortunat/0000-0002-9483-6030; Leuenberger, Markus C/0000-0003-4299-6793	Deutsche Forschungsgemeinschaft; Helmholtz Gemeinschaft; Schweizerischer Nationalfonds; EC	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Gemeinschaft(Helmholtz Association); Schweizerischer Nationalfonds(Swiss National Science Foundation (SNSF)); EC(European CommissionEuropean Commission Joint Research Centre)	We thank two anonymous reviewers for carefully reviewing the manuscript. Supported in part by Deutsche Forschungsgemeinschaft, Helmholtz Gemeinschaft, and Schweizerischer Nationalfonds. This work is a contribution to EPICA, a joint European Science Foundation/European Commission (EC) scientific program, funded by the EC under the Environment and Climate Program and by national contributions from Belgium, Denmark, France, Germany, Italy, the Netherlands, Norway, Sweden, Switzerland, and the UK. The main logistic support at Dome C was provided by the Institut Polaire Francais-Paul Emile Victor (IPEV) and PNRA. Ice core material was also used from TALDICE, a joint European program led by Italy and funded by national contributions from Italy, France, Germany, Switzerland, and the UK. The main logistical support at Talos Dome was provided by PNRA. This is EPICA publication 284. The data are accessible online at http://doi.pangaea.de/10.1594/PANGAEA.772713.	Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Bard E, 2000, SCIENCE, V289, P1321, DOI 10.1126/science.289.5483.1321; Broecker W, 2007, EARTH PLANET SC LETT, V256, P90, DOI 10.1016/j.epsl.2007.01.015; Broecker W, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043969; Burke A, 2012, SCIENCE, V335, P557, DOI 10.1126/science.1208163; Ciais P, 2012, NAT GEOSCI, V5, P74, DOI [10.1038/NGEO1324, 10.1038/ngeo1324]; Elsig J, 2009, NATURE, V461, P507, DOI 10.1038/nature08393; Fischer H, 2010, QUATERNARY SCI REV, V29, P193, DOI 10.1016/j.quascirev.2009.06.007; Hodell DA, 2001, EARTH PLANET SC LETT, V192, P109, DOI 10.1016/S0012-821X(01)00430-7; Kohler P, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2008PA001703; Kohler P, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001228; Kohler P, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002345; Laj C, 2004, GEOPHYS MONOGR SER, V145, P255, DOI 10.1029/145GM19; Lemieux-Dudon B, 2010, QUATERNARY SCI REV, V29, P8, DOI 10.1016/j.quascirev.2009.11.010; LEUENBERGER M, 1992, NATURE, V357, P488, DOI 10.1038/357488a0; Lourantou A, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003545; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Lund DC, 2011, NAT GEOSCI, V4, P771, DOI [10.1038/NGEO1272, 10.1038/ngeo1272]; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Muscheler R, 2005, QUATERNARY SCI REV, V24, P1849, DOI 10.1016/j.quascirev.2005.01.012; Oliver KIC, 2010, CLIM PAST, V6, P645, DOI 10.5194/cp-6-645-2010; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Schmitt J, 2011, ATMOS MEAS TECH, V4, P1445, DOI 10.5194/amt-4-1445-2011; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Smith HJ, 1999, NATURE, V400, P248, DOI 10.1038/22291; Southon J, 2012, QUATERNARY SCI REV, V33, P32, DOI 10.1016/j.quascirev.2011.11.022; Stenni B, 2001, SCIENCE, V293, P2074, DOI 10.1126/science.1059702; Stott L, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001690; Tschumi T, 2011, CLIM PAST, V7, P771, DOI 10.5194/cp-7-771-2011; Yu JM, 2010, SCIENCE, V330, P1084, DOI 10.1126/science.1193221; Zech R, 2011, CLIM PAST, V7, P501, DOI 10.5194/cp-7-501-2011; Zeng N, 2007, CLIM PAST, V3, P135, DOI 10.5194/cp-3-135-2007; ZHANG J, 1995, GEOCHIM COSMOCHIM AC, V59, P107, DOI 10.1016/0016-7037(95)91550-D	35	267	270	6	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2012	336	6082					711	714		10.1126/science.1217161	http://dx.doi.org/10.1126/science.1217161			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22461496	Green Submitted			2022-12-28	WOS:000303872300047
J	O'Shea, P				O'Shea, Paul			Physics and Medicine 4 Future medicine shaped by an interdisciplinary new biology	LANCET			English	Article							SYSTEMS BIOLOGY; PHARMACEUTICAL-INDUSTRY; CLINICAL-TRIALS; METABOLOMICS; DISCOVERY; MODELS; LIFE; ERA	The projected effects of the new biology on future medicine are described. The new biology is essentially the result of shifts in the way biological research has progressed over the past few years, mainly through the involvement of physical scientists and engineers in biological thinking and research with the establishment of new teams and task forces to address the new challenges in biology. Their contributions go well beyond the historical contributions of mathematics, physical sciences, and engineering to medical practice that were largely equipment oriented. Over the next generation, the entire fabric of the biosciences will change as research barriers between disciplines diminish and eventually cease to exist. The resulting effects are starting to be noticed in front-line medicine and the prospects for the future are immense and potentially society changing. The most likely disciplines to have early effects are outlined and form the main thrust of this paper, with speculation about other disciplines and emphasis that although physics-based and engineering-based biology will change future medicine, the physical sciences and engineering will also be changed by these developments. Essentially, physics is being redefined by the need to accommodate these new views of what constitutes biological systems and how they function.	Univ Nottingham, Cell Biophys Grp, Sch Biol, Nottingham NG7 2RD, England	University of Nottingham	O'Shea, P (corresponding author), Univ Nottingham, Cell Biophys Grp, Sch Biol, Univ Pk, Nottingham NG7 2RD, England.	paul.oshea@nottingham.ac.uk		O'Shea, paul/0000-0001-9313-8313	Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Leverhulme Trust; Medical Research Council; Medical Research Council [G1001500] Funding Source: researchfish; MRC [G1001500] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Leverhulme Trust(Leverhulme Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	I am grateful to the Biotechnology and Biological Sciences Research Council, Engineering and Physical Sciences Research Council, Leverhulme Trust, and Medical Research Council for financial support for my research; my colleagues Douglas Kell (particularly for figure 2) and Charles ffrench-Constant for critically reading this review more than once and for their incisive and helpful comments; and Pierre De Meyts for permission to use his cartoon (figure 5).	Allen S, 2003, BIOCHEM SOC T, V31, P1052; Berner ES, 1999, CLIN DECISION SUPPOR; BIRKS J. B., 1962, RUTHERFORD MANCHESTE; Davidovits P., 2018, PHYS BIOL MED, V5th; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; European Science Foundation, ADV SYST BIOL MED AP; Evans WE, 2004, NATURE, V429, P464, DOI 10.1038/nature02626; Farrar JT, 2010, NAT MED, V16, P1284, DOI 10.1038/nm.2249; Hood L, 2008, ANNU REV ANAL CHEM, V1, P1, DOI 10.1146/annurev.anchem.1.031207.113113; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Keevil SF, 2012, LANCET, V379, P1517, DOI 10.1016/S0140-6736(11)60282-1; Kell DB, 2004, BIOESSAYS, V26, P99, DOI 10.1002/bies.10385; Kell DB, 2008, J THEOR BIOL, V252, P538, DOI 10.1016/j.jtbi.2007.10.023; Kell DB, 2007, IUBMB LIFE, V59, P689, DOI 10.1080/15216540701694252; Kell DB, 2006, DRUG DISCOV TODAY, V11, P1085, DOI 10.1016/j.drudis.2006.10.004; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Lazebnik Y, 2002, CANCER CELL, V2, P179, DOI 10.1016/S1535-6108(02)00133-2; McLuhan M, 1971, MEDIUM IS MESSAGE; Melin J, 2007, ANNU REV BIOPH BIOM, V36, P213, DOI 10.1146/annurev.biophys.36.040306.132646; Melzer A, 2012, LANCET, V379, P1534, DOI 10.1016/S0140-6736(12)60428-0; MNneil SE, 2005, J LEUKOCYTE BIOL, V78, P585, DOI 10.1189/jlb.0205074; Morris P, 2012, LANCET, V379, P1525, DOI 10.1016/S0140-6736(12)60429-2; *NAT AC SCI I MED, 2004, FAC INT RES; Nobelprize.org, NOB PRIZ CHEM 1908; Noble D, 2010, PHILOS T R SOC A, V368, P1125, DOI 10.1098/rsta.2009.0245; O'Hagan S, 2005, ANAL CHEM, V77, P290, DOI 10.1021/ac049146x; O'Shea P, 2008, PHYS WORLD, V21, P29; Richens JL, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-29; Royal Academy of Engineering, 2012, SYST BIOL VIS ENG ME; Sadiq SK, 2008, PHILOS T R SOC A, V366, P3199, DOI 10.1098/rsta.2008.0100; Schmid EF, 2005, DRUG DISCOV TODAY, V10, P1031, DOI 10.1016/S1359-6446(05)03524-5; Solovev AA, 2012, ACS NANO, V6, P1751, DOI 10.1021/nn204762w; Stein L, 2002, NATURE, V417, P119, DOI 10.1038/417119a; Vafadar-Isfahani B, 2012, J ALZHEIMERS DIS, V28, P625, DOI 10.3233/JAD-2011-111505; Van der Greef J, 2006, PHARMACOGENOMICS, V7, P1087, DOI 10.2217/14622416.7.7.1087; Vere K, 2011, FUNCT OPT IMAGING, DOI [10.1109/FOI.2011.6154818, DOI 10.1109/FOI.2011.6154818]; Wang ZL, 2012, ADV MATER, V24, P280, DOI 10.1002/adma.201102958; West GB, 2012, LANCET, V379, P1551, DOI 10.1016/S0140-6736(12)60281-5	40	12	12	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2012	379	9825					1544	1550		10.1016/S0140-6736(12)60476-0	http://dx.doi.org/10.1016/S0140-6736(12)60476-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930BJ	22516560				2022-12-28	WOS:000303110200033
J	Helander, MG				Helander, Michael G.			Solution-Processible Electrodes	SCIENCE			English	Editorial Material									Univ Toronto, Dept Mat Sci & Engn, Toronto, ON M5S 3E4, Canada	University of Toronto	Helander, MG (corresponding author), Univ Toronto, Dept Mat Sci & Engn, Toronto, ON M5S 3E4, Canada.	michael.helander@utoronto.ca						Forrest SR, 2004, NATURE, V428, P911, DOI 10.1038/nature02498; GORDY W, 1956, J CHEM PHYS, V24, P439, DOI 10.1063/1.1742493; Hallwachs W, 1888, ANN PHY CHEMIE, V269, P301, DOI [10.1002/andp.18882690206, DOI 10.1002/ANDP.18882690206]; HERRING C, 1949, REV MOD PHYS, V21, P185, DOI 10.1103/RevModPhys.21.185; Hertz H. R., 1887, ANN PHYS, V267, P983; Zhou YH, 2012, SCIENCE, V336, P327, DOI 10.1126/science.1218829	6	4	4	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2012	336	6079					302	303		10.1126/science.1220829	http://dx.doi.org/10.1126/science.1220829			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22517846				2022-12-28	WOS:000302995400030
J	Dahm, P				Dahm, Philipp			Review: PSA-based screening does not reduce prostate cancer mortality or all-cause mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Florida, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Dahm, P (corresponding author), Univ Florida, Gainesville, FL 32610 USA.		Dahm, Philipp/I-1614-2019	Dahm, Philipp/0000-0003-2819-2553				[Anonymous], 2011, SCREEN PROST CANC DR; NIH Consensus Development Program, 2011, NIH STATE OF THE SCI	2	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2012	156	8							JC4-2	10.7326/0003-4819-156-8-201204170-02002	http://dx.doi.org/10.7326/0003-4819-156-8-201204170-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930PO	22508742				2022-12-28	WOS:000303151800001
J	Laxminarayan, R; Heymann, DL				Laxminarayan, Ramanan; Heymann, David L.			Challenges of drug resistance in the developing world	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTIBIOTIC USE; IMPACT; ASSOCIATION; INFECTIONS; PREVALENCE; COUNTRIES; CHILDREN; VACCINE; EUROPE		[Heymann, David L.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Laxminarayan, Ramanan] Ctr Dis Dynam Econ & Policy, Washington, DC USA	University of London; London School of Hygiene & Tropical Medicine	Heymann, DL (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	david.heymann@hpa.org.uk	Laxminarayan, Ramanan/ABD-5050-2021					Apisarnthanarak A, 2008, INFECT CONT HOSP EP, V29, P572, DOI 10.1086/587496; Berkley JA, 2001, LANCET, V357, P1753, DOI 10.1016/S0140-6736(00)04897-2; Dagan R, 2008, LANCET INFECT DIS, V8, P785, DOI 10.1016/S1473-3099(08)70281-0; Dong HJ, 1999, HEALTH POLICY, V48, P29, DOI 10.1016/S0168-8510(99)00026-3; Dong HJ, 1999, INT J TECHNOL ASSESS, V15, P686, DOI 10.1017/S0266462399015482; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hamel MJ, 2008, AM J TROP MED HYG, V79, P320, DOI 10.4269/ajtmh.2008.79.320; Health Action International, 2010, BEING SICK NEED MED; Heymann DL, 2006, CELL, V124, P671, DOI 10.1016/j.cell.2006.02.009; IMS Health, 2011, MIDAS MARK SEGM DAT; Irungu P, 2011, ANAL EC INCENTIVES I; Jones N, 1998, AIDS, V12, P2177, DOI 10.1097/00002030-199816000-00013; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Larsson DGJ, 2009, REGUL TOXICOL PHARM, V53, P161, DOI 10.1016/j.yrtph.2009.01.008; Laxminarayan R., 2006, EC INFECT DIS, P49; Laxminarayan R, 2011, HEALTH AFFAIR, V30, P1096, DOI 10.1377/hlthaff.2011.0405; Lim V K, 1992, Malays J Pathol, V14, P41; Madhi SA, 2000, CLIN INFECT DIS, V31, P170, DOI 10.1086/313925; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Nickerson EK, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004308, 10.1371/journal.pone.0006512]; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; Radyowijati A, 2003, SOC SCI MED, V57, P733, DOI 10.1016/S0277-9536(02)00422-7; Steinfeld H., 2006, Livestock Report 2006, P3; Sweidan M., 2005, P 2 NAT WORKSH RAT U, P1; Trape JF, 1998, CR ACAD SCI III-VIE, V321, P689, DOI 10.1016/S0764-4469(98)80009-7; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; World Health Organization, 2009, COMM BAS SURV ANT US	28	105	106	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2012	344								e1567	10.1136/bmj.e1567	http://dx.doi.org/10.1136/bmj.e1567			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923GM	22491075	Green Submitted			2022-12-28	WOS:000302607700010
J	Park, DH; Singh, D				Park, Derek H.; Singh, Dishan			The management of ingrowing toenails	BMJ-BRITISH MEDICAL JOURNAL			English	Review							WEDGE RESECTION; PHENOLIZATION; EXCISION; NAIL		[Park, Derek H.; Singh, Dishan] Royal Natl Orthopaed Hosp, Foot & Ankle Unit, Stanmore HA7 4LP, Middx, England	University of London; University College London; Royal National Orthopaedic Hospital NHS Trust	Park, DH (corresponding author), Royal Natl Orthopaed Hosp, Foot & Ankle Unit, Stanmore HA7 4LP, Middx, England.	derekpark@doctors.net.uk		Park, Derek/0000-0001-5082-8832				Bos AMC, 2007, BRIT J SURG, V94, P292, DOI 10.1002/bjs.5691; BREARLEY R, 1958, LANCET, V2, P122; DeLauro T M, 1995, Clin Podiatr Med Surg, V12, P201; DIXON GL, 1983, FOOT ANKLE, V3, P254, DOI 10.1177/107110078300300503; Espensen EH, 2002, J AM PODIAT MED ASSN, V92, P287, DOI 10.7547/87507315-92-5-287; FOWLER AW, 1958, BRIT J SURG, V45, P382, DOI 10.1002/bjs.18004519217; GREIG JD, 1991, J BONE JOINT SURG BR, V73, P131, DOI 10.1302/0301-620X.73B1.1991748; Heifetz CJ, 1937, AM J SURG, V38, P298, DOI [10.1016/S0002-9610(37)90439-2, DOI 10.1016/S0002-9610(37)90439-2]; Herold N, 2001, J Foot Ankle Surg, V40, P390; ISSA MM, 1988, BRIT J SURG, V75, P181, DOI 10.1002/bjs.1800750232; LAXTON C, 1995, J PUBLIC HEALTH MED, V17, P311; Lerner LH, 1962, CURR PODIATR, V11, P26; LLOYDDAVIES RW, 1963, BRIT J SURG, V50, P592, DOI 10.1002/bjs.18005022407; Pardo Castello V, 1960, DIS NAILS; PARRINELLO JF, 1995, J AM PODIAT MED ASSN, V85, P696, DOI 10.7547/87507315-85-11-696; ROSS WR, 1969, SURG CLIN N AM, V49, P1499, DOI 10.1016/S0039-6109(16)39016-8; Rounding C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001541.pub2; Shaikh FM, 2008, J AM PODIAT MED ASSN, V98, P118, DOI 10.7547/0980118; SYKES P A, 1986, Journal of the Royal College of Surgeons of Edinburgh, V31, P300; VANDERHAM AC, 1990, J BONE JOINT SURG BR, V72, P507, DOI 10.1302/0301-620X.72B3.2341458; Winograd A.M., 1929, J AM MED ASS, V92, P229, DOI [10.1001/jama.1929.92700290001011, DOI 10.1001/JAMA.1929.92700290001011]; ZADIK FR, 1950, J BONE JOINT SURG BR, V32, P66, DOI 10.1302/0301-620X.32B1.66; Zaias N., 1980, NAIL HLTH DIS; ZOOK EG, 1980, J HAND SURG-AM, V5, P528, DOI 10.1016/S0363-5023(80)80100-6	24	12	12	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2012	344								e2089	10.1136/bmj.e2089	http://dx.doi.org/10.1136/bmj.e2089			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923GM	22491483				2022-12-28	WOS:000302607700013
J	Cheung, KMC; Cheung, JPY; Samartzis, D; Mak, KC; Wong, YW; Cheung, WY; Akbarnia, BA; Luk, KDK				Cheung, Kenneth Man-Chee; Cheung, Jason Pui-Yin; Samartzis, Dino; Mak, Kin-Cheung; Wong, Yat-Wa; Cheung, Wai-Yuen; Akbarnia, Behrooz A.; Luk, Keith Dip-Kei			Magnetically controlled growing rods for severe spinal curvature in young children: a prospective case series	LANCET			English	Article							EARLY-ONSET SCOLIOSIS; IDIOPATHIC SCOLIOSIS; CONGENITAL SCOLIOSIS; INFANTILE SCOLIOSIS; PULMONARY-FUNCTION; OUTCOMES; GROWTH; FUSION; MANAGEMENT; ANESTHESIA	Background Scoliosis in skeletally immature children is often treated by implantation of a rod to straighten the spine. Rods can be distracted (lengthened) as the spine grows, but patients need many invasive operations under general anaesthesia. Such operations are costly and associated with negative psychosocial outcomes. We assessed the effectiveness and safety of a new magnetically controlled growing rod (MCGR) for non-invasive outpatient distractions. Methods We implanted the MCGR in five patients, two of whom have now reached 24 months' follow-up. Each patient underwent monthly outpatient distractions. We used radiography to measure the magnitude of the spinal curvature, rod distraction length, and spinal length. We assessed clinical outcome by measuring the degree of pain, function, mental health, satisfaction with treatment, and procedure-related complications. Findings In the two patients with 24 months' follow-up, the mean degree of scoliosis, measured by Cobb angle, was 67 degrees (SD 10 degrees) before implantation and 29 degrees (4 degrees) at 24 months. Length of the instrumented segment of the spine increased by a mean of 1.9 mm (0.4 mm) with each distraction. Mean predicted versus actual rod distraction lengths were 2.3 mm (1.2 mm) versus 1.4 mm (0.7 mm) for patient 1, and 2.0 mm (0.2 mm) and 2.1 mm (0.7 mm) versus 1.9 mm (0.6 mm) and 1.7 mm (0.8 mm) for patient 2's right and left rods, respectively. Throughout follow-up, both patients had no pain, had good functional outcome, and were satisfied with the procedure. No MCGR-related complications were noted. Interpretation The MCGR procedure can be safely and effectively used in outpatient settings, and minimises surgical scarring and psychological distress, improves quality of life, and is more cost-effective than is the traditional growing rod procedure. The technique could be used for non-invasive correction of abnormalities in other disorders.	[Cheung, Kenneth Man-Chee] Univ Hong Kong, Queen Mary Hosp, Dept Orthopaed & Traumatol, Div Spine Surg, Pokfulam, Hong Kong, Peoples R China; [Akbarnia, Behrooz A.] San Diego Ctr Spinal Disorders, La Jolla, CA USA	University of Hong Kong	Cheung, KMC (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Orthopaed & Traumatol, Div Spine Surg, 102 Pokfulam Rd, Pokfulam, Hong Kong, Peoples R China.	cheungmc@hku.hk	Cheung, Jason Pui Yin/J-2214-2012; Cheung, Jason Pui Yin/AAJ-2016-2020; Akbarnia, Behrooz/AAL-8255-2021	Cheung, Jason Pui Yin/0000-0002-7052-0875; Cheung, Kenneth/0000-0001-8304-0419; Samartzis, Dino/0000-0002-7473-1311	Ellipse Technologies	Ellipse Technologies	Ellipse Technologies.	Akbarnia BA, 2005, SPINE, V30, pS46, DOI 10.1097/01.brs.0000175190.08134.73; Akbarnia BA, 2011, SPINE, DOI [10.1097/BRS.0b013e318240ff67, DOI 10.1097/BRS.0B013E318240FF]; Akbarnia BA, 2009, J CHILD ORTHOP, V3, P530; Akbarnia BA, 2008, SPINE, V33, P984, DOI 10.1097/BRS.0b013e31816c8b4e; Bess S, 2010, J BONE JOINT SURG AM, V92A, P2533, DOI 10.2106/JBJS.I.01471; Cahill PJ, 2010, SPINE, V35, pE1199, DOI 10.1097/BRS.0b013e3181e21b50; Caldas JCS, 2004, PEDIATR ANESTH, V14, P910, DOI 10.1111/j.1460-9592.2004.01350.x; COBB JR, 1960, J BONE JOINT SURG AM, V42, P1413, DOI 10.2106/00004623-196042080-00012; DIMEGLIO A, 1992, J PEDIATR ORTHOP B, V1, P102, DOI 10.1097/01202412-199201020-00003; Dimeglio A., 2001, J PEDIATR ORTHOPED, V21, P459; Elsebai HB, J PEDIAT ORTHOP, V31, P1; Goldberg CJ, 2003, SPINE, V28, P2397, DOI 10.1097/01.BRS.0000085367.24266.CA; JAMES JIP, 1959, J BONE JOINT SURG BR, V41, P719, DOI 10.1302/0301-620X.41B4.719; JAMES JIP, 1954, J BONE JOINT SURG BR, V36, P36, DOI 10.1302/0301-620X.36B1.36; Kain ZN, 1999, ANESTH ANALG, V88, P1042, DOI 10.1097/00000539-199905000-00013; Kain ZN, 1996, ARCH PEDIAT ADOL MED, V150, P1238, DOI 10.1001/archpedi.1996.02170370016002; Karol LA, 2008, J BONE JOINT SURG AM, V90A, P1272, DOI 10.2106/JBJS.G.00184; MCMASTER MJ, 1979, J BONE JOINT SURG BR, V61, P36, DOI 10.1302/0301-620X.61B1.422633; Mehta MH, 2005, J BONE JOINT SURG BR, V87B, P1237, DOI 10.1302/0301-620X.87B9.16124; Robinson CM, 1996, J BONE JOINT SURG AM, V78A, P1140, DOI 10.2106/00004623-199608000-00003; Sankar WN, 2011, SPINE, V36, P806, DOI 10.1097/BRS.0b013e318214d78f; Scoliosis Research Society, SRS 30 QUEST; Sponseller PD, 2007, SPINE, V32, pS81, DOI 10.1097/BRS.0b013e3181453073; Sponseller PD, 2009, SPINE, V34, P1711, DOI 10.1097/BRS.0b013e3181a9ece5; Thompson GH, 2007, J PEDIATR ORTHOPED, V27, P354, DOI 10.1097/BPO.0b013e3180333eea; Thompson GH, 2005, SPINE, V30, P2039, DOI 10.1097/01.brs.0000179082.92712.89; Vitale MG, 2008, SPINE, V33, P1242, DOI 10.1097/BRS.0b013e3181714536; WINTER RB, 1984, J BONE JOINT SURG AM, V66A, P1188, DOI 10.2106/00004623-198466080-00006; Yang JS, 2011, SPINE, V36, P1639, DOI 10.1097/BRS.0b013e31822a982f; Yilmaz G, 2010, SPINE, V35, P730, DOI 10.1097/BRS.0b013e3181bcc3a3	30	194	209	1	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2012	379	9830					1967	1974		10.1016/S0140-6736(12)60112-3	http://dx.doi.org/10.1016/S0140-6736(12)60112-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951YV	22520264	Green Submitted			2022-12-28	WOS:000304757700031
J	Casasnovas, O; Coiffier, B				Casasnovas, Olivier; Coiffier, Bertrand			Escalated BEACOPP in advanced Hodgkin's lymphoma	LANCET			English	Editorial Material							CHEMOTHERAPY; SALVAGE; TRIAL		[Coiffier, Bertrand] Hosp Civils Lyon, Lyon, France; [Coiffier, Bertrand] Univ Lyon 1, F-69365 Lyon, France; [Coiffier, Bertrand] Ctr Hosp Lyon Sud, Dept Haematol, F-69310 Pierre Benite, France; [Casasnovas, Olivier] Hop Bocage, Dijon, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; CHU Dijon Bourgogne	Coiffier, B (corresponding author), Hosp Civils Lyon, Lyon, France.	bertrand.coiffier@chu-lyon.fr	shaoping, liang/I-3447-2012	Casasnovas, Rene-Olivier/0000-0002-1156-8983				Aleman BMP, 2003, NEW ENGL J MED, V348, P2396, DOI 10.1056/NEJMoa022628; Dann EJ, 2007, BLOOD, V109, P905, DOI 10.1182/blood-2006-04-019901; Engert A, 2012, LANCET, V379, P1791, DOI 10.1016/S0140-6736(11)61940-5; Engert A, 2009, J CLIN ONCOL, V27, P4548, DOI 10.1200/JCO.2008.19.8820; Federico M, 2009, J CLIN ONCOL, V27, P805, DOI 10.1200/JCO.2008.17.0910; Ferme C, 2006, BLOOD, V107, P4636, DOI 10.1182/blood-2005-11-4429; Gallamini A, 2007, J CLIN ONCOL, V25, P3746, DOI 10.1200/JCO.2007.11.6525; Hutchings M, 2006, BLOOD, V107, P52, DOI 10.1182/blood-2005-06-2252; Morschhauser F, 2008, J CLIN ONCOL, V26, P5980, DOI 10.1200/JCO.2007.15.5887; Viviani S, 2011, NEW ENGL J MED, V365, P203, DOI 10.1056/NEJMoa1100340	10	2	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 12	2012	379	9828					1767	1768		10.1016/S0140-6736(12)60153-6	http://dx.doi.org/10.1016/S0140-6736(12)60153-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	941BR	22480757				2022-12-28	WOS:000303937700007
J	Estey, E				Estey, Elihu			Treatment of AML: resurrection for gemtuzumab ozogamicin?	LANCET			English	Editorial Material							ACUTE MYELOID-LEUKEMIA; MYLOTARG		[Estey, Elihu] Univ Washington, Med Ctr, Seattle, WA 98195 USA; [Estey, Elihu] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Estey, E (corresponding author), Univ Washington, Med Ctr, Seattle, WA 98195 USA.	eestey@uw.edu						Burnett AK, 2011, BLOOD, V118; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; Burnett AK, 2011, J CLIN ONCOL, V29, P369, DOI 10.1200/JCO.2010.31.4310; Castaigne S, 2012, LANCET, V379, P1508, DOI 10.1016/S0140-6736(12)60485-1; Estey EH, 2002, BLOOD, V99, P4222, DOI 10.1182/blood-2001-12-0174; Larson RA, 2005, CANCER, V104, P1442, DOI 10.1002/cncr.21326; Lowenberg B, 2009, NEW ENGL J MED, V361, P1235, DOI 10.1056/NEJMoa0901409; Petersdorf S., 2009, BLOOD, V114, P790; Walter RB, 2012, BLOOD, V119, P6198, DOI 10.1182/blood-2011-11-325050; Walter RB, 2011, J CLIN ONCOL, V29, P1190, DOI 10.1200/JCO.2010.31.8121; Walter RB, 2010, J CLIN ONCOL, V28, P1766, DOI 10.1200/JCO.2009.25.1066	11	14	14	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2012	379	9825					1468	1469		10.1016/S0140-6736(12)60534-0	http://dx.doi.org/10.1016/S0140-6736(12)60534-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930BJ	22482941				2022-12-28	WOS:000303110200007
J	Cohen, SP; White, RL; Kurihara, C; Larkin, TM; Chang, A; Griffith, SR; Gilligan, C; Larkin, R; Morlando, B; Pasquina, PF; Yaksh, TL; Nguyen, C				Cohen, Steven P.; White, Ronald L.; Kurihara, Connie; Larkin, Thomas M.; Chang, Audrey; Griffith, Scott R.; Gilligan, Christopher; Larkin, Ralph; Morlando, Benny; Pasquina, Paul F.; Yaksh, Tony L.; Nguyen, Conner			Epidural Steroids, Etanercept, or Saline in Subacute Sciatica A Multicenter, Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							LOW-BACK-PAIN; NECROSIS-FACTOR-ALPHA; CORTICOSTEROID INJECTIONS; DOUBLE-BLIND; TRANSFORAMINAL INJECTION; EQUIVALENCE TRIAL; NEUROPATHIC PAIN; DISC HERNIATION; MANAGEMENT; EFFICACY	Background: Perineural inhibitors of tumor necrosis factor have recently generated intense interest as an alternative to epidural steroid injections for lumbosacral radiculopathy. Objective: To evaluate whether epidural steroids, etanercept, or saline better improves pain and function in adults with lumbosacral radiculopathy. Design: A multicenter, 3-group, randomized, placebo-controlled trial conducted from 2008 to 2011. Randomization was computer-generated and stratified by site. Pharmacists prepared the syringes. Patients, treating physicians, and nurses assessing outcomes were blinded to treatment assignment. (ClinicalTrials.gov registration number: NCT00733096) Setting: Military and civilian treatment centers. Patients: 84 adults with lumbosacral radiculopathy of less than 6 months' duration. Intervention: 2 epidural injections of steroids, etanercept, or saline, mixed with bupivacaine and separated by 2 weeks. Measurements: The primary outcome measure was leg pain 1 month after the second injection. All patients had 1-month follow-up visits; patients whose condition improved remained blinded for the 6-month study period. Results: The group that received epidural steroids had greater reductions in the primary outcome measure than those who received saline (mean difference, -1.26 [95% CI, -2.79 to 0.27]; P = 0.11) or etanercept (mean difference, -1.01 [CI, -2.60 to 0.58]; P = 0.21). For back pain, smaller differences favoring steroids compared with saline (mean difference, -0.52 [CI, -1.85 to 0.81]; P = 0.44) and etanercept (mean difference, -0.92 [CI, -2.28 to 0.44]; P = 0.18) were observed. The largest differences were noted for functional capacity, in which etanercept fared worse than the other treatments: steroids vs. etanercept (mean difference, -16.16 [CI, -26.05 to -6.27]; P = 0.002), steroids vs. saline (mean difference, -5.87 [CI, -15.59 to 3.85]; P = 0.23), and etanercept vs. saline (mean difference, 10.29 [CI, 0.55 to 20.04]; P = 0.04). More patients treated with epidural steroids (75%) reported 50% or greater leg pain relief and a positive global perceived effect at 1 month than those who received saline (50%) or etanercept (42%) (P = 0.09). Limitation: Short-term follow-up, small sample size, and a possibly subtherapeutic dose of etanercept. Conclusion: Epidural steroid injections may provide modest short-term pain relief for some adults with lumbosacral radiculopathy, but larger studies with longer follow-up are needed to confirm their benefits.	Johns Hopkins Sch Med, Baltimore, MD USA; Landstuhl Reg Med Ctr, Landstuhl, Germany; Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; Pkwy Neurosci & Spine Inst, Hagerstown, MD USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; CUNY John Jay Coll Criminal Justice, New York, NY 10019 USA; Univ Calif San Diego, San Diego, CA 92103 USA	Johns Hopkins University; Johns Hopkins Medicine; Landstuhl Regional Medical Center; Walter Reed National Military Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; City University of New York (CUNY) System; John Jay College of Criminal Justice (CUNY); University of California System; University of California San Diego	Cohen, SP (corresponding author), 550 N Broadway,Suite 301, Baltimore, MD 21029 USA.	scohen40@jhmi.edu	Larkin, Thomas/AAI-5892-2021; Yaksh, Tony/D-4119-2009; Gilligan, Christopher/AAL-3831-2021	Gilligan, Christopher/0000-0003-4769-9907	John P. Murtha Neuroscience and Pain Institute; International Spinal Intervention Society; Center for Rehabilitation Sciences Research	John P. Murtha Neuroscience and Pain Institute; International Spinal Intervention Society; Center for Rehabilitation Sciences Research	The John P. Murtha Neuroscience and Pain Institute, International Spinal Intervention Society, and Center for Rehabilitation Sciences Research.	Ackerman WE, 2007, ANESTH ANALG, V104, P1217, DOI 10.1213/01.ane.0000260307.16555.7f; Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Anderberg L, 2007, EUR SPINE J, V16, P321, DOI 10.1007/s00586-006-0142-8; Arden NK, 2005, RHEUMATOLOGY, V44, P1399, DOI 10.1093/rheumatology/kei028; Armon C, 2007, NEUROLOGY, V68, P723, DOI 10.1212/01.wnl.0000256734.34238.e7; Bliddal H, 2006, SCAND J RHEUMATOL, V35, P341, DOI 10.1080/03009740600844530; Brisby H, 2006, J BONE JOINT SURG AM, V88A, P68, DOI 10.2106/JBJS.E.01282; Carette S, 1997, NEW ENGL J MED, V336, P1634, DOI 10.1056/NEJM199706053362303; Chou R, 2010, JAMA-J AM MED ASSOC, V303, P1295, DOI 10.1001/jama.2010.344; Chou R, 2009, SPINE, V34, P1078, DOI 10.1097/BRS.0b013e3181a103b1; Cohen SP, 2007, CLIN J PAIN, V23, P45, DOI 10.1097/01.ajp.0000210941.04182.ea; Cohen SP, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1088; Cohen SP, 2009, ANESTHESIOLOGY, V110, P1116, DOI 10.1097/ALN.0b013e3181a05aa0; Cohen SP, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2718; Crow WT, 2009, J AM OSTEOPATH ASSOC, V109, P229; Dahl E, 2008, CLIN J PAIN, V24, P172, DOI 10.1097/AJP.0b013e31815b32c8; DePalma MJ, 2008, SPINE J, V8, P45, DOI 10.1016/j.spinee.2007.09.009; Dobrydnjov I, 2002, ACTA ANAESTH SCAND, V46, P806, DOI 10.1034/j.1399-6576.2002.460709.x; Dogrul A, 2011, ACTA DIABETOL, V48, P135, DOI 10.1007/s00592-010-0237-x; El Sissi W, 2010, J INT MED RES, V38, P2135, DOI 10.1177/147323001003800629; Fairbank J C, 1980, Physiotherapy, V66, P271; Finckh A, 2006, SPINE, V31, P377, DOI 10.1097/01.brs.0000199917.04145.80; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Genevay S, 2011, ANN RHEUM DIS; Ghahreman A, 2010, PAIN MED, V11, P1149, DOI 10.1111/j.1526-4637.2010.00908.x; Houten John K, 2002, Spine J, V2, P70, DOI 10.1016/S1529-9430(01)00159-0; Igarashi T, 2000, SPINE, V25, P2975, DOI 10.1097/00007632-200012010-00003; Karppinen J, 2001, SPINE, V26, P1059, DOI 10.1097/00007632-200105010-00015; Keller RB, 1999, J BONE JOINT SURG AM, V81A, P752, DOI 10.2106/00004623-199906000-00002; Kennedy DJ, 2009, PAIN MED, V10, P1389, DOI 10.1111/j.1526-4637.2009.00728.x; Khoromi S, 2007, PAIN, V130, P66, DOI 10.1016/j.pain.2006.10.029; Komori H, 1998, SPINE, V23, P67, DOI 10.1097/00007632-199801010-00015; Koshi Edvin B, 2007, Pain Pract, V7, P4, DOI 10.1111/j.1533-2500.2007.00104.x; Kraemer J, 1997, Eur Spine J, V6, P357, DOI 10.1007/BF01142687; Kume K, 2008, ANN RHEUM DIS S, V67, P131; Malik K, 2007, ANAESTH INTENS CARE, V35, P301; Manchikanti Laxmaiah, 2004, Pain Physician, V7, P465; Manchikanti L, 2008, PAIN PHYSICIAN, V11, P801; Manchikanti L, 2008, PAIN PHYSICIAN, V11, P833; Novak S, 2008, ARCH PHYS MED REHAB, V89, P543, DOI 10.1016/j.apmr.2007.11.008; Okoro T, 2010, J SPINAL DISORD TECH, V23, P74, DOI 10.1097/BSD.0b013e31819afdc4; Olmarker K, 2003, SPINE, V28, P1635, DOI 10.1097/00007632-200308010-00002; Olmarker K, 2001, SPINE, V26, P863, DOI 10.1097/00007632-200104150-00007; Parr AT, 2009, PAIN PHYSICIAN, V12, P163; Peul WC, 2007, NEW ENGL J MED, V356, P2245, DOI 10.1056/NEJMoa064039; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE133, DOI 10.1097/00007632-200203010-00020; Quintao NLM, 2006, NEUROPHARMACOLOGY, V50, P614, DOI 10.1016/j.neuropharm.2005.11.007; Rabinovitch DL, 2009, SPINE J, V9, P509, DOI 10.1016/j.spinee.2009.03.003; Rathmell JP, 2004, ANESTHESIOLOGY, V100, P1595, DOI 10.1097/00000542-200406000-00035; RIDLEY MG, 1988, BRIT J RHEUMATOL, V27, P295; Riew KD, 2006, J BONE JOINT SURG AM, V88A, P1722, DOI 10.2106/JBJS.E.00278; Sayegh FE, 2009, SPINE, V34, P1441, DOI 10.1097/BRS.0b013e3181a4804a; Sibell David M, 2007, Curr Pain Headache Rep, V11, P14, DOI 10.1007/s11916-007-0016-8; Staal JB, 2009, SPINE, V34, P49, DOI 10.1097/BRS.0b013e3181909558; Taruilli AW, 2007, NEUROL CLIN, V25, P387, DOI 10.1016/j.ncl.2007.01.008; Thomas E, 2003, CLIN RHEUMATOL, V22, P299, DOI 10.1007/s10067-003-0736-z; Valat JP, 2010, BEST PRACT RES CL RH, V24, P241, DOI 10.1016/j.berh.2009.11.005; Valat JP, 2003, ANN RHEUM DIS, V62, P639, DOI 10.1136/ard.62.7.639; Watanabe K, 2011, EUR SPINE J, V20, P1877, DOI 10.1007/s00586-011-1854-y; Weiler C, 2005, SPINE, V30, P44, DOI 10.1097/01.brs.0000149186.63457.20; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441; Wilson-MacDonald J, 2005, J BONE JOINT SURG BR, V87B, P352, DOI 10.1302/0301-620X.87B3.15338	62	101	102	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2012	156	8					551	U154		10.7326/0003-4819-156-8-201204170-00397	http://dx.doi.org/10.7326/0003-4819-156-8-201204170-00397			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930PO	22508732				2022-12-28	WOS:000303151800014
J	Epstein, K				Epstein, Keith			Is spending on proton beam therapy for cancer going too far, too fast?	BRITISH MEDICAL JOURNAL			English	Editorial Material							COST-EFFECTIVENESS; RADIATION-THERAPY; PROSTATE					keith@kepstein.com						Chen R, 2012, JAMA            0418; Jakel O, 2007, RADIOTHER ONCOL, V83, P133, DOI 10.1016/j.radonc.2007.03.010; Kim S, 2011, EUR UROL, V60, P908, DOI 10.1016/j.eururo.2011.05.052; Konski A, 2007, J CLIN ONCOL, V25, P3603, DOI 10.1200/JCO.2006.09.0811; Lundkvist J, 2005, CANCER-AM CANCER SOC, V103, P793, DOI 10.1002/cncr.20844	5	11	12	0	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 17	2012	344								e2488	10.1136/bmj.e2488	http://dx.doi.org/10.1136/bmj.e2488			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	931CN	22511301				2022-12-28	WOS:000303192100019
J	Gibson, WT; Gibson, MC				Gibson, W. T.; Gibson, M. C.			Growing Cells Push Back under Pressure	CELL			English	Editorial Material							DROSOPHILA; GROWTH; ARABIDOPSIS	In both plants and animals, the interplay between mechanical force generation and mechanical sensing plays a stabilizing role in many developmental processes. Uyttewaal et al. now demonstrate that cells in the Arabidopsis shoot apical meristem respond to local mechanical stresses by reorienting their growth, thereby guiding morphogenesis. Notably, the mechanism underlying such guidance is amplification-not suppression-of growth-rate heterogeneity.	[Gibson, M. C.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Gibson, W. T.] CALTECH, Pasadena, CA 91125 USA; [Gibson, M. C.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; California Institute of Technology; University of Kansas; University of Kansas Medical Center	Gibson, MC (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	mg2@stowers.org						Aigouy B, 2010, CELL, V142, P773, DOI 10.1016/j.cell.2010.07.042; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Desprat N, 2008, DEV CELL, V15, P470, DOI 10.1016/j.devcel.2008.07.009; Dumais J, 2007, CURR OPIN PLANT BIOL, V10, P58, DOI 10.1016/j.pbi.2006.11.014; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Savin T, 2011, NATURE, V476, P57, DOI 10.1038/nature10277; Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102; Uyttewaal M, 2012, CELL, V149, P439, DOI 10.1016/j.cell.2012.02.048	10	5	5	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 13	2012	149	2					259	261		10.1016/j.cell.2012.03.019	http://dx.doi.org/10.1016/j.cell.2012.03.019			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500795	Bronze, Green Submitted			2022-12-28	WOS:000302805600007
J	Zeng, HK; Shen, EH; Hohmann, JG; Oh, SW; Bernard, A; Royall, JJ; Glattfelder, KJ; Sunkin, SM; Morris, JA; Guillozet-Bongaarts, AL; Smith, KA; Ebbert, AJ; Swanson, B; Kuan, L; Page, DT; Overly, CC; Lein, ES; Hawrylycz, MJ; Hof, PR; Hyde, TM; Kleinman, JE; Jones, AR				Zeng, Hongkui; Shen, Elaine H.; Hohmann, John G.; Oh, Seung Wook; Bernard, Amy; Royall, Joshua J.; Glattfelder, Katie J.; Sunkin, Susan M.; Morris, John A.; Guillozet-Bongaarts, Angela L.; Smith, Kimberly A.; Ebbert, Amanda J.; Swanson, Beryl; Kuan, Leonard; Page, Damon T.; Overly, Caroline C.; Lein, Ed S.; Hawrylycz, Michael J.; Hof, Patrick R.; Hyde, Thomas M.; Kleinman, Joel E.; Jones, Allan R.			Large-Scale Cellular-Resolution Gene Profiling in Human Neocortex Reveals Species-Specific Molecular Signatures	CELL			English	Article							HUMAN BRAIN; COPY NUMBER; EVOLUTION; EXPRESSION; TRANSCRIPTOME; NEURONS; INSIGHTS; GENOME; INTERNEURONS; PATTERNS	Although there have been major advances in elucidating the functional biology of the human brain, relatively little is known of its cellular and molecular organization. Here we report a large-scale characterization of the expression of similar to 1,000 genes important for neural functions by in situ hybridization at a cellular resolution in visual and temporal cortices of adult human brains. These data reveal diverse gene expression patterns and remarkable conservation of each individual gene's expression among individuals (95%), cortical areas (84%), and between human and mouse (79%). A small but substantial number of genes (21%) exhibited species-differential expression. Distinct molecular signatures, comprised of genes both common between species and unique to each, were identified for each major cortical cell type. The data suggest that gene expression profile changes may contribute to differential cortical function across species, and in particular, a shift from corticosubcortical to more predominant corticocortical communications in the human brain.	[Zeng, Hongkui; Shen, Elaine H.; Hohmann, John G.; Oh, Seung Wook; Bernard, Amy; Royall, Joshua J.; Glattfelder, Katie J.; Sunkin, Susan M.; Morris, John A.; Guillozet-Bongaarts, Angela L.; Smith, Kimberly A.; Ebbert, Amanda J.; Swanson, Beryl; Kuan, Leonard; Page, Damon T.; Overly, Caroline C.; Lein, Ed S.; Hawrylycz, Michael J.; Jones, Allan R.] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Hof, Patrick R.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA; [Hof, Patrick R.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY 10029 USA; [Hyde, Thomas M.] Lieber Inst Brain Dev, Baltimore, MD 21205 USA; [Hyde, Thomas M.; Kleinman, Joel E.] NIMH, Sect Neuropathol, Clin Brain Disorders Branch,NIH, Genes Cognit & Psychosis Program,Intramural Res P, Bethesda, MD 20892 USA	Allen Institute for Brain Science; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Zeng, HK (corresponding author), Allen Inst Brain Sci, Seattle, WA 98103 USA.	hongkuiz@alleninstitute.org; allanj@alleninstitute.org		Bernard, Amy/0000-0003-2540-1153; OH, SEUNG WOOK/0000-0001-7632-6822	Allen Institute for Brain Science; Allen Institute	Allen Institute for Brain Science; Allen Institute	We are grateful for the technical support and expertise of the Atlas Production Team, led by Paul Wohnoutka, and the Information Technology Team, led by Chinh Dang, at the Allen Institute, without which the work would have not been accomplished. We thank Drs. Deborah Mash and Margaret Basile of the University of Miami Brain Endowment Bank for providing tissue. This work was funded by the Allen Institute for Brain Science. The authors wish to thank the Allen Institute founders, Paul G. Allen and Jody Allen, for their vision, encouragement, and support.	Abrahams BS, 2007, P NATL ACAD SCI USA, V104, P17849, DOI 10.1073/pnas.0706128104; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Ayoub AE, 2009, CEREB CORTEX, V19, P1705, DOI 10.1093/cercor/bhp025; Burki F, 2004, NAT GENET, V36, P1061, DOI 10.1038/ng1431; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Carroll SB, 2003, NATURE, V422, P849, DOI 10.1038/nature01495; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gilbert SL, 2005, NAT REV GENET, V6, P581, DOI 10.1038/nrg1634; Gu JY, 2003, TRENDS GENET, V19, P63, DOI 10.1016/S0168-9525(02)00040-9; Herculano-Houzel S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.031.2009; Hoerder-Suabedissen A, 2009, CEREB CORTEX, V19, P1738, DOI 10.1093/cercor/bhn195; HOF PR, 1995, J COMP NEUROL, V362, P109, DOI 10.1002/cne.903620107; Hurd YL, 2000, J COMP NEUROL, V425, P583, DOI 10.1002/1096-9861(20001002)425:4<583::AID-CNE8>3.0.CO;2-#; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Khaitovich P, 2006, NAT REV GENET, V7, P693, DOI 10.1038/nrg1940; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lipska BK, 2006, BIOL PSYCHIAT, V60, P650, DOI 10.1016/j.biopsych.2006.06.019; Suarez-Sola ML, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.007.2009; MARINPADILLA M, 1992, J COMP NEUROL, V321, P223, DOI 10.1002/cne.903210205; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Mazziotta J, 2001, J AM MED INFORM ASSN, V8, P401, DOI 10.1136/jamia.2001.0080401; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Morris JA, 2010, P NATL ACAD SCI USA, V107, P19049, DOI 10.1073/pnas.1003732107; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Petanjek Z, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.026.2009; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Popesco MC, 2006, SCIENCE, V313, P1304, DOI 10.1126/science.1127980; Preuss TM, 2004, NAT REV GENET, V5, P850, DOI 10.1038/nrg1469; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sikela JM, 2006, PLOS GENET, V2, P646, DOI 10.1371/journal.pgen.0020080; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Vallender EJ, 2008, TRENDS NEUROSCI, V31, P637, DOI 10.1016/j.tins.2008.08.010; Varki A, 2008, NAT REV GENET, V9, P749, DOI 10.1038/nrg2428; Yu Frank H, 2004, Sci STKE, V2004, pre15, DOI 10.1126/stke.2532004re15; Zaitsev AV, 2009, CEREB CORTEX, V19, P1597, DOI 10.1093/cercor/bhn198	46	215	216	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 13	2012	149	2					483	496		10.1016/j.cell.2012.02.052	http://dx.doi.org/10.1016/j.cell.2012.02.052			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500809	Bronze, Green Accepted			2022-12-28	WOS:000302805600024
J	Colliex, C				Colliex, Christian			Watching Solution Growth of Nanoparticles in Graphene Cells	SCIENCE			English	Editorial Material							MICROSCOPY		Univ Paris 11, Phys Solides Lab, CNRS, UMR 8502, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay	Colliex, C (corresponding author), Univ Paris 11, Phys Solides Lab, CNRS, UMR 8502, Batiment 510, F-91405 Orsay, France.	christian.colliex@u-psud.fr						de Jonge N, 2009, P NATL ACAD SCI USA, V106, P2159, DOI 10.1073/pnas.0809567106; de Jonge N, 2011, NAT NANOTECHNOL, V6, P695, DOI [10.1038/NNANO.2011.161, 10.1038/nnano.2011.161]; Erni R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.096101; Grogan JM, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.061405; Muller DA, 2008, SCIENCE, V319, P1073, DOI 10.1126/science.1148820; Okazaki T, 2011, ANGEW CHEM INT EDIT, V50, P4853, DOI 10.1002/anie.201007832; Radisic A, 2006, NANO LETT, V6, P238, DOI 10.1021/nl052175i; Ruska E, 1942, KOLLOID Z, V100, P212, DOI 10.1007/BF01519549; Suenaga K, 2000, SCIENCE, V290, P2280, DOI 10.1126/science.290.5500.2280; Yuk JM, 2012, SCIENCE, V336, P61, DOI 10.1126/science.1217654; Yuk JM, 2011, NANO LETT, V11, P3290, DOI 10.1021/nl201647p; Zagonel LF, 2011, NANO LETT, V11, P568, DOI 10.1021/nl103549t; Zheng HM, 2009, SCIENCE, V324, P1309, DOI 10.1126/science.1172104	13	16	16	2	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2012	336	6077					44	45		10.1126/science.1219835	http://dx.doi.org/10.1126/science.1219835			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920LG	22491844				2022-12-28	WOS:000302405400043
J	Shapiro, BJ; Friedman, J; Cordero, OX; Preheim, SP; Timberlake, SC; Szabo, G; Polz, MF; Alm, EJ				Shapiro, B. Jesse; Friedman, Jonathan; Cordero, Otto X.; Preheim, Sarah P.; Timberlake, Sonia C.; Szabo, Gitta; Polz, Martin F.; Alm, Eric J.			Population Genomics of Early Events in the Ecological Differentiation of Bacteria	SCIENCE			English	Article							FUNDAMENTAL UNITS; RECOMBINATION; SELECTION	Genetic exchange is common among bacteria, but its effect on population diversity during ecological differentiation remains controversial. A fundamental question is whether advantageous mutations lead to selection of clonal genomes or, as in sexual eukaryotes, sweep through populations on their own. Here, we show that in two recently diverged populations of ocean bacteria, ecological differentiation has occurred akin to a sexual mechanism: A few genome regions have swept through subpopulations in a habitat-specific manner, accompanied by gradual separation of gene pools as evidenced by increased habitat specificity of the most recent recombinations. These findings reconcile previous, seemingly contradictory empirical observations of the genetic structure of bacterial populations and point to a more unified process of differentiation in bacteria and sexual eukaryotes than previously thought.	[Cordero, Otto X.; Preheim, Sarah P.; Szabo, Gitta; Polz, Martin F.; Alm, Eric J.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Shapiro, B. Jesse; Friedman, Jonathan; Alm, Eric J.] MIT, Program Computat & Syst Biol, Cambridge, MA 02139 USA; [Shapiro, B. Jesse; Alm, Eric J.] Broad Inst, Cambridge, MA 02142 USA; [Timberlake, Sonia C.; Alm, Eric J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Polz, MF (corresponding author), MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA.	mpolz@mit.edu; ejalm@mit.edu	Polz, Martin/ABE-7199-2020; Friedman, Jonathan/I-6930-2019; Shapiro, B. Jesse/U-9337-2019; Preheim, Sarah P/B-3432-2010	Friedman, Jonathan/0000-0001-8476-8030; Shapiro, B. Jesse/0000-0001-6819-8699; Preheim, Sarah P/0000-0001-7365-2382; /0000-0001-9296-3733; Szabo, Gitta/0000-0002-0397-3022; Polz, Martin/0000-0002-4975-2946	NSF [DEB-0918333, 0821391]; Gordon and Betty Moore Foundation; Department of Energy Genomes; Moore Foundation; Broad Institute; Natural Sciences and Engineering Research Council of Canada; Harvard MIDAS Center for Communicable Disease Dynamics; Merck-MIT; Netherlands Organisation for Scientific Research; Rosztoczy Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER; Division Of Ocean Sciences [0911031] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Department of Energy Genomes(United States Department of Energy (DOE)); Moore Foundation(Gordon and Betty Moore Foundation); Broad Institute; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Harvard MIDAS Center for Communicable Disease Dynamics; Merck-MIT(Merck & Company); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Rosztoczy Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank E. DeLong, S. W. Chisholm, J. Wakeley, P. Sabeti, W. Hanage, D. Neafsey, and M. Coleman for valuable suggestions and comments, and X. Didelot and P. Marttinen for help with software. Funding for this work was provided by NSF grant DEB-0918333 (to E.J.A. and M.F.P.), the NSF-supported Woods Hole Center for Oceans and Human Health (COOH), and grants from the Gordon and Betty Moore Foundation and the Department of Energy Genomes to Life program (M.F.P.). Funding for genome sequencing was provided by the Moore Foundation and the Broad Institute's SPARC program. Computational resources were provided by NSF grant 0821391. Support was provided by a Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada and a postdoctoral fellowship from the Harvard MIDAS Center for Communicable Disease Dynamics (B.J.S.); a Merck-MIT fellowship (J.F.); the Netherlands Organisation for Scientific Research (O.X.C.); and the Rosztoczy Foundation (G.S.). Whole genomes sequences have been deposited at the DNA Data Bank of Japan, European Molecular Biology Laboratory, and GenBank under accessions AHTI00000000, AICZ00000000, and AIDA00000000-AIDS00000000 (table S6).	Bisharat N, 2005, EMERG INFECT DIS, V11, P30, DOI 10.3201/eid1101.040440; Chiavelli DA, 2001, APPL ENVIRON MICROB, V67, P3220, DOI 10.1128/AEM.67.7.3220-3225.2001; Cohan FM, 2007, CURR BIOL, V17, pR373, DOI 10.1016/j.cub.2007.03.032; Coleman ML, 2010, P NATL ACAD SCI USA, V107, P18634, DOI 10.1073/pnas.1009480107; Denef VJ, 2010, ISME J, V4, P599, DOI 10.1038/ismej.2009.158; Denef VJ, 2010, P NATL ACAD SCI USA, V107, P2383, DOI 10.1073/pnas.0907041107; DYKHUIZEN DE, 1991, J BACTERIOL, V173, P7257, DOI 10.1128/jb.173.22.7257-7268.1991; Eppley JM, 2007, GENETICS, V177, P407, DOI 10.1534/genetics.107.072892; Falush D, 2006, PHILOS T R SOC B, V361, P2045, DOI 10.1098/rstb.2006.1925; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; GUTTMAN DS, 1994, GENETICS, V138, P993; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; King T, 2004, J BACTERIOL, V186, P5614, DOI 10.1128/JB.186.17.5614-5620.2004; Koeppel A, 2008, P NATL ACAD SCI USA, V105, P2504, DOI 10.1073/pnas.0712205105; Lawrence JG, 2002, THEOR POPUL BIOL, V61, P449, DOI 10.1006/tpbi.2002.1587; Majewski J, 2001, FEMS MICROBIOL LETT, V199, P161, DOI 10.1016/S0378-1097(01)00183-5; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; Neafsey DE, 2010, SCIENCE, V330, P514, DOI 10.1126/science.1193036; Papke RT, 2007, P NATL ACAD SCI USA, V104, P14092, DOI 10.1073/pnas.0706358104; Preheim SP, 2011, APPL ENVIRON MICROB, V77, P7195, DOI 10.1128/AEM.00665-11; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Satchell KJF, 2011, ANNU REV MICROBIOL, V65, P71, DOI 10.1146/annurev-micro-090110-102943; Shapiro BJ, 2009, TRENDS MICROBIOL, V17, P196, DOI 10.1016/j.tim.2009.02.002; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Visick KL, 2009, MOL MICROBIOL, V74, P782, DOI 10.1111/j.1365-2958.2009.06899.x	25	335	337	4	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2012	336	6077					48	51		10.1126/science.1218198	http://dx.doi.org/10.1126/science.1218198			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920LG	22491847	Green Accepted, Green Submitted			2022-12-28	WOS:000302405400046
J	Qaseem, A; Forland, F; Macbeth, F; Ollenschlager, G; Phillips, S; van der Wees, P				Qaseem, Amir; Forland, Frode; Macbeth, Fergus; Ollenschlaeger, Guenter; Phillips, Sue; van der Wees, Philip		Board Trustees Guidelines Int Netw	Guidelines International Network: Toward International Standards for Clinical Practice Guidelines	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-CARE; QUALITATIVE RESEARCH; SYSTEMATIC REVIEWS; AMERICAN-COLLEGE; RECOMMENDATIONS; IMPLEMENTATION; STRENGTH; CONSENSUS; GRADE; APPROPRIATENESS	Guideline development processes vary substantially, and many guidelines do not meet basic quality criteria. Standards for guideline development can help organizations ensure that recommendations are evidence-based and can help users identify high-quality guidelines. Such organizations as the U. S. Institute of Medicine and the United Kingdom's National Institute for Health and Clinical Excellence have developed recommendations to define trustworthy guidelines within their locales. Many groups charged with guideline development find the lengthy list of standards developed by such organizations to be aspirational but infeasible to follow in entirety. Founded in 2002, the Guidelines International Network (G-I-N) is a network of guideline developers that includes 93 organizations and 89 individual members representing 46 countries. The G-I-N board of trustees recognized the importance of guideline development processes that are both rigorous and feasible even for modestly funded groups to implement and initiated an effort toward consensus about minimum standards for high-quality guidelines. In contrast to other existing standards for guideline development at national or local levels, the key components proposed by G-I-N will represent the consensus of an international, multidisciplinary group of active guideline developers. This article presents G-I-N's proposed set of key components for guideline development. These key components address panel composition, decision-making process, conflicts of interest, guideline objective, development methods, evidence review, basis of recommendations, ratings of evidence and recommendations, guideline review, updating processes, and funding. It is hoped that this article promotes discussion and eventual agreement on a set of international standards for guideline development.	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA	American College of Physicians	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	aqaseem@acponline.org	van der Wees, Philip Jan/L-4748-2015	Ollenschlaeger, Guenter/0000-0002-8929-808X; Phillips, Susan/0000-0001-7336-2190	G-I-N's operating budget	G-I-N's operating budget	From G-I-N's operating budget.	American College of Cardiology Foundation and American Heart Association, 2010, METH MAN POL ACCF AH; American Society of Clinical Oncology, 2011, AM SOC CLIN ONC GUID; [Anonymous], RES POLICY; [Anonymous], 2001, APPRAISAL GUIDELINES; Ansari MT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000151; Atkins D, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-38; Atkins D, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-25; Baumann MH, 2007, CHEST, V132, P1015, DOI 10.1378/chest.07-1271; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE472, DOI 10.1503/cmaj.091716; Browman GP, 2010, J SURG ONCOL, V101, P1, DOI 10.1002/jso.21419; Browman GP, 2000, INT J TECHNOL ASSESS, V16, P959, DOI 10.1017/S0266462300103034; Burgers JS, 2003, INT J QUAL HEALTH C, V15, P31, DOI 10.1093/intqhc/15.1.31; Burgers JS, 2003, BRIT J GEN PRACT, V53, P15; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Calderon C, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-138; Calogne N, 2010, US PREVENTIVE SERVIC; CARTER AO, 1995, CAN MED ASSOC J, V153, P901; Christiaens T, 2004, SCAND J PRIM HEALTH, V22, P141, DOI 10.1080/02813430410006521; Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18; Committee of Ministers of the Council of Europe, 2001, DEV METH DRAW GUID B; Cook DJ, 1997, ANN INTERN MED, V127, P210, DOI 10.7326/0003-4819-127-3-199708010-00006; Cook DJ, 1997, ANN INTERN MED, V126, P376, DOI 10.7326/0003-4819-126-5-199703010-00006; Davis D, 2007, HDB CLIN PRACTICE GU; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Eccles M, 2008, SYSTEMATIC REV HLTH, P400; Edlund W, 2004, AM ACAD NEUROLOGY CL; Fervers B, 2005, INT J QUAL HEALTH C, V17, P123, DOI 10.1093/intqhc/mzi011; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; Francke Anneke L, 2008, BMC Med Inform Decis Mak, V8, P38, DOI 10.1186/1472-6947-8-38; Freeman AC, 2001, BRIT MED J, V323, P1100, DOI 10.1136/bmj.323.7321.1100; FRETHEIM A, 2006, HEALTH RES POLICY SY, V4, P15, DOI DOI 10.1186/1478-4505-4-15; Gabbay J, 2004, BRIT MED J, V329, P1013, DOI 10.1136/bmj.329.7473.1013; Garfield FB, 2000, INT J TECHNOL ASSESS, V16, P1050, DOI 10.1017/S0266462300103113; Giacomini M. K, 2001, EVIDENCE BASED MED, V6, P4, DOI DOI 10.1136/EBM.6.1.4; Graham Ian D, 2005, Evid Based Nurs, V8, P68, DOI 10.1136/ebn.8.3.68; Green J, 1998, BMJ-BRIT MED J, V316, P1230, DOI 10.1136/bmj.316.7139.1230; Greenhalgh T, 1996, BRIT MED J, V313, P957; Griffiths F, 2005, BMJ-BRIT MED J, V330, P511, DOI 10.1136/bmj.38336.482720.8F; Grilli R, 2000, LANCET, V355, P103, DOI 10.1016/S0140-6736(99)02171-6; Grimshaw J, 1995, J Eval Clin Pract, V1, P37, DOI 10.1111/j.1365-2753.1995.tb00006.x; Grimshaw J, 1995, Qual Health Care, V4, P55, DOI 10.1136/qshc.4.1.55; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Grol R, 2003, BRIT J CANCER, V89, pS4, DOI 10.1038/sj.bjc.6601077; Grol R, 1998, BRIT MED J, V317, P858, DOI 10.1136/bmj.317.7162.858; Gross PA, 2001, MED CARE, V39, pII85; Grupo de trabajo sobre GPC, 2007, ELABORACION GUIAS PR; Guidelines International Network, DEV TRAIN RES; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; HAINES A, 1994, BMJ-BRIT MED J, V308, P1488, DOI 10.1136/bmj.308.6942.1488; Harris JS, 2008, J OCCUP ENVIRON MED, V50, P282, DOI 10.1097/JOM.0b013e3181651613; Harrison MB, 2010, CAN MED ASSOC J, V182, pE78, DOI 10.1503/cmaj.081232; Hayward R S, 1993, Ann Intern Med, V118, P731; Heathfield H, 1998, BRIT MED J, V316, P1959, DOI 10.1136/bmj.316.7149.1959; Heffner JE, 1997, AM J RESP CRIT CARE, V156, P2015, DOI 10.1164/ajrccm.156.6.ats9-97; Hutchings Andrew, 2006, J Health Serv Res Policy, V11, P172, DOI 10.1258/135581906777641659; Institute of Medicine, 2011, CLIN PRACT GUID WE C; Institute of Medicine, 2011, FIND WHAT WORKS HEAL; Institute of Medicine, 2009, CONFL INT MED RES ED; Jaime J, 2005, INT J TECHNOL ASSESS, V16, P957; Kahan JP, 1996, MED CARE, V34, P512, DOI 10.1097/00005650-199606000-00002; Kavanagh BP, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000094; Krahn M, 2008, JAMA-J AM MED ASSOC, V300, P436, DOI 10.1001/jama.300.4.436; Kuehn BM, 2011, JAMA-J AM MED ASSOC, V305, P1846, DOI 10.1001/jama.2011.597; LEWIS S, 1995, CAN MED ASSOC J, V153, P1073; Lomotan EA, 2010, QUAL SAF HEALTH CARE, V19, P509, DOI 10.1136/qshc.2009.032565; MCDONALD CJ, 1994, JAMA-J AM MED ASSOC, V271, P872, DOI 10.1001/jama.271.11.872; McGory ML, 2005, J AM COLL SURGEONS, V201, P870, DOI 10.1016/j.jamcollsurg.2005.07.009; Mlika-Cabanne N, 2011, BMJ QUAL SAF, V20, P141, DOI 10.1136/bmjqs.2010.040923; Moreira T, 2005, SOC SCI MED, V60, P1975, DOI 10.1016/j.socscimed.2004.08.062; Murphy E., 1998, HLTH TECHNOLOGY ASSE, V2, P1, DOI DOI 10.3310/HTA2160; National Health and Medical Research Council, 2009, NHMRC LEVELS EVIDENC; National Health and Medical Research Council, 1999, GUID DEV IMPL EV CLI; National Health and Medical Research Council Australia, 2011, PROC REQ M 2011 NHMR; Ollenschlager G, 2004, QUAL SAF HEALTH CARE, V13, P455, DOI 10.1136/qshc.2003.009761; Owens DK, 2011, ANN INTERN MED, V154, P638, DOI 10.7326/0003-4819-154-9-201105030-00010; Oxman AD, 2007, 112007 NORW KNOWL CT; Oxman Andrew D, 2006, Health Res Policy Syst, V4, P14, DOI 10.1186/1478-4505-4-14; Oxman Andrew D, 2006, Health Res Policy Syst, V4, P20, DOI 10.1186/1478-4505-4-20; Oxman Andrew D, 2006, Health Res Policy Syst, V4, P19, DOI 10.1186/1478-4505-4-19; Pagliari C, 2002, J EVAL CLIN PRACT, V8, P145, DOI 10.1046/j.1365-2753.2002.00333.x; Pagliari C, 2001, J EVAL CLIN PRACT, V7, P165, DOI 10.1046/j.1365-2753.2001.00272.x; Popay J, 1998, J ROY SOC MED, V91, P32, DOI 10.1177/014107689809135S08; Pronovost P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1714; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Qaseem A, 2010, ANN INTERN MED, V152, P366, DOI 10.7326/0003-4819-152-6-201003160-00006; Raine R, 2005, BMJ-BRIT MED J, V331, P631, DOI 10.1136/bmj.331.7517.631; Rosenfeld Richard M, 2006, Otolaryngol Head Neck Surg, V135, pS1, DOI 10.1016/j.otohns.2006.06.1277; Rosenfeld RM, 2009, OTOLARYNG HEAD NECK, V140, P1, DOI 10.1016/j.otohns.2008.11.024; Rubenstein LV, 2006, J GEN INTERN MED, V21, pS58, DOI 10.1111/j.1525-1497.2006.00364.x; Rycroft-Malone J, 2001, QUAL HEALTH CARE, V10, P238, DOI 10.1136/qhc.0100238..; Schunemann Holger J, 2006, Health Res Policy Syst, V4, P21, DOI 10.1186/1478-4505-4-21; Schunemann Holger J, 2006, Health Res Policy Syst, V4, P25, DOI 10.1186/1478-4505-4-25; Schunemann Holger J, 2006, Health Res Policy Syst, V4, P22, DOI 10.1186/1478-4505-4-22; Scottish Intercollegiate Guidelines Network, 2008, SIGN 50 GUID DEV HDB; Shaneyfelt TM, 2009, JAMA-J AM MED ASSOC, V301, P868, DOI 10.1001/jama.2009.225; Shaneyfelt TM, 1999, JAMA-J AM MED ASSOC, V281, P1900, DOI 10.1001/jama.281.20.1900; Shekelle PG, 1996, HEALTH SERV RES, V31, P453; Shekelle PG, 2000, HEALTH SERV RES, V34, P1429; Shekelle PG, 1999, BRIT MED J, V318, P593, DOI 10.1136/bmj.318.7183.593; Shiffman RN, 2003, ANN INTERN MED, V139, P493, DOI 10.7326/0003-4819-139-6-200309160-00013; Shiffman RN, 2005, BMC MED INFORM DECIS, V5, P23, DOI [10.1186/1472-6947-5-23, DOI 10.1186/1472-6947-5-23]; The Intensive Care Society, 2010, SSQ COMM GUID POL; The National Institute for Health and Clinical Excellence, 2009, GUID MAN JAN 2009; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; Van der Wees PJ, 2011, PHYS THER, V91, P1551, DOI 10.2522/ptj.20100305; Wedzicha W, 2011, BREATHE, V8, P9, DOI 10.1183/20734735.012011; Winn Rodger J, 2003, J Natl Compr Canc Netw, V1, P5; WOOLF SH, 1992, ARCH INTERN MED, V152, P946, DOI 10.1001/archinte.152.5.946; Woolf SH, 1996, ANNU REV PUBL HEALTH, V17, P511, DOI 10.1146/annurev.pu.17.050196.002455; World Health Organization, 2003, GLOB PROGR EV HTLH P	112	494	527	0	27	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2012	156	7					525	U103		10.7326/0003-4819-156-7-201204030-00009	http://dx.doi.org/10.7326/0003-4819-156-7-201204030-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	921GP	22473437				2022-12-28	WOS:000302466400006
J	Hiess, J; Condon, DJ; McLean, N; Noble, SR				Hiess, Joe; Condon, Daniel J.; McLean, Noah; Noble, Stephen R.			U-238/U-235 Systematics in Terrestrial Uranium-Bearing Minerals	SCIENCE			English	Article							DECAY CONSTANTS; ISOTOPIC COMPOSITION; FRACTIONATION; CM-247; GEOCHRONOLOGY; ABUNDANCE; ANOXIA	The present-day U-238/U-235 ratio has fundamental implications for uranium-lead geochronology and cosmochronology. A value of 137.88 has previously been considered invariant and has been used without uncertainty to calculate terrestrial mineral ages. We report high-precision U-238/U-235 measurements for a suite of uranium-bearing minerals from 58 samples representing a diverse range of lithologies. This data set exhibits a range in U-238/U-235 values of >5 per mil, with no clear relation to any petrogenetic, secular, or regional trends. Variation between comagmatic minerals suggests that U-238/U-235 fractionation processes operate at magmatic temperatures. A mean U-238/U-235 value of 137.818 +/- 0.045 (2 sigma) in zircon samples reflects the average uranium isotopic composition and variability of terrestrial zircon. This distribution is broadly representative of the average crustal and "bulk Earth" U-238/U-235 composition.	[Hiess, Joe; Condon, Daniel J.; Noble, Stephen R.] British Geol Survey, NERC Isotope Geosci Lab, Keyworth NG12 5GG, Notts, England; [McLean, Noah] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; Massachusetts Institute of Technology (MIT)	Hiess, J (corresponding author), British Geol Survey, NERC Isotope Geosci Lab, Keyworth NG12 5GG, Notts, England.	jies@bgs.ac.uk	McLean, Noah/H-5770-2012; Condon, Daniel/A-4249-2008	Condon, Daniel/0000-0002-9082-3283; McLean, Noah/0000-0003-0388-1862; Noble, Stephen/0000-0002-8966-2048	UK Natural Environment Research Council (NERC) [NE/C517909/1, IP/1028/0508]; European Community [215458]; NSF [EAR 0451802]; Natural Environment Research Council [NE/C517909/1] Funding Source: researchfish	UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Community(European Commission); NSF(National Science Foundation (NSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Supported by the UK Natural Environment Research Council (NERC) (fellowship NE/C517909/1, NERC Isotope Geosciences Facilities Steering Committee award IP/1028/0508, and recurrent support to the NERC Isotope Geoscience Laboratory), the European Community's Seventh Framework Programme (FP7/2007-2013) grant agreement 215458, and NSF award EAR 0451802 (the EARTHTIME project). We thank N. Atkinson, M. Horstwood, and N. Roberts for assistance in the laboratory; J. Aleinikoff, J. Boyce, D. Chew, P. Fitzgerald, D. Kimbrough, C. Kirkland, J. Mattinson, R. Parrish, P. Renne, N. Reyner, G. Rossmann, M. Schmitz, K. Sircombe, M. Wingate, and J. Woodhead for provision of samples; GEUS (Denmark) for permission to publish data on 492118/20; S. Bowring, R. Parrish, B. Schoene, M. Schmitz, J. Mattinson, and others for discussions; and three reviewers for helpful comments.	Amelin Y, 2005, SCIENCE, V310, P839, DOI 10.1126/science.1117919; Amelin Y, 2010, EARTH PLANET SC LETT, V300, P343, DOI 10.1016/j.epsl.2010.10.015; Bigeleisen J, 1996, P NATL ACAD SCI USA, V93, P9393, DOI 10.1073/pnas.93.18.9393; BLAKE JB, 1973, NATURE-PHYS SCI, V243, P138, DOI 10.1038/physci243138a0; BLAKE JB, 1973, NATURE-PHYS SCI, V242, P98, DOI 10.1038/physci242098a0; Bopp CJ, 2009, GEOLOGY, V37, P611, DOI 10.1130/G25550A.1; Bouvier A, 2011, GEOCHIM COSMOCHIM AC, V75, P5310, DOI 10.1016/j.gca.2011.06.033; Brennecka GA, 2010, SCIENCE, V327, P449, DOI 10.1126/science.1180871; Brennecka GA, 2011, P NATL ACAD SCI USA, V108, P17631, DOI 10.1073/pnas.1106039108; Brennecka GA, 2011, ENVIRON SCI TECHNOL, V45, P1370, DOI 10.1021/es103061v; Brennecka GA, 2010, EARTH PLANET SC LETT, V291, P228, DOI 10.1016/j.epsl.2010.01.023; Buchachenko AL, 2001, J PHYS CHEM A, V105, P9995, DOI 10.1021/jp011261d; Chabaux F, 2003, REV MINERAL GEOCHEM, V52, P533, DOI 10.2113/0520533; CHEN JH, 1986, EARTH PLANET SC LETT, V80, P241, DOI 10.1016/0012-821X(86)90108-1; Condon DJ, 2010, GEOCHIM COSMOCHIM AC, V74, P7127, DOI 10.1016/j.gca.2010.09.019; COWAN GA, 1976, GEOCHIM COSMOCHIM AC, V40, P1487, DOI 10.1016/0016-7037(76)90087-9; De Laeter JR, 2003, PURE APPL CHEM, V75, P683, DOI 10.1351/pac200375060683; DOE BR, 1965, AM MINERAL, V50, P613; JAFFEY AH, 1971, PHYS REV C, V4, P1889, DOI 10.1103/PhysRevC.4.1889; Keegan E, 2008, APPL GEOCHEM, V23, P765, DOI 10.1016/j.apgeochem.2007.12.004; KIGOSHI K, 1971, SCIENCE, V173, P47, DOI 10.1126/science.173.3991.47; Mattinson J. M., 2000, EOS AGU SPRING M S; Mattinson JM, 2010, CHEM GEOL, V275, P186, DOI 10.1016/j.chemgeo.2010.05.007; Montoya-Pino C, 2010, GEOLOGY, V38, P315, DOI 10.1130/G30652.1; Nebel O, 2011, EARTH PLANET SC LETT, V301, P1, DOI 10.1016/j.epsl.2010.11.004; Renne PR, 2010, GEOCHIM COSMOCHIM AC, V74, P5349, DOI 10.1016/j.gca.2010.06.017; Richter S, 2008, INT J MASS SPECTROM, V269, P145, DOI 10.1016/j.ijms.2007.09.012; Richter S, 1999, INT J MASS SPECTROM, V193, P9, DOI 10.1016/S1387-3806(99)00102-5; Rudge JF, 2010, NAT GEOSCI, V3, P439, DOI 10.1038/NGEO872; Schauble EA, 2007, GEOCHIM COSMOCHIM AC, V71, P2170, DOI 10.1016/j.gca.2007.02.004; Scherer E, 2001, SCIENCE, V293, P683, DOI 10.1126/science.1061372; Schoene B, 2006, GEOCHIM COSMOCHIM AC, V70, P426, DOI 10.1016/j.gca.2005.09.007; Selby D, 2005, EARTH PLANET SC LETT, V235, P1, DOI 10.1016/j.epsl.2005.02.018; Soderlund U, 2004, EARTH PLANET SC LETT, V219, P311, DOI 10.1016/S0012-821X(04)00012-3; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P359, DOI 10.1016/0012-821X(77)90060-7; Stirling CH, 2005, GEOCHIM COSMOCHIM AC, V69, P1059, DOI 10.1016/j.gca.2004.06.034; Stirling CH, 2007, EARTH PLANET SC LETT, V264, P208, DOI 10.1016/j.epsl.2007.09.019; Stirling CH, 2006, EARTH PLANET SC LETT, V251, P386, DOI 10.1016/j.epsl.2006.09.023; Vermeesch P, 2010, CHEM GEOL, V271, P108, DOI 10.1016/j.chemgeo.2010.01.002; Weyer S, 2008, GEOCHIM COSMOCHIM AC, V72, P345, DOI 10.1016/j.gca.2007.11.012	40	429	441	4	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1610	1614		10.1126/science.1215507	http://dx.doi.org/10.1126/science.1215507			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461608	Green Submitted, Green Accepted			2022-12-28	WOS:000302062600041
J	Li, H; Opgenorth, PH; Wernick, DG; Rogers, S; Wu, TY; Higashide, W; Malati, P; Huo, YX; Cho, KM; Liao, JC				Li, Han; Opgenorth, Paul H.; Wernick, David G.; Rogers, Steve; Wu, Tung-Yun; Higashide, Wendy; Malati, Peter; Huo, Yi-Xin; Cho, Kwang Myung; Liao, James C.			Integrated Electromicrobial Conversion of CO2 to Higher Alcohols	SCIENCE			English	Article							ESCHERICHIA-COLI; CARBON-DIOXIDE; FORMIC-ACID; REDUCTION		[Li, Han; Wernick, David G.; Wu, Tung-Yun; Liao, James C.] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA; [Li, Han; Liao, James C.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA; [Opgenorth, Paul H.; Liao, James C.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Rogers, Steve; Higashide, Wendy; Huo, Yi-Xin; Cho, Kwang Myung] Easel Biotechnol, Los Angeles, CA 90024 USA; [Malati, Peter] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA; [Liao, James C.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Liao, JC (corresponding author), Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA.	liaoj@seas.ucla.edu		Liao, James/0000-0002-4580-7276; huo, yixin/0000-0003-4644-999X	Advanced Research Projects Agency-Energy (ARPA-E)	Advanced Research Projects Agency-Energy (ARPA-E)(United States Department of Energy (DOE))	This work is supported by the Electrofuel program of Advanced Research Projects Agency-Energy (ARPA-E).	Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Atsumi S, 2010, APPL MICROBIOL BIOT, V85, P651, DOI 10.1007/s00253-009-2085-6; Blankenship RE, 2011, SCIENCE, V332, P805, DOI 10.1126/science.1200165; IKEDA S, 1987, B CHEM SOC JPN, V60, P2517, DOI 10.1246/bcsj.60.2517; Mehdi H, 2008, TOP CATAL, V48, P49, DOI 10.1007/s11244-008-9047-6; Michan C, 1999, J BACTERIOL, V181, P2759; Pohlmann A, 2000, MOL MICROBIOL, V38, P626, DOI 10.1046/j.1365-2958.2000.02157.x; TOUATI D, 1988, J BACTERIOL, V170, P2511, DOI 10.1128/jb.170.6.2511-2520.1988; UDUPA KS, 1971, ELECTROCHIM ACTA, V16, P1593, DOI 10.1016/0013-4686(71)80028-2	9	447	478	29	671	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1596	1596		10.1126/science.1217643	http://dx.doi.org/10.1126/science.1217643			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461604				2022-12-28	WOS:000302062600036
J	Rankin, EB; Wu, C; Khatri, R; Wilson, TLS; Andersen, R; Araldi, E; Rankin, AL; Yuan, J; Kuo, CJ; Schipani, E; Giaccia, AJ				Rankin, Erinn B.; Wu, Colleen; Khatri, Richa; Wilson, Tremika L. S.; Andersen, Rebecca; Araldi, Elisa; Rankin, Andrew L.; Yuan, Jenny; Kuo, Calvin J.; Schipani, Emestina; Giaccia, Amato J.			The HIF Signaling Pathway in Osteoblasts Directly Modulates Erythropoiesis through the Production of EPO	CELL			English	Article							HYPOXIA-INDUCIBLE-FACTOR; HEMATOPOIETIC STEM-CELLS; TUMOR-SUPPRESSOR; MICE; NICHE; HIF-1-ALPHA; ANEMIA; DIFFERENTIATION; PROGENITORS; DEFICIENCY	Osteoblasts are an important component of the hematopoietic microenvironment in bone. However, the mechanisms by which osteoblasts control hematopoiesis remain unknown. We show that augmented HIF signaling in osteoprogenitors results in HSC niche expansion associated with selective expansion of the erythroid lineage. Increased red blood cell production occurred in an EPO-dependent manner with increased EPO expression in bone and suppressed EPO expression in the kidney. In contrast, inactivation of HIF in osteoprogenitors reduced EPO expression in bone. Importantly, augmented HIF activity in osteoprogenitors protected mice from stress-induced anemia. Pharmacologic or genetic inhibition of prolyl hydroxylases1/2/3 in osteoprogenitors elevated EPO expression in bone and increased hematocrit. These data reveal an unexpected role for osteoblasts in the production of EPO and modulation of erythropoiesis. Furthermore, these studies demonstrate a molecular role for osteoblastic PHD/VHL/HIF signaling that can be targeted to elevate both HSCs and erythroid progenitors in the local hematopoietic microenvironment.	[Rankin, Erinn B.; Wu, Colleen; Andersen, Rebecca; Giaccia, Amato J.] Stanford Univ, Div Radiat & Canc Biol, Dept Radiat Oncol, Ctr Clin Sci Res, Stanford, CA 94303 USA; [Yuan, Jenny; Kuo, Calvin J.] Stanford Univ, Div Hematol, Stanford, CA 94303 USA; [Khatri, Richa; Wilson, Tremika L. S.; Araldi, Elisa; Schipani, Emestina] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Endocrine Unit, Boston, MA 02114 USA; [Rankin, Andrew L.] Pfizer, Inflammat & Immunol, Cambridge, MA 02140 USA	Stanford University; Stanford University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Pfizer	Giaccia, AJ (corresponding author), Stanford Univ, Div Radiat & Canc Biol, Dept Radiat Oncol, Ctr Clin Sci Res, Stanford, CA 94303 USA.	giaccia@stanford.edu	Araldi, Elisa/AAZ-5946-2021	Rankin, Erinn/0000-0002-2045-2296; Araldi, Elisa/0000-0002-6596-6784; Kuo, Calvin/0000-0002-7427-5985; Andersen, Rebecca/0000-0002-0702-3120	NIH [CA67166, CA088480, AR048191-06]; Sydney Frank Foundation; NIH National Research Service from the National Cancer Institute [T32 CA09151]; Canadian Institutes of Health Research; NATIONAL CANCER INSTITUTE [P01CA067166, R01CA116685, T32CA009151, R37CA088480, R01CA088480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085527] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sydney Frank Foundation; NIH National Research Service from the National Cancer Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants CA67166 and CA088480 and the Sydney Frank Foundation (A.J.G.) and NIH AR048191-06 (A.J.G. and E.S.). E.B.R. is supported by the NIH National Research Service Award T32 CA09151 from the National Cancer Institute. C.W. is supported by a Canadian Institutes of Health Research Fellowship. The authors would like to thank all of the investigators that generated and made the floxed/transgenic mice available for these studies: Dr. Volker Haase (Vhlh floxed), Dr. Randall Johnson (Hif-1 floxed), Drs. Brian Keith and Celeste Simon (Hif-2 floxed), Dr. Guo-Hua Fong (Phd1,2,3 floxed), and Dr. Andrew McMahon (Osterix-Cre).	Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Akeno N, 2002, ENDOCRINOLOGY, V143, P420, DOI 10.1210/en.143.2.420; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Flygare J, 2011, BLOOD, V117, P3435, DOI 10.1182/blood-2010-07-295550; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Haase VH, 2010, AM J PHYSIOL-RENAL, V299, pF1, DOI 10.1152/ajprenal.00174.2010; Hsieh MM, 2007, BLOOD, V110, P2140, DOI 10.1182/blood-2007-02-073254; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kapitsinou PP, 2008, CELL DEATH DIFFER, V15, P650, DOI 10.1038/sj.cdd.4402313; Kapitsinou PP, 2010, BLOOD, V116, P3039, DOI 10.1182/blood-2010-02-270322; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Maes C, 2010, EMBO J, V29, P424, DOI 10.1038/emboj.2009.361; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Minamishima YA, 2010, SCIENCE, V329, P407, DOI 10.1126/science.1192811; Murray JK, 2010, J COMB CHEM, V12, P676, DOI 10.1021/cc100073a; Obara N, 2008, BLOOD, V111, P5223, DOI 10.1182/blood-2007-10-115857; Ohishi M, 2009, AM J PATHOL, V174, P2160, DOI 10.2353/ajpath.2009.081026; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Tam BYY, 2006, NAT MED, V12, P793, DOI 10.1038/nm1428; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Weidemann A, 2009, J CLIN INVEST, V119, P3373, DOI 10.1172/JCI39378; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Yan L, 2010, EXPERT OPIN THER PAT, V20, P1219, DOI 10.1517/13543776.2010.510836; Yoon D, 2006, J BIOL CHEM, V281, P25703, DOI 10.1074/jbc.M602329200; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912; Zhan Yuxia, 2008, V430, P161, DOI 10.1007/978-1-59745-182-6_11; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	43	198	219	3	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 30	2012	149	1					63	74		10.1016/j.cell.2012.01.051	http://dx.doi.org/10.1016/j.cell.2012.01.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464323	Bronze, Green Accepted			2022-12-28	WOS:000302235400010
J	Treutlein, P				Treutlein, Philipp			A Single Spin Feels the Vibrations	SCIENCE			English	Editorial Material							ATOMS; DIAMOND		Univ Basel, Dept Phys, CH-4056 Basel, Switzerland	University of Basel	Treutlein, P (corresponding author), Univ Basel, Dept Phys, CH-4056 Basel, Switzerland.	philipp.treutlein@unibas.ch	Treutlein, Philipp/H-6158-2012	Treutlein, Philipp/0000-0001-9025-9574				Arcizet O, 2011, NAT PHYS, V7, P879, DOI [10.1038/nphys2070, 10.1038/NPHYS2070]; Balasubramanian G, 2008, NATURE, V455, P648, DOI 10.1038/nature07278; Balasubramanian G, 2009, NAT MATER, V8, P383, DOI [10.1038/nmat2420, 10.1038/NMAT2420]; Cho A, 2010, SCIENCE, V327, P516, DOI 10.1126/science.327.5965.516; Hunger D, 2011, CR PHYS, V12, P871, DOI 10.1016/j.crhy.2011.04.015; Kolkowitz S, 2012, SCIENCE, V335, P1603, DOI 10.1126/science.1216821; Miller R, 2005, J PHYS B-AT MOL OPT, V38, pS551, DOI 10.1088/0953-4075/38/9/007; O'Connell AD, 2010, NATURE, V464, P697, DOI 10.1038/nature08967; Rabl P, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.041302; Rugar D, 2004, NATURE, V430, P329, DOI 10.1038/nature02658; Treutlein P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.140403	12	5	5	3	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1584	1585		10.1126/science.1220167	http://dx.doi.org/10.1126/science.1220167			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461599				2022-12-28	WOS:000302062600031
J	[Anonymous]				[Anonymous]			BMJ WINTER APPEAL BMJ readers raise almost 34 pound 000 for Lifebox	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAR 28	2012	344								e2330	10.1136/bmj.e2330	http://dx.doi.org/10.1136/bmj.e2330			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962YR	22457443				2022-12-28	WOS:000305587800001
J	Pozzo, M; Davies, C; Gubbins, D; Alfe, D				Pozzo, Monica; Davies, Chris; Gubbins, David; Alfe, Dario			Thermal and electrical conductivity of iron at Earth's core conditions	NATURE			English	Article							HEAT-FLUX; EFFICIENCY; CONVECTION; GEODYNAMO; METALS	The Earth acts as a gigantic heat engine driven by the decay of radiogenic isotopes and slow cooling, which gives rise to plate tectonics, volcanoes and mountain building. Another key product is the geomagnetic field, generated in the liquid iron core by a dynamo running on heat released by cooling and freezing (as the solid inner core grows), and on chemical convection (due to light elements expelled from the liquid on freezing). The power supplied to the geodynamo, measured by the heat flux across the core-mantle boundary (CMB), places constraints on Earth's evolution(1). Estimates of CMB heat flux(2-5) depend on properties of iron mixtures under the extreme pressure and temperature conditions in the core, most critically on the thermal and electrical conductivities. These quantities remain poorly known because of inherent experimental and theoretical difficulties. Here we use density functional theory to compute these conductivities in liquid iron mixtures at core conditions from first principles-unlike previous estimates, which relied on extrapolations. The mixtures of iron, oxygen, sulphur and silicon are taken from earlier work(6) and fit the seismologically determined core density and inner-core boundary density jump(7,8). We find both conductivities to be two to three times higher than estimates in current use. The changes are so large that core thermal histories and power requirements need to be reassessed. New estimates indicate that the adiabatic heat flux is 15 to 16 terawatts at the CMB, higher than present estimates of CMB heat flux based on mantle convection(1); the top of the core must be thermally stratified and any convection in the upper core must be driven by chemical convection against the adverse thermal buoyancy or lateral variations in CMB heat flow. Power for the geodynamo is greatly restricted, and future models of mantle evolution will need to incorporate a high CMB heat flux and explain the recent formation of the inner core.	[Pozzo, Monica; Alfe, Dario] UCL, Dept Earth Sci, London WC1E 6BT, England; [Pozzo, Monica; Alfe, Dario] UCL, Thomas Young Ctr UCL, London WC1E 6BT, England; [Davies, Chris; Gubbins, David] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Gubbins, David] Univ Calif San Diego, Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA; [Alfe, Dario] UCL, Dept Phys & Astron, London WC1E 6BT, England; [Alfe, Dario] UCL, London Ctr Nanotechnol, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of Leeds; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of London; University College London; University of London; University College London	Alfe, D (corresponding author), UCL, Dept Earth Sci, Gower St, London WC1E 6BT, England.	d.alfe@ucl.ac.uk	Pozzo, Monica/C-4965-2011; Davies, Chris/I-7652-2012; Alfe`, Dario/C-1521-2008	Pozzo, Monica/0000-0003-1004-9273; Davies, Chris/0000-0002-1074-3815; Alfe`, Dario/0000-0002-9741-8678; Gubbins, David/0000-0002-8125-4752	CSEDI from the National Science Foundation [EAR1065597]; Natural Environment Research Council [NE/H01571X/1, NE/H02462X/1]; NERC [NE/H01571X/1, NE/H02462X/1] Funding Source: UKRI	CSEDI from the National Science Foundation; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	D.G. is supported by CSEDI grant EAR1065597 from the National Science Foundation. C. D. is supported by a Natural Environment Research Council personal fellowship, NE/H01571X/1. M. P. is supported by NERC grant NE/H02462X/1 to D. A. Calculations were performed on the UK national facility HECToR.	Alfe D, 2007, CONTEMP PHYS, V48, P63, DOI 10.1080/00107510701529653; Alfe D, 1999, NATURE, V401, P462, DOI 10.1038/46758; Alfe D, 1999, COMPUT PHYS COMMUN, V118, P31, DOI 10.1016/S0010-4655(98)00195-7; Alfe D, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.024102; Alfe D, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.060101; Anufriev AP, 2005, PHYS EARTH PLANET IN, V152, P163, DOI 10.1016/j.pepi.2005.06.004; Bi Y, 2002, J PHYS-CONDENS MAT, V14, P10849, DOI 10.1088/0953-8984/14/44/389; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Buffett BA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014649; Buffett BA, 2000, SCIENCE, V290, P1338, DOI 10.1126/science.290.5495.1338; Davies CJ, 2011, GEOPHYS J INT, V187, P549, DOI 10.1111/j.1365-246X.2011.05144.x; Davies GF, 2007, PHYS EARTH PLANET IN, V160, P215, DOI 10.1016/j.pepi.2006.11.001; Davies GF, 1998, CHEM GEOL, V145, P479, DOI 10.1016/S0009-2541(97)00156-3; de Koker N, 2012, P NATL ACAD SCI USA, V109, P4070, DOI 10.1073/pnas.1111841109; Desjarlais MP, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.025401; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Gubbins D, 2004, GEOPHYS J INT, V157, P1407, DOI 10.1111/j.1365-246X.2004.02219.x; Gubbins D, 2003, GEOPHYS J INT, V155, P609, DOI 10.1046/j.1365-246X.2003.02064.x; Gubbins D., 2007, ENCY GEOMAGNETISM PA, P287; Gubbins D., 1987, GEOMAGN AERON, P30; Hirose K, 2011, MINERAL MAG, V75, P1027; Jackson A, 2000, PHILOS T ROY SOC A, V358, P957, DOI 10.1098/rsta.2000.0569; Keeler R. N., 1971, PHYS HIGH ENERGY DEN, V48, P106; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Kuang WL, 1997, NATURE, V389, P371, DOI 10.1038/38712; Labrosse S, 1997, PHYS EARTH PLANET IN, V99, P1, DOI 10.1016/S0031-9201(96)03207-4; Lay T, 2008, NAT GEOSCI, V1, P25, DOI 10.1038/ngeo.2007.44; LISTER JR, 1995, PHYS EARTH PLANET IN, V91, P17, DOI 10.1016/0031-9201(95)03042-U; Masters G, 2003, PHYS EARTH PLANET IN, V140, P159, DOI 10.1016/j.pepi.2003.07.008; Mattsson T. R., 2007, PHYS REV LETT, V97; Nakagawa T, 2008, EARTH PLANET SC LETT, V271, P348, DOI 10.1016/j.epsl.2008.04.013; Olson P., 2000, EARTHS CORE LOWER MA, P1; Pozzo M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.054203; Silvestrelli PL, 1997, PHYS REV B, V55, P15515, DOI 10.1103/PhysRevB.55.15515; Stacey FD, 2001, PHYS EARTH PLANET IN, V124, P153, DOI 10.1016/S0031-9201(01)00186-8; WANG Y, 1991, PHYS REV B, V44, P13298, DOI 10.1103/PhysRevB.44.13298	38	391	395	3	268	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2012	485	7398					355	U99		10.1038/nature11031	http://dx.doi.org/10.1038/nature11031			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22495307	Green Submitted			2022-12-28	WOS:000304099100039
J	Dikshit, R; Gupta, PC; Ramasundarahettige, C; Gajalakshmi, V; Aleksandrowicz, L; Badwe, R; Kumar, R; Roy, S; Suraweera, W; Bray, F; Mallath, M; Singh, PK; Sinha, DN; Shet, AS; Gelband, H; Jha, P				Dikshit, Rajesh; Gupta, Prakash C.; Ramasundarahettige, Chinthanie; Gajalakshmi, Vendhan; Aleksandrowicz, Lukasz; Badwe, Rajendra; Kumar, Rajesh; Roy, Sandip; Suraweera, Wilson; Bray, Freddie; Mallath, Mohandas; Singh, Poonam K.; Sinha, Dhirendra N.; Shet, Arun S.; Gelband, Hellen; Jha, Prabhat		Million Death Study Collaborators	Cancer mortality in India: a nationally representative survey	LANCET			English	Article							CERVICAL-CANCER; DEATHS; COUNTRIES; SMOKING; BREAST	Background The age-specific mortality rates and total deaths from specific cancers have not been documented for the various regions and subpopulations of India. We therefore assessed the cause of death in 2001-03 in homes in small areas that were chosen to be representative of all the parts of India. Methods At least 130 trained physicians independently assigned causes to 122 429 deaths, which occurred in 1.1 million homes in 6671 small areas that were randomly selected to be representative of all of India, based on a structured non-medical surveyor's field report. Findings 7137 of 122 429 study deaths were due to cancer, corresponding to 556 400 national cancer deaths in India in 2010. 395 400 (71%) cancer deaths occurred in people aged 30-69 years (200 100 men and 195 300 women). At 30-69 years, the three most common fatal cancers were oral (including lip and pharynx, 45 800 [22.9%]), stomach (25 200 [12.6%]), and lung (including trachea and larynx, 22 900 [11.4%]) in men, and cervical (33 400 [17.1%]), stomach (27 500 [14.1%]), and breast (19 900 [10.2%]) in women. Tobacco-related cancers represented 42.0% (84 000) of male and 18.3% (35 700) of female cancer deaths and there were twice as many deaths from oral cancers as lung cancers. Age-standardised cancer mortality rates per 100 000 were similar in rural (men 95.6 [99% CI 89.6-101.7] and women 96.6 [90.7-102.6]) and urban areas (men 102.4 [92.7-112.1] and women 91.2 [81.9-100.5]), but varied greatly between the states, and were two times higher in the least educated than in the most educated adults (men, illiterate 106.6 [97.4-115.7] vs most educated 45.7 [37.8-53.6]; women, illiterate 106.7 [99.9-113.6] vs most educated 43.4 [30.7-56.1]). Cervical cancer was far less common in Muslim than in Hindu women (study deaths 24, age-standardised mortality ratio 0.68 [0.64-0.71] vs 340, 1.06 [1.05-1.08]). Interpretation Prevention of tobacco-related and cervical cancers and earlier detection of treatable cancers would reduce cancer deaths in India, particularly in the rural areas that are underserved by cancer services. The substantial variation in cancer rates in India suggests other risk factors or causative agents that remain to be discovered.	[Ramasundarahettige, Chinthanie; Aleksandrowicz, Lukasz; Suraweera, Wilson; Jha, Prabhat] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada; [Ramasundarahettige, Chinthanie; Aleksandrowicz, Lukasz; Suraweera, Wilson; Jha, Prabhat] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5B 1W8, Canada; [Dikshit, Rajesh; Badwe, Rajendra; Mallath, Mohandas] Tata Mem Hosp, Bombay 400012, Maharashtra, India; [Gajalakshmi, Vendhan] Epidemiol Res Ctr, Madras, Tamil Nadu, India; [Gupta, Prakash C.] Healis Seskaria Inst Publ Hlth, Navi Mumbai, India; [Kumar, Rajesh] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Roy, Sandip] Kolkata Med Coll, Kolkata, India; [Shet, Arun S.] St Johns Natl Acad Hlth Sci, Bangalore, Karnataka, India; [Bray, Freddie] Int Agcy Res Canc, F-69372 Lyon, France; [Gelband, Hellen] Ctr Dis Dynam Econ & Policy, Washington, DC USA	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Tata Memorial Centre (TMC); Tata Memorial Hospital; Indian Council of Medical Research (ICMR); ICMR - National Institute of Epidemiology (NIE); Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; St. John's National Academy of Health Sciences; World Health Organization; International Agency for Research on Cancer (IARC)	Jha, P (corresponding author), Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada.	jhap@smh.ca	Suraweera, Wilson MG/O-8962-2014	Bray, Freddie/0000-0002-3248-7787; Suraweera, Wilson/0000-0001-9673-5746; Shet, Arun/0000-0002-4146-0703; Jha, Prabhat/0000-0001-7067-8341; Aleksandrowicz, Lukasz/0000-0002-3644-1372; Shet, Anita/0000-0002-7204-8164	John E Fogarty International Center of the National Institutes of Health [R01-TW05991-01, TW07939-01]; Bill & Melinda Gates Foundation; Canada Research chair programme; University of Toronto; US National Institutes of Health; FOGARTY INTERNATIONAL CENTER [R01TW007939, R01TW005991] Funding Source: NIH RePORTER	John E Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Canada Research chair programme(Canada Research Chairs); University of Toronto(University of Toronto); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Bill & Melinda Gates Foundation and US National Institutes of Health.; This study is supported by grants from the John E Fogarty International Center of the National Institutes of Health (R01-TW05991-01 and TW07939-01), Bill & Melinda Gates Foundation (Catalytic Grant for Tobacco Control in India, and Disease Control Priorities Network), Canada Research chair programme and the University of Toronto (to PJ). The opinions expressed in this report are those of the authors and do not necessarily represent those of the Government of India, Office of the RGI or study sponsors. We thank the Office of the RGI for the productive collaboration on the MDS; A Bernstein, S Rathi, and A Wong for their helpful comments on the report; and B Pezzack for graphics and J Tieulent for providing International Agency for Research Cancer mortality estimates.	[Anonymous], CAUS DEATH IND 2001; [Anonymous], 2005, SPEC FERT MORT SURV; [Anonymous], 2010, GLOB AD TOB SURV GAT; Bhat PNM, 2002, POP STUD-J DEMOG, V56, P119, DOI 10.1080/00324720215930; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Dhillon PK, 2011, BRIT J CANCER, V105, P723, DOI 10.1038/bjc.2011.301; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; Doll R., 1966, CANC INCIDENCE 5 CON, VI; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GAJALAKSHMI CK, 1993, ACTA ONCOL, V32, P617, DOI 10.3109/02841869309092439; Gajalakshmi V, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-47; Gupta P C, 1996, Tob Control, V5, P114, DOI 10.1136/tc.5.2.114; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Jha P., 2011, Economic and Political Weekly, V46, P44; Jha P, 2002, NATL MED J INDIA, V15, P32; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Jha P, 2006, LANCET, V368, P367, DOI 10.1016/S0140-6736(06)68975-7; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; Jussawalla DJ, 1973, INDIAN J CANC S1; Kumar R, 2006, Indian J Public Health, V50, P90; MALHORTR.SL, 1967, GUT, V8, P361, DOI 10.1136/gut.8.4.361; Murthy NS, 2011, ASIAN PAC J CANCER P, V12, P387; National AIDS Control Organization, 2005, NAT AIDS CONTR ORG A; National Cancer Registry Programme. Indian Council of Medical Research, 2010, 3 YEAR REP POP BAS C; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Peto R, 2000, LANCET, V355, P1822, DOI 10.1016/S0140-6736(00)02277-7; Rao D. N., 1998, Indian Journal of Cancer, V35, P10; Registrar General of India, 2010, SAMPL REG SYST STAT; Registrar General of India, SPEC B MAT MORT IND; Sankaranarayanan R, 2007, LANCET, V370, P398, DOI 10.1016/S0140-6736(07)61195-7; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Sgaier SK, 2007, SCIENCE, V318, P1074, DOI 10.1126/science.1149157; SIVANANDAN V, 2004, ASSESSMENT COMPLETEN; SUTNICK AI, 1980, NEW ENGL J MED, V303, P945; Takiar R, 2010, ASIAN PAC J CANCER P, V11, P1045; United Nations Population Division, 2011, WORLD POP PROSP; Varmus H, 2002, NAT GENET, V32, P3, DOI 10.1038/ng963; World Health Organisation, 1993, ICD 10 CLASSIFICATIO; World Health Organisation, 2002, PREV HEP B IND OV; [No title captured]	40	312	315	1	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2012	379	9828					1807	1816		10.1016/S0140-6736(12)60358-4	http://dx.doi.org/10.1016/S0140-6736(12)60358-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	941BR	22460346				2022-12-28	WOS:000303937700035
J	Garber, AJ; King, AB; Del Prato, S; Sreenan, S; Balci, MK; Munoz-Torres, M; Rosenstock, J; Endahl, LA; Francisco, AMO; Hollander, P				Garber, Alan J.; King, Allen B.; Del Prato, Stefano; Sreenan, Seamus; Balci, Mustafa K.; Munoz-Torres, Manuel; Rosenstock, Julio; Endahl, Lars A.; Francisco, Ann Marie Ocampo; Hollander, Priscilla		NN1250-3582 BEGIN BB T2D Trial Inv	Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial	LANCET			English	Article							NPH INSULIN; HYPOGLYCEMIC EVENTS; SULFONYLUREA; THERAPY	Background Basal insulin therapy does not stop loss of beta-cell function, which is the hallmark of type 2 diabetes mellitus, and thus diabetes control inevitably deteriorates. Insulin degludec is a new, ultra-longacting basal insulin. We aimed to assess efficacy and safety of insulin degludec compared with insulin glargine in patients with type 2 diabetes mellitus. Methods In this 52 week, phase 3, open-label, treat-to-target, non-inferiority trial, undertaken at 123 sites in 12 countries, we enrolled adults (aged >= 18 years) with type 2 diabetes mellitus and a glycated haemoglobin (HbA(1c)) of 7.0-10.0% after 3 months or more of any insulin regimen (with or without oral antidiabetic drugs). We randomly allocated eligible participants in a 3:1 ratio to receive once-daily subcutaneous insulin degludec or glargine, stratified by previous insulin regimen, via a central interactive response system. Basal insulin was titrated to a target plasma glucose concentration of 3.9-<5.0 mmol/L self-measured before breakfast. The primary outcome was non-inferiority of degludec to glargine measured by change in HbA(1c) from baseline to week 52 (non-inferiority limit of 0.4%) by ANOVA in the full analysis set. We assessed rates of hypoglycaemia in all treated patients. This study is registered with ClinicalTrials.gov, number NCT00972283. Findings 744 (99%) of 755 participants randomly allocated degludec and 248 (99%) of 251 allocated glargine were included in the full analysis set (mean age 58.9 years [SD 9.3], diabetes duration 13.5 years [7.3], HbA(1c) 8.3% [0.8], and fasting plasma glucose 9.2 mmol/L [3.1]); 618 (82%) and 211 (84%) participants completed the trial. After 1 year, HbA(1c) decreased by 1.1% in the degludec group and 1.2% in the glargine group (estimated treatment difference [degludec-glargine] 0.08%, 95% CI-0.05 to 0.21), confirming non-inferiority. Rates of overall confi rmed hypoglycaemia (plasma glucose <3.1 mmol/L or severe episodes requiring assistance) were lower with degludec than glargine (11.1 vs 13.6 episodes per patient-year of exposure; estimated rate ratio 0.82, 95% CI 0.69 to 0.99; p=0.0359), as were rates of nocturnal confi rmed hypoglycaemia (1.4 vs 1.8 episodes per patient-year of exposure; 0.75, 0.58 to 0.99; p=0.0399). Rates of severe hypoglycaemia seemed similar (0.06 vs 0.05 episodes per patient-year of exposure for degludec and glargine) but were too low for assessment of differences. Rates of other adverse events did not differ between groups. Interpretation A policy of suboptimum diabetes control to reduce the risk of hypoglycaemia and its consequences in advanced type 2 diabetes mellitus might be unwarranted with newer basal insulins such as degludec, which are associated with lower risks of hypoglycaemia than insulin glargine.	[Garber, Alan J.] Baylor Coll Med, Houston, TX USA; [King, Allen B.] Diabet Care Ctr, Salinas, CA USA; [Del Prato, Stefano] Univ Pisa, Pisa, Italy; [Sreenan, Seamus] Connolly Hosp, Dublin, Ireland; [Balci, Mustafa K.] Akdeniz Univ, Sch Med, TR-07058 Antalya, Turkey; [Munoz-Torres, Manuel] Univ Hosp San Cecilio, Granada, Spain; [Rosenstock, Julio] Dallas Diabet & Endocrine Ctr Med City, Dallas, TX USA; [Endahl, Lars A.] Novo Nordisk, Soborg, Denmark; [Hollander, Priscilla] Baylor Med Ctr, Dallas, TX USA	Baylor College of Medicine; University of Pisa; Akdeniz University; Hospital Universitario San Cecilio; Diabetes & Endocrine Center	Garber, AJ (corresponding author), Baylor Coll Med, 1709 Dryden Rd,Suite 1000, Houston, TX USA.	agarber@bcm.tmc.edu	Torres, Manuel Muñoz/O-2330-2016; Del+Prato, Stefano/AAC-9197-2021; BALCI, Mustafa Kemal/C-2979-2016; Del Prato, Stefano/K-3405-2016; King, Allen/AAC-8126-2019; Merino-Torres, Juan F/T-8698-2018	Torres, Manuel Muñoz/0000-0002-9645-3260; BALCI, Mustafa Kemal/0000-0002-6494-3249; Del Prato, Stefano/0000-0002-5388-0270; Merino-Torres, Juan F/0000-0002-0191-4504	Novo Nordisk (Bagsvaerd, Denmark); Novo Nordisk; Eli Lilly; Amylin Pharmaceuticals; Animas Corporation; Sanofi-Aventis; Medtronic; Merck; Novartis; Bristol-Myers Squibb; MannKind	Novo Nordisk (Bagsvaerd, Denmark)(Novo Nordisk); Novo Nordisk(Novo Nordisk); Eli Lilly(Eli Lilly); Amylin Pharmaceuticals(Bristol-Myers Squibb); Animas Corporation; Sanofi-Aventis(Sanofi-Aventis); Medtronic(Medtronic); Merck(Merck & Company); Novartis(Novartis); Bristol-Myers Squibb(Bristol-Myers Squibb); MannKind	This trial was sponsored by Novo Nordisk (Bagsvaerd, Denmark). We thank the trial investigators, trial staff, and trial participants for their participation (the appendix lists principal investigators), Anjun Cao (Novo Nordisk) for statistical support, and Liz Bullock of Water-Meadow Medical (sponsored by Novo Nordisk) for assisting with the submission and the preparation of tables and figures. We thank Tulay Cushman, Jennifer Faleska, and Carolynne Van Houten, all of Novo Nordisk, for medical writing and editorial support.; AJG has served as a consultant on advisory boards or panels for GlaxoSmithKline, Novo Nordisk, Merck, and Daiichi-Sankyo, Takeda, LipoScience, and Boehringer Ingelheim and speakers' bureaux for GlaxoSmithKline, Merck, Novo Nordisk, Santarus, and Daiichi-Sankyo. AJG is on the American Association of Clinical Endocrinologists board of directors. ABK has participated in speakers' bureaux for Novo Nordisk, Eli Lilly, Amylin Pharmaceuticals, Animas Corporation, and Sanofi-Aventis and has received research support from Novo Nordisk, Eli Lilly, Amylin Pharmaceuticals, Animas Corporation, Sanofi-Aventis, and Medtronic. SDP has served on scientific advisory boards and received honoraria or consulting fees and has received grants or research support from insulin manufacturers, Novo Nordisk, Eli Lilly, and Sanofi-Aventis. SS has received grant support from Novo Nordisk and Sanofi-Aventis and is a member of local advisory boards for Novo Nordisk, Merck, Novartis, Bristol-Myers Squibb, and Eli Lilly. MKB and MM-T declare that they have no conflicts of interest. JR has served on scientific advisory boards and received honoraria or consulting fees and grants or research support from insulin manufacturers, Novo Nordisk, Eli Lilly, Sanofi-Aventis and MannKind. LAE and AMOF are employees of Novo Nordisk and own stock in the company. PH has served on advisory boards for Novo Nordisk, Roche, Orexigen, and Pfizer. The authors received no payment for writing or contributing to this report.	[Anonymous], 2001, J Postgrad Med, V47, P199; Banarer S, 2004, MED CLIN N AM, V88, P1107, DOI 10.1016/j.mcna.2004.04.003; Blonde L, 2009, DIABETES OBES METAB, V11, P623, DOI 10.1111/j.1463-1326.2009.01060.x; Bonds DE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4909; Brod M, 2011, VALUE HEALTH, V14, P665, DOI 10.1016/j.jval.2011.02.001; Childs BP, 2005, DIABETES CARE, V28, P1245; Cryer PE, 2002, DIABETOLOGIA, V45, P937, DOI 10.1007/s00125-002-0822-9; Cuddihy RM, 2011, DIABETES EDUCATOR, V37, P111, DOI 10.1177/0145721710388426; Davis S, 2004, J DIABETES COMPLICAT, V18, P60, DOI 10.1016/S1056-8727(03)00058-8; Frier BM, 2008, DIABETES-METAB RES, V24, P87, DOI 10.1002/dmrr.796; Frier BM, 2011, DIABETES CARE, V34, pS132, DOI 10.2337/dc11-s220; Heise T, 2011, DIABETES S1, V60, pLB11; Heise T, 2011, DIABETES, V60, pA263; Hermansen K, 2006, DIABETES CARE, V29, P1269, DOI 10.2337/dc05-1365; Johnston SS, 2011, DIABETES CARE, V34, P1164, DOI 10.2337/dc10-1915; Jonassen I, 2010, DIABETES, V59, pA11; Nakar S, 2007, J DIABETES COMPLICAT, V21, P220, DOI 10.1016/j.jdiacomp.2006.02.004; Riddle MC, 2003, DIABETES CARE, V26, P3080, DOI 10.2337/diacare.26.11.3080; RIDDLE MC, 1989, DIABETES CARE, V12, P623, DOI 10.2337/diacare.12.9.623; Robinson RTCE, 2003, DIABETES, V52, P1469, DOI 10.2337/diabetes.52.6.1469; Swinnen SG, 2011, COCHRANE DB SYST REV, V6; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; Ware JE, 2007, USERS MANUAL SF 36V2; Williams SA, 2011, DIABETES RES CLIN PR, V91, P363, DOI 10.1016/j.diabres.2010.12.027; World Medical Association Inc, 2009, J Indian Med Assoc, V107, P403; Zinman B, 2011, LANCET, V377, P924, DOI 10.1016/S0140-6736(10)62305-7; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	27	254	265	2	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2012	379	9825					1498	1507		10.1016/S0140-6736(12)60205-0	http://dx.doi.org/10.1016/S0140-6736(12)60205-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930BJ	22521072				2022-12-28	WOS:000303110200028
J	Bolch, T; Kulkarni, A; Kaab, A; Huggel, C; Paul, F; Cogley, JG; Frey, H; Kargel, JS; Fujita, K; Scheel, M; Bajracharya, S; Stoffel, M				Bolch, T.; Kulkarni, A.; Kaab, A.; Huggel, C.; Paul, F.; Cogley, J. G.; Frey, H.; Kargel, J. S.; Fujita, K.; Scheel, M.; Bajracharya, S.; Stoffel, M.			The State and Fate of Himalayan Glaciers	SCIENCE			English	Review							DEBRIS-COVERED GLACIERS; KARAKORAM HIMALAYA; WESTERN HIMALAYA; CLIMATE-CHANGE; MASS-BALANCE; SUPRAGLACIAL LAKES; WATER AVAILABILITY; NEPAL HIMALAYA; FLUCTUATIONS; PRECIPITATION	Himalayan glaciers are a focus of public and scientific debate. Prevailing uncertainties are of major concern because some projections of their future have serious implications for water resources. Most Himalayan glaciers are losing mass at rates similar to glaciers elsewhere, except for emerging indications of stability or mass gain in the Karakoram. A poor understanding of the processes affecting them, combined with the diversity of climatic conditions and the extremes of topographical relief within the region, makes projections speculative. Nevertheless, it is unlikely that dramatic changes in total runoff will occur soon, although continuing shrinkage outside the Karakoram will increase the seasonality of runoff, affect irrigation and hydropower, and alter hazards.	[Bolch, T.; Huggel, C.; Paul, F.; Frey, H.; Scheel, M.] Univ Zurich, Dept Geog, CH-8057 Zurich, Switzerland; [Bolch, T.] Tech Univ Dresden, Inst Cartog, D-01069 Dresden, Germany; [Kulkarni, A.] Indian Inst Sci, Divecha Ctr Climate Change, Bangalore 560012, Karnataka, India; [Kaab, A.] Univ Oslo, Dept Geosci, N-0316 Oslo, Norway; [Huggel, C.; Frey, H.; Scheel, M.; Stoffel, M.] Univ Geneva, Inst Environm Sci, CH-1227 Geneva, Switzerland; [Cogley, J. G.] Trent Univ, Dept Geog, Peterborough, ON K9J 7B8, Canada; [Kargel, J. S.] Univ Arizona, Dept Hydrol & Water Resources, Tucson, AZ 85721 USA; [Fujita, K.] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan; [Bajracharya, S.] Int Ctr Integrated Mt Dev ICIMOD, Kathmandu, Nepal; [Stoffel, M.] Univ Bern, Inst Geol Sci, CH-3012 Bern, Switzerland	University of Zurich; Technische Universitat Dresden; Indian Institute of Science (IISC) - Bangalore; University of Oslo; University of Geneva; Trent University; University of Arizona; Nagoya University; University of Bern	Bolch, T (corresponding author), Univ Zurich, Dept Geog, CH-8057 Zurich, Switzerland.	tobias.bolch@geo.uzh.ch	Stoffel, Markus/A-1793-2017; Frey, Holger/E-7545-2012; Bolch, Tobias/A-1935-2008; Fujita, Koji/E-6104-2010; Kääb, Andreas/AAG-8769-2020; Bolch, Tobias/ABE-6635-2020	Stoffel, Markus/0000-0003-0816-1303; Bolch, Tobias/0000-0002-8201-5059; Fujita, Koji/0000-0003-3753-4981; Kääb, Andreas/0000-0002-6017-6564; Bolch, Tobias/0000-0002-8201-5059; Frey, Holger/0000-0003-0705-3570	European Union [22708]; European Space Agency [4000101778/10/I-AM, 21088/07/I-EC]; Global Land Ice Measurements from Space (GLIMS) initiative; NASA; Deutsche Forschungsgemeinschaft (DFG)	European Union(European Commission); European Space Agency(European Space AgencyEuropean Commission); Global Land Ice Measurements from Space (GLIMS) initiative; NASA(National Aeronautics & Space Administration (NASA)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work has been supported by the European Union FP7 project HighNoon (grant 22708), the European Space Agency projects Glaciers_cci (4000101778/10/I-AM) and GlobGlacier (21088/07/I-EC), and the Global Land Ice Measurements from Space (GLIMS) initiative. J.S.K. acknowledges the support of NASA and T. B. the support of Deutsche Forschungsgemeinschaft (DFG). This review has benefited greatly from discussions with E. Berthier, M. Bishop, U. Haritashya, D. Quincey, A. Racoviteanu, J. Wahr, and M. Zemp. Glacier inventory data for Shyok Basin was provided by R. Bhambri.	AGETA Y, 1984, GEOGR ANN A, V66, P249, DOI 10.2307/520698; Azam MF, 2012, J GLACIOL, V58, P315, DOI 10.3189/2012JoG11J123; Bajracharya S. R., 2011, CLIMATE CHANGE GEOPH; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; Berthier E, 2007, REMOTE SENS ENVIRON, V108, P327, DOI 10.1016/j.rse.2006.11.017; Bhambri R, 2011, J GLACIOL, V57, P543, DOI 10.3189/002214311796905604; Bhambri R, 2009, PROG PHYS GEOG, V33, P672, DOI 10.1177/0309133309348112; Bhutiyani MR, 1999, J GLACIOL, V45, P112, DOI 10.3189/S0022143000003099; Bohner J, 2006, BOREAS, V35, P279, DOI 10.1080/03009480500456073; Bolch T, 2011, CRYOSPHERE, V5, P349, DOI 10.5194/tc-5-349-2011; Bookhagen B, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001426; Cogley JG, 2011, ANN GLACIOL, V52, P69, DOI 10.3189/172756411799096277; Cogley JG, 2010, SCIENCE, V327, P522, DOI 10.1126/science.327.5965.522-a; Copland L, 2011, ARCT ANTARCT ALP RES, V43, P503, DOI 10.1657/1938-4246-43.4.503; Copland L, 2009, ANN GLACIOL, V50, P41, DOI 10.3189/172756409789624229; Dyurgerov M.B., 2005, GLACIERS CHANGING EA; Farinotti D, 2009, J GLACIOL, V55, P422, DOI 10.3189/002214309788816759; Fowler HJ, 2006, J CLIMATE, V19, P4276, DOI 10.1175/JCLI3860.1; Fujita K, 2011, P NATL ACAD SCI USA, V108, P14011, DOI 10.1073/pnas.1106242108; Fujita K, 2008, EARTH PLANET SC LETT, V276, P14, DOI 10.1016/j.epsl.2008.08.028; Gardelle J, 2012, NAT GEOSCI, V5, P322, DOI [10.1038/ngeo1450, 10.1038/NGEO1450]; Gardelle J, 2011, GLOBAL PLANET CHANGE, V75, P47, DOI 10.1016/j.gloplacha.2010.10.003; Haritashya UK, 2009, CLIMATIC CHANGE, V94, P5, DOI 10.1007/s10584-009-9555-9; Heid T, 2011, CRYOSPHERE DISCUSS, V5, P3025, DOI DOI 10.5194/TCD-5-3025-2011; Hewitt K, 2011, MT RES DEV, V31, P188, DOI 10.1659/MRD-JOURNAL-D-11-00020.1; Hewitt K, 2010, PHYS GEOGR, V31, P528, DOI 10.2747/0272-3646.31.6.528; Immerzeel WW, 2012, CLIMATIC CHANGE, V110, P721, DOI 10.1007/s10584-011-0143-4; Immerzeel WW, 2010, SCIENCE, V328, P1382, DOI 10.1126/science.1183188; Iturrizaga L, 2011, Z GEOMORPHOL, V55, P205, DOI 10.1127/0372-8854/2011/0055S3-0059; Jacob T, 2012, NATURE, V482, P514, DOI 10.1038/nature10847; Kaab A, 2005, REMOTE SENS ENVIRON, V94, P463, DOI 10.1016/j.rse.2004.11.003; Karma T., 2003, BULL GLACIOL RES, V20, P29; Kaser G, 2010, P NATL ACAD SCI USA, V107, P20223, DOI 10.1073/pnas.1008162107; Kulkarni AV, 2011, INT J REMOTE SENS, V32, P601, DOI 10.1080/01431161.2010.517802; Liu SY, 2006, ANN GLACIOL-SER, V43, P91, DOI 10.3189/172756406781812168; Matsuo K, 2010, EARTH PLANET SC LETT, V290, P30, DOI 10.1016/j.epsl.2009.11.053; MAYEWSKI PA, 1979, ARCTIC ALPINE RES, V11, P267, DOI 10.2307/1550417; Moors EJ, 2011, ENVIRON SCI POLICY, V14, P758, DOI 10.1016/j.envsci.2011.03.005; Nie Y, 2010, J GEOGR SCI, V20, P667, DOI 10.1007/s11442-010-0803-8; Quincey DJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049004; Quincey DJ, 2009, J GLACIOL, V55, P596, DOI 10.3189/002214309789470987; Radic V, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001373; Rees HG, 2006, HYDROL PROCESS, V20, P2157, DOI 10.1002/hyp.6209; Richardson SD, 2000, QUATERN INT, V65-6, P31, DOI 10.1016/S1040-6182(99)00035-X; Sakai A, 2009, J GLACIOL, V55, P909, DOI 10.3189/002214309790152555; Sakai A, 2000, IAHS-AISH P, P119; Sakai A, 2010, J GLACIOL, V56, P177, DOI 10.3189/002214310791190785; Sarikaya MA, 2012, REMOTE SENS LETT, V3, P77, DOI 10.1080/01431161.2010.536181; Scherler D, 2011, NAT GEOSCI, V4, P156, DOI [10.1038/ngeo1068, 10.1038/NGEO1068]; Schmidt S, 2012, ARCT ANTARCT ALP RES, V44, P107, DOI 10.1657/1938-4246-44.1.107; Schmidt S, 2009, J GLACIOL, V55, P949, DOI 10.3189/002214309790794878; Shekhar MS, 2010, ANN GLACIOL, V51, P105, DOI 10.3189/172756410791386508; Shrestha AB, 1999, J CLIMATE, V12, P2775, DOI 10.1175/1520-0442(1999)012<2775:MTTITH>2.0.CO;2; Shrestha AB, 2000, INT J CLIMATOL, V20, P317, DOI 10.1002/(SICI)1097-0088(20000315)20:3&lt;317::AID-JOC476&gt;3.0.CO;2-G; Winiger M, 2005, HYDROL PROCESS, V19, P2329, DOI 10.1002/hyp.5887; Xin W., 2008, ML RES DEV, V28, P310, DOI DOI 10.1659/MRD.0894; Xu BQ, 2009, P NATL ACAD SCI USA, V106, P22114, DOI [10.1073/pnas.0910444106, 10.1073/pnas.pnas.0910444106]; Yang XG, 2011, ARCT ANTARCT ALP RES, V43, P147, DOI 10.1657/1938-4246-43.1.147; Zemp M, 2009, ANN GLACIOL, V50, P101, DOI 10.3189/172756409787769591	59	1259	1329	45	576	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2012	336	6079					310	314		10.1126/science.1215828	http://dx.doi.org/10.1126/science.1215828			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22517852	Green Accepted			2022-12-28	WOS:000302995400036
J	Hamburg, MA				Hamburg, Margaret A.			FDA's Approach to Regulation of Products of Nanotechnology	SCIENCE			English	Editorial Material									US FDA, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Hamburg, MA (corresponding author), US FDA, Silver Spring, MD 20993 USA.	margaret.hamburg@fda.hhs.gov						[Anonymous], 2001, WHATS SO SPEC NAN; EC, REC DEF NAN; FDA, CONS WHETH FDA REG P; FDA, NAN REG SCI RES CAT; Health Canada, 2011, POL STAT HLTH CAN WO; Holdren J. P., 2011, POLICY PRINCIPLES US; Kesisoglou F, 2007, ADV DRUG DELIVER REV, V59, P631, DOI 10.1016/j.addr.2007.05.003; Lovestam G., 2010, CONSIDERATIONS DEFIN; Moghimi SM, 2005, FASEB J, V19, P311, DOI 10.1096/fj.04-2747rev; NNI, 2010, CAPST M RISK MAN MET; Scientific Committee of Emerging and Newly Identified Health Risks, 2010, SCI BAS DEF TERM NAN; T. Earles, EMERGING TECHNOLOGIE; Zolnik BS, 2009, ADV DRUG DELIVER REV, V61, P422, DOI 10.1016/j.addr.2009.03.006	13	102	104	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2012	336	6079					299	300		10.1126/science.1205441	http://dx.doi.org/10.1126/science.1205441			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	928PO	22517845				2022-12-28	WOS:000302995400028
J	Hemmingsen, B; Lundby, L; Wetterslev, J; Vaag, A; Gluud, C; Lund, SS; Almdal, T				Hemmingsen, Bianca; Lundby, Louise; Wetterslev, Jorn; Vaag, Allan; Gluud, Christian; Lund, Soren S.; Almdal, Thomas			Comparison of metformin and insulin versus insulin alone for type 2 diabetes: systematic review of randomised clinical trials with meta-analyses and trial sequential analyses	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GLYCEMIC CONTROL; EMPIRICAL-EVIDENCE; INFORMATION SIZE; STARTING INSULIN; DOUBLE-BLIND; NPH INSULIN; OPEN-LABEL; THERAPY; COMBINATION; MELLITUS	Objectives To compare the benefits and harms of metformin and insulin versus insulin alone as reported in randomised clinical trials of patients with type 2 diabetes. Design Systematic review of randomised clinical trials with meta-analyses and trial sequential analyses. Data sources The Cochrane Library, Medline, Embase, Science Citation Index Expanded, Latin American Caribbean Health Sciences Literature, and Cumulative Index to Nursing and Allied Health Literature until March 2011. We also searched abstracts presented at the American Diabetes Association and European Association for the Study of Diabetes Congresses, contacted relevant trial authors and pharmaceutical companies, hand searched reference lists of included trials, and searched the US Food and Drug Administration website. Review methods Two authors independently screened titles and abstracts for randomised clinical trials comparing metformin and insulin versus insulin alone (with or without placebo) in patients with type 2 diabetes, older than 18 years, and with an intervention period of at least 12 weeks. We included trials irrespective of language, publication status, predefined outcomes, antidiabetic interventions used before randomisation, and reported outcomes. Results We included 26 randomised trials with 2286 participants, of which 23 trials with 2117 participants could provide data. All trials had high risk of bias. Data were sparse for outcomes relevant to patients. Metformin and insulin versus insulin alone did not significantly affect all cause mortality (relative risk 1.30, 95% confidence interval 0.57 to 2.99) or cardiovascular mortality (1.70, 0.35 to 8.30). Trial sequential analyses showed that more trials were needed before reliable conclusions could be drawn regarding these outcomes. In a fixed effect model, but not in a random effects model, severe hypoglycaemia was significantly more frequent with metformin and insulin than with insulin alone (2.83, 1.17 to 6.86). In a random effects model, metformin and insulin resulted in reduced HbA(1c), weight gain, and insulin dose, compared with insulin alone; trial sequential analyses showed sufficient evidence for a HbA1c reduction of 0.5%, lower weight gain of 1 kg, and lower insulin dose of 5 U/day. Conclusions There was no evidence or even a trend towards improved all cause mortality or cardiovascular mortality with metformin and insulin, compared with insulin alone in type 2 diabetes. Data were limited by the severe lack of data reported by trials for patient relevant outcomes and by poor bias control.	[Hemmingsen, Bianca; Wetterslev, Jorn; Gluud, Christian] Copenhagen Univ Hosp, Rigshosp, Ctr Clin Intervent Res, Copenhagen Trial Unit, DK-2100 Copenhagen, Denmark; [Lundby, Louise] Hvidovre Univ Hosp, Dept Paediat, DK-2650 Hvidovre, Denmark; [Vaag, Allan] Copenhagen Univ Hosp, Rigshosp, Dept Endocrinol, DK-2100 Copenhagen, Denmark; [Lund, Soren S.; Almdal, Thomas] Steno Diabet Ctr, DK-2820 Gentofte, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Steno Diabetes Center	Hemmingsen, B (corresponding author), Copenhagen Univ Hosp, Rigshosp, Ctr Clin Intervent Res, Copenhagen Trial Unit, DK-2100 Copenhagen, Denmark.	bh@ctu.rh.dk	Gluud, Christian/AAY-1027-2021; Wetterslev, Jørn/ABF-1251-2020; Gluud, Christian/HGB-3191-2022; Lundby-Christensen, Louise/AER-4577-2022; Hug, Balthasar L./G-1568-2010	Gluud, Christian/0000-0002-8861-0799; Wetterslev, Jørn/0000-0001-7778-1771; Vaag, Allan Arthur/0000-0002-3690-2191; Lundby-Christensen, Louise/0000-0003-3803-5383	Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Denmark (the Copenhagen Insulin and Metformin Therapy Trial Group)	Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Denmark (the Copenhagen Insulin and Metformin Therapy Trial Group)	This study received funding from the Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Denmark (the Copenhagen Insulin and Metformin Therapy Trial Group). The funding source had no role in the design and conduct of the study; the extraction, management, analysis, or interpretation of the data; or the preparation, review, or approval of the manuscript.	Altuntas Y, 2003, DIABETES OBES METAB, V5, P371, DOI 10.1046/j.1463-1326.2003.00283.x; American Hospital Formulary Service Drug Information, 1999, METF HYDR, P2755; Andersson C, 2010, DIABETOLOGIA, V53, P2546, DOI 10.1007/s00125-010-1906-6; [Anonymous], 2011, REV MAN REVMAN COMP; Aviles-Santa L, 1999, ANN INTERN MED, V131, P182, DOI 10.7326/0003-4819-131-3-199908030-00004; Bennett WL, 2011, ANN INTERN MED, V154, P602, DOI 10.7326/0003-4819-154-9-201105030-00336; Brok J, 2009, INT J EPIDEMIOL, V38, P287, DOI 10.1093/ije/dyn188; Brok J, 2008, J CLIN EPIDEMIOL, V61, P763, DOI 10.1016/j.jclinepi.2007.10.007; Civera M, 2008, DIABETES RES CLIN PR, V79, P42, DOI 10.1016/j.diabres.2007.07.001; DEMETS DL, 1987, STAT MED, V6, P341, DOI 10.1002/sim.4780060325; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Douek IF, 2005, DIABETIC MED, V22, P634, DOI 10.1111/j.1464-5491.2005.01475.x; Food and Drug Administration, 2008, GUID IND DIAB MELL E; Galani V, 2011, INT J PHARM BIOL ARC, V2, P563; GIUGLIANO D, 1993, EUR J CLIN PHARMACOL, V44, P107, DOI 10.1007/BF00315466; Gluud C, 2007, J HEPATOL, V46, P734, DOI 10.1016/j.jhep.2007.01.003; Goudswaard AN, 2004, COCHRANE DB SYST REV, P4; Gram J, 2011, DIABETES CARE, V34, P27, DOI 10.2337/dc10-0531; Heine RJ, 1995, NETH J MED, V47, pA59; Hemmingsen B, 2011, METFORMIN PLUS INSUL; Hemmingsen B, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6898; Hemmingsen B, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008143.pub2; Hermann LS, 2001, DIABETES OBES METAB, V3, P428, DOI 10.1046/j.1463-1326.2001.00160.x; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hirsch IB, 1999, DIABETES CARE, V22, P854, DOI 10.2337/diacare.22.5.854b; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; International Diabetes Federation Clinical Guidelines Task Force, 2005, EV BAS GUID TYP 2 DI; Johansen K, 1999, DIABETES CARE, V22, P33, DOI 10.2337/diacare.22.1.33; Kabadi UM, 2006, DIABETES RES CLIN PR, V72, P265, DOI 10.1016/j.diabres.2005.10.024; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Kokic S, 2003, COLLEGIUM ANTROPOL, V27, P181; Kokic Slaven, 2010, Diabetologia Croatica, V39, P37; Kooy A, 2009, ARCH INTERN MED, V169, P616, DOI 10.1001/archinternmed.2009.20; Kvapil A, 2006, DIABETES OBES METAB, V8, P39, DOI 10.1111/j.1463-1326.2005.00492.x; Lamanna C, 2011, DIABETES OBES METAB, V13, P221, DOI 10.1111/j.1463-1326.2010.01349.x; Massi-Benedetti M, 2008, DIABETES CARE, V31, pS131, DOI 10.2337/dc08-s233; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; Onuchin SG, 2010, TERAPEVT ARKH, V82, P34; Ponssen HH, 2000, CLIN THER, V22, P709, DOI 10.1016/S0149-2918(00)90005-5; Relimpio F, 1998, DIABETIC MED, V15, P997, DOI 10.1002/(SICI)1096-9136(1998120)15:12<997::AID-DIA716>3.0.CO;2-B; Riddle MC, 2002, DIABETES CARE, V25, P395, DOI 10.2337/diacare.25.2.395; Robinson AC, 1998, DIABETES CARE, V21, P701, DOI 10.2337/diacare.21.5.701; Ryysy L, 2001, DIABETES CARE, V24, P549, DOI 10.2337/diacare.24.3.549; Saenz A, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002966.PUB3; Schnack C., 1996, Diabetologia, V39, pA33; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; South Danish Diabetes Study, 2011, EV ANT TREATM TYP 2; Strowig SM, 2002, DIABETES CARE, V25, P1691, DOI 10.2337/diacare.25.10.1691; The Copenhagen Trial Unit, 2011, TRIAL SEQ AN COMP PR; Thorlund K., 2011, USER MANUAL TRIAL SE, P1, DOI DOI 10.1158/1055-9965.EPI-08-0169; Thorlund K, 2011, PLOS ONE, V10, P1371; Thorlund K, 2009, INT J EPIDEMIOL, V38, P276, DOI 10.1093/ije/dyn179; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Ushakova O, 2007, CLIN THER, V29, P2374, DOI 10.1016/j.clinthera.2007.11.017; Vahatalo M, 2007, SCAND J PRIM HEALTH, V25, P147, DOI 10.1080/02813430701507719; Van der Waal PS, 1996, NETH J MED, V48, pA49; VanderWal PS, 1996, DIABETES, V45, P1059; Vella S, 2010, DIABETOLOGIA, V53, P809, DOI 10.1007/s00125-009-1636-9; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Wetterslev J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-86; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Wulffele MG, 2004, J INTERN MED, V256, P1, DOI 10.1111/j.1365-2796.2004.01328.x; Wulffele MG, 2002, DIABETES CARE, V25, P2133, DOI 10.2337/diacare.25.12.2133; Yilmaz H, 2007, ACTA DIABETOL, V44, P187, DOI 10.1007/s00592-007-0004-9; Yki-Jarvinen H, 1999, ANN INTERN MED, V130, P389, DOI 10.7326/0003-4819-130-5-199903020-00002	66	59	65	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2012	344								e1771	10.1136/bmj.e1771	http://dx.doi.org/10.1136/bmj.e1771			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	931CU	22517929	hybrid			2022-12-28	WOS:000303192900004
J	Galvagno, SM; Haut, ER; Zafar, SN; Millin, MG; Efron, DT; Koenig, GJ; Baker, SP; Bowman, SM; Pronovost, PJ; Haider, AH				Galvagno, Samuel M., Jr.; Haut, Elliott R.; Zafar, S. Nabeel; Millin, Michael G.; Efron, David T.; Koenig, George J., Jr.; Baker, Susan P.; Bowman, Stephen M.; Pronovost, Peter J.; Haider, Adil H.			Association Between Helicopter vs Ground Emergency Medical Services and Survival for Adults With Major Trauma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IN-HOSPITAL MORTALITY; LARGE DATA SETS; MULTIPLE IMPUTATION; PROPENSITY SCORES; CAUSAL INFERENCE; OUTCOMES; TRANSPORT; INJURY; INSTRUMENTS; HEALTH	Context Helicopter emergency medical services and their possible effect on outcomes for traumatically injured patients remain a subject of debate. Because helicopter services are a limited and expensive resource, a methodologically rigorous investigation of its effectiveness compared with ground emergency medical services is warranted. Objective To assess the association between the use of helicopter vs ground services and survival among adults with serious traumatic injuries. Design, Setting, and Participants Retrospective cohort study involving 223 475 patients older than 15 years, having an injury severity score higher than 15, and sustaining blunt or penetrating trauma that required transport to US level I or II trauma centers and whose data were recorded in the 2007-2009 versions of the American College of Surgeons National Trauma Data Bank. Interventions Transport by helicopter or ground emergency services to level I or level II trauma centers. Main Outcome Measures Survival to hospital discharge and discharge disposition. Results A total of 61 909 patients were transported by helicopter and 161 566 patients were transported by ground. Overall, 7813 patients (12.6%) transported by helicopter died compared with 17 775 patients (11%) transported by ground services. Before propensity score matching, patients transported by helicopter to level I and level II trauma centers had higher Injury Severity Scores. In the propensity score-matched multivariable regression model, for patients transported to level I trauma centers, helicopter transport was associated with an improved odds of survival compared with ground transport (odds ratio [OR], 1.16; 95% CI, 1.14-1.17; P<.001; absolute risk reduction [ARR], 1.5%). For patients transported to level II trauma centers, helicopter transport was associated with an improved odds of survival (OR, 1.15; 95% CI, 1.13-1.17; P<.001; ARR, 1.4%). A greater proportion (18.2%) of those transported to level I trauma centers by helicopter were discharged to rehabilitation compared with 12.7% transported by ground services (P<.001), and 9.3% transported by helicopter were discharged to intermediate facilities compared with 6.5% by ground services (P<.001). Fewer patients transported by helicopter left level II trauma centers against medical advice (0.5% vs 1.0%, P<.001). Conclusion Among patients with major trauma admitted to level I or level II trauma centers, transport by helicopter compared with ground services was associated with improved survival to hospital discharge after controlling for multiple known confounders. JAMA. 2012;307(15):1602-1610	[Galvagno, Samuel M., Jr.] Univ Maryland, Div Trauma Anesthesiol, Ctr Shock Trauma, Program Trauma,Dept Anesthesiol,Sch Med,Med Ctr, Baltimore, MD 21201 USA; [Haut, Elliott R.; Efron, David T.; Haider, Adil H.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Haut, Elliott R.; Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Haut, Elliott R.; Millin, Michael G.] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD USA; [Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, Dept Nursing, Baltimore, MD USA; [Haut, Elliott R.; Millin, Michael G.; Haider, Adil H.] Johns Hopkins Univ, Sch Med, Div Acute Care Surg Trauma Emergency Surg & Crit, Baltimore, MD USA; [Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, Ctr Innovat Qual Patient Care, Safety Res Grp, Baltimore, MD USA; [Haider, Adil H.] Johns Hopkins Univ, Sch Med, Ctr Surg Trials & Outcomes Res, Baltimore, MD USA; [Haut, Elliott R.] Grad Training Program Clin Invest, Baltimore, MD USA; [Baker, Susan P.; Bowman, Stephen M.; Pronovost, Peter J.; Haider, Adil H.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Zafar, S. Nabeel] Aga Khan Univ, Dept Surg, Karachi, Pakistan; [Koenig, George J., Jr.] Thomas Jefferson Univ, Sch Med, Dept Surg, Div Acute Care Surg, Philadelphia, PA 19107 USA	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Aga Khan University; Jefferson University	Galvagno, SM (corresponding author), Univ Maryland, Div Trauma Anesthesiol, Ctr Shock Trauma, Program Trauma,Dept Anesthesiol,Sch Med,Med Ctr, S8B05,22 S Greene St, Baltimore, MD 21201 USA.	sgalvagno@anes.umm.edu	Bowman, Stephen/AAF-2154-2019; Haut, Elliott R./J-3948-2019	Haut, Elliott/0000-0001-7075-771X; Galvagno, Samuel/0000-0001-5563-4092; Zafar, Syed Nabeel/0000-0003-3843-9687	National Institutes of Health; Agency for Healthcare Research [1K08HS017952-01]; American College of Surgeons; National Institute of General Medical Sciences [K23GM093112-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS017952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM093112] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research; American College of Surgeons; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr Galvagno was funded in part by an institutional training grant (T-32 Ruth Kischstein grant) from the National Institutes of Health when this study was initiated as part of his PhD program at Johns Hopkins Bloomberg School of Public Health. Dr Haut receives support from a mentored clinical scientist development award (1K08HS017952-01) from the Agency for Healthcare Research. Dr Haider receives support from the American College of Surgeons (C. James Carrico fellowship in trauma and critical care) and from the National Institute of General Medical Sciences (career development award K23GM093112-01).	American College of Surgeons, 2007, NAT TRAUM DAT BANK N; Arnold AM, 2003, AM J EPIDEMIOL, V157, P74, DOI 10.1093/aje/kwf156; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Bledsoe BE, 2006, J TRAUMA, V60, P1257, DOI 10.1097/01.ta.0000196489.19928.c0; Bledsoe Bryan E, 2003, Emerg Med Serv, V32, P88; Braitman LE, 2002, ANN INTERN MED, V137, P693, DOI 10.7326/0003-4819-137-8-200210150-00015; Brown JB, 2010, J TRAUMA, V69, P1030, DOI 10.1097/TA.0b013e3181f6f450; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; D'Agostino RB, 2007, JAMA-J AM MED ASSOC, V297, P314, DOI 10.1001/jama.297.3.314; Frankema SPG, 2004, BRIT J SURG, V91, P1520, DOI 10.1002/bjs.4756; Galvagno Samuel M Jr, 2011, Air Med J, V30, P258, DOI 10.1016/j.amj.2011.04.006; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Hemmila MR, 2010, ARCH SURG-CHICAGO, V145, P939, DOI 10.1001/archsurg.2010.193; Iirola TT, 2006, EUR J EMERG MED, V13, P335, DOI 10.1097/01.mej.0000224429.51623.fb; KANE G, 1985, J TRAUMA, V25, P482, DOI 10.1097/00005373-198506000-00002; Lindenauer PK, 2004, JAMA-J AM MED ASSOC, V291, P2092, DOI 10.1001/jama.291.17.2092; Little RJ, 2000, ANNU REV PUBL HEALTH, V21, P121, DOI 10.1146/annurev.publhealth.21.1.121; McCowan CL, 2007, PREHOSP EMERG CARE, V11, P383, DOI 10.1080/10903120701536867; Mitchell AD, 2007, CAN J SURG, V50, P129; Moore Lynne, 2009, J Emerg Trauma Shock, V2, P73, DOI 10.4103/0974-2700.44774; Oyetunji T, 2010, J SURG RES, V159, P627, DOI 10.1016/j.jss.2009.08.026; Oyetunji TA, 2011, J SURG RES, V165, pE37, DOI 10.1016/j.jss.2010.09.025; Ringburg Akkie N, 2009, Air Med J, V28, P298, DOI 10.1016/j.amj.2009.03.007; Roudsari B, 2008, INJURY PREV, V14, P96, DOI 10.1136/ip.2007.017129; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; RUBIN DB, 1996, J AM STAT ASSOC, V91, P473, DOI DOI 10.2307/2291635; Rubin DB, 2007, STAT MED, V26, P20, DOI 10.1002/sim.2739; Schafer JL, 2008, PSYCHOL METHODS, V13, P279, DOI 10.1037/a0014268; Stewart KE, 2011, ACAD EMERG MED, V18, P1208, DOI 10.1111/j.1553-2712.2011.01207.x; Stewart KE, 2011, PREHOSP EMERG CARE, V15, P193, DOI 10.3109/10903127.2010.541979; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Stuart EA, 2009, AM J EPIDEMIOL, V169, P1133, DOI 10.1093/aje/kwp026; Sullivent EE, 2011, PREHOSP EMERG CARE, V15, P295, DOI 10.3109/10903127.2011.569849; Taylor CB, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2009.09.030; Thomas SH, 2002, J TRAUMA, V52, P136, DOI 10.1097/00005373-200201000-00023; Thomas Stephen H, 2003, Curr Opin Anaesthesiol, V16, P153, DOI 10.1097/00001503-200304000-00008; Thomas Stephen H, 2002, Prehosp Emerg Care, V6, P359, DOI 10.1080/10903120290938508; World Health Organization, 2008, GLOB BURD DIS 2004 U	39	203	206	1	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2012	307	15					1602	1610		10.1001/jama.2012.467	http://dx.doi.org/10.1001/jama.2012.467			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927GU	22511688	Green Accepted, Bronze			2022-12-28	WOS:000302896100022
J	Spence, D				Spence, Des			Bad medicine: health promotion	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Department of Health Saving Mothers, 2009, 4 DEP HLTH; Every contact counts, RAIS HLTH CONS US BR; National End of Life Intelligence Network, 2012, DEATHS LIVER DIS IMP; National Obesity Observatory (NOO), TRENDS OB PREV; Shipton D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4347; WOOD DA, 1994, BRIT MED J, V308, P313, DOI 10.1136/bmj.308.6924.313	6	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 17	2012	344								e2755	10.1136/bmj.e2755	http://dx.doi.org/10.1136/bmj.e2755			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	931CN	22511211				2022-12-28	WOS:000303192100017
J	Villalon-Gomez, JM				Villalon-Gomez, Jose M.			Thiazides increased hyponatremia, but not hospitalizations, in patients with hypertension	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Floyd Family Med Residency Program, Rome, GA USA		Villalon-Gomez, JM (corresponding author), Floyd Family Med Residency Program, Rome, GA USA.							Clayton JA, 2006, BRIT J CLIN PHARMACO, V61, P87, DOI 10.1111/j.1365-2125.2005.02531.x; Wright JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001841.pub2	2	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2012	156	8							JC4-11	10.7326/0003-4819-156-8-201204170-02011	http://dx.doi.org/10.7326/0003-4819-156-8-201204170-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930PO	22508751				2022-12-28	WOS:000303151800010
J	Wright, J				Wright, John			A new scramble for Africa: how rich world donors are damaging healthcare	BRITISH MEDICAL JOURNAL			English	Editorial Material									Bradford Royal Infirm, Bradford, W Yorkshire, England	Bradford Royal Infirmary	Wright, J (corresponding author), Bradford Royal Infirm, Bradford, W Yorkshire, England.	John.Wright@bthft.nhs.uk	Wright, John/H-1624-2012	Wright, John/0000-0001-9572-7293					0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 17	2012	344								e2726	10.1136/bmj.e2726	http://dx.doi.org/10.1136/bmj.e2726			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	931CN	22511210				2022-12-28	WOS:000303192100016
J	Bajard, L; Oates, AC				Bajard, Lola; Oates, Andrew C.			Breathe in and Straighten Your Back: Hypoxia, Notch, and Scoliosis	CELL			English	Editorial Material							SEGMENTATION	In this issue of Cell, Sparrow et al. propose a new mechanism for sporadically occurring congenital scoliosis in which Notch signaling and hypoxia converge in the embryo on somite patterning via the segmentation clock. This interaction between hypoxia and a predisposed genetic background might underlie other birth defects with incomplete penetrance.	[Bajard, Lola; Oates, Andrew C.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Oates, AC (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	oates@mpi-cbg.de		bajard, Lola/0000-0001-9002-7095	HFSP; Max Planck Society; European Research Council under the European Communities [207634]	HFSP(Human Frontier Science Program); Max Planck Society(Max Planck Society); European Research Council under the European Communities	Thanks to P. Turnpenny for comments. L. B. is supported by an HFSP Long Term Fellowship, and A.O. is supported by the Max Planck Society and the European Research Council under the European Communities Seventh Framework Programme (FP7/2007-2013)/ERC grant 207634.	Alexander PG, 2010, BIRTH DEFECTS RES C, V90, P118, DOI 10.1002/bdrc.20179; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Geoffroy Saint Hilaire E., 1820, J COMPLEMENTAIRE SCI, P7; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Offiah A, 2010, AM J MED GENET A, V152A, P1357, DOI 10.1002/ajmg.a.33361; Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sparrow DB, 2012, CELL, V149, P295, DOI 10.1016/j.cell.2012.02.054; Sparrow DB, 2011, MAMM GENOME, V22, P362, DOI 10.1007/s00335-011-9335-5; Webster William S., 2007, Birth Defects Research, V81, P215, DOI 10.1002/bdrc.20102	10	4	4	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 13	2012	149	2					255	256		10.1016/j.cell.2012.03.024	http://dx.doi.org/10.1016/j.cell.2012.03.024			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500793	Bronze			2022-12-28	WOS:000302805600005
J	Uyttewaal, M; Burian, A; Alim, K; Landrein, BT; Borowska-Wykret, D; Dedieu, A; Peaucelle, A; Ludynia, M; Traas, J; Boudaoud, A; Kwiatkowska, D; Hamant, O				Uyttewaal, Magalie; Burian, Agata; Alim, Karen; Landrein, Benoi T.; Borowska-Wykret, Dorota; Dedieu, Annick; Peaucelle, Alexis; Ludynia, Michal; Traas, Jan; Boudaoud, Arezki; Kwiatkowska, Dorota; Hamant, Olivier			Mechanical Stress Acts via Katanin to Amplify Differences in Growth Rate between Adjacent Cells in Arabidopsis	CELL			English	Article							SCANNING-ELECTRON-MICROSCOPY; CORTICAL MICROTUBULES; POSITIONAL INFORMATION; EXTERNAL FORCES; SHOOT APEX; SURFACE; TISSUE; PLANTS; MORPHOGENESIS; DYNAMICS	The presence of diffuse morphogen gradients in tissues supports a view in which growth is locally homogenous. Here we challenge this view: we used a high-resolution quantitative approach to reveal significant growth variability among neighboring cells in the shoot apical meristem, the plant stem cell niche. This variability was strongly decreased in a mutant impaired in the microtubule-severing protein katanin. Major shape defects in the mutant could be related to a local decrease in growth heterogeneity. We show that katanin is required for the cell's competence to respond to the mechanical forces generated by growth. This provides the basis for a model in which microtubule dynamics allow the cell to respond efficiently to mechanical forces. This in turn can amplify local growth-rate gradients, yielding more heterogeneous growth and supporting morphogenesis.	[Uyttewaal, Magalie; Landrein, Benoi T.; Dedieu, Annick; Traas, Jan; Boudaoud, Arezki; Hamant, Olivier] UCB Lyon 1, ENS, CNRS, Lab Reprod & Dev Plantes,INRA, F-69364 Lyon 07, France; [Landrein, Benoi T.; Boudaoud, Arezki; Hamant, Olivier] Univ Lyon, ENS Lyon, CNRS, Lab Joliot Curie, F-69364 Lyon 07, France; [Uyttewaal, Magalie; Peaucelle, Alexis] UMR1318 INRA AgroParisTech, Ctr Versailles, Inst Jean Pierre Bourgin, F-78026 Versailles, France; [Burian, Agata; Borowska-Wykret, Dorota; Ludynia, Michal; Kwiatkowska, Dorota] Univ Silesia, Dept Biophys & Morphogenesis Plants, PL-40032 Katowice, Poland; [Alim, Karen] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Peaucelle, Alexis] Univ Paris Diderot, UFR Phys Paris 7, F-75205 Paris, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Silesia in Katowice; Harvard University; UDICE-French Research Universities; Universite Paris Cite	Boudaoud, A (corresponding author), UCB Lyon 1, ENS, CNRS, Lab Reprod & Dev Plantes,INRA, 46 Allee Italie, F-69364 Lyon 07, France.	arezki.boudaoud@ens-lyon.fr; dorota.kwiatkowska@us.edu.pl; olivier.hamant@ens-lyon.fr	Kwiatkowska, Dorota/AAD-4275-2019; Burian, Agata/AAD-7447-2019; Boudaoud, Arezki/Q-7436-2016; Alim, Karen/C-6424-2014; Traas, Jan/AAZ-7004-2020; Landrein, Benoit/AAD-8272-2019	Kwiatkowska, Dorota/0000-0002-0102-6988; Boudaoud, Arezki/0000-0002-2780-4717; Traas, Jan/0000-0001-5107-1472; Landrein, Benoit/0000-0002-2371-9996; Hamant, Olivier/0000-0001-6906-6620; Ludynia, Michal/0000-0003-1992-8880; Alim, Karen/0000-0002-2527-5831; Burian, Agata/0000-0002-8912-483X; BERNE DEDIEU, Annick/0000-0002-9982-8793	INRA, France; Ministry of Science and Higher Education, Poland; National Science Foundation [NSF PHY05-51164]; Agence Nationale de la Recherche [ANR-10-BLAN-1516 "Mechastem"]	INRA, France; Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); National Science Foundation(National Science Foundation (NSF)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This research was supported by a bilateral grant from INRA, France and Ministry of Science and Higher Education, Poland, by the National Science Foundation under grant no. NSF PHY05-51164, and by a grant from Agence Nationale de la Recherche ANR-10-BLAN-1516 "Mechastem". K. A. and A. B. are grateful to Boris Shraiman for hospitality and discussions. We thank Ewa Teper (Laboratory of Scanning Electron Microscopy, Faculty of Earth Sciences, University of Silesia) for the excellent technical assistance at Scanning Electron Microscopy and Platim (UMS 3444 Biosciences Gerland-Lyon Sud) for help with imaging.	Aegerter-Wilmsen T, 2007, MECH DEVELOP, V124, P318, DOI 10.1016/j.mod.2006.12.005; Allard JF, 2010, MOL BIOL CELL, V21, P278, DOI 10.1091/mbc.E09-07-0579; Bichet A, 2001, PLANT J, V25, P137, DOI 10.1046/j.1365-313x.2001.00946.x; Boehm B, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000420; Burk DH, 2002, PLANT CELL, V14, P2145, DOI 10.1105/tpc.003947; Burk DH, 2001, PLANT CELL, V13, P807, DOI 10.1105/tpc.13.4.807; CLEARY AL, 1993, PLANT CELL PHYSIOL, V34, P1003; Coen E, 2004, P NATL ACAD SCI USA, V101, P4728, DOI 10.1073/pnas.0306308101; Corson F, 2009, P NATL ACAD SCI USA, V106, P8453, DOI 10.1073/pnas.0812493106; Desprez T, 2002, PLANT PHYSIOL, V128, P482, DOI 10.1104/pp.010822; Dixit R, 2004, PLANT CELL, V16, P2546, DOI 10.1105/tpc.104.161030; Dumais J, 2002, PLANT J, V31, P229, DOI 10.1046/j.1365-313X.2001.01350.x; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Farge E, 2003, CURR BIOL, V13, P1365, DOI 10.1016/S0960-9822(03)00576-1; Fink J, 2011, NAT CELL BIOL, V13, P771, DOI 10.1038/ncb2269; Gennes P.G.d., 1993, PHYS LIQUID CRYSTALS; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; GREEN PB, 1966, AUST J BIOL SCI, V19, P421, DOI 10.1071/BI9660421; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Heisler MG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000516; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Jaeger J, 2008, DEVELOPMENT, V135, P3175, DOI 10.1242/dev.018697; Jarvis MC, 2003, PLANT CELL ENVIRON, V26, P977, DOI 10.1046/j.1365-3040.2003.01034.x; Kwiatkowska D, 2003, J EXP BOT, V54, P1585, DOI 10.1093/jxb/erg166; Landsberg KP, 2009, CURR BIOL, V19, P1950, DOI 10.1016/j.cub.2009.10.021; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Mirabet V, 2011, ANNU REV PLANT BIOL, V62, P365, DOI 10.1146/annurev-arplant-042110-103852; Monshausen GB, 2009, TRENDS CELL BIOL, V19, P228, DOI 10.1016/j.tcb.2009.02.005; Nakamura M, 2010, NAT CELL BIOL, V12, P1064, DOI 10.1038/ncb2110; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Oates AC, 2011, DEVELOPMENT, V138, P601, DOI 10.1242/dev.059923; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Peaucelle A, 2011, CURR BIOL, V21, P1720, DOI 10.1016/j.cub.2011.08.057; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Routier-Kierzkowska AL, 2008, FUNCT PLANT BIOL, V35, P1034, DOI 10.1071/FP08047; Ryden P, 2003, PLANT PHYSIOL, V132, P1033, DOI 10.1104/pp.103.021873; SAKAGUCHI S, 1988, BOT MAG TOKYO, V101, P497, DOI 10.1007/BF02488091; Shaw SL, 2003, SCIENCE, V300, P1715, DOI 10.1126/science.1083529; Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Stoppin-Mellet V, 2006, PLANT J, V46, P1009, DOI 10.1111/j.1365-313X.2006.02761.x; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; Towers M, 2009, DEVELOPMENT, V136, P179, DOI 10.1242/dev.024158; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wartlick O, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001255; Wasteneys GO, 2009, TRENDS CELL BIOL, V19, P62, DOI 10.1016/j.tcb.2008.11.004; WILLIAMS MH, 1987, MICRON MICROSC ACTA, V18, P27, DOI 10.1016/0739-6260(87)90016-5; WILLIAMS MH, 1988, PROTOPLASMA, V147, P77, DOI 10.1007/BF01403879; WILLIAMSON RE, 1990, AUST J PLANT PHYSIOL, V17, P601, DOI 10.1071/PP9900601; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Wymer CL, 1996, PLANT PHYSIOL, V110, P425, DOI 10.1104/pp.110.2.425; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	52	289	294	2	104	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 13	2012	149	2					439	451		10.1016/j.cell.2012.02.048	http://dx.doi.org/10.1016/j.cell.2012.02.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500806	Bronze			2022-12-28	WOS:000302805600021
J	Graber, C				Graber, Cynthia			Diagnostics: Getting a clear picture	NATURE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					S7	S7		10.1038/nature11101	http://dx.doi.org/10.1038/nature11101			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22509508	Bronze			2022-12-28	WOS:000303149900049
J	Fuchs, T; Puellmann, K; Schneider, S; Kruth, J; Schulze, TJ; Neumaier, M; Beham, AW; Kaminski, WE				Fuchs, Tina; Puellmann, Kerstin; Schneider, Sven; Kruth, Jens; Schulze, Torsten J.; Neumaier, Michael; Beham, Alexander W.; Kaminski, Wolfgang E.			An autoimmune double attack	LANCET			English	Editorial Material							NEUTROPHILS		[Fuchs, Tina; Schneider, Sven; Neumaier, Michael; Kaminski, Wolfgang E.] Univ Heidelberg, Med Fac Mannheim, Inst Clin Chem, D-68167 Mannheim, Germany; [Kruth, Jens] Univ Heidelberg, Med Fac Mannheim, Dept Med, D-68167 Mannheim, Germany; [Schulze, Torsten J.] Univ Heidelberg, Med Fac Mannheim, Inst Transfus Med & Immunol, D-68167 Mannheim, Germany; [Puellmann, Kerstin] Hannover Med Sch, Dept Haematol Haemostasis Oncol & Stem Cell Trans, D-3000 Hannover, Germany; [Beham, Alexander W.] Univ Gottingen, Dept Surg, Gottingen, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Hannover Medical School; University of Gottingen	Kaminski, WE (corresponding author), Univ Heidelberg, Med Fac Mannheim, Inst Clin Chem, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.	wolfgang.kaminski@umm.de		Schulze, Torsten J/0000-0003-0204-2207				Beham AW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002375; Lechner K, 2010, BLOOD, V116, P1831, DOI 10.1182/blood-2010-03-259325; Lewandowski K, 2011, INT J LAB HEMATOL, V33, P447, DOI 10.1111/j.1751-553X.2011.01312.x; Meyer O, 2003, TRANSFUSION, V43, P345, DOI 10.1046/j.1537-2995.2003.00340.x; Puellmann K, 2006, P NATL ACAD SCI USA, V103, P14441, DOI 10.1073/pnas.0603406103	5	13	13	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 7	2012	379	9823					1364	1364		10.1016/S0140-6736(11)61939-9	http://dx.doi.org/10.1016/S0140-6736(11)61939-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922FB	22483032				2022-12-28	WOS:000302531100035
J	Alberts, SR; Sargent, DJ; Nair, S; Mahoney, MR; Mooney, M; Thibodeau, SN; Smyrk, TC; Sinicrope, FA; Chan, E; Gill, S; Kahlenberg, MS; Shields, AF; Quesenberry, JT; Webb, TA; Farr, GH; Pockaj, BA; Grothey, A; Goldberg, RM				Alberts, Steven R.; Sargent, Daniel J.; Nair, Suresh; Mahoney, Michelle R.; Mooney, Margaret; Thibodeau, Stephen N.; Smyrk, Thomas C.; Sinicrope, Frank A.; Chan, Emily; Gill, Sharlene; Kahlenberg, Morton S.; Shields, Anthony F.; Quesenberry, James T.; Webb, Thomas A.; Farr, Gist H., Jr.; Pockaj, Barbara A.; Grothey, Axel; Goldberg, Richard M.			Effect of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon Cancer A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							METASTATIC COLORECTAL-CANCER; EPITHELIAL-MESENCHYMAL TRANSITION; MRC COIN TRIAL; 1ST-LINE TREATMENT; ADJUVANT TREATMENT; PHASE-III; CHEMOTHERAPY; PANITUMUMAB; FLUOROPYRIMIDINE; IRINOTECAN	Context Leucovorin, fluorouracil, and oxaliplatin (FOLFOX) is the standard adjuvant therapy for resected stage III colon cancer. Adding cetuximab to FOLFOX benefits patients with metastatic wild-type KRAS but not mutated KRAS colon cancer. Objective To assess the potential benefit of cetuximab added to the modified sixth version of the FOLFOX regimen (mFOLFOX6) in patients with resected stage III wild-type KRAS colon cancer. Design, Setting, and Participants A randomized trial of 2686 patients aged 18 years or older at multiple institutions across North America enrolled following resection and informed consent between February 10, 2004, and November 25, 2009. The primary randomized comparison was 12 biweekly cycles of mFOLFOX6 with and without cetuximab. KRAS mutation status was centrally determined. The trial was halted after a planned interim analysis of 48% of predicted events (246/515) occurring in 1863 (of 2070 planned) patients with tumors having wild-type KRAS. A total of 717 patients with mutated KRAS and 106 with indeterminate KRAS were accrued. The 2070 patients with wild-type KRAS provided 90% power to detect a hazard ratio (HR) of 1.33 (2-sided alpha=.05), with planned interim efficacy analyses after 25%, 50%, and 75% of expected relapses. Main Outcome Measures Disease-free survival in patients with wild-type KRAS mutations. Secondary end points included overall survival and toxicity. Results Median (range) follow-up was 28 (0-68) months. The trial demonstrated no benefit when adding cetuximab. Three-year disease-free survival for mFOLFOX6 alone was 74.6% vs 71.5% with the addition of cetuximab (HR, 1.21; 95% CI, 0.98-1.49; P=.08) in patients with wild-type KRAS, and 67.1% vs 65.0% (HR, 1.12; 95% CI, 0.86-1.46; P=.38) in patients with mutated KRAS, with no significant benefit in any subgroups assessed. Among all patients, grade 3 or higher adverse events (72.5% vs 52.3%; odds ratio [OR], 2.4; 95% CI, 2.1-2.8; P<.001) and failure to complete 12 cycles (33% vs 23%; OR, 1.6; 95% CI, 1.4-1.9; P<.001) were significantly higher with cetuximab. Increased toxicity and greater detrimental differences in all outcomes were observed in patients aged 70 years or older. Conclusion Among patients with stage III resected colon cancer, the use of cetuximab with adjuvant mFOLFOX6 compared with mFOLFOX6 alone did not result in improved disease-free survival.	[Alberts, Steven R.; Sinicrope, Frank A.; Grothey, Axel] Mayo Clin, Dept Oncol, Rochester, MN 55905 USA; [Sargent, Daniel J.; Mooney, Margaret] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Nair, Suresh] Lehigh Valley Hosp, Allentown, PA USA; [Mooney, Margaret] NCI, Clin Invest Branch, Canc Therapy Evaluat Program, Bethesda, MD 20892 USA; [Chan, Emily] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Gill, Sharlene] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Kahlenberg, Morton S.] Surg Oncol Associates S Texas, San Antonio, TX USA; [Shields, Anthony F.] Karmanos Canc Inst, Detroit, MI USA; [Quesenberry, James T.] Siouxland Hematol Oncol Associates, Sioux City, IA USA; [Webb, Thomas A.] Illinois Oncol Res Assoc, Community Clin Oncol Program, Peoria, IL USA; [Farr, Gist H., Jr.] Ochsner Community Clin Oncol Program, New Orleans, LA USA; [Goldberg, Richard M.] Ohio State Univ, Columbus, OH 43210 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Lehigh Valley Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University; British Columbia Cancer Agency; Barbara Ann Karmanos Cancer Institute; Ochsner Health System; University System of Ohio; Ohio State University	Alberts, SR (corresponding author), Mayo Clin, Dept Oncol, Rochester, MN 55905 USA.		Gill, Sharlene/U-7155-2019; Goldberg, Richard M/M-1311-2013; Goldberg, Richard/O-1871-2017	Goldberg, Richard/0000-0003-3713-6895; Sargent, Daniel/0000-0002-2684-4741	National Cancer Institute, Department of Health and Human Services [CA-25224, CA-37404, CA-35103, CA-35113, CA-35272, CA-114740, CA-32102, CA-14028, CA49957, CA21115, CA31946, CA12027, CA37377]; Bristol-Myers Squibb; ImClone; sanofi-aventis; Pfizer; sanofi-aventis by the North Central Cancer Treatment Group (NCCTG); Merck Serono; Eastern Cooperative Oncology Group; National Comprehensive Cancer Network; Genentech; Southwest Oncology Group; NATIONAL CANCER INSTITUTE [U10CA180835, U10CA049957, U10CA032102, U24CA114740, U10CA014028, U10CA035272, U10CA021115, U10CA035103, U10CA035113, U10CA031946, U10CA037377, U10CA012027, U10CA025224, U10CA037404] Funding Source: NIH RePORTER	National Cancer Institute, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Bristol-Myers Squibb(Bristol-Myers Squibb); ImClone; sanofi-aventis(Sanofi-Aventis); Pfizer(Pfizer); sanofi-aventis by the North Central Cancer Treatment Group (NCCTG); Merck Serono(Merck & Company); Eastern Cooperative Oncology Group; National Comprehensive Cancer Network; Genentech(Roche HoldingGenentech); Southwest Oncology Group; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Alberts reported receiving grants from Pfizer, Bristol-Myers Squibb, and sanofi-aventis by the North Central Cancer Treatment Group (NCCTG) for support of the conduct of this trial. Dr Sargent reported receiving grants from Pfizer, Bristol-Myers Squibb, and sanofi-aventis for support to NCCTG for conduct of this trial. Dr Nair reported receiving support for travel to meetings from National Cancer Institute Cooperative Group. Dr Sinicrope reported receiving consultancy fees from Merck Serono, receiving grants from the National Institutes of Health, payment for lectures including service on service bureaus from the University of Kansas, and travel meeting expenses from the American Society of Clinical Oncology. Dr Chan reported receiving a grant from the Eastern Cooperative Oncology Group; being a board member of Colorectal Cancer Index and Reviews and HCPLive.com Oncology Advisory Board; being a consultant on advisory boards of Amgen, ImClone, Bristol-Myers Squibb, Genentech, Pfizer, and Celgene; receiving grants and travel meeting expenses from National Comprehensive Cancer Network; receiving travel meeting expenses from Chemotherapy Foundation; and being an institutional investigator in numerous clinical trials involving multiple pharmaceutical companies. Dr Gill reported receiving payment for lectures including service on speakers bureaus from Bristol-Myers Squibb. Dr Kahlenberg reported receiving payment for lectures including service on speakers bureaus from Genentech. Dr Shields reported receiving grant and support for travel to meetings for the study from Southwest Oncology Group. Dr Grothey reported receiving grants and consultancy fees from sanofi-aventis. No other authors provided any financial disclosures.; This trial was conducted as a collaborative trial of the North Central Cancer Treatment Group (NCCTG), Mayo Clinic, and was supported in part by Public Health Service grants CA-25224, CA-37404, CA-35103, CA-35113, CA-35272, CA-114740, CA-32102, CA-14028, CA49957, CA21115, CA31946, CA12027, CA37377 from the National Cancer Institute, Department of Health and Human Services. Bristol-Myers Squibb, ImClone, sanofi-aventis, and Pfizer provided unrestricted support to NCCTG for conduct of trial. Bristol-Myers Squibb provided cetuximab to NCCTG.	Adams RA, 2009, BRIT J CANCER, V100, P251, DOI 10.1038/sj.bjc.6604877; Adams RA, 2011, LANCET ONCOL, V12, P642, DOI 10.1016/S1470-2045(11)70102-4; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Bardelli A, 2010, J CLIN ONCOL, V28, P1254, DOI 10.1200/JCO.2009.24.6116; Bokemeyer C, 2011, ANN ONCOL, V22, P1535, DOI 10.1093/annonc/mdq632; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; Cancer Therapy Evaluation Program, 2003, CANC THER EV PROGR C; COX DR, 1972, J R STAT SOC B, V34, P187; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Iiizumi M, 2008, BBA-REV CANCER, V1786, P87, DOI 10.1016/j.bbcan.2008.07.002; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Karamouzis MV, 2009, LANCET ONCOL, V10, P709, DOI 10.1016/S1470-2045(09)70137-8; Kruser TJ, 2010, EXP CELL RES, V316, P1083, DOI 10.1016/j.yexcr.2010.01.009; Kuebler JP, 2007, J CLIN ONCOL, V25, P2198, DOI 10.1200/JCO.2006.08.2974; MOERTEL CG, 1995, ANN INTERN MED, V122, P321, DOI 10.7326/0003-4819-122-5-199503010-00001; Natalwala A, 2008, WORLD J GASTROENTERO, V14, P3792, DOI 10.3748/wjg.14.3792; National Cancer Institute, MAN PART CLIN TRIALS; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Riethdorf S, 2008, INT J CANCER, V123, P1991, DOI 10.1002/ijc.23825; Saltz LB, 2007, J CLIN ONCOL, V25, P3456, DOI 10.1200/JCO.2007.11.2144; Shin SY, 2010, CANCER RES, V70, P6715, DOI 10.1158/0008-5472.CAN-10-1377; Tveit K, 2010, ANN ONCOL, V21, P9; Van Cutsem E, 2009, J CLIN ONCOL, V27, P3117, DOI 10.1200/JCO.2008.21.6663; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Vincenzi B, 2008, CRIT REV ONCOL HEMAT, V68, P93, DOI 10.1016/j.critrevonc.2008.07.006; Ychou M, 2009, ANN ONCOL, V20, P674, DOI 10.1093/annonc/mdn680	33	370	377	1	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2012	307	13					1383	1393		10.1001/jama.2012.385	http://dx.doi.org/10.1001/jama.2012.385			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919AY	22474202	Green Accepted			2022-12-28	WOS:000302294200025
J	Chen, J; Mckay, RM; Parada, LF				Chen, Jian; Mckay, Renee M.; Parada, Luis F.			Malignant Glioma: Lessons from Genomics, Mouse Models, and Stem Cells	CELL			English	Review							TUMOR-INITIATING CELLS; GROWTH-FACTOR RECEPTOR; SUBVENTRICULAR ZONE; ENDOTHELIAL-CELLS; IDH2 MUTATIONS; DISTINCT CELL; ADULT SVZ; GLIOBLASTOMA; BRAIN; ORIGIN	Eighty percent of malignant tumors that develop in the central nervous system are malignant gliomas, which are essentially incurable. Here, we discuss how recent sequencing studies are identifying unexpected drivers of gliomagenesis, including mutations in isocitrate dehydrogenase 1 and the NF-kappa B pathway, and how genome-wide analyses are reshaping the classification schemes for tumors and enhancing prognostic value of molecular markers. We discuss the controversies surrounding glioma stem cells and explore how the integration of new molecular data allows for the generation of more informative animal models to advance our knowledge of glioma's origin, progression, and treatment.	[Chen, Jian; Mckay, Renee M.; Parada, Luis F.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Parada, LF (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA.	luis.parada@utsouthwestern.edu	Parada, luis F/B-9400-2014		NATIONAL CANCER INSTITUTE [R01CA131313] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA131313] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguirre AA, 2004, J CELL BIOL, V165, P575, DOI 10.1083/jcb.200311141; Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Attolini CSO, 2010, P NATL ACAD SCI USA, V107, P17604, DOI 10.1073/pnas.1009117107; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bredel M, 2011, NEW ENGL J MED, V364, P627, DOI 10.1056/NEJMoa1006312; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; CBTRUS, 2009, CBTRUS STAT REP PRIM; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Christensen K, 2008, J NEURO-ONCOL, V90, P157, DOI 10.1007/s11060-008-9648-8; Clarke L, 2009, STEM CELLS, V27, P1879, DOI 10.1002/stem.96; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Curtis SJ, 2010, CELL STEM CELL, V7, P127, DOI 10.1016/j.stem.2010.05.021; Dang L, 2010, NATURE, V465, P966, DOI 10.1038/nature09132; de Groot JF, 2010, NEURO-ONCOLOGY, V12, P233, DOI 10.1093/neuonc/nop027; di Tomaso E, 2011, CANCER RES, V71, P19, DOI 10.1158/0008-5472.CAN-10-2602; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Folkins C, 2009, CANCER RES, V69, P7243, DOI 10.1158/0008-5472.CAN-09-0167; Friedman J.M., 1999, NEUROFIBROMATOSIS PH, P19; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gonzalez-Perez O, 2011, BRAIN RES REV, V67, P147, DOI 10.1016/j.brainresrev.2011.01.001; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Greaves M, 2010, SEMIN CANCER BIOL, V20, P65, DOI 10.1016/j.semcancer.2010.03.002; Green A, 2010, NEW ENGL J MED, V362, P369, DOI 10.1056/NEJMc0910063; Gutmann DH, 2002, NEUROLOGY, V59, P759, DOI 10.1212/WNL.59.5.759; Hodgson JG, 2009, NEURO-ONCOLOGY, V11, P477, DOI 10.1215/15228517-2008-113; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Jacques TS, 2010, EMBO J, V29, P222, DOI 10.1038/emboj.2009.327; Jansen M, 2010, LANCET NEUROL, V9, P717, DOI 10.1016/S1474-4422(10)70105-8; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Joo KM, 2008, LAB INVEST, V88, P808, DOI 10.1038/labinvest.2008.57; Jordan CT, 2009, CELL STEM CELL, V4, P203, DOI 10.1016/j.stem.2009.02.003; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Klein T, 2003, J HISTOCHEM CYTOCHEM, V51, P697, DOI 10.1177/002215540305100601; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Kranendijk M, 2010, SCIENCE, V330, P336, DOI 10.1126/science.1192632; Kwon CH, 2008, CANCER RES, V68, P3286, DOI 10.1158/0008-5472.CAN-07-6867; Lai A, 2011, J CLIN ONCOL, V29, P4482, DOI 10.1200/JCO.2010.33.8715; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Latini A, 2003, EUR J NEUROSCI, V17, P2017, DOI 10.1046/j.1460-9568.2003.02639.x; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Maher EA, 2006, CANCER RES, V66, P11502, DOI 10.1158/0008-5472.CAN-06-2072; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Persson AI, 2010, CANCER CELL, V18, P669, DOI 10.1016/j.ccr.2010.10.033; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Piccirillo SGM, 2009, ONCOGENE, V28, P1807, DOI 10.1038/onc.2009.27; Po A, 2010, EMBO J, V29, P2646, DOI 10.1038/emboj.2010.131; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reilly KM, 2001, SEMIN CANCER BIOL, V11, P177, DOI 10.1006/scbi.2000.0375; Reitman ZJ, 2010, CANCER CELL, V17, P215, DOI 10.1016/j.ccr.2010.02.024; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Stiles CD, 2008, NEURON, V58, P832, DOI 10.1016/j.neuron.2008.05.031; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tso CL, 2006, CANCER RES, V66, P159, DOI 10.1158/0008-5472.CAN-05-0077; Uhrbom L, 2005, CANCER RES, V65, P2065, DOI 10.1158/0008-5472.CAN-04-3588; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Vitucci M, 2011, BRIT J CANCER, V104, P545, DOI 10.1038/sj.bjc.6606031; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944; Zheng HW, 2010, CANCER CELL, V17, P497, DOI 10.1016/j.ccr.2010.03.020; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004	107	386	404	5	92	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 30	2012	149	1					36	47		10.1016/j.cell.2012.03.009	http://dx.doi.org/10.1016/j.cell.2012.03.009			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464322	Bronze, Green Accepted			2022-12-28	WOS:000302235400008
J	Dal Conte, S; Giannetti, C; Coslovich, G; Cilento, F; Bossini, D; Abebaw, T; Banfi, F; Ferrini, G; Eisaki, H; Greven, M; Damascelli, A; van der Marel, D; Parmigiani, F				Dal Conte, S.; Giannetti, C.; Coslovich, G.; Cilento, F.; Bossini, D.; Abebaw, T.; Banfi, F.; Ferrini, G.; Eisaki, H.; Greven, M.; Damascelli, A.; van der Marel, D.; Parmigiani, F.			Disentangling the Electronic and Phononic Glue in a High-T-c Superconductor	SCIENCE			English	Article							TEMPERATURE; EXCITATIONS	Unveiling the nature of the bosonic excitations that mediate the formation of Cooper pairs is a key issue for understanding unconventional superconductivity. A fundamental step toward this goal would be to identify the relative weight of the electronic and phononic contributions to the overall frequency (Omega)-dependent bosonic function, Pi(Omega). We performed optical spectroscopy on Bi2Sr2Ca0.92Y0.08Cu2O8+delta crystals with simultaneous time and frequency resolution; this technique allowed us to disentangle the electronic and phononic contributions by their different temporal evolution. The spectral distribution of the electronic excitations and the strength of their interaction with fermionic quasiparticles fully account for the high critical temperature of the superconducting phase transition.	[Giannetti, C.; Banfi, F.; Ferrini, G.] Univ Cattolica Sacro Cuore, I LAMP Interdisciplinary Labs Adv Mat Phys, I-25121 Brescia, Italy; [Dal Conte, S.] Univ Pavia, Dept Phys A Volta, I-27100 Pavia, Italy; [Giannetti, C.; Bossini, D.; Banfi, F.; Ferrini, G.] Univ Cattolica Sacro Cuore, Dept Phys, I-25121 Brescia, Italy; [Coslovich, G.; Cilento, F.; Abebaw, T.; Parmigiani, F.] Univ Trieste, Dept Phys, I-34127 Trieste, Italy; [Eisaki, H.] Natl Inst Adv Ind Sci & Technol, Nanoelect Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Greven, M.] Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA; [Damascelli, A.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Damascelli, A.] Univ British Columbia, Quantum Matter Inst, Vancouver, BC V6T 1Z4, Canada; [van der Marel, D.] Univ Geneva, Dept Phys Mat Condensee, CH-1211 Geneva, Switzerland; [Parmigiani, F.] Sincrotrone Trieste SCpA, I-34012 Basovizza, Italy	Catholic University of the Sacred Heart; University of Pavia; Catholic University of the Sacred Heart; University of Trieste; National Institute of Advanced Industrial Science & Technology (AIST); University of Minnesota System; University of Minnesota Twin Cities; University of British Columbia; University of British Columbia; University of Geneva; Elettra Sincrotrone Trieste	Giannetti, C (corresponding author), Univ Cattolica Sacro Cuore, I LAMP Interdisciplinary Labs Adv Mat Phys, I-25121 Brescia, Italy.	claudio.giannetti@unicatt.it	Banfi, Francesco/N-3104-2015; damascelli, andrea/P-6329-2014; Bossini, Davide/I-4501-2014; Ferrini, Gabriele/G-2395-2010; Eisaki, Hiroshi/F-6317-2018; van der Marel, Dirk/G-4618-2012; Giannetti, Claudio/E-6694-2012; Dal Conte, Stefano/K-9145-2017; Assefa, Tadesse/ABD-2999-2021	Banfi, Francesco/0000-0002-7465-8417; damascelli, andrea/0000-0001-9895-2226; Ferrini, Gabriele/0000-0002-5062-9099; Eisaki, Hiroshi/0000-0002-8299-6416; van der Marel, Dirk/0000-0001-5266-9847; Giannetti, Claudio/0000-0003-2664-9492; Dal Conte, Stefano/0000-0001-8582-3185; Assefa, Tadesse/0000-0003-3904-0846; Cilento, Federico/0000-0002-4121-1694; Parmigiani, Fulvio/0000-0001-9529-7406; Bossini, Davide/0000-0003-3537-497X	Universita Cattolica del Sacro Cuore [D2.2 2010]; Italian Ministry of University and Research [FIRBRBAP045JF2, FIRB-RBAP06AWK3]; Swiss National Science Foundation [200020-130052]; U.S. Department of Energy [DE-AC03-76SF00515]; Killam; Sloan Foundation; Canada Research Chair Programs; Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation (CFI); NSERC; Canadian Institute for Advanced Research (CIFAR); British Columbia Synchrotron Institute (BCSI)	Universita Cattolica del Sacro Cuore; Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); U.S. Department of Energy(United States Department of Energy (DOE)); Killam; Sloan Foundation(Alfred P. Sloan Foundation); Canada Research Chair Programs(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); British Columbia Synchrotron Institute (BCSI)	We thank M. Capone and A. Chubukov for discussions and suggestions. Partially supported by the Universita Cattolica del Sacro Cuore (grant D2.2 2010) (C.G., F.B., and G.F.), by the Italian Ministry of University and Research (grants FIRBRBAP045JF2 and FIRB-RBAP06AWK3) (F.C., G.C., and F.P.) and by the Swiss National Science Foundation (grant 200020-130052) and its Materials with Novel Electronic Properties (MaNEP) program (D.v.d.M.). The crystal growth work was performed in M.G.'s prior laboratory at Stanford University, supported by the U.S. Department of Energy under contract DE-AC03-76SF00515. Work at the University of British Columbia was supported by the Killam, Sloan Foundation, and Canada Research Chair Programs, the Steacie Fellowship Program of the Natural Sciences and Engineering Research Council of Canada (NSERC), the Canada Foundation for Innovation (CFI), NSERC, the Canadian Institute for Advanced Research (CIFAR) Quantum Materials Program, and the British Columbia Synchrotron Institute (BCSI).	Ahmadi O, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.167005; ALLEN PB, 1987, PHYS REV LETT, V59, P1460, DOI 10.1103/PhysRevLett.59.1460; Carbone F, 2008, P NATL ACAD SCI USA, V105, P20161, DOI 10.1073/pnas.0811335106; Cilento F, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3291105; Dahm T, 2009, NAT PHYS, V5, P217, DOI 10.1038/NPHYS1180; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; Devereaux TP, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.117004; Eisaki H, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.064512; Gadermaier C, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.257001; Giannetti C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1354; Hwang J, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.144508; Iwasawa H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.157005; Kaufmann HJ, 1998, J SUPERCOND, V11, P755, DOI 10.1023/A:1022601409015; Kovaleva NN, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.054511; Kresin VZ, 2009, REV MOD PHYS, V81, P481, DOI 10.1103/RevModPhys.81.481; Lanzara A, 2001, NATURE, V412, P510, DOI 10.1038/35087518; Le Tacon M, 2011, NAT PHYS, V7, P725, DOI [10.1038/nphys2041, 10.1038/NPHYS2041]; Lee J, 2006, NATURE, V442, P546, DOI 10.1038/nature04973; Li Y, 2010, NATURE, V468, P283, DOI 10.1038/nature09477; MILLIS AJ, 1988, PHYS REV B, V37, P4975, DOI 10.1103/PhysRevB.37.4975; Mishchenko AS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.036402; Monthoux P, 2007, NATURE, V450, P1177, DOI 10.1038/nature06480; Norman MR, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.140501; Perfetti L, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.197001; Reznik D, 2006, NATURE, V440, P1170, DOI 10.1038/nature04704; Sangiovanni G, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.046404; Schachinger E, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/67003; van der Marel D, 2003, NATURE, V425, P271, DOI 10.1038/nature01978; van Heumen E, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.184512; Varma CM, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.155113	31	147	147	2	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1600	1603		10.1126/science.1216765	http://dx.doi.org/10.1126/science.1216765			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461606	Green Submitted			2022-12-28	WOS:000302062600038
J	Campbell, IH; O'Neill, HSC				Campbell, Ian H.; O'Neill, Hugh St C.			Evidence against a chondritic Earth	NATURE			English	Article							TRACE-ELEMENT SYSTEMATICS; MANTLE PLUMES; MAGMA OCEAN; ISOTOPE HETEROGENEITY; EARLY DIFFERENTIATION; COLLISIONAL EROSION; SUPERIOR PROVINCE; GREENSTONE-BELT; SOLAR-SYSTEM; LU-HF	The Nd-142/Nd-144 ratio of the Earth is greater than the solar ratio as inferred from chondritic meteorites, which challenges a fundamental assumption of modern geochemistry-that the composition of the silicate Earth is 'chondritic', meaning that it has refractory element ratios identical to those found in chondrites. The popular explanation for this and other paradoxes of mantle geochemistry, a hidden layer deep in the mantle enriched in incompatible elements, is inconsistent with the heat flux carried by mantle plumes. Either the matter from which the Earth formed was not chondritic, or the Earth has lost matter by collisional erosion in the later stages of planet formation.	[Campbell, Ian H.; O'Neill, Hugh St C.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia	Australian National University	Campbell, IH (corresponding author), Australian Natl Univ, Res Sch Earth Sci, GPO Box 4, Canberra, ACT 0200, Australia.	Ian.Campbell@anu.edu.au	Campbell, Ian/A-4941-2008; O'Neill, Hugh S/G-2302-2011	Campbell, Ian/0000-0001-8578-0154; O'Neill, Hugh S/0000-0001-7018-9783				ALLEGRE CJ, 1983, NATURE, V303, P762, DOI 10.1038/303762a0; Anderson OL, 2002, PHYS EARTH PLANET IN, V131, P1, DOI 10.1016/S0031-9201(02)00009-2; Andreasen R, 2008, EARTH PLANET SC LETT, V266, P14, DOI 10.1016/j.epsl.2007.10.009; Andreasen R, 2007, ASTROPHYS J, V665, P874, DOI 10.1086/518819; ARMSTRONG RL, 1991, AUST J EARTH SCI, V38, P613, DOI 10.1080/08120099108727995; Barth MG, 2000, CHEM GEOL, V165, P197, DOI 10.1016/S0009-2541(99)00173-4; Bourdon B, 2008, PHILOS T R SOC A, V366, P4105, DOI 10.1098/rsta.2008.0125; Bouvier A, 2008, EARTH PLANET SC LETT, V273, P48, DOI 10.1016/j.epsl.2008.06.010; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Boyet M, 2007, EARTH PLANET SC LETT, V262, P505, DOI 10.1016/j.epsl.2007.08.009; Boyet M, 2006, EARTH PLANET SC LETT, V250, P254, DOI 10.1016/j.epsl.2006.07.046; Brandon AD, 2009, GEOCHIM COSMOCHIM AC, V73, P6421, DOI 10.1016/j.gca.2009.07.015; Burkhardt C, 2011, EARTH PLANET SC LETT, V312, P390, DOI 10.1016/j.epsl.2011.10.010; Campbell I. H., 1998, EARTHS MANTLE COMPOS; CAMPBELL IH, 1990, EARTH PLANET SC LETT, V99, P79, DOI 10.1016/0012-821X(90)90072-6; Campbell IH, 2001, GEOL S AM S, P5; CAMPBELL IH, 1992, J GEOL, V100, P497, DOI 10.1086/629605; Carlson RW, 2007, SCIENCE, V316, P1175, DOI 10.1126/science.1140189; Caro G, 2006, GEOCHIM COSMOCHIM AC, V70, P164, DOI 10.1016/j.gca.2005.08.015; Caro G, 2008, NATURE, V452, P336, DOI 10.1038/nature06760; Caro G, 2011, ANNU REV EARTH PL SC, V39, P31, DOI 10.1146/annurev-earth-040610-133400; Caro G, 2010, GEOCHIM COSMOCHIM AC, V74, P3333, DOI 10.1016/j.gca.2010.02.025; Davies GF, 2007, PHYS EARTH PLANET IN, V160, P215, DOI 10.1016/j.pepi.2006.11.001; DAVIES GF, 1988, J GEOPHYS RES-SOLID, V93, P10467, DOI 10.1029/JB093iB09p10467; DAVIES GF, 1990, EARTH PLANET SC LETT, V99, P94, DOI 10.1016/0012-821X(90)90073-7; Davies JH, 2010, SOLID EARTH, V1, P5, DOI 10.5194/se-1-5-2010; Drake MJ, 2002, NATURE, V416, P39, DOI 10.1038/416039a; Galer S. J. G., 1996, GEOPHYS MONOGR SER, V95, P75, DOI DOI 10.1029/GM095; Gando A, 2011, NAT GEOSCI, V4, P647, DOI 10.1038/ngeo1205; GRIFFITHS RW, 1990, EARTH PLANET SC LETT, V99, P66, DOI 10.1016/0012-821X(90)90071-5; Halliday AN, 2001, EARTH PLANET SC LETT, V192, P545, DOI 10.1016/S0012-821X(01)00479-4; HART SR, 1992, SCIENCE, V256, P517, DOI 10.1126/science.256.5056.517; Hollings P, 1999, PRECAMBRIAN RES, V93, P257, DOI 10.1016/S0301-9268(98)00088-6; Hollings P, 1999, LITHOS, V46, P137, DOI 10.1016/S0024-4937(98)00058-9; Jackson M. G., 2011, NATURE; Kerrich R, 1999, LITHOS, V46, P163, DOI 10.1016/S0024-4937(98)00059-0; Kinoshita N, 2011, MINERAL MAG, V75, P1191; Kleine T, 2009, GEOCHIM COSMOCHIM AC, V73, P5150, DOI 10.1016/j.gca.2008.11.047; Korenaga J, 2009, GEOCHIM COSMOCHIM AC, V73, P6952, DOI 10.1016/j.gca.2009.08.020; Labrosse S, 2007, NATURE, V450, P866, DOI 10.1038/nature06356; Lay T, 2008, NAT GEOSCI, V1, P25, DOI 10.1038/ngeo.2007.44; LESHER CM, 1995, LITHOS, V34, P127, DOI 10.1016/0024-4937(94)00036-2; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; Lodders K., 2009, LANDOLTBORNSTEIN B, V4B, P560; LOPER DE, 1995, J GEOPHYS RES-SOL EA, V100, P6397, DOI 10.1029/94JB02048; Meibom A, 1999, METEORIT PLANET SCI, V34, P7, DOI 10.1111/j.1945-5100.1999.tb01728.x; NYQUIST LE, 1995, GEOCHIM COSMOCHIM AC, V59, P2817, DOI 10.1016/0016-7037(95)00175-Y; O'Neill HSC, 2008, PHILOS T R SOC A, V366, P4205, DOI 10.1098/rsta.2008.0111; ONIONS RK, 1983, NATURE, V306, P429, DOI 10.1038/306429a0; Palme H, 2003, GEOCHIM COSMOCHIM AC, V67, pA372; Patchett PJ, 2004, EARTH PLANET SC LETT, V222, P29, DOI 10.1016/j.epsl.2004.02.030; Pourmand A., CHEM GEOL IN PRESS; Qin LP, 2011, GEOCHIM COSMOCHIM AC, V75, P7806, DOI 10.1016/j.gca.2011.10.009; Regelous M, 2008, EARTH PLANET SC LETT, V272, P330, DOI 10.1016/j.epsl.2008.05.001; RICHARDS MA, 1989, SCIENCE, V246, P103, DOI 10.1126/science.246.4926.103; Safronov V., 1972, EVOLUTION PROTOPLANE; SLEEP NH, 1990, J GEOPHYS RES-SOLID, V95, P6715, DOI 10.1029/JB095iB05p06715; Tolstikhin IN, 2006, CHEM GEOL, V226, P79, DOI 10.1016/j.chemgeo.2005.09.015; TONKS WB, 1993, J GEOPHYS RES-PLANET, V98, P5319, DOI 10.1029/92JE02726; Torsvik TH, 2010, NATURE, V466, P352, DOI 10.1038/nature09216; Trinquier A, 2009, SCIENCE, V324, P374, DOI 10.1126/science.1168221; WASSON JT, 1988, PHILOS T R SOC A, V325, P535, DOI 10.1098/rsta.1988.0066; White W. M., 2011, MINERAL MAG, V75, P1191; Zhong SJ, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003972; ZINDLER A, 1986, ANNU REV EARTH PL SC, V14, P493, DOI 10.1146/annurev.ea.14.050186.002425	66	89	92	1	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2012	483	7391					553	558		10.1038/nature10901	http://dx.doi.org/10.1038/nature10901			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915EF	22460899				2022-12-28	WOS:000302006100030
J	Goya, M; Pratcorona, L; Merced, C; Rodo, C; Valle, L; Romero, A; Juan, M; Rodriguez, A; Munoz, B; Santacruz, B; Bello-Munoz, JC; Llurba, E; Higueras, T; Cabero, L; Carreras, E				Goya, Maria; Pratcorona, Laia; Merced, Carme; Rodo, Carlota; Valle, Leonor; Romero, Azahar; Juan, Miquel; Rodriguez, Alberto; Munoz, Begona; Santacruz, Belen; Bello-Munoz, Juan Carlos; Llurba, Elisa; Higueras, Teresa; Cabero, Luis; Carreras, Elena		Pesario Cervical Para Evitar Prem	Cervical pessary in pregnant women with a short cervix (PECEP): an open-label randomised controlled trial	LANCET			English	Article							SPONTANEOUS PRETERM BIRTH; PREMATURE DELIVERY; GESTATIONAL-AGE; LENGTH; PREDICTION; RISK; HISTORY	Background Most previous studies of the use of cervical pessaries were either retrospective or case controlled and their results showed that this intervention might be a preventive strategy for women at risk of preterm birth; no randomised controlled trials have been undertaken. We therefore undertook a randomised, controlled trial to investigate whether the insertion of a cervical pessary in women with a short cervix identified by use of routine transvaginal scanning at 20-23 weeks of gestation reduces the rate of early preterm delivery. Methods The Pesario Cervical para Evitar Prematuridad (PECEP) trial was undertaken in five hospitals in Spain. Pregnant women (aged 18-43 years) with a cervical length of 25 mm or less were randomly assigned according to a computer-generated allocation sequence by use of central telephone in a 1: 1 ratio to the cervical pessary or expectant management (without a cervical pessary) group. Because of the nature of the intervention, this study was not masked. The primary outcome was spontaneous delivery before 34 weeks of gestation. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00706264. Findings 385 pregnant women with a short cervix were assigned to the pessary (n=192) and expectant management groups (n=193), and 190 were analysed in each group. Spontaneous delivery before 34 weeks of gestation was significantly less frequent in the pessary group than in the expectant management group (12 [6%] vs 51 [27%], odds ratio 0.18, 95% CI 0.08-0.37; p<0.0001). No serious adverse effects associated with the use of a cervical pessary were reported. Interpretation Cervical pessary use could prevent preterm birth in a population of appropriately selected at-risk women previously screened for cervical length assessment at the midtrimester scan.	[Goya, Maria; Pratcorona, Laia; Merced, Carme; Rodo, Carlota; Bello-Munoz, Juan Carlos; Llurba, Elisa; Higueras, Teresa; Cabero, Luis; Carreras, Elena] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Obstet, Maternal Fetal Med Unit, Barcelona 08036, Spain; [Goya, Maria; Llurba, Elisa; Cabero, Luis; Carreras, Elena] Inst Salud Carlos III, Maternal & Child Hlth & Dev Network SAMID, Madrid, Spain; [Llurba, Elisa] Inst Salud Carlos III, Ctr Biomed Res Rare Dis CIBERER, Madrid, Spain; [Valle, Leonor; Romero, Azahar] Hosp Univ Materno Infantil Canarias, Dept Obstet, Maternal Fetal Med Unit, Las Palmas Gran Canaria, Spain; [Juan, Miquel] Hosp Son Llatzer, Dept Obstet, Maternal Fetal Med Unit, Balearic Isl, Spain; [Rodriguez, Alberto] Inst Univ Dexeus, Maternal Fetal Med Unit, Dept Obstet, Barcelona, Spain; [Munoz, Begona] Hosp St Joan de Reus, Dept Obstet, Maternal Fetal Med Unit, Tarragona, Spain; [Santacruz, Belen] Hosp Fuenlabrada, Dept Obstet, Maternal Fetal Med Unit, Madrid, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Hospital Universitari Son Llatzer; Hospital Universitario Fuenlabrada	Carreras, E (corresponding author), Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Obstet, Maternal Fetal Med Unit, Passeig Vall dHebron 119-129, Barcelona 08036, Spain.	ecarreras@vhebron.net	Roura, Lluis Cabero/O-1209-2015; Carreras, Elena/N-7698-2016; Maquedano, Marisa/H-4541-2011; Sao Aviles, Augusto/GOH-0884-2022; Goya, Maria M/L-5125-2018; MARTIN, BELEN BSM SANTACRUZ/E-8078-2018; RODO, CARLOTA/K-9179-2017	Roura, Lluis Cabero/0000-0002-1905-5680; Carreras, Elena/0000-0003-3471-7248; Goya, Maria M/0000-0003-4001-2017; MARTIN, BELEN BSM SANTACRUZ/0000-0003-1817-3092; RODO, CARLOTA/0000-0001-8801-5677; Bello-Munoz, Juan Carlos/0000-0001-7716-8715; CAVALLE BUSQUETS, PERE/0000-0002-5683-7219; Sao Aviles, Augusto/0000-0001-8497-0909; Pratcorona, Laia/0000-0002-3805-1589; Llurba Olive, Elisa/0000-0003-4048-6407	Instituto Carlos III, Madrid, Spain [071086]; Instituto Carlos III	Instituto Carlos III, Madrid, Spain(Instituto de Salud Carlos III); Instituto Carlos III(Instituto de Salud Carlos III)	Instituto Carlos III.; This study was supported by a grant (Fondo de Investigaciones Sanitarias number 071086) from the Instituto Carlos III, Madrid, Spain. We thank Christine O'Hara and Steve Brown for their help with the English version of this report; all the physicians who recruited individuals for the PECEP trial throughout the country, especially Ricardo Rubio (Hospital del Mar, Barcelona, Spain), Angels Vives (Hospital de Terrasa, Spain), Celia Barrionuevo, Armando Hernandez, Guillermo Landini, Gustavo Legaz, Romina Castagno, Laura Perdomo, and Guillem Cabero (Hospital Quiron, Barcelona, Spain); participants who agreed to take part in the study; people who sat on the multiple review committees that helped to refine the study protocol, especially Kypros Nicolaides who worked with us on the complex consent issues; and the Clara-Angela-Foundation for developing and manufacturing the cervical pessaries used in this trial.	Abdel-Aleem H, 2010, COCHRANE DB SYST REV, V9; Arabin B, 2003, J PERINAT MED, V31, P122, DOI 10.1515/JPM.2003.017; Celik E, 2008, ULTRASOUND OBST GYN, V31, P549, DOI 10.1002/uog.5333; Crispi F., 2004, PROG OBSTET GINECOL, V47, P264, DOI [10.1016/S0304-5013(04)76002-1, DOI 10.1016/S0304-5013(04)76002-1]; CROSS RG, 1959, LANCET, V2, P127; Domin CM, 2010, ULTRASOUND Q, V26, P241, DOI 10.1097/RUQ.0b013e3181fe0e05; Draper ES, 1999, BRIT MED J, V319, P1093, DOI 10.1136/bmj.319.7217.1093; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Goya M, 2011, ULTRASOUND OBST GYN, V38, P205, DOI 10.1002/uog.8960; Heath VCF, 1998, ULTRASOUND OBST GYN, V12, P312, DOI 10.1046/j.1469-0705.1998.12050312.x; Hegeman MA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-44; Honest H, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13430; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Iams JD, 2008, LANCET, V371, P164, DOI 10.1016/S0140-6736(08)60108-7; Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904; Koppe JGV-VP, 1998, TXB PERINATAL MED, P1362; Mercer BM, 1999, AM J OBSTET GYNECOL, V181, P1216, DOI 10.1016/S0002-9378(99)70111-0; Newcomer J, 2000, OBSTET GYNECOL SURV, V55, P443, DOI 10.1097/00006254-200007000-00023; Sieroszewski P, 2009, J MATERN-FETAL NEO M, V22, P469, DOI 10.1080/14767050802531748; To MS, 2006, AM J OBSTET GYNECOL, V194, P1360, DOI 10.1016/j.ajog.2005.11.001; To MS, 2006, ULTRASOUND OBST GYN, V27, P362, DOI 10.1002/uog.2773; To MS, 2001, ULTRASOUND OBST GYN, V17, P217, DOI 10.1046/j.1469-0705.2001.00369.x; Werner EF, 2011, ULTRASOUND OBST GYN, V38, P32, DOI 10.1002/uog.8911	24	284	309	2	49	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 12	2012	379	9828					1800	1806		10.1016/S0140-6736(12)60030-0	http://dx.doi.org/10.1016/S0140-6736(12)60030-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	941BR	22475493				2022-12-28	WOS:000303937700034
J	Muller, P; Rogers, KW; Jordan, BM; Lee, JS; Robson, D; Ramanathan, S; Schier, AF				Mueller, Patrick; Rogers, Katherine W.; Jordan, Ben M.; Lee, Joon S.; Robson, Drew; Ramanathan, Sharad; Schier, Alexander F.			Differential Diffusivity of Nodal and Lefty Underlies a Reaction-Diffusion Patterning System	SCIENCE			English	Article							LEFT-RIGHT ASYMMETRY; MORPHOGEN GRADIENT; MECHANISM; GENERATION; STABILITY; MOLECULES; DYNAMICS; XENOPUS; STRIPE; RANGE	Biological systems involving short-range activators and long-range inhibitors can generate complex patterns. Reaction-diffusion models postulate that differences in signaling range are caused by differential diffusivity of inhibitor and activator. Other models suggest that differential clearance underlies different signaling ranges. To test these models, we measured the biophysical properties of the Nodal/Lefty activator/inhibitor system during zebrafish embryogenesis. Analysis of Nodal and Lefty gradients revealed that Nodals have a shorter range than Lefty proteins. Pulse-labeling analysis indicated that Nodals and Leftys have similar clearance kinetics, whereas fluorescence recovery assays revealed that Leftys have a higher effective diffusion coefficient than Nodals. These results indicate that differential diffusivity is the major determinant of the differences in Nodal/Lefty range and provide biophysical support for reaction-diffusion models of activator/inhibitor-mediated patterning.	[Mueller, Patrick; Rogers, Katherine W.; Lee, Joon S.; Robson, Drew; Ramanathan, Sharad; Schier, Alexander F.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Jordan, Ben M.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Ramanathan, Sharad; Schier, Alexander F.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Ramanathan, Sharad; Schier, Alexander F.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Harvard University	Muller, P (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	pmueller@fas.harvard.edu; schier@fas.harvard.edu	Müller, Patrick/C-8096-2014	Müller, Patrick/0000-0002-0702-6209; Robson, Drew/0000-0002-0150-1515; Rogers, Katherine/0000-0001-5700-2662; Schier, Alexander Franz/0000-0001-7645-5325	European Molecular Biology Organization; Human Frontier Science Program (HFSP) [RGP0066/2004-C]; NSF; NIH [5RO1GM56211]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056211] Funding Source: NIH RePORTER	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program (HFSP)(Human Frontier Science Program); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank X. Zhang for help with the cloning of Cyclops constructs, H. Othmer and A. Lander for helpful discussions, J. Dubrulle for discussions and primers for quantitative reverse transcription polymerase chain reaction, and S. Mango for comments on the manuscript. Supported by European Molecular Biology Organization and Human Frontier Science Program (HFSP) Long-Term Fellowships (P.M.), the NSF Graduate Research Fellowship Program (K.W.R.), NIH grant 5RO1GM56211, and HFSP grant RGP0066/2004-C.	Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; Chen Y, 2001, NATURE, V411, P607, DOI 10.1038/35079121; Chen Y, 2002, CURR BIOL, V12, P2124, DOI 10.1016/S0960-9822(02)01362-3; Duboc V, 2008, DEV BIOL, V320, P49, DOI 10.1016/j.ydbio.2008.04.012; Economou AD, 2012, NAT GENET, V44, P348, DOI 10.1038/ng.1090; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Grande C, 2009, NATURE, V457, P1007, DOI 10.1038/nature07603; GRANERO MI, 1977, J MATH BIOL, V4, P21, DOI 10.1007/BF00276349; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774; Klein DE, 2004, NATURE, V430, P1040, DOI 10.1038/nature02840; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Le Good JA, 2005, CURR BIOL, V15, P31, DOI 10.1016/j.cub.2004.12.062; LENGYEL I, 1991, SCIENCE, V251, P650, DOI 10.1126/science.251.4994.650; Marjoram L, 2011, DEVELOPMENT, V138, P475, DOI 10.1242/dev.056010; Meinhardt H, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001362; Muller P, 2011, DEV CELL, V21, P145, DOI 10.1016/j.devcel.2011.06.001; Nakamura T, 2006, DEV CELL, V11, P495, DOI 10.1016/j.devcel.2006.08.002; Rogers KW, 2011, ANNU REV CELL DEV BI, V27, P377, DOI 10.1146/annurev-cellbio-092910-154148; Schier AF, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003459; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037; Yamaguchi M, 2007, P NATL ACAD SCI USA, V104, P4790, DOI 10.1073/pnas.0607790104; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391; Zhang LJ, 2007, BIOTECHNIQUES, V42, P446, DOI 10.2144/000112453; Zhou SH, 2012, CURR BIOL, V22, P668, DOI 10.1016/j.cub.2012.02.065	30	252	259	1	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2012	336	6082					721	724		10.1126/science.1221920	http://dx.doi.org/10.1126/science.1221920			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22499809	Green Accepted			2022-12-28	WOS:000303872300050
J	Jafferbhoy, S; Rustum, Q				Jafferbhoy, Sadaf; Rustum, Quatullah			Achalasia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jafferbhoy, Sadaf; Rustum, Quatullah] Barnsley Dist Hosp NHS Fdn Trust, Barnsley, England		Jafferbhoy, S (corresponding author), Barnsley Dist Hosp NHS Fdn Trust, Barnsley, England.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 12	2012	366	15					E23	E23		10.1056/NEJMicm1108474	http://dx.doi.org/10.1056/NEJMicm1108474			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923GV	22494139				2022-12-28	WOS:000302608600008
J	Lickwar, CR; Mueller, F; Hanlon, SE; McNally, JG; Lieb, JD				Lickwar, Colin R.; Mueller, Florian; Hanlon, Sean E.; McNally, James G.; Lieb, Jason D.			Genome-wide protein-DNA binding dynamics suggest a molecular clutch for transcription factor function	NATURE			English	Article							GLUCOCORTICOID-RECEPTOR; EUKARYOTIC GENOME; BUDDING YEAST; LIVING CELLS; CHROMATIN; PROMOTER; EQUILIBRIUM; MECHANISM; EXCHANGE; SITES	Dynamic access to genetic information is central to organismal development and environmental response. Consequently, genomic processes must be regulated by mechanisms that alter genome function relatively rapidly(1-4). Conventional chromatin immunoprecipitation (ChIP) experiments measure transcription factor occupancy(5), but give no indication of kinetics and are poor predictors of transcription factor function at a given locus. To measure transcription-factor-binding dynamics across the genome, we performed competition ChIP (refs 6, 7) with a sequence-specific Saccharomyces cerevisiae transcription factor, Rap1 (ref. 8). Rap1-binding dynamics and Rap1 occupancy were only weakly correlated (R-2 = 0.14), but binding dynamics were more strongly linked to function than occupancy. Long Rap1 residence was coupled to transcriptional activation, whereas fast binding turnover, which we refer to as 'treadmilling', was linked to low transcriptional output. Thus, DNA-binding events that seem identical by conventional ChIP may have different underlying modes of interaction that lead to opposing functional outcomes. We propose that transcription factor binding turnover is a major point of regulation in determining the functional consequences of transcription factor binding, and is mediated mainly by control of competition between transcription factors and nucleosomes. Our model predicts a clutch-like mechanism that rapidly engages a treadmilling transcription factor into a stable binding state, or vice versa, to modulate transcription factor function.	[Lickwar, Colin R.; Hanlon, Sean E.; Lieb, Jason D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Curriculum Genet & Mol Biol, Dept Biol,Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Mueller, Florian; McNally, James G.] NCI, LRBGE, NIH, Bethesda, MD 20892 USA; [Mueller, Florian] Ctr Natl Rech Sci, Inst Pasteur, Grp Imagerie & Modelisat, Unite Rech Associee 2582, F-75015 Paris, France	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lieb, JD (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Curriculum Genet & Mol Biol, Dept Biol,Carolina Ctr Genome Sci, CB 3280,408 Fordham Hall, Chapel Hill, NC 27599 USA.	jlieb@bio.unc.edu	Mueller, Florian/C-9075-2012	Mueller, Florian/0000-0002-9622-4396; Hanlon, Sean/0000-0001-6899-6906; Lieb, Jason/0000-0001-7601-8061	US National Institutes of Health (NIH) [R01-GM072518]; NIH, National Cancer Institute, Center for Cancer Research; Region Ile-de-France in the framework of C'Nano IdF, the nanoscience competence center of Paris Region; NATIONAL CANCER INSTITUTE [ZIABC010561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072518] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Region Ile-de-France in the framework of C'Nano IdF, the nanoscience competence center of Paris Region(Region Ile-de-France); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Kaplan and O. Rando for help with their turnover model, T. Palpant and S. Adar for help with time course experiments, and A. Leonardo Iniguez and H. Rosenbaum of Roche Nimblegen for pre-release custom HD4 12-plex microarrays. This work was supported by the US National Institutes of Health (NIH) Grant R01-GM072518 (to J.D.L.), and the intramural program of the NIH, National Cancer Institute, Center for Cancer Research (to J.G.M. and F.M.). F.M. was also supported in part by the Region Ile-de-France in the framework of C'Nano IdF, the nanoscience competence center of Paris Region.	Anderson JD, 2001, J MOL BIOL, V307, P977, DOI 10.1006/jmbi.2001.4528; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Buck MJ, 2006, NAT GENET, V38, P1446, DOI 10.1038/ng1917; Cesaroni M, 2008, BIOINFORMATICS, V24, P2918, DOI 10.1093/bioinformatics/btn542; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; ERLMANN T, 1990, J BIOL CHEM, V265, P17222; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Ganapathi M, 2011, NUCLEIC ACIDS RES, V39, P2032, DOI 10.1093/nar/gkq1161; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Gorski SA, 2008, MOL CELL, V30, P486, DOI 10.1016/j.molcel.2008.04.021; HOFFMAN CS, 1997, CURRENT PROTOCOLS MO, V2; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Karpova TS, 2008, SCIENCE, V319, P466, DOI 10.1126/science.1150559; Koerber RT, 2009, MOL CELL, V35, P889, DOI 10.1016/j.molcel.2009.09.011; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Layer JH, 2010, J BIOL CHEM, V285, P15489, DOI 10.1074/jbc.M110.104810; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Liu X, 2001, Pac Symp Biocomput, P127; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Mueller F, 2008, BIOPHYS J, V94, P3323, DOI 10.1529/biophysj.107.123182; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Pelechano V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015442; Pina B, 2003, MOL GENET GENOMICS, V268, P791, DOI 10.1007/s00438-002-0801-3; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Rossetti L, 2001, J MOL BIOL, V306, P903, DOI 10.1006/jmbi.2001.4458; Segal E, 2009, NAT REV GENET, V10, P443, DOI 10.1038/nrg2591; SIKORSKI RS, 1989, GENETICS, V122, P19; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; van Werven FJ, 2009, NAT STRUCT MOL BIOL, V16, P1043, DOI 10.1038/nsmb.1674; Voss TC, 2011, CELL, V146, P544, DOI 10.1016/j.cell.2011.07.006; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025; Zanton SJ, 2004, P NATL ACAD SCI USA, V101, P16843, DOI 10.1073/pnas.0404988101	38	170	172	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					251	U141		10.1038/nature10985	http://dx.doi.org/10.1038/nature10985			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22498630	Green Accepted, Green Submitted			2022-12-28	WOS:000303149900037
J	Ismail-Beigi, F				Ismail-Beigi, Faramarz			Glycemic Management of Type 2 Diabetes Mellitus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLUCOSE CONTROL; CARDIOVASCULAR-DISEASE; BARIATRIC SURGERY; CLINICAL-PRACTICE; AMERICAN-COLLEGE; INSULIN GLARGINE; RANDOMIZED-TRIAL; ORAL MEDICATIONS; ASSOCIATION; CARE	A 39-year-old man with a 2-year history of type 2 diabetes mellitus presents for care. He has no microvascular or macrovascular complications. His family history is positive for type 2 diabetes and cardiovascular disease in his mother and older brother. On examination, his weight is 99.8 kg (220 lb), with a body-mass index (BMI; the weight in kilograms divided by the square of the height in meters) of 37, and his blood pressure is 125/85 mm Hg. His glycated hemoglobin level is 8.9%, serum creatinine level 1.0 mg per deciliter (88.4 mu mol per liter), low-density lipoprotein (LDL) cholesterol 88 mg per deciliter (2.3 mmol per liter), high-density lipoprotein (HDL) cholesterol 45 mg per deciliter (1.2 mmol per liter), and triglyceride level 130 mg per deciliter (1.5 mmol per liter); he does not have microalbuminuria. His medications include metformin (500 mg twice daily), glipizide (5 mg twice daily), simvastatin (20 mg daily), and lisinopril (10 mg daily). What would you recommend to improve his glycemic control?	[Ismail-Beigi, Faramarz] Case Western Reserve Univ, Dept Med, Univ Hosp, Cleveland, OH 44106 USA; [Ismail-Beigi, Faramarz] Case Western Reserve Univ, Vet Affairs Med Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; University Hospitals of Cleveland; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Ismail-Beigi, F (corresponding author), Case Western Reserve Univ, Dept Med, 10900 Euclid Ave, Cleveland, OH 44106 USA.	fxi2@case.edu			Eli Lilly	Eli Lilly(Eli Lilly)	Dr. Ismail-Beigi reports receiving consulting fees from Eli Lilly and owning stock in Thermalin Diabetes. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011, 10.2337/dc12-s004]; [Anonymous], 1996, DIABETES; Bennett WL, 2012, ANN INTERN MED, V156, P27, DOI 10.7326/0003-4819-156-1-201201030-00005; Bennett WL, 2011, ANN INTERN MED, V154, P602, DOI 10.7326/0003-4819-154-9-201105030-00336; Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; Chiasson JL, 2004, DIABETOLOGIA, V47, P969, DOI 10.1007/s00125-004-1409-4; Davis SN, 2011, ENDOCR PRACT, V17, P845, DOI 10.4158/EP10401.OR; de Galan BE, 2009, DIABETOLOGIA, V52, P2328, DOI 10.1007/s00125-009-1484-7; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; [Department of Veterans Affairs Department of Defense], 2010, MAN DIAB MELL PRIM C; Desouza C, 2003, DIABETES CARE, V26, P1485, DOI 10.2337/diacare.26.5.1485; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gerstein HC, 2006, DIABETIC MED, V23, P736, DOI 10.1111/j.1464-5491.2006.01881.x; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Giugliano D, 2011, DIABETES RES CLIN PR, V92, P1, DOI 10.1016/j.diabres.2010.08.006; Handelsman Y, 2011, ENDOCR PRACT, V17, P287, DOI 10.4158/EP.17.2.287; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holman RR, 2009, NEW ENGL J MED, V361, P1736, DOI 10.1056/NEJMoa0905479; Hung AM, 2012, KIDNEY INT      0118; Ismail-Beigi F, 2011, ANN INTERN MED, V154, P554, DOI 10.7326/0003-4819-154-8-201104190-00007; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Leahy JL, 2010, J CLIN ENDOCR METAB, V95, P4206, DOI 10.1210/jc.2010-0668; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Mingrone G, 2012, NEW ENGL J MED, DOI [10.1056/NEJMoa1200111, DOI 10.1056/NEJMOA1200111]; Narayan KMV, 2010, NEW ENGL J MED, V363, P1196, DOI 10.1056/NEJMp1002024; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nyalakonda K, 2010, ENDOCR PRACT, V16, P1038, DOI 10.4158/EP10112.RA; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Qaseem A, 2012, ANN INTERN MED, V156, P218, DOI 10.7326/0003-4819-156-3-201202070-00011; Qaseern A, 2007, ANN INTERN MED, V147, P417, DOI 10.7326/0003-4819-147-6-200709180-00012; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Ralston JD, 2009, DIABETES CARE, V32, P234, DOI 10.2337/dc08-1220; Rodbard Helena W, 2007, Endocr Pract, V13 Suppl 1, P1; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sarwar N, 2010, LANCET, V376, P957, DOI 10.1016/S0140-6736(10)61450-X; Schauer PR, 2012, NEW ENGL J MED, DOI [10.1056/NEJMoa1200225, DOI 10.1056/NEJMOA1200225]; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; Tahrani AA, 2011, LANCET, V378, P182, DOI 10.1016/S0140-6736(11)60207-9; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; TURNER RC, 1995, DIABETES, V44, P1249; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wennberg DE, 2010, NEW ENGL J MED, V363, P1245, DOI 10.1056/NEJMsa0902321; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Whitmer RA, 2009, JAMA-J AM MED ASSOC, V301, P1565, DOI 10.1001/jama.2009.460; Wilcox R, 2008, AM HEART J, V155, P712, DOI 10.1016/j.ahj.2007.11.029; Wolfram T, 2011, ENDOCR PRACT, V17, P132, DOI 10.4158/EP10204.RA	56	126	132	1	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 5	2012	366	14					1319	1327		10.1056/NEJMcp1013127	http://dx.doi.org/10.1056/NEJMcp1013127			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919QJ	22475595				2022-12-28	WOS:000302343000009
J	Lane, R				Lane, Richard			Donna McKay: taking a long lens on human rights	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 31	2012	379	9822					1189	1189		10.1016/S0140-6736(12)60499-1	http://dx.doi.org/10.1016/S0140-6736(12)60499-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	918DV	22464375				2022-12-28	WOS:000302230400019
J	Novoa, EM; Pavon-Eternod, M; Pan, T; de Pouplana, LR				Novoa, Eva Maria; Pavon-Eternod, Mariana; Pan, Tao; de Pouplana, Lluis Ribas			A Role for tRNA Modifications in Genome Structure and Codon Usage	CELL			English	Article							ESCHERICHIA-COLI; TRANSLATION EFFICIENCY; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; PHYLOGENETIC ANALYSIS; ADENOSINE-DEAMINASE; PROTEIN EXPRESSION; BACILLUS-SUBTILIS; SELECTION	Transfer RNA (tRNA) gene content is a differentiating feature of genomes that contributes to the efficiency of the translational apparatus, but the principles shaping tRNA gene copy number and codon composition are poorly understood. Here, we report that the emergence of two specific tRNA modifications shaped the structure and composition of all extant genomes. Through the analysis of more than 500 genomes, we identify two kingdom-specific tRNA modifications as major contributors that separated archaeal, bacterial, and eukaryal genomes in terms of their tRNA gene composition. We show that, contrary to prior observations, genomic codon usage and tRNA gene frequencies correlate in all kingdoms if these two modifications are taken into account and that presence or absence of these modifications explains patterns of gene expression observed in previous studies. Finally, we experimentally demonstrate that human gene expression levels correlate well with genomic codon composition if these identified modifications are considered.	[Novoa, Eva Maria; de Pouplana, Lluis Ribas] Inst Res Biomed, Barcelona 08028, Catalonia, Spain; [Pavon-Eternod, Mariana; Pan, Tao] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [de Pouplana, Lluis Ribas] Catalan Inst Res & Adv Studies, Barcelona 08010, Catalonia, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Chicago; ICREA	de Pouplana, LR (corresponding author), Inst Res Biomed, C Baldiri Reixac 15-21, Barcelona 08028, Catalonia, Spain.	lluis.ribas@irbbarcelona.org	Novoa, Eva Maria/B-1004-2015; de Pouplana, Lluis Ribas/AAA-4738-2019; Novoa, Eva Maria/B-1004-2015	Novoa, Eva Maria/0000-0002-9367-6311; de Pouplana, Lluis Ribas/0000-0002-2087-0359; Novoa, Eva Maria/0000-0001-5567-1299	Spanish Ministry of Education and Science [BIO2009-09776]; European Union [MEPHITIS-223024]; La Caixa/IRB; NIH [1F31CA139968]; NATIONAL CANCER INSTITUTE [F31CA139968] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Spanish Ministry of Education and Science(Spanish Government); European Union(European Commission); La Caixa/IRB; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ICREA(ICREA)	We thank Dr. M. Santos and Dr. V. de Crecy-Lagard for their critical analysis of the manuscript. We also thank E. Planet and D. Rossell for their help with the statistical analysis of the data. This work has been supported by grant BIO2009-09776 from the Spanish Ministry of Education and Science, and by grant MEPHITIS-223024 from the European Union. E.M.N. is supported by a La Caixa/IRB International Ph.D. Programme Fellowship. M.P.-E. was supported by a Ruth Kirshstein Pre-doctoral Fellowship from the NIH (1F31CA139968).	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; AKASHI H, 1994, GENETICS, V136, P927; Akashi H, 2003, GENETICS, V164, P1291; BENNETZEN JL, 1982, J BIOL CHEM, V257, P3026; Brochier C, 2002, NATURE, V417, P244, DOI 10.1038/417244a; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Chen SL, 2004, P NATL ACAD SCI USA, V101, P3480, DOI 10.1073/pnas.0307827100; Dittmar KA, 2005, EMBO REP, V6, P151, DOI 10.1038/sj.embor.7400341; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Duret L, 2000, TRENDS GENET, V16, P287, DOI 10.1016/S0168-9525(00)02041-2; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; Elf J, 2003, SCIENCE, V300, P1718, DOI 10.1126/science.1083811; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fitz-Gibbon ST, 1999, NUCLEIC ACIDS RES, V27, P4218, DOI 10.1093/nar/27.21.4218; Gerber AP, 2001, TRENDS BIOCHEM SCI, V26, P376, DOI 10.1016/S0968-0004(01)01827-8; Gerber AP, 1999, SCIENCE, V286, P1146, DOI 10.1126/science.286.5442.1146; Geslain R, 2010, J MOL BIOL, V396, P821, DOI 10.1016/j.jmb.2009.12.018; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GONOS ES, 1990, FEBS LETT, V276, P138, DOI 10.1016/0014-5793(90)80527-P; Grosjean H, 2010, FEBS LETT, V584, P252, DOI 10.1016/j.febslet.2009.11.052; Hershberg R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000556; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Iwasaki W, 2007, BIOINFORMATICS, V23, pI230, DOI 10.1093/bioinformatics/btm165; Jolliffe I, 2011, PRINCIPAL COMPONENT; Kanaya S, 2001, J MOL EVOL, V53, P290, DOI 10.1007/s002390010219; Kanaya S, 1999, GENE, V238, P143, DOI 10.1016/S0378-1119(99)00225-5; Knight R. D., 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-4-RESEARCH0010; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Ledoux S, 2009, NAT STRUCT MOL BIOL, V16, P359, DOI 10.1038/nsmb.1581; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Maas S, 2000, BIOESSAYS, V22, P790, DOI 10.1002/1521-1878(200009)22:9<790::AID-BIES4>3.0.CO;2-0; Man O, 2007, NAT GENET, V39, P415, DOI 10.1038/ng1967; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; Mata J, 2005, TRENDS BIOCHEM SCI, V30, P506, DOI 10.1016/j.tibs.2005.07.005; McInerney JO, 1998, BIOINFORMATICS, V14, P372, DOI 10.1093/bioinformatics/14.4.372; Mian IS, 1998, J COMPUT BIOL, V5, P57, DOI 10.1089/cmb.1998.5.57; Moriyama EN, 1998, NUCLEIC ACIDS RES, V26, P3188, DOI 10.1093/nar/26.13.3188; Nasvall SJ, 2004, RNA, V10, P1662, DOI 10.1261/rna.7106404; Navon S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r12; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Pavon-Eternod M, 2010, RNA, V16, P267, DOI 10.1261/rna.1928110; Ran WQ, 2010, MOL BIOL EVOL, V27, P2129, DOI 10.1093/molbev/msq102; Sharp PM, 2010, PHILOS T R SOC B, V365, P1203, DOI 10.1098/rstb.2009.0305; Sharp PM, 2005, NUCLEIC ACIDS RES, V33, P1141, DOI 10.1093/nar/gki242; SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/nar/16.17.8207; Snel B, 1999, NAT GENET, V21, P108, DOI 10.1038/5052; Stetter K.O., 1996, CIBA F SYMP, V202, P11; Stetter KO, 1996, CIBA F SYMP, V202, P1; Supek F, 2010, GENETICS, V185, P1129, DOI 10.1534/genetics.110.115477; Supek F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001004; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tekaia F, 1999, GENOME RES, V9, P550; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Tuller T, 2007, PLOS COMPUT BIOL, V3, P2510, DOI 10.1371/journal.pcbi.0030248; Withers M, 2006, RNA, V12, P933, DOI 10.1261/rna.2272306; Wolf J, 2002, EMBO J, V21, P3841, DOI 10.1093/emboj/cdf362; Yang S, 2005, P NATL ACAD SCI USA, V102, P373, DOI 10.1073/pnas.0408810102; Yang ZH, 2008, MOL BIOL EVOL, V25, P568, DOI 10.1093/molbev/msm284; YOKOYAMA S, 1985, P NATL ACAD SCI USA, V82, P4905, DOI 10.1073/pnas.82.15.4905; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554	71	172	184	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 30	2012	149	1					202	213		10.1016/j.cell.2012.01.050	http://dx.doi.org/10.1016/j.cell.2012.01.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464330	Bronze			2022-12-28	WOS:000302235400021
J	Garnett, MJ; Edelman, EJ; Heidorn, SJ; Greenman, CD; Dastur, A; Lau, KW; Greninger, P; Thompson, IR; Luo, X; Soares, J; Liu, QS; Iorio, F; Surdez, D; Chen, L; Milano, RJ; Bignell, GR; Tam, AT; Davies, H; Stevenson, JA; Barthorpe, S; Lutz, SR; Kogera, F; Lawrence, K; McLaren-Douglas, A; Mitropoulos, X; Mironenko, T; Thi, H; Richardson, L; Zhou, WJ; Jewitt, F; Zhang, TH; O'Brien, P; Boisvert, JL; Price, S; Hur, W; Yang, WJ; Deng, XM; Butler, A; Choi, HG; Chang, J; Baselga, J; Stamenkovic, I; Engelman, JA; Sharma, SV; Delattre, O; Saez-Rodriguez, J; Gray, NS; Settleman, J; Futreal, PA; Haber, DA; Stratton, MR; Ramaswamy, S; McDermott, U; Benes, CH				Garnett, Mathew J.; Edelman, Elena J.; Heidorn, Sonja J.; Greenman, Chris D.; Dastur, Anahita; Lau, King Wai; Greninger, Patricia; Thompson, I. Richard; Luo, Xi; Soares, Jorge; Liu, Qingsong; Iorio, Francesco; Surdez, Didier; Chen, Li; Milano, Randy J.; Bignell, Graham R.; Tam, Ah T.; Davies, Helen; Stevenson, Jesse A.; Barthorpe, Syd; Lutz, Stephen R.; Kogera, Fiona; Lawrence, Karl; McLaren-Douglas, Anne; Mitropoulos, Xeni; Mironenko, Tatiana; Thi, Helen; Richardson, Laura; Zhou, Wenjun; Jewitt, Frances; Zhang, Tinghu; O'Brien, Patrick; Boisvert, Jessica L.; Price, Stacey; Hur, Wooyoung; Yang, Wanjuan; Deng, Xianming; Butler, Adam; Choi, Hwan Geun; Chang, JaeWon; Baselga, Jose; Stamenkovic, Ivan; Engelman, Jeffrey A.; Sharma, Sreenath V.; Delattre, Olivier; Saez-Rodriguez, Julio; Gray, Nathanael S.; Settleman, Jeffrey; Futreal, P. Andrew; Haber, Daniel A.; Stratton, Michael R.; Ramaswamy, Sridhar; McDermott, Ultan; Benes, Cyril H.			Systematic identification of genomic markers of drug sensitivity in cancer cells	NATURE			English	Article							MESENCHYMAL PROGENITOR CELLS; KINASE INHIBITOR; IN-VIVO; POLY(ADP-RIBOSE) POLYMERASE; EWINGS-SARCOMA; LUNG-CANCER; P53 PATHWAY; GROWTH; EXPRESSION; MELANOMA	Clinical responses to anticancer therapies are often restricted to a subset of patients. In some cases, mutated cancer genes are potent biomarkers for responses to targeted agents. Here, to uncover new biomarkers of sensitivity and resistance to cancer therapeutics, we screened a panel of several hundred cancer cell lines-which represent much of the tissue-type and genetic diversity of human cancers-with 130 drugs under clinical and preclinical investigation. In aggregate, we found that mutated cancer genes were associated with cellular response to most currently available cancer drugs. Classic oncogene addiction paradigms were modified by additional tissue-specific or expression biomarkers, and some frequently mutated genes were associated with sensitivity to a broad range of therapeutic agents. Unexpected relationships were revealed, including the marked sensitivity of Ewing's sarcoma cells harbouring the EWS (also known as EWSR1)-FLI1 gene translocation to poly(ADP-ribose) polymerase (PARP) inhibitors. By linking drug activity to the functional complexity of cancer genomes, systematic pharmacogenomic profiling in cancer cell lines provides a powerful biomarker discovery platform to guide rational cancer therapeutic strategies.	[Garnett, Mathew J.; Heidorn, Sonja J.; Greenman, Chris D.; Lau, King Wai; Thompson, I. Richard; Soares, Jorge; Iorio, Francesco; Bignell, Graham R.; Davies, Helen; Barthorpe, Syd; Kogera, Fiona; Lawrence, Karl; McLaren-Douglas, Anne; Mironenko, Tatiana; Richardson, Laura; Jewitt, Frances; O'Brien, Patrick; Price, Stacey; Yang, Wanjuan; Butler, Adam; Futreal, P. Andrew; Stratton, Michael R.; McDermott, Ultan] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; [Edelman, Elena J.; Dastur, Anahita; Greninger, Patricia; Luo, Xi; Chen, Li; Milano, Randy J.; Stevenson, Jesse A.; Lutz, Stephen R.; Mitropoulos, Xeni; Thi, Helen; Boisvert, Jessica L.; Baselga, Jose; Engelman, Jeffrey A.; Sharma, Sreenath V.; Settleman, Jeffrey; Haber, Daniel A.; Ramaswamy, Sridhar; Benes, Cyril H.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Charlestown, MA 02129 USA; [Liu, Qingsong; Zhou, Wenjun; Zhang, Tinghu; Hur, Wooyoung; Deng, Xianming; Choi, Hwan Geun; Chang, JaeWon; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Liu, Qingsong; Zhou, Wenjun; Zhang, Tinghu; Hur, Wooyoung; Deng, Xianming; Choi, Hwan Geun; Chang, JaeWon; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Iorio, Francesco; Saez-Rodriguez, Julio] EMBL EBI, Cambridge CB10 1SD, England; [Surdez, Didier; Delattre, Olivier] Inst Curie, Lab Genet & Biol Canc, F-75248 Paris 05, France; [Stamenkovic, Ivan] CHU Vaudois, Inst Pathol, Div Expt Pathol, CH-1005 Lausanne, Switzerland; [Haber, Daniel A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Wellcome Trust Sanger Institute; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Howard Hughes Medical Institute	McDermott, U (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England.	um1@sanger.ac.uk; cbenes@partners.org	Iorio, Francesco/H-3284-2019; Surdez, Didier/ABG-4565-2020; 刘, 青松/AEM-1932-2022; Thompson, I Richard/J-9900-2016; Saez-Rodriguez, Julio/H-7114-2019; Chang, Jae Won/AAN-4139-2020; Lawrence, Karl P/I-8271-2019; Iorio, Francesco/H-3282-2019; Liu, Qingsong/AFS-0714-2022	Iorio, Francesco/0000-0001-7063-8913; 刘, 青松/0000-0002-7829-2547; Thompson, I Richard/0000-0002-9554-550X; Saez-Rodriguez, Julio/0000-0002-8552-8976; Lawrence, Karl P/0000-0003-0124-961X; Liu, Qingsong/0000-0002-7829-2547; Gill, Sonja/0000-0002-7273-9053; Chen, Li/0000-0001-9303-4047; delattre, olivier/0000-0002-8730-2276; Deng, Xianming/0000-0002-9354-5864; McDermott, Ultan/0000-0001-9032-4700	Wellcome Trust [086357]; National Institutes of Health [P41GM079575-02, 1U54HG006097-01]; Howard Hughes Medical Institute; Cancer Research UK Clinician Scientist Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM079575] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Cancer Research UK Clinician Scientist Fellowship(Cancer Research UK); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Lo Grasso of the Scripps Research Institute for providing the inhibitor JNK9L. This work was supported by a grant from the Wellcome Trust (086357; M. R. S., P. A. F., J.S., D. A. H.) and by grants from the National Institutes of Health (P41GM079575-02 to N.S.G. and 1U54HG006097-01 to N.S.G. and D. A. H.). S. R. is supported by a Physician-Scientist Early Career Award from the Howard Hughes Medical Institute. U. M. is supported by a Cancer Research UK Clinician Scientist Fellowship.	Balamuth NJ, 2010, LANCET ONCOL, V11, P184, DOI 10.1016/S1470-2045(09)70286-4; Boisvert-Adamo K, 2009, MOL CANCER RES, V7, P549, DOI 10.1158/1541-7786.MCR-08-0358; Boland CR, 1998, CANCER RES, V58, P5248; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Byron SA, 2008, CANCER RES, V68, P6902, DOI 10.1158/0008-5472.CAN-08-0770; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Deng L, 2010, CANCER BIOL THER, V9, P875, DOI 10.4161/cbt.9.11.11634; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Dry JR, 2010, CANCER RES, V70, P2264, DOI 10.1158/0008-5472.CAN-09-1577; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Kelland LR, 1999, J NATL CANCER I, V91, P1940, DOI 10.1093/jnci/91.22.1940; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Konecny GE, 2011, CLIN CANCER RES, V17, P1591, DOI 10.1158/1078-0432.CCR-10-2307; Kunii K, 2008, CANCER RES, V68, P2340, DOI 10.1158/0008-5472.CAN-07-5229; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; McCabe N, 2005, CANCER BIOL THER, V4, P934, DOI 10.4161/cbt.4.9.2141; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; McDermott U, 2009, J CLIN ONCOL, V27, P5650, DOI 10.1200/JCO.2009.22.9054; O'Farrell AM, 2003, BLOOD, V101, P3597, DOI 10.1182/blood-2002-07-2307; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Riggi N, 2006, CANCER RES, V66, P7016, DOI 10.1158/0008-5472.CAN-05-3979; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shoemaker R H, 1988, Prog Clin Biol Res, V276, P265; Suwaki N, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002004; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Weber DM, 2007, NEW ENGL J MED, V357, P2133, DOI 10.1056/NEJMoa070596; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	37	1609	1636	10	371	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2012	483	7391					570	U87		10.1038/nature11005	http://dx.doi.org/10.1038/nature11005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915EF	22460902	Green Accepted, Green Submitted			2022-12-28	WOS:000302006100033
J	Cristofolini, P; Christmann, G; Tsintzos, SI; Deligeorgis, G; Konstantinidis, G; Hatzopoulos, Z; Savvidis, PG; Baumberg, JJ				Cristofolini, Peter; Christmann, Gabriel; Tsintzos, Simeon I.; Deligeorgis, George; Konstantinidis, George; Hatzopoulos, Zacharias; Savvidis, Pavlos G.; Baumberg, Jeremy J.			Coupling Quantum Tunneling with Cavity Photons	SCIENCE			English	Article							ELECTROMAGNETICALLY INDUCED TRANSPARENCY; BOSE-EINSTEIN CONDENSATION; POLARITONS; LIGHT; MICROCAVITY; STORAGE	Tunneling of electrons through a potential barrier is fundamental to chemical reactions, electronic transport in semiconductors and superconductors, magnetism, and devices such as terahertz oscillators. Whereas tunneling is typically controlled by electric fields, a completely different approach is to bind electrons into bosonic quasiparticles with a photonic component. Quasiparticles made of such light-matter microcavity polaritons have recently been demonstrated to Bose-condense into superfluids, whereas spatially separated Coulomb-bound electrons and holes possess strong dipole interactions. We use tunneling polaritons to connect these two realms, producing bosonic quasiparticles with static dipole moments. Our resulting three-state system yields dark polaritons analogous to those in atomic systems or optical waveguides, thereby offering new possibilities for electromagnetically induced transparency, room-temperature condensation, and adiabatic photon-to-electron transfer.	[Cristofolini, Peter; Christmann, Gabriel; Tsintzos, Simeon I.; Baumberg, Jeremy J.] Univ Cambridge, Cavendish Lab, NanoPhoton Ctr, Cambridge CB3 0HE, England; [Tsintzos, Simeon I.; Deligeorgis, George; Konstantinidis, George; Hatzopoulos, Zacharias; Savvidis, Pavlos G.] FORTH IESL, Iraklion 71110, Crete, Greece; [Savvidis, Pavlos G.] Univ Crete, Dept Mat Sci & Technol, Iraklion 71003, Greece	University of Cambridge; University of Crete	Baumberg, JJ (corresponding author), Univ Cambridge, Cavendish Lab, NanoPhoton Ctr, Cambridge CB3 0HE, England.	jjb12@cam.ac.uk	Baumberg, Jeremy J/C-1409-2009; Konstantinidis, George/A-1719-2014; Deligeorgis, George/E-8450-2010; Hatzopoulos, Zaharias/G-8312-2011; Tsintzos, Symeon/E-3861-2017; Savvidis, Pavlos G/A-4157-2009; Christmann, Gabriel/A-8836-2013	Baumberg, Jeremy J/0000-0002-9606-9488; Konstantinidis, George/0000-0002-1072-9618; Deligeorgis, George/0000-0002-4339-4914; Tsintzos, Symeon/0000-0003-3491-3513; Savvidis, Pavlos G/0000-0002-8186-6679; Tsintzos, Symeon/0000-0002-9503-964X	UK Engineering and Physical Sciences Research Council [EP/G060649/1, EP/F011393]; European Union [CLERMONT4 PITNGA-2009-235114, INDEX FP7-2011-289968]; POLATOM European Science Foundation Research Network; EPSRC [EP/G060649/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G060649/1] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Union(European Commission); POLATOM European Science Foundation Research Network; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Supported by UK Engineering and Physical Sciences Research Council grants EP/G060649/1 and EP/F011393, European Union grants CLERMONT4 PITNGA-2009-235114 and INDEX FP7-2011-289968, and the POLATOM European Science Foundation Research Network Programme.	Amo A, 2009, NATURE, V457, P291, DOI 10.1038/nature07640; Balili R, 2007, SCIENCE, V316, P1007, DOI 10.1126/science.1140990; CAPASSO F, 1987, SCIENCE, V235, P172, DOI 10.1126/science.235.4785.172; Christmann G, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3559909; Christmann G, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.113308; Christopoulos S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.126405; Filinov A, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.070401; Fleischhauer M, 2000, PHYS REV LETT, V84, P5094, DOI 10.1103/PhysRevLett.84.5094; High AA, 2008, SCIENCE, V321, P229, DOI 10.1126/science.1157845; Kasprzak J, 2006, NATURE, V443, P409, DOI 10.1038/nature05131; Lagoudakis KG, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.120403; Liu C, 2001, NATURE, V409, P490, DOI 10.1038/35054017; Lukin MD, 2001, NATURE, V413, P273, DOI 10.1038/35095000; Lukin MD, 2000, PHYS REV LETT, V84, P4232, DOI 10.1103/PhysRevLett.84.4232; Moller D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.170504; Mucke M, 2010, NATURE, V465, P755, DOI 10.1038/nature09093; Phillips DF, 2001, PHYS REV LETT, V86, P783, DOI 10.1103/PhysRevLett.86.783; Poggio M, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.121305; Schinner GJ, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.165308; Tsintzos SI, 2008, NATURE, V453, P372, DOI 10.1038/nature06979; Voros Z, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.016403; Yanik MF, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.233903	22	106	108	2	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2012	336	6082					704	707		10.1126/science.1219010	http://dx.doi.org/10.1126/science.1219010			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22491095				2022-12-28	WOS:000303872300045
J	Johnson, K; Zhu, ST; Tremblay, MS; Payette, JN; Wang, JN; Bouchez, LC; Meeusen, S; Althage, A; Cho, CY; Wu, X; Schultz, PG				Johnson, Kristen; Zhu, Shoutian; Tremblay, Matthew S.; Payette, Joshua N.; Wang, Jianing; Bouchez, Laure C.; Meeusen, Shelly; Althage, Alana; Cho, Charles Y.; Wu, Xu; Schultz, Peter G.			A Stem Cell-Based Approach to Cartilage Repair	SCIENCE			English	Article							ARTICULAR-CARTILAGE; CHONDROCYTE DIFFERENTIATION; TRANSCRIPTION FACTOR; OSTEOARTHRITIS; BONE; PATHOGENESIS; FILAMIN; GENE; CHONDROGENESIS; EXPRESSION	Osteoarthritis (OA) is a degenerative joint disease that involves the destruction of articular cartilage and eventually leads to disability. Molecules that promote the selective differentiation of multipotent mesenchymal stem cells (MSCs) into chondrocytes may stimulate the repair of damaged cartilage. Using an image-based high-throughput screen, we identified the small molecule kartogenin, which promotes chondrocyte differentiation (median effective concentration = 100 nM), shows chondroprotective effects in vitro, and is efficacious in two OA animal models. Kartogenin binds filamin A, disrupts its interaction with the transcription factor core-binding factor beta subunit (CBF beta), and induces chondrogenesis by regulating the CBF beta-RUNX1 transcriptional program. This work provides new insights into the control of chondrogenesis that may ultimately lead to a stem cell-based therapy for osteoarthritis.	[Johnson, Kristen; Tremblay, Matthew S.; Meeusen, Shelly; Althage, Alana; Cho, Charles Y.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Zhu, Shoutian; Tremblay, Matthew S.; Payette, Joshua N.; Wang, Jianing; Bouchez, Laure C.; Schultz, Peter G.] Scripps Res Inst, La Jolla, CA 92037 USA; [Wu, Xu] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA	Novartis; Scripps Research Institute; Harvard University; Massachusetts General Hospital	Johnson, K (corresponding author), Novartis Res Fdn, Genom Inst, 10675 John Jay Hopkins Dr, San Diego, CA 92121 USA.	kjohnson@gnf.org; schultz@scripps.edu	Zhu, Shoutian/M-2108-2018	Zhu, Shoutian/0000-0001-6748-225X; Johnson, Kristen/0000-0003-0788-7217; bouchez, laure/0000-0003-4583-6760	California Institute for Regenerative Medicine [TR2-01829]	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	This work was funded by grants from the California Institute for Regenerative Medicine (TR2-01829 to P.G.S.). We are grateful to J. Walker for help in gene expression analysis. Microarray data have been deposited in the National Center for Biotechnology Information's Gene Expression Omnibus with accession number GSE35546. A patent application has been submitted by the authors on the use of kartogenin for chondrogenesis.	Adya N, 2000, SEMIN CELL DEV BIOL, V11, P361, DOI 10.1006/scdb.2000.0189; Charbord P, 2010, HUM GENE THER, V21, P1045, DOI 10.1089/hum.2010.115; Coluet J, 2009, DRUG DISCOV TODAY, V14, P913, DOI 10.1016/j.drudis.2009.07.012; Connelly JT, 2008, J CELL PHYSIOL, V217, P145, DOI 10.1002/jcp.21484; Drissi H, 2002, J CELL BIOCHEM, V86, P403, DOI 10.1002/jcb.10238; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Goldring MB, 2010, ANN NY ACAD SCI, V1192, P230, DOI 10.1111/j.1749-6632.2009.05240.x; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Grogan SP, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2719; Hunter DJ, 2011, NAT REV RHEUMATOL, V7, P13, DOI 10.1038/nrrheum.2010.178; Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041; Koelling S, 2009, CELL STEM CELL, V4, P324, DOI 10.1016/j.stem.2009.01.015; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2011, J CELL BIOCHEM, V112, P750, DOI 10.1002/jcb.22994; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; LOHMANDER LS, 1994, ANN RHEUM DIS, V53, P8, DOI 10.1136/ard.53.1.8; Lotz MK, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3046; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Read SJ, 2008, EXPERT OPIN INV DRUG, V17, P619, DOI 10.1517/13543784.17.5.619 ; Reginster JY, 2002, RHEUMATOLOGY, V41, P1, DOI 10.1093/rheumatology/41.suppl_1.1; Reijman M, 2004, ARTHRITIS RHEUM-US, V50, P2471, DOI 10.1002/art.20332; Rutgers M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3050; Smith GN, 2006, FRONT BIOSCI-LANDMRK, V11, P3081, DOI 10.2741/2034; Soung DY, 2007, J BONE MINER RES, V22, P1260, DOI 10.1359/JBMR.070502; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; van der Kraan PM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2896; VANDERKRAAN PM, 1989, AM J PATHOL, V135, P1001; Wang Y, 2007, ONCOGENE, V26, P6061, DOI 10.1038/sj.onc.1210435; Wang YJ, 2005, J BONE MINER RES, V20, P1624, DOI 10.1359/JBMR.050516; Wotton S, 2008, ONCOGENE, V27, P5856, DOI 10.1038/onc.2008.195; Wurdak H, 2010, P NATL ACAD SCI USA, V107, P16542, DOI 10.1073/pnas.1010300107; Yoshida N, 2005, MOL CELL BIOL, V25, P1003, DOI 10.1128/MCB.25.3.1003-1012.2005; Zhu ST, 2009, CELL STEM CELL, V4, P416, DOI 10.1016/j.stem.2009.04.001	35	458	508	8	306	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2012	336	6082					717	721		10.1126/science.1215157	http://dx.doi.org/10.1126/science.1215157			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22491093				2022-12-28	WOS:000303872300049
J	Schlappa, J; Wohlfeld, K; Zhou, KJ; Mourigal, M; Haverkort, MW; Strocov, VN; Hozoi, L; Monney, C; Nishimoto, S; Singh, S; Revcolevschi, A; Caux, JS; Patthey, L; Ronnow, HM; van den Brink, J; Schmitt, T				Schlappa, J.; Wohlfeld, K.; Zhou, K. J.; Mourigal, M.; Haverkort, M. W.; Strocov, V. N.; Hozoi, L.; Monney, C.; Nishimoto, S.; Singh, S.; Revcolevschi, A.; Caux, J. -S.; Patthey, L.; Ronnow, H. M.; van den Brink, J.; Schmitt, T.			Spin-orbital separation in the quasi-one-dimensional Mott insulator Sr2CuO3	NATURE			English	Article							X-RAY-SCATTERING; CHARGE SEPARATION	When viewed as an elementary particle, the electron has spin and charge. When binding to the atomic nucleus, it also acquires an angular momentum quantum number corresponding to the quantized atomic orbital it occupies. Even if electrons in solids form bands and delocalize from the nuclei, in Mott insulators they retain their three fundamental quantum numbers: spin, charge and orbital(1). The hallmark of one-dimensional physics is a breaking up of the elementary electron into its separate degrees of freedom(2). The separation of the electron into independent quasi-particles that carry either spin (spinons) or charge (holons) was first observed fifteen years ago(3). Here we report observation of the separation of the orbital degree of freedom (orbiton) using resonant inelastic X-ray scattering on the one-dimensional Mott insulator Sr2CuO3. We resolve an orbiton separating itself from spinons and propagating through the lattice as a distinct quasi-particle with a substantial dispersion in energy over momentum, of about 0.2 electronvolts, over nearly one Brillouin zone.	[Schlappa, J.; Zhou, K. J.; Strocov, V. N.; Monney, C.; Patthey, L.; Schmitt, T.] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Schlappa, J.] Helmholtz Zentrum Berlin Mat & Energie GmbH, Inst Methoden & Instrumentierung Forsch Synchrotr, D-12489 Berlin, Germany; [Wohlfeld, K.; Hozoi, L.; Nishimoto, S.; van den Brink, J.] IFW Dresden, Inst Theoret Solid State Phys, D-01069 Dresden, Germany; [Mourigal, M.; Ronnow, H. M.] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Haverkort, M. W.] Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany; [Singh, S.; Revcolevschi, A.] Univ Paris 11, ICMMO UMR 8182, F-91405 Orsay, France; [Caux, J. -S.] Univ Amsterdam, Inst Theoret Phys, NL-1090 GL Amsterdam, Netherlands; [Patthey, L.] SwissFEL, CH-5232 Villigen, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Institute for Integrative Nanosciences (IIN); Leibniz Institute for Solid State & Materials Research Dresden; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; University of Amsterdam	Schlappa, J (corresponding author), Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland.	justine.schlappa@helmholtz-berlin.de; thorsten.schmitt@psi.ch	Patthey, Luc/G-6130-2018; Wohlfeld, Krzysztof/Q-2351-2019; Ronnow, Henrik M/A-4953-2009; Mourigal, Martin/AAJ-4237-2020; Monney, Claude/C-5553-2011; Mourigal, Martin/F-4495-2010; van den Brink, Jeroen/E-5670-2011; Wohlfeld, Krzysztof/B-4489-2014; Schmitt, Thorsten/A-7025-2010; Haverkort, Maurits W./D-2319-2009; van den Brink, Jeroen/Y-3931-2019	Patthey, Luc/0000-0001-6101-8069; Wohlfeld, Krzysztof/0000-0002-6524-8264; Ronnow, Henrik M/0000-0002-8832-8865; Mourigal, Martin/0000-0003-2772-8440; Monney, Claude/0000-0003-3496-1435; Mourigal, Martin/0000-0003-2772-8440; van den Brink, Jeroen/0000-0001-6594-9610; Wohlfeld, Krzysztof/0000-0002-6524-8264; Haverkort, Maurits W./0000-0002-7216-3146; Zhou, Ke-Jin/0000-0001-9293-0595	Swiss National Science Foundation and its NCCR MaNEP; Alexander von Humboldt foundation; Foundation for Fundamental Research on Matter; Netherlands Organisation for Scientific Research; European contract NOVMAG; Division of Materials Science and Engineering, US Department of Energy [DE-SC0007091]	Swiss National Science Foundation and its NCCR MaNEP; Alexander von Humboldt foundation(Alexander von Humboldt Foundation); Foundation for Fundamental Research on Matter(FOM (The Netherlands)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European contract NOVMAG; Division of Materials Science and Engineering, US Department of Energy(United States Department of Energy (DOE))	This work was performed at the ADRESS beamline of the Swiss Light Source using the SAXES instrument jointly built by the Paul Scherrer Institut, Switzerland, and Politecnico di Milano, Italy. We acknowledge support from the Swiss National Science Foundation and its NCCR MaNEP. K. W. acknowledges support from the Alexander von Humboldt foundation and discussions with M. Daghofer and S.-L. Drechsler. J.-S.C. acknowledges support from the Foundation for Fundamental Research on Matter and from the Netherlands Organisation for Scientific Research. S. S. and A. R. acknowledge the support of the European contract NOVMAG. This research benefited from the RIXS collaboration supported by the Computational Materials Science Network programme of the Division of Materials Science and Engineering, US Department of Energy, grant no. DE-SC0007091.	Ament LJP, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.705; Ament LJP, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.117003; ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; Braicovich L, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.077002; Brunner M, 2000, EUR PHYS J B, V16, P209, DOI 10.1007/s100510070220; Caux JS, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/12/P12013; Fujisawa H, 1999, PHYS REV B, V59, P7358, DOI 10.1103/PhysRevB.59.7358; Ghiringhelli G, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2372731; GIAMARCHI T., 2004, INT SERIES MONOGRAPH; Glawion S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.107402; Gruninger M, 2002, NATURE, V418, P39, DOI 10.1038/418039a; Haverkort MW, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.167404; Hozoi L, 2011, SCI REP-UK, V1, DOI 10.1038/srep00065; Kim BJ, 2006, NAT PHYS, V2, P397, DOI 10.1038/nphys316; Kim C, 1996, PHYS REV LETT, V77, P4054, DOI 10.1103/PhysRevLett.77.4054; KUGEL KI, 1982, USP FIZ NAUK+, V136, P621, DOI 10.1070/PU1982v025n04ABEH004537; Le Tacon M, 2011, NAT PHYS, V7, P725, DOI [10.1038/nphys2041, 10.1038/NPHYS2041]; LUO J, 1993, PHYS REV LETT, V71, P287, DOI 10.1103/PhysRevLett.71.287; MACFARLANE RM, 1971, PHYS REV B-SOLID ST, V4, P3054, DOI 10.1103/PhysRevB.4.3054; Moretti Sala M, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/4/043026; Neudert R, 2000, PHYS REV B, V62, P10752, DOI 10.1103/PhysRevB.62.10752; Oles AM, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.214431; Schlappa J, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.047401; Senthil T, 2001, PHYS REV LETT, V86, P292, DOI 10.1103/PhysRevLett.86.292; Strocov VN, 2010, J SYNCHROTRON RADIAT, V17, P631, DOI 10.1107/S0909049510019862; Suzuura H, 1997, PHYS REV B, V56, P3548, DOI 10.1103/PhysRevB.56.3548; Ulrich C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.107205; van Veenendaal M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.117404; Walters AC, 2009, NAT PHYS, V5, P867, DOI 10.1038/NPHYS1405; Wohlfeld K, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.147201	30	222	222	6	187	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					82	U108		10.1038/nature10974	http://dx.doi.org/10.1038/nature10974			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22522933	Green Submitted			2022-12-28	WOS:000303451900038
J	Talkowski, ME; Rosenfeld, JA; Blumenthal, I; Pillalamarri, V; Chiang, C; Heilbut, A; Ernst, C; Hanscom, C; Rossin, E; Lindgren, AM; Pereira, S; Ruderfer, D; Kirby, A; Ripke, S; Harris, DJ; Lee, JH; Ha, K; Kim, HG; Solomon, BD; Gropman, AL; Lucente, D; Sims, K; Ohsumi, TK; Borowsky, ML; Loranger, S; Quade, B; Lage, K; Miles, J; Wu, BL; Shen, YP; Neale, B; Shaffer, LG; Daly, MJ; Morton, CC; Gusella, JF				Talkowski, Michael E.; Rosenfeld, Jill A.; Blumenthal, Ian; Pillalamarri, Vamsee; Chiang, Colby; Heilbut, Adrian; Ernst, Carl; Hanscom, Carrie; Rossin, Elizabeth; Lindgren, Amelia M.; Pereira, Shahrin; Ruderfer, Douglas; Kirby, Andrew; Ripke, Stephan; Harris, David J.; Lee, Ji-Hyun; Ha, Kyungsoo; Kim, Hyung-Goo; Solomon, Benjamin D.; Gropman, Andrea L.; Lucente, Diane; Sims, Katherine; Ohsumi, Toshiro K.; Borowsky, Mark L.; Loranger, Stephanie; Quade, Bradley; Lage, Kasper; Miles, Judith; Wu, Bai-Lin; Shen, Yiping; Neale, Benjamin; Shaffer, Lisa G.; Daly, Mark J.; Morton, Cynthia C.; Gusella, James F.			Sequencing Chromosomal Abnormalities Reveals Neurodevelopmental Loci that Confer Risk across Diagnostic Boundaries	CELL			English	Article							AUTISM SPECTRUM DISORDERS; PITT-HOPKINS-SYNDROME; CHROMATIN REMODELING FACTOR; GENOME-WIDE ASSOCIATION; MICRODELETION SYNDROME; DEVELOPMENTAL DELAY; SUSCEPTIBILITY LOCI; BIPOLAR DISORDER; CHD8 INTERACTS; SCHIZOPHRENIA	Balanced chromosomal abnormalities (BCAs) represent a relatively untapped reservoir of single-gene disruptions in neurodevelopmental disorders (NDDs). We sequenced BCAs in patients with autism or related NDDs, revealing disruption of 33 loci in four general categories: (1) genes previously associated with abnormal neurodevelopment (e. g., AUTS2, FOXP1, and CDKL5), (2) single-gene contributors to microdeletion syndromes (MBD5, SATB2, EHMT1, and SNURF-SNRPN), (3) novel risk loci (e. g., CHD8, KIRREL3, and ZNF507), and (4) genes associated with later-onset psychiatric disorders (e. g., TCF4, ZNF804A, PDE10A, GRIN2B, and ANK3). We also discovered among neurodevelopmental cases a profoundly increased burden of copy-number variants from these 33 loci and a significant enrichment of polygenic risk alleles from genome-wide association studies of autism and schizophrenia. Our findings suggest a polygenic risk model of autism and reveal that some neurodevelopmental genes are sensitive to perturbation by multiple mutational mechanisms, leading to variable phenotypic outcomes that manifest at different life stages.	[Talkowski, Michael E.; Blumenthal, Ian; Pillalamarri, Vamsee; Chiang, Colby; Heilbut, Adrian; Ernst, Carl; Hanscom, Carrie; Rossin, Elizabeth; Ruderfer, Douglas; Kirby, Andrew; Ripke, Stephan; Lee, Ji-Hyun; Lucente, Diane; Sims, Katherine; Shen, Yiping; Neale, Benjamin; Daly, Mark J.; Gusella, James F.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Rossin, Elizabeth; Kirby, Andrew; Ripke, Stephan; Lage, Kasper; Neale, Benjamin; Daly, Mark J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Ohsumi, Toshiro K.; Borowsky, Mark L.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Quade, Bradley; Wu, Bai-Lin; Shen, Yiping; Morton, Cynthia C.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Talkowski, Michael E.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Gusella, James F.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Talkowski, Michael E.; Rossin, Elizabeth; Ruderfer, Douglas; Kirby, Andrew; Ripke, Stephan; Lage, Kasper; Neale, Benjamin; Daly, Mark J.; Morton, Cynthia C.; Gusella, James F.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02143 USA; [Rosenfeld, Jill A.; Shaffer, Lisa G.] PerkinElmer Inc, Signature Genom Labs, Spokane, WA 99207 USA; [Lindgren, Amelia M.; Pereira, Shahrin; Morton, Cynthia C.] Brigham & Womens Hosp, Dept Obstet, Boston, MA 02115 USA; [Lindgren, Amelia M.; Pereira, Shahrin; Morton, Cynthia C.] Brigham & Womens Hosp, Dept Gynecol, Boston, MA 02115 USA; [Lindgren, Amelia M.; Pereira, Shahrin; Morton, Cynthia C.] Brigham & Womens Hosp, Dept Reprod Biol, Boston, MA 02115 USA; [Harris, David J.] Childrens Hosp Boston, Div Clin Genet, Boston, MA 02115 USA; [Wu, Bai-Lin; Shen, Yiping] Childrens Hosp Boston, Dept Lab Med, Boston, MA 02115 USA; [Ha, Kyungsoo] Georgia Hlth Sci Univ, Canc Res Ctr, Augusta, GA 30912 USA; [Kim, Hyung-Goo] Georgia Hlth Sci Univ, Inst Mol Med & Genet, Dept Obstet & Gynecol, Augusta, GA 30912 USA; [Solomon, Benjamin D.] NHGRI, Med Genet Branch, Bethesda, MD 20892 USA; [Gropman, Andrea L.] Childrens Natl Med Ctr, Dept Neurol, Washington, DC 20010 USA; [Gropman, Andrea L.] George Washington Univ Hlth Sci, Dept Neurol, Washington, DC 20052 USA; [Loranger, Stephanie; Daly, Mark J.; Gusella, James F.] Autism Consortium Boston, Boston, MA 02115 USA; [Lage, Kasper] Massachusetts Gen Hosp, MassGen Hosp Children, Pediat Surg Res Labs, Boston, MA 02114 USA; [Lage, Kasper] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Lage, Kasper] Univ Copenhagen, Ctr Prot Res, DK-1165 Copenhagen, Denmark; [Miles, Judith] Univ Missouri Hosp & Clin, Thompson Ctr Autism & Neurodev Disorders, Dept Pediat, Columbia, MO 65201 USA; [Miles, Judith] Univ Missouri Hosp & Clin, Thompson Ctr Autism & Neurodev Disorders, Dept Med Genet, Columbia, MO 65201 USA; [Miles, Judith] Univ Missouri Hosp & Clin, Thompson Ctr Autism & Neurodev Disorders, Dept Pathol, Columbia, MO 65201 USA; [Wu, Bai-Lin] Fudan Univ, Childrens Hosp, Shanghai 200032, Peoples R China; [Wu, Bai-Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Shen, Yiping] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Shanghai 200025, Peoples R China	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University System of Georgia; Augusta University; University System of Georgia; Augusta University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Children's National Health System; George Washington University; Harvard University; Massachusetts General Hospital; Technical University of Denmark; University of Copenhagen; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Fudan University; Fudan University; Shanghai Jiao Tong University	Gusella, JF (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	gusella@helix.mgh.harvard.edu	Heilbut, Adrian M/J-9427-2012; Daly, Mark J/B-2453-2017; Ripke, Stephan/AAK-5486-2021; Ruderfer, Douglas M/M-5795-2016	Heilbut, Adrian M/0000-0002-8169-7967; Daly, Mark J/0000-0002-0949-8752; Ruderfer, Douglas M/0000-0002-2365-386X; Chiang, Colby/0000-0002-4113-6065; Talkowski, Michael/0000-0003-2889-0992; ripke, stephan/0000-0003-3622-835X	National Institutes of Health [GM061354, HD065286]; Simons Foundation Autism Research Initiative; Autism Speaks; Division of Intramural Research, National Human Genome Research Institute, National Institutes of Health and Human Services; National Institute of Mental Health National Research Service [MH087123]; Massachusetts General Hospital Executive Committee; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD065286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, P01GM061354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH087123, R00MH095867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation Autism Research Initiative; Autism Speaks; Division of Intramural Research, National Human Genome Research Institute, National Institutes of Health and Human Services; National Institute of Mental Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Massachusetts General Hospital Executive Committee; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to all participating subjects and families and to the many healthcare professionals who have contributed to this study, including Mary-Alice Abbott, Darius J. Adams, Kwame Anyane-Yeboa, Stephen G. Bamforth, Tina Bartell, David P. Bick, Joann N. Bodurtha, Carol Clericuzio, Stephanie Cohen, Kristin Dalton, Maria Descartes, Joanne Milisa Drautz, Dawn L. Earl, Luis F. Escobar, Shannon Gerner, Edwin Guzman, Kenneth Handelman, Tim Heshka, Robert J. Hopkin, Micheil Innes, Debby Lambert, Emmanuelle Lemyre, Cynthia Lim, Livija Medne, Graciela Moya, Katie Rutledge, Wendy Smith, Mark Stephan, Darci Sternen, Katie Stoll, Paulien van Galen, Nancy J. Van Vranken, Erica Wahl, Susan E. Wiley, Amy L. White, Anne Woods, and Elaine H. Zackai. The invaluable control data for this study were provided by Pamela Sklar, Shaun Purcell, the International Schizophrenia Consortium, the Wellcome Trust Case Control Consortium, Evan Eichler, Bradley Coe, and Greg Cooper. We thank Tammy Gillis, Mary Anne Anderson, Jayla Ruliera, and Thon de Boer for technical assistance. We also thank Dennis Gurgul, Nilay Roy, and Brent Richter of Partners Research Computing at Massachusetts General Hospital, and contributing staff from Signature Genomic Laboratories and Children's Hospital Boston. This work was funded by grants GM061354 and HD065286 from the National Institutes of Health, the Simons Foundation Autism Research Initiative, and Autism Speaks. This research was also supported by the Division of Intramural Research, National Human Genome Research Institute, National Institutes of Health and Human Services. M. T. was supported by a National Institute of Mental Health National Research Service Award (MH087123) and an Massachusetts General Hospital Executive Committee on Research Fund for Medical Discovery Award. L. G. S. and J. A. R. are employees of Signature Genomic Laboratories, PerkinElmer.	Amiel J, 2007, AM J HUM GENET, V80, P988, DOI 10.1086/515582; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Batsukh T, 2010, HUM MOL GENET, V19, P2858, DOI 10.1093/hmg/ddq189; Blake DJ, 2010, SCHIZOPHRENIA BULL, V36, P443, DOI 10.1093/schbul/sbq035; Chiang C, 2012, NAT GENET, V44, P390, DOI 10.1038/ng.2202; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Higgins AW, 2008, AM J HUM GENET, V82, P712, DOI 10.1016/j.ajhg.2008.01.011; Kehler J, 2011, CURR PHARM DESIGN, V17, P137, DOI 10.2174/138161211795049624; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kleefstra T, 2006, AM J HUM GENET, V79, P370, DOI 10.1086/505693; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Lakics V, 2010, NEUROPHARMACOLOGY, V59, P367, DOI 10.1016/j.neuropharm.2010.05.004; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Meerabux JMA, 2009, J HUM GENET, V54, P386, DOI 10.1038/jhg.2009.47; Morikawa Y, 2007, NEUROSCIENCE, V150, P880, DOI 10.1016/j.neuroscience.2007.10.013; MURRAY RM, 1987, BRIT MED J, V295, P681, DOI 10.1136/bmj.295.6600.681; Nishiyama M, 2009, NAT CELL BIOL, V11, P172, DOI 10.1038/ncb1831; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Owen MJ, 2011, BRIT J PSYCHIAT, V198, P173, DOI 10.1192/bjp.bp.110.084384; Ravel C, 2006, HUM REPROD, V21, P1484, DOI 10.1093/humrep/del024; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rodriguez-Paredes M, 2009, NUCLEIC ACIDS RES, V37, P2449, DOI 10.1093/nar/gkp101; Rosenfeld JA, 2010, GENET MED, V12, P694, DOI 10.1097/GIM.0b013e3181f0c5f3; Rosenfeld JA, 2009, GENET MED, V11, P797, DOI 10.1097/GIM.0b013e3181bd38a9; Rosenfeld JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006568; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Sultana R, 2002, GENOMICS, V80, P129, DOI 10.1006/geno.2002.6810; Talkowski ME, 2011, AM J HUM GENET, V89, P551, DOI 10.1016/j.ajhg.2011.09.011; Talkowski ME, 2011, AM J HUM GENET, V88, P469, DOI 10.1016/j.ajhg.2011.03.013; Tamura S, 2005, NEUROSCIENCE, V133, P615, DOI 10.1016/j.neuroscience.2005.03.030; Thompson BA, 2008, MOL CELL BIOL, V28, P3894, DOI 10.1128/MCB.00322-08; Walters JTR, 2010, ARCH GEN PSYCHIAT, V67, P692, DOI 10.1001/archgenpsychiatry.2010.81; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Weinberger DR, 1986, NEUROLOGY SCHIZOPHRE, P387; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Williams HJ, 2011, HUM MOL GENET, V20, P387, DOI 10.1093/hmg/ddq471; Zahir F, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.050823	45	392	412	0	61	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 27	2012	149	3								10.1016/j.cell.2012.03.028	http://dx.doi.org/10.1016/j.cell.2012.03.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22521361	Green Accepted, Bronze			2022-12-28	WOS:000303443100006
J	Bhaskaran, K; Douglas, I; Evans, S; van Staa, T; Smeeth, L				Bhaskaran, Krishnan; Douglas, Ian; Evans, Stephen; van Staa, Tjeerd; Smeeth, Liam			Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICATION; ANGIOGENESIS; METAANALYSIS; TESTS	Objectives To investigate whether there is an association between use of angiotensin receptor blockers and risk of cancer. Design Cohort study of risk of cancer in people treated with angiotensin receptor blockers compared with angiotensin converting enzyme (ACE) inhibitors. Effects were explored with time updated covariates in Cox models adjusted for age, sex, body mass index (BMI), diabetes and metformin/insulin use, hypertension, heart failure, statin use, socioeconomic status, alcohol, smoking, and calendar year. Absolute changes in risk were predicted from a Poisson model incorporating the strongest determinants of risk from the main analysis. Setting UK primary care practices contributing to the General Practice Research Database. Participants 377 649 new users of angiotensin receptor blockers or ACE inhibitors with at least one year of initial treatment. Main outcome measures Adjusted hazard ratios for all cancer and major site specific cancers (breast, lung, colon, prostate) by exposure to angiotensin receptor blockers and by cumulative duration of use. Results Follow-up ended a median of 4.6 years after the start of treatment; 20 203 cancers were observed. There was no evidence of any increase in overall risk of cancer among those ever exposed to angiotensin receptor blockers (adjusted hazard ratio 1.03, 95% confidence interval 0.99 to 1.06, P=0.10). For specific cancers, there was some evidence of an increased risk of breast and prostate cancer (1.11, 1.01 to 1.21, P=0.02; and 1.10, 1.00 to 1.20, P=0.04; respectively), which in absolute terms corresponded to an estimated 0.5 and 1.1 extra cases, respectively, per 1000 person years of follow-up among those with the highest baseline risk. Longer duration of treatment did not seem to be associated with higher risk (P> 0.15 in each case). There was a decreased risk of lung cancer (0.84, 0.75 to 0.94), but no effect on colon cancer (1.02, 0.91 to 1.16). Conclusions Use of angiotensin receptor blockers was not associated with an increased risk of cancer overall. Observed increased risks for breast and prostate cancer were small in absolute terms, and the lack of association with duration of treatment meant that non-causal explanations could not be excluded.	[Bhaskaran, Krishnan; Douglas, Ian; Smeeth, Liam] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Evans, Stephen] Univ London London Sch Hyg & Trop Med, Dept Med Stat, London WC1E 7HT, England; [van Staa, Tjeerd] Med & Healthcare Prod Regulatory Agcy, Gen Practice Res Database, London, England; [van Staa, Tjeerd] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; The Medicines & Healthcare Products Regulatory Agency; Utrecht University	Bhaskaran, K (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Keppel St, London WC1E 7HT, England.	krishnan.bhaskaran@lshtm.ac.uk	; Smeeth, Liam/X-5862-2018	Bhaskaran, Krishnan/0000-0001-5364-8757; Smeeth, Liam/0000-0002-9168-6022; Evans, Stephen/0000-0002-1474-2596; van Staa, Tjeerd/0000-0001-9363-742X	National Institute for Health Research; Wellcome Trust; MRC; Takeda; General Practice Research Database (GPRD); MHRA; Medical Research Council; NIHR; Innovative Medicine Initiative; UK Department of Health; Technology Strategy Board; EU; Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences; GlaxoSmithKline; Novo Nordisk; Dutch Medicines Evaluation Board; Dutch Ministry of Health; MRC [G0802403] Funding Source: UKRI; Medical Research Council [G0802403] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10090, PDF-2011-04-007] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Takeda(Takeda Pharmaceutical Company Ltd); General Practice Research Database (GPRD); MHRA; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); Innovative Medicine Initiative; UK Department of Health; Technology Strategy Board; EU(European Commission); Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences; GlaxoSmithKline(GlaxoSmithKline); Novo Nordisk(Novo Nordisk); Dutch Medicines Evaluation Board; Dutch Ministry of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This report is independent research arising from a postdoctoral fellowship (for KB) supported by the National Institute for Health Research. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, or the Department of Health. LS is supported by a Wellcome Trust senior research fellowship in clinical science. ID is supported by an MRC methodology research fellowship. General Practice Research Database (GPRD) is owned by the Secretary of State of the UK Department of Health and operates within the MHRA (Medicines and Healthcare products Regulatory Agency). The views expressed in this paper are those of the authors and do not reflect the official policy or position of the MHRA. The funding sources detailed above had no role in the design, conduct, analysis, or reporting of the study. All authors carried out this research independently of the funding bodies; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: ID has previously received consultancy fees from Takeda (unrelated to the submitted work); the General Practice Research Database (GPRD) has received funding from the MHRA, Wellcome Trust, Medical Research Council, NIHR Health Technology Assessment programme, Innovative Medicine Initiative, UK Department of Health, Technology Strategy Board, Seventh Framework Programme EU, various universities, contract research organisations and pharmaceutical companies; the Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, has received unrestricted funding for pharmacoepidemiological research from GlaxoSmithKline, Novo Nordisk, Top Institute Pharma (www.tipharma.nl, includes co-funding from universities, government, and industry), the Dutch Medicines Evaluation Board, and the Dutch Ministry of Health.	[Anonymous], 2011, READ COD; Bangalore S, 2011, LANCET ONCOL, V12, P65, DOI 10.1016/S1470-2045(10)70260-6; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; [British Medical Association Royal Pharmaceutical Society of Great Britain], 2011, 61 BMA RPS BRIT NAT; Coleman CI, 2008, J HYPERTENS, V26, P622, DOI 10.1097/HJH.0b013e3282f3ef5e; Department for Communities and Local Government, 2011, IND MULT DEPR; Deshayes F, 2005, TRENDS ENDOCRIN MET, V16, P293, DOI 10.1016/j.tem.2005.07.009; Fryzek JP, 2006, BREAST CANCER RES TR, V97, P231, DOI 10.1007/s10549-005-9091-x; Fryzek JP, 2005, BRIT J CANCER, V92, P1302, DOI 10.1038/sj.bjc.6602490; Golder S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001026; Gong QK, 2010, PANCREAS, V39, P581, DOI 10.1097/MPA.0b013e3181c314cd; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Greene AS, 2002, CURR HYPERTENS REP, V4, P56, DOI 10.1007/s11906-002-0054-x; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Huang CC, 2011, AM J CARDIOL, V107, P1028, DOI 10.1016/j.amjcard.2010.11.026; Koomen ER, 2009, CANCER EPIDEMIOL, V33, P391, DOI 10.1016/j.canep.2009.10.005; Lithell H, 2003, J HYPERTENS, V21, P875, DOI 10.1097/00004872-200305000-00011; Matchar DB, 2008, ANN INTERN MED, V148, P16, DOI 10.7326/0003-4819-148-1-200801010-00189; Munzenmaier DH, 1996, HYPERTENSION, V27, P760, DOI 10.1161/01.HYP.27.3.760; Parkinson J, 2007, PHARMACOVIGILANCE, P341, DOI DOI 10.1002/9780470059210.CH27; Pasternak B, 2011, CIRCULATION, V123, P1729, DOI 10.1161/CIRCULATIONAHA.110.007336; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; SADOSHIMA J, 1993, CIRC RES, V73, P424, DOI 10.1161/01.RES.73.3.424; Sipahi I, 2010, LANCET ONCOL, V11, P627, DOI 10.1016/S1470-2045(10)70106-6; Teo KK, 2011, J HYPERTENS, V29, P623, DOI 10.1097/HJH.0b013e328344a7de; Walther T, 2003, FASEB J, V17, P2061, DOI 10.1096/fj.03-0129com; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	28	75	77	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2012	344								e2697	10.1136/bmj.e2697	http://dx.doi.org/10.1136/bmj.e2697			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	934HB	22531797	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000303433700004
J	Holmes, D				Holmes, David			Molly Stevens: material girl	LANCET			English	Biographical-Item																			0	0	0	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 21	2012	379	9825					1479	1479		10.1016/S0140-6736(12)60620-5	http://dx.doi.org/10.1016/S0140-6736(12)60620-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930BJ	22521061				2022-12-28	WOS:000303110200013
J	Rice, SA; Chee, R; Rustin, MHA				Rice, Shantini A.; Chee, Ronnie; Rustin, Malcolm H. A.			Repeatedly red faced	LANCET			English	Editorial Material							MANNOSE-BINDING LECTIN; GENE		[Rice, Shantini A.; Rustin, Malcolm H. A.] Royal Free Hosp, Dept Dermatol, London NW3 2QG, England; [Chee, Ronnie] Royal Free Hosp, Dept Immunol, London NW3 2QG, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Rice, SA (corresponding author), Royal Free Hosp, Dept Dermatol, Pond St, London NW3 2QG, England.	shantini@doctors.org.uk						Hibberd ML, 1999, LANCET, V353, P1049, DOI 10.1016/S0140-6736(98)08350-0; IKEDA K, 1987, J BIOL CHEM, V262, P7451; Lipscombe R. J., 1992, Human Molecular Genetics, V1, P709, DOI 10.1093/hmg/1.9.709; Soborg C, 2003, J INFECT DIS, V188, P777, DOI 10.1086/377183; TURNER M W, 1991, Clinical and Experimental Immunology, V86, P53	5	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 21	2012	379	9825					1560	1560		10.1016/S0140-6736(11)61932-6	http://dx.doi.org/10.1016/S0140-6736(11)61932-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930BJ	22521073				2022-12-28	WOS:000303110200035
J	Astafiev, OV; Ioffe, LB; Kafanov, S; Pashkin, YA; Arutyunov, KY; Shahar, D; Cohen, O; Tsai, JS				Astafiev, O. V.; Ioffe, L. B.; Kafanov, S.; Pashkin, Yu. A.; Arutyunov, K. Yu.; Shahar, D.; Cohen, O.; Tsai, J. S.			Coherent quantum phase slip	NATURE			English	Article							SUPERCONDUCTIVITY; SUPPRESSION; NANOWIRES	A hundred years after the discovery of superconductivity, one fundamental prediction of the theory, coherent quantum phase slip (CQPS), has not been observed. CQPS is a phenomenon exactly dual(1) to the Josephson effect; whereas the latter is a coherent transfer of charges between superconducting leads(2,3), the former is a coherent transfer of vortices or fluxes across a superconducting wire. In contrast to previously reported observations(4-8) of incoherent phase slip, CQPS has been only a subject of theoretical study(9-12). Its experimental demonstration is made difficult by quasiparticle dissipation due to gapless excitations in nanowires or in vortex cores. This difficulty might be overcome by using certain strongly disordered superconductors near the superconductor-insulator transition. Here we report direct observation of CQPS in a narrow segment of a superconducting loop made of strongly disordered indium oxide; the effect is made manifest through the superposition of quantum states with different numbers of flux quanta(13). As with the Josephson effect, our observation should lead to new applications in superconducting electronics and quantum metrology(1,10,11).	[Astafiev, O. V.; Kafanov, S.; Pashkin, Yu. A.; Tsai, J. S.] NEC Green Innovat Res Labs, Tsukuba, Ibaraki 3058501, Japan; [Astafiev, O. V.; Kafanov, S.; Pashkin, Yu. A.; Tsai, J. S.] Inst Phys & Chem Res RIKEN, Tsukuba, Ibaraki 3058501, Japan; [Ioffe, L. B.] Rutgers State Univ, Dept Phys & Astron, Ctr Mat Theory, Piscataway, NJ 08854 USA; [Pashkin, Yu. A.] Univ Lancaster, Dept Phys, Lancaster LA1 4YB, England; [Arutyunov, K. Yu.] Univ Jyvaskyla, Dept Phys, Jyvaskyla 40014, Finland; [Arutyunov, K. Yu.] Moscow MV Lomonosov State Univ, Inst Nucl Phys, Moscow 119899, Russia; [Shahar, D.; Cohen, O.] Weizmann Inst Sci, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel	RIKEN; Rutgers State University New Brunswick; Lancaster University; University of Jyvaskyla; Lomonosov Moscow State University; National Research Centre - Kurchatov Institute; Institute of High Energy Physics - IHEP; Weizmann Institute of Science	Astafiev, OV (corresponding author), NEC Green Innovat Res Labs, 34 Miyukigaoka, Tsukuba, Ibaraki 3058501, Japan.	astf@zb.jp.nec.com	Astafiev, Oleg/L-9771-2013; Arutyunov, Konstantin Yu/K-6430-2015; Tsai, Jaw-Shen/I-7813-2012; Pashkin, Yuri/M-8540-2015; Kafanov, Sergey/R-4075-2016	Pashkin, Yuri/0000-0003-4767-8217; Kafanov, Sergey/0000-0002-7953-101X	MEXT KAKENHI; Ministry of Science and Education of Russian Federation [2010-1.5-508-005-037]; ARO [W911NF-09-1-0395]; DARPA [HR0011-09-1- 0009]; NIRT [ECS-0608842]; Minerva Fund; Grants-in-Aid for Scientific Research [21102002] Funding Source: KAKEN	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Science and Education of Russian Federation(Ministry of Education and Science, Russian Federation); ARO; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIRT(Indian Council of Medical Research (ICMR)); Minerva Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to M. Feigel'man, J. Mooij and Y. Nazarov for discussions. This work was supported by Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST), MEXT KAKENHI "Quantum Cybernetics", Ministry of Science and Education of Russian Federation grant 2010-1.5-508-005-037. L. B. I. was supported by ARO W911NF-09-1-0395, DARPA HR0011-09-1- 0009 and NIRT ECS-0608842. D. S. and O.C. were supported by Minerva Fund.	Abdumalikov AA, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.180502; Arutyunov KY, 2008, PHYS REP, V464, P1, DOI 10.1016/j.physrep.2008.04.009; Arutyunov KY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00293; Astafiev O, 2010, SCIENCE, V327, P840, DOI 10.1126/science.1181918; Averin D. V., 1984, ZH EKSP TEOR FIZ, V88, P407; Bezryadin A, 2000, NATURE, V404, P971, DOI 10.1038/35010060; Feigel'man MV, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.027001; Feigel'man MV, 2010, ANN PHYS-NEW YORK, V325, P1390, DOI 10.1016/j.aop.2010.04.001; FINKELSTEIN AM, 1994, PHYSICA B, V197, P636, DOI 10.1016/0921-4526(94)90267-4; GIORDANO N, 1988, PHYS REV LETT, V61, P2137, DOI 10.1103/PhysRevLett.61.2137; Golubev DS, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.014504; Hongisto TT, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.097001; Hriscu AM, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.174511; Hriscu AM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.077004; Johansson A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.116805; Lehtinen J. S., 2011, EVIDENCE QUANTUM PHA; LITTLE WA, 1967, PHYS REV, V156, P396, DOI 10.1103/PhysRev.156.396; Manucharyan VE, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.024521; Matveev KA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.096802; Mooij JE, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/219; Mooij JE, 2006, NAT PHYS, V2, P169, DOI 10.1038/nphys234; Pop I. M., 2011, EXPT DEMONSTRATION A; Sacepe B, 2011, NAT PHYS, V7, P239, DOI 10.1038/NPHYS1892; Sacepe B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1140; Tinkham M., 1996, INTRO SUPERCONDUCTIV, V2nd ed.; Vanevic M., 2011, QUANTUM PHASE SLIPS; Wallraff A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060501; Zaikin AD, 1997, PHYS REV LETT, V78, P1552, DOI 10.1103/PhysRevLett.78.1552; Zgirski M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.054508	30	180	184	3	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2012	484	7394					355	358		10.1038/nature10930	http://dx.doi.org/10.1038/nature10930			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927YM	22517162	Green Submitted			2022-12-28	WOS:000302946500028
J	Boesch, D				Boesch, Donald			Deep-water drilling remains a risky business	NATURE			English	Editorial Material									Univ Maryland, Ctr Environm Sci Cambridge, College Pk, MD 20742 USA	University System of Maryland; University of Maryland Center for Environmental Science; University of Maryland College Park	Boesch, D (corresponding author), Univ Maryland, Ctr Environm Sci Cambridge, College Pk, MD 20742 USA.	boesch@umces.edu		Boesch, Donald/0000-0002-8154-133X					0	7	8	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2012	484	7394					289	289		10.1038/484289a	http://dx.doi.org/10.1038/484289a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	927YM	22517129	Bronze			2022-12-28	WOS:000302946500004
J	Gordon, SC				Gordon, Suzanne C.			Ask Me If I Cleaned My Hands	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Cornell Univ Press, Richmond, CA USA		Gordon, SC (corresponding author), Cornell Univ Press, Richmond, CA USA.	lsupport@comcast.net							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2012	307	15					1591	1592		10.1001/jama.2012.474	http://dx.doi.org/10.1001/jama.2012.474			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927GU	22511686				2022-12-28	WOS:000302896100020
J	Sheets, NC; Goldin, GH; Meyer, AM; Wu, Y; Chang, YK; Sturmer, T; Holmes, JA; Reeve, BB; Godley, PA; Carpenter, WR; Chen, RC				Sheets, Nathan C.; Goldin, Gregg H.; Meyer, Anne-Marie; Wu, Yang; Chang, YunKyung; Stuermer, Til; Holmes, Jordan A.; Reeve, Bryce B.; Godley, Paul A.; Carpenter, William R.; Chen, Ronald C.			Intensity-Modulated Radiation Therapy, Proton Therapy, or Conformal Radiation Therapy and Morbidity and Disease Control in Localized Prostate Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; SEER-MEDICARE DATA; GASTROINTESTINAL TOXICITY; RADICAL PROSTATECTOMY; DOSE-ESCALATION; 70 GY; RADIOTHERAPY; URINARY; ADENOCARCINOMA	Context There has been rapid adoption of newer radiation treatments such as intensity-modulated radiation therapy (IMRT) and proton therapy despite greater cost and limited demonstrated benefit compared with previous technologies. Objective To determine the comparative morbidity and disease control of IMRT, proton therapy, and conformal radiation therapy for primary prostate cancer treatment. Design, Setting, and Patients Population-based study using Surveillance, Epidemiology, and End Results-Medicare-linked data from 2000 through 2009 for patients with nonmetastatic prostate cancer. Main Outcome Measures Rates of gastrointestinal and urinary morbidity, erectile dysfunction, hip fractures, and additional cancer therapy. Results Use of IMRT vs conformal radiation therapy increased from 0.15% in 2000 to 95.9% in 2008. In propensity score-adjusted analyses (N=12 976), men who received IMRT vs conformal radiation therapy were less likely to receive a diagnosis of gastrointestinal morbidities (absolute risk, 13.4 vs 14.7 per 100 person-years; relative risk [RR], 0.91; 95% CI, 0.86-0.96) and hip fractures (absolute risk, 0.8 vs 1.0 per 100 person-years; RR, 0.78; 95% CI, 0.65-0.93) but more likely to receive a diagnosis of erectile dysfunction (absolute risk, 5.9 vs 5.3 per 100 person-years; RR, 1.12; 95% CI, 1.03-1.20). Intensity-modulated radiation therapy patients were less likely to receive additional cancer therapy (absolute risk, 2.5 vs 3.1 per 100 person-years; RR, 0.81; 95% CI, 0.73-0.89). In a propensity score-matched comparison between IMRT and proton therapy (n=1368), IMRT patients had a lower rate of gastrointestinal morbidity (absolute risk, 12.2 vs 17.8 per 100 person-years; RR, 0.66; 95% CI, 0.55-0.79). There were no significant differences in rates of other morbidities or additional therapies between IMRT and proton therapy. Conclusions Among patients with nonmetastatic prostate cancer, the use of IMRT compared with conformal radiation therapy was associated with less gastrointestinal morbidity and fewer hip fractures but more erectile dysfunction; IMRT compared with proton therapy was associated with less gastrointestinal morbidity. JAMA. 2012;307(15):1611-1620	[Sheets, Nathan C.; Goldin, Gregg H.; Holmes, Jordan A.; Chen, Ronald C.] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC USA; [Meyer, Anne-Marie; Godley, Paul A.; Carpenter, William R.; Chen, Ronald C.] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA; [Holmes, Jordan A.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Meyer, Anne-Marie; Wu, Yang; Reeve, Bryce B.; Godley, Paul A.; Carpenter, William R.; Chen, Ronald C.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Chang, YunKyung] Univ N Carolina, Sch Nursing, Chapel Hill, NC USA; [Stuermer, Til] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Reeve, Bryce B.; Carpenter, William R.] Univ N Carolina, Sch Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Chen, RC (corresponding author), Univ N Carolina Hosp, Dept Radiat Oncol, CB 7512, Chapel Hill, NC 27599 USA.	ronald_chen@med.unc.edu	Stürmer, Til/AAB-5459-2022; Carpenter, William/E-5125-2013; Reeve, Bryce/AAE-7657-2019		National Institute on Aging at the National Institutes of Health (NIH) [RO1 AG023178, RO1 AG018833]; University of North Carolina (UNC) Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) center from the Agency for Healthcare Research and Quality; UNC Center of Excellence in Pharmacoepidemiology and Public Health; Merck; sanofi-aventis; Agency for Healthcare Research and Quality, US Department of Health and Human Services as part of the DEcIDE [HHSA290-2005-0040-I-TO6]; National Institute of Nursing Research (NINR) at the NIH [2T32NR008856]; NATIONAL CANCER INSTITUTE [P30CA016086, U54CA153602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [T32NR008856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023178, R01AG018833] Funding Source: NIH RePORTER	National Institute on Aging at the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of North Carolina (UNC) Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) center from the Agency for Healthcare Research and Quality; UNC Center of Excellence in Pharmacoepidemiology and Public Health; Merck(Merck & Company); sanofi-aventis(Sanofi-Aventis); Agency for Healthcare Research and Quality, US Department of Health and Human Services as part of the DEcIDE; National Institute of Nursing Research (NINR) at the NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Sturmer reports receiving investigator-initiated research funding and support as principal investigator (RO1 AG023178) and coinvestigator (RO1 AG018833) from the National Institute on Aging at the National Institutes of Health (NIH), funding as principal investigator of the University of North Carolina (UNC) Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) center from the Agency for Healthcare Research and Quality, salary support from the UNC Center of Excellence in Pharmacoepidemiology and Public Health, consultancy on the Genentech CER advisory board, and from unrestricted research grants from Merck and sanofi-aventis to the UNC. Dr Godley reports receiving compensation for participating in the data and safety monitoring committee for Ferring Pharmaceuticals, which manufactures Degarelix, a hormonal treatment for prostate cancer that is not directly related to the subject of this study, and receiving compensation for consultancy with GlaxoSmithKline. No other disclosures were reported.; This research was funded by the Agency for Healthcare Research and Quality, US Department of Health and Human Services as part of the DEcIDE program, contract HHSA290-2005-0040-I-TO6. This publication was made possible by grant 2T32NR008856 from the National Institute of Nursing Research (NINR) at the NIH.	Al-Mamgani A, 2009, INT J RADIAT ONCOL, V73, P685, DOI 10.1016/j.ijrobp.2008.04.063; Bekelman JE, 2011, INT J RADIAT ONCOL, V81, pE325, DOI 10.1016/j.ijrobp.2011.02.006; Brookhart MA, 2010, PHARMACOEPIDEM DR S, V19, P537, DOI 10.1002/pds.1908; Brookhart M Alan, 2007, Int J Biostat, V3, P14; Chen RC, 2009, J CLIN ONCOL, V27, P3916, DOI 10.1200/JCO.2008.18.6486; Choe KS, 2010, INT J RADIAT ONCOL, V76, P755, DOI 10.1016/j.ijrobp.2009.02.026; Dearnaley DP, 2007, LANCET ONCOL, V8, P475, DOI 10.1016/S1470-2045(07)70143-2; Elliott SP, 2011, CANCER-AM CANCER SOC, V117, P4557, DOI 10.1002/cncr.25994; Fiorino C, 2009, RADIOTHER ONCOL, V93, P153, DOI 10.1016/j.radonc.2009.08.004; Giordano SH, 2006, CANCER, V107, P423, DOI 10.1002/cncr.21999; Goozner M, 2010, J NATL CANCER I, V102, P450, DOI 10.1093/jnci/djq112; Hu JC, 2009, JAMA-J AM MED ASSOC, V302, P1557, DOI 10.1001/jama.2009.1451; Hurwitz MD, 2008, NAT CLIN PRACT ONCOL, V5, P668, DOI 10.1038/ncponc1224; Institute for Clinical and Economic Review, 2009, MAN OPT LOW RISK PRO; Institute of Medicine, 2009, IN NAT PRIOR COMP EF; Kim S, 2011, EUR UROL, V60, P908, DOI 10.1016/j.eururo.2011.05.052; Klabunde CN, 2007, ANN EPIDEMIOL, V17, P584, DOI 10.1016/j.annepidem.2007.03.011; Lips I, 2007, INT J RADIAT ONCOL, V69, P656, DOI 10.1016/j.ijrobp.2007.04.013; Lowrance WT, 2010, J UROLOGY, V183, P1366, DOI 10.1016/j.juro.2009.12.021; LuYao GL, 1996, J NATL CANCER I, V88, P166, DOI 10.1093/jnci/88.3-4.166; Michalski JM, 2010, INT J RADIAT ONCOL, V76, pS123, DOI 10.1016/j.ijrobp.2009.03.078; Newhauser WD, 2008, PHYS MED BIOL, V53, P2327, DOI 10.1088/0031-9155/53/9/009; Nguyen PL, 2011, J CLIN ONCOL, V29, P1517, DOI 10.1200/JCO.2010.31.1217; Nutting CM, 2000, INT J RADIAT ONCOL, V48, P649, DOI 10.1016/S0360-3016(00)00653-2; Pollack A, 2000, J CLIN ONCOL, V18, P3904, DOI 10.1200/JCO.2000.18.23.3904; Pollack A, 2002, INT J RADIAT ONCOL, V53, P1097, DOI 10.1016/S0360-3016(02)02829-8; PONTES JE, 1993, CANCER, V71, P976, DOI 10.1002/1097-0142(19930201)71:3+<976::AID-CNCR2820711413>3.0.CO;2-M; Potosky AL, 2004, J NATL CANCER I, V96, P1358, DOI 10.1093/jnci/djh259; Potosky AL, 2002, MED CARE, V40, P62; Roach M, 2010, INT J RADIAT ONCOL, V76, pS130, DOI 10.1016/j.ijrobp.2009.04.094; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Shahinian VB, 2005, NEW ENGL J MED, V352, P154, DOI 10.1056/NEJMoa041943; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; StatBite, 2010, JNCI-J NATL CANCER I, V102, P450; Tepper JE, 2008, J CLIN ONCOL, V26, P2436, DOI 10.1200/JCO.2008.17.1165; Terasawa T, 2009, ANN INTERN MED, V151, P556, DOI 10.7326/0003-4819-151-8-200910200-00145; Trofimov A, 2007, INT J RADIAT ONCOL, V69, P444, DOI 10.1016/j.ijrobp.2007.03.018; Valdagni R, 2008, INT J RADIAT ONCOL, V71, P1065, DOI 10.1016/j.ijrobp.2007.11.037; Viswanathan AN, 2010, INT J RADIAT ONCOL, V76, pS116, DOI 10.1016/j.ijrobp.2009.02.090; Warren JL, 2002, MED CARE, V40, P3; Wilt TJ, 2008, ANN INTERN MED, V148, P435, DOI 10.7326/0003-4819-148-6-200803180-00209; Zelefsky MJ, 2008, INT J RADIAT ONCOL, V70, P1124, DOI 10.1016/j.ijrobp.2007.11.044; Zietman AL, 2005, JAMA-J AM MED ASSOC, V294, P1233, DOI 10.1001/jama.294.10.1233; Zietman AL, 2007, J CLIN ONCOL, V25, P3565, DOI 10.1200/JCO.2007.11.9768; Zietman AL, 2010, J CLIN ONCOL, V28, P1106, DOI 10.1200/JCO.2009.25.8475	45	345	350	1	54	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2012	307	15					1611	1620		10.1001/jama.2012.460	http://dx.doi.org/10.1001/jama.2012.460			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927GU	22511689	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000302896100023
J	Tan, HJ; Norton, EC; Ye, ZJ; Hafez, KS; Gore, JL; Miller, DC				Tan, Hung-Jui; Norton, Edward C.; Ye, Zaojun; Hafez, Khaled S.; Gore, John L.; Miller, David C.			Long-term Survival Following Partial vs Radical Nephrectomy Among Older Patients With Early-Stage Kidney Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RENAL-CELL CARCINOMA; NEPHRON-SPARING SURGERY; RISING INCIDENCE; COMPLICATIONS; TRENDS; MASSES; CARE; EPIDEMIOLOGY; VALIDATION; DISEASE	Context Although partial nephrectomy is the preferred treatment for many patients with early-stage kidney cancer, recent clinical trial data, which demonstrate better survival for patients treated with radical nephrectomy, have generated new uncertainty regarding the comparative effectiveness of these treatment options. Objective To compare long-term survival after partial vs radical nephrectomy among a population-based patient cohort whose treatment reflects contemporary surgical practice. Design, Setting, and Patients We performed a retrospective cohort study of Medicare beneficiaries with clinical stage T1a kidney cancer treated with partial or radical nephrectomy from 1992 through 2007. Using an instrumental variable approach to account for measured and unmeasured differences between treatment groups, we fit a 2-stage residual inclusion model to estimate the treatment effect of partial nephrectomy on long-term survival. Main Outcome Measures Overall and kidney cancer-specific survival. Results Among 7138 Medicare beneficiaries with early-stage kidney cancer, we identified 1925 patients (27.0%) treated with partial nephrectomy and 5213 patients (73.0%) treated with radical nephrectomy. During a median follow-up of 62 months, 487 (25.3%) and 2164 (41.5%) patients died following partial or radical nephrectomy, respectively. Kidney cancer was the cause of death for 37 patients (1.9%) treated with partial nephrectomy, and 222 patients (4.3%) treated with radical nephrectomy. Patients treated with partial nephrectomy had a significantly lower risk of death (hazard ratio [HR], 0.54; 95% CI, 0.34-0.85). This corresponded with a predicted survival increase with partial nephrectomy of 5.6 (95% CI, 1.9-9.3), 11.8 (95% CI, 3.9-19.7), and 15.5 (95% CI, 5.0-26.0) percentage points at 2, 5, and 8 years posttreatment (P<.001). No difference was noted in kidney cancer-specific survival (HR, 0.82; 95% CI, 0.19-3.49). Conclusion Among Medicare beneficiaries with early-stage kidney cancer who were candidates for either surgery, treatment with partial rather than radical nephrectomy was associated with improved survival. JAMA. 2012;307(15):1629-1635	[Tan, Hung-Jui; Ye, Zaojun; Miller, David C.] Univ Michigan, Dept Urol, Dow Div Hlth Serv Res, Ann Arbor, MI 48109 USA; [Norton, Edward C.] Univ Michigan, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; [Norton, Edward C.] Univ Michigan, Dept Econ, Ann Arbor, MI 48109 USA; [Norton, Edward C.; Miller, David C.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; [Hafez, Khaled S.; Miller, David C.] Univ Michigan, Dept Urol, Div Urol Oncol, Ann Arbor, MI 48109 USA; [Norton, Edward C.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Gore, John L.] Univ Washington, Dept Urol, Seattle, WA 98195 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Bureau of Economic Research; University of Washington; University of Washington Seattle	Miller, DC (corresponding author), Univ Michigan, Dept Urol, Dow Div Hlth Serv Res, N Campus Res Complex,2800 Plymouth Rd,Bldg 520,3r, Ann Arbor, MI 48109 USA.	dcmiller@umich.edu	, Edward/AAQ-1719-2021; Norton, Edward C/B-2211-2009	, Edward/0000-0003-4555-0631; Norton, Edward C/0000-0003-4555-0631; Gore, John/0000-0002-2847-5062	National Institutes of Health; National Cancer Institute; Agency for Healthcare Research and Quality [K08 HS018346-01A1]; New York Academy of Medicine; University of Michigan Comprehensive Cancer Center; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018346] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [F32CA123819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); New York Academy of Medicine; University of Michigan Comprehensive Cancer Center; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Gore reports being a member of the paid advisory board for Blue Cross Blue Shield of America; and the receipt of grants or pending grants from the National Institutes of Health and the National Cancer Institute. Dr Miller reports provision of consultancy services for United Health-Care; receipt of salary from Blue Cross Blue Shield of Michigan; receipt of lecture or speakers bureau honorarium from the American Society of Clinical Oncology; receipt of travel/accomodations/meeting expenses from the Kidney Cancer Association; and serving on the medical advisory board for the Kidney Cancer Association. The other authors report no disclosures.; This research was supported by funding from the Agency for Healthcare Research and Quality (K08 HS018346-01A1), the Edwin Beer Research Fellowship in Urology and Urology-Related Fields from the New York Academy of Medicine, and the University of Michigan Comprehensive Cancer Center.	Agency for Healthcare Research and Quality, GUID PAT SAF IND 200; Bach PB, 2002, MED CARE, V40, P19; Chow WH, 1999, JAMA-J AM MED ASSOC, V281, P1628, DOI 10.1001/jama.281.17.1628; Cooperberg MR, 2011, J UROLOGY, V186, P394, DOI 10.1016/j.juro.2011.03.130; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dulabon LM, 2010, CANCER-AM CANCER SOC, V116, P2316, DOI 10.1002/cncr.24965; Edge SB, 2010, AJCC CANC STAGING MA; Fergany AF, 2000, J UROLOGY, V163, P442, DOI 10.1016/S0022-5347(05)67896-2; Gill IS, 2007, J UROLOGY, V178, P41, DOI 10.1016/j.juro.2007.03.038; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hankey BF, 1999, CANCER EPIDEM BIOMAR, V8, P1117; Harris KM, 1998, HEALTH SERV RES, V33, P1337; Hollenbeck BK, 2006, UROLOGY, V67, P254, DOI 10.1016/j.urology.2005.08.050; Hollingsworth JM, 2007, CANCER-AM CANCER SOC, V109, P1763, DOI 10.1002/cncr.22600; Hollingsworth JM, 2006, JNCI-J NATL CANCER I, V98, P1331, DOI 10.1093/jnci/djj362; Howlader N, 2011, SEER CANC STAT REV 1; Huang WC, 2006, LANCET ONCOL, V7, P735, DOI 10.1016/S1470-2045(06)70803-8; Huang WC, 2009, J UROLOGY, V181, P55, DOI 10.1016/j.juro.2008.09.017; IEZZONI LI, 1994, MED CARE, V32, P700, DOI 10.1097/00005650-199407000-00004; Lane BR, 2011, J UROLOGY, V185, P421, DOI 10.1016/j.juro.2010.09.131; Lau WKO, 2000, MAYO CLIN PROC, V75, P1236; Miller DC, 2008, CANCER-AM CANCER SOC, V112, P511, DOI 10.1002/cncr.23218; Miller DC, 2010, J UROLOGY, V184, P2254, DOI 10.1016/j.juro.2010.08.018; Miller DC, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-92; Miller DC, 2006, J UROLOGY, V175, P853, DOI 10.1016/S0022-5347(05)00422-2; Morrill R, 1999, URBAN GEOGR, V20, P727, DOI 10.2747/0272-3638.20.8.727; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; Novick A C, 1992, Semin Urol, V10, P12; Novick AC, GUIDELINE MANAGEMENT; Russo P, 2008, CANCER, V113, P84, DOI 10.1002/cncr.23520; Saigal CS, 2010, UROL ONCOL-SEMIN ORI, V28, P308, DOI 10.1016/j.urolonc.2008.09.022; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Tan HJ, 2011, J UROLOGY, V186, P1254, DOI 10.1016/j.juro.2011.05.074; Terza JV, 2008, J HEALTH ECON, V27, P531, DOI 10.1016/j.jhealeco.2007.09.009; Terza JV, 2008, HEALTH SERV RES, V43, P1102, DOI 10.1111/j.1475-6773.2007.00807.x; Thompson RH, 2008, J UROLOGY, V179, P468, DOI 10.1016/j.juro.2007.09.077; Thompson RH, 2010, EUR UROL, V58, P340, DOI 10.1016/j.eururo.2010.05.047; Van Poppel H, 2007, EUR UROL, V51, P1606, DOI 10.1016/j.eururo.2006.11.013; Van Poppel H, 2011, EUR UROL, V59, P543, DOI 10.1016/j.eururo.2010.12.013; Warren JL, 2002, MED CARE, V40, P3; Weingart SN, 2000, MED CARE, V38, P796, DOI 10.1097/00005650-200008000-00004; Zini L, 2009, CANCER-AM CANCER SOC, V115, P1465, DOI 10.1002/cncr.24035	43	304	327	1	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2012	307	15					1629	1635		10.1001/jama.2012.475	http://dx.doi.org/10.1001/jama.2012.475			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927GU	22511691	Green Accepted, Bronze			2022-12-28	WOS:000302896100025
J	Duncan, JS; Whittle, MC; Nakamura, K; Abell, AN; Midland, AA; Zawistowski, JS; Johnson, NL; Granger, DA; Jordan, NV; Darr, DB; Usary, J; Kuan, PF; Smalley, DM; Major, B; He, XP; Hoadley, KA; Zhou, B; Sharpless, NE; Perou, CM; Kim, WY; Gomez, SM; Chen, X; Jin, J; Frye, SV; Earp, HS; Graves, LM; Johnson, GL				Duncan, James S.; Whittle, Martin C.; Nakamura, Kazuhiro; Abell, Amy N.; Midland, Alicia A.; Zawistowski, Jon S.; Johnson, Nancy L.; Granger, Deborah A.; Jordan, Nicole Vincent; Darr, David B.; Usary, Jerry; Kuan, Pei-Fen; Smalley, David M.; Major, Ben; He, Xiaping; Hoadley, Katherine A.; Zhou, Bing; Sharpless, Norman E.; Perou, Charles M.; Kim, William Y.; Gomez, Shawn M.; Chen, Xin; Jin, Jian; Frye, Stephen V.; Earp, H. Shelton; Graves, Lee M.; Johnson, Gary L.			Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer	CELL			English	Article							RESISTANCE; MYC; PHOSPHORYLATION; EXPRESSION; RECEPTOR; KINASES; TRIAL; HER2	Kinase inhibitors have limited success in cancer treatment because tumors circumvent their action. Using a quantitative proteomics approach, we assessed kinome activity in response to MEK inhibition in triple-negative breast cancer (TNBC) cells and genetically engineered mice (GEMMs). MEK inhibition caused acute ERK activity loss, resulting in rapid c-Myc degradation that induced expression and activation of several receptor tyrosine kinases (RTKs). RNAi knockdown of ERK or c-Myc mimicked RTK induction by MEK inhibitors, and prevention of proteasomal c-Myc degradation blocked kinome reprogramming. MEK inhibitor-induced RTK stimulation overcame MEK2 inhibition, but not MEK1 inhibition, reactivating ERK and producing drug resistance. The C3Tag GEMM for TNBC similarly induced RTKs in response to MEK inhibition. The inhibitor-induced RTK profile suggested a kinase inhibitor combination therapy that produced GEMM tumor apoptosis and regression where single agents were ineffective. This approach defines mechanisms of drug resistance, allowing rational design of combination therapies for cancer.	[Duncan, James S.; Whittle, Martin C.; Nakamura, Kazuhiro; Abell, Amy N.; Zawistowski, Jon S.; Johnson, Nancy L.; Granger, Deborah A.; Jordan, Nicole Vincent; Smalley, David M.; Earp, H. Shelton; Graves, Lee M.; Johnson, Gary L.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Midland, Alicia A.; Gomez, Shawn M.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Curriculum Bioinformat & Computat Biol, Chapel Hill, NC 27599 USA; [Darr, David B.; Usary, Jerry; He, Xiaping; Hoadley, Katherine A.; Zhou, Bing; Sharpless, Norman E.; Perou, Charles M.; Kim, William Y.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27599 USA; [Kuan, Pei-Fen] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Biostat, Chapel Hill, NC 27599 USA; [Major, Ben] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Zhou, Bing; Sharpless, Norman E.; Kim, William Y.; Earp, H. Shelton] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Med, Chapel Hill, NC 27599 USA; [Chen, Xin; Jin, Jian; Frye, Stephen V.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Johnson, GL (corresponding author), Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA.	glj@med.unc.edu	zhou, bing/C-2150-2011; Perou, Charles M/H-9934-2014; Kuan, Pei Fen/GRX-4622-2022; Graves, Lee/AAG-5470-2021	Perou, Charles M/0000-0001-9827-2247; Gomez, Shawn/0000-0002-8251-4552; Major, Michael/0000-0002-6753-8513; Hoadley, Katherine/0000-0002-1216-477X; Sharpless, Norman/0000-0001-7078-9455; Chen, Xin/0000-0002-5208-2154	NIH [GM30324, U54CA156735, DK37871, GM007040, CA71341]; NCI Breast SPORE [CA58223]; Breast Cancer Research Fund; University Cancer Research Fund; CIHR; High-throughput Sequencing and Proteomics Cores; NATIONAL CANCER INSTITUTE [F31CA165595, P30CA016086, P50CA058223, U54CA156735, T32CA071341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007040, R37GM030324, R01GM101141, R01GM030324] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Breast SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Fund; University Cancer Research Fund; CIHR(Canadian Institutes of Health Research (CIHR)); High-throughput Sequencing and Proteomics Cores; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM30324, U54CA156735, and DK37871, NCI Breast SPORE CA58223, Breast Cancer Research Fund, and the University Cancer Research Fund. N.V.J. and M. W. are supported by NIH training grants GM007040 and CA71341. J.D. was supported by CIHR postdoctoral fellowship. The authors also acknowledge support by the High-throughput Sequencing and Proteomics Cores. Kinome illustration reproduced courtesy of Cell Signaling Technology, Inc. (http://www.cellsignal.com).	Amin DN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000389; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Bianchi G, 2009, ANTI-CANCER DRUG, V20, P616, DOI 10.1097/CAD.0b013e32832b2ea0; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297; Finn RS, 2009, J CLIN ONCOL, V27, P3908, DOI 10.1200/JCO.2008.18.1925; Garrett JT, 2011, P NATL ACAD SCI USA, V108, P5021, DOI 10.1073/pnas.1016140108; Gilmartin AG, 2011, CLIN CANCER RES, V17, P989, DOI 10.1158/1078-0432.CCR-10-2200; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Marampon F, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-31; Marchetti S, 2005, MOL CELL BIOL, V25, P854, DOI 10.1128/MCB.25.2.854-864.2005; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Oppermann FS, 2009, MOL CELL PROTEOMICS, V8, P1751, DOI 10.1074/mcp.M800588-MCP200; Oster SK, 2000, MOL CELL BIOL, V20, P6768, DOI 10.1128/MCB.20.18.6768-6778.2000; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wierstra I, 2008, ADV CANCER RES, V99, P113, DOI 10.1016/S0065-230X(07)99004-1	23	518	532	2	98	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 13	2012	149	2					307	321		10.1016/j.cell.2012.02.053	http://dx.doi.org/10.1016/j.cell.2012.02.053			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500798	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000302805600011
J	McKinnon, WB				McKinnon, William B.			The Strangest Terrestrial Planet	SCIENCE			English	Editorial Material							MERCURY; MESSENGER; CORE		[McKinnon, William B.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63122 USA; [McKinnon, William B.] Washington Univ, McDonnell Ctr Space Sci, St Louis, MO 63122 USA	Washington University (WUSTL); Washington University (WUSTL)	McKinnon, WB (corresponding author), Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63122 USA.	mckinnon@wustl.edu						Folkner WM, 1997, SCIENCE, V278, P1749, DOI 10.1126/science.278.5344.1749; Hanson B, 2008, SCIENCE, V321, P58, DOI 10.1126/science.321.5885.58; Head JW, 2011, SCIENCE, V333, P1853, DOI 10.1126/science.1211997; Keil K, 2010, CHEM ERDE-GEOCHEM, V70, P295, DOI 10.1016/j.chemer.2010.02.002; Kerr RA, 2011, SCIENCE, V333, P1812, DOI 10.1126/science.333.6051.1812; Malavergne V, 2010, ICARUS, V206, P199, DOI 10.1016/j.icarus.2009.09.001; Margot JL, 2007, SCIENCE, V316, P710, DOI 10.1126/science.1140514; Morard G, 2010, GEOCHIM COSMOCHIM AC, V74, P3659, DOI 10.1016/j.gca.2010.03.025; Nittler LR, 2011, SCIENCE, V333, P1847, DOI 10.1126/science.1211567; Peale SJ, 2002, METEORIT PLANET SCI, V37, P1269, DOI 10.1111/j.1945-5100.2002.tb00895.x; Schubert G., 1988, MERCURY, P429; Smith DE, 2012, SCIENCE, V336, P214, DOI 10.1126/science.1218809; Solomon SC, 2009, EARTH PLANET SC LETT, V285, P225, DOI 10.1016/j.epsl.2009.03.042; Zuber MT, 2012, SCIENCE, V336, P217, DOI 10.1126/science.1218805; [No title captured]	15	1	1	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2012	336	6078					162	163		10.1126/science.1220825	http://dx.doi.org/10.1126/science.1220825			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924PN	22499928				2022-12-28	WOS:000302703900029
J	Mogilner, A; Allard, J; Wollman, R				Mogilner, Alex; Allard, Jun; Wollman, Roy			Cell Polarity: Quantitative Modeling as a Tool in Cell Biology	SCIENCE			English	Review							SYMMETRY-BREAKING; ELEGANS EMBRYO; FEEDBACK LOOPS; POLARIZATION; YEAST; MEMBRANE; DYNAMICS; NETWORK; ESTABLISHMENT; MECHANISMS	Among a number of innovative approaches that have modernized cell biology, modeling has a prominent yet unusual place. One popular view is that we progress linearly, from conceptual to ever more detailed models. We review recent discoveries of cell polarity mechanisms, in which modeling played an important role, to demonstrate that the experiment-theory feedback loop requires diverse models characterized by varying levels of biological detail and mathematical complexity. We argue that a quantitative model is a tool that has to fit an experimental study, and the model's value should be judged not by how complex and detailed it is, but by what could be learned from it.	[Mogilner, Alex; Allard, Jun] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Mogilner, Alex; Allard, Jun] Univ Calif Davis, Dept Math, Davis, CA 95616 USA; [Wollman, Roy] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA	University of California System; University of California Davis; University of California System; University of California Davis; Stanford University	Mogilner, A (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA.	mogilner@math.ucdavis.edu			NIH [2R01GM068952]; NSF [DMS-1118206]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068952] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Li and D. Lew for helpful discussions. This work was supported by NIH grant 2R01GM068952 and NSF grant DMS-1118206 to A.M.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Altschuler SJ, 2008, NATURE, V454, P886, DOI 10.1038/nature07119; Bois JS, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028103; Dawes AT, 2011, BIOPHYS J, V101, P1412, DOI 10.1016/j.bpj.2011.07.030; Dayel MJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000201; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Fivaz M, 2008, CURR BIOL, V18, P44, DOI 10.1016/j.cub.2007.11.051; Gao JT, 2011, P NATL ACAD SCI USA, V108, P7647, DOI 10.1073/pnas.1017567108; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Howell AS, 2009, CELL, V139, P731, DOI 10.1016/j.cell.2009.10.024; Inagaki N, 2011, DEV NEUROBIOL, V71, P584, DOI 10.1002/dneu.20837; Irazoqui JE, 2003, NAT CELL BIOL, V5, P1062, DOI 10.1038/ncb1068; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001121; Johnson JM, 2011, CURR OPIN GENET DEV, V21, P740, DOI 10.1016/j.gde.2011.09.007; Kabaso D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001127; Kozlov MM, 2007, BIOPHYS J, V93, P3811, DOI 10.1529/biophysj.107.110411; Kwon YK, 2007, BIOPHYS J, V92, P2975, DOI 10.1529/biophysj.106.097097; Lander AD, 2011, CELL, V144, P955, DOI 10.1016/j.cell.2011.03.009; Layton AT, 2011, CURR BIOL, V21, P184, DOI 10.1016/j.cub.2011.01.012; Marco E, 2007, CELL, V129, P411, DOI 10.1016/j.cell.2007.02.043; Maree AFM, 2006, B MATH BIOL, V68, P1169, DOI 10.1007/s11538-006-9131-7; Meinhardt H, 1999, J CELL SCI, V112, P2867; Mortimer D, 2009, P NATL ACAD SCI USA, V106, P10296, DOI 10.1073/pnas.0900715106; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Onsum MD, 2009, CURR OPIN CELL BIOL, V21, P74, DOI 10.1016/j.ceb.2009.01.001; Ozbudak EM, 2005, DEV CELL, V9, P565, DOI 10.1016/j.devcel.2005.08.014; Reeves GT, 2009, PLOS BIOL, V7, P32, DOI 10.1371/journal.pbio.1000021; Seetapun D, 2010, CURR BIOL, V20, P979, DOI 10.1016/j.cub.2010.04.040; Sekimoto K, 2004, EUR PHYS J E, V13, P247, DOI 10.1140/epje/i2003-10073-y; Shao DY, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.108104; Slaughter BD, 2009, DEV CELL, V17, P823, DOI 10.1016/j.devcel.2009.10.022; Tostevin F, 2008, BIOPHYS J, V95, P4512, DOI 10.1529/biophysj.108.136416; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; van der Gucht J, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001909; Vilar JMG, 2003, J CELL BIOL, V161, P471, DOI 10.1083/jcb.200301125; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Xiong YA, 2010, P NATL ACAD SCI USA, V107, P17079, DOI 10.1073/pnas.1011271107; Zheng ZZ, 2011, MATH BIOSCI ENG, V8, P1135, DOI 10.3934/mbe.2011.8.1135; Ziebert F, 2012, J R SOC INTERFACE, V9, P1084, DOI 10.1098/rsif.2011.0433	43	74	74	2	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2012	336	6078					175	179		10.1126/science.1216380	http://dx.doi.org/10.1126/science.1216380			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924PN	22499937				2022-12-28	WOS:000302703900037
J	Vinson, V; Purnell, BA; Zahn, LM; Travis, J				Vinson, Valda; Purnell, Beverly A.; Zahn, Laura M.; Travis, John			Does It Compute? INTRODUCTION	SCIENCE			English	Editorial Material																			0	1	1	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2012	336	6078					171	174		10.1126/science.336.6078.171	http://dx.doi.org/10.1126/science.336.6078.171			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924PN	22499935				2022-12-28	WOS:000302703900036
J	Booth, BBB; Dunstone, NJ; Halloran, PR; Andrews, T; Bellouin, N				Booth, Ben B. B.; Dunstone, Nick J.; Halloran, Paul R.; Andrews, Timothy; Bellouin, Nicolas			Aerosols implicated as a prime driver of twentieth-century North Atlantic climate variability	NATURE			English	Article							MULTIDECADAL OSCILLATION; RAINFALL; TEMPERATURES	Systematic climate shifts have been linked to multidecadal variability in observed sea surface temperatures in the North Atlantic Ocean(1). These links are extensive, influencing a range of climate processes such as hurricane activity(2) and African Sahel(3-5) and Amazonian(5) droughts. The variability is distinct from historical global-mean temperature changes and is commonly attributed to natural ocean oscillations(6-10). A number of studies have provided evidence that aerosols can influence long-term changes in sea surface temperatures(11,12), but climate models have so far failed to reproduce these interactions(6,9) and the role of aerosols in decadal variability remains unclear. Here we use a state-of-the-art Earth system climate model to show that aerosol emissions and periods of volcanic activity explain 76 per cent of the simulated multidecadal variance in detrended 1860-2005 North Atlantic sea surface temperatures. After 1950, simulated variability is within observational estimates; our estimates for 1910-1940 capture twice the warming of previous generation models but do not explain the entire observed trend. Other processes, such as ocean circulation, may also have contributed to variability in the early twentieth century. Mechanistically, we find that inclusion of aerosol-cloud microphysical effects, which were included in few previous multimodel ensembles, dominates the magnitude (80 per cent) and the spatial pattern of the total surface aerosol forcing in the North Atlantic. Our findings suggest that anthropogenic aerosol emissions influenced a range of societally important historical climate events such as peaks in hurricane activity and Sahel drought. Decadal-scale model predictions of regional Atlantic climate will probably be improved by incorporating aerosol-cloud microphysical interactions and estimates of future concentrations of aerosols, emissions of which are directly addressable by policy actions.	[Booth, Ben B. B.; Dunstone, Nick J.; Halloran, Paul R.; Andrews, Timothy; Bellouin, Nicolas] Met Off Hadley Ctr, Exeter EX1 3PB, Devon, England	Met Office - UK; Hadley Centre	Booth, BBB (corresponding author), Met Off Hadley Ctr, FitzRoy Rd, Exeter EX1 3PB, Devon, England.	ben.booth@metoffice.gov.uk	Kushnir, Yochanan/B-4472-2013; Dunstone, Nick/G-6304-2012; Halloran, Paul R/G-3965-2012; Andrews, Timothy/C-5912-2014	Dunstone, Nick/0000-0001-6859-6814; Halloran, Paul R/0000-0002-9227-0678; Andrews, Timothy/0000-0002-8248-8753; Bellouin, Nicolas/0000-0003-2109-9559	Office of Science, US Department of Energy; DECC/Defra Met Office Hadley Centre [GA01101]; EU	Office of Science, US Department of Energy(United States Department of Energy (DOE)); DECC/Defra Met Office Hadley Centre; EU(European Commission)	We are grateful for discussion and input from D. Smith, D. Sexton, J. Murphy, M. Palmer, C. Roberts and J. Knight during the analysis and writing of this paper. We acknowledge the modelling groups, the Program for Climate Model Diagnosis and Intercomparison and the WCRP's Working Group on Coupled Modelling for their roles in making available the WCRP CMIP3 multimodel data set. Support of this data set is provided by the Office of Science, US Department of Energy. The authors were supported by the Joint DECC/Defra Met Office Hadley Centre Climate Programme (GA01101) and the EU FP7 THOR project.	Ackerley D, 2011, J CLIMATE, V24, P4999, DOI 10.1175/JCLI-D-11-00019.1; Baines PG, 2007, J CLIMATE, V20, P2721, DOI 10.1175/JCLI4177.1; Bellouin N, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016074; Bjerknes J., 1964, ADV GEOPHYS, V10, P1, DOI [10.1016/S0065-2687(08)60005-9, DOI 10.1016/S0065-2687(08)60005-9]; Chang CY, 2011, J CLIMATE, V24, P2540, DOI 10.1175/2010JCLI4065.1; Chen W, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013596; Chylek P, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042793; Collins WJ, 2011, GEOSCI MODEL DEV, V4, P1051, DOI 10.5194/gmd-4-1051-2011; Curtis S, 2008, CLIM DYNAM, V30, P343, DOI 10.1007/s00382-007-0295-0; Dong BW, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025766; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Evan AT, 2009, SCIENCE, V324, P778, DOI 10.1126/science.1167404; FOLLAND CK, 1986, NATURE, V320, P602, DOI 10.1038/320602a0; Goldenberg SB, 2001, SCIENCE, V293, P474, DOI 10.1126/science.1060040; Hoerling M, 2006, J CLIMATE, V19, P3989, DOI 10.1175/JCLI3842.1; Jones CD, 2011, GEOSCI MODEL DEV, V4, P543, DOI 10.5194/gmd-4-543-2011; Kerr RA, 2000, SCIENCE, V288, P1984, DOI 10.1126/science.288.5473.1984; Knight JR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026242; Knight JR, 2009, J CLIMATE, V22, P1610, DOI 10.1175/2008JCLI2628.1; Knight JR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024233; Lohmann U, 2005, ATMOS CHEM PHYS, V5, P715, DOI 10.5194/acp-5-715-2005; Mann M.E., 2006, EOS, V87, P233, DOI 10.1029/2006EO240001; Ottera OH, 2010, NAT GEOSCI, V3, P688, DOI 10.1038/NGEO955; Quaas J, 2009, ATMOS CHEM PHYS, V9, P8697, DOI 10.5194/acp-9-8697-2009; SATO M, 1993, J GEOPHYS RES-ATMOS, V98, P22987, DOI 10.1029/93JD02553; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Sutton RT, 2005, SCIENCE, V309, P115, DOI 10.1126/science.1109496; Ting MF, 2009, J CLIMATE, V22, P1469, DOI 10.1175/2008JCLI2561.1; Trenberth KE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026894; Zhang R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026267	30	651	664	13	283	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					228	U110		10.1038/nature10946	http://dx.doi.org/10.1038/nature10946			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22498628	Green Accepted			2022-12-28	WOS:000303149900032
J	Humphries, C				Humphries, Courtney			Progressive multiple sclerosis: The treatment gap	NATURE			English	Editorial Material																			0	9	9	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					S10	S10		10.1038/nature11108	http://dx.doi.org/10.1038/nature11108			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22509511	Bronze			2022-12-28	WOS:000303149900052
J	So, AD; Ruiz-Esparza, Q; Gupta, N; Cars, O				So, Anthony D.; Ruiz-Esparza, Quentin; Gupta, Neha; Cars, Otto			3Rs for innovating novel antibiotics: sharing resources, risks, and rewards	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[So, Anthony D.; Ruiz-Esparza, Quentin; Gupta, Neha] Duke Univ, Program Global Hlth & Technol Access, Sanford Sch Publ Policy, Durham, NC 27708 USA; [Cars, Otto] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Duke University; Uppsala University	So, AD (corresponding author), Duke Univ, Program Global Hlth & Technol Access, Sanford Sch Publ Policy, Durham, NC 27708 USA.	anthony.so@duke.edu						Aronsson B., 2009, BACTERIAL CHALLENGE; Austin CP, 2004, SCIENCE, V306, P1138, DOI 10.1126/science.1105511; BCC Research, 2010, THER DRUGS CENTR NER; BCC Research, 2010, CARD THER DRUGS TECH; BCC Research, 2010, INF DIS TREATM GLOB; Bergstrom R, 2011, DRUG RESIST UPDATE, V14, P77, DOI 10.1016/j.drup.2011.01.005; Bleicher KH, 2003, NAT REV DRUG DISCOV, V2, P369, DOI 10.1038/nrd1086; Collins FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002747; DiMasi JA, 2004, DRUG INF J, V38, P211, DOI 10.1177/009286150403800301; Fikes B, 2010, N COUNTY TIMES  0920; Fischer A, 2005, PLOS MED, V2, P845, DOI 10.1371/journal.pmed.0020243; Ghosh S, 2010, HINDU; Goss CH, 2008, CHILD HEALTH CARE, V37, P5, DOI 10.1080/02739610701766859; Hamad B, 2006, NAT REV DRUG DISCOV, V9, P675; Hamad B, 2010, NAT REV DRUG DISCOV, V9, P675, DOI 10.1038/nrd3267; Innovative Medicines Initiative, NEWDRUGS4BADBUGS ND4; Kesselheim AS, 2010, HEALTH AFFAIR, V29, P1689, DOI 10.1377/hlthaff.2009.0439; Laxminarayan R, 2001, ANTIBIOTIC RESISTANC; Mossialos E, POLICIES INCENTIVES; Nwaka S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000293; Nwaka S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000440; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Projan SJ, 2003, CURR OPIN MICROBIOL, V6, P427, DOI 10.1016/j.mib.2003.08.003; Rai A, 2008, YALE J HLTH POLICY L, V8, P53; ReAct, 2011, REACT POL SEM 23 MAY; Schmid M, 2004, NATURE, V2, P239; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; Wellcome Trust, 2010, THER	28	21	21	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2012	344								e1782	10.1136/bmj.e1782	http://dx.doi.org/10.1136/bmj.e1782			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	923GM	22491076	Green Submitted			2022-12-28	WOS:000302607700011
J	Klitzman, R; Appelbaum, PS				Klitzman, Robert; Appelbaum, Paul S.			To Protect Human Subjects, Review What Was Done, Not Proposed	SCIENCE			English	Editorial Material							MULTICENTER		[Klitzman, Robert] Columbia Univ, Bioeth Program, New York, NY 10032 USA	Columbia University	Klitzman, R (corresponding author), Columbia Univ, Bioeth Program, New York, NY 10032 USA.	rlk2@columbia.edu	Appelbaum, Paul/AFU-3908-2022	Appelbaum, Paul/0000-0002-1940-0042	NATIONAL LIBRARY OF MEDICINE [G13LM009996] Funding Source: NIH RePORTER; NLM NIH HHS [5-G13-LM009996-02, G13 LM009996] Funding Source: Medline; PHS HHS [R01-NG04214] Funding Source: Medline	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], 2010, ETHICAL IMPERIALISM; Appelbaum Paul S, 2004, IRB, V26, P1, DOI 10.2307/3564231; Department of Health and Human Services, 2011, FED REG, V76, P44512; Dyrbye LN, 2007, ACAD MED, V82, P654, DOI 10.1097/ACM.0b013e318065be1e; Emanuel EJ, 2005, AM J BIOETHICS, V5, P9, DOI 10.1080/15265160500244959; Emanuel EJ, 2004, ANN INTERN MED, V141, P282, DOI 10.7326/0003-4819-141-4-200408170-00008; Greene SM, 2006, J CLIN EPIDEMIOL, V59, P784, DOI 10.1016/j.jclinepi.2005.11.018; International Compilation of Human Research Standards, INT COMP HUM RES STA; IRS, FY 2012 BUDG PROP SU; IRS, FY 2011 ENF SERV RES; Joffe S, 2001, LANCET, V358, P1772, DOI 10.1016/S0140-6736(01)06805-2; Kim S, 2009, NATURE, V457, P534, DOI 10.1038/457534a; Klitzman R, 2007, J EMPIR RES HUM RES, V2, P61, DOI 10.1525/jer.2007.2.4.61; Klitzman Robert, 2011, AJOB Prim Res, V2, P24; Klitzman R, 2011, BMC MED ETHICS, V12, DOI 10.1186/1472-6939-12-13; Plumley A. H., 1996, DETERMINANTS INDIVID; Rid A, 2010, JAMA-J AM MED ASSOC, V304, P1472, DOI 10.1001/jama.2010.1414; Shah S, 2004, JAMA-J AM MED ASSOC, V291, P476, DOI 10.1001/jama.291.4.476; Stair TO, 2001, ACAD EMERG MED, V8, P636, DOI 10.1111/j.1553-2712.2001.tb00177.x; *US GEN ACC OFF, 1996, SCI RES CONT VIG CRI; Vick CC, 2005, AM J SURG, V190, P805, DOI 10.1016/j.amjsurg.2005.07.024	21	10	10	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1576	1577		10.1126/science.1217225	http://dx.doi.org/10.1126/science.1217225			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	915YD	22461594	Green Accepted, Green Submitted			2022-12-28	WOS:000302062600026
J	Liu, FQ; Bakht, S; Dean, C				Liu, Fuquan; Bakht, Saleha; Dean, Caroline			Cotranscriptional Role for Arabidopsis DICER-LIKE 4 in Transcription Termination	SCIENCE			English	Article							RNA-POLYMERASE-II; SIRNA BIOGENESIS; FLC; DICER-LIKE-4; PHASE; DCL4; FCA	Transcription termination is emerging as an important component of gene regulation necessary to partition the genome and minimize transcriptional interference. We have discovered a role for the Arabidopsis RNA silencing enzyme DICER-LIKE 4 (DCL4) in transcription termination of an endogenous Arabidopsis gene, FCA. DCL4 directly associates with FCA chromatin in the 3' region and promotes cleavage of the nascent transcript in a domain downstream of the canonical polyA site. In a dcl4 mutant, the resulting transcriptional read-through triggers an RNA interference-mediated gene silencing of a transgene containing the same 3' region. We conclude that DCL4 promotes transcription termination of the Arabidopsis FCA gene, reducing the amount of aberrant RNA produced from the locus.	[Liu, Fuquan; Bakht, Saleha; Dean, Caroline] John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; [Liu, Fuquan] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Queens University Belfast	Dean, C (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	caroline.dean@jic.ac.uk	Liu, Fuquan/AGD-6751-2022	Dean, Caroline/0000-0002-6555-3525	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D010799/1]; EU [LSHG-CT-2006-037900]; Biotechnology and Biological Sciences Research Council [BBS/E/J/000CA447, BB/D010799/1, BB/G01406X/1] Funding Source: researchfish; BBSRC [BB/D010799/1, BB/G01406X/1, BBS/E/J/000CA447] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a UK Biotechnology and Biological Sciences Research Council (BBSRC) Core Strategic grant to John Innes Centre, UK BBSRC grant BB/D010799/1 (C.D.), and EU Framework VI program Integrated Project LSHG-CT-2006-037900. We thank C. Melnyk and I. Searle in D. C. Baulcombe's group at Cambridge University for dcl3-7 seeds; O. Voinnet (ETH Zurich) for seeds of dcl4-3, dcl4-4, and dcl4-6; T. Fukuhara (Tokyo University of Agriculture and Technology) for the DCL4 antibody; and G. Szittya for excellent comments on the manuscript.	Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Du QS, 2007, J VIROL, V81, P9142, DOI 10.1128/JVI.02885-06; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Ghazal G, 2009, MOL CELL, V36, P99, DOI 10.1016/j.molcel.2009.07.029; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kuehner JN, 2011, NAT REV MOL CELL BIO, V12, P283, DOI 10.1038/nrm3098; Liu FQ, 2007, MOL CELL, V28, P398, DOI 10.1016/j.molcel.2007.10.018; Liu FQ, 2010, SCIENCE, V327, P94, DOI 10.1126/science.1180278; Macknight R, 2002, PLANT CELL, V14, P877, DOI 10.1105/tpc.010456; Swiezewski S, 2007, P NATL ACAD SCI USA, V104, P3633, DOI 10.1073/pnas.0611459104; Vazquez F, 2006, TRENDS PLANT SCI, V11, P460, DOI 10.1016/j.tplants.2006.07.006; West S, 2006, MOL CELL, V21, P437, DOI 10.1016/j.molcel.2005.12.008; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; West S, 2008, MOL CELL, V29, P600, DOI 10.1016/j.molcel.2007.12.019; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Zaratiegui M, 2011, NATURE, V479, P135, DOI 10.1038/nature10501	21	31	38	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1621	1623		10.1126/science.1214402	http://dx.doi.org/10.1126/science.1214402			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461611				2022-12-28	WOS:000302062600044
J	Mourik, V; Zuo, K; Frolov, SM; Plissard, SR; Bakkers, EPAM; Kouwenhoven, LP				Mourik, V.; Zuo, K.; Frolov, S. M.; Plissard, S. R.; Bakkers, E. P. A. M.; Kouwenhoven, L. P.			Signatures of Majorana Fermions in Hybrid Superconductor-Semiconductor Nanowire Devices	SCIENCE			English	Article							ANDREEV BOUND-STATES; QUANTUM-DOT	Majorana fermions are particles identical to their own antiparticles. They have been theoretically predicted to exist in topological superconductors. Here, we report electrical measurements on indium antimonide nanowires contacted with one normal (gold) and one superconducting (niobium titanium nitride) electrode. Gate voltages vary electron density and define a tunnel barrier between normal and superconducting contacts. In the presence of magnetic fields on the order of 100 millitesla, we observe bound, midgap states at zero bias voltage. These bound states remain fixed to zero bias, even when magnetic fields and gate voltages are changed over considerable ranges. Our observations support the hypothesis of Majorana fermions in nanowires coupled to superconductors.	[Mourik, V.; Zuo, K.; Frolov, S. M.; Bakkers, E. P. A. M.; Kouwenhoven, L. P.] Delft Univ Technol, Kavli Inst Nanosci, NL-2600 GA Delft, Netherlands; [Plissard, S. R.; Bakkers, E. P. A. M.] Eindhoven Univ Technol, Dept Appl Phys, NL-5600 MB Eindhoven, Netherlands	Delft University of Technology; Eindhoven University of Technology	Kouwenhoven, LP (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, NL-2600 GA Delft, Netherlands.	l.p.kouwenhoven@tudelft.nl	Mourik, Vincent/F-4137-2017; , Plissard/B-4502-2012; Mourik, Vincent/AAS-8612-2020	Mourik, Vincent/0000-0003-1522-7403; , Plissard/0000-0002-0769-5429; Mourik, Vincent/0000-0003-1522-7403	European Research Council; Netherlands Organization for Scientific Research (NWO); Foundation for Fundamental Research on Matter (FOM); Microsoft Corporation Station Q	European Research Council(European Research Council (ERC)European Commission); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Foundation for Fundamental Research on Matter (FOM)(FOM (The Netherlands)); Microsoft Corporation Station Q(Microsoft)	We thank D. Thoen and T. Klapwijk for sharing their NbTiN technology and A. Akhmerov, J. Alicea, C. Beenakker, M. Freedman, F. Hassler, G. Immink, H. Keijzers, C. Marcus, S. Nadj-Perge, Y. Nazarov, I. van Weperen, M. Wimmer, and D. van Woerkom for discussions and assistance. This work has been supported by European Research Council, Netherlands Organization for Scientific Research (NWO), Foundation for Fundamental Research on Matter (FOM), and Microsoft Corporation Station Q.	Alicea J, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.125318; Brouwer PW, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.196804; Dirks T, 2011, NAT PHYS, V7, P386, DOI 10.1038/NPHYS1911; Flensberg K, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.180516; Franz M., 2010, PHYSICS, V3, P24; Fu L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096407; Ivanov DA, 2001, PHYS REV LETT, V86, P268, DOI 10.1103/PhysRevLett.86.268; Kitaev AY., 2001, PHYS-USP+, V44, P131, DOI [10.1070/1063-7869/44/10S/S29, DOI 10.1070/1063-7869/44/10S/S29]; Law KT, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.237001; le Sueur H, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.197002; Lutchyn RM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.127001; Lutchyn RM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.077001; Majorana E., 1981, SORYUSIRON KENKYU, V63, P149; Nadj-Perge S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.166801; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; Nilsson HA, 2009, NANO LETT, V9, P3151, DOI 10.1021/nl901333a; Oreg Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.177002; Pillet JD, 2010, NAT PHYS, V6, P965, DOI 10.1038/NPHYS1811; Plissard SR, 2012, NANO LETT, V12, P1794, DOI 10.1021/nl203846g; Potter AC, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.227003; Read N, 2000, PHYS REV B, V61, P10267, DOI 10.1103/PhysRevB.61.10267; Sasaki S, 2000, NATURE, V405, P764, DOI 10.1038/35015509; Sau JD, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.064512; Sau JD, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.214509; Sau JD, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.040502; Stanescu TD, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.144522; Streda P, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.256601; VANWEES BJ, 1992, PHYS REV LETT, V69, P510, DOI 10.1103/PhysRevLett.69.510; Wilczek F, 2009, NAT PHYS, V5, P614, DOI 10.1038/nphys1380; Wimmer M, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/5/053016; Wimmer M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.046803; Zareyan M, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.184505	32	3014	3048	31	1058	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2012	336	6084					1003	1007		10.1126/science.1222360	http://dx.doi.org/10.1126/science.1222360			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22499805	Green Submitted			2022-12-28	WOS:000304406800037
J	van Vollenhoven, RF; Geborek, P; Forslind, K; Albertsson, K; Ernestam, S; Petersson, IF; Chatzidionysiou, K; Bratt, J				van Vollenhoven, Ronald F.; Geborek, Pierre; Forslind, Kristina; Albertsson, Kristina; Ernestam, Sofia; Petersson, Ingemar F.; Chatzidionysiou, Katerina; Bratt, Johan		Swefot Study Grp	Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial	LANCET			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; ANTITUMOR NECROSIS FACTOR; EULAR RECOMMENDATIONS; PLUS METHOTREXATE; JOINT DESTRUCTION; MANAGEMENT; HYDROXYCHLOROQUINE; SULFASALAZINE; ETANERCEPT; THERAPY	Background Analysis of the Swedish Farmacotherapy (Swefot) trial at 12 months showed that the addition of an anti-tumour-necrosis-factor agent gave an improved clinical outcome compared with the addition of conventional disease-modifying antirheumatic drugs in patients with methotrexate-refractory early rheumatoid arthritis. Here we report the 2 year follow-up assessment. Methods In this randomised, non-blinded, parallel-group trial, we enrolled adult patients older than 18 years with rheumatoid arthritis and a symptom duration of less than 1 year from 15 rheumatology units in Sweden between December, 2002 and December, 2006. All patients were started on methotrexate. After 3-4 months, those who failed treatment were randomly assigned (1: 1) to group A (conventional treatment; additional sulfasalazine and hydroxychloroquine) or group B (biological treatment; additional infliximab). Randomisation was done with a computer-generated sequence. We analysed clinical outcomes at months 18 and 24 by the response criteria of the American College of Rheumatology and the European League Against Rheumatism, and radiographs of patients' hands and feet at months 12 and 24 using the Van der Heijde modification of the Sharp score. Analysis was by intention to treat. This trial is registered with www.ClinicalTrials.gov, number NCT00764725. Findings Of 493 screened individuals, we enrolled 487, of whom 258 were randomly allocated to treatment. The proportion of patients in group B who received a EULAR-defined good response was non-significantly greater than it was in group A at 18 months (49 of 128 [38%] vs 38 of 130 [29%]) and at 24 months (49 of 128 [38%] vs 40 of 130 [31%]; p=0.204). After 24 months, radiological disease progression was greater in patients in group A than it was in those in group B (mean 7.23 [SD 12.72] vs 4.00 [10.0]; p=0.009). We recorded three serious adverse events: an extended generalised illness in group A, an extended febrile episode in group B, and a generalised illness in group B. Interpretation Additional biological treatment is a valid option for patients who fail initial methotrexate treatment. However, improved clinical outcomes after 12 months and better radiographical results after 24 months should be weighed against the absence of a convincing clinical difference at 24 months and substantially higher costs. Therefore, for many patients who fail initial methotrexate treatment, add-on treatment with disease-modifying antirheumatic drugs is an appropriate treatment option.	[van Vollenhoven, Ronald F.] Karolinska Univ Hosp, Inflammatory Dis ClinTRID, Unit Clin Therapy Res, Rheumatol Clin, S-17176 Stockholm, Sweden; [van Vollenhoven, Ronald F.; Chatzidionysiou, Katerina] Karolinska Inst, Unit Clin Therapy Res, Stockholm, Sweden; [Geborek, Pierre; Forslind, Kristina] Lund Univ, Dept Clin Sci Lund, Rheumatol Sect, Lund, Sweden; [Forslind, Kristina] Helsingborg Hosp, Dept Internal Med, Rheumatol Sect, Helsingborg, Sweden; [Petersson, Ingemar F.] Skane Univ Hosp, Lund, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Lund University; Helsingborgs Hospital; Lund University; Skane University Hospital	van Vollenhoven, RF (corresponding author), Karolinska Univ Hosp, Inflammatory Dis ClinTRID, Unit Clin Therapy Res, Rheumatol Clin, S-17176 Stockholm, Sweden.	ronald.van.vollenhoven@ki.se	Ljung, Lotta/H-8919-2019; van Vollenhoven, Ronald/ABE-1244-2021; Chatzidionysiou, Katerina/AAB-9359-2021	Ljung, Lotta/0000-0001-8999-0925; Petersson, Ingemar/0000-0001-9139-1892; Chatzidionysiou, Katerina/0000-0002-2163-0525; Chatzidionysiou, Katerina/0000-0002-2669-1247	Swedish Rheumatism Association; Stockholm County; Schering-Plough/Merck Sharp and Dohme; Abbott; GlaxoSmithKline; Merck Sharp and Dohme; Pfizer; Roche; UCB Pharma; Schering-Plough Sweden; Swedish health-care system	Swedish Rheumatism Association; Stockholm County(Stockholm County Council); Schering-Plough/Merck Sharp and Dohme; Abbott(Abbott Laboratories); GlaxoSmithKline(GlaxoSmithKline); Merck Sharp and Dohme(Merck & Company); Pfizer(Pfizer); Roche(Roche Holding); UCB Pharma(UCB Pharma SA); Schering-Plough Sweden(Merck & CompanySchering Plough Corporation); Swedish health-care system	Swedish Rheumatism Association, Stockholm County, and Schering-Plough/Merck Sharp and Dohme.; RFvV has received research support and honoraria from Abbott, GlaxoSmithKline, Merck Sharp and Dohme, Pfizer, Roche, and UCB Pharma. All other authors declare that they have no conflicts of interest.; The study was supported in part by a grant from the Swedish Rheumatism Association. RFvV and SE were supported by clinical research funds from Stockholm County. An annual unrestricted grant was provided by Schering-Plough Sweden that was used to support the study coordinator (MW). The same company also provided support for a medical monitor (between Oct 1, 2006, and March 31, 2007), several investigator meetings, the logistics involved in the radiographical analyses, and a research assistant. For the most part, time commitments of study investigators and study nurses were subsumed under daily care of patients, meaning that the most important sponsor of this study was the Swedish health-care system. We would like to thank all participating patients and the study nurses, co-investigators, and colleagues who made this trial possible. We would also like to thank Bjorn Svensson, who founded and led the BARFOT study group, Ingiald Hafstrom who continues to lead the BARFOT study group, and all the members of this group in which the idea of the Swefot clinical trial was first proposed.	Alonso-Ruiz A, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-52; Askling J, 2009, ARTHRITIS RHEUM-US, V60, P3180, DOI 10.1002/art.24941; Baecklund E, 1998, BRIT MED J, V317, P180, DOI 10.1136/bmj.317.7152.180; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Bruynesteyn K, 2002, J RHEUMATOL, V29, P2306; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; Emery P, 2008, RHEUMATOLOGY, V47, P392, DOI 10.1093/rheumatology/kem257; Emery P, 2008, LANCET, V372, P375, DOI 10.1016/S0140-6736(08)61000-4; Gaujoux-Viala C, 2010, ANN RHEUM DIS, V69, P1004, DOI 10.1136/ard.2009.127225; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Graudal N, 2010, ARTHRITIS RHEUM-US, V62, P2852, DOI 10.1002/art.27592; Grigor C, 2004, LANCET, V364, P263, DOI 10.1016/S0140-6736(04)16676-2; Keystone EC, 2009, J RHEUMATOL, V36, P11, DOI 10.3899/jrheum.090125; Landewe R, 2006, ARTHRITIS RHEUM-US, V54, P3119, DOI 10.1002/art.22143; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Mottonen T, 1999, LANCET, V353, P1568, DOI 10.1016/S0140-6736(98)08513-4; Nam JL, 2010, ANN RHEUM DIS, V69, P976, DOI 10.1136/ard.2009.126573; O'Dell JR, 2002, ARTHRITIS RHEUM, V46, P1164, DOI 10.1002/art.10228; ODell JR, 1996, NEW ENGL J MED, V334, P1287, DOI 10.1056/NEJM199605163342002; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Svensson B, 2005, ARTHRITIS RHEUM-US, V52, P3360, DOI 10.1002/art.21298; TUGWELL P, 1995, NEW ENGL J MED, V333, P137, DOI 10.1056/NEJM199507203330301; van der Heijde D, 2005, ARTHRITIS RHEUM-US, V52, P49, DOI 10.1002/art.20775; van Vollenhoven RF, 2009, LANCET, V374, P459, DOI 10.1016/S0140-6736(09)60944-2; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Verstappen SMM, 2007, ANN RHEUM DIS, V66, P1443, DOI 10.1136/ard.2007.071092; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Wessels JAM, 2007, ARTHRITIS RHEUM-US, V56, P1765, DOI 10.1002/art.22640	29	156	169	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2012	379	9827					1712	1720		10.1016/S0140-6736(12)60027-0	http://dx.doi.org/10.1016/S0140-6736(12)60027-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937KX	22464340				2022-12-28	WOS:000303658500031
J	Feng, F; Yang, F; Rong, W; Wu, XG; Zhang, J; Chen, S; He, CZ; Zhou, JM				Feng, Feng; Yang, Fan; Rong, Wei; Wu, Xiaogang; Zhang, Jie; Chen, She; He, Chaozu; Zhou, Jian-Min			A Xanthomonas uridine 5 '-monophosphate transferase inhibits plant immune kinases	NATURE			English	Article							PSEUDOMONAS-SYRINGAE EFFECTOR; INNATE IMMUNITY; FIC DOMAIN; CYTOPLASMIC KINASE; III EFFECTORS; HOST TARGET; RECEPTOR; ARABIDOPSIS; CAMPESTRIS; AMPYLATION	Plant innate immunity is activated on the detection of pathogen-associated molecular patterns (PAMPs) at the cell surface, or of pathogen effector proteins inside the plant cell(1-4). Together, PAMP-triggered immunity and effector-triggered immunity constitute powerful defences against various phytopathogens. Pathogenic bacteria inject a variety of effector proteins into the host cell to assist infection or propagation. A number of effector proteins have been shown to inhibit plant immunity(5), but the biochemical basis remains unknown for the vast majority of these effectors. Here we show that the Xanthomonas campestris pathovar campestris type III effector AvrAC enhances virulence and inhibits plant immunity by specifically targeting Arabidopsis BIK1 and RIPK, two receptor-like cytoplasmic kinases known to mediate immune signalling(6-8). AvrAC is a uridylyl transferase that adds uridine 5'-monophosphate to and conceals conserved phosphorylation sites in the activation loop of BIK1 and RIPK, reducing their kinase activity and consequently inhibiting downstream signalling.	[Feng, Feng; Yang, Fan; Wu, Xiaogang; Zhang, Jie; Chen, She; Zhou, Jian-Min] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Feng, Feng] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Feng, Feng; He, Chaozu] Tsinghua Univ, Grad Sch Shenzhen, Shenzhen 518055, Peoples R China; [Rong, Wei; He, Chaozu] Hainan Univ, Hainan Key Lab Sustainable Utilizat Trop Bioresou, Haikou 570228, Hainan, Peoples R China; [Zhou, Jian-Min] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China; [Zhou, Jian-Min] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing 100101, Peoples R China	National Institute of Biological Sciences, Beijing; Tsinghua University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Hainan University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Zhou, JM (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	czhe@hainu.edu.cn; zhoujianmin@nibs.ac.cn	Zhou, Jian-Min/A-3140-2013	Zhou, Jian-Min/0000-0002-9943-2975	Chinese Ministry of Science and Technology [2011CB100700, 2010CB835301, 2010CB835204]; Hainan University	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Hainan University	The authors thank J. Chai for sharing plasmids before publication, A. Bent for the XccB186 strain, S. Y. He and F. White for helpful comments. J.-M.Z. was supported by grants from the Chinese Ministry of Science and Technology (2011CB100700; 2010CB835301). S. C. was supported by a grant from the Chinese Ministry of Science and Technology (2010CB835204) C. H. was supported by Funds from Hainan University.	Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Block A, 2011, CURR OPIN MICROBIOL, V14, P39, DOI 10.1016/j.mib.2010.12.011; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Cheng W, 2011, CELL HOST MICROBE, V10, P616, DOI 10.1016/j.chom.2011.10.013; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Chung EH, 2011, CELL HOST MICROBE, V9, P125, DOI 10.1016/j.chom.2011.01.009; Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818; Laluk K, 2011, PLANT CELL, V23, P2831, DOI 10.1105/tpc.111.087122; Li XY, 2005, P NATL ACAD SCI USA, V102, P12990, DOI 10.1073/pnas.0502425102; Liu J, 2011, CELL HOST MICROBE, V9, P137, DOI 10.1016/j.chom.2011.01.010; Lu DP, 2010, P NATL ACAD SCI USA, V107, P496, DOI 10.1073/pnas.0909705107; Luong P, 2010, J BIOL CHEM, V285, P20155, DOI 10.1074/jbc.M110.114884; Macho AP, 2007, MOL PLANT PATHOL, V8, P437, DOI 10.1111/J.1364-3703.2007.00404.X; Mattoo S, 2011, J BIOL CHEM, V286, P32834, DOI 10.1074/jbc.M111.227603; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schechter LM, 2004, J BACTERIOL, V186, P543, DOI 10.1128/JB.186.2.543-555.2004; Schwessinger B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002046; Segonzac C, 2011, CURR OPIN MICROBIOL, V14, P54, DOI 10.1016/j.mib.2010.12.005; Sun WX, 2006, PLANT CELL, V18, P764, DOI 10.1105/tpc.105.037648; Veronese P, 2006, PLANT CELL, V18, P257, DOI 10.1105/tpc.105.035576; Wang LF, 2007, MOL PLANT PATHOL, V8, P491, DOI 10.1111/J.1364-3703.2007.00409.X; White FF, 2009, MOL PLANT PATHOL, V10, P749, DOI 10.1111/j.1364-3703.2009.00590.x; Woolery AR, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00113; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Xiao JY, 2010, NAT STRUCT MOL BIOL, V17, P1004, DOI 10.1038/nsmb.1867; Xu RQ, 2008, J BACTERIOL, V190, P343, DOI 10.1128/JB.00978-07; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Yuan J, 1996, J BACTERIOL, V178, P6399, DOI 10.1128/jb.178.21.6399-6402.1996; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Zhang J, 2010, CELL HOST MICROBE, V7, P290, DOI 10.1016/j.chom.2010.03.007; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	39	229	250	11	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					114	U149		10.1038/nature10962	http://dx.doi.org/10.1038/nature10962			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22504181				2022-12-28	WOS:000303451900045
J	Kalra, SS; Abdelaal, E; Marcus, R; Sheppard, M; Byrne, J				Kalra, Sundeep Singh; Abdelaal, Eltigani; Marcus, Robert; Sheppard, Mary; Byrne, Jonathan			Fooled by the heart	LANCET			English	Editorial Material							PRIMARY CARDIAC LYMPHOMA		[Kalra, Sundeep Singh; Abdelaal, Eltigani; Byrne, Jonathan] Kings Coll Hosp NHS Trust, Dept Cardiol, London, England; [Marcus, Robert] Kings Coll Hosp NHS Trust, Dept Haematol, London, England; [Sheppard, Mary] Royal Brompton Hosp, Dept Histopathol, London SW3 6LY, England	King's College Hospital NHS Foundation Trust; King's College Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; Royal Brompton Hospital	Kalra, SS (corresponding author), Kings Coll Hosp, Dept Cardiol, Denmark Hill, London SE5 9RS, England.	sundeep.kalra@nhs.net	Sheppard, Mary N/AAB-3364-2019	Sheppard, Mary N/0000-0003-2724-3881				Chim S, 1997, AM J HEMATOL, V54, P79; CURTSINGER CR, 1989, CANCER, V64, P521, DOI 10.1002/1097-0142(19890715)64:2<521::AID-CNCR2820640227>3.0.CO;2-T; Ikeda H, 2004, PATHOL INT, V54, P187, DOI 10.1111/j.1440-1827.2003.01606.x; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Patel J, 2010, ANN ONCOL, V21, P1041, DOI 10.1093/annonc/mdp424	5	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 14	2012	379	9824					1460	1460		10.1016/S0140-6736(12)60274-8	http://dx.doi.org/10.1016/S0140-6736(12)60274-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	926BR	22500879				2022-12-28	WOS:000302806800035
J	Blaha, MJ; Nasir, K; Blumenthal, RS				Blaha, Michael J.; Nasir, Khurram; Blumenthal, Roger S.			Statin Therapy for Healthy Men Identified as "Increased Risk"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							C-REACTIVE PROTEIN; PRIMARY PREVENTION; EVENTS; WOMEN; ROSUVASTATIN		[Blaha, Michael J.; Nasir, Khurram; Blumenthal, Roger S.] Johns Hopkins Ciccarone Ctr Prevent Heart Dis, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Blumenthal, RS (corresponding author), Johns Hopkins Ciccarone Ctr Prevent Heart Dis, Blalock 524C Cardiol,600 N Wolfe St, Baltimore, MD 21287 USA.	rblument@jhmi.edu	Blumenthal, Roger S/H-3223-2018	Blumenthal, Roger S/0000-0003-1910-3168				Bernick C, 2005, NEUROLOGY, V65, P1388, DOI 10.1212/01.wnl.0000182897.18229.ec; Blaha MJ, 2011, LANCET, V378, P684, DOI 10.1016/S0140-6736(11)60784-8; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Kostis WJ, 2012, J AM COLL CARDIOL, V59, P572, DOI 10.1016/j.jacc.2011.09.067; Kostis WJ, 2011, J CLIN LIPIDOL, V5, P97, DOI 10.1016/j.jacl.2011.01.006; Lytsy P, 2012, INT J BEHAV MED, V19, P134, DOI 10.1007/s12529-011-9157-6; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2010, CIRC-CARDIOVASC QUAL, V3, P447, DOI 10.1161/CIRCOUTCOMES.110.938118; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001	10	24	25	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2012	307	14					1489	1490		10.1001/jama.2012.425	http://dx.doi.org/10.1001/jama.2012.425			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922HN	22496260				2022-12-28	WOS:000302538100019
J	Le Fanu, J				Le Fanu, James			Mathematics is bad for you: population risk reduction medicalises us all	BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIOVASCULAR-DISEASE; GLUCOSE		Mawbey Brough Hlth Ctr, London SW8 2UD, England		Le Fanu, J (corresponding author), Mawbey Brough Hlth Ctr, London SW8 2UD, England.	james.lefanu@btinternet.com						Byrne CD, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5004; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Jackson R, 2008, HEART, V94, P1, DOI 10.1136/hrt.2007.138040; Lanchester J., 2010, WHOOPS WHY EVERYONE; Lawes CMM, 2004, DIABETES CARE, V27, P2836; Le Fanu J., 2011, RISE FALL MODERN MED; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Toop L, 2001, BRIT MED J, V323, P246, DOI 10.1136/bmj.323.7307.246; Westin S, 2005, BRIT MED J, V330, P1461, DOI 10.1136/bmj.330.7506.1461; 1983, EUR HEART J, V4, P141; 1999, BRIT MED J, V319, P1276, DOI DOI 10.1136/BMJ.319.7219.1276	11	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 11	2012	344								e2612	10.1136/bmj.e2612	http://dx.doi.org/10.1136/bmj.e2612			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	927UH	22496306				2022-12-28	WOS:000302935200013
J	Nishijima, DK; Simel, DL; Wisner, DH; Holmes, JF				Nishijima, Daniel K.; Simel, David L.; Wisner, David H.; Holmes, James F.			Does This Adult Patient Have a Blunt Intra-abdominal Injury?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SURGEON-PERFORMED ULTRASOUND; DIAGNOSTIC PERITONEAL-LAVAGE; ABDOMINAL-TRAUMA; COMPUTED-TOMOGRAPHY; SONOGRAPHY; ULTRASONOGRAPHY; ALGORITHM; MANAGEMENT; PHYSICIANS; TRIAL	Context Blunt abdominal trauma often presents a substantial diagnostic challenge. Well-informed clinical examination can identify patients who require further diagnostic evaluation for intra-abdominal injuries after blunt abdominal trauma. Objective To systematically assess the precision and accuracy of symptoms, signs, laboratory tests, and bedside imaging studies to identify intra-abdominal injuries in patients with blunt abdominal trauma. Data Sources We conducted a structured search of MEDLINE (1950-January 2012) and EMBASE (1980-January 2012) to identify English-language studies examining the identification of intra-abdominal injuries. A separate, structured search was conducted for studies evaluating bedside ultrasonography. Study Selection We included studies of diagnostic accuracy for intra-abdominal injury that compared at least 1 finding with a reference standard of abdominal computed tomography, diagnostic peritoneal lavage, laparotomy, autopsy, and/or clinical course for intra-abdominal injury. Twelve studies on clinical findings and 22 studies on bedside ultrasonography met inclusion criteria for data extraction. Data Extraction Critical appraisal and data extraction were independently performed by 2 authors. Data Synthesis The prevalence of intra-abdominal injury in adult emergency department patients with blunt abdominal trauma among all evidence level 1 and 2 studies was 13% (95% CI, 10%-17%), with 4.7% (95% CI, 2.5%-8.6%) requiring therapeutic surgery or angiographic embolization of injuries. The presence of a seat belt sign (likelihood ratio [LR] range, 5.6-9.9), rebound tenderness (LR, 6.5; 95% CI, 1.8-24), hypotension (LR, 5.2; 95% CI, 3.5-7.5), abdominal distention (LR, 3.8; 95% CI, 1.9-7.6), or guarding (LR, 3.7; 95% CI, 2.3-5.9) suggest an intra-abdominal injury. The absence of abdominal tenderness to palpation does not rule out an intra-abdominal injury (summary LR, 0.61; 95% CI, 0.46-0.80). The presence of intraperitoneal fluid or organ injury on bedside ultrasound assessment is more accurate than any history and physical examination findings (adjusted summary LR, 30; 95% CI, 20-46); conversely, a normal ultrasound result decreases the chance of injury detection (adjusted summary LR, 0.26; 95% CI, 0.19-0.34). Test results increasing the likelihood of intra-abdominal injury include a base deficit less than -6 mEq/ L (LR, 18; 95% CI, 11-30), elevated liver transaminases (LR range, 2.5-5.2), hematuria (LR range, 3.7-4.1), anemia (LR range, 2.2-3.3), and abnormal chest radiograph (LR range, 2.5-3.8). Symptoms and signs may be most useful in combination, particularly in identification of patients who do not need further diagnostic workup. Conclusions Bedside ultrasonography has the highest accuracy of all individual findings, but a normal result does not rule out an intra-abdominal injury. Combinations of clinical findings may be most useful to determine which patients do not require further evaluation, but the ideal combination of variables for identifying patients without intra-abdominal injury requires further study. JAMA. 2012; 307(14): 1517-1527 www.jama.com	[Nishijima, Daniel K.; Holmes, James F.] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA; [Wisner, David H.] Univ Calif Davis, Sch Med, Dept Surg, Sacramento, CA 95817 USA; [Simel, David L.] Durham Vet Affairs Med Ctr, Dept Med, Durham, NC USA; [Simel, David L.] Duke Univ, Durham, NC USA	University of California System; University of California Davis; University of California System; University of California Davis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University	Nishijima, DK (corresponding author), Univ Calif Davis, Sch Med, Dept Emergency Med, 2315 Stockton Blvd,PSSB 2100, Sacramento, CA 95817 USA.	daniel.nishijima@ucdmc.ucdavis.edu			Mentored Clinical Research Training Program Award [K30, KL2]; National Center for Research Resources (NCRR) [UL1 RR024146]; National Institutes of Health (NIH); NIH Roadmap for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024146] Funding Source: NIH RePORTER	Mentored Clinical Research Training Program Award; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The study did not receive any direct funding. Dr Nishijima was supported through a Mentored Clinical Research Training Program Award (K30 and KL2), grant UL1 RR024146 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and the NIH Roadmap for Medical Research.	Beck D, 2004, J TRAUMA, V57, P296, DOI 10.1097/01.TA.0000130612.60661.C3; Bode PJ, 1999, AM J ROENTGENOL, V172, P905, DOI 10.2214/ajr.172.4.10587119; Borenstein M., 2009, INTRO METAANALYSIS; Boulanger BR, 1999, J TRAUMA, V47, P632, DOI 10.1097/00005373-199910000-00005; Boulanger BR, 1996, J TRAUMA, V40, P867, DOI 10.1097/00005373-199606000-00003; Brenchley J, 2006, EMERG MED J, V23, P446, DOI 10.1136/emj.2005.026864; Brooks A, 2004, EMERG MED J, V21, DOI 10.1136/emj.2003.006932; Chandler CF, 1997, AM SURGEON, V63, P885; Committee on Trauma ACoS, 2008, ATLS ADV TRAUM LIF S; Eddy DM, 1992, METAANALYSIS CONFIDE; Fakhry SM, 2000, J TRAUMA, V48, P408, DOI 10.1097/00005373-200003000-00007; Ferrera PC, 1998, AM J EMERG MED, V16, P145, DOI 10.1016/S0735-6757(98)90032-8; Gardner RL, 2007, AM J EMERG MED, V25, P643, DOI 10.1016/j.ajem.2006.11.037; GOLETTI O, 1994, J TRAUMA, V36, P178, DOI 10.1097/00005373-199402000-00004; GRIESHOP NA, 1995, J TRAUMA, V38, P727, DOI 10.1097/00005373-199505000-00008; Healey MA, 1996, J TRAUMA, V40, P875, DOI 10.1097/00005373-199606000-00004; Heilbrun Marta E, 2005, J Am Coll Radiol, V2, P889, DOI 10.1016/j.jacr.2005.06.013; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; Hoff WS, 2002, J TRAUMA, V53, P602, DOI 10.1097/00005373-200209000-00038; Holmes JF, 2012, AM J EMERG MED, V30, P574, DOI 10.1016/j.ajem.2011.02.016; Holmes JF, 2009, ANN EMERG MED, V54, P575, DOI 10.1016/j.annemergmed.2009.04.007; Isenhour JL, 2007, EMERG MED CLIN N AM, V25, P713, DOI 10.1016/j.emc.2007.06.002; Jansen JO, 2008, BMJ-BRIT MED J, V336, P938, DOI 10.1136/bmj.39534.686192.80; Jhirad R, 1998, J TRAUMA, V45, P64, DOI 10.1097/00005373-199807000-00013; Jindal A, 2002, WORLD J SURG, V26, P13; Kern SJ, 1997, AM SURGEON, V63, P669; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Linsenmaier U, 2002, EUR RADIOL, V12, P1728, DOI 10.1007/s00330-001-1225-x; Ma O John, 2005, Emerg Med Australas, V17, P24, DOI 10.1111/j.1742-6723.2005.00681.x; MACKERSIE RC, 1989, ARCH SURG-CHICAGO, V124, P809; McGahan JP, 1997, J ULTRAS MED, V16, P653; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; MCKENNEY M, 1994, J TRAUMA, V37, P439, DOI 10.1097/00005373-199409000-00018; Melniker LA, 2006, ANN EMERG MED, V48, P227, DOI 10.1016/j.annemergmed.2006.01.008; Miller MT, 2003, J TRAUMA, V54, P52, DOI 10.1097/00005373-200301000-00007; Mofidi M, 2010, AM J EMERG MED, V28, P933, DOI 10.1016/j.ajem.2009.06.002; Niederee MJ, 2003, AM SURGEON, V69, P293; Pannu N, 2006, JAMA-J AM MED ASSOC, V295, P2765, DOI 10.1001/jama.295.23.2765; PEITZMAN AB, 1986, J TRAUMA, V26, P585, DOI 10.1097/00005373-198607000-00001; Poletti PA, 2004, J TRAUMA, V57, P1072, DOI 10.1097/01.TA.0000092680.73274.E1; Poletti PA, 2003, RADIOLOGY, V227, P95, DOI 10.1148/radiol.2271020139; Richards JR, 1997, INJURY, V28, P181, DOI 10.1016/S0020-1383(96)00187-8; Richards JR, 2002, J CLIN ULTRASOUND, V30, P59, DOI 10.1002/jcu.10033.abs; Richards JR, 1998, AM J EMERG MED, V16, P338, DOI 10.1016/S0735-6757(98)90122-X; Rodriguez A, 1982, Am Surg, V48, P457; Rose JS, 2001, J TRAUMA, V51, P545, DOI 10.1097/00005373-200109000-00022; ROTHLIN MA, 1993, J TRAUMA, V34, P488; ROZYCKI GS, 1995, J TRAUMA, V39, P492; Rozycki GS, 1998, ANN SURG, V228, P557, DOI 10.1097/00000658-199810000-00012; SAHDEV P, 1991, ANN EMERG MED, V20, P838, DOI 10.1016/S0196-0644(05)81422-2; Schurink GWH, 1997, INJURY, V28, P261, DOI 10.1016/S0020-1383(97)00007-7; Shackford SR, 1999, J TRAUMA, V46, P553, DOI 10.1097/00005373-199904000-00003; Shuman W P, 2000, Radiology, V215 Suppl, P143; Simel DL, 2009, J CLIN EPIDEMIOL, V62, P1292, DOI 10.1016/j.jclinepi.2009.02.007; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Soyuncu S, 2007, INJURY, V38, P564, DOI 10.1016/j.injury.2007.01.010; Stengel D, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004446.pub2; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; TSO P, 1992, J TRAUMA, V33, P39, DOI 10.1097/00005373-199207000-00009; Velmahos GC, 1999, AM SURGEON, V65, P181	60	86	94	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2012	307	14					1517	1527		10.1001/jama.2012.422	http://dx.doi.org/10.1001/jama.2012.422			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922HN	22496266	Green Accepted			2022-12-28	WOS:000302538100026
J	Rueangweerayut, R; Phyo, AP; Uthaisin, C; Poravuth, Y; Binh, TQ; Tinto, H; Penali, LK; Valecha, N; Tien, NT; Abdulla, S; Borghini-Fuhrer, I; Duparc, S; Shin, CS; Fleckenstein, L				Rueangweerayut, Ronnatrai; Phyo, Aung Pyae; Uthaisin, Chirapong; Poravuth, Yi; Tran Quang Binh; Tinto, Halidou; Penali, Louis K.; Valecha, Neena; Nong Thi Tien; Abdulla, Salim; Borghini-Fuhrer, Isabelle; Duparc, Stephan; Shin, Chang-Sik; Fleckenstein, Lawrence		Pyronaridine-Artesunate Study Team	Pyronaridine-Artesunate versus Mefloquine plus Artesunate for Malaria	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNCOMPLICATED FALCIPARUM-MALARIA; ARTEMISININ-RESISTANT MALARIA; PLASMODIUM-FALCIPARUM; EFFICACY; COMBINATION; ARTEMETHER	BACKGROUND Pyronaridine-artesunate is an artemisinin-based combination therapy under evaluation for the treatment of Plasmodium falciparum and P. vivax malaria. METHODS We conducted a phase 3, open-label, multicenter, noninferiority trial that included 1271 patients between 3 and 60 years of age from Asia (81.3%) or Africa (18.7%) with microscopically confirmed, uncomplicated P. falciparum malaria. Patients underwent randomization for treatment with a fixed-dose combination of 180 mg of pyronaridine and 60 mg of artesunate or with 250 mg of mefloquine plus 100 mg of artesunate. Doses were calculated according to body weight and administered once daily for 3 days. RESULTS Pyronaridine-artesunate was noninferior to mefloquine plus artesunate for the primary outcome: adequate clinical and parasitologic response in the per-protocol population on day 28, corrected for reinfection with the use of polymerase-chain-reaction (PCR) genotyping. For this outcome, efficacy in the group receiving pyronaridine-artesunate was 99.2% (743 of 749 patients; 95% confidence interval [CI], 98.3 to 99.7) and that in the group receiving mefloquine plus artesunate was 97.8% (360 of 368 patients; 95% CI, 95.8 to 99.1), with a treatment difference of 1.4 percentage points (95% CI, 0.0 to 3.5; P = 0.05). In the intention-to-treat population, efficacy on day 42 in the group receiving pyronaridine-artesunate was 83.1% (705 of 848 patients; 95% CI, 80.4 to 85.6) and that in the group receiving mefloquine plus artesunate was 83.9% (355 of 423 patients; 95% CI, 80.1 to 87.3). In Cambodia, where there were 211 study patients, the median parasite clearance time was prolonged for both treatments: 64 hours versus 16.0 to 38.9 hours in other countries (P<0.001, on the basis of Kaplan-Meier estimates). Kaplan-Meier estimates of the recrudescence rate in the intention-to-treat population in Cambodia until day 42 were higher with pyronaridine-artesunate than with mefloquine plus artesunate (10.2% [95% CI, 5.4 to 18.6] vs. 0%; P = 0.04 as calculated with the log-rank test), but similar for the other countries combined (4.7% [95% CI, 3.3 to 6.7] and 2.8% [95% CI, 1.5 to 5.3], respectively; P = 0.24). Elevated levels of aminotransferases were observed in those receiving pyronaridine-artesunate. Two patients receiving mefloquine plus artesunate had seizures. CONCLUSIONS Fixed-dose pyronaridine-artesunate was efficacious in the treatment of uncomplicated P. falciparum malaria. In Cambodia, extended parasite clearance times were suggestive of in vivo resistance to artemisinin. (Funded by Shin Poong Pharmaceutical Company and the Medicines for Malaria Venture; ClinicalTrials.gov number, NCT00403260.)	[Borghini-Fuhrer, Isabelle] Med Malaria Venture, Int Ctr Cointrin, CH-1215 Geneva 15, Switzerland; [Rueangweerayut, Ronnatrai] Mae Sot Gen Hosp, Dept Internal Med, Tak, Thailand; [Phyo, Aung Pyae] Mae Sot, Shoklo Malaria Res Unit, Tak, Thailand; [Uthaisin, Chirapong] Mae Ramat Hosp, Tak, Thailand; [Poravuth, Yi] Natl Malaria Ctr, Phnom Penh, Cambodia; [Tran Quang Binh] Choray Hosp, Dak O Hlth Ctr, Ho Chi Minh City, Vietnam; [Nong Thi Tien] Natl Inst Malariol Parasitol & Entomol, Commune Xy Hlth Ctr, Hanoi, Vietnam; [Tinto, Halidou] Ctr Muraz, W African Network Monitoring Antimalarial Treatme, Bobo Dioulasso, Burkina Faso; [Penali, Louis K.] Inst Pasteur, Abidjan, Cote Ivoire; [Valecha, Neena] Natl Inst Malaria Res, Delhi, India; [Abdulla, Salim] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Shin, Chang-Sik] Shin Poong Pharmaceut Co, Seoul, South Korea; [Fleckenstein, Lawrence] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA	Mahidol University; Centre Muraz; Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Ifakara Health Institute; University of Iowa	Borghini-Fuhrer, I (corresponding author), Med Malaria Venture, Int Ctr Cointrin, Rte Pre Bois 20,POB 1826, CH-1215 Geneva 15, Switzerland.	borghinii@mmv.org	Phyo, Aung Pyae/K-2413-2019; Phyo, Aung Pyae/GYU-6181-2022; Duparc, Stephan/AAH-8758-2020	Phyo, Aung Pyae/0000-0002-0383-9624; Phyo, Aung Pyae/0000-0002-0383-9624; Duparc, Stephan/0000-0002-9649-4847; Fleckenstein, Lawrence/0000-0001-5320-4531; Tinto, Halidou/0000-0002-0472-3586	Shin Poong Pharmaceutical Company and Medicines for Malaria Venture	Shin Poong Pharmaceutical Company and Medicines for Malaria Venture	Supported by a private-public partnership between Shin Poong Pharmaceutical Company and Medicines for Malaria Venture.	[Anonymous], 2003, ASS MON ANT DRUG EFF; [Anonymous], CONT MAL MULT RES CA; [Anonymous], 2007, METHODS TECHNIQUES C; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; BEM JL, 1992, J TROP MED HYG, V95, P167; Delacollette C, 2009, SE ASIAN J TROP MED, V40, P674; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Douglas NM, 2011, CLIN INFECT DIS, V52, P612, DOI 10.1093/cid/ciq249; Douglas NM, 2010, LANCET INFECT DIS, V10, P405, DOI 10.1016/S1473-3099(10)70079-7; Felger Ingrid, 2002, Methods Mol Med, V72, P117, DOI 10.1385/1-59259-271-6:117; Food and Drug Administration, 2009, GUID IND DRUG IND LI; Guerin PJ, 2009, CURR OPIN INFECT DIS, V22, P593, DOI 10.1097/QCO.0b013e328332c4a7; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; Maude RJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-31; Nevin RL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-188; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Poravuth Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014501; Price R, 1999, AM J TROP MED HYG, V60, P547, DOI 10.4269/ajtmh.1999.60.547; Ramharter M, 2008, J INFECT DIS, V198, P911, DOI 10.1086/591096; Ribeiro I R, 1998, Med Trop (Mars), V58, P50; Ringwald P, 1998, CLIN INFECT DIS, V26, P946, DOI 10.1086/513942; Ringwald P, 1996, LANCET, V347, P24, DOI 10.1016/S0140-6736(96)91558-5; Simpson JA, 2000, ANTIMICROB AGENTS CH, V44, P3414, DOI 10.1128/AAC.44.12.3414-3424.2000; Sinclair D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007483.pub2; Stepniewska K, 2008, ANTIMICROB AGENTS CH, V52, P1589, DOI 10.1128/AAC.00903-07; Tshefu AK, 2010, LANCET, V375, P1457, DOI 10.1016/S0140-6736(10)60322-4; WHITE NJ, 1992, BRIT J CLIN PHARMACO, V34, P1; WHO, 2010, GUID TREATM MAL, V2nd; WHO, 2008, GLOB MAL CONTR EL RE; Wongsrichanalai C, 1999, B WORLD HEALTH ORGAN, V77, P392; Wongsrichanalai C, 2008, EMERG INFECT DIS, V14, P716, DOI 10.3201/eid1405.071601	31	56	57	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 5	2012	366	14					1298	1309		10.1056/NEJMoa1007125	http://dx.doi.org/10.1056/NEJMoa1007125			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919QJ	22475593	Green Published			2022-12-28	WOS:000302343000007
J	Stirling, CH				Stirling, Claudine H.			Keeping Time with Earth's Heaviest Element	SCIENCE			English	Editorial Material							EARLY SOLAR-SYSTEM; ISOTOPE FRACTIONATION; HEAVY-ELEMENTS; U-238/U-235; URANIUM; REDUCTION; RATIOS; CM-247		Univ Otago, Dept Chem, Dunedin, New Zealand	University of Otago	Stirling, CH (corresponding author), Univ Otago, Dept Chem, POB 56, Dunedin, New Zealand.	cstirling@chemistry.otago.ac.nz						Amelin Y, 2010, EARTH PLANET SC LETT, V300, P343, DOI 10.1016/j.epsl.2010.10.015; Bigeleisen J, 1996, J AM CHEM SOC, V118, P3676, DOI 10.1021/ja954076k; Bopp CJ, 2010, ENVIRON SCI TECHNOL, V44, P5927, DOI 10.1021/es100643v; Bopp CJ, 2009, GEOLOGY, V37, P611, DOI 10.1130/G25550A.1; Brennecka GA, 2010, SCIENCE, V327, P449, DOI 10.1126/science.1180871; Brennecka GA, 2010, EARTH PLANET SC LETT, V291, P228, DOI 10.1016/j.epsl.2010.01.023; Hiess J, 2012, SCIENCE, V335, P1610, DOI 10.1126/science.1215507; Montoya-Pino C, 2010, GEOLOGY, V38, P315, DOI 10.1130/G30652.1; Rademacher LK, 2006, ENVIRON SCI TECHNOL, V40, P6943, DOI 10.1021/es0604360; Schauble EA, 2007, GEOCHIM COSMOCHIM AC, V71, P2170, DOI 10.1016/j.gca.2007.02.004; Stirling CH, 2005, GEOCHIM COSMOCHIM AC, V69, P1059, DOI 10.1016/j.gca.2004.06.034; Stirling CH, 2007, EARTH PLANET SC LETT, V264, P208, DOI 10.1016/j.epsl.2007.09.019; Stirling CH, 2006, EARTH PLANET SC LETT, V251, P386, DOI 10.1016/j.epsl.2006.09.023; Weyer S, 2008, GEOCHIM COSMOCHIM AC, V72, P345, DOI 10.1016/j.gca.2007.11.012	14	4	4	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1585	1586		10.1126/science.1220333	http://dx.doi.org/10.1126/science.1220333			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461600				2022-12-28	WOS:000302062600032
J	Boyce, N				Boyce, Niall			Emma Plugge: time for outrage	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 26	2012	379	9830					1941	1941		10.1016/S0140-6736(12)60535-2	http://dx.doi.org/10.1016/S0140-6736(12)60535-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951YV	22521519				2022-12-28	WOS:000304757700016
J	Neale, BM; Kou, Y; Liu, L; Ma'ayan, A; Samocha, KE; Sabo, A; Lin, CF; Stevens, C; Wang, LS; Makarov, V; Polak, P; Yoon, S; Maguire, J; Crawford, EL; Campbell, NG; Geller, ET; Valladares, O; Schafer, C; Liu, H; Zhao, T; Cai, GQ; Lihm, J; Dannenfelser, R; Jabado, O; Peralta, Z; Nagaswamy, U; Muzny, D; Reid, JG; Newsham, I; Wu, YQ; Lewis, L; Han, Y; Voight, BF; Lim, E; Rossin, E; Kirby, A; Flannick, J; Fromer, M; Shakir, K; Fennell, T; Garimella, K; Banks, E; Poplin, R; Gabriel, S; DePristo, M; Wimbish, JR; Boone, BE; Levy, SE; Betancur, C; Sunyaev, S; Boerwinkle, E; Buxbaum, JD; Cook, EH; Devlin, B; Gibbs, RA; Roeder, K; Schellenberg, GD; Sutcliffe, JS; Daly, MJ				Neale, Benjamin M.; Kou, Yan; Liu, Li; Ma'ayan, Avi; Samocha, Kaitlin E.; Sabo, Aniko; Lin, Chiao-Feng; Stevens, Christine; Wang, Li-San; Makarov, Vladimir; Polak, Paz; Yoon, Seungtai; Maguire, Jared; Crawford, Emily L.; Campbell, Nicholas G.; Geller, Evan T.; Valladares, Otto; Schafer, Chad; Liu, Han; Zhao, Tuo; Cai, Guiqing; Lihm, Jayon; Dannenfelser, Ruth; Jabado, Omar; Peralta, Zuleyma; Nagaswamy, Uma; Muzny, Donna; Reid, Jeffrey G.; Newsham, Irene; Wu, Yuanqing; Lewis, Lora; Han, Yi; Voight, Benjamin F.; Lim, Elaine; Rossin, Elizabeth; Kirby, Andrew; Flannick, Jason; Fromer, Menachem; Shakir, Khalid; Fennell, Tim; Garimella, Kiran; Banks, Eric; Poplin, Ryan; Gabriel, Stacey; DePristo, Mark; Wimbish, Jack R.; Boone, Braden E.; Levy, Shawn E.; Betancur, Catalina; Sunyaev, Shamil; Boerwinkle, Eric; Buxbaum, Joseph D.; Cook, Edwin H., Jr.; Devlin, Bernie; Gibbs, Richard A.; Roeder, Kathryn; Schellenberg, Gerard D.; Sutcliffe, James S.; Daly, Mark J.			Patterns and rates of exonic de novo mutations in autism spectrum disorders	NATURE			English	Article							DNA-SEQUENCING DATA; ASSOCIATION; FRAMEWORK; DISEASE	Autism spectrum disorders (ASD) are believed to have genetic and environmental origins, yet in only a modest fraction of individuals can specific causes be identified(1,2). To identify further genetic risk factors, here we assess the role of de novo mutations in ASD by sequencing the exomes of ASD cases and their parents (n = 175 trios). Fewer than half of the cases (46.3%) carry a missense or nonsense de novo variant, and the overall rate of mutation is only modestly higher than the expected rate. In contrast, the proteins encoded by genes that harboured de novo missense or nonsense mutations showed a higher degree of connectivityamong themselves and to previous ASD genes(3) as indexed by protein-protein interaction screens. The small increase in the rate of de novo events, when taken together with the protein interaction results, are consistent with an important but limited role for de novo point mutations in ASD, similar to that documented for de novo copy number variants. Genetic models incorporating these data indicate that most of the observed de novo events are unconnected to ASD; those that do confer risk are distributed across many genes and are incompletely penetrant (that is, not necessarily sufficient for disease). Our results support polygenic models in which spontaneous coding mutations in any of a large number of genes increases risk by 5- to 20-fold. Despite the challenge posed by such models, results from de novo events and a large parallel case-control study provide strong evidence in favour of CHD8 and KATNAL2 as genuine autism risk factors.	[Neale, Benjamin M.; Samocha, Kaitlin E.; Lim, Elaine; Rossin, Elizabeth; Kirby, Andrew; Fromer, Menachem; Daly, Mark J.] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Neale, Benjamin M.; Samocha, Kaitlin E.; Lim, Elaine; Rossin, Elizabeth; Kirby, Andrew; Fromer, Menachem; Daly, Mark J.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Neale, Benjamin M.; Samocha, Kaitlin E.; Stevens, Christine; Polak, Paz; Maguire, Jared; Voight, Benjamin F.; Lim, Elaine; Rossin, Elizabeth; Kirby, Andrew; Flannick, Jason; Fromer, Menachem; Shakir, Khalid; Fennell, Tim; Garimella, Kiran; Banks, Eric; Poplin, Ryan; Gabriel, Stacey; DePristo, Mark; Sunyaev, Shamil; Daly, Mark J.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Kou, Yan; Ma'ayan, Avi; Dannenfelser, Ruth] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Kou, Yan; Makarov, Vladimir; Yoon, Seungtai; Cai, Guiqing; Lihm, Jayon; Buxbaum, Joseph D.] Mt Sinai Sch Med, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [Liu, Li; Schafer, Chad; Roeder, Kathryn] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15232 USA; [Sabo, Aniko; Nagaswamy, Uma; Muzny, Donna; Reid, Jeffrey G.; Newsham, Irene; Wu, Yuanqing; Lewis, Lora; Han, Yi; Boerwinkle, Eric; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Makarov, Vladimir; Yoon, Seungtai; Cai, Guiqing; Lihm, Jayon; Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Polak, Paz; Sunyaev, Shamil] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Polak, Paz; Sunyaev, Shamil] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Crawford, Emily L.; Campbell, Nicholas G.; Sutcliffe, James S.] Vanderbilt Univ, Vanderbilt Brain Inst, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Crawford, Emily L.; Campbell, Nicholas G.; Sutcliffe, James S.] Vanderbilt Univ, Vanderbilt Brain Inst, Dept Psychiat, Nashville, TN 37232 USA; [Liu, Han; Zhao, Tuo] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; [Liu, Han; Zhao, Tuo] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21205 USA; [Jabado, Omar; Peralta, Zuleyma; Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Voight, Benjamin F.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Wimbish, Jack R.; Boone, Braden E.; Levy, Shawn E.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Betancur, Catalina] INSERM, U952, F-75005 Paris, France; [Betancur, Catalina] CNRS, UMR 7224, F-75005 Paris, France; [Betancur, Catalina] Univ Paris 06, F-75005 Paris, France; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Houston, TX 77030 USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY 10029 USA; [Cook, Edwin H., Jr.] Univ Illinois, Dept Psychiat, Chicago, IL 60608 USA; [Devlin, Bernie] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Carnegie Mellon University; Baylor College of Medicine; Icahn School of Medicine at Mount Sinai; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Vanderbilt University; Vanderbilt University; Johns Hopkins University; Johns Hopkins University; Icahn School of Medicine at Mount Sinai; University of Pennsylvania; Pennsylvania Medicine; HudsonAlpha Institute for Biotechnology; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Texas System; University of Texas Health Science Center Houston; Icahn School of Medicine at Mount Sinai; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Daly, MJ (corresponding author), Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA.	joseph.buxbaum@mssm.edu; kathryn.roeder@gmail.com; mjdaly@atgu.mgh.harvard.edu	Liu, Li/G-1897-2015; Polak, Paz/AAH-9380-2020; Buxbaum, Joseph D/G-6001-2010; Fromer, Menachem/G-2116-2012; Betancur, Catalina/K-3791-2017; Daly, Mark J/B-2453-2017; Sutcliffe, James S/C-1348-2012; Ma'ayan, Avi/AAG-3131-2019	Fromer, Menachem/0000-0003-3749-4342; Betancur, Catalina/0000-0002-3327-4804; Daly, Mark J/0000-0002-0949-8752; Sutcliffe, James S/0000-0001-5200-6007; Ma'ayan, Avi/0000-0002-6904-1017; Valladares, Otto/0000-0001-8055-2187; Geller, Evan/0000-0002-8035-8736; Buxbaum, Joseph/0000-0001-8898-8313; Stevens, Christine/0000-0002-2621-2234; Garimella, Kiran/0000-0002-6212-5736; Dannenfelser, Ruth/0000-0002-8766-6424; Samocha, Kaitlin/0000-0002-1704-3352	NIH [R01MH089208, R01 MH089025, R01 MH089004, R01MH089175, R01 MH089482, P50 HD055751, RO1 MH057881, R01 MH061009]; Seaver Foundation; NIH NCRR [UL1 RR024975]; Vanderbilt Kennedy Center for Research on Human Development [P30 HD015052];  [R01MH084676];  [U54 HG003273];  [U54 HG003067]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055751] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975, KL2RR024977, TL1RR024978] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558, T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH089004, R01MH089025, R01MH057881, R01MH089482, R01MH084676, R01MH089175, R01MH061009, R01MH089208] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Seaver Foundation; NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Vanderbilt Kennedy Center for Research on Human Development; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was directly supported by NIH grants R01MH089208 (M.J.D.), R01 MH089025 (J.D.B.), R01 MH089004 (G. D. S.), R01MH089175 (R. A. G.) and R01 MH089482 (J.S.S.), and supported in part by NIH grants P50 HD055751 (E. H. C.), RO1 MH057881 (B. D.) and R01 MH061009 (J.S.S.). Y.K., G. C. and S.Y. are Seaver Fellows, supported by the Seaver Foundation. We thank T. Lehner, A. Felsenfeld and P. Bender for their support and contribution to the project. We thank S. Sanders and M. State for discussions on the interpretation of de novo events. We thank D. Reich for comments on the abstract and message of the manuscript. We thank E. Lander and D. Altshuler for comments on the manuscript. We acknowledge the assistance of M. Potter, A. McGrew and G. Crockett without whom these studies would not be possible, and Center for Human Genetics Research resources: Computational Genomics Core, Genetic Studies Ascertainment Core and DNA Resources core, supported in part by NIH NCRR grant UL1 RR024975, and the Vanderbilt Kennedy Center for Research on Human Development (P30 HD015052). This work was supported in part by R01MH084676 (S. S.). We acknowledge the clinicians and organizations that contributed to samples used in this study and the particular support of the Mount Sinai School of Medicine, University of Illinois-Chicago, Vanderbilt University, the Autism Genetics Resource Exchange and the institutions of the Boston Autism Consortium. We acknowledge A. Estes and G. Dawson for patient collection/characterization. We acknowledge partial support from U54 HG003273 (R. A. G.) and U54 HG003067 (E. Lander). J.D.B., B. D., M.J.D., R. A. G., A. S., G. D. S. and J.S.S. are lead investigators in the Autism Sequencing Consortium (ASC). The ASC is comprised of groups sharing massively parallel sequencing data in autism. Finally, we are grateful to the many families, without whose participation this project would not have been possible.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Lage K, 2008, P NATL ACAD SCI USA, V105, P20870, DOI 10.1073/pnas.0810772105; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sebat J, 2009, TRENDS GENET, V25, P528, DOI 10.1016/j.tig.2009.10.004; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029	18	1224	1263	2	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2012	485	7397					242	U129		10.1038/nature11011	http://dx.doi.org/10.1038/nature11011			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22495311	Green Submitted, Green Accepted			2022-12-28	WOS:000303799800042
J	Barbez, E; Kubes, M; Rolcik, J; Beziat, C; Pencik, A; Wang, BJ; Rosquete, MR; Zhu, JS; Dobrev, PI; Lee, Y; Zazimalova, E; Petrasek, J; Geisler, M; Friml, J; Kleine-Vehn, J				Barbez, Elke; Kubes, Martin; Rolcik, Jakub; Beziat, Chloe; Pencik, Ales; Wang, Bangjun; Rosquete, Michel Ruiz; Zhu, Jinsheng; Dobrev, Petre I.; Lee, Yuree; Zazimalova, Eva; Petrasek, Jan; Geisler, Markus; Friml, Jiri; Kleine-Vehn, Juergen			A novel putative auxin carrier family regulates intracellular auxin homeostasis in plants	NATURE			English	Article							SOLID-PHASE EXTRACTION; TOBACCO CELLS; ABSCISIC-ACID; ARABIDOPSIS; EFFLUX; TRANSPORT; PROTEINS; BIOSYNTHESIS; LOCALIZATION; PURIFICATION	The phytohormone auxin acts as a prominent signal, providing, by its local accumulation or depletion in selected cells, a spatial and temporal reference for changes in the developmental program(1-7). The distribution of auxin depends on both auxin metabolism (biosynthesis, conjugation and degradation)(8-10) and cellular auxin transport(11-15). We identified in silico a novel putative auxin transport facilitator family, called PIN-LIKES (PILS). Here we illustrate that PILS proteins are required for auxin-dependent regulation of plant growth by determining the cellular sensitivity to auxin. PILS proteins regulate intracellular auxin accumulation at the endoplasmic reticulum and thus auxin availability for nuclear auxin signalling. PILS activity affects the level of endogenous auxin indole-3-acetic acid (IAA), presumably via intracellular accumulation and metabolism. Our findings reveal that the transport machinery to compartmentalize auxin within the cell is of an unexpected molecular complexity and demonstrate this compartmentalization to be functionally important for a number of developmental processes.	[Barbez, Elke; Beziat, Chloe; Rosquete, Michel Ruiz; Friml, Jiri; Kleine-Vehn, Juergen] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Barbez, Elke; Beziat, Chloe; Rosquete, Michel Ruiz; Friml, Jiri; Kleine-Vehn, Juergen] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Barbez, Elke; Beziat, Chloe; Rosquete, Michel Ruiz; Kleine-Vehn, Juergen] Univ Nat Resources & Life Siences BOKU, Dept Appl Genet & Cell Biol, A-1190 Vienna, Austria; [Kubes, Martin; Dobrev, Petre I.; Zazimalova, Eva; Petrasek, Jan] Acad Sci Czech Republ, Inst Expt Bot, CR-16502 Prague 6, Czech Republic; [Rolcik, Jakub] Palacky Univ, Fac Sci, Lab Growth Regulators, Olomouc 78371, Czech Republic; [Rolcik, Jakub] Inst Expt Bot AS CR, Olomouc 78371, Czech Republic; [Pencik, Ales] Palacky Univ, Fac Sci, Dept Growth Regulators, Ctr Reg Hana Biotechnol & Agr Res, Olomouc 78371, Czech Republic; [Wang, Bangjun; Zhu, Jinsheng; Geisler, Markus] Univ Fribourg, Dept Biol Plant Biol, CH-1700 Fribourg, Switzerland; [Lee, Yuree] Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Palacky University Olomouc; University of Fribourg; University of Lausanne	Kleine-Vehn, J (corresponding author), Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium.	juergen.kleine-vehn@boku.ac.at	Friml, Jiri/D-9511-2012; Kleine-Vehn, Jürgen/C-8984-2014; Zhu, Jinsheng/AEN-5830-2022; Geisler, Markus M/B-3921-2012; Barbez, Elke/AAP-2131-2021; Petrasek, Jan/AAW-1081-2021; Dobrev, Petre I./H-2391-2014; Pencik, Ales/D-4488-2018; Kubes, Martin/F-9761-2014; Petrasek, Jan/C-8240-2009; Eva, Zazimalova/G-7432-2014	Friml, Jiri/0000-0002-8302-7596; Kleine-Vehn, Jürgen/0000-0002-4354-3756; Zhu, Jinsheng/0000-0002-8131-1876; Geisler, Markus M/0000-0002-6641-5810; Petrasek, Jan/0000-0002-6719-2735; Pencik, Ales/0000-0002-1314-2249; Petrasek, Jan/0000-0002-6719-2735; Eva, Zazimalova/0000-0002-8325-7092; Lee, Yuree/0000-0002-4663-6974; Barbez, Elke/0000-0002-5531-7916; Kubes, Martin/0000-0003-2182-4490	Vienna Science and Technology Fund (WWTF); Agency for Innovation by Science and Technology (IWT); Research Foundation-Flanders; Swiss National Funds; Ministry of Education, Youth and Sports of the Czech Republic [LC06034]; Grant Agency of the Czech Republic [P305/11/2476, P305/11/0797]	Vienna Science and Technology Fund (WWTF); Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation-Flanders(FWO); Swiss National Funds(Swiss National Science Foundation (SNSF)); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	We are grateful to C. Braeckman for plant transformation; W. Ardiles for sequencing support; L. Charrier for technical assistance; A. Maizel, N. Geldner and P. Pimpl for providing material; J.K.-V. group members for critical reading of the manuscript and the BOKU-VIBT Imaging Center for access and expertise. This work was supported by the Vienna Science and Technology Fund (WWTF) (to J.K.-V.), the Agency for Innovation by Science and Technology (IWT) (predoctoral fellowship to E. B.), the Odysseus program of the Research Foundation-Flanders (to J.F.), the Swiss National Funds (to M. G.), the Ministry of Education, Youth and Sports of the Czech Republic (LC06034) (to E.Z.), Grant Agency of the Czech Republic project P305/11/2476 (to J.P.) and P305/11/0797 (to E.Z).	Bailly A, 2008, J BIOL CHEM, V283, P21817, DOI 10.1074/jbc.M709655200; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Bennett MJ, 1996, SCIENCE, V273, P948, DOI 10.1126/science.273.5277.948; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Delbarre A, 1996, PLANTA, V198, P532, DOI 10.1007/BF00262639; Dobrev PI, 2002, J CHROMATOGR A, V950, P21, DOI 10.1016/S0021-9673(02)00024-9; Dobrev PI, 2005, J CHROMATOGR A, V1075, P159, DOI 10.1016/j.chroma.2005.02.091; Dubrovsky JG, 2008, P NATL ACAD SCI USA, V105, P8790, DOI 10.1073/pnas.0712307105; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Ikeda Y, 2009, NAT CELL BIOL, V11, P731, DOI 10.1038/ncb1879; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Langhans M, 2008, TRAFFIC, V9, P770, DOI 10.1111/j.1600-0854.2008.00719.x; Lee SH, 2006, PLANT CELL, V18, P1604, DOI 10.1105/tpc.105.035972; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Leyser O, 2006, CURR BIOL, V16, pR424, DOI 10.1016/j.cub.2006.05.014; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Marin E, 2010, PLANT CELL, V22, P1104, DOI 10.1105/tpc.109.072553; Mravec J, 2009, NATURE, V459, P1136, DOI 10.1038/nature08066; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Pencik A, 2009, TALANTA, V80, P651, DOI 10.1016/j.talanta.2009.07.043; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Prasad K, 2011, CURR BIOL, V21, P1123, DOI 10.1016/j.cub.2011.05.009; Proost S, 2009, PLANT CELL, V21, P3718, DOI 10.1105/tpc.109.071506; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Sauer M, 2006, NAT PROTOC, V1, P98, DOI 10.1038/nprot.2006.15; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sorefan K, 2009, NATURE, V459, P583, DOI 10.1038/nature07875; Spyropoulos IC, 2004, BIOINFORMATICS, V20, P3258, DOI 10.1093/bioinformatics/bth358; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Zazimalova E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001552; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308	35	240	264	14	206	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					119	U155		10.1038/nature11001	http://dx.doi.org/10.1038/nature11001			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22504182	Green Submitted			2022-12-28	WOS:000303451900046
J	Cassel, CK; Guest, JA				Cassel, Christine K.; Guest, James A.			Choosing Wisely Helping Physicians and Patients Make Smart Decisions About Their Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TOP 5 LISTS; PROFESSIONALISM; RESPONSIBILITY; HEALTH		[Cassel, Christine K.] ABIM Fdn, Philadelphia, PA 19106 USA; [Guest, James A.] Consumer Reports, Yonkers, NY USA	American Board of Internal Medicine	Cassel, CK (corresponding author), ABIM Fdn, 510 Walnut St,17th Floor, Philadelphia, PA 19106 USA.	ccassel@abim.org						Aguilar I, 2011, ARCH INTERN MED, V171, P1385, DOI 10.1001/archinternmed.2011.231; [Anonymous], 44 PERC HLTH AD GETT; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Brett AS, 2012, JAMA-J AM MED ASSOC, V307, P149, DOI 10.1001/jama.2011.1999; Brody H, 2010, NEW ENGL J MED, V362, P283, DOI 10.1056/NEJMp0911423; Campbell EG, 2007, ANN INTERN MED, V147, P795, DOI 10.7326/0003-4819-147-11-200712040-00012; Crosson FJ, CHANGE MICROENVIRONM; Grady D, 2010, ARCH INTERN MED, V170, P749, DOI 10.1001/archinternmed.2010.90; Kale MS, 2011, ARCH INTERN MED, V171, P1856, DOI 10.1001/archinternmed.2011.501; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012	10	632	641	1	31	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2012	307	17					1801	1802		10.1001/jama.2012.476	http://dx.doi.org/10.1001/jama.2012.476			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933TV	22492759				2022-12-28	WOS:000303386800016
J	Arie, S				Arie, Sophie			What can we learn from asthma in elite athletes?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PERFORMANCE					mail@sophiearie.com						Asthma UK, KEY FACTS STAT; BBC Sport Academy, PAUL OV ASTHM; Dickinson JW, 2005, THORAX, V60, P629, DOI 10.1136/thx.2004.037499; McKenzie DC, 2011, CLIN J SPORT MED, V21, P46, DOI 10.1097/IAE.0b013e318203c0ef; NHS Choices, PAUL RADCL ASTHM; Pluim BM, 2011, SPORTS MED, V41, P39, DOI 10.2165/11537540-000000000-00000; Weiler JM, 2000, J ALLERGY CLIN IMMUN, V106, P267, DOI 10.1067/mai.2000.108605	7	7	7	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2012	344								e2556	10.1136/bmj.e2556	http://dx.doi.org/10.1136/bmj.e2556			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934HB	22531868				2022-12-28	WOS:000303433700002
J	Farla, RJM; Jackson, I; Gerald, JDF; Faul, UH; Zimmerman, ME				Farla, Robert J. M.; Jackson, Ian; Gerald, John D. Fitz; Faul, Ulrich H.; Zimmerman, Mark E.			Dislocation Damping and Anisotropic Seismic Wave Attenuation in Earth's Upper Mantle	SCIENCE			English	Article							LATTICE PREFERRED ORIENTATION; POLYCRYSTALLINE OLIVINE; SHEAR; MODEL; VISCOELASTICITY; DIFFUSION; RHEOLOGY; VELOCITY; FLOW	Crystal defects form during tectonic deformation and are reactivated by the shear stress associated with passing seismic waves. Although these defects, known as dislocations, potentially contribute to the attenuation of seismic waves in Earth's upper mantle, evidence for dislocation damping from laboratory studies has been circumstantial. We experimentally determined the shear modulus and associated strain-energy dissipation in pre-deformed synthetic olivine aggregates under high pressures and temperatures. Enhanced high-temperature background dissipation occurred in specimens pre-deformed by dislocation creep in either compression or torsion, the enhancement being greater for prior deformation in torsion. These observations suggest the possibility of anisotropic attenuation in relatively coarse-grained rocks where olivine is or was deformed at relatively high stress by dislocation creep in Earth's upper mantle.	[Farla, Robert J. M.; Jackson, Ian; Gerald, John D. Fitz] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Faul, Ulrich H.] Boston Univ, Dept Earth Sci, Boston, MA USA; [Zimmerman, Mark E.] Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA	Australian National University; Boston University; University of Minnesota System; University of Minnesota Twin Cities	Farla, RJM (corresponding author), Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06520 USA.	robert.farla@yale.edu	jackson, ian/H-4739-2011	jackson, ian/0000-0001-5200-9734; Faul, Ulrich/0000-0001-5036-4572	Australian government; Research School of Earth Sciences-Australian National University; NASA [NNX11AF58G]	Australian government(Australian GovernmentCGIAR); Research School of Earth Sciences-Australian National University(Australian National University); NASA(National Aeronautics & Space Administration (NASA))	We thank H. Kokkonen, C. Saint, H. Miller, and F. Brink for experimental help and D. Kohlstedt for allowing us to use his laboratory at the University of Minnesota. The Australian government (an Endeavor International Postgraduate Research Scholarship), a Mervyn and Katalin Paterson Fellowship (Research School of Earth Sciences-Australian National University), and NASA grant NNX11AF58G supported this work. We thank three anonymous reviewers for helping to improve the manuscript. The raw data are available in the supplementary materials.	Artemieva IM, 2004, GEOPHYS J INT, V157, P607, DOI 10.1111/j.1365-246X.2004.02195.x; Barnford D., 1977, GEOPHYS J ROY ASTRON, V49, P1; Cammarano F, 2008, GEOPHYS J INT, V175, P116, DOI 10.1111/j.1365-246X.2008.03863.x; Cooper RF, 2002, REV MINERAL GEOCHEM, V51, P253, DOI 10.2138/gsrmg.51.1.253; Dalton CA, 2009, EARTH PLANET SC LETT, V284, P65, DOI 10.1016/j.epsl.2009.04.009; Farla RJM, 2011, PHYS CHEM MINER, V38, P363, DOI 10.1007/s00269-010-0410-3; FORSYTH DW, 1975, GEOPHYS J ROY ASTR S, V43, P103, DOI 10.1111/j.1365-246X.1975.tb00630.x; GOETZE C, 1973, J GEOPHYS RES, V78, P5961, DOI 10.1029/JB078i026p05961; GREEN HW, 1972, EARTH PLANET SC LETT, V15, P239, DOI 10.1016/0012-821X(72)90169-0; Gribb TT, 1998, J GEOPHYS RES-SOL EA, V103, P27267, DOI 10.1029/98JB02786; Gueguen Y., 1973, Physics of the Earth and Planetary Interiors, V7, P39, DOI 10.1016/0031-9201(73)90038-1; GUEGUEN Y, 1989, PHYS EARTH PLANET IN, V55, P254, DOI 10.1016/0031-9201(89)90073-3; HESS HH, 1964, NATURE, V203, P629, DOI 10.1038/203629a0; JACKSON I, 1993, GEOPHYS RES LETT, V20, P2115, DOI 10.1029/93GL02504; JACKSON I, 1993, PURE APPL GEOPHYS, V141, P445, DOI 10.1007/BF00998339; Jackson I., 2007, TREATISE GEOPHYS, V2, P493; Jackson I, 2006, MAT SCI ENG A-STRUCT, V442, P170, DOI 10.1016/j.msea.2006.01.136; Jackson I, 2010, PHYS EARTH PLANET IN, V183, P151, DOI 10.1016/j.pepi.2010.09.005; KOHLSTEDT DL, 1995, J GEOPHYS RES-SOL EA, V100, P17587, DOI 10.1029/95JB01460; Mainprice D., 2007, TREATISE GEOPHYS, V2, P437, DOI DOI 10.1016/B978-044452748-6.00045-6; MINSTER JB, 1981, PHILOS T R SOC A, V299, P319, DOI 10.1098/rsta.1981.0025; Mizukami T, 2004, NATURE, V427, P432, DOI 10.1038/nature02179; PATERSON MS, 1982, B MINERAL, V105, P20; RAITT RW, 1969, J GEOPHYS RES, V74, P3095, DOI 10.1029/JB074i012p03095; Tan BH, 2001, PHYS CHEM MINER, V28, P641, DOI 10.1007/s002690100189; Tommasi A, 2000, J GEOPHYS RES-SOL EA, V105, P7893, DOI 10.1029/1999JB900411; TORIUMI M, 1979, CONTRIB MINERAL PETR, V68, P181, DOI 10.1007/BF00371899; ZHANG SQ, 1995, NATURE, V375, P774, DOI 10.1038/375774a0	28	34	34	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2012	336	6079					332	335		10.1126/science.1218318	http://dx.doi.org/10.1126/science.1218318			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22517856				2022-12-28	WOS:000302995400041
J	Henry, M; Beguin, M; Requier, F; Rollin, O; Odoux, JF; Aupinel, P; Aptel, J; Tchamitchian, S; Decourtye, A				Henry, Mickael; Beguin, Maxime; Requier, Fabrice; Rollin, Orianne; Odoux, Jean-Francois; Aupinel, Pierrick; Aptel, Jean; Tchamitchian, Sylvie; Decourtye, Axel			A Common Pesticide Decreases Foraging Success and Survival in Honey Bees	SCIENCE			English	Article							APIS-MELLIFERA; SYSTEMIC INSECTICIDES; RECEPTORS; BEHAVIOR; MEMORY; DANCE	Nonlethal exposure of honey bees to thiamethoxam (neonicotinoid systemic pesticide) causes high mortality due to homing failure at levels that could put a colony at risk of collapse. Simulated exposure events on free-ranging foragers labeled with a radio-frequency identification tag suggest that homing is impaired by thiamethoxam intoxication. These experiments offer new insights into the consequences of common neonicotinoid pesticides used worldwide.	[Henry, Mickael; Aptel, Jean; Tchamitchian, Sylvie] INRA, Abeilles & Environm UR406, F-84914 Avignon, France; [Henry, Mickael; Beguin, Maxime; Rollin, Orianne; Aptel, Jean; Tchamitchian, Sylvie; Decourtye, Axel] UMT Protect Abeilles Environm, F-84914 Avignon, France; [Beguin, Maxime] Assoc Dev Apiculture Provencale, F-13626 Aix En Provence, France; [Requier, Fabrice] CNRS, Ctr Etud Biol Chize, USC INRA 1339, UPR1934, F-79360 Beauvoir Sur Niort, France; [Requier, Fabrice; Odoux, Jean-Francois; Aupinel, Pierrick] INRA, UE Entomol, UE1255, F-17700 Surgeres, France; [Rollin, Orianne; Decourtye, Axel] Assoc Coordinat Tech Agr, F-84914 Avignon, France	INRAE; Centre National de la Recherche Scientifique (CNRS); INRAE; INRAE	Henry, M (corresponding author), INRA, Abeilles & Environm UR406, F-84914 Avignon, France.	mickael.henry@avignon.inra.fr	ODOUX, Jean-François/AAB-3596-2019; Aupinel, Pierrick/Y-5436-2019; Rollin, Orianne/R-9705-2019	ODOUX, Jean-François/0000-0002-6264-4376; Rollin, Orianne/0000-0002-1455-9302; Tchamitchian, Marc/0000-0002-9251-2403; Requier, Fabrice/0000-0003-1638-3141	European Community [797/2004]; French Ministry of Agriculture [11-45R]	European Community(European Commission); French Ministry of Agriculture	This study was funded by the European Community program (797/2004) for French beekeeping coordinated by the French Ministry of Agriculture (convention FranceAgriMer 11-45R). Special thanks go to L. Belzunces, J. L. Brunet, B. Vaissie re, A. Maisonnasse, D. Fortini, Y. Le Conte, C. McDonnell, P. Jourdan, J. P. Vermandere, and V. Bretagnolle for valuable help and corrections, as well as three anonymous reviewers for useful comments on the manuscript. We are grateful to M. Grijolot for allowing experiments to take place in his fields. RFID devices were designed by Tag Tracing Solutions, Valence, France, and adapted to honey bees with the help of J. Fourrier, F. Brun, J. Devillers, M. Gauthier, and the ECOBEE monitoring facility. Data are in the supporting online material.	Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Bortolotti Laura, 2003, Bulletin of Insectology, V56, P63; Colin ME, 2004, ARCH ENVIRON CON TOX, V47, P387, DOI 10.1007/s00244-004-3052-y; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Decourtye A, 2004, PESTIC BIOCHEM PHYS, V78, P83, DOI 10.1016/j.pestbp.2003.10.001; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; Decourtye A, 2011, ECOTOXICOLOGY, V20, P429, DOI 10.1007/s10646-011-0594-4; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Dukas R, 2008, INSECT SOC, V55, P252, DOI 10.1007/s00040-008-0995-4; Henry M, 2012, ECOL MODEL, V225, P103, DOI 10.1016/j.ecolmodel.2011.11.015; Khoury DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018491; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Maienfisch P, 2001, PEST MANAG SCI, V57, P165, DOI 10.1002/1526-4998(200102)57:2<165::AID-PS289>3.0.CO;2-G; Menzel R, 2006, J COMP PHYSIOL A, V192, P889, DOI 10.1007/s00359-006-0136-3; Millar Neil S., 2007, Invertebrate Neuroscience, V7, P53, DOI 10.1007/s10158-006-0040-0; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Riley JR, 2005, NATURE, V435, P205, DOI 10.1038/nature03526; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Schmickl T, 2007, ECOL MODEL, V204, P219, DOI 10.1016/j.ecolmodel.2007.01.001; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Steffan-Dewenter I, 2003, P ROY SOC B-BIOL SCI, V270, P569, DOI 10.1098/rspb.2002.2292; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743	27	892	954	39	1307	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2012	336	6079					348	350		10.1126/science.1215039	http://dx.doi.org/10.1126/science.1215039			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22461498	Green Submitted			2022-12-28	WOS:000302995400046
J	Zhou, YH; Fuentes-Hernandez, C; Shim, J; Meyer, J; Giordano, AJ; Li, H; Winget, P; Papadopoulos, T; Cheun, H; Kim, J; Fenoll, M; Dindar, A; Haske, W; Najafabadi, E; Khan, TM; Sojoudi, H; Barlow, S; Graham, S; Bredas, JL; Marder, SR; Kahn, A; Kippelen, B				Zhou, Yinhua; Fuentes-Hernandez, Canek; Shim, Jaewon; Meyer, Jens; Giordano, Anthony J.; Li, Hong; Winget, Paul; Papadopoulos, Theodoros; Cheun, Hyeunseok; Kim, Jungbae; Fenoll, Mathieu; Dindar, Amir; Haske, Wojciech; Najafabadi, Ehsan; Khan, Talha M.; Sojoudi, Hossein; Barlow, Stephen; Graham, Samuel; Bredas, Jean-Luc; Marder, Seth R.; Kahn, Antoine; Kippelen, Bernard			A Universal Method to Produce Low-Work Function Electrodes for Organic Electronics	SCIENCE			English	Article							POLYMER SOLAR-CELLS; LIGHT-EMITTING-DIODES; INDIUM TIN OXIDE; TRANSPARENT; PERFORMANCE; TRANSISTORS; EFFICIENCY; LAYER; ACCEPTOR	Organic and printed electronics technologies require conductors with a work function that is sufficiently low to facilitate the transport of electrons in and out of various optoelectronic devices. We show that surface modifiers based on polymers containing simple aliphatic amine groups substantially reduce the work function of conductors including metals, transparent conductive metal oxides, conducting polymers, and graphene. The reduction arises from physisorption of the neutral polymer, which turns the modified conductors into efficient electron-selective electrodes in organic optoelectronic devices. These polymer surface modifiers are processed in air from solution, providing an appealing alternative to chemically reactive low-work function metals. Their use can pave the way to simplified manufacturing of low-cost and large-area organic electronic technologies.	[Zhou, Yinhua; Fuentes-Hernandez, Canek; Shim, Jaewon; Cheun, Hyeunseok; Kim, Jungbae; Fenoll, Mathieu; Dindar, Amir; Haske, Wojciech; Najafabadi, Ehsan; Khan, Talha M.; Kippelen, Bernard] Georgia Inst Technol, Sch Elect & Comp Engn, Ctr Organ Photon & Elect COPE, Atlanta, GA 30332 USA; [Meyer, Jens; Kahn, Antoine] Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA; [Giordano, Anthony J.; Li, Hong; Winget, Paul; Papadopoulos, Theodoros; Barlow, Stephen; Bredas, Jean-Luc; Marder, Seth R.] Georgia Inst Technol, Sch Chem & Biochem, Ctr Organ Photon & Elect COPE, Atlanta, GA 30332 USA; [Fenoll, Mathieu] Solvay SA, B-1120 Brussels, Belgium; [Sojoudi, Hossein; Graham, Samuel] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Ctr Organ Photon & Elect COPE, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; Princeton University; University System of Georgia; Georgia Institute of Technology; Solvay SA; University System of Georgia; Georgia Institute of Technology	Kippelen, B (corresponding author), Georgia Inst Technol, Sch Elect & Comp Engn, Ctr Organ Photon & Elect COPE, Atlanta, GA 30332 USA.	kippelen@ece.gatech.edu	Barlow, Stephen/E-9754-2010; Zhou, Yinhua/G-5306-2010; Kippelen, Bernard/I-4058-2013; Giordano, Anthony/D-2641-2012; Marder, Seth/GRR-9990-2022; Meyer, Jens/B-7834-2013; Barlow, Stephen/ABE-6100-2021; Papadopoulos, Theodoros A/J-3471-2013; Fuentes-Hernandez, Canek/ABC-8912-2020; Bredas, Jean-Luc E/A-3431-2008; Fuentes Hernandez, Canek/G-3974-2011	Kippelen, Bernard/0000-0002-8417-7051; Barlow, Stephen/0000-0001-9059-9974; Papadopoulos, Theodoros A/0000-0003-0201-4900; Fuentes-Hernandez, Canek/0000-0001-7958-3699; Bredas, Jean-Luc E/0000-0001-7278-4471; Zhou, Yinhua/0000-0001-6424-9962	Center for Interface Science: Solar Electric Materials, an Energy Frontier Research Center; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0001084, DE-FG02-05ER46165]; NSF Science and Technology Centers [DMR-0120967]; Office of Naval Research [N0001404-1-0120]; NSF [DMR-1005892, CMMI-0927736, DGE-0644493]; Deutsche Forschungsgemeinschaft; National Defense Science and Engineering Graduate Fellowship program	Center for Interface Science: Solar Electric Materials, an Energy Frontier Research Center; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF Science and Technology Centers; Office of Naval Research(Office of Naval Research); NSF(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Defense Science and Engineering Graduate Fellowship program	Supported by the Center for Interface Science: Solar Electric Materials, an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under award DE-SC0001084 (Y.Z., J.S., J.M., H.C., H.L., P.W., S.B., J.-L.B., S.R.M., and S.G.), the NSF Science and Technology Centers program under agreement DMR-0120967 (C.F.-H., J.K., E.N., and A.D.), Office of Naval Research grant N0001404-1-0120) (T.M.K. and B.K.), NSF grants DMR-1005892 (A.K.) and CMMI-0927736 (H.S.), the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under award DE-FG02-05ER46165 (W.H. and T.P.), the Deutsche Forschungsgemeinschaft postdoctoral fellowship program (J.M.), and the National Defense Science and Engineering Graduate Fellowship program and NSF graduate research fellowship DGE-0644493 (A.J.G.).	Broker B, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3049616; Bulliard X, 2010, ADV FUNCT MATER, V20, P4381, DOI 10.1002/adfm.201000960; Chen HY, 2009, NAT PHOTONICS, V3, P649, DOI 10.1038/NPHOTON.2009.192; Cheng YJ, 2010, J AM CHEM SOC, V132, P17381, DOI 10.1021/ja108259n; Cheun H, 2010, J PHYS CHEM C, V114, P20713, DOI 10.1021/jp106641j; Cheun H, 2010, OPT EXPRESS, V18, pA506, DOI 10.1364/OE.18.00A506; Choi S, 2010, OPT EXPRESS, V18, pA458, DOI 10.1364/OE.18.00A458; Friend RH, 1999, NATURE, V397, P121, DOI 10.1038/16393; He YJ, 2010, J AM CHEM SOC, V132, P1377, DOI 10.1021/ja908602j; Heimel G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.196806; Heimel G, 2008, ACCOUNTS CHEM RES, V41, P721, DOI 10.1021/ar700284q; Hsieh SN, 2009, ORG ELECTRON, V10, P1626, DOI 10.1016/j.orgel.2009.08.017; Huang F, 2007, ADV MATER, V19, P2010, DOI 10.1002/adma.200602967; Huang F, 2010, CHEM SOC REV, V39, P2500, DOI 10.1039/b907991m; Huang JS, 2007, ADV FUNCT MATER, V17, P1966, DOI 10.1002/adfm.200700051; Hwang DK, 2011, ADV MATER, V23, P1293, DOI 10.1002/adma.201004278; Inganas O, 2011, NAT PHOTONICS, V5, P201, DOI 10.1038/nphoton.2011.46; Jakobsson FLE, 2006, CHEM PHYS LETT, V433, P110, DOI 10.1016/j.cplett.2006.11.007; Jo G, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3514551; Latini G, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2829387; Li H, 2010, J MATER CHEM, V20, P2630, DOI 10.1039/b921768a; Lindell L, 2006, CHEM MATER, V18, P4246, DOI 10.1021/cm061081m; Lindell L, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2912818; Ma WL, 2005, ADV MATER, V17, P274, DOI 10.1002/adma.200400963; Meyer J, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2975176; Na SI, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3522893; Nuesch F, 1999, APPL PHYS LETT, V74, P880, DOI 10.1063/1.123397; Oh SH, 2008, ADV MATER, V20, P1624, DOI 10.1002/adma.200702229; Osikowicz W, 2004, APPL PHYS LETT, V85, P1616, DOI 10.1063/1.1785873; Rolland A, 1996, JPN J APPL PHYS 1, V35, P4257, DOI 10.1143/JJAP.35.4257; Schlapak R, 2007, LANGMUIR, V23, P8916, DOI 10.1021/la700476w; Schmidt H, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3455108; Sharma A, 2009, J APPL PHYS, V105, DOI 10.1063/1.3095492; Wagenpfahl A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.115306; Wang L, 2006, NAT MATER, V5, P893, DOI 10.1038/nmat1755; Yan H, 2009, NATURE, V457, P679, DOI 10.1038/nature07727; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; Zhou YH, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3499299; Zhou YH, 2009, SOL ENERG MAT SOL C, V93, P497, DOI 10.1016/j.solmat.2008.11.002	39	1690	1713	55	1516	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2012	336	6079					327	332		10.1126/science.1218829	http://dx.doi.org/10.1126/science.1218829			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22517855				2022-12-28	WOS:000302995400040
J	Zhu, JY; Sharma, DB; Gray, SW; Chen, AB; Weeks, JC; Schrag, D				Zhu, Junya; Sharma, Dhruv B.; Gray, Stacy W.; Chen, Aileen B.; Weeks, Jane C.; Schrag, Deborah			Carboplatin and Paclitaxel With vs Without Bevacizumab in Older Patients With Advanced Non-Small Cell Lung Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEER-MEDICARE DATA; PROPENSITY SCORE; TARGETED THERAPIES; COMORBIDITY INDEX; SUPPORTIVE CARE; CHEMOTHERAPY; CLAIMS; BIAS; EPIDEMIOLOGY; METAANALYSIS	Context A previous randomized trial demonstrated that adding bevacizumab to carboplatin and paclitaxel improved survival in advanced non-small cell lung cancer (NSCLC). However, longer survival was not observed in the subgroup of patients aged 65 years or older. Objective To examine whether adding bevacizumab to carboplatin and paclitaxel chemotherapy is associated with improved survival in older patients with NSCLC. Design, Setting, and Participants Retrospective cohort study of 4168 Medicare beneficiaries aged 65 years or older with stage IIIB or stage IV non-squamous cell NSCLC diagnosed in 2002-2007 in a Surveillance, Epidemiology, and End Results (SEER) region. Patients were categorized into 3 cohorts based on diagnosis year and type of initial chemotherapy administered within 4 months of diagnosis: (1) diagnosis in 2006-2007 and bevacizumab-carboplatin-paclitaxel therapy; (2) diagnosis in 2006-2007 and carboplatin-paclitaxel therapy; or (3) diagnosis in 2002-2005 and carboplatin-paclitaxel therapy. The associations between carboplatin-paclitaxel with vs without bevacizumab and overall survival were compared using Cox proportional hazards models and propensity score analyses including information about patient characteristics recorded in SEER-Medicare. Main Outcome Measure Overall survival measured from the first date of chemotherapy treatment until death or the censoring date of December 31, 2009. Results The median survival estimates were 9.7 (interquartile range [IQR], 4.4-18.6) months for bevacizumab-carboplatin-paclitaxel, 8.9 (IQR, 3.5-19.3) months for carboplatin-paclitaxel in 2006-2007, and 8.0 (IQR, 3.7-17.2) months for carboplatin-paclitaxel in 2002-2005. One-year survival probabilities were 39.6% (95% CI, 34.6%-45.4%) for bevacizumab-carboplatin-paclitaxel vs 40.1% (95% CI, 37.4%-43.0%) for carboplatin-paclitaxel in 2006-2007 and 35.6% (95% CI, 33.8%-37.5%) for carboplatin-paclitaxel in 2002-2005. Neither multivariable nor propensity score-adjusted Cox models demonstrated a survival advantage for bevacizumab-carboplatin-paclitaxel compared with carboplatin-paclitaxel cohorts. In propensity score-stratified models, the hazard ratio for overall survival for bevacizumab-carboplatin-paclitaxel compared with carboplatin-paclitaxel in 2006-2007 was 1.01 (95% CI, 0.89-1.16; P=.85) and compared with carboplatin-paclitaxel in 2002-2005 was 0.93 (95% CI, 0.83-1.06; P=.28). The propensity score-weighted model and propensity score-matching model similarly failed to demonstrate a statistically significant superiority for bevacizumab-carboplatin-paclitaxel. Subgroup and sensitivity analyses for key variables did not change these findings. Conclusion Adding bevacizumab to carboplatin and paclitaxel chemotherapy was not associated with better survival among Medicare patients with advanced NSCLC. JAMA. 2012; 307(15):1593-1601	[Chen, Aileen B.; Weeks, Jane C.; Schrag, Deborah] Dana Farber Canc Inst, Ctr Outcomes & Policy Res, Boston, MA 02215 USA; [Zhu, Junya] Dana Farber Canc Inst, Ctr Patient Safety, Boston, MA 02215 USA; [Sharma, Dhruv B.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Gray, Stacy W.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Chen, Aileen B.] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Schrag, D (corresponding author), Dana Farber Canc Inst, Ctr Outcomes & Policy Res, 450 Brookline Ave, Boston, MA 02215 USA.	deb_schrag@dfci.harvard.edu	Gray, Stacy/AAJ-2956-2020; Gray, Stacy/GRF-6833-2022	Gray, Stacy/0000-0001-6948-0143; Chen, Aileen/0000-0002-5385-3360	National Cancer Institute (NCI) [RC2CA148185-01, PO1-CA134294]; Agency for Healthcare Research and Quality (AHRQ) [HHSA290201000006I]; NCI's SEER [N01-PC-35136, N01-PC-35139, N02-PC-15105]; Centers for Disease Control and Prevention [U55/CCR921930-02]; Center for Patient Safety, Dana-Farber Cancer Institute; Division of Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; Center for Outcomes and Evidence, AHRQ; NATIONAL CANCER INSTITUTE [K05CA166208, P01CA134294, RC2CA148185] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCI's SEER; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Center for Patient Safety, Dana-Farber Cancer Institute; Division of Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; Center for Outcomes and Evidence, AHRQ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Project support was obtained from the National Cancer Institute (NCI) RC2CA148185-01 (to Dr Weeks). This project was also funded under contract HHSA290201000006I (to Dr Schrag) from the Agency for Healthcare Research and Quality (AHRQ) as part of the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) program. Dr Sharma was supported by NCI grant PO1-CA134294. The collection of the California cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; the NCI's SEER program under contract N01-PC-35136 awarded to the Northern California Cancer Center, contract N01-PC-35139 awarded to the University of Southern California, and contract N02-PC-15105 awarded to the Public Health Institute; and the Centers for Disease Control and Prevention's National Program of Cancer Registries under agreement U55/CCR921930-02 awarded to the Public Health Institute.; We acknowledge support from Saul Weingart, MD, PhD, Center for Patient Safety, Dana-Farber Cancer Institute; Sebastian Schneeweiss, MD, ScD, Division of Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; and William Lawrence, MD, MS, Center for Outcomes and Evidence, AHRQ. No financial compensation was received. This study used the linked SEER-Medicare database. This resource has been made available to the research community through collaborative efforts of the NCI and CMS. We acknowledge the efforts of the Applied Research Program, NCI; the Office of Research, Development and Information, CMS; Information Management Services (IMS) Inc; and the SEER program tumor registries in the creation and ongoing maintenance of the SEER-Medicare database.	Altekruse S. F., 1975, SEER CANC STAT REV 1; Bach PB, 2002, MED CARE, V40, P19; Burdett S, 2008, J CLIN ONCOL, V26, P4617, DOI 10.1200/JCO.2008.17.7162; Centers for Medicaid and Medicare Services, MED NAT COV DET MA 2; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohen MH, 2007, ONCOLOGIST, V12, P713, DOI 10.1634/theoncologist.12-6-713; D'Agostino RB, 2007, JAMA-J AM MED ASSOC, V297, P314, DOI 10.1001/jama.297.3.314; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Davidoff AJ, 2010, J CLIN ONCOL, V28, P2191, DOI 10.1200/JCO.2009.25.4052; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Engels EA, 2011, AM J EPIDEMIOL, V174, P860, DOI 10.1093/aje/kwr146; Goulart B, 2011, VALUE HEALTH, V14, P836, DOI 10.1016/j.jval.2011.04.004; Greene FL, 2002, AJCC CANC STAGING HD; Gridelli C, 2008, J CLIN ONCOL, V26, P13, DOI 10.1200/JCO.2007.14.1820; Gridelli C, 2007, ONCOLOGIST, V12, P1183, DOI 10.1634/theoncologist.12-10-1183; Gridelli C, 2009, LUNG CANCER, V66, P282, DOI 10.1016/j.lungcan.2009.08.006; Grusenmeyer PA, 2006, J CLIN ONCOL S, V24, p18S; Iannettoni MD, 2010, JAMA-J AM MED ASSOC, V304, P2296, DOI 10.1001/jama.2010.1723; Jacobson M, 2006, HEALTH AFFAIR, V25, P437, DOI 10.1377/hlthaff.25.2.437; Jatoi A, 2005, J CLIN ONCOL, V23, P9113, DOI 10.1200/JCO.2005.03.7465; Klabunde CN, 2007, ANN EPIDEMIOL, V17, P584, DOI 10.1016/j.annepidem.2007.03.011; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Lamont EB, 2005, J NATL CANCER I, V97, P1080, DOI 10.1093/jnci/dji189; Levesque LE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5087; Lunceford JK, 2004, STAT MED, V23, P2937, DOI 10.1002/SIM.1903; MERZA T, 2007, J CLIN ONCOL S, V25, pS687; Mitka M, 2010, JAMA-J AM MED ASSOC, V304, P624, DOI 10.1001/jama.2010.1055; National Cancer Institute, SURV EP END RES; Ramalingam SS, 2008, J CLIN ONCOL, V26, P60, DOI 10.1200/JCO.2007.13.1144; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Warren JL, 2002, MED CARE, V40, P3; Warren JL, 2002, MED CARE, V40, P55; Yang K, 2010, CLIN DRUG INVEST, V30, P229, DOI 10.2165/11532260-000000000-00000	37	95	97	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2012	307	15					1593	1601		10.1001/jama.2012.454	http://dx.doi.org/10.1001/jama.2012.454			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927GU	22511687	Green Accepted, Bronze			2022-12-28	WOS:000302896100021
J	Dhonukshe, P; Weits, DA; Cruz-Ramirez, A; Deinum, EE; Tindemans, SH; Kakar, K; Prasad, K; Mahonen, AP; Ambrose, C; Sasabe, M; Wachsmann, G; Luijten, M; Bennett, T; Machida, Y; Heidstra, R; Wasteneys, G; Mulder, BM; Scheres, S				Dhonukshe, Pankaj; Weits, Daan A.; Cruz-Ramirez, Alfredo; Deinum, Eva E.; Tindemans, Simon H.; Kakar, Klementina; Prasad, Kalika; Mahonen, Ari Pekka; Ambrose, Chris; Sasabe, Michiko; Wachsmann, Guy; Luijten, Marijn; Bennett, Tom; Machida, Yasunori; Heidstra, Renze; Wasteneys, Geoffrey; Mulder, Bela M.; Scheres, Ben			RETRACTED: A PLETHORA-Auxin Transcription Module Controls Cell Division Plane Rotation through MAP65 and CLASP(Retracted article. See vol. 155, pg. 1189, 2013)	CELL			English	Article; Retracted Publication							MICROTUBULE-ASSOCIATED PROTEINS; ARABIDOPSIS-THALIANA ROOT; CORTICAL MICROTUBULES; SELF-ORGANIZATION; AXIS FORMATION; GENE ENCODES; PATTERNS; GROWTH; RECEPTOR; DIFFERENTIATION	Despite their pivotal role in plant development, control mechanisms for oriented cell divisions have remained elusive. Here, we describe how a precisely regulated cell division orientation switch in an Arabidopsis stem cell is controlled by upstream patterning factors. We show that the stem cell regulatory PLETHORA transcription factors induce division plane reorientation by local activation of auxin signaling, culminating in enhanced expression of the microtubule-associated MAP65 proteins. MAP65 upregulation is sufficient to reorient the cortical microtubular array through a CLASP microtubule-cell cortex interaction mediator-dependent mechanism. CLASP differentially localizes to cell faces in a microtubule- and MAP65-dependent manner. Computational simulations clarify how precise 90 degrees switches in cell division planes can follow self-organizing properties of the microtubule array in combination with biases in CLASP localization. Our work demonstrates how transcription factor-mediated processes regulate the cellular machinery to control orientation of formative cell divisions in plants.	[Dhonukshe, Pankaj; Weits, Daan A.; Cruz-Ramirez, Alfredo; Kakar, Klementina; Prasad, Kalika; Mahonen, Ari Pekka; Wachsmann, Guy; Luijten, Marijn; Bennett, Tom; Heidstra, Renze; Scheres, Ben] Univ Utrecht, Dept Biol, NL-3584 CH Utrecht, Netherlands; [Deinum, Eva E.; Tindemans, Simon H.; Mulder, Bela M.] FOM Inst AMOLF, NL-1098 XG Amsterdam, Netherlands; [Ambrose, Chris; Wasteneys, Geoffrey] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; [Sasabe, Michiko; Machida, Yasunori] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan; [Mulder, Bela M.] Wageningen Univ, Lab Plant Cell Biol, NL-6708 PB Wageningen, Netherlands	Utrecht University; AMOLF; University of British Columbia; Nagoya University; Wageningen University & Research	Dhonukshe, P (corresponding author), Univ Utrecht, Dept Biol, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	p.b.dhonukshe@uu.nl; b.scheres@uu.nl	Cruz-Ramirez, Luis Alfredo/B-7588-2009; Ramírez, Luis Alfredo Cruz/K-2548-2019; Mähönen, Ari Pekka/B-9764-2015; Wasteneys, Geoffrey/AGQ-5388-2022; Mulder, Bela/C-1070-2012	Cruz-Ramirez, Luis Alfredo/0000-0001-9973-5784; Ramírez, Luis Alfredo Cruz/0000-0001-9973-5784; Mähönen, Ari Pekka/0000-0001-6051-866X; Wasteneys, Geoffrey/0000-0002-8746-7994; Mulder, Bela/0000-0002-8620-5749; Scheres, Ben/0000-0001-5400-9578; Weits, Daniel/0000-0003-4423-5568; Bennett, Tom/0000-0003-1612-4019; Chris, Ambrose/0000-0003-2234-7075	Netherlands Scientific Organization's (NWO's)-VENI; Utrecht University; European Research Council; HFSP; EMBO; Netherlands Genomics Initiative (NGI); NWO-Horizon; Natural Sciences and Engineering Research Council of Canada; Netherlands Consortium for System Biology; Foundation for Fundamental Research on Matter (FOM)-NWO	Netherlands Scientific Organization's (NWO's)-VENI; Utrecht University; European Research Council(European Research Council (ERC)European Commission); HFSP(Human Frontier Science Program); EMBO(European Molecular Biology Organization (EMBO)); Netherlands Genomics Initiative (NGI); NWO-Horizon(Netherlands Organization for Scientific Research (NWO)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Netherlands Consortium for System Biology; Foundation for Fundamental Research on Matter (FOM)-NWO	We thank Mark Estelle, Kenichiro Hayashi, Martine Pastuglia, Marcus Heisler, and Takashi Hashimoto for sharing published materials; Anirban Baral for help with experiments; and Frits Kindt and Ronald Leito for photography and image processing. This work was supported by: Netherlands Scientific Organization's (NWO's)-VENI Grant (P. D.), Utrecht University Independent Investigator Grant (P. D.), European Research Council Advanced Investigator Grant (B. S.), HFSP fellowship (A. P. M.), EMBO fellowship (K. P.), Netherlands Genomics Initiative (NGI) and NWO-Horizon grants (M. L. and R. H.), Natural Sciences and Engineering Research Council of Canada Grant (G. W. and C. A.), Netherlands Consortium for System Biology's grant (B. S. and E. E. D.), and Foundation for Fundamental Research on Matter (FOM)-NWO (B.M.M.).	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Allard JF, 2010, MOL BIOL CELL, V21, P278, DOI 10.1091/mbc.E09-07-0579; Ambrose C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1444; Ambrose JC, 2008, MOL BIOL CELL, V19, P4730, DOI 10.1091/mbc.E08-06-0665; Ambrose JC, 2007, PLANT CELL, V19, P2763, DOI 10.1105/tpc.107.053777; Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; Bennett T, 2010, PLANT CELL, V22, P640, DOI 10.1105/tpc.109.072272; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Camilleri C, 2002, PLANT CELL, V14, P833, DOI 10.1105/tpc.010402; Campilho A, 2006, PLANT J, V48, P619, DOI 10.1111/j.1365-313X.2006.02892.x; Chan J, 1999, P NATL ACAD SCI USA, V96, P14931, DOI 10.1073/pnas.96.26.14931; De Smet I, 2008, SCIENCE, V322, P594, DOI 10.1126/science.1160158; De Smet I, 2011, NAT REV MOL CELL BIO, V12, P177, DOI 10.1038/nrm3064; De Smet I, 2010, P NATL ACAD SCI USA, V107, P2705, DOI 10.1073/pnas.0915001107; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dhonukshe P, 2006, DEV CELL, V10, P137, DOI 10.1016/j.devcel.2005.11.015; Dhonukshe P, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-11; Dhonukshe P, 2008, NATURE, V456, P962, DOI 10.1038/nature07409; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; DOLAN L, 1993, DEVELOPMENT, V119, P71; Eren EC, 2010, MOL BIOL CELL, V21, P2674, DOI 10.1091/mbc.E10-02-0136; Fache V, 2010, PLANT CELL, V22, P3804, DOI 10.1105/tpc.110.080606; Gaillard J, 2008, MOL BIOL CELL, V19, P4534, DOI 10.1091/mbc.E08-04-0341; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Granger CL, 2001, PROTOPLASMA, V216, P201, DOI 10.1007/BF02673872; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; GUNNING BES, 1978, PLANTA, V143, P121, DOI 10.1007/BF00387786; Hamann T, 1999, DEVELOPMENT, V126, P1387; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Hayashi K, 2008, P NATL ACAD SCI USA, V105, P5632, DOI 10.1073/pnas.0711146105; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; JURGENS G, 1995, CELL, V81, P467, DOI 10.1016/0092-8674(95)90065-9; KARES C, 1990, PLANT MOL BIOL, V15, P225, DOI 10.1007/BF00036909; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kirik V, 2007, J CELL SCI, V120, P4416, DOI 10.1242/jcs.024950; Lau S, 2011, NAT CELL BIOL, V13, P611, DOI 10.1038/ncb2212; Li H, 2009, PLANT MOL BIOL, V69, P313, DOI 10.1007/s11103-008-9426-1; Lucas JR, 2011, PLANT CELL, V23, P1889, DOI 10.1105/tpc.111.084970; MANDERS EMM, 1992, J CELL SCI, V103, P857; Muller S, 2009, TRENDS CELL BIOL, V19, P180, DOI 10.1016/j.tcb.2009.02.002; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; Petersson SV, 2009, PLANT CELL, V21, P1659, DOI 10.1105/tpc.109.066480; Petricka JJ, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000497; PICKETTHEAPS JD, 1966, J CELL SCI, V1, P109; Rasmussen CG, 2011, ANNU REV PLANT BIOL, V62, P387, DOI 10.1146/annurev-arplant-042110-103802; Rasmussen CG, 2011, J CELL SCI, V124, P270, DOI 10.1242/jcs.073676; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Smertenko A, 2000, NAT CELL BIOL, V2, P750, DOI 10.1038/35036390; Smertenko AP, 2008, PLANT CELL, V20, P3346, DOI 10.1105/tpc.108.063362; Smith LG, 2001, NAT REV MOL CELL BIO, V2, P33, DOI 10.1038/35048050; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Ten Hove CA, 2010, CURR BIOL, V20, P452, DOI 10.1016/j.cub.2010.01.018; TORRESRUIZ RA, 1994, DEVELOPMENT, V120, P2967; TRAAS J, 1995, NATURE, V375, P676, DOI 10.1038/375676a0; Tromas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006648; Ueda K, 1999, PROTOPLASMA, V206, P201, DOI 10.1007/BF01279267; Van Damme D, 2004, PLANT PHYSIOL, V136, P3956, DOI 10.1104/pp.104.051623; Wasteneys GO, 2009, TRENDS CELL BIOL, V19, P62, DOI 10.1016/j.tcb.2008.11.004; Willemsen V, 2008, DEV CELL, V15, P913, DOI 10.1016/j.devcel.2008.09.019; Xu J, 2006, SCIENCE, V311, P385, DOI 10.1126/science.1121790	66	38	41	0	75	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 13	2012	149	2					383	396		10.1016/j.cell.2012.02.051	http://dx.doi.org/10.1016/j.cell.2012.02.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500804	Bronze			2022-12-28	WOS:000302805600017
J	Djuranovic, S; Nahvi, A; Green, R				Djuranovic, Sergej; Nahvi, Ali; Green, Rachel			miRNA-Mediated Gene Silencing by Translational Repression Followed by mRNA Deadenylation and Decay	SCIENCE			English	Article							POLY(A) TAIL; MAMMALIAN-CELLS; GW182 PROTEINS; LET-7 MICRORNA; INITIATION; CAP; CCR4-NOT; TARGETS; DEGRADATION; INHIBITION	microRNAs (miRNAs) regulate gene expression through translational repression and/or messenger RNA (mRNA) deadenylation and decay. Because translation, deadenylation, and decay are closely linked processes, it is important to establish their ordering and thus to define the molecular mechanism of silencing. We have investigated the kinetics of these events in miRNA-mediated gene silencing by using a Drosophila S2 cell-based controllable expression system and show that mRNAs with both natural and engineered 3' untranslated regions with miRNA target sites are first subject to translational inhibition, followed by effects on deadenylation and decay. We next used a natural translational elongation stall to show that miRNA-mediated silencing inhibits translation at an early step, potentially translation initiation.	[Green, Rachel] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst HHMI, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Green, R (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst HHMI, Baltimore, MD 21205 USA.	ragreen@jhmi.edu		Djuranovic, Sergej/0000-0002-9417-0822	HHMI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059425] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Wehner, J. Doudna, M. Jinek, N. Guydosh, and J. Coller for helpful comments. Funding is from HHMI.	Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Beilharz TH, 2007, RNA, V13, P982, DOI 10.1261/rna.569407; Beilharz TH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006783; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Chekulaeva M, 2011, NAT STRUCT MOL BIOL, V18, P1218, DOI 10.1038/nsmb.2166; Ding XC, 2009, EMBO J, V28, P213, DOI 10.1038/emboj.2008.275; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Fabian MR, 2011, NAT STRUCT MOL BIOL, V18, P1211, DOI 10.1038/nsmb.2149; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Iwasaki S, 2009, MOL CELL, V34, P58, DOI 10.1016/j.molcel.2009.02.010; JOHANSEN H, 1989, GENE DEV, V3, P882, DOI 10.1101/gad.3.6.882; Kuroha K, 2010, EMBO REP, V11, P956, DOI 10.1038/embor.2010.169; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Muckenthaler M, 1997, RNA, V3, P983; Nahvi A, 2009, RNA, V15, P814, DOI 10.1261/rna.1565109; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Selvaraj A, 2005, GENE DEV, V19, P891, DOI 10.1101/gad.1301805; Wakiyama M, 2007, GENE DEV, V21, P1857, DOI 10.1101/gad.1566707; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Zdanowicz A, 2009, MOL CELL, V35, P881, DOI 10.1016/j.molcel.2009.09.009	30	608	640	8	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2012	336	6078					237	240		10.1126/science.1215691	http://dx.doi.org/10.1126/science.1215691			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924PN	22499947	Green Accepted			2022-12-28	WOS:000302703900052
J	Elmunzer, BJ; Scheiman, JM; Lehman, GA; Chak, A; Mosler, P; Higgins, PDR; Hayward, RA; Romagnuolo, J; Elta, GH; Sherman, S; Waljee, AK; Repaka, A; Atkinson, MR; Cote, GA; Kwon, RS; McHenry, L; Piraka, CR; Wamsteker, EJ; Watkins, JL; Korsnes, SJ; Schmidt, SE; Turner, SM; Nicholson, S; Fogel, EL				Elmunzer, B. Joseph; Scheiman, James M.; Lehman, Glen A.; Chak, Amitabh; Mosler, Patrick; Higgins, Peter D. R.; Hayward, Rodney A.; Romagnuolo, Joseph; Elta, Grace H.; Sherman, Stuart; Waljee, Akbar K.; Repaka, Aparna; Atkinson, Matthew R.; Cote, Gregory A.; Kwon, Richard S.; McHenry, Lee; Piraka, Cyrus R.; Wamsteker, Erik J.; Watkins, James L.; Korsnes, Sheryl J.; Schmidt, Suzette E.; Turner, Sarah M.; Nicholson, Sylvia; Fogel, Evan L.		USCORE	A Randomized Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; BILIARY SPHINCTEROTOMY; METAANALYSIS; COMPLICATIONS; DICLOFENAC; SEVERITY; REDUCE; RISK	BACKGROUND Preliminary research suggests that rectally administered nonsteroidal antiinflammatory drugs may reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP). METHODS In this multicenter, randomized, placebo-controlled, double-blind clinical trial, we assigned patients at elevated risk for post-ERCP pancreatitis to receive a single dose of rectal indomethacin or placebo immediately after ERCP. Patients were determined to be at high risk on the basis of validated patient-and procedure-related risk factors. The primary outcome was post-ERCP pancreatitis, which was defined as new upper abdominal pain, an elevation in pancreatic enzymes to at least three times the upper limit of the normal range 24 hours after the procedure, and hospitalization for at least 2 nights. RESULTS A total of 602 patients were enrolled and completed follow-up. The majority of patients (82%) had a clinical suspicion of sphincter of Oddi dysfunction. Post-ERCP pancreatitis developed in 27 of 295 patients (9.2%) in the indomethacin group and in 52 of 307 patients (16.9%) in the placebo group (P=0.005). Moderate-to-severe pancreatitis developed in 13 patients (4.4%) in the indomethacin group and in 27 patients (8.8%) in the placebo group (P=0.03). CONCLUSIONS Among patients at high risk for post-ERCP pancreatitis, rectal indomethacin significantly reduced the incidence of the condition. (Funded by the National Institutes of Health; ClinicalTrials.gov number, NCT00820612.)	[Elmunzer, B. Joseph] Univ Michigan, Med Ctr, Taubman Ctr 3912, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Hayward, Rodney A.] Univ Michigan, Med Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA; [Hayward, Rodney A.; Waljee, Akbar K.] VA Ann Arbor Healthcare Syst, Ann Arbor, MI USA; [Lehman, Glen A.; Sherman, Stuart; Cote, Gregory A.; McHenry, Lee; Watkins, James L.; Schmidt, Suzette E.; Fogel, Evan L.] Indiana Univ, Med Ctr, Div Gastroenterol, Indianapolis, IN USA; [Chak, Amitabh; Repaka, Aparna; Atkinson, Matthew R.] Univ Hosp, Case Med Ctr, Div Gastroenterol, Cleveland, OH USA; [Mosler, Patrick; Turner, Sarah M.; Nicholson, Sylvia] Univ Kentucky, Med Ctr, Div Digest Dis & Nutr, Lexington, KY 40506 USA; [Romagnuolo, Joseph] Med Univ S Carolina, Div Gastroenterol, Charleston, SC USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Indiana University System; Indiana University-Purdue University Indianapolis; Case Western Reserve University; University Hospitals of Cleveland; University of Kentucky; Medical University of South Carolina	Elmunzer, BJ (corresponding author), Univ Michigan, Med Ctr, Taubman Ctr 3912, Div Gastroenterol, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	badihe@umich.edu	Higgins, Peter D.R./A-3511-2009; Waljee, Akbar K/G-2067-2010; Piraka, Cyrus/AGM-9815-2022	Higgins, Peter D.R./0000-0003-1602-4341; Waljee, Akbar K/0000-0003-1964-8790; Romagnuolo, Joseph/0000-0002-5630-3022; Korsnes, Sheryl/0000-0003-0953-0035	NIH [1R21DK090343-01, UL1RR024986]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK090343] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants (1R21DK090343-01 and UL1RR024986) from the NIH, which also funded the analysis by the Methods Core of the Michigan Center for Diabetes Translational Research.	Andriulli A, 2000, GASTROINTEST ENDOSC, V51, P1, DOI 10.1016/S0016-5107(00)70377-4; Andriulli A, 2007, GASTROINTEST ENDOSC, V65, P624, DOI 10.1016/j.gie.2006.10.030; [Anonymous], NAT INP SAMPL; COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; Dumonceau JM, 2010, GASTROINTEST ENDOSC, V71, P934, DOI 10.1016/j.gie.2009.10.055; Elmunzer BJ, 2008, GUT, V57, P1262, DOI 10.1136/gut.2007.140756; Fazel A, 2003, GASTROINTEST ENDOSC, V57, P291, DOI 10.1067/mge.2003.124; Freeman ML, 2007, CLIN GASTROENTEROL H, V5, P1354, DOI 10.1016/j.cgh.2007.09.007; Freeman ML, 1996, NEW ENGL J MED, V335, P909, DOI 10.1056/NEJM199609263351301; Freeman ML, 2004, GASTROINTEST ENDOSC, V59, P845, DOI 10.1016/S0016-5107(04)00353-0; GROSS V, 1993, HEPATO-GASTROENTEROL, V40, P522; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Khoshbaten M, 2008, J GASTROEN HEPATOL, V23, pE11, DOI 10.1111/j.1440-1746.2007.05096.x; Loza AM, 2007, REV ESP ENFERM DIG, V99, P330; Makela A, 1997, SCAND J CLIN LAB INV, V57, P401, DOI 10.3109/00365519709084587; Mallery JS, 2003, GASTROINTEST ENDOSC, V57, P633, DOI 10.1053/ge.2003.v57.amge030576633; Murray B, 2003, GASTROENTEROLOGY, V124, P1786, DOI 10.1016/S0016-5085(03)00384-6; NELSON DB, 1994, J CLIN GASTROENTEROL, V19, P283, DOI 10.1097/00004836-199412000-00004; Singh P, 2004, GASTROINTEST ENDOSC, V60, P544, DOI 10.1016/S0016-5107(04)02013-9; Sotoudehmanesh R, 2007, AM J GASTROENTEROL, V102, P978, DOI 10.1111/j.1572-0241.2007.01165.x; Tarnasky PR, 1998, GASTROENTEROLOGY, V115, P1518, DOI 10.1016/S0016-5085(98)70031-9; Van der Marel CD, 2004, PEDIATR ANESTH, V14, P443	22	437	463	2	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 12	2012	366	15					1414	1422		10.1056/NEJMoa1111103	http://dx.doi.org/10.1056/NEJMoa1111103			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923GV	22494121	Green Accepted			2022-12-28	WOS:000302608600005
J	Cheeseman, IH; Miller, BA; Nair, S; Nkhoma, S; Tan, A; Tan, JC; Al Saai, S; Phyo, AP; Moo, CL; Lwin, KM; McGready, R; Ashley, E; Imwong, M; Stepniewska, K; Yi, P; Dondorp, AM; Mayxay, M; Newton, PN; White, NJ; Nosten, F; Ferdig, MT; Anderson, TJC				Cheeseman, Ian H.; Miller, Becky A.; Nair, Shalini; Nkhoma, Standwell; Tan, Asako; Tan, John C.; Al Saai, Salma; Phyo, Aung Pyae; Moo, Carit Ler; Lwin, Khin Maung; McGready, Rose; Ashley, Elizabeth; Imwong, Mallika; Stepniewska, Kasia; Yi, Poravuth; Dondorp, Arjen M.; Mayxay, Mayfong; Newton, Paul N.; White, Nicholas J.; Nosten, Francois; Ferdig, Michael T.; Anderson, Timothy J. C.			A Major Genome Region Underlying Artemisinin Resistance in Malaria	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; POSITIVE SELECTION; HIGH-ALTITUDE; PARASITES; POPULATIONS; ADAPTATION; EVOLUTION; SPREAD	Evolving resistance to artemisinin-based compounds threatens to derail attempts to control malaria. Resistance has been confirmed in western Cambodia and has recently emerged in western Thailand, but is absent from neighboring Laos. Artemisinin resistance results in reduced parasite clearance rates (CRs) after treatment. We used a two-phase strategy to identify genome region(s) underlying this ongoing selective event. Geographical differentiation and haplotype structure at 6969 polymorphic single-nucleotide polymorphisms (SNPs) in 91 parasites from Cambodia, Thailand, and Laos identified 33 genome regions under strong selection. We screened SNPs and microsatellites within these regions in 715 parasites from Thailand, identifying a selective sweep on chromosome 13 that shows strong association (P = 10(-6) to 10(-12)) with slow CRs, illustrating the efficacy of targeted association for identifying the genetic basis of adaptive traits.	[Cheeseman, Ian H.; Nair, Shalini; Nkhoma, Standwell; Al Saai, Salma; Anderson, Timothy J. C.] Texas Biomed Res Inst, San Antonio, TX 78245 USA; [Miller, Becky A.; Tan, Asako; Tan, John C.; Ferdig, Michael T.] Univ Notre Dame, Eck Inst Global Hlth, Dept Biol Sci, Notre Dame, IN 46556 USA; [Phyo, Aung Pyae; Moo, Carit Ler; Lwin, Khin Maung; McGready, Rose; Ashley, Elizabeth; Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot, Tak, Thailand; [McGready, Rose; Ashley, Elizabeth; Imwong, Mallika; Stepniewska, Kasia; Dondorp, Arjen M.; White, Nicholas J.; Nosten, Francois] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [McGready, Rose; Ashley, Elizabeth; Stepniewska, Kasia; Dondorp, Arjen M.; Newton, Paul N.; White, Nicholas J.; Nosten, Francois] Churchill Hosp, Ctr Trop Med, Oxford OX3 7LJ, England; [Mayxay, Mayfong; Newton, Paul N.] Mahosot Hosp, Trust Mahosot Hosp, Oxford Trop Med Res Collaborat, Viangchan, Laos; [Stepniewska, Kasia] Worldwide Antimalarial Resistance Network, Oxford, England; [Yi, Poravuth] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia	Texas Biomedical Research Institute; University of Notre Dame; Mahidol University; Mahidol University; University of Oxford; Worldwide Antimalarial Resistance Network (WWARN); National Center Parasitology, Entomology & Malaria Control	Anderson, TJC (corresponding author), Texas Biomed Res Inst, San Antonio, TX 78245 USA.	tanderso@txbiomedgenetics.org	Imwong, Mallika/ABE-6493-2020; Phyo, Aung Pyae/K-2413-2019; Phyo, Aung Pyae/GYU-6181-2022; White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019; Nosten, Francois/AAC-5509-2019; McGready, Rose/A-3290-2014; Ferdig, Michael/C-6627-2016	Phyo, Aung Pyae/0000-0002-0383-9624; Phyo, Aung Pyae/0000-0002-0383-9624; White, Nick/0000-0002-1897-1978; Nosten, Francois/0000-0002-7951-0745; McGready, Rose/0000-0003-1621-3257; Newton, Paul/0000-0002-4608-6431; Ashley, Elizabeth/0000-0002-7620-4822; cheeseman, ian/0000-0003-4426-4027; Stepniewska, Kasia/0000-0002-1713-6209	Wellcome Trust; National Institutes of Health [R01 AI048071/AI075145]; National Center for Research Resources [C06 RR013556]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR013556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI048071, R01AI048071, R01AI075145] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Clinical work was funded by the Wellcome Trust. Molecular work was funded by the National Institutes of Health (grant R01 AI048071/AI075145) in facilities constructed with support from Research Facilities Improvement Program grant no. C06 RR013556 from the National Center for Research Resources. We thank patients and staff who contributed to data collection in Thailand, Cambodia (C. Nguon, C. Meng Chuor, and D. Socheat), and Laos (M. Khanthavong, O. Chanthongthip, B. Soonthornsata, T. Pongvongsa, S. Phompida, and B. Hongvanthong); K. Burgoine, P. Singhasivanon, P. Ringwald, M. Zlojutro Kos, and J. Currans' lab. Microarray data have been submitted to the National Center for Biotechnology Information's Gene Expression Omnibus under accession nos. GSM818073 to GSM818239. The authors declare no competing financial interests.	Anderson T, 2011, PHARMACOGENOMICS, V12, P59, DOI [10.2217/pgs.10.165, 10.2217/PGS.10.165]; Anderson TJC, 2010, J INFECT DIS, V201, P1326, DOI 10.1086/651562; Anderson TJC, 2005, MOL BIOL EVOL, V22, P2362, DOI 10.1093/molbev/msi235; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Deplaine G, 2011, ANTIMICROB AGENTS CH, V55, P2576, DOI 10.1128/AAC.01409-10; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Eastman RT, 2009, NAT REV MICROBIOL, V7, P864, DOI 10.1038/nrmicro2239; Hunt P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-499; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; Kidgell C, 2006, PLOS PATHOG, V2, P562, DOI 10.1371/journal.ppat.0020057; LEWONTIN RC, 1973, GENETICS, V74, P175; Mayxay M, 2012, AM J TROP MED HYG, V86, P403, DOI 10.4269/ajtmh.2012.11-0497; Mok S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-391; Nair S, 2007, MOL BIOL EVOL, V24, P562, DOI 10.1093/molbev/msl185; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Przeworski M, 2005, EVOLUTION, V59, P2312, DOI 10.1554/05-273.1; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Saralamba S, 2011, P NATL ACAD SCI USA, V108, P397, DOI 10.1073/pnas.1006113108; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Tan JC, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r35; Tucker MS, 2012, ANTIMICROB AGENTS CH, V56, P302, DOI 10.1128/AAC.05540-11; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	24	289	301	0	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2012	336	6077					79	82		10.1126/science.1215966	http://dx.doi.org/10.1126/science.1215966			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920LG	22491853	Green Accepted			2022-12-28	WOS:000302405400055
J	Hollenberg, AN				Hollenberg, Anthony N.			Metabolic Health and Nuclear-Receptor Sensitivity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INSULIN SENSITIVITY; IN-VIVO; NCOR		[Hollenberg, Anthony N.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Hollenberg, Anthony N.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Hollenberg, AN (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.							Astapovaa I, 2008, P NATL ACAD SCI USA, V105, P19544, DOI 10.1073/pnas.0804604105; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Nofsinger RR, 2008, P NATL ACAD SCI USA, V105, P20021, DOI 10.1073/pnas.0811012105; Sutanto MM, 2010, J BIOL CHEM, V285, P18485, DOI 10.1074/jbc.M110.107680; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017	5	9	9	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 5	2012	366	14					1345	1347		10.1056/NEJMcibr1114529	http://dx.doi.org/10.1056/NEJMcibr1114529			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	919QJ	22475600				2022-12-28	WOS:000302343000015
J	Rehman, HU				Rehman, H. U.			CASE REPORT A 90 year old man with difficulty swallowing and proximal muscle weakness	BRITISH MEDICAL JOURNAL			English	Editorial Material							EATON-MYASTHENIC-SYNDROME; GRAVIS		Regina QuAppelle Hlth Reg, Dept Internal Med, Regina, SK S4P 3X1, Canada		Rehman, HU (corresponding author), Regina QuAppelle Hlth Reg, Dept Internal Med, Regina, SK S4P 3X1, Canada.	habib31@sasktel.net						KEESEY JC, 1989, MUSCLE NERVE, V12, P613, DOI 10.1002/mus.880120802; Mareska M, 2004, SEMIN NEUROL, V24, P149, DOI 10.1055/s-2004-830900; ONEILL JH, 1988, BRAIN, V111, P577, DOI 10.1093/brain/111.3.577; Pascuzzi RM, 2002, THER APHER, V6, P57, DOI 10.1046/j.1526-0968.2002.00403.x; Wirtz PW, 2002, J NEUROL NEUROSUR PS, V73, P766, DOI 10.1136/jnnp.73.6.766	5	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 4	2012	344								e461	10.1136/bmj.e461	http://dx.doi.org/10.1136/bmj.e461			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923HC	22491704				2022-12-28	WOS:000302609300011
J	Smith, AJ; Dieppe, P; Porter, M; Blom, AW				Smith, Alison J.; Dieppe, Paul; Porter, Martyn; Blom, Ashley W.		Natl Joint Registry England & Wale	Risk of cancer in first seven years after metal-on-metal hip replacement compared with other bearings and general population: linkage study between the National Joint Registry of England and Wales and hospital episode statistics	BRITISH MEDICAL JOURNAL			English	Article							FOLLOW-UP; ARTHROPLASTY; METAANALYSIS; MORTALITY; IMPLANTS; COBALT; KNEE	Objective To determine whether use of metal-on-metal bearing surfaces is associated with an increased risk of a diagnosis of cancer in the early years after total hip replacement and specifically with an increase in malignant melanoma and haematological, prostate, and renal tract cancers. Design Linkage study with multivariable competing risks flexible parametric survival model to examine the incidence of new diagnoses of cancer in patients with metal-on-metal hip replacement compared with those with alternative bearings and to compare the observed incidence of diagnoses in patients undergoing hip replacement with that predicted by national incidence rates in the general population. Setting National Joint Registry of England and Wales (NJR) linked to NHS hospital episode statistics data. Participants 40 576 patients with hip replacement with metal-on-metal bearing surfaces and 248 995 with alternative bearings. Main outcome measures Incidence of all cancers and incidence of malignant melanoma and prostate, renal tract, and haematological cancers. Results The incidence of new diagnoses of cancer was low after hip replacement (1.25% at one year, 95% confidence interval 1.21% to 1.30%) and lower than that predicted from the age and sex matched normal population (1.65%, 1.60% to 1.70%). Compared with alternative bearings, there was no evidence that metal-on-metal bearing surfaces were associated with an increased risk of any cancer diagnosis in the seven years after surgery (mean follow-up of three years, 23% (n = 67 361) of patients observed for five years or more). Similarly, there was no increase in the risk of malignant melanoma or haematological, prostate, and renal tract cancers. The adjusted five year incidence of all cancers for men aged 60 was 4.8% (4.4% to 5.3%) with resurfacing, 6.2% (5.7% to 6.7%) with stemmed metal-on-metal, and 6.7% (6.5% to 7.0%) for other bearing surfaces. Equivalent rates for women aged 60 were lower: 3.1% (2.8% to 3.4%) with resurfacing, 4.0% (3.7% to 4.3%) with stemmed metal-on-metal, and 4.4% (4.2% to 4.5%) with other bearings. Conclusions These data are reassuring, but the findings are observational with short follow-up. The use of hospital episode statistics data might underestimate cancer diagnoses, and there is the possibility of confounding by indication. Furthermore, as some cancers have a long latency period it is important that we study the longer term outcomes and continue to investigate the effects of exposure to orthopaedic metals.	[Smith, Alison J.; Blom, Ashley W.] Univ Bristol, Musculosketal Res Unit, Sch Clin Sci, Avon Orthopaed Ctr, Bristol BS10 5NB, Avon, England; [Dieppe, Paul] Univ Plymouth, Peninsula Med Sch, Exeter EX1 2LU, Devon, England; [Dieppe, Paul] Univ Exeter, Exeter EX1 2LU, Devon, England; [Porter, Martyn] Ctr Hip Surg, Wigan WN6 9EP, Lancs, England	University of Bristol; University of Exeter; University of Plymouth; University of Exeter	Smith, AJ (corresponding author), Univ Bristol, Musculosketal Res Unit, Sch Clin Sci, Avon Orthopaed Ctr, Bristol BS10 5NB, Avon, England.	alison.smith@bristol.ac.uk		Blom, Ashley/0000-0002-9940-1095	National Joint Registry for England and Wales Steering Committee (NJRSC); DePuy	National Joint Registry for England and Wales Steering Committee (NJRSC); DePuy	This study was funded by the National Joint Registry for England and Wales Steering Committee (NJRSC) as one of several specialist topic areas included in its ongoing work programme. MP is a member of the NJRSC and is chair of the Editorial Board. Decisions over the design, data analysis, and data interpretation were made independently by the authors. The decision to submit for publication was made by AWB.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: MP receives royalties from the manufacturer DePuy for a cemented hip prosthesis.	AOANJRR, 2010, ANN REP AOANJRR; Bozic KJ, 2010, CLIN ORTHOP RELAT R, V468, P2357, DOI 10.1007/s11999-010-1262-3; CASE CP, 1994, J BONE JOINT SURG BR, V76B, P701, DOI 10.1302/0301-620X.76B5.8083255; Coviello E., 2009, STCOMPADJ STATA MODU; Doherty AT, 2001, J BONE JOINT SURG BR, V83B, P1075, DOI 10.1302/0301-620X.83B7.10102; Dowson D, 2004, J ARTHROPLASTY, V19, P124, DOI 10.1016/j.arth.2004.09.016; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Haddad FS, 2011, J BONE JOINT SURG BR, V93B, P572, DOI 10.1302/0301-620X.93B4.26429; Hart AJ, 2011, J BONE JOINT SURG BR, V93B, P1308, DOI 10.1302/0301-620X.93B10.26249; Jameson SS, 2011, J BONE JOINT SURG BR, V93B, P876, DOI 10.1302/0301-620X.93B7.26657; Judge A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4092; Keegan GM, 2007, J BONE JOINT SURG BR, V89B, P567, DOI 10.1302/0301-620X.89B5.18903; Keegan GM, 2008, CRIT REV TOXICOL, V38, P645, DOI [10.1080/10408440701845534, 10.1080/10408440701845534 ]; Lie SA, 2000, ACTA ORTHOP SCAND, V71, P19, DOI 10.1080/00016470052943838; LUMB GD, 1994, SCI TOTAL ENVIRON, V148, P185, DOI 10.1016/0048-9697(94)90395-6; National Joint Registry for England and Wales, 2011, 8 ANN REP NJR; Office for National Statistics, 2011, CANC STAT REG REG CA; Onega T, 2006, CANCER EPIDEM BIOMAR, V15, P1532, DOI 10.1158/1055-9965.EPI-06-0127; Parry MC, 2010, BIOMATERIALS, V31, P4477, DOI 10.1016/j.biomaterials.2010.02.038; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Smith AJ, 2012, LANCET          0312; Thomas E, 2000, INT J CANCER, V88, P497, DOI 10.1002/1097-0215(20001101)88:3<497::AID-IJC27>3.3.CO;2-A; Visuri T, 2003, ACTA ORTHOP SCAND, V74, P351, DOI 10.1080/00016470310014300; Visuri T, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-78; Wagner P, 2011, EUR J CANCER, V47, P1061, DOI 10.1016/j.ejca.2010.11.023; World Health Organisation Global Health Observatory, 2012, CANC MORT MORB	26	96	98	0	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 3	2012	344								e2383	10.1136/bmj.e2383	http://dx.doi.org/10.1136/bmj.e2383			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923GM	22490979	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000302607700002
J	Boucrot, E; Pick, A; Camdere, G; Liska, N; Evergren, E; McMahon, HT; Kozlov, MM				Boucrot, Emmanuel; Pick, Adi; Camdere, Gamze; Liska, Nicole; Evergren, Emma; McMahon, Harvey T.; Kozlov, Michael M.			Membrane Fission Is Promoted by Insertion of Amphipathic Helices and Is Restricted by Crescent BAR Domains	CELL			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; INFLUENZA-VIRUS; COATED PITS; EPSIN 1; CURVATURE; MECHANISMS; PROTEINS; SCISSION; VESICLE; DEFORMATION	Shallow hydrophobic insertions and crescent-shaped BAR scaffolds promote membrane curvature. Here, we investigate membrane fission by shallow hydrophobic insertions quantitatively and mechanistically. We provide evidence that membrane insertion of the ENTH domain of epsin leads to liposome vesiculation, and that epsin is required for clathrin-coated vesicle budding in cells. We also show that BAR-domain scaffolds from endophilin, amphiphysin, GRAF, and beta 2-centaurin limit membrane fission driven by hydrophobic insertions. A quantitative assay for vesiculation reveals an antagonistic relationship between amphipathic helices and scaffolds of N-BAR domains in fission. The extent of vesiculation by these proteins and vesicle size depend on the number and length of amphipathic helices per BAR domain, in accord with theoretical considerations. This fission mechanism gives a new framework for understanding membrane scission in the absence of mechanoenzymes such as dynamin and suggests how Arf and Sar proteins work in vesicle scission.	[Boucrot, Emmanuel; Camdere, Gamze; Liska, Nicole; Evergren, Emma; McMahon, Harvey T.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Pick, Adi; Kozlov, Michael M.] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel	MRC Laboratory Molecular Biology; Tel Aviv University; Sackler Faculty of Medicine	McMahon, HT (corresponding author), MRC Lab Mol Biol, Hills Rd, Cambridge CB2 0QH, England.	hmm@mrc-lmb.cam.ac.uk; michk@post.tau.ac.il	Evergren, Emma/X-3677-2019	Evergren, Emma/0000-0002-0775-2921; Boucrot, Emmanuel/0000-0001-7312-6462	Israel Science Foundation (ISF); Marie Curie Network "Virus Entry"; Medical Research Council UK [U105178795]; Cambridge Overseas Trust; Trinity College Cambridge; Austrian Academy; MRC [MC_U105178795] Funding Source: UKRI; Medical Research Council [MC_U105178795] Funding Source: researchfish	Israel Science Foundation (ISF)(Israel Science Foundation); Marie Curie Network "Virus Entry"; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cambridge Overseas Trust; Trinity College Cambridge; Austrian Academy; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Sew Yeu Peak-Chew for Mass Spectrometry, Tom Kirchhausen and David Drubin for the kind gift of sigma 2-EGFP BSC1 cells and SK-MEL-2 genome-edited cells, respectively, Rohit Mittal for helpful comments, and Felix Campeio for a supplemental computation. This work was supported by the Israel Science Foundation (ISF) and Marie Curie Network "Virus Entry" (M.M.K.), the Medical Research Council UK (grant number U105178795) (H.T.M., E.E., E.B.), Cambridge Overseas Trust and Trinity College Cambridge (G.C.), and Austrian Academy Science Fellowship (N.L.). E.B. designed, performed, and quantified live and fixed-cell imaging and ligand uptake, A.P. did theoretical modeling, G.C. and N.L. purified proteins and performed vesiculation assay and electron microscopy, E.E. performed and quantified electron microscopy of clathrin-coated pits, H.T.M. designed and performed vesiculation assay and supervised the project, M.M.K. suggested the mechanism and supervised the theoretical modeling. H.T.M., M.M.K., and E.B. wrote the paper with input from all the other authors.	Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Beck R, 2011, J CELL BIOL, V194, P765, DOI 10.1083/jcb.201011027; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; Chen C, 2008, P NATL ACAD SCI USA, V105, P11790, DOI 10.1073/pnas.0803711105; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Chen H, 2009, P NATL ACAD SCI USA, V106, P13838, DOI 10.1073/pnas.0907008106; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Coon Brian G, 2011, Commun Integr Biol, V4, P95, DOI 10.4161/cib.4.1.14129; Corda D, 2006, TRENDS CELL BIOL, V16, P167, DOI 10.1016/j.tcb.2006.01.007; Doyon JB, 2011, NAT CELL BIOL, V13, P331, DOI 10.1038/ncb2175; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; GOORMAGHTIGH E, 1986, ANAL BIOCHEM, V159, P122, DOI 10.1016/0003-2697(86)90316-7; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; Hughes AC, 2004, MOL BRAIN RES, V128, P182, DOI 10.1016/j.molbrainres.2004.06.016; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; HUSE DA, 1991, PHYS REV LETT, V66, P437, DOI 10.1103/PhysRevLett.66.437; Jakobsson J, 2008, P NATL ACAD SCI USA, V105, P6445, DOI 10.1073/pnas.0710267105; Kazazic M, 2009, TRAFFIC, V10, P235, DOI 10.1111/j.1600-0854.2008.00858.x; Kozlovsky Y, 2003, BIOPHYS J, V85, P85, DOI 10.1016/S0006-3495(03)74457-9; Kweon DH, 2006, MOL CELLS, V21, P428; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000204; Lundmark R, 2008, CURR BIOL, V18, P1802, DOI 10.1016/j.cub.2008.10.044; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; Schwarz US, 1999, PHYS REV E, V59, P5528, DOI 10.1103/PhysRevE.59.5528; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Wang J, 2011, P NATL ACAD SCI USA, V108, P12277, DOI 10.1073/pnas.1013101108; Williger BT, 1999, FEBS LETT, V454, P85, DOI 10.1016/S0014-5793(99)00771-1	40	266	267	0	100	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 30	2012	149	1					124	136		10.1016/j.cell.2012.01.047	http://dx.doi.org/10.1016/j.cell.2012.01.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464325	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000302235400015
J	Gasper, BJ; Minchella, DJ; Weaver, GC; Csonka, LN; Gardner, SM				Gasper, Brittany J.; Minchella, Dennis J.; Weaver, Gabriela C.; Csonka, Laszlo N.; Gardner, Stephanie M.			Adapting to Osmotic Stress and the Process of Science	SCIENCE			English	Editorial Material							INQUIRY		[Gasper, Brittany J.; Minchella, Dennis J.; Csonka, Laszlo N.; Gardner, Stephanie M.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Weaver, Gabriela C.] Purdue Univ, Discovery Learning Res Ctr, W Lafayette, IN 47907 USA; [Weaver, Gabriela C.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Gardner, SM (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	sgardne@purdue.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Brewer CA, 2011, VISION CHANGE UNDERG; CSONKA LN, 1991, ANNU REV MICROBIOL, V45, P569, DOI 10.1146/annurev.mi.45.100191.003033; Culham DE, 2008, BIOCHEMISTRY-US, V47, P13584, DOI 10.1021/bi801576x; DUNLAP VJ, 1985, J BACTERIOL, V163, P296, DOI 10.1128/JB.163.1.296-304.1985; Gardner SM, 2011, J UNDERGRAD NEUROSCI, V10, pA24; Gasper B. J., 2011, J MICROBIOL BIOL ED, V12; Gasper B. J., 2012, DNA CELL BIOL; Lindgren C. A., 2010, CHRONICLE HIGHE 0418; Luckie DB, 2004, ADV PHYSIOL EDUC, V28, P199, DOI 10.1152/advan.00025.2004; Weaver G., 2006, CHEM ED, V11, P125, DOI DOI 10.1333/S00897061008A; Weaver GC, 2008, NAT CHEM BIOL, V4, P577, DOI 10.1038/nchembio1008-577	11	7	7	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1590	1591		10.1126/science.1215582	http://dx.doi.org/10.1126/science.1215582			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461603				2022-12-28	WOS:000302062600035
J	Dixon, JR; Selvaraj, S; Yue, F; Kim, A; Li, Y; Shen, Y; Hu, M; Liu, JS; Ren, B				Dixon, Jesse R.; Selvaraj, Siddarth; Yue, Feng; Kim, Audrey; Li, Yan; Shen, Yin; Hu, Ming; Liu, Jun S.; Ren, Bing			Topological domains in mammalian genomes identified by analysis of chromatin interactions	NATURE			English	Article							EMBRYONIC STEM-CELLS; NUCLEAR LAMINA INTERACTIONS; GENE-EXPRESSION; ORGANIZATION; ARCHITECTURE; DROSOPHILA; PLURIPOTENT; PRINCIPLES; BOUNDARY; LOCUS	The spatial organization of the genome is intimately linked to its biological function, yet our understanding of higher order genomic structure is coarse, fragmented and incomplete. In the nucleus of eukaryotic cells, interphase chromosomes occupy distinct chromosome territories, and numerous models have been proposed for how chromosomes fold within chromosome territories(1). These models, however, provide only few mechanistic details about the relationship between higher order chromatin structure and genome function. Recent advances in genomic technologies have led to rapid advances in the study of three-dimensional genome organization. In particular, Hi-C has been introduced as a method for identifying higher order chromatin interactions genome wide(2). Here we investigate the three-dimensional organization of the human and mouse genomes in embryonic stem cells and terminally differentiated cell types at unprecedented resolution. We identify large, megabase-sized local chromatin interaction domains, which we term 'topological domains', as a pervasive structural feature of the genome organization. These domains correlate with regions of the genome that constrain the spread of heterochromatin. The domains are stable across different cell types and highly conserved across species, indicating that topological domains are an inherent property of mammalian genomes. Finally, we find that the boundaries of topological domains are enriched for the insulator binding protein CTCF, housekeeping genes, transfer RNAs and short interspersed element (SINE) retrotransposons, indicating that these factors may have a role in establishing the topological domain structure of the genome.	[Dixon, Jesse R.; Selvaraj, Siddarth; Yue, Feng; Kim, Audrey; Li, Yan; Shen, Yin; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Dixon, Jesse R.] Univ Calif San Diego, Med Scientist Training Program, La Jolla, CA 92093 USA; [Dixon, Jesse R.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Selvaraj, Siddarth] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Hu, Ming; Liu, Jun S.] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; [Ren, Bing] Univ Calif San Diego, Sch Med, UCSD Moores Canc Ctr, Inst Genom Med,Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; University of California System; University of California San Diego	Ren, B (corresponding author), Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	biren@ucsd.edu	Dixon, Jesse/AAT-2914-2020	Dixon, Jesse/0000-0002-6273-2181; Hu, Ming/0000-0002-6062-8794	Ludwig Institute for Cancer Research; California Institute for Regenerative Medicine (CIRM) [RN2-00905-1]; NIH [B.R. R01GH003991]; Rett Syndrome Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003991] Funding Source: NIH RePORTER	Ludwig Institute for Cancer Research; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rett Syndrome Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are grateful for the comments from and discussions with Z. Qin, A. Desai and members of the Ren laboratory during the course of the study. We also thank W. Bickmore and R. Eskeland for sharing the FISH data generated in mouse ES cells. This work was supported by funding from the Ludwig Institute for Cancer Research, California Institute for Regenerative Medicine (CIRM, RN2-00905-1) (to B.R.) and NIH (B.R. R01GH003991). J.R.D. is funded by a pre-doctoral training grant from CIRM. Y.S. is supported by a postdoctoral fellowship from the Rett Syndrome Research Foundation.	Amouyal M, 2010, BIOCHEM CELL BIOL, V88, P875, DOI 10.1139/O10-110; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Capelson M, 2004, BIOL CELL, V96, P617, DOI 10.1016/j.biolcel.2004.06.004; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; Ebersole T, 2011, CELL CYCLE, V10, P2779, DOI 10.4161/cc.10.16.17092; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim YJ, 2011, P NATL ACAD SCI USA, V108, P7391, DOI 10.1073/pnas.1018279108; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lunyak VV, 2007, SCIENCE, V317, P248, DOI 10.1126/science.1140871; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Scott KC, 1999, GENETICS, V153, P787; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947	29	3747	3839	19	480	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					376	380		10.1038/nature11082	http://dx.doi.org/10.1038/nature11082			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22495300	Green Accepted, Green Submitted			2022-12-28	WOS:000304099100044
J	Pedersen, BK				Pedersen, Bente Klarlund			A Muscular Twist on the Fate of Fat	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Pedersen, Bente Klarlund] Rigshosp, Ctr Inflammat & Metab, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Pedersen, Bente Klarlund] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen	Pedersen, BK (corresponding author), Rigshosp, Ctr Inflammat & Metab, Dept Infect Dis, DK-2100 Copenhagen, Denmark.		Pedersen, Bente Klarlund/AGR-3217-2022	Pedersen, Bente Klarlund/0000-0001-6508-6288				Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106	5	25	27	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 19	2012	366	16					1544	1545		10.1056/NEJMcibr1201024	http://dx.doi.org/10.1056/NEJMcibr1201024			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	927UE	22512488				2022-12-28	WOS:000302934800016
J	Sassower, KC; Allister, LM; Westra, SJ				Sassower, Kenneth C.; Allister, Lauren M.; Westra, Sjirk J.			Case 12-2012: A 10-Month-Old Girl with Vomiting and Episodes of Unresponsiveness	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLAIN FILM DIAGNOSIS; INTUSSUSCEPTION; CHILDREN; MANAGEMENT		[Sassower, Kenneth C.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Allister, Lauren M.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Westra, Sjirk J.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Sassower, Kenneth C.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Westra, Sjirk J.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Allister, Lauren M.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Sassower, KC (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.			Westra, Sjirk/0000-0002-9952-6891	Massachusetts General Hospital for Children; Harvard Medical School Department of Continuing Education	Massachusetts General Hospital for Children; Harvard Medical School Department of Continuing Education	Presented at the postgraduate course Primary Care Pediatrics (course directors: Peter T. Greenspan, M.D., Ronald E. Kleinman, M.D., John Patrick T. Co, M.D., M.P.H., Ronni L. Goldsmith, M.D., and Janice A. Lowe, M.D.), sponsored by Massachusetts General Hospital for Children and Harvard Medical School Department of Continuing Education.	Al-Twaijri WA, 2002, PEDIATR NEUROL, V26, P365, DOI 10.1016/S0887-8994(01)00416-7; Applegate KE, 2009, PEDIATR RADIOL, V39, DOI DOI 10.1007/S00247-009-1178-9; BRAY PF, 1977, JAMA-J AM MED ASSOC, V237, P1342, DOI 10.1001/jama.237.13.1342; BRUNQUELL P, 1990, EPILEPSIA, V31, P401, DOI 10.1111/j.1528-1157.1990.tb05495.x; Daneman A, 2004, PEDIATR RADIOL, V34, P97, DOI 10.1007/s00247-003-1082-7; Henrikson S, 2003, PEDIATR RADIOL, V33, P190, DOI 10.1007/s00247-002-0848-7; Hooker RL, 2008, RADIOLOGY, V248, P987, DOI 10.1148/radiol.2491071821; King D, 2003, CLIN PEDIAT EMERG ME, V4, P171; Kleizen KJ, 2009, ACTA PAEDIATR, V98, P1822, DOI 10.1111/j.1651-2227.2009.01466.x; Ko HS, 2007, EUR RADIOL, V17, P2411, DOI 10.1007/s00330-007-0589-y; Kuppermann N, 2000, ARCH PEDIAT ADOL MED, V154, P250, DOI 10.1001/archpedi.154.3.250; Lehman RK, 2008, CLIN PEDIATR EMERG M, V9, P68, DOI 10.1016/j.cpem.2008.02.003; Lloyd DA, 2004, PEDIAT GASTROINTESTI, V4th, P604; LUKS FI, 1992, AM J EMERG MED, V10, P574, DOI 10.1016/0735-6757(92)90188-4; MERADJI M, 1994, BRIT J RADIOL, V67, P147, DOI 10.1259/0007-1285-67-794-147; Morrison J, 2009, J PEDIATR-US, V155, P556, DOI 10.1016/j.jpeds.2009.04.006; Nelson DS, 2006, TXB PEDIAT EMERGENCY, P201; Owens JA, 2005, J DEV BEHAV PEDIATR, V26, P312, DOI 10.1097/00004703-200508000-00011; Pumberger W, 2004, AM J EMERG MED, V22, P307, DOI 10.1016/j.ajem.2004.04.010; RATCLIFFE JF, 1992, AM J ROENTGENOL, V158, P619, DOI 10.2214/ajr.158.3.1739006; Roskind CG, 2007, PEDIATR EMERG CARE, V23, P785, DOI 10.1097/PEC.0b013e31815a0013; SARGENT MA, 1994, PEDIATR RADIOL, V24, P17, DOI 10.1007/BF02017652; Sassower K, 1991, EPILEPSY BEHAV, P223; Stevens MW, 2000, TXB PEDIAT EMERGENCY, P629; Tenenbein M, 1987, Pediatr Emerg Care, V3, P22, DOI 10.1097/00006565-198703000-00006; Waseem M, 2008, PEDIATR EMERG CARE, V24, P793, DOI 10.1097/PEC.0b013e31818c2a3e; Yang S T, 1995, Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, V36, P170	27	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 19	2012	366	16					1527	1536		10.1056/NEJMcpc1103563	http://dx.doi.org/10.1056/NEJMcpc1103563			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927UE	22512486				2022-12-28	WOS:000302934800012
J	Kent, DM; Shah, ND				Kent, David M.; Shah, Nilay D.			Risk Models and Patient-Centered Evidence Should Physicians Expect One Right Answer?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CLINICAL-TRIALS		[Kent, David M.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; [Shah, Nilay D.] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN USA	Tufts Medical Center; Mayo Clinic	Kent, DM (corresponding author), Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, 800 Washington St,POB 63, Boston, MA 02111 USA.	dkent1@tuftsmedicalcenter.org						Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; Hasford J, 2010, J CLIN EPIDEMIOL, V63, P1298, DOI 10.1016/j.jclinepi.2009.10.009; Kent DM, SUPPLEMENTARY MAT UN; Kent DM, 2007, JAMA-J AM MED ASSOC, V298, P1209, DOI 10.1001/jama.298.10.1209; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Quanstrum KH, 2010, NEW ENGL J MED, V363, P1076, DOI 10.1056/NEJMsb1002538; Steyerberg EW, 2005, J CLIN EPIDEMIOL, V58, P383, DOI 10.1016/j.jclinepi.2004.07.008	8	32	32	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2012	307	15					1585	1586		10.1001/jama.2012.469	http://dx.doi.org/10.1001/jama.2012.469			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927GU	22511683				2022-12-28	WOS:000302896100017
J	Zhao, YY; Weir, MA; Manno, M; Cordy, P; Gomes, T; Hackam, DG; Juurlink, DN; Mamdani, M; Moist, L; Parikh, CR; Paterson, JM; Wald, R; Yao, Z; Garg, AX				Zhao, Ying Y.; Weir, Matthew A.; Manno, Michael; Cordy, Peter; Gomes, Tara; Hackam, Daniel G.; Juurlink, David N.; Mamdani, Muhammad; Moist, Louise; Parikh, Chirag R.; Paterson, J. Michael; Wald, Ron; Yao, Zhan; Garg, Amit X.			New Fibrate Use and Acute Renal Outcomes in Elderly Adults A Population-Based Study	ANNALS OF INTERNAL MEDICINE			English	Article							FENOFIBRATE INCREASES CREATININEMIA; EXTREMITY ARTERIAL-DISEASE; GLOMERULAR-FILTRATION-RATE; CARDIOVASCULAR EVENTS; SERUM CREATININE; CLINICAL-TRIALS; THERAPY; PROGRESSION; GEMFIBROZIL; PREVENTION	Background: Fibric acid derivatives (fibrates) have been shown to increase serum creatinine level in randomized trials. Objective: To assess renal outcomes in elderly adults within 90 days of a new fibrate prescription. Design: Population-based cohort study. Setting: Ontario, Canada. Patients: Patients aged 66 years or older with a new outpatient prescription for a fibrate or ezetimibe (comparator drug) between January 2004 and December 2008. Measurements: Hospitalization for an increase in serum creatinine level (primary outcome) and consultation with a nephrologist, receipt of dialysis for severe acute kidney injury, all-cause mortality, and increases in serum creatinine level (secondary outcomes). All outcomes were assessed within 90 days of a new prescription for ezetimibe or a fibrate. Results: Compared with ezetimibe users (n = 61 831), fibrate users (n = 19 072) were more likely to be hospitalized for an increase in serum creatinine level (adjusted odds ratio, 2.4 [95% CI, 1.7 to 3.3]) and were more likely to consult a nephrologist (absolute risk difference, 0.15% [CI, 0.01% to 0.29%]; adjusted odds ratio, 1.3 [CI, 1.0 to 1.6]). There were no differences between groups in the risk for all-cause mortality or receiving dialysis for severe acute kidney injury. In a subpopulation of 1110 patients (fibrates, n = 220; ezetimibe, n = 890), 9.1% of fibrate users and 0.3% of ezetimibe users had an increase in serum creatinine level of 50% or more (absolute difference, 8.8% [CI, 4.5% to 13.1%]; odds ratio, 29.6 [CI, 8.7 to 100.5]). Risks were greater among fibrate users with chronic kidney disease. Limitations: Because hospitalizations for an increase in serum creatinine level were underestimated, absolute differences may be misleading. Most patients (91%) were prescribed fenofibrate. Serum creatinine levels were measured as part of routine care and were not available for everyone or at predefined times. Conclusion: New fibrate use in elderly adults was associated with an increase in serum creatinine level and a small 90-day absolute increase in hospitalizations and nephrologist consultations. There was no detectable effect on dialysis for severe acute kidney injury or on mortality. The mechanism and clinical significance of the increase in serum creatinine level with fibrates is unclear.	Yale Univ, Sch Med, New Haven, CT USA; Univ Western Ontario, London, ON, Canada; Univ Toronto, Inst Clin Evaluat Sci, Toronto, ON, Canada; [Mamdani, Muhammad] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; McMaster Univ, Hamilton, ON, Canada	Yale University; Western University (University of Western Ontario); University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; McMaster University	Garg, AX (corresponding author), London Hlth Sci Ctr, Room ELL-101,800 Commissioners Rd E, London, ON N6A 4G5, Canada.	amit.garg@lhsc.on.ca	Garg, Amit X/G-3295-2011; Weir, Matthew/G-3354-2011; Moist, Louise/G-3334-2011; Hackam, Dan G/A-1143-2009	Gomes, Tara/0000-0002-1468-1965; Parikh, Chirag/0000-0001-9051-7385	Ontario Ministry of Health; Long-Term Care Drug Innovation Fund; University of Western Ontario; Ministry of Health and Long-Term Care; Canadian Institutes of Health Research	Ontario Ministry of Health(Ministry of Health and Long-Term Care, Ontario); Long-Term Care Drug Innovation Fund; University of Western Ontario; Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This project was conducted at the Institute for Clinical Evaluative Sciences and was supported by a grant from the Ontario Ministry of Health and Long-Term Care Drug Innovation Fund. The Institute for Clinical Evaluative Sciences is funded by an annual grant from the Ministry of Health and Long-Term Care. Dr. Weir was supported by the Clinician Investigator Program at the University of Western Ontario. He also receives funding from the Ministry of Health and Long-Term Care. Dr. Hackam was supported by a Canadian Institutes of Health Research New Investigator Award. Dr. Wald was supported by the Randomized Controlled Trial Mentoring Program of Canadian Institutes of Health Research. Dr. Garg was supported by a Canadian Institutes of Health Research Clinician-Scientist Award.	Abourbih S, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2009.03.030; Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Angeles C, 2004, AM J KIDNEY DIS, V44, P543, DOI 10.1053/j.ajkd.2004.05.040; Ansquer JC, 2005, AM J KIDNEY DIS, V45, P485, DOI 10.1053/j.ajkd.2004.11.004; Ansquer JC, 2008, AM J KIDNEY DIS, V51, P904, DOI 10.1053/j.ajkd.2008.01.014; Austin PC, 2003, JAMA-J AM MED ASSOC, V289, P3241, DOI 10.1001/jama.289.24.3241; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Broeders N, 2000, NEPHROL DIAL TRANSPL, V15, P1993, DOI 10.1093/ndt/15.12.1993; Bruce R, 1996, NEPHRON, V73, P490; Charach G, 2005, NEPHRON CLIN PRACT, V100, pC120, DOI 10.1159/000085291; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; Coca SG, 2006, JAMA-J AM MED ASSOC, V296, P1377, DOI 10.1001/jama.296.11.1377; Davis TME, 2011, DIABETOLOGIA, V54, P280, DOI 10.1007/s00125-010-1951-1; Forsblom C, 2010, DIABETES CARE, V33, P215, DOI 10.2337/dc09-0621; Gajdos M, 2003, CLIN NEPHROL, V60, P65; Genest J, 2004, AM J CARDIOL, V93, P848, DOI 10.1016/j.amjcard.2003.12.022; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hottelart C, 2002, NEPHRON, V92, P536, DOI 10.1159/000064083; Hottelart C, 1999, NEPHROLOGIE, V20, P41; Jha P, 1996, J AM COLL CARDIOL, V27, P1335, DOI 10.1016/0735-1097(96)00018-6; Jun M, 2010, LANCET, V375, P1875, DOI 10.1016/S0140-6736(10)60656-3; Juurlink D, 2006, CANADIAN I HLTH INFO; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; Kazumi T, 2003, CURR THER RES CLIN E, V64, P434, DOI 10.1016/S0011-393X(03)00127-9; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Keech AC, 2007, LANCET, V370, P1687, DOI 10.1016/S0140-6736(07)61607-9; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Lipscombe J, 2001, CLIN NEPHROL, V55, P39; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Mamdani M, 2004, LANCET, V363, P1751, DOI 10.1016/S0140-6736(04)16299-5; Mamdani MM, 2001, CAN MED ASSOC J, V164, P1695; Mcquade CR, 2008, AM J HEALTH-SYST PH, V65, P138, DOI 10.2146/ajhp070005; Meade T, 2002, BRIT MED J, V325, P1139, DOI 10.1136/bmj.325.7373.1139; Meade TW, 2001, CURR CONTR TRIALS C, V2, P195, DOI 10.1186/CVM-2-4-195; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Merck Canada Inc, 2011, EZ PROD MON; Ritter JL, 2001, PHARMACOTHERAPY, V21, P1145, DOI 10.1592/phco.21.13.1145.34623; Rizos Evangelos, 2002, Journal of Cardiovascular Pharmacology and Therapeutics, V7, P219, DOI 10.1177/107424840200700404; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Sica DA, 2009, CURR ATHEROSCLER REP, V11, P338, DOI 10.1007/s11883-009-0051-5; Smulders YM, 1997, EUR J CLIN INVEST, V27, P997, DOI 10.1046/j.1365-2362.1997.2330779.x; Statistics Canada, 2010, POP SEX AG GROUP PRO; Tonelli M, 2004, AM J KIDNEY DIS, V44, P832, DOI 10.1053/j.ajkd.2004.07.009; Tonelli M, 2004, KIDNEY INT, V66, P1123, DOI 10.1111/j.1523-1755.2004.00862.x; Tu K, 2003, CAN MED ASSOC J, V168, P553; U.S. Food and Drug Administration, 2011, END MET DRUGS ADV CO; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073	54	79	81	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2012	156	8					560	+		10.7326/0003-4819-156-8-201204170-00401	http://dx.doi.org/10.7326/0003-4819-156-8-201204170-00401			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930PO	22508733	Green Accepted			2022-12-28	WOS:000303151800015
J	Remais, JV; Eisenberg, JNS				Remais, Justin V.; Eisenberg, Joseph N. S.			Balance between clinical and environmental responses to infectious diseases	LANCET			English	Editorial Material							NEGLECTED TROPICAL DISEASES; HEALTH; CHINA		[Remais, Justin V.] Emory Univ, Dept Environm Hlth, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Eisenberg, Joseph N. S.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	Emory University; Rollins School Public Health; University of Michigan System; University of Michigan	Remais, JV (corresponding author), Emory Univ, Dept Environm Hlth, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	justin.remais@emory.edu	Remais, Justin/V-3207-2019	Remais, Justin/0000-0002-0223-4615	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI091864, R01AI050038] Funding Source: NIH RePORTER; NIAID NIH HHS [R01AI050038, R01 AI050038, K01 AI091864, K01AI091864] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Boone SA, 2007, APPL ENVIRON MICROB, V73, P1687, DOI 10.1128/AEM.02051-06; Chadwick E, 1843, REPORT SANITARY CO S; Charest S, 1969, Clin Proc Child Hosp Dist Columbia, V25, P308; Feingold BJ, 2010, ENVIRON HEALTH PERSP, V118, P1165, DOI 10.1289/ehp.0901866; Gould IM, 2006, LANCET, V368, P824, DOI 10.1016/S0140-6736(06)69303-3; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; HARE R, 1961, BRIT MED J, V2, P333, DOI 10.1136/bmj.2.5248.333; Huang SS, 2006, ARCH INTERN MED, V166, P1945, DOI 10.1001/archinte.166.18.1945; Keiser J, 2005, LANCET INFECT DIS, V5, P695, DOI 10.1016/S1473-3099(05)70268-1; Lerer LB, 1999, LANCET, V354, P1123, DOI 10.1016/S0140-6736(05)76917-8; Li T, 2010, TRENDS PARASITOL, V26, P264, DOI 10.1016/j.pt.2010.02.007; Mahmoud A, 2009, HEALTH AFFAIR, V28, P1726, DOI 10.1377/hlthaff.28.6.1726; Platt R, 2011, NEW ENGL J MED, V364, P1464, DOI 10.1056/NEJMe1014292; Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904; Singer BH, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000104; Snow J., 1855, MODE COMMUNICATION C; Spear RC, 2006, SCIENCE, V314, P1081, DOI 10.1126/science.314.5802.1081c; Sripa B, 2007, PLOS MED, V4, P1148, DOI 10.1371/journal.pmed.0040201; Stiles C, 1939, J PARASITOL, V25, P296; Wang LD, 2009, NEW ENGL J MED, V360, P121, DOI 10.1056/NEJMoa0800135; WOOLLEY PV, 1957, AMER J ROENTGENOL RA, V78, P547; Worrell C, 2011, APPL ENVIRON MICROB, V77, P2192, DOI 10.1128/AEM.01561-10	22	9	9	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 14	2012	379	9824					1457	1459		10.1016/S0140-6736(11)61227-0	http://dx.doi.org/10.1016/S0140-6736(11)61227-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	926BR	22475491	Green Accepted			2022-12-28	WOS:000302806800034
J	Grainger, J; Dufau, S; Montant, M; Ziegler, JC; Fagot, J				Grainger, Jonathan; Dufau, Stephane; Montant, Marie; Ziegler, Johannes C.; Fagot, Joel			Orthographic Processing in Baboons (Papio papio)	SCIENCE			English	Article							WORD FORM AREA; MODEL; MONKEYS	Skilled readers use information about which letters are where in a word (orthographic information) in order to access the sounds and meanings of printed words. We asked whether efficient processing of orthographic information could be achieved in the absence of prior language knowledge. To do so, we trained baboons to discriminate English words from nonsense combinations of letters that resembled real words. The results revealed that the baboons were using orthographic information in order to efficiently discriminate words from letter strings that were not words. Our results demonstrate that basic orthographic processing skills can be acquired in the absence of preexisting linguistic representations.	[Grainger, Jonathan] CNRS, F-13331 Marseille, France; Aix Marseille Univ, Lab Psychol Cognit, Federat Rech 3C, Brain & Language Res Inst, F-13331 Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Grainger, J (corresponding author), CNRS, 3 Pl Victor Hugo, F-13331 Marseille, France.	jonathan.grainger@univ-amu.fr	Dufau, Stephane/B-6349-2008; fagot, joel/H-6412-2011; Grainger, Jonathan/C-9299-2009; Ziegler, Johannes/C-2234-2008	Dufau, Stephane/0000-0002-2692-2084; Ziegler, Johannes/0000-0002-2061-5729; fagot, joel/0000-0002-9824-9685	European Research Council (ERC) [230313]; Provence regional council	European Research Council (ERC)(European Research Council (ERC)); Provence regional council	J.G. was supported by the European Research Council (ERC grant 230313). J.F. was supported by research grant Volet Exploratoire 2008 from the Provence regional council. This research was conducted at the Rousset-sur-Arc primate center (CNRS-UPS846), France. The authors thank its staff for technical support. Data are available at (dryad/science Supporting Online Material). J.G., J.F., and J.C.Z. conceived the study and designed the experiment; J.F., M. M., and S. D. implemented the experiment; S. D. analyzed the data; J.F. wrote the test program and conducted the experiment; J.G. wrote the first draft; and all authors contributed equally to latter versions of this article.	Brincat SL, 2006, NEURON, V49, P17, DOI 10.1016/j.neuron.2005.11.026; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; Dehaene S, 2009, READING BRAIN; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Fagot J, 2010, BEHAV RES METHODS, V42, P507, DOI 10.3758/BRM.42.2.507; Fobes J.L., 1982, P219; Grainger J, 1996, PSYCHOL REV, V103, P518, DOI 10.1037/0033-295X.103.3.518; Grainger J, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00054; Keuleers E, 2012, BEHAV RES METHODS, V44, P287, DOI 10.3758/s13428-011-0118-4; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; Nation K, 2008, Q J EXP PSYCHOL, V61, P1121, DOI 10.1080/17470210802034603; Parron C, 2010, LEARN BEHAV, V38, P374, DOI 10.3758/LB.38.4.374; Ramus F, 2000, SCIENCE, V288, P349, DOI 10.1126/science.288.5464.349; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Seyfarth RM, 2010, BRAIN LANG, V115, P92, DOI 10.1016/j.bandl.2009.10.003; Whitney C, 2001, PSYCHON B REV, V8, P221, DOI 10.3758/BF03196158; Yarkoni T, 2008, PSYCHON B REV, V15, P971, DOI 10.3758/PBR.15.5.971; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3	21	101	101	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2012	336	6078					245	248		10.1126/science.1218152	http://dx.doi.org/10.1126/science.1218152			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924PN	22499949				2022-12-28	WOS:000302703900054
J	Graham-Rowe, D				Graham-Rowe, Duncan			Drugs: An injection of hope	NATURE			English	Editorial Material																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					S4	S4		10.1038/nature11109	http://dx.doi.org/10.1038/nature11109			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22509505				2022-12-28	WOS:000303149900046
J	Rehman, HU				Rehman, H. U.			CASE REPORT A woman with generalised weakness, hypokalaemia, and metabolic acidosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SJOGRENS-SYNDROME		Regina Gen Hosp, Dept Med, Regina, SK S4P 0W5, Canada	University of Saskatchewan	Rehman, HU (corresponding author), Regina Gen Hosp, Dept Med, Regina, SK S4P 0W5, Canada.							Franceschini F, 2005, AUTOIMMUNITY, V38, P55, DOI 10.1080/08916930400022954; HAMM LL, 1990, KIDNEY INT, V38, P728, DOI 10.1038/ki.1990.265; Kirschbaum B, 1999, J LAB CLIN MED, V133, P597, DOI 10.1016/S0022-2143(99)90190-7; Laing CM, 2006, J NEPHROL, V19, pS46; Locht H, 2008, J RHEUMATOL, V35, P845; Manthorpe R, 2002, ANN RHEUM DIS, V61, P482, DOI 10.1136/ard.61.6.482; Ren H, 2008, J RHEUMATOL, V35, P278; ROTHSTEIN M, 1990, ENDOCRIN METAB CLIN, V19, P869, DOI 10.1016/S0889-8529(18)30298-6; Soriano JR, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000023430.92674.E5; WRONG O, 1998, OXFORD TXB CLIN NEPH, P1375; Yazisiz V, 2009, RHEUMATOL INT, V29, P403, DOI 10.1007/s00296-008-0698-1	11	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 12	2012	344								e2545	10.1136/bmj.e2545	http://dx.doi.org/10.1136/bmj.e2545			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927UK	22498955				2022-12-28	WOS:000302935500002
J	Spence, D				Spence, Des			The Economist	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	1	1	2	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 11	2012	344								e2620	10.1136/bmj.e2620	http://dx.doi.org/10.1136/bmj.e2620			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	927UH	22496307				2022-12-28	WOS:000302935200014
J	Yuk, JM; Park, J; Ercius, P; Kim, K; Hellebusch, DJ; Crommie, MF; Lee, JY; Zettl, A; Alivisatos, AP				Yuk, Jong Min; Park, Jungwon; Ercius, Peter; Kim, Kwanpyo; Hellebusch, Daniel J.; Crommie, Michael F.; Lee, Jeong Yong; Zettl, A.; Alivisatos, A. Paul			High-Resolution EM of Colloidal Nanocrystal Growth Using Graphene Liquid Cells	SCIENCE			English	Article							TRANSMISSION ELECTRON-MICROSCOPY; HIGH-QUALITY; NANOPARTICLES; PARTICLES; NANOWIRES; SHEETS; FILMS	We introduce a new type of liquid cell for in situ transmission electron microscopy (TEM) based on entrapment of a liquid film between layers of graphene. The graphene liquid cell facilitates atomic-level resolution imaging while sustaining the most realistic liquid conditions achievable under electron-beam radiation. We employ this cell to explore the mechanism of colloidal platinum nanocrystal growth. Direct atomic-resolution imaging allows us to visualize critical steps in the process, including site-selective coalescence, structural reshaping after coalescence, and surface faceting.	[Yuk, Jong Min; Lee, Jeong Yong] Korea Adv Inst Sci & Technol, Dept Mat Sci & Engn, Taejon 305701, South Korea; [Yuk, Jong Min; Kim, Kwanpyo; Crommie, Michael F.; Zettl, A.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Yuk, Jong Min; Park, Jungwon; Kim, Kwanpyo; Crommie, Michael F.; Zettl, A.; Alivisatos, A. Paul] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA; [Park, Jungwon; Hellebusch, Daniel J.; Alivisatos, A. Paul] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Ercius, Peter] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Natl Ctr Electron Microscopy, Berkeley, CA 94720 USA; [Kim, Kwanpyo; Crommie, Michael F.; Zettl, A.] Univ Calif Berkeley, Ctr Integrated Nanomech Syst, Berkeley, CA 94720 USA	Korea Advanced Institute of Science & Technology (KAIST); University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Lee, JY (corresponding author), Korea Adv Inst Sci & Technol, Dept Mat Sci & Engn, Taejon 305701, South Korea.	j.y.lee@kaist.ac.kr; azettl@berkeley.edu; alivis@berkeley.edu	Yuk, Jong Min/I-8770-2016; Kim, Kwanpyo/D-9121-2011; Lee, Jeong Yong/C-8864-2011; Alivisatos, Paul/N-8863-2015; Zettl, Alex K/O-4925-2016; Ercius, Peter/AAN-2870-2020; Park, Jungwon/O-1153-2016; Lee, Junyoung/D-5463-2012	Yuk, Jong Min/0000-0002-4677-7363; Kim, Kwanpyo/0000-0001-8497-2330; Alivisatos, Paul/0000-0001-6895-9048; Zettl, Alex K/0000-0001-6330-136X; Ercius, Peter/0000-0002-6762-9976; Park, Jungwon/0000-0003-2927-4331; Lee, Junyoung/0000-0001-6689-2759	Physical Chemistry of Inorganic Nanoscrystals Program [KC3105]; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy (DOE) [DE-AC02-05CH11231]; DOE [DE-AC02-05CH11231]; National Research Foundation of Korea; Ministry of Education, Science and Technology [2010-0029714]; Office of Energy Research, Office of Basic Energy Sciences, Materials Sciences and Engineering Division, of the DOE [DE-AC02-05CH11231]; Office of Naval Research [N00014-09-1-1066]; NSF [EEC-0832819]	Physical Chemistry of Inorganic Nanoscrystals Program; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Office of Energy Research, Office of Basic Energy Sciences, Materials Sciences and Engineering Division, of the DOE(United States Department of Energy (DOE)); Office of Naval Research(Office of Naval Research); NSF(National Science Foundation (NSF))	Work on preparation of a nanocrystal growth solution, portions of the design and construction of GLCs, and data analysis was supported by the Physical Chemistry of Inorganic Nanoscrystals Program, KC3105, Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy (DOE) under contract DE-AC02-05CH11231. Portions of the present study were performed at the National Center for Electron Microscopy, Lawrence Berkeley National Laboratory, which is supported by the DOE under contract no. DE-AC02-05CH11231. J.M.Y. and J.Y.L. acknowledge the financial support from Priority Research Centers Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (grant no. 2010-0029714). A.Z. acknowledges support from the Director, Office of Energy Research, Office of Basic Energy Sciences, Materials Sciences and Engineering Division, of the DOE under contract DE-AC02-05CH11231, which provided for the design and construction of the GLC, and support from the Office of Naval Research under grant N00014-09-1-1066, which provided for graphene growth and spectral characterization. K. K. received further support from the NSF (grant EEC-0832819) for preliminary TEM imaging and analysis.	Bishop KJM, 2009, SMALL, V5, P1600, DOI 10.1002/smll.200900358; Coleman JN, 2011, SCIENCE, V331, P568, DOI 10.1126/science.1194975; de Jonge N, 2011, NAT NANOTECHNOL, V6, P695, DOI [10.1038/NNANO.2011.161, 10.1038/nnano.2011.161]; Erni R, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.165443; Evans JE, 2011, NANO LETT, V11, P2809, DOI 10.1021/nl201166k; Fang ZZ, 2008, INT MATER REV, V53, P326, DOI 10.1179/174328008X353538; Koenig SP, 2011, NAT NANOTECHNOL, V6, P543, DOI [10.1038/nnano.2011.123, 10.1038/NNANO.2011.123]; Kolmakov A, 2011, NAT NANOTECHNOL, V6, P651, DOI [10.1038/NNANO.2011.130, 10.1038/nnano.2011.130]; Lee Z, 2009, NANO LETT, V9, P3365, DOI 10.1021/nl901664k; Li XL, 2008, NAT NANOTECHNOL, V3, P538, DOI 10.1038/nnano.2008.210; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Lu XM, 2008, J AM CHEM SOC, V130, P8900, DOI 10.1021/ja803343m; Lu XM, 2009, ANNU REV PHYS CHEM, V60, P167, DOI 10.1146/annurev.physchem.040808.090434; Meyer JC, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2901147; Meyer JC, 2008, NATURE, V454, P319, DOI 10.1038/nature07094; Meyer JC, 2007, NATURE, V446, P60, DOI 10.1038/nature05545; Nair RR, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3492845; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Radmilovic V, 2011, NAT MATER, V10, P710, DOI [10.1038/NMAT3077, 10.1038/nmat3077]; Regan W, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3337091; Schapotschnikow P, 2008, NANO LETT, V8, P2930, DOI 10.1021/nl8017862; Stach EA, 2008, MATER TODAY, V11, P50, DOI 10.1016/S1369-7021(09)70007-0; Wen CY, 2009, SCIENCE, V326, P1247, DOI 10.1126/science.1178606; Williamson MJ, 2003, NAT MATER, V2, P532, DOI 10.1038/nmat944; Wu YMA, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/19/195603; Xie X, 2009, NANO LETT, V9, P2565, DOI 10.1021/nl900677y; Xu K, 2010, SCIENCE, V329, P1188, DOI 10.1126/science.1192907; Yuk JM, 2011, NANO LETT, V11, P3290, DOI 10.1021/nl201647p; Zewail AH, 2010, SCIENCE, V328, P187, DOI 10.1126/science.1166135; Zheng HM, 2009, NANO LETT, V9, P2460, DOI 10.1021/nl9012369; Zheng HM, 2009, SCIENCE, V324, P1309, DOI 10.1126/science.1172104	31	759	773	28	883	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2012	336	6077					61	64		10.1126/science.1217654	http://dx.doi.org/10.1126/science.1217654			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920LG	22491849				2022-12-28	WOS:000302405400050
J	Szent-Gyorgyi, LE; Desai, S; Kim, D; Sax, PE; Greenberg, JO				Szent-Gyorgyi, Lara E.; Desai, Sonali; Kim, Daniel; Sax, Paul E.; Greenberg, Jeffrey O.			Removing Legal Barriers to High-Quality Care for HIV-Infected Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Szent-Gyorgyi, Lara E.; Desai, Sonali; Greenberg, Jeffrey O.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Sax, Paul E.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Desai, Sonali; Kim, Daniel; Sax, Paul E.; Greenberg, Jeffrey O.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Szent-Gyorgyi, LE (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.							LIFSON AR, 1992, CLIN INFECT DIS, V14, P966, DOI 10.1093/clinids/14.4.966-a; May M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6016; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; 2006, MMWR MORB MORTAL WKL, V55, P1	4	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 5	2012	366	14					1268	1270		10.1056/NEJMp1114446	http://dx.doi.org/10.1056/NEJMp1114446			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	919QJ	22475590				2022-12-28	WOS:000302343000003
J	Kitsios, GD; Kent, DM				Kitsios, Georgios D.; Kent, David M.			Personalised medicine: not just in our genes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GENOME-WIDE ASSOCIATION; PERCUTANEOUS CORONARY INTERVENTION; CLINICAL-TRIALS; INDIVIDUAL PATIENTS; RISK; PHARMACOGENOMICS; HETEROGENEITY; PREDICTION; BENEFIT		[Kent, David M.] Tufts Univ, Sackler Sch Grad Biomed Sci, Clin & Translat Sci Program, Boston, MA 02111 USA; [Kitsios, Georgios D.; Kent, David M.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA; [Kitsios, Georgios D.] Lahey Clin Med Ctr, Dept Gen Internal Med, Burlington, MA 01803 USA	Tufts University; Tufts Medical Center; Lahey Hospital & Medical Center	Kent, DM (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Clin & Translat Sci Program, Boston, MA 02111 USA.	dkent1@tuftsmedicalcenter.org		Kitsios, Georgios/0000-0002-1018-948X	NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025752] Funding Source: NIH RePORTER; NCRR NIH HHS [UL1 RR025752] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Aradi D, 2010, AM HEART J, V160, P543, DOI 10.1016/j.ahj.2010.06.004; Barber MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009763; Becquement L, 2011, PHARMACOGENOMICS, V12, P113, DOI 10.2217/PGS.10.147; Combescure C, 2010, J THROMB HAEMOST, V8, P923, DOI 10.1111/j.1538-7836.2010.03809.x; Dahabreh IJ, 2011, ANN INTERN MED, V154, P37, DOI 10.7326/0003-4819-154-1-201101040-00006; Flockhart DA, 2008, GENET MED, V10, P139, DOI 10.1097/GIM.0b013e318163c35f; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Hayward RA, 2005, HEALTH AFFAIR, V24, P1571, DOI 10.1377/hlthaff.24.6.1571; Hayward Rodney A, 2006, BMC Med Res Methodol, V6, P18, DOI 10.1186/1471-2288-6-18; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Holmes DR, 2010, J AM COLL CARDIOL, V56, P321, DOI 10.1016/j.jacc.2010.05.013; Holmes MV, 2011, JAMA-J AM MED ASSOC, V306, P2704, DOI 10.1001/jama.2011.1880; Holmes MV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007960; Imai K, 2011, CLIN CHEM, V57, P518, DOI 10.1373/clinchem.2010.158220; Institute for Clinical Systems Improvement, 2010, DIAGN TREATM CHEST P; Institute for Clinical Systems Improvement, 2011, ANT THER SUPPL GUID; Ioannidis JPA, 2009, CIRC-CARDIOVASC GENE, V2, P7, DOI 10.1161/CIRCGENETICS.108.833392; Janssens A Cecile Jw, 2010, Investig Genet, V1, P10, DOI 10.1186/2041-2223-1-10; Kangelaris KN, 2009, J GEN INTERN MED, V24, P656, DOI 10.1007/s11606-009-0949-1; Kent DM, 2007, JAMA-J AM MED ASSOC, V298, P1209, DOI 10.1001/jama.298.10.1209; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Kent DM, 2002, AM J MED, V113, P104, DOI 10.1016/S0002-9343(02)01160-9; Kravitz RL, 2004, MILBANK Q, V82, P661, DOI 10.1111/j.0887-378X.2004.00327.x; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Medical Services Commission, 2011, WARF THER MAN INV PR; Nissen SE, 2011, JAMA-J AM MED ASSOC, V306, P2727, DOI 10.1001/jama.2011.1865; Rothwell PM, 1999, LANCET, V353, P2105, DOI 10.1016/S0140-6736(98)11415-0; ROTHWELL PM, 1995, LANCET, V345, P1616, DOI 10.1016/S0140-6736(95)90120-5; Snoep JD, 2007, AM HEART J, V154, P221, DOI 10.1016/j.ahj.2007.04.014; Sofi F, 2010, THROMB HAEMOSTASIS, V103, P841, DOI 10.1160/TH09-06-0418; Swen JJ, 2007, PLOS MED, V4, P1317, DOI 10.1371/journal.pmed.0040209; US FDA, 2011, TABL PHARM BIOM DRUG; Veenstra DL, 2000, AAPS PHARMSCI, V2, part. no.	34	29	30	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2012	344								e2161	10.1136/bmj.e2161	http://dx.doi.org/10.1136/bmj.e2161			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	923GM	22491484	Green Published			2022-12-28	WOS:000302607700012
J	Arie, S				Arie, Sophie			Remembering Karen Woo Sophie Arie introduces the individuals shortlisted for the Karen Woo award	BRITISH MEDICAL JOURNAL			English	Editorial Material												mail@sophiearie.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 2	2012	344								e2437	10.1136/bmj.e2437	http://dx.doi.org/10.1136/bmj.e2437			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	923GB	22474269				2022-12-28	WOS:000302606500009
J	Gardner, C				Gardner, Caleb			Where all the ladders start	LANCET			English	Editorial Material									Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University	Gardner, C (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA.	cgardn12@jhmi.edu							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 31	2012	379	9822					1190	1191		10.1016/S0140-6736(12)60500-5	http://dx.doi.org/10.1016/S0140-6736(12)60500-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	918DV	22470930	Bronze			2022-12-28	WOS:000302230400020
J	Branford, WR; Ladak, S; Read, DE; Zeissler, K; Cohen, LF				Branford, W. R.; Ladak, S.; Read, D. E.; Zeissler, K.; Cohen, L. F.			Emerging Chirality in Artificial Spin Ice	SCIENCE			English	Article							ENTROPY; FILMS; MODEL	Artificial spin ice, made up of planar nanostructured arrays of simple ferromagnetic bars, is a playground for rich physics associated with the spin alignment of the bars and spin texture associated with the magnetic frustration at the bar vertices. The phase diagram is exotic, showing magnetic monopole-like defects and liquid and solid phases of spins arranged in loop states with predicted chiral order. We show that magnetotransport measurements in connected honeycomb structures yield the onset of an anomalous Hall signal at 50 kelvin. The temperature scale can be attributed to the long-range dipolar ice phase. The topological Hall signal arises because chiral loops form at the sample edges, indicating a generic route to exotic states via nanoarray edge structure.	[Branford, W. R.; Ladak, S.; Read, D. E.; Zeissler, K.; Cohen, L. F.] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London SW7 2AZ, England; [Read, D. E.] Cardiff Univ, Sch Phys & Astron, Cardiff CF24 3AA, S Glam, Wales	Imperial College London; Cardiff University	Branford, WR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Prince Consort Rd, London SW7 2AZ, England.	w.branford@imperial.ac.uk	Read, Dan/G-5115-2011; Branford, Will R/K-4375-2012	Read, Dan/0000-0002-4178-4986; Branford, Will R/0000-0002-4821-4097; Ladak, Sam/0000-0002-0275-0927; Cohen, Lesley/0000-0002-5123-5171; Zeissler, Katharina/0000-0002-2698-3493	Engineering and Physical Sciences Research Council [EP/G004765/1]; Leverhulme Trust [F/07058/AW]; Engineering and Physical Sciences Research Council [EP/E016243/1] Funding Source: researchfish; EPSRC [EP/E016243/1, EP/G004765/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Leverhulme Trust(Leverhulme Trust); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge Engineering and Physical Sciences Research Council Career Acceleration Fellowships (EP/G004765/1) and the Leverhulme Trust (F/07058/AW) for funding.	Branford WR, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/2/042; Branford WR, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.227201; Branford WR, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1923755; Castelnovo C, 2008, NATURE, V451, P42, DOI 10.1038/nature06433; Chern GW, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.207202; Epshtein EM, 2003, J MAGN MAGN MATER, V258, P80, DOI 10.1016/S0304-8853(02)01115-0; Harris MJ, 1997, PHYS REV LETT, V79, P2554, DOI 10.1103/PhysRevLett.79.2554; Hayashi M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.037204; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Ladak S, 2010, NAT PHYS, V6, P359, DOI 10.1038/NPHYS1628; Ladak S, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/023023; Macdonald AJ, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/16/164208; Machida Y, 2010, NATURE, V463, P210, DOI 10.1038/nature08680; Mengotti E, 2011, NAT PHYS, V7, P68, DOI [10.1038/nphys1794, 10.1038/NPHYS1794]; Moller G, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.140409; Morgan JP, 2011, NAT PHYS, V7, P75, DOI 10.1038/NPHYS1853; Neubauer A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.186602; Nisoli C, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.047205; Nisoli C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.217203; Onoda M, 2002, J PHYS SOC JPN, V71, P19, DOI 10.1143/JPSJ.71.19; Pauling L, 1935, J AM CHEM SOC, V57, P2680, DOI 10.1021/ja01315a102; Ramirez AP, 1999, NATURE, V399, P333, DOI 10.1038/20619; Rougemaille N, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.057209; SHERRINGTON D, 1975, PHYS REV LETT, V35, P1792, DOI 10.1103/PhysRevLett.35.1792; Tanaka M, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.052411; Wang RF, 2006, NATURE, V439, P303, DOI 10.1038/nature04447; Williams JR, 2007, SCIENCE, V317, P638, DOI 10.1126/science.1144657; Wills AS, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.144407	29	91	93	2	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1597	1600		10.1126/science.1211379	http://dx.doi.org/10.1126/science.1211379			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461605	Green Submitted			2022-12-28	WOS:000302062600037
J	Emery, P; Buch, MH				Emery, Paul; Buch, Maya H.			Towards an optimum strategy in rheumatoid arthritis	LANCET			English	Editorial Material							RANDOMIZED-TRIAL; DOUBLE-BLIND; METHOTREXATE; INFLIXIMAB; REMISSION		[Emery, Paul] Univ Leeds, Div Rheumat & Musculoskeletal Dis, Leeds Inst Mol Med, Chapel Allerton Hosp, Leeds LS7 4SA, W Yorkshire, England; Leeds Teaching Hosp NHS Trust, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds LS7 4SA, W Yorkshire, England	Chapel Allerton Hospital; University of Leeds; Leeds Biomedical Research Centre; University of Leeds	Emery, P (corresponding author), Univ Leeds, Div Rheumat & Musculoskeletal Dis, Leeds Inst Mol Med, Chapel Allerton Hosp, Leeds LS7 4SA, W Yorkshire, England.	p.emery@leeds.ac.uk	emery, paul/B-3560-2013	Buch, Maya/0000-0002-8962-5642	Arthritis Research UK [18475] Funding Source: Medline; Versus Arthritis [18475] Funding Source: Medline; National Institute for Health Research [NF-SI-0508-10299] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis); National Institute for Health Research(National Institute for Health Research (NIHR))		Bakker MF, 2012, ANN INTERN MED, V156, P329, DOI 10.7326/0003-4819-156-5-201203060-00004; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Buch MH, 2007, RHEUMATOLOGY, V46, P1153, DOI 10.1093/rheumatology/kem075; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; EMERY P, 1995, ANN RHEUM DIS, V54, P944, DOI 10.1136/ard.54.12.944; Emery P, 2011, ANN RHEUM DIS     S3, V70, P262; Emery P, 2012, ANN RHEUM DIS, V71, P989, DOI 10.1136/annrheumdis-2011-201066; Quinn MA, 2005, ARTHRITIS RHEUM-US, V52, P27, DOI 10.1002/art.20712; Saleem B, 2011, ANN RHEUM DIS, V70, P792, DOI 10.1136/ard.2010.134445; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; van Vollenhoven RF, 2009, LANCET, V374, P459, DOI 10.1016/S0140-6736(09)60944-2; van Vollenhoven RF, 2012, LANCET, V379, P1712, DOI 10.1016/S0140-6736(12)60027-0	13	5	5	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2012	379	9827					1682	1684		10.1016/S0140-6736(12)60164-0	http://dx.doi.org/10.1016/S0140-6736(12)60164-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937KX	22464342				2022-12-28	WOS:000303658500007
J	Jenal, M; Elkon, R; Loayza-Puch, F; van Haaften, G; Kuhn, U; Menzies, FM; Vrielink, JAFO; Bos, AJ; Drost, J; Rooijers, K; Rubinsztein, DC; Agami, R				Jenal, Mathias; Elkon, Ran; Loayza-Puch, Fabricio; van Haaften, Gijs; Kuehn, Uwe; Menzies, Fiona M.; Vrielink, Joachim A. F. Oude; Bos, Arnold J.; Drost, Jarno; Rooijers, Koos; Rubinsztein, David C.; Agami, Reuven			The Poly(A)-Binding Protein Nuclear 1 Suppresses Alternative Cleavage and Polyadenylation Sites	CELL			English	Article							OCULOPHARYNGEAL MUSCULAR-DYSTROPHY; MESSENGER-RNA POLYADENYLATION; 3' UNTRANSLATED REGIONS; B-CELL DIFFERENTIATION; POLY(A) TAIL LENGTH; BINDING PROTEINS; CANCER; MICRORNAS; GENES; TRANSCRIPTION	Alternative cleavage and polyadenylation (APA) is emerging as an important layer of gene regulation. Factors controlling APA are largely unknown. We developed a reporter-based RNAi screen for APA and identified PABPN1 as a regulator of this process. Genome-wide analysis of APA in human cells showed that loss of PABPN1 resulted in extensive 30 untranslated region shortening. Messenger RNA transcription, stability analyses, and in vitro cleavage assays indicated enhanced usage of proximal cleavage sites (CSs) as the underlying mechanism. Using Cyclin D1 as a test case, we demonstrated that enhanced usage of proximal CSs compromises microRNA-mediated repression. Triplet-repeat expansion in PABPN1 (trePABPN1) causes autosomal-dominant oculopharyngeal muscular dystrophy (OPMD). The expression of trePABPN1 in both a mouse model of OPMD and human cells elicited broad induction of proximal CS usage, linked to binding to endogenous PABPN1 and its sequestration in nuclear aggregates. Our results elucidate a novel function for PABPN1 as a suppressor of APA.	[Jenal, Mathias; Elkon, Ran; Loayza-Puch, Fabricio; van Haaften, Gijs; Vrielink, Joachim A. F. Oude; Bos, Arnold J.; Drost, Jarno; Rooijers, Koos; Agami, Reuven] Netherlands Canc Inst, Div Gene Regulat, NL-1066 CX Amsterdam, Netherlands; [Kuehn, Uwe] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Germany; [Menzies, Fiona M.; Rubinsztein, David C.] Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England; [Agami, Reuven] Ctr Biomed Genet, NL-3584 CG Utrecht, Netherlands	Netherlands Cancer Institute; Martin Luther University Halle Wittenberg; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Agami, R (corresponding author), Netherlands Canc Inst, Div Gene Regulat, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.agami@nki.nl	Drost, Jarno/J-9758-2012; Rubinsztein, David C/C-3472-2011; Drost, Jarno/M-6964-2017; van Haaften, Gijs/G-7832-2012; agami, reuven/GOG-8289-2022	Drost, Jarno/0000-0002-2941-6179; Drost, Jarno/0000-0002-2941-6179; van Haaften, Gijs/0000-0003-3033-0329; Loayza-Puch, Fabricio/0000-0002-2999-8594; Agami, Reuven/0000-0002-2848-2473; Rooijers, Koos/0000-0002-0412-468X	ERC (European Research Council); KWF (Dutch cancer foundation); Horizon; VICI-NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek); CBG (Centre for Biomedical Genetics); SNF (The Swiss National Science Foundation); VENI-NWO; Wellcome Trust	ERC (European Research Council)(European Research Council (ERC)); KWF (Dutch cancer foundation)(KWF Kankerbestrijding); Horizon; VICI-NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek); CBG (Centre for Biomedical Genetics); SNF (The Swiss National Science Foundation)(Swiss National Science Foundation (SNSF)); VENI-NWO(Netherlands Organization for Scientific Research (NWO)); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank all members of the Agami group including Bob Rosier for technical help and discussions. We thank Roderick Beijersbergen, Pasi Halonen, and Ben Morris from the NKI Robotics and screening center. Further we are grateful to Arno Velds and Ron Kerkhoven at the NKI Central genomics facility for deep sequencing our samples. This work was supported by funds from the ERC (European Research Council), KWF (Dutch cancer foundation), Horizon and VICI-NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek), and CBG (Centre for Biomedical Genetics) to R. A., the SNF (The Swiss National Science Foundation) to M.J., the VENI-NWO to G. v. H., and the Wellcome Trust Principal Research Fellowship to D.C.R.	Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Bear DG, 2003, EXP CELL RES, V286, P332, DOI 10.1016/S0014-4827(03)00123-X; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Beck AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008768; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Blumen SC, 1997, NEUROMUSCULAR DISORD, V7, pS38, DOI 10.1016/S0960-8966(97)00080-1; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Calado A, 2000, RNA, V6, P245, DOI 10.1017/S1355838200991908; Davies JE, 2011, HUM MOL GENET, V20, P1154, DOI 10.1093/hmg/ddq559; Davies JE, 2005, NAT MED, V11, P672, DOI 10.1038/nm1242; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Gomez-Benito M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025449; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hu J, 2005, RNA, V11, P1485, DOI 10.1261/rna.2107305; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Kedde M, 2008, CELL CYCLE, V7, P899, DOI 10.4161/cc.7.7.5644; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Kuhn U, 2009, J BIOL CHEM, V284, P22803, DOI 10.1074/jbc.M109.018226; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Lee JY, 2007, NUCLEIC ACIDS RES, V35, pD165, DOI 10.1093/nar/gkl870; Lemay JF, 2010, RNA BIOL, V7, P291, DOI 10.4161/rna.7.3.11649; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Lutz CS, 2008, ACS CHEM BIOL, V3, P609, DOI 10.1021/cb800138w; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Nunes NM, 2010, EMBO J, V29, P1523, DOI 10.1038/emboj.2010.42; Ozsolak F, 2010, CELL, V143, P1018, DOI 10.1016/j.cell.2010.11.020; Ruegg S, 2005, SWISS MED WKLY, V135, P574; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; Takagaki Y, 1998, MOL CELL, V2, P761, DOI 10.1016/S1097-2765(00)80291-9; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Tavanez JP, 2005, RNA, V11, P752, DOI 10.1261/rna.7217105; Thome FS, 1997, ADV PERIT D, V13, P141; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; WAHLE E, 1995, J BIOL CHEM, V270, P2800, DOI 10.1074/jbc.270.6.2800; Wahle E., 1994, RNA PROCESSING PRACT, VII, P1; Zhang XK, 2010, CELL CYCLE, V9, P4437, DOI 10.4161/cc.9.22.13887	44	232	238	1	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 27	2012	149	3								10.1016/j.cell.2012.03.022	http://dx.doi.org/10.1016/j.cell.2012.03.022			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22502866	Bronze			2022-12-28	WOS:000303443100007
J	Heller, S; Buse, J; Fisher, M; Garg, S; Marre, M; Merker, L; Renard, E; Russell-Jones, D; Philotheou, A; Francisco, AMO; Pei, HL; Bode, B				Heller, Simon; Buse, John; Fisher, Miles; Garg, Satish; Marre, Michel; Merker, Ludwig; Renard, Eric; Russell-Jones, David; Philotheou, Areti; Francisco, Ann Marie Ocampo; Pei, Huiling; Bode, Bruce		BEGIN Basal-Bolus Type 1 Trial Inv	Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial	LANCET			English	Article							HYPOGLYCEMIA UNAWARENESS; PRODUCTIVITY; THERAPY; IMPACT; LIFE	Background Intensive basal-bolus insulin therapy has been shown to improve glycaemic control and reduce the risk of long-term complications that are associated with type 1 diabetes mellitus. Insulin degludec is a new, ultra-longacting basal insulin. We therefore compared the efficacy and safety of insulin degludec and insulin glargine, both administered once daily with mealtime insulin aspart, in basal-bolus therapy for type 1 diabetes. Methods In an open-label, treat-to-target, non-inferiority trial, undertaken at 79 sites (hospitals and centres) in six countries, adults (aged >= 18 years) with type 1 diabetes (glycated haemoglobin [HbA(1c)] <= 10% [86 mmol/mol]), who had been treated with basal-bolus insulin for at least 1 year, were randomly assigned in a 3:1 ratio, with a computer-generated blocked allocation sequence, to insulin degludec or insulin glargine without stratification by use of a central interactive response system. The primary outcome was non-inferiority of degludec to glargine, assessed as a reduction in HbA(1c) after 52 weeks, with the intention-to-treat analysis. This trial is registered with ClinicalTrials.gov, number NCT00982228. Findings Of 629 participants, 472 were randomly assigned to insulin degludec and 157 to insulin glargine; all were analysed in their respective treatment groups. At 1 year, HbA(1c) had fallen by 0.40% points (SE 0.03) and 0.39% points (0.07), respectively, with insulin degludec and insulin glargine (estimated treatment difference -0.01% points [95% CI -0.14 to 0.11]; p<0.0001 for non-inferiority testing) and 188 (40%) and 67 (43%) participants achieved a target HbA(1c) of less than 7% (<53 mmol/mol). Rates of overall confirmed hypoglycaemia (plasma glucose <3.1 mmol/L or severe) were similar in the insulin degludec and insulin glargine groups (42.54 vs 40.18 episodes per patient-year of exposure; estimated rate ratio [degludec to glargine] 1.07 [0.89 to 1.28]; p=0.48). The rate of nocturnal confirmed hypoglycaemia was 25% lower with degludec than with glargine (4.41 vs 5.86 episodes per patient-year of exposure; 0.75 [0.59 to 0.96]; p=0.021). Overall serious adverse event rates (14 vs 16 events per 100 patient-years of exposure) were similar for the insulin degludec and insulin glargine groups. Interpretation Insulin degludec might be a useful basal insulin for patients with type 1 diabetes because it provides effective glycaemic control while lowering the risk of nocturnal hypoglycaemia, which is a major limitation of insulin therapy.	[Heller, Simon] Univ Sheffield, Sch Med, Sheffield S10 2RX, S Yorkshire, England; [Buse, John] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Fisher, Miles] Glasgow Royal Infirm, Glasgow G4 0SF, Lanark, Scotland; [Garg, Satish] Barbara Davis Ctr Childhood Diabet, Aurora, CO USA; [Marre, Michel] Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Paris, France; [Merker, Ludwig] Diabet & Nierenzentrum, Dormagen, Germany; [Renard, Eric] Montpellier Univ Hosp, Montpellier, France; [Russell-Jones, David] Royal Surrey Cty Hosp, Surrey, England; [Russell-Jones, David] Univ Surrey, Surrey, England; [Philotheou, Areti] Univ Cape Town, Private Acad Hosp, ZA-7925 Cape Town, South Africa; [Francisco, Ann Marie Ocampo] Novo Nordisk, Soborg, Denmark; [Pei, Huiling] Novo Nordisk, Princeton, NJ USA; [Bode, Bruce] Atlanta Diabet Associates, Atlanta, GA USA	University of Sheffield; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Glasgow; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Universite de Montpellier; CHU de Montpellier; Royal Surrey County Hospital; University of Surrey; University of Cape Town; Novo Nordisk	Heller, S (corresponding author), Univ Sheffield, Sch Med, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	s.heller@sheffield.ac.uk	Lyudmila, Suplotova A/J-3596-2014; Buse, John Bernard/J-9742-2019	Lyudmila, Suplotova A/0000-0001-9253-8075; Buse, John Bernard/0000-0002-9723-3876; Marre, Michel/0000-0002-3071-1837; kerlan, veronique/0000-0001-8105-6628; Heller, Simon/0000-0002-2425-9565	Novo Nordisk; Novo Nordisk (Bagsvaerd, Denmark); Eli Lilly; Sanofi; University of Colorado for clinical research; Merck; Cebix; MannKind; Medtronic MiniMed; DexCom; Amylin Pharmaceutical; Andromeda; Bayhill Therapeutics; Biodel; Boehringer Ingelheim; Bristol-Myers Squibb; Catabasis; Diartis; Elcelyx; Exsulin; GI Dynamics; Halozyme; Hoffman-La Roche; Johnson and Johnson; Lexicon; LipoScience; Metabolon; Novan; Novo Nordisk Pharmaceuticals; Osiris Therapeutics; Orexigen; Pfizer; Tolerex; Transition Therapeutics; TransPharma; Amylin; AstraZeneca; Takeda; Servier; Merck Serono; Dohme; GlaxoSmithKline; Merck Sharp	Novo Nordisk(Novo Nordisk); Novo Nordisk (Bagsvaerd, Denmark)(Novo Nordisk); Eli Lilly(Eli Lilly); Sanofi; University of Colorado for clinical research; Merck(Merck & Company); Cebix; MannKind; Medtronic MiniMed; DexCom; Amylin Pharmaceutical(Bristol-Myers Squibb); Andromeda; Bayhill Therapeutics; Biodel; Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Catabasis; Diartis; Elcelyx; Exsulin; GI Dynamics; Halozyme; Hoffman-La Roche; Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Lexicon; LipoScience; Metabolon; Novan; Novo Nordisk Pharmaceuticals(Novo Nordisk); Osiris Therapeutics; Orexigen; Pfizer(Pfizer); Tolerex; Transition Therapeutics; TransPharma; Amylin; AstraZeneca(AstraZeneca); Takeda(Takeda Pharmaceutical Company Ltd); Servier(Servier); Merck Serono(Merck & Company); Dohme; GlaxoSmithKline(GlaxoSmithKline); Merck Sharp	BB has received payment for consultancy, research support, and speakers' bureau and medical advisory board participation from Novo Nordisk, Eli Lilly, and Sanofi. SG has received grants through the University of Colorado for clinical research from Novo Nordisk, Sanofi, Merck, Eli Lilly, Cebix, MannKind, Medtronic MiniMed, and DexCom; he has also received honoraria for giving lectures from DexCom, Merck, and Sanofi; neither he nor any of his family members have stocks in any of the pharmaceutical or device companies. JB is an investigator, consultant, or both, without any direct financial benefit to him under contracts between his employer and Amylin Pharmaceutical, Andromeda, Bayhill Therapeutics, Biodel, Boehringer Ingelheim, Bristol-Myers Squibb, Catabasis, Diartis, Elcelyx, Eli Lilly, Exsulin, GI Dynamics, Halozyme, Hoffman-La Roche, Johnson and Johnson, Lexicon, LipoScience, Medtronic MiniMed, Merck, Metabolon, Novan, Novo Nordisk Pharmaceuticals, Osiris Therapeutics, Orexigen, Pfizer, Sanofi, Tolerex, Transition Therapeutics, and TransPharma. MF has served on advisory boards and has received honoraria for lectures from Novo Nordisk, Eli Lilly, and Sanofi, and the Diabetes Department at Glasgow Royal Infirmary has received payment for participation in studies from Novo Nordisk, Eli Lilly, and Sanofi. SH has received payment for lecture fees, consultancy, and research support from Amylin, AstraZeneca, Eli Lilly, Johnson and Johnson, Mannkind, Novo Nordisk, Sanofi, and Takeda. LM has received honoraria as consultant or speaker from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Merck Sharpe and Dohme, Novo Nordisk, and Roche Pharma; neither he nor his family members hold stocks in pharmaceutical or device companies. MM has received research funds from Novo Nordisk, Sanofi, Novartis, Merck, and Servier, and has received honoraria as consultant or speaker from Novo Nordisk, Sanofi, Eli Lilly, Servier, Merck, and Abbott. AP has received research support and has acted as consultant and speaker for Novo Nordisk and Sanofi; neither she nor any of her family members own stocks in any of the pharmaceutical or device companies. ER has received honoraria as consultant or speaker from Novo Nordisk, Eli Lilly, Sanofi, Roche Diagnostics, Medtronic, Abbott Diabetes Care, Lifescan, Animas, Novartis, Merck Sharp and Dohme, A Menarini Diagnostics, and GlaxoSmithKline. DR-J has received research grants from Novo Nordisk, Takeda, Pfizer, Boehringer Ingelheim, Eli Lilly, and Merck Serono; he has also received honoraria for giving lectures from Novo Nordisk, Eli Lilly, Takeda, Merck Sharp and Dohme, and GlaxoSmithKline. AMOF and HP are employees and shareholders of Novo Nordisk. The authors did not receive any payment for writing or contributing to the report.; The study was sponsored by Novo Nordisk (Bagsvaerd, Denmark). We thank the investigators, trial staff, and participants for their participation (see appendix p 29 for principal investigators). We also thank Abha Chandra and Carolynne Van Houten, employees of Novo Nordisk, Princeton, USA, for providing medical writing and editorial assistance, and Liz Bullock, at Watermeadow Medical (sponsored by Novo Nordisk), for production and submission assistance.	[Anonymous], 2001, J Postgrad Med, V47, P199; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Birkeland KI, 2011, DIABETES CARE, V34, P661, DOI 10.2337/dc10-1925; Brod M, 2011, VALUE HEALTH, V14, P665, DOI 10.1016/j.jval.2011.02.001; Chico A, 2003, DIABETES CARE, V26, P1153, DOI 10.2337/diacare.26.4.1153; Davis RE, 2005, CURR MED RES OPIN, V21, P1477, DOI 10.1185/030079905X61929; DeVries JH, 2007, DIABETES-METAB RES, V23, P441, DOI 10.1002/dmrr.762; Frier BM, 2008, DIABETES-METAB RES, V24, P87, DOI 10.1002/dmrr.796; Hamann A, 2003, DIABETES CARE, V26, P1738, DOI 10.2337/diacare.26.6.1738; Heise T, 2011, DIABETES S1, V60, pLB11; Heise T, 2011, DIABETES, V60, pA263; Heller SR, 2007, DIABETOLOGIA, V50, P1140, DOI 10.1007/s00125-007-0599-y; Jonassen I, 2010, DIABETES, V59, pA11; King P, 1998, DIABETES CARE, V21, P341, DOI 10.2337/diacare.21.3.341; Lindholm A, 2002, DIABETES CARE, V25, P876, DOI 10.2337/diacare.25.5.876; Little S, 2011, DIABETES TECHNOL THE, V13, DOI 10.1089/dia.2011.0022; Mire-Sluis AR, 2004, J IMMUNOL METHODS, V289, P1, DOI 10.1016/j.jim.2004.06.002; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Smith CB, 2009, DIABETES CARE, V32, P1196, DOI 10.2337/dc08-2259; US Food and Drug Administration Center for Drug Evaluation and Research (CDER), 2008, DIABETES MELLITUS DE; VENEMAN T, 1993, DIABETES, V42, P1233, DOI 10.2337/diabetes.42.9.1233; World Medical Association Inc, 2009, J Indian Med Assoc, V107, P403	24	258	265	0	39	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2012	379	9825					1489	1497		10.1016/S0140-6736(12)60204-9	http://dx.doi.org/10.1016/S0140-6736(12)60204-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930BJ	22521071				2022-12-28	WOS:000303110200027
J	Hapgood, M				Hapgood, Mike			Prepare for the coming space weather storm	NATURE			English	Editorial Material									[Hapgood, Mike] UK Sci & Technol Facil Council, Space Environm Grp RAL Space, Swindon, Wilts, England; [Hapgood, Mike] Rutherford Appleton Lab RAL, Didcot, Oxon, England	UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC)	Hapgood, M (corresponding author), UK Sci & Technol Facil Council, Space Environm Grp RAL Space, Swindon, Wilts, England.	mike.hapgood@stfc.ac.uk	Hapgood, Mike/D-6269-2014	Hapgood, Mike/0000-0002-0211-0241				[Anonymous], 2012, DEV THREATS EL PULS, pEv26; National Research Council Space Studies Board, 2008, SEV SPAC WEATH EV UN; Thomson AWP, 2011, SPACE WEATHER, V9, DOI 10.1029/2011SW000696	3	32	33	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2012	484	7394					311	313		10.1038/484311a	http://dx.doi.org/10.1038/484311a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927YM	22517148	Bronze			2022-12-28	WOS:000302946500012
J	Kass, N; Faden, R; Tunis, S				Kass, Nancy; Faden, Ruth; Tunis, Sean			Addressing Low-Risk Comparative Effectiveness Research in Proposed Changes to US Federal Regulations Governing Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRIALS; CARE		[Kass, Nancy] Berman Inst Bioeth, Baltimore, MD 21205 USA; [Kass, Nancy] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Faden, Ruth] Johns Hopkins Berman Inst Bioeth, Baltimore, MD USA; [Tunis, Sean] Ctr Med Technol Policy, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Kass, N (corresponding author), Berman Inst Bioeth, 1809 Ashland Ave, Baltimore, MD 21205 USA.	nkass@jhu.edu			CCR NIH HHS [RC1RR028876] Funding Source: Medline	CCR NIH HHS		Agency of Healthcare Research and Quality, 2011, AHRQ SUPP PRIM CAR P; Department of Health and Human Services, 2011, PIL STUD DEV TEST NO; Department of Health and Human Services Office of the Secretary of Food and Drug Administration, HUM SUBJ RES PROT EN; Faden RR, 2011, HASTINGS CENT REP, V41, P3; FEDERMAN DD, 2002, RESPONSIBLE RES SYST; Largent EA, 2011, HASTINGS CENT REP, V41, P37; Lo B, 2011, JAMA-J AM MED ASSOC, V306, P2260, DOI 10.1001/jama.2011.1727; Patient Centered Outcomes Research Institute (PCORI), DEV PCORIS NAT PRIOR; Truog RD, 1999, NEW ENGL J MED, V340, P804, DOI 10.1056/NEJM199903113401013; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624	10	35	35	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2012	307	15					1589	1590		10.1001/jama.2012.491	http://dx.doi.org/10.1001/jama.2012.491			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	927GU	22511685				2022-12-28	WOS:000302896100019
J	Tiffin, PA; Dowell, JS; McLachlan, JC				Tiffin, Paul A.; Dowell, Jonathan S.; McLachlan, John C.			Widening access to UK medical education for under-represented socioeconomic groups: modelling the impact of the UKCAT in the 2009 cohort	BMJ-BRITISH MEDICAL JOURNAL			English	Article							UNITED-KINGDOM; STUDENT SELECTION; HEALTH-CARE; SCHOOLS; APPLICANTS; PARTICIPATION; PERFORMANCE; ADMISSIONS; DIVERSITY; PHYSICIAN	Objective To determine whether the use of the UK clinical aptitude test (UKCAT) in the medical schools admissions process reduces the relative disadvantage encountered by certain sociodemographic groups. Design Prospective cohort study. Setting Applicants to 22 UK medical schools in 2009 that were members of the consortium of institutions utilising the UKCAT as a component of their admissions process. Participants 8459 applicants (24 844 applications) to UKCAT consortium member medical schools where data were available on advanced qualifications and socioeconomic background. Main outcome measures The probability of an application resulting in an offer of a place on a medicine course according to seven educational and sociodemographic variables depending on how the UKCAT was used by the medical school (in borderline cases, as a factor in admissions, or as a threshold). Results On univariate analysis all educational and sociodemographic variables were significantly associated with the relative odds of an application being successful. The multilevel multiple logistic regression models, however, varied between medical schools according to the way that the UKCAT was used. For example, a candidate from a non-professional background was much less likely to receive a conditional offer of a place compared with an applicant from a higher social class when applying to an institution using the test only in borderline cases (odds ratio 0.51, 95% confidence interval 0.45 to 0.60). No such effect was observed for such candidates applying to medical schools using the threshold approach (1.27, 0.84 to 1.91). These differences were generally reflected in the interactions observed when the analysis was repeated, pooling the data. Notably, candidates from several under-represented groups applying to medical schools that used a threshold approach to the UKCAT were less disadvantaged than those applying to the other institutions in the consortium. These effects were partially reflected in significant differences in the absolute proportion of such candidates finally taking up places in the different types of medical schools; stronger use of the test score (as a factor or threshold) was associated with a significantly increased odds of entrants being male (1.74, 1.25 to 2.41) and from a low socioeconomic background (3.57, 1.03 to 12.39). There was a non-significant trend towards entrants being from a state (non-grammar) school (1.60, 0.97 to 2.62) where a stronger use of the test was employed. Use of the test only in borderline cases was associated with increased odds of entrants having relatively low academic attainment (5.19, 2.02 to 13.33) and English as a second language (2.15, 1.03 to 4.48). Conclusions The use of the UKCAT may lead to more equitable provision of offers to those applying to medical school from under-represented sociodemographic groups. This may translate into higher numbers of some, but not all, relatively disadvantaged students entering the UK medical profession.	[Tiffin, Paul A.] Univ Durham, Sch Med & Hlth, Wolfson Res Inst, Stockton On Tees TS17 6BH, England; [Dowell, Jonathan S.] Univ Dundee, Sch Med, Dundee, Scotland	Durham University; University of Dundee	Tiffin, PA (corresponding author), Univ Durham, Sch Med & Hlth, Wolfson Res Inst, Queens Campus, Stockton On Tees TS17 6BH, England.	p.a.tiffin@durham.ac.uk	McLachlan, John/AAF-4203-2021; Tiffin, Paul/AAO-1834-2020	Tiffin, Paul/0000-0003-1770-5034; McLachlan, John/0000-0001-5493-2645	UKCAT consortium of Universities	UKCAT consortium of Universities	This study was funded by the UKCAT consortium of Universities via a grant to Durham University. JSD and JCMcL are members of the UKCAT Consortium board and research panel.	Adam J, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-98; [Anonymous], 2011, MULTIPROCESSOR EDITI; *BMA BOARD MED ED, 2004, DEM MED SCH DISC DOC; Cassidy J, 2008, BRIT MED J, V336, P691, DOI 10.1136/bmj.39519.621111.59; COLLIER J, 1986, MED EDUC, V20, P86, DOI 10.1111/j.1365-2923.1986.tb01052.x; Commission for Racial Equality, 1988, MED SCH ADM REP FORM; Dacre Jane, 2008, BMJ, V336, P749, DOI 10.1136/bmj.39505.566701.94; Davidson JM, 1998, BRIT MED J, V317, P1425, DOI 10.1136/bmj.317.7170.1425; FENNEMA K, 1990, J FAM PRACTICE, V30, P441; Ferguson E, 2000, J OCCUP ORGAN PSYCH, V73, P321, DOI 10.1348/096317900167056; Goho J, 2006, MED TEACH, V28, P335, DOI 10.1080/01421590600603418; Hoare A, 2011, STUD HIGH EDUC, V36, P21, DOI 10.1080/03075070903414297; James D, 2008, MED EDUC, V42, P294, DOI 10.1111/j.1365-2923.2008.03006.x; James D, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c478; Komaromy M, 1996, NEW ENGL J MED, V334, P1305, DOI 10.1056/NEJM199605163342006; Lakhan Shaheen Emmanuel, 2003, BMC Med Educ, V3, P6, DOI 10.1186/1472-6920-3-6; Lambert TW, 2003, BRIT MED J, V326, P194, DOI 10.1136/bmj.326.7382.194; Mathers J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d918; Mathers J, 2009, MED EDUC, V43, P219, DOI 10.1111/j.1365-2923.2008.03274.x; McKinstry B, 2008, BRIT MED J, V336, P748, DOI 10.1136/bmj.39505.491065.94; McLachlan JC, 2005, MED EDUC, V39, P872, DOI 10.1111/j.1365-2929.2005.02257.x; McManus IC, 2005, BRIT MED J, V331, P555, DOI 10.1136/bmj.331.7516.555; McManus IC, 1998, BRIT MED J, V317, P1111; MCMANUS IC, 1995, BRIT MED J, V310, P496, DOI 10.1136/bmj.310.6978.496; ONS, 2011, NAT STAT SOC CLASS N; Paley J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d424; Panel for Fair Access to the Professions, 2009, FIN REP PAN FAIR ACC; Papadakis MA, 2005, NEW ENGL J MED, V353, P2673, DOI 10.1056/NEJMsa052596; Pearson VUE, 2008, WORLDS LEADING COMPU; Powis D, 2007, TEACH TEACH EDUC, V23, P1235, DOI 10.1016/j.tate.2007.06.001; Royal College of Physicians, 2009, WOM MED FUT SUMM FIN; Saha S, 1999, ARCH INTERN MED, V159, P997, DOI 10.1001/archinte.159.9.997; Saha S, 2008, JAMA-J AM MED ASSOC, V300, P1135, DOI 10.1001/jama.300.10.1135; Schwartz, 2004, FAIR ADMISSIONS HIGH; Seyan K, 2004, BRIT MED J, V328, P1545, DOI 10.1136/bmj.328.7455.1545; Turner R, 2011, MED EDUC, V45, P298, DOI 10.1111/j.1365-2923.2010.03874.x; UKCAT Consortium, 2009, UK CLIN APT TEST UKC; Verbeke G, 2001, BIOMETRICS, V57, P7, DOI 10.1111/j.0006-341X.2001.00007.x; Whitla DK, 2003, ACAD MED, V78, P460, DOI 10.1097/00001888-200305000-00007; Wright SR, 2010, MED EDUC, V44, P1069, DOI 10.1111/j.1365-2923.2010.03792.x; Yates J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2040	41	52	52	1	34	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2012	344								e1805	10.1136/bmj.e1805	http://dx.doi.org/10.1136/bmj.e1805			27	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	931CN	22511300	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000303192100002
J	Wendler, D				Wendler, David			Consent for Research With Biological Samples: One-Time General Consent Versus a Gift Model	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INFORMED-CONSENT; TRIBE		NIH, Ctr Clin, Dept Bioeth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Wendler, D (corresponding author), NIH, Ctr Clin, Dept Bioeth, Bldg 10,Room 1C118, Bethesda, MD 20892 USA.	dwendler@nih.gov	Taylor, Brent C/A-8069-2009; Rossi, Paolo Giorgi/K-6367-2016	Taylor, Brent C/0000-0002-2140-8377; Rossi, Paolo Giorgi/0000-0001-9703-2460				Caplan AL, 2011, LANCET, V377, P621, DOI 10.1016/S0140-6736(10)60818-5; CLAYTON EW, 1995, JAMA-J AM MED ASSOC, V274, P1786, DOI 10.1001/jama.274.22.1786; Eiseman E., 1999, HDB HUMAN TISSUE SOU; Goldenberg AJ, 2009, J PEDIATR-US, V155, P578, DOI 10.1016/j.jpeds.2009.04.034; Hansson MG, 2006, LANCET ONCOL, V7, P266, DOI 10.1016/S1470-2045(06)70618-0; Harmon A., 2010, NY TIMES        0421; Helgesson Gert, 2005, Med Health Care Philos, V8, P315, DOI 10.1007/s11019-005-0397-6; Hull SC, 2008, AM J BIOETHICS, V8, P62, DOI 10.1080/15265160802478404; Kim SYH, 2009, NEUROLOGY, V72, P149, DOI 10.1212/01.wnl.0000339039.18931.a2; Mello MM, 2010, NEW ENGL J MED, V363, P204, DOI 10.1056/NEJMp1005203; MURRAY TH, 1987, HASTINGS CENT REP, V17, P30, DOI 10.2307/3562041; National Bioethics Advisory Commission, 2000, RES INV HUM BIOL MAT, VII; National Bioethics Advisory Committee, 1999, RES INV HUM BIOL MAT, V1; Nelson RM, 2001, PEDIATRICS, V107, P1451; Persson AH, 2003, BIOBANKS RESOURCES H, P227; Rhodes R, 2011, AM J BIOETHICS, V11, P1, DOI 10.1080/15265161.2011.615588; U.S. Department of Health and Human Services, ADV NOT PROP RUL HUM; Wendler D, 2006, BMJ-BRIT MED J, V332, P544, DOI 10.1136/bmj.332.7540.544	18	8	9	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2012	156	8					596	U122		10.7326/0003-4819-156-8-201204170-00011	http://dx.doi.org/10.7326/0003-4819-156-8-201204170-00011			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930PO	22508735				2022-12-28	WOS:000303151800019
J	Morelli, LG; Uriu, K; Ares, S; Oates, AC				Morelli, Luis G.; Uriu, Koichiro; Ares, Saul; Oates, Andrew C.			Computational Approaches to Developmental Patterning	SCIENCE			English	Review							SEGMENTATION CLOCK; VERTEBRATE SEGMENTATION; BIOLOGY; SOMITOGENESIS; DYNAMICS; SYNCHRONIZATION; MORPHOGENESIS; OSCILLATIONS; MATHEMATICS; DROSOPHILA	Computational approaches are breaking new ground in understanding how embryos form. Here, we discuss recent studies that couple precise measurements in the embryo with appropriately matched modeling and computational methods to investigate classic embryonic patterning strategies. We include signaling gradients, activator-inhibitor systems, and coupled oscillators, as well as emerging paradigms such as tissue deformation. Parallel progress in theory and experiment will play an increasingly central role in deciphering developmental patterning.	[Morelli, Luis G.; Uriu, Koichiro; Oates, Andrew C.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Morelli, Luis G.; Ares, Saul] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Morelli, Luis G.] Univ Buenos Aires, Dept Fis, Consejo Nacl Invest Cient & Tecn, RA-1428 Buenos Aires, DF, Argentina; [Uriu, Koichiro] RIKEN Adv Sci Inst, Theoret Biol Lab, Wako, Saitama 3510198, Japan; [Ares, Saul] CSIC, Ctr Nacl Biotecnol, Log Genom Syst Lab, E-28049 Madrid, Spain; [Ares, Saul] GISC, Madrid, Spain	Max Planck Society; Max Planck Society; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; RIKEN; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Oates, AC (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	oates@mpi-cbg.de	Ares, Saúl/B-4082-2008; Uriu, Koichiro/L-3596-2015; Morelli, Luis G/A-6345-2009	Ares, Saúl/0000-0001-6214-4083; Morelli, Luis G/0000-0001-5614-073X; Uriu, Koichiro/0000-0003-1802-2470	Max Planck Society; European Research Council (ERC) under the European Communities [207634]; Japan Society for the Promotion of Science; CSIC [JAEDOC014]; European Social Fund; Ministerio de Ciencia e Innovacion (Spain) through MOSAICO	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Council (ERC) under the European Communities(European Research Council (ERC)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CSIC; European Social Fund(European Social Fund (ESF)); Ministerio de Ciencia e Innovacion (Spain) through MOSAICO	We thank F. Julicher, C.-P. Heisenberg, S. Grill, P. R. ten Wolde, T. Bollenbach, P. Formosa-Jordan, and members of the Oates and Julicher groups for discussion and critical comments. This work was supported by the Max Planck Society and the European Research Council (ERC) under the European Communities Seventh Framework Programme (FP7/2007-2013)/ERC grant 207634. K. U. is supported by the Japan Society for the Promotion of Science for Young Scientists. S. A. acknowledges funding from CSIC through the "Junta para la Ampliacion de Estudios" program (JAEDOC014, 2010 call) co-funded by the European Social Fund, and from Ministerio de Ciencia e Innovacion (Spain) through MOSAICO.	Aigouy B, 2010, CELL, V142, P773, DOI 10.1016/j.cell.2010.07.042; AKAM M, 1989, NATURE, V341, P282, DOI 10.1038/341282a0; Bois JS, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028103; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Economou AD, 2012, NAT GENET, V44, P348, DOI 10.1038/ng.1090; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Giudicelli F, 2007, PLOS BIOL, V5, P1309, DOI 10.1371/journal.pbio.0050150; Gorfinkiel N, 2011, GENESIS, V49, P522, DOI 10.1002/dvg.20704; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Herrgen L, 2010, CURR BIOL, V20, P1244, DOI 10.1016/j.cub.2010.06.034; Howard J, 2011, NAT REV MOL CELL BIO, V12, P392, DOI 10.1038/nrm3120; Inaba M, 2012, SCIENCE, V335, P677, DOI 10.1126/science.1212821; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Joanny JF, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/422; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Lewis J, 2008, SCIENCE, V322, P399, DOI 10.1126/science.1166154; Little SC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000596; Ma D, 2008, P NATL ACAD SCI USA, V105, P18800, DOI 10.1073/pnas.0808868105; Manu, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000303; Manu, 2009, PLOS BIOL, V7, P591, DOI 10.1371/journal.pbio.1000049; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; Meinhardt H., 1982, MODELS BIOL PATTERN; Morelli LG, 2009, HFSP J, V3, P55, DOI 10.2976/1.3027088; Murray J. D., 2001, MATH BIOL, V18; Nakamasu A, 2009, P NATL ACAD SCI USA, V106, P8429, DOI 10.1073/pnas.0808622106; Niwa Y, 2011, GENE DEV, V25, P1115, DOI [10.1101/gad.2035311, 10.1101/gad.2035311.]; Oates AC, 2012, DEVELOPMENT, V139, P625, DOI 10.1242/dev.063735; Oates AC, 2009, NAT REV GENET, V10, P517, DOI 10.1038/nrg2548; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Plikus MV, 2011, SCIENCE, V332, P586, DOI 10.1126/science.1201647; Reeves GT, 2006, DEV CELL, V11, P289, DOI 10.1016/j.devcel.2006.08.006; Riedel-Kruse IH, 2007, SCIENCE, V317, P1911, DOI 10.1126/science.1142538; Roth S, 2011, DEV GENES EVOL, V221, P255, DOI 10.1007/s00427-011-0378-0; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Tkacik G, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/15/153102; Tomlin CJ, 2007, NAT REV GENET, V8, P331, DOI 10.1038/nrg2098; Trier SM, 2011, CURR OPIN GENET DEV, V21, P664, DOI 10.1016/j.gde.2011.08.005; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Uriu K, 2010, P NATL ACAD SCI USA, V107, P4979, DOI 10.1073/pnas.0907122107; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0	41	61	62	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2012	336	6078					187	191		10.1126/science.1215478	http://dx.doi.org/10.1126/science.1215478			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924PN	22499940				2022-12-28	WOS:000302703900040
J	Morin, A; Urban, J; Adams, PD; Foster, I; Sali, A; Baker, D; Sliz, P				Morin, A.; Urban, J.; Adams, P. D.; Foster, I.; Sali, A.; Baker, D.; Sliz, P.			Shining Light into Black Boxes	SCIENCE			English	Editorial Material							REPRODUCIBLE RESEARCH		[Morin, A.; Sliz, P.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Urban, J.] Univ Calif Berkeley, Sch Law, Berkeley, CA 94720 USA; [Adams, P. D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Foster, I.] Argonne Natl Lab, Argonne, IL 60439 USA; [Foster, I.] Univ Chicago, Argonne, IL 60439 USA; [Sali, A.] Univ Calif San Francisco, San Francisco, CA 94158 USA; [Baker, D.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	Harvard University; Harvard Medical School; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Sliz, P (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	piotr_sliz@hms.harvard.edu	Foster, Ian/GNH-1877-2022; Adams, Paul David/A-1977-2013	Foster, Ian/0000-0003-2129-5269; Adams, Paul David/0000-0001-9333-8219; Sliz, Piotr/0000-0002-6522-0835	NIGMS NIH HHS [P01 GM063210] Funding Source: Medline; NLM NIH HHS [R01 LM010132] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [R01LM010132] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		[Anonymous], 2006, OFFICIAL J L, V391, p0001i; [Anonymous], 2008, PLOS COMPUT BIOL; Barnes N, 2010, NATURE, V467, P753, DOI 10.1038/467753a; Baxter SM, 2006, PLOS COMPUT BIOL, V2, P975, DOI 10.1371/journal.pcbi.0020087; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Birney E., 2009, NATURE, V461, P168, DOI DOI 10.1038/461168A; Cech TR, 2003, PLANT PHYSIOL, V132, P19, DOI 10.1104/pp.900068; Edwards A, 2008, NAT STRUCT MOL BIOL, V15, P116, DOI 10.1038/nsmb0208-116; Greenstein D., 2007, OPEN SOURCE COLLABOR; Hanson B, 2011, SCIENCE, V331, P649, DOI 10.1126/science.1203354; Hecker F, 1999, IEEE SOFTWARE, V16, P45, DOI 10.1109/52.744568; HermundstadAM BassettDS, 2013, P NATL ACAD SCI US, V110, P6169, DOI 10.1073/pnas.1219562110; Ince DC, 2012, NATURE, V482, P485, DOI 10.1038/nature10836; Ioannidis JPA, 2011, SCIENCE, V334, P1230, DOI 10.1126/science.1211811; Mesirov JP, 2010, SCIENCE, V327, P415, DOI 10.1126/science.1179653; National Institutes of Health, 1999, FED REG, V64, P72090; Peng RD, 2011, SCIENCE, V334, P1226, DOI 10.1126/science.1213847; Piwowar HA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000308; Ritzel M. W., 2001, J BIOL CHEM, V276, P2914; Sampat BN, 2010, NATURE, V468, P755, DOI 10.1038/468755a; Stodden V., 2010, 477310 MIT SLOAN SCH; Stodden V, 2009, COMPUT SCI ENG, V11, P35, DOI 10.1109/MCSE.2009.19; Thomson Reuters, 2012, 2010 J CIT REP; Tuma R. S., 2011, ONCOLOGY TIMES  0107; Weitz D., 1993, HIGH TECH L J; Wilson GV, 2006, AM SCI, V94, P5, DOI 10.1511/2006.57.3473	26	109	111	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2012	336	6078					159	160		10.1126/science.1218263	http://dx.doi.org/10.1126/science.1218263			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924PN	22499926	Green Accepted			2022-12-28	WOS:000302703900027
J	Baker, M				Baker, Monya			THE INTERACTION MAP	NATURE			English	Editorial Material							PROTEIN-PROTEIN INTERACTIONS											Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Lievens S, 2009, J PROTEOME RES, V8, P877, DOI 10.1021/pr8005167; Suter B., 2012, 2 HYBRID TECHNOLOGIE; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106	12	17	19	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					271	275		10.1038/484271a	http://dx.doi.org/10.1038/484271a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22498631	Bronze			2022-12-28	WOS:000303149900041
J	Ransohoff, RM				Ransohoff, Richard M.			Perspective: Let the sunshine in!	NATURE			English	Editorial Material																			0	0	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					S8	S8		10.1038/nature11106	http://dx.doi.org/10.1038/nature11106			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22509509	Bronze			2022-12-28	WOS:000303149900050
J	Ritter, S; Nolleke, C; Hahn, C; Reiserer, A; Neuzner, A; Uphoff, M; Mucke, M; Figueroa, E; Bochmann, J; Rempe, G				Ritter, Stephan; Noelleke, Christian; Hahn, Carolin; Reiserer, Andreas; Neuzner, Andreas; Uphoff, Manuel; Muecke, Martin; Figueroa, Eden; Bochmann, Joerg; Rempe, Gerhard			An elementary quantum network of single atoms in optical cavities	NATURE			English	Article							ENTANGLEMENT DISTRIBUTION; LINEAR OPTICS; ENSEMBLES; MEMORY; COMMUNICATION; TRANSITIONS; INFORMATION; REPEATERS; INTERFACE; DISTANCE	Quantum networks are distributed quantum many-body systems with tailored topology and controlled information exchange. They are the backbone of distributed quantum computing architectures and quantum communication. Here we present a prototype of such a quantum network based on single atoms embedded in optical cavities. We show that atom-cavity systems form universal nodes capable of sending, receiving, storing and releasing photonic quantum information. Quantum connectivity between nodes is achieved in the conceptually most fundamental way-by the coherent exchange of a single photon. We demonstrate the faithful transfer of an atomic quantum state and the creation of entanglement between two identical nodes in separate laboratories. The non-local state that is created is manipulated by local quantum bit (qubit) rotation. This efficient cavity-based approach to quantum networking is particularly promising because it offers a clear perspective for scalability, thus paving the way towards large-scale quantum networks and their applications.	[Ritter, Stephan; Noelleke, Christian; Hahn, Carolin; Reiserer, Andreas; Neuzner, Andreas; Uphoff, Manuel; Muecke, Martin; Figueroa, Eden; Bochmann, Joerg; Rempe, Gerhard] Max Planck Inst Quantum Opt, D-85748 Garching, Germany	Max Planck Society	Ritter, S (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	stephan.ritter@mpq.mpg.de	Reiserer, Andreas/G-4980-2017; Reiserer, Andreas/J-3243-2014; Ritter, Stephan/F-1579-2010	Reiserer, Andreas/0000-0001-9595-7363; Reiserer, Andreas/0000-0001-9595-7363; Ritter, Stephan/0000-0001-9002-7407	Deutsche Forschungsgemeinschaft (Research Unit 635); European Union; Bundesministerium fur Bildung und Forschung via IKT (QK_QuOReP); Alexander von Humboldt Foundation	Deutsche Forschungsgemeinschaft (Research Unit 635)(German Research Foundation (DFG)); European Union(European Commission); Bundesministerium fur Bildung und Forschung via IKT (QK_QuOReP)(Federal Ministry of Education & Research (BMBF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We thank D. Moehring for contributions during the early stage of the experiments, and B. Mayer and M. Padilla from the Walter Schottky Institut for gold coating of the fast-moving mirror. This work was supported by the Deutsche Forschungsgemeinschaft (Research Unit 635), by the European Union (Collaborative Project AQUTE) and by the Bundesministerium fur Bildung und Forschung via IKT 2020 (QK_QuOReP). E.F. acknowledges support from the Alexander von Humboldt Foundation.	Acin A, 2007, NAT PHYS, V3, P256, DOI 10.1038/nphys549; Bochmann J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.203601; Boozer AD, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.193601; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Choi KS, 2010, NATURE, V468, P412, DOI 10.1038/nature09568; Chou CW, 2007, SCIENCE, V316, P1316, DOI 10.1126/science.1140300; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; Duan LM, 2010, REV MOD PHYS, V82, P1209, DOI 10.1103/RevModPhys.82.1209; Duan LM, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.032333; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Eisaman MD, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3610677; Greentree AD, 2006, NAT PHYS, V2, P856, DOI 10.1038/nphys466; Hammerer K, 2010, REV MOD PHYS, V82, P1041, DOI 10.1103/RevModPhys.82.1041; Hartmann MJ, 2006, NAT PHYS, V2, P849, DOI 10.1038/nphys462; Isenhower L, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.010503; Jaksch D, 2000, PHYS REV LETT, V85, P2208, DOI 10.1103/PhysRevLett.85.2208; Jungnitsch B, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.190502; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Kuhn A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.067901; Lettner M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.210503; Lloyd S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.167903; Lounis B, 2005, REP PROG PHYS, V68, P1129, DOI 10.1088/0034-4885/68/5/R04; Lvovsky AI, 2009, NAT PHOTONICS, V3, P706, DOI 10.1038/nphoton.2009.231; MASSAR S, 1995, PHYS REV LETT, V74, P1259, DOI 10.1103/PhysRevLett.74.1259; Moehring DL, 2007, NATURE, V449, P68, DOI 10.1038/nature06118; Mucke M, 2010, NATURE, V465, P755, DOI 10.1038/nature09093; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Nussmann S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.173602; Olmschenk S, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.052314; Sangouard N, 2011, REV MOD PHYS, V83, P33, DOI 10.1103/RevModPhys.83.33; Specht HP, 2011, NATURE, V473, P190, DOI 10.1038/nature09997; Timoney N, 2011, NATURE, V476, P185, DOI 10.1038/nature10319; Torma P, 1998, PHYS REV LETT, V81, P2185, DOI 10.1103/PhysRevLett.81.2185; van Enk SJ, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.052318; Volz J, 2011, NATURE, V475, P210, DOI 10.1038/nature10225; Wilk T, 2007, SCIENCE, V317, P488, DOI 10.1126/science.1143835; Yuan ZS, 2008, NATURE, V454, P1098, DOI 10.1038/nature07241	38	578	584	8	180	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					195	U73		10.1038/nature11023	http://dx.doi.org/10.1038/nature11023			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22498625	Green Submitted			2022-12-28	WOS:000303149900026
J	Van Driessche, AES; Benning, LG; Rodriguez-Blanco, JD; Ossorio, M; Bots, P; Garcia-Ruiz, JM				Van Driessche, A. E. S.; Benning, L. G.; Rodriguez-Blanco, J. D.; Ossorio, M.; Bots, P.; Garcia-Ruiz, J. M.			The Role and Implications of Bassanite as a Stable Precursor Phase to Gypsum Precipitation	SCIENCE			English	Article							STABILITY; CLUSTERS; PATHWAY; CASO4	Calcium sulfate minerals such as gypsum play important roles in natural and industrial processes, but their precipitation mechanisms remain largely unexplored. We used time-resolved sample quenching and high-resolution microscopy to demonstrate that gypsum forms via a three-stage process: (i) homogeneous precipitation of nanocrystalline hemihydrate bassanite below its predicted solubility, (ii) self-assembly of bassanite into elongated aggregates co-oriented along their c axis, and (iii) transformation into dihydrate gypsum. These findings indicate that a stable nanocrystalline precursor phase can form below its bulk solubility and that in the CaSO4 system, the self-assembly of nanoparticles plays a crucial role. Understanding why bassanite forms prior to gypsum can lead to more efficient anti-scaling strategies for water desalination and may help to explain the persistence of CaSO4 phases in regions of low water activity on Mars.	[Benning, L. G.; Rodriguez-Blanco, J. D.; Ossorio, M.; Bots, P.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Van Driessche, A. E. S.; Ossorio, M.; Garcia-Ruiz, J. M.] Univ Granada, Lab Estudios Cristalog, Inst Andaluz Ciencias Tierra, Consejo Super Invest Cientif, Granada 18100, Spain	University of Leeds; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT); University of Granada	Benning, LG (corresponding author), Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England.	l.g.benning@leeds.ac.uk; jmgruiz@ugr.es	Benning, Liane G/E-7071-2011; García-Ruiz, Juan Manuel/U-1085-2019; Bots, Pieter/E-4317-2012; Rodriguez-Blanco, Juan Diego/D-5197-2013; Garcia-Ruiz, Juan Manuel/C-4389-2015; Van Driessche, Alexander/AAF-9905-2019; Rodriguez-Blanco, Juan Diego/AAW-7242-2021	Benning, Liane G/0000-0001-9972-5578; García-Ruiz, Juan Manuel/0000-0002-4743-8718; Rodriguez-Blanco, Juan Diego/0000-0001-5978-3001; Garcia-Ruiz, Juan Manuel/0000-0002-4743-8718; Rodriguez-Blanco, Juan Diego/0000-0001-5978-3001; Bots, Pieter/0000-0001-6863-0648; Van Driessche, Alexander E.S./0000-0003-2528-3425	Marie Curie EU-FP6 Mineral Nucleation and Growth Kinetics (MIN-GRO) Research and Training Network [MRTNCT-2006-035488]; School of Earth and Environment at the University of Leeds; Ministerio de Ciencia e Innovacion (MICINN) [CGL2010-16882]	Marie Curie EU-FP6 Mineral Nucleation and Growth Kinetics (MIN-GRO) Research and Training Network; School of Earth and Environment at the University of Leeds; Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Supported by the Marie Curie EU-FP6 Mineral Nucleation and Growth Kinetics (MIN-GRO) Research and Training Network (contract MRTNCT-2006-035488), the School of Earth and Environment at the University of Leeds, the Consolider-Ingenio 2010 project "Factoria Espanola de Cristalizacion," and project CGL2010-16882 of the Ministerio de Ciencia e Innovacion (MICINN). We thank M. Ward, A. Brown, and S. Allshorn for help with sample preparation and characterization and three anonymous reviewers for their helpful comments.	BALL MC, 1978, J CHEM SOC FARAD T 1, V74, P1477, DOI 10.1039/f19787401477; Ben Ahmed S, 2004, DESALINATION, V167, P311, DOI 10.1016/j.desal.2004.06.140; BRECEVIC L, 1989, J CRYST GROWTH, V98, P504, DOI 10.1016/0022-0248(89)90168-1; BUICK R, 1990, SEDIMENTOLOGY, V37, P247, DOI 10.1111/j.1365-3091.1990.tb00958.x; Dey A, 2010, NAT MATER, V9, P1010, DOI [10.1038/nmat2900, 10.1038/NMAT2900]; Freyer D, 2003, MONATSH CHEM, V134, P693, DOI 10.1007/s00706-003-0590-3; Garcia-Ruiz JM, 2007, GEOLOGY, V35, P327, DOI 10.1130/G23393A.1; Gower LB, 2008, CHEM REV, V108, P4551, DOI 10.1021/cr800443h; Langevin Y, 2005, SCIENCE, V307, P1584, DOI 10.1126/science.1109091; Lin Z, 2006, J AM CHEM SOC, V128, P6126, DOI 10.1021/ja057121p; McHale JM, 1997, SCIENCE, V277, P788, DOI 10.1126/science.277.5327.788; Mi BX, 2010, ENVIRON SCI TECHNOL, V44, P2022, DOI 10.1021/es903623r; Navrotsky A, 2004, P NATL ACAD SCI USA, V101, P12096, DOI 10.1073/pnas.0404778101; NAVROTSKY A, 1994, REV MINERAL, V29, P309; Ranade MR, 2002, P NATL ACAD SCI USA, V99, P6476, DOI 10.1073/pnas.251534898; Rodriguez-Blanco JD, 2011, NANOSCALE, V3, P265, DOI 10.1039/c0nr00589d; Singh NB, 2007, PROG CRYST GROWTH CH, V53, P57, DOI 10.1016/j.pcrysgrow.2007.01.002; Tobler DJ, 2009, GEOCHIM COSMOCHIM AC, V73, P5377, DOI 10.1016/j.gca.2009.06.002; Van Driessche AES, 2011, P NATL ACAD SCI USA, V108, P15721, DOI 10.1073/pnas.1105233108; Wagman D. D., 1982, J PHYS CHEM REF D S2, V11; Wang YW, 2012, CHEM COMMUN, V48, P504, DOI 10.1039/c1cc14210k; Warren JK., 2006, EVAPORITES SEDIMENTS, DOI [10.1007/3-540-32344-9, DOI 10.1007/3-540-32344-9]; WINKLER B, 1994, PHYS CHEM MINER, V21, P539; Wray JJ, 2010, ICARUS, V209, P416, DOI 10.1016/j.icarus.2010.06.001; Zhang HZ, 2009, PHYS CHEM CHEM PHYS, V11, P2553, DOI 10.1039/b819623k	25	239	241	11	245	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2012	336	6077					69	72		10.1126/science.1215648	http://dx.doi.org/10.1126/science.1215648			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920LG	22491851				2022-12-28	WOS:000302405400052
J	Kirz, J; Miao, JW				Kirz, Janos; Miao, Jianwei			David Sayre (1924-2012) OBITUARY	NATURE			English	Biographical-Item									[Kirz, Janos] SUNY Stony Brook, New York, NY USA; [Kirz, Janos] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Miao, Jianwei] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Miao, Jianwei] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Kirz, J (corresponding author), SUNY Stony Brook, New York, NY USA.		Kirz, Janos/AHE-9085-2022					SAYRE D, PUBLICATION LIST	1	4	4	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2012	484	7392					38	38		10.1038/484038a	http://dx.doi.org/10.1038/484038a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	919QN	22481349	Bronze			2022-12-28	WOS:000302343400023
J	Shakun, JD; Clark, PU; He, F; Marcott, SA; Mix, AC; Liu, ZY; Otto-Bliesner, B; Schmittner, A; Bard, E				Shakun, Jeremy D.; Clark, Peter U.; He, Feng; Marcott, Shaun A.; Mix, Alan C.; Liu, Zhengyu; Otto-Bliesner, Bette; Schmittner, Andreas; Bard, Edouard			Global warming preceded by increasing carbon dioxide concentrations during the last deglaciation	NATURE			English	Article							ICE CORE RECORDS; ATMOSPHERIC CO2; CLIMATE SENSITIVITY; GLACIAL MAXIMUM; ATLANTIC; OCEAN; TEMPERATURE; CALIBRATION; GREENLAND; RISE	The covariation of carbon dioxide (CO2) concentration and temperature in Antarctic ice-core records suggests a close link between CO2 and climate during the Pleistocene ice ages. The role and relative importance of CO2 in producing these climate changes remains unclear, however, in part because the ice-core deuterium record reflects local rather than global temperature. Here we construct a record of global surface temperature from 80 proxy records and show that temperature is correlated with and generally lags CO2 during the last (that is, the most recent) deglaciation. Differences between the respective temperature changes of the Northern Hemisphere and Southern Hemisphere parallel variations in the strength of the Atlantic meridional overturning circulation recorded in marine sediments. These observations, together with transient global climate model simulations, support the conclusion that an antiphased hemispheric temperature response to ocean circulation changes superimposed on globally in-phase warming driven by increasing CO2 concentrations is an explanation for much of the temperature change at the end of the most recent ice age.	[Shakun, Jeremy D.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Shakun, Jeremy D.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Clark, Peter U.; Marcott, Shaun A.; Mix, Alan C.; Schmittner, Andreas] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [He, Feng; Liu, Zhengyu] Univ Wisconsin, Ctr Climat Res, Madison, WI 53706 USA; [Liu, Zhengyu] Univ Wisconsin, Dept Atmospher & Ocean Sci, Madison, WI 53706 USA; [Liu, Zhengyu] Peking Univ, Lab Ocean Atmosphere Studies, Beijing 100871, Peoples R China; [Otto-Bliesner, Bette] Natl Ctr Atmospher Res, Climate & Global Dynam Div, Boulder, CO 80307 USA; [Bard, Edouard] Univ Aix Marseille, CNRS, Coll France, CEREGE, F-13545 Aix En Provence, France	Harvard University; Columbia University; Oregon State University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Peking University; National Center Atmospheric Research (NCAR) - USA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; PSL Research University Paris; College de France	Shakun, JD (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	shakun@fas.harvard.edu	Marcott, Shaun A/L-7098-2015; Schmittner, Andreas/O-9647-2015; Otto-Bliesner, Bette/AAY-7691-2020; Bard, Edouard/G-7717-2014; He, Feng/B-3583-2008	Marcott, Shaun A/0000-0003-3264-0523; Schmittner, Andreas/0000-0002-8376-0843; He, Feng/0000-0002-3355-6406	Office of Science of the Department of Energy [DE-AC05-00OR22725]; NSF [AGS-0602395]; NOAA	Office of Science of the Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	Discussions with numerous people, including E. J. Brook, A. E. Carlson, N. G. Pisias and J. Shaman, contributed to this research. We acknowledge the palaeoclimate community for generating the proxy data sets used here. In particular, we thank S. Barker, T. Barrows, E. Calvo, J. Kaiser, A. Koutavas, Y. Kubota, V. Peck, C. Pelejero, J.-R. Petit, J. Sachs, E. Schefuss, J. Tierney and G. Wei for providing proxy data, and R. Gyllencreutz and J. Mangerud for providing unpublished results of the DATED Project on the retreat history of the Eurasian ice sheets. The NOAA NGDC and PANGAEA databases were also essential to this work. This research used resources of the Oak Ridge Leadership Computing Facility, located in the National Center for Computational Sciences at Oak Ridge National Laboratory, which is supported by the Office of Science of the Department of Energy under contract no. DE-AC05-00OR22725. NCAR is sponsored by the NSF. J.D.S. is supported by a NOAA Climate and Global Change Postdoctoral Fellowship. This research was supported by the NSF Paleoclimate Program for the Paleovar Project through grant AGS-0602395.	Alley RB, 1999, ANNU REV EARTH PL SC, V27, P149, DOI 10.1146/annurev.earth.27.1.149; Alley RB, 2002, QUATERNARY SCI REV, V21, P431, DOI 10.1016/S0277-3791(01)00072-5; Anand P, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000846; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Barker S, 2009, NATURE, V457, P1097, DOI 10.1038/nature07770; Blunier T, 2007, CLIM PAST, V3, P325, DOI 10.5194/cp-3-325-2007; Broccoli AJ, 2000, J CLIMATE, V13, P951, DOI 10.1175/1520-0442(2000)013<0951:TCATLG>2.0.CO;2; Chiang JCH, 2005, CLIM DYNAM, V25, P477, DOI 10.1007/s00382-005-0040-5; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Clark PU, 2004, SCIENCE, V304, P1141, DOI 10.1126/science.1094449; CLARK PU, 2012, P NATL ACAD SCI USA; Crowley TJ, 1992, PALEOCEANOGRAPHY, V7, P489, DOI 10.1029/92PA01058; Cuffey KM, 1997, J GEOPHYS RES-OCEANS, V102, P26383, DOI 10.1029/96JC03981; DELMAS RJ, 1980, NATURE, V284, P155, DOI 10.1038/284155a0; Dyke AS, 2004, DEV QUA SCI, V2, P373, DOI 10.1016/S1571-0866(04)80209-4; Fischer H, 1999, SCIENCE, V283, P1712, DOI 10.1126/science.283.5408.1712; HANSEN J, 1985, SCIENCE, V229, P857, DOI 10.1126/science.229.4716.857; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Huybers P, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2002PA000857; Huybers P, 2008, NAT GEOSCI, V1, P787, DOI 10.1038/ngeo311; IMBRIE J, 1993, PALEOCEANOGRAPHY, V8, P699, DOI 10.1029/93PA02751; Jansen E, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P433; Jouzel J, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002677; Kim JH, 2008, GEOCHIM COSMOCHIM AC, V72, P1154, DOI 10.1016/j.gca.2007.12.010; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lemieux-Dudon B, 2010, QUATERNARY SCI REV, V29, P8, DOI 10.1016/j.quascirev.2009.11.010; Liu Z, 2009, SCIENCE, V325, P310, DOI 10.1126/science.1171041; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; MANABE S, 1985, J GEOPHYS RES-ATMOS, V90, P2167, DOI 10.1029/JD090iD01p02167; Marchitto TM, 2007, SCIENCE, V316, P1456, DOI 10.1126/science.1138679; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Mix AC, 1986, PALEOCEANOGRAPHY, V1, P43, DOI 10.1029/PA001i001p00043; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Muller PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1757, DOI 10.1016/S0016-7037(98)00097-0; NEFTEL A, 1982, NATURE, V295, P220, DOI 10.1038/295220a0; Rasmussen SO, 2008, QUATERNARY SCI REV, V27, P18, DOI 10.1016/j.quascirev.2007.01.016; Schmittner A, 2003, QUATERNARY SCI REV, V22, P659, DOI 10.1016/S0277-3791(02)00184-1; Schmittner A, 2008, NATURE, V456, P373, DOI 10.1038/nature07531; Schmittner A, 2011, SCIENCE, V334, P1385, DOI 10.1126/science.1203513; Schneider T, 2001, J CLIMATE, V14, P853, DOI 10.1175/1520-0442(2001)014<0853:AOICDE>2.0.CO;2; Schneider von Deimling T, 2006, CLIM DYNAM, V27, P149, DOI 10.1007/s00382-006-0126-8; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; SKINNER LC, 2010, NATURE, V3281, P1147; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; Stocker TF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000920; Stott L, 2007, SCIENCE, V318, P435, DOI 10.1126/science.1143791; Svensson A, 2008, CLIM PAST, V4, P47, DOI 10.5194/cp-4-47-2008; Toggweiler JR, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001758; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154; van Ommen T.D., 2011, CLIMATE DISCUSSIONS, V7, P397, DOI DOI 10.5194/CPD-7-397-2011; Viau AE, 2008, CAN J EARTH SCI, V45, P1435, DOI 10.1139/E08-036; VONSTORCH H, 1999, STAT ANAL CLIMATE RE, P115; Weaver AJ, 1998, NATURE, V394, P847, DOI 10.1038/29695; Yokoyama Y, 2000, NATURE, V406, P713, DOI 10.1038/35021035	54	815	843	46	792	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2012	484	7392					49	54		10.1038/nature10915	http://dx.doi.org/10.1038/nature10915			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	919QN	22481357	Green Published			2022-12-28	WOS:000302343400032
J	van der Sar, T; Wang, ZH; Blok, MS; Bernien, H; Taminiau, TH; Toyli, DM; Lidar, DA; Awschalom, DD; Hanson, R; Dobrovitski, VV				van der Sar, T.; Wang, Z. H.; Blok, M. S.; Bernien, H.; Taminiau, T. H.; Toyli, D. M.; Lidar, D. A.; Awschalom, D. D.; Hanson, R.; Dobrovitski, V. V.			Decoherence-protected quantum gates for a hybrid solid-state spin register	NATURE			English	Article							NUCLEAR-SPIN; COHERENT DYNAMICS; DIAMOND; MEMORY; ELECTRON; BATH	Protecting the dynamics of coupled quantum systems from decoherence by the environment is a key challenge for solid-state quantum information processing(1,2). An idle quantum bit (qubit) can be efficiently insulated from the outside world by dynamical decoupling(3), as has recently been demonstrated for individual solid-state qubits(4-9). However, protecting qubit coherence during a multi-qubit gate is a non-trivial problem(3,10,11): in general, the decoupling disrupts the interqubit dynamics and hence conflicts with gate operation. This problem is particularly salient for hybrid systems(12-22), in which different types of qubit evolve and decohere at very different rates. Here we present the integration of dynamical decoupling into quantum gates for a standard hybrid system, the electron-nuclear spin register. Our design harnesses the internal resonance in the coupled-spin system to resolve the conflict between gate operation and decoupling. We experimentally demonstrate these gates using a two-qubit register in diamond operating at room temperature. Quantum tomography reveals that the qubits involved in the gate operation are protected as accurately as idle qubits. We also perform Grover's quantum search algorithm(1), and achieve fidelities of more than 90% even though the algorithm run-time exceeds the electron spin dephasing time by two orders of magnitude. Our results directly allow decoherence-protected interface gates between different types of solid-state qubit. Ultimately, quantum gates with integrated decoupling may reach the accuracy threshold for fault-tolerant quantum information processing with solid-state devices(1,11).	[Wang, Z. H.; Dobrovitski, V. V.] Ames Lab, Ames, IA 50011 USA; [Wang, Z. H.; Dobrovitski, V. V.] Iowa State Univ, Ames, IA 50011 USA; [van der Sar, T.; Blok, M. S.; Bernien, H.; Taminiau, T. H.; Hanson, R.] Delft Univ Technol, Kavli Inst Nanosci, NL-2600 GA Delft, Netherlands; [Toyli, D. M.; Awschalom, D. D.] Univ Calif Santa Barbara, Ctr Spintron & Quantum Computat, Santa Barbara, CA 93106 USA; [Lidar, D. A.] Univ So Calif, Dept Elect Engn, Los Angeles, CA 90089 USA; [Lidar, D. A.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Lidar, D. A.] Univ So Calif, Dept Phys, Los Angeles, CA 90089 USA; [Lidar, D. A.] Univ So Calif, Ctr Quantum Informat Sci & Technol, Los Angeles, CA 90089 USA	United States Department of Energy (DOE); Ames National Laboratory; Iowa State University; Delft University of Technology; University of California System; University of California Santa Barbara; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Dobrovitski, VV (corresponding author), Ames Lab, Ames, IA 50011 USA.	slava@ameslab.gov	Bernien, Hannes/AAM-5598-2020; Blok, Machiel/J-6707-2012; Lidar, Daniel/A-5871-2008; Hanson, Ronald/B-9555-2008; van der Sar, Toeno/Q-8751-2017; Taminiau, Tim Hugo H/A-8094-2008; Blok, Machiel/GNP-0018-2022; Bernien, Hannes/E-6197-2012	Bernien, Hannes/0000-0002-1950-7368; Lidar, Daniel/0000-0002-1671-1515; van der Sar, Toeno/0000-0002-6197-4808; Taminiau, Tim Hugo H/0000-0002-2355-727X; Blok, Machiel/0000-0001-9736-4158; 	Dutch Organization for Fundamental Research on Matter; Netherlands Organization for Scientific Research; DARPA QuEST; AFOSR; ARO MURI; National Science Foundation [CHM-924318, CHM-1037992, PHY-0969969]; ARO MURI [W911NF-11-1-0268]; US Department of Defense; Department of Energy, Basic Energy Sciences [DE-AC02-07CH11358]; Division Of Chemistry [0924318] Funding Source: National Science Foundation	Dutch Organization for Fundamental Research on Matter; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); DARPA QuEST(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); ARO MURI(MURI); National Science Foundation(National Science Foundation (NSF)); ARO MURI(MURI); US Department of Defense(United States Department of Defense); Department of Energy, Basic Energy Sciences(United States Department of Energy (DOE)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank L. DiCarlo, F. Jelezko, M. D. Lukin and L. M. K. Vandersypen for discussions and comments. T.v.d.S., H.B. and R.H. acknowledge support from the Dutch Organization for Fundamental Research on Matter and the Netherlands Organization for Scientific Research. D.D.A. acknowledges support from DARPA QuEST, AFOSR and ARO MURI, and R.H. acknowledges support from DARPA QuEST. D.A.L. was sponsored by the National Science Foundation under grant numbers CHM-924318, CHM-1037992 and PHY-0969969, ARO MURI grant W911NF-11-1-0268, and by the US Department of Defense. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressly or implied, of the US Government. Work at Ames Laboratory was supported by the Department of Energy, Basic Energy Sciences under contract number DE-AC02-07CH11358.	Arcizet O, 2011, NAT PHYS, V7, P879, DOI [10.1038/nphys2070, 10.1038/NPHYS2070]; Barthel C, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.266808; Bermudez A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.150503; Biercuk MJ, 2009, NATURE, V458, P996, DOI 10.1038/nature07951; Bluhm H, 2011, NAT PHYS, V7, P109, DOI 10.1038/NPHYS1856; Childress L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.070504; Childress L, 2006, SCIENCE, V314, P281, DOI 10.1126/science.1131871; de Lange G, 2010, SCIENCE, V330, P60, DOI 10.1126/science.1192739; DiCarlo L, 2009, NATURE, V460, P240, DOI 10.1038/nature08121; Du JF, 2009, NATURE, V461, P1265, DOI 10.1038/nature08470; Fuchs GD, 2011, NAT PHYS, V7, P789, DOI 10.1038/nphys2026; Hanson R, 2008, SCIENCE, V320, P352, DOI 10.1126/science.1155400; Jiang L, 2009, SCIENCE, V326, P267, DOI 10.1126/science.1176496; Kubo Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.140502; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Morton JJL, 2008, NATURE, V455, P1085, DOI 10.1038/nature07295; Neumann P, 2008, SCIENCE, V320, P1326, DOI 10.1126/science.1157233; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Rabl P, 2010, NAT PHYS, V6, P602, DOI 10.1038/NPHYS1679; Ryan CA, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.200402; Sagi Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.053201; Smeltzer B, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.050302; Steiner M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.035205; Viola L, 1999, PHYS REV LETT, V83, P4888, DOI 10.1103/PhysRevLett.83.4888; West JR, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.230503; Yao N. Y., 2010, NATURE COMM IN PRESS; [No title captured]	30	267	268	3	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2012	484	7392					82	86		10.1038/nature10900	http://dx.doi.org/10.1038/nature10900			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	919QN	22481361	Green Submitted			2022-12-28	WOS:000302343400038
J	Loewenstein, G; Volpp, KG; Asch, DA				Loewenstein, George; Volpp, Kevin G.; Asch, David A.			Incentives in Health Different Prescriptions for Physicians and Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Loewenstein, George] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; [Loewenstein, George; Volpp, Kevin G.; Asch, David A.] Univ Penn, Penn CMU Roybal Ctr Behav Econ & Hlth P30, Philadelphia, PA 19104 USA; [Loewenstein, George; Volpp, Kevin G.; Asch, David A.] Univ Penn, Leonard Davis Inst Ctr Hlth Incent & Behav Econ, Philadelphia, PA 19104 USA; [Volpp, Kevin G.; Asch, David A.] Univ Penn, Dept Med, Wharton Sch, Philadelphia, PA 19104 USA; [Volpp, Kevin G.; Asch, David A.] Univ Penn, Dept Hlth Care Management, Wharton Sch, Philadelphia, PA 19104 USA; [Volpp, Kevin G.; Asch, David A.] Ctr Hlth Equity Res & Promot, Philadelphia, PA USA; [Volpp, Kevin G.; Asch, David A.] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA	Carnegie Mellon University; Carnegie Mellon University; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Loewenstein, G (corresponding author), Carnegie Mellon Univ, 5000 Forbes Ave,BP 319D, Pittsburgh, PA 15213 USA.	gl20@andrew.cmu.edu	Loewenstein, George/G-7616-2014	Loewenstein, George/0000-0003-2790-0474; Volpp, Kevin/0000-0003-1423-4599; Asch, David/0000-0002-7970-286X	NATIONAL INSTITUTE ON AGING [P30AG034546] Funding Source: NIH RePORTER; NIA NIH HHS [P30 AG034546] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abaluck J, 2011, AM ECON REV, V101, P1180, DOI 10.1257/aer.101.4.1180; Brook RH, 2010, JAMA-J AM MED ASSOC, V304, P795, DOI 10.1001/jama.2010.1174; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Fendrick AM, 2010, HEALTH AFFAIR, V29, P2017, DOI 10.1377/hlthaff.2010.0878; Gneezy U, 2004, ROUNDTABLE SER BEHAV, P572; Jacobson M, 2006, HEALTH AFFAIR, V25, P437, DOI 10.1377/hlthaff.25.2.437; Newhouse JP, 1993, FREE ALL LESSONS RAN; Schwartz B., 2005, PARADOX CHOICE WHY M; Shafrin J, 2010, HEALTH ECON, V19, P562, DOI 10.1002/hec.1495; Volpp KG, 2011, NEW ENGL J MED, V365, P388, DOI 10.1056/NEJMp1105966	10	23	23	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2012	307	13					1375	1376		10.1001/jama.2012.387	http://dx.doi.org/10.1001/jama.2012.387			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	919AY	22474198	Green Accepted			2022-12-28	WOS:000302294200021
J	Lamming, DW; Ye, L; Katajisto, P; Goncalves, MD; Saitoh, M; Stevens, DM; Davis, JG; Salmon, AB; Richardson, A; Ahima, RS; Guertin, DA; Sabatini, DM; Baur, JA				Lamming, Dudley W.; Ye, Lan; Katajisto, Pekka; Goncalves, Marcus D.; Saitoh, Maki; Stevens, Deanna M.; Davis, James G.; Salmon, Adam B.; Richardson, Arlan; Ahima, Rexford S.; Guertin, David A.; Sabatini, David M.; Baur, Joseph A.			Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity	SCIENCE			English	Article							LIFE-SPAN EXTENSION; CALORIE RESTRICTION; GLUCOSE-METABOLISM; COMPLEX 2; KINASE; TOR; SENSITIVITY; DROSOPHILA; ABLATION; RECEPTOR	Rapamycin, an inhibitor of mechanistic target of rapamycin complex 1 (mTORC1), extends the life spans of yeast, flies, and mice. Calorie restriction, which increases life span and insulin sensitivity, is proposed to function by inhibition of mTORC1, yet paradoxically, chronic administration of rapamycin substantially impairs glucose tolerance and insulin action. We demonstrate that rapamycin disrupted a second mTOR complex, mTORC2, in vivo and that mTORC2 was required for the insulin-mediated suppression of hepatic gluconeogenesis. Further, decreased mTORC1 signaling was sufficient to extend life span independently from changes in glucose homeostasis, as female mice heterozygous for both mTOR and mLST8 exhibited decreased mTORC1 activity and extended life span but had normal glucose tolerance and insulin sensitivity. Thus, mTORC2 disruption is an important mediator of the effects of rapamycin in vivo.	[Lamming, Dudley W.; Katajisto, Pekka; Saitoh, Maki; Stevens, Deanna M.; Guertin, David A.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lamming, Dudley W.; Katajisto, Pekka; Saitoh, Maki; Stevens, Deanna M.; Guertin, David A.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lamming, Dudley W.; Katajisto, Pekka; Saitoh, Maki; Stevens, Deanna M.; Guertin, David A.; Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Lamming, Dudley W.; Katajisto, Pekka; Saitoh, Maki; Stevens, Deanna M.; Guertin, David A.; Sabatini, David M.] Seven Cambridge Ctr, Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Lamming, Dudley W.; Katajisto, Pekka; Saitoh, Maki; Stevens, Deanna M.; Guertin, David A.; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Ye, Lan; Davis, James G.; Baur, Joseph A.] Univ Penn, Perelman Sch Med, Dept Physiol, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Goncalves, Marcus D.; Ahima, Rexford S.] Univ Penn, Perelman Sch Med, Dept Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Salmon, Adam B.; Richardson, Arlan] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78245 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Texas System; University of Texas Health San Antonio	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu; baur@mail.med.upenn.edu	Lamming, Dudley/O-7191-2015; Goncalves, Marcus/L-6073-2019; Ahima, Rexford/W-1394-2019	Lamming, Dudley/0000-0002-0079-4467; Goncalves, Marcus/0000-0002-0784-9248; Baur, Joseph/0000-0001-8262-6549; Katajisto, Pekka/0000-0002-3033-4189; /0000-0002-1446-7256	American Federation for Aging Research (AFAR); Bingham Trust from Penn's Institute on Aging; NIH [CA129105]; AFAR; Starr Foundation; Koch Institute; Ellison Medical Foundation; Damon Runyon Fellowship; Ruth L. Kirschstein National Research Service [1F32AG032833-01A1]; American Heart Association [7600031]; Academy of Finland; Foundations' post-doc pool; NATIONAL CANCER INSTITUTE [R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG032833] Funding Source: NIH RePORTER	American Federation for Aging Research (AFAR); Bingham Trust from Penn's Institute on Aging; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AFAR; Starr Foundation; Koch Institute; Ellison Medical Foundation(Lawrence Ellison Foundation); Damon Runyon Fellowship; Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Academy of Finland(Academy of Finland); Foundations' post-doc pool; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank all the members of the Baur and Sabatini laboratories, especially D. Frederick, A. Hutchins, P. Hsu, H. Keys, N. Kalaany, M. Laplante, M. Pacold, and Y. Sancak for help with protocols, reagents, and advice. We also thank D. Cohen and D. Harrison for valuable advice and consultation, C. Patterson for critical reading of the manuscript, and G. Bell of the Whitehead Institute Bioinformatics and Research Computing group for help with statistical analysis and R. The mtor-, Raptor-, and mlst8-deficient mice were generated in collaboration with Bristol-Meyers Squibb. Rictor conditional knockout mice were the kind gift of M. Magnuson. This project was supported by a research grant from the American Federation for Aging Research (AFAR) and a Bingham Trust Pilot Award from Penn's Institute on Aging to J.A.B.; a grant from NIH (CA129105) and awards from AFAR, the Starr Foundation, the Koch Institute Frontier Research Program, and the Ellison Medical Foundation to D.M.S.; and a Damon Runyon Fellowship to D.A.G. D.W.L. was supported by a Ruth L. Kirschstein National Research Service Award (1F32AG032833-01A1), L.Y. is supported by a postdoctoral fellowship from the American Heart Association (7600031), and P.K. is supported by the Academy of Finland and the Foundations' post-doc pool. Core services were provided by Penn's Diabetes and Endocrinology Research Center (P30DK19525). D.M.S. is an investigator of the Howard Hughes Medical Institute.	Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Cybulski N, 2009, P NATL ACAD SCI USA, V106, P9902, DOI 10.1073/pnas.0811321106; Dominici FP, 2002, J ENDOCRINOL, V173, P81, DOI 10.1677/joe.0.1730081; Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; Johnston O, 2008, J AM SOC NEPHROL, V19, P1411, DOI 10.1681/ASN.2007111202; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kumar A, 2010, DIABETES, V59, P1397, DOI 10.2337/db09-1061; Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; OLSHANSKY SJ, 1985, AM J PUBLIC HEALTH, V75, P754, DOI 10.2105/AJPH.75.7.754; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Teutonico A, 2005, J AM SOC NEPHROL, V16, P3128, DOI 10.1681/ASN.2005050487; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Weindruch R., 1988, RETARDATION AGING DI; Zheng YB, 2009, J ENDOCRINOL, V203, P337, DOI 10.1677/JOE-09-0181	30	812	850	4	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1638	1643		10.1126/science.1215135	http://dx.doi.org/10.1126/science.1215135			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461615	Green Accepted, Green Submitted			2022-12-28	WOS:000302062600049
J	Hughes, V				Hughes, Virginia			Genomics: A complex code	NATURE			English	Editorial Material																			0	8	8	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					S3	S3		10.1038/nature11105	http://dx.doi.org/10.1038/nature11105			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22509504	Bronze			2022-12-28	WOS:000303149900045
